ID   1433B_HUMAN             Reviewed;         246 AA.
AC   P31946; A8K9K2; E1P616;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   18-APR-2012, entry version 141.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein 1054;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=YWHAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Keratinocyte;
RX   MEDLINE=93294871; PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21638749; PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11; 14-57; 63-70; 106-117; 130-169 AND 215-246,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 3-20.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [9]
RP   INTERACTION WITH CRTC2.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [10]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [11]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [12]
RP   INTERACTION WITH YAP1.
RX   PubMed=17974916; DOI=10.1101/gad.1602907;
RA   Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J.,
RA   Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G.,
RA   Lai Z.C., Guan K.L.;
RT   "Inactivation of YAP oncoprotein by the Hippo pathway is involved in
RT   cell contact inhibition and tissue growth control.";
RL   Genes Dev. 21:2747-2761(2007).
RN   [13]
RP   INTERACTION WITH ROR2, FUNCTION, PHOSPHORYLATION, DIMERIZATION, AND
RP   MASS SPECTROMETRY.
RX   PubMed=17717073; DOI=10.1210/me.2007-0323;
RA   Liu Y., Ross J.F., Bodine P.V.N., Billiard J.;
RT   "Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-
RT   3(beta) phosphorylation and promotes osteoblast differentiation and
RT   bone formation.";
RL   Mol. Endocrinol. 21:3050-3061(2007).
RN   [14]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-117, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-239, MASS SPECTROMETRY,
RP   INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
RN   [20]
RP   VARIANT ILE-99.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2.
CC   -!- SUBUNIT: Homodimer. Interacts with SAMSN1 and KRPCE (By
CC       similarity). Interacts with SSH1 and TORC2/CRTC2. Interacts with
CC       ABL1; the interaction results in cytoplasmic location of ABL1 and
CC       inhibition of cABL-mediated apoptosis. Interacts with ROR2
CC       (dimer); the interaction results in phosphorylation of YWHAB on
CC       tyrosine residues. Interacts with GAB2 and YAP1 (phosphorylated
CC       form). Interacts with the phosphorylated (by AKT1) form of SRPK2.
CC       Interacts with PKA-phosphorylated AANAT.
CC   -!- INTERACTION:
CC       Q9P0K1-3:ADAM22; NbExp=2; IntAct=EBI-359815, EBI-1567267;
CC       P30304:CDC25A; NbExp=8; IntAct=EBI-359815, EBI-747671;
CC       O94921:CDK14; NbExp=5; IntAct=EBI-359815, EBI-1043945;
CC       Q13627-2:DYRK1A; NbExp=3; IntAct=EBI-359815, EBI-1053621;
CC       Q11184:let-756 (xeno); NbExp=2; IntAct=EBI-359815, EBI-3843983;
CC       Q99683:MAP3K5; NbExp=3; IntAct=EBI-359815, EBI-476263;
CC       P04049:RAF1; NbExp=10; IntAct=EBI-359815, EBI-365996;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Note=Identified by
CC       mass spectrometry in melanosome fractions from stage I to stage
CC       IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P31946-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P31946-2; Sequence=VSP_018632;
CC         Note=Acetylated on Met-1 (By similarity);
CC   -!- PTM: The alpha, brain-specific form differs from the beta form in
CC       being phosphorylated (By similarity).
CC   -!- PTM: Isoform Short contains a N-acetylmethionine at position 1 (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X57346; CAA40621.1; -; mRNA.
DR   EMBL; AK292717; BAF85406.1; -; mRNA.
DR   EMBL; AL008725; CAA15497.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75893.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75894.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75896.1; -; Genomic_DNA.
DR   EMBL; BC001359; AAH01359.1; -; mRNA.
DR   IPI; IPI00216318; -.
DR   IPI; IPI00759832; -.
DR   PIR; S34755; S34755.
DR   RefSeq; NP_003395.1; NM_003404.3.
DR   RefSeq; NP_647539.1; NM_139323.2.
DR   UniGene; Hs.643544; -.
DR   PDB; 2BQ0; X-ray; 2.50 A; A/B=1-239.
DR   PDB; 2C23; X-ray; 2.65 A; A=1-239.
DR   PDB; 4DNK; X-ray; 2.20 A; A/B=1-246.
DR   PDBsum; 2BQ0; -.
DR   PDBsum; 2C23; -.
DR   PDBsum; 4DNK; -.
DR   ProteinModelPortal; P31946; -.
DR   SMR; P31946; 1-234.
DR   DIP; DIP-743N; -.
DR   IntAct; P31946; 36.
DR   MINT; MINT-99570; -.
DR   STRING; P31946; -.
DR   PhosphoSite; P31946; -.
DR   DMDM; 1345590; -.
DR   Cornea-2DPAGE; P31946; -.
DR   OGP; P31946; -.
DR   REPRODUCTION-2DPAGE; IPI00216318; -.
DR   PRIDE; P31946; -.
DR   DNASU; 7529; -.
DR   Ensembl; ENST00000353703; ENSP00000300161; ENSG00000166913.
DR   Ensembl; ENST00000372839; ENSP00000361930; ENSG00000166913.
DR   GeneID; 7529; -.
DR   KEGG; hsa:7529; -.
DR   UCSC; uc002xmt.3; human.
DR   CTD; 7529; -.
DR   GeneCards; GC20P043515; -.
DR   H-InvDB; HIX0015846; -.
DR   HGNC; HGNC:12849; YWHAB.
DR   HPA; CAB003759; -.
DR   HPA; HPA007925; -.
DR   HPA; HPA011212; -.
DR   MIM; 601289; gene.
DR   neXtProt; NX_P31946; -.
DR   PharmGKB; PA37438; -.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00650000092989; -.
DR   HOGENOM; HBG611720; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P31946; -.
DR   KO; K06630; -.
DR   OMA; MGREYRE; -.
DR   OrthoDB; EOG4N30PR; -.
DR   PhylomeDB; P31946; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; hdac_classii_pathway; Signaling events mediated by HDAC Class II.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_111045; Developmental Biology.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_116125; Disease.
DR   Reactome; REACT_21257; Metabolism of RNA.
DR   Reactome; REACT_578; Apoptosis.
DR   Reactome; REACT_6900; Immune System.
DR   Reactome; REACT_71; Gene Expression.
DR   EvolutionaryTrace; P31946; -.
DR   NextBio; 29453; -.
DR   ArrayExpress; P31946; -.
DR   Bgee; P31946; -.
DR   CleanEx; HS_YWHAB; -.
DR   Genevestigator; P31946; -.
DR   GermOnline; ENSG00000166913; Homo sapiens.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine binding; IPI:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:Reactome.
DR   GO; GO:0008633; P:activation of pro-apoptotic gene products; TAS:Reactome.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IDA:BHF-UCL.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0008629; P:induction of apoptosis by intracellular signals; TAS:Reactome.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0016071; P:mRNA metabolic process; TAS:Reactome.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:Reactome.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367900.
FT   INIT_MET      1      1       Removed; alternate.
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000003.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                beta/alpha; alternate.
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed.
FT   MOD_RES       6      6       Phosphoserine.
FT   MOD_RES      70     70       N6-acetyllysine.
FT   MOD_RES     117    117       N6-acetyllysine.
FT   MOD_RES     186    186       Phosphoserine (By similarity).
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                /FTId=VSP_018632.
FT   VARIANT      99     99       V -> I (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_064762.
FT   HELIX         5     17
FT   HELIX        21     32
FT   HELIX        40     67
FT   HELIX        75    105
FT   HELIX       107    110
FT   HELIX       114    133
FT   HELIX       138    161
FT   HELIX       167    182
FT   HELIX       187    202
FT   HELIX       203    207
FT   TURN        210    212
FT   HELIX       213    231
SQ   SEQUENCE   246 AA;  28082 MW;  6BE1A9BF97468017 CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLIPN ATQPESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   1433E_HUMAN             Reviewed;         255 AA.
AC   P62258; B3KY71; D3DTH5; P29360; P42655; Q4VJB6; Q53XZ5; Q63631;
AC   Q7M4R4;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   18-APR-2012, entry version 99.
DE   RecName: Full=14-3-3 protein epsilon;
DE            Short=14-3-3E;
GN   Name=YWHAE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=95372385; PubMed=7644510; DOI=10.1073/pnas.92.17.7892;
RA   Conklin D.S., Galaktionov K., Beach D.;
RT   "14-3-3 proteins associate with cdc25 phosphatases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7892-7896(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   MEDLINE=97011338; PubMed=8858348;
RA   Chong S.S., Tanigami A., Roschke A.V., Ledbetter D.H.;
RT   "14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on
RT   chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome
RT   region.";
RL   Genome Res. 6:735-741(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=96300316; PubMed=8684458; DOI=10.1038/382308a0;
RA   Jin D.-Y., Lyu M.S., Kozak C.A., Jeang K.-T.;
RT   "Function of 14-3-3 proteins.";
RL   Nature 382:308-308(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SV), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=20417184; DOI=10.1016/j.bbrc.2010.04.104;
RA   Han D., Ye G., Liu T., Chen C., Yang X., Wan B., Pan Y., Yu L.;
RT   "Functional identification of a novel 14-3-3 epsilon splicing variant
RT   suggests dimerization is not necessary for 14-3-3 epsilon to inhibit
RT   UV-induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 396:401-406(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Luk S.C.W., Lee C.Y., Waye M.M.Y.;
RT   "Sequence determination of human epsilon 14-3-3 protein.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tanigami A., Chong S.S., Ledbetter D.H.;
RT   "14-3-3 epsilon genomic sequence.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND SV).
RC   TISSUE=Caudate nucleus, Heart, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 1-19.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-19; 30-50 AND 131-170, ACETYLATION AT MET-1, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [13]
RP   PROTEIN SEQUENCE OF 103-108; 120-123; 131-141 AND 143-153.
RC   TISSUE=Histiocytic lymphoma;
RX   MEDLINE=91224664; PubMed=2026444;
RA   Demeter J., Medzihradszky D., Kha H., Goetzl E.J., Turck C.W.;
RT   "Isolation and partial characterization of the structures of
RT   fibroblast activating factor-related proteins from U937 cells.";
RL   Immunology 72:350-354(1991).
RN   [14]
RP   PROTEIN SEQUENCE OF 131-141 AND 154-190, AND MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [15]
RP   INTERACTION WITH HCV CORE PROTEIN.
RX   MEDLINE=20111292; PubMed=10644344;
RX   DOI=10.1128/JVI.74.4.1736-1741.2000;
RA   Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O.;
RT   "Hepatitis C virus core protein interacts with 14-3-3 protein and
RT   activates the kinase Raf-1.";
RL   J. Virol. 74:1736-1741(2000).
RN   [16]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [17]
RP   INTERACTION WITH CDKN1B, AND SUBCELLULAR LOCATION.
RX   PubMed=12042314; DOI=10.1074/jbc.M203668200;
RA   Fujita N., Sato S., Katayama K., Tsuruo T.;
RT   "Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3
RT   and cytoplasmic localization.";
RL   J. Biol. Chem. 277:28706-28713(2002).
RN   [18]
RP   INTERACTION WITH GRB10.
RX   PubMed=15722337; DOI=10.1074/jbc.M501477200;
RA   Urschel S., Bassermann F., Bai R.Y., Munch S., Peschel C., Duyster J.;
RT   "Phosphorylation of grb10 regulates its interaction with 14-3-3.";
RL   J. Biol. Chem. 280:16987-16993(2005).
RN   [19]
RP   INTERACTION WITH ABL1, AND MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [20]
RP   INTERACTION WITH YWHAZ.
RX   PubMed=16376338; DOI=10.1016/j.febslet.2005.12.024;
RA   Gu Y.-M., Jin Y.-H., Choi J.-K., Baek K.-H., Yeo C.-Y., Lee K.-Y.;
RT   "Protein kinase A phosphorylates and regulates dimerization of 14-3-3
RT   epsilon.";
RL   FEBS Lett. 580:305-310(2006).
RN   [21]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [22]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-38 AND SER-210, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-69; LYS-118 AND
RP   LYS-123, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-233, MASS SPECTROMETRY,
RP   INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC   -!- SUBUNIT: Homodimer. Heterodimerizes with YWHAZ. Interacts with
CC       NDEL1, RGNEF and TIAM2 (By similarity). Interacts with HCV core
CC       protein. Interacts with ABL1 (phosphorylated form); the
CC       interaction retains it in the cytoplasm. Weakly interacts with
CC       CDKN1B. Interacts with GAB2. Interacts with phosphorylated GRB10.
CC       Interacts with PKA-phosphorylated AANAT. Interacts with the
CC       phosphorylated (by AKT1) form of SRPK2.
CC   -!- INTERACTION:
CC       O00257-3:CBX4; NbExp=2; IntAct=EBI-356498, EBI-4392727;
CC       O94921:CDK14; NbExp=3; IntAct=EBI-356498, EBI-1043945;
CC       Q9UKT5:FBXO4; NbExp=5; IntAct=EBI-356498, EBI-960409;
CC       P61981:YWHAG; NbExp=4; IntAct=EBI-356498, EBI-359832;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Melanosome.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P62258-1; Sequence=Displayed;
CC       Name=SV;
CC         IsoId=P62258-2; Sequence=VSP_040621;
CC         Note=Unable to dimerize with YWHAZ;
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U20972; AAC50175.1; -; mRNA.
DR   EMBL; U54778; AAC50710.1; -; mRNA.
DR   EMBL; U43399; AAC50625.1; -; mRNA.
DR   EMBL; U43430; AAD00026.1; -; mRNA.
DR   EMBL; U28936; AAA75301.1; -; mRNA.
DR   EMBL; AB017103; BAA32538.1; -; Genomic_DNA.
DR   EMBL; AY883089; AAX68683.1; -; mRNA.
DR   EMBL; AK128785; BAG54733.1; -; mRNA.
DR   EMBL; AK295260; BAG58249.1; -; mRNA.
DR   EMBL; AK316185; BAH14556.1; -; mRNA.
DR   EMBL; BT007161; AAP35825.1; -; mRNA.
DR   EMBL; CH471108; EAW90628.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90629.1; -; Genomic_DNA.
DR   EMBL; BC000179; AAH00179.1; -; mRNA.
DR   EMBL; BC001440; AAH01440.1; -; mRNA.
DR   IPI; IPI00000816; -.
DR   IPI; IPI00974544; -.
DR   PIR; A61235; A61235.
DR   PIR; I38947; I38947.
DR   RefSeq; NP_006752.1; NM_006761.4.
DR   UniGene; Hs.513851; -.
DR   PDB; 2BR9; X-ray; 1.75 A; A=1-233.
DR   PDB; 3UAL; X-ray; 1.80 A; A=1-232.
DR   PDB; 3UBW; X-ray; 1.90 A; A=1-234.
DR   PDBsum; 2BR9; -.
DR   PDBsum; 3UAL; -.
DR   PDBsum; 3UBW; -.
DR   ProteinModelPortal; P62258; -.
DR   DIP; DIP-36676N; -.
DR   IntAct; P62258; 82.
DR   MINT; MINT-4998623; -.
DR   STRING; P62258; -.
DR   PhosphoSite; P62258; -.
DR   DMDM; 51702210; -.
DR   OGP; P42655; -.
DR   UCD-2DPAGE; P62258; -.
DR   PeptideAtlas; P62258; -.
DR   PRIDE; P62258; -.
DR   DNASU; 7531; -.
DR   Ensembl; ENST00000264335; ENSP00000264335; ENSG00000108953.
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   UCSC; uc002fsj.3; human.
DR   CTD; 7531; -.
DR   GeneCards; GC17M001247; -.
DR   H-InvDB; HIX0013397; -.
DR   H-InvDB; HIX0013751; -.
DR   H-InvDB; HIX0030006; -.
DR   HGNC; HGNC:12851; YWHAE.
DR   HPA; CAB016200; -.
DR   HPA; CAB021109; -.
DR   HPA; CAB047350; -.
DR   HPA; HPA008445; -.
DR   MIM; 605066; gene.
DR   neXtProt; NX_P62258; -.
DR   Orphanet; 217385; 17p13.3 microduplication syndrome.
DR   PharmGKB; PA37440; -.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00650000093317; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P62258; -.
DR   KO; K06630; -.
DR   OMA; KESALIM; -.
DR   OrthoDB; EOG4HHP34; -.
DR   PhylomeDB; P62258; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; lis1pathway; Lissencephaly gene (LIS1) in neuronal migration and development.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Pathway_Interaction_DB; telomerasepathway; Regulation of Telomerase.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; hdac_classii_pathway; Signaling events mediated by HDAC Class II.
DR   Pathway_Interaction_DB; tgfbrpathway; TGF-beta receptor signaling.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_115566; Cell Cycle.
DR   EvolutionaryTrace; P62258; -.
DR   NextBio; 29461; -.
DR   PMAP-CutDB; P62258; -.
DR   ArrayExpress; P62258; -.
DR   Bgee; P62258; -.
DR   CleanEx; HS_YWHAE; -.
DR   Genevestigator; P62258; -.
DR   GermOnline; ENSG00000108953; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine binding; IPI:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0008624; P:induction of apoptosis by extracellular signals; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    255       14-3-3 protein epsilon.
FT                                /FTId=PRO_0000058618.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        130    130       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES      38     38       Phosphothreonine.
FT   MOD_RES      50     50       N6-acetyllysine.
FT   MOD_RES      69     69       N6-acetyllysine.
FT   MOD_RES     118    118       N6-acetyllysine.
FT   MOD_RES     123    123       N6-acetyllysine.
FT   MOD_RES     210    210       Phosphoserine.
FT   VAR_SEQ       1     22       Missing (in isoform SV).
FT                                /FTId=VSP_040621.
FT   CONFLICT    106    107       KH -> NY (in Ref. 13; AA sequence).
FT   CONFLICT    143    143       E -> F (in Ref. 13; AA sequence).
FT   CONFLICT    148    148       S -> T (in Ref. 13; AA sequence).
FT   HELIX         4     17
FT   HELIX        20     31
FT   HELIX        39     73
FT   HELIX        76    106
FT   HELIX       108    111
FT   HELIX       115    135
FT   HELIX       138    162
FT   HELIX       168    183
FT   HELIX       188    204
FT   HELIX       205    208
FT   TURN        211    213
FT   HELIX       214    231
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   1433F_HUMAN             Reviewed;         246 AA.
AC   Q04917;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   18-APR-2012, entry version 136.
DE   RecName: Full=14-3-3 protein eta;
DE   AltName: Full=Protein AS1;
GN   Name=YWHAH; Synonyms=YWHA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=94032477; PubMed=8218406; DOI=10.1016/0167-4781(93)90053-G;
RA   Swanson K.D., Dhar M.S., Joshi J.G.;
RT   "The human and bovine 14-3-3 eta protein mRNAs are highly conserved in
RT   both their translated and untranslated regions.";
RL   Biochim. Biophys. Acta 1216:145-148(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   MEDLINE=92251832; PubMed=1578511; DOI=10.1002/jnr.490310403;
RA   Ichimura-Ohshima Y., Morii K., Ichimura T., Araki K., Takahashi Y.,
RA   Isobe T., Minoshima S., Fukuyama R., Shimizu N., Kuwano R.;
RT   "cDNA cloning and chromosome assignment of the gene for human brain
RT   14-3-3 protein eta chain.";
RL   J. Neurosci. Res. 31:600-605(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Leffers H., Tommerup N., Celis J.E.;
RL   Submitted (MAR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=96123461; PubMed=8561965; DOI=10.1007/BF02740697;
RA   Muratake T., Hayashi S., Ichimura Y., Morii K., Kuwano R.,
RA   Ichikawa T., Kumanishi T., Isobe T., Watanabe M., Kondo H.;
RT   "The effect on methamphetamine on the mRNA level for 14.3.3 eta chain
RT   in the human cultured cells.";
RL   Mol. Neurobiol. 11:223-230(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=96411648; PubMed=8812417; DOI=10.1006/geno.1996.0426;
RA   Muratake T., Hayashi S., Ichikawa T., Kumanishi T., Ichimura Y.,
RA   Kuwano R., Isobe T., Wang Y., Minoshima S., Shimizu N., Takahashi Y.;
RT   "Structural organization and chromosomal assignment of the human 14-3-
RT   3 eta chain gene (YWHAH).";
RL   Genomics 36:63-69(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-225.
RC   TISSUE=Keratinocyte;
RX   MEDLINE=93294871; PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-10.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-10; 29-50; 62-69; 126-132; 144-155; 163-172 AND
RP   218-227, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT GLY-2, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V.;
RL   Submitted (AUG-2005) to UniProtKB.
RN   [12]
RP   INTERACTION WITH AR; ESR1; ESR2; MC2R; NRIP1; NR3C1; PPARBP AND THRA.
RX   MEDLINE=21168078; PubMed=11266503; DOI=10.1210/me.15.4.501;
RA   Zilliacus J., Holter E., Wakui H., Tazawa H., Treuter E.,
RA   Gustafsson J.-A.;
RT   "Regulation of glucocorticoid receptor activity by 14-3-3-dependent
RT   intracellular relocalization of the corepressor RIP140.";
RL   Mol. Endocrinol. 15:501-511(2001).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH PDPK1.
RX   PubMed=12177059; DOI=10.1074/jbc.M205141200;
RA   Sato S., Fujita N., Tsuruo T.;
RT   "Regulation of kinase activity of 3-phosphoinositide-dependent protein
RT   kinase-1 by binding to 14-3-3.";
RL   J. Biol. Chem. 277:39360-39367(2002).
RN   [14]
RP   INTERACTION WITH CDKN1B.
RX   PubMed=14504289; DOI=10.1074/jbc.M306614200;
RA   Fujita N., Sato S., Tsuruo T.;
RT   "Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein
RT   S6 kinases promotes its binding to 14-3-3 and cytoplasmic
RT   localization.";
RL   J. Biol. Chem. 278:49254-49260(2003).
RN   [15]
RP   INTERACTION WITH ABL1, AND MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [16]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS), MASS SPECTROMETRY, INTERACTION
RP   WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC       Negatively regulates the kinase activity of PDPK1.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with many nuclear
CC       hormone receptors and cofactors including AR, ESR1, ESR2, MC2R,
CC       NR3C1, NRIP1, PPARBP and THRA. Interacts with ABL1 (phosphorylated
CC       form); the interaction retains it in the cytoplasm. Interacts with
CC       RGNEF and CDK16 (By similarity). Weakly interacts with CDKN1B.
CC       Interacts with GAB2. Interacts with KCNK18 in a phosphorylation-
CC       dependent manner. Interacts with SAMSN1 (By similarity). Interacts
CC       with the 'Ser-241' phosphorylated form of PDPK1.
CC   -!- INTERACTION:
CC       O94921:CDK14; NbExp=3; IntAct=EBI-306940, EBI-1043945;
CC       O60565:GREM1; NbExp=5; IntAct=EBI-306940, EBI-944395;
CC       Q96L34:MARK4; NbExp=4; IntAct=EBI-306940, EBI-302319;
CC       Q8TEW0:PARD3; NbExp=6; IntAct=EBI-306940, EBI-81968;
CC       Q9NPB6:PARD6A; NbExp=2; IntAct=EBI-306940, EBI-81876;
CC       Q9BYG5:PARD6B; NbExp=2; IntAct=EBI-306940, EBI-295391;
CC       Q9BYG4:PARD6G; NbExp=2; IntAct=EBI-306940, EBI-295417;
CC       P41743:PRKCI; NbExp=3; IntAct=EBI-306940, EBI-286199;
CC       P04049:RAF1; NbExp=2; IntAct=EBI-306940, EBI-365996;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in the brain and present in
CC       other tissues albeit at lower levels.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L20422; AAA35483.1; -; mRNA.
DR   EMBL; X80536; CAA56676.1; -; Genomic_DNA.
DR   EMBL; X78138; CAA55017.1; -; mRNA.
DR   EMBL; X57345; CAA40620.1; -; mRNA.
DR   EMBL; D78577; BAA11418.1; -; Genomic_DNA.
DR   EMBL; S80794; AAB36036.1; -; mRNA.
DR   EMBL; CR456612; CAG30498.1; -; mRNA.
DR   EMBL; Z82248; CAB05112.1; -; Genomic_DNA.
DR   EMBL; BC003047; AAH03047.1; -; mRNA.
DR   IPI; IPI00216319; -.
DR   PIR; S34756; S34756.
DR   PIR; S38509; S38509.
DR   PIR; S38532; S38532.
DR   RefSeq; NP_003396.1; NM_003405.3.
DR   UniGene; Hs.226755; -.
DR   PDB; 2C63; X-ray; 2.15 A; A/B/C/D=1-246.
DR   PDB; 2C74; X-ray; 2.70 A; A/B=1-246.
DR   PDBsum; 2C63; -.
DR   PDBsum; 2C74; -.
DR   ProteinModelPortal; Q04917; -.
DR   SMR; Q04917; 3-235.
DR   DIP; DIP-27566N; -.
DR   IntAct; Q04917; 106.
DR   MINT; MINT-124456; -.
DR   STRING; Q04917; -.
DR   PhosphoSite; Q04917; -.
DR   DMDM; 1345593; -.
DR   PeptideAtlas; Q04917; -.
DR   PRIDE; Q04917; -.
DR   DNASU; 7533; -.
DR   Ensembl; ENST00000248975; ENSP00000248975; ENSG00000128245.
DR   GeneID; 7533; -.
DR   KEGG; hsa:7533; -.
DR   UCSC; uc003alz.3; human.
DR   CTD; 7533; -.
DR   GeneCards; GC22P032340; -.
DR   H-InvDB; HIX0016401; -.
DR   HGNC; HGNC:12853; YWHAH.
DR   HPA; CAB025918; -.
DR   MIM; 113508; gene.
DR   neXtProt; NX_Q04917; -.
DR   PharmGKB; PA37442; -.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00650000092989; -.
DR   HOGENOM; HBG611720; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; Q04917; -.
DR   KO; K06630; -.
DR   OMA; KYLIKNC; -.
DR   OrthoDB; EOG48PMM0; -.
DR   PhylomeDB; Q04917; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   EvolutionaryTrace; Q04917; -.
DR   NextBio; 29471; -.
DR   ArrayExpress; Q04917; -.
DR   Bgee; Q04917; -.
DR   CleanEx; HS_YWHAH; -.
DR   Genevestigator; Q04917; -.
DR   GermOnline; ENSG00000128245; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0035259; F:glucocorticoid receptor binding; IPI:UniProtKB.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; ISS:UniProtKB.
DR   GO; GO:0006713; P:glucocorticoid catabolic process; IDA:UniProtKB.
DR   GO; GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; ISS:UniProtKB.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-dependent; IDA:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    246       14-3-3 protein eta.
FT                                /FTId=PRO_0000058623.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        132    132       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       2      2       N-acetylglycine.
FT   MOD_RES      25     25       Phosphoserine.
FT   MOD_RES     117    117       Phosphotyrosine (By similarity).
FT   CONFLICT    144    144       N -> T (in Ref. 9; CAA40620).
FT   CONFLICT    157    157       A -> G (in Ref. 1; AAA35483).
FT   CONFLICT    237    237       Q -> L (in Ref. 1; AAA35483).
FT   HELIX         4     16
FT   HELIX        20     31
FT   HELIX        39     73
FT   HELIX        76    106
FT   TURN        107    111
FT   HELIX       117    137
FT   HELIX       140    164
FT   HELIX       170    185
FT   HELIX       190    206
FT   HELIX       207    210
FT   TURN        213    215
FT   HELIX       216    234
SQ   SEQUENCE   246 AA;  28219 MW;  D70FBC100C45D6E5 CRC64;
     MGDREQLLQR ARLAEQAERY DDMASAMKAV TELNEPLSNE DRNLLSVAYK NVVGARRSSW
     RVISSIEQKT MADGNEKKLE KVKAYREKIE KELETVCNDV LSLLDKFLIK NCNDFQYESK
     VFYLKMKGDY YRYLAEVASG EKKNSVVEAS EAAYKEAFEI SKEQMQPTHP IRLGLALNFS
     VFYYEIQNAP EQACLLAKQA FDDAIAELDT LNEDSYKDST LIMQLLRDNL TLWTSDQQDE
     EAGEGN
//
ID   1433G_HUMAN             Reviewed;         247 AA.
AC   P61981; O70457; P35214; Q6FH52; Q9UDP2; Q9UN99;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   18-APR-2012, entry version 97.
DE   RecName: Full=14-3-3 protein gamma;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein gamma, N-terminally processed;
GN   Name=YWHAG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION, AND INTERACTION WITH
RP   RAF1.
RC   TISSUE=Vascular smooth muscle;
RX   MEDLINE=99360936; PubMed=10433554; DOI=10.1089/104454999315105;
RA   Autieri M.V., Carbone C.J.;
RT   "14-3-3gamma interacts with and is phosphorylated by multiple protein
RT   kinase C isoforms in PDGF-stimulated human vascular smooth muscle
RT   cells.";
RL   DNA Cell Biol. 18:555-564(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   MEDLINE=99417686; PubMed=10486217; DOI=10.1006/geno.1999.5887;
RA   Horie M., Suzuki M., Takahashi E., Tanigami A.;
RT   "Cloning, expression, and chromosomal mapping of the human 14-3-3gamma
RT   gene (YWHAG) to 7q11.23.";
RL   Genomics 60:241-243(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrial tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-10; 13-56; 62-69; 133-172 AND 199-227, CLEAVAGE
RP   OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND VAL-2,
RP   PHOSPHORYLATION AT THR-145, AND MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Hepatoma;
RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 2-12.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-10; 13-19; 29-42; 62-69; 133-143 AND 218-227,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT VAL-2, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 92-110; 199-217 AND 228-247, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [11]
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT VAL-2, AND MASS
RP   SPECTROMETRY.
RX   PubMed=14534293; DOI=10.1074/jbc.M309039200;
RA   Towbin H., Bair K.W., DeCaprio J.A., Eck M.J., Kim S., Kinder F.R.,
RA   Morollo A., Mueller D.R., Schindler P., Song H.K., van Oostrum J.,
RA   Versace R.W., Voshol H., Wood J., Zabludoff S., Phillips P.E.;
RT   "Proteomics-based target identification: bengamides as a new class of
RT   methionine aminopeptidase inhibitors.";
RL   J. Biol. Chem. 278:52964-52971(2003).
RN   [12]
RP   INTERACTION WITH CRTC2.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [13]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [14]
RP   INTERACTION WITH ABL1, AND MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [15]
RP   FUNCTION IN TP53 ACTIVATION, AND INTERACTION WITH MDM4.
RX   PubMed=16511572; DOI=10.1038/sj.emboj.7601010;
RA   Jin Y., Dai M.S., Lu S.Z., Xu Y., Luo Z., Zhao Y., Lu H.;
RT   "14-3-3gamma binds to MDMX that is phosphorylated by UV-activated
RT   Chk1, resulting in p53 activation.";
RL   EMBO J. 25:1207-1218(2006).
RN   [16]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS), MASS SPECTROMETRY, INTERACTION
RP   WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC   -!- SUBUNIT: Homodimer. Interacts with SAMSN1 (By similarity).
CC       Interacts with RAF1, SSH1 and CRTC2/TORC2. Interacts with ABL1
CC       (phosphorylated form); the interaction retains it in the
CC       cytoplasm. Interacts with GAB2. Interacts with MDM4
CC       (phosphorylated); negatively regulates MDM4 activity toward TP53.
CC       Interacts with PKA-phosphorylated AANAT.
CC   -!- INTERACTION:
CC       P62258:YWHAE; NbExp=4; IntAct=EBI-359832, EBI-356498;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, skeletal muscle,
CC       and heart.
CC   -!- PTM: Phosphorylated by various PKC isozymes.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF142498; AAD48408.1; -; mRNA.
DR   EMBL; AB024334; BAA85184.1; -; mRNA.
DR   EMBL; CR541904; CAG46702.1; -; mRNA.
DR   EMBL; CR541925; CAG46723.1; -; mRNA.
DR   EMBL; AC006388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC020963; AAH20963.1; -; mRNA.
DR   IPI; IPI00220642; -.
DR   RefSeq; NP_036611.2; NM_012479.3.
DR   UniGene; Hs.520974; -.
DR   PDB; 2B05; X-ray; 2.55 A; A/B/C/D/E/F=2-246.
DR   PDBsum; 2B05; -.
DR   ProteinModelPortal; P61981; -.
DR   SMR; P61981; 2-234.
DR   IntAct; P61981; 51.
DR   MINT; MINT-248956; -.
DR   STRING; P61981; -.
DR   PhosphoSite; P61981; -.
DR   DMDM; 48428721; -.
DR   Cornea-2DPAGE; P61981; -.
DR   REPRODUCTION-2DPAGE; IPI00220642; -.
DR   PeptideAtlas; P61981; -.
DR   PRIDE; P61981; -.
DR   DNASU; 7532; -.
DR   Ensembl; ENST00000307630; ENSP00000306330; ENSG00000170027.
DR   GeneID; 7532; -.
DR   KEGG; hsa:7532; -.
DR   UCSC; uc011kgj.1; human.
DR   CTD; 7532; -.
DR   GeneCards; GC07M075956; -.
DR   H-InvDB; HIX0006789; -.
DR   HGNC; HGNC:12852; YWHAG.
DR   HPA; CAB013274; -.
DR   HPA; CAB018389; -.
DR   HPA; HPA026918; -.
DR   MIM; 605356; gene.
DR   neXtProt; NX_P61981; -.
DR   PharmGKB; PA37441; -.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00650000092989; -.
DR   HOGENOM; HBG611720; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P61981; -.
DR   KO; K06630; -.
DR   OMA; CSETQHE; -.
DR   OrthoDB; EOG48PMM0; -.
DR   PhylomeDB; P61981; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_115566; Cell Cycle.
DR   EvolutionaryTrace; P61981; -.
DR   NextBio; 29467; -.
DR   ArrayExpress; P61981; -.
DR   Bgee; P61981; -.
DR   CleanEx; HS_YWHAG; -.
DR   Genevestigator; P61981; -.
DR   GermOnline; ENSG00000170027; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:UniProtKB.
DR   GO; GO:0008426; F:protein kinase C inhibitor activity; NAS:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0045664; P:regulation of neuron differentiation; IMP:UniProtKB.
DR   GO; GO:0009966; P:regulation of signal transduction; NAS:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:UniProtKB.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   CHAIN         1    247       14-3-3 protein gamma.
FT                                /FTId=PRO_0000367907.
FT   INIT_MET      1      1       Removed; alternate.
FT   CHAIN         2    247       14-3-3 protein gamma, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000058606.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        132    132       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                gamma; alternate; partial.
FT   MOD_RES       2      2       N-acetylvaline; in 14-3-3 protein gamma,
FT                                N-terminally processed; partial.
FT   MOD_RES       2      2       N-acetylvaline; partial.
FT   MOD_RES     117    117       Phosphotyrosine (By similarity).
FT   MOD_RES     145    145       Phosphothreonine.
FT   CONFLICT      4      4       R -> P (in Ref. 1; AAD48408).
FT   CONFLICT     19     19       R -> G (in Ref. 1; AAD48408).
FT   CONFLICT     78     78       Missing (in Ref. 1; AAD48408).
FT   CONFLICT     89     89       I -> V (in Ref. 1; AAD48408).
FT   CONFLICT    104    104       L -> V (in Ref. 1; AAD48408).
FT   CONFLICT    109    109       I -> Y (in Ref. 1; AAD48408).
FT   CONFLICT    119    122       SKVF -> RKDL (in Ref. 1; AAD48408).
FT   CONFLICT    144    145       AT -> GD (in Ref. 1; AAD48408).
FT   CONFLICT    157    158       AH -> R (in Ref. 1; AAD48408).
FT   CONFLICT    200    202       AFD -> EFE (in Ref. 1; AAD48408).
FT   CONFLICT    214    214       D -> E (in Ref. 1; AAD48408).
FT   CONFLICT    240    240       D -> DH (in Ref. 1; AAD48408).
FT   HELIX         4     16
FT   HELIX        20     31
FT   HELIX        39     73
FT   HELIX        76    106
FT   TURN        107    111
FT   HELIX       117    137
FT   HELIX       140    164
FT   HELIX       170    185
FT   HELIX       190    206
FT   HELIX       208    210
FT   TURN        213    215
FT   HELIX       216    233
SQ   SEQUENCE   247 AA;  28303 MW;  B0D16C6DE1F4455D CRC64;
     MVDREQLVQK ARLAEQAERY DDMAAAMKNV TELNEPLSNE ERNLLSVAYK NVVGARRSSW
     RVISSIEQKT SADGNEKKIE MVRAYREKIE KELEAVCQDV LSLLDNYLIK NCSETQYESK
     VFYLKMKGDY YRYLAEVATG EKRATVVESS EKAYSEAHEI SKEHMQPTHP IRLGLALNYS
     VFYYEIQNAP EQACHLAKTA FDDAIAELDT LNEDSYKDST LIMQLLRDNL TLWTSDQQDD
     DGGEGNN
//
ID   1433S_HUMAN             Reviewed;         248 AA.
AC   P31947; Q6FH30; Q6FH51; Q96DH0;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   18-APR-2012, entry version 127.
DE   RecName: Full=14-3-3 protein sigma;
DE   AltName: Full=Epithelial cell marker protein 1;
DE   AltName: Full=Stratifin;
GN   Name=SFN; Synonyms=HME1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Epithelium;
RX   MEDLINE=93002614; PubMed=1390337;
RA   Prasad G.L., Valverius E.M., McDuffie E., Cooper H.L.;
RT   "Complementary DNA cloning of a novel epithelial cell marker protein,
RT   HME1, that may be down-regulated in neoplastic mammary cells.";
RL   Cell Growth Differ. 3:507-513(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 19-25;
RP   42-49; 118-122; 130-139; 149-159; 161-181; 196-199; 225-229 AND
RP   231-239.
RC   TISSUE=Keratinocyte;
RX   MEDLINE=93294871; PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   MEDLINE=98324083; PubMed=9659898; DOI=10.1016/S1097-2765(00)80002-7;
RA   Hermeking H., Lengauer C., Polyak K., He T.-C., Zhang L.,
RA   Thiagalingam S., Kinzler K.W., Vogelstein B.;
RT   "14-3-3 sigma is a p53-regulated inhibitor of G2/M progression.";
RL   Mol. Cell 1:3-11(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cervix, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 42-49 AND 118-122.
RC   TISSUE=Keratinocyte;
RX   MEDLINE=93162043; PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH XPO7; ARHGAP1; EIF4A1; VPS26A; VPS29
RP   AND VPS35.
RX   PubMed=15282546; DOI=10.1038/sj.emboj.7600338;
RA   Mingot J.-M., Bohnsack M.T., Jaekle U., Goerlich D.;
RT   "Exportin 7 defines a novel general nuclear export pathway.";
RL   EMBO J. 23:3227-3236(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH PHOSPHOSERINE
RP   PEPTIDE.
RX   PubMed=15731107; DOI=10.1074/jbc.M500982200;
RA   Wilker E.W., Grant R.A., Artim S.C., Yaffe M.B.;
RT   "A structural basis for 14-3-3sigma functional specificity.";
RL   J. Biol. Chem. 280:18891-18898(2005).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. When
CC       bound to KRT17, regulates protein synthesis and epithelial cell
CC       growth by stimulating Akt/mTOR pathway (By similarity).
CC   -!- FUNCTION: p53-regulated inhibitor of G2/M progression.
CC   -!- SUBUNIT: Homodimer. Interacts with KRT17 and SAMSN1 (By
CC       similarity). Found in a complex with XPO7, EIF4A1, ARHGAP1,
CC       VPS26A, VPS29, VPS35 and SFN. Interacts with GAB2. Interacts with
CC       SRPK2.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=2; IntAct=EBI-476295, EBI-375543;
CC       Q14103-4:HNRNPD; NbExp=7; IntAct=EBI-476295, EBI-432545;
CC       O00444:PLK4; NbExp=2; IntAct=EBI-476295, EBI-746202;
CC       Q8NHY2:RFWD2; NbExp=3; IntAct=EBI-476295, EBI-1176214;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus (By similarity).
CC       Secreted. Note=May be secreted by a non-classical secretory
CC       pathway.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31947-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31947-2; Sequence=VSP_021768;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Present mainly in tissues enriched in
CC       stratified squamous keratinizing epithelium.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M93010; AAA59546.1; -; mRNA.
DR   EMBL; X57348; CAA40623.1; -; mRNA.
DR   EMBL; AF029081; AAC52029.1; -; Genomic_DNA.
DR   EMBL; AF029082; AAC52030.1; -; mRNA.
DR   EMBL; CR541905; CAG46703.1; -; mRNA.
DR   EMBL; CR541926; CAG46724.1; -; mRNA.
DR   EMBL; AL034380; CAB92118.1; -; Genomic_DNA.
DR   EMBL; BC000329; AAH00329.1; -; mRNA.
DR   EMBL; BC000995; AAH00995.1; -; mRNA.
DR   EMBL; BC001550; AAH01550.1; -; mRNA.
DR   EMBL; BC002995; AAH02995.1; -; mRNA.
DR   EMBL; BC023552; AAH23552.1; -; mRNA.
DR   IPI; IPI00013890; -.
DR   IPI; IPI00411765; -.
DR   PIR; S34753; S34753.
DR   PIR; S38956; S38956.
DR   RefSeq; NP_006133.1; NM_006142.3.
DR   UniGene; Hs.523718; -.
DR   PDB; 1YWT; X-ray; 2.40 A; A/B=1-248.
DR   PDB; 1YZ5; X-ray; 2.80 A; A/B=1-248.
DR   PDB; 3IQJ; X-ray; 1.15 A; A=1-231.
DR   PDB; 3IQU; X-ray; 1.05 A; A=1-231.
DR   PDB; 3IQV; X-ray; 1.20 A; A=1-231.
DR   PDB; 3LW1; X-ray; 1.28 A; A=1-248.
DR   PDB; 3MHR; X-ray; 1.15 A; A=1-231.
DR   PDB; 3O8I; X-ray; 2.00 A; A=1-231.
DR   PDB; 3P1N; X-ray; 1.40 A; A=1-231.
DR   PDB; 3P1O; X-ray; 1.90 A; A=1-231.
DR   PDB; 3P1P; X-ray; 1.95 A; A=1-231.
DR   PDB; 3P1Q; X-ray; 1.70 A; A=1-231.
DR   PDB; 3P1R; X-ray; 1.70 A; A=1-231.
DR   PDB; 3P1S; X-ray; 1.65 A; A=1-231.
DR   PDBsum; 1YWT; -.
DR   PDBsum; 1YZ5; -.
DR   PDBsum; 3IQJ; -.
DR   PDBsum; 3IQU; -.
DR   PDBsum; 3IQV; -.
DR   PDBsum; 3LW1; -.
DR   PDBsum; 3MHR; -.
DR   PDBsum; 3O8I; -.
DR   PDBsum; 3P1N; -.
DR   PDBsum; 3P1O; -.
DR   PDBsum; 3P1P; -.
DR   PDBsum; 3P1Q; -.
DR   PDBsum; 3P1R; -.
DR   PDBsum; 3P1S; -.
DR   ProteinModelPortal; P31947; -.
DR   SMR; P31947; 2-232.
DR   DIP; DIP-29861N; -.
DR   IntAct; P31947; 19.
DR   MINT; MINT-108060; -.
DR   STRING; P31947; -.
DR   PhosphoSite; P31947; -.
DR   DMDM; 398953; -.
DR   Aarhus/Ghent-2DPAGE; 9109; IEF.
DR   Cornea-2DPAGE; P31947; -.
DR   OGP; P31947; -.
DR   SWISS-2DPAGE; P31947; -.
DR   PeptideAtlas; P31947; -.
DR   PRIDE; P31947; -.
DR   DNASU; 2810; -.
DR   Ensembl; ENST00000339276; ENSP00000340989; ENSG00000175793.
DR   GeneID; 2810; -.
DR   KEGG; hsa:2810; -.
DR   UCSC; uc001bnc.1; human.
DR   CTD; 2810; -.
DR   GeneCards; GC01P027189; -.
DR   H-InvDB; HIX0199941; -.
DR   HGNC; HGNC:10773; SFN.
DR   HPA; CAB006268; -.
DR   HPA; CAB040552; -.
DR   HPA; HPA011105; -.
DR   MIM; 601290; gene.
DR   neXtProt; NX_P31947; -.
DR   PharmGKB; PA177; -.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00650000093317; -.
DR   HOGENOM; HBG611720; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P31947; -.
DR   KO; K06644; -.
DR   OMA; AFMKSAV; -.
DR   OrthoDB; EOG4XH00X; -.
DR   PhylomeDB; P31947; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   EvolutionaryTrace; P31947; -.
DR   NextBio; 11071; -.
DR   ArrayExpress; P31947; -.
DR   Bgee; P31947; -.
DR   CleanEx; HS_SFN; -.
DR   Genevestigator; P31947; -.
DR   GermOnline; ENSG00000175793; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:InterPro.
DR   GO; GO:0008426; F:protein kinase C inhibitor activity; TAS:ProtInc.
DR   GO; GO:0008630; P:DNA damage response, signal transduction resulting in induction of apoptosis; IDA:HGNC.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC.
DR   GO; GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Secreted.
FT   CHAIN         1    248       14-3-3 protein sigma.
FT                                /FTId=PRO_0000058643.
FT   SITE         56     56       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES      64     64       Phosphoserine (By similarity).
FT   MOD_RES     216    216       Phosphoserine (By similarity).
FT   MOD_RES     248    248       Phosphoserine.
FT   VAR_SEQ      85    116       Missing (in isoform 2).
FT                                /FTId=VSP_021768.
FT   VARIANT     155    155       M -> I (in dbSNP:rs11542705).
FT                                /FTId=VAR_048095.
FT   CONFLICT     77     77       K -> M (in Ref. 4; CAG46703).
FT   CONFLICT    120    120       Y -> H (in Ref. 2; AAA59546).
FT   CONFLICT    242    242       A -> V (in Ref. 2; AAA59546).
FT   HELIX         3     15
FT   HELIX        19     31
FT   HELIX        38     66
FT   HELIX        67     69
FT   HELIX        80    104
FT   TURN        105    107
FT   STRAND      108    110
FT   HELIX       114    133
FT   HELIX       137    161
FT   HELIX       167    182
FT   HELIX       187    202
FT   HELIX       205    207
FT   TURN        210    212
FT   HELIX       213    229
SQ   SEQUENCE   248 AA;  27774 MW;  7F4B44E3AA59ECE6 CRC64;
     MERASLIQKA KLAEQAERYE DMAAFMKGAV EKGEELSCEE RNLLSVAYKN VVGGQRAAWR
     VLSSIEQKSN EEGSEEKGPE VREYREKVET ELQGVCDTVL GLLDSHLIKE AGDAESRVFY
     LKMKGDYYRY LAEVATGDDK KRIIDSARSA YQEAMDISKK EMPPTNPIRL GLALNFSVFH
     YEIANSPEEA ISLAKTTFDE AMADLHTLSE DSYKDSTLIM QLLRDNLTLW TADNAGEEGG
     EAPQEPQS
//
ID   1433T_HUMAN             Reviewed;         245 AA.
AC   P27348; D6W4Z5; Q567U5; Q5TZU8; Q9UP48;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   18-APR-2012, entry version 133.
DE   RecName: Full=14-3-3 protein theta;
DE   AltName: Full=14-3-3 protein T-cell;
DE   AltName: Full=14-3-3 protein tau;
DE   AltName: Full=Protein HS1;
GN   Name=YWHAQ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=T-cell;
RX   MEDLINE=91198149; PubMed=2015305; DOI=10.1016/0167-4781(91)90136-A;
RA   Nielsen P.J.;
RT   "Primary structure of a human protein kinase regulator protein.";
RL   Biochim. Biophys. Acta 1088:425-428(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Keratinocyte;
RX   MEDLINE=93294871; PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-18.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-9; 28-49; 61-68; 104-115; 139-167 AND 213-222,
RP   ACETYLATION AT MET-1, AND MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma, and Hepatoma;
RA   Bienvenut W.V., Dhillon A.S., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 73-245.
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PHOSPHORYLATION AT SER-232, AND MASS SPECTROMETRY.
RX   PubMed=9360956; DOI=10.1074/jbc.272.46.28882;
RA   Dubois T., Rommel C., Howell S., Steinhussen U., Soneji Y.,
RA   Morrice N., Moelling K., Aitken A.;
RT   "14-3-3 is phosphorylated by casein kinase I on residue 233.
RT   Phosphorylation at this site in vivo regulates Raf/14-3-3
RT   interaction.";
RL   J. Biol. Chem. 272:28882-28888(1997).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=11080204; DOI=10.1046/j.1471-4159.2000.0752511.x;
RA   Malaspina A., Kaushik N., de Belleroche J.;
RT   "A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal
RT   cord.";
RL   J. Neurochem. 75:2511-2520(2000).
RN   [11]
RP   INTERACTION WITH CDKN1B.
RX   PubMed=12042314; DOI=10.1074/jbc.M203668200;
RA   Fujita N., Sato S., Katayama K., Tsuruo T.;
RT   "Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3
RT   and cytoplasmic localization.";
RL   J. Biol. Chem. 277:28706-28713(2002).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH PDPK1.
RX   PubMed=12177059; DOI=10.1074/jbc.M205141200;
RA   Sato S., Fujita N., Tsuruo T.;
RT   "Regulation of kinase activity of 3-phosphoinositide-dependent protein
RT   kinase-1 by binding to 14-3-3.";
RL   J. Biol. Chem. 277:39360-39367(2002).
RN   [13]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [14]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1; LYS-3; LYS-49; LYS-68 AND
RP   LYS-115, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   MEDLINE=95327195; PubMed=7603573; DOI=10.1038/376188a0;
RA   Xiao B., Smerdon S.J., Jones D.H., Dodson G.G., Soneji Y., Aitken A.,
RA   Gamblin S.J.;
RT   "Structure of a 14-3-3 protein and implications for coordination of
RT   multiple signalling pathways.";
RL   Nature 376:188-191(1995).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-234, MASS SPECTROMETRY,
RP   INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC       Negatively regulates the kinase activity of PDPK1.
CC   -!- SUBUNIT: Homodimer. Interacts with CDK16 (By similarity).
CC       Interacts with SSH1. Interacts with CDKN1B ('Thr-198'
CC       phosphorylated form); the interaction translocates CDKN1B to the
CC       cytoplasm. Interacts with GAB2. Interacts with the 'Ser-241'
CC       phosphorylated form of PDPK1.
CC   -!- INTERACTION:
CC       Q9P0K1-3:ADAM22; NbExp=2; IntAct=EBI-359854, EBI-1567267;
CC       P49407:ARRB1; NbExp=3; IntAct=EBI-359854, EBI-743313;
CC       P32121:ARRB2; NbExp=3; IntAct=EBI-359854, EBI-714559;
CC       O94921:CDK14; NbExp=3; IntAct=EBI-359854, EBI-1043945;
CC       P00533:EGFR; NbExp=4; IntAct=EBI-359854, EBI-297353;
CC       P23945:FSHR; NbExp=3; IntAct=EBI-359854, EBI-848239;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=In neurons, axonally
CC       transported to the nerve terminals.
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in brain, heart and
CC       pancreas, and at lower levels in kidney and placenta. Up-regulated
CC       in the lumbar spinal cord from patients with sporadic amyotrophic
CC       lateral sclerosis (ALS) compared with controls, with highest
CC       levels of expression in individuals with predominant lower motor
CC       neuron involvement.
CC   -!- PTM: Ser-232 is probably phosphorylated by CK1.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X56468; CAA39840.1; -; mRNA.
DR   EMBL; X57347; CAA40622.1; -; mRNA.
DR   EMBL; BT020014; AAV38817.1; -; mRNA.
DR   EMBL; CH471053; EAX00977.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00979.1; -; Genomic_DNA.
DR   EMBL; BC050601; AAH50601.1; -; mRNA.
DR   EMBL; BC056867; AAH56867.1; -; mRNA.
DR   EMBL; BC093019; AAH93019.1; -; mRNA.
DR   EMBL; AF070556; AAC28640.1; -; mRNA.
DR   IPI; IPI00018146; -.
DR   PIR; S15076; S15076.
DR   RefSeq; NP_006817.1; NM_006826.2.
DR   UniGene; Hs.74405; -.
DR   PDB; 2BTP; X-ray; 2.80 A; A/B=1-234.
DR   PDBsum; 2BTP; -.
DR   ProteinModelPortal; P27348; -.
DR   SMR; P27348; 1-230.
DR   DIP; DIP-27584N; -.
DR   IntAct; P27348; 28.
DR   MINT; MINT-121282; -.
DR   STRING; P27348; -.
DR   PhosphoSite; P27348; -.
DR   DMDM; 112690; -.
DR   Cornea-2DPAGE; P27348; -.
DR   OGP; P27348; -.
DR   REPRODUCTION-2DPAGE; IPI00018146; -.
DR   PeptideAtlas; P27348; -.
DR   PRIDE; P27348; -.
DR   DNASU; 10971; -.
DR   Ensembl; ENST00000238081; ENSP00000238081; ENSG00000134308.
DR   Ensembl; ENST00000381844; ENSP00000371267; ENSG00000134308.
DR   GeneID; 10971; -.
DR   KEGG; hsa:10971; -.
DR   UCSC; uc002qzx.3; human.
DR   CTD; 10971; -.
DR   GeneCards; GC02M009724; -.
DR   H-InvDB; HIX0029798; -.
DR   H-InvDB; HIX0077146; -.
DR   HGNC; HGNC:12854; YWHAQ.
DR   HPA; CAB010286; -.
DR   HPA; HPA007925; -.
DR   MIM; 609009; gene.
DR   neXtProt; NX_P27348; -.
DR   PharmGKB; PA37443; -.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00650000092989; -.
DR   HOGENOM; HBG611720; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P27348; -.
DR   KO; K06630; -.
DR   OMA; SGDDRKQ; -.
DR   OrthoDB; EOG480HXJ; -.
DR   PhylomeDB; P27348; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   EvolutionaryTrace; P27348; -.
DR   NextBio; 41686; -.
DR   PMAP-CutDB; P27348; -.
DR   ArrayExpress; P27348; -.
DR   Bgee; P27348; -.
DR   CleanEx; HS_YWHAQ; -.
DR   Genevestigator; P27348; -.
DR   GermOnline; ENSG00000134308; Homo sapiens.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-dependent; IDA:BHF-UCL.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   CHAIN         1    245       14-3-3 protein theta.
FT                                /FTId=PRO_0000058636.
FT   SITE         56     56       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        127    127       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES       3      3       N6-acetyllysine.
FT   MOD_RES      49     49       N6-acetyllysine.
FT   MOD_RES      68     68       N6-acetyllysine.
FT   MOD_RES     115    115       N6-acetyllysine.
FT   MOD_RES     232    232       Phosphoserine.
FT   CONFLICT    136    136       D -> N (in Ref. 3; AAV38817).
FT   HELIX         3     15
FT   HELIX        19     31
FT   HELIX        38     68
FT   HELIX        75    103
FT   TURN        104    108
FT   HELIX       112    132
FT   HELIX       135    159
FT   HELIX       165    180
FT   HELIX       185    201
FT   TURN        202    205
FT   HELIX       208    227
SQ   SEQUENCE   245 AA;  27764 MW;  175534325E9E37C4 CRC64;
     MEKTELIQKA KLAEQAERYD DMATCMKAVT EQGAELSNEE RNLLSVAYKN VVGGRRSAWR
     VISSIEQKTD TSDKKLQLIK DYREKVESEL RSICTTVLEL LDKYLIANAT NPESKVFYLK
     MKGDYFRYLA EVACGDDRKQ TIDNSQGAYQ EAFDISKKEM QPTHPIRLGL ALNFSVFYYE
     ILNNPELACT LAKTAFDEAI AELDTLNEDS YKDSTLIMQL LRDNLTLWTS DSAGEECDAA
     EGAEN
//
ID   1433Z_HUMAN             Reviewed;         245 AA.
AC   P63104; A8K1N0; P29213; P29312; Q32P43; Q5XJ08; Q6GPI2; Q6IN74;
AC   Q6NUR9; Q6P3U9; Q86V33;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=14-3-3 protein zeta/delta;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
GN   Name=YWHAZ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=92250445; PubMed=1577711;
RA   Zupan L.A., Steffens D.L., Berry C.A., Landt M.L., Gross R.W.;
RT   "Cloning and expression of a human 14-3-3 protein mediating
RT   phospholipolysis. Identification of an arachidonoyl-enzyme
RT   intermediate during catalysis.";
RL   J. Biol. Chem. 267:8707-8710(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RX   MEDLINE=98173806; PubMed=9512661; DOI=10.1016/S0167-4781(97)00171-1;
RA   Seluja G.A., Pietromonaco S.F., Elias L.;
RT   "Two unique 5' untranslated regions in mRNAs encoding human 14-3-3
RT   zeta: differential expression in hemopoietic cells.";
RL   Biochim. Biophys. Acta 1395:281-287(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, Eye, Melanoma, PNS, Skin, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-18.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-9; 12-18; 28-49; 61-68; 86-91; 128-158 AND
RP   213-222, ACETYLATION AT MET-1, AND MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma, and Platelet;
RA   Bienvenut W.V., Potts A., Barblan J., Claeys D., Quadroni M.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 92-103; 140-157; 194-212 AND 223-245, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION AT THR-232, INTERACTION WITH RAF1, AND FUNCTION.
RX   PubMed=9360956; DOI=10.1074/jbc.272.46.28882;
RA   Dubois T., Rommel C., Howell S., Steinhussen U., Soneji Y.,
RA   Morrice N., Moelling K., Aitken A.;
RT   "14-3-3 is phosphorylated by casein kinase I on residue 233.
RT   Phosphorylation at this site in vivo regulates Raf/14-3-3
RT   interaction.";
RL   J. Biol. Chem. 272:28882-28888(1997).
RN   [10]
RP   INTERACTION WITH TLK2.
RX   PubMed=10455159; DOI=10.1074/jbc.274.35.24865;
RA   Zhang S., Xing H., Muslin A.J.;
RT   "Nuclear localization of protein kinase U-alpha is regulated by 14-3-
RT   3.";
RL   J. Biol. Chem. 274:24865-24872(1999).
RN   [11]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [12]
RP   PHOSPHORYLATION AT SER-58, AND INTERACTION WITH AKT1.
RX   PubMed=11956222; DOI=10.1074/jbc.M203167200;
RA   Powell D.W., Rane M.J., Chen Q., Singh S., McLeish K.R.;
RT   "Identification of 14-3-3zeta as a protein kinase B/Akt substrate.";
RL   J. Biol. Chem. 277:21639-21642(2002).
RN   [13]
RP   PHOSPHORYLATION AT SER-58, AND DIMERIZATION.
RX   PubMed=12865427; DOI=10.1074/jbc.M304689200;
RA   Woodcock J.M., Murphy J., Stomski F.C., Berndt M.C., Lopez A.F.;
RT   "The dimeric versus monomeric status of 14-3-3zeta is controlled by
RT   phosphorylation of Ser58 at the dimer interface.";
RL   J. Biol. Chem. 278:36323-36327(2003).
RN   [14]
RP   INTERACTION WITH AANAT, AND FUNCTION.
RX   PubMed=14578935; DOI=10.1038/nsb1005;
RA   Zheng W., Zhang Z., Ganguly S., Weller J.L., Klein D.C., Cole P.A.;
RT   "Cellular stabilization of the melatonin rhythm enzyme induced by
RT   nonhydrolyzable phosphonate incorporation.";
RL   Nat. Struct. Biol. 10:1054-1057(2003).
RN   [15]
RP   PHOSPHORYLATION AT SER-184, INTERACTION WITH BAX, FUNCTION, AND
RP   MUTAGENESIS OF SER-184.
RX   PubMed=15071501; DOI=10.1038/sj.emboj.7600194;
RA   Tsuruta F., Sunayama J., Mori Y., Hattori S., Shimizu S.,
RA   Tsujimoto Y., Yoshioka K., Masuyama N., Gotoh Y.;
RT   "JNK promotes Bax translocation to mitochondria through
RT   phosphorylation of 14-3-3 proteins.";
RL   EMBO J. 23:1889-1899(2004).
RN   [16]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [17]
RP   INTERACTION WITH MLLT7.
RX   PubMed=16114898; DOI=10.1021/bi050618r;
RA   Obsilova V., Vecer J., Herman P., Pabianova A., Sulc M., Teisinger J.,
RA   Boura E., Obsil T.;
RT   "14-3-3 protein interacts with nuclear localization sequence of
RT   forkhead transcription factor FoxO4.";
RL   Biochemistry 44:11608-11617(2005).
RN   [18]
RP   INTERACTION WITH SSH1.
RX   PubMed=15660133; DOI=10.1038/sj.emboj.7600543;
RA   Soosairajah J., Maiti S., Wiggan O., Sarmiere P., Moussi N.,
RA   Sarcevic B., Sampath R., Bamburg J.R., Bernard O.;
RT   "Interplay between components of a novel LIM kinase-slingshot
RT   phosphatase complex regulates cofilin.";
RL   EMBO J. 24:473-486(2005).
RN   [19]
RP   PHOSPHORYLATION AT SER-58, AND MUTAGENESIS OF SER-58.
RX   PubMed=15883165; DOI=10.1074/jbc.M409081200;
RA   Ma Y., Pitson S., Hercus T., Murphy J., Lopez A., Woodcock J.;
RT   "Sphingosine activates protein kinase A type II by a novel cAMP-
RT   independent mechanism.";
RL   J. Biol. Chem. 280:26011-26017(2005).
RN   [20]
RP   INTERACTION WITH ABL1, MASS SPECTROMETRY, PHOSPHORYLATION AT SER-184,
RP   AND MUTAGENESIS OF SER-184.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [21]
RP   INTERACTION WITH AANAT, AND FUNCTION.
RX   PubMed=15644438; DOI=10.1073/pnas.0406871102;
RA   Ganguly S., Weller J.L., Ho A., Chemineau P., Malpaux B., Klein D.C.;
RT   "Melatonin synthesis: 14-3-3-dependent activation and inhibition of
RT   arylalkylamine N-acetyltransferase mediated by phosphoserine-205.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1222-1227(2005).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [23]
RP   PHOSPHORYLATION AT SER-58, DIMERIZATION, INTERACTION WITH TP53 AND
RP   YWHAE, FUNCTION, AND MUTAGENESIS OF SER-58.
RX   PubMed=16376338; DOI=10.1016/j.febslet.2005.12.024;
RA   Gu Y.-M., Jin Y.-H., Choi J.-K., Baek K.-H., Yeo C.-Y., Lee K.-Y.;
RT   "Protein kinase A phosphorylates and regulates dimerization of 14-3-3
RT   epsilon.";
RL   FEBS Lett. 580:305-310(2006).
RN   [24]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [25]
RP   INTERACTION WITH NOXA1, AND MUTAGENESIS OF LYS-49.
RX   PubMed=17913709; DOI=10.1074/jbc.M704754200;
RA   Kim J.-S., Diebold B.A., Babior B.M., Knaus U.G., Bokoch G.M.;
RT   "Regulation of Nox1 activity via PKA-mediated phosphorylation of NoxA1
RT   and 14-3-3 binding.";
RL   J. Biol. Chem. 282:34787-34800(2007).
RN   [26]
RP   INTERACTION WITH ARHGEF2.
RX   PubMed=14970201; DOI=10.1074/jbc.M400084200;
RA   Zenke F.T., Krendel M., DerMardirossian C., King C.C., Bohl B.P.,
RA   Bokoch G.M.;
RT   "p21-activated kinase 1 phosphorylates and regulates 14-3-3 binding to
RT   GEF-H1, a microtubule-localized Rho exchange factor.";
RL   J. Biol. Chem. 279:18392-18400(2004).
RN   [27]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-210, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3; LYS-49; LYS-68; LYS-115
RP   AND LYS-120, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE=99417955; PubMed=10488331; DOI=10.1016/S1097-2765(00)80363-9;
RA   Rittinger K., Budman J., Xu J., Volinia S., Cantley L.C.,
RA   Smerdon S.J., Gamblin S.J., Yaffe M.B.;
RT   "Structural analysis of 14-3-3 phosphopeptide complexes identifies a
RT   dual role for the nuclear export signal of 14-3-3 in ligand binding.";
RL   Mol. Cell 4:153-166(1999).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) IN COMPLEX WITH AANAT.
RX   PubMed=11336675; DOI=10.1016/S0092-8674(01)00316-6;
RA   Obsil T., Ghirlando R., Klein D.C., Ganguly S., Dyda F.;
RT   "Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase
RT   complex. a role for scaffolding in enzyme regulation.";
RL   Cell 105:257-267(2001).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH HISTONE H3
RP   PHOSPHOPEPTIDE.
RX   PubMed=16246723; DOI=10.1016/j.molcel.2005.08.032;
RA   Macdonald N., Welburn J.P.I., Noble M.E.M., Nguyen A., Yaffe M.B.,
RA   Clynes D., Moggs J.G., Orphanides G., Thomson S., Edmunds J.W.,
RA   Clayton A.L., Endicott J.A., Mahadevan L.C.;
RT   "Molecular basis for the recognition of phosphorylated and
RT   phosphoacetylated histone h3 by 14-3-3.";
RL   Mol. Cell 20:199-211(2005).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 1-230 IN COMPLEX WITH
RP   PSEUDOMONAS AERUGINOSA EXOS.
RX   PubMed=17235285; DOI=10.1038/sj.emboj.7601530;
RA   Ottmann C., Yasmin L., Weyand M., Veesenmeyer J.L., Diaz M.H.,
RA   Palmer R.H., Francis M.S., Hauser A.R., Wittinghofer A., Hallberg B.;
RT   "Phosphorylation-independent interaction between 14-3-3 and exoenzyme
RT   S: from structure to pathogenesis.";
RL   EMBO J. 26:902-913(2007).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC   -!- SUBUNIT: Interacts with CDK16 and BSPRY (By similarity). Interacts
CC       with WEE1 (C-terminal). Interacts with SAMSN1 (By similarity).
CC       Interacts with MLF1 (phosphorylated form); the interaction retains
CC       it in the cytoplasm (By similarity). Interacts with Thr-
CC       phosphorylated ITGB2 (By similarity). Interacts with BCL2L11 (By
CC       similarity). Homodimer. Heterodimerizes with YWHAE. Homo- and
CC       hetero-dimerization is inhibited by phosphorylation on Ser-58.
CC       Interacts with FOXO4, NOXA1, SSH1 and ARHGEF2. Interacts with
CC       Pseudomonas aeruginosa exoS (unphosphorylated form). Interacts
CC       with BAX; the interaction occurs in the cytoplasm. Under stress
CC       conditions, MAPK8-mediated phosphorylation releases BAX to
CC       mitochondria. Interacts with phosphorylated RAF1; the interaction
CC       is inhibited when YWHAZ is phosphorylated on Thr-232. Interacts
CC       with TP53; the interaction enhances p53 transcriptional activity.
CC       The Ser-58 phosphorylated form inhibits this interaction and p53
CC       transcriptional activity. Interacts with ABL1 (phosphorylated
CC       form); the interaction retains ABL1 in the cytoplasm. Interacts
CC       with PKA-phosphorylated AANAT; the interaction modulates AANAT
CC       enzymatic activity by increasing affinity for arylalkylamines and
CC       acetyl-CoA and protecting the enzyme from dephosphorylation and
CC       proteasomal degradation. It may also prevent thiol-dependent
CC       inactivation. Interacts with AKT1; the interaction phosphorylates
CC       YWHAZ and modulates dimerization. Interacts with GAB2 and TLK2.
CC   -!- INTERACTION:
CC       Q29495:AANAT (xeno); NbExp=3; IntAct=EBI-347088, EBI-446413;
CC       P00519:ABL1; NbExp=2; IntAct=EBI-347088, EBI-375543;
CC       Q9P0K1-3:ADAM22; NbExp=3; IntAct=EBI-347088, EBI-1567267;
CC       O00257-3:CBX4; NbExp=2; IntAct=EBI-347088, EBI-4392727;
CC       P23528:CFL1; NbExp=2; IntAct=EBI-347088, EBI-352733;
CC       P00533:EGFR; NbExp=4; IntAct=EBI-347088, EBI-297353;
CC       P30793:GCH1; NbExp=4; IntAct=EBI-347088, EBI-958183;
CC       Q99683:MAP3K5; NbExp=2; IntAct=EBI-347088, EBI-476263;
CC       Q7KZI7:MARK2; NbExp=3; IntAct=EBI-347088, EBI-516560;
CC       Q9NYL2:MLTK; NbExp=4; IntAct=EBI-347088, EBI-602273;
CC       Q8TEW0:PARD3; NbExp=3; IntAct=EBI-347088, EBI-81968;
CC       P04049:RAF1; NbExp=3; IntAct=EBI-347088, EBI-365996;
CC       P57059:SIK1; NbExp=4; IntAct=EBI-347088, EBI-1181640;
CC       Q9Y2K2:SIK3; NbExp=5; IntAct=EBI-347088, EBI-1181460;
CC       O00506:STK25; NbExp=2; IntAct=EBI-347088, EBI-618295;
CC       P36897:TGFBR1; NbExp=4; IntAct=EBI-347088, EBI-1027557;
CC       P84198:VIM (xeno); NbExp=5; IntAct=EBI-347088, EBI-457639;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Note=Located to stage
CC       I to stage IV melanosomes.
CC   -!- PTM: The delta, brain-specific form differs from the zeta form in
CC       being phosphorylated (By similarity). Phosphorylation on Ser-184
CC       by MAPK8; promotes dissociation of BAX and translocation of BAX to
CC       mitochondria. Phosphorylation on Ser-58 by PKA; disrupts
CC       homodimerization and heterodimerization with YHAE and TP53. This
CC       phosphorylation appears to be activated by sphingosine.
CC       Phosphorylation on Thr-232; inhibits binding of RAF1.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -!- CAUTION: Was originally (PubMed:1577711) thought to have
CC       phospholipase A2 activity.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH51814.1; Type=Erroneous initiation;
CC       Sequence=AAH73141.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M86400; AAA36446.1; -; mRNA.
DR   EMBL; U28964; AAC52052.1; -; mRNA.
DR   EMBL; AK289945; BAF82634.1; -; mRNA.
DR   EMBL; CH471060; EAW91823.1; -; Genomic_DNA.
DR   EMBL; BC003623; AAH03623.3; -; mRNA.
DR   EMBL; BC051814; AAH51814.1; ALT_INIT; mRNA.
DR   EMBL; BC063824; AAH63824.2; -; mRNA.
DR   EMBL; BC068456; AAH68456.2; -; mRNA.
DR   EMBL; BC072426; AAH72426.2; -; mRNA.
DR   EMBL; BC073141; AAH73141.1; ALT_INIT; mRNA.
DR   EMBL; BC083508; AAH83508.2; -; mRNA.
DR   EMBL; BC099904; AAH99904.1; -; mRNA.
DR   EMBL; BC101483; AAI01484.1; -; mRNA.
DR   EMBL; BC108281; AAI08282.1; -; mRNA.
DR   EMBL; BC111951; AAI11952.1; -; mRNA.
DR   IPI; IPI00021263; -.
DR   PIR; A38246; PSHUAM.
DR   RefSeq; NP_001129171.1; NM_001135699.1.
DR   RefSeq; NP_001129172.1; NM_001135700.1.
DR   RefSeq; NP_001129173.1; NM_001135701.1.
DR   RefSeq; NP_001129174.1; NM_001135702.1.
DR   RefSeq; NP_003397.1; NM_003406.3.
DR   RefSeq; NP_663723.1; NM_145690.2.
DR   UniGene; Hs.492407; -.
DR   PDB; 1IB1; X-ray; 2.70 A; A/B/C/D=1-245.
DR   PDB; 1QJA; X-ray; 2.00 A; A/B=1-245.
DR   PDB; 1QJB; X-ray; 2.00 A; A/B=1-245.
DR   PDB; 2C1J; X-ray; 2.60 A; A/B=1-245.
DR   PDB; 2C1N; X-ray; 2.00 A; A/B=1-245.
DR   PDB; 2O02; X-ray; 1.50 A; A/B=1-230.
DR   PDB; 2WH0; X-ray; 2.25 A; A/B/C/D=1-245.
DR   PDB; 3CU8; X-ray; 2.40 A; A/B=1-245.
DR   PDB; 3NKX; X-ray; 2.40 A; A/B=1-245.
DR   PDB; 3RDH; X-ray; 2.39 A; A/B/C/D=1-245.
DR   PDBsum; 1IB1; -.
DR   PDBsum; 1QJA; -.
DR   PDBsum; 1QJB; -.
DR   PDBsum; 2C1J; -.
DR   PDBsum; 2C1N; -.
DR   PDBsum; 2O02; -.
DR   PDBsum; 2WH0; -.
DR   PDBsum; 3CU8; -.
DR   PDBsum; 3NKX; -.
DR   PDBsum; 3RDH; -.
DR   ProteinModelPortal; P63104; -.
DR   DIP; DIP-563N; -.
DR   IntAct; P63104; 75.
DR   MINT; MINT-89071; -.
DR   STRING; P63104; -.
DR   PhosphoSite; P63104; -.
DR   DMDM; 52000887; -.
DR   Cornea-2DPAGE; P29312; -.
DR   DOSAC-COBS-2DPAGE; P63104; -.
DR   OGP; P63104; -.
DR   UCD-2DPAGE; P63104; -.
DR   PRIDE; P63104; -.
DR   DNASU; 7534; -.
DR   Ensembl; ENST00000353245; ENSP00000309503; ENSG00000164924.
DR   Ensembl; ENST00000395951; ENSP00000379281; ENSG00000164924.
DR   Ensembl; ENST00000395953; ENSP00000379283; ENSG00000164924.
DR   Ensembl; ENST00000395956; ENSP00000379286; ENSG00000164924.
DR   Ensembl; ENST00000395957; ENSP00000379287; ENSG00000164924.
DR   Ensembl; ENST00000395958; ENSP00000379288; ENSG00000164924.
DR   Ensembl; ENST00000419477; ENSP00000395114; ENSG00000164924.
DR   Ensembl; ENST00000457309; ENSP00000398599; ENSG00000164924.
DR   GeneID; 7534; -.
DR   KEGG; hsa:7534; -.
DR   UCSC; uc003yjv.2; human.
DR   CTD; 7534; -.
DR   GeneCards; GC08M101930; -.
DR   H-InvDB; HIX0034328; -.
DR   HGNC; HGNC:12855; YWHAZ.
DR   HPA; CAB005065; -.
DR   MIM; 601288; gene.
DR   neXtProt; NX_P63104; -.
DR   PharmGKB; PA37444; -.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00650000092989; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P63104; -.
DR   KO; K06630; -.
DR   OMA; VMDKNEL; -.
DR   OrthoDB; EOG4N30PR; -.
DR   PhylomeDB; P63104; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_21257; Metabolism of RNA.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   Reactome; REACT_71; Gene Expression.
DR   DrugBank; DB01381; Ginkgo biloba.
DR   EvolutionaryTrace; P63104; -.
DR   NextBio; 29475; -.
DR   ArrayExpress; P63104; -.
DR   Bgee; P63104; -.
DR   Genevestigator; P63104; -.
DR   GermOnline; ENSG00000164924; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0006916; P:anti-apoptosis; TAS:ProtInc.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0016071; P:mRNA metabolic process; TAS:Reactome.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   CHAIN         1    245       14-3-3 protein zeta/delta.
FT                                /FTId=PRO_0000058627.
FT   SITE         56     56       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   SITE        127    127       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES       3      3       N6-acetyllysine.
FT   MOD_RES      49     49       N6-acetyllysine.
FT   MOD_RES      58     58       Phosphoserine; by PKA and PKB/AKT1.
FT   MOD_RES      68     68       N6-acetyllysine.
FT   MOD_RES     115    115       N6-acetyllysine.
FT   MOD_RES     120    120       N6-acetyllysine.
FT   MOD_RES     184    184       Phosphoserine; by MAPK8.
FT   MOD_RES     207    207       Phosphoserine.
FT   MOD_RES     210    210       Phosphoserine.
FT   MOD_RES     232    232       Phosphothreonine; by CK1.
FT   MUTAGEN      49     49       K->E: Loss of interaction with NOXA1.
FT   MUTAGEN      58     58       S->A: Loss of sphingosine-activated PKA
FT                                phosphorylation. Promotes
FT                                homodimerization and heterodimerization
FT                                with YWHAE. Enhanced transcriptional
FT                                activity of P53.
FT   MUTAGEN      58     58       S->E: Loss of homodimerization. Reduced
FT                                dimerization with YWHAE. Significantly
FT                                reduced interaction with P53. No
FT                                enhancement of P53 transcriptional
FT                                activity.
FT   MUTAGEN     184    184       S->A: On DNA damage, loss of MAPK8-
FT                                mediated phosphorylation. Loss of binding
FT                                ABL1. Attenuates ABL1-mediated apoptosis.
FT                                No loss of interaction with BAX under
FT                                stress conditions. Inhibits translocation
FT                                of BAX to mitochondria.
FT   CONFLICT     22     22       M -> V (in Ref. 5; AAH68456).
FT   HELIX         3     15
FT   HELIX        19     31
FT   HELIX        38     65
FT   HELIX        78    103
FT   HELIX       105    108
FT   HELIX       112    131
FT   HELIX       138    159
FT   HELIX       165    180
FT   HELIX       185    201
FT   HELIX       203    205
FT   TURN        208    210
FT   HELIX       211    229
SQ   SEQUENCE   245 AA;  27745 MW;  D464DF2286BBFE60 CRC64;
     MDKNELVQKA KLAEQAERYD DMAACMKSVT EQGAELSNEE RNLLSVAYKN VVGARRSSWR
     VVSSIEQKTE GAEKKQQMAR EYREKIETEL RDICNDVLSL LEKFLIPNAS QAESKVFYLK
     MKGDYYRYLA EVAAGDDKKG IVDQSQQAYQ EAFEISKKEM QPTHPIRLGL ALNFSVFYYE
     ILNSPEKACS LAKTAFDEAI AELDTLSEES YKDSTLIMQL LRDNLTLWTS DTQGDEAEAG
     EGGEN
//
ID   1A01_HUMAN              Reviewed;         365 AA.
AC   P30443; O77964; O78171; Q9MYA3; Q9TP25; Q9TQP5;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 112.
DE   RecName: Full=HLA class I histocompatibility antigen, A-1 alpha chain;
DE   AltName: Full=MHC class I antigen A*1;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RX   MEDLINE=88234547; PubMed=3375250; DOI=10.1073/pnas.85.11.4005;
RA   Parham P., Lomen C.E., Lawlor D.A., Ways J.P., Holmes N., Coppin H.L.,
RA   Salter R.D., Wan A.M., Ennis P.D.;
RT   "Nature of polymorphism in HLA-A, -B, and -C molecules.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:4005-4009(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RA   Warren E.;
RL   Submitted (APR-1989) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*01:01).
RX   MEDLINE=91067475; PubMed=2251137; DOI=10.1093/nar/18.22.6701;
RA   Girdlestone J.;
RT   "Nucleotide sequence of an HLA-A1 gene.";
RL   Nucleic Acids Res. 18:6701-6701(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*01:01).
RX   MEDLINE=98007773; PubMed=9349617;
RX   DOI=10.1111/j.1399-0039.1997.tb02885.x;
RA   Laforet M., Froelich N., Parissiadis A., Pfeiffer B., Schell A.,
RA   Faller B., Woehl-Jaegle M.L., Cazenave J.-P., Tongio M.M.;
RT   "A nucleotide insertion in exon 4 is responsible for the absence of
RT   expression of an HLA-A*01 allele.";
RL   Tissue Antigens 50:347-350(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RA   Waller M.J., Robinson J., Marsh S.G.E.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE A*01:01).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*01:02).
RX   MEDLINE=95282145; PubMed=7761977;
RX   DOI=10.1111/j.1399-0039.1995.tb02437.x;
RA   Browning M.J., Madrigal J.A., Krausa P., Kowalski H., Allsopp C.E.,
RA   Little A.-M., Turner S., Adams E.J., Arnett K.L., Bodmer W.F.,
RA   Parham P.;
RT   "The HLA-A,B,C genotype of the class I negative cell line Daudi
RT   reveals novel HLA-A and -B alleles.";
RL   Tissue Antigens 45:177-187(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:03).
RX   MEDLINE=98101100; PubMed=9438203; DOI=10.1016/S0198-8859(97)00204-8;
RA   Sitha S., Scheltinga S.A., Johnston-Dow L.A., White C.B.,
RA   der van Zwan A.W., Bakema J.E., Rozemuller E.H., van der Tweel J.G.,
RA   Kronink M.N., Tilanus M.G.J.;
RT   "A generic sequencing based typing approach for the identification of
RT   HLA-A diversity.";
RL   Hum. Immunol. 57:120-128(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:03).
RC   TISSUE=Blood;
RX   MEDLINE=21100775; PubMed=11182232; DOI=10.1016/S0198-8859(00)00238-X;
RA   Poland G.A., Sohni Y., Domanico M., Kroning C.M., DeGoey S.R.,
RA   Jimale M., Jacobson R.M., Moore S.B.;
RT   "High frequency of HLA-A*0103 allele in a Somali population.";
RL   Hum. Immunol. 62:197-200(2001).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:06).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:07).
RA   Tamouza R., Fortier C., Mahfoudh N., Schaeffer V., Poirier J.C.,
RA   Marzais F., Gautreau C., Charron D.;
RT   "A new HLA-A*01 allele.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   SULFATION.
RX   MEDLINE=88088800; PubMed=3121736;
RA   Sant A.J., Zacheis M., Rumbarger T., Giacoletto K.S., Schwartz B.D.;
RT   "Human Ia alpha- and beta-chains are sulfated.";
RL   J. Immunol. 140:155-160(1988).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 25-298 IN COMPLEX WITH MAGE
RP   ANTIGENIC PEPTIDE AND ANTIBODY, AND DISULFIDE BONDS.
RX   PubMed=15537658; DOI=10.1074/jbc.M411323200;
RA   Hulsmeyer M., Chames P., Hillig R.C., Stanfield R.L., Held G.,
RA   Coulie P.G., Alings C., Wille G., Saenger W., Uchanska-Ziegler B.,
RA   Hoogenboom H.R., Ziegler A.;
RT   "A major histocompatibility complex-peptide-restricted antibody and t
RT   cell receptor molecules recognize their target by distinct binding
RT   modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1
RT   in complex with FAB-HYB3.";
RL   J. Biol. Chem. 280:2972-2980(2005).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Sulfated.
CC   -!- PTM: Polyubiquitinated in a post ER compartment through
CC       interaction with human herpesvirus 8 MIR1 protein. This targets
CC       the protein for rapid degradation via the ubiquitin system (By
CC       similarity).
CC   -!- POLYMORPHISM: The following alleles of A-1 are known: A*01:01,
CC       A*01:02, A*01:03, A*01:06 and A*01:07. The sequence shown is that
CC       of A*01:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24043; AAA59652.1; -; Genomic_DNA.
DR   EMBL; X55710; CAA39243.1; -; Genomic_DNA.
DR   EMBL; Z93949; CAB07989.1; -; Genomic_DNA.
DR   EMBL; AJ278305; CAB93537.1; -; Genomic_DNA.
DR   EMBL; BC003069; AAH03069.1; -; mRNA.
DR   EMBL; U07161; AAA80569.1; -; mRNA.
DR   EMBL; Y12469; CAA73072.1; -; Genomic_DNA.
DR   EMBL; Y12470; CAA73073.1; -; Genomic_DNA.
DR   EMBL; AF214112; AAF19525.1; -; Genomic_DNA.
DR   EMBL; AF214111; AAF19525.1; JOINED; Genomic_DNA.
DR   EMBL; AF143232; AAD33894.1; -; Genomic_DNA.
DR   EMBL; AF143231; AAD33894.1; JOINED; Genomic_DNA.
DR   EMBL; AF219633; AAF73862.1; -; Genomic_DNA.
DR   EMBL; AF219632; AAF73862.1; JOINED; Genomic_DNA.
DR   IPI; IPI00026569; -.
DR   PIR; I38518; I38518.
DR   PIR; I61856; I61856.
DR   RefSeq; NP_001229687.1; NM_001242758.1.
DR   UniGene; Hs.181244; -.
DR   PDB; 1W72; X-ray; 2.15 A; A/D=25-298.
DR   PDB; 3BO8; X-ray; 1.80 A; A=25-298.
DR   PDBsum; 1W72; -.
DR   PDBsum; 3BO8; -.
DR   ProteinModelPortal; P30443; -.
DR   SMR; P30443; 25-298.
DR   MINT; MINT-4655826; -.
DR   STRING; P30443; -.
DR   DMDM; 231347; -.
DR   PRIDE; P30443; -.
DR   DNASU; 3105; -.
DR   Ensembl; ENST00000431795; ENSP00000396220; ENSG00000229215.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   Ensembl; ENST00000448357; ENSP00000402461; ENSG00000224320.
DR   GeneID; 3105; -.
DR   KEGG; hsa:3105; -.
DR   UCSC; uc011ejp.2; human.
DR   CTD; 3105; -.
DR   GeneCards; GC06P029921; -.
DR   H-InvDB; HIX0165925; -.
DR   H-InvDB; HIX0166103; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30443; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   KO; K06751; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30443; -.
DR   NextBio; 12319; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30443; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Immunoglobulin domain; Membrane;
KW   MHC I; Polymorphism; Reference proteome; Signal; Sulfation;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-1 alpha chain.
FT                                /FTId=PRO_0000018813.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES      83     83       Sulfotyrosine (Potential).
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      33     33       F -> S (in allele A*01:02;
FT                                dbSNP:rs2075684).
FT                                /FTId=VAR_004332.
FT   VARIANT      41     41       R -> S (in allele A*01:02).
FT                                /FTId=VAR_004333.
FT   VARIANT      80     80       G -> R (in allele A*01:07).
FT                                /FTId=VAR_016719.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056247.
FT   VARIANT      91     91       M -> V (in allele A*01:07).
FT                                /FTId=VAR_016720.
FT   VARIANT     100    100       A -> E (in allele A*01:07).
FT                                /FTId=VAR_016721.
FT   VARIANT     114    114       D -> A (in allele A*01:07).
FT                                /FTId=VAR_016722.
FT   VARIANT     121    121       I -> M (in allele A*01:03).
FT                                /FTId=VAR_016723.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056248.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056249.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056250.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056251.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_056252.
FT   VARIANT     180    180       R -> L (in allele A*01:06).
FT                                /FTId=VAR_016724.
FT   VARIANT     182    182       V -> A (in allele A*01:06).
FT                                /FTId=VAR_016725.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056253.
FT   STRAND       27     38
FT   TURN         39     41
FT   STRAND       42     52
FT   STRAND       55     61
FT   STRAND       70     73
FT   HELIX        74     78
FT   HELIX        81    108
FT   STRAND      113    115
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   STRAND      250    254
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    297
SQ   SEQUENCE   365 AA;  40846 MW;  8667AFF3F06C4932 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQKME PRAPWIEQEG PEYWDQETRN MKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAVHAAEQR
     RVYLEGRCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A02_HUMAN              Reviewed;         365 AA.
AC   P01892; O19619; P06338; P10313; P30444; P30445; P30446; P30514;
AC   Q29680; Q29837; Q29899; Q95352; Q95380; Q9TPX8; Q9TPX9; Q9TPY0;
AC   Q9TQH5; Q9TQI3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   18-APR-2012, entry version 144.
DE   RecName: Full=HLA class I histocompatibility antigen, A-2 alpha chain;
DE   AltName: Full=MHC class I antigen A*2;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*02:01).
RX   MEDLINE=85132727; PubMed=2982951;
RA   Koller B.H., Orr H.T.;
RT   "Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-
RT   A alleles at the nucleotide level.";
RL   J. Immunol. 134:2727-2733(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*02:01).
RX   MEDLINE=89122144; PubMed=2914713; DOI=10.1007/BF00395855;
RA   Cianetti L., Testa U., Scotto L., la Valle R., Simeone A., Boccoli G.,
RA   Giannella G., Peschle C., Boncinelli E.;
RT   "Three new class I HLA alleles: structure of mRNAs and alternative
RT   mechanisms of processing.";
RL   Immunogenetics 29:80-91(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*02:01).
RX   MEDLINE=90207291; PubMed=2320591; DOI=10.1073/pnas.87.7.2833;
RA   Ennis P.D., Zemmour J., Salter R.D., Parham P.;
RT   "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction:
RT   frequency and nature of errors produced in amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 91-365.
RX   MEDLINE=86033791; PubMed=3863816;
RA   Davidson W.F., Kress M., Khoury G., Jay G.;
RT   "Comparison of HLA class I gene sequences. Derivation of locus-
RT   specific oligonucleotide probes specific for HLA-A, HLA-B, and HLA-C
RT   genes.";
RL   J. Biol. Chem. 260:13414-13423(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELES A*02:01; A*02:11 AND A*02:12).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 39-365 (ALLELE A*02:01).
RX   MEDLINE=85230571; PubMed=3874058;
RA   Krangel M.S.;
RT   "Unusual RNA splicing generates a secreted form of HLA-A2 in a
RT   mutagenized B lymphoblastoid cell line.";
RL   EMBO J. 4:1205-1210(1985).
RN   [7]
RP   PROTEIN SEQUENCE OF 25-295 (ALLELE A*02:01).
RX   MEDLINE=80056745; PubMed=92029; DOI=10.1073/pnas.76.9.4395;
RA   Orr H.T., Lopez de Castro J.A., Parham P., Ploegh H.L.,
RA   Strominger J.L.;
RT   "Comparison of amino acid sequences of two human histocompatibility
RT   antigens, HLA-A2 and HLA-B7: location of putative alloantigenic
RT   sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:4395-4399(1979).
RN   [8]
RP   SEQUENCE REVISION (ALLELE A*02:01).
RX   MEDLINE=82247941; PubMed=6179086; DOI=10.1073/pnas.79.12.3813;
RA   Lopez de Castro J.A., Strominger J.L., Strong D.M., Orr H.T.;
RT   "Structure of crossreactive human histocompatibility antigens HLA-A28
RT   and HLA-A2: possible implications for the generation of HLA
RT   polymorphism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:3813-3817(1982).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*02:01).
RC   TISSUE=Blood;
RX   MEDLINE=95137784; PubMed=7836067; DOI=10.1016/0198-8859(94)90087-6;
RA   Balas A., Garcia-Sanchez F., Gomez-Reino F., Vicario J.L.;
RT   "HLA class I allele (HLA-A2) expression defect associated with a
RT   mutation in its enhancer B inverted CAT box in two families.";
RL   Hum. Immunol. 41:69-73(1994).
RN   [10]
RP   SEQUENCE REVISION.
RA   Balas A.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*02:01).
RA   Cox S.T.;
RT   "Confirmation of HLA-A*0201.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-298 (ALLELES A*02:02 AND
RP   A*02:03).
RX   MEDLINE=87306734; PubMed=3497874; DOI=10.1007/BF00365911;
RA   Mattson D.H., Handy D.E., Bradley D.A., Coligan J.E., Cowan E.P.,
RA   Biddison W.E.;
RT   "DNA sequences of the genes that encode the CTL-defined HLA-A2
RT   variants M7 and DK1.";
RL   Immunogenetics 26:190-192(1987).
RN   [13]
RP   NUCLEOTIDE SEQUENCE (ALLELES A*02:03 AND A*02:05).
RX   MEDLINE=87252273; PubMed=3496393;
RA   Holmes N., Ennis P., Wan A.M., Denney D.W., Parham P.;
RT   "Multiple genetic mechanisms have contributed to the generation of the
RT   HLA-A2/A28 family of class I MHC molecules.";
RL   J. Immunol. 139:936-941(1987).
RN   [14]
RP   NUCLEOTIDE SEQUENCE (ALLELES A*02:03 AND A*02:05).
RA   Domena J.D.;
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-365 (ALLELE A*02:04).
RX   MEDLINE=92039809; PubMed=1937577; DOI=10.1007/BF00211991;
RA   Castano A.R., Lopez de Castro J.A.;
RT   "Structure of the HLA-A*0204 antigen, found in South American Indians.
RT   Spatial clustering of HLA-A2 subtype polymorphism.";
RL   Immunogenetics 34:281-285(1991).
RN   [16]
RP   NUCLEOTIDE SEQUENCE OF 9-365 (ALLELE A*02:04).
RX   MEDLINE=92269956; PubMed=1589035; DOI=10.1038/357329a0;
RA   Watkins D.I., McAdam S.N., Liu X., Stang C.R., Milford E.L.,
RA   Levine C.G., Garber T.L., Dogon A.L., Lord C.I., Ghim S.H.,
RA   Troup G.M., Hughes A.L., Letvin N.L.;
RT   "New recombinant HLA-B alleles in a tribe of South American
RT   Amerindians indicate rapid evolution of MHC class I loci.";
RL   Nature 357:329-333(1992).
RN   [17]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*02:06).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [18]
RP   PARTIAL PROTEIN SEQUENCE (ALLELE A*02:06).
RX   MEDLINE=86305811; PubMed=3489037;
RA   Ezquerra A., Domenech N., van der Poel J., Strominger J.L., Vega M.A.,
RA   Lopez de Castro J.A.;
RT   "Molecular analysis of an HLA-A2 functional variant CLA defined by
RT   cytolytic T lymphocytes.";
RL   J. Immunol. 137:1642-1649(1986).
RN   [19]
RP   PARTIAL PROTEIN SEQUENCE (ALLELE A*02:07).
RX   MEDLINE=88113844; PubMed=2448239; DOI=10.1007/BF00346586;
RA   Domenech N., Ezquerra A., Castano R., Lopez de Castro J.A.;
RT   "Structural analysis of HLA-A2.4 functional variant KNE. Implications
RT   for the mapping of HLA-A2-specific T-cell epitopes.";
RL   Immunogenetics 27:196-202(1988).
RN   [20]
RP   PARTIAL PROTEIN SEQUENCE (ALLELE A*02:08).
RX   MEDLINE=88314183; PubMed=2457548; DOI=10.1007/BF00375853;
RA   Domenech N., Castano R., Goulmy E., Lopez de Castro J.A.;
RT   "Molecular analysis of HLA-A2.4 functional variant KLO: close
RT   structural and evolutionary relatedness to the HLA-A2.2 subtype.";
RL   Immunogenetics 28:143-152(1988).
RN   [21]
RP   PARTIAL PROTEIN SEQUENCE (ALLELE A*02:09).
RX   MEDLINE=88186100; PubMed=3258580; DOI=10.1007/BF00395130;
RA   Castano R., Ezquerra A., Domenech N., Lopez de Castro J.A.;
RT   "An HLA-A2 population variant with structural polymorphism in the
RT   alpha 3 region.";
RL   Immunogenetics 27:345-355(1988).
RN   [22]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*02:10).
RX   MEDLINE=89122133; PubMed=2783680; DOI=10.1007/BF00395859;
RA   Epstein H., Kennedy L., Holmes N.;
RT   "An Oriental HLA-A2 subtype is closely related to a subset of
RT   Caucasoid HLA-A2 alleles.";
RL   Immunogenetics 29:112-116(1989).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-365 (ALLELE A*02:11).
RX   MEDLINE=92218010; PubMed=1559719; DOI=10.1007/BF00189898;
RA   Castano A.R., Lopez de Castro J.A.;
RT   "Structure of the HLA-A*0211 (A2.5) subtype: further evidence for
RT   selection-driven diversification of HLA-A2 antigens.";
RL   Immunogenetics 35:344-346(1992).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*02:13).
RX   MEDLINE=94222455; PubMed=8168863; DOI=10.1007/BF00189243;
RA   Barber D.F., Fernandez J.M., Lopez de Castro J.A.;
RT   "Primary structure of a new HLA-A2 subtype: HLA-A*0213.";
RL   Immunogenetics 39:378-378(1994).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*02:16).
RX   MEDLINE=95278976; PubMed=7759139; DOI=10.1007/BF00164000;
RA   Barouch D., Krausa P., Bodmer J., Browning M.J., McMichael A.J.;
RT   "Identification of a novel HLA-A2 subtype, HLA-A*0216.";
RL   Immunogenetics 41:388-388(1995).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*02:17).
RC   TISSUE=Blood;
RX   MEDLINE=95381236; PubMed=7652742;
RX   DOI=10.1111/j.1399-0039.1995.tb02464.x;
RA   Selvakumar A., Granja C.B., Salazar M., Alosco S.M., Yunis E.J.,
RA   Dupont B.;
RT   "A novel subtype of A2 (A*0217) isolated from the South American
RT   Indian B-cell line AMALA.";
RL   Tissue Antigens 45:343-347(1995).
RN   [27]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*02:18).
RC   TISSUE=Blood;
RA   Kashiwase K., Tokunaga K., Ishikawa Y., Oohashi H., Hashimoto M.,
RA   Akaza T., Tadokoro K., Juji T.;
RT   "A new A2 sequence HLA-A2K from Japanese.";
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [28]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*02:20).
RC   TISSUE=Blood;
RX   MEDLINE=97161038; PubMed=9008310;
RX   DOI=10.1111/j.1399-0039.1996.tb02691.x;
RA   Fleischhauer K., Zino E., Mazzi B., Severini G.M., Benazzi E.,
RA   Bordignon C.;
RT   "HLA-A*02 subtype distribution in Caucasians from northern Italy:
RT   identification of A*0220.";
RL   Tissue Antigens 48:673-679(1996).
RN   [29]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*02:21).
RC   TISSUE=Blood;
RA   Szmania S., Baxter-Lowe L.A.;
RT   "Nucleotide sequence of a novel HLA-A2 gene.";
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [30]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*02:31).
RX   MEDLINE=20156437; PubMed=10689125; DOI=10.1016/S0198-8859(99)00155-X;
RA   Ellis J.M., Henson V., Slack R., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Frequencies of HLA-A2 alleles in five U.S. population groups.
RT   Predominance Of A*02011 and identification of HLA-A*0231.";
RL   Hum. Immunol. 61:334-340(2000).
RN   [31]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-298 (ALLELE A*02:34).
RX   MEDLINE=20208581; PubMed=10746792;
RX   DOI=10.1034/j.1399-0039.2000.550212.x;
RA   Moses J.H., Greville W.D., Downes J., McClenahan W., Kennedy A.,
RA   Dunckley H.;
RT   "A new HLA-A*02 allele, A*0234, detected by polymerase chain reaction
RT   using sequence-specific primers (PCR-SSP).";
RL   Tissue Antigens 55:175-177(2000).
RN   [32]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*02:35; A*02:36 AND A*02:37).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352 AND SER-356, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352 AND SER-356, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [35]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF A*02:01.
RX   MEDLINE=88014204; PubMed=3309677; DOI=10.1038/329506a0;
RA   Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L.,
RA   Wiley D.C.;
RT   "Structure of the human class I histocompatibility antigen, HLA-A2.";
RL   Nature 329:506-512(1987).
RN   [37]
RP   INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P12I.
RX   PubMed=11390610; DOI=10.1128/JVI.75.13.6086-6094.2001;
RA   Johnson J.M., Nicot C., Fullen J., Ciminale V., Casareto L.,
RA   Mulloy J.C., Jacobson S., Franchini G.;
RT   "Free major histocompatibility complex class I heavy chain is
RT   preferentially targeted for degradation by human T-cell
RT   leukemia/lymphotropic virus type 1 p12(I) protein.";
RL   J. Virol. 75:6086-6094(2001).
RN   [38]
RP   INTERACTION WITH HUMAN HERPESVIRUS 8 MIR1 PROTEIN, AND UBIQUITINATION.
RX   PubMed=12006494; DOI=10.1093/emboj/21.10.2418;
RA   Hewitt E.W., Duncan L., Mufti D., Baker J., Stevenson P.G.,
RA   Lehner P.J.;
RT   "Ubiquitylation of MHC class I by the K3 viral protein signals
RT   internalization and TSG101-dependent degradation.";
RL   EMBO J. 21:2418-2429(2002).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 25-300 OF HLA-A/B2M
RP   HETERODIMER IN COMPLEX WITH TRAC AND TRBC1, AND DISULFIDE BONDS.
RX   PubMed=12796775; DOI=10.1038/ni942;
RA   Stewart-Jones G.B.E., McMichael A.J., Bell J.I., Stuart D.I.,
RA   Jones E.Y.;
RT   "A structural basis for immunodominant human T cell receptor
RT   recognition.";
RL   Nat. Immunol. 4:657-663(2003).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF A*02:01.
RX   MEDLINE=91245570; PubMed=2038058; DOI=10.1016/0022-2836(91)90567-P;
RA   Saper M.A., Bjorkman P.J., Wiley D.C.;
RT   "Refined structure of the human histocompatibility antigen HLA-A2 at
RT   2.6-A resolution.";
RL   J. Mol. Biol. 219:277-319(1991).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein.
CC       Interacts with HTLV-1 accessory protein p12I.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment through
CC       interaction with human herpesvirus 8 MIR1 protein. This targets
CC       the protein for rapid degradation via the ubiquitin system.
CC   -!- POLYMORPHISM: The following alleles of A-2 are known: A*02:01,
CC       A*02:02, A*02:03, A*02:04, A*02:05, A*02:06 (A2.4A), A*02:07,
CC       A*02:08, A*02:09, A*02:10, A*02:11 (A2.5), A*02:12, A*02:13
CC       (A*02SLU), A*02:16, A*02:17, A*02:18 (A2K), A*02:19, A*02:20,
CC       A*02:21, A*02:31, A*02:34 (A*AAT), A*02:35, A*02:36 and A*02:37.
CC       The sequence shown is that of A*02:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA41022.1; Type=Miscellaneous discrepancy; Note=The sequence differs from that shown extensively;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02883; AAA98727.1; -; Genomic_DNA.
DR   EMBL; M84379; AAA59606.1; -; mRNA.
DR   EMBL; X02457; CAA26297.1; -; mRNA.
DR   EMBL; M11887; AAA52656.1; -; mRNA.
DR   EMBL; M19670; AAA03683.2; -; Genomic_DNA.
DR   EMBL; M17690; AAB02120.1; -; Genomic_DNA.
DR   EMBL; U03863; AAA03604.1; -; mRNA.
DR   EMBL; M86404; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X57954; CAA41022.1; ALT_SEQ; mRNA.
DR   EMBL; U02935; AAA76608.2; -; Genomic_DNA.
DR   EMBL; AJ555412; CAD87771.1; -; Genomic_DNA.
DR   EMBL; U03862; AAA03603.1; -; mRNA.
DR   EMBL; M24042; AAA59653.1; -; mRNA.
DR   EMBL; Z23071; CAA80612.1; -; mRNA.
DR   EMBL; M84377; AAA59603.1; -; mRNA.
DR   EMBL; X60764; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M84378; AAA59604.1; -; mRNA.
DR   EMBL; Z27120; CAA81644.1; -; mRNA.
DR   EMBL; Z46633; CAA86602.1; -; mRNA.
DR   EMBL; U18930; AAA87076.1; -; mRNA.
DR   EMBL; D83515; BAA11935.1; -; mRNA.
DR   EMBL; X96724; CAA65501.1; -; mRNA.
DR   EMBL; U56825; AAB17465.1; -; mRNA.
DR   EMBL; AF113924; AAD23437.1; -; Genomic_DNA.
DR   EMBL; AF113923; AAD23437.1; JOINED; Genomic_DNA.
DR   EMBL; AF129431; AAD30272.1; -; Genomic_DNA.
DR   EMBL; AF129429; AAD30272.1; JOINED; Genomic_DNA.
DR   EMBL; AF129430; AAD30272.1; JOINED; Genomic_DNA.
DR   EMBL; AF157311; AAD45690.1; -; Genomic_DNA.
DR   EMBL; AF157310; AAD45690.1; JOINED; Genomic_DNA.
DR   EMBL; AF157309; AAD45689.1; -; Genomic_DNA.
DR   EMBL; AF157308; AAD45689.1; JOINED; Genomic_DNA.
DR   EMBL; AF157564; AAD45324.1; -; Genomic_DNA.
DR   EMBL; AF157563; AAD45324.1; JOINED; Genomic_DNA.
DR   IPI; IPI00876963; -.
DR   PIR; B24512; HLHU10.
DR   PIR; I37470; I37470.
DR   PIR; I37542; I37542.
DR   PIR; I38418; I38418.
DR   PIR; I38442; I38442.
DR   PIR; I38443; I38443.
DR   PIR; I55948; HLHUA2.
DR   PIR; I61857; I61857.
DR   PIR; I61902; I61902.
DR   PIR; I84448; I84448.
DR   UniGene; Hs.181244; -.
DR   PDB; 1AKJ; X-ray; 2.65 A; A=25-300.
DR   PDB; 1AO7; X-ray; 2.60 A; A=25-299.
DR   PDB; 1AQD; X-ray; 2.45 A; C/F/I/L=127-141.
DR   PDB; 1B0G; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1B0R; X-ray; 2.90 A; A=25-299.
DR   PDB; 1BD2; X-ray; 2.50 A; A=25-299.
DR   PDB; 1DUY; X-ray; 2.15 A; A/D=25-299.
DR   PDB; 1DUZ; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1EEY; X-ray; 2.25 A; A/D=25-299.
DR   PDB; 1EEZ; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 1HHG; X-ray; 2.60 A; A/D=25-299.
DR   PDB; 1HHH; X-ray; 3.00 A; A=25-299.
DR   PDB; 1HHI; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1HHJ; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1HHK; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1HLA; X-ray; 3.50 A; A=25-294.
DR   PDB; 1I1F; X-ray; 2.80 A; A/D=25-299.
DR   PDB; 1I1Y; X-ray; 2.20 A; A/D=25-299.
DR   PDB; 1I4F; X-ray; 1.40 A; A=25-299.
DR   PDB; 1I7R; X-ray; 2.20 A; A/D=25-299.
DR   PDB; 1I7T; X-ray; 2.80 A; A/D=25-299.
DR   PDB; 1I7U; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1IM3; X-ray; 2.20 A; A/E/I/M=25-299.
DR   PDB; 1JF1; X-ray; 1.85 A; A=25-299.
DR   PDB; 1JHT; X-ray; 2.15 A; A=25-299.
DR   PDB; 1LP9; X-ray; 2.00 A; A/H=25-299.
DR   PDB; 1OGA; X-ray; 1.40 A; A=25-300.
DR   PDB; 1P7Q; X-ray; 3.40 A; A=25-300.
DR   PDB; 1QEW; X-ray; 2.20 A; A=25-299.
DR   PDB; 1QR1; X-ray; 2.40 A; A/D=25-299.
DR   PDB; 1QRN; X-ray; 2.80 A; A=25-298.
DR   PDB; 1QSE; X-ray; 2.80 A; A=25-298.
DR   PDB; 1QSF; X-ray; 2.80 A; A=25-298.
DR   PDB; 1S8D; X-ray; 2.20 A; A=25-299.
DR   PDB; 1S9W; X-ray; 2.20 A; A=25-298.
DR   PDB; 1S9X; X-ray; 2.50 A; A=25-298.
DR   PDB; 1S9Y; X-ray; 2.30 A; A=25-298.
DR   PDB; 1T1W; X-ray; 2.20 A; A=25-299.
DR   PDB; 1T1X; X-ray; 2.20 A; A=25-299.
DR   PDB; 1T1Y; X-ray; 2.00 A; A=25-299.
DR   PDB; 1T1Z; X-ray; 1.90 A; A=25-299.
DR   PDB; 1T20; X-ray; 2.20 A; A=25-299.
DR   PDB; 1T21; X-ray; 2.19 A; A=25-299.
DR   PDB; 1T22; X-ray; 2.20 A; A=25-299.
DR   PDB; 1TVB; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1TVH; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1UR7; Model; -; A=25-299.
DR   PDB; 2AV1; X-ray; 1.95 A; A/D=25-299.
DR   PDB; 2AV7; X-ray; 2.05 A; A/D=25-299.
DR   PDB; 2BNQ; X-ray; 1.70 A; A=25-300.
DR   PDB; 2BNR; X-ray; 1.90 A; A=25-300.
DR   PDB; 2C7U; X-ray; 2.38 A; A/D=25-300.
DR   PDB; 2CLR; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 2F53; X-ray; 2.10 A; A=25-299.
DR   PDB; 2F54; X-ray; 2.70 A; A/F=25-298.
DR   PDB; 2GIT; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 2GJ6; X-ray; 2.56 A; A=25-299.
DR   PDB; 2GT9; X-ray; 1.75 A; A/D=25-299.
DR   PDB; 2GTW; X-ray; 1.55 A; A/D=25-299.
DR   PDB; 2GTZ; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 2GUO; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 2J8U; X-ray; 2.88 A; A/H=25-299.
DR   PDB; 2JCC; X-ray; 2.50 A; A/H=25-299.
DR   PDB; 2P5E; X-ray; 1.89 A; A=25-300.
DR   PDB; 2P5W; X-ray; 2.20 A; A=25-300.
DR   PDB; 2PYE; X-ray; 2.30 A; A=25-300.
DR   PDB; 2UWE; X-ray; 2.40 A; A/H=25-299.
DR   PDB; 2V2W; X-ray; 1.60 A; A/D=25-300.
DR   PDB; 2V2X; X-ray; 1.60 A; A/D=25-300.
DR   PDB; 2VLJ; X-ray; 2.40 A; A=25-300.
DR   PDB; 2VLK; X-ray; 2.50 A; A=25-300.
DR   PDB; 2VLL; X-ray; 1.60 A; A/D=25-300.
DR   PDB; 2VLR; X-ray; 2.30 A; A/F=25-300.
DR   PDB; 2X4N; X-ray; 2.34 A; A/D=25-299.
DR   PDB; 2X4O; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4P; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4Q; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 2X4R; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4S; X-ray; 2.55 A; A/D=25-299.
DR   PDB; 2X4T; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4U; X-ray; 2.10 A; A/D=25-299.
DR   PDB; 2X70; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3BGM; X-ray; 1.60 A; A=25-298.
DR   PDB; 3BH8; X-ray; 1.65 A; A=25-298.
DR   PDB; 3BH9; X-ray; 1.70 A; A=25-299.
DR   PDB; 3BHB; X-ray; 2.20 A; A=25-298.
DR   PDB; 3D25; X-ray; 1.30 A; A=25-298.
DR   PDB; 3D39; X-ray; 2.81 A; A=25-299.
DR   PDB; 3D3V; X-ray; 2.80 A; A=25-299.
DR   PDB; 3FQN; X-ray; 1.65 A; A=25-299.
DR   PDB; 3FQR; X-ray; 1.70 A; A=25-299.
DR   PDB; 3FQT; X-ray; 1.80 A; A=25-299.
DR   PDB; 3FQU; X-ray; 1.80 A; A=25-299.
DR   PDB; 3FQW; X-ray; 1.93 A; A=25-299.
DR   PDB; 3FQX; X-ray; 1.70 A; A=25-299.
DR   PDB; 3FT2; X-ray; 1.80 A; A=25-299.
DR   PDB; 3FT3; X-ray; 1.95 A; A=25-299.
DR   PDB; 3FT4; X-ray; 1.90 A; A=25-299.
DR   PDB; 3GIV; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3GJF; X-ray; 1.90 A; A/D=25-300.
DR   PDB; 3GSN; X-ray; 2.80 A; H=25-298.
DR   PDB; 3GSO; X-ray; 1.60 A; A=25-298.
DR   PDB; 3GSQ; X-ray; 2.12 A; A=25-298.
DR   PDB; 3GSR; X-ray; 1.95 A; A=25-298.
DR   PDB; 3GSU; X-ray; 1.80 A; A=25-299.
DR   PDB; 3GSV; X-ray; 1.90 A; A=25-299.
DR   PDB; 3GSW; X-ray; 1.81 A; A=25-298.
DR   PDB; 3GSX; X-ray; 2.10 A; A=25-298.
DR   PDB; 3H7B; X-ray; 1.88 A; A/D=25-299.
DR   PDB; 3H9H; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3H9S; X-ray; 2.70 A; A=25-299.
DR   PDB; 3HAE; X-ray; 2.90 A; A/D/J/P=25-300.
DR   PDB; 3HG1; X-ray; 3.00 A; A=25-300.
DR   PDB; 3HLA; X-ray; 2.60 A; A=25-294.
DR   PDB; 3HPJ; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3I6G; X-ray; 2.20 A; A/D=25-299.
DR   PDB; 3I6K; X-ray; 2.80 A; A/E=25-299.
DR   PDB; 3IXA; X-ray; 2.10 A; A/D=25-299.
DR   PDB; 3KLA; X-ray; 1.65 A; A/D=25-299.
DR   PDB; 3MGO; X-ray; 2.30 A; A/D/G/J=25-299.
DR   PDB; 3MGT; X-ray; 2.20 A; A/D/G/J=25-299.
DR   PDB; 3MR9; X-ray; 1.93 A; A=25-300.
DR   PDB; 3MRB; X-ray; 1.40 A; A=25-300.
DR   PDB; 3MRC; X-ray; 1.80 A; A=25-300.
DR   PDB; 3MRD; X-ray; 1.70 A; A=25-300.
DR   PDB; 3MRE; X-ray; 1.10 A; A=25-300.
DR   PDB; 3MRF; X-ray; 2.30 A; A=25-300.
DR   PDB; 3MRG; X-ray; 1.30 A; A=25-300.
DR   PDB; 3MRH; X-ray; 2.40 A; A=25-300.
DR   PDB; 3MRI; X-ray; 2.10 A; A=25-300.
DR   PDB; 3MRJ; X-ray; 1.87 A; A=25-300.
DR   PDB; 3MRK; X-ray; 1.40 A; A=25-300.
DR   PDB; 3MRL; X-ray; 2.41 A; A=25-300.
DR   PDB; 3MRM; X-ray; 1.90 A; A=25-300.
DR   PDB; 3MRN; X-ray; 2.30 A; A=25-300.
DR   PDB; 3MRO; X-ray; 2.35 A; A=25-300.
DR   PDB; 3MRP; X-ray; 2.10 A; A=25-300.
DR   PDB; 3MRQ; X-ray; 2.20 A; A=25-300.
DR   PDB; 3MRR; X-ray; 1.60 A; A=25-300.
DR   PDB; 3MYJ; X-ray; 1.89 A; A/D=25-299.
DR   PDB; 3O3A; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 3O3B; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 3O3D; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 3O3E; X-ray; 1.85 A; A/D=25-299.
DR   PDB; 3O4L; X-ray; 2.54 A; A=25-300.
DR   PDB; 3PWJ; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 3PWL; X-ray; 1.65 A; A/D=25-299.
DR   PDB; 3PWN; X-ray; 1.60 A; A/D=25-299.
DR   PDB; 3PWP; X-ray; 2.69 A; A=25-299.
DR   PDB; 3QDG; X-ray; 2.69 A; A=25-299.
DR   PDB; 3QDJ; X-ray; 2.30 A; A=25-299.
DR   PDB; 3QDM; X-ray; 2.80 A; A=25-299.
DR   PDB; 3QEQ; X-ray; 2.59 A; A=25-299.
DR   PDB; 3QFD; X-ray; 1.68 A; A/D=25-299.
DR   PDB; 3QFJ; X-ray; 2.29 A; A=25-299.
DR   PDB; 3REW; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 3UTQ; X-ray; 1.67 A; A=25-300.
DR   PDB; 3UTS; X-ray; 2.71 A; A/F=25-300.
DR   PDB; 3UTT; X-ray; 2.60 A; A/F=25-299.
DR   PDBsum; 1AKJ; -.
DR   PDBsum; 1AO7; -.
DR   PDBsum; 1AQD; -.
DR   PDBsum; 1B0G; -.
DR   PDBsum; 1B0R; -.
DR   PDBsum; 1BD2; -.
DR   PDBsum; 1DUY; -.
DR   PDBsum; 1DUZ; -.
DR   PDBsum; 1EEY; -.
DR   PDBsum; 1EEZ; -.
DR   PDBsum; 1HHG; -.
DR   PDBsum; 1HHH; -.
DR   PDBsum; 1HHI; -.
DR   PDBsum; 1HHJ; -.
DR   PDBsum; 1HHK; -.
DR   PDBsum; 1HLA; -.
DR   PDBsum; 1I1F; -.
DR   PDBsum; 1I1Y; -.
DR   PDBsum; 1I4F; -.
DR   PDBsum; 1I7R; -.
DR   PDBsum; 1I7T; -.
DR   PDBsum; 1I7U; -.
DR   PDBsum; 1IM3; -.
DR   PDBsum; 1JF1; -.
DR   PDBsum; 1JHT; -.
DR   PDBsum; 1LP9; -.
DR   PDBsum; 1OGA; -.
DR   PDBsum; 1P7Q; -.
DR   PDBsum; 1QEW; -.
DR   PDBsum; 1QR1; -.
DR   PDBsum; 1QRN; -.
DR   PDBsum; 1QSE; -.
DR   PDBsum; 1QSF; -.
DR   PDBsum; 1S8D; -.
DR   PDBsum; 1S9W; -.
DR   PDBsum; 1S9X; -.
DR   PDBsum; 1S9Y; -.
DR   PDBsum; 1T1W; -.
DR   PDBsum; 1T1X; -.
DR   PDBsum; 1T1Y; -.
DR   PDBsum; 1T1Z; -.
DR   PDBsum; 1T20; -.
DR   PDBsum; 1T21; -.
DR   PDBsum; 1T22; -.
DR   PDBsum; 1TVB; -.
DR   PDBsum; 1TVH; -.
DR   PDBsum; 1UR7; -.
DR   PDBsum; 2AV1; -.
DR   PDBsum; 2AV7; -.
DR   PDBsum; 2BNQ; -.
DR   PDBsum; 2BNR; -.
DR   PDBsum; 2C7U; -.
DR   PDBsum; 2CLR; -.
DR   PDBsum; 2F53; -.
DR   PDBsum; 2F54; -.
DR   PDBsum; 2GIT; -.
DR   PDBsum; 2GJ6; -.
DR   PDBsum; 2GT9; -.
DR   PDBsum; 2GTW; -.
DR   PDBsum; 2GTZ; -.
DR   PDBsum; 2GUO; -.
DR   PDBsum; 2J8U; -.
DR   PDBsum; 2JCC; -.
DR   PDBsum; 2P5E; -.
DR   PDBsum; 2P5W; -.
DR   PDBsum; 2PYE; -.
DR   PDBsum; 2UWE; -.
DR   PDBsum; 2V2W; -.
DR   PDBsum; 2V2X; -.
DR   PDBsum; 2VLJ; -.
DR   PDBsum; 2VLK; -.
DR   PDBsum; 2VLL; -.
DR   PDBsum; 2VLR; -.
DR   PDBsum; 2X4N; -.
DR   PDBsum; 2X4O; -.
DR   PDBsum; 2X4P; -.
DR   PDBsum; 2X4Q; -.
DR   PDBsum; 2X4R; -.
DR   PDBsum; 2X4S; -.
DR   PDBsum; 2X4T; -.
DR   PDBsum; 2X4U; -.
DR   PDBsum; 2X70; -.
DR   PDBsum; 3BGM; -.
DR   PDBsum; 3BH8; -.
DR   PDBsum; 3BH9; -.
DR   PDBsum; 3BHB; -.
DR   PDBsum; 3D25; -.
DR   PDBsum; 3D39; -.
DR   PDBsum; 3D3V; -.
DR   PDBsum; 3FQN; -.
DR   PDBsum; 3FQR; -.
DR   PDBsum; 3FQT; -.
DR   PDBsum; 3FQU; -.
DR   PDBsum; 3FQW; -.
DR   PDBsum; 3FQX; -.
DR   PDBsum; 3FT2; -.
DR   PDBsum; 3FT3; -.
DR   PDBsum; 3FT4; -.
DR   PDBsum; 3GIV; -.
DR   PDBsum; 3GJF; -.
DR   PDBsum; 3GSN; -.
DR   PDBsum; 3GSO; -.
DR   PDBsum; 3GSQ; -.
DR   PDBsum; 3GSR; -.
DR   PDBsum; 3GSU; -.
DR   PDBsum; 3GSV; -.
DR   PDBsum; 3GSW; -.
DR   PDBsum; 3GSX; -.
DR   PDBsum; 3H7B; -.
DR   PDBsum; 3H9H; -.
DR   PDBsum; 3H9S; -.
DR   PDBsum; 3HAE; -.
DR   PDBsum; 3HG1; -.
DR   PDBsum; 3HLA; -.
DR   PDBsum; 3HPJ; -.
DR   PDBsum; 3I6G; -.
DR   PDBsum; 3I6K; -.
DR   PDBsum; 3IXA; -.
DR   PDBsum; 3KLA; -.
DR   PDBsum; 3MGO; -.
DR   PDBsum; 3MGT; -.
DR   PDBsum; 3MR9; -.
DR   PDBsum; 3MRB; -.
DR   PDBsum; 3MRC; -.
DR   PDBsum; 3MRD; -.
DR   PDBsum; 3MRE; -.
DR   PDBsum; 3MRF; -.
DR   PDBsum; 3MRG; -.
DR   PDBsum; 3MRH; -.
DR   PDBsum; 3MRI; -.
DR   PDBsum; 3MRJ; -.
DR   PDBsum; 3MRK; -.
DR   PDBsum; 3MRL; -.
DR   PDBsum; 3MRM; -.
DR   PDBsum; 3MRN; -.
DR   PDBsum; 3MRO; -.
DR   PDBsum; 3MRP; -.
DR   PDBsum; 3MRQ; -.
DR   PDBsum; 3MRR; -.
DR   PDBsum; 3MYJ; -.
DR   PDBsum; 3O3A; -.
DR   PDBsum; 3O3B; -.
DR   PDBsum; 3O3D; -.
DR   PDBsum; 3O3E; -.
DR   PDBsum; 3O4L; -.
DR   PDBsum; 3PWJ; -.
DR   PDBsum; 3PWL; -.
DR   PDBsum; 3PWN; -.
DR   PDBsum; 3PWP; -.
DR   PDBsum; 3QDG; -.
DR   PDBsum; 3QDJ; -.
DR   PDBsum; 3QDM; -.
DR   PDBsum; 3QEQ; -.
DR   PDBsum; 3QFD; -.
DR   PDBsum; 3QFJ; -.
DR   PDBsum; 3REW; -.
DR   PDBsum; 3UTQ; -.
DR   PDBsum; 3UTS; -.
DR   PDBsum; 3UTT; -.
DR   ProteinModelPortal; P01892; -.
DR   SMR; P01892; 25-298.
DR   DIP; DIP-6085N; -.
DR   IntAct; P01892; 5.
DR   MINT; MINT-5000859; -.
DR   STRING; P01892; -.
DR   PhosphoSite; P01892; -.
DR   DMDM; 122138; -.
DR   PRIDE; P01892; -.
DR   Ensembl; ENST00000412679; ENSP00000399020; ENSG00000235657.
DR   Ensembl; ENST00000457879; ENSP00000403575; ENSG00000235657.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pk29899; -.
DR   H-InvDB; HIX0166393; -.
DR   H-InvDB; HIX0166937; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P01892; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_116125; Disease.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P01892; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P01892; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral reproduction; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Host-virus interaction; Immunity;
KW   Membrane; MHC I; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-2 alpha chain.
FT                                /FTId=PRO_0000018814.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     352    352       Phosphoserine.
FT   MOD_RES     356    356       Phosphoserine.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      33     33       F -> Y (in allele A*02:05, allele
FT                                A*02:06, allele A*02:08, allele A*02:10
FT                                and allele A*02:21).
FT                                /FTId=VAR_004334.
FT   VARIANT      54     54       D -> N (in allele A*02:21).
FT                                /FTId=VAR_004335.
FT   VARIANT      65     65       A -> G (in allele A*02:31).
FT                                /FTId=VAR_016726.
FT   VARIANT      67     67       Q -> R (in allele A*02:02, allele A*02:05
FT                                and allele A*02:08).
FT                                /FTId=VAR_004336.
FT   VARIANT      90     90       K -> N (in allele A*02:08 and allele
FT                                A*02:20).
FT                                /FTId=VAR_004337.
FT   VARIANT      94     94       H -> Q (in allele A*02:34 and allele
FT                                A*02:35).
FT                                /FTId=VAR_016727.
FT   VARIANT      97     97       T -> I (in allele A*02:11).
FT                                /FTId=VAR_004338.
FT   VARIANT      98     98       H -> D (in allele A*02:11 and allele
FT                                A*02:35).
FT                                /FTId=VAR_016728.
FT   VARIANT     119    119       V -> L (in allele A*02:02, allele
FT                                A*02:05, allele A*02:08 and allele
FT                                A*02:17).
FT                                /FTId=VAR_004339.
FT   VARIANT     121    121       R -> M (in allele A*02:04 and allele
FT                                A*02:17).
FT                                /FTId=VAR_004340.
FT   VARIANT     123    123       Y -> C (in allele A*02:07 and allele
FT                                A*02:18).
FT                                /FTId=VAR_004341.
FT   VARIANT     123    123       Y -> F (in allele A*02:10 and allele
FT                                A*02:17).
FT                                /FTId=VAR_004342.
FT   VARIANT     131    131       W -> G (in allele A*02:10).
FT                                /FTId=VAR_004343.
FT   VARIANT     162    162       M -> K (in allele A*02:18).
FT                                /FTId=VAR_004344.
FT   VARIANT     173    173       A -> T (in allele A*02:03).
FT                                /FTId=VAR_004345.
FT   VARIANT     176    176       V -> E (in allele A*02:03 and allele
FT                                A*02:13).
FT                                /FTId=VAR_004346.
FT   VARIANT     180    180       L -> Q (in allele A*02:12, allele A*02:13
FT                                and allele A*02:37).
FT                                /FTId=VAR_004348.
FT   VARIANT     180    180       L -> W (in allele A*02:02, allele
FT                                A*02:03, allele A*02:05 and allele
FT                                A*02:08).
FT                                /FTId=VAR_004347.
FT   VARIANT     187    187       T -> E (in allele A*02:16; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_004349.
FT   VARIANT     190    190       E -> D (in allele A*02:36 and allele
FT                                A*02:37).
FT                                /FTId=VAR_016729.
FT   VARIANT     191    191       W -> G (in allele A*02:36 and allele
FT                                A*02:37).
FT                                /FTId=VAR_016730.
FT   VARIANT     260    260       A -> E (in allele A*02:09).
FT                                /FTId=VAR_004350.
FT   CONFLICT    115    115       G -> V (in Ref. 4; AAA52656).
FT   CONFLICT    140    140       Y -> V (in Ref. 4; AAA52656).
FT   CONFLICT    277    277       Q -> E (in Ref. 4; AAA52656).
FT   CONFLICT    318    318       F -> L (in Ref. 4; AAA52656).
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      113    115
FT   STRAND      118    127
FT   STRAND      131    142
FT   STRAND      145    150
FT   STRAND      154    161
FT   HELIX       162    173
FT   HELIX       176    184
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    235
FT   STRAND      238    243
FT   STRAND      246    248
FT   STRAND      252    254
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    297
SQ   SEQUENCE   365 AA;  40922 MW;  B54A97B24B337C08 CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDGETRK VKAHSQTHRV DLGTLRGYYN QSEAGSHTVQ
     RMYGCDVGSD WRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQTTKHK WEAAHVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A03_HUMAN              Reviewed;         365 AA.
AC   P04439; O19546; O19756; Q65A82; Q9GJE6; Q9GJE7; Q9GJE8; Q9MYE6;
AC   Q9MYG4; Q9TPR8;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 117.
DE   RecName: Full=HLA class I histocompatibility antigen, A-3 alpha chain;
DE   AltName: Full=MHC class I antigen A*3;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:01).
RX   MEDLINE=84207948; PubMed=6609814;
RA   Strachan T., Sodoyer R., Damotte M., Jordan B.R.;
RT   "Complete nucleotide sequence of a functional class I HLA gene, HLA-
RT   A3: implications for the evolution of HLA genes.";
RL   EMBO J. 3:887-894(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:01).
RA   Ellexson M.E., Hildebrand W.H.;
RL   Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE A*03:01).
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:02).
RX   MEDLINE=85290871; PubMed=2993417;
RA   Cowan E.P., Jordan B.E., Coligan J.E.;
RT   "Molecular cloning and DNA sequence analysis of genes encoding
RT   cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype.";
RL   J. Immunol. 135:2835-2841(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:02).
RA   Bettinotti M.P., Hadzikadic L., Adams S., Marincola F.M.;
RT   "Complete coding sequence of HLA-A*0302.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Mayor N.P.;
RT   "Full length sequence of an HLA-A*0301 intron 2 variant.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-341 (ALLELE A*03:04).
RX   MEDLINE=99180630; PubMed=10079303; DOI=10.1007/s002510050506;
RA   Santos S., Balas A., Garcia-Sanchez F., Lillo R., Merino J.L.,
RA   Vicario J.L.;
RT   "Complete cDNA coding sequence of a new HLA-A3 subtype (A*0304) with a
RT   new HLA polymorphism at exon 3.";
RL   Immunogenetics 49:360-361(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*03:05).
RA   Becher M.P., Wu J., Williams T.;
RT   "Novel human HLA-A alleles identified in potential bone marrow
RT   donors.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-298 (ALLELE A*03:05).
RC   TISSUE=Blood;
RA   Poli F., Frison S., Crespiatico L., Longhi E.;
RT   "Identification of a HLA-A*03 new variant.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*03:06).
RX   MEDLINE=22131939; PubMed=12135434;
RX   DOI=10.1034/j.1399-0039.2002.590413.x;
RA   Bradshaw D., Gans C.P., Jones P., Rizzuto G., Steiner N., Mitton W.,
RA   Ng J., Koester R., Hartzman R.J., Hurley C.K.;
RT   "Novel HLA-A locus alleles including A*01012, A*0306, A*0308, A*2616,
RT   A*2617, A*3009, A*3206, A*3403, A*3602 and A*6604.";
RL   Tissue Antigens 59:325-327(2002).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 25-298 (ALLELE A*03:01) IN
RP   COMPLEX WITH PLP1 ANTIGENIC PEPTIDE, AND DISULFIDE BONDS.
RX   PubMed=21543847; DOI=10.1107/S0907444911007888;
RA   McMahon R.M., Friis L., Siebold C., Friese M.A., Fugger L.,
RA   Jones E.Y.;
RT   "Structure of HLA-A*0301 in complex with a peptide of proteolipid
RT   protein: insights into the role of HLA-A alleles in susceptibility to
RT   multiple sclerosis.";
RL   Acta Crystallogr. D 67:447-454(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-3 are known: A*03:01 (A-
CC       3.1), A*03:02, A*03:04, A*03:05 and A*03:06. The sequence shown is
CC       that of A*03:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00492; CAA25162.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U32184; AAB63980.1; -; mRNA.
DR   EMBL; BA000025; BAB63400.1; -; Genomic_DNA.
DR   EMBL; AF217561; AAF28734.1; -; mRNA.
DR   EMBL; AF015930; AAB66582.1; -; mRNA.
DR   EMBL; AF190719; AAF03243.1; -; Genomic_DNA.
DR   EMBL; AF190718; AAF03243.1; JOINED; Genomic_DNA.
DR   EMBL; AJ401085; CAC06086.1; -; Genomic_DNA.
DR   EMBL; AJ401086; CAC06087.1; -; Genomic_DNA.
DR   EMBL; AJ401087; CAC06088.1; -; Genomic_DNA.
DR   EMBL; AJ748743; CAG38621.1; -; Genomic_DNA.
DR   EMBL; AL671277; CAI18372.1; -; Genomic_DNA.
DR   EMBL; AF226843; AAF29557.1; -; Genomic_DNA.
DR   EMBL; AF226842; AAF29557.1; JOINED; Genomic_DNA.
DR   IPI; IPI00647634; -.
DR   PIR; A02192; HLHUA3.
DR   RefSeq; NP_002107.3; NM_002116.7.
DR   UniGene; Hs.181244; -.
DR   PDB; 2XPG; X-ray; 2.60 A; A=25-298.
DR   PDB; 3RL2; X-ray; 2.39 A; A=25-298.
DR   PDBsum; 2XPG; -.
DR   PDBsum; 3RL2; -.
DR   ProteinModelPortal; P04439; -.
DR   SMR; P04439; 25-298.
DR   IntAct; P04439; 2.
DR   STRING; P04439; -.
DR   DMDM; 34223717; -.
DR   PRIDE; P04439; -.
DR   DNASU; 3105; -.
DR   Ensembl; ENST00000376809; ENSP00000366005; ENSG00000206503.
DR   Ensembl; ENST00000396634; ENSP00000379873; ENSG00000206503.
DR   GeneID; 3105; -.
DR   KEGG; hsa:3105; -.
DR   UCSC; uc003nok.3; human.
DR   CTD; 3105; -.
DR   GeneCards; GC06P029921; -.
DR   H-InvDB; HIX0005684; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P04439; -.
DR   PharmGKB; PA35055; -.
DR   eggNOG; NOG42056; -.
DR   GeneTree; ENSGT00650000093032; -.
DR   HOVERGEN; HBG016709; -.
DR   KO; K06751; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; il12_2pathway; IL12-mediated signaling events.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 12319; -.
DR   PMAP-CutDB; P04439; -.
DR   Bgee; P04439; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P04439; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-3 alpha chain.
FT                                /FTId=PRO_0000018815.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_050310.
FT   VARIANT      94     94       Q -> H (in dbSNP:rs1059463).
FT                                /FTId=VAR_050311.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_050312.
FT   VARIANT     121    121       I -> M (in dbSNP:rs1136695).
FT                                /FTId=VAR_050313.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_050314.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_050315.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_050316.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_050317.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_050318.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_050319.
FT   VARIANT     176    176       E -> V (in allele A*03:02).
FT                                /FTId=VAR_004351.
FT   VARIANT     180    180       L -> Q (in allele A*03:02).
FT                                /FTId=VAR_004352.
FT   VARIANT     185    185       D -> E (in allele A*03:05;
FT                                dbSNP:rs1059542).
FT                                /FTId=VAR_016604.
FT   VARIANT     186    186       G -> A (in allele A*03:06).
FT                                /FTId=VAR_033149.
FT   VARIANT     199    199       G -> R (in allele A*03:04).
FT                                /FTId=VAR_016605.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_050320.
FT   CONFLICT    319    319       G -> A (in Ref. 8; AAB66582).
FT   STRAND       27     36
FT   STRAND       45     49
FT   STRAND       58     61
FT   STRAND       64     66
FT   HELIX        75     78
FT   HELIX        82    101
FT   STRAND      118    123
FT   STRAND      125    127
FT   STRAND      139    142
FT   STRAND      146    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    184
FT   HELIX       188    197
FT   TURN        201    203
FT   STRAND      207    217
FT   STRAND      219    230
FT   STRAND      232    235
FT   STRAND      238    243
FT   STRAND      251    254
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    297
SQ   SEQUENCE   365 AA;  40841 MW;  DEDFCEC4450E0580 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL
     RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A11_HUMAN              Reviewed;         365 AA.
AC   P13746; O19605; O19606; Q29747; Q29835; Q9BCN0; Q9MYI5; Q9TQE9;
AC   Q9TQP6; Q9TQP7;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=HLA class I histocompatibility antigen, A-11 alpha chain;
DE   AltName: Full=MHC class I antigen A*11;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*11:01 AND A*11:02).
RX   MEDLINE=89030641; PubMed=2460344;
RA   Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.;
RT   "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for
RT   trans-species mode of evolution.";
RL   EMBO J. 7:2765-2774(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*11:01 AND A*11:02).
RX   MEDLINE=94287401; PubMed=8016845;
RX   DOI=10.1111/j.1399-0039.1994.tb02304.x;
RA   Lin L., Tokunaga K., Ishikawa Y., Bannai M., Kashiwase K., Kuwata S.,
RA   Akaza T., Tadokoro K., Shibata Y., Juji T.;
RT   "Sequence analysis of serological HLA-A11 split antigens, A11.1 and
RT   A11.2.";
RL   Tissue Antigens 43:78-82(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-365 (ALLELE A*11:01).
RX   MEDLINE=87192928; PubMed=2437024; DOI=10.1007/BF00404694;
RA   Cowan E.P., Jelachich M.L., Biddison W.E., Coligan J.E.;
RT   "DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows
RT   identification of residues involved in epitopes recognized by
RT   antibodies and T cells.";
RL   Immunogenetics 25:241-250(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:03).
RC   TISSUE=Blood;
RX   MEDLINE=20166353; PubMed=10703613;
RX   DOI=10.1034/j.1399-0039.2000.550113.x;
RA   Tijssen H.J., Sistermans E.A., van den Beucken M.J.G., Krausa P.,
RA   Joosten I.;
RT   "Complete sequence analysis of the A*1103 allele.";
RL   Tissue Antigens 55:68-70(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:03).
RC   TISSUE=Blood;
RX   MEDLINE=20340071; PubMed=10885562;
RX   DOI=10.1034/j.1399-0039.2000.550504.x;
RA   Tijssen H.J., Sistermans E.A., Joosten I.;
RT   "A unique second donor splice site in the intron 5 sequence of the
RT   HLA-A*11 alleles results in a class I transcript encoding a molecule
RT   with an elongated cytoplasmic domain.";
RL   Tissue Antigens 55:422-428(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:04).
RA   Bettinotti M.P.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*11:04).
RA   Chandanayingyong D., Sirikong M., Luangtrakool K., Srinak D.,
RA   Rungroung E., Bejchandra S.;
RT   "A11 alleles (A*11O4).";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*11:05).
RX   MEDLINE=99321035; PubMed=10395112;
RX   DOI=10.1034/j.1399-0039.1999.530612.x;
RA   Morrell G., Whalley J., Stewart A., Day S., Lewis L., Makar Y.,
RA   Ross J., Dunn P.P.;
RT   "Identification of an HLA-A11 serological variant and its
RT   characterization by sequencing based typing.";
RL   Tissue Antigens 53:591-594(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*11:05).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:07).
RX   MEDLINE=21561663; PubMed=11703829;
RX   DOI=10.1034/j.1399-0039.2001.580309.x;
RA   Pyo C.W., Choi H.B., Han H., Hong Y.S., Kim T.G.;
RT   "Identification of HLA-A*11 variant (A*1107) in the Korean
RT   population.";
RL   Tissue Antigens 58:190-192(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 25-299 (ALLELE A*11:01) IN
RP   COMPLEX WITH SARS NUCLEOCAPSID PEPTIDE, AND DISULFIDE BONDS.
RX   PubMed=16041067; DOI=10.1107/S0907444905013090;
RA   Blicher T., Kastrup J.S., Buus S., Gajhede M.;
RT   "High-resolution structure of HLA-A*1101 in complex with SARS
RT   nucleocapsid peptide.";
RL   Acta Crystallogr. D 61:1031-1040(2005).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13746-1; Sequence=Displayed;
CC       Name=2; Synonyms=Long;
CC         IsoId=P13746-2; Sequence=VSP_008099;
CC         Note=Only produced by allele A*1103;
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-11 are known: A*11:01 (A-
CC       11E), A*11:02 (A-11K), A*11:03, A*11:04, A*11:05 and A*11:07. The
CC       sequence shown is that of A*11:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13111; CAA31503.1; -; mRNA.
DR   EMBL; X13112; CAA31504.1; -; mRNA.
DR   EMBL; D16841; BAA04117.1; -; mRNA.
DR   EMBL; D16842; BAA04118.1; -; mRNA.
DR   EMBL; M16010; AAA65449.1; -; Genomic_DNA.
DR   EMBL; M16007; AAA65449.1; JOINED; Genomic_DNA.
DR   EMBL; M16008; AAA65449.1; JOINED; Genomic_DNA.
DR   EMBL; M16009; AAA65449.1; JOINED; Genomic_DNA.
DR   EMBL; Y17224; CAB38056.1; -; mRNA.
DR   EMBL; Y17224; CAB38057.1; -; mRNA.
DR   EMBL; X91399; CAA62745.1; -; mRNA.
DR   EMBL; U50574; AAB60406.1; -; mRNA.
DR   EMBL; AF030910; AAB87052.1; -; Genomic_DNA.
DR   EMBL; AF030909; AAB87052.1; JOINED; Genomic_DNA.
DR   EMBL; AF030908; AAB87051.1; -; Genomic_DNA.
DR   EMBL; AF030907; AAB87051.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306733; CAC37336.1; -; Genomic_DNA.
DR   EMBL; AF147455; AAD33991.1; -; Genomic_DNA.
DR   EMBL; AF147454; AAD33991.1; JOINED; Genomic_DNA.
DR   EMBL; AF165065; AAF25781.1; -; mRNA.
DR   IPI; IPI00472112; -.
DR   IPI; IPI00472448; -.
DR   PIR; I83063; I83063.
DR   PIR; S03536; A47636.
DR   UniGene; Hs.181244; -.
DR   PDB; 1Q94; X-ray; 2.40 A; A/D=25-299.
DR   PDB; 1QVO; X-ray; 2.22 A; A/D=25-299.
DR   PDB; 1X7Q; X-ray; 1.45 A; A=25-299.
DR   PDB; 2HN7; X-ray; 1.60 A; A=25-299.
DR   PDBsum; 1Q94; -.
DR   PDBsum; 1QVO; -.
DR   PDBsum; 1X7Q; -.
DR   PDBsum; 2HN7; -.
DR   ProteinModelPortal; P13746; -.
DR   STRING; P13746; -.
DR   DMDM; 122157; -.
DR   PRIDE; P13746; -.
DR   Ensembl; ENST00000376809; ENSP00000366005; ENSG00000206503.
DR   Ensembl; ENST00000396634; ENSP00000379873; ENSG00000206503.
DR   GeneCards; GC06P029921; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P13746; -.
DR   HOVERGEN; HBG016709; -.
DR   EvolutionaryTrace; P13746; -.
DR   Bgee; P13746; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P13746; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Host-virus interaction; Immunity; Membrane; MHC I;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-11 alpha chain.
FT                                /FTId=PRO_0000018816.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VAR_SEQ     337    337       S -> SGGEGVK (in isoform 2).
FT                                /FTId=VSP_008099.
FT   VARIANT      43     43       E -> K (in allele A*11:02).
FT                                /FTId=VAR_004353.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056254.
FT   VARIANT      94     94       Q -> H (in dbSNP:rs1059463).
FT                                /FTId=VAR_056255.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056256.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056257.
FT   VARIANT     133    133       F -> L (in allele A*11:07;
FT                                dbSNP:rs1059488).
FT                                /FTId=VAR_016731.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056258.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056259.
FT   VARIANT     168    168       K -> E (in allele A*11:05).
FT                                /FTId=VAR_016732.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_056260.
FT   VARIANT     175    175       H -> R (in allele A*11:03).
FT                                /FTId=VAR_016733.
FT   VARIANT     176    176       A -> E (in allele A*11:03).
FT                                /FTId=VAR_016734.
FT   VARIANT     187    187       R -> T (in allele A*11:04).
FT                                /FTId=VAR_016735.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056261.
FT   VARIANT     345    345       T -> S (in allele A*11:05).
FT                                /FTId=VAR_016736.
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      113    115
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    159
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   STRAND      252    254
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    297
SQ   SEQUENCE   365 AA;  40937 MW;  FE449CE2D4BF6CC5 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHAAEQQ
     RAYLEGRCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A1L1_HUMAN             Reviewed;         501 AA.
AC   Q96QU6; Q8WUL4; Q96LX5;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   18-APR-2012, entry version 75.
DE   RecName: Full=1-aminocyclopropane-1-carboxylate synthase-like protein 1;
DE            Short=ACC synthase-like protein 1;
GN   Name=ACCS; Synonyms=PHACS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   MEDLINE=21363427; PubMed=11470512; DOI=10.1016/S0378-1119(01)00533-9;
RA   Koch K.A., Capitani G., Gruetter M.G., Kirsch J.F.;
RT   "The human cDNA for a homologue of the plant enzyme 1-
RT   aminocyclopropane-1-carboxylate synthase encodes a protein lacking
RT   that activity.";
RL   Gene 272:75-84(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-421.
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-221 AND LEU-393.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Does not catalyze the synthesis of 1-aminocyclopropane-
CC       1-carboxylate but is capable of catalyzing the deamination of L-
CC       vinylglycine.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family.
CC   -!- CAUTION: Similar to plant 1-aminocyclopropane-1-carboxylate
CC       synthases but lacks a number of residues which are necessary for
CC       activity.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY026508; AAK11482.1; -; mRNA.
DR   EMBL; AK057649; BAB71541.1; -; mRNA.
DR   EMBL; CH471064; EAW68072.1; -; Genomic_DNA.
DR   EMBL; BC020197; AAH20197.1; -; mRNA.
DR   IPI; IPI00411817; -.
DR   RefSeq; NP_001120691.1; NM_001127219.1.
DR   RefSeq; NP_115981.1; NM_032592.3.
DR   UniGene; Hs.126706; -.
DR   HSSP; P37821; 1M4N.
DR   ProteinModelPortal; Q96QU6; -.
DR   SMR; Q96QU6; 75-482.
DR   MINT; MINT-1470212; -.
DR   STRING; Q96QU6; -.
DR   DMDM; 74717198; -.
DR   PRIDE; Q96QU6; -.
DR   DNASU; 84680; -.
DR   Ensembl; ENST00000263776; ENSP00000263776; ENSG00000110455.
DR   Ensembl; ENST00000448099; ENSP00000402569; ENSG00000110455.
DR   GeneID; 84680; -.
DR   KEGG; hsa:84680; -.
DR   UCSC; uc001mxx.2; human.
DR   CTD; 84680; -.
DR   GeneCards; GC11P044045; -.
DR   H-InvDB; HIX0201626; -.
DR   HGNC; HGNC:23989; ACCS.
DR   HPA; HPA018873; -.
DR   HPA; HPA021654; -.
DR   MIM; 608405; gene.
DR   neXtProt; NX_Q96QU6; -.
DR   PharmGKB; PA162375284; -.
DR   eggNOG; COG0436; -.
DR   GeneTree; ENSGT00390000005703; -.
DR   HOGENOM; HBG713659; -.
DR   HOVERGEN; HBG055243; -.
DR   InParanoid; Q96QU6; -.
DR   OMA; CEAGEAF; -.
DR   OrthoDB; EOG4P8FJ0; -.
DR   PhylomeDB; Q96QU6; -.
DR   NextBio; 74721; -.
DR   ArrayExpress; Q96QU6; -.
DR   Bgee; Q96QU6; -.
DR   CleanEx; HS_ACCS; -.
DR   Genevestigator; Q96QU6; -.
DR   GO; GO:0016847; F:1-aminocyclopropane-1-carboxylate synthase activity; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; NAS:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; NAS:UniProtKB.
DR   GO; GO:0016769; F:transferase activity, transferring nitrogenous groups; IEA:InterPro.
DR   Gene3D; G3DSA:3.90.1150.10; PyrdxlP-dep_Trfase_major_sub2; 2.
DR   InterPro; IPR001176; ACC_synthase.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase_major_dom.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_major_sub2.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   PRINTS; PR00753; ACCSYNTHASE.
DR   SUPFAM; SSF53383; PyrdxlP-dep_Trfase_major; 1.
DR   PROSITE; PS00105; AA_TRANSFER_CLASS_1; FALSE_NEG.
PE   2: Evidence at transcript level;
KW   Complete proteome; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome.
FT   CHAIN         1    501       1-aminocyclopropane-1-carboxylate
FT                                synthase-like protein 1.
FT                                /FTId=PRO_0000318071.
FT   BINDING     105    105       Substrate (By similarity).
FT   MOD_RES     323    323       N6-(pyridoxal phosphate)lysine (By
FT                                similarity).
FT   VARIANT      59     59       D -> N (in dbSNP:rs33952257).
FT                                /FTId=VAR_048227.
FT   VARIANT     134    134       D -> E (in dbSNP:rs2018795).
FT                                /FTId=VAR_048228.
FT   VARIANT     221    221       G -> E (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs35514614).
FT                                /FTId=VAR_038685.
FT   VARIANT     393    393       S -> L (in a breast cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_038686.
FT   VARIANT     421    421       P -> L (in dbSNP:rs3107275).
FT                                /FTId=VAR_038687.
FT   CONFLICT     94     94       N -> S (in Ref. 2; BAB71541).
FT   CONFLICT    410    410       F -> L (in Ref. 2; BAB71541).
SQ   SEQUENCE   501 AA;  57324 MW;  62C99045F0BF8D5E CRC64;
     MFTLPQKDFR APTTCLGPTC MQDLGSSHGE DLEGECSRKL DQKLPELRGV GDPAMISSDT
     SYLSSRGRMI KWFWDSAEEG YRTYHMDEYD EDKNPSGIIN LGTSENKLCF DLLSWRLSQR
     DMQRVEPSLL QYADWRGHLF LREEVAKFLS FYCKSPVPLR PENVVVLNGG ASLFSALATV
     LCEAGEAFLI PTPYYGAITQ HVCLYGNIRL AYVYLDSEVT GLDTRPFQLT VEKLEMALRE
     AHSEGVKVKG LILISPQNPL GDVYSPEELQ EYLVFAKRHR LHVIVDEVYM LSVFEKSVGY
     RSVLSLERLP DPQRTHVMWA TSKDFGMSGL RFGTLYTENQ DVATAVASLC RYHGLSGLVQ
     YQMAQLLRDR DWINQVYLPE NHARLKAAHT YVSEELRALG IPFLSRGAGF FIWVDLRKYL
     PKGTFEEEML LWRRFLDNKV LLSFGKAFEC KEPGWFRFVF SDQVHRLCLG MQRVQQVLAG
     KSQVAEDPRP SQSQEPSDQR R
//
ID   1A1L2_HUMAN             Reviewed;         568 AA.
AC   Q4AC99;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   18-APR-2012, entry version 57.
DE   RecName: Full=1-aminocyclopropane-1-carboxylate synthase-like protein 2;
DE            Short=ACC synthase-like protein 2;
GN   Name=ACCSL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-529.
RA   Totoki Y., Yada T., Sakaki Y., Takeda T.;
RT   "Identification of novel human genes predicted by combining multiple
RT   gene-finders.";
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family.
CC   -!- CAUTION: Similar to plant 1-aminocyclopropane-1-carboxylate
CC       synthases but lacks a number of residues which are necessary for
CC       activity.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB231734; BAE17132.1; -; mRNA.
DR   EMBL; AC134775; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   IPI; IPI00399296; -.
DR   RefSeq; NP_001027025.2; NM_001031854.2.
DR   UniGene; Hs.558851; -.
DR   ProteinModelPortal; Q4AC99; -.
DR   SMR; Q4AC99; 135-554.
DR   DMDM; 296439453; -.
DR   PRIDE; Q4AC99; -.
DR   Ensembl; ENST00000378832; ENSP00000368109; ENSG00000205126.
DR   GeneID; 390110; -.
DR   KEGG; hsa:390110; -.
DR   UCSC; uc001mxw.1; human.
DR   CTD; 390110; -.
DR   GeneCards; GC11P044027; -.
DR   HGNC; HGNC:34391; ACCSL.
DR   neXtProt; NX_Q4AC99; -.
DR   PharmGKB; PA164714805; -.
DR   eggNOG; COG0436; -.
DR   GeneTree; ENSGT00390000005703; -.
DR   HOGENOM; HBG713659; -.
DR   HOVERGEN; HBG055243; -.
DR   InParanoid; Q4AC99; -.
DR   OMA; IIDEIYM; -.
DR   OrthoDB; EOG4P8FJ0; -.
DR   NextBio; 103406; -.
DR   Genevestigator; Q4AC99; -.
DR   GO; GO:0016847; F:1-aminocyclopropane-1-carboxylate synthase activity; IEA:InterPro.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0016769; F:transferase activity, transferring nitrogenous groups; IEA:InterPro.
DR   Gene3D; G3DSA:3.40.640.10; PyrdxlP-dep_Trfase_major_sub1; 1.
DR   Gene3D; G3DSA:3.90.1150.10; PyrdxlP-dep_Trfase_major_sub2; 2.
DR   InterPro; IPR001176; ACC_synthase.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase_major_dom.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_major_sub2.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   PRINTS; PR00753; ACCSYNTHASE.
DR   SUPFAM; SSF53383; PyrdxlP-dep_Trfase_major; 1.
DR   PROSITE; PS00105; AA_TRANSFER_CLASS_1; FALSE_NEG.
PE   2: Evidence at transcript level;
KW   Complete proteome; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome.
FT   CHAIN         1    568       1-aminocyclopropane-1-carboxylate
FT                                synthase-like protein 2.
FT                                /FTId=PRO_0000337057.
FT   MOD_RES     395    395       N6-(pyridoxal phosphate)lysine (By
FT                                similarity).
FT   VARIANT     529    529       C -> R (in dbSNP:rs2074051).
FT                                /FTId=VAR_060626.
FT   CONFLICT    192    192       S -> R (in Ref. 1; BAE17132).
FT   CONFLICT    272    272       F -> S (in Ref. 1; BAE17132).
FT   CONFLICT    276    276       L -> P (in Ref. 1; BAE17132).
FT   CONFLICT    311    311       L -> P (in Ref. 1; BAE17132).
FT   CONFLICT    434    434       K -> E (in Ref. 1; BAE17132).
FT   CONFLICT    454    454       C -> R (in Ref. 1; BAE17132).
SQ   SEQUENCE   568 AA;  65249 MW;  233FC638E76AC393 CRC64;
     MSHRSDTLPV PSGQRRGRVP RDHSIYTQLL EITLHLQQAM TEHFVQLTSR QGLSLEERRH
     TEAICEHEAL LSRLICRMIN LLQSGAASGL ELQVPLPSED SRGDVRYGQR AQLSGQPDPV
     PQLSDCEAAF VNRDLSIRGI DISVFYQSSF QDYNAYQKDK YHKDKNTLGF INLGTSENKL
     CMDLMTERLQ ESDMNCIEDT LLQYPDWRGQ PFLREEVARF LTYYCRAPTR LDPENVVVLN
     GCCSVFCALA MVLCDPGEAF LVPAPFYGGF AFSSRLYAKV ELIPVHLESE VTVTNTHPFQ
     LTVDKLEEAL LEARLEGKKV RGLVLINPQN PLGDIYSPDS LMKYLEFAKR YNLHVIIDEI
     YMLSVFDESI TFHSILSMKS LPDSNRTHVI WGTSKDFGIS GFRFGALYTH NKEVASAVSA
     FGYLHSISGI TQHKLCQLLQ NTEWIDKVYL PTNCYRLREA HKYITAELKA LEIPFHNRSS
     GLYVWINLKK YLDPCTFEEE RLLYCRFLDN KLLLSRGKTY MCKEPGWFCL IFADELPRLK
     LAMRRFCDVL QEQKEALIVK QLEDAMRE
//
ID   1A23_HUMAN              Reviewed;         365 AA.
AC   P30447; Q9TQF1; Q9TQF8; Q9TQG5; Q9TQM6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 100.
DE   RecName: Full=HLA class I histocompatibility antigen, A-23 alpha chain;
DE   AltName: Full=HLA class I histocompatibility antigen, A-9 alpha chain;
DE   AltName: Full=MHC class I antigen A*23;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*23:01).
RX   MEDLINE=92104637; PubMed=1729171; DOI=10.1007/BF00216625;
RA   Little A.-M., Madrigal J.A., Parham P.;
RT   "Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3.";
RL   Immunogenetics 35:41-45(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*23:02 AND A*23:03).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*23:04 AND A*23:05).
RX   MEDLINE=21068830; PubMed=11169246;
RX   DOI=10.1034/j.1399-0039.2000.560610.x;
RA   Steiner N.K., Edson S.M., Mitton W., Ng J., Hartzman R.J.,
RA   Hurley C.K.;
RT   "Seven novel HLA-A alleles carry previously observed polymorphisms.";
RL   Tissue Antigens 56:551-552(2000).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-23 are known: A*23:01,
CC       A*23:02, A*23:03, A*23:04 and A*23:05. The sequence shown is that
CC       of A*23:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64742; AAA03662.1; -; mRNA.
DR   EMBL; AF137080; AAD33736.1; -; Genomic_DNA.
DR   EMBL; AF137079; AAD33736.1; JOINED; Genomic_DNA.
DR   EMBL; AF102572; AAD28171.1; -; Genomic_DNA.
DR   EMBL; AF102571; AAD28171.1; JOINED; Genomic_DNA.
DR   EMBL; AF135549; AAD22272.1; -; Genomic_DNA.
DR   EMBL; AF135548; AAD22272.1; JOINED; Genomic_DNA.
DR   EMBL; AF140860; AAD31878.1; -; Genomic_DNA.
DR   EMBL; AF140859; AAD31878.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472151; -.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P30447; -.
DR   SMR; P30447; 25-298.
DR   STRING; P30447; -.
DR   DMDM; 231359; -.
DR   PRIDE; P30447; -.
DR   Ensembl; ENST00000442068; ENSP00000404428; ENSG00000223980.
DR   Ensembl; ENST00000454091; ENSP00000410645; ENSG00000223980.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Po29897; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30447; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4T783X; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30447; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-23 alpha chain.
FT                                /FTId=PRO_0000018817.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      31     31       Y -> C (in allele A*23:05).
FT                                /FTId=VAR_016606.
FT   VARIANT     151    151       K -> N (in allele A*23:03).
FT                                /FTId=VAR_016607.
FT   VARIANT     180    180       L -> W (in allele A*23:02).
FT                                /FTId=VAR_016608.
FT   VARIANT     190    191       DG -> EW (in allele A*23:04).
FT                                /FTId=VAR_016609.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056262.
SQ   SEQUENCE   365 AA;  40733 MW;  C372DE503BF393D0 CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDEETGK VKAHSQTDRE NLRIALRYYN QSEAGSHTLQ
     MMFGCDVGSD GRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTVHIVG IIAGLVLLGA VITGAVVAAV MWRRNSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A24_HUMAN              Reviewed;         365 AA.
AC   P05534; P30448; P30449; Q29908; Q29909; Q29910; Q95355;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2003, sequence version 2.
DT   18-APR-2012, entry version 127.
DE   RecName: Full=HLA class I histocompatibility antigen, A-24 alpha chain;
DE   AltName: Full=Aw-24;
DE   AltName: Full=HLA class I histocompatibility antigen, A-9 alpha chain;
DE   AltName: Full=MHC class I antigen A*24;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*2401).
RX   MEDLINE=85206128; PubMed=2987115; DOI=10.1007/BF00430931;
RA   N'Guyen C., Sodoyer R., Trucy J., Strachan T., Jordan B.R.;
RT   "The HLA-AW24 gene: sequence, surroundings and comparison with the
RT   HLA-A2 and HLA-A3 genes.";
RL   Immunogenetics 21:479-489(1985).
RN   [2]
RP   SEQUENCE REVISION.
RA   Jordan B.R.;
RL   Submitted (JUL-1988) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELES A*24:02 AND
RP   A*24:03).
RX   MEDLINE=92104637; PubMed=1729171; DOI=10.1007/BF00216625;
RA   Little A.-M., Madrigal J.A., Parham P.;
RT   "Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3.";
RL   Immunogenetics 35:41-45(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*24:02).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*24:02).
RX   MEDLINE=98007772; PubMed=9349616;
RX   DOI=10.1111/j.1399-0039.1997.tb02884.x;
RA   Laforet M., Froelich N., Parissiadis A., Bausinger H., Pfeiffer B.,
RA   Tongio M.M.;
RT   "An intronic mutation responsible for a low level of expression of an
RT   HLA-A*24 allele.";
RL   Tissue Antigens 50:340-346(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*24:08).
RC   TISSUE=Blood;
RA   Kashiwase K., Tokunaga K., Ishikawa Y., Qiu L., Furuya M.,
RA   Sawanaka K., Akaza T., Tadokoro K., Juji T.;
RT   "Sequence analysis of a serological subtype, HLA-A9HH, observed in
RT   Japanese and the confirmatory sequence of A*2408.";
RL   MHC 3:9-14(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-337 (ALLELE A*24:29).
RA   Dunn P.;
RT   "Confirmation of the sequence of HLA-A*2429 allele found in a
RT   potential bone marrow donor.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*24:10).
RC   TISSUE=Blood;
RX   MEDLINE=97161044; PubMed=9008316;
RX   DOI=10.1111/j.1399-0039.1996.tb02697.x;
RA   Gao X., Matheson B.;
RT   "A novel HLA-A*24 (A*2410) identified in a Javanese population.";
RL   Tissue Antigens 48:711-713(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES A*24:06; A*24:13
RP   AND A*24:14).
RC   TISSUE=Blood;
RX   MEDLINE=97417771; PubMed=9271829;
RX   DOI=10.1111/j.1399-0039.1997.tb02858.x;
RA   Gao X., Lester S., Matheson B., Boettcher B., McCluskey J.;
RT   "Three newly identified A*24 alleles: A*2406, A*2413 and A*2414.";
RL   Tissue Antigens 50:192-196(1997).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.39 ANGSTROMS) OF 25-298 (ALLELE A*24:02) IN
RP   COMPLEX WITH B2M AND CD8, AND DISULFIDE BONDS.
RX   PubMed=21645925; DOI=10.1016/j.molimm.2011.05.009;
RA   Shi Y., Qi J., Iwamoto A., Gao G.F.;
RT   "Plasticity of human CD8alphaalpha binding to peptide-HLA-A*2402.";
RL   Mol. Immunol. 48:2198-2202(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-24 are known: A*2401,
CC       A*24:02, A*24:03, A*24:06, A*24:08 (A9HH), A*24:10 (A*24JV),
CC       A*24:13 (A*24YM), A*24:14 (A*24SA) and A*24:29. Allele A*24:02 is
CC       represented in all major racial groups. Allele A*24:06 and allele
CC       A*24:13 are found in the Australian Aborigenal population. Allele
CC       A*24:14 is found in individuals of South American descent. The
CC       sequence shown is that of A*24:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15497; AAA59611.1; -; Genomic_DNA.
DR   EMBL; M64740; AAA59600.1; -; mRNA.
DR   EMBL; M64741; AAA59601.1; -; Genomic_DNA.
DR   EMBL; Z72422; CAA96532.1; -; Genomic_DNA.
DR   EMBL; D83516; BAA11936.1; -; mRNA.
DR   EMBL; U37111; AAA83264.1; -; Genomic_DNA.
DR   EMBL; U37110; AAA83264.1; JOINED; Genomic_DNA.
DR   EMBL; U37113; AAA83265.1; -; Genomic_DNA.
DR   EMBL; U37112; AAA83265.1; JOINED; Genomic_DNA.
DR   EMBL; U37115; AAB40048.1; -; Genomic_DNA.
DR   EMBL; U37114; AAB40048.1; JOINED; Genomic_DNA.
DR   EMBL; U19733; AAB60651.1; -; Genomic_DNA.
DR   EMBL; U18987; AAB60651.1; JOINED; Genomic_DNA.
DR   IPI; IPI00742968; -.
DR   PIR; I54416; I54416.
DR   UniGene; Hs.181244; -.
DR   PDB; 2BCK; X-ray; 2.80 A; A/D=25-300.
DR   PDB; 3I6L; X-ray; 2.40 A; D=25-298.
DR   PDB; 3NFN; X-ray; 2.39 A; A=25-298.
DR   PDB; 3QZW; X-ray; 2.80 A; A/D=25-298.
DR   PDBsum; 2BCK; -.
DR   PDBsum; 3I6L; -.
DR   PDBsum; 3NFN; -.
DR   PDBsum; 3QZW; -.
DR   ProteinModelPortal; P05534; -.
DR   SMR; P05534; 25-298.
DR   STRING; P05534; -.
DR   DMDM; 32363482; -.
DR   PRIDE; P05534; -.
DR   Ensembl; ENST00000431795; ENSP00000396220; ENSG00000229215.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   Ensembl; ENST00000448357; ENSP00000402461; ENSG00000224320.
DR   GeneCards; GC06P029921; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P05534; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   EvolutionaryTrace; P05534; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P05534; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-24 alpha chain.
FT                                /FTId=PRO_0000018818.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT       5      5       A -> G (in allele A*2401).
FT                                /FTId=VAR_004354.
FT   VARIANT      27     27       H -> Q (in allele A*24:08;
FT                                dbSNP:rs41541319).
FT                                /FTId=VAR_004355.
FT   VARIANT      86     86       E -> G (in allele A*24:08).
FT                                /FTId=VAR_004356.
FT   VARIANT      89     89       G -> R (in allele A*24:08 and allele
FT                                A*24:29).
FT                                /FTId=VAR_004357.
FT   VARIANT     119    119       L -> V (in allele A*24:14).
FT                                /FTId=VAR_015765.
FT   VARIANT     121    121       M -> R (in allele A*24:14).
FT                                /FTId=VAR_015766.
FT   VARIANT     123    123       F -> Y (in allele A*24:14).
FT                                /FTId=VAR_015767.
FT   VARIANT     131    131       G -> W (in allele A*24:14).
FT                                /FTId=VAR_015768.
FT   VARIANT     180    180       Q -> L (in allele A*24:13).
FT                                /FTId=VAR_015769.
FT   VARIANT     180    180       Q -> W (in allele A*24:06; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_004358.
FT   VARIANT     187    187       T -> R (in allele A*24:10).
FT                                /FTId=VAR_015770.
FT   VARIANT     190    191       DG -> EW (in allele A*24:03 and allele
FT                                A*24:10).
FT                                /FTId=VAR_004359.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056263.
FT   VARIANT     206    206       T -> A (in allele A*2401).
FT                                /FTId=VAR_004360.
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    159
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    197
FT   HELIX       200    203
FT   STRAND      212    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      252    254
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      290    292
FT   STRAND      294    296
SQ   SEQUENCE   365 AA;  40689 MW;  D33684D126F98EC3 CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDEETGK VKAHSQTDRE NLRIALRYYN QSEAGSHTLQ
     MMFGCDVGSD GRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQITKRK WEAAHVAEQQ
     RAYLEGTCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTVPIVG IIAGLVLLGA VITGAVVAAV MWRRNSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A25_HUMAN              Reviewed;         365 AA.
AC   P18462; Q95362; Q9TQE8; Q9TQG0; Q9UQU3;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   18-APR-2012, entry version 110.
DE   RecName: Full=HLA class I histocompatibility antigen, A-25 alpha chain;
DE   AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain;
DE   AltName: Full=MHC class I antigen A*25;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*25:01).
RX   MEDLINE=90207291; PubMed=2320591; DOI=10.1073/pnas.87.7.2833;
RA   Ennis P.D., Zemmour J., Salter R.D., Parham P.;
RT   "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction:
RT   frequency and nature of errors produced in amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE A*25:01).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*25:02).
RC   TISSUE=Hematopoietic;
RX   MEDLINE=97045042; PubMed=8881046; DOI=10.1007/s002510050175;
RA   Krausa P., Young D.M., Gotch F.;
RT   "Identification of a new HLA-A allele (A*2502) by PCR-SSP.";
RL   Immunogenetics 45:84-85(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*25:02).
RA   Guttridge M.G.;
RT   "Sequence confirmation of HLA-A*2502.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*25:03).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-25 are known: A*25:01
CC       A*25:02 and A*25:03. The sequence shown is that of A*25:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32321; AAA36234.1; -; mRNA.
DR   EMBL; BC008611; AAH08611.1; -; mRNA.
DR   EMBL; X97802; CAA66389.1; -; mRNA.
DR   EMBL; AJ238524; CAB41888.1; -; Genomic_DNA.
DR   EMBL; AF137076; AAD33737.1; -; Genomic_DNA.
DR   EMBL; AF137075; AAD33737.1; JOINED; Genomic_DNA.
DR   EMBL; AF148898; AAD34010.1; -; Genomic_DNA.
DR   EMBL; AF148897; AAD34010.1; JOINED; Genomic_DNA.
DR   IPI; IPI00785070; -.
DR   PIR; A35997; A35997.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P18462; -.
DR   SMR; P18462; 25-299.
DR   STRING; P18462; -.
DR   DMDM; 122158; -.
DR   PRIDE; P18462; -.
DR   Ensembl; ENST00000383605; ENSP00000373100; ENSG00000206505.
DR   Ensembl; ENST00000383617; ENSP00000373112; ENSG00000206505.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pn29898; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P18462; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4NZTV0; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P18462; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-25 alpha chain.
FT                                /FTId=PRO_0000018819.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      33     33       Y -> F (in allele A*25:03;
FT                                dbSNP:rs2075684).
FT                                /FTId=VAR_016737.
FT   VARIANT      94     94       H -> Q (in allele A*25:02).
FT                                /FTId=VAR_004361.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056264.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056265.
SQ   SEQUENCE   365 AA;  41218 MW;  00F71BD2F97C3620 CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAHSQTDRE SLRIALRYYN QSEDGSHTIQ
     RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW
     RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A26_HUMAN              Reviewed;         365 AA.
AC   P30450; O02963; O78073; P79563; Q30208; Q31623; Q95377; Q9BD15;
AC   Q9BD19; Q9MW42; Q9TQK5;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   18-APR-2012, entry version 110.
DE   RecName: Full=HLA class I histocompatibility antigen, A-26 alpha chain;
DE   AltName: Full=MHC class I antigen A*26;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELES A*26:01 AND A*26:02).
RX   MEDLINE=93235211; PubMed=8475492;
RX   DOI=10.1111/j.1399-0039.1993.tb01982.x;
RA   Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   du Toit E.D., Parham P.;
RT   "Structural diversity in the HLA-A10 family of alleles: correlations
RT   with serology.";
RL   Tissue Antigens 41:72-80(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*26:01).
RX   MEDLINE=90256559; PubMed=1692821; DOI=10.1016/0198-8859(90)90047-S;
RA   Zinzsner H., Masset M., Bourge J.-F., Colombani J., Cohen D.,
RA   Degos L., Paul P.;
RT   "Nucleotide sequence of the HLA-A26 class I gene: identification of
RT   specific residues and molecular mapping of public HLA class I
RT   epitopes.";
RL   Hum. Immunol. 27:155-166(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*26:01; A*26:02; A*26:03 AND
RP   A*26:04).
RC   TISSUE=Blood;
RX   MEDLINE=94299439; PubMed=8026990; DOI=10.1016/0198-8859(94)90263-1;
RA   Ishikawa Y., Tokunaga K., Lin L., Imanishi T., Saitou S.,
RA   Kashiwase K., Akaza T., Tadokoro K., Juji T.;
RT   "Sequences of four splits of HLA-A10 group. Implications for serologic
RT   cross-reactivities and their evolution.";
RL   Hum. Immunol. 39:220-224(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*26:01).
RC   TISSUE=Lymphocyte;
RA   Miyashita H., Fujiyoshi T., Yashiki S., Kuwayama M., Fujiyama C.,
RA   Sonoda S.;
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*26:03).
RC   TISSUE=Lymphocyte;
RX   MEDLINE=96435465; PubMed=8838351;
RX   DOI=10.1111/j.1399-0039.1995.tb03134.x;
RA   Miyashita H., Fujiyoshi T., Yashiki S., Kuwayama M., Fujiyama C.,
RA   Sonoda S.;
RT   "Cloning of HLA-A26 cDNA from Japanese donors possessing 'ATL-
RT   associated HLA haplotypes'.";
RL   Tissue Antigens 46:398-400(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*26:05).
RC   TISSUE=Blood;
RA   Maruya E., Ishikawa Y., Lin L., Tokunaga K., Kimura A., Saitou S.,
RA   Nita H., Juji T., Saji H.;
RT   "A novel A26 sequence found in Japanese, and identification of four
RT   major HLA-A26 subtypes.";
RL   Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*26:07).
RX   MEDLINE=96387673; PubMed=8795143;
RX   DOI=10.1111/j.1399-0039.1996.tb02578.x;
RA   Arnett K.L., Moses J.H., Williams F., Marsh S.G.E., Bodmer J.G.,
RA   Parham P., Middleton D.;
RT   "HLA-A *2607: sequence of a novel A*26 subtype predicted by DNA typing
RT   which shares the MA2.1 epitope with A*02, B*57 and B*58.";
RL   Tissue Antigens 47:422-425(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*26:08).
RX   MEDLINE=97051455; PubMed=8896181;
RX   DOI=10.1111/j.1399-0039.1996.tb02631.x;
RA   Szmania S., Baxter-Lowe L.A.;
RT   "Nucleotide sequence for HLA-A*2608 which encodes glutamine at codon
RT   156.";
RL   Tissue Antigens 48:210-212(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*26:08).
RA   Ellexson M.E., Hildebrand W.H.;
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*26:12).
RX   MEDLINE=20548605; PubMed=11098929;
RX   DOI=10.1034/j.1399-0039.2000.560401.x;
RA   Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H.,
RA   Hurley C.K.;
RT   "Diversity is demonstrated in class I HLA-A and HLA-B alleles in
RT   Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-
RT   B*1403, *4016, *4703.";
RL   Tissue Antigens 56:291-302(2000).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*26:12).
RX   MEDLINE=21160440; PubMed=11260503;
RX   DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*26:15).
RA   Voorter C.E., Gervais T., van den Berg-Loonene E.M.;
RT   "New HLA-A alleles detected by sequence-based typing.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 26-298 (ALLELE A*26:07).
RA   Moine A.;
RT   "A new variant form of a HLA A*2607 allele.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-365 (ALLELE A*26:01).
RX   MEDLINE=89122144; PubMed=2914713; DOI=10.1007/BF00395855;
RA   Cianetti L., Testa U., Scotto L., la Valle R., Simeone A., Boccoli G.,
RA   Giannella G., Peschle C., Boncinelli E.;
RT   "Three new class I HLA alleles: structure of mRNAs and alternative
RT   mechanisms of processing.";
RL   Immunogenetics 29:80-91(1989).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-26 are known: A*26:01,
CC       A*26:02, A*26:03, A*26:04 (A-10SA), A*26:05, A*26:07, A*26:08,
CC       A*26:12 and A*26:15. The sequence shown is that of A*26:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03697; AAA03720.1; -; mRNA.
DR   EMBL; M98453; AAA35991.1; -; mRNA.
DR   EMBL; D14350; BAA03279.1; -; mRNA.
DR   EMBL; D14351; BAA03280.1; -; mRNA.
DR   EMBL; D14354; BAA03282.1; -; mRNA.
DR   EMBL; D16843; BAA04119.1; -; mRNA.
DR   EMBL; D32130; BAA06856.1; -; mRNA.
DR   EMBL; D32131; BAA06857.1; -; mRNA.
DR   EMBL; D32129; BAA06855.1; -; mRNA.
DR   EMBL; D50068; BAA08783.1; -; mRNA.
DR   EMBL; L48341; AAF25960.1; -; Genomic_DNA.
DR   EMBL; U52429; AAB08574.1; -; mRNA.
DR   EMBL; U45480; AAB38491.1; -; mRNA.
DR   EMBL; AF065487; AAC17438.1; -; Genomic_DNA.
DR   EMBL; AF065486; AAC17438.1; JOINED; Genomic_DNA.
DR   EMBL; AF042187; AAD02210.1; -; Genomic_DNA.
DR   EMBL; AF042186; AAD02210.1; JOINED; Genomic_DNA.
DR   EMBL; AJ291695; CAC27239.1; -; Genomic_DNA.
DR   EMBL; AJ291696; CAC27239.1; JOINED; Genomic_DNA.
DR   EMBL; AJ290394; CAC27416.2; -; mRNA.
DR   EMBL; M24095; AAA59655.1; -; mRNA.
DR   IPI; IPI00743359; -.
DR   PIR; A37028; A37028.
DR   PIR; I38436; I38436.
DR   PIR; I84487; I84487.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P30450; -.
DR   STRING; P30450; -.
DR   DMDM; 1168209; -.
DR   PRIDE; P30450; -.
DR   Ensembl; ENST00000383605; ENSP00000373100; ENSG00000206505.
DR   Ensembl; ENST00000383617; ENSP00000373112; ENSG00000206505.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pn29898; -.
DR   H-InvDB; HIX0033011; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30450; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30450; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-26 alpha chain.
FT                                /FTId=PRO_0000018820.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      60     60       F -> L (in allele A*26:15).
FT                                /FTId=VAR_016341.
FT   VARIANT      86     87       RN -> GE (in allele A*26:07).
FT                                /FTId=VAR_016342.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_050321.
FT   VARIANT      90     90       N -> K (in allele A*26:07).
FT                                /FTId=VAR_016343.
FT   VARIANT      94     94       H -> Q (in dbSNP:rs1059463).
FT                                /FTId=VAR_050322.
FT   VARIANT      98    101       DRAN -> HRVD (in allele A*26:03).
FT                                /FTId=VAR_004362.
FT   VARIANT     100    100       A -> E (in allele A*26:05).
FT                                /FTId=VAR_016344.
FT   VARIANT     101    101       N -> D (in dbSNP:rs1136688).
FT                                /FTId=VAR_050323.
FT   VARIANT     129    129       P -> S (in dbSNP:rs1136700).
FT                                /FTId=VAR_050324.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_050325.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_050326.
FT   VARIANT     140    140       D -> N (in allele A*26:02).
FT                                /FTId=VAR_004364.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_050327.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_050328.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_050329.
FT   VARIANT     176    176       E -> V (in allele A*26:12).
FT                                /FTId=VAR_016345.
FT   VARIANT     180    180       W -> Q (in allele A*26:08; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016346.
FT   VARIANT     180    180       W -> R (in dbSNP:rs9260155).
FT                                /FTId=VAR_050330.
FT   VARIANT     185    185       E -> D (in dbSNP:rs1059542).
FT                                /FTId=VAR_050331.
FT   VARIANT     187    187       R -> L (in allele A*26:04).
FT                                /FTId=VAR_004363.
FT   VARIANT     306    306       I -> V (in dbSNP:rs1136949).
FT                                /FTId=VAR_014603.
FT   CONFLICT    153    153       D -> H (in Ref. 14; AAA59655).
FT   CONFLICT    160    160       A -> G (in Ref. 14; AAA59655).
SQ   SEQUENCE   365 AA;  41062 MW;  44B54DD363B46EDA CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ
     RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW
     RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A29_HUMAN              Reviewed;         365 AA.
AC   P30512; O02955; O19687; O98011; P30451; P79562;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   18-APR-2012, entry version 110.
DE   RecName: Full=HLA class I histocompatibility antigen, A-29 alpha chain;
DE   AltName: Full=Aw-19;
DE   AltName: Full=MHC class I antigen A*29;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*29:01).
RX   MEDLINE=89065816; PubMed=2461903; DOI=10.1007/BF02341610;
RA   Trapani J.A., Mizuno S., Kang S.H., Yang S.Y., Dupont B.;
RT   "Molecular mapping of a new public HLA class I epitope shared by all
RT   HLA-B and HLA-C antigens and defined by a monoclonal antibody.";
RL   Immunogenetics 29:25-32(1989).
RN   [2]
RP   SEQUENCE REVISION TO 345.
RA   Yang S.Y.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*29:01).
RA   Szmania S., Baxter-Lowe L.A.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*29:02).
RX   MEDLINE=92145462; PubMed=1782566;
RA   Tabary T., Prochnicka-Chalufour A., Cornillet P., Lehoang P.,
RA   Betuel H., Cohen H.M.;
RT   "HLA-A29 sub-types and 'Birdshot' choroido-retinopathy susceptibility:
RT   a possible 'resistance motif' in the HLA-A29.1 molecule.";
RL   C. R. Acad. Sci. III, Sci. Vie 313:599-605(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELE A*29:03).
RX   MEDLINE=98119601; PubMed=9459513;
RX   DOI=10.1111/j.1399-0039.1998.tb02956.x;
RA   Prokupek B., Dunn P., Ross J., Jordan F., Holman R., Madrigal J.A.,
RA   Little A.-M.;
RT   "HLA-A*2903 expresses an epitope shared with HLA-A*8001.";
RL   Tissue Antigens 51:115-118(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*29:04).
RX   MEDLINE=21160440; PubMed=11260503;
RX   DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-29 are known: A*29:01
CC       (A29.1), A*29:02 (A29.2), A*29:03 and A*29:04. The sequence shown
CC       is that of A*29:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M23739; AAB47873.1; -; mRNA.
DR   EMBL; U83415; AAB53373.1; -; mRNA.
DR   EMBL; X60108; CAA42702.1; -; mRNA.
DR   EMBL; AJ000661; CAA04209.1; -; mRNA.
DR   EMBL; Y09218; CAA70419.1; -; Genomic_DNA.
DR   EMBL; AF042189; AAD02224.1; -; Genomic_DNA.
DR   EMBL; AF042188; AAD02224.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472921; -.
DR   PIR; A45847; A45847.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P30512; -.
DR   SMR; P30512; 25-294.
DR   IntAct; P30512; 6.
DR   STRING; P30512; -.
DR   DMDM; 2851401; -.
DR   PRIDE; P30512; -.
DR   Ensembl; ENST00000412057; ENSP00000411730; ENSG00000231834.
DR   Ensembl; ENST00000456012; ENSP00000408986; ENSG00000231834.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pl29898; -.
DR   H-InvDB; HIX0166683; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30512; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30512; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-29 alpha chain.
FT                                /FTId=PRO_0000018821.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      90     90       N -> H (in allele A*29:04).
FT                                /FTId=VAR_016347.
FT   VARIANT     126    126       H -> D (in allele A*29:02, allele A*29:03
FT                                and allele A*29:04).
FT                                /FTId=VAR_004365.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_056266.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056267.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056268.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056269.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056270.
FT   VARIANT     190    191       EW -> DG (in allele A*29:03).
FT                                /FTId=VAR_010372.
SQ   SEQUENCE   365 AA;  40863 MW;  56E4B9039B3C783C CRC64;
     MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFTTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDLQTRN VKAQSQTDRA NLGTLRGYYN QSEAGSHTIQ
     MMYGCHVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A30_HUMAN              Reviewed;         365 AA.
AC   P16188; O19598; O62921; P30452; Q9UIP7;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=HLA class I histocompatibility antigen, A-30 alpha chain;
DE   AltName: Full=MHC class I antigen A*30;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*30:01).
RX   MEDLINE=90038496; PubMed=2478623;
RA   Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.;
RT   "Molecular analysis of the serologically defined HLA-Aw19 antigens. A
RT   genetically distinct family of HLA-A antigens comprising A29, A31,
RT   A32, and Aw33, but probably not A30.";
RL   J. Immunol. 143:3371-3378(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*30:01).
RX   MEDLINE=95176329; PubMed=7871528;
RX   DOI=10.1111/j.1399-0039.1994.tb02393.x;
RA   Olerup O., Daniels T.J., Baxter-Lowe L.;
RT   "Correct sequence of the A*3001 allele obtained by PCR-SSP typing and
RT   automated nucleotide sequencing.";
RL   Tissue Antigens 44:265-267(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*30:02).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-279 (ALLELE A*30:03).
RX   MEDLINE=93209813; PubMed=8458735; DOI=10.1016/0198-8859(93)90004-K;
RA   Choo S.Y., Starling G.C., Anasetti C., Hansen J.A.;
RT   "Selection of an unrelated donor for marrow transplantation
RT   facilitated by the molecular characterization of a novel HLA-A
RT   allele.";
RL   Hum. Immunol. 36:20-26(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*30:04).
RX   MEDLINE=96058597; PubMed=8522453; DOI=10.1016/0198-8859(95)00046-7;
RA   Krausa P., Carcassi C., Orru S., Bodmer J.G., Browning M.J., Contu L.;
RT   "Defining the allelic variants of HLA-A30 in the Sardinian population
RT   using amplification refractory mutation system -- polymerase chain
RT   reaction.";
RL   Hum. Immunol. 44:35-42(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 26-206 (ALLELE A*30:04).
RX   MEDLINE=96435464; PubMed=8838350;
RX   DOI=10.1111/j.1399-0039.1995.tb03133.x;
RA   Lienert K., Russ G., Bennett G., Gao X., McCluskey J.;
RT   "HLA-A*3004: a new A30 allele identified in an Australian Caucasoid
RT   population.";
RL   Tissue Antigens 46:394-397(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-205 (ALLELE A*30:04).
RX   MEDLINE=96124443; PubMed=8560452;
RX   DOI=10.1111/j.1399-0039.1995.tb02500.x;
RA   Blasczyk R., Wehling J., Paessler M., Hahn U., Huhn D., Salama A.;
RT   "A novel HLA-A30 allele (A*3004) identified by single-strand
RT   conformation polymorphism analysis and confirmed by solid-phase
RT   sequencing.";
RL   Tissue Antigens 46:322-326(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*30:06).
RX   MEDLINE=20548605; PubMed=11098929;
RX   DOI=10.1034/j.1399-0039.2000.560401.x;
RA   Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H.,
RA   Hurley C.K.;
RT   "Diversity is demonstrated in class I HLA-A and HLA-B alleles in
RT   Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-
RT   B*1403, *4016, *4703.";
RL   Tissue Antigens 56:291-302(2000).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*30:07).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [10]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*30:08).
RX   MEDLINE=21108617; PubMed=11169261;
RX   DOI=10.1034/j.1399-0039.2001.057001070.x;
RA   Cox S.T., Mcwhinnie A.J., Koester R.P., Heine U., Holman R.,
RA   Madrigal A.J., Little A.-M.;
RT   "Further diversity at HLA-A and -B loci identified in Afro-Caribbean
RT   potential bone marrow donors.";
RL   Tissue Antigens 57:70-72(2001).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-30 are known: A*30:01
CC       (A30.3), A*30:02, A*30:03, A*30:04 (A30W7), A*30:06, A*30:07 and
CC       A*30:08. The sequence shown is that of A*30:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30576; AAA59612.1; -; Genomic_DNA.
DR   EMBL; U07234; AAA70162.1; -; mRNA.
DR   EMBL; X61702; CAA43871.1; -; mRNA.
DR   EMBL; M93657; AAA58650.1; -; Genomic_DNA.
DR   EMBL; Z34921; CAA84401.1; -; Genomic_DNA.
DR   EMBL; U19734; AAB53658.1; -; Genomic_DNA.
DR   EMBL; U18988; AAB53658.1; JOINED; Genomic_DNA.
DR   EMBL; U24261; AAB50434.1; -; mRNA.
DR   EMBL; X83770; CAA58723.1; -; Genomic_DNA.
DR   EMBL; X83771; CAA58724.1; -; Genomic_DNA.
DR   EMBL; AF028714; AAC14191.1; -; Genomic_DNA.
DR   EMBL; AF028713; AAC14191.1; JOINED; Genomic_DNA.
DR   EMBL; AF065643; AAC18600.1; -; Genomic_DNA.
DR   EMBL; AF065642; AAC18600.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249308; CAB57306.1; -; Genomic_DNA.
DR   EMBL; AJ249309; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249310; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249311; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249312; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249313; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249314; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249315; CAB57306.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472855; -.
DR   PIR; I38519; I38519.
DR   PIR; I54307; I54307.
DR   PIR; I56039; I56039.
DR   ProteinModelPortal; P16188; -.
DR   SMR; P16188; 25-298.
DR   STRING; P16188; -.
DR   DMDM; 1345596; -.
DR   PRIDE; P16188; -.
DR   Ensembl; ENST00000376809; ENSP00000366005; ENSG00000206503.
DR   Ensembl; ENST00000396634; ENSP00000379873; ENSG00000206503.
DR   GeneCards; GC06P029921; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P16188; -.
DR   HOVERGEN; HBG016709; -.
DR   Bgee; P16188; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P16188; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-30 alpha chain.
FT                                /FTId=PRO_0000018822.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      21     21       H -> Q (in allele A*30:02, allele A*30:04
FT                                and allele A*30:08).
FT                                /FTId=VAR_004366.
FT   VARIANT      33     33       S -> Y (in allele A*30:08).
FT                                /FTId=VAR_010284.
FT   VARIANT      55     55       T -> A (in allele A*30:06).
FT                                /FTId=VAR_016653.
FT   VARIANT      80     80       R -> G (in allele A*30:03).
FT                                /FTId=VAR_004367.
FT   VARIANT      86     86       Q -> E (in allele A*30:07).
FT                                /FTId=VAR_016738.
FT   VARIANT      89     90       RN -> GK (in allele A*30:07).
FT                                /FTId=VAR_016739.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056271.
FT   VARIANT      94     94       Q -> H (in allele A*30:02, allele
FT                                A*30:03, allele A*30:04, allele A*30:06
FT                                and allele A*30:07; dbSNP:rs1059463).
FT                                /FTId=VAR_004368.
FT   VARIANT     100    101       VD -> EN (in allele A*30:02, allele
FT                                A*30:03, allele A*30:04, allele A*30:06
FT                                and allele A*30:07).
FT                                /FTId=VAR_004369.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056272.
FT   VARIANT     121    121       I -> M (in dbSNP:rs1136695).
FT                                /FTId=VAR_056273.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_056274.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056275.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056276.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056277.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056278.
FT   VARIANT     175    176       RW -> HV (in allele A*30:04 and allele
FT                                A*30:06).
FT                                /FTId=VAR_004370.
FT   VARIANT     176    176       W -> R (in allele A*30:02, allele A*30:03
FT                                and allele A*30:07).
FT                                /FTId=VAR_004371.
FT   VARIANT     180    180       L -> W (in allele A*30:04 and allele
FT                                A*30:06).
FT                                /FTId=VAR_004372.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056279.
FT   CONFLICT     33     33       S -> F (in Ref. 1; AAA59612).
SQ   SEQUENCE   365 AA;  40905 MW;  521166D95FB1DC28 CRC64;
     MAVMAPRTLL LLLSGALALT HTWAGSHSMR YFSTSVSRPG SGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQER PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYEQH AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARWAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A31_HUMAN              Reviewed;         365 AA.
AC   P16189; O62924; O98009; O98137; Q8MHM1; Q9TPQ3; Q9TQ24; Q9UQU6;
AC   Q9UQU7;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 2.
DT   18-APR-2012, entry version 106.
DE   RecName: Full=HLA class I histocompatibility antigen, A-31 alpha chain;
DE   AltName: Full=MHC class I antigen A*31;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*31:01).
RX   MEDLINE=90038496; PubMed=2478623;
RA   Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.;
RT   "Molecular analysis of the serologically defined HLA-Aw19 antigens. A
RT   genetically distinct family of HLA-A antigens comprising A29, A31,
RT   A32, and Aw33, but probably not A30.";
RL   J. Immunol. 143:3371-3378(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*31:01).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*31:01).
RX   MEDLINE=96387675; PubMed=8795145;
RX   DOI=10.1111/j.1399-0039.1996.tb02580.x;
RA   Arnett K.L., Adams E.J., Parham P.;
RT   "On the sequence of A*3101.";
RL   Tissue Antigens 47:428-430(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 9-365 (ALLELE A*31:01).
RX   MEDLINE=92269956; PubMed=1589035; DOI=10.1038/357329a0;
RA   Watkins D.I., McAdam S.N., Liu X., Stang C.R., Milford E.L.,
RA   Levine C.G., Garber T.L., Dogon A.L., Lord C.I., Ghim S.H.,
RA   Troup G.M., Hughes A.L., Letvin N.L.;
RT   "New recombinant HLA-B alleles in a tribe of South American
RT   Amerindians indicate rapid evolution of MHC class I loci.";
RL   Nature 357:329-333(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*31:04).
RA   Bettinotti M.P., Dhillon G., Hackett J., Simonis T.B., Marincola F.M.;
RT   "A new HLA-A*31 allele.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*31:03).
RA   Bunce M., Dunn P., Ross J.;
RT   "Characterization of two new HLA-A alleles identified by PCR-SSP.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*31:04).
RA   Mitsuishi Y.;
RT   "New HLA-A31 allele identified in African American population.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*31:02).
RA   Dunn P.P.;
RT   "Characterization of an HLA-A*31 variant.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*31:05).
RA   Juji T., Akesaka T., Kashiwase K., Ishikawa Y.;
RT   "HLA-A31012V1.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*31:02).
RX   MEDLINE=21160440; PubMed=11260503;
RX   DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*31:06).
RC   TISSUE=Blood;
RA   Anholts J.D.H.;
RT   "Four new HLA alleles found, and confirmation of DRB1*0322, DRB1*1433
RT   and A*3106.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   ASSOCIATION OF ALLELE A*31:01 WITH CARBAMAZEPINE-INDUCED
RP   HYPERSENSITIVITY REACTIONS.
RX   PubMed=21428769; DOI=10.1056/NEJMoa1013297;
RA   McCormack M., Alfirevic A., Bourgeois S., Farrell J.J.,
RA   Kasperaviciute D., Carrington M., Sills G.J., Marson T., Jia X.,
RA   de Bakker P.I., Chinthapalli K., Molokhia M., Johnson M.R.,
RA   O'Connor G.D., Chaila E., Alhusaini S., Shianna K.V., Radtke R.A.,
RA   Heinzen E.L., Walley N., Pandolfo M., Pichler W., Park B.K.,
RA   Depondt C., Sisodiya S.M., Goldstein D.B., Deloukas P., Delanty N.,
RA   Cavalleri G.L., Pirmohamed M.;
RT   "HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in
RT   Europeans.";
RL   N. Engl. J. Med. 364:1134-1143(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-31 are known: A*31:01,
CC       A*31:02, A*31:03, A*31:04, A*31:05 (A3101v1) and A*31:06. The
CC       sequence shown is that of A*31:01. Allele A*31:01 is associated
CC       with carbamazepine-induced hypersensitivity reactions among
CC       subjects of Northern European ancestry [MIM:608579].
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30578; AAA59613.1; -; Genomic_DNA.
DR   EMBL; M84375; AAA59599.1; -; mRNA.
DR   EMBL; L78918; AAB05976.1; -; Genomic_DNA.
DR   EMBL; AF148863; AAD39981.1; -; Genomic_DNA.
DR   EMBL; AF067439; AAC18859.1; -; Genomic_DNA.
DR   EMBL; AF067438; AAC18859.1; JOINED; Genomic_DNA.
DR   EMBL; AF105028; AAC79721.1; -; Genomic_DNA.
DR   EMBL; AF105027; AAC79721.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239045; CAB43109.1; -; Genomic_DNA.
DR   EMBL; AJ239046; CAB43110.1; -; Genomic_DNA.
DR   EMBL; AB032597; BAA84645.1; -; Genomic_DNA.
DR   EMBL; AF041370; AAD02207.1; -; Genomic_DNA.
DR   EMBL; AF041369; AAD02207.1; JOINED; Genomic_DNA.
DR   EMBL; AJ506789; CAD44950.1; -; Genomic_DNA.
DR   EMBL; AJ506790; CAD44950.1; JOINED; Genomic_DNA.
DR   IPI; IPI00646225; -.
DR   PIR; I72170; I72170.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P16189; -.
DR   STRING; P16189; -.
DR   DMDM; 231367; -.
DR   PRIDE; P16189; -.
DR   Ensembl; ENST00000412057; ENSP00000411730; ENSG00000231834.
DR   Ensembl; ENST00000456012; ENSP00000408986; ENSG00000231834.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pl29898; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   MIM; 608579; phenotype.
DR   neXtProt; NX_P16189; -.
DR   Orphanet; 179; Chorioretinopathy, Birdshot type.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P16189; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-31 alpha chain.
FT                                /FTId=PRO_0000018823.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      90     90       N -> K (in allele A*31:02).
FT                                /FTId=VAR_016348.
FT   VARIANT     114    114       A -> D (in allele A*31:03).
FT                                /FTId=VAR_016349.
FT   VARIANT     121    121       M -> I (in allele A*31:03 and allele
FT                                A*31:04).
FT                                /FTId=VAR_010373.
FT   VARIANT     138    138       Q -> R (in allele A*31:03, allele A*31:04
FT                                and allele A*31:06).
FT                                /FTId=VAR_010374.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056280.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056281.
FT   VARIANT     190    191       EW -> DG (in allele A*31:05).
FT                                /FTId=VAR_016350.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056282.
SQ   SEQUENCE   365 AA;  41004 MW;  4E760C821A3C553B CRC64;
     MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFTTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQER PEYWDQETRN VKAHSQIDRV DLGTLRGYYN QSEAGSHTIQ
     MMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A32_HUMAN              Reviewed;         365 AA.
AC   P10314; O77937; Q29838; Q8MHN9; Q9MYE9; Q9MYG5; Q9TQF5; Q9TQF9;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=HLA class I histocompatibility antigen, A-32 alpha chain;
DE   AltName: Full=MHC class I antigen A*32;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*32:01).
RA   Domena J.D.;
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 25-298 (ALLELE A*32:01).
RX   MEDLINE=87058961; PubMed=2431040;
RA   Wan A.M., Ennis P., Parham P., Holmes N.;
RT   "The primary structure of HLA-A32 suggests a region involved in
RT   formation of the Bw4/Bw6 epitopes.";
RL   J. Immunol. 137:3671-3674(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*32:02).
RC   TISSUE=Blood;
RX   MEDLINE=97045038; PubMed=8881042; DOI=10.1007/s002510050171;
RA   Zino E., Severini G.M., Mazzi B., Bordignon C., Benazzi E.,
RA   Fleischhauer K.;
RT   "Sequencing of a new HLA-A*32 subtype (A*3202).";
RL   Immunogenetics 45:76-77(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*32:03 AND A*32:04).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*32:03).
RA   Kanaan C., Hepner J., Thornton A.;
RT   "Confirmatory exon 2 and 3 sequence for HLA-A*3203.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*32:05).
RA   Bettinotti M.P., Hadzikadic L., Adams S., Marincola F.M.;
RT   "A new HLA A-32 allele.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*32:06).
RA   Jones P.F., Hurley C.K.;
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-32 are known: A*32:01,
CC       A*32:02, A*32:03, A*32:04, A*32:05 and A*32:06. The sequence shown
CC       is that of A*32:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03907; AAA03605.1; -; mRNA.
DR   EMBL; X97120; CAA65786.1; -; mRNA.
DR   EMBL; AF072762; AAC26020.1; -; Genomic_DNA.
DR   EMBL; AF072761; AAC26020.1; JOINED; Genomic_DNA.
DR   EMBL; AF137078; AAD33738.1; -; Genomic_DNA.
DR   EMBL; AF137077; AAD33738.1; JOINED; Genomic_DNA.
DR   EMBL; AF139892; AAD33849.1; -; Genomic_DNA.
DR   EMBL; AF139891; AAD33849.1; JOINED; Genomic_DNA.
DR   EMBL; AF517562; AAM78538.1; -; Genomic_DNA.
DR   EMBL; AF517561; AAM78538.1; JOINED; Genomic_DNA.
DR   EMBL; AF217560; AAF28733.1; -; mRNA.
DR   EMBL; AF226837; AAF29554.1; -; Genomic_DNA.
DR   EMBL; AF226836; AAF29554.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472825; -.
DR   PIR; A26088; HLHU32.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P10314; -.
DR   SMR; P10314; 25-294.
DR   STRING; P10314; -.
DR   DMDM; 1168210; -.
DR   PRIDE; P10314; -.
DR   Ensembl; ENST00000442068; ENSP00000404428; ENSG00000223980.
DR   Ensembl; ENST00000454091; ENSP00000410645; ENSG00000223980.
DR   UCSC; uc011jeb.2; human.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Po29897; -.
DR   H-InvDB; HIX0078423; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P10314; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P10314; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-32 alpha chain.
FT                                /FTId=PRO_0000018824.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      89     90       RN -> GK (in allele A*32:05).
FT                                /FTId=VAR_016656.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056283.
FT   VARIANT     101    101       S -> N (in allele A*32:03).
FT                                /FTId=VAR_016657.
FT   VARIANT     121    121       M -> I (in allele A*32:04).
FT                                /FTId=VAR_016831.
FT   VARIANT     129    129       P -> S (in allele A*32:04).
FT                                /FTId=VAR_016832.
FT   VARIANT     133    133       L -> F (in allele A*32:04).
FT                                /FTId=VAR_016833.
FT   VARIANT     138    138       Q -> R (in allele A*32:04).
FT                                /FTId=VAR_016834.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056284.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056285.
FT   VARIANT     168    168       Q -> K (in allele A*32:04).
FT                                /FTId=VAR_016835.
FT   VARIANT     175    175       R -> H (in allele A*32:02, allele A*32:04
FT                                and allele A*32:06).
FT                                /FTId=VAR_004373.
FT   VARIANT     176    176       V -> E (in allele A*32:04).
FT                                /FTId=VAR_016836.
FT   VARIANT     180    180       L -> Q (in allele A*32:02).
FT                                /FTId=VAR_004374.
FT   VARIANT     185    185       E -> D (in allele A*32:04).
FT                                /FTId=VAR_016837.
SQ   SEQUENCE   365 AA;  41048 MW;  BF7AF225329E0319 CRC64;
     MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAHSQTDRE SLRIALRYYN QSEAGSHTIQ
     MMYGCDVGPD GRLLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA MFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A33_HUMAN              Reviewed;         365 AA.
AC   P16190; O02939; O02954;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 3.
DT   18-APR-2012, entry version 106.
DE   RecName: Full=HLA class I histocompatibility antigen, A-33 alpha chain;
DE   AltName: Full=Aw-19;
DE   AltName: Full=Aw-33;
DE   AltName: Full=MHC class I antigen A*33;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*33:01).
RX   MEDLINE=90038496; PubMed=2478623;
RA   Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.;
RT   "Molecular analysis of the serologically defined HLA-Aw19 antigens. A
RT   genetically distinct family of HLA-A antigens comprising A29, A31,
RT   A32, and Aw33, but probably not A30.";
RL   J. Immunol. 143:3371-3378(1989).
RN   [2]
RP   SEQUENCE REVISION TO 178-179; 210 AND 345.
RA   Yang S.Y.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*33:01).
RA   Szmania S., Baxter-Lowe L.A.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*3302).
RX   MEDLINE=93369838; PubMed=8362415;
RX   DOI=10.1111/j.1399-0039.1993.tb02006.x;
RA   Kato N., Kikuchi A., Kano K., Egawa K., Takiguchi M.;
RT   "Molecular analysis of a novel HLA-A33 subtype associated with HLA-
RT   B44.";
RL   Tissue Antigens 41:211-213(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*33:03).
RX   MEDLINE=95242316; PubMed=7725315;
RX   DOI=10.1111/j.1399-0039.1995.tb02418.x;
RA   Balas A., Garcia-Sanchez F., Vicario J.L.;
RT   "Molecular characterization of a novel HLA-A33 allele (A*3303).";
RL   Tissue Antigens 45:73-76(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-99 AND 122-205 (ALLELES
RP   A*33:01 AND A*33:03).
RX   MEDLINE=95381237; PubMed=7652743;
RX   DOI=10.1111/j.1399-0039.1995.tb02465.x;
RA   Blasczyk R., Wehling J., Hahn U., Schwella N., Huhn D., Salama A.;
RT   "Identification of a novel HLA-A33 subtype (A*3303) and correction of
RT   the A*3301 sequence.";
RL   Tissue Antigens 45:348-352(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*33:01 AND A*33:03).
RA   Gao X., Jakobsen I., Serjeantson S.W.;
RL   Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-33 are known: A*33:01
CC       (Aw-33.1), A*3302 and A*33:03. The sequence shown is that of
CC       A*33:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30580; AAB47870.1; -; Genomic_DNA.
DR   EMBL; U83416; AAB53374.1; -; mRNA.
DR   EMBL; L06440; AAA71914.1; -; mRNA.
DR   EMBL; U09740; AAA79865.1; -; mRNA.
DR   EMBL; X83004; CAA58125.1; -; Genomic_DNA.
DR   EMBL; X83005; CAA58126.1; -; Genomic_DNA.
DR   EMBL; X83002; CAA58123.1; -; Genomic_DNA.
DR   EMBL; X83003; CAA58124.1; -; Genomic_DNA.
DR   EMBL; U19735; AAB60652.1; -; Genomic_DNA.
DR   EMBL; U19736; AAB60653.1; -; Genomic_DNA.
DR   IPI; IPI00472013; -.
DR   PIR; I38610; I38610.
DR   PIR; S51099; S51099.
DR   PIR; S51100; S51100.
DR   ProteinModelPortal; P16190; -.
DR   SMR; P16190; 25-294.
DR   STRING; P16190; -.
DR   DMDM; 2851527; -.
DR   PRIDE; P16190; -.
DR   Ensembl; ENST00000412057; ENSP00000411730; ENSG00000231834.
DR   Ensembl; ENST00000456012; ENSP00000408986; ENSG00000231834.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pl29898; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P16190; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P16190; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-33 alpha chain.
FT                                /FTId=PRO_0000018825.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      41     41       R -> S (in allele A*3302).
FT                                /FTId=VAR_004375.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056286.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056287.
FT   VARIANT     195    195       H -> Y (in allele A*3302 and allele
FT                                A*33:03).
FT                                /FTId=VAR_004376.
FT   VARIANT     217    218       AV -> PI (in allele A*3302).
FT                                /FTId=VAR_004377.
FT   VARIANT     358    358       M -> V (in allele A*3302).
FT                                /FTId=VAR_004378.
FT   CONFLICT    210    210       K -> R (in Ref. 3; AAB53374).
SQ   SEQUENCE   365 AA;  40892 MW;  060AE508EADEB328 CRC64;
     MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFTTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAHSQIDRV DLGTLRGYYN QSEAGSHTIQ
     MMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRHLENGK ETLQRTDPPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A34_HUMAN              Reviewed;         365 AA.
AC   P30453; P30454;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=HLA class I histocompatibility antigen, A-34 alpha chain;
DE   AltName: Full=Aw-34;
DE   AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain;
DE   AltName: Full=MHC class I antigen A*34;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*34:01 AND A*34:02).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*34:01 AND A*34:02).
RX   MEDLINE=93235211; PubMed=8475492;
RX   DOI=10.1111/j.1399-0039.1993.tb01982.x;
RA   Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   du Toit E.D., Parham P.;
RT   "Structural diversity in the HLA-A10 family of alleles: correlations
RT   with serology.";
RL   Tissue Antigens 41:72-80(1993).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-34 are known: A*34:01
CC       (Aw-34.1) and A*34:02 (Aw-34.2). The sequence shown is that of
CC       A*34:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61704; CAA43873.1; -; mRNA.
DR   EMBL; X61705; CAA43874.1; -; mRNA.
DR   IPI; IPI00743503; -.
DR   PIR; I37477; I37477.
DR   PIR; I37483; I37483.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P30453; -.
DR   SMR; P30453; 25-294.
DR   STRING; P30453; -.
DR   DMDM; 231368; -.
DR   PRIDE; P30453; -.
DR   Ensembl; ENST00000383605; ENSP00000373100; ENSG00000206505.
DR   Ensembl; ENST00000383617; ENSP00000373112; ENSG00000206505.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pn29898; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30453; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30453; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-34 alpha chain.
FT                                /FTId=PRO_0000018826.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       3      3       I -> V (in allele A*34:02).
FT                                /FTId=VAR_004379.
FT   VARIANT      90     90       K -> N (in allele A*34:02).
FT                                /FTId=VAR_004380.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056288.
FT   VARIANT     121    121       R -> I (in allele A*34:02).
FT                                /FTId=VAR_004381.
FT   VARIANT     129    129       P -> S (in allele A*34:02).
FT                                /FTId=VAR_004382.
FT   VARIANT     138    138       Q -> R (in allele A*34:02).
FT                                /FTId=VAR_004383.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056289.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056290.
FT   VARIANT     180    180       W -> L (in allele A*34:02).
FT                                /FTId=VAR_004384.
FT   VARIANT     312    312       L -> I (in allele A*34:02).
FT                                /FTId=VAR_004385.
SQ   SEQUENCE   365 AA;  41055 MW;  063BF63E6E6E01F6 CRC64;
     MAIMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRK VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ
     RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG ILAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A36_HUMAN              Reviewed;         365 AA.
AC   P30455; Q9MY89;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 96.
DE   RecName: Full=HLA class I histocompatibility antigen, A-36 alpha chain;
DE   AltName: Full=Aw-36;
DE   AltName: Full=MHC class I antigen A*36;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*36:01).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*36:02).
RA   Rizzuto G.A., Hurley C.K.;
RT   "Novel HLA-A Allele.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-36 are known: A*36:01 and
CC       A*36:02. The sequence shown is that of A*36:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61700; CAA43869.1; -; mRNA.
DR   EMBL; AF274505; AAF78082.1; -; Genomic_DNA.
DR   EMBL; AF274504; AAF78082.1; JOINED; Genomic_DNA.
DR   IPI; IPI00644748; -.
DR   PIR; I37478; I37478.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P30455; -.
DR   STRING; P30455; -.
DR   DMDM; 231370; -.
DR   PRIDE; P30455; -.
DR   Ensembl; ENST00000431795; ENSP00000396220; ENSG00000229215.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   Ensembl; ENST00000448357; ENSP00000402461; ENSG00000224320.
DR   GeneCards; GC06P029921; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30455; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30455; -.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-36 alpha chain.
FT                                /FTId=PRO_0000018827.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056291.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056292.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056293.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056294.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056295.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_056296.
FT   VARIANT     182    182       V -> A (in allele A*36:02).
FT                                /FTId=VAR_016610.
FT   VARIANT     185    185       E -> D (in allele A*36:02).
FT                                /FTId=VAR_016611.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056297.
SQ   SEQUENCE   365 AA;  40934 MW;  BA00A0085989CD3E CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQKME PRAPWIEQEG PEYWDQETRN MKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAVHAAEQR
     RVYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A43_HUMAN              Reviewed;         365 AA.
AC   P30456; O19509;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=HLA class I histocompatibility antigen, A-43 alpha chain;
DE   AltName: Full=Aw-43;
DE   AltName: Full=MHC class I antigen A*43;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*43:01).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*43:01).
RX   MEDLINE=93235211; PubMed=8475492;
RX   DOI=10.1111/j.1399-0039.1993.tb01982.x;
RA   Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   du Toit E.D., Parham P.;
RT   "Structural diversity in the HLA-A10 family of alleles: correlations
RT   with serology.";
RL   Tissue Antigens 41:72-80(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*43:01).
RX   MEDLINE=99446859; PubMed=10519370;
RX   DOI=10.1034/j.1399-0039.1999.540314.x;
RA   Bei M., Ng J., Slack R., Ellis J., Hartzman R.J., Hurley C.K.;
RT   "The relative frequencies of HLA-A*10 alleles in five major United
RT   States ethnic populations.";
RL   Tissue Antigens 54:295-299(1999).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The only allele of A-43 known is A*43:01 which is
CC       shown here.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61703; CAA43872.1; -; mRNA.
DR   EMBL; AF008306; AAB65408.1; -; Genomic_DNA.
DR   EMBL; AF008305; AAB65408.1; JOINED; Genomic_DNA.
DR   IPI; IPI00785070; -.
DR   PIR; I72171; I72171.
DR   PIR; S16769; S16769.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P30456; -.
DR   SMR; P30456; 25-299.
DR   STRING; P30456; -.
DR   DMDM; 231371; -.
DR   PRIDE; P30456; -.
DR   Ensembl; ENST00000383605; ENSP00000373100; ENSG00000206505.
DR   Ensembl; ENST00000383617; ENSP00000373112; ENSG00000206505.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pn29898; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30456; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30456; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-43 alpha chain.
FT                                /FTId=PRO_0000018828.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056298.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056299.
SQ   SEQUENCE   365 AA;  41033 MW;  213FC69745FB4B0B CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDLQTRN VKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ
     RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW
     RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A66_HUMAN              Reviewed;         365 AA.
AC   P30457; P30458;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=HLA class I histocompatibility antigen, A-66 alpha chain;
DE   AltName: Full=Aw-66;
DE   AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain;
DE   AltName: Full=MHC class I antigen A*66;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*66:01 AND A*66:02).
RX   MEDLINE=92044300; PubMed=1940790; DOI=10.1084/jem.174.5.1085;
RA   Madrigal J., Belich M.P., Benjamin R.J., Little A.-M.,
RA   Hildebrand W.H., Mann D.L., Parham P.;
RT   "Molecular definition of a polymorphic antigen (LA45) of free HLA-A
RT   and -B heavy chains found on the surfaces of activated B and T
RT   cells.";
RL   J. Exp. Med. 174:1085-1095(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*66:02).
RX   MEDLINE=90237739; PubMed=2139695; DOI=10.1084/jem.171.5.1431;
RA   Schnabl E., Stockinger H., Majdic O., Gaugitsch H., Lindley I.J.D.,
RA   Maurer D., Hajek-Rosenmayr A., Knapp W.;
RT   "Activated human T lymphocytes express MHC class I heavy chains not
RT   associated with beta 2-microglobulin.";
RL   J. Exp. Med. 171:1431-1442(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-322 (ALLELE A*66:01).
RA   Hurley C.K., Bei M.;
RL   Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-66 are known: A*66:01 and
CC       A*66:02 (Aw67). The sequence shown is that of A*66:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61711; CAA43880.1; -; mRNA.
DR   EMBL; X61712; CAA43881.1; -; mRNA.
DR   EMBL; X51745; CAA36034.1; -; mRNA.
DR   EMBL; U17571; AAA56781.1; -; mRNA.
DR   IPI; IPI00785070; -.
DR   PIR; JL0135; JL0135.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P30457; -.
DR   SMR; P30457; 25-299.
DR   STRING; P30457; -.
DR   DMDM; 231372; -.
DR   Ensembl; ENST00000383605; ENSP00000373100; ENSG00000206505.
DR   Ensembl; ENST00000383617; ENSP00000373112; ENSG00000206505.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pn29898; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30457; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30457; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-66 alpha chain.
FT                                /FTId=PRO_0000018829.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      28     28       S -> W (in allele A*66:02).
FT                                /FTId=VAR_004386.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056300.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056301.
FT   VARIANT     114    114       D -> A (in allele A*66:02).
FT                                /FTId=VAR_004387.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056302.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056303.
FT   VARIANT     187    187       R -> E (in allele A*66:02; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_004388.
SQ   SEQUENCE   365 AA;  41082 MW;  A3272DBE4008328D CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ
     RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW
     RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A68_HUMAN              Reviewed;         365 AA.
AC   P01891; O19673; O19695; O19794; O19795; O43907; O77938; O98010;
AC   P10315; P79505; Q9MYA5; Q9MYC4; Q9TQG7; Q9TQN5; Q9UIN2;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 4.
DT   18-APR-2012, entry version 126.
DE   RecName: Full=HLA class I histocompatibility antigen, A-68 alpha chain;
DE   AltName: Full=Aw-68;
DE   AltName: Full=HLA class I histocompatibility antigen, A-28 alpha chain;
DE   AltName: Full=MHC class I antigen A*68;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*68:02).
RX   MEDLINE=87252273; PubMed=3496393;
RA   Holmes N., Ennis P., Wan A.M., Denney D.W., Parham P.;
RT   "Multiple genetic mechanisms have contributed to the generation of the
RT   HLA-A2/A28 family of class I MHC molecules.";
RL   J. Immunol. 139:936-941(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*68:02).
RA   Domena J.D.;
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*68:03).
RX   MEDLINE=97045039; PubMed=8881043; DOI=10.1007/s002510050172;
RA   Ellexson M., Lau M., Terasaki P., Hildebrand W.H.;
RT   "Molecular characterization of HLA-A*6803.";
RL   Immunogenetics 45:78-79(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*68:08).
RX   MEDLINE=99321037; PubMed=10395114;
RX   DOI=10.1034/j.1399-0039.1999.530614.x;
RA   Cox S.T., Arguello J.R., Marsh S.G.E., Boham E., Lau M., Kwan P.L.,
RA   Madrigal J.A., Little A.-M.;
RT   "Sequence of HLA-A*6808.";
RL   Tissue Antigens 53:597-600(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*68:011).
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of HLA-A*68011.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*68:17).
RX   MEDLINE=20340076; PubMed=10885567;
RX   DOI=10.1034/j.1399-0039.2000.550509.x;
RA   Ramon D., Scott I., Cox S.T., Pesoa S., Vullo C., Little A.-M.,
RA   Madrigal J.A.;
RT   "HLA-A*6817, identified in the Kolla Amerindians of north-west
RT   Argentina possesses a novel nucleotide substitution.";
RL   Tissue Antigens 55:453-454(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*68:06).
RA   Bei M., Hurley C.K.;
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*68:03).
RC   TISSUE=Blood;
RX   MEDLINE=97419180; PubMed=9271640; DOI=10.1007/s002510050304;
RA   Vargas-Alarcon G., Martinez-Laso J., Gomez-Casado E., Perez-Blas M.,
RA   Granados J., Alegre R., Alvarez M., Zuniga J., Arnaiz-Villena A.;
RT   "Description of HLA-A*6803 and A*68N in Mazatecan Indians from
RT   Mexico.";
RL   Immunogenetics 46:446-447(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*68:03).
RC   TISSUE=Blood;
RA   Blasczyk R.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*68:02).
RA   Edson S.M., Hurley C.K.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*68:09 AND A*68:10).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-206 (ALLELE A*68:16).
RX   MEDLINE=20260982; PubMed=10803837; DOI=10.1007/s002510050618;
RA   Gomez-Casado E., Martinez-Laso J., Gonzalez-Hevilla M., Longas J.,
RA   Rubio I., Silvera-Redondo C., Garcia-Gomez A., Lowy E.,
RA   Arnaiz-Villena A.;
RT   "A novel HLA-A*6816 allele possible generated by a point mutation in a
RT   Chilean from Punta Arenas (Magellan Strait).";
RL   Immunogenetics 51:257-260(2000).
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*68:07 AND A*68:17).
RX   MEDLINE=21160440; PubMed=11260503;
RX   DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-297 (ALLELE A*68:01).
RX   MEDLINE=86055720; PubMed=3877632;
RA   Holmes N., Parham P.;
RT   "Exon shuffling in vivo can generate novel HLA class I molecules.";
RL   EMBO J. 4:2849-2854(1985).
RN   [15]
RP   PROTEIN SEQUENCE OF 25-294 (A*68:01).
RX   MEDLINE=82247941; PubMed=6179086; DOI=10.1073/pnas.79.12.3813;
RA   Lopez de Castro J.A., Strominger J.L., Strong D.M., Orr H.T.;
RT   "Structure of crossreactive human histocompatibility antigens HLA-A28
RT   and HLA-A2: possible implications for the generation of HLA
RT   polymorphism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:3813-3817(1982).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*68:01).
RX   MEDLINE=93078854; PubMed=1448153; DOI=10.1038/360364a0;
RA   Guo H.-C., Jardetzky T.S., Garrett T.P.J., Lane W.S., Strominger J.L.,
RA   Wiley D.C.;
RT   "Different length peptides bind to HLA-Aw68 similarly at their ends
RT   but bulge out in the middle.";
RL   Nature 360:364-366(1992).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*68:01).
RX   MEDLINE=93078855; PubMed=1448154; DOI=10.1038/360367a0;
RA   Silver M.L., Guo H.-C., Strominger J.L., Wiley D.C.;
RT   "Atomic structure of a human MHC molecule presenting an influenza
RT   virus peptide.";
RL   Nature 360:367-369(1992).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 25-199 (A*68:01).
RX   MEDLINE=95166800; PubMed=7862664; DOI=10.1073/pnas.92.4.1218;
RA   Collins E.J., Garboczi D.N., Karpusas M.N., Wiley D.C.;
RT   "The three-dimensional structure of a class I major histocompatibility
RT   complex molecule missing the alpha 3 domain of the heavy chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1218-1221(1995).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-68 are known: A*68:01
CC       (Aw68.1), A*68:02, A*68:03. A*68:04, A*68:05, A*68:06, A*68:07,
CC       A*68:08, A*68:09, A*68:10, A*68:16 and A*68:17. The sequence shown
CC       is that of A*68:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03861; AAA03602.1; -; mRNA.
DR   EMBL; X03070; CAB56605.1; -; Genomic_DNA.
DR   EMBL; X03071; CAB56606.1; -; Genomic_DNA.
DR   EMBL; U41057; AAB41292.1; -; mRNA.
DR   EMBL; AJ315642; CAC44382.1; -; Genomic_DNA.
DR   EMBL; AF144013; AAF74211.1; -; Genomic_DNA.
DR   EMBL; AJ245567; CAB59722.1; -; Genomic_DNA.
DR   EMBL; U91628; AAB50567.1; -; Genomic_DNA.
DR   EMBL; U91627; AAB50567.1; JOINED; Genomic_DNA.
DR   EMBL; U89946; AAB82079.1; -; Genomic_DNA.
DR   EMBL; U89947; AAB82080.1; -; Genomic_DNA.
DR   EMBL; AJ001274; CAA04647.1; -; mRNA.
DR   EMBL; AF072770; AAC25782.1; -; Genomic_DNA.
DR   EMBL; AF072769; AAC25782.1; JOINED; Genomic_DNA.
DR   EMBL; AF135545; AAD22270.1; -; Genomic_DNA.
DR   EMBL; AF135544; AAD22270.1; JOINED; Genomic_DNA.
DR   EMBL; AF108431; AAD27539.1; -; Genomic_DNA.
DR   EMBL; AF108430; AAD27539.1; JOINED; Genomic_DNA.
DR   EMBL; AJ223972; CAA11708.1; -; Genomic_DNA.
DR   EMBL; AF041372; AAD02208.1; -; Genomic_DNA.
DR   EMBL; AF041371; AAD02208.1; JOINED; Genomic_DNA.
DR   EMBL; AF268398; AAF73477.1; -; Genomic_DNA.
DR   EMBL; AF268397; AAF73477.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472882; -.
DR   PIR; A02187; HLHU28.
DR   PIR; A24671; HLHUAW.
DR   PIR; I38441; I38441.
DR   UniGene; Hs.181244; -.
DR   PDB; 1HSB; X-ray; 1.90 A; A=25-294.
DR   PDB; 1TMC; X-ray; 2.30 A; A=25-199.
DR   PDB; 2HLA; X-ray; 2.60 A; A=25-294.
DR   PDBsum; 1HSB; -.
DR   PDBsum; 1TMC; -.
DR   PDBsum; 2HLA; -.
DR   ProteinModelPortal; P01891; -.
DR   SMR; P01891; 25-294.
DR   MINT; MINT-274751; -.
DR   STRING; P01891; -.
DR   DMDM; 13124681; -.
DR   PRIDE; P01891; -.
DR   Ensembl; ENST00000412679; ENSP00000399020; ENSG00000235657.
DR   Ensembl; ENST00000457879; ENSP00000403575; ENSG00000235657.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pk29899; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P01891; -.
DR   HOVERGEN; HBG016709; -.
DR   EvolutionaryTrace; P01891; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P01891; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Host-virus interaction; Immunity;
KW   Membrane; MHC I; Polymorphism; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-68 alpha chain.
FT                                /FTId=PRO_0000018830.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      36     36       V -> M (in allele A*68:02).
FT                                /FTId=VAR_004389.
FT   VARIANT      86     87       RN -> EE (in allele A*68:10).
FT                                /FTId=VAR_010362.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056304.
FT   VARIANT      94     94       Q -> H (in allele A*68:03, allele A*68:04
FT                                and allele A*68:05; dbSNP:rs1059463).
FT                                /FTId=VAR_010363.
FT   VARIANT      97     97       T -> I (in allele A*68:04).
FT                                /FTId=VAR_010364.
FT   VARIANT      98     98       D -> H (in allele A*68:05).
FT                                /FTId=VAR_010365.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056305.
FT   VARIANT     121    121       M -> R (in allele A*68:02).
FT                                /FTId=VAR_004390.
FT   VARIANT     129    129       S -> P (in allele A*68:02;
FT                                dbSNP:rs1136700).
FT                                /FTId=VAR_004391.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056306.
FT   VARIANT     138    138       R -> E (in allele A*68:06; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_010366.
FT   VARIANT     138    138       R -> H (in allele A*68:02).
FT                                /FTId=VAR_004392.
FT   VARIANT     140    140       D -> H (in allele A*68:06 and allele
FT                                A*68:07).
FT                                /FTId=VAR_010367.
FT   VARIANT     140    140       D -> V (in allele A*68:17).
FT                                /FTId=VAR_010368.
FT   VARIANT     140    140       D -> Y (in allele A*68:02).
FT                                /FTId=VAR_004393.
FT   VARIANT     175    175       H -> L (in allele A*68:16).
FT                                /FTId=VAR_010369.
FT   VARIANT     180    180       W -> L (in allele A*68:08).
FT                                /FTId=VAR_010370.
FT   VARIANT     180    180       W -> Q (in allele A*68:09; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_010371.
FT   CONFLICT    206    206       T -> A (in Ref. 12; AAF74211).
FT   CONFLICT    231    231       S -> G (in Ref. 15; AA sequence).
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    235
FT   STRAND      238    243
FT   STRAND      246    248
FT   STRAND      252    254
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      290    292
SQ   SEQUENCE   365 AA;  40909 MW;  78539C59DB8B1DFC CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     MMYGCDVGSD GRFLRGYRQD AYDGKDYIAL KEDLRSWTAA DMAAQTTKHK WEAAHVAEQW
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWVA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A69_HUMAN              Reviewed;         365 AA.
AC   P10316; B1PKZ3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 2.
DT   18-APR-2012, entry version 108.
DE   RecName: Full=HLA class I histocompatibility antigen, A-69 alpha chain;
DE   AltName: Full=Aw-69;
DE   AltName: Full=HLA class I histocompatibility antigen, A-28 alpha chain;
DE   AltName: Full=MHC class I antigen A*69;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*69:01).
RA   Yan L., Zhu F., He Y.;
RL   Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-298 (ALLELE A*69:01).
RX   MEDLINE=86055720; PubMed=3877632;
RA   Holmes N., Parham P.;
RT   "Exon shuffling in vivo can generate novel HLA class I molecules.";
RL   EMBO J. 4:2849-2854(1985).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The only allele of A-69 known is A*69:01 which is
CC       shown here.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU445484; ACA35004.1; -; Genomic_DNA.
DR   EMBL; X03158; CAB56607.1; -; Genomic_DNA.
DR   EMBL; X03159; CAB56608.1; -; Genomic_DNA.
DR   IPI; IPI00760554; -.
DR   PIR; B24671; HLHU69.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; P10316; -.
DR   SMR; P10316; 25-300.
DR   STRING; P10316; -.
DR   DMDM; 115502347; -.
DR   Ensembl; ENST00000412679; ENSP00000399020; ENSG00000235657.
DR   Ensembl; ENST00000457879; ENSP00000403575; ENSG00000235657.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Pk29899; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P10316; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P10316; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   CHAIN         1    365       HLA class I histocompatibility antigen,
FT                                A-69 alpha chain.
FT                                /FTId=PRO_0000080740.
FT   TOPO_DOM     25    307       Extracellular (Potential).
FT   TRANSMEM    308    328       Helical; (Potential).
FT   TOPO_DOM    329    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056307.
FT   VARIANT      94     94       Q -> H (in dbSNP:rs1059463).
FT                                /FTId=VAR_056308.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056309.
SQ   SEQUENCE   365 AA;  40977 MW;  050F1B01157EFDF6 CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTVQ
     RMYGCDVGSD WRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQTTKHK WEAAHVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A74_HUMAN              Reviewed;         365 AA.
AC   P30459; O19647; O43906; O46874; Q95IZ5; Q9UIN1;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 100.
DE   RecName: Full=HLA class I histocompatibility antigen, A-74 alpha chain;
DE   AltName: Full=Aw-19;
DE   AltName: Full=Aw-74;
DE   AltName: Full=MHC class I antigen A*74;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*74:01).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*74:01).
RA   Hurley C.K.;
RL   Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-206 (ALLELES A*74:02 AND A*74:03).
RC   TISSUE=Blood;
RX   MEDLINE=97051454; PubMed=8896180;
RX   DOI=10.1111/j.1399-0039.1996.tb02630.x;
RA   Blasczyk R., Wehling J., Onaldi-Mohr D., Rebmann V.,
RA   Chandanayingyong D., Grosse-Wilde H.;
RT   "Structural definition of the A*74 group: implications for matching in
RT   bone marrow transplantation with alternative donors.";
RL   Tissue Antigens 48:205-209(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-206 (ALLELE A*74:04).
RX   MEDLINE=21108617; PubMed=11169261;
RX   DOI=10.1034/j.1399-0039.2001.057001070.x;
RA   Cox S.T., Mcwhinnie A.J., Koester R.P., Heine U., Holman R.,
RA   Madrigal A.J., Little A.-M.;
RT   "Further diversity at HLA-A and -B loci identified in Afro-Caribbean
RT   potential bone marrow donors.";
RL   Tissue Antigens 57:70-72(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 25-206 (ALLELE A*74:05).
RX   MEDLINE=21160440; PubMed=11260503;
RX   DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345; SER-356 AND
RP   SER-359, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR.
CC   -!- POLYMORPHISM: The following alleles of A-74 are known: A*74:01
CC       A*74:02, A*74:03, A*74:04 and A*74:05. The sequence shown is that
CC       of A*74:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61701; CAA43870.1; -; mRNA.
DR   EMBL; U17569; AAA56779.1; -; mRNA.
DR   EMBL; U17570; AAA56780.1; -; mRNA.
DR   EMBL; AJ223060; CAA11063.1; -; mRNA.
DR   EMBL; AJ002678; CAA05681.1; -; mRNA.
DR   EMBL; AJ249370; CAB58124.1; -; Genomic_DNA.
DR   EMBL; AF255721; AAK49188.1; -; Genomic_DNA.
DR   EMBL; AF255720; AAK49188.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472222; -.
DR   PIR; I37482; I37482.
DR   ProteinModelPortal; P30459; -.
DR   SMR; P30459; 25-294.
DR   STRING; P30459; -.
DR   DMDM; 231375; -.
DR   PRIDE; P30459; -.
DR   Ensembl; ENST00000442068; ENSP00000404428; ENSG00000223980.
DR   Ensembl; ENST00000454091; ENSP00000410645; ENSG00000223980.
DR   GeneCards; GC06P029921; -.
DR   GeneCards; GC06Po29897; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30459; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; P30459; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-74 alpha chain.
FT                                /FTId=PRO_0000018831.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     345    345       Phosphoserine.
FT   MOD_RES     356    356       Phosphoserine.
FT   MOD_RES     359    359       Phosphoserine.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      23     23       R -> W (in allele A*74:02;
FT                                dbSNP:rs41564012).
FT                                /FTId=VAR_010375.
FT   VARIANT      86     86       Q -> G (in allele A*74:04; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016612.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056310.
FT   VARIANT      90     90       N -> K (in allele A*74:04).
FT                                /FTId=VAR_016613.
FT   VARIANT      97     97       T -> A (in allele A*74:05).
FT                                /FTId=VAR_016614.
FT   VARIANT     103    103       G -> A (in allele A*74:03).
FT                                /FTId=VAR_016615.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056311.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056312.
SQ   SEQUENCE   365 AA;  40891 MW;  C94BF2569A852371 CRC64;
     MAVMAPRTLL LLLLGALALT QTRAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAHSQTDRV DLGTLRGYYN QSEAGSHTIQ
     MMYGCDVGPD GRLLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA MFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A80_HUMAN              Reviewed;         365 AA.
AC   Q09160;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   18-APR-2012, entry version 96.
DE   RecName: Full=HLA class I histocompatibility antigen, A-80 alpha chain;
DE   AltName: Full=Aw-80;
DE   AltName: Full=HLA class I histocompatibility antigen, A-1 alpha chain;
DE   AltName: Full=MHC class I antigen A*80;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*80:01).
RX   MEDLINE=94245293; PubMed=8188325; DOI=10.1007/BF00176169;
RA   Balas A., Garcia-Sanchez F., Gomez-Reino F., Vicario J.L.;
RT   "Characterization of a new and highly distinguishable HLA-A allele in
RT   a Spanish family.";
RL   Immunogenetics 39:452-452(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*80:01).
RX   PubMed=8284791; DOI=10.1111/j.1399-0039.1993.tb02186.x;
RA   Domena J.D., Hildebrand W.H., Bias W.B., Parham P.;
RT   "A sixth family of HLA-A alleles defined by HLA-A*8001.";
RL   Tissue Antigens 42:156-159(1993).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The only allele of A-80 known is A*80:01 which is
CC       shown here.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03754; AAC04322.1; -; mRNA.
DR   EMBL; L18898; AAA17012.1; -; mRNA.
DR   IPI; IPI00472736; -.
DR   PIR; I59638; I38439.
DR   UniGene; Hs.181244; -.
DR   ProteinModelPortal; Q09160; -.
DR   STRING; Q09160; -.
DR   DMDM; 1168212; -.
DR   PRIDE; Q09160; -.
DR   Ensembl; ENST00000431795; ENSP00000396220; ENSG00000229215.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   Ensembl; ENST00000448357; ENSP00000402461; ENSG00000224320.
DR   GeneCards; GC06P029921; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   neXtProt; NX_Q09160; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-A; -.
DR   Genevestigator; Q09160; -.
DR   GermOnline; ENSG00000204632; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-80 alpha chain.
FT                                /FTId=PRO_0000018832.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT     121    121       I -> M (in dbSNP:rs1136695).
FT                                /FTId=VAR_056313.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_056314.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056315.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056316.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056317.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056318.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_056319.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056320.
SQ   SEQUENCE   365 AA;  40792 MW;  CE1BC1CD60CA8FA8 CRC64;
     MAVMPPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDSQFVQF
     DSDAASQRME PRAPWIEQEE PEYWDEETRN VKAHSQTNRA NLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAARRAEQL
     RAYLEGECVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGKEKR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IIAGLVLLGA VIAGAVVAAV MWRKKSSVRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1B07_HUMAN              Reviewed;         362 AA.
AC   P01889; Q29638; Q29681; Q29854; Q29861; Q31613; Q5SRJ2; Q9GIX1;
AC   Q9TP95;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 3.
DT   18-APR-2012, entry version 131.
DE   RecName: Full=HLA class I histocompatibility antigen, B-7 alpha chain;
DE   AltName: Full=MHC class I antigen B*7;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*07:02).
RX   MEDLINE=90207291; PubMed=2320591; DOI=10.1073/pnas.87.7.2833;
RA   Ennis P.D., Zemmour J., Salter R.D., Parham P.;
RT   "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction:
RT   frequency and nature of errors produced in amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*07:02).
RX   MEDLINE=90315860; PubMed=2700944;
RA   Parham P., Benjamin R.J., Chen B.P., Clayberger C., Ennis P.D.,
RA   Krensky A.M., Lawlor D.A., Littman D.R., Norment A.M., Orr H.T.,
RA   Salter R.D., Zemmour J.;
RT   "Diversity of class I HLA molecules: functional and evolutionary
RT   interactions with T cells.";
RL   Cold Spring Harb. Symp. Quant. Biol. 54:529-543(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*07:02).
RX   MEDLINE=85287366; PubMed=2993161; DOI=10.1007/BF00563508;
RA   Sood A.K., Pan J., Biro P.A., Pereira D., Srivastava R., Reddy V.B.,
RA   Duceman B.W., Weissman S.M.;
RT   "Structure and polymorphism of class I MHC antigen mRNA.";
RL   Immunogenetics 22:101-121(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*07:02).
RA   Ellexson M.E., Zhang L., Hildebrand W.H.;
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*07:03).
RX   MEDLINE=94148707; PubMed=8106270; DOI=10.1016/0198-8859(93)90533-7;
RA   Bergmans A., Tijssen H., Lardy J., Reekers P.;
RT   "Complete nucleotide sequence of HLA-B*0703, a B7-variant (BPOT).";
RL   Hum. Immunol. 38:159-162(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*07:04).
RX   MEDLINE=95381233; PubMed=7652739;
RX   DOI=10.1111/j.1399-0039.1995.tb02461.x;
RA   Kubens B.S., Arnett K.L., Adams E.J., Parham P., Grosse-Wilde H.;
RT   "Definition of a new HLA-B7 subtype (B*0704) by isoelectric focusing,
RT   family studies and DNA sequence analysis.";
RL   Tissue Antigens 45:322-327(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*07:05).
RX   MEDLINE=95184211; PubMed=7878658;
RX   DOI=10.1111/j.1399-0039.1994.tb02402.x;
RA   Arnett K.L., Adams E.J., Domena J.D., Parham P.;
RT   "Structure of a novel subtype of B7 (B*0705) isolated from a Chinese
RT   individual.";
RL   Tissue Antigens 44:318-321(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*07:03 AND B*07:05).
RX   MEDLINE=96128250; PubMed=8537119;
RA   Smith K.D., Epperson D.F., Lutz C.T.;
RT   "Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in
RT   peptide antigen presentation.";
RL   Immunogenetics 43:27-37(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*07:06).
RX   MEDLINE=96369317; PubMed=8773323;
RX   DOI=10.1111/j.1399-0039.1996.tb02561.x;
RA   Sanz L., Vilches C., de Pablo R., Bunce M., Moreno M.E., Kreisler M.;
RT   "Haplotypic association of two new HLA class I alleles: Cw*15052 and
RT   B*0706: evolutionary relationships of HLA-Cw*15 alleles.";
RL   Tissue Antigens 47:329-332(1996).
RN   [10]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*07:18).
RA   Bettinotti M.P., Hadzikadic L., Dhillon G., Barracchini K.,
RA   Marincola F.M.;
RT   "A new HLA-B allele.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*07:02).
RA   Marsh S.G.E.;
RT   "Intron sequences of HLA class I.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*07:02).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*07:24).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=21442086; PubMed=11556973;
RX   DOI=10.1034/j.1399-0039.2001.057005471.x;
RA   Middleton D., Curran M.D., Anholts J.D., Reilly E.R., Schreuder G.M.;
RT   "Characterisation of a new HLA-B allele, HLA-B*0724.";
RL   Tissue Antigens 57:471-473(2001).
RN   [16]
RP   PROTEIN SEQUENCE OF 25-295 (B*07:02).
RX   MEDLINE=80088278; PubMed=518865; DOI=10.1021/bi00592a030;
RA   Orr H.T., Lopez de Castro J.A., Lancet D., Strominger J.L.;
RT   "Complete amino acid sequence of a papain-solubilized human
RT   histocompatibility antigen, HLA-B7. 2. Sequence determination and
RT   search for homologies.";
RL   Biochemistry 18:5711-5720(1979).
RN   [17]
RP   INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P12I.
RX   PubMed=11390610; DOI=10.1128/JVI.75.13.6086-6094.2001;
RA   Johnson J.M., Nicot C., Fullen J., Ciminale V., Casareto L.,
RA   Mulloy J.C., Jacobson S., Franchini G.;
RT   "Free major histocompatibility complex class I heavy chain is
RT   preferentially targeted for degradation by human T-cell
RT   leukemia/lymphotropic virus type 1 p12(I) protein.";
RL   J. Virol. 75:6086-6094(2001).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). Interacts with HTLV-1 accessory protein p12I.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-7 are known: B*07:02
CC       (B7.2), B*07:03 (BPOT), B*07:04, B*07:05, B*07:06 (B7_L79),
CC       B*07:18 and B*07:24. The sequence shown is B*07:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32317; AAA36230.1; -; mRNA.
DR   EMBL; M16102; AAA59622.1; ALT_SEQ; mRNA.
DR   EMBL; U29057; AAA91229.1; -; mRNA.
DR   EMBL; X64454; CAA45785.1; -; mRNA.
DR   EMBL; U04245; AAA87398.1; -; mRNA.
DR   EMBL; L33922; AAA65639.1; -; mRNA.
DR   EMBL; U21052; AAA92563.1; -; mRNA.
DR   EMBL; U21053; AAA92564.1; -; mRNA.
DR   EMBL; X91749; CAA62864.1; -; mRNA.
DR   EMBL; AF189017; AAF01052.1; -; mRNA.
DR   EMBL; AJ309047; CAC35468.1; -; Genomic_DNA.
DR   EMBL; AJ292075; CAC33440.1; -; Genomic_DNA.
DR   EMBL; AL671883; CAI18148.1; -; Genomic_DNA.
DR   EMBL; AK313911; BAG36634.1; -; mRNA.
DR   EMBL; AJ401222; CAC10402.1; -; Genomic_DNA.
DR   IPI; IPI00004657; -.
DR   PIR; B35997; HLHUB7.
DR   PIR; I54418; I54418.
DR   PIR; I59651; I59651.
DR   PIR; S60601; S60601.
DR   RefSeq; NP_005505.2; NM_005514.6.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P01889; -.
DR   SMR; P01889; 25-300.
DR   IntAct; P01889; 4.
DR   STRING; P01889; -.
DR   DMDM; 122162; -.
DR   PRIDE; P01889; -.
DR   Ensembl; ENST00000412585; ENSP00000399168; ENSG00000234745.
DR   GeneID; 3106; -.
DR   KEGG; hsa:3106; -.
DR   UCSC; uc003ntg.1; human.
DR   CTD; 3106; -.
DR   GeneCards; GC06M031321; -.
DR   H-InvDB; HIX0078239; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   HPA; CAB015418; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P01889; -.
DR   PharmGKB; PA35056; -.
DR   eggNOG; NOG42056; -.
DR   GeneTree; ENSGT00650000093032; -.
DR   HOVERGEN; HBG016709; -.
DR   KO; K06751; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 12323; -.
DR   Bgee; P01889; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P01889; -.
DR   GermOnline; ENSG00000204523; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:2001198; P:regulation of dendritic cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0032655; P:regulation of interleukin-12 production; IMP:BHF-UCL.
DR   GO; GO:0032675; P:regulation of interleukin-6 production; IMP:BHF-UCL.
DR   GO; GO:0002667; P:regulation of T cell anergy; IMP:BHF-UCL.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Host-virus interaction; Immunity; Membrane; MHC I;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-7 alpha chain.
FT                                /FTId=PRO_0000018833.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_050332.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_050333.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_050334.
FT   VARIANT      35     35       S -> A (in dbSNP:rs1131170).
FT                                /FTId=VAR_050335.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_050336.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061386.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061387.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061388.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_050337.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_050338.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059467.
FT   VARIANT      93     95       AQA -> TNT (in allele B*07:03).
FT                                /FTId=VAR_016351.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_050339.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059468.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_050340.
FT   VARIANT     118    119       TL -> II (in allele B*07:18).
FT                                /FTId=VAR_016352.
FT   VARIANT     121    121       S -> R (in allele B*07:18).
FT                                /FTId=VAR_016353.
FT   VARIANT     137    137       H -> Y (in dbSNP:rs1050379).
FT                                /FTId=VAR_050341.
FT   VARIANT     138    138       D -> H (in dbSNP:rs709055).
FT                                /FTId=VAR_061389.
FT   VARIANT     138    138       D -> N (in allele B*07:05 and allele
FT                                B*07:06).
FT                                /FTId=VAR_016354.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_050342.
FT   VARIANT     180    180       R -> D (in allele B*07:04; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016355.
FT   VARIANT     187    187       E -> A (in dbSNP:rs2308466).
FT                                /FTId=VAR_059469.
FT   VARIANT     187    187       E -> G (in dbSNP:rs2308466).
FT                                /FTId=VAR_059470.
FT   VARIANT     187    187       E -> K (in dbSNP:rs2523600).
FT                                /FTId=VAR_059471.
FT   VARIANT     187    187       E -> L (in allele B*07:24; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016616.
FT   VARIANT     187    187       E -> Q (in dbSNP:rs2523600).
FT                                /FTId=VAR_059472.
FT   VARIANT     187    187       E -> V (in dbSNP:rs2308466).
FT                                /FTId=VAR_059473.
FT   VARIANT     195    195       Y -> H (in dbSNP:rs1050696).
FT                                /FTId=VAR_050343.
FT   VARIANT     306    306       V -> I (in allele B*07:05;
FT                                dbSNP:rs1131500).
FT                                /FTId=VAR_016356.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_050344.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061390.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061391.
FT   CONFLICT     15     18       AALA -> GPW (in Ref. 3; AAA59622).
FT   CONFLICT    266    266       Q -> E (in Ref. 16; AA sequence).
FT   CONFLICT    268    268       W -> S (in Ref. 3; AAA59622).
FT   CONFLICT    297    297       R -> G (in Ref. 3; AAA59622).
FT   CONFLICT    314    315       GL -> RP (in Ref. 3; AAA59622).
SQ   SEQUENCE   362 AA;  40460 MW;  5E5A7BDE031403D6 CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTLQ
     SMYGCDVGPD GRLLRGHDQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQR
     RAYLEGECVE WLRRYLENGK DKLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B08_HUMAN              Reviewed;         362 AA.
AC   P30460; O62901; O95730; O98140; P79542; Q95369; Q95J00; Q9GJ20;
AC   Q9MY78; Q9MYF4; Q9TQH6; Q9TQM2; Q9UQT0;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 121.
DE   RecName: Full=HLA class I histocompatibility antigen, B-8 alpha chain;
DE   AltName: Full=MHC class I antigen B*8;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*08:01).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*08:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE B*08:01).
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*08:04).
RX   MEDLINE=97473039; PubMed=9331954;
RX   DOI=10.1111/j.1399-0039.1997.tb02875.x;
RA   Hoyer R.J., Bratlie A., Schreuder G.M., Hurley C.K.;
RT   "Characterization of a novel HLA-B allele, B*0804, in a Norwegian
RT   family.";
RL   Tissue Antigens 50:308-310(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 33-257 (ALLELE B*08:04).
RA   Eberle M., Lorentzen D., Iwanaga K.K., Watkins D.I.;
RT   "Identification of a new HLA-B*08 variant, B*08NEW.";
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*08:07).
RA   Marcos C.Y., Lazaro A.M., Noreen H., Stastny P.;
RT   "New HLA-B locus allele.";
RL   Submitted (MAY-2010) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*08:07 AND
RP   B*08:09).
RX   MEDLINE=20236861; PubMed=10777103;
RX   DOI=10.1034/j.1399-0039.2000.550311.x;
RA   Kennedy C.T., Dodd R., Le T., Wallace R., Ng G., Greville W.D.,
RA   Kennedy A., Taverniti A., Moses J.H., Clow N., Watson N., Dunckley H.;
RT   "Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides
RT   (PCR-SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529,
RT   B*3532, B*4025, B*5304 and B*5508.";
RL   Tissue Antigens 55:266-270(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 116-206 (ALLELE B*08:09).
RX   MEDLINE=20166355; PubMed=10703615;
RX   DOI=10.1034/j.1399-0039.2000.550115.x;
RA   Elsner H.-A., Blasczyk R.;
RT   "Identification of the novel allele HLA-B*0809 in a Caucasian
RT   individual: estimation of allogeneic potential between B*08
RT   variants.";
RL   Tissue Antigens 55:74-77(2000).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*08:09; B*08:12;
RP   B*08:13 AND B*08:14).
RX   MEDLINE=21276061; PubMed=11380951;
RX   DOI=10.1034/j.1399-0039.2001.057004373.x;
RA   Steiner N.K., Gans C.P., Kosman C., Baldassarre L.A., Edson S.,
RA   Jones P.F., Rizzuto G., Pimtanothai N., Koester R., Mitton W., Ng J.,
RA   Hartzman R.J., Hurley C.K.;
RT   "Novel HLA-B alleles associated with antigens in the 8C CREG.";
RL   Tissue Antigens 57:373-375(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*08:10).
RA   Day S.;
RT   "A new B*08 variant allele.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 25-300.
RX   MEDLINE=97130420; PubMed=8976183; DOI=10.1084/jem.184.6.2279;
RA   Reid S.W., McAdam S., Smith K.J., Klenerman P., O'Callaghan C.A.,
RA   Harlos K., Jakobsen B.K., McMichael A.J., Bell J.I., Stuart D.I.,
RA   Jones E.Y.;
RT   "Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.";
RL   J. Exp. Med. 184:2279-2286(1996).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-8 are known: B*08:01,
CC       B*08:04, B*08:06, B*08:07 (B*NV), B*08:09 (B*HM; B*08HO), B*08:10,
CC       B*08:12, B*08:13 and B*08:14. The sequence shown is B*08:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24036; AAA52662.1; -; Genomic_DNA.
DR   EMBL; AJ295294; CAC18876.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63309.1; -; Genomic_DNA.
DR   EMBL; U67331; AAB07726.1; -; Genomic_DNA.
DR   EMBL; U67330; AAB07726.1; JOINED; Genomic_DNA.
DR   EMBL; U74386; AAB41720.1; -; mRNA.
DR   EMBL; AF056483; AAC14124.2; -; Genomic_DNA.
DR   EMBL; AF105226; AAD05244.1; -; Genomic_DNA.
DR   EMBL; AF127248; AAD31431.1; -; Genomic_DNA.
DR   EMBL; AF127247; AAD31431.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131853; CAA10522.1; -; Genomic_DNA.
DR   EMBL; AF102560; AAD28165.1; -; Genomic_DNA.
DR   EMBL; AF102559; AAD28165.1; JOINED; Genomic_DNA.
DR   EMBL; AF226151; AAF36681.1; -; Genomic_DNA.
DR   EMBL; AF226150; AAF36681.1; JOINED; Genomic_DNA.
DR   EMBL; AF279675; AAF81604.1; -; Genomic_DNA.
DR   EMBL; AF279674; AAF81604.1; JOINED; Genomic_DNA.
DR   EMBL; AF310145; AAG27470.1; -; Genomic_DNA.
DR   EMBL; AF310144; AAG27470.1; JOINED; Genomic_DNA.
DR   EMBL; AY016212; AAK38401.1; -; Genomic_DNA.
DR   EMBL; AY016211; AAK38401.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133101; CAB38945.1; -; Genomic_DNA.
DR   EMBL; AJ133102; CAB38945.1; JOINED; Genomic_DNA.
DR   IPI; IPI00479242; -.
DR   PIR; I84431; I84431.
DR   UniGene; Hs.130838; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 1AGB; X-ray; 2.20 A; A=25-300.
DR   PDB; 1AGC; X-ray; 2.10 A; A=25-300.
DR   PDB; 1AGD; X-ray; 2.05 A; A=25-300.
DR   PDB; 1AGE; X-ray; 2.30 A; A=25-300.
DR   PDB; 1AGF; X-ray; 2.20 A; A=25-300.
DR   PDB; 1M05; X-ray; 1.90 A; A/C=25-301.
DR   PDB; 1MI5; X-ray; 2.50 A; A=25-301.
DR   PDB; 3FFC; X-ray; 2.80 A; A/F=25-301.
DR   PDB; 3SJV; X-ray; 3.10 A; A/F/K/P=25-301.
DR   PDBsum; 1AGB; -.
DR   PDBsum; 1AGC; -.
DR   PDBsum; 1AGD; -.
DR   PDBsum; 1AGE; -.
DR   PDBsum; 1AGF; -.
DR   PDBsum; 1M05; -.
DR   PDBsum; 1MI5; -.
DR   PDBsum; 3FFC; -.
DR   PDBsum; 3SJV; -.
DR   ProteinModelPortal; P30460; -.
DR   SMR; P30460; 25-300.
DR   STRING; P30460; -.
DR   DMDM; 231381; -.
DR   PRIDE; P30460; -.
DR   Ensembl; ENST00000425848; ENSP00000400842; ENSG00000223532.
DR   UCSC; uc011fcp.1; human.
DR   GeneCards; GC06M031321; -.
DR   H-InvDB; HIX0078437; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30460; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30460; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30460; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30460; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-8 alpha chain.
FT                                /FTId=PRO_0000018834.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056321.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056322.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056323.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061392.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061393.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061394.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056324.
FT   VARIANT      87     87       N -> D (in allele B*08:10;
FT                                dbSNP:rs1050570).
FT                                /FTId=VAR_016502.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059474.
FT   VARIANT      91     91       F -> S (in allele B*08:04).
FT                                /FTId=VAR_016503.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056325.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059475.
FT   VARIANT     101    101       S -> N (in allele B*08:06;
FT                                dbSNP:rs1050388).
FT                                /FTId=VAR_016504.
FT   VARIANT     119    119       L -> W (in allele B*08:09).
FT                                /FTId=VAR_016505.
FT   VARIANT     121    121       S -> R (in allele B*08:12).
FT                                /FTId=VAR_016506.
FT   VARIANT     121    121       S -> T (in allele B*08:09).
FT                                /FTId=VAR_016507.
FT   VARIANT     137    138       HN -> YH (in allele B*08:14).
FT                                /FTId=VAR_016519.
FT   VARIANT     137    137       H -> Y (in dbSNP:rs1050379).
FT                                /FTId=VAR_056326.
FT   VARIANT     138    138       N -> D (in allele B*08:07).
FT                                /FTId=VAR_016508.
FT   VARIANT     140    140       Y -> D (in allele B*08:14).
FT                                /FTId=VAR_016520.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056327.
FT   VARIANT     176    176       V -> E (in allele B*08:06).
FT                                /FTId=VAR_016509.
FT   VARIANT     180    180       D -> L (in allele B*08:13; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016510.
FT   VARIANT     180    180       D -> R (in allele B*08:06; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016511.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056328.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056329.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061395.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061396.
FT   STRAND       27     36
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   STRAND       70     73
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    174
FT   HELIX       177    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40331 MW;  9B2A9760021680DF CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFDTAMSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI FKTNTQTDRE SLRNLRGYYN QSEAGSHTLQ
     SMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAARVAEQD
     RAYLEGTCVE WLRRYLENGK DTLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B13_HUMAN              Reviewed;         362 AA.
AC   P30461; O02956; O78180; Q29661; Q29933; Q9GIY5;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=HLA class I histocompatibility antigen, B-13 alpha chain;
DE   AltName: Full=MHC class I antigen B*13;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*13:02).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*13:02).
RX   MEDLINE=88152906; PubMed=3257938; DOI=10.1007/BF00376123;
RA   Zemmour J., Ennis P.D., Parham P., Dupont B.;
RT   "Comparison of the structure of HLA-Bw47 to HLA-B13 and its
RT   relationship to 21-hydroxylase deficiency.";
RL   Immunogenetics 27:281-287(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*13:01).
RX   MEDLINE=89122134; PubMed=2914710; DOI=10.1007/BF00395860;
RA   Kato K., Dupont B., Yang S.Y.;
RT   "Localization of nucleotide sequence which determines Mongoloid
RT   subtype of HLA-B13.";
RL   Immunogenetics 29:117-120(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*13:01 AND B*13:02).
RC   TISSUE=Blood;
RX   MEDLINE=96053518; PubMed=7558929; DOI=10.1016/0198-8859(94)00120-F;
RA   Lin L., Tokunaga K., Nakajima F., Ishikawa Y., Kashiwase K.,
RA   Tanaka H., Kuwata S., Sideltseva E., Akaza T., Tadokoro K.,
RA   Shibata Y., Chandanayingyong D., Juji T.;
RT   "Both HLA-B*1301 and B*1302 exist in Asian populations and are
RT   associated with different haplotypes.";
RL   Hum. Immunol. 43:51-56(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*13:03).
RC   TISSUE=Blood;
RX   MEDLINE=96232969; PubMed=8655357; DOI=10.1016/0198-8859(95)00143-3;
RA   Balas A., Garcia-Sanchez F., Vicario J.L.;
RT   "HLA-B*1303: a new example of poor correlation between serology and
RT   structure.";
RL   Hum. Immunol. 45:32-36(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*13:04).
RX   MEDLINE=97469330; PubMed=9328792; DOI=10.1016/S0198-8859(97)00055-4;
RA   Ellexson M., Lai-Kwan P., Lau M., Muto K., Terasaki P., Cole J.,
RA   Thompson C., Hildebrand W.H.;
RT   "Polymorphism at codons 114, 116, 145, and 163 muddle the typing of
RT   HLA-B1304.";
RL   Hum. Immunol. 55:66-73(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*13:08).
RA   Carter V., Dunn P.P.;
RT   "Identification of a HLA-B*13 null allele.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-13 are known: B*13:01
CC       (B13.1), B*13:02 (B13.2), B*13:04 and B*13:08. The sequence shown
CC       is that of B*13:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24041; AAA59660.1; -; Genomic_DNA.
DR   EMBL; M19757; AAA52657.1; -; Genomic_DNA.
DR   EMBL; M24075; AAA59627.1; -; Genomic_DNA.
DR   EMBL; D50290; BAA08821.1; -; mRNA.
DR   EMBL; D50291; BAA08822.1; -; mRNA.
DR   EMBL; U14943; AAB06829.1; -; mRNA.
DR   EMBL; U75533; AAC31793.1; -; mRNA.
DR   EMBL; AJ295279; CAC17137.1; -; Genomic_DNA.
DR   IPI; IPI00472458; -.
DR   PIR; A45850; A45850.
DR   PIR; I54442; I54442.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30461; -.
DR   SMR; P30461; 25-300.
DR   MINT; MINT-1195012; -.
DR   STRING; P30461; -.
DR   DMDM; 231382; -.
DR   PRIDE; P30461; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30461; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30461; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30461; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-13 alpha chain.
FT                                /FTId=PRO_0000018835.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT     118    119       TW -> II (in allele B*13:01).
FT                                /FTId=VAR_016357.
FT   VARIANT     121    121       T -> R (in allele B*13:01).
FT                                /FTId=VAR_016358.
FT   VARIANT     138    138       N -> D (in allele B*13:04).
FT                                /FTId=VAR_016360.
FT   VARIANT     140    140       L -> S (in allele B*13:04).
FT                                /FTId=VAR_016361.
FT   VARIANT     169    169       L -> R (in allele B*13:03 and allele
FT                                B*13:04; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016362.
FT   VARIANT     183    183       Y -> C (in allele B*13:08).
FT                                /FTId=VAR_016359.
FT   VARIANT     187    187       E -> L (in allele B*13:03 and allele
FT                                B*13:04).
FT                                /FTId=VAR_016363.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056330.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056331.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061397.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061398.
SQ   SEQUENCE   362 AA;  40474 MW;  28FF66B20961C75C CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFITVG YVDDTQFVRF
     DSDATSPRMA PRAPWIEQEG PEYWDRETQI SKTNTQTYRE NLRTALRYYN QSEAGSHTWQ
     TMYGCDLGPD GRLLRGHNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQLK WEAARVAEQL
     RAYLEGECVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B14_HUMAN              Reviewed;         362 AA.
AC   P30462; O02862; P30463;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 103.
DE   RecName: Full=HLA class I histocompatibility antigen, B-14 alpha chain;
DE   AltName: Full=MHC class I antigen B*14;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES B*14:01 AND B*14:02).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*14:02).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*14:03).
RX   MEDLINE=20548605; PubMed=11098929;
RX   DOI=10.1034/j.1399-0039.2000.560401.x;
RA   Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H.,
RA   Hurley C.K.;
RT   "Diversity is demonstrated in class I HLA-A and HLA-B alleles in
RT   Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-
RT   B*1403, *4016, *4703.";
RL   Tissue Antigens 56:291-302(2000).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-14 are known: B*14:01
CC       (Bw-64; B-64), B*14:02 (Bw-65, B-65) and B*14:03. The sequence
CC       shown is that of B*14:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24040; AAA59661.1; -; Genomic_DNA.
DR   EMBL; M24032; AAA59664.1; -; Genomic_DNA.
DR   EMBL; AJ301657; CAC20461.1; -; Genomic_DNA.
DR   EMBL; U91331; AAB61335.1; -; Genomic_DNA.
DR   EMBL; U91330; AAB61335.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472130; -.
DR   PIR; I61859; I61859.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30462; -.
DR   SMR; P30462; 25-300.
DR   STRING; P30462; -.
DR   DMDM; 231383; -.
DR   PRIDE; P30462; -.
DR   Ensembl; ENST00000425848; ENSP00000400842; ENSG00000223532.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30462; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30462; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30462; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-14 alpha chain.
FT                                /FTId=PRO_0000018836.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   MOD_RES     352    352       Phosphoserine.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056332.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056333.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056334.
FT   VARIANT      35     35       S -> A (in allele B*14:02 and allele
FT                                B*14:03; dbSNP:rs1131170).
FT                                /FTId=VAR_016364.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056335.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061399.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061400.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061401.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056336.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056337.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059476.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056338.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059477.
FT   VARIANT     180    180       L -> R (in allele B*14:03).
FT                                /FTId=VAR_016654.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056339.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056340.
SQ   SEQUENCE   362 AA;  40358 MW;  9039122CC400337F CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI CKTNTQTDRE SLRNLRGYYN QSEAGSHTLQ
     WMYGCDVGPD GRLLRGYNQF AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGTCVE WLRRHLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B15_HUMAN              Reviewed;         362 AA.
AC   P30464; B0V0B8; P30465; P30513; Q29633; Q29636; Q29829; Q29953;
AC   Q29982; Q95343; Q95344; Q9BD06;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 111.
DE   RecName: Full=HLA class I histocompatibility antigen, B-15 alpha chain;
DE   AltName: Full=MHC class I antigen B*15;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*15:02).
RX   MEDLINE=92196792; PubMed=1801311;
RX   DOI=10.1111/j.1399-0039.1991.tb01895.x;
RA   Little A.-M., Parham P.;
RT   "The HLA-Bw75 subtype of B15: molecular characterization and
RT   comparison with crossreacting antigens.";
RL   Tissue Antigens 38:186-190(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*15:01; B*15:11 AND B*15:19).
RX   MEDLINE=94367483; PubMed=7521976;
RX   DOI=10.1111/j.1399-0039.1994.tb02327.x;
RA   Hildebrand W.H., Domena J.D., Shen S.Y., Lau M., Terasaki P.I.,
RA   Bunce M., Marsh S.G.E., Guttridge M.G., Bias W.B., Parham P.;
RT   "HLA-B15: a widespread and diverse family of HLA-B alleles.";
RL   Tissue Antigens 43:209-218(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*15:01; B*15:02 AND B*15:11).
RC   TISSUE=Blood;
RX   MEDLINE=96369309; PubMed=8773315;
RX   DOI=10.1111/j.1399-0039.1996.tb02553.x;
RA   Lin L., Tokunaga K., Tanaka H., Nakajima F., Imanishi T.,
RA   Kashiwase K., Bannai M., Mizuno S., Akaza T., Tadokoro K., Shibata Y.,
RA   Juji T.;
RT   "Further molecular diversity in the HLA-B15 group.";
RL   Tissue Antigens 47:265-274(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*15:03).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*15:04).
RX   MEDLINE=92269956; PubMed=1589035; DOI=10.1038/357329a0;
RA   Watkins D.I., McAdam S.N., Liu X., Stang C.R., Milford E.L.,
RA   Levine C.G., Garber T.L., Dogon A.L., Lord C.I., Ghim S.H.,
RA   Troup G.M., Hughes A.L., Letvin N.L.;
RT   "New recombinant HLA-B alleles in a tribe of South American
RT   Amerindians indicate rapid evolution of MHC class I loci.";
RL   Nature 357:329-333(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*15:04).
RC   TISSUE=Blood;
RA   Ramos M., Barber D.F., Layrisse Z., de Castro J.A.;
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*15:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*15:66).
RX   MEDLINE=22140958; PubMed=12144628;
RX   DOI=10.1034/j.1399-0039.2002.590511.x;
RA   Cox S.T., Prokupek B., Baker F., Holman R., Leung V.T., Wong A.S.,
RA   Madrigal J.A., Little A.-M.;
RT   "Identification of HLA-B*1566.";
RL   Tissue Antigens 59:424-425(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-362 (ALLELE B*15:01).
RX   MEDLINE=89233295; PubMed=2714852; DOI=10.1007/BF00352839;
RA   Pohla H., Kuon W., Tabaczewski P., Doerner C., Weiss E.H.;
RT   "Allelic variation in HLA-B and HLA-C sequences and the evolution of
RT   the HLA-B alleles.";
RL   Immunogenetics 29:297-307(1989).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-362 (ALLELE B*15:01).
RX   MEDLINE=93138717; PubMed=8423049; DOI=10.1007/BF00216833;
RA   Choo S.Y., Fan L.A., Hansen J.A.;
RT   "Allelic variations clustered in the antigen binding sites of HLA-Bw62
RT   molecules.";
RL   Immunogenetics 37:108-113(1993).
RN   [12]
RP   ASSOCIATION OF ALLELE B*15:02 WITH STEVENS-JOHNSON SYNDROME.
RX   PubMed=15057820; DOI=10.1038/428486a;
RA   Chung W.-H., Hung S.-I., Hong H.-S., Hsih M.-S., Yang L.-C., Ho H.-C.,
RA   Wu J.-Y., Chen Y.-T.;
RT   "Medical genetics: a marker for Stevens-Johnson syndrome.";
RL   Nature 428:486-486(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 25-300 (ALLELE B*15:01) IN
RP   COMPLEX WITH EBV NUCLEAR ANTIGEN AND UBE2 PEPTIDES, AND DISULFIDE
RP   BONDS.
RX   PubMed=17057332; DOI=10.1107/S0907444906027636;
RA   Roder G., Blicher T., Justesen S., Johannesen B., Kristensen O.,
RA   Kastrup J., Buus S., Gajhede M.;
RT   "Crystal structures of two peptide-HLA-B*1501 complexes; structural
RT   characterization of the HLA-B62 supertype.";
RL   Acta Crystallogr. D 62:1300-1310(2006).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-15 are known: B*15:01
CC       (Bw-62; B-62), B*15:02 (Bw-75, B-75), B*15:03 (Bw-72; B-72; B-70)
CC       B*15:04, B*15:11, B*15:19 and B*15:66. The sequence shown is that
CC       of B*15:01.
CC   -!- DISEASE: Defects in HLA-B are a cause of susceptibility to
CC       Stevens-Johnson syndrome (SJS) [MIM:608579]. A rare blistering
CC       mucocutaneous disease that share clinical and histopathologic
CC       features with toxic epidermal necrolysis. Both disorders are
CC       characterized by high fever, malaise, and a rapidly developing
CC       blistering exanthema of macules and target-like lesions
CC       accompanied by mucosal involvement. Stevens-Johnson syndrome is a
CC       milder disease characterized by destruction and detachment of the
CC       skin epithelium and mucous membranes involving less than 10% of
CC       the body surface area. Ocular symptoms include ulcerative
CC       conjunctivitis, keratitis, iritis, uveitis and sometimes
CC       blindness. It can be caused by a severe adverse reaction to
CC       particular types of medication, although Mycoplasma infections may
CC       induce some cases. Note=Allele B*15:02 is associated with
CC       susceptibility to Stevens-Johnson syndrome.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M75138; AAA59630.1; -; mRNA.
DR   EMBL; U03859; AAA03601.1; -; mRNA.
DR   EMBL; U03027; AAA18902.1; -; mRNA.
DR   EMBL; L11604; AAA56836.1; -; mRNA.
DR   EMBL; D50292; BAA08823.1; -; mRNA.
DR   EMBL; D50293; BAA08824.1; -; mRNA.
DR   EMBL; D50294; BAA08825.1; -; mRNA.
DR   EMBL; X61709; CAA43878.1; -; mRNA.
DR   EMBL; M84382; AAA59632.1; -; mRNA.
DR   EMBL; U70528; AAB16918.1; -; mRNA.
DR   EMBL; AJ295140; CAC17462.1; -; Genomic_DNA.
DR   EMBL; AJ308399; CAC33441.1; -; Genomic_DNA.
DR   EMBL; CR759828; CAQ10738.1; -; Genomic_DNA.
DR   EMBL; M28203; AAA53258.1; -; mRNA.
DR   EMBL; M83193; AAA58628.1; -; mRNA.
DR   IPI; IPI00646083; -.
DR   PIR; G01230; G01230.
DR   PIR; I38421; I38421.
DR   PIR; I62042; I62042.
DR   PIR; S16789; S16789.
DR   PIR; S24433; S24433.
DR   PIR; S77966; S77966.
DR   UniGene; Hs.77961; -.
DR   PDB; 1XR8; X-ray; 2.30 A; A=25-300.
DR   PDB; 1XR9; X-ray; 1.79 A; A=25-300.
DR   PDB; 3C9N; X-ray; 1.87 A; A=25-300.
DR   PDBsum; 1XR8; -.
DR   PDBsum; 1XR9; -.
DR   PDBsum; 3C9N; -.
DR   ProteinModelPortal; P30464; -.
DR   STRING; P30464; -.
DR   DMDM; 34305703; -.
DR   PRIDE; P30464; -.
DR   Ensembl; ENST00000450871; ENSP00000388208; ENSG00000232126.
DR   UCSC; uc011hpo.2; human.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   MIM; 608579; phenotype.
DR   neXtProt; NX_P30464; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30464; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30464; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30464; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-15 alpha chain.
FT                                /FTId=PRO_0000018837.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      48     48       A -> S (in allele B*15:03).
FT                                /FTId=VAR_016365.
FT   VARIANT      69     70       MA -> EE (in allele B*15:03).
FT                                /FTId=VAR_016366.
FT   VARIANT      87     87       E -> N (in allele B*15:02 and allele
FT                                B*15:11; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016367.
FT   VARIANT      91     91       S -> C (in allele B*15:66).
FT                                /FTId=VAR_016368.
FT   VARIANT      91     91       S -> Y (in allele B*15:11).
FT                                /FTId=VAR_016369.
FT   VARIANT     118    119       TL -> II (in allele B*15:02).
FT                                /FTId=VAR_016370.
FT   VARIANT     119    119       L -> W (in allele B*15:04).
FT                                /FTId=VAR_016371.
FT   VARIANT     121    121       R -> T (in allele B*15:04).
FT                                /FTId=VAR_016372.
FT   VARIANT     137    137       H -> Y (in allele B*15:02).
FT                                /FTId=VAR_016373.
FT   VARIANT     180    180       W -> L (in allele B*15:02 and allele
FT                                B*15:03).
FT                                /FTId=VAR_016374.
FT   VARIANT     190    191       EW -> DG (in allele B*15:19).
FT                                /FTId=VAR_016375.
FT   VARIANT     274    274       P -> L (in allele B*15:19).
FT                                /FTId=VAR_016376.
FT   STRAND       27     36
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     77
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    219
FT   STRAND      222    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40388 MW;  86E938087372EBE0 CRC64;
     MRVTAPRTVL LLLSGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRMA PRAPWIEQEG PEYWDRETQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQW
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B18_HUMAN              Reviewed;         362 AA.
AC   P30466; O62897; Q29845; Q5JP37; Q9BCM6; Q9GJ23; Q9MY84; Q9MYC7;
AC   Q9TP37; Q9TQH7;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 106.
DE   RecName: Full=HLA class I histocompatibility antigen, B-18 alpha chain;
DE   AltName: Full=MHC class I antigen B*18;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*18:01).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*18:02).
RC   TISSUE=Blood;
RX   MEDLINE=95270437; PubMed=7751157; DOI=10.1016/0198-8859(94)00073-Y;
RA   Lin L., Tokunaga K., Ishikawa Y., Kashiwase K., Nakajima F.,
RA   Nishimura M., Kuwata S., Akaza T., Tadokoro K., Shibata Y., Juji T.;
RT   "A new B18 sequence (B*1802) from Asian individuals.";
RL   Hum. Immunol. 42:23-26(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*18:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*18:03).
RA   Dunn P.P.J.;
RT   "Complete nucleotide sequencing of HLA class I genes.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*18:07).
RA   Kennedy C.T., Dodd R., Le T., Wallace R., Ng G., Hersee J.,
RA   Taverniti A., Kennedy A., Moses J., Trejaut J., Dunckley H.;
RT   "HLA-B typing with sequence specific oligonucleotides reveals a new
RT   allele, B*MF.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*18:07; B*18:10;
RP   B*18:11; B*18:12 AND B*18:13).
RX   MEDLINE=21442089; PubMed=11556976;
RX   DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-18 are known: B*18:01
CC       B*18:02, B*18:03, B*18:07 (B*MF), B*18:10, B*18:11, B*18:12 and
CC       B*18:13. The sequence shown is that of B*18:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24039; AAA59662.1; -; Genomic_DNA.
DR   EMBL; D25275; BAA04965.1; -; mRNA.
DR   EMBL; AJ310507; CAC34572.1; -; Genomic_DNA.
DR   EMBL; AJ309979; CAC34305.1; -; Genomic_DNA.
DR   EMBL; AL845443; CAI41903.1; -; Genomic_DNA.
DR   EMBL; AF117775; AAD13298.1; -; Genomic_DNA.
DR   EMBL; AF117774; AAD13298.1; JOINED; Genomic_DNA.
DR   EMBL; AF054010; AAC32821.1; -; Genomic_DNA.
DR   EMBL; AF054009; AAC32821.1; JOINED; Genomic_DNA.
DR   EMBL; AF198651; AAF20813.1; -; Genomic_DNA.
DR   EMBL; AF198650; AAF20813.1; JOINED; Genomic_DNA.
DR   EMBL; AF266526; AAF73066.1; -; Genomic_DNA.
DR   EMBL; AF266525; AAF73066.1; JOINED; Genomic_DNA.
DR   EMBL; AF275717; AAF85974.1; -; Genomic_DNA.
DR   EMBL; AF275716; AAF85974.1; JOINED; Genomic_DNA.
DR   EMBL; AF310139; AAG27466.1; -; Genomic_DNA.
DR   EMBL; AF310138; AAG27466.1; JOINED; Genomic_DNA.
DR   IPI; IPI00827612; -.
DR   PIR; I61860; I61860.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30466; -.
DR   SMR; P30466; 25-300.
DR   STRING; P30466; -.
DR   DMDM; 231388; -.
DR   PRIDE; P30466; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   UCSC; uc011imy.2; human.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30466; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30466; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30466; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-18 alpha chain.
FT                                /FTId=PRO_0000018838.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      87     87       N -> E (in allele B*18:12; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016661.
FT   VARIANT      91     91       S -> F (in allele B*18:07).
FT                                /FTId=VAR_016662.
FT   VARIANT      98     98       Y -> D (in allele B*18:03).
FT                                /FTId=VAR_016377.
FT   VARIANT     121    121       R -> N (in allele B*18:02; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016378.
FT   VARIANT     180    180       L -> R (in allele B*18:13).
FT                                /FTId=VAR_016663.
FT   VARIANT     187    187       T -> E (in allele B*18:10; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016664.
FT   VARIANT     195    195       H -> Y (in allele B*18:10 and allele
FT                                B*18:11).
FT                                /FTId=VAR_016665.
SQ   SEQUENCE   362 AA;  40275 MW;  106552F4A0F28E17 CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFHTSVSRPG RGEPRFISVG YVDGTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRNTQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRHLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B27_HUMAN              Reviewed;         362 AA.
AC   P03989; O19692; P10317; P10318; P19373; P30467; Q08136; Q29693;
AC   Q29846; Q29961;
DT   23-OCT-1986, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 2.
DT   18-APR-2012, entry version 130.
DE   RecName: Full=HLA class I histocompatibility antigen, B-27 alpha chain;
DE   AltName: Full=MHC class I antigen B*27;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*27:01).
RX   MEDLINE=86138405; PubMed=3912316;
RA   Weiss E.H., Kuon W., Doerner C., Lang M., Riethmueller G.;
RT   "Organization, sequence and expression of the HLA-B27 gene: a
RT   molecular approach to analyze HLA and disease associations.";
RL   Immunobiology 170:367-380(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-361 (ALLELE B*27:01).
RX   MEDLINE=86149317; PubMed=3485286; DOI=10.1073/pnas.83.5.1428;
RA   Szoets H., Riethmueller G., Weiss E., Meo T.;
RT   "Complete sequence of HLA-B27 cDNA identified through the
RT   characterization of structural markers unique to the HLA-A, -B, and -C
RT   allelic series.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1428-1432(1986).
RN   [3]
RP   PROTEIN SEQUENCE OF 25-295 (B*27:01).
RX   MEDLINE=85226361; PubMed=2408663; DOI=10.1021/bi00328a025;
RA   Ezquerra A., Bragado R., Vega M.A., Strominger J.L., Woody J.,
RA   Lopez de Castro J.A.;
RT   "Primary structure of papain-solubilized human histocompatibility
RT   antigen HLA-B27.";
RL   Biochemistry 24:1733-1741(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES B*27:01 AND B*27:02).
RX   MEDLINE=86220133; PubMed=3011411;
RA   Seemann G.H.A., Rein R.S., Brown C.S., Ploegh H.L.;
RT   "Gene conversion-like mechanisms may generate polymorphism in human
RT   class I genes.";
RL   EMBO J. 5:547-552(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:02).
RX   MEDLINE=96086486; PubMed=7482496;
RX   DOI=10.1111/j.1399-0039.1995.tb02475.x;
RA   Moses J.H., Marsh S.G.E., Arnett K.L., Adams E.J., Bodmer J.G.,
RA   Parham P.;
RT   "On the nucleotide sequences of B*2702 and B*2705.";
RL   Tissue Antigens 46:50-53(1995).
RN   [6]
RP   PROTEIN SEQUENCE OF 86-107 AND 171-181 (B*27:02).
RX   MEDLINE=86042671; PubMed=2414775; DOI=10.1073/pnas.82.21.7394;
RA   Vega M.A., Ezquerra A., Rojo S., Aparicio P., Bragado R.,
RA   Lopez de Castro J.A.;
RT   "Structural analysis of an HLA-B27 functional variant: identification
RT   of residues that contribute to the specificity of recognition by
RT   cytolytic T lymphocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:7394-7398(1985).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*27:03).
RX   MEDLINE=88227491; PubMed=3286582; DOI=10.1016/0198-8859(88)90072-9;
RA   Choo S.Y., St John T., Orr H.T., Hansen J.A.;
RT   "Molecular analysis of the variant alloantigen HLA-B27d (HLA-B*2703)
RT   identifies a unique single amino acid substitution.";
RL   Hum. Immunol. 21:209-219(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*27:04 AND B*27:06).
RX   MEDLINE=96134006; PubMed=8550101; DOI=10.1007/BF00176678;
RA   Rudwaleit M., Bowness P., Wordsworth P.;
RT   "The nucleotide sequence of HLA-B*2704 reveals a new amino acid
RT   substitution in exon 4 which is also present in HLA-B*2706.";
RL   Immunogenetics 43:160-162(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-298 (ALLELE B*27:05).
RX   PubMed=3489755;
RA   Coppin H.L., McDevitt H.O.;
RT   "Absence of polymorphism between HLA-B27 genomic exon sequences
RT   isolated from normal donors and ankylosing spondylitis patients.";
RL   J. Immunol. 137:2168-2172(1986).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:06).
RX   MEDLINE=94102824; PubMed=8276469; DOI=10.1007/BF00241265;
RA   Vilches C., de Pablo R., Kreisler M.;
RT   "Nucleotide sequence of HLA-B*2706.";
RL   Immunogenetics 39:219-219(1994).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:07).
RX   MEDLINE=91268545; PubMed=1711072;
RA   Choo Y.S., Fan L.A., Hansen J.A.;
RT   "A novel HLA-B27 allele maps B27 allospecificity to the region around
RT   position 70 in the alpha 1 domain.";
RL   J. Immunol. 147:174-180(1991).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:08).
RX   MEDLINE=95064789; PubMed=7974468;
RX   DOI=10.1111/j.1399-0039.1994.tb02356.x;
RA   Hildebrand W.H., Domena J.D., Shen S.Y., Marsh S.G.E., Bunce M.,
RA   Guttridge M.G., Darke C., Parham P.;
RT   "The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27
RT   (B*2708).";
RL   Tissue Antigens 44:47-51(1994).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:09).
RC   TISSUE=Blood;
RX   MEDLINE=94375872; PubMed=8089488;
RA   Del Porto P., D'Amato M., Fiorillo M.T., Tuosto L., Piccolella E.,
RA   Sorrentino R.;
RT   "Identification of a novel HLA-B27 subtype by restriction analysis of
RT   a cytotoxic gamma/delta T cell clone.";
RL   J. Immunol. 153:3093-3100(1994).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-300.
RX   MEDLINE=92405152; PubMed=1525820; DOI=10.1016/0092-8674(92)90252-8;
RA   Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C.;
RT   "The three-dimensional structure of HLA-B27 at 2.1-A resolution
RT   suggests a general mechanism for tight peptide binding to MHC.";
RL   Cell 70:1035-1048(1992).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-300.
RX   MEDLINE=92018187; PubMed=1922337; DOI=10.1038/353321a0;
RA   Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C.;
RT   "The structure of HLA-B27 reveals nonamer self-peptides bound in an
RT   extended conformation.";
RL   Nature 353:321-325(1991).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-300.
RX   MEDLINE=22344622; PubMed=12244049; DOI=10.1074/jbc.M206392200;
RA   Hulsmeyer M., Hillig R.C., Volz A., Ruhl M., Schroder W., Saenger W.,
RA   Ziegler A., Uchanska-Ziegler B.;
RT   "HLA-B27 subtypes differentially associated with disease exhibit
RT   subtle structural alterations.";
RL   J. Biol. Chem. 277:47844-47853(2002).
RN   [18]
RP   3D-STRUCTURE MODELING OF 115-206.
RX   MEDLINE=95148615; PubMed=7846047; DOI=10.1073/pnas.92.3.753;
RA   Rognan D., Scapozza L., Folkers G., Daser A.;
RT   "Rational design of nonnatural peptides as high-affinity ligands for
RT   the HLA-B*2705 human leukocyte antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:753-757(1995).
RN   [19]
RP   DISEASE, AND POSSIBLE PROTECTIVE ROLE OF ALLELE B*27:07.
RX   PubMed=15603872; DOI=10.1016/j.humimm.2004.08.177;
RA   Varnavidou-Nicolaidou A., Karpasitou K., Georgiou D., Stylianou G.,
RA   Kokkofitou A., Michalis C., Constantina C., Gregoriadou C.,
RA   Kyriakides G.;
RT   "HLA-B27 in the Greek Cypriot population: distribution of subtypes in
RT   patients with ankylosing spondylitis and other HLA-B27-related
RT   diseases. The possible protective role of B*2707.";
RL   Hum. Immunol. 65:1451-1454(2004).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-27 are known:
CC       B*27:01=B*27:05, B*27:02 (B27.2; B-27k; B27e), B*27:03 (B27d),
CC       B*27:04, B*27:06, B*27:07, B*27:08 (B7Qui) and B*27:09 (B27-ci).
CC       The sequence shown is that of B*27:01.
CC   -!- DISEASE: Defects in HLA-B are a cause of susceptibility to
CC       spondyloarthropathy type 1 (SPDA1) [MIM:106300]. It is a chronic
CC       rheumatic disease with multifactorial inheritance. It includes a
CC       spectrum of related disorders comprising ankylosing spondylitis, a
CC       subset of psoriatic arthritis, reactive arthritis (e.g.,Reiter
CC       syndrome), arthritis associated with inflammatory bowel disease
CC       and undifferentiated spondyloarthropathy. These disorders may
CC       occur simultaneously or sequentially in the same patient, probably
CC       representing various phenotypic expressions of the same disease.
CC       Ankylosing spondylitis is the form of rheumatoid arthritis
CC       affecting the spine and is considered the prototype of
CC       seronegative spondyloarthropathies. It produces pain and stiffness
CC       as a result of inflammation of the sacroiliac, intervertebral, and
CC       costovertebral joints. Note=In the Greek Cypriot population, a
CC       restricted number of HLA-B27 subtypes are associated with
CC       ankylosing spondylitis and other B27-related diseases and an
CC       elevated frequency of the B*2702 allele in ankylosing spondylitis
CC       patients is identified. The allele B*2707 seems to have a
CC       protective role in this population because it was found only in
CC       the healthy controls.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03945; CAA27578.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X03664; CAA27301.1; -; Genomic_DNA.
DR   EMBL; X03667; CAA27301.1; JOINED; Genomic_DNA.
DR   EMBL; L38504; AAA69724.1; -; mRNA.
DR   EMBL; M54883; AAA59616.1; -; Genomic_DNA.
DR   EMBL; X03665; CAA27302.1; -; Genomic_DNA.
DR   EMBL; X03666; CAA27302.1; JOINED; Genomic_DNA.
DR   EMBL; M12967; AAA36221.1; -; Genomic_DNA.
DR   EMBL; U27608; AAC50444.1; -; mRNA.
DR   EMBL; U35734; AAC50447.1; -; mRNA.
DR   EMBL; M14013; AAA59643.1; -; Genomic_DNA.
DR   EMBL; X73578; CAA51980.1; -; mRNA.
DR   EMBL; M62852; AAA59647.1; -; mRNA.
DR   EMBL; L19923; AAA59658.1; -; mRNA.
DR   EMBL; Z33453; CAA83876.1; -; mRNA.
DR   IPI; IPI00471986; -.
DR   PIR; I37515; I37515.
DR   PIR; I56116; I56116.
DR   PIR; S07441; HLHUB2.
DR   UniGene; Hs.77961; -.
DR   PDB; 1HSA; X-ray; 2.10 A; A/D=25-300.
DR   PDB; 1JGD; X-ray; 1.90 A; A=25-300.
DR   PDB; 1JGE; X-ray; 2.10 A; A=25-300.
DR   PDB; 1K5N; X-ray; 1.09 A; A=25-300.
DR   PDB; 1OF2; X-ray; 2.20 A; A=25-300.
DR   PDB; 1OGT; X-ray; 1.47 A; A=25-300.
DR   PDB; 1ROG; Model; -; A=25-206.
DR   PDB; 1ROH; Model; -; A=25-206.
DR   PDB; 1ROI; Model; -; A=25-206.
DR   PDB; 1ROJ; Model; -; A=25-206.
DR   PDB; 1ROK; Model; -; A=25-206.
DR   PDB; 1ROL; Model; -; A=25-206.
DR   PDB; 1UXS; X-ray; 1.55 A; A=25-300.
DR   PDB; 1UXW; X-ray; 1.71 A; A=25-300.
DR   PDB; 1W0V; X-ray; 2.27 A; A=25-300.
DR   PDB; 1W0W; X-ray; 2.10 A; A=25-300.
DR   PDB; 2A83; X-ray; 1.40 A; A=25-300.
DR   PDB; 2BSR; X-ray; 2.30 A; A=25-300.
DR   PDB; 2BSS; X-ray; 2.00 A; A=25-300.
DR   PDB; 2BST; X-ray; 2.10 A; A=25-300.
DR   PDB; 3B3I; X-ray; 1.86 A; A=25-300.
DR   PDB; 3B6S; X-ray; 1.80 A; A=25-300.
DR   PDB; 3BP4; X-ray; 1.85 A; A=25-300.
DR   PDB; 3BP7; X-ray; 1.80 A; A=25-300.
DR   PDB; 3CZF; X-ray; 1.20 A; A=25-300.
DR   PDB; 3D18; X-ray; 1.74 A; A=25-300.
DR   PDB; 3DTX; X-ray; 2.10 A; A=25-300.
DR   PDB; 3HCV; X-ray; 1.95 A; A=25-300.
DR   PDB; 3LV3; X-ray; 1.94 A; A=25-300.
DR   PDBsum; 1HSA; -.
DR   PDBsum; 1JGD; -.
DR   PDBsum; 1JGE; -.
DR   PDBsum; 1K5N; -.
DR   PDBsum; 1OF2; -.
DR   PDBsum; 1OGT; -.
DR   PDBsum; 1ROG; -.
DR   PDBsum; 1ROH; -.
DR   PDBsum; 1ROI; -.
DR   PDBsum; 1ROJ; -.
DR   PDBsum; 1ROK; -.
DR   PDBsum; 1ROL; -.
DR   PDBsum; 1UXS; -.
DR   PDBsum; 1UXW; -.
DR   PDBsum; 1W0V; -.
DR   PDBsum; 1W0W; -.
DR   PDBsum; 2A83; -.
DR   PDBsum; 2BSR; -.
DR   PDBsum; 2BSS; -.
DR   PDBsum; 2BST; -.
DR   PDBsum; 3B3I; -.
DR   PDBsum; 3B6S; -.
DR   PDBsum; 3BP4; -.
DR   PDBsum; 3BP7; -.
DR   PDBsum; 3CZF; -.
DR   PDBsum; 3D18; -.
DR   PDBsum; 3DTX; -.
DR   PDBsum; 3HCV; -.
DR   PDBsum; 3LV3; -.
DR   ProteinModelPortal; P03989; -.
DR   SMR; P03989; 25-300.
DR   DIP; DIP-6188N; -.
DR   MINT; MINT-247525; -.
DR   STRING; P03989; -.
DR   DMDM; 34305677; -.
DR   PRIDE; P03989; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 106300; phenotype.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P03989; -.
DR   Orphanet; 240841; Abacavir toxicity.
DR   Orphanet; 240845; Allopurinol toxicity.
DR   Orphanet; 825; Ankylosing spondylitis.
DR   Orphanet; 117; Behcet disease.
DR   Orphanet; 240857; Carbamazepine toxicity.
DR   Orphanet; 240871; Flucloxacilline toxicity.
DR   Orphanet; 240899; Phenytoin toxicity.
DR   Orphanet; 36426; Stevens-Johnson syndrome.
DR   Orphanet; 241001; Susceptibility to hepatitis due to flucloxacilline treatment.
DR   Orphanet; 241005; Susceptibility to hypersensitivity syndrome due to abacavir treatment.
DR   Orphanet; 241035; Susceptibility to toxic epidermal necrolysis due to allopurinol treatment.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P03989; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P03989; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P03989; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005624; C:membrane fraction; TAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Host-virus interaction; Immunity;
KW   Membrane; MHC I; Polymorphism; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-27 alpha chain.
FT                                /FTId=PRO_0000018839.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056341.
FT   VARIANT      83     83       Y -> H (in allele B*27:03).
FT                                /FTId=VAR_016379.
FT   VARIANT     101    101       D -> N (in allele B*27:02).
FT                                /FTId=VAR_016380.
FT   VARIANT     101    101       D -> S (in allele B*27:04, allele B*27:06
FT                                and allele B*27:08; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016381.
FT   VARIANT     104    105       TL -> IA (in allele B*27:02).
FT                                /FTId=VAR_016382.
FT   VARIANT     104    104       T -> N (in allele B*27:08).
FT                                /FTId=VAR_016383.
FT   VARIANT     106    107       LR -> RG (in allele B*27:08).
FT                                /FTId=VAR_016384.
FT   VARIANT     121    121       N -> S (in allele B*27:07).
FT                                /FTId=VAR_016385.
FT   VARIANT     137    138       YH -> HN (in allele B*27:07).
FT                                /FTId=VAR_016386.
FT   VARIANT     138    138       H -> D (in allele B*27:06).
FT                                /FTId=VAR_016387.
FT   VARIANT     140    140       D -> H (in allele B*27:09).
FT                                /FTId=VAR_016388.
FT   VARIANT     140    140       D -> Y (in allele B*27:06 and allele
FT                                B*27:07).
FT                                /FTId=VAR_016389.
FT   VARIANT     155    155       S -> R (in allele B*27:07).
FT                                /FTId=VAR_016390.
FT   VARIANT     176    176       V -> E (in allele B*27:04 and allele
FT                                B*27:06).
FT                                /FTId=VAR_016391.
FT   VARIANT     235    235       A -> G (in allele B*27:04 and allele
FT                                B*27:06).
FT                                /FTId=VAR_016392.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056342.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056343.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061402.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061403.
FT   CONFLICT    206    206       A -> V (in Ref. 2).
FT   CONFLICT    266    266       Q -> E (in Ref. 3; AA sequence).
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      113    115
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   TURN        199    204
FT   STRAND      210    219
FT   STRAND      222    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40428 MW;  C8D2F154E3292031 CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFHTSVSRPG RGEPRFITVG YVDDTLFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRETQI CKAKAQTDRE DLRTLLRYYN QSEAGSHTLQ
     NMYGCDVGPD GRLLRGYHQD AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGECVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B35_HUMAN              Reviewed;         362 AA.
AC   P30685; O62919; P30468; P30469; P30470; P30471; P30472; P30473;
AC   P30474; Q9GJM7; Q9TPV2; Q9TQH3; Q9TQH9; Q9TQN4; Q9TQN6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 118.
DE   RecName: Full=HLA class I histocompatibility antigen, B-35 alpha chain;
DE   AltName: Full=MHC class I antigen B*35;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*35:01).
RX   MEDLINE=89339610; PubMed=2788131; DOI=10.1007/BF02421534;
RA   Ooba T., Hayashi H., Karaki S., Tanabe M., Kano K., Takiguchi M.;
RT   "The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by
RT   two genetic mechanisms.";
RL   Immunogenetics 30:76-80(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*35:02).
RX   MEDLINE=91365651; PubMed=1890016; DOI=10.1016/0198-8859(91)90020-A;
RA   Chertkoff L.P., Herrera M., Fainboim L., Satz M.L.;
RT   "Complete nucleotide sequence of a genomic clone encoding HLA-B35
RT   isolated from a Caucasian individual of Hispanic origin.
RT   Identification of a new variant of HLA-B35.";
RL   Hum. Immunol. 31:153-158(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*35:03).
RX   MEDLINE=92176661; PubMed=1541831;
RA   Zemmour J., Little A.-M., Schendel D.J., Parham P.;
RT   "The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35
RT   allele, which also has a point mutation in the translation initiation
RT   codon.";
RL   J. Immunol. 148:1941-1948(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*35:03).
RC   TISSUE=Blood;
RX   MEDLINE=95279930; PubMed=7759996; DOI=10.1084/jem.181.6.2037;
RA   Beck Y., Satz L., Takamiya Y., Nakayama S., Ling L., Ishikawa Y.,
RA   Nagao T., Uchida H., Tokunaga K., Mueller C., Juji T., Takiguchi M.;
RT   "Polymorphism of human minor histocompatibility antigens: T cell
RT   recognition of human minor histocompatibility peptides presented by
RT   HLA-B35 subtype molecules.";
RL   J. Exp. Med. 181:2037-2048(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELES B*35:05 AND B*35:06).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*35:07 AND B*35:08).
RX   MEDLINE=93303752; PubMed=8316945;
RX   DOI=10.1111/j.1399-0039.1993.tb01993.x;
RA   Theiler G., Pando M., Delfino J.M., Takiguchi M., Satz M.L.;
RT   "Isolation and characterization of two new functional subtypes of HLA-
RT   B35.";
RL   Tissue Antigens 41:143-147(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*35:08).
RX   MEDLINE=94186367; PubMed=8138421; DOI=10.1016/0198-8859(93)90553-D;
RA   Steinle A., Reinhardt C., Noessner E., Uchanska-Ziegler B.,
RA   Ziegler A., Schendel D.J.;
RT   "Microheterogeneity in HLA-B35 alleles influences peptide-dependent
RT   allorecognition by cytotoxic T cells but not binding of a peptide-
RT   restricted monoclonal antibody.";
RL   Hum. Immunol. 38:261-269(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 9-362 (ALLELE B*35:04).
RX   MEDLINE=92269956; PubMed=1589035; DOI=10.1038/357329a0;
RA   Watkins D.I., McAdam S.N., Liu X., Stang C.R., Milford E.L.,
RA   Levine C.G., Garber T.L., Dogon A.L., Lord C.I., Ghim S.H.,
RA   Troup G.M., Hughes A.L., Letvin N.L.;
RT   "New recombinant HLA-B alleles in a tribe of South American
RT   Amerindians indicate rapid evolution of MHC class I loci.";
RL   Nature 357:329-333(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*35:29 AND
RP   B*35:32).
RX   MEDLINE=20236861; PubMed=10777103;
RX   DOI=10.1034/j.1399-0039.2000.550311.x;
RA   Kennedy C.T., Dodd R., Le T., Wallace R., Ng G., Greville W.D.,
RA   Kennedy A., Taverniti A., Moses J.H., Clow N., Watson N., Dunckley H.;
RT   "Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides
RT   (PCR-SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529,
RT   B*3532, B*4025, B*5304 and B*5508.";
RL   Tissue Antigens 55:266-270(2000).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES B*35:25; B*35:28; B*35:29;
RP   B*35:30 AND B*35:36).
RX   MEDLINE=21442089; PubMed=11556976;
RX   DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 25-300.
RX   MEDLINE=96209671; PubMed=8624811; DOI=10.1016/S1074-7613(00)80429-X;
RA   Smith K.J., Reid S.W., Stuart D.I., McMichael A.J., Jones E.Y.,
RA   Bell J.I.;
RT   "An altered position of the alpha 2 helix of MHC class I is revealed
RT   by the crystal structure of HLA-B*3501.";
RL   Immunity 4:203-214(1996).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   MEDLINE=99096952; PubMed=9878435; DOI=10.1006/jmbi.1998.2363;
RA   Menssen R., Orth P., Ziegler A., Saenger W.;
RT   "Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due
RT   to non-standard positioning of the C-terminus.";
RL   J. Mol. Biol. 285:645-653(1999).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-35 are known: B*35:01,
CC       B*35:02, B*35:03, B*35:04, B*35:05 (B35-G), B*35:06 (B35-K),
CC       B*35:07, B*35:08, B*35:25, B*35:28, B*35:29 (B*KG), B*35:30,
CC       B*35:32 (B*TMUL) and B*35:36. The sequence shown is that of
CC       B*35:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28115; AAA59617.1; -; Genomic_DNA.
DR   EMBL; M28109; AAA59617.1; JOINED; Genomic_DNA.
DR   EMBL; M28110; AAA59617.1; JOINED; Genomic_DNA.
DR   EMBL; M28111; AAA59617.1; JOINED; Genomic_DNA.
DR   EMBL; M28112; AAA59617.1; JOINED; Genomic_DNA.
DR   EMBL; M28113; AAA59617.1; JOINED; Genomic_DNA.
DR   EMBL; M28114; AAA59617.1; JOINED; Genomic_DNA.
DR   EMBL; M63454; AAA59682.1; -; Genomic_DNA.
DR   EMBL; M81798; AAA59684.1; -; mRNA.
DR   EMBL; D50299; BAA08828.1; -; mRNA.
DR   EMBL; M84385; AAA59635.1; -; mRNA.
DR   EMBL; M84381; AAA59631.1; -; mRNA.
DR   EMBL; L04695; AAA59694.1; -; mRNA.
DR   EMBL; L04696; AAA52674.1; -; mRNA.
DR   EMBL; Z22651; CAA80366.1; -; mRNA.
DR   EMBL; M86403; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF117771; AAD23460.1; -; Genomic_DNA.
DR   EMBL; AF117770; AAD23460.1; JOINED; Genomic_DNA.
DR   EMBL; AF134867; AAD30277.1; -; Genomic_DNA.
DR   EMBL; AF134866; AAD30277.1; JOINED; Genomic_DNA.
DR   EMBL; AF061864; AAC32570.1; -; Genomic_DNA.
DR   EMBL; AF061863; AAC32570.1; JOINED; Genomic_DNA.
DR   EMBL; AF108429; AAD27538.1; -; Genomic_DNA.
DR   EMBL; AF108428; AAD27538.1; JOINED; Genomic_DNA.
DR   EMBL; AF176078; AAD51745.1; -; Genomic_DNA.
DR   EMBL; AF176077; AAD51745.1; JOINED; Genomic_DNA.
DR   EMBL; AF110505; AAD26151.1; -; Genomic_DNA.
DR   EMBL; AF110504; AAD26151.1; JOINED; Genomic_DNA.
DR   EMBL; AF282766; AAG01819.1; -; Genomic_DNA.
DR   EMBL; AF282765; AAG01819.1; JOINED; Genomic_DNA.
DR   IPI; IPI00646083; -.
DR   PIR; A45880; A45880.
DR   PIR; I54298; I54298.
DR   PIR; I56133; I56133.
DR   PIR; I61904; I61904.
DR   PIR; I61907; I61907.
DR   PIR; I81233; I81233.
DR   UniGene; Hs.77961; -.
DR   PDB; 1A1N; X-ray; 2.00 A; A=25-300.
DR   PDB; 1A9B; X-ray; 3.20 A; A/D=25-301.
DR   PDB; 1A9E; X-ray; 2.50 A; A=25-301.
DR   PDB; 1CG9; X-ray; 2.70 A; A=25-301.
DR   PDB; 1XH3; X-ray; 1.48 A; A=25-300.
DR   PDB; 1ZHK; X-ray; 1.60 A; A=25-300.
DR   PDB; 1ZHL; X-ray; 1.50 A; A=25-300.
DR   PDB; 1ZSD; X-ray; 1.70 A; A=25-300.
DR   PDB; 2AK4; X-ray; 2.50 A; A/F/K/Q=25-300.
DR   PDB; 2AXF; X-ray; 1.80 A; A=25-300.
DR   PDB; 2AXG; X-ray; 2.00 A; A=25-300.
DR   PDB; 2CIK; X-ray; 1.75 A; A=25-300.
DR   PDB; 2FYY; X-ray; 1.50 A; A=25-300.
DR   PDB; 2FZ3; X-ray; 1.90 A; A=25-300.
DR   PDB; 2H6P; X-ray; 1.90 A; A=25-300.
DR   PDB; 2NW3; X-ray; 1.70 A; A=25-300.
DR   PDB; 2NX5; X-ray; 2.70 A; A/F/K/Q=25-300.
DR   PDB; 3BW9; X-ray; 1.75 A; A=25-300.
DR   PDB; 3BWA; X-ray; 1.30 A; A=25-300.
DR   PDB; 3KWW; X-ray; 2.18 A; A=25-300.
DR   PDB; 3KXF; X-ray; 3.10 A; A/C/I/K=25-300.
DR   PDB; 3LKN; X-ray; 2.00 A; A=25-300.
DR   PDB; 3LKO; X-ray; 1.80 A; A=25-300.
DR   PDB; 3LKP; X-ray; 1.80 A; A=25-300.
DR   PDB; 3LKQ; X-ray; 1.80 A; A=25-300.
DR   PDB; 3LKR; X-ray; 2.00 A; A=25-300.
DR   PDB; 3LKS; X-ray; 1.90 A; A=25-300.
DR   PDB; 3MV7; X-ray; 2.00 A; A=25-300.
DR   PDB; 3MV8; X-ray; 2.10 A; A=25-300.
DR   PDB; 3MV9; X-ray; 2.70 A; A=25-300.
DR   PDB; 3VFS; X-ray; 1.85 A; A=25-300.
DR   PDB; 3VFT; X-ray; 1.95 A; A=25-300.
DR   PDB; 3VFU; X-ray; 1.65 A; A=25-300.
DR   PDB; 3VFV; X-ray; 1.55 A; A=25-300.
DR   PDB; 3VFW; X-ray; 2.30 A; A=25-300.
DR   PDBsum; 1A1N; -.
DR   PDBsum; 1A9B; -.
DR   PDBsum; 1A9E; -.
DR   PDBsum; 1CG9; -.
DR   PDBsum; 1XH3; -.
DR   PDBsum; 1ZHK; -.
DR   PDBsum; 1ZHL; -.
DR   PDBsum; 1ZSD; -.
DR   PDBsum; 2AK4; -.
DR   PDBsum; 2AXF; -.
DR   PDBsum; 2AXG; -.
DR   PDBsum; 2CIK; -.
DR   PDBsum; 2FYY; -.
DR   PDBsum; 2FZ3; -.
DR   PDBsum; 2H6P; -.
DR   PDBsum; 2NW3; -.
DR   PDBsum; 2NX5; -.
DR   PDBsum; 3BW9; -.
DR   PDBsum; 3BWA; -.
DR   PDBsum; 3KWW; -.
DR   PDBsum; 3KXF; -.
DR   PDBsum; 3LKN; -.
DR   PDBsum; 3LKO; -.
DR   PDBsum; 3LKP; -.
DR   PDBsum; 3LKQ; -.
DR   PDBsum; 3LKR; -.
DR   PDBsum; 3LKS; -.
DR   PDBsum; 3MV7; -.
DR   PDBsum; 3MV8; -.
DR   PDBsum; 3MV9; -.
DR   PDBsum; 3VFS; -.
DR   PDBsum; 3VFT; -.
DR   PDBsum; 3VFU; -.
DR   PDBsum; 3VFV; -.
DR   PDBsum; 3VFW; -.
DR   ProteinModelPortal; P30685; -.
DR   SMR; P30685; 25-300.
DR   STRING; P30685; -.
DR   DMDM; 231390; -.
DR   PRIDE; P30685; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   H-InvDB; HIX0167180; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30685; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30685; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30685; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30685; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-35 alpha chain.
FT                                /FTId=PRO_0000018840.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      40     40       G -> V (in allele B*35:07).
FT                                /FTId=VAR_016393.
FT   VARIANT      48     48       A -> S (in allele B*35:25).
FT                                /FTId=VAR_016394.
FT   VARIANT      69     69       T -> E (in allele B*35:25; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016395.
FT   VARIANT      87     87       N -> E (in allele B*35:28; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016396.
FT   VARIANT      91     91       F -> S (in allele B*35:28).
FT                                /FTId=VAR_016397.
FT   VARIANT      98     98       Y -> D (in allele B*35:29).
FT                                /FTId=VAR_016398.
FT   VARIANT     107    107       G -> D (in allele B*35:36).
FT                                /FTId=VAR_016399.
FT   VARIANT     118    119       II -> TL (in allele B*35:05 and allele
FT                                B*35:32).
FT                                /FTId=VAR_016400.
FT   VARIANT     121    121       R -> S (in allele B*35:05 and allele
FT                                B*35:30).
FT                                /FTId=VAR_016401.
FT   VARIANT     127    127       L -> V (in allele B*35:32).
FT                                /FTId=VAR_016402.
FT   VARIANT     133    133       L -> F (in allele B*35:02).
FT                                /FTId=VAR_016403.
FT   VARIANT     138    138       D -> N (in allele B*35:02, allele B*35:04
FT                                and allele B*35:06).
FT                                /FTId=VAR_016404.
FT   VARIANT     140    140       S -> F (in allele B*35:06 and allele
FT                                B*35:36).
FT                                /FTId=VAR_016405.
FT   VARIANT     140    140       S -> Y (in allele B*35:02, allele B*35:03
FT                                and allele B*35:04).
FT                                /FTId=VAR_016406.
FT   VARIANT     180    180       L -> R (in allele B*35:08).
FT                                /FTId=VAR_016407.
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40455 MW;  52906854FC43E7A6 CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRNTQI FKTNTQTYRE SLRNLRGYYN QSEAGSHIIQ
     RMYGCDLGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B37_HUMAN              Reviewed;         362 AA.
AC   P18463; O19627; Q546L8; Q95HA3; Q95HA8; Q95HM9; Q9GJ31;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   18-APR-2012, entry version 106.
DE   RecName: Full=HLA class I histocompatibility antigen, B-37 alpha chain;
DE   AltName: Full=MHC class I antigen B*37;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*37:01).
RX   MEDLINE=90207291; PubMed=2320591; DOI=10.1073/pnas.87.7.2833;
RA   Ennis P.D., Zemmour J., Salter R.D., Parham P.;
RT   "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction:
RT   frequency and nature of errors produced in amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*37:01).
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of B*3701.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*37:04).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=22025782; PubMed=12028544;
RX   DOI=10.1034/j.1399-0039.2002.590213.x;
RA   Estefania E., Gomez-Lozano N., de Pablo R., Moreno M.E., Vilches C.;
RT   "Complementary DNA sequence of the novel HLA-B*3704 allele.";
RL   Tissue Antigens 59:142-144(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*37:05).
RX   MEDLINE=22131942; PubMed=12135437;
RX   DOI=10.1034/j.1399-0039.2002.590416.x;
RA   Pyo C.-W., Han H., Kim T.G.;
RT   "Identification of a new HLA-B allele, B*3705 containing a Bw6
RT   sequence motif.";
RL   Tissue Antigens 59:335-337(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 1-322 (ALLELE B*37:01).
RA   Hurley C.K., Bei M., Rodriguez S., Johnson A.;
RL   Submitted (JUN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*37:04).
RA   Gans C.P., Hurley C.K.;
RT   "Novel HLA-B allele.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-37 are known: B*37:01,
CC       B*37:04 and B*37:05. The sequence shown is that of B*37:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32320; AAA36233.1; -; mRNA.
DR   EMBL; AJ310358; CAC38763.1; -; Genomic_DNA.
DR   EMBL; AF389378; AAL26324.1; -; mRNA.
DR   EMBL; AF418978; AAL07502.1; -; mRNA.
DR   EMBL; AF284828; AAK82990.1; -; Genomic_DNA.
DR   EMBL; AF284826; AAK82990.1; JOINED; Genomic_DNA.
DR   EMBL; AF284827; AAK82990.1; JOINED; Genomic_DNA.
DR   EMBL; U11267; AAA19927.1; -; mRNA.
DR   EMBL; AF303102; AAG21400.1; -; Genomic_DNA.
DR   EMBL; AF303101; AAG21400.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472652; -.
DR   PIR; C35997; C35997.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P18463; -.
DR   SMR; P18463; 25-300.
DR   STRING; P18463; -.
DR   DMDM; 122160; -.
DR   PRIDE; P18463; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P18463; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P18463; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P18463; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-37 alpha chain.
FT                                /FTId=PRO_0000018841.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      35     35       S -> A (in dbSNP:rs1131170).
FT                                /FTId=VAR_056344.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056345.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061404.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061405.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061406.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056346.
FT   VARIANT     104    104       T -> N (in allele B*37:05).
FT                                /FTId=VAR_016408.
FT   VARIANT     106    107       LR -> RG (in allele B*37:05).
FT                                /FTId=VAR_016409.
FT   VARIANT     195    195       Y -> H (in allele B*37:04).
FT                                /FTId=VAR_016410.
SQ   SEQUENCE   362 AA;  40456 MW;  FAB4375F05474725 CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFHTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE DLRTLLRYYN QSEAGSHTIQ
     RMSGCDVGPD GRLLRGYNQF AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQD
     RAYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B38_HUMAN              Reviewed;         362 AA.
AC   Q95365; O19779; O77959; O78160; Q29935; Q29936; Q95IB8; Q95IH5;
AC   Q9BCM8; Q9MY92; Q9MYG1; Q9TPT2;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   18-APR-2012, entry version 97.
DE   RecName: Full=HLA class I histocompatibility antigen, B-38 alpha chain;
DE   AltName: Full=Bw-4;
DE   AltName: Full=MHC class I antigen B*38;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*38:01).
RX   MEDLINE=95242308; PubMed=7725307;
RX   DOI=10.1111/j.1399-0039.1995.tb02410.x;
RA   Adams E.J., Martinez-Naves E., Arnett K.L., Little A.-M., Tyan D.B.,
RA   Parham P.;
RT   "HLA-B16 antigens: sequence of the ST-16 antigen, further definition
RT   of two B38 subtypes and evidence for convergent evolution of B*3902.";
RL   Tissue Antigens 45:18-26(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*38:01).
RA   Morlighem G.;
RL   Submitted (NOV-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*38:02).
RA   Little A.-M., Domena J.D., Hildebrand W.H., Parham P.;
RL   Submitted (FEB-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*38:02).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:02).
RX   MEDLINE=98116675; PubMed=9455497; DOI=10.1016/S0198-8859(97)00112-2;
RA   Steiner N.K., Ng J., Bush J., Hartzman R.J., Johnston-Dow L.,
RA   Hurley C.K.;
RT   "HLA-B alleles associated with the B15 serologically defined
RT   antigens.";
RL   Hum. Immunol. 56:84-93(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:02).
RA   Guttridge M.G., Hammond L., Darke C.;
RT   "Confirmatory sequence and serology of HLA-B*38021.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 26-206 (ALLELE B*38:03).
RX   MEDLINE=99254921; PubMed=10323342;
RX   DOI=10.1034/j.1399-0039.1999.530408.x;
RA   Balas A., Santos S., Garcia-Sanchez F., Lillo R., Merino J.L.,
RA   Vicario J.L.;
RT   "Characterization of a new HLA-B*38 allele (B*3803) in a Spanish
RT   Caucasian individual which is closely related to the Oriental B*38021
RT   and B*39021 alleles.";
RL   Tissue Antigens 53:374-377(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES B*38:04 AND B*38:06).
RX   MEDLINE=21276061; PubMed=11380951;
RX   DOI=10.1034/j.1399-0039.2001.057004373.x;
RA   Steiner N.K., Gans C.P., Kosman C., Baldassarre L.A., Edson S.,
RA   Jones P.F., Rizzuto G., Pimtanothai N., Koester R., Mitton W., Ng J.,
RA   Hartzman R.J., Hurley C.K.;
RT   "Novel HLA-B alleles associated with antigens in the 8C CREG.";
RL   Tissue Antigens 57:373-375(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-298 (ALLELE B*38:05).
RX   MEDLINE=21970277; PubMed=11972879;
RX   DOI=10.1034/j.1399-0039.2002.590109.x;
RA   Garcia-Sanchez F., Fernandez-De-Velasco J., Lillo R.,
RA   Alvarez-Doval A., Rodriguez M.A., Aviles M.J., Balas A., Vicario J.L.;
RT   "Two new HLA class I alleles recognised by PCR sequence-specific
RT   primer and sequencing based typing: B*3805 and Cw*0408.";
RL   Tissue Antigens 59:47-48(2002).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:07).
RA   Cavett J.W., Hildebrand W.H., Bennett T.T., Sparkman J.N.;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:08).
RA   Chapman G., Dodd R., Greville W.D., Dunckley H.;
RT   "Novel HLA-B allele Identified by PCR SSO.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-298 (ALLELE B*38:01).
RX   MEDLINE=89379286; PubMed=2777338; DOI=10.1007/BF02421207;
RA   Mueller C.A., Engler-Blum G., Gekeler V., Steiert I., Weiss E.,
RA   Schmidt H.;
RT   "Genetic and serological heterogeneity of the supertypic HLA-B locus
RT   specificities Bw4 and Bw6.";
RL   Immunogenetics 30:200-207(1989).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-38 are known: B*38:01,
CC       B*38:02, B*38:03, B*38:04, B*38:05, B*38:06, B*38:07 and B*38:08.
CC       The sequence shown is that of B*38:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36591; AAA73509.1; -; mRNA.
DR   EMBL; U40498; AAD00010.1; -; mRNA.
DR   EMBL; L22028; AAA59618.1; -; mRNA.
DR   EMBL; AJ297317; CAC29063.1; -; Genomic_DNA.
DR   EMBL; U90241; AAB82305.1; -; Genomic_DNA.
DR   EMBL; U90240; AAB82305.1; JOINED; Genomic_DNA.
DR   EMBL; AJ308991; CAC34965.1; -; Genomic_DNA.
DR   EMBL; AJ308992; CAC34965.1; JOINED; Genomic_DNA.
DR   EMBL; AF081275; AAC32198.1; -; mRNA.
DR   EMBL; AF081276; AAC32199.1; -; Genomic_DNA.
DR   EMBL; AF181858; AAD56222.1; -; Genomic_DNA.
DR   EMBL; AF181857; AAD56222.1; JOINED; Genomic_DNA.
DR   EMBL; AF262961; AAF78055.1; -; Genomic_DNA.
DR   EMBL; AF262960; AAF78055.1; JOINED; Genomic_DNA.
DR   EMBL; AF218804; AAF67340.1; -; Genomic_DNA.
DR   EMBL; AF218802; AAF67340.1; JOINED; Genomic_DNA.
DR   EMBL; AF218803; AAF67340.1; JOINED; Genomic_DNA.
DR   EMBL; AF281054; AAK69506.1; -; Genomic_DNA.
DR   EMBL; AF281053; AAK69506.1; JOINED; Genomic_DNA.
DR   EMBL; AF402321; AAL04500.1; -; Genomic_DNA.
DR   EMBL; AF402320; AAL04500.1; JOINED; Genomic_DNA.
DR   EMBL; M29864; AAA36222.1; -; Genomic_DNA.
DR   IPI; IPI00473068; -.
DR   PIR; A59028; A59028.
DR   PIR; I54463; I54463.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q95365; -.
DR   SMR; Q95365; 25-300.
DR   STRING; Q95365; -.
DR   DMDM; 34305608; -.
DR   PRIDE; Q95365; -.
DR   Ensembl; ENST00000425848; ENSP00000400842; ENSG00000223532.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q95365; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; Q95365; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; Q95365; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-38 alpha chain.
FT                                /FTId=PRO_0000018842.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056347.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056348.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056349.
FT   VARIANT      35     35       S -> A (in allele B*38:05;
FT                                dbSNP:rs1131170).
FT                                /FTId=VAR_016411.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056350.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061407.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061408.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061409.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056351.
FT   VARIANT      69     69       E -> T (in allele B*38:06 and allele
FT                                B*38:07; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016412.
FT   VARIANT      82     82       E -> G (in allele B*38:07).
FT                                /FTId=VAR_016413.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056352.
FT   VARIANT      87     87       N -> E (in allele B*38:03 and allele
FT                                B*38:04; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016414.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059478.
FT   VARIANT      91     91       C -> F (in allele B*38:06 and allele
FT                                B*38:07).
FT                                /FTId=VAR_016415.
FT   VARIANT      91     91       C -> S (in allele B*38:03).
FT                                /FTId=VAR_016416.
FT   VARIANT      98     98       Y -> D (in allele B*38:03).
FT                                /FTId=VAR_016417.
FT   VARIANT     101    101       N -> S (in allele B*38:03).
FT                                /FTId=VAR_016418.
FT   VARIANT     104    104       I -> T (in allele B*38:02, allele
FT                                B*38:03, allele B*38:04 and allele
FT                                B*38:08).
FT                                /FTId=VAR_016419.
FT   VARIANT     187    187       T -> M (in allele B*38:08).
FT                                /FTId=VAR_016420.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056353.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056354.
FT   CONFLICT    130    131       DG -> ER (in Ref. 12; AAA36222).
FT   CONFLICT    191    192       WL -> CV (in Ref. 12; AAA36222).
SQ   SEQUENCE   362 AA;  40416 MW;  41F49A1A19DF21C7 CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI CKTNTQTYRE NLRIALRYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHNQF AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RTYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B39_HUMAN              Reviewed;         362 AA.
AC   P30475; O02960; O78217; P30476; P79504; Q29665; Q29697; Q29749;
AC   Q29847; Q29852; Q29858; Q8HWF0; Q9TPQ7;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 106.
DE   RecName: Full=HLA class I histocompatibility antigen, B-39 alpha chain;
DE   AltName: Full=MHC class I antigen B*39;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES B*39:01 AND B*39:02).
RX   MEDLINE=93131294; PubMed=8420828; DOI=10.1007/BF00191887;
RA   Kato N., Karaki S., Kashiwase K., Mueller C., Akaza T., Juji T.,
RA   Kano K., Takiguchi M.;
RT   "Molecular analysis of HLA-B39 subtypes.";
RL   Immunogenetics 37:212-216(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*39:02 AND B*39:05).
RX   MEDLINE=95242308; PubMed=7725307;
RX   DOI=10.1111/j.1399-0039.1995.tb02410.x;
RA   Adams E.J., Martinez-Naves E., Arnett K.L., Little A.-M., Tyan D.B.,
RA   Parham P.;
RT   "HLA-B16 antigens: sequence of the ST-16 antigen, further definition
RT   of two B38 subtypes and evidence for convergent evolution of B*3902.";
RL   Tissue Antigens 45:18-26(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*39:04).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=95189597; PubMed=7533753; DOI=10.1016/0198-8859(94)90042-6;
RA   Ogawa A., Tokunaga K., Nakajima F., Kikuchi A., Karaki S.,
RA   Kashiwase K., Ge J., Hannestad K., Juji T., Takiguchi M.;
RT   "Identification of the gene encoding a novel HLA-B39 subtype. Two
RT   amino acid substitutions on the beta-sheet out of the peptide-binding
RT   floor form a novel serological epitope.";
RL   Hum. Immunol. 41:241-247(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*39:09).
RC   TISSUE=Blood;
RX   MEDLINE=96435466; PubMed=8838352;
RX   DOI=10.1111/j.1399-0039.1995.tb03135.x;
RA   Ramos M., Postigo J.M., Vilches C., Layrisse Z., Lopez de Castro J.A.;
RT   "Primary structure of a novel HLA-B39 allele (B*3909) from the Warao
RT   Indians of Venezuela. Further evidence for local HLA-B diversification
RT   in South America.";
RL   Tissue Antigens 46:401-404(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*39:06).
RX   MEDLINE=96387677; PubMed=8795147;
RX   DOI=10.1111/j.1399-0039.1996.tb02582.x;
RA   Zhao W., Fernandez-Vina M.A., Lazaro A.M., Araujo H.A., Miller S.,
RA   Stastny P.;
RT   "Full cDNA of a novel HLA-B39 subtype, B*39061.";
RL   Tissue Antigens 47:435-437(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*39:06).
RA   Zhang L., Ellexson M.E., Hildebrand W.H.;
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*39:10).
RX   MEDLINE=97142356; PubMed=8988545;
RX   DOI=10.1111/j.1399-0039.1996.tb02676.x;
RA   Wells R.S., Parham P.;
RT   "A novel recombinant HLA-B*39 allele (B*3910) in a South African
RT   Zulu.";
RL   Tissue Antigens 48:595-597(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*39:10).
RX   MEDLINE=97378891; PubMed=9234488;
RX   DOI=10.1111/j.1399-0039.1997.tb02814.x;
RA   Vilches C., Bunce M., de Pablo R., Moreno M.E., Puente S., Sanz L.,
RA   Kreisler M.;
RT   "The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi
RT   population from Equatorial Guinea.";
RL   Tissue Antigens 49:644-648(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*39:01).
RA   Kashiwase K.;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*39:24).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=22447027; PubMed=12558815;
RX   DOI=10.1046/j.1365-2370.2003.00362.x;
RA   Estefania E., Gomez-Lozano N., de Pablo R., Moreno M.E., Vilches C.;
RT   "Complementary DNA sequence of the HLA-B*3924 allele.";
RL   Eur. J. Immunogenet. 30:11-12(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 10-362 (ALLELE B*39:08).
RX   MEDLINE=96435470; PubMed=8838356;
RX   DOI=10.1111/j.1399-0039.1995.tb03139.x;
RA   Adams E.J., Little A.-M., Arnett K.L., McAuley J.E., Williams R.C.,
RA   Parham P.;
RT   "Three new HLA-B alleles found in Mexican-Americans.";
RL   Tissue Antigens 46:414-416(1995).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*39:12).
RX   MEDLINE=99299758; PubMed=10372543;
RX   DOI=10.1034/j.1399-0039.1999.530504.x;
RA   Marcos C.Y., Fernandez-Vina M.A., Lazaro A.M., Moraes M.E.,
RA   Moraes J.R., Stastny P.;
RT   "Novel HLA-A and HLA-B alleles in South American Indians.";
RL   Tissue Antigens 53:476-485(1999).
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*39:12).
RX   MEDLINE=20066996; PubMed=10600013; DOI=10.1016/S0198-8859(99)00092-0;
RA   Lazaro A.M., Moraes M.E., Marcos C.Y., Moraes J.R.,
RA   Fernandez-Vina M.A., Stastny P.;
RT   "Evolution of HLA-class I compared to HLA-class II polymorphism in
RT   Terena, a South-American Indian tribe.";
RL   Hum. Immunol. 60:1138-1149(1999).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*39:23).
RX   MEDLINE=21160452; PubMed=11260515;
RX   DOI=10.1034/j.1399-0039.2001.057002169.x;
RA   Akesaka T., Kashiwase K., Ishikawa Y., Tanaka H., Shimizu M.,
RA   Kawai S., Akaza T., Takahashi T., Juji T.;
RT   "Allele frequency of HLA-B39 in the Japanese population and
RT   identification of a novel B39 allele, B*3923.";
RL   Tissue Antigens 57:169-172(2001).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 60-196 (ALLELE B*39:07).
RX   MEDLINE=95317819; PubMed=7797264; DOI=10.1007/BF00164983;
RA   Garber T.L., Butler L.M., Trachtenberg E.A., Erlich H.A., Rickards O.,
RA   De Stefano G., Watkins D.I.;
RT   "HLA-B alleles of the Cayapa of Ecuador: new B39 and B15 alleles.";
RL   Immunogenetics 42:19-27(1995).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-39 are known: B*39:01
CC       (B39.1), B*39:02 (B9.2), B*39:03, B*39:04 (B39N), B*39:05 (ST-16),
CC       B*39:06 (B39G), B*39:07 (B39uw3), B*39:09, B*39:10, B*39:12
CC       (B3901v), B*39:23 (B39022v1) and B*39:24. The sequence shown is
CC       that of B*39:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M94052; AAA52658.1; -; Genomic_DNA.
DR   EMBL; M94051; AAA52660.1; -; Genomic_DNA.
DR   EMBL; M94053; AAA52659.1; -; Genomic_DNA.
DR   EMBL; U04243; AAA87396.1; -; mRNA.
DR   EMBL; L36318; AAA73942.1; -; mRNA.
DR   EMBL; L22649; AAA69861.1; -; Genomic_DNA.
DR   EMBL; U29480; AAC50392.1; -; mRNA.
DR   EMBL; L42024; AAB59484.1; -; mRNA.
DR   EMBL; U29083; AAC32741.1; -; mRNA.
DR   EMBL; U56246; AAB01985.1; -; Genomic_DNA.
DR   EMBL; Y09058; CAA70261.1; -; mRNA.
DR   EMBL; AB091216; BAC11810.1; -; Genomic_DNA.
DR   EMBL; AB091218; BAC11811.1; -; Genomic_DNA.
DR   EMBL; AF428252; AAN63555.1; -; mRNA.
DR   EMBL; L42280; AAB51452.1; -; Genomic_DNA.
DR   EMBL; U76395; AAB39108.1; -; Genomic_DNA.
DR   EMBL; U76394; AAB39108.1; JOINED; Genomic_DNA.
DR   EMBL; AB032097; BAA84116.1; -; Genomic_DNA.
DR   EMBL; U15640; AAA74047.1; -; Genomic_DNA.
DR   IPI; IPI00472800; -.
DR   PIR; I38876; I38876.
DR   PIR; I54314; I54314.
DR   PIR; I54505; I54505.
DR   PIR; I68850; I68850.
DR   PIR; I84488; I84488.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30475; -.
DR   SMR; P30475; 25-300.
DR   STRING; P30475; -.
DR   DMDM; 231398; -.
DR   PRIDE; P30475; -.
DR   Ensembl; ENST00000425848; ENSP00000400842; ENSG00000223532.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30475; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30475; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30475; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-39 alpha chain.
FT                                /FTId=PRO_0000018843.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056355.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056356.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056357.
FT   VARIANT      33     33       Y -> D (in allele B*39:12).
FT                                /FTId=VAR_016659.
FT   VARIANT      35     35       S -> A (in allele B*39:04 and allele
FT                                B*39:12; dbSNP:rs1131170).
FT                                /FTId=VAR_016421.
FT   VARIANT      36     36       V -> M (in allele B*39:04;
FT                                dbSNP:rs1050486).
FT                                /FTId=VAR_016660.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061410.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061411.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061412.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056358.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056359.
FT   VARIANT      87     87       N -> E (in allele B*39:02, allele B*39:08
FT                                and allele B*39:23; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016422.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059479.
FT   VARIANT      91     91       C -> S (in allele B*39:02, allele B*39:08
FT                                and allele B*39:23).
FT                                /FTId=VAR_016423.
FT   VARIANT      91     91       C -> Y (in allele B*39:10).
FT                                /FTId=VAR_016424.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056360.
FT   VARIANT      98     98       D -> Y (in allele B*39:05, allele B*39:07
FT                                and allele B*39:08; dbSNP:rs1131215).
FT                                /FTId=VAR_016425.
FT   VARIANT     119    119       L -> W (in allele B*39:06).
FT                                /FTId=VAR_016426.
FT   VARIANT     121    121       R -> S (in allele B*39:03 and allele
FT                                B*39:24).
FT                                /FTId=VAR_016427.
FT   VARIANT     121    121       R -> T (in allele B*39:06).
FT                                /FTId=VAR_016428.
FT   VARIANT     122    122       M -> T (in allele B*39:24).
FT                                /FTId=VAR_016429.
FT   VARIANT     123    123       Y -> S (in allele B*39:09).
FT                                /FTId=VAR_016430.
FT   VARIANT     138    138       N -> D (in allele B*39:07).
FT                                /FTId=VAR_016431.
FT   VARIANT     140    140       F -> S (in allele B*39:07).
FT                                /FTId=VAR_016432.
FT   VARIANT     168    168       Q -> R (in allele B*39:23).
FT                                /FTId=VAR_016433.
FT   VARIANT     180    180       L -> R (in allele B*39:08).
FT                                /FTId=VAR_016434.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056361.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056362.
SQ   SEQUENCE   362 AA;  40328 MW;  422698063DEAB039 CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI CKTNTQTDRE SLRNLRGYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHNQF AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RTYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B40_HUMAN              Reviewed;         362 AA.
AC   Q04826; O19556; O19651; P01890; P30477; P30478; Q29762; Q29842;
AC   Q29855; Q30173; Q31603; Q9TPT6;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   18-APR-2012, entry version 110.
DE   RecName: Full=HLA class I histocompatibility antigen, B-40 alpha chain;
DE   AltName: Full=Bw-60;
DE   AltName: Full=MHC class I antigen B*40;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*40:01).
RX   MEDLINE=87192942; PubMed=2437025; DOI=10.1007/BF00404425;
RA   Ways J.W., Lawlor D.A., Wan A.M., Parham P.;
RT   "A transposable epitope of HLA-B7, B40 molecules.";
RL   Immunogenetics 25:323-328(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*40:01).
RX   MEDLINE=94294981; PubMed=7517584;
RX   DOI=10.1111/j.1399-0039.1994.tb02294.x;
RA   Little A.-M., Domena J.D., Hildebrand W.H., Shen S.Y., Barber L.D.,
RA   Marsh S.G.E., Bias W.B., Parham P.;
RT   "HLA-B67: a member of the HLA-B16 family that expresses the ME1
RT   epitope.";
RL   Tissue Antigens 43:38-43(1994).
RN   [3]
RP   PROTEIN SEQUENCE OF 25-295 (B*40:01).
RX   MEDLINE=84000412; PubMed=6193808; DOI=10.1021/bi00285a036;
RA   Lopez de Castro J.A., Bragado R., Strong D.M., Strominger J.L.;
RT   "Primary structure of papain-solubilized human histocompatibility
RT   antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants.";
RL   Biochemistry 22:3961-3969(1983).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*40:02).
RX   MEDLINE=93127148; PubMed=1362296;
RX   DOI=10.1111/j.1399-0039.1992.tb02053.x;
RA   Domena J.D., Johnston-Dow L., Parham P.;
RT   "The B*4002 allele encodes the B61 antigen: B40* is identical to
RT   B61.";
RL   Tissue Antigens 40:254-256(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 13-318 (ALLELE B*40:02).
RC   TISSUE=Blood;
RX   MEDLINE=93127149; PubMed=1481202;
RX   DOI=10.1111/j.1399-0039.1992.tb02054.x;
RA   Lin L., Watanabe Y., Tokunaga K., Kuwata S., Kohsaka T., Akaza T.;
RT   "A common Japanese haplotype HLA-A26-Cw3-B61-DR9-DQ3 carries HLA-
RT   B*4002.";
RL   Tissue Antigens 40:257-260(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELES B*40:03 AND B*40:04).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*40:05).
RX   MEDLINE=93056529; PubMed=1385528;
RA   Hildebrand W.H., Madrigal J.A., Belich M.P., Zemmour J., Ward F.E.,
RA   Williams R.C., Parham P.;
RT   "Serologic cross-reactivities poorly reflect allelic relationships in
RT   the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2
RT   helix.";
RL   J. Immunol. 149:3563-3568(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*40:06).
RA   Herrero M.J.;
RL   Submitted (FEB-1995) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*40:06).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*40:08).
RX   MEDLINE=96097410; PubMed=8525480;
RX   DOI=10.1111/j.1399-0039.1995.tb03120.x;
RA   Adams E.J., Little A.-M., Arnett K.L., Leushner J., Parham P.;
RT   "Identification of a novel HLA-B40 allele (B*4008) in a patient with
RT   leukemia.";
RL   Tissue Antigens 46:204-205(1995).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-206 (ALLELE B*40:09).
RX   MEDLINE=99299758; PubMed=10372543;
RX   DOI=10.1034/j.1399-0039.1999.530504.x;
RA   Marcos C.Y., Fernandez-Vina M.A., Lazaro A.M., Moraes M.E.,
RA   Moraes J.R., Stastny P.;
RT   "Novel HLA-A and HLA-B alleles in South American Indians.";
RL   Tissue Antigens 53:476-485(1999).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*40:16).
RX   MEDLINE=20548605; PubMed=11098929;
RX   DOI=10.1034/j.1399-0039.2000.560401.x;
RA   Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H.,
RA   Hurley C.K.;
RT   "Diversity is demonstrated in class I HLA-A and HLA-B alleles in
RT   Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-
RT   B*1403, *4016, *4703.";
RL   Tissue Antigens 56:291-302(2000).
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*40:27).
RA   Pimtanothai N., Hurley C.K.;
RT   "Novel HLA-B allele.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-40 are known: B*40:01,
CC       B*40:02, B*40:03 (B40-G1), B*40:04 (B40-G2), B*40:05 (BN21),
CC       B*40:06, B*40:08, B*40:09, B*40:16 and B*40:27. The sequence shown
CC       is that of B*40:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03698; AAA03719.1; -; mRNA.
DR   EMBL; L41628; AAA65040.1; -; Genomic_DNA.
DR   EMBL; L09736; AAA36224.1; -; mRNA.
DR   EMBL; D14343; BAA03277.1; -; mRNA.
DR   EMBL; M84383; AAA59633.1; -; mRNA.
DR   EMBL; M84384; AAA59634.1; -; mRNA.
DR   EMBL; M84694; AAA03661.1; -; mRNA.
DR   EMBL; X84725; CAA59215.1; -; mRNA.
DR   EMBL; AJ300180; CAC15501.1; -; Genomic_DNA.
DR   EMBL; AJ292253; CAC29021.1; -; Genomic_DNA.
DR   EMBL; L41353; AAC41923.1; -; Genomic_DNA.
DR   EMBL; L76934; AAA96270.1; -; mRNA.
DR   EMBL; AF017023; AAB70252.1; -; Genomic_DNA.
DR   EMBL; AF017022; AAB70252.1; JOINED; Genomic_DNA.
DR   EMBL; AF181472; AAD56943.1; -; Genomic_DNA.
DR   EMBL; AF181471; AAD56943.1; JOINED; Genomic_DNA.
DR   IPI; IPI00746105; -.
DR   PIR; I38437; HLHU40.
DR   PIR; I56149; I56149.
DR   PIR; I59655; I59655.
DR   PIR; I61905; I61905.
DR   PIR; I61906; I61906.
DR   PIR; S52486; S52486.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q04826; -.
DR   SMR; Q04826; 25-298.
DR   STRING; Q04826; -.
DR   DMDM; 416557; -.
DR   PRIDE; Q04826; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q04826; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; Q04826; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; Q04826; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Host-virus interaction; Immunity; Membrane; MHC I;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-40 alpha chain.
FT                                /FTId=PRO_0000018844.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT       9      9       L -> V (in allele B*40:01).
FT                                /FTId=VAR_016435.
FT   VARIANT      14     15       WG -> SA (in allele B*40:01).
FT                                /FTId=VAR_016436.
FT   VARIANT      17     17       V -> L (in allele B*40:01).
FT                                /FTId=VAR_016437.
FT   VARIANT      35     36       SV -> AM (in allele B*40:01 and allele
FT                                B*40:16).
FT                                /FTId=VAR_016438.
FT   VARIANT      87     87       E -> N (in allele B*40:08; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016439.
FT   VARIANT      91     91       S -> F (in allele B*40:08).
FT                                /FTId=VAR_016440.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056363.
FT   VARIANT     118    119       TL -> II (in allele B*40:03).
FT                                /FTId=VAR_016441.
FT   VARIANT     119    119       L -> W (in allele B*40:06).
FT                                /FTId=VAR_016442.
FT   VARIANT     121    121       S -> R (in allele B*40:01 and allele
FT                                B*40:03).
FT                                /FTId=VAR_016443.
FT   VARIANT     121    121       S -> T (in allele B*40:06).
FT                                /FTId=VAR_016444.
FT   VARIANT     127    127       V -> L (in allele B*40:03).
FT                                /FTId=VAR_016445.
FT   VARIANT     137    137       H -> Y (in allele B*40:09;
FT                                dbSNP:rs1050379).
FT                                /FTId=VAR_016658.
FT   VARIANT     138    138       N -> D (in allele B*40:04 and allele
FT                                B*40:09).
FT                                /FTId=VAR_016446.
FT   VARIANT     140    140       Y -> N (in allele B*40:27).
FT                                /FTId=VAR_016447.
FT   VARIANT     140    140       Y -> S (in allele B*40:04).
FT                                /FTId=VAR_016448.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056364.
FT   VARIANT     167    167       T -> S (in allele B*40:01).
FT                                /FTId=VAR_016449.
FT   VARIANT     171    171       W -> L (in allele B*40:01).
FT                                /FTId=VAR_016450.
FT   VARIANT     176    176       V -> E (in allele B*40:05 and allele
FT                                B*40:16).
FT                                /FTId=VAR_016451.
FT   VARIANT     180    180       L -> R (in allele B*40:16).
FT                                /FTId=VAR_016655.
FT   VARIANT     187    187       E -> L (in allele B*40:05; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016452.
FT   VARIANT     201    202       ET -> DK (in allele B*40:01 and allele
FT                                B*40:16).
FT                                /FTId=VAR_016453.
FT   VARIANT     204    204       Q -> E (in allele B*40:01 and allele
FT                                B*40:16).
FT                                /FTId=VAR_016454.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056365.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056366.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061413.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061414.
FT   CONFLICT    167    167       Missing (in Ref. 3; AA sequence).
SQ   SEQUENCE   362 AA;  40505 MW;  7D66503ACD865152 CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFHTSVSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTLQ
     SMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGECVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B41_HUMAN              Reviewed;         362 AA.
AC   P30479; O19595; Q29848; Q5TK77; Q9MY79; Q9MY94;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 105.
DE   RecName: Full=HLA class I histocompatibility antigen, B-41 alpha chain;
DE   AltName: Full=Bw-41;
DE   AltName: Full=MHC class I antigen B*41;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*41:01).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of B*4101.";
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*41:02).
RX   MEDLINE=95237906; PubMed=7721359; DOI=10.1007/BF00172162;
RA   Rufer N., Roosnek E., Kressig R., Jeannet M., Tiercy J.-M.;
RT   "Sequencing of a new HLA-B41 subtype (B*4102) that occurs with a high
RT   frequency in the Caucasoid population.";
RL   Immunogenetics 41:333-333(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*41:03).
RX   MEDLINE=98378282; PubMed=9714480;
RX   DOI=10.1111/j.1399-0039.1998.tb03029.x;
RA   Hurley C.K., Steiner N.K., Kosman C., Mitton W., Koester R., Bei M.,
RA   Bush J., McCormack J., Hahn A., Henson V., Hoyer R., Wade J.A.,
RA   Hartzman R.J., Ng J.;
RT   "Novel HLA-A and HLA-B alleles.";
RL   Tissue Antigens 52:84-87(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*41:04).
RX   MEDLINE=21108621; PubMed=11169265;
RX   DOI=10.1034/j.1399-0039.2001.057001083.x;
RA   Turner D.M., Vlachos G., Cavanna S.L., Brown J., Brown C.,
RA   Navarrete C.V.;
RT   "A novel HLA allele, B*4104, identified in a cord blood donor.";
RL   Tissue Antigens 57:83-84(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*41:05).
RA   Gans C.P., Hurley C.K.;
RT   "Novel HLA-B allele.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-41 are known: B*41:01,
CC       B*41:02 (B41.2), B*41:03, B*41:04 and B*41:05. The sequence shown
CC       is that of B*41:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24035; AAA59666.1; -; Genomic_DNA.
DR   EMBL; AJ309193; CAC38392.1; -; Genomic_DNA.
DR   EMBL; X81363; CAA57128.1; -; mRNA.
DR   EMBL; AF028596; AAC33187.1; -; Genomic_DNA.
DR   EMBL; AF028595; AAC33187.1; JOINED; Genomic_DNA.
DR   EMBL; AF258782; AAF76144.1; -; Genomic_DNA.
DR   EMBL; AF279118; AAF81603.1; -; Genomic_DNA.
DR   EMBL; AF279117; AAF81603.1; JOINED; Genomic_DNA.
DR   IPI; IPI00026602; -.
DR   PIR; I37492; I37492.
DR   PIR; I61864; I61864.
DR   UniGene; Hs.77961; -.
DR   PDB; 3LN4; X-ray; 1.30 A; A=25-298.
DR   PDB; 3LN5; X-ray; 1.90 A; A=25-298.
DR   PDBsum; 3LN4; -.
DR   PDBsum; 3LN5; -.
DR   ProteinModelPortal; P30479; -.
DR   SMR; P30479; 25-298.
DR   STRING; P30479; -.
DR   DMDM; 231402; -.
DR   PRIDE; P30479; -.
DR   Ensembl; ENST00000425848; ENSP00000400842; ENSG00000223532.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30479; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30479; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30479; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30479; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-41 alpha chain.
FT                                /FTId=PRO_0000018845.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056367.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056368.
FT   VARIANT     104    104       N -> K (in allele B*41:05).
FT                                /FTId=VAR_016459.
FT   VARIANT     119    119       W -> L (in allele B*41:02, allele B*41:03
FT                                and allele B*41:04).
FT                                /FTId=VAR_016455.
FT   VARIANT     121    121       R -> S (in allele B*41:02 and allele
FT                                B*41:04).
FT                                /FTId=VAR_016456.
FT   VARIANT     127    127       V -> L (in allele B*41:04).
FT                                /FTId=VAR_016457.
FT   VARIANT     138    138       N -> D (in allele B*41:04).
FT                                /FTId=VAR_016458.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056369.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056370.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056371.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061415.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061416.
FT   STRAND       27     36
FT   STRAND       45     49
FT   STRAND       58     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        82    105
FT   STRAND      118    123
FT   STRAND      125    127
FT   STRAND      139    142
FT   STRAND      146    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    184
FT   HELIX       188    197
FT   TURN        201    204
FT   STRAND      207    230
FT   STRAND      232    235
FT   STRAND      238    243
FT   TURN        249    251
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40539 MW;  7443DC40CF7A38F5 CRC64;
     MRVTAPRTVL LLLSAALALT ETWAGSHSMR YFHTAMSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTWQ
     RMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAARVAEQD
     RAYLEGTCVE WLRRYLENGK DTLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B42_HUMAN              Reviewed;         362 AA.
AC   P30480; P79555;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=HLA class I histocompatibility antigen, B-42 alpha chain;
DE   AltName: Full=MHC class I antigen B*42;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*42:01).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*42:02).
RX   MEDLINE=97387746; PubMed=9243763;
RX   DOI=10.1111/j.1399-0039.1997.tb02841.x;
RA   Lardy N.M., Otting N., van de Weerd M.J., van de Horst A.R.,
RA   Waal L.P., Bontrop R.E.;
RT   "Full-length cDNA nucleotide sequence of the HLA-B*4202 allele.";
RL   Tissue Antigens 50:83-84(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*42:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-42 are known: B*42:01
CC       (Bw-42) and B*42:02. The sequence shown is that of B*42:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24034; AAA59667.1; -; Genomic_DNA.
DR   EMBL; U88407; AAC16437.1; -; mRNA.
DR   EMBL; AJ309194; CAC38393.1; -; Genomic_DNA.
DR   IPI; IPI00472676; -.
DR   PIR; I61865; I61865.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30480; -.
DR   SMR; P30480; 25-300.
DR   IntAct; P30480; 26.
DR   STRING; P30480; -.
DR   DMDM; 231403; -.
DR   PRIDE; P30480; -.
DR   Ensembl; ENST00000412585; ENSP00000399168; ENSG00000234745.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   HPA; CAB015418; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30480; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; REACT_6900; Immune System.
DR   Bgee; P30480; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30480; -.
DR   GermOnline; ENSG00000204523; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-42 alpha chain.
FT                                /FTId=PRO_0000018846.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056372.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056373.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056374.
FT   VARIANT      33     33       Y -> H (in allele B*42:02).
FT                                /FTId=VAR_016460.
FT   VARIANT      35     35       S -> A (in dbSNP:rs1131170).
FT                                /FTId=VAR_056375.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056376.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061417.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061418.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061419.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056377.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056378.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059480.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056379.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059481.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056380.
FT   VARIANT     137    137       H -> Y (in dbSNP:rs1050379).
FT                                /FTId=VAR_056381.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056382.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056383.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056384.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061420.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061421.
SQ   SEQUENCE   362 AA;  40333 MW;  C9155AB015DEA1BE CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTLQ
     SMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAARVAEQD
     RAYLEGTCVE WLRRYLENGK DTLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B44_HUMAN              Reviewed;         362 AA.
AC   P30481; P10320; P30482; P79524; Q29850; Q5RIP1; Q860I4; Q861B5;
AC   Q9BCM7; Q9MYC3; Q9UQS8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 110.
DE   RecName: Full=HLA class I histocompatibility antigen, B-44 alpha chain;
DE   AltName: Full=Bw-44;
DE   AltName: Full=MHC class I antigen B*44;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*44:02).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*44:03).
RX   MEDLINE=91335451; PubMed=1871765;
RX   DOI=10.1111/j.1399-0039.1991.tb01859.x;
RA   Fleischhauer K., Kernan N.A., Dupont B., Yang S.Y.;
RT   "The two major subtypes of HLA-B44 differ for a single amino acid in
RT   codon 156.";
RL   Tissue Antigens 37:133-137(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*44:03).
RX   MEDLINE=96435470; PubMed=8838356;
RX   DOI=10.1111/j.1399-0039.1995.tb03139.x;
RA   Adams E.J., Little A.-M., Arnett K.L., McAuley J.E., Williams R.C.,
RA   Parham P.;
RT   "Three new HLA-B alleles found in Mexican-Americans.";
RL   Tissue Antigens 46:414-416(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*44:07).
RX   MEDLINE=97004417; PubMed=8851728;
RX   DOI=10.1111/j.1399-0039.1996.tb02527.x;
RA   Vilches C., Sanz L., de Pablo R., Moreno M.E., Puente S., Kreisler M.;
RT   "Molecular characterization of the new alleles HLA-B*8101 and
RT   B*4407.";
RL   Tissue Antigens 47:139-142(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*44:08).
RX   MEDLINE=97387735; PubMed=9243752;
RX   DOI=10.1111/j.1399-0039.1997.tb02830.x;
RA   Darke C., Street J., Fussell H., Thomas M., Guttridge M.,
RA   Goldberg T.E., Arnett K.L., Parham P.;
RT   "A new HLA-B44 variant (B44BO [B*4408]) identified by serology.";
RL   Tissue Antigens 50:32-37(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*44:12).
RA   Cox S.T., McWhinnie A.J., Prokupek B., Madrigal A., Little A.-M.;
RT   "Further diversity within the HLA-B44 group: two novel alleles
RT   identified in UK Caucasoid potential bone marrow donors.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*44:13).
RX   MEDLINE=20208584; PubMed=10746795;
RX   DOI=10.1034/j.1399-0039.2000.550215.x;
RA   Cox S.T., McWhinnie A.J., Prokupek B., Madrigal A., Little A.-M.;
RT   "HLA-B*4413 identified in a UK Caucasoid potential bone marrow
RT   donor.";
RL   Tissue Antigens 55:185-187(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE (ALLELES B*44:02 AND B*44:09).
RA   Dunn P.P.J.;
RT   "Complete nucleotide sequencing of HLA class I genes.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*44:05).
RA   Vilches C., Sepulveda S.;
RT   "Complete cDNA sequence of HLA-B*4405.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*44:04).
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of HLA-B*4404.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-362 (ALLELE B*44:02).
RX   MEDLINE=86249389; PubMed=3459708; DOI=10.1007/BF00372673;
RA   Kottmann A.H., Seemann G.H.A., Guessow H.D., Roos M.H.;
RT   "DNA sequence of the coding region of the HLA-B44 gene.";
RL   Immunogenetics 23:396-400(1986).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-44 are known: B*44:02 (B-
CC       12; B44.2), B*44:04, B*44:05, B*44:07, B*44:08 (B44BO), B*44:09,
CC       B*44:12 and B*44:13. The sequence shown is that of B*44:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24038; AAA59663.1; -; Genomic_DNA.
DR   EMBL; X64366; CAA45718.1; -; mRNA.
DR   EMBL; L42282; AAB51454.1; -; Genomic_DNA.
DR   EMBL; L42283; AAB51455.1; -; Genomic_DNA.
DR   EMBL; X90391; CAA62036.1; -; mRNA.
DR   EMBL; U64801; AAB40632.1; -; mRNA.
DR   EMBL; AJ133267; CAB38071.2; -; Genomic_DNA.
DR   EMBL; AJ131118; CAB37868.1; -; mRNA.
DR   EMBL; AJ309936; CAC33891.1; -; Genomic_DNA.
DR   EMBL; AJ309937; CAC33892.1; -; Genomic_DNA.
DR   EMBL; AJ535113; CAD59381.1; -; mRNA.
DR   EMBL; AJ550735; CAD79566.1; -; Genomic_DNA.
DR   EMBL; BX248310; CAI18717.1; -; Genomic_DNA.
DR   EMBL; M15470; AAA59619.1; -; mRNA.
DR   IPI; IPI00743117; -.
DR   PIR; A25295; HLHUB4.
DR   PIR; I61861; I61861.
DR   PIR; S25415; S25415.
DR   UniGene; Hs.77961; -.
DR   PDB; 1M6O; X-ray; 1.60 A; A=25-300.
DR   PDB; 1SYS; X-ray; 2.40 A; A=25-300.
DR   PDB; 1SYV; X-ray; 1.70 A; A=25-300.
DR   PDB; 3DX6; X-ray; 1.70 A; A=25-300.
DR   PDB; 3DX7; X-ray; 1.60 A; A=25-300.
DR   PDB; 3DX8; X-ray; 2.10 A; A=25-300.
DR   PDB; 3DXA; X-ray; 3.50 A; A/F/K=25-300.
DR   PDB; 3KPL; X-ray; 1.96 A; A=25-300.
DR   PDB; 3KPM; X-ray; 1.60 A; A=25-300.
DR   PDB; 3KPN; X-ray; 2.00 A; A=25-300.
DR   PDB; 3KPO; X-ray; 2.30 A; A=25-300.
DR   PDB; 3KPP; X-ray; 1.90 A; A=25-300.
DR   PDB; 3KPQ; X-ray; 1.84 A; A=25-300.
DR   PDB; 3KPR; X-ray; 2.60 A; A/F=25-300.
DR   PDB; 3KPS; X-ray; 2.70 A; A=25-300.
DR   PDB; 3L3D; X-ray; 1.80 A; A=25-300.
DR   PDB; 3L3G; X-ray; 2.10 A; A=25-300.
DR   PDB; 3L3I; X-ray; 1.70 A; A=25-300.
DR   PDB; 3L3J; X-ray; 2.40 A; A=25-300.
DR   PDB; 3L3K; X-ray; 2.60 A; A=25-300.
DR   PDBsum; 1M6O; -.
DR   PDBsum; 1SYS; -.
DR   PDBsum; 1SYV; -.
DR   PDBsum; 3DX6; -.
DR   PDBsum; 3DX7; -.
DR   PDBsum; 3DX8; -.
DR   PDBsum; 3DXA; -.
DR   PDBsum; 3KPL; -.
DR   PDBsum; 3KPM; -.
DR   PDBsum; 3KPN; -.
DR   PDBsum; 3KPO; -.
DR   PDBsum; 3KPP; -.
DR   PDBsum; 3KPQ; -.
DR   PDBsum; 3KPR; -.
DR   PDBsum; 3KPS; -.
DR   PDBsum; 3L3D; -.
DR   PDBsum; 3L3G; -.
DR   PDBsum; 3L3I; -.
DR   PDBsum; 3L3J; -.
DR   PDBsum; 3L3K; -.
DR   ProteinModelPortal; P30481; -.
DR   SMR; P30481; 25-300.
DR   STRING; P30481; -.
DR   DMDM; 231404; -.
DR   PRIDE; P30481; -.
DR   Ensembl; ENST00000421349; ENSP00000405365; ENSG00000228964.
DR   UCSC; uc011jii.2; human.
DR   GeneCards; GC06M031321; -.
DR   H-InvDB; HIX0167415; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30481; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30481; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30481; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30481; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-44 alpha chain.
FT                                /FTId=PRO_0000018847.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      65     65       T -> A (in allele B*44:07 and allele
FT                                B*44:08).
FT                                /FTId=VAR_016461.
FT   VARIANT      69     70       KE -> MA (in allele B*44:08).
FT                                /FTId=VAR_016462.
FT   VARIANT      85     85       D -> E (in allele B*44:13).
FT                                /FTId=VAR_016463.
FT   VARIANT      87     87       E -> N (in allele B*44:12; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016464.
FT   VARIANT     101    101       N -> S (in allele B*44:09).
FT                                /FTId=VAR_016465.
FT   VARIANT     104    107       TALR -> NLRG (in allele B*44:09).
FT                                /FTId=VAR_016466.
FT   VARIANT     140    140       D -> Y (in allele B*44:05).
FT                                /FTId=VAR_016467.
FT   VARIANT     180    180       D -> L (in allele B*44:03, allele B*44:07
FT                                and allele B*44:13; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016468.
FT   VARIANT     180    180       D -> R (in allele B*44:04; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016469.
FT   VARIANT     187    187       L -> T (in allele B*44:04; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016470.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056385.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056386.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061422.
FT   CONFLICT    106    106       L -> A (in Ref. 12; AAA59619).
FT   CONFLICT    223    223       V -> A (in Ref. 12; AAA59619).
FT   CONFLICT    229    229       A -> S (in Ref. 12; AAA59619).
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    219
FT   STRAND      222    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      290    292
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40481 MW;  E45C71FDEFC628AD CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE NLRTALRYYN QSEAGSHIIQ
     RMYGCDVGPD GRLLRGYDQD AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQD
     RAYLEGLCVE SLRRYLENGK ETLQRADPPK THVTHHPISD HEVTLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B45_HUMAN              Reviewed;         362 AA.
AC   P30483; Q9GIZ0; Q9MX21;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 100.
DE   RecName: Full=HLA class I histocompatibility antigen, B-45 alpha chain;
DE   AltName: Full=Bw-45;
DE   AltName: Full=MHC class I antigen B*45;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*45:01).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*45:04).
RA   Carey K., Green A., Dunn P.P.;
RT   "The complete nucleotide sequence of a variant HLA-B*4501 allele.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*45:01).
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*45:03).
RX   MEDLINE=21108617; PubMed=11169261;
RX   DOI=10.1034/j.1399-0039.2001.057001070.x;
RA   Cox S.T., Mcwhinnie A.J., Koester R.P., Heine U., Holman R.,
RA   Madrigal A.J., Little A.-M.;
RT   "Further diversity at HLA-A and -B loci identified in Afro-Caribbean
RT   potential bone marrow donors.";
RL   Tissue Antigens 57:70-72(2001).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-45 are known: B*45:01 (B-
CC       12), B*45:03 and B*45:04. The sequence shown is that of B*45:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61710; CAA43879.1; -; mRNA.
DR   EMBL; AJ278944; CAC07211.1; -; Genomic_DNA.
DR   EMBL; AJ458992; CAD30340.1; -; Genomic_DNA.
DR   EMBL; AJ275937; CAB83041.1; -; Genomic_DNA.
DR   IPI; IPI00472416; -.
DR   PIR; I37519; I37519.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30483; -.
DR   SMR; P30483; 25-298.
DR   STRING; P30483; -.
DR   DMDM; 231406; -.
DR   PRIDE; P30483; -.
DR   Ensembl; ENST00000450871; ENSP00000388208; ENSG00000232126.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30483; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30483; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30483; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-45 alpha chain.
FT                                /FTId=PRO_0000018848.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056387.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056388.
FT   VARIANT     139    139       Q -> R (in allele B*45:03).
FT                                /FTId=VAR_016471.
FT   VARIANT     191    191       S -> W (in allele B*45:04).
FT                                /FTId=VAR_016472.
SQ   SEQUENCE   362 AA;  40414 MW;  A6C843121D613695 CRC64;
     MRVTAPRTVL LLLSAALALT ETWAGSHSMR YFHTAMSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTWQ
     RMYGCDLGPD GRLLRGYNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQD
     RAYLEGLCVE SLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B46_HUMAN              Reviewed;         362 AA.
AC   P30484; Q9TPR2;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 103.
DE   RecName: Full=HLA class I histocompatibility antigen, B-46 alpha chain;
DE   AltName: Full=Bw-46;
DE   AltName: Full=MHC class I antigen B*46;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*46:01).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*46:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*46:02).
RX   MEDLINE=20340078; PubMed=10885569;
RX   DOI=10.1034/j.1399-0039.2000.550511.x;
RA   Akesaka T., Kashiwase K., Shimamura M., Ishikawa Y., Tanaka H.,
RA   Fujii M., Akaza T., Honda K., Yuasa S., Takahashi T., Juji T.;
RT   "Identification of a novel HLA-B46 allele, B*4602, in Japanese.";
RL   Tissue Antigens 55:460-462(2000).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-46 are known: B*46:01 and
CC       B*46:02. The sequence shown is that of B*46:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24033; AAA59665.1; -; mRNA.
DR   EMBL; AJ310508; CAC34573.1; -; Genomic_DNA.
DR   EMBL; AB032091; BAA84111.1; -; Genomic_DNA.
DR   IPI; IPI00744375; -.
DR   PIR; I61863; I61863.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30484; -.
DR   SMR; P30484; 25-300.
DR   STRING; P30484; -.
DR   DMDM; 231407; -.
DR   PRIDE; P30484; -.
DR   Ensembl; ENST00000450871; ENSP00000388208; ENSG00000232126.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30484; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30484; -.
DR   GermOnline; ENSG00000204523; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-46 alpha chain.
FT                                /FTId=PRO_0000018849.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      98     98       D -> G (in allele B*46:02).
FT                                /FTId=VAR_016473.
SQ   SEQUENCE   362 AA;  40440 MW;  481B4C6876CB0E85 CRC64;
     MRVTAPRTVL LLLSGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRMA PRAPWIEQEG PEYWDRETQK YKRQAQTDRV SLRNLRGYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQW
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B47_HUMAN              Reviewed;         362 AA.
AC   P30485; O19555; O77933; Q95392; Q9GIL3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 95.
DE   RecName: Full=HLA class I histocompatibility antigen, B-47 alpha chain;
DE   AltName: Full=Bw-47;
DE   AltName: Full=MHC class I antigen B*47;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*47:01).
RX   MEDLINE=88152906; PubMed=3257938; DOI=10.1007/BF00376123;
RA   Zemmour J., Ennis P.D., Parham P., Dupont B.;
RT   "Comparison of the structure of HLA-Bw47 to HLA-B13 and its
RT   relationship to 21-hydroxylase deficiency.";
RL   Immunogenetics 27:281-287(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*47:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-302 (ALLELE B*47:02).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=97316881; PubMed=9174155;
RX   DOI=10.1111/j.1399-0039.1997.tb02797.x;
RA   Fischer G.F., Broer E., Fae I., Leitner D., Mayr W.R.;
RT   "Nucleotide sequence analysis of an HLA-B47 variant (HLA-B*4702).";
RL   Tissue Antigens 49:540-542(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*47:03).
RX   MEDLINE=20548605; PubMed=11098929;
RX   DOI=10.1034/j.1399-0039.2000.560401.x;
RA   Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H.,
RA   Hurley C.K.;
RT   "Diversity is demonstrated in class I HLA-A and HLA-B alleles in
RT   Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-
RT   B*1403, *4016, *4703.";
RL   Tissue Antigens 56:291-302(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*47:03).
RA   Kosman C.A., Hurley C.K.;
RT   "Novel HLA class I B locus alleles.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-47 are known: B*47:01,
CC       B*47:02 and B*47:03. The sequence shown is that of B*47:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M19756; AAA52664.1; -; Genomic_DNA.
DR   EMBL; AJ308398; CAC33087.2; -; Genomic_DNA.
DR   EMBL; AJ295141; CAC17463.2; -; Genomic_DNA.
DR   EMBL; Y09118; CAA70335.1; -; mRNA.
DR   EMBL; AF016843; AAB70513.1; -; Genomic_DNA.
DR   EMBL; AF016842; AAB70513.1; JOINED; Genomic_DNA.
DR   EMBL; AF071764; AAC23752.1; -; Genomic_DNA.
DR   EMBL; AF071763; AAC23752.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472402; -.
DR   PIR; I68724; I68724.
DR   ProteinModelPortal; P30485; -.
DR   SMR; P30485; 25-300.
DR   STRING; P30485; -.
DR   DMDM; 231408; -.
DR   PRIDE; P30485; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30485; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30485; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30485; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-47 alpha chain.
FT                                /FTId=PRO_0000018850.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT     101    101       D -> S (in allele B*47:02 and allele
FT                                B*47:03; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016474.
FT   VARIANT     104    104       T -> N (in allele B*47:02 and allele
FT                                B*47:03).
FT                                /FTId=VAR_016475.
FT   VARIANT     106    107       LR -> RG (in allele B*47:02).
FT                                /FTId=VAR_016476.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056389.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056390.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061424.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061425.
SQ   SEQUENCE   362 AA;  40571 MW;  E3D3E4CBF8C15EAE CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE DLRTLLRYYN QSEAGSHTLQ
     RMFGCDVGPD GRLLRGYHQD AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGECVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV VCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B48_HUMAN              Reviewed;         362 AA.
AC   P30486; Q29764;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 102.
DE   RecName: Full=HLA class I histocompatibility antigen, B-48 alpha chain;
DE   AltName: Full=Bw-48;
DE   AltName: Full=MHC class I antigen B*48;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*48:01).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*48:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-206 (ALLELE B*48:03).
RX   MEDLINE=99299758; PubMed=10372543;
RX   DOI=10.1034/j.1399-0039.1999.530504.x;
RA   Marcos C.Y., Fernandez-Vina M.A., Lazaro A.M., Moraes M.E.,
RA   Moraes J.R., Stastny P.;
RT   "Novel HLA-A and HLA-B alleles in South American Indians.";
RL   Tissue Antigens 53:476-485(1999).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-48 are known: B*48:01 and
CC       B*48:03. The sequence shown is that of B*48:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84380; AAA59629.1; -; mRNA.
DR   EMBL; AJ309139; CAC38066.1; -; Genomic_DNA.
DR   EMBL; L76931; AAB59617.1; -; mRNA.
DR   IPI; IPI00472057; -.
DR   PIR; I61903; I61903.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30486; -.
DR   SMR; P30486; 25-300.
DR   STRING; P30486; -.
DR   DMDM; 231409; -.
DR   PRIDE; P30486; -.
DR   Ensembl; ENST00000412585; ENSP00000399168; ENSG00000234745.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   HPA; CAB015418; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30486; -.
DR   HOVERGEN; HBG016709; -.
DR   Bgee; P30486; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30486; -.
DR   GermOnline; ENSG00000204523; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-48 alpha chain.
FT                                /FTId=PRO_0000018851.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056391.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056392.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056393.
FT   VARIANT      35     35       S -> A (in dbSNP:rs1131170).
FT                                /FTId=VAR_056394.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056395.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061426.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061427.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061428.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056396.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056397.
FT   VARIANT     121    121       S -> R (in allele B*48:03).
FT                                /FTId=VAR_016477.
FT   VARIANT     137    137       H -> Y (in dbSNP:rs1050379).
FT                                /FTId=VAR_056398.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056399.
FT   VARIANT     187    187       E -> A (in dbSNP:rs2308466).
FT                                /FTId=VAR_059482.
FT   VARIANT     187    187       E -> G (in dbSNP:rs2308466).
FT                                /FTId=VAR_059483.
FT   VARIANT     187    187       E -> K (in dbSNP:rs2523600).
FT                                /FTId=VAR_059484.
FT   VARIANT     187    187       E -> Q (in dbSNP:rs2523600).
FT                                /FTId=VAR_059485.
FT   VARIANT     187    187       E -> V (in dbSNP:rs2308466).
FT                                /FTId=VAR_059486.
FT   VARIANT     195    195       Y -> H (in dbSNP:rs1050696).
FT                                /FTId=VAR_056400.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056401.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056402.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061429.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061430.
SQ   SEQUENCE   362 AA;  40362 MW;  8FADC7B64EBD5C8D CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTLQ
     SMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLRSWTAA DTAAQISQRK LEAARVAEQL
     RAYLEGECVE WLRRYLENGK DKLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWTA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B49_HUMAN              Reviewed;         362 AA.
AC   P30487; O19625; Q9MY37; Q9MY93;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   18-APR-2012, entry version 100.
DE   RecName: Full=HLA class I histocompatibility antigen, B-49 alpha chain;
DE   AltName: Full=HLA class I histocompatibility antigen, B-21 alpha chain;
DE   AltName: Full=MHC class I antigen B*49;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*49:01).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   SEQUENCE REVISION TO 78.
RX   MEDLINE=93056529; PubMed=1385528;
RA   Hildebrand W.H., Madrigal J.A., Belich M.P., Zemmour J., Ward F.E.,
RA   Williams R.C., Parham P.;
RT   "Serologic cross-reactivities poorly reflect allelic relationships in
RT   the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2
RT   helix.";
RL   J. Immunol. 149:3563-3568(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 1-322 (ALLELE B*49:01).
RA   Hurley C.K., Bei M., Rodriguez S., Johnson A.;
RL   Submitted (JUN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*49:02).
RA   Gans C.P., Hurley C.K.;
RT   "Novel HLA-B Allele.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*49:03).
RX   MEDLINE=21442088; PubMed=11556975;
RX   DOI=10.1034/j.1399-0039.2001.057005478.x;
RA   Darke C., Street J., Guttridge M.G.;
RT   "Sequence, genetics and serology of a new HLA-B allele: B*4903.";
RL   Tissue Antigens 57:478-480(2001).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-49 are known: B*49:01,
CC       B*49:02 and B*49:03 (B*RA). The sequence shown is that of B*49:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24037; AAA02950.1; -; mRNA.
DR   EMBL; U11263; AAA19923.1; -; mRNA.
DR   EMBL; AF262959; AAF78054.1; -; Genomic_DNA.
DR   EMBL; AF262958; AAF78054.1; JOINED; Genomic_DNA.
DR   EMBL; AJ288980; CAB88084.1; -; Genomic_DNA.
DR   IPI; IPI00472456; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30487; -.
DR   SMR; P30487; 25-300.
DR   STRING; P30487; -.
DR   DMDM; 1345599; -.
DR   PRIDE; P30487; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; GC06M031321; -.
DR   H-InvDB; HIX0166654; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30487; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30487; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30487; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-49 alpha chain.
FT                                /FTId=PRO_0000018852.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056403.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056404.
FT   VARIANT      48     48       T -> A (in allele B*49:03).
FT                                /FTId=VAR_016512.
FT   VARIANT      56     56       L -> Q (in allele B*49:03).
FT                                /FTId=VAR_016513.
FT   VARIANT      65     65       T -> A (in allele B*49:03).
FT                                /FTId=VAR_016514.
FT   VARIANT      69     69       K -> T (in allele B*49:03).
FT                                /FTId=VAR_016515.
FT   VARIANT     104    104       I -> T (in allele B*49:02).
FT                                /FTId=VAR_016516.
SQ   SEQUENCE   362 AA;  40581 MW;  77B1C82AD3DAEB4A CRC64;
     MRVTAPRTVL LLLSAALALT ETWAGSHSMR YFHTAMSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE NLRIALRYYN QSEAGSHTWQ
     RMYGCDLGPD GRLLRGYNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B50_HUMAN              Reviewed;         362 AA.
AC   P30488; O19615; O19624; O19641; O19783; O46702; O78172; Q9TQG1;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 99.
DE   RecName: Full=HLA class I histocompatibility antigen, B-50 alpha chain;
DE   AltName: Full=Bw-50;
DE   AltName: Full=HLA class I histocompatibility antigen, B-21 alpha chain;
DE   AltName: Full=MHC class I antigen B*50;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*50:01).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 1-322 (ALLELE B*50:01).
RA   Hurley C.K., Bei M., Rodriguez S., Johnson A.;
RT   "HLA-B71.";
RL   Submitted (JUN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*50:01).
RA   Ando H., Mizuki N., Ohno S., Inoko H.;
RT   "Identification of new HLA-B alleles among Greek population.";
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*50:02).
RX   MEDLINE=97387736; PubMed=9243753;
RX   DOI=10.1111/j.1399-0039.1997.tb02831.x;
RA   Vilches C., Bunce M., de Pablo R., Murray A.K., McIntyre C.A.,
RA   Kreisler M.;
RT   "Complete coding regions of two novel HLA-B alleles detected by
RT   phototyping (PCR-SSP) in the British Caucasoid population: B*5108 and
RT   B*5002.";
RL   Tissue Antigens 50:38-41(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*50:02).
RA   Balas A., Santos S., Vicario J.L.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*50:02).
RC   TISSUE=Blood;
RX   MEDLINE=98357735; PubMed=9694362;
RX   DOI=10.1111/j.1399-0039.1998.tb03012.x;
RA   Darke C., Guttridge M.G., Thompson J., Street J., Thomas M.;
RT   "Molecular, serological and population studies on a novel HLA-B allele
RT   -- HLA-B*5002.";
RL   Tissue Antigens 51:666-670(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*50:02).
RC   TISSUE=Blood;
RA   Gao X., Matheson B.;
RT   "A novel hla-b50 variant found in an Australian Caucasoid donor.";
RL   Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*50:02).
RA   Steiner N.K., Hurley C.K.;
RT   "Novel HLA-B alleles.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*50:04).
RX   MEDLINE=21442089; PubMed=11556976;
RX   DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-50 are known: B*50:01,
CC       B*50:02 (B*45ZJ; B50IM) and B*50:04. The sequence shown is that of
CC       B*50:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61706; CAA43875.1; -; mRNA.
DR   EMBL; U11261; AAA19921.1; -; mRNA.
DR   EMBL; D50693; BAA23588.1; -; Genomic_DNA.
DR   EMBL; Y08995; CAA70199.1; -; mRNA.
DR   EMBL; AF006634; AAD01274.1; -; mRNA.
DR   EMBL; Y14205; CAA74596.1; -; Genomic_DNA.
DR   EMBL; U58318; AAB87724.1; -; Genomic_DNA.
DR   EMBL; U58317; AAB87724.1; JOINED; Genomic_DNA.
DR   EMBL; AF008927; AAB63511.1; -; Genomic_DNA.
DR   EMBL; AF008926; AAB63511.1; JOINED; Genomic_DNA.
DR   EMBL; AF136398; AAD34474.1; -; Genomic_DNA.
DR   EMBL; AF136397; AAD34474.1; JOINED; Genomic_DNA.
DR   IPI; IPI00471955; -.
DR   PIR; I37520; I37520.
DR   ProteinModelPortal; P30488; -.
DR   SMR; P30488; 25-298.
DR   STRING; P30488; -.
DR   DMDM; 231411; -.
DR   PRIDE; P30488; -.
DR   Ensembl; ENST00000450871; ENSP00000388208; ENSG00000232126.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30488; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30488; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30488; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-50 alpha chain.
FT                                /FTId=PRO_0000018853.
FT   TOPO_DOM     25    309       Extracellular (Potential).
FT   TRANSMEM    310    333       Helical; (Potential).
FT   TOPO_DOM    334    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056405.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056406.
FT   VARIANT     127    127       L -> V (in allele B*50:04).
FT                                /FTId=VAR_016517.
FT   VARIANT     191    191       W -> S (in allele B*50:02).
FT                                /FTId=VAR_016518.
SQ   SEQUENCE   362 AA;  40541 MW;  729B0736F81C4AB4 CRC64;
     MRVTAPRTVL LLLSAALALT ETWAGSHSMR YFHTAMSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTWQ
     RMYGCDLGPD GRLLRGYNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B51_HUMAN              Reviewed;         362 AA.
AC   P18464; O19675; O78173; P30489; Q29851; Q29857; Q96IT9; Q9MY43;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   18-APR-2012, entry version 117.
DE   RecName: Full=HLA class I histocompatibility antigen, B-51 alpha chain;
DE   AltName: Full=MHC class I antigen B*51;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*51:01).
RX   MEDLINE=90207291; PubMed=2320591; DOI=10.1073/pnas.87.7.2833;
RA   Ennis P.D., Zemmour J., Salter R.D., Parham P.;
RT   "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction:
RT   frequency and nature of errors produced in amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*51:01).
RX   MEDLINE=89080265; PubMed=2909619;
RA   Hayashi H., Ennis P.D., Ariga H., Salter R.D., Parham P., Kano K.,
RA   Takiguchi M.;
RT   "HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the
RT   helical region of the alpha 1 domain.";
RL   J. Immunol. 142:306-311(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*51:01).
RX   MEDLINE=89233295; PubMed=2714852; DOI=10.1007/BF00352839;
RA   Pohla H., Kuon W., Tabaczewski P., Doerner C., Weiss E.H.;
RT   "Allelic variation in HLA-B and HLA-C sequences and the evolution of
RT   the HLA-B alleles.";
RL   Immunogenetics 29:297-307(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*51:04).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*51:03).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=94069479; PubMed=8248893;
RX   DOI=10.1111/j.1399-0039.1993.tb02164.x;
RA   Kawaguchi G., Nakayama S., Nagao T., Takiguchi M.;
RT   "A single amino acid substitution at residue 167 forms a novel HLA-B51
RT   subtype.";
RL   Tissue Antigens 42:39-41(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*51:02).
RX   MEDLINE=97083138; PubMed=8929712;
RX   DOI=10.1111/j.1399-0039.1996.tb02513.x;
RA   Prilliman K., Steiner N.K., Ellexson M., Stewart D., Lau M.,
RA   Terasaki P., Hurley C.K., Hildebrand W.H.;
RT   "Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the
RT   HLA-B5 family.";
RL   Tissue Antigens 47:49-57(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*51:08).
RX   MEDLINE=97387736; PubMed=9243753;
RX   DOI=10.1111/j.1399-0039.1997.tb02831.x;
RA   Vilches C., Bunce M., de Pablo R., Murray A.K., McIntyre C.A.,
RA   Kreisler M.;
RT   "Complete coding regions of two novel HLA-B alleles detected by
RT   phototyping (PCR-SSP) in the British Caucasoid population: B*5108 and
RT   B*5002.";
RL   Tissue Antigens 50:38-41(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*51:01).
RX   MEDLINE=21553639; PubMed=11696219;
RX   DOI=10.1034/j.1399-0039.2001.580202.x;
RA   Sano K., Yabuki K., Imagawa Y., Shiina T., Mizuki N., Ohno S.,
RA   Kulski J.K., Inoko H.;
RT   "The absence of disease-specific polymorphisms within the HLA-B51 gene
RT   that is the susceptible locus for Behcet's disease.";
RL   Tissue Antigens 58:77-82(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*51:01).
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-206 (ALLELE B*51:01).
RX   MEDLINE=95176330; PubMed=7871529;
RX   DOI=10.1111/j.1399-0039.1994.tb02394.x;
RA   Steinle A., Schendel D.J.;
RT   "HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).";
RL   Tissue Antigens 44:268-270(1994).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-362 (ALLELE B*51:01).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*51:24).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=21466687; PubMed=11580855;
RX   DOI=10.1034/j.1399-0039.2001.580107.x;
RA   Anholts J.D.H., Kemps-Mols B., Verduijn W., Oudshoorn M.,
RA   Schreuder G.M.T.;
RT   "Three newly identified HLA-B alleles: B*5124, B*5306, B*5307 and
RT   confirmation of B*0809 and B*5606.";
RL   Tissue Antigens 58:38-41(2001).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 25-300 (B*51:01).
RX   MEDLINE=20432310; PubMed=10975842;
RA   Maenaka K., Maenaka T., Tomiyama H., Takiguchi M., Stuart D.I.,
RA   Jones E.Y.;
RT   "Nonstandard peptide binding revealed by crystal structures of HLA-
RT   B*5101 complexed with HIV immunodominant epitopes.";
RL   J. Immunol. 165:3260-3267(2000).
RN   [14]
RP   INVOLVEMENT IN BEHCET DISEASE.
RX   PubMed=15063364; DOI=10.1016/j.coph.2003.10.009;
RA   Arayssi T., Hamdan A.;
RT   "New insights into the pathogenesis and therapy of Behcet's disease.";
RL   Curr. Opin. Pharmacol. 4:183-188(2004).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-51 are known: B*51:01,
CC       B*51:03, B*51:04, B*51:08 and B*51:24. The sequence shown is that
CC       of B*51:01.
CC   -!- MISCELLANEOUS: There is evidence that HLA-B51 is associated with
CC       susceptibility to Behcet disease. However, it is not certain
CC       whether HLA-B51 itself or a closely linked gene is responsible for
CC       susceptibility. The world distribution of HLA-B51 in healthy
CC       people corresponds to the global distribution of Behcet disease;
CC       in Southern hemisphere countries (Africa, South Pacific, etc.) and
CC       in some parts of Europe, the prevalence of HLA-B51 in healthy
CC       people is low or null, corresponding to a low prevalence of Behcet
CC       disease. The wide variation that exists in the relative risk of
CC       HLA-B51 would support other nongenetic risk factors.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32319; AAA36232.1; -; mRNA.
DR   EMBL; M22792; AAA59620.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M22786; AAA59620.1; JOINED; Genomic_DNA.
DR   EMBL; M22787; AAA59620.1; JOINED; Genomic_DNA.
DR   EMBL; M22788; AAA59620.1; JOINED; Genomic_DNA.
DR   EMBL; M22789; AAA59620.1; JOINED; Genomic_DNA.
DR   EMBL; M22790; AAA59620.1; JOINED; Genomic_DNA.
DR   EMBL; M22791; AAA59620.1; JOINED; Genomic_DNA.
DR   EMBL; L41087; AAA64513.1; -; Genomic_DNA.
DR   EMBL; L41086; AAA64513.1; JOINED; Genomic_DNA.
DR   EMBL; Z15143; CAA78849.1; -; mRNA.
DR   EMBL; M80670; AAA52661.1; -; Genomic_DNA.
DR   EMBL; L41925; AAC41979.1; -; mRNA.
DR   EMBL; Y08994; CAA70198.1; -; mRNA.
DR   EMBL; AB056860; BAB64902.1; -; Genomic_DNA.
DR   EMBL; AB056862; BAB64904.1; -; Genomic_DNA.
DR   EMBL; AB056863; BAB64905.1; -; Genomic_DNA.
DR   EMBL; AB056864; BAB64906.1; -; Genomic_DNA.
DR   EMBL; AB056865; BAB64907.1; -; Genomic_DNA.
DR   EMBL; AJ278903; CAC05371.1; -; Genomic_DNA.
DR   EMBL; BC007243; AAH07243.1; -; mRNA.
DR   EMBL; AJ276995; CAB86196.1; -; Genomic_DNA.
DR   EMBL; Z46808; CAA86838.1; -; mRNA.
DR   IPI; IPI00718924; -.
DR   PIR; A30345; A30345.
DR   PIR; I37120; I37120.
DR   UniGene; Hs.77961; -.
DR   PDB; 1E27; X-ray; 2.20 A; A=25-300.
DR   PDB; 1E28; X-ray; 3.00 A; A=25-300.
DR   PDBsum; 1E27; -.
DR   PDBsum; 1E28; -.
DR   ProteinModelPortal; P18464; -.
DR   SMR; P18464; 25-300.
DR   DIP; DIP-6150N; -.
DR   MINT; MINT-144207; -.
DR   STRING; P18464; -.
DR   DMDM; 122172; -.
DR   PRIDE; P18464; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   H-InvDB; HIX0005715; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P18464; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P18464; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P18464; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P18464; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-51 alpha chain.
FT                                /FTId=PRO_0000018854.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT     118    121       TWQT -> IIQR (in allele B*51:04).
FT                                /FTId=VAR_016478.
FT   VARIANT     155    155       S -> R (in allele B*51:24).
FT                                /FTId=VAR_017442.
FT   VARIANT     176    176       E -> V (in allele B*51:08).
FT                                /FTId=VAR_016479.
FT   VARIANT     180    180       L -> D (in allele B*51:08; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016480.
FT   VARIANT     191    191       W -> G (in allele B*51:03).
FT                                /FTId=VAR_016481.
FT   VARIANT     195    195       H -> Y (in allele B*51:02).
FT                                /FTId=VAR_016482.
FT   STRAND       27     36
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     78
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      252    254
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      290    292
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40566 MW;  D104163B4CC71F92 CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRNTQI FKTNTQTYRE NLRIALRYYN QSEAGSHTWQ
     TMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRHLENGK ETLQRADPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B52_HUMAN              Reviewed;         362 AA.
AC   P30490; Q9MY75; Q9TPT4;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=HLA class I histocompatibility antigen, B-52 alpha chain;
DE   AltName: Full=Bw-52;
DE   AltName: Full=HLA class I histocompatibility antigen, B-5 alpha chain;
DE   AltName: Full=MHC class I antigen B*52;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*52:01).
RX   MEDLINE=89080265; PubMed=2909619;
RA   Hayashi H., Ennis P.D., Ariga H., Salter R.D., Parham P., Kano K.,
RA   Takiguchi M.;
RT   "HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the
RT   helical region of the alpha 1 domain.";
RL   J. Immunol. 142:306-311(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*52:02).
RA   Jones P.F., Hurley C.K.;
RT   "Novel HLA-B allele.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*52:03).
RA   Gans C.P., Hurley C.K.;
RT   "Novel HLA-B allele.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-52 are known: B*52:01,
CC       B*52:02 (B*52012V) and B*52:03. The sequence shown is that of
CC       B*52:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22799; AAA59645.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M22793; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22794; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22795; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22796; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22797; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22798; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; AF181845; AAF00933.1; -; Genomic_DNA.
DR   EMBL; AF181844; AAF00933.1; JOINED; Genomic_DNA.
DR   EMBL; AF281153; AAF81610.1; -; Genomic_DNA.
DR   EMBL; AF281152; AAF81610.1; JOINED; Genomic_DNA.
DR   IPI; IPI00744689; -.
DR   PIR; B30345; B30345.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30490; -.
DR   SMR; P30490; 25-300.
DR   STRING; P30490; -.
DR   DMDM; 231413; -.
DR   PRIDE; P30490; -.
DR   Ensembl; ENST00000450871; ENSP00000388208; ENSG00000232126.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30490; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30490; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30490; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-52 alpha chain.
FT                                /FTId=PRO_0000018855.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      69     70       TE -> MA (in allele B*52:02).
FT                                /FTId=VAR_016521.
FT   VARIANT     176    176       E -> V (in allele B*52:03).
FT                                /FTId=VAR_016522.
FT   VARIANT     195    195       H -> Y (in allele B*52:03).
FT                                /FTId=VAR_016523.
SQ   SEQUENCE   362 AA;  40521 MW;  A32E36370FD84F91 CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE NLRIALRYYN QSEAGSHTWQ
     TMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRHLENGK ETLQRADPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B53_HUMAN              Reviewed;         362 AA.
AC   P30491; O78053; O78138; Q30198; Q5TK76; Q9BD43; Q9GJF0; Q9MY42;
AC   Q9TP36; Q9TQH8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=HLA class I histocompatibility antigen, B-53 alpha chain;
DE   AltName: Full=Bw-53;
DE   AltName: Full=MHC class I antigen B*53;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*53:01).
RX   MEDLINE=91033941; PubMed=1699887; DOI=10.1007/BF02114973;
RA   Hayashi H., Ooba T., Nakayama S., Sekimata M., Kano K., Takiguchi M.;
RT   "Allospecificities between HLA-Bw53 and HLA-B35 are generated by
RT   substitution of the residues associated with HLA-Bw4/Bw6 public
RT   epitopes.";
RL   Immunogenetics 32:195-199(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 5-206 (ALLELE B*53:01).
RC   TISSUE=Blood;
RX   MEDLINE=98025078; PubMed=9321426; DOI=10.1007/s002510050307;
RA   Gomez-Casado E., Vargas-Alarcon G., Martinez-Laso J., Perez-Blas M.,
RA   Granados J., Layrisse Z., Montoya F., Varela P., Arnaiz-Villena A.;
RT   "Generation of the HLA-B35, -B5, -B16, and B15 groups of alleles
RT   studied by intron 1 and 2 sequence analysis.";
RL   Immunogenetics 46:469-476(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of HLA-B*5301.";
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*53:02).
RA   Hurley C.K., Hoyer R.J.;
RT   "Human MHC class I antigen HLA-B*5302.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*53:03 AND
RP   B*53:05).
RX   MEDLINE=21442089; PubMed=11556976;
RX   DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*53:04).
RX   MEDLINE=20236861; PubMed=10777103;
RX   DOI=10.1034/j.1399-0039.2000.550311.x;
RA   Kennedy C.T., Dodd R., Le T., Wallace R., Ng G., Greville W.D.,
RA   Kennedy A., Taverniti A., Moses J.H., Clow N., Watson N., Dunckley H.;
RT   "Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides
RT   (PCR-SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529,
RT   B*3532, B*4025, B*5304 and B*5508.";
RL   Tissue Antigens 55:266-270(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*53:05).
RA   Tait B., Holdsworth R., Cantwell L., Boyle A., Diviney M.;
RT   "Confirmatory B*5305 sequence.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*53:06 AND
RP   B*53:07).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=21466687; PubMed=11580855;
RX   DOI=10.1034/j.1399-0039.2001.580107.x;
RA   Anholts J.D.H., Kemps-Mols B., Verduijn W., Oudshoorn M.,
RA   Schreuder G.M.T.;
RT   "Three newly identified HLA-B alleles: B*5124, B*5306, B*5307 and
RT   confirmation of B*0809 and B*5606.";
RL   Tissue Antigens 58:38-41(2001).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 25-302.
RX   MEDLINE=96209672; PubMed=8624812; DOI=10.1016/S1074-7613(00)80430-6;
RA   Smith K.J., Reid S.W., Harlos K., McMichael A.J., Stuart D.I.,
RA   Bell J.I., Jones E.Y.;
RT   "Bound water structure and polymorphic amino acids act together to
RT   allow the binding of different peptides to MHC class I HLA-B53.";
RL   Immunity 4:215-228(1996).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-53 are known: B*53:01,
CC       B*53:02, B*53:03, B*53:04, B*53:05, B*53:06 and B*53:07. The
CC       sequence shown is that of B*53:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M58636; AAA36228.1; -; Genomic_DNA.
DR   EMBL; U90566; AAB96793.1; -; Genomic_DNA.
DR   EMBL; AJ311599; CAC35317.1; -; Genomic_DNA.
DR   EMBL; U63562; AAB05926.1; -; Genomic_DNA.
DR   EMBL; U63561; AAB05926.1; JOINED; Genomic_DNA.
DR   EMBL; AF071770; AAC35939.1; -; Genomic_DNA.
DR   EMBL; AF071769; AAC35939.1; JOINED; Genomic_DNA.
DR   EMBL; AF198653; AAF20814.1; -; Genomic_DNA.
DR   EMBL; AF198652; AAF20814.1; JOINED; Genomic_DNA.
DR   EMBL; AF117773; AAD23461.1; -; Genomic_DNA.
DR   EMBL; AF117772; AAD23461.1; JOINED; Genomic_DNA.
DR   EMBL; AF304003; AAG53942.1; -; Genomic_DNA.
DR   EMBL; AF304002; AAG53942.1; JOINED; Genomic_DNA.
DR   EMBL; AJ276996; CAB86197.1; -; Genomic_DNA.
DR   EMBL; AJ293856; CAC05305.1; -; Genomic_DNA.
DR   EMBL; AJ293857; CAC05305.1; JOINED; Genomic_DNA.
DR   IPI; IPI00655604; -.
DR   PIR; A45834; A45834.
DR   UniGene; Hs.77961; -.
DR   PDB; 1A1M; X-ray; 2.30 A; A=25-300.
DR   PDB; 1A1O; X-ray; 2.30 A; A=25-300.
DR   PDBsum; 1A1M; -.
DR   PDBsum; 1A1O; -.
DR   ProteinModelPortal; P30491; -.
DR   SMR; P30491; 25-300.
DR   DIP; DIP-6054N; -.
DR   STRING; P30491; -.
DR   DMDM; 231414; -.
DR   PRIDE; P30491; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30491; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30491; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30491; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30491; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-53 alpha chain.
FT                                /FTId=PRO_0000018856.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT     101    101       N -> D (in allele B*53:03).
FT                                /FTId=VAR_016524.
FT   VARIANT     101    101       N -> S (in allele B*53:05).
FT                                /FTId=VAR_016525.
FT   VARIANT     104    105       IA -> TL (in allele B*53:03).
FT                                /FTId=VAR_016526.
FT   VARIANT     118    118       I -> T (in allele B*53:07).
FT                                /FTId=VAR_016527.
FT   VARIANT     123    123       Y -> S (in allele B*53:07).
FT                                /FTId=VAR_016528.
FT   VARIANT     127    127       L -> V (in allele B*53:07).
FT                                /FTId=VAR_016529.
FT   VARIANT     137    138       HD -> YN (in allele B*53:07).
FT                                /FTId=VAR_016530.
FT   VARIANT     140    140       S -> F (in allele B*53:04 and allele
FT                                B*53:07).
FT                                /FTId=VAR_016531.
FT   VARIANT     176    176       V -> E (in allele B*53:06).
FT                                /FTId=VAR_016532.
FT   VARIANT     195    195       Y -> H (in allele B*53:02 and allele
FT                                B*53:06).
FT                                /FTId=VAR_016533.
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      131    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    172
FT   TURN        173    175
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   TURN        249    251
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      290    292
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40495 MW;  57BAA748D7854658 CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRNTQI FKTNTQTYRE NLRIALRYYN QSEAGSHIIQ
     RMYGCDLGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B54_HUMAN              Reviewed;         362 AA.
AC   P30492; Q9TPQ9;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=HLA class I histocompatibility antigen, B-54 alpha chain;
DE   AltName: Full=Bw-22;
DE   AltName: Full=Bw-54;
DE   AltName: Full=MHC class I antigen B*54;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*54:01).
RX   MEDLINE=92148136; PubMed=1737933;
RA   Hildebrand W.H., Madrigal J.A., Little A.-M., Parham P.;
RT   "HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha
RT   1-helix.";
RL   J. Immunol. 148:1155-1162(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*54:02).
RA   Juji T., Akesaka T., Kashiwase K., Ishikawa Y.;
RT   "HLA-B5401V1.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-54 are known: B*54:01 and
CC       B*54:02 (B5401V). The sequence shown is that of B*54:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M77774; AAA03686.1; -; mRNA.
DR   EMBL; AB032095; BAA84114.1; -; Genomic_DNA.
DR   IPI; IPI00472282; -.
DR   PIR; I56130; I56130.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30492; -.
DR   SMR; P30492; 25-300.
DR   STRING; P30492; -.
DR   DMDM; 231415; -.
DR   PRIDE; P30492; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30492; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30492; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30492; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-54 alpha chain.
FT                                /FTId=PRO_0000018857.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      33     33       Y -> H (in allele B*54:02).
FT                                /FTId=VAR_016534.
FT   VARIANT      35     36       AM -> SV (in allele B*54:02).
FT                                /FTId=VAR_016535.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056407.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059487.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056408.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059488.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056409.
SQ   SEQUENCE   362 AA;  40380 MW;  111730024578515D CRC64;
     MRVTAPRTLL LLLWGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTWQ
     TMYGCDLGPD GRLLRGHNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B55_HUMAN              Reviewed;         362 AA.
AC   P30493; O78163; P30494; P79489; P79523; Q8MGQ3; Q9GIZ9; Q9GJ00;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 102.
DE   RecName: Full=HLA class I histocompatibility antigen, B-55 alpha chain;
DE   AltName: Full=Bw-55;
DE   AltName: Full=HLA class I histocompatibility antigen, B-12 alpha chain;
DE   AltName: Full=MHC class I antigen B*55;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB; ORFNames=CDABP0067;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*55:01 AND B*55:02).
RX   MEDLINE=92148136; PubMed=1737933;
RA   Hildebrand W.H., Madrigal J.A., Little A.-M., Parham P.;
RT   "HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha
RT   1-helix.";
RL   J. Immunol. 148:1155-1162(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE B*55:01).
RC   TISSUE=Leukemia;
RA   Zhou J., Yu W., Tang H., Mei G., Tsang Y.T.M., Bouck J., Gibbs R.A.,
RA   Margolin J.F.;
RT   "Pediatric leukemia cDNA sequencing project.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELES B*55:01 AND B*55:12).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*55:04).
RC   TISSUE=Blood;
RX   MEDLINE=97295817; PubMed=9151389;
RX   DOI=10.1111/j.1399-0039.1997.tb02765.x;
RA   Bannai M., Tokunaga K., Tanaka H., Lin L., Kashiwase K., Tokunaga K.,
RA   Juji T.;
RT   "Five HLA-B22 group alleles in Japanese.";
RL   Tissue Antigens 49:376-382(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*55:05).
RX   MEDLINE=97316880; PubMed=9174154;
RX   DOI=10.1111/j.1399-0039.1997.tb02796.x;
RA   Szmania S., Seurynck K., Baxter-Lowe L.A.;
RT   "Nucleotide sequence of HLA-B*5505, which expresses a unique HLA class
RT   I polymorphism.";
RL   Tissue Antigens 49:537-539(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*55:08).
RX   MEDLINE=20236861; PubMed=10777103;
RX   DOI=10.1034/j.1399-0039.2000.550311.x;
RA   Kennedy C.T., Dodd R., Le T., Wallace R., Ng G., Greville W.D.,
RA   Kennedy A., Taverniti A., Moses J.H., Clow N., Watson N., Dunckley H.;
RT   "Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides
RT   (PCR-SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529,
RT   B*3532, B*4025, B*5304 and B*5508.";
RL   Tissue Antigens 55:266-270(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*55:09).
RX   MEDLINE=21466688; PubMed=11580856;
RX   DOI=10.1034/j.1399-0039.2001.580108.x;
RA   Voorter C.E., Hepkema B.G., Mulkers E.M.T., Lems S.P.M.,
RA   van den Berg-Loonen E.M.;
RT   "Identification of two new HLA-B22 variants, HLA-B*5509 and B*5606.";
RL   Tissue Antigens 58:42-46(2001).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-55 are known: B*55:01,
CC       B*55:02, B*55:04 (B55.2), B*55:05, B*55:08 (B*ER), B*55:09 and
CC       B*55:12. The sequence shown is that of B*55:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M77777; AAA03688.1; -; mRNA.
DR   EMBL; M77778; AAA03687.1; -; mRNA.
DR   EMBL; AY007140; AAG02001.1; -; mRNA.
DR   EMBL; AJ310509; CAC34574.1; -; Genomic_DNA.
DR   EMBL; AJ420106; CAD12250.1; -; Genomic_DNA.
DR   EMBL; AJ420333; CAD12454.1; -; Genomic_DNA.
DR   EMBL; D85761; BAA12868.1; -; mRNA.
DR   EMBL; U63653; AAB40126.1; -; mRNA.
DR   EMBL; AF091344; AAC61281.1; -; Genomic_DNA.
DR   EMBL; AF091343; AAC61281.1; JOINED; Genomic_DNA.
DR   EMBL; AJ250628; CAC12872.1; -; Genomic_DNA.
DR   EMBL; AJ250629; CAC12873.1; -; Genomic_DNA.
DR   IPI; IPI00472767; -.
DR   PIR; I72752; I72752.
DR   PIR; I72753; I72753.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30493; -.
DR   SMR; P30493; 25-300.
DR   STRING; P30493; -.
DR   DMDM; 231416; -.
DR   PRIDE; P30493; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30493; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30493; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30493; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-55 alpha chain.
FT                                /FTId=PRO_0000018858.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056410.
FT   VARIANT      82     82       E -> A (in allele B*55:05).
FT                                /FTId=VAR_016483.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056411.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059489.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056412.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059490.
FT   VARIANT     101    101       S -> N (in allele B*55:12;
FT                                dbSNP:rs1050388).
FT                                /FTId=VAR_016484.
FT   VARIANT     119    119       W -> L (in allele B*55:04 and allele
FT                                B*55:08; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016698.
FT   VARIANT     121    121       T -> R (in allele B*55:08).
FT                                /FTId=VAR_016699.
FT   VARIANT     121    121       T -> S (in allele B*55:04).
FT                                /FTId=VAR_016700.
FT   VARIANT     127    127       L -> V (in allele B*55:04 and allele
FT                                B*55:08).
FT                                /FTId=VAR_016701.
FT   VARIANT     140    140       L -> Y (in allele B*55:04 and allele
FT                                B*55:08).
FT                                /FTId=VAR_016702.
FT   VARIANT     155    155       S -> R (in allele B*55:04 and allele
FT                                B*55:08).
FT                                /FTId=VAR_016703.
FT   VARIANT     176    176       E -> V (in allele B*55:02, allele
FT                                B*55:04, allele B*55:08 and allele
FT                                B*55:12).
FT                                /FTId=VAR_016485.
FT   VARIANT     180    180       L -> R (in allele B*55:09).
FT                                /FTId=VAR_016704.
FT   VARIANT     187    187       T -> E (in allele B*55:09; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016705.
FT   VARIANT     187    187       T -> L (in allele B*55:08; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016706.
SQ   SEQUENCE   362 AA;  40496 MW;  8F3C1F6D245257C4 CRC64;
     MRVTAPRTLL LLLWGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTWQ
     TMYGCDLGPD GRLLRGHNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B56_HUMAN              Reviewed;         362 AA.
AC   P30495; O19758; P30496; P79490; Q9GIM3; Q9GJ17; Q9TPR4;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=HLA class I histocompatibility antigen, B-56 alpha chain;
DE   AltName: Full=Bw-22;
DE   AltName: Full=Bw-56;
DE   AltName: Full=MHC class I antigen B*56;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*56:01 AND B*56:02).
RX   MEDLINE=92148136; PubMed=1737933;
RA   Hildebrand W.H., Madrigal J.A., Little A.-M., Parham P.;
RT   "HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha
RT   1-helix.";
RL   J. Immunol. 148:1155-1162(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*56:03).
RC   TISSUE=Blood;
RX   MEDLINE=97295817; PubMed=9151389;
RX   DOI=10.1111/j.1399-0039.1997.tb02765.x;
RA   Bannai M., Tokunaga K., Tanaka H., Lin L., Kashiwase K., Tokunaga K.,
RA   Juji T.;
RT   "Five HLA-B22 group alleles in Japanese.";
RL   Tissue Antigens 49:376-382(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*56:04).
RA   Steiner N.K., Lee K.W., Hurley C.K.;
RT   "Novel HLA-B alleles.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*56:05).
RA   Juji T., Akesaka T., Kashiwase K.;
RT   "HLA-B56V1(B*5605).";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*56:06).
RX   MEDLINE=21466688; PubMed=11580856;
RX   DOI=10.1034/j.1399-0039.2001.580108.x;
RA   Voorter C.E., Hepkema B.G., Mulkers E.M.T., Lems S.P.M.,
RA   van den Berg-Loonen E.M.;
RT   "Identification of two new HLA-B22 variants, HLA-B*5509 and B*5606.";
RL   Tissue Antigens 58:42-46(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*56:07).
RX   MEDLINE=20548613; PubMed=11098937;
RX   DOI=10.1034/j.1399-0039.2000.560409.x;
RA   Voorter C.E., van der Vlies S., Kik M., van den Berg-Loonen E.M.;
RT   "Unexpected Bw4 and Bw6 reactivity patterns in new alleles.";
RL   Tissue Antigens 56:363-370(2000).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-56 are known: B*56:01,
CC       B*56:02, B*56:03 (B22N), B*56:04, B*56:05 (B56V1), B*56:06 and
CC       B*56:07. The sequence shown is that of B*56:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M77775; AAA03690.1; -; mRNA.
DR   EMBL; M77776; AAA03689.1; -; mRNA.
DR   EMBL; D85762; BAA12869.1; -; mRNA.
DR   EMBL; U93914; AAB62223.1; -; Genomic_DNA.
DR   EMBL; U93913; AAB62223.1; JOINED; Genomic_DNA.
DR   EMBL; AB030574; BAA82677.1; -; Genomic_DNA.
DR   EMBL; Y18542; CAC12884.1; -; Genomic_DNA.
DR   EMBL; Y18543; CAC12884.1; JOINED; Genomic_DNA.
DR   EMBL; Y18544; CAC12896.1; -; Genomic_DNA.
DR   EMBL; Y18545; CAC12896.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472284; -.
DR   PIR; I72754; I72754.
DR   PIR; I72755; I72755.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30495; -.
DR   STRING; P30495; -.
DR   DMDM; 231418; -.
DR   PRIDE; P30495; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30495; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30495; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30495; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-56 alpha chain.
FT                                /FTId=PRO_0000018859.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056413.
FT   VARIANT      69     69       E -> T (in allele B*56:06; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016486.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056414.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059491.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056415.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059492.
FT   VARIANT     101    101       S -> N (in allele B*56:07;
FT                                dbSNP:rs1050388).
FT                                /FTId=VAR_016487.
FT   VARIANT     104    107       NLRG -> TALR (in allele B*56:07).
FT                                /FTId=VAR_016488.
FT   VARIANT     119    119       W -> L (in allele B*56:02, allele B*56:03
FT                                and allele B*56:04).
FT                                /FTId=VAR_016489.
FT   VARIANT     121    121       T -> R (in allele B*56:02, allele B*56:03
FT                                and allele B*56:04).
FT                                /FTId=VAR_016490.
FT   VARIANT     127    127       L -> V (in allele B*56:03, allele
FT                                B*56:04, allele B*56:05 and allele
FT                                B*56:06).
FT                                /FTId=VAR_016491.
FT   VARIANT     138    138       N -> D (in allele B*56:03).
FT                                /FTId=VAR_016707.
FT   VARIANT     140    140       L -> S (in allele B*56:03).
FT                                /FTId=VAR_016708.
FT   VARIANT     140    140       L -> Y (in allele B*56:05 and allele
FT                                B*56:06; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016492.
FT   VARIANT     176    176       V -> E (in allele B*56:03, allele B*56:05
FT                                and allele B*56:06).
FT                                /FTId=VAR_016493.
FT   VARIANT     180    180       L -> W (in allele B*56:03).
FT                                /FTId=VAR_016709.
FT   VARIANT     195    195       Y -> H (in allele B*56:05 and allele
FT                                B*56:06).
FT                                /FTId=VAR_016494.
SQ   SEQUENCE   362 AA;  40478 MW;  D442225B8A09D667 CRC64;
     MRVTAPRTLL LLLWGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTWQ
     TMYGCDLGPD GRLLRGHNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B57_HUMAN              Reviewed;         362 AA.
AC   P18465; O62917; P30497; P79496; Q29679; Q5QT24;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   18-APR-2012, entry version 110.
DE   RecName: Full=HLA class I histocompatibility antigen, B-57 alpha chain;
DE   AltName: Full=Bw-57;
DE   AltName: Full=MHC class I antigen B*57;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*57:01).
RX   MEDLINE=90207291; PubMed=2320591; DOI=10.1073/pnas.87.7.2833;
RA   Ennis P.D., Zemmour J., Salter R.D., Parham P.;
RT   "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction:
RT   frequency and nature of errors produced in amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*57:01).
RX   MEDLINE=91067476; PubMed=2251138; DOI=10.1093/nar/18.22.6702;
RA   Isamat M., Girdlestone J., Milstein C.;
RT   "Nucleotide sequence of an HLA-Bw57 gene.";
RL   Nucleic Acids Res. 18:6702-6702(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Cox S.T.;
RT   "Confirmation of B*5701.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*57:02).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*57:03).
RC   TISSUE=Blood;
RA   Petersdorf E.;
RT   "Molecular diversity of HLA-B.";
RL   Submitted (DEC-1994) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*57:03).
RX   MEDLINE=97378891; PubMed=9234488;
RX   DOI=10.1111/j.1399-0039.1997.tb02814.x;
RA   Vilches C., Bunce M., de Pablo R., Moreno M.E., Puente S., Sanz L.,
RA   Kreisler M.;
RT   "The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi
RT   population from Equatorial Guinea.";
RL   Tissue Antigens 49:644-648(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*57:05).
RX   MEDLINE=21442089; PubMed=11556976;
RX   DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-57 are known: B*57:01,
CC       B*57:02 (Bw57.2), B*57:03 (B-57SAU) and B*57:05. The sequence
CC       shown is that of B*57:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32318; AAA36231.1; -; mRNA.
DR   EMBL; X55711; CAA39244.1; -; Genomic_DNA.
DR   EMBL; AJ458991; CAD30339.1; -; Genomic_DNA.
DR   EMBL; X61707; CAA43876.1; -; mRNA.
DR   EMBL; U18790; AAB60361.1; -; mRNA.
DR   EMBL; Y09157; CAA70355.1; -; mRNA.
DR   EMBL; AF061860; AAC32568.1; -; Genomic_DNA.
DR   EMBL; AF061859; AAC32568.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472434; -.
DR   PIR; D35997; D35997.
DR   UniGene; Hs.77961; -.
DR   PDB; 2BVO; X-ray; 1.65 A; A=25-300.
DR   PDB; 2BVP; X-ray; 1.35 A; A=25-300.
DR   PDB; 2BVQ; X-ray; 2.00 A; A=25-300.
DR   PDB; 2HJL; X-ray; 1.50 A; A=21-45.
DR   PDB; 2RFX; X-ray; 2.50 A; A=25-299.
DR   PDB; 3VH8; X-ray; 1.80 A; A/D=25-299.
DR   PDBsum; 2BVO; -.
DR   PDBsum; 2BVP; -.
DR   PDBsum; 2BVQ; -.
DR   PDBsum; 2HJL; -.
DR   PDBsum; 2RFX; -.
DR   PDBsum; 3VH8; -.
DR   ProteinModelPortal; P18465; -.
DR   SMR; P18465; 25-298.
DR   STRING; P18465; -.
DR   DMDM; 122174; -.
DR   PRIDE; P18465; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P18465; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P18465; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P18465; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P18465; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-57 alpha chain.
FT                                /FTId=PRO_0000018860.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT     121    121       V -> R (in allele B*57:05; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016669.
FT   VARIANT     127    127       V -> L (in allele B*57:05).
FT                                /FTId=VAR_016670.
FT   VARIANT     137    137       H -> Y (in allele B*57:05).
FT                                /FTId=VAR_016671.
FT   VARIANT     138    138       D -> N (in allele B*57:02, allele B*57:03
FT                                and allele B*57:05).
FT                                /FTId=VAR_016495.
FT   VARIANT     140    140       S -> Y (in allele B*57:02, allele B*57:03
FT                                and allele B*57:05).
FT                                /FTId=VAR_016496.
FT   VARIANT     180    180       L -> R (in allele B*57:02 and allele
FT                                B*57:05).
FT                                /FTId=VAR_016497.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056416.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056417.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061431.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061432.
FT   STRAND       27     36
FT   STRAND       41     43
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      133    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    219
FT   STRAND      222    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      290    292
FT   STRAND      294    296
SQ   SEQUENCE   362 AA;  40224 MW;  C1EFCF089096AFF9 CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRMA PRAPWIEQEG PEYWDGETRN MKASAQTYRE NLRIALRYYN QSEAGSHIIQ
     VMYGCDVGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B58_HUMAN              Reviewed;         362 AA.
AC   P10319; Q29925; Q9TP35; Q9TPS6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   18-APR-2012, entry version 110.
DE   RecName: Full=HLA class I histocompatibility antigen, B-58 alpha chain;
DE   AltName: Full=Bw-58;
DE   AltName: Full=MHC class I antigen B*58;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*58:01).
RX   MEDLINE=86008247; PubMed=2995352;
RA   Ways J.P., Coppin H.L., Parham P.;
RT   "The complete primary structure of HLA-Bw58.";
RL   J. Biol. Chem. 260:11924-11933(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*58:01).
RC   TISSUE=Blood;
RA   Inoue T., Ogawa A.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*58:02).
RX   MEDLINE=95282145; PubMed=7761977;
RX   DOI=10.1111/j.1399-0039.1995.tb02437.x;
RA   Browning M.J., Madrigal J.A., Krausa P., Kowalski H., Allsopp C.E.,
RA   Little A.-M., Turner S., Adams E.J., Arnett K.L., Bodmer W.F.,
RA   Parham P.;
RT   "The HLA-A,B,C genotype of the class I negative cell line Daudi
RT   reveals novel HLA-A and -B alleles.";
RL   Tissue Antigens 45:177-187(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 1-206 (ALLELE B*58:04).
RX   MEDLINE=22282374; PubMed=12392514;
RX   DOI=10.1034/j.1399-0039.2002.600210.x;
RA   Williams T.M., Wu J., Bassinger S., Feldman D., Birkos S., Kearns J.,
RA   Kamoun M.;
RT   "New HLA-B alleles identified and sequences extended in potential bone
RT   marrow donors: B*5804, B*4418, B*1558, and B*4805.";
RL   Tissue Antigens 60:186-188(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*58:05).
RX   MEDLINE=21442089; PubMed=11556976;
RX   DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
RN   [6]
RP   ASSOCIATION OF ALLELE B*58:01 WITH SEVERE CUTANEOUS ADVERSE REACTIONS
RP   TO ALLOPURINOL.
RX   PubMed=15743917; DOI=10.1073/pnas.0409500102;
RA   Hung S.I., Chung W.H., Liou L.B., Chu C.C., Lin M., Huang H.P.,
RA   Lin Y.L., Lan J.L., Yang L.C., Hong H.S., Chen M.J., Lai P.C.,
RA   Wu M.S., Chu C.Y., Wang K.H., Chen C.H., Fann C.S., Wu J.Y.,
RA   Chen Y.T.;
RT   "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse
RT   reactions caused by allopurinol.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:4134-4139(2005).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-58 are known: B*58:01,
CC       B*58:02, B*58:04 and B*58:05. The sequence shown is that of
CC       B*58:01. Allele B*58:01 is an important genetic risk factor for
CC       severe cutaneous adverse reactions to allopurinol in the Han
CC       Chinese population [MIM:608579].
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M11799; AAA59628.1; -; Genomic_DNA.
DR   EMBL; AB008102; BAA22916.1; -; mRNA.
DR   EMBL; L33923; AAA74406.1; -; mRNA.
DR   EMBL; AF189247; AAF04579.1; -; Genomic_DNA.
DR   EMBL; AF189245; AAF04579.1; JOINED; Genomic_DNA.
DR   EMBL; AF189246; AAF04579.1; JOINED; Genomic_DNA.
DR   EMBL; AF201475; AAF21438.1; -; Genomic_DNA.
DR   EMBL; AF201474; AAF21438.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472138; -.
DR   PIR; A23895; HLHUB8.
DR   PIR; I84490; I84490.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P10319; -.
DR   SMR; P10319; 25-298.
DR   STRING; P10319; -.
DR   DMDM; 122168; -.
DR   PRIDE; P10319; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   MIM; 608579; phenotype.
DR   neXtProt; NX_P10319; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P10319; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P10319; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-58 alpha chain.
FT                                /FTId=PRO_0000018861.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      86     86       G -> E (in allele B*58:04).
FT                                /FTId=VAR_016498.
FT   VARIANT     118    119       II -> TL (in allele B*58:02).
FT                                /FTId=VAR_016499.
FT   VARIANT     121    121       R -> W (in allele B*58:02).
FT                                /FTId=VAR_016500.
FT   VARIANT     171    171       W -> L (in allele B*58:05).
FT                                /FTId=VAR_016666.
FT   VARIANT     176    176       V -> A (in allele B*58:05).
FT                                /FTId=VAR_016667.
FT   VARIANT     187    187       L -> T (in allele B*58:05; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016668.
SQ   SEQUENCE   362 AA;  40337 MW;  2056116240BB9AC0 CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDGETRN MKASAQTYRE NLRIALRYYN QSEAGSHIIQ
     RMYGCDLGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B59_HUMAN              Reviewed;         362 AA.
AC   Q29940; O02957;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 91.
DE   RecName: Full=HLA class I histocompatibility antigen, B-59 alpha chain;
DE   AltName: Full=MHC class I antigen B*59;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*59:01).
RX   MEDLINE=93369833; PubMed=8362411;
RX   DOI=10.1111/j.1399-0039.1993.tb02001.x;
RA   Hildebrand W.H., Domena J.D., Parham P.;
RT   "Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-
RT   B51, and not a subtype of HLA-B8.";
RL   Tissue Antigens 41:190-195(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*59:01).
RC   TISSUE=Blood;
RA   Lin L., Tokunaga K.;
RL   Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L07743; AAA59621.1; -; mRNA.
DR   EMBL; D50300; BAA08829.1; -; mRNA.
DR   IPI; IPI00472073; -.
DR   PIR; I59633; I59633.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q29940; -.
DR   SMR; Q29940; 25-300.
DR   STRING; Q29940; -.
DR   DMDM; 34305704; -.
DR   PRIDE; Q29940; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q29940; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; Q29940; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; Q29940; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-59 alpha chain.
FT                                /FTId=PRO_0000018862.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056418.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056419.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059493.
SQ   SEQUENCE   362 AA;  40584 MW;  F07B384BC182A3B1 CRC64;
     MRVTAPRTLL LLLWGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI FKTNTQTYRE NLRIALRYYN QSEAGSHTWQ
     TMYGCDLGPD GRLLRGHNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B67_HUMAN              Reviewed;         362 AA.
AC   Q29836; Q29678; Q8SNC5; Q95IA6; Q9BD38;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=HLA class I histocompatibility antigen, B-67 alpha chain;
DE   AltName: Full=MHC class I antigen B*67;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*67:01).
RX   MEDLINE=94294981; PubMed=7517584;
RX   DOI=10.1111/j.1399-0039.1994.tb02294.x;
RA   Little A.-M., Domena J.D., Hildebrand W.H., Shen S.Y., Barber L.D.,
RA   Marsh S.G.E., Bias W.B., Parham P.;
RT   "HLA-B67: a member of the HLA-B16 family that expresses the ME1
RT   epitope.";
RL   Tissue Antigens 43:38-43(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 26-205 (ALLELE B*67:01).
RC   TISSUE=Blood;
RA   Petersdorf E.;
RT   "Molecular diversity of HLA-B.";
RL   Submitted (DEC-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*67:02).
RA   Iglehart B.A., Leffell M.S.;
RT   "HLA-B*6702 (Promoter-3'UTR).";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*67:02).
RA   Baldassarre L.A., Hurley C.K.;
RT   "Novel HLA-B allele (HLA-B*67012 variant).";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-67 are known: B*67:01 (B-
CC       67LAV) and B*67:02. The sequence shown is that of B*67:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L17005; AAC37548.1; -; mRNA.
DR   EMBL; U18789; AAB60360.1; -; mRNA.
DR   EMBL; AF487379; AAL93257.1; -; Genomic_DNA.
DR   EMBL; AF321835; AAK09378.1; -; Genomic_DNA.
DR   EMBL; AF321834; AAK09378.1; JOINED; Genomic_DNA.
DR   EMBL; AY050196; AAL18235.1; -; Genomic_DNA.
DR   EMBL; AY050195; AAL18235.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472867; -.
DR   PIR; I59645; I59645.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q29836; -.
DR   SMR; Q29836; 25-300.
DR   STRING; Q29836; -.
DR   DMDM; 34222510; -.
DR   PRIDE; Q29836; -.
DR   Ensembl; ENST00000412585; ENSP00000399168; ENSG00000234745.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   HPA; CAB015418; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q29836; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; REACT_6900; Immune System.
DR   Bgee; Q29836; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; Q29836; -.
DR   GermOnline; ENSG00000204523; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-67 alpha chain.
FT                                /FTId=PRO_0000018863.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056420.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056421.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056422.
FT   VARIANT      35     35       S -> A (in dbSNP:rs1131170).
FT                                /FTId=VAR_056423.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056424.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061433.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061434.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061435.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056425.
FT   VARIANT      69     69       E -> G (in allele B*67:02).
FT                                /FTId=VAR_016536.
FT   VARIANT      76     76       I -> V (in allele B*67:02).
FT                                /FTId=VAR_016537.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056426.
FT   VARIANT      87     87       N -> E (in allele B*67:02; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016538.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059494.
FT   VARIANT      90     90       I -> K (in allele B*67:02).
FT                                /FTId=VAR_016539.
FT   VARIANT      93     93       A -> R (in allele B*67:02; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016540.
FT   VARIANT      97     97       T -> A (in allele B*67:02;
FT                                dbSNP:rs1050393).
FT                                /FTId=VAR_016541.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059495.
FT   VARIANT     100    100       E -> V (in allele B*67:02).
FT                                /FTId=VAR_016542.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056427.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056428.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056429.
SQ   SEQUENCE   362 AA;  40342 MW;  3F6A17FC10230F70 CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHNQF AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RTYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B73_HUMAN              Reviewed;         363 AA.
AC   Q31612;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 95.
DE   RecName: Full=HLA class I histocompatibility antigen, B-73 alpha chain;
DE   AltName: Full=MHC class I antigen B*73;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*73:01).
RX   MEDLINE=95026796; PubMed=7524186;
RX   DOI=10.1111/j.1399-0039.1994.tb02344.x;
RA   Parham P., Arnett K.L., Adams E.J., Barber L.D., Domena J.D.,
RA   Stewart D., Hildebrand W.H., Little A.-M.;
RT   "The HLA-B73 antigen has a most unusual structure that defines a
RT   second lineage of HLA-B alleles.";
RL   Tissue Antigens 43:302-313(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*73:01).
RX   MEDLINE=94299292; PubMed=7517915; DOI=10.1007/BF00188185;
RA   Vilches C., de Pablo R., Herrero M.J., Moreno M.E., Kreisler M.;
RT   "HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif
RT   variant and a B pocket identical to HLA-B27.";
RL   Immunogenetics 40:166-166(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*73:01).
RX   MEDLINE=96164742; PubMed=8547229;
RX   DOI=10.1111/j.1744-313X.1995.tb00237.x;
RA   Hoffmann H.J., Kristensen T.J., Jensen T.G., Graugaard B., Lamm L.U.;
RT   "Antigenic characteristics and cDNA sequences of HLA-B73.";
RL   Eur. J. Immunogenet. 22:231-240(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*73:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U04787; AAA53175.1; -; mRNA.
DR   EMBL; X77658; CAA54739.1; -; mRNA.
DR   EMBL; L24373; AAA96733.1; -; mRNA.
DR   EMBL; AJ311601; CAC35319.2; -; Genomic_DNA.
DR   IPI; IPI00472943; -.
DR   PIR; I37512; S42102.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q31612; -.
DR   SMR; Q31612; 25-300.
DR   STRING; Q31612; -.
DR   PhosphoSite; Q31612; -.
DR   DMDM; 34222512; -.
DR   PRIDE; Q31612; -.
DR   Ensembl; ENST00000412585; ENSP00000399168; ENSG00000234745.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   HPA; CAB015418; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q31612; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; REACT_6900; Immune System.
DR   Bgee; Q31612; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; Q31612; -.
DR   GermOnline; ENSG00000204523; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    363       HLA class I histocompatibility antigen,
FT                                B-73 alpha chain.
FT                                /FTId=PRO_0000018864.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    363       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056430.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056431.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056432.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056433.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056434.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059496.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056435.
FT   CONFLICT    338    339       SG -> C (in Ref. 4; CAC35319).
SQ   SEQUENCE   363 AA;  40435 MW;  04522E97C1E11C40 CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFHTSVSRPG RGEPRFITVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI CKAKAQTDRV GLRNLRGYYN QSEDGSHTWQ
     TMYGCDMGPD GRLLRGYNQF AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGECVE WLRRHLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL QEPCTLRWKP
     SSQSTIPIVG IVAGLAVLVV TVAVVAVVAA VMCRRKSSGG KGGSYSQAAS SDSAQGSDVS
     LTA
//
ID   1B78_HUMAN              Reviewed;         362 AA.
AC   P30498; O62915; Q29924; Q546M4;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=HLA class I histocompatibility antigen, B-78 alpha chain;
DE   AltName: Full=MHC class I antigen B*78;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*78:01).
RX   MEDLINE=93056508; PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*78:01).
RX   MEDLINE=90217537; PubMed=1691230;
RA   Sekimata M., Hiraiwa M., Andrien M., Dupont E., Karaki S.,
RA   Yamamoto J., Kano K., Takiguchi M.;
RT   "Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B
RT   SNA.";
RL   J. Immunol. 144:3228-3233(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*78:02).
RX   MEDLINE=97083138; PubMed=8929712;
RX   DOI=10.1111/j.1399-0039.1996.tb02513.x;
RA   Prilliman K., Steiner N.K., Ellexson M., Stewart D., Lau M.,
RA   Terasaki P., Hurley C.K., Hildebrand W.H.;
RT   "Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the
RT   HLA-B5 family.";
RL   Tissue Antigens 47:49-57(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*78:01).
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of B*7801.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*78:03).
RX   MEDLINE=21442089; PubMed=11556976;
RX   DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-78 are known: B*78:01 (B
CC       SNA), B*78:02 and B*78:03. The sequence shown is that of B*78:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61708; CAA43877.1; -; mRNA.
DR   EMBL; M33573; AAA59644.1; -; Genomic_DNA.
DR   EMBL; L41214; AAC41980.1; -; mRNA.
DR   EMBL; AJ309192; CAC38391.1; -; Genomic_DNA.
DR   EMBL; AF061856; AAC32566.1; -; Genomic_DNA.
DR   EMBL; AF061855; AAC32566.1; JOINED; Genomic_DNA.
DR   IPI; IPI00746605; -.
DR   PIR; I37522; I37522.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30498; -.
DR   SMR; P30498; 25-300.
DR   STRING; P30498; -.
DR   DMDM; 231421; -.
DR   PRIDE; P30498; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30498; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P30498; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; P30498; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-78 alpha chain.
FT                                /FTId=PRO_0000018865.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      91     91       F -> C (in allele B*78:03).
FT                                /FTId=VAR_016672.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056436.
FT   VARIANT      98     98       D -> Y (in allele B*78:02).
FT                                /FTId=VAR_016501.
SQ   SEQUENCE   362 AA;  40478 MW;  D2D6142768F28E6C CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRNTQI FKTNTQTDRE SLRNLRGYYN QSEAGSHTWQ
     TMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRHLENGK ETLQRADPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B81_HUMAN              Reviewed;         362 AA.
AC   Q31610;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 102.
DE   RecName: Full=HLA class I histocompatibility antigen, B-81 alpha chain;
DE   AltName: Full=B'DT;
DE   AltName: Full=MHC class I antigen B*81;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*81:01).
RX   MEDLINE=96115676; PubMed=8847228; DOI=10.1016/0198-8859(95)00082-F;
RA   Ellexson M.E., Zhang G., Stewart D., Lau M., Teresi G., Terasaki P.,
RA   Roe B.A., Hildebrand W.H.;
RT   "Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant
RT   alpha-helical motifs produce complex serologic recognition patterns
RT   for the HLA-B''DT'' and HLA-B''NM5'' antigens.";
RL   Hum. Immunol. 44:103-110(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*81:01).
RX   MEDLINE=97004417; PubMed=8851728;
RX   DOI=10.1111/j.1399-0039.1996.tb02527.x;
RA   Vilches C., Sanz L., de Pablo R., Moreno M.E., Puente S., Kreisler M.;
RT   "Molecular characterization of the new alleles HLA-B*8101 and
RT   B*4407.";
RL   Tissue Antigens 47:139-142(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*81:01).
RA   Hildebrand W.H., Ellexson M.E.;
RT   "HLA-B'DT', a class I allele most homologous with HLA-B-4801.";
RL   Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L37880; AAC41941.1; -; mRNA.
DR   EMBL; X90390; CAA62035.1; -; mRNA.
DR   EMBL; U09912; AAF70855.1; -; mRNA.
DR   IPI; IPI00472753; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q31610; -.
DR   SMR; Q31610; 25-300.
DR   STRING; Q31610; -.
DR   DMDM; 34222511; -.
DR   PRIDE; Q31610; -.
DR   Ensembl; ENST00000412585; ENSP00000399168; ENSG00000234745.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   HPA; CAB015418; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q31610; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; REACT_6900; Immune System.
DR   Bgee; Q31610; -.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; Q31610; -.
DR   GermOnline; ENSG00000204523; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-81 alpha chain.
FT                                /FTId=PRO_0000018866.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056437.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056438.
FT   VARIANT      35     35       S -> A (in dbSNP:rs1131170).
FT                                /FTId=VAR_056439.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056440.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061436.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061437.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061438.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056441.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056442.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059497.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056443.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059498.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056444.
FT   VARIANT     137    137       H -> Y (in dbSNP:rs1050379).
FT                                /FTId=VAR_056445.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056446.
FT   VARIANT     187    187       E -> A (in dbSNP:rs2308466).
FT                                /FTId=VAR_059499.
FT   VARIANT     187    187       E -> G (in dbSNP:rs2308466).
FT                                /FTId=VAR_059500.
FT   VARIANT     187    187       E -> K (in dbSNP:rs2523600).
FT                                /FTId=VAR_059501.
FT   VARIANT     187    187       E -> Q (in dbSNP:rs2523600).
FT                                /FTId=VAR_059502.
FT   VARIANT     187    187       E -> V (in dbSNP:rs2308466).
FT                                /FTId=VAR_059503.
FT   VARIANT     195    195       Y -> H (in dbSNP:rs1050696).
FT                                /FTId=VAR_056447.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056448.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056449.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061439.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061440.
SQ   SEQUENCE   362 AA;  40400 MW;  CB2660A583C8A0D8 CRC64;
     MLVMAPRTVL LLLWGAVALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTLQ
     SMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLRSWTAA DTAAQISQRK LEAARVAEQL
     RAYLEGECVE WLRRYLENGK DKLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWTA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B82_HUMAN              Reviewed;         362 AA.
AC   Q29718; Q29695; Q29742; Q8MHN4; Q9MY61; Q9MYB8;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 92.
DE   RecName: Full=HLA class I histocompatibility antigen, B-82 alpha chain;
DE   AltName: Full=MHC class I antigen B*82;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELE B*82:01).
RX   MEDLINE=96303895; PubMed=8740766;
RX   DOI=10.1111/j.1399-0039.1996.tb02538.x;
RA   Hurley C.K., Steiner N.K., Hoyer R.J., Menchaca E., Mitton W.,
RA   Simonis T., Hartzman R.J., Johnson A.H., Ng J.;
RT   "Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity
RT   of serologic identification of HLA types.";
RL   Tissue Antigens 47:179-187(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*82:01).
RA   Ellexson M.E., Hildebrand W.H.;
RL   Submitted (OCT-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 1-24 (ALLELE B*82:01).
RA   Blasczyk R.;
RT   "Exon 1 sequence of HLA-B*8201.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*82:01).
RA   Chopek M., Nielsen J., Zhang H.;
RL   Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*82:02).
RX   MEDLINE=20470604; PubMed=11019925;
RX   DOI=10.1034/j.1399-0039.2000.560216.x;
RA   Cox S.T., Hossain E., McWhinnie A., Prokupek B.M., Madrigal J.A.,
RA   Little A.-M.;
RT   "HLA-B*8202 identified in a Caucasoid potential bone marrow donor.";
RL   Tissue Antigens 56:188-191(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*82:02).
RA   Diviney M., Hepner J., Cantwell L., Boyle A., Kanaan C.,
RA   Holdsworth R., Tait B.;
RT   "Confirmation of HLA-B*8202.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of B-82 are known: B*82:01 and
CC       B*82:02. The sequence shown is that of B*82:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U36492; AAB18369.1; -; mRNA.
DR   EMBL; U29241; AAC50691.1; -; Genomic_DNA.
DR   EMBL; U38800; AAC99997.1; -; mRNA.
DR   EMBL; AJ278748; CAC00634.1; -; Genomic_DNA.
DR   EMBL; U43337; AAA87573.1; -; mRNA.
DR   EMBL; AJ251755; CAB75360.1; -; Genomic_DNA.
DR   EMBL; AF525410; AAM83101.1; -; Genomic_DNA.
DR   EMBL; AF525409; AAM83101.1; JOINED; Genomic_DNA.
DR   IPI; IPI00472210; -.
DR   ProteinModelPortal; Q29718; -.
DR   SMR; Q29718; 25-300.
DR   STRING; Q29718; -.
DR   DMDM; 34222509; -.
DR   PRIDE; Q29718; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   GeneCards; GC06M031321; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q29718; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; Q29718; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-B; -.
DR   Genevestigator; Q29718; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-82 alpha chain.
FT                                /FTId=PRO_0000018867.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Helical; (Potential).
FT   TOPO_DOM    333    362       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061441.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061442.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061443.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                /FTId=VAR_056450.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056451.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059504.
FT   VARIANT      97     97       T -> A (in dbSNP:rs1050393).
FT                                /FTId=VAR_056452.
FT   VARIANT      98     98       D -> Y (in dbSNP:rs1131215).
FT                                /FTId=VAR_059505.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056453.
FT   VARIANT     186    186       D -> G (in allele B*82:02).
FT                                /FTId=VAR_016543.
SQ   SEQUENCE   362 AA;  40421 MW;  273D957D582B3673 CRC64;
     MRVTAPRTLL LLLWGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTLQ
     RMFGCDLGPD GRLLRGHNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQD
     RAYLEDLCVE SLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1C01_HUMAN              Reviewed;         366 AA.
AC   P30499; O02865; O19676; P30500; Q29986; Q9UQS9;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-1 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*1;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*01:01).
RX   MEDLINE=89215297; PubMed=2708822;
RA   Ellis S.A., Strachan T., Palmer M.S., McMichael A.J.;
RT   "Complete nucleotide sequence of a unique HLA class I C locus product
RT   expressed on the human choriocarcinoma cell line BeWo.";
RL   J. Immunol. 142:3281-3285(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CW*01:02).
RX   MEDLINE=87192941; PubMed=3032784; DOI=10.1007/BF00404424;
RA   Gussow D., Rein R.S., Meijer I., de Hoog W., Seemann G.H.,
RA   Hochstenbach F.M., Ploegh H.L.;
RT   "Isolation, expression, and the primary structure of HLA-Cw1 and HLA-
RT   Cw2 genes: evolutionary aspects.";
RL   Immunogenetics 25:313-322(1987).
RN   [3]
RP   ERRATUM.
RA   Gussow D., Rein R.S., Meijer I., de Hoog W., Seemann G.H.,
RA   Hochstenbach F.M., Ploegh H.L.;
RL   Immunogenetics 27:158-158(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*01:02).
RX   MEDLINE=93031775; PubMed=1384166;
RX   DOI=10.1111/j.1399-0039.1992.tb01943.x;
RA   Zemmour J., Gumperz J.E., Hildebrand W.H., Ward F.E., Marsh S.G.E.,
RA   Williams R.C., Parham P.;
RT   "The molecular basis for reactivity of anti-Cw1 and anti-Cw3
RT   alloantisera with HLA-B46 haplotypes.";
RL   Tissue Antigens 39:249-257(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-206 (ALLELE CW*01:02).
RX   MEDLINE=95176330; PubMed=7871529;
RX   DOI=10.1111/j.1399-0039.1994.tb02394.x;
RA   Steinle A., Schendel D.J.;
RT   "HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).";
RL   Tissue Antigens 44:268-270(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*01:03).
RC   TISSUE=Peripheral blood;
RX   MEDLINE=98335880; PubMed=9672159;
RX   DOI=10.1111/j.1399-0039.1998.tb02995.x;
RA   Wang H., Nakajima F., Tokunaga K., Kashiwase K., Ishikawa Y., Juji T.;
RT   "Cw*0103, a new allele encoding for a novel HLA-Cw1 split in the
RT   Japanese population.";
RL   Tissue Antigens 51:571-573(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*01:04).
RA   Day S.;
RT   "Full length sequencing of a new Cw*01 variant allele.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-1 are known: Cw*01:01
CC       (Cw1.1), Cw*01:02 (Cw1.2), Cw*01:03 and Cw*01:04. The sequence
CC       shown is that of Cw*01:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26429; AAA59701.1; -; mRNA.
DR   EMBL; M16272; AAA59700.1; -; Genomic_DNA.
DR   EMBL; M84171; AAA59685.1; -; mRNA.
DR   EMBL; Z46809; CAA86839.1; -; mRNA.
DR   EMBL; D64145; BAA19531.1; -; mRNA.
DR   EMBL; AJ133100; CAB38942.1; -; Genomic_DNA.
DR   IPI; IPI00026650; -.
DR   PIR; I37528; I37528.
DR   PIR; I54430; I54430.
DR   PIR; I59622; I59622.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30499; -.
DR   SMR; P30499; 26-298.
DR   STRING; P30499; -.
DR   DMDM; 231423; -.
DR   PRIDE; P30499; -.
DR   Ensembl; ENST00000438171; ENSP00000393374; ENSG00000237022.
DR   GeneCards; GC06M031236; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P30499; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P30499; -.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-1 alpha chain.
FT                                /FTId=PRO_0000018868.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       5      5       E -> A (in allele Cw*01:02, allele
FT                                Cw*01:03 and allele Cw*01:04).
FT                                /FTId=VAR_016544.
FT   VARIANT      43     43       E -> K (in dbSNP:rs1050438).
FT                                /FTId=VAR_056454.
FT   VARIANT      48     48       S -> A (in dbSNP:rs707911).
FT                                /FTId=VAR_061444.
FT   VARIANT      48     48       S -> P (in dbSNP:rs707911).
FT                                /FTId=VAR_061445.
FT   VARIANT      48     48       S -> T (in dbSNP:rs707911).
FT                                /FTId=VAR_061446.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056455.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056456.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056457.
FT   VARIANT      92     92       N -> K (in allele Cw*01:02, allele
FT                                Cw*01:03 and allele Cw*01:04).
FT                                /FTId=VAR_016545.
FT   VARIANT     138    138       D -> N (in allele Cw*01:03).
FT                                /FTId=VAR_016546.
FT   VARIANT     140    140       Y -> F (in allele Cw*01:03).
FT                                /FTId=VAR_016547.
FT   VARIANT     140    140       Y -> S (in allele Cw*01:04).
FT                                /FTId=VAR_016548.
FT   VARIANT     179    179       E -> Q (in allele Cw*01:02, allele
FT                                Cw*01:03 and allele Cw*01:04).
FT                                /FTId=VAR_016549.
FT   VARIANT     180    180       R -> W (in allele Cw*01:04).
FT                                /FTId=VAR_016550.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056458.
FT   VARIANT     202    202       S -> T (in allele Cw*01:02, allele
FT                                Cw*01:03 and allele Cw*01:04).
FT                                /FTId=VAR_016551.
FT   VARIANT     243    243       W -> R (in allele Cw*01:04).
FT                                /FTId=VAR_016552.
FT   VARIANT     272    272       M -> V (in allele Cw*01:04).
FT                                /FTId=VAR_016553.
FT   VARIANT     328    328       V -> M (in allele Cw*01:04).
FT                                /FTId=VAR_016554.
FT   VARIANT     364    364       S -> C (in allele Cw*01:02, allele
FT                                Cw*01:03 and allele Cw*01:04).
FT                                /FTId=VAR_016555.
SQ   SEQUENCE   366 AA;  40965 MW;  285CCFCB92788744 CRC64;
     MRVMEPRTLI LLLSGALALT ETWACSHSMK YFFTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YNRQAQTDRV SLRNLRGYYN QSEAGSHTLQ
     WMCGCDLGPD GRLLRGYDQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEER
     RAYLEGTCVE WLRRYLENGK ESLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQWDGEDQTQ DTELVETRPA GDGTFQKWAA VMVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVVAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIASKA
//
ID   1C02_HUMAN              Reviewed;         366 AA.
AC   P30501; P30502;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-2 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*2;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*02:01).
RX   MEDLINE=89215297; PubMed=2708822;
RA   Ellis S.A., Strachan T., Palmer M.S., McMichael A.J.;
RT   "Complete nucleotide sequence of a unique HLA class I C locus product
RT   expressed on the human choriocarcinoma cell line BeWo.";
RL   J. Immunol. 142:3281-3285(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*02:02).
RX   MEDLINE=89235215; PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-83, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Hepatoma;
RX   PubMed=16097034; DOI=10.1002/pmic.200401217;
RA   Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,
RA   Demol H., Martens L., Goethals M., Vandekerckhove J.;
RT   "Global phosphoproteome analysis on human HepG2 hepatocytes using
RT   reversed-phase diagonal LC.";
RL   Proteomics 5:3589-3599(2005).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-2 are known: Cw*02:01
CC       (Cw2.1) and Cw*02:02 (Cw2.2). The sequence shown is that of
CC       Cw*02:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26430; AAA59703.1; -; mRNA.
DR   EMBL; M24030; AAA59671.1; -; Genomic_DNA.
DR   IPI; IPI00472605; -.
DR   PIR; I61866; I61866.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30501; -.
DR   SMR; P30501; 26-302.
DR   STRING; P30501; -.
DR   PhosphoSite; P30501; -.
DR   DMDM; 231429; -.
DR   PRIDE; P30501; -.
DR   Ensembl; ENST00000420206; ENSP00000410214; ENSG00000228299.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mk31228; -.
DR   H-InvDB; HIX0166423; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P30501; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P30501; -.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-2 alpha chain.
FT                                /FTId=PRO_0000018869.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES      83     83       Phosphotyrosine.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       5      5       E -> A (in allele Cw*02:02).
FT                                /FTId=VAR_016556.
FT   VARIANT      10     10       I -> L (in allele Cw*02:02).
FT                                /FTId=VAR_016557.
FT   VARIANT      73     74       GR -> AP (in allele Cw*02:02).
FT                                /FTId=VAR_016558.
FT   VARIANT      92     92       N -> K (in allele Cw*02:02).
FT                                /FTId=VAR_016559.
FT   VARIANT     137    137       Y -> H (in dbSNP:rs2308574).
FT                                /FTId=VAR_056459.
FT   VARIANT     179    179       E -> Q (in allele Cw*02:02).
FT                                /FTId=VAR_016560.
FT   VARIANT     202    202       K -> T (in allele Cw*02:02).
FT                                /FTId=VAR_016561.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056460.
FT   VARIANT     364    364       S -> C (in allele Cw*02:02).
FT                                /FTId=VAR_016562.
SQ   SEQUENCE   366 AA;  41095 MW;  AD8025DEB7DA8CE6 CRC64;
     MRVMEPRTLI LLLSGALALT ETWACSHSMR YFYTAVSRPS RGEPHFIAVG YVDDTQFVRF
     DSDAASPRGE PRGRWVEQEG PEYWDRETQK YNRQAQTDRV NLRKLRGYYN QSEAGSHTLQ
     RMYGCDLGPD GRLLRGYDQS AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEEW
     RAYLEGECVE WLRRYLENGK EKLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPTEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVVAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIASKA
//
ID   1C03_HUMAN              Reviewed;         366 AA.
AC   P04222; O62883; O78060; O78068; O78069; P30503; Q29743; Q29992;
AC   Q29993; Q9GIK8; Q9TQB4;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 112.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-3 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*3;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*03:04).
RX   MEDLINE=84207947; PubMed=6609813;
RA   Sodoyer R., Damotte M., Delovitch T.L., Trucy J., Jordan B.R.,
RA   Strachan T.;
RT   "Complete nucleotide sequence of a gene encoding a functional human
RT   class I histocompatibility antigen (HLA-CW3).";
RL   EMBO J. 3:879-885(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*03:02).
RX   MEDLINE=93031775; PubMed=1384166;
RX   DOI=10.1111/j.1399-0039.1992.tb01943.x;
RA   Zemmour J., Gumperz J.E., Hildebrand W.H., Ward F.E., Marsh S.G.E.,
RA   Williams R.C., Parham P.;
RT   "The molecular basis for reactivity of anti-Cw1 and anti-Cw3
RT   alloantisera with HLA-B46 haplotypes.";
RL   Tissue Antigens 39:249-257(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELES CW*03:03 AND CW*03:04).
RA   Domena J.D.;
RL   Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*03:03).
RC   TISSUE=Peripheral blood;
RA   Wang H., Tokunaga K., Kuwata S.;
RT   "DNA typing of HLA-C locus alleles in Japanese.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-206 (ALLELE CW*03:04).
RX   MEDLINE=96217561; PubMed=8613148; DOI=10.1007/s002510050093;
RA   Zarling A.L., Smith K.D., Lutz C.T., Lee D.R.;
RT   "Correction of the HLA-Cw3 genomic sequence tentatively identifies it
RT   as HLA-Cw*0304.";
RL   Immunogenetics 44:82-83(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*03:07).
RX   PubMed=11580854; DOI=10.1034/j.1399-0039.2001.580106.x;
RA   Santos S., Vicario J.L., Garcia-Sanchez F., Aviles M.J., Balas A.;
RT   "Sequencing based typing for HLA-C. Identification of three new
RT   alleles: Cw*0307, Cw*0502 and Cw*0504.";
RL   Tissue Antigens 58:34-37(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES CW*03:05;
RP   CW*03:06; CW*03:08 AND CW*03:09).
RX   MEDLINE=98349393; PubMed=9686604;
RA   Turner S., Ellexson M.E., Hickman H.D., Sidebottom D.A.,
RA   Fernandez-Vina M., Confer D.L., Hildebrand W.H.;
RT   "Sequence-based typing provides a new look at HLA-C diversity.";
RL   J. Immunol. 161:1406-1413(1998).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CW*03:13).
RX   MEDLINE=21970278; PubMed=11972880;
RX   DOI=10.1034/j.1399-0039.2002.590110.x;
RA   Cox S.T., Ogilvie H., Bohan E.M., Holman R., Prentice H.G., Potter M.,
RA   Madrigal J.A., Little A.-M.;
RT   "Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208.";
RL   Tissue Antigens 59:49-51(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-3 are known: Cw*03:02
CC       (Cw3.2), Cw*03:03, Cw*03:04 (Cw3.1), Cw*03:05, Cw*03:06, Cw*03:07,
CC       Cw*03:08, Cw*03:09 and Cw*03:13. The sequence shown is that of
CC       Cw*03:04.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00495; CAA25190.1; -; Genomic_DNA.
DR   EMBL; M84172; AAA59686.1; -; mRNA.
DR   EMBL; M99389; AAA88088.1; -; mRNA.
DR   EMBL; M99390; AAA88089.1; -; mRNA.
DR   EMBL; D50853; BAA32610.1; -; mRNA.
DR   EMBL; U44064; AAB02773.1; -; Genomic_DNA.
DR   EMBL; AF039198; AAD37816.1; -; Genomic_DNA.
DR   EMBL; AF037079; AAC17715.1; -; Genomic_DNA.
DR   EMBL; AF037078; AAC17715.1; JOINED; Genomic_DNA.
DR   EMBL; AF003284; AAC17716.1; -; Genomic_DNA.
DR   EMBL; AF003283; AAC17716.1; JOINED; Genomic_DNA.
DR   EMBL; AF037075; AAC17717.1; -; Genomic_DNA.
DR   EMBL; AF037074; AAC17717.1; JOINED; Genomic_DNA.
DR   EMBL; AF037077; AAC17718.1; -; Genomic_DNA.
DR   EMBL; AF037076; AAC17718.1; JOINED; Genomic_DNA.
DR   EMBL; AJ298116; CAC18746.1; -; Genomic_DNA.
DR   IPI; IPI00651697; -.
DR   PIR; A02190; HLHUW3.
DR   PIR; I81231; I81231.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 1EFX; X-ray; 3.00 A; A=25-302.
DR   PDBsum; 1EFX; -.
DR   ProteinModelPortal; P04222; -.
DR   SMR; P04222; 25-302.
DR   STRING; P04222; -.
DR   DMDM; 34223716; -.
DR   PRIDE; P04222; -.
DR   Ensembl; ENST00000457903; ENSP00000390851; ENSG00000225691.
DR   UCSC; uc011hpe.2; human.
DR   GeneCards; GC06M031236; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P04222; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P04222; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P04222; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-3 alpha chain.
FT                                /FTId=PRO_0000018870.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056461.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056462.
FT   VARIANT      90     90       K -> N (in allele Cw*03:08;
FT                                dbSNP:rs28626310).
FT                                /FTId=VAR_016569.
FT   VARIANT     101    101       S -> N (in allele Cw*03:07).
FT                                /FTId=VAR_016565.
FT   VARIANT     104    104       N -> K (in allele Cw*03:07).
FT                                /FTId=VAR_016566.
FT   VARIANT     115    115       G -> R (in allele Cw*03:03 and allele
FT                                Cw*03:13).
FT                                /FTId=VAR_016563.
FT   VARIANT     118    118       I -> T (in allele Cw*03:05 and allele
FT                                Cw*03:13).
FT                                /FTId=VAR_016564.
FT   VARIANT     119    119       I -> L (in allele Cw*03:02, allele
FT                                Cw*03:05 and allele Cw*03:13).
FT                                /FTId=VAR_016567.
FT   VARIANT     121    121       R -> S (in allele Cw*03:05).
FT                                /FTId=VAR_016617.
FT   VARIANT     127    127       V -> L (in allele Cw*03:09).
FT                                /FTId=VAR_016618.
FT   VARIANT     138    138       D -> V (in allele Cw*03:06).
FT                                /FTId=VAR_016619.
FT   VARIANT     140    140       Y -> S (in allele Cw*03:02).
FT                                /FTId=VAR_016568.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056463.
FT   CONFLICT     33     33       Y -> C (in Ref. 1; CAA25190).
FT   CONFLICT     64     65       AA -> DE (in Ref. 1; CAA25190).
FT   CONFLICT     78     79       QE -> RK (in Ref. 1; CAA25190).
FT   CONFLICT     93     93       R -> P (in Ref. 1; CAA25190).
FT   CONFLICT    140    140       Y -> H (in Ref. 1; CAA25190).
FT   CONFLICT    161    161       D -> N (in Ref. 1; CAA25190).
FT   CONFLICT    205    205       R -> G (in Ref. 1; CAA25190).
FT   STRAND       28     36
FT   TURN         39     41
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   STRAND       69     71
FT   HELIX        74     77
FT   HELIX        81    108
FT   STRAND      118    128
FT   STRAND      131    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    216
FT   STRAND      222    235
FT   STRAND      238    243
FT   TURN        249    251
FT   STRAND      261    263
FT   STRAND      268    274
FT   HELIX       277    280
FT   STRAND      281    286
FT   STRAND      294    296
SQ   SEQUENCE   366 AA;  40861 MW;  47E55680EA1F6D97 CRC64;
     MRVMAPRTLI LLLSGALALT ETWAGSHSMR YFYTAVSRPG RGEPHFIAVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQTDRV SLRNLRGYYN QSEAGSHIIQ
     RMYGCDVGPD GRLLRGYDQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRYLKNGK ETLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQWDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVVAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C04_HUMAN              Reviewed;         366 AA.
AC   P30504; O78067; O78072; O78090; O78149; Q29921; Q9UM42;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-4 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*4;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*04:01).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*04:01).
RX   MEDLINE=91277627; PubMed=1711567; DOI=10.1084/jem.174.1.53;
RA   Grassi F., Meneveri R., Gullberg M., Lopalco L., Rossi G.B., Lanza P.,
RA   de Santis C., Brattsand G., Butto S., Ginelli E., Beretta A.,
RA   Siccardi A.G.;
RT   "Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic
RT   epitope borne by class I major histocompatibility complex heavy
RT   chains.";
RL   J. Exp. Med. 174:53-62(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*04:01).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 1-365 (ALLELE CW*04:01).
RA   Dunn P.P., van Dam M., Crosby I., Carter V.;
RT   "A sequencing strategy for the rapid sequencing of HLA class I genes
RT   using random in vitro DNA transposition.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*04:03).
RC   TISSUE=B-cell;
RX   MEDLINE=97037653; PubMed=8883300;
RX   DOI=10.1111/j.1399-0039.1996.tb02615.x;
RA   Little A.-M., Mason A., Marsh S.G.E., Parham P.;
RT   "HLA-C typing of eleven Papua New Guineans: identification of an HLA-
RT   Cw4/Cw2 hybrid allele.";
RL   Tissue Antigens 48:113-117(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES CW*04:04 AND CW*04:05).
RX   MEDLINE=98349393; PubMed=9686604;
RA   Turner S., Ellexson M.E., Hickman H.D., Sidebottom D.A.,
RA   Fernandez-Vina M., Confer D.L., Hildebrand W.H.;
RT   "Sequence-based typing provides a new look at HLA-C diversity.";
RL   J. Immunol. 161:1406-1413(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*04:06).
RX   MEDLINE=99189031; PubMed=10090622;
RX   DOI=10.1034/j.1399-0039.1999.530212.x;
RA   Ren E.C., Haniff F., Loh M.T., Chan S.H., Petersdorf E., Hansen J.;
RT   "Identification of a novel HLA-C allele, Cw*0406, in a Singapore
RT   Malay.";
RL   Tissue Antigens 53:198-200(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*04:06).
RX   MEDLINE=99321038; PubMed=10395115;
RX   DOI=10.1034/j.1399-0039.1999.530615.x;
RA   Carbonnelle E., Poirier J.C., Fortier C., Marzais F., Visser C.J.T.,
RA   Borie C., Toubert A., Raffoux C., Charron D., Tamouza R.;
RT   "Characterization of a novel HLA-Cw*04 variant in a Laotian family:
RT   HLA-Cw*0406.";
RL   Tissue Antigens 53:601-603(1999).
RN   [9]
RP   INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P12I.
RX   PubMed=11390610; DOI=10.1128/JVI.75.13.6086-6094.2001;
RA   Johnson J.M., Nicot C., Fullen J., Ciminale V., Casareto L.,
RA   Mulloy J.C., Jacobson S., Franchini G.;
RT   "Free major histocompatibility complex class I heavy chain is
RT   preferentially targeted for degradation by human T-cell
RT   leukemia/lymphotropic virus type 1 p12(I) protein.";
RL   J. Virol. 75:6086-6094(2001).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). Interacts with HTLV-1 p12I accessory protein.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-4 are known: Cw*04:01
CC       Cw*04:03, Cw*04:04, Cw*04:05 and Cw*04:06. The sequence shown is
CC       that of Cw*04:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84386; AAA59705.1; -; mRNA.
DR   EMBL; X58536; CAA41427.1; -; mRNA.
DR   EMBL; AJ278494; CAB95011.1; -; Genomic_DNA.
DR   EMBL; AJ238694; CAB41889.2; -; Genomic_DNA.
DR   EMBL; L54059; AAB04639.1; -; Genomic_DNA.
DR   EMBL; U96787; AAC17719.1; -; Genomic_DNA.
DR   EMBL; U96786; AAC17719.1; JOINED; Genomic_DNA.
DR   EMBL; AF036557; AAC17720.1; -; Genomic_DNA.
DR   EMBL; AF036556; AAC17720.1; JOINED; Genomic_DNA.
DR   EMBL; AF076476; AAC27626.1; -; Genomic_DNA.
DR   EMBL; AF062588; AAC16245.1; -; Genomic_DNA.
DR   EMBL; AF062587; AAC16245.1; JOINED; Genomic_DNA.
DR   IPI; IPI00795906; -.
DR   PIR; A59028; A59028.
DR   PIR; JH0526; JH0526.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 1IM9; X-ray; 2.80 A; A/E=25-299.
DR   PDB; 1QQD; X-ray; 2.70 A; A=26-298.
DR   PDBsum; 1IM9; -.
DR   PDBsum; 1QQD; -.
DR   ProteinModelPortal; P30504; -.
DR   SMR; P30504; 26-298.
DR   IntAct; P30504; 12.
DR   MINT; MINT-101019; -.
DR   STRING; P30504; -.
DR   DMDM; 231433; -.
DR   PRIDE; P30504; -.
DR   Ensembl; ENST00000400341; ENSP00000383195; ENSG00000206435.
DR   Ensembl; ENST00000400394; ENSP00000383244; ENSG00000206452.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mn31226; -.
DR   GeneCards; GC06Mo31229; -.
DR   H-InvDB; HIX0186567; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P30504; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P30504; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P30504; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-4 alpha chain.
FT                                /FTId=PRO_0000018871.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      33     33       S -> Y (in allele Cw*04:03 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016571.
FT   VARIANT      35     35       S -> A (in allele Cw*04:03 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016572.
FT   VARIANT      38     38       W -> R (in allele Cw*04:03 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016573.
FT   VARIANT      40     40       G -> S (in allele Cw*04:03 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016574.
FT   VARIANT      45     45       R -> H (in allele Cw*04:03 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016575.
FT   VARIANT      52     52       V -> L (in allele Cw*04:05).
FT                                /FTId=VAR_016576.
FT   VARIANT      73     73       E -> A (in allele Cw*04:03 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016577.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056464.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056465.
FT   VARIANT      97     97       A -> T (in dbSNP:rs41543814).
FT                                /FTId=VAR_056466.
FT   VARIANT     180    180       R -> L (in allele Cw*04:04 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016578.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_056467.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056468.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056469.
FT   VARIANT     327    327       M -> V (in allele Cw*04:03 and allele
FT                                Cw*04:06).
FT                                /FTId=VAR_016579.
FT   STRAND       27     36
FT   STRAND       45     52
FT   STRAND       55     61
FT   STRAND       64     66
FT   STRAND       70     73
FT   HELIX        74     76
FT   HELIX        81    108
FT   STRAND      118    127
FT   STRAND      131    142
FT   STRAND      145    150
FT   STRAND      157    161
FT   HELIX       162    173
FT   HELIX       176    185
FT   HELIX       187    198
FT   HELIX       200    203
FT   STRAND      210    217
FT   STRAND      219    235
FT   STRAND      238    243
FT   HELIX       249    251
FT   STRAND      252    254
FT   STRAND      261    263
FT   STRAND      265    274
FT   HELIX       278    280
FT   STRAND      281    286
FT   STRAND      290    292
FT   STRAND      294    296
SQ   SEQUENCE   366 AA;  40995 MW;  E883EB3968658DCB CRC64;
     MRVMAPRTLI LLLSGALALT ETWAGSHSMR YFSTSVSWPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRGE PREPWVEQEG PEYWDRETQK YKRQAQADRV NLRKLRGYYN QSEDGSHTLQ
     RMFGCDLGPD GRLLRGYNQF AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQR
     RAYLEGTCVE WLRRYLENGK ETLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQWDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWKP
     SSQPTIPIVG IVAGLAVLAV LAVLGAMVAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C05_HUMAN              Reviewed;         366 AA.
AC   Q9TNN7; O02866; O62888; Q9TPV8; Q9TPX2;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   18-APR-2012, entry version 91.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-5 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*5;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*05:01).
RA   Baurain J.-F., Coulie P.G.;
RT   "New HLA-C alleles, on the basis of their transmembrane or cytoplasmic
RT   regions.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*05:01).
RA   Ellexson M.E., Zhang W., Hildebrand W.H.;
RT   "Cw*0501new.";
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 1-298 (ALLELE CW*05:01).
RC   TISSUE=Peripheral blood;
RA   Wang H., Tokunaga K.;
RT   "HLA-C locus polymorphisms in Japanese.";
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*05:02).
RA   Santos S., Vicario J.L., Balas A.;
RT   "Novel HLA-C allele.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*05:03).
RX   MEDLINE=20340082; PubMed=10885573;
RX   DOI=10.1034/j.1399-0039.2000.550515.x;
RA   Huang L.Q., Boon T., Van Pel A.;
RT   "Identification of a novel HLA-Cw*05 allele, Cw*0503.";
RL   Tissue Antigens 55:473-474(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*05:04).
RA   Santos S., Balas A., Vicario J.L.;
RT   "New HLA-Cw5 antigen.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-5 are known: Cw*05:01
CC       Cw*0502, Cw*05:03 and Cw*05:04. The sequence shown is that of
CC       Cw*05:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ010748; CAA09340.1; -; mRNA.
DR   EMBL; U57028; AAD11469.1; -; mRNA.
DR   EMBL; D64148; BAA19534.1; -; mRNA.
DR   EMBL; AF047367; AAC05205.2; -; Genomic_DNA.
DR   EMBL; AF047366; AAC05205.2; JOINED; Genomic_DNA.
DR   EMBL; AF168611; AAD50823.1; -; mRNA.
DR   EMBL; AF173008; AAD51331.1; -; Genomic_DNA.
DR   EMBL; AF173007; AAD51331.1; JOINED; Genomic_DNA.
DR   IPI; IPI00795906; -.
DR   PIR; A59028; A59028.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q9TNN7; -.
DR   SMR; Q9TNN7; 26-298.
DR   STRING; Q9TNN7; -.
DR   DMDM; 34305707; -.
DR   PRIDE; Q9TNN7; -.
DR   Ensembl; ENST00000400341; ENSP00000383195; ENSG00000206435.
DR   Ensembl; ENST00000400394; ENSP00000383244; ENSG00000206452.
DR   UCSC; uc011imr.2; human.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mn31226; -.
DR   GeneCards; GC06Mo31229; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_Q9TNN7; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; Q9TNN7; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-5 alpha chain.
FT                                /FTId=PRO_0000018872.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056470.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056471.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056472.
FT   VARIANT     138    138       N -> D (in allele Cw*05:04).
FT                                /FTId=VAR_016580.
FT   VARIANT     140    140       F -> S (in allele Cw*05:04).
FT                                /FTId=VAR_016581.
FT   VARIANT     201    201       K -> E (in allele Cw*0502).
FT                                /FTId=VAR_016582.
FT   VARIANT     207    208       EH -> DP (in allele Cw*05:03).
FT                                /FTId=VAR_016583.
FT   VARIANT     218    218       V -> I (in allele Cw*05:03).
FT                                /FTId=VAR_016584.
FT   VARIANT     223    223       A -> V (in allele Cw*05:03).
FT                                /FTId=VAR_016585.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056473.
SQ   SEQUENCE   366 AA;  40912 MW;  26454A7EE68151DA CRC64;
     MRVMAPRTLI LLLSGALALT ETWACSHSMR YFYTAVSRPG RGEPRFIAVG YVDDTQFVQF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQTDRV NLRKLRGYYN QSEAGSHTLQ
     RMYGCDLGPD GRLLRGYNQF AYDGKDYIAL NEDLRSWTAA DKAAQITQRK WEAAREAEQR
     RAYLEGTCVE WLRRYLENGK KTLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWGP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVMAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C06_HUMAN              Reviewed;         366 AA.
AC   Q29963; O19505; O78063; Q29989;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 105.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-6 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*6;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*06:02).
RX   MEDLINE=89233298; PubMed=2714853; DOI=10.1007/BF00352842;
RA   Mizuno S., Kang S.H., Lee H.W., Trapani J.A., Dupont B., Yang S.Y.;
RT   "Isolation and expression of a cDNA clone encoding HLA-CW6: unique
RT   characteristics of HLA-C encoded gene products.";
RL   Immunogenetics 29:323-330(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*06:02).
RX   MEDLINE=92285886; PubMed=1598685;
RX   DOI=10.1111/j.1399-0039.1992.tb01923.x;
RA   Steinle A., Noessner E., Schendel D.J.;
RT   "Isolation and characterization of a genomic HLA-Cw6 clone.";
RL   Tissue Antigens 39:134-137(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-366 (ALLELE CW*06:02).
RX   MEDLINE=89233295; PubMed=2714852; DOI=10.1007/BF00352839;
RA   Pohla H., Kuon W., Tabaczewski P., Doerner C., Weiss E.H.;
RT   "Allelic variation in HLA-B and HLA-C sequences and the evolution of
RT   the HLA-B alleles.";
RL   Immunogenetics 29:297-307(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*06:03).
RX   MEDLINE=98349393; PubMed=9686604;
RA   Turner S., Ellexson M.E., Hickman H.D., Sidebottom D.A.,
RA   Fernandez-Vina M., Confer D.L., Hildebrand W.H.;
RT   "Sequence-based typing provides a new look at HLA-C diversity.";
RL   J. Immunol. 161:1406-1413(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*06:04).
RC   TISSUE=Blood;
RX   MEDLINE=99321026; PubMed=10395103;
RX   DOI=10.1034/j.1399-0039.1999.530603.x;
RA   Inoue T., Ogawa A., Tokunaga K., Ishikawa Y., Kashiwase K., Tanaka H.,
RA   Park M.H., Jia G.J., Chimge N.-O., Sideltseva E.W., Akaza T.,
RA   Tadokoro K., Takahashi T., Juji T.;
RT   "Diversity of HLA-B17 alleles and haplotypes in East Asians and a
RT   novel Cw6 allele (Cw*0604) associated with B*5701.";
RL   Tissue Antigens 53:534-544(1999).
RN   [6]
RP   ASSOCIATION OF ALLELE CW*06:02 WITH PSORIASIS.
RX   PubMed=11122018; DOI=10.1046/j.1365-2133.2000.03885.x;
RA   Mallon E., Bunce M., Savoie H., Rowe A., Newson R., Gotch F.,
RA   Bunker C.B.;
RT   "HLA-C and guttate psoriasis.";
RL   Br. J. Dermatol. 143:1177-1182(2000).
RN   [7]
RP   ASSOCIATION OF ALLELE CW*06:02 WITH PSORIASIS.
RX   PubMed=16235096; DOI=10.1007/s00439-005-0048-2;
RA   Helms C., Saccone N.L., Cao L., Daw J.A.W., Cao K., Hsu T.M.,
RA   Taillon-Miller P., Duan S., Gordon D., Pierce B., Ott J., Rice J.,
RA   Fernandez-Vina M.A., Kwok P.-Y., Menter A., Bowcock A.M.;
RT   "Localization of PSORS1 to a haplotype block harboring HLA-C and
RT   distinct from corneodesmosin and HCR.";
RL   Hum. Genet. 118:466-476(2005).
RN   [8]
RP   INVOLVEMENT IN PSORS1.
RX   PubMed=16642438; DOI=10.1086/503821;
RA   Nair R.P., Stuart P.E., Nistor I., Hiremagalore R., Chia N.V.C.,
RA   Jenisch S., Weichenthal M., Abecasis G.R., Lim H.W., Christophers E.,
RA   Voorhees J.J., Elder J.T.;
RT   "Sequence and haplotype analysis supports HLA-C as the psoriasis
RT   susceptibility 1 gene.";
RL   Am. J. Hum. Genet. 78:827-851(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-6 are known: Cw*06:02
CC       Cw*06:03 and Cw*06:04. Allele Cw*062 is a risk factor that confers
CC       susceptibility to psoriasis. The sequence shown is that of
CC       Cw*06:02.
CC   -!- DISEASE: Genetic variations in HLA-C are a cause of susceptibility
CC       to psoriasis type 1 (PSORS1) [MIM:177900]. Psoriasis is a common,
CC       chronic inflammatory disease of the skin with multifactorial
CC       etiology. It is characterized by red, scaly plaques usually found
CC       on the scalp, elbows and knees. These lesions are caused by
CC       abnormal keratinocyte proliferation and infiltration of
CC       inflammatory cells into the dermis and epidermis.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28160; AAA36235.1; -; mRNA.
DR   EMBL; Z22752; CAA80437.1; -; Genomic_DNA.
DR   EMBL; Z22753; CAA80437.1; JOINED; Genomic_DNA.
DR   EMBL; Z22754; CAA80437.1; JOINED; Genomic_DNA.
DR   EMBL; M28206; AAA57258.1; -; mRNA.
DR   EMBL; AF019568; AAC17721.1; -; Genomic_DNA.
DR   EMBL; AF019567; AAC17721.1; JOINED; Genomic_DNA.
DR   EMBL; AB008136; BAA22919.1; -; Genomic_DNA.
DR   IPI; IPI00744964; -.
DR   PIR; I68749; I68749.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q29963; -.
DR   SMR; Q29963; 26-298.
DR   STRING; Q29963; -.
DR   DMDM; 34305706; -.
DR   PRIDE; Q29963; -.
DR   Ensembl; ENST00000420206; ENSP00000410214; ENSG00000228299.
DR   UCSC; uc011gas.2; human.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mk31228; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   MIM; 177900; phenotype.
DR   neXtProt; NX_Q29963; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; Q29963; -.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-6 alpha chain.
FT                                /FTId=PRO_0000018873.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      33     33       D -> Y (in allele Cw*06:03).
FT                                /FTId=VAR_016620.
FT   VARIANT      43     43       E -> K (in dbSNP:rs1050438).
FT                                /FTId=VAR_056474.
FT   VARIANT      48     48       S -> A (in dbSNP:rs707911).
FT                                /FTId=VAR_061447.
FT   VARIANT      48     48       S -> P (in dbSNP:rs707911).
FT                                /FTId=VAR_061448.
FT   VARIANT      48     48       S -> T (in dbSNP:rs707911).
FT                                /FTId=VAR_061449.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056475.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056476.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056477.
FT   VARIANT      97     97       A -> T (in dbSNP:rs41543814).
FT                                /FTId=VAR_056478.
FT   VARIANT     137    137       Y -> H (in dbSNP:rs2308574).
FT                                /FTId=VAR_056479.
FT   VARIANT     180    180       W -> L (in allele Cw*06:04).
FT                                /FTId=VAR_016621.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_056480.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056481.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056482.
FT   CONFLICT     33     33       D -> C (in Ref. 3; AAA57258).
FT   CONFLICT    202    202       T -> S (in Ref. 1; AAA36235).
SQ   SEQUENCE   366 AA;  40969 MW;  45876CB22256DE80 CRC64;
     MRVMAPRTLI LLLSGALALT ETWACSHSMR YFDTAVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQADRV NLRKLRGYYN QSEDGSHTLQ
     WMYGCDLGPD GRLLRGYDQS AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQW
     RAYLEGTCVE WLRRYLENGK ETLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVMAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C07_HUMAN              Reviewed;         366 AA.
AC   P10321; O78061; O78083; Q29631; Q29652; Q29867; Q29990; Q95463;
AC   Q95603; Q9MY31; Q9TQP9;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 3.
DT   18-APR-2012, entry version 119.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-7 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*7;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*07:04).
RX   MEDLINE=96086482; PubMed=7482492;
RX   DOI=10.1111/j.1399-0039.1995.tb02471.x;
RA   Vilches C., Bunce M., de Pablo R., Herrero M.J., Kreisler M.;
RT   "Anchored PCR cloning of the novel HLA-Cw*0704 allele detected by PCR-
RT   SSP.";
RL   Tissue Antigens 46:19-23(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES CW*07:02 AND CW*07:04).
RC   TISSUE=Blood;
RX   MEDLINE=96232973; PubMed=8655361; DOI=10.1016/0198-8859(95)00150-6;
RA   Wang H., Tokunaga K., Ishikawa Y., Asahina A., Kuwata S., Akaza T.,
RA   Tadokoro K., Shibata Y., Takiguchi M., Juji T.;
RT   "Identification and DNA typing of two Cw7 alleles (Cw*0702 and
RT   Cw*0704) in Japanese, with the corrected sequence of Cw*0702.";
RL   Hum. Immunol. 45:52-58(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*07:06).
RX   MEDLINE=97161041; PubMed=9008313;
RX   DOI=10.1111/j.1399-0039.1996.tb02694.x;
RA   Vilches C., Bunce M., Sanz L., de Pablo R., Puente S., Kreisler M.;
RT   "Molecular cloning of two new HLA-C alleles: Cw*1801 and Cw*0706.";
RL   Tissue Antigens 48:698-702(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CW*07:02).
RX   MEDLINE=98099755; PubMed=9435339; DOI=10.1007/s002510050350;
RA   Cooper S.L., Adams E.J., Wells R.S., Walker C.M., Parham P.;
RT   "A major histocompatibility complex class I allele shared by two
RT   species of chimpanzee.";
RL   Immunogenetics 47:212-217(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*07:11).
RX   MEDLINE=99299762; PubMed=10372547;
RX   DOI=10.1034/j.1399-0039.1999.530508.x;
RA   Baurain J.-F., Coulie P.G.;
RT   "Correction of HLA-Cw*0501 and identification of HLA-Cw*0711.";
RL   Tissue Antigens 53:510-512(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES CW*07:02 AND CW*07:04).
RC   TISSUE=Blood;
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*07:04).
RC   TISSUE=Melanoma;
RA   Coulie P.G.;
RT   "Identification of a new HLA-Cw7 allele.";
RL   Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-206 (ALLELE CW*07:01).
RX   MEDLINE=95176330; PubMed=7871529;
RX   DOI=10.1111/j.1399-0039.1994.tb02394.x;
RA   Steinle A., Schendel D.J.;
RT   "HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).";
RL   Tissue Antigens 44:268-270(1994).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-366 (ALLELE CW*07:03).
RX   MEDLINE=86033791; PubMed=3863816;
RA   Davidson W.F., Kress M., Khoury G., Jay G.;
RT   "Comparison of HLA class I gene sequences. Derivation of locus-
RT   specific oligonucleotide probes specific for HLA-A, HLA-B, and HLA-C
RT   genes.";
RL   J. Biol. Chem. 260:13414-13423(1985).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*07:09).
RX   MEDLINE=98349393; PubMed=9686604;
RA   Turner S., Ellexson M.E., Hickman H.D., Sidebottom D.A.,
RA   Fernandez-Vina M., Confer D.L., Hildebrand W.H.;
RT   "Sequence-based typing provides a new look at HLA-C diversity.";
RL   J. Immunol. 161:1406-1413(1998).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-338 (ALLELE CW*07:01).
RX   MEDLINE=99416847; PubMed=10488744;
RX   DOI=10.1034/j.1399-0039.1999.540208.x;
RA   van der Vlies S.A., Voorter C.E., van den Berg-Loonen E.M.;
RT   "There is more to HLA -C than exons 2 and 3: sequencing exons 1, 4 and
RT   5.";
RL   Tissue Antigens 54:169-177(1999).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 77-309 (ALLELE CW*07:01).
RX   MEDLINE=89233295; PubMed=2714852; DOI=10.1007/BF00352839;
RA   Pohla H., Kuon W., Tabaczewski P., Doerner C., Weiss E.H.;
RT   "Allelic variation in HLA-B and HLA-C sequences and the evolution of
RT   the HLA-B alleles.";
RL   Immunogenetics 29:297-307(1989).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-7 are known: Cw*07:01,
CC       Cw*07:02, Cw*07:03, Cw*07:04, Cw*07:06, Cw*07:09 and Cw*07:11. The
CC       sequence shown is that of Cw*07:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X83394; CAA58313.1; -; mRNA.
DR   EMBL; D38526; BAA07531.1; -; mRNA.
DR   EMBL; D49819; BAA08625.1; -; mRNA.
DR   EMBL; D49552; BAA08500.1; -; mRNA.
DR   EMBL; X97321; CAA65986.1; -; mRNA.
DR   EMBL; AJ001977; CAA05125.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ010749; CAA09341.1; -; mRNA.
DR   EMBL; AJ293016; CAC04321.1; -; Genomic_DNA.
DR   EMBL; AJ293017; CAC04322.1; -; Genomic_DNA.
DR   EMBL; AJ291815; CAC19191.1; -; Genomic_DNA.
DR   EMBL; U09853; AAA50217.1; -; mRNA.
DR   EMBL; AL671883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z46810; CAA86840.1; -; mRNA.
DR   EMBL; M11886; AAA52665.1; -; mRNA.
DR   EMBL; AF015557; AAC17722.1; -; Genomic_DNA.
DR   EMBL; AF015556; AAC17722.1; JOINED; Genomic_DNA.
DR   EMBL; Y18533; CAB71800.1; -; Genomic_DNA.
DR   EMBL; Y18534; CAB71800.1; JOINED; Genomic_DNA.
DR   EMBL; Y18535; CAB71800.1; JOINED; Genomic_DNA.
DR   EMBL; Y18536; CAB71800.1; JOINED; Genomic_DNA.
DR   EMBL; M28207; AAA53259.1; -; mRNA.
DR   IPI; IPI00642409; -.
DR   PIR; A24512; HLHUC4.
DR   PIR; I37078; I37078.
DR   PIR; I37529; I37529.
DR   PIR; I68750; I68750.
DR   RefSeq; NP_002108.4; NM_002117.5.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 3BZF; X-ray; 2.50 A; P/Q=3-11.
DR   PDBsum; 3BZF; -.
DR   ProteinModelPortal; P10321; -.
DR   SMR; P10321; 26-298.
DR   STRING; P10321; -.
DR   DMDM; 84028168; -.
DR   PRIDE; P10321; -.
DR   DNASU; 3107; -.
DR   Ensembl; ENST00000376228; ENSP00000365402; ENSG00000204525.
DR   GeneID; 3107; -.
DR   KEGG; hsa:3107; -.
DR   UCSC; uc003nsy.3; human.
DR   CTD; 3107; -.
DR   GeneCards; GC06M031236; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P10321; -.
DR   PharmGKB; PA35057; -.
DR   GeneTree; ENSGT00650000093032; -.
DR   HOVERGEN; HBG016709; -.
DR   KO; K06751; -.
DR   OrthoDB; EOG4F4SBG; -.
DR   PhylomeDB; P10321; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P10321; -.
DR   NextBio; 12327; -.
DR   Bgee; P10321; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P10321; -.
DR   GermOnline; ENSG00000204525; Homo sapiens.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-7 alpha chain.
FT                                /FTId=PRO_0000018874.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      10     10       L -> I (in dbSNP:rs2308527).
FT                                /FTId=VAR_059506.
FT   VARIANT      43     43       E -> K (in dbSNP:rs1050438).
FT                                /FTId=VAR_050345.
FT   VARIANT      48     48       S -> A (in dbSNP:rs707911).
FT                                /FTId=VAR_061450.
FT   VARIANT      48     48       S -> P (in dbSNP:rs707911).
FT                                /FTId=VAR_061451.
FT   VARIANT      48     48       S -> T (in dbSNP:rs707911).
FT                                /FTId=VAR_061452.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_050346.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_050347.
FT   VARIANT      90     90       K -> N (in allele Cw*07:01;
FT                                dbSNP:rs28626310).
FT                                /FTId=VAR_016590.
FT   VARIANT      97     97       A -> T (in dbSNP:rs41543814).
FT                                /FTId=VAR_050348.
FT   VARIANT     101    101       S -> N (in allele Cw*07:09;
FT                                dbSNP:rs2308557).
FT                                /FTId=VAR_016591.
FT   VARIANT     104    104       N -> K (in allele Cw*07:09;
FT                                dbSNP:rs17408553).
FT                                /FTId=VAR_016592.
FT   VARIANT     119    119       L -> F (in allele Cw*07:04 and allele
FT                                Cw*07:11).
FT                                /FTId=VAR_016593.
FT   VARIANT     123    123       S -> C (in dbSNP:rs1131115).
FT                                /FTId=VAR_059507.
FT   VARIANT     123    123       S -> F (in dbSNP:rs1131115).
FT                                /FTId=VAR_059508.
FT   VARIANT     123    123       S -> Y (in allele Cw*07:01;
FT                                dbSNP:rs1131115).
FT                                /FTId=VAR_016594.
FT   VARIANT     137    137       Y -> H (in dbSNP:rs2308574).
FT                                /FTId=VAR_050349.
FT   VARIANT     140    140       S -> F (in allele Cw*07:04 and allele
FT                                Cw*07:11).
FT                                /FTId=VAR_016595.
FT   VARIANT     171    171       L -> W (in allele Cw*07:03;
FT                                dbSNP:rs1050366).
FT                                /FTId=VAR_016646.
FT   VARIANT     180    180       L -> D (in allele Cw*07:04 and allele
FT                                Cw*07:11; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016596.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_050350.
FT   VARIANT     187    187       T -> L (in allele Cw*07:03; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016647.
FT   VARIANT     201    201       E -> K (in allele Cw*07:04 and allele
FT                                Cw0711; dbSNP:rs1131103).
FT                                /FTId=VAR_016597.
FT   VARIANT     208    208       P -> H (in dbSNP:rs1131096).
FT                                /FTId=VAR_061453.
FT   VARIANT     208    208       P -> R (in dbSNP:rs1131096).
FT                                /FTId=VAR_061454.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_050351.
FT   VARIANT     328    328       V -> I (in dbSNP:rs1050118).
FT                                /FTId=VAR_050352.
FT   VARIANT     330    330       A -> V (in dbSNP:rs1050105).
FT                                /FTId=VAR_050353.
FT   VARIANT     331    331       M -> K (in allele Cw*07:06).
FT                                /FTId=VAR_016598.
FT   VARIANT     331    331       M -> V (in dbSNP:rs1130935).
FT                                /FTId=VAR_050354.
FT   VARIANT     348    348       A -> V (in allele Cw*07:06).
FT                                /FTId=VAR_016599.
FT   VARIANT     350    350       C -> S (in dbSNP:rs35708511).
FT                                /FTId=VAR_061455.
FT   VARIANT     363    363       T -> A (in allele Cw*07:11).
FT                                /FTId=VAR_016600.
FT   CONFLICT     15     16       GG -> AA (in Ref. 7; AAA50217).
FT   CONFLICT     41     41       R -> A (in Ref. 10; AAA52665).
FT   CONFLICT    309    309       M -> V (in Ref. 13; AAA53259).
SQ   SEQUENCE   366 AA;  40649 MW;  59C23D95FD1D0BC8 CRC64;
     MRVMAPRALL LLLSGGLALT ETWACSHSMR YFDTAVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQADRV SLRNLRGYYN QSEDGSHTLQ
     RMSGCDLGPD GRLLRGYDQS AYDGKDYIAL NEDLRSWTAA DTAAQITQRK LEAARAAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRAEPPK THVTHHPLSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHMQHEGL QEPLTLSWEP
     SSQPTIPIMG IVAGLAVLVV LAVLGAVVTA MMCRRKSSGG KGGSCSQAAC SNSAQGSDES
     LITCKA
//
ID   1C08_HUMAN              Reviewed;         366 AA.
AC   P30505; P30506; P30507;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 96.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-8 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*8;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES CW*08:01 AND CW*08:02).
RX   MEDLINE=93031775; PubMed=1384166;
RX   DOI=10.1111/j.1399-0039.1992.tb01943.x;
RA   Zemmour J., Gumperz J.E., Hildebrand W.H., Ward F.E., Marsh S.G.E.,
RA   Williams R.C., Parham P.;
RT   "The molecular basis for reactivity of anti-Cw1 and anti-Cw3
RT   alloantisera with HLA-B46 haplotypes.";
RL   Tissue Antigens 39:249-257(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*08:03).
RX   MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-8 are known: Cw*08:01
CC       (Cw8.1), Cw*08:02 (Cw8.2) and Cw*08:03. The sequence shown is that
CC       of Cw*08:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84173; AAA59687.1; -; mRNA.
DR   EMBL; M84174; AAA59688.1; -; mRNA.
DR   EMBL; Z15144; CAA78850.1; -; mRNA.
DR   IPI; IPI00472903; -.
DR   PIR; I37135; I37135.
DR   PIR; I81232; I81232.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30505; -.
DR   STRING; P30505; -.
DR   DMDM; 231434; -.
DR   PRIDE; P30505; -.
DR   Ensembl; ENST00000400341; ENSP00000383195; ENSG00000206435.
DR   Ensembl; ENST00000400394; ENSP00000383244; ENSG00000206452.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mn31226; -.
DR   GeneCards; GC06Mo31229; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P30505; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P30505; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-8 alpha chain.
FT                                /FTId=PRO_0000018875.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056483.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056484.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056485.
FT   VARIANT     162    162       T -> K (in allele Cw*08:02).
FT                                /FTId=VAR_016586.
FT   VARIANT     176    176       T -> E (in allele Cw*08:02; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016587.
FT   VARIANT     180    180       L -> R (in allele Cw*08:02).
FT                                /FTId=VAR_016588.
FT   VARIANT     199    199       G -> R (in allele Cw*08:03).
FT                                /FTId=VAR_016589.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056486.
SQ   SEQUENCE   366 AA;  40773 MW;  2A84D41389A0486A CRC64;
     MRVMAPRTLI LLLSGALALT ETWACSHSMR YFYTAVSRPG RGEPRFIAVG YVDDTQFVQF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQTDRV SLRNLRGYYN QSEAGSHTLQ
     RMYGCDLGPD GRLLRGYNQF AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAARTAEQL
     RAYLEGTCVE WLRRYLENGK KTLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWGP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVMAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C12_HUMAN              Reviewed;         366 AA.
AC   P30508; O02863; O19652; O62882; O78062; O78166; O78211; O78214;
AC   P30509; Q29768; Q31627; Q860R1; Q860R2; Q99528; Q9GIK4; Q9TPS4;
AC   Q9UM32; Q9UM33;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 105.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-12 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*12;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*12:02).
RX   MEDLINE=88330144; PubMed=2843461; DOI=10.1007/BF00345504;
RA   Takata H., Inoko H., Ando A., Haranaka M., Watanabe B., Tsuji K.,
RA   Iri H.;
RT   "Cloning and analysis of HLA class I cDNA encoding a new HLA-C
RT   specificity Cx52.";
RL   Immunogenetics 28:265-270(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CW*12:02).
RX   MEDLINE=89309827; PubMed=2787363;
RA   Takiguchi M., Nishimura I., Hayashi H., Karaki S., Kariyone A.,
RA   Kano K.;
RT   "The structure and expression of genes encoding serologically
RT   undetected HLA-C locus antigens.";
RL   J. Immunol. 143:1372-1378(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*12:02).
RX   MEDLINE=94131818; PubMed=7905471; DOI=10.1016/0198-8859(93)90509-Y;
RA   Vilches C., de Pablo R., Herrero M.J., Moreno M.E., Kreisler M.;
RT   "Molecular cloning and polymerase chain reaction-sequence-specific
RT   oligonucleotide detection of the allele encoding the novel
RT   allospecificity HLA-Cw6.2 (Cw*1502) in Spanish gypsies.";
RL   Hum. Immunol. 37:259-263(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 1-298 (ALLELE CW*12:02).
RC   TISSUE=Peripheral blood;
RA   Wang H., Tokunaga K.;
RT   "HLA-C alleles in Japanese and a novel allele from a non-Japanese
RT   individual.";
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*12:02).
RA   Greville W.D., Ng G., Kennedy A., Kennedy C.T., Le T., Dodd R.,
RA   Wallace R., Dunckley H.;
RT   "An HLA-Cw allele detected by PCR-SSO.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*12:03).
RC   TISSUE=Blood;
RX   MEDLINE=95141286; PubMed=7839353;
RX   DOI=10.1111/j.1399-0039.1994.tb02379.x;
RA   Cereb N., Choi J.W., Lee S., Maye P., Kong Y., Yang S.Y.;
RT   "Identification of two new HLA-C alleles, Cw*1203 and Cw*1402, from
RT   the sequence analysis of seven HLA homozygous cell lines carrying HLA-
RT   C blank.";
RL   Tissue Antigens 44:193-195(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*12:03).
RA   Pablo R.;
RL   Submitted (OCT-1994) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*12:03).
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 1-298 (ALLELE CW*12:03).
RC   TISSUE=Peripheral blood;
RA   Wang H., Tokunaga K.;
RT   "HLA-C locus polymorphisms in Japanese.";
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*12:04).
RX   MEDLINE=98119598; PubMed=9459510;
RX   DOI=10.1111/j.1399-0039.1998.tb02953.x;
RA   Vilches C., Bunce M., van Dam M., de Pablo R.;
RT   "A new pair of HLA-C alleles, Cw*12042 and Cw*1203, differing at the
RT   KIR-related dimorphism of codons 77-80.";
RL   Tissue Antigens 51:101-105(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 1-227 (ALLELE CW*12:04).
RA   Tatari Z.;
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES CW*12:04 AND
RP   CW*12:06).
RX   MEDLINE=98349393; PubMed=9686604;
RA   Turner S., Ellexson M.E., Hickman H.D., Sidebottom D.A.,
RA   Fernandez-Vina M., Confer D.L., Hildebrand W.H.;
RT   "Sequence-based typing provides a new look at HLA-C diversity.";
RL   J. Immunol. 161:1406-1413(1998).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELE CW*12:05).
RX   MEDLINE=98119594; PubMed=9459506;
RX   DOI=10.1111/j.1399-0039.1998.tb02949.x;
RA   Grundschober C., Labonne M., Javaux F., Steiner Q.G., Gebuhrer L.,
RA   Tiercy J.-M.;
RT   "Sequence of four new HLA-Cw alleles: a possible role of interallelic
RT   recombination.";
RL   Tissue Antigens 51:72-79(1998).
RN   [14]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*12:07).
RA   Davey S., Dunn P.P.;
RT   "Nucleotide sequence of an HLA-Cw*1203 variant allele with a new
RT   polymorphic position in exon 2.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CW*12:08).
RX   MEDLINE=21970278; PubMed=11972880;
RX   DOI=10.1034/j.1399-0039.2002.590110.x;
RA   Cox S.T., Ogilvie H., Bohan E.M., Holman R., Prentice H.G., Potter M.,
RA   Madrigal J.A., Little A.-M.;
RT   "Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208.";
RL   Tissue Antigens 59:49-51(2002).
RN   [16]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*12:09).
RA   Day S., Carter V.;
RT   "Identification of confirmatory sequence of Cw*1209.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-208 AND THR-363.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-12 are known: Cw*12:02,
CC       Cw*12:03, Cw*12:04, Cw*12:05, Cw*12:06, Cw*12:07, Cw*12:08 and
CC       Cw*12:09. The sequence shown is that of Cw*12:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M21963; AAA59847.1; -; mRNA.
DR   EMBL; M28172; AAA59670.1; -; Genomic_DNA.
DR   EMBL; X70856; CAA50209.1; -; mRNA.
DR   EMBL; X70857; CAA50210.1; -; mRNA.
DR   EMBL; D64152; BAA19537.1; -; mRNA.
DR   EMBL; D83741; BAA32615.1; -; mRNA.
DR   EMBL; AF189726; AAF04581.1; -; Genomic_DNA.
DR   EMBL; AF189725; AAF04581.1; JOINED; Genomic_DNA.
DR   EMBL; U06695; AAA92995.1; -; mRNA.
DR   EMBL; U06696; AAA92996.1; -; mRNA.
DR   EMBL; X82122; CAA57634.1; -; mRNA.
DR   EMBL; AJ420248; CAD12433.1; -; Genomic_DNA.
DR   EMBL; D64146; BAA19532.1; -; mRNA.
DR   EMBL; Y11843; CAA72592.1; -; mRNA.
DR   EMBL; X99704; CAA68035.1; -; mRNA.
DR   EMBL; AF015559; AAC17724.1; -; Genomic_DNA.
DR   EMBL; AF015558; AAC17724.1; JOINED; Genomic_DNA.
DR   EMBL; AF036553; AAC17725.1; -; Genomic_DNA.
DR   EMBL; AF036552; AAC17725.1; JOINED; Genomic_DNA.
DR   EMBL; Z83247; CAB05845.1; -; mRNA.
DR   EMBL; Z80228; CAB02409.1; -; Genomic_DNA.
DR   EMBL; AJ249163; CAB53538.1; -; Genomic_DNA.
DR   EMBL; AJ249164; CAB53539.1; -; Genomic_DNA.
DR   EMBL; AJ304496; CAC19018.1; -; Genomic_DNA.
DR   EMBL; AJ550622; CAD79471.1; -; Genomic_DNA.
DR   EMBL; AJ550623; CAD79472.1; -; Genomic_DNA.
DR   IPI; IPI00743716; -.
DR   PIR; A59028; A59028.
DR   PIR; I37526; I37526.
DR   PIR; I38507; I38507.
DR   PIR; I54449; I54449.
DR   PIR; I72113; I72113.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30508; -.
DR   SMR; P30508; 26-302.
DR   IntAct; P30508; 5.
DR   STRING; P30508; -.
DR   DMDM; 34223723; -.
DR   PRIDE; P30508; -.
DR   Ensembl; ENST00000420206; ENSP00000410214; ENSG00000228299.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mk31228; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P30508; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P30508; -.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-12 alpha chain.
FT                                /FTId=PRO_0000018876.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056487.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056488.
FT   VARIANT      90     90       K -> N (in allele Cw*12:08;
FT                                dbSNP:rs28626310).
FT                                /FTId=VAR_016622.
FT   VARIANT      97     97       A -> T (in allele Cw*12:05 and allele
FT                                Cw*12:09; dbSNP:rs41543814).
FT                                /FTId=VAR_016623.
FT   VARIANT     101    101       S -> G (in allele Cw*12:07).
FT                                /FTId=VAR_016624.
FT   VARIANT     101    101       S -> N (in allele Cw*12:04, allele
FT                                Cw*12:05 and allele Cw*12:09;
FT                                dbSNP:rs2308557).
FT                                /FTId=VAR_016625.
FT   VARIANT     104    104       N -> K (in allele Cw*12:04, allele
FT                                Cw*12:05 and allele Cw*12:09;
FT                                dbSNP:rs17408553).
FT                                /FTId=VAR_016626.
FT   VARIANT     121    121       R -> W (in allele Cw*12:03, allele
FT                                Cw*12:04, allele Cw*12:05, allele
FT                                Cw*12:06, allele Cw*12:07 and allele
FT                                Cw*12:09).
FT                                /FTId=VAR_016627.
FT   VARIANT     137    137       Y -> H (in dbSNP:rs2308574).
FT                                /FTId=VAR_056489.
FT   VARIANT     144    144       G -> V (in allele Cw*12:06).
FT                                /FTId=VAR_016628.
FT   VARIANT     180    180       W -> R (in allele Cw*12:09).
FT                                /FTId=VAR_016629.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_056490.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056491.
FT   VARIANT     208    208       H -> P.
FT                                /FTId=VAR_054155.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056492.
FT   VARIANT     363    363       A -> T.
FT                                /FTId=VAR_054156.
FT   CONFLICT     25     25       C -> G (in Ref. 1).
FT   CONFLICT    140    140       S -> V (in Ref. 1; AAA59847).
SQ   SEQUENCE   366 AA;  40886 MW;  598C8795CD033FB7 CRC64;
     MRVMAPRTLI LLLSGALALT ETWACSHSMR YFYTAVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQADRV SLRNLRGYYN QSEAGSHTLQ
     RMYGCDLGPD GRLLRGYDQS AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQW
     RAYLEGTCVE WLRRYLENGK ETLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVMAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C14_HUMAN              Reviewed;         366 AA.
AC   P30510; O62879; O78178; Q29641; Q30192; Q9MY35; Q9TQJ5;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   29-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 99.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-14 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*14;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CW*14:02), AND VARIANT
RP   MET-272.
RX   MEDLINE=89309827; PubMed=2787363;
RA   Takiguchi M., Nishimura I., Hayashi H., Karaki S., Kariyone A.,
RA   Kano K.;
RT   "The structure and expression of genes encoding serologically
RT   undetected HLA-C locus antigens.";
RL   J. Immunol. 143:1372-1378(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*14:02).
RC   TISSUE=Blood;
RX   MEDLINE=95141286; PubMed=7839353;
RX   DOI=10.1111/j.1399-0039.1994.tb02379.x;
RA   Cereb N., Choi J.W., Lee S., Maye P., Kong Y., Yang S.Y.;
RT   "Identification of two new HLA-C alleles, Cw*1203 and Cw*1402, from
RT   the sequence analysis of seven HLA homozygous cell lines carrying HLA-
RT   C blank.";
RL   Tissue Antigens 44:193-195(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*14:02).
RA   Zhang L., Ellexson M.E., Hildebrand W.H.;
RL   Submitted (NOV-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-298 (ALLELE CW*14:02).
RC   TISSUE=Blood;
RX   MEDLINE=96387679; PubMed=8795149;
RX   DOI=10.1111/j.1399-0039.1996.tb02584.x;
RA   Wang H., Tokunaga K., Ogawa A., Akaza T., Tadokoro K., Takiguchi M.,
RA   Shibata Y., Juji T.;
RT   "DNA typing of Cw*14 alleles in Japanese and the corrected sequence of
RT   Cw*1402.";
RL   Tissue Antigens 47:442-446(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*14:02).
RX   MEDLINE=98349393; PubMed=9686604;
RA   Turner S., Ellexson M.E., Hickman H.D., Sidebottom D.A.,
RA   Fernandez-Vina M., Confer D.L., Hildebrand W.H.;
RT   "Sequence-based typing provides a new look at HLA-C diversity.";
RL   J. Immunol. 161:1406-1413(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*14:03).
RC   TISSUE=Blood;
RX   MEDLINE=96026856; PubMed=7499177; DOI=10.1016/0198-8859(95)00041-2;
RA   Wang H., Tokunaga K., Ishikawa Y., Lin L., Kashiwase K., Nakajima F.,
RA   Ogawa A., Kuwata S., Akaza T., Tadokoro K., Shibata Y., Yoshikura H.,
RA   Juji T.;
RT   "A new HLA-C allele, Cw*1403, associated with HLA-B44 in Japanese.";
RL   Hum. Immunol. 43:295-300(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*14:03).
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*14:04).
RX   MEDLINE=20367641; PubMed=10912513; DOI=10.1007/s002510000178;
RA   Santos S., Vicario J.L., Aviles M.J., Garcia-Sanchez F., Balas A.;
RT   "HLA-Cw*1404: a new HLA-C allele with a hybrid 77Asn-80Asn NK motif.";
RL   Immunogenetics 51:610-612(2000).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-14 are known: Cw*14:02
CC       (CB-1), Cw*14:03 (CX44) and Cw*14:04. The sequence shown is that
CC       of Cw*14:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28171; AAA59669.1; -; Genomic_DNA.
DR   EMBL; U06487; AAA92994.1; -; mRNA.
DR   EMBL; U41386; AAC32743.1; -; mRNA.
DR   EMBL; D49820; BAA89793.1; -; mRNA.
DR   EMBL; AF015555; AAC17726.1; -; Genomic_DNA.
DR   EMBL; AF015554; AAC17726.1; JOINED; Genomic_DNA.
DR   EMBL; D31817; BAA06604.1; -; mRNA.
DR   EMBL; AJ420249; CAD12434.1; -; Genomic_DNA.
DR   EMBL; AF104219; AAD21014.1; -; Genomic_DNA.
DR   EMBL; AF104218; AAD21014.1; JOINED; Genomic_DNA.
DR   IPI; IPI00749025; -.
DR   PIR; I56034; I56034.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30510; -.
DR   SMR; P30510; 26-298.
DR   STRING; P30510; -.
DR   DMDM; 34395950; -.
DR   PRIDE; P30510; -.
DR   Ensembl; ENST00000438171; ENSP00000393374; ENSG00000237022.
DR   GeneCards; GC06M031236; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_P30510; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; P30510; -.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-14 alpha chain.
FT                                /FTId=PRO_0000018877.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      45     45       R -> H (in allele Cw*14:03).
FT                                /FTId=VAR_016636.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056493.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056494.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056495.
FT   VARIANT      97     97       T -> A (in allele Cw*14:04).
FT                                /FTId=VAR_016637.
FT   VARIANT     101    101       S -> N (in allele Cw*14:03).
FT                                /FTId=VAR_016638.
FT   VARIANT     137    137       Y -> H (in dbSNP:rs2308574).
FT                                /FTId=VAR_056496.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_056497.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056498.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056499.
FT   CONFLICT     16     16       A -> T (in Ref. 2; AAA92994).
FT   CONFLICT     43     43       E -> G (in Ref. 2; AAA92994).
FT   CONFLICT    202    202       T -> S (in Ref. 1; AAA59669).
SQ   SEQUENCE   366 AA;  40838 MW;  792D335D12D6547E CRC64;
     MRVMAPRTLI LLLSGALALT ETWACSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQTDRV SLRNLRGYYN QSEAGSHTLQ
     WMFGCDLGPD GRLLRGYDQS AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQR
     RAYLEGTCVE WLRRYLENGK ETLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQWDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVVAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C15_HUMAN              Reviewed;         366 AA.
AC   Q07000; O78165; Q29864; Q29991; Q31605; Q9BD28; Q9GJ33; Q9MY49;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   18-APR-2012, entry version 94.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-15 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*15;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*15:02).
RX   MEDLINE=94131818; PubMed=7905471; DOI=10.1016/0198-8859(93)90509-Y;
RA   Vilches C., de Pablo R., Herrero M.J., Moreno M.E., Kreisler M.;
RT   "Molecular cloning and polymerase chain reaction-sequence-specific
RT   oligonucleotide detection of the allele encoding the novel
RT   allospecificity HLA-Cw6.2 (Cw*1502) in Spanish gypsies.";
RL   Hum. Immunol. 37:259-263(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*15:02).
RC   TISSUE=Peripheral blood;
RA   Wang H., Tokunaga K.;
RT   "HLA-C locus polymorphisms in Japanese.";
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*15:02).
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 1-275 (ALLELE CW*15:02).
RA   Witter K., Zahn R., Scholz S., Albert E.;
RT   "Group specific amplification and sequencing of HLA-C locus.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*15:03).
RA   Domena J.D.;
RL   Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*15:04).
RX   MEDLINE=94041472; PubMed=8225443; DOI=10.1007/BF00171805;
RA   Pablo R., Vilches C., Moreno M.E., Kreisler M.;
RT   "A novel HLA-C allele (Cw*1504) related to the Cw6.2 phenotype.";
RL   Immunogenetics 39:79-79(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*15:05).
RX   MEDLINE=94364645; PubMed=8082899; DOI=10.1007/BF00189983;
RA   Vilches C., de Pablo R., Herrero M.J., Moreno M.E., Kreisler M.;
RT   "Cw*1505: a novel HLA-C allele isolated from a B*7301 haplotype.";
RL   Immunogenetics 40:313-313(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*15:05).
RX   MEDLINE=96369317; PubMed=8773323;
RX   DOI=10.1111/j.1399-0039.1996.tb02561.x;
RA   Sanz L., Vilches C., de Pablo R., Bunce M., Moreno M.E., Kreisler M.;
RT   "Haplotypic association of two new HLA class I alleles: Cw*15052 and
RT   B*0706: evolutionary relationships of HLA-Cw*15 alleles.";
RL   Tissue Antigens 47:329-332(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*15:10).
RA   Tamouza R., Schaeffer V., Marzais F., Poirier J.C., Fortier C.,
RA   Charron D.;
RT   "New HLA-Cw*15 sequence.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*15:11).
RA   Greville W.D., Chapman G., Le T., Dodd R., Taverniti A., Dunckley H.;
RT   "Novel HLA-Cw allele detected by PCR-SSO.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-15 are known: Cw*15:02,
CC       Cw*15:03, Cw*15:04, Cw*15:05, Cw*15:10 and Cw*15:11. The sequence
CC       shown is that of Cw*15:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X67818; CAA48029.1; -; mRNA.
DR   EMBL; D83031; BAA32614.1; -; mRNA.
DR   EMBL; AJ420250; CAD12435.1; -; Genomic_DNA.
DR   EMBL; AJ272049; CAB75584.1; -; Genomic_DNA.
DR   EMBL; M99388; AAA88087.1; -; mRNA.
DR   EMBL; X73518; CAA51917.1; -; mRNA.
DR   EMBL; X78343; CAA55138.1; -; mRNA.
DR   EMBL; X87841; CAA61110.1; -; mRNA.
DR   EMBL; AF302134; AAG33823.1; -; Genomic_DNA.
DR   EMBL; AF302133; AAG33823.1; JOINED; Genomic_DNA.
DR   EMBL; AF335317; AAK07656.1; -; Genomic_DNA.
DR   EMBL; AF335316; AAK07656.1; JOINED; Genomic_DNA.
DR   IPI; IPI00471951; -.
DR   PIR; I37523; I37523.
DR   PIR; I37527; I37527.
DR   PIR; I37544; I37544.
DR   ProteinModelPortal; Q07000; -.
DR   SMR; Q07000; 26-302.
DR   STRING; Q07000; -.
DR   DMDM; 543713; -.
DR   PRIDE; Q07000; -.
DR   Ensembl; ENST00000400341; ENSP00000383195; ENSG00000206435.
DR   Ensembl; ENST00000400394; ENSP00000383244; ENSG00000206452.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mn31226; -.
DR   GeneCards; GC06Mo31229; -.
DR   H-InvDB; HIX0167430; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_Q07000; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; Q07000; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-15 alpha chain.
FT                                /FTId=PRO_0000018878.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      40     40       G -> S (in allele Cw*15:11).
FT                                /FTId=VAR_016639.
FT   VARIANT      45     45       H -> R (in allele Cw*15:10).
FT                                /FTId=VAR_016640.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056500.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056501.
FT   VARIANT      90     90       N -> K (in allele Cw*15:11).
FT                                /FTId=VAR_016641.
FT   VARIANT      97     97       T -> A (in allele Cw*15:03).
FT                                /FTId=VAR_016642.
FT   VARIANT     137    137       H -> Y (in allele Cw*15:04).
FT                                /FTId=VAR_016643.
FT   VARIANT     140    140       L -> F (in allele Cw*15:05).
FT                                /FTId=VAR_016644.
FT   VARIANT     140    140       L -> S (in allele Cw*15:04).
FT                                /FTId=VAR_016645.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_056502.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056503.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056504.
FT   CONFLICT      5      5       A -> T (in Ref. 2; BAA32614).
SQ   SEQUENCE   366 AA;  40863 MW;  FDF703B7AFB05FDD CRC64;
     MRVMAPRTLL LLLSGALALT ETWACSHSMR YFYTAVSRPG RGEPHFIAVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQN YKRQAQTDRV NLRKLRGYYN QSEAGSHIIQ
     RMYGCDLGPD GRLLRGHDQL AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVMAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C16_HUMAN              Reviewed;         366 AA.
AC   Q29960; O78091; O78202; Q29862; Q29959; Q9MY74; Q9MYI3; Q9TNZ8;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 94.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-16 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*16;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*16:01), AND ALTERNATIVE
RP   SPLICING.
RX   MEDLINE=89122144; PubMed=2914713; DOI=10.1007/BF00395855;
RA   Cianetti L., Testa U., Scotto L., la Valle R., Simeone A., Boccoli G.,
RA   Giannella G., Peschle C., Boncinelli E.;
RT   "Three new class I HLA alleles: structure of mRNAs and alternative
RT   mechanisms of processing.";
RL   Immunogenetics 29:80-91(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*16:02).
RX   MEDLINE=95164264; PubMed=7860363; DOI=10.1016/0198-8859(94)90011-6;
RA   Vilches C., Herrero M.J., de Pablo R., Moreno M.E., Bunce M.,
RA   Kreisler M.;
RT   "Molecular characterization of a novel, serologically detectable, HLA-
RT   C allele: Cw*1602.";
RL   Hum. Immunol. 41:167-170(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-338 (ALLELE CW*16:04).
RX   MEDLINE=99416847; PubMed=10488744;
RX   DOI=10.1034/j.1399-0039.1999.540208.x;
RA   van der Vlies S.A., Voorter C.E., van den Berg-Loonen E.M.;
RT   "There is more to HLA -C than exons 2 and 3: sequencing exons 1, 4 and
RT   5.";
RL   Tissue Antigens 54:169-177(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE CW*16:04).
RX   MEDLINE=98349393; PubMed=9686604;
RA   Turner S., Ellexson M.E., Hickman H.D., Sidebottom D.A.,
RA   Fernandez-Vina M., Confer D.L., Hildebrand W.H.;
RT   "Sequence-based typing provides a new look at HLA-C diversity.";
RL   J. Immunol. 161:1406-1413(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*16:04).
RX   MEDLINE=98119594; PubMed=9459506;
RX   DOI=10.1111/j.1399-0039.1998.tb02949.x;
RA   Grundschober C., Labonne M., Javaux F., Steiner Q.G., Gebuhrer L.,
RA   Tiercy J.-M.;
RT   "Sequence of four new HLA-Cw alleles: a possible role of interallelic
RT   recombination.";
RL   Tissue Antigens 51:72-79(1998).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system (By similarity).
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q29960-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q29960-2; Sequence=VSP_008096;
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-16 are known: Cw*16:01,
CC       Cw*16:02 (CW*CL10V) and Cw*16:04. The sequence shown is that of
CC       Cw*16:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24097; AAA59656.1; -; mRNA.
DR   EMBL; M24097; AAA59657.1; -; mRNA.
DR   EMBL; X76189; CAA53783.1; -; mRNA.
DR   EMBL; AJ011883; CAB65547.1; -; Genomic_DNA.
DR   EMBL; Y18657; CAB72095.1; -; Genomic_DNA.
DR   EMBL; Y18658; CAB72095.1; JOINED; Genomic_DNA.
DR   EMBL; Y18659; CAB72095.1; JOINED; Genomic_DNA.
DR   EMBL; Y18139; CAB71932.1; -; Genomic_DNA.
DR   EMBL; U96789; AAC17728.1; -; Genomic_DNA.
DR   EMBL; U96788; AAC17728.1; JOINED; Genomic_DNA.
DR   EMBL; Z75172; CAA99487.1; -; Genomic_DNA.
DR   IPI; IPI00472035; -.
DR   IPI; IPI00745649; -.
DR   PIR; A59028; A59028.
DR   PIR; S42823; S42823.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q29960; -.
DR   SMR; Q29960; 26-302.
DR   STRING; Q29960; -.
DR   DMDM; 34305705; -.
DR   PRIDE; Q29960; -.
DR   Ensembl; ENST00000438171; ENSP00000393374; ENSG00000237022.
DR   GeneCards; GC06M031236; -.
DR   H-InvDB; HIX0078594; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_Q29960; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; Q29960; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Host-virus interaction; Immunity;
KW   Membrane; MHC I; Polymorphism; Reference proteome; Secreted; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-16 alpha chain.
FT                                /FTId=PRO_0000018879.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VAR_SEQ     299    338       Missing (in isoform 2).
FT                                /FTId=VSP_008096.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056505.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056506.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056507.
FT   VARIANT     101    101       S -> N (in allele Cw*16:02).
FT                                /FTId=VAR_016630.
FT   VARIANT     104    104       N -> K (in allele Cw*16:02).
FT                                /FTId=VAR_016631.
FT   VARIANT     137    137       Y -> H (in dbSNP:rs2308574).
FT                                /FTId=VAR_056508.
FT   VARIANT     153    153       H -> D (in allele Cw*16:02 and allele
FT                                Cw*16:04).
FT                                /FTId=VAR_016632.
FT   VARIANT     157    157       C -> W (in allele Cw*16:02 and allele
FT                                Cw*16:04).
FT                                /FTId=VAR_016633.
FT   VARIANT     180    180       Q -> W (in allele Cw*16:04; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016634.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_056509.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056510.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056511.
SQ   SEQUENCE   366 AA;  40753 MW;  5F8001BB016F1610 CRC64;
     MRVMAPRTLI LLLSGALALT ETWACSHSMR YFYTAVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQTDRV SLRNLRGYYN QSEAGSHTLQ
     WMYGCDLGPD GRLLRGYDQS AYDGKDYIAL NEHLRSCTAA DTAAQITQRK WEAARAAEQQ
     RAYLEGTCVE WLRRYLENGK ETLQRAEHPK THVTHHLVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IVAGLAVLAV LAVLGAVVAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   1C17_HUMAN              Reviewed;         372 AA.
AC   Q95604; O02864; O02958; Q29643; Q9MY30;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   18-APR-2012, entry version 94.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-17 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*17;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=D6S204, HLA-JY3, HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*17:01).
RA   Herrero M.J.;
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*17:01).
RA   Wells R.S., Parham P.;
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*17:01).
RA   Herrero M.J., Vilches C.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*17:01).
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-298 (ALLELE CW*17:01).
RC   TISSUE=Blood;
RA   Yang S., Cereb N.;
RT   "Nucleotide sequence analysis of HLA-Cw blank alleles from seven B
RT   cell lines.";
RL   Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 1-289 (ALLELE CW*17:02).
RC   TISSUE=Peripheral blood;
RA   Wang H., Tokunaga K.;
RT   "HLA-C locus polymorphisms in Japanese.";
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-338 (ALLELE CW*17:03).
RX   MEDLINE=99416847; PubMed=10488744;
RX   DOI=10.1034/j.1399-0039.1999.540208.x;
RA   van der Vlies S.A., Voorter C.E., van den Berg-Loonen E.M.;
RT   "There is more to HLA -C than exons 2 and 3: sequencing exons 1, 4 and
RT   5.";
RL   Tissue Antigens 54:169-177(1999).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-17 are known: Cw*17:01,
CC       Cw*17:02 and Cw*17:03. The sequence shown is that of Cw*17:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X98742; CAA67294.1; -; mRNA.
DR   EMBL; U62824; AAB67322.1; -; mRNA.
DR   EMBL; Y10520; CAA71531.1; -; mRNA.
DR   EMBL; AJ420252; CAD12437.1; -; Genomic_DNA.
DR   EMBL; U06835; AAA17674.1; -; mRNA.
DR   EMBL; D64149; BAA20857.1; -; mRNA.
DR   EMBL; Y18537; CAB71837.1; -; Genomic_DNA.
DR   EMBL; Y18538; CAB71837.1; JOINED; Genomic_DNA.
DR   EMBL; Y18539; CAB71837.1; JOINED; Genomic_DNA.
DR   EMBL; Y18540; CAB71837.1; JOINED; Genomic_DNA.
DR   EMBL; Y18541; CAB71837.1; JOINED; Genomic_DNA.
DR   IPI; IPI00473006; -.
DR   PIR; A59028; A59028.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.656020; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q95604; -.
DR   SMR; Q95604; 26-298.
DR   STRING; Q95604; -.
DR   DMDM; 34395506; -.
DR   PRIDE; Q95604; -.
DR   Ensembl; ENST00000400341; ENSP00000383195; ENSG00000206435.
DR   Ensembl; ENST00000400394; ENSP00000383244; ENSG00000206452.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mn31226; -.
DR   GeneCards; GC06Mo31229; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_Q95604; -.
DR   eggNOG; NOG42056; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; Q95604; -.
DR   GermOnline; ENSG00000204525; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    372       HLA class I histocompatibility antigen,
FT                                Cw-17 alpha chain.
FT                                /FTId=PRO_0000018880.
FT   TOPO_DOM     25    317       Extracellular (Potential).
FT   TRANSMEM    318    338       Helical; (Potential).
FT   TOPO_DOM    339    372       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    317       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT       7      8       QA -> RT (in allele Cw*17:02).
FT                                /FTId=VAR_016648.
FT   VARIANT      10     10       L -> I (in allele Cw*17:02).
FT                                /FTId=VAR_016649.
FT   VARIANT      24     24       A -> T (in allele Cw*17:03).
FT                                /FTId=VAR_016650.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056512.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056513.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056514.
FT   VARIANT      97     97       A -> T (in dbSNP:rs41543814).
FT                                /FTId=VAR_056515.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056516.
SQ   SEQUENCE   372 AA;  41238 MW;  D5DDCE6361D93AA2 CRC64;
     MRVMAPQALL LLLSGALALI ETWAGSHSMR YFYTAVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQADRV NLRKLRGYYN QSEAGSHTIQ
     RMYGCDLGPD GRLLRGYNQF AYDGKDYIAL NEDLRSWTAA DTAAQISQRK LEAAREAEQL
     RAYLEGECVE WLRGYLENGK ETLQRAERPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL QEPCTLRWKP
     SSQPTIPNLG IVSGPAVLAV LAVLAVLAVL GAVVAAVIHR RKSSGGKGGS CSQAASSNSA
     QGSDESLIAC KA
//
ID   1C18_HUMAN              Reviewed;         366 AA.
AC   Q29865; O78203; P79498;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 86.
DE   RecName: Full=HLA class I histocompatibility antigen, Cw-18 alpha chain;
DE   AltName: Full=MHC class I antigen Cw*18;
DE   Flags: Precursor;
GN   Name=HLA-C; Synonyms=HLAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*18:01).
RX   MEDLINE=97161041; PubMed=9008313;
RX   DOI=10.1111/j.1399-0039.1996.tb02694.x;
RA   Vilches C., Bunce M., Sanz L., de Pablo R., Puente S., Kreisler M.;
RT   "Molecular cloning of two new HLA-C alleles: Cw*1801 and Cw*0706.";
RL   Tissue Antigens 48:698-702(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE CW*18:01).
RX   MEDLINE=22512041; PubMed=12622774;
RX   DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE CW*18:01).
RX   MEDLINE=98119594; PubMed=9459506;
RX   DOI=10.1111/j.1399-0039.1998.tb02949.x;
RA   Grundschober C., Labonne M., Javaux F., Steiner Q.G., Gebuhrer L.,
RA   Tiercy J.-M.;
RT   "Sequence of four new HLA-Cw alleles: a possible role of interallelic
RT   recombination.";
RL   Tissue Antigens 51:72-79(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CW*18:02).
RX   MEDLINE=97378891; PubMed=9234488;
RX   DOI=10.1111/j.1399-0039.1997.tb02814.x;
RA   Vilches C., Bunce M., de Pablo R., Moreno M.E., Puente S., Sanz L.,
RA   Kreisler M.;
RT   "The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi
RT   population from Equatorial Guinea.";
RL   Tissue Antigens 49:644-648(1997).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment through
CC       interaction with human herpesvirus 8 MIR1 protein. This targets
CC       the protein for rapid degradation via the ubiquitin system (By
CC       similarity).
CC   -!- POLYMORPHISM: The following alleles of Cw-18 are known: Cw*18:01
CC       (Cw*04GB) and Cw*18:02 (Cw*18GB). The sequence shown is that of
CC       Cw*18:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X96582; CAA65401.1; -; mRNA.
DR   EMBL; AJ420253; CAD12438.1; -; Genomic_DNA.
DR   EMBL; Z80227; CAB02408.1; -; Genomic_DNA.
DR   EMBL; Y09156; CAA70354.1; -; mRNA.
DR   IPI; IPI00472162; -.
DR   ProteinModelPortal; Q29865; -.
DR   SMR; Q29865; 26-298.
DR   STRING; Q29865; -.
DR   DMDM; 34304188; -.
DR   PRIDE; Q29865; -.
DR   Ensembl; ENST00000420206; ENSP00000410214; ENSG00000228299.
DR   GeneCards; GC06M031236; -.
DR   GeneCards; GC06Mk31228; -.
DR   HGNC; HGNC:4933; HLA-C.
DR   MIM; 142840; gene.
DR   neXtProt; NX_Q29865; -.
DR   HOVERGEN; HBG016709; -.
DR   CleanEx; HS_HLA-C; -.
DR   Genevestigator; Q29865; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    366       HLA class I histocompatibility antigen,
FT                                Cw-18 alpha chain.
FT                                /FTId=PRO_0000018881.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    333       Helical; (Potential).
FT   TOPO_DOM    334    366       Cytoplasmic (Potential).
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) (By similarity).
FT   DISULFID    125    188       By similarity.
FT   DISULFID    227    283       By similarity.
FT   VARIANT      10     10       L -> I (in dbSNP:rs2308527).
FT                                /FTId=VAR_059509.
FT   VARIANT      43     43       E -> K (in dbSNP:rs1050438).
FT                                /FTId=VAR_056517.
FT   VARIANT      48     48       S -> A (in dbSNP:rs707911).
FT                                /FTId=VAR_061456.
FT   VARIANT      48     48       S -> P (in dbSNP:rs707911).
FT                                /FTId=VAR_061457.
FT   VARIANT      48     48       S -> T (in dbSNP:rs707911).
FT                                /FTId=VAR_061458.
FT   VARIANT      73     73       A -> E (in dbSNP:rs1050409).
FT                                /FTId=VAR_056518.
FT   VARIANT      76     76       V -> M (in dbSNP:rs1065382).
FT                                /FTId=VAR_056519.
FT   VARIANT      90     90       K -> N (in dbSNP:rs28626310).
FT                                /FTId=VAR_056520.
FT   VARIANT      97     97       A -> T (in dbSNP:rs41543814).
FT                                /FTId=VAR_056521.
FT   VARIANT     182    182       A -> V (in dbSNP:rs1059539).
FT                                /FTId=VAR_056522.
FT   VARIANT     201    201       E -> K (in dbSNP:rs1131103).
FT                                /FTId=VAR_056523.
FT   VARIANT     272    272       V -> M (in dbSNP:rs1050276).
FT                                /FTId=VAR_056524.
FT   VARIANT     319    319       V -> A (in allele Cw*18:02).
FT                                /FTId=VAR_016635.
SQ   SEQUENCE   366 AA;  40933 MW;  67CE7E948E4327D8 CRC64;
     MRVMAPRALL LLLSGGLALT ETWACSHSMR YFDTAVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQADRV NLRKLRGYYN QSEDGSHTLQ
     RMFGCDLGPD GRLLRGYNQF AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQR
     RAYLEGTCVE WLRRYLENGK ETLQRAEHPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQWDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWKP
     SSQPTIPIVG IVAGLAVLVV LAVLGAVVAV VMCRRKSSGG KGGSCSQAAS SNSAQGSDES
     LIACKA
//
ID   2A5A_HUMAN              Reviewed;         486 AA.
AC   Q15172; B2R6D2; B7Z7L2; D3DT99; Q2NL72; Q5VVB2; Q8TBI9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform;
DE   AltName: Full=PP2A B subunit isoform B'-alpha;
DE   AltName: Full=PP2A B subunit isoform B56-alpha;
DE   AltName: Full=PP2A B subunit isoform PR61-alpha;
DE            Short=PR61alpha;
DE   AltName: Full=PP2A B subunit isoform R5-alpha;
GN   Name=PPP2R5A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary cancer;
RX   MEDLINE=96064678; PubMed=7592815; DOI=10.1074/jbc.270.44.26123;
RA   McCright B., Virshup D.M.;
RT   "Identification of a new family of protein phosphatase 2A regulatory
RT   subunits.";
RL   J. Biol. Chem. 270:26123-26128(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 47-56; 129-132; 347-354; 448-462 AND 471-480.
RC   TISSUE=Brain;
RX   MEDLINE=96276417; PubMed=8694763;
RA   Zolnierowicz S., van Hoof C., Andjelkovic N., Cron P., Stevens I.,
RA   Merlevede W., Goris J., Hemmings B.A.;
RT   "The variable subunit associated with protein phosphatase 2A0 defines
RT   a novel multimember family of regulatory subunits.";
RL   Biochem. J. 317:187-194(1996).
RN   [7]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   MEDLINE=96355607; PubMed=8703017; DOI=10.1074/jbc.271.36.22081;
RA   McCright B., Rivers A.M., Audlin S., Virshup D.M.;
RT   "The B56 family of protein phosphatase 2A (PP2A) regulatory subunits
RT   encodes differentiation-induced phosphoproteins that target PP2A to
RT   both nucleus and cytoplasm.";
RL   J. Biol. Chem. 271:22081-22089(1996).
RN   [8]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SGOL1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-42, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules. Interacts with SGOL1.
CC   -!- INTERACTION:
CC       O96017:CHEK2; NbExp=2; IntAct=EBI-641666, EBI-1180783;
CC       Q9BVP2:GNL3; NbExp=3; IntAct=EBI-641666, EBI-641642;
CC       P30154:PPP2R1B; NbExp=2; IntAct=EBI-641666, EBI-357094;
CC       Q5FBB7:SGOL1; NbExp=3; IntAct=EBI-641666, EBI-989069;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Chromosome, centromere.
CC       Note=From mitotic prophase to metaphase, localizes at the inner
CC       centromere between a pair of sister kinetochores. Decreased
CC       expression at the onset of anaphase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15172-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15172-2; Sequence=VSP_042889;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Widely expressed with the highest expression
CC       in heart and skeletal muscle.
CC   -!- PTM: Phosphorylated on serine residues.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B56
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42373; AAC37601.1; -; mRNA.
DR   EMBL; AK302202; BAH13648.1; -; mRNA.
DR   EMBL; AK312530; BAG35429.1; -; mRNA.
DR   EMBL; AL451060; CAH71821.1; -; Genomic_DNA.
DR   EMBL; AL360091; CAH71821.1; JOINED; Genomic_DNA.
DR   EMBL; AL360091; CAH73229.1; -; Genomic_DNA.
DR   EMBL; AL451060; CAH73229.1; JOINED; Genomic_DNA.
DR   EMBL; CH471100; EAW93392.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93393.1; -; Genomic_DNA.
DR   EMBL; BC022474; AAH22474.1; -; mRNA.
DR   EMBL; BC110883; AAI10884.1; -; mRNA.
DR   IPI; IPI00014978; -.
DR   IPI; IPI00983231; -.
DR   PIR; I55449; I55449.
DR   RefSeq; NP_001186685.1; NM_001199756.1.
DR   RefSeq; NP_006234.1; NM_006243.3.
DR   UniGene; Hs.497684; -.
DR   ProteinModelPortal; Q15172; -.
DR   SMR; Q15172; 63-461.
DR   DIP; DIP-459N; -.
DR   IntAct; Q15172; 13.
DR   MINT; MINT-88251; -.
DR   STRING; Q15172; -.
DR   PhosphoSite; Q15172; -.
DR   DMDM; 7387496; -.
DR   OGP; Q15172; -.
DR   PeptideAtlas; Q15172; -.
DR   PRIDE; Q15172; -.
DR   DNASU; 5525; -.
DR   Ensembl; ENST00000261461; ENSP00000261461; ENSG00000066027.
DR   Ensembl; ENST00000537030; ENSP00000442866; ENSG00000066027.
DR   GeneID; 5525; -.
DR   KEGG; hsa:5525; -.
DR   UCSC; uc001hjb.3; human.
DR   CTD; 5525; -.
DR   GeneCards; GC01P212458; -.
DR   H-InvDB; HIX0001568; -.
DR   HGNC; HGNC:9309; PPP2R5A.
DR   MIM; 601643; gene.
DR   neXtProt; NX_Q15172; -.
DR   PharmGKB; PA33672; -.
DR   eggNOG; NOG264925; -.
DR   GeneTree; ENSGT00550000074525; -.
DR   HOGENOM; HBG602178; -.
DR   HOVERGEN; HBG000009; -.
DR   InParanoid; Q15172; -.
DR   KO; K11584; -.
DR   OMA; HELESNR; -.
DR   OrthoDB; EOG483D4M; -.
DR   PhylomeDB; Q15172; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_383; DNA Replication.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 21392; -.
DR   ArrayExpress; Q15172; -.
DR   Bgee; Q15172; -.
DR   CleanEx; HS_PPP2R5A; -.
DR   Genevestigator; Q15172; -.
DR   GermOnline; ENSG00000066027; Homo sapiens.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:BHF-UCL.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc.
DR   GO; GO:0090005; P:negative regulation of establishment of protein localization in plasma membrane; IMP:BHF-UCL.
DR   GO; GO:0090219; P:negative regulation of lipid kinase activity; IMP:BHF-UCL.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002554; PP2A_B56.
DR   PANTHER; PTHR10257; B56; 1.
DR   Pfam; PF01603; B56; 1.
DR   PIRSF; PIRSF028043; PP2A_B56; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Centromere; Chromosome; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    486       Serine/threonine-protein phosphatase 2A
FT                                56 kDa regulatory subunit alpha isoform.
FT                                /FTId=PRO_0000071448.
FT   COMPBIAS      2      5       Poly-Ser.
FT   MOD_RES      41     41       Phosphoserine.
FT   MOD_RES      42     42       Phosphoserine.
FT   VAR_SEQ       1     61       MSSSSPPAGAASAAISASEKVDGFTRKSVRKAQRQKRSQGS
FT                                SQFRSQGSQAELHPLPQLKD -> MIMN (in isoform
FT                                2).
FT                                /FTId=VSP_042889.
FT   CONFLICT     52     52       E -> F (in Ref. 6; AA sequence).
FT   CONFLICT     54     54       H -> S (in Ref. 6; AA sequence).
FT   CONFLICT    176    176       Q -> R (in Ref. 5; AAH22474).
FT   CONFLICT    389    389       D -> N (in Ref. 5; AAH22474).
FT   CONFLICT    451    451       R -> E (in Ref. 6; AA sequence).
SQ   SEQUENCE   486 AA;  56194 MW;  D31407F7032A6D44 CRC64;
     MSSSSPPAGA ASAAISASEK VDGFTRKSVR KAQRQKRSQG SSQFRSQGSQ AELHPLPQLK
     DATSNEQQEL FCQKLQQCCI LFDFMDSVSD LKSKEIKRAT LNELVEYVST NRGVIVESAY
     SDIVKMISAN IFRTLPPSDN PDFDPEEDEP TLEASWPHIQ LVYEFFLRFL ESPDFQPSIA
     KRYIDQKFVQ QLLELFDSED PRERDFLKTV LHRIYGKFLG LRAFIRKQIN NIFLRFIYET
     EHFNGVAELL EILGSIINGF ALPLKAEHKQ FLMKVLIPMH TAKGLALFHA QLAYCVVQFL
     EKDTTLTEPV IRGLLKFWPK TCSQKEVMFL GEIEEILDVI EPTQFKKIEE PLFKQISKCV
     SSSHFQVAER ALYFWNNEYI LSLIEENIDK ILPIMFASLY KISKEHWNPT IVALVYNVLK
     TLMEMNGKLF DDLTSSYKAE RQREKKKELE REELWKKLEE LKLKKALEKQ NSAYNMHSIL
     SNTSAE
//
ID   2A5B_HUMAN              Reviewed;         497 AA.
AC   Q15173; Q13853;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 112.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform;
DE   AltName: Full=PP2A B subunit isoform B'-beta;
DE   AltName: Full=PP2A B subunit isoform B56-beta;
DE   AltName: Full=PP2A B subunit isoform PR61-beta;
DE   AltName: Full=PP2A B subunit isoform R5-beta;
GN   Name=PPP2R5B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-1).
RC   TISSUE=Fetal brain;
RX   MEDLINE=96064678; PubMed=7592815; DOI=10.1074/jbc.270.44.26123;
RA   McCright B., Virshup D.M.;
RT   "Identification of a new family of protein phosphatase 2A regulatory
RT   subunits.";
RL   J. Biol. Chem. 270:26123-26128(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-2), AND PARTIAL PROTEIN
RP   SEQUENCE.
RC   TISSUE=Brain;
RX   MEDLINE=96276417; PubMed=8694763;
RA   Zolnierowicz S., van Hoof C., Andjelkovic N., Cron P., Stevens I.,
RA   Merlevede W., Goris J., Hemmings B.A.;
RT   "The variable subunit associated with protein phosphatase 2A0 defines
RT   a novel multimember family of regulatory subunits.";
RL   Biochem. J. 317:187-194(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA-1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   MEDLINE=96355607; PubMed=8703017; DOI=10.1074/jbc.271.36.22081;
RA   McCright B., Rivers A.M., Audlin S., Virshup D.M.;
RT   "The B56 family of protein phosphatase 2A (PP2A) regulatory subunits
RT   encodes differentiation-induced phosphoproteins that target PP2A to
RT   both nucleus and cytoplasm.";
RL   J. Biol. Chem. 271:22081-22089(1996).
RN   [5]
RP   INTERACTION WITH SGOL1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [6]
RP   FUNCTION, PHOSPHORYLATION AT SER-32; SER-35; SER-44; SER-46; SER-47
RP   AND SER-48, AND INTERACTION WITH AKT1.
RX   PubMed=21329884; DOI=10.1016/j.molcel.2011.02.007;
RA   Rodgers J.T., Vogel R.O., Puigserver P.;
RT   "Clk2 and B56-beta mediate insulin-regulated assembly of the PP2A
RT   phosphatase holoenzyme complex on Akt.";
RL   Mol. Cell 41:471-479(2011).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment. The phosphorylated form mediates the interaction
CC       between AKT1 and PP2A phosphatase leading to dephosphorylation of
CC       AKT1 on the 'Thr-308' and 'Ser-373' residues.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules. Interacts with SGOL1. Interacts with
CC       AKT1.
CC   -!- INTERACTION:
CC       O96017:CHEK2; NbExp=2; IntAct=EBI-1369497, EBI-1180783;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta-1;
CC         IsoId=Q15173-1; Sequence=Displayed;
CC       Name=Beta-2;
CC         IsoId=Q15173-2; Sequence=VSP_005109;
CC   -!- TISSUE SPECIFICITY: Highest expression in brain.
CC   -!- INDUCTION: By retinoic acid; in neuroblastoma cell lines.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B56
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42374; AAC37602.1; -; mRNA.
DR   EMBL; Z69028; CAA93152.1; -; mRNA.
DR   EMBL; BC045619; AAH45619.1; -; mRNA.
DR   IPI; IPI00014980; -.
DR   IPI; IPI00219690; -.
DR   PIR; I70147; I70147.
DR   RefSeq; NP_006235.1; NM_006244.3.
DR   UniGene; Hs.75199; -.
DR   ProteinModelPortal; Q15173; -.
DR   SMR; Q15173; 66-437.
DR   IntAct; Q15173; 4.
DR   MINT; MINT-2835290; -.
DR   STRING; Q15173; -.
DR   PhosphoSite; Q15173; -.
DR   DMDM; 7387497; -.
DR   PRIDE; Q15173; -.
DR   DNASU; 5526; -.
DR   Ensembl; ENST00000164133; ENSP00000164133; ENSG00000068971.
DR   GeneID; 5526; -.
DR   KEGG; hsa:5526; -.
DR   UCSC; uc001oby.3; human.
DR   CTD; 5526; -.
DR   GeneCards; GC11P064692; -.
DR   H-InvDB; HIX0009775; -.
DR   HGNC; HGNC:9310; PPP2R5B.
DR   HPA; HPA036607; -.
DR   MIM; 601644; gene.
DR   neXtProt; NX_Q15173; -.
DR   PharmGKB; PA33673; -.
DR   eggNOG; NOG264925; -.
DR   GeneTree; ENSGT00550000074525; -.
DR   HOGENOM; HBG602178; -.
DR   HOVERGEN; HBG000009; -.
DR   InParanoid; Q15173; -.
DR   KO; K11584; -.
DR   OMA; PQVATSG; -.
DR   PhylomeDB; Q15173; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_116125; Disease.
DR   Reactome; REACT_383; DNA Replication.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 21396; -.
DR   ArrayExpress; Q15173; -.
DR   Bgee; Q15173; -.
DR   CleanEx; HS_PPP2R5B; -.
DR   Genevestigator; Q15173; -.
DR   GermOnline; ENSG00000068971; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc.
DR   GO; GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002554; PP2A_B56.
DR   PANTHER; PTHR10257; B56; 1.
DR   Pfam; PF01603; B56; 1.
DR   PIRSF; PIRSF028043; PP2A_B56; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   CHAIN         1    497       Serine/threonine-protein phosphatase 2A
FT                                56 kDa regulatory subunit beta isoform.
FT                                /FTId=PRO_0000071450.
FT   MOD_RES      32     32       Phosphoserine; by CLK2 (Probable).
FT   MOD_RES      35     35       Phosphoserine; by CLK2 (Probable).
FT   MOD_RES      44     44       Phosphoserine; by CLK2 (Probable).
FT   MOD_RES      46     46       Phosphoserine; by CLK2 (Probable).
FT   MOD_RES      47     47       Phosphoserine; by CLK2 (Probable).
FT   MOD_RES      48     48       Phosphoserine; by CLK2 (Probable).
FT   VAR_SEQ       1     19       METKLPPASTPTSPSSPGL -> MITVNPPLPQDTVNLF
FT                                (in isoform Beta-2).
FT                                /FTId=VSP_005109.
FT   CONFLICT     57     58       QE -> IF (in Ref. 2; AA sequence).
FT   CONFLICT    177    178       ES -> GA (in Ref. 2; AA sequence).
FT   CONFLICT    181    181       F -> M (in Ref. 2; AA sequence).
FT   CONFLICT    184    184       S -> M (in Ref. 2; AA sequence).
FT   CONFLICT    461    461       W -> E (in Ref. 2; AA sequence).
SQ   SEQUENCE   497 AA;  57393 MW;  8BEF84F20A77982D CRC64;
     METKLPPAST PTSPSSPGLS PVPPPDKVDG FSRRSLRRAR PRRSHSSSQF RYQSNQQELT
     PLPLLKDVPA SELHELLSRK LAQCGVMFDF LDCVADLKGK EVKRAALNEL VECVGSTRGV
     LIEPVYPDII RMISVNIFRT LPPSENPEFD PEEDEPNLEP SWPHLQLVYE FFLRFLESPD
     FQPSVAKRYV DQKFVLMLLE LFDSEDPRER EYLKTILHRV YGKFLGLRAY IRKQCNHIFL
     RFIYEFEHFN GVAELLEILG SIINGFALPL KTEHKQFLVR VLIPLHSVKS LSVFHAQLAY
     CVVQFLEKDA TLTEHVIRGL LKYWPKTCTQ KEVMFLGEME EILDVIEPSQ FVKIQEPLFK
     QVARCVSSPH FQVAERALYF WNNEYILSLI EDNCHTVLPA VFGTLYQVSK EHWNQTIVSL
     IYNVLKTFME MNGKLFDELT ASYKLEKQQE QQKAQERQEL WQGLEELRLR RLQGTQGAKE
     APLQRLTPQV AASGGQS
//
ID   2A5D_HUMAN              Reviewed;         602 AA.
AC   Q14738; A8K3I9; B5BUA6; O00494; O00696; Q15171; Q5TC39;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 131.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform;
DE   AltName: Full=PP2A B subunit isoform B'-delta;
DE   AltName: Full=PP2A B subunit isoform B56-delta;
DE   AltName: Full=PP2A B subunit isoform PR61-delta;
DE   AltName: Full=PP2A B subunit isoform R5-delta;
GN   Name=PPP2R5D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM DELTA-1).
RC   TISSUE=Fetal brain;
RX   MEDLINE=96355607; PubMed=8703017; DOI=10.1074/jbc.271.36.22081;
RA   McCright B., Rivers A.M., Audlin S., Virshup D.M.;
RT   "The B56 family of protein phosphatase 2A (PP2A) regulatory subunits
RT   encodes differentiation-induced phosphoproteins that target PP2A to
RT   both nucleus and cytoplasm.";
RL   J. Biol. Chem. 271:22081-22089(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS DELTA-1 AND DELTA-3).
RC   TISSUE=Brain cortex;
RX   MEDLINE=97324098; PubMed=9180267; DOI=10.1016/S0014-5793(97)00392-X;
RA   Tanabe O., Gomez G.A., Nishito Y., Usui H., Takeda M.;
RT   "Molecular heterogeneity of the cDNA encoding a 74-kDa regulatory
RT   subunit (B'' or delta) of human protein phosphatase 2A.";
RL   FEBS Lett. 408:52-56(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM DELTA-2), AND PROTEIN SEQUENCE OF
RP   501-508; 550-559; 573-580 AND 584-601 (DELTA-1).
RC   TISSUE=Bone marrow, and Brain cortex;
RX   MEDLINE=96159032; PubMed=8566219; DOI=10.1016/0014-5793(95)01500-0;
RA   Tanabe O., Nagase T., Murakami T., Nozaki H., Usui H., Nishito Y.,
RA   Hayashi H., Kagamiyama H., Takeda M.;
RT   "Molecular cloning of a 74-kDa regulatory subunit (B'' or delta) of
RT   human protein phosphatase 2A.";
RL   FEBS Lett. 379:107-111(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM DELTA-2).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM DELTA-1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS DELTA-1 AND DELTA-2).
RC   TISSUE=Colon, Eye, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH SGOL1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-598, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix adenocarcinoma;
RX   PubMed=16565220; DOI=10.1073/pnas.0507066103;
RA   Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
RT   "Phosphoproteome analysis of the human mitotic spindle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-598, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-553, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-573, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules. Interacts with SGOL1.
CC   -!- INTERACTION:
CC       Q13136:PPFIA1; NbExp=2; IntAct=EBI-396563, EBI-745426;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Nuclear in
CC       interphase, nuclear during mitosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Delta-1;
CC         IsoId=Q14738-1; Sequence=Displayed;
CC       Name=Delta-2;
CC         IsoId=Q14738-2; Sequence=VSP_005111;
CC       Name=Delta-3;
CC         IsoId=Q14738-3; Sequence=VSP_005110;
CC   -!- TISSUE SPECIFICITY: Isoform Delta-2 is widely expressed. Isoform
CC       Delta-1 is highly expressed in brain.
CC   -!- INDUCTION: By retinoic acid; in neuroblastoma cell lines.
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B56
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L76702; AAB69751.1; -; mRNA.
DR   EMBL; AB000634; BAA20381.1; -; mRNA.
DR   EMBL; AB000635; BAA20382.1; -; mRNA.
DR   EMBL; D78360; BAA11372.1; -; mRNA.
DR   EMBL; AK290604; BAF83293.1; -; mRNA.
DR   EMBL; AB451342; BAG70156.1; -; mRNA.
DR   EMBL; AB451357; BAG70171.1; -; mRNA.
DR   EMBL; AL136304; CAI19791.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04133.1; -; Genomic_DNA.
DR   EMBL; BC010692; AAH10692.1; -; mRNA.
DR   EMBL; BC001095; AAH01095.1; -; mRNA.
DR   EMBL; BC001175; AAH01175.1; -; mRNA.
DR   IPI; IPI00000030; -.
DR   IPI; IPI00219543; -.
DR   IPI; IPI00219544; -.
DR   PIR; S68686; S68686.
DR   RefSeq; NP_006236.1; NM_006245.2.
DR   RefSeq; NP_851307.1; NM_180976.1.
DR   RefSeq; NP_851308.1; NM_180977.1.
DR   UniGene; Hs.533308; -.
DR   ProteinModelPortal; Q14738; -.
DR   SMR; Q14738; 110-512.
DR   DIP; DIP-29961N; -.
DR   IntAct; Q14738; 14.
DR   MINT; MINT-5006095; -.
DR   STRING; Q14738; -.
DR   PhosphoSite; Q14738; -.
DR   DMDM; 7387495; -.
DR   PRIDE; Q14738; -.
DR   DNASU; 5528; -.
DR   Ensembl; ENST00000394110; ENSP00000377669; ENSG00000112640.
DR   Ensembl; ENST00000485511; ENSP00000417963; ENSG00000112640.
DR   GeneID; 5528; -.
DR   KEGG; hsa:5528; -.
DR   UCSC; uc003oth.3; human.
DR   UCSC; uc010jyd.3; human.
DR   UCSC; uc021yzq.1; human.
DR   CTD; 5528; -.
DR   GeneCards; GC06P042952; -.
DR   HGNC; HGNC:9312; PPP2R5D.
DR   HPA; HPA029045; -.
DR   HPA; HPA029046; -.
DR   MIM; 601646; gene.
DR   neXtProt; NX_Q14738; -.
DR   PharmGKB; PA33676; -.
DR   eggNOG; NOG264925; -.
DR   GeneTree; ENSGT00550000074525; -.
DR   HOGENOM; HBG602178; -.
DR   HOVERGEN; HBG000009; -.
DR   InParanoid; Q14738; -.
DR   KO; K11584; -.
DR   OMA; AVIMFSV; -.
DR   OrthoDB; EOG4RXXZV; -.
DR   PhylomeDB; Q14738; -.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Pathway_Interaction_DB; aurora_a_pathway; Aurora A signaling.
DR   Pathway_Interaction_DB; aurora_b_pathway; Aurora B signaling.
DR   Pathway_Interaction_DB; wnt_canonical_pathway; Canonical Wnt signaling pathway.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; lis1pathway; Lissencephaly gene (LIS1) in neuronal migration and development.
DR   Pathway_Interaction_DB; mtor_4pathway; mTOR signaling pathway.
DR   Pathway_Interaction_DB; ps1pathway; Presenilin action in Notch and Wnt signaling.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_383; DNA Replication.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 21410; -.
DR   ArrayExpress; Q14738; -.
DR   Bgee; Q14738; -.
DR   CleanEx; HS_PPP2R5D; -.
DR   Genevestigator; Q14738; -.
DR   GermOnline; ENSG00000112640; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002554; PP2A_B56.
DR   PANTHER; PTHR10257; B56; 1.
DR   Pfam; PF01603; B56; 1.
DR   PIRSF; PIRSF028043; PP2A_B56; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat.
FT   CHAIN         1    602       Serine/threonine-protein phosphatase 2A
FT                                56 kDa regulatory subunit delta isoform.
FT                                /FTId=PRO_0000071452.
FT   REPEAT       37     38       1.
FT   REPEAT       39     40       2.
FT   REPEAT       41     42       3.
FT   REPEAT       43     44       4.
FT   REPEAT       45     46       5.
FT   REPEAT       47     48       6; approximate.
FT   REPEAT       49     50       7; approximate.
FT   REPEAT       51     52       8.
FT   REGION       37     52       8 X 2 AA approximate tandem repeats of Q-
FT                                P.
FT   MOTIF       523    530       SH3-binding; class I (Potential).
FT   MOTIF       548    565       Nuclear localization signal (Potential).
FT   MOD_RES     553    553       Phosphothreonine.
FT   MOD_RES     573    573       Phosphoserine.
FT   MOD_RES     598    598       Phosphoserine.
FT   VAR_SEQ      11    116       Missing (in isoform Delta-3).
FT                                /FTId=VSP_005110.
FT   VAR_SEQ      85    116       Missing (in isoform Delta-2).
FT                                /FTId=VSP_005111.
SQ   SEQUENCE   602 AA;  69992 MW;  F15F71AF4E565387 CRC64;
     MPYKLKKEKE PPKVAKCTAK PSSSGKDGGG ENTEEAQPQP QPQPQPQAQS QPPSSNKRPS
     NSTPPPTQLS KIKYSGGPQI VKKERRQSSS RFNLSKNREL QKLPALKDSP TQEREELFIQ
     KLRQCCVLFD FVSDPLSDLK FKEVKRAGLN EMVEYITHSR DVVTEAIYPE AVTMFSVNLF
     RTLPPSSNPT GAEFDPEEDE PTLEAAWPHL QLVYEFFLRF LESPDFQPNI AKKYIDQKFV
     LALLDLFDSE DPRERDFLKT ILHRIYGKFL GLRAYIRRQI NHIFYRFIYE TEHHNGIAEL
     LEILGSIING FALPLKEEHK MFLIRVLLPL HKVKSLSVYH PQLAYCVVQF LEKESSLTEP
     VIVGLLKFWP KTHSPKEVMF LNELEEILDV IEPSEFSKVM EPLFRQLAKC VSSPHFQVAE
     RALYYWNNEY IMSLISDNAA RVLPIMFPAL YRNSKSHWNK TIHGLIYNAL KLFMEMNQKL
     FDDCTQQYKA EKQKGRFRMK EREEMWQKIE ELARLNPQYP MFRAPPPLPP VYSMETETPT
     AEDIQLLKRT VETEAVQMLK DIKKEKVLLR RKSELPQDVY TIKALEAHKR AEEFLTASQE
     AL
//
ID   2A5E_HUMAN              Reviewed;         467 AA.
AC   Q16537; A4FU37; B7ZKK8; Q52LW4;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform;
DE   AltName: Full=PP2A B subunit isoform B'-epsilon;
DE   AltName: Full=PP2A B subunit isoform B56-epsilon;
DE   AltName: Full=PP2A B subunit isoform PR61-epsilon;
DE   AltName: Full=PP2A B subunit isoform R5-epsilon;
GN   Name=PPP2R5E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 449-455.
RC   TISSUE=Fetal retina;
RX   MEDLINE=96276417; PubMed=8694763;
RA   Zolnierowicz S., van Hoof C., Andjelkovic N., Cron P., Stevens I.,
RA   Merlevede W., Goris J., Hemmings B.A.;
RT   "The variable subunit associated with protein phosphatase 2A0 defines
RT   a novel multimember family of regulatory subunits.";
RL   Biochem. J. 317:187-194(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   MEDLINE=96355607; PubMed=8703017; DOI=10.1074/jbc.271.36.22081;
RA   McCright B., Rivers A.M., Audlin S., Virshup D.M.;
RT   "The B56 family of protein phosphatase 2A (PP2A) regulatory subunits
RT   encodes differentiation-induced phosphoproteins that target PP2A to
RT   both nucleus and cytoplasm.";
RL   J. Biol. Chem. 271:22081-22089(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH SGOL1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment.
CC   -!- SUBUNIT: Found in a complex with at least ARL2, PPP2CB; PPP2R1A,
CC       PPP2R2A, PPP2R5E and TBCD (By similarity). PP2A consists of a
CC       common heterodimeric core enzyme, composed of a 36 kDa catalytic
CC       subunit (subunit C) and a 65 kDa constant regulatory subunit (PR65
CC       or subunit A), that associates with a variety of regulatory
CC       subunits. Proteins that associate with the core dimer include
CC       three families of regulatory subunits B (the R2/B/PR55/B55,
CC       R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the 48 kDa
CC       variable regulatory subunit, viral proteins, and cell signaling
CC       molecules. Interacts with SGOL1.
CC   -!- INTERACTION:
CC       O96017:CHEK2; NbExp=3; IntAct=EBI-968374, EBI-1180783;
CC       P30154:PPP2R1B; NbExp=2; IntAct=EBI-968374, EBI-357094;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- PTM: Phosphorylated on serine residues.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B56
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z69029; CAA93153.1; -; mRNA.
DR   EMBL; L76703; AAB69752.1; -; mRNA.
DR   EMBL; BC093766; AAH93766.1; -; mRNA.
DR   EMBL; BC101479; AAI01480.1; -; mRNA.
DR   EMBL; BC143231; AAI43232.1; -; mRNA.
DR   IPI; IPI00002853; -.
DR   RefSeq; NP_006237.1; NM_006246.2.
DR   UniGene; Hs.334868; -.
DR   ProteinModelPortal; Q16537; -.
DR   SMR; Q16537; 51-423.
DR   IntAct; Q16537; 10.
DR   MINT; MINT-1198703; -.
DR   STRING; Q16537; -.
DR   PhosphoSite; Q16537; -.
DR   DMDM; 7387498; -.
DR   PRIDE; Q16537; -.
DR   DNASU; 5529; -.
DR   Ensembl; ENST00000337537; ENSP00000337641; ENSG00000154001.
DR   Ensembl; ENST00000422769; ENSP00000404632; ENSG00000154001.
DR   GeneID; 5529; -.
DR   KEGG; hsa:5529; -.
DR   UCSC; uc001xgd.1; human.
DR   CTD; 5529; -.
DR   GeneCards; GC14M063838; -.
DR   H-InvDB; HIX0037720; -.
DR   HGNC; HGNC:9313; PPP2R5E.
DR   HPA; HPA006034; -.
DR   MIM; 601647; gene.
DR   neXtProt; NX_Q16537; -.
DR   PharmGKB; PA33677; -.
DR   eggNOG; NOG264925; -.
DR   GeneTree; ENSGT00550000074525; -.
DR   HOVERGEN; HBG000009; -.
DR   InParanoid; Q16537; -.
DR   KO; K11584; -.
DR   OrthoDB; EOG483D4M; -.
DR   PhylomeDB; Q16537; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_383; DNA Replication.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 21418; -.
DR   ArrayExpress; Q16537; -.
DR   Bgee; Q16537; -.
DR   CleanEx; HS_PPP2R5E; -.
DR   Genevestigator; Q16537; -.
DR   GermOnline; ENSG00000154001; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; G3DSA:1.25.10.10; ARM-like; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002554; PP2A_B56.
DR   PANTHER; PTHR10257; B56; 1.
DR   Pfam; PF01603; B56; 1.
DR   PIRSF; PIRSF028043; PP2A_B56; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    467       Serine/threonine-protein phosphatase 2A
FT                                56 kDa regulatory subunit epsilon
FT                                isoform.
FT                                /FTId=PRO_0000071454.
FT   MOD_RES       7      7       Phosphothreonine.
SQ   SEQUENCE   467 AA;  54699 MW;  DD9CE11433F499CF CRC64;
     MSSAPTTPPS VDKVDGFSRK SVRKARQKRS QSSSQFRSQG KPIELTPLPL LKDVPSSEQP
     ELFLKKLQQC CVIFDFMDTL SDLKMKEYKR STLNELVDYI TISRGCLTEQ TYPEVVRMVS
     CNIFRTLPPS DSNEFDPEED EPTLEASWPH LQLVYEFFIR FLESQEFQPS IAKKYIDQKF
     VLQLLELFDS EDPRERDYLK TVLHRIYGKF LGLRAFIRKQ INNIFLRFVY ETEHFNGVAE
     LLEILGSIIN GFALPLKAEH KQFLVKVLIP LHTVRSLSLF HAQLAYCIVQ FLEKDPSLTE
     PVIRGLMKFW PKTCSQKEVM FLGELEEILD VIEPSQFVKI QEPLFKQIAK CVSSPHFQVA
     ERALYYWNNE YIMSLIEENS NVILPIMFSS LYRISKEHWN PAIVALVYNV LKAFMEMNST
     MFDELTATYK SDRQREKKKE KEREELWKKL EDLELKRGLR RDGIIPT
//
ID   2A5G_HUMAN              Reviewed;         524 AA.
AC   Q13362; B5BUA5; Q14391; Q15060; Q15174;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   18-APR-2012, entry version 121.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform;
DE   AltName: Full=PP2A B subunit isoform B'-gamma;
DE   AltName: Full=PP2A B subunit isoform B56-gamma;
DE   AltName: Full=PP2A B subunit isoform PR61-gamma;
DE   AltName: Full=PP2A B subunit isoform R5-gamma;
DE   AltName: Full=Renal carcinoma antigen NY-REN-29;
GN   Name=PPP2R5C; Synonyms=KIAA0044;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GAMMA-3).
RC   TISSUE=Umbilical vein;
RX   MEDLINE=96214950; PubMed=8617797; DOI=10.1074/jbc.271.9.5164;
RA   Tehrani M.A., Mumby M.C., Kamibayashi C.;
RT   "Identification of a novel protein phosphatase 2A regulatory subunit
RT   highly expressed in muscle.";
RL   J. Biol. Chem. 271:5164-5170(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GAMMA-1).
RC   TISSUE=Fetal retina;
RX   MEDLINE=96276417; PubMed=8694763;
RA   Zolnierowicz S., van Hoof C., Andjelkovic N., Cron P., Stevens I.,
RA   Merlevede W., Goris J., Hemmings B.A.;
RT   "The variable subunit associated with protein phosphatase 2A0 defines
RT   a novel multimember family of regulatory subunits.";
RL   Biochem. J. 317:187-194(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA-3).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-524 (ISOFORM GAMMA-2).
RC   TISSUE=Bone marrow;
RX   MEDLINE=96051398; PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S.,
RA   Seki N., Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II.
RT   The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-524 (ISOFORM GAMMA-1).
RX   MEDLINE=96064678; PubMed=7592815; DOI=10.1074/jbc.270.44.26123;
RA   McCright B., Virshup D.M.;
RT   "Identification of a new family of protein phosphatase 2A regulatory
RT   subunits.";
RL   J. Biol. Chem. 270:26123-26128(1995).
RN   [7]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   MEDLINE=96355607; PubMed=8703017; DOI=10.1074/jbc.271.36.22081;
RA   McCright B., Rivers A.M., Audlin S., Virshup D.M.;
RT   "The B56 family of protein phosphatase 2A (PP2A) regulatory subunits
RT   encodes differentiation-induced phosphoproteins that target PP2A to
RT   both nucleus and cytoplasm.";
RL   J. Biol. Chem. 271:22081-22089(1996).
RN   [8]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   MEDLINE=99438124; PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH SGOL1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16580887; DOI=10.1016/j.devcel.2006.03.010;
RA   Tang Z., Shu H., Qi W., Mahmood N.A., Mumby M.C., Yu H.;
RT   "PP2A is required for centromeric localization of Sgo1 and proper
RT   chromosome segregation.";
RL   Dev. Cell 10:575-585(2006).
RN   [10]
RP   FUNCTION, INTERACTION WITH IER3 AND ERK KINASES, AND PHOSPHORYLATION.
RX   PubMed=16456541; DOI=10.1038/sj.emboj.7600980;
RA   Letourneux C., Rocher G., Porteu F.;
RT   "B56-containing PP2A dephosphorylate ERK and their activity is
RT   controlled by the early gene IEX-1 and ERK.";
RL   EMBO J. 25:727-738(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-348; TYR-349 AND
RP   TYR-354, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17053785; DOI=10.1038/sj.emboj.7601384;
RA   Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,
RA   Lottspeich F., Chen Z.;
RT   "Tyrosine phosphorylated Par3 regulates epithelial tight junction
RT   assembly promoted by EGFR signaling.";
RL   EMBO J. 25:5058-5070(2006).
RN   [12]
RP   INTERACTION WITH SGOL1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [13]
RP   FUNCTION, INTERACTION WITH TP53, AND INDUCTION.
RX   PubMed=17245430; DOI=10.1038/sj.emboj.7601519;
RA   Li H.H., Cai X., Shouse G.P., Piluso L.G., Liu X.;
RT   "A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-
RT   induced dephosphorylation of p53 at Thr55.";
RL   EMBO J. 26:402-411(2007).
RN   [14]
RP   INTERACTION WITH TP53.
RX   PubMed=17967874; DOI=10.1128/MCB.00983-07;
RA   Shouse G.P., Cai X., Liu X.;
RT   "Serine 15 phosphorylation of p53 directs its interaction with
RT   B56gamma and the tumor suppressor activity of B56gamma-specific
RT   protein phosphatase 2A.";
RL   Mol. Cell. Biol. 28:448-456(2008).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 1-442 IN COMPLEX WITH PPP2CA
RP   AND PPP2R1A.
RX   PubMed=17174897; DOI=10.1016/j.cell.2006.11.033;
RA   Xu Y., Xing Y., Chen Y., Chao Y., Lin Z., Fan E., Yu J.W., Strack S.,
RA   Jeffrey P.D., Shi Y.;
RT   "Structure of the protein phosphatase 2A holoenzyme.";
RL   Cell 127:1239-1251(2006).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 30-436 IN COMPLEX WITH
RP   PPP2CA AND PPP2R1A.
RX   PubMed=17086192; DOI=10.1038/nature05351;
RA   Cho U.S., Xu W.;
RT   "Crystal structure of a protein phosphatase 2A heterotrimeric
RT   holoenzyme.";
RL   Nature 445:53-57(2007).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 34-436 IN COMPLEX WITH
RP   PPP2CA; PPP2R1A AND SGOL1.
RX   PubMed=19716788; DOI=10.1016/j.molcel.2009.06.031;
RA   Xu Z., Cetin B., Anger M., Cho U.S., Helmhart W., Nasmyth K., Xu W.;
RT   "Structure and function of the PP2A-shugoshin interaction.";
RL   Mol. Cell 35:426-441(2009).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 11-380.
RX   PubMed=18618707; DOI=10.1002/prot.22150;
RA   Magnusdottir A., Stenmark P., Flodin S., Nyman T., Kotenyova T.,
RA   Graeslund S., Ogg D., Nordlund P.;
RT   "The structure of the PP2A regulatory subunit B56 gamma: the remaining
RT   piece of the PP2A jigsaw puzzle.";
RL   Proteins 74:212-221(2009).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment. The PP2A-PPP2R5C holoenzyme may specifically
CC       dephosphorylate and activate TP53 and play a role in DNA damage-
CC       induced inhibition of cell proliferation. PP2A-PPP2R5C may also
CC       regulate the ERK signaling pathway through ERK dephosphorylation.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of PPP2CA a 36 kDa catalytic subunit (subunit C) and
CC       PPP2R1A a 65 kDa constant regulatory subunit (PR65 or subunit A),
CC       that associates with a variety of regulatory subunits. Proteins
CC       that associate with the core dimer include three families of
CC       regulatory subunits B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59
CC       and R5/B'/B56 families), the 48 kDa variable regulatory subunit,
CC       viral proteins, and cell signaling molecules. Interacts with
CC       PPP2CA AND PPP2R1A; the interaction is direct. Interacts with
CC       SGOL1; the interaction is direct. Isoform 1 and isoform 2 interact
CC       with TP53 (phosphorylated at Ser-15 by ATM); increased upon DNA
CC       damage it drives PP2A-mediated dephosphorylation of TP53 at Thr-
CC       55. Interacts with IER3 and/or ERK kinases; regulates ERK
CC       dephosphorylation.
CC   -!- INTERACTION:
CC       O96017:CHEK2; NbExp=4; IntAct=EBI-1266176, EBI-1180783;
CC       P30153:PPP2R1A; NbExp=2; IntAct=EBI-1266173, EBI-302388;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Gamma-3;
CC         IsoId=Q13362-1; Sequence=Displayed;
CC       Name=Gamma-1;
CC         IsoId=Q13362-2; Sequence=VSP_005112;
CC       Name=Gamma-2;
CC         IsoId=Q13362-3; Sequence=VSP_005113;
CC   -!- TISSUE SPECIFICITY: Highest levels in heart, skeletal muscle and
CC       brain. Lower levels in pancreas, kidney, lung and placenta. Very
CC       low levels in liver.
CC   -!- INDUCTION: Up-regulated upon DNA damage.
CC   -!- PTM: Isoform Gamma-3 is phosphorylated on serine residues. Isoform
CC       Gamma-1 phosphorylation by ERK2 is IER3-dependent and inhibits ERK
CC       dephosphorylation by PP2A-PPP2R5C.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B56
CC       family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50387.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U37352; AAC50387.1; ALT_INIT; mRNA.
DR   EMBL; Z69030; CAA93154.1; -; mRNA.
DR   EMBL; AB451341; BAG70155.1; -; mRNA.
DR   EMBL; CH471061; EAW81756.1; -; Genomic_DNA.
DR   EMBL; D26445; BAA05465.1; -; mRNA.
DR   EMBL; L42375; AAC37603.1; -; mRNA.
DR   IPI; IPI00012834; -.
DR   IPI; IPI00185637; -.
DR   IPI; IPI00220145; -.
DR   RefSeq; NP_002710.2; NM_002719.3.
DR   RefSeq; NP_848701.1; NM_178586.2.
DR   RefSeq; NP_848702.1; NM_178587.2.
DR   UniGene; Hs.368264; -.
DR   PDB; 2IAE; X-ray; 3.50 A; B/E=30-436.
DR   PDB; 2JAK; X-ray; 2.60 A; A=11-380.
DR   PDB; 2NPP; X-ray; 3.30 A; B/E=1-442.
DR   PDB; 2NYL; X-ray; 3.80 A; B/E=38-425.
DR   PDB; 2NYM; X-ray; 3.60 A; B/E=38-425.
DR   PDB; 3FGA; X-ray; 2.70 A; B=34-436.
DR   PDBsum; 2IAE; -.
DR   PDBsum; 2JAK; -.
DR   PDBsum; 2NPP; -.
DR   PDBsum; 2NYL; -.
DR   PDBsum; 2NYM; -.
DR   PDBsum; 3FGA; -.
DR   ProteinModelPortal; Q13362; -.
DR   SMR; Q13362; 34-436.
DR   DIP; DIP-29396N; -.
DR   DIP; DIP-39401N; -.
DR   IntAct; Q13362; 6.
DR   MINT; MINT-2835438; -.
DR   STRING; Q13362; -.
DR   PhosphoSite; Q13362; -.
DR   DMDM; 116241235; -.
DR   PRIDE; Q13362; -.
DR   DNASU; 5527; -.
DR   Ensembl; ENST00000334743; ENSP00000333905; ENSG00000078304.
DR   GeneID; 5527; -.
DR   KEGG; hsa:5527; -.
DR   UCSC; uc001ykn.3; human.
DR   UCSC; uc001yko.3; human.
DR   UCSC; uc001ykp.3; human.
DR   CTD; 5527; -.
DR   GeneCards; GC14P102228; -.
DR   HGNC; HGNC:9311; PPP2R5C.
DR   HPA; HPA027553; -.
DR   MIM; 601645; gene.
DR   neXtProt; NX_Q13362; -.
DR   PharmGKB; PA33674; -.
DR   eggNOG; NOG264925; -.
DR   GeneTree; ENSGT00550000074525; -.
DR   HOVERGEN; HBG000009; -.
DR   KO; K11584; -.
DR   PhylomeDB; Q13362; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_383; DNA Replication.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; Q13362; -.
DR   NextBio; 21400; -.
DR   PMAP-CutDB; Q13362; -.
DR   ArrayExpress; Q13362; -.
DR   Bgee; Q13362; -.
DR   CleanEx; HS_PPP2R5C; -.
DR   Genevestigator; Q13362; -.
DR   GermOnline; ENSG00000078304; Homo sapiens.
DR   GO; GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; NAS:UniProtKB.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0042771; P:DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasomal ubiquitin-dependent protein catabolic process; IMP:MGI.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002554; PP2A_B56.
DR   PANTHER; PTHR10257; B56; 1.
DR   Pfam; PF01603; B56; 1.
DR   PIRSF; PIRSF028043; PP2A_B56; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Centromere; Chromosome;
KW   Complete proteome; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    524       Serine/threonine-protein phosphatase 2A
FT                                56 kDa regulatory subunit gamma isoform.
FT                                /FTId=PRO_0000071457.
FT   MOTIF       416    422       Nuclear localization signal (Potential).
FT   MOD_RES     348    348       Phosphotyrosine.
FT   MOD_RES     349    349       Phosphotyrosine.
FT   MOD_RES     354    354       Phosphotyrosine.
FT   MOD_RES     497    497       Phosphoserine (By similarity).
FT   VAR_SEQ     443    524       YTVYSQASTMSIPVAMETDGPLFEDVQMLRKTVKDEAHQAQ
FT                                KDPKKDRPLARRKSELPQDPHTKKALEAHCRADELASQDGR
FT                                -> VLKKRIT (in isoform Gamma-1).
FT                                /FTId=VSP_005112.
FT   VAR_SEQ     443    481       Missing (in isoform Gamma-2).
FT                                /FTId=VSP_005113.
FT   VARIANT     515    515       A -> P (in dbSNP:rs3742424).
FT                                /FTId=VAR_051745.
FT   CONFLICT    494    494       R -> L (in Ref. 1; AAC50387).
FT   HELIX        40     48
FT   STRAND       59     62
FT   HELIX        63     80
FT   HELIX        91    103
FT   HELIX       131    146
FT   HELIX       152    155
FT   TURN        156    158
FT   HELIX       161    170
FT   HELIX       176    192
FT   HELIX       194    196
FT   HELIX       197    212
FT   HELIX       221    233
FT   HELIX       241    249
FT   HELIX       252    255
FT   HELIX       258    262
FT   HELIX       264    277
FT   HELIX       279    281
FT   HELIX       282    291
FT   HELIX       301    313
FT   HELIX       317    335
FT   HELIX       340    347
FT   HELIX       348    351
FT   HELIX       353    361
FT   HELIX       363    366
FT   TURN        367    369
SQ   SEQUENCE   524 AA;  61061 MW;  B9CBF54550D713F8 CRC64;
     MLTCNKAGSR MVVDAANSNG PFQPVVLLHI RDVPPADQEK LFIQKLRQCC VLFDFVSDPL
     SDLKWKEVKR AALSEMVEYI THNRNVITEP IYPEVVHMFA VNMFRTLPPS SNPTGAEFDP
     EEDEPTLEAA WPHLQLVYEF FLRFLESPDF QPNIAKKYID QKFVLQLLEL FDSEDPRERD
     FLKTTLHRIY GKFLGLRAYI RKQINNIFYR FIYETEHHNG IAELLEILGS IINGFALPLK
     EEHKIFLLKV LLPLHKVKSL SVYHPQLAYC VVQFLEKDST LTEPVVMALL KYWPKTHSPK
     EVMFLNELEE ILDVIEPSEF VKIMEPLFRQ LAKCVSSPHF QVAERALYYW NNEYIMSLIS
     DNAAKILPIM FPSLYRNSKT HWNKTIHGLI YNALKLFMEM NQKLFDDCTQ QFKAEKLKEK
     LKMKEREEAW VKIENLAKAN PQYTVYSQAS TMSIPVAMET DGPLFEDVQM LRKTVKDEAH
     QAQKDPKKDR PLARRKSELP QDPHTKKALE AHCRADELAS QDGR
//
ID   2AAA_HUMAN              Reviewed;         589 AA.
AC   P30153; Q13773; Q6ICQ3; Q96DH3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 4.
DT   18-APR-2012, entry version 127.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform;
DE   AltName: Full=Medium tumor antigen-associated 61 kDa protein;
DE   AltName: Full=PP2A subunit A isoform PR65-alpha;
DE   AltName: Full=PP2A subunit A isoform R1-alpha;
GN   Name=PPP2R1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 242-255.
RC   TISSUE=Placenta;
RX   MEDLINE=90046854; PubMed=2554323; DOI=10.1073/pnas.86.22.8669;
RA   Walter G., Ferre F., Espiritu O., Carbone-Wiley A.;
RT   "Molecular cloning and sequence of cDNA encoding polyoma medium tumor
RT   antigen-associated 61-kDa protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8669-8672(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=90241887; PubMed=2159327; DOI=10.1021/bi00465a002;
RA   Hemmings B.A., Adams-Pearson C., Maurer F., Mueller P., Goris J.,
RA   Merlevede W., Hofsteenge J., Stone S.R.;
RT   "Alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A
RT   have a similar 39 amino acid repeating structure.";
RL   Biochemistry 29:3166-3173(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 34-46, AND MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 204-214; 261-272 AND 521-527.
RX   MEDLINE=96276417; PubMed=8694763;
RA   Zolnierowicz S., van Hoof C., Andjelkovic N., Cron P., Stevens I.,
RA   Merlevede W., Goris J., Hemmings B.A.;
RT   "The variable subunit associated with protein phosphatase 2A0 defines
RT   a novel multimember family of regulatory subunits.";
RL   Biochem. J. 317:187-194(1996).
RN   [7]
RP   BINDING DOMAINS.
RX   MEDLINE=94076400; PubMed=8254721;
RA   Ruediger R., Hentz M., Fait J., Mumby M., Walter G.;
RT   "Molecular model of the A subunit of protein phosphatase 2A:
RT   interaction with other subunits and tumor antigens.";
RL   J. Virol. 68:123-129(1994).
RN   [8]
RP   INTERACTION WITH IPO9.
RX   PubMed=12670497; DOI=10.1016/S0006-291X(03)00434-0;
RA   Lubert E.J., Sarge K.D.;
RT   "Interaction between protein phosphatase 2A and members of the
RT   importin beta superfamily.";
RL   Biochem. Biophys. Res. Commun. 303:908-913(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION,
RP   AND INTERACTION WITH SGOL1.
RX   PubMed=16580887; DOI=10.1016/j.devcel.2006.03.010;
RA   Tang Z., Shu H., Qi W., Mahmood N.A., Mumby M.C., Yu H.;
RT   "PP2A is required for centromeric localization of Sgo1 and proper
RT   chromosome segregation.";
RL   Dev. Cell 10:575-585(2006).
RN   [10]
RP   INTERACTION WITH TP53.
RX   PubMed=17245430; DOI=10.1038/sj.emboj.7601519;
RA   Li H.H., Cai X., Shouse G.P., Piluso L.G., Liu X.;
RT   "A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-
RT   induced dephosphorylation of p53 at Thr55.";
RL   EMBO J. 26:402-411(2007).
RN   [11]
RP   INTERACTION WITH PLA2G16.
RX   PubMed=17374643; DOI=10.1242/jcs.000018;
RA   Nazarenko I., Schafer R., Sers C.;
RT   "Mechanisms of the HRSL3 tumor suppressor function in ovarian
RT   carcinoma cells.";
RL   J. Cell Sci. 120:1393-1404(2007).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-280, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   MEDLINE=99142607; PubMed=9989501; DOI=10.1016/S0092-8674(00)80963-0;
RA   Groves M.R., Hanlon N., Turowski P., Hemmings B.A., Barford D.;
RT   "The structure of the protein phosphatase 2A PR65/A subunit reveals
RT   the conformation of its 15 tandemly repeated HEAT motifs.";
RL   Cell 96:99-110(1999).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 9-589 IN COMPLEX WITH WITH
RP   PPP2CA AND PPME1.
RX   PubMed=18394995; DOI=10.1016/j.cell.2008.02.041;
RA   Xing Y., Li Z., Chen Y., Stock J.B., Jeffrey P.D., Shi Y.;
RT   "Structural mechanism of demethylation and inactivation of protein
RT   phosphatase 2A.";
RL   Cell 133:154-163(2008).
CC   -!- FUNCTION: The PR65 subunit of protein phosphatase 2A serves as a
CC       scaffolding molecule to coordinate the assembly of the catalytic
CC       subunit and a variable regulatory B subunit. Required for proper
CC       chromosome segregation and for centromeric localization of SGOL1
CC       in mitosis.
CC   -!- SUBUNIT: Found in a complex with at least ARL2, PPP2CB, PPP2R1A,
CC       PPP2R2A, PPP2R5E and TBCD (By similarity). PP2A consists of a
CC       common heterodimeric core enzyme, composed of PPP2CA a 36 kDa
CC       catalytic subunit (subunit C) and PPP2R1A a 65 kDa constant
CC       regulatory subunit (PR65 or subunit A), that associates with a
CC       variety of regulatory subunits. Proteins that associate with the
CC       core dimer include three families of regulatory subunits B (the
CC       R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the
CC       48 kDa variable regulatory subunit, viral proteins, and cell
CC       signaling molecules. Interacts with IPO9. Interacts with TP53 and
CC       SGOL1. Interacts with PLA2G16; this interaction might decrease
CC       PP2A activity.
CC   -!- INTERACTION:
CC       Q8TCG1:KIAA1524; NbExp=4; IntAct=EBI-302388, EBI-1379376;
CC       P53816:PLA2G16; NbExp=7; IntAct=EBI-302388, EBI-746318;
CC       P67775:PPP2CA; NbExp=14; IntAct=EBI-302388, EBI-712311;
CC       Q00005:PPP2R2B; NbExp=5; IntAct=EBI-302388, EBI-1052159;
CC       Q13362-1:PPP2R5C; NbExp=3; IntAct=EBI-302388, EBI-1266170;
CC       Q13362-2:PPP2R5C; NbExp=2; IntAct=EBI-302388, EBI-1266173;
CC       Q60996-3:Ppp2r5c (xeno); NbExp=2; IntAct=EBI-302388, EBI-1369292;
CC       P60510:PPP4C; NbExp=3; IntAct=EBI-302388, EBI-1046072;
CC       O43815:STRN; NbExp=4; IntAct=EBI-302388, EBI-1046642;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Chromosome,
CC       centromere. Note=Centromeric localization requires the presence of
CC       BUB1.
CC   -!- DOMAIN: Each HEAT repeat appears to consist of two alpha helices
CC       joined by a hydrophilic region, the intrarepeat loop. The repeat
CC       units may be arranged laterally to form a rod-like structure.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit A
CC       family.
CC   -!- SIMILARITY: Contains 15 HEAT repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M31786; AAA35531.1; -; mRNA.
DR   EMBL; J02902; AAA36399.1; -; mRNA.
DR   EMBL; CR450340; CAG29336.1; -; mRNA.
DR   EMBL; BC001537; AAH01537.1; -; mRNA.
DR   IPI; IPI00554737; -.
DR   PIR; A34541; A34541.
DR   RefSeq; NP_055040.2; NM_014225.5.
DR   UniGene; Hs.467192; -.
DR   PDB; 1B3U; X-ray; 2.30 A; A/B=2-589.
DR   PDB; 2IE3; X-ray; 2.80 A; A=1-589.
DR   PDB; 2IE4; X-ray; 2.60 A; A=1-589.
DR   PDB; 2NPP; X-ray; 3.30 A; A/D=1-589.
DR   PDB; 2NYL; X-ray; 3.80 A; A/D=8-589.
DR   PDB; 2NYM; X-ray; 3.60 A; A/D=8-589.
DR   PDB; 2PKG; X-ray; 3.30 A; A/B=10-589.
DR   PDB; 3C5W; X-ray; 2.80 A; A=9-589.
DR   PDB; 3DW8; X-ray; 2.85 A; A/D=9-589.
DR   PDB; 3K7V; X-ray; 2.85 A; A=1-589.
DR   PDB; 3K7W; X-ray; 2.96 A; A=1-589.
DR   PDBsum; 1B3U; -.
DR   PDBsum; 2IE3; -.
DR   PDBsum; 2IE4; -.
DR   PDBsum; 2NPP; -.
DR   PDBsum; 2NYL; -.
DR   PDBsum; 2NYM; -.
DR   PDBsum; 2PKG; -.
DR   PDBsum; 3C5W; -.
DR   PDBsum; 3DW8; -.
DR   PDBsum; 3K7V; -.
DR   PDBsum; 3K7W; -.
DR   ProteinModelPortal; P30153; -.
DR   SMR; P30153; 2-589.
DR   DIP; DIP-29394N; -.
DR   IntAct; P30153; 84.
DR   MINT; MINT-1141071; -.
DR   STRING; P30153; -.
DR   PhosphoSite; P30153; -.
DR   DMDM; 143811355; -.
DR   OGP; P30153; -.
DR   REPRODUCTION-2DPAGE; IPI00554737; -.
DR   PRIDE; P30153; -.
DR   DNASU; 5518; -.
DR   Ensembl; ENST00000322088; ENSP00000324804; ENSG00000105568.
DR   GeneID; 5518; -.
DR   KEGG; hsa:5518; -.
DR   UCSC; uc002pyp.3; human.
DR   CTD; 5518; -.
DR   GeneCards; GC19P052693; -.
DR   H-InvDB; HIX0015400; -.
DR   HGNC; HGNC:9302; PPP2R1A.
DR   HPA; CAB018599; -.
DR   MIM; 605983; gene.
DR   neXtProt; NX_P30153; -.
DR   PharmGKB; PA33666; -.
DR   eggNOG; NOG247268; -.
DR   GeneTree; ENSGT00510000046709; -.
DR   HOGENOM; HBG526812; -.
DR   HOVERGEN; HBG000011; -.
DR   InParanoid; P30153; -.
DR   KO; K03456; -.
DR   OMA; LFLIQLK; -.
DR   OrthoDB; EOG45MN4X; -.
DR   PhylomeDB; P30153; -.
DR   BioCyc; MetaCyc:ENSG00000105568-MONOMER; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_21257; Metabolism of RNA.
DR   Reactome; REACT_383; DNA Replication.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   Reactome; REACT_71; Gene Expression.
DR   EvolutionaryTrace; P30153; -.
DR   NextBio; 21342; -.
DR   PMAP-CutDB; P30153; -.
DR   ArrayExpress; P30153; -.
DR   Bgee; P30153; -.
DR   CleanEx; HS_PPP2R1A; -.
DR   Genevestigator; P30153; -.
DR   GermOnline; ENSG00000105568; Homo sapiens.
DR   GO; GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB.
DR   GO; GO:0005625; C:soluble fraction; NAS:UniProtKB.
DR   GO; GO:0003823; F:antigen binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB.
DR   GO; GO:0006672; P:ceramide metabolic process; NAS:UniProtKB.
DR   GO; GO:0007059; P:chromosome segregation; IDA:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0000188; P:inactivation of MAPK activity; NAS:UniProtKB.
DR   GO; GO:0006917; P:induction of apoptosis; TAS:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; NAS:UniProtKB.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome.
DR   GO; GO:0006461; P:protein complex assembly; TAS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; NAS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB.
DR   GO; GO:0006275; P:regulation of DNA replication; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; NAS:UniProtKB.
DR   GO; GO:0030111; P:regulation of Wnt receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; NAS:UniProtKB.
DR   GO; GO:0019932; P:second-messenger-mediated signaling; NAS:UniProtKB.
DR   Gene3D; G3DSA:1.25.10.10; ARM-like; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000357; HEAT.
DR   InterPro; IPR021133; HEAT_type_2.
DR   Pfam; PF02985; HEAT; 2.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; 11.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Centromere; Chromosome;
KW   Chromosome partition; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    589       Serine/threonine-protein phosphatase 2A
FT                                65 kDa regulatory subunit A alpha
FT                                isoform.
FT                                /FTId=PRO_0000071400.
FT   REPEAT        8     46       HEAT 1.
FT   REPEAT       47     84       HEAT 2.
FT   REPEAT       85    123       HEAT 3.
FT   REPEAT      124    161       HEAT 4.
FT   REPEAT      162    200       HEAT 5.
FT   REPEAT      201    239       HEAT 6.
FT   REPEAT      240    278       HEAT 7.
FT   REPEAT      279    321       HEAT 8.
FT   REPEAT      322    360       HEAT 9.
FT   REPEAT      361    399       HEAT 10.
FT   REPEAT      400    438       HEAT 11.
FT   REPEAT      439    477       HEAT 12.
FT   REPEAT      478    516       HEAT 13.
FT   REPEAT      517    555       HEAT 14.
FT   REPEAT      556    589       HEAT 15.
FT   REGION        8    399       PP2A subunit B binding.
FT   REGION       47    321       Polyoma small and medium T antigens
FT                                Binding.
FT   REGION       85    239       SV40 small T antigen binding.
FT   REGION      400    589       PP2A subunit C binding.
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     280    280       N6-acetyllysine.
FT   CONFLICT    130    130       P -> A (in Ref. 1; AAA35531).
FT   CONFLICT    258    258       R -> A (in Ref. 2; AAA36399).
FT   CONFLICT    272    272       K -> R (in Ref. 6; AA sequence).
FT   CONFLICT    551    551       L -> P (in Ref. 3; CAG29336).
FT   TURN          6      8
FT   HELIX        11     19
FT   HELIX        25     33
FT   HELIX        35     41
FT   HELIX        44     49
FT   HELIX        51     57
FT   HELIX        63     73
FT   HELIX        78     80
FT   HELIX        83     89
FT   HELIX        90     96
FT   HELIX       102    116
FT   HELIX       121    126
FT   HELIX       128    136
FT   HELIX       141    147
FT   HELIX       148    150
FT   HELIX       151    154
FT   TURN        155    157
FT   HELIX       160    174
FT   HELIX       179    194
FT   HELIX       198    203
FT   HELIX       205    213
FT   HELIX       218    221
FT   HELIX       224    234
FT   HELIX       237    239
FT   HELIX       240    243
FT   HELIX       245    252
FT   HELIX       257    265
FT   HELIX       267    274
FT   HELIX       276    281
FT   HELIX       283    291
FT   HELIX       296    311
FT   TURN        315    317
FT   HELIX       318    324
FT   HELIX       326    334
FT   HELIX       339    346
FT   HELIX       349    352
FT   HELIX       353    356
FT   HELIX       358    364
FT   HELIX       366    373
FT   HELIX       378    385
FT   HELIX       389    394
FT   HELIX       397    412
FT   HELIX       417    434
FT   HELIX       436    438
FT   HELIX       441    449
FT   HELIX       450    452
FT   HELIX       456    473
FT   HELIX       475    481
FT   HELIX       483    488
FT   TURN        489    491
FT   HELIX       495    520
FT   HELIX       522    527
FT   HELIX       528    530
FT   HELIX       534    547
FT   HELIX       548    550
FT   HELIX       553    567
FT   HELIX       573    585
SQ   SEQUENCE   589 AA;  65309 MW;  5174EBE94D537836 CRC64;
     MAAADGDDSL YPIAVLIDEL RNEDVQLRLN SIKKLSTIAL ALGVERTRSE LLPFLTDTIY
     DEDEVLLALA EQLGTFTTLV GGPEYVHCLL PPLESLATVE ETVVRDKAVE SLRAISHEHS
     PSDLEAHFVP LVKRLAGGDW FTSRTSACGL FSVCYPRVSS AVKAELRQYF RNLCSDDTPM
     VRRAAASKLG EFAKVLELDN VKSEIIPMFS NLASDEQDSV RLLAVEACVN IAQLLPQEDL
     EALVMPTLRQ AAEDKSWRVR YMVADKFTEL QKAVGPEITK TDLVPAFQNL MKDCEAEVRA
     AASHKVKEFC ENLSADCREN VIMSQILPCI KELVSDANQH VKSALASVIM GLSPILGKDN
     TIEHLLPLFL AQLKDECPEV RLNIISNLDC VNEVIGIRQL SQSLLPAIVE LAEDAKWRVR
     LAIIEYMPLL AGQLGVEFFD EKLNSLCMAW LVDHVYAIRE AATSNLKKLV EKFGKEWAHA
     TIIPKVLAMS GDPNYLHRMT TLFCINVLSE VCGQDITTKH MLPTVLRMAG DPVANVRFNV
     AKSLQKIGPI LDNSTLQSEV KPILEKLTQD QDVDVKYFAQ EALTVLSLA
//
ID   2AAB_HUMAN              Reviewed;         601 AA.
AC   P30154; B0YJ69; O75620; Q8NHV8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   18-APR-2012, entry version 116.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform;
DE   AltName: Full=PP2A subunit A isoform PR65-beta;
DE   AltName: Full=PP2A subunit A isoform R1-beta;
GN   Name=PPP2R1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=99014242; PubMed=9795170; DOI=10.1016/S0378-1119(98)00350-3;
RA   Baysal B.E., Farr J.E., Goss J.R., Devlin B., Richard C.W. III;
RT   "Genomic organization and precise physical location of protein
RT   phosphatase 2A regulatory subunit A beta isoform gene on chromosome
RT   band 11q23.";
RL   Gene 217:107-116(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-8; SER-65;
RP   ASP-90; PRO-101; GLU-343; ALA-448; GLY-504 AND ALA-545.
RX   MEDLINE=98438696; PubMed=9765152; DOI=10.1126/science.282.5387.284;
RA   Wang S.S., Esplin E.D., Li J.L., Huang L., Gazdar A., Minna J.,
RA   Evans G.A.;
RT   "Alterations of the PPP2R1B gene in human lung and colon cancer.";
RL   Science 282:284-287(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=21214715; PubMed=11313745; DOI=10.1038/sj/ejhg/5200585;
RA   Baysal B.E., Willett-Brozick J.E., Taschner P.E.M., Dauwerse J.G.,
RA   Devilee P., Devlin B.;
RT   "A high-resolution integrated map spanning the SDHD gene at 11q23: a
RT   1.1-Mb BAC contig, a partial transcript map and 15 new repeat
RT   polymorphisms in a tumour-suppressor region.";
RL   Eur. J. Hum. Genet. 9:121-129(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 31-601 (ISOFORM 1).
RX   MEDLINE=90241887; PubMed=2159327; DOI=10.1021/bi00465a002;
RA   Hemmings B.A., Adams-Pearson C., Maurer F., Mueller P., Goris J.,
RA   Merlevede W., Hofsteenge J., Stone S.R.;
RT   "Alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A
RT   have a similar 39 amino acid repeating structure.";
RL   Biochemistry 29:3166-3173(1990).
RN   [9]
RP   INTERACTION WITH RAF1.
RX   PubMed=10801873; DOI=10.1074/jbc.M003259200;
RA   Abraham D., Podar K., Pacher M., Kubicek M., Welzel N., Hemmings B.A.,
RA   Dilworth S.M., Mischak H., Kolch W., Baccarini M.;
RT   "Raf-1-associated protein phosphatase 2A as a positive regulator of
RT   kinase activation.";
RL   J. Biol. Chem. 275:22300-22304(2000).
RN   [10]
RP   INTERACTION WITH IPO9.
RX   PubMed=12670497; DOI=10.1016/S0006-291X(03)00434-0;
RA   Lubert E.J., Sarge K.D.;
RT   "Interaction between protein phosphatase 2A and members of the
RT   importin beta superfamily.";
RL   Biochem. Biophys. Res. Commun. 303:908-913(2003).
RN   [11]
RP   INTERACTION WITH SGOL1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   VARIANT ASP-90.
RX   PubMed=10597236; DOI=10.1038/sj.onc.1203070;
RA   Campbell I.G., Manolitsas T.;
RT   "Absence of PPP2R1B gene alterations in primary ovarian cancers.";
RL   Oncogene 18:6367-6369(1999).
RN   [14]
RP   VARIANTS ALA-15; PRO-365; GLU-498; ILE-499 AND GLY-500.
RX   MEDLINE=20357135; PubMed=10896920; DOI=10.1136/gut.47.2.268;
RA   Takagi Y., Futamura M., Yamaguchi K., Aoki S., Takahashi T., Saji S.;
RT   "Alterations of the PPP2R1B gene located at 11q23 in human colorectal
RT   cancers.";
RL   Gut 47:268-271(2000).
RN   [15]
RP   VARIANT ASP-90.
RX   MEDLINE=21992605; PubMed=11996789; DOI=10.1016/S0165-4608(01)00597-0;
RA   Hemmer S., Wasenius V.M., Haglund C., Zhu Y., Knuutila S.,
RA   Franssila K., Joensuu H.;
RT   "Alterations in the suppressor gene PPP2R1B in parathyroid
RT   hyperplasias and adenomas.";
RL   Cancer Genet. Cytogenet. 134:13-17(2002).
CC   -!- FUNCTION: The PR65 subunit of protein phosphatase 2A serves as a
CC       scaffolding molecule to coordinate the assembly of the catalytic
CC       subunit and a variable regulatory B subunit.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules. Interacts with IPO9. Interacts with
CC       SGOL1. Interacts with RAF1.
CC   -!- INTERACTION:
CC       P67775:PPP2CA; NbExp=6; IntAct=EBI-357094, EBI-712311;
CC       P63151:PPP2R2A; NbExp=2; IntAct=EBI-357094, EBI-1048931;
CC       Q15172:PPP2R5A; NbExp=2; IntAct=EBI-357094, EBI-641666;
CC       Q16537:PPP2R5E; NbExp=2; IntAct=EBI-357094, EBI-968374;
CC       P11233:RALA; NbExp=6; IntAct=EBI-357094, EBI-1036803;
CC       O08722:Unc5b (xeno); NbExp=4; IntAct=EBI-357094, EBI-4404185;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30154-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P30154-2; Sequence=VSP_036460;
CC   -!- DOMAIN: Each HEAT repeat appears to consist of two alpha helices
CC       joined by a hydrophilic region, the intrarepeat loop. The repeat
CC       units may be arranged laterally to form a rod-like structure.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit A
CC       family.
CC   -!- SIMILARITY: Contains 15 HEAT repeats.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA59983.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF083439; AAC63525.1; -; Genomic_DNA.
DR   EMBL; AF083425; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083426; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083427; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083428; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083429; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083430; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083431; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083432; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083433; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083434; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083435; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083436; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083437; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF083438; AAC63525.1; JOINED; Genomic_DNA.
DR   EMBL; AF087438; AAC69624.1; -; mRNA.
DR   EMBL; AF163473; AAG39644.1; -; mRNA.
DR   EMBL; EF445011; ACA06046.1; -; Genomic_DNA.
DR   EMBL; EF445011; ACA06047.1; -; Genomic_DNA.
DR   EMBL; AP000925; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67150.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67151.1; -; Genomic_DNA.
DR   EMBL; BC027596; AAH27596.1; -; mRNA.
DR   EMBL; M65254; AAA59983.1; ALT_SEQ; mRNA.
DR   IPI; IPI00294178; -.
DR   IPI; IPI00335449; -.
DR   PIR; B34541; B34541.
DR   RefSeq; NP_001171033.1; NM_001177562.1.
DR   RefSeq; NP_001171034.1; NM_001177563.1.
DR   RefSeq; NP_002707.3; NM_002716.4.
DR   RefSeq; NP_859050.1; NM_181699.2.
DR   RefSeq; NP_859051.1; NM_181700.1.
DR   UniGene; Hs.584790; -.
DR   ProteinModelPortal; P30154; -.
DR   SMR; P30154; 19-601.
DR   IntAct; P30154; 51.
DR   MINT; MINT-1150161; -.
DR   STRING; P30154; -.
DR   PhosphoSite; P30154; -.
DR   DMDM; 116241236; -.
DR   PRIDE; P30154; -.
DR   DNASU; 5519; -.
DR   Ensembl; ENST00000427203; ENSP00000415759; ENSG00000137713.
DR   GeneID; 5519; -.
DR   KEGG; hsa:5519; -.
DR   UCSC; uc001plw.1; human.
DR   UCSC; uc001plx.1; human.
DR   CTD; 5519; -.
DR   GeneCards; GC11M111631; -.
DR   HGNC; HGNC:9303; PPP2R1B.
DR   HPA; CAB004034; -.
DR   HPA; HPA018908; -.
DR   MIM; 603113; gene.
DR   neXtProt; NX_P30154; -.
DR   PharmGKB; PA33667; -.
DR   eggNOG; NOG247268; -.
DR   GeneTree; ENSGT00510000046709; -.
DR   HOVERGEN; HBG000011; -.
DR   KO; K03456; -.
DR   OMA; KQWRVRL; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_383; DNA Replication.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 21346; -.
DR   ArrayExpress; P30154; -.
DR   Bgee; P30154; -.
DR   CleanEx; HS_PPP2R1B; -.
DR   Genevestigator; P30154; -.
DR   GermOnline; ENSG00000137713; Homo sapiens.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB.
DR   Gene3D; G3DSA:1.25.10.10; ARM-like; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000357; HEAT.
DR   InterPro; IPR021133; HEAT_type_2.
DR   Pfam; PF02985; HEAT; 2.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; 12.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Polymorphism;
KW   Reference proteome; Repeat.
FT   CHAIN         1    601       Serine/threonine-protein phosphatase 2A
FT                                65 kDa regulatory subunit A beta isoform.
FT                                /FTId=PRO_0000071403.
FT   REPEAT       20     58       HEAT 1.
FT   REPEAT       59     96       HEAT 2.
FT   REPEAT       97    135       HEAT 3.
FT   REPEAT      136    173       HEAT 4.
FT   REPEAT      174    212       HEAT 5.
FT   REPEAT      213    251       HEAT 6.
FT   REPEAT      252    290       HEAT 7.
FT   REPEAT      291    333       HEAT 8.
FT   REPEAT      334    372       HEAT 9.
FT   REPEAT      373    411       HEAT 10.
FT   REPEAT      412    450       HEAT 11.
FT   REPEAT      451    489       HEAT 12.
FT   REPEAT      490    528       HEAT 13.
FT   REPEAT      529    567       HEAT 14.
FT   REPEAT      568    601       HEAT 15.
FT   VAR_SEQ     598    601       LALA -> VAQRLRKLEFPVKDSGEPSVPRADKNHFPRPTV
FT                                PGEDMGKGPVYQLRGDTRDTLAQLGIAELVHFSQSTD (in
FT                                isoform 2).
FT                                /FTId=VSP_036460.
FT   VARIANT       8      8       G -> R (in a lung cancer patient).
FT                                /FTId=VAR_022895.
FT   VARIANT      15     15       G -> A (in a colorectal cancer patient).
FT                                /FTId=VAR_022896.
FT   VARIANT      65     65       P -> S (in a lung cancer patient).
FT                                /FTId=VAR_022897.
FT   VARIANT      90     90       G -> D (in a lung cancer patient;
FT                                dbSNP:rs1805076).
FT                                /FTId=VAR_006384.
FT   VARIANT     101    101       L -> P (in a colon adenocarcinoma).
FT                                /FTId=VAR_022898.
FT   VARIANT     343    343       K -> E (in a lung cancer patient).
FT                                /FTId=VAR_022899.
FT   VARIANT     365    365       S -> P (in a colorectal cancer patient).
FT                                /FTId=VAR_022900.
FT   VARIANT     448    448       V -> A (in a colon adenocarcinoma).
FT                                /FTId=VAR_022901.
FT   VARIANT     498    498       V -> E (in a colorectal cancer patient).
FT                                /FTId=VAR_022902.
FT   VARIANT     499    499       L -> I (in a colorectal cancer patient).
FT                                /FTId=VAR_022903.
FT   VARIANT     500    500       V -> G (in a colorectal cancer patient).
FT                                /FTId=VAR_022904.
FT   VARIANT     504    504       D -> G (in a lung cancer patient).
FT                                /FTId=VAR_022905.
FT   VARIANT     545    545       V -> A (in a colon adenocarcinoma).
FT                                /FTId=VAR_022906.
FT   CONFLICT     74     74       E -> V (in Ref. 8; AAA59983).
FT   CONFLICT    178    178       I -> T (in Ref. 1; AAC63525, 3; AAG39644
FT                                and 8; AAA59983).
FT   CONFLICT    411    411       Q -> R (in Ref. 8; AAA59983).
SQ   SEQUENCE   601 AA;  66214 MW;  86AB20D7505210B0 CRC64;
     MAGASELGTG PGAAGGDGDD SLYPIAVLID ELRNEDVQLR LNSIKKLSTI ALALGVERTR
     SELLPFLTDT IYDEDEVLLA LAEQLGNFTG LVGGPDFAHC LLPPLENLAT VEETVVRDKA
     VESLRQISQE HTPVALEAYF VPLVKRLASG DWFTSRTSAC GLFSVCYPRA SNAVKAEIRQ
     QFRSLCSDDT PMVRRAAASK LGEFAKVLEL DSVKSEIVPL FTSLASDEQD SVRLLAVEAC
     VSIAQLLSQD DLETLVMPTL RQAAEDKSWR VRYMVADRFS ELQKAMGPKI TLNDLIPAFQ
     NLLKDCEAEV RAAAAHKVKE LGENLPIEDR ETIIMNQILP YIKELVSDTN QHVKSALASV
     IMGLSTILGK ENTIEHLLPL FLAQLKDECP DVRLNIISNL DCVNEVIGIR QLSQSLLPAI
     VELAEDAKWR VRLAIIEYMP LLAGQLGVEF FDEKLNSLCM AWLVDHVYAI REAATNNLMK
     LVQKFGTEWA QNTIVPKVLV MANDPNYLHR MTTLFCINAL SEACGQEITT KQMLPIVLKM
     AGDQVANVRF NVAKSLQKIG PILDTNALQG EVKPVLQKLG QDEDMDVKYF AQEAISVLAL
     A
//
ID   2ABA_HUMAN              Reviewed;         447 AA.
AC   P63151; B2RBU8; B4E1T7; P50409; Q00007;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2004, sequence version 1.
DT   18-APR-2012, entry version 86.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform;
DE   AltName: Full=PP2A subunit B isoform B55-alpha;
DE   AltName: Full=PP2A subunit B isoform PR55-alpha;
DE   AltName: Full=PP2A subunit B isoform R2-alpha;
DE   AltName: Full=PP2A subunit B isoform alpha;
GN   Name=PPP2R2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Lung fibroblast;
RX   MEDLINE=91198016; PubMed=1849734; DOI=10.1021/bi00229a001;
RA   Mayer R.E., Hendrix P., Cron P., Matthies R., Stone S.R., Goris J.,
RA   Merlevede W., Hofsteenge J., Hemmings B.A.;
RT   "Structure of the 55-kDa regulatory subunit of protein phosphatase 2A:
RT   evidence for a neuronal-specific isoform.";
RL   Biochemistry 30:3589-3597(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH TP53.
RX   PubMed=17245430; DOI=10.1038/sj.emboj.7601519;
RA   Li H.H., Cai X., Shouse G.P., Piluso L.G., Liu X.;
RT   "A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-
RT   induced dephosphorylation of p53 at Thr55.";
RL   EMBO J. 26:402-411(2007).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment.
CC   -!- SUBUNIT: Found in a complex with at least ARL2, PPP2CB, PPP2R1A,
CC       PPP2R2A, PPP2R5E and TBCD (By similarity). PP2A consists of a
CC       common heterodimeric core enzyme, composed of a 36 kDa catalytic
CC       subunit (subunit C) and a 65 kDa constant regulatory subunit (PR65
CC       or subunit A), that associates with a variety of regulatory
CC       subunits. Proteins that associate with the core dimer include
CC       three families of regulatory subunits B (the R2/B/PR55/B55,
CC       R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the 48 kDa
CC       variable regulatory subunit, viral proteins, and cell signaling
CC       molecules. Interacts with TP53.
CC   -!- INTERACTION:
CC       P30154:PPP2R1B; NbExp=2; IntAct=EBI-1048931, EBI-357094;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P63151-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P63151-2; Sequence=VSP_043100;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B
CC       family.
CC   -!- SIMILARITY: Contains 7 WD repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64929; AAA36490.1; -; mRNA.
DR   EMBL; AK303981; BAG64899.1; -; mRNA.
DR   EMBL; AK314823; BAG37345.1; -; mRNA.
DR   EMBL; AC022911; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471080; EAW63578.1; -; Genomic_DNA.
DR   EMBL; BC041071; AAH41071.1; -; mRNA.
DR   IPI; IPI00332511; -.
DR   IPI; IPI00798041; -.
DR   PIR; A38351; A38351.
DR   RefSeq; NP_001171062.1; NM_001177591.1.
DR   RefSeq; NP_002708.1; NM_002717.3.
DR   UniGene; Hs.146339; -.
DR   PDB; 3DW8; X-ray; 2.85 A; B/E=1-447.
DR   PDBsum; 3DW8; -.
DR   ProteinModelPortal; P63151; -.
DR   SMR; P63151; 8-446.
DR   DIP; DIP-29398N; -.
DR   IntAct; P63151; 7.
DR   MINT; MINT-2835351; -.
DR   STRING; P63151; -.
DR   PhosphoSite; P63151; -.
DR   DMDM; 52783535; -.
DR   PeptideAtlas; P63151; -.
DR   PRIDE; P63151; -.
DR   DNASU; 5520; -.
DR   Ensembl; ENST00000315985; ENSP00000325074; ENSG00000221914.
DR   Ensembl; ENST00000380737; ENSP00000370113; ENSG00000221914.
DR   GeneID; 5520; -.
DR   KEGG; hsa:5520; -.
DR   UCSC; uc003xeu.3; human.
DR   CTD; 5520; -.
DR   GeneCards; GC08P026204; -.
DR   H-InvDB; HIX0007394; -.
DR   HGNC; HGNC:9304; PPP2R2A.
DR   MIM; 604941; gene.
DR   neXtProt; NX_P63151; -.
DR   PharmGKB; PA33668; -.
DR   eggNOG; COG5170; -.
DR   GeneTree; ENSGT00390000006311; -.
DR   HOVERGEN; HBG000012; -.
DR   InParanoid; P63151; -.
DR   KO; K04354; -.
DR   OrthoDB; EOG4M0F1K; -.
DR   PhylomeDB; P63151; -.
DR   Pathway_Interaction_DB; tgfbrpathway; TGF-beta receptor signaling.
DR   Reactome; REACT_115566; Cell Cycle.
DR   Reactome; REACT_21257; Metabolism of RNA.
DR   Reactome; REACT_71; Gene Expression.
DR   EvolutionaryTrace; P63151; -.
DR   NextBio; 21352; -.
DR   ArrayExpress; P63151; -.
DR   Bgee; P63151; -.
DR   CleanEx; HS_PPP2R2A; -.
DR   Genevestigator; P63151; -.
DR   GermOnline; ENSG00000147459; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 3.
DR   InterPro; IPR000009; PP2A_PR55.
DR   InterPro; IPR018067; PP2A_PR55_CS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   PANTHER; PTHR11871; Pp2A_PR55; 1.
DR   PIRSF; PIRSF037309; PP2A_PR55; 1.
DR   PRINTS; PR00600; PP2APR55.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; WD40_like; 1.
DR   PROSITE; PS01024; PR55_1; 1.
DR   PROSITE; PS01025; PR55_2; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; FALSE_NEG.
DR   PROSITE; PS50082; WD_REPEATS_2; FALSE_NEG.
DR   PROSITE; PS50294; WD_REPEATS_REGION; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Reference proteome; Repeat; WD repeat.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    447       Serine/threonine-protein phosphatase 2A
FT                                55 kDa regulatory subunit B alpha
FT                                isoform.
FT                                /FTId=PRO_0000071415.
FT   REPEAT       26     65       WD 1.
FT   REPEAT       91    132       WD 2.
FT   REPEAT      175    213       WD 3.
FT   REPEAT      224    264       WD 4.
FT   REPEAT      283    321       WD 5.
FT   REPEAT      338    379       WD 6.
FT   REPEAT      414    446       WD 7.
FT   MOD_RES       2      2       N-acetylalanine.
FT   VAR_SEQ       1      2       MA -> MFPKFSLRSMFH (in isoform 2).
FT                                /FTId=VSP_043100.
FT   STRAND       13     16
FT   HELIX        27     29
FT   STRAND       42     45
FT   STRAND       52     57
FT   STRAND       71     77
FT   STRAND       83     85
FT   HELIX        86     88
FT   STRAND       90     92
FT   STRAND       98    101
FT   STRAND      106    114
FT   STRAND      119    132
FT   STRAND      156    172
FT   STRAND      182    185
FT   STRAND      189    195
FT   STRAND      197    204
FT   STRAND      207    216
FT   HELIX       222    224
FT   STRAND      229    234
FT   STRAND      241    246
FT   STRAND      251    255
FT   TURN        256    258
FT   STRAND      260    262
FT   STRAND      267    269
FT   HELIX       280    284
FT   STRAND      288    293
FT   STRAND      300    312
FT   STRAND      323    325
FT   HELIX       327    329
FT   TURN        330    332
FT   HELIX       333    338
FT   HELIX       341    343
FT   STRAND      355    359
FT   STRAND      365    370
FT   TURN        371    373
FT   STRAND      376    380
FT   HELIX       410    412
FT   STRAND      421    424
FT   STRAND      426    434
FT   STRAND      439    443
SQ   SEQUENCE   447 AA;  51692 MW;  F4D407FF7ADA4ED6 CRC64;
     MAGAGGGNDI QWCFSQVKGA VDDDVAEADI ISTVEFNHSG ELLATGDKGG RVVIFQQEQE
     NKIQSHSRGE YNVYSTFQSH EPEFDYLKSL EIEEKINKIR WLPQKNAAQF LLSTNDKTIK
     LWKISERDKR PEGYNLKEED GRYRDPTTVT TLRVPVFRPM DLMVEASPRR IFANAHTYHI
     NSISINSDYE TYLSADDLRI NLWHLEITDR SFNIVDIKPA NMEELTEVIT AAEFHPNSCN
     TFVYSSSKGT IRLCDMRASA LCDRHSKLFE EPEDPSNRSF FSEIISSISD VKFSHSGRYM
     MTRDYLSVKI WDLNMENRPV ETYQVHEYLR SKLCSLYEND CIFDKFECCW NGSDSVVMTG
     SYNNFFRMFD RNTKRDITLE ASRENNKPRT VLKPRKVCAS GKRKKDEISV DSLDFNKKIL
     HTAWHPKENI IAVATTNNLY IFQDKVN
//
ID   2ABB_HUMAN              Reviewed;         443 AA.
AC   Q00005; A6NEJ2; A8K102; B3KPD0; B7Z2F2; B7Z304; D3DQF7; D3DQF8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   18-APR-2012, entry version 127.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform;
DE   AltName: Full=PP2A subunit B isoform B55-beta;
DE   AltName: Full=PP2A subunit B isoform PR55-beta;
DE   AltName: Full=PP2A subunit B isoform R2-beta;
DE   AltName: Full=PP2A subunit B isoform beta;
GN   Name=PPP2R2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   MEDLINE=91198016; PubMed=1849734; DOI=10.1021/bi00229a001;
RA   Mayer R.E., Hendrix P., Cron P., Matthies R., Stone S.R., Goris J.,
RA   Merlevede W., Hofsteenge J., Hemmings B.A.;
RT   "Structure of the 55-kDa regulatory subunit of protein phosphatase 2A:
RT   evidence for a neuronal-specific isoform.";
RL   Biochemistry 30:3589-3597(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain, and Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-197 (ISOFORM 2).
RA   Strausberg R.L.;
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INVOLVEMENT IN SCA12.
RX   MEDLINE=20047763; PubMed=10581021; DOI=10.1038/70493;
RA   Holmes S.E., O'Hearn E.E., McInnis M.G., Gorelick-Feldman D.A.,
RA   Kleiderlein J.J., Callahan C., Kwak N.G., Ingersoll-Ashworth R.G.,
RA   Sherr M., Sumner A.J., Sharp A.H., Ananth U., Seltzer W.K., Boss M.A.,
RA   Vieria-Saecker A.-M., Epplen J.T., Riess O., Ross C.A., Margolis R.L.;
RT   "Expansion of a novel CAG trinucleotide repeat in the 5' region of
RT   PPP2R2B is associated with SCA12.";
RL   Nat. Genet. 23:391-392(1999).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment. Within the PP2A holoenzyme complex, isoform 2 is
CC       required to promote proapoptotic activity (By similarity). Isoform
CC       2 regulates neuronal survival through the mitochondrial fission
CC       and fusion balance (By similarity).
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules.
CC   -!- INTERACTION:
CC       O15530:PDPK1; NbExp=8; IntAct=EBI-1052159, EBI-717097;
CC       P30153:PPP2R1A; NbExp=5; IntAct=EBI-1052159, EBI-302388;
CC       P23443:RPS6KB1; NbExp=2; IntAct=EBI-1052159, EBI-1775921;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm (By similarity).
CC       Cytoplasm, cytoskeleton (By similarity). Membrane (By similarity).
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm (By similarity).
CC       Mitochondrion (By similarity). Mitochondrion outer membrane (By
CC       similarity). Note=Under basal conditions, localizes to both
CC       cytosolic and mitochondrial compartments. Relocalizes from the
CC       cytosolic to the mitochondrial compartment during apoptosis. Its
CC       targeting to the outer mitochondrial membrane (OMM) involves an
CC       association with import receptors of the TOM complex and is
CC       required to promote proapoptotic activity (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Bbeta, Bbeta1;
CC         IsoId=Q00005-1; Sequence=Displayed;
CC       Name=2; Synonyms=Bbeta2;
CC         IsoId=Q00005-2; Sequence=VSP_037976;
CC         Note=Contains a cryptic mitochondrial transit peptide at
CC         positions 1-26 (By similarity);
CC       Name=3;
CC         IsoId=Q00005-3; Sequence=VSP_037977;
CC       Name=4;
CC         IsoId=Q00005-4; Sequence=VSP_037978;
CC       Name=5;
CC         IsoId=Q00005-5; Sequence=VSP_037979;
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- DOMAIN: The N-terminal 26 residues of isoform 2 constitute a
CC       cryptic mitochondrial matrix import signal with critical basic and
CC       hydrophobic residues, that is necessary and sufficient for
CC       targeting the PP2A holoenzyme to the outer mitochondrial membrane
CC       (OMM) and does not affect holoenzyme formation or catalytic
CC       activity (By similarity).
CC   -!- DOMAIN: The last WD repeat of isoform 2 constitutes a
CC       mitochondrial stop-transfer domain that confers resistance to the
CC       unfolding step process required for import and therefore prevents
CC       PPP2R2B matrix translocation and signal sequence cleavage (By
CC       similarity).
CC   -!- DISEASE: Defects in PPP2R2B are the cause of spinocerebellar
CC       ataxia type 12 (SCA12) [MIM:604326]. Spinocerebellar ataxia is a
CC       clinically and genetically heterogeneous group of cerebellar
CC       disorders. Patients show progressive incoordination of gait and
CC       often poor coordination of hands, speech and eye movements, due to
CC       degeneration of the cerebellum with variable involvement of the
CC       brainstem and spinal cord. SCA12 is an autosomal dominant
CC       cerebellar ataxia (ADCA).
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B
CC       family.
CC   -!- SIMILARITY: Contains 7 WD repeats.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH31790.1; Type=Erroneous initiation;
CC       Sequence=BAG51642.1; Type=Erroneous termination; Positions=116; Note=Translated as Lys;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PPP2R2B";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64930; AAA36493.1; -; mRNA.
DR   EMBL; AK056192; BAG51642.1; ALT_SEQ; mRNA.
DR   EMBL; AK289717; BAF82406.1; -; mRNA.
DR   EMBL; AK294659; BAH11838.1; -; mRNA.
DR   EMBL; AK295347; BAH12040.1; -; mRNA.
DR   EMBL; AC008728; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010251; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011386; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091919; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091924; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61829.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61831.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61832.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61834.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61835.1; -; Genomic_DNA.
DR   EMBL; BC031790; AAH31790.1; ALT_INIT; mRNA.
DR   EMBL; BI490027; -; NOT_ANNOTATED_CDS; mRNA.
DR   IPI; IPI00020850; -.
DR   IPI; IPI00376972; -.
DR   IPI; IPI00376973; -.
DR   IPI; IPI00944548; -.
DR   IPI; IPI00944557; -.
DR   PIR; B38351; B38351.
DR   RefSeq; NP_001120853.1; NM_001127381.1.
DR   RefSeq; NP_004567.1; NM_004576.2.
DR   RefSeq; NP_858060.1; NM_181674.2.
DR   RefSeq; NP_858061.1; NM_181675.2.
DR   RefSeq; NP_858062.1; NM_181676.2.
DR   RefSeq; NP_858063.1; NM_181677.2.
DR   RefSeq; NP_858064.1; NM_181678.2.
DR   UniGene; Hs.655213; -.
DR   ProteinModelPortal; Q00005; -.
DR   SMR; Q00005; 23-442.
DR   IntAct; Q00005; 168.
DR   STRING; Q00005; -.
DR   PhosphoSite; Q00005; -.
DR   DMDM; 231446; -.
DR   PRIDE; Q00005; -.
DR   DNASU; 5521; -.
DR   Ensembl; ENST00000336640; ENSP00000336591; ENSG00000156475.
DR   Ensembl; ENST00000356826; ENSP00000349283; ENSG00000156475.
DR   Ensembl; ENST00000394409; ENSP00000377931; ENSG00000156475.
DR   Ensembl; ENST00000394410; ENSP00000377932; ENSG00000156475.
DR   Ensembl; ENST00000394411; ENSP00000377933; ENSG00000156475.
DR   Ensembl; ENST00000394413; ENSP00000377935; ENSG00000156475.
DR   Ensembl; ENST00000394414; ENSP00000377936; ENSG00000156475.
DR   Ensembl; ENST00000453001; ENSP00000398779; ENSG00000156475.
DR   GeneID; 5521; -.
DR   KEGG; hsa:5521; -.
DR   UCSC; uc003loe.3; human.
DR   UCSC; uc003loi.4; human.
DR   UCSC; uc011dbu.2; human.
DR   UCSC; uc011dbv.2; human.
DR   CTD; 5521; -.
DR   GeneCards; GC05M145967; -.
DR   GeneCards; GC05M145969; -.
DR   H-InvDB; HIX0021292; -.
DR   HGNC; HGNC:9305; PPP2R2B.
DR   HPA; HPA038118; -.
DR   MIM; 604325; gene.
DR   MIM; 604326; phenotype.
DR   neXtProt; NX_Q00005; -.
DR   Orphanet; 98762; Spinocerebellar ataxia type 12.
DR   PharmGKB; PA33669; -.
DR   eggNOG; COG5170; -.
DR   GeneTree; ENSGT00390000006311; -.
DR   HOVERGEN; HBG000012; -.
DR   InParanoid; Q00005; -.
DR   KO; K04354; -.
DR   OMA; VFQREQE; -.
DR   OrthoDB; EOG4M0F1K; -.
DR   NextBio; 21356; -.
DR   ArrayExpress; Q00005; -.
DR   Bgee; Q00005; -.
DR   CleanEx; HS_PPP2R2B; -.
DR   Genevestigator; Q00005; -.
DR   GermOnline; ENSG00000156475; Homo sapiens.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 3.
DR   InterPro; IPR000009; PP2A_PR55.
DR   InterPro; IPR018067; PP2A_PR55_CS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   PANTHER; PTHR11871; Pp2A_PR55; 1.
DR   PIRSF; PIRSF037309; PP2A_PR55; 1.
DR   PRINTS; PR00600; PP2APR55.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; WD40_like; 1.
DR   PROSITE; PS01024; PR55_1; 1.
DR   PROSITE; PS01025; PR55_2; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; FALSE_NEG.
DR   PROSITE; PS50294; WD_REPEATS_REGION; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Neurodegeneration; Polymorphism; Reference proteome; Repeat;
KW   Spinocerebellar ataxia; WD repeat.
FT   CHAIN         1    443       Serine/threonine-protein phosphatase 2A
FT                                55 kDa regulatory subunit B beta isoform.
FT                                /FTId=PRO_0000071421.
FT   REPEAT       22     61       WD 1.
FT   REPEAT       87    128       WD 2.
FT   REPEAT      171    209       WD 3.
FT   REPEAT      220    260       WD 4.
FT   REPEAT      279    317       WD 5.
FT   REPEAT      334    375       WD 6.
FT   REPEAT      410    442       WD 7.
FT   VAR_SEQ       1     21       MEEDIDTRKINNSFLRDHSYA -> MKCFSRYLPYIFRPPN
FT                                TILSSSCH (in isoform 2).
FT                                /FTId=VSP_037976.
FT   VAR_SEQ       1     21       MEEDIDTRKINNSFLRDHSYA -> MIPGIGTLTQDTLWCF
FT                                SQVKGTIEIGT (in isoform 3).
FT                                /FTId=VSP_037977.
FT   VAR_SEQ       1      1       M -> MVLQPSERHYRDWNHRRLGPWCSPTGSPAPLSCETG
FT                                CGEGSWILVCRLLVPTQVSLLSM (in isoform 4).
FT                                /FTId=VSP_037978.
FT   VAR_SEQ       1      1       M -> MLLSLPALHLQTSEHHPFFQLPHRRLGPWCSPTGSP
FT                                APLSCETGCGEGSWILVCRLLVPTQVSLLSM (in
FT                                isoform 5).
FT                                /FTId=VSP_037979.
FT   VARIANT      36     36       G -> V (in dbSNP:rs11547494).
FT                                /FTId=VAR_051738.
FT   CONFLICT     22     22       T -> A (in Ref. 2; BAH11838).
FT   CONFLICT    109    109       S -> F (in Ref. 2; BAH12040).
FT   CONFLICT    163    163       T -> S (in Ref. 6; BI490027).
FT   CONFLICT    164    164       P -> S (in Ref. 2; BAF82406).
FT   CONFLICT    292    292       S -> R (in Ref. 2; BAH12040).
SQ   SEQUENCE   443 AA;  51710 MW;  C383C834B2852B8F CRC64;
     MEEDIDTRKI NNSFLRDHSY ATEADIISTV EFNHTGELLA TGDKGGRVVI FQREQESKNQ
     VHRRGEYNVY STFQSHEPEF DYLKSLEIEE KINKIRWLPQ QNAAYFLLST NDKTVKLWKV
     SERDKRPEGY NLKDEEGRLR DPATITTLRV PVLRPMDLMV EATPRRVFAN AHTYHINSIS
     VNSDYETYMS ADDLRINLWN FEITNQSFNI VDIKPANMEE LTEVITAAEF HPHHCNTFVY
     SSSKGTIRLC DMRASALCDR HTKFFEEPED PSNRSFFSEI ISSISDVKFS HSGRYIMTRD
     YLTVKVWDLN MENRPIETYQ VHDYLRSKLC SLYENDCIFD KFECVWNGSD SVIMTGSYNN
     FFRMFDRNTK RDVTLEASRE NSKPRAILKP RKVCVGGKRR KDEISVDSLD FSKKILHTAW
     HPSENIIAVA ATNNLYIFQD KVN
//
ID   2ABD_HUMAN              Reviewed;         453 AA.
AC   Q66LE6; A8KAK0; Q5SQJ2; Q9P1Y7;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   18-APR-2012, entry version 80.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform;
DE   AltName: Full=PP2A subunit B isoform B55-delta;
DE   AltName: Full=PP2A subunit B isoform PR55-delta;
DE   AltName: Full=PP2A subunit B isoform R2-delta;
DE   AltName: Full=PP2A subunit B isoform delta;
GN   Name=PPP2R2D; Synonyms=KIAA1541;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 34-453.
RC   TISSUE=Brain;
RX   MEDLINE=20277482; PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: B regulatory subunit of protein phosphatase 2A (PP2A)
CC       that plays a key role in cell cycle by controlling mitosis entry
CC       and exit. The activity of PP2A complexes containing PPP2R2D (PR55-
CC       delta) fluctuate during the cell cycle: the activity is high in
CC       interphase and low in mitosis. During mitosis, activity of PP2A is
CC       inhibited via interaction with phosphorylated ENSA and ARPP19
CC       inhibitors. Within the PP2A complexes, the B regulatory subunits
CC       modulate substrate selectivity and catalytic activity, and also
CC       may direct the localization of the catalytic enzyme to a
CC       particular subcellular compartment (By similarity).
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules. Interacts with ENSA (when
CC       phosphorylated at 'Ser-67') and ARPP19 (when phosphorylated at
CC       'Ser-62'), leading to inhibit PP2A activity (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B
CC       family.
CC   -!- SIMILARITY: Contains 7 WD repeats.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA96065.1; Type=Erroneous initiation;
CC       Sequence=CAI16703.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK293065; BAF85754.1; -; mRNA.
DR   EMBL; AL732395; CAI16703.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC047379; AAH47379.1; -; mRNA.
DR   EMBL; AB040974; BAA96065.1; ALT_INIT; mRNA.
DR   IPI; IPI00470920; -.
DR   RefSeq; NP_060931.2; NM_018461.3.
DR   UniGene; Hs.380372; -.
DR   UniGene; Hs.657480; -.
DR   ProteinModelPortal; Q66LE6; -.
DR   SMR; Q66LE6; 14-452.
DR   IntAct; Q66LE6; 26.
DR   STRING; Q66LE6; -.
DR   DMDM; 74736328; -.
DR   PRIDE; Q66LE6; -.
DR   DNASU; 55844; -.
DR   Ensembl; ENST00000455566; ENSP00000399970; ENSG00000175470.
DR   GeneID; 55844; -.
DR   KEGG; hsa:55844; -.
DR   UCSC; uc001lks.3; human.
DR   CTD; 55844; -.
DR   GeneCards; GC10P133747; -.
DR   HGNC; HGNC:23732; PPP2R2D.
DR   MIM; 613992; gene.
DR   neXtProt; NX_Q66LE6; -.
DR   PharmGKB; PA134899040; -.
DR   eggNOG; COG5170; -.
DR   GeneTree; ENSGT00390000006311; -.
DR   HOGENOM; HBG443924; -.
DR   HOVERGEN; HBG000012; -.
DR   InParanoid; Q66LE6; -.
DR   KO; K04354; -.
DR   OrthoDB; EOG4M0F1K; -.
DR   NextBio; 61085; -.
DR   ArrayExpress; Q66LE6; -.
DR   Bgee; Q66LE6; -.
DR   CleanEx; HS_PPP2R2D; -.
DR   Genevestigator; Q66LE6; -.
DR   GermOnline; ENSG00000175470; Homo sapiens.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; ISS:UniProtKB.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0010458; P:exit from mitosis; ISS:UniProtKB.
DR   GO; GO:0007067; P:mitosis; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 3.
DR   InterPro; IPR000009; PP2A_PR55.
DR   InterPro; IPR018067; PP2A_PR55_CS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   PANTHER; PTHR11871; Pp2A_PR55; 1.
DR   PIRSF; PIRSF037309; PP2A_PR55; 1.
DR   PRINTS; PR00600; PP2APR55.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; WD40_like; 1.
DR   PROSITE; PS01024; PR55_1; 1.
DR   PROSITE; PS01025; PR55_2; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; FALSE_NEG.
DR   PROSITE; PS50082; WD_REPEATS_2; FALSE_NEG.
DR   PROSITE; PS50294; WD_REPEATS_REGION; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Complete proteome; Cytoplasm; Mitosis;
KW   Polymorphism; Reference proteome; Repeat; WD repeat.
FT   CHAIN         1    453       Serine/threonine-protein phosphatase 2A
FT                                55 kDa regulatory subunit B delta
FT                                isoform.
FT                                /FTId=PRO_0000071433.
FT   REPEAT       32     71       WD 1.
FT   REPEAT       97    138       WD 2.
FT   REPEAT      181    219       WD 3.
FT   REPEAT      230    270       WD 4.
FT   REPEAT      289    327       WD 5.
FT   REPEAT      344    385       WD 6.
FT   REPEAT      420    452       WD 7.
FT   COMPBIAS      3      8       Poly-Gly.
FT   VARIANT     358    358       G -> S (in dbSNP:rs34473884).
FT                                /FTId=VAR_057127.
FT   CONFLICT    290    290       I -> V (in Ref. 1; BAF85754).
FT   CONFLICT    311    311       Y -> H (in Ref. 1; BAF85754).
FT   CONFLICT    321    321       M -> T (in Ref. 1; BAF85754).
FT   CONFLICT    449    449       Q -> R (in Ref. 1; BAF85754).
SQ   SEQUENCE   453 AA;  52042 MW;  0669CDB80AF4400E CRC64;
     MAGAGGGGCP AGGNDFQWCF SQVKGAIDED VAEADIISTV EFNYSGDLLA TGDKGGRVVI
     FQREQENKSR PHSRGEYNVY STFQSHEPEF DYLKSLEIEE KINKIRWLPQ QNAAHFLLST
     NDKTIKLWKI SERDKRAEGY NLKDEDGRLR DPFRITALRV PILKPMDLMV EASPRRIFAN
     AHTYHINSIS VNSDHETYLS ADDLRINLWH LEITDRSFNI VDIKPANMEE LTEVITAAEF
     HPHQCNVFVY SSSKGTIRLC DMRSSALCDR HSKFFEEPED PSSRSFFSEI ISSISDVKFS
     HSGRYMMTRD YLSVKVWDLN MESRPVETHQ VHEYLRSKLC SLYENDCIFD KFECCWNGSD
     SAIMTGSYNN FFRMFDRDTR RDVTLEASRE SSKPRASLKP RKVCTGGKRR KDEISVDSLD
     FNKKILHTAW HPVDNVIAVA ATNNLYIFQD KIN
//
ID   2ABG_HUMAN              Reviewed;         447 AA.
AC   Q9Y2T4; A8MSY7; Q7Z4V7; Q8NEC4; Q9H3G7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 4.
DT   18-APR-2012, entry version 103.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform;
DE   AltName: Full=IMYPNO1;
DE   AltName: Full=PP2A subunit B isoform B55-gamma;
DE   AltName: Full=PP2A subunit B isoform PR55-gamma;
DE   AltName: Full=PP2A subunit B isoform R2-gamma;
DE   AltName: Full=PP2A subunit B isoform gamma;
GN   Name=PPP2R2C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=20039617; PubMed=10574460; DOI=10.1093/dnares/6.5.323;
RA   Torres R., Ide S.E., Dehejia A., Baras A., Polymeropoulos M.H.;
RT   "Genomic structure and localization of the human phosphatase 2A BR
RT   gamma regulatory subunit.";
RL   DNA Res. 6:323-327(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=20399570; PubMed=10945473; DOI=10.1006/geno.2000.6219;
RA   Hu P., Yu L., Zhang M., Zheng L., Zhao Y., Fu Q., Zhao S.;
RT   "Molecular cloning and mapping of the brain-abundant B1gamma subunit
RT   of protein phosphatase 2A, PPP2R2C, to human chromosome 4p16.";
RL   Genomics 67:83-86(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA homologous to Oryctolagus cuniculus
RT   protein phosphatase 2A1 B gamma subunit.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y2T4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y2T4-2; Sequence=VSP_036457;
CC       Name=3;
CC         IsoId=Q9Y2T4-3; Sequence=VSP_036458;
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B
CC       family.
CC   -!- SIMILARITY: Contains 7 WD repeats.
CC   -!- CAUTION: The EMBL entry for PubMed:10574460 is not complete, the
CC       paper shows the rest of the sequence (residues 1 to 23).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF096160; AAD20987.1; -; Genomic_DNA.
DR   EMBL; AF096153; AAD20987.1; JOINED; Genomic_DNA.
DR   EMBL; AF096154; AAD20987.1; JOINED; Genomic_DNA.
DR   EMBL; AF096155; AAD20987.1; JOINED; Genomic_DNA.
DR   EMBL; AF096156; AAD20987.1; JOINED; Genomic_DNA.
DR   EMBL; AF096157; AAD20987.1; JOINED; Genomic_DNA.
DR   EMBL; AF096158; AAD20987.1; JOINED; Genomic_DNA.
DR   EMBL; AF096159; AAD20987.1; JOINED; Genomic_DNA.
DR   EMBL; AF086924; AAG39636.1; -; mRNA.
DR   EMBL; AF145027; AAP97279.1; -; mRNA.
DR   EMBL; AK093115; BAG52658.1; -; mRNA.
DR   EMBL; AC116317; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471131; EAW82395.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82394.1; -; Genomic_DNA.
DR   EMBL; BC032954; AAH32954.1; -; mRNA.
DR   IPI; IPI00032462; -.
DR   IPI; IPI00178803; -.
DR   IPI; IPI00871687; -.
DR   PIR; JC7153; JC7153.
DR   RefSeq; NP_001193925.1; NM_001206996.1.
DR   RefSeq; NP_870991.1; NM_181876.2.
DR   UniGene; Hs.479069; -.
DR   UniGene; Hs.694633; -.
DR   ProteinModelPortal; Q9Y2T4; -.
DR   SMR; Q9Y2T4; 21-442.
DR   IntAct; Q9Y2T4; 14.
DR   STRING; Q9Y2T4; -.
DR   PhosphoSite; Q9Y2T4; -.
DR   DMDM; 145559437; -.
DR   PRIDE; Q9Y2T4; -.
DR   DNASU; 5522; -.
DR   Ensembl; ENST00000382599; ENSP00000372042; ENSG00000074211.
DR   GeneID; 5522; -.
DR   KEGG; hsa:5522; -.
DR   UCSC; uc003gja.3; human.
DR   UCSC; uc003gjb.3; human.
DR   UCSC; uc003gjc.3; human.
DR   CTD; 5522; -.
DR   GeneCards; GC04M006322; -.
DR   HGNC; HGNC:9306; PPP2R2C.
DR   MIM; 605997; gene.
DR   neXtProt; NX_Q9Y2T4; -.
DR   PharmGKB; PA33670; -.
DR   eggNOG; COG5170; -.
DR   GeneTree; ENSGT00390000006311; -.
DR   HOGENOM; HBG443924; -.
DR   HOVERGEN; HBG000012; -.
DR   KO; K04354; -.
DR   OMA; MGEDTDT; -.
DR   OrthoDB; EOG4M0F1K; -.
DR   NextBio; 21370; -.
DR   ArrayExpress; Q9Y2T4; -.
DR   Bgee; Q9Y2T4; -.
DR   CleanEx; HS_PPP2R2C; -.
DR   Genevestigator; Q9Y2T4; -.
DR   GermOnline; ENSG00000074211; Homo sapiens.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; NAS:UniProtKB.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; NAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   Gene3D; G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 2.
DR   InterPro; IPR000009; PP2A_PR55.
DR   InterPro; IPR018067; PP2A_PR55_CS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   PANTHER; PTHR11871; Pp2A_PR55; 1.
DR   PIRSF; PIRSF037309; PP2A_PR55; 1.
DR   PRINTS; PR00600; PP2APR55.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; WD40_like; 1.
DR   PROSITE; PS01024; PR55_1; 1.
DR   PROSITE; PS01025; PR55_2; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; FALSE_NEG.
DR   PROSITE; PS50082; WD_REPEATS_2; FALSE_NEG.
DR   PROSITE; PS50294; WD_REPEATS_REGION; FALSE_NEG.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Reference proteome; Repeat;
KW   WD repeat.
FT   CHAIN         1    447       Serine/threonine-protein phosphatase 2A
FT                                55 kDa regulatory subunit B gamma
FT                                isoform.
FT                                /FTId=PRO_0000071428.
FT   REPEAT       22     61       WD 1.
FT   REPEAT       87    128       WD 2.
FT   REPEAT      171    209       WD 3.
FT   REPEAT      220    260       WD 4.
FT   REPEAT      279    317       WD 5.
FT   REPEAT      334    375       WD 6.
FT   REPEAT      410    446       WD 7.
FT   VAR_SEQ       1     23       MGEDTDTRKINHSFLRDHSYVTE -> MGLSFFSKHLPIQE
FT                                GQPWALKTP (in isoform 2).
FT                                /FTId=VSP_036457.
FT   VAR_SEQ       1     23       MGEDTDTRKINHSFLRDHSYVTE -> MGKRDT (in
FT                                isoform 3).
FT                                /FTId=VSP_036458.
FT   CONFLICT     66     66       E -> D (in Ref. 2; AAG39636).
FT   CONFLICT    253    253       R -> P (in Ref. 2; AAG39636).
FT   CONFLICT    293    293       G -> D (in Ref. 2; AAG39636 and 3;
FT                                AAP97279).
SQ   SEQUENCE   447 AA;  51515 MW;  DB002C2384686BBD CRC64;
     MGEDTDTRKI NHSFLRDHSY VTEADIISTV EFNHTGELLA TGDKGGRVVI FQREPESKNA
     PHSQGEYDVY STFQSHEPEF DYLKSLEIEE KINKIKWLPQ QNAAHSLLST NDKTIKLWKI
     TERDKRPEGY NLKDEEGKLK DLSTVTSLQV PVLKPMDLMV EVSPRRIFAN GHTYHINSIS
     VNSDCETYMS ADDLRINLWH LAITDRSFNI VDIKPANMED LTEVITASEF HPHHCNLFVY
     SSSKGSLRLC DMRAAALCDK HSKLFEEPED PSNRSFFSEI ISSVSDVKFS HSGRYMLTRD
     YLTVKVWDLN MEARPIETYQ VHDYLRSKLC SLYENDCIFD KFECAWNGSD SVIMTGAYNN
     FFRMFDRNTK RDVTLEASRE SSKPRAVLKP RRVCVGGKRR RDDISVDSLD FTKKILHTAW
     HPAENIIAIA ATNNLYIFQD KVNSDMH
//
ID   2B11_HUMAN              Reviewed;         266 AA.
AC   P04229; A4F5N0; A8K098; O62869; P13758; Q06662; Q30116; Q30117;
AC   Q5Y7E9; Q7M2H4; Q95461; Q9BCL7; Q9GIK5; Q9MXZ0; Q9MXZ5; Q9TQ91;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   29-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 123.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-1 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*1;
DE            Short=DR-1;
DE            Short=DR1;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*01:01).
RX   MEDLINE=86055719; PubMed=2998758;
RA   Tonnelle C., Demars R., Long E.O.;
RT   "DO beta: a new beta chain gene in HLA-D with a distinct regulation of
RT   expression.";
RL   EMBO J. 4:2839-2847(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*01:01).
RX   MEDLINE=85216509; PubMed=3858829; DOI=10.1073/pnas.82.10.3405;
RA   Bell J.I., Estess P., St John T., Saiki R., Watling D.L., Erlich H.A.,
RA   McDevitt H.O.;
RT   "DNA sequence and characterization of human class II major
RT   histocompatibility complex beta chains from the DR1 haplotype.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3405-3409(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*01:03).
RX   MEDLINE=90111153; PubMed=1688595;
RA   Coppin H.L., Avoustin P., Fabron J., Huchenq A., Garnier J.-M.,
RA   Thomsen M., De Preval C.;
RT   "Evolution of the HLA-DR1 gene family. Structural and functional
RT   analysis of the new allele 'DR-BON'.";
RL   J. Immunol. 144:984-989(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=16140993; DOI=10.1101/gr.3554305;
RA   Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S.,
RA   Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V.;
RT   "Ancient haplotypes of the HLA Class II region.";
RL   Genome Res. 15:1250-1257(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DRB1*01:01), AND VARIANT
RP   ARG-262.
RX   PubMed=17345114; DOI=10.1007/s00251-007-0196-8;
RA   von Salome J., Gyllensten U., Bergstroem T.F.;
RT   "Full-length sequence analysis of the HLA-DRB1 locus suggests a recent
RT   origin of alleles.";
RL   Immunogenetics 59:261-271(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RC   TISSUE=B-cell;
RX   MEDLINE=93216303; PubMed=8462990; DOI=10.1007/BF00216386;
RA   Louis P., Eliaou J.F., Kerlan-Candon S., Pinet V., Vincent R.,
RA   Clot J.;
RT   "Polymorphism in the regulatory region of HLA-DRB genes correlating
RT   with haplotype evolution.";
RL   Immunogenetics 38:21-26(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*01:04).
RA   Middleton D., Versluis L.F., Tilanus M.G.J.;
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PROTEIN SEQUENCE OF 30-64.
RC   TISSUE=B-cell;
RX   MEDLINE=83153579; PubMed=6600932; DOI=10.1021/bi00270a027;
RA   Walker L.E., Hewick R., Hunkapiller M.W., Hood L.E., Dreyer W.J.,
RA   Reisfeld R.A.;
RT   "N-terminal amino acid sequences of the alpha and beta chains of HLA-
RT   DR1 and HLA-DR2 antigens.";
RL   Biochemistry 22:185-188(1983).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*01:06).
RX   MEDLINE=99217676; PubMed=10203026;
RX   DOI=10.1034/j.1399-0039.1999.530313.x;
RA   Palou E., Mongay L., Arias M.T., Isart F., Suarez B., Masso M.,
RA   Fabregat V., Martorell J., Gaya A.;
RT   "Identification of a novel DRB1-allele (DRB1*0106) by sequence-based
RT   typing.";
RL   Tissue Antigens 53:308-310(1999).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*01:07).
RX   PubMed=12753659; DOI=10.1034/j.1399-0039.2003.00034.x;
RA   Voorter C.E.M., Hepkema B.G., Lems S.P.M., van den Berg-Loonen E.M.;
RT   "Identification of three new DRB1 alleles, DRB1*0107, *0425 and *13012
RT   and confirmation of DRB4*01033.";
RL   Tissue Antigens 61:398-402(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*01:05).
RA   Kashiwase K., Akaza T., Juji T.;
RT   "HLA-DRB1 new alleles.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*01:07).
RA   Dormoy A., Froelich N., Leisenbach R., Tongio M.M.;
RT   "A new HLA-DRB1*01 allele.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-122 (ALLELE DRB1*01:02).
RC   TISSUE=Blood;
RA   Hashemi S., Couture C., Cole R., Buyse I.;
RT   "Identification and sequencing of a novel DRB1*01 allele.";
RL   Submitted (AUG-1995) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 37-266 (ALLELE DRB1*01:02).
RX   MEDLINE=88229101; PubMed=2453563;
RA   Hurley C.K., Ziff B.L., Silver J., Gregersen P.K., Hartzman R.,
RA   Johnson A.H.;
RT   "Polymorphism of the HLA-DR1 haplotype in American blacks.
RT   Identification of a DR1 beta-chain determinant recognized in the mixed
RT   lymphocyte reaction.";
RL   J. Immunol. 140:4019-4023(1988).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 43-115 (ALLELES DRB1*01:01 AND
RP   DRB1*01:02).
RC   TISSUE=Blood;
RA   Arnaiz-Villena A.;
RT   "HLA class II polymorphism.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   DISEASE.
RX   MEDLINE=22870318; PubMed=14508706; DOI=10.1086/378097;
RA   Rossman M.D., Thompson B., Frederick M., Maliarik M., Iannuzzi M.C.,
RA   Rybicki B.A., Pandey J.P., Newman L.S., Magira E., Beznik-Cizman B.,
RA   Monos D.;
RT   "HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks
RT   and whites.";
RL   Am. J. Hum. Genet. 73:720-735(2003).
RN   [18]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [19]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [20]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [21]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [22]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [23]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [24]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 32-219.
RX   MEDLINE=93302847; PubMed=8316295; DOI=10.1038/364033a0;
RA   Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G.,
RA   Strominger J.L., Wiley D.C.;
RT   "Three-dimensional structure of the human class II histocompatibility
RT   antigen HLA-DR1.";
RL   Nature 364:33-39(1993).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 32-219.
RX   MEDLINE=94195388; PubMed=8145819; DOI=10.1038/368215a0;
RA   Stern L.J., Brown J.H., Jardetzky T.J., Gorga J.C., Urban R.G.,
RA   Strominger J.L., Wiley D.C.;
RT   "Crystal structure of the human class II MHC protein HLA-DR1 complexed
RT   with an influenza virus peptide.";
RL   Nature 368:215-221(1994).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF COMPLEX WITH SEB.
RX   MEDLINE=94203282; PubMed=8152483; DOI=10.1038/368711a0;
RA   Jardetzky T.S., Brown J.H., Gorga J.C., Stern L.J., Urban R.G.,
RA   Chi Y.I., Stauffacher C., Strominger J.L., Wiley D.C.;
RT   "Three-dimensional structure of a human class II histocompatibility
RT   molecule complexed with superantigen.";
RL   Nature 368:711-718(1994).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route; where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules; and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments; exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides; autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs; other cells of the gastrointestinal tract; such
CC       as epithelial cells; express MHC class II molecules and CD74 and
CC       act as APCs; which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen; three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs; CD74 undergoes a sequential
CC       degradation by various proteases; including CTSS and CTSL; leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells; the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules; increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-1 are known:
CC       DRB1*01:01; DRB1*01:02; DRB1*01:03; DRB1*01:04; DRB1*01:05;
CC       DRB1*01:06; DRB1*01:07; DRB1*01:08; DRB1*01:09; DRB1*01:10;
CC       DRB1*01:11; DRB1*01:12; DRB1*01:13; DRB1*01:14; DRB1*01:15;
CC       DRB1*01:16; DRB1*01:17; DRB1*01:18; DRB1*01:19; DRB1*01:20 and
CC       DRB1*01:21. The sequence shown is that of DRB1*01:01.
CC   -!- DISEASE: Genetic variation in HLA-DRB1 is a cause of
CC       susceptibility to sarcoidosis type 1 (SS1) [MIM:181000].
CC       Sarcoidosis is an idiopathic, systemic, inflammatory disease
CC       characterized by the formation of immune granulomas in involved
CC       organs. Granulomas predominantly invade the lungs and the
CC       lymphatic system, but also skin, liver, spleen, eyes and other
CC       organs may be involved.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03069; CAA26873.1; -; mRNA.
DR   EMBL; M11161; AAA59781.1; -; mRNA.
DR   EMBL; M33600; AAA59782.1; -; mRNA.
DR   EMBL; AY663400; AAU87993.1; -; Genomic_DNA.
DR   EMBL; AM419948; CAL99240.1; -; Genomic_DNA.
DR   EMBL; AK289463; BAF82152.1; -; mRNA.
DR   EMBL; X64547; CAA45845.1; -; Genomic_DNA.
DR   EMBL; X99896; CAA68171.1; -; mRNA.
DR   EMBL; AF089723; AAD51131.1; -; Genomic_DNA.
DR   EMBL; AJ276206; CAC27123.1; -; Genomic_DNA.
DR   EMBL; AB015184; BAA28761.1; -; Genomic_DNA.
DR   EMBL; AJ303118; CAC19693.1; -; Genomic_DNA.
DR   EMBL; Z50871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M21008; AAA59780.1; -; mRNA.
DR   EMBL; AF029288; AAF65497.1; -; Genomic_DNA.
DR   EMBL; AF029293; AAF65502.1; -; Genomic_DNA.
DR   IPI; IPI00738107; -.
DR   PIR; A19197; A19197.
DR   PIR; D24669; HLHU1B.
DR   PIR; I56072; I56072.
DR   PIR; PH0147; PH0147.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   PDB; 1AQD; X-ray; 2.45 A; B/E/H/K=30-227.
DR   PDB; 1DLH; X-ray; 2.80 A; B/E=32-219.
DR   PDB; 1FYT; X-ray; 2.60 A; B=30-221.
DR   PDB; 1HXY; X-ray; 2.60 A; B=30-219.
DR   PDB; 1JWM; X-ray; 2.70 A; B=30-219.
DR   PDB; 1JWS; X-ray; 2.60 A; B=30-219.
DR   PDB; 1JWU; X-ray; 2.30 A; B=30-219.
DR   PDB; 1KG0; X-ray; 2.65 A; B=32-219.
DR   PDB; 1KLG; X-ray; 2.40 A; B=30-219.
DR   PDB; 1KLU; X-ray; 1.93 A; B=30-219.
DR   PDB; 1LO5; X-ray; 3.20 A; B=30-219.
DR   PDB; 1PYW; X-ray; 2.10 A; B=30-219.
DR   PDB; 1R5I; X-ray; 2.60 A; B/F=30-219.
DR   PDB; 1SEB; X-ray; 2.70 A; B/F=30-221.
DR   PDB; 1SJE; X-ray; 2.45 A; B=30-219.
DR   PDB; 1SJH; X-ray; 2.25 A; B=30-219.
DR   PDB; 1T5W; X-ray; 2.40 A; B/E=30-219.
DR   PDB; 1T5X; X-ray; 2.50 A; B=30-219.
DR   PDB; 2FSE; X-ray; 3.10 A; B/D=33-217.
DR   PDB; 2G9H; X-ray; 2.00 A; B=30-219.
DR   PDB; 2IAM; X-ray; 2.80 A; B=30-219.
DR   PDB; 2IAN; X-ray; 2.80 A; B/G/L/Q=30-219.
DR   PDB; 2ICW; X-ray; 2.41 A; B/E=30-219.
DR   PDB; 2IPK; X-ray; 2.30 A; B=30-219.
DR   PDB; 2OJE; X-ray; 3.00 A; B/F=30-219.
DR   PDB; 2XN9; X-ray; 2.30 A; E=30-219.
DR   PDB; 3L6F; X-ray; 2.10 A; B=30-221.
DR   PDB; 3PDO; X-ray; 1.95 A; B=30-227.
DR   PDB; 3PGC; X-ray; 2.66 A; B/E=30-227.
DR   PDB; 3PGD; X-ray; 2.72 A; B/E=30-227.
DR   PDB; 3QXA; X-ray; 2.71 A; B/E=30-219.
DR   PDB; 3QXD; X-ray; 2.30 A; B/E=30-219.
DR   PDB; 3S4S; X-ray; 2.40 A; B/E=30-221.
DR   PDB; 3S5L; X-ray; 2.10 A; B/E=30-221.
DR   PDBsum; 1AQD; -.
DR   PDBsum; 1DLH; -.
DR   PDBsum; 1FYT; -.
DR   PDBsum; 1HXY; -.
DR   PDBsum; 1JWM; -.
DR   PDBsum; 1JWS; -.
DR   PDBsum; 1JWU; -.
DR   PDBsum; 1KG0; -.
DR   PDBsum; 1KLG; -.
DR   PDBsum; 1KLU; -.
DR   PDBsum; 1LO5; -.
DR   PDBsum; 1PYW; -.
DR   PDBsum; 1R5I; -.
DR   PDBsum; 1SEB; -.
DR   PDBsum; 1SJE; -.
DR   PDBsum; 1SJH; -.
DR   PDBsum; 1T5W; -.
DR   PDBsum; 1T5X; -.
DR   PDBsum; 2FSE; -.
DR   PDBsum; 2G9H; -.
DR   PDBsum; 2IAM; -.
DR   PDBsum; 2IAN; -.
DR   PDBsum; 2ICW; -.
DR   PDBsum; 2IPK; -.
DR   PDBsum; 2OJE; -.
DR   PDBsum; 2XN9; -.
DR   PDBsum; 3L6F; -.
DR   PDBsum; 3PDO; -.
DR   PDBsum; 3PGC; -.
DR   PDBsum; 3PGD; -.
DR   PDBsum; 3QXA; -.
DR   PDBsum; 3QXD; -.
DR   PDBsum; 3S4S; -.
DR   PDBsum; 3S5L; -.
DR   ProteinModelPortal; P04229; -.
DR   SMR; P04229; 30-219.
DR   DIP; DIP-6143N; -.
DR   IntAct; P04229; 1.
DR   MINT; MINT-203282; -.
DR   STRING; P04229; -.
DR   PhosphoSite; P04229; -.
DR   DMDM; 34395916; -.
DR   PRIDE; P04229; -.
DR   Ensembl; ENST00000360004; ENSP00000353099; ENSG00000196126.
DR   GeneCards; GC06M032546; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   HPA; CAB015400; -.
DR   HPA; CAB034021; -.
DR   MIM; 142857; gene.
DR   MIM; 181000; phenotype.
DR   neXtProt; NX_P04229; -.
DR   eggNOG; NOG68200; -.
DR   HOVERGEN; HBG012730; -.
DR   InParanoid; P04229; -.
DR   OrthoDB; EOG461454; -.
DR   Pathway_Interaction_DB; il12_stat4pathway; IL12 signaling mediated by STAT4.
DR   Pathway_Interaction_DB; il12_2pathway; IL12-mediated signaling events.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Reactome; REACT_6900; Immune System.
DR   DrugBank; DB05259; Glatiramer Acetate.
DR   EvolutionaryTrace; P04229; -.
DR   Bgee; P04229; -.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; P04229; -.
DR   GermOnline; ENSG00000196126; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum;
KW   Endosome; Glycoprotein; Golgi apparatus; Immunity; Isopeptide bond;
KW   Lysosome; Membrane; MHC II; Polymorphism; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-1 beta chain.
FT                                /FTId=PRO_0000018949.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID     44    108       By similarity.
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT       5      5       K -> R (in dbSNP:rs9270305).
FT                                /FTId=VAR_056527.
FT   VARIANT      13     13       T -> A (in dbSNP:rs1059553).
FT                                /FTId=VAR_033377.
FT   VARIANT      29     29       A -> S (in dbSNP:rs9270299).
FT                                /FTId=VAR_033378.
FT   VARIANT      33     33       R -> K (in dbSNP:rs34716432).
FT                                /FTId=VAR_033379.
FT   VARIANT      33     33       R -> Q (in dbSNP:rs34716432).
FT                                /FTId=VAR_033380.
FT   VARIANT      39     39       Q -> E (in allele DRB1*01:07).
FT                                /FTId=VAR_016740.
FT   VARIANT      66     66       S -> Y (in dbSNP:rs16822820).
FT                                /FTId=VAR_033381.
FT   VARIANT      74     74       G -> R (in allele DRB1*01:05).
FT                                /FTId=VAR_016741.
FT   VARIANT      76     76       Y -> F (in dbSNP:rs1060346).
FT                                /FTId=VAR_033382.
FT   VARIANT      89     89       Y -> S (in dbSNP:rs36074728).
FT                                /FTId=VAR_033383.
FT   VARIANT      96     96       L -> I (in allele DRB1*01:03).
FT                                /FTId=VAR_016710.
FT   VARIANT      99     99       Q -> D (in allele DRB1*01:03; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016711.
FT   VARIANT      99     99       Q -> E (in dbSNP:rs17881965).
FT                                /FTId=VAR_033384.
FT   VARIANT      99     99       Q -> H (in dbSNP:rs17879599).
FT                                /FTId=VAR_033385.
FT   VARIANT     100    100       R -> A (in allele DRB1*01:06; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016742.
FT   VARIANT     100    100       R -> E (in allele DRB1*01:03; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016712.
FT   VARIANT     102    102       A -> G (in dbSNP:rs17878857).
FT                                /FTId=VAR_033386.
FT   VARIANT     103    103       A -> E (in dbSNP:rs16822805).
FT                                /FTId=VAR_033387.
FT   VARIANT     106    106       T -> N (in allele DRB1*01:04;
FT                                dbSNP:rs16822752).
FT                                /FTId=VAR_016713.
FT   VARIANT     107    107       Y -> H (in dbSNP:rs16822512).
FT                                /FTId=VAR_033388.
FT   VARIANT     114    114       V -> A (in allele DRB1*01:02;
FT                                dbSNP:rs17424145).
FT                                /FTId=VAR_016714.
FT   VARIANT     115    115       G -> V (in allele DRB1*01:02, allele
FT                                DRB1*01:04 and allele DRB1*01:06;
FT                                dbSNP:rs2230810).
FT                                /FTId=VAR_016715.
FT   VARIANT     164    164       G -> D (in dbSNP:rs1059633).
FT                                /FTId=VAR_033389.
FT   VARIANT     169    169       A -> T (in dbSNP:rs2308768).
FT                                /FTId=VAR_033390.
FT   VARIANT     171    171       V -> M (in dbSNP:rs701829).
FT                                /FTId=VAR_033391.
FT   VARIANT     178    178       Q -> H (in dbSNP:rs701830).
FT                                /FTId=VAR_033392.
FT   VARIANT     195    195       R -> Q (in dbSNP:rs3205588).
FT                                /FTId=VAR_033393.
FT   VARIANT     210    210       T -> I (in dbSNP:rs17423930).
FT                                /FTId=VAR_033394.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_033395.
FT   VARIANT     253    253       Q -> E (in allele DRB1*01:02).
FT                                /FTId=VAR_016716.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_056528.
FT   CONFLICT     25     25       P -> R (in Ref. 2; AAA59781).
FT   CONFLICT     36     36       F -> S (in Ref. 9; AA sequence).
FT   CONFLICT     58     59       RC -> LF (in Ref. 9; AA sequence).
FT   CONFLICT     80     80       T -> E (in Ref. 2; AAA59781).
FT   CONFLICT    100    103       RRAA -> KRGQ (in Ref. 2; AAA59781).
FT   CONFLICT    192    192       T -> I (in Ref. 2; AAA59781).
FT   STRAND       36     47
FT   TURN         48     51
FT   STRAND       52     61
FT   STRAND       64     70
FT   TURN         71     73
FT   STRAND       75     80
FT   HELIX        81     83
FT   HELIX        84     92
FT   HELIX        94    101
FT   HELIX       103    106
FT   HELIX       108    115
FT   TURN        116    121
FT   STRAND      127    134
FT   STRAND      138    140
FT   STRAND      142    154
FT   STRAND      157    162
FT   STRAND      171    173
FT   STRAND      180    182
FT   STRAND      184    192
FT   STRAND      199    205
FT   STRAND      213    218
SQ   SEQUENCE   266 AA;  29914 MW;  CC9CC7E2D0DD036C CRC64;
     MVCLKLPGGS CMTALTVTLM VLSSPLALAG DTRPRFLWQL KFECHFFNGT ERVRLLERCI
     YNQEESVRFD SDVGEYRAVT ELGRPDAEYW NSQKDLLEQR RAAVDTYCRH NYGVGESFTV
     QRRVEPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKAG VVSTGLIQNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
ID   2B13_HUMAN              Reviewed;         266 AA.
AC   P01912;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   18-APR-2012, entry version 111.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-3 chain;
DE   AltName: Full=Clone P2-beta-3;
DE   AltName: Full=MHC class II antigen DRB1*3;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*03:01).
RX   MEDLINE=84261468; PubMed=6589154;
RA   Peterson P.A., Gustafsson K., Wiman K.G., Emmoth E., Larhammar D.,
RA   Boehme J., Hyldig-Nielsen J.J., Ronne H., Rask L.;
RT   "Mutations and selection in the generation of class II
RT   histocompatibility antigen polymorphism.";
RL   EMBO J. 3:1655-1660(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*03:01).
RX   MEDLINE=84031733; PubMed=6415003; DOI=10.1016/0198-8859(83)90087-3;
RA   Larhammar D., Andersson G., Andersson M., Bill P., Boehme J.,
RA   Claesson L., Denaro M., Emmoth E., Gustafsson K., Hammarling U.,
RA   Heldin E., Hyldig-Nielsen J.-J., Lind P., Schenning L., Servenius B.,
RA   Widmark E., Rask L., Peterson P.A.;
RT   "Molecular analysis of human class II transplantation antigens and
RT   their genes.";
RL   Hum. Immunol. 8:95-103(1983).
RN   [3]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [4]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [5]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [6]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [7]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [8]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [9]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-48, AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 34-220 OF HLA-DRA/HLA-DRB1
RP   HETERODIMER IN COMPLEX WITH CD74 PEPTIDE (CLIP), SUBUNIT, AND
RP   DISULFIDE BONDS.
RX   MEDLINE=96085023; PubMed=7477400; DOI=10.1038/378457a0;
RA   Ghosh P., Amaya M., Mellins E., Wiley D.C.;
RT   "The structure of an intermediate in class II MHC maturation: CLIP
RT   bound to HLA-DR3.";
RL   Nature 378:457-462(1995).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route; where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules; and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments; exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides; autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs; other cells of the gastrointestinal tract; such
CC       as epithelial cells; express MHC class II molecules and CD74 and
CC       act as APCs; which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen; three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs; CD74 undergoes a sequential
CC       degradation by various proteases; including CTSS and CTSL; leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells; the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules; increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-3 are known:
CC       DRB1*03:01; DRB1*03:02; DRB1*03:03; DRB1*03:04; DRB1*03:05;
CC       DRB1*03:06; DRB1*03:07; DRB1*03:08; DRB1*03:09; DRB1*03:10;
CC       DRB1*03:11; DRB1*03:12; DRB1*03:13; DRB1*03:14; DRB1*03:15;
CC       DRB1*03:16; DRB1*03:17; DRB1*03:18; DRB1*03:19; DRB1*03:20;
CC       DRB1*03:21; DRB1*03:22; DRB1*03:23; DRB1*03:24; DRB1*03:25;
CC       DRB1*03:26; DRB1*03:27; DRB1*03:28; DRB1*03:29; DRB1*03:30;
CC       DRB1*03:31; DRB1*03:32; DRB1*03:33; DRB1*03:34; DRB1*03:35;
CC       DRB1*03:36; DRB1*03:37; DRB1*03:38; DRB1*03:39; DRB1*03:40 and
CC       DRB1*03:41. The sequence shown is that of DRB1*03:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00699; CAA25295.1; -; mRNA.
DR   IPI; IPI00473139; -.
DR   PIR; I37546; HLHU3D.
DR   RefSeq; NP_001230894.1; NM_001243965.1.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   PDB; 1A6A; X-ray; 2.75 A; B=34-220.
DR   PDBsum; 1A6A; -.
DR   ProteinModelPortal; P01912; -.
DR   SMR; P01912; 34-220.
DR   DIP; DIP-6064N; -.
DR   IntAct; P01912; 8.
DR   STRING; P01912; -.
DR   PRIDE; P01912; -.
DR   DNASU; 3123; -.
DR   Ensembl; ENST00000328980; ENSP00000331343; ENSG00000206306.
DR   Ensembl; ENST00000399450; ENSP00000382378; ENSG00000206240.
DR   GeneID; 3123; -.
DR   KEGG; hsa:3123; -.
DR   UCSC; uc011eri.2; human.
DR   CTD; 3123; -.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mn32480; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   neXtProt; NX_P01912; -.
DR   HOVERGEN; HBG012730; -.
DR   KO; K06752; -.
DR   OrthoDB; EOG461454; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P01912; -.
DR   NextBio; 12394; -.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; P01912; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-3 chain.
FT                                /FTId=PRO_0000018965.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   REGION       30    123       Beta-1.
FT   REGION      124    217       Beta-2.
FT   REGION      218    227       Connecting peptide.
FT   CARBOHYD     48     48       N-linked (GlcNAc...).
FT   DISULFID     44    108
FT   DISULFID    146    202
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT      55     55       Y -> F (in dbSNP:rs16822516).
FT                                /FTId=VAR_050371.
FT   VARIANT     106    106       N -> T (in dbSNP:rs9269941).
FT                                /FTId=VAR_050372.
FT   VARIANT     164    164       G -> S (in dbSNP:rs1059633).
FT                                /FTId=VAR_050373.
FT   VARIANT     169    169       T -> A (in dbSNP:rs2308768).
FT                                /FTId=VAR_050374.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_056545.
FT   STRAND       37     47
FT   TURN         48     51
FT   STRAND       52     61
FT   STRAND       64     70
FT   TURN         71     73
FT   STRAND       75     80
FT   HELIX        81     83
FT   HELIX        84     92
FT   HELIX        94    101
FT   HELIX       103    106
FT   HELIX       108    115
FT   TURN        116    121
FT   STRAND      127    134
FT   STRAND      138    140
FT   STRAND      143    150
FT   STRAND      152    154
FT   STRAND      157    162
FT   STRAND      180    182
FT   STRAND      184    187
FT   STRAND      189    191
FT   STRAND      199    205
FT   STRAND      213    218
SQ   SEQUENCE   266 AA;  30120 MW;  37329B097C6BEEB4 CRC64;
     MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEYS TSECHFFNGT ERVRYLDRYF
     HNQEENVRFD SDVGEFRAVT ELGRPDAEYW NSQKDLLEQK RGRVDNYCRH NYGVVESFTV
     QRRVHPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKTG VVSTGLIHNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PRGFLS
//
ID   2B14_HUMAN              Reviewed;         266 AA.
AC   P13760; O19717; O19739; P13759; Q29875; Q30145; Q9GIX9; Q9GIY4;
AC   Q9MY13; Q9XRY5;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   18-APR-2012, entry version 122.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-4 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*4;
DE            Short=DR-4;
DE            Short=DR4;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DRB1*04:01).
RX   MEDLINE=87250499; PubMed=3036826;
RA   Andersson G., Larhammar D., Widmark E., Servenius B., Peterson P.A.,
RA   Rask L.;
RT   "Class II genes of the human major histocompatibility complex.
RT   Organization and evolutionary relationship of the DR beta genes.";
RL   J. Biol. Chem. 262:8748-8758(1987).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION.
RA   Andersson G., Larhammar D., Widmark E., Servenius B., Peterson P.A.,
RA   Rask L.;
RL   J. Biol. Chem. 263:8551-8551(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE DRB1*04:01).
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*04:01).
RX   MEDLINE=87317627; PubMed=3476943; DOI=10.1073/pnas.84.17.6234;
RA   Bell J.I., Denney D. Jr., Foster L., Belt T.K., Todd J.A.,
RA   McDevitt H.O.;
RT   "Allelic variation in the DR subregion of the human major
RT   histocompatibility complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6234-6238(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*04:01).
RX   MEDLINE=85270485; PubMed=3860851; DOI=10.1073/pnas.82.15.5165;
RA   Spies T., Sorrentino R., Boss J.M., Okada K., Strominger J.L.;
RT   "Structural organization of the DR subregion of the human major
RT   histocompatibility complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:5165-5169(1985).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*04:01).
RX   MEDLINE=97253496; PubMed=9098937;
RX   DOI=10.1111/j.1399-0039.1997.tb02751.x;
RA   Thonnard J., Gervais T., Heusterpreute M., Mersch G., De Canck I.,
RA   De Greef C., Demanet C., Van Waeyenberge C.;
RT   "A new silent mutation at codon 35 in exon 2 yielding a DRB1*04012
RT   allele.";
RL   Tissue Antigens 49:274-276(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*04:02).
RX   MEDLINE=22246460; PubMed=12358860;
RX   DOI=10.1046/j.1365-2370.2002.00354.x;
RA   Ramon D., Corell A., Cox S.T., Soteriou B., Madrigal J.A.,
RA   Marsh S.G.E.;
RT   "Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041
RT   alleles.";
RL   Eur. J. Immunogenet. 29:453-455(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 43-115 (ALLELE DRB1*04:03).
RC   TISSUE=Blood;
RA   Arnaiz-Villena A.;
RT   "HLA class II polymorphism.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-122 (ALLELE DRB1*04:03).
RA   Greville W.D., van Eijck A., Dunckley H.;
RT   "New HLA class II (DRB1) alleles detected by sequencing-based
RT   typing.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*04:03).
RA   Guttridge M.G., Hammond L.;
RT   "Confirmatory sequence of HLA-DRB1*04032.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*04:04).
RX   MEDLINE=85296375; PubMed=3875800; DOI=10.1038/317166a0;
RA   Cairns J.S., Curtsinger J.M., Dahl C.A., Freeman S., Alter B.J.,
RA   Bach F.H.;
RT   "Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-
RT   recognized determinants.";
RL   Nature 317:166-168(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-123 (ALLELE DRB1*04:04).
RX   MEDLINE=86206008; PubMed=3458223; DOI=10.1073/pnas.83.8.2642;
RA   Gregersen P.K., Shen M., Song Q.-L., Merryman P., Degar S., Seki T.,
RA   Maccari J., Goldberg D., Murphy H., Schwenzer J., Wang C.Y.,
RA   Winchester R.J., Nepom G.T., Silver J.;
RT   "Molecular diversity of HLA-DR4 haplotypes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:2642-2646(1986).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*04:11).
RA   Zhao W., Fernandez-Vina M.A., Stastny P.;
RT   "Full cDNA sequence of HLA-DRB1*0411.";
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [15]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [16]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [17]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [18]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [19]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [20]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF COMPLEX WITH A COLLAGEN
RP   PEPTIDE.
RX   MEDLINE=98014591; PubMed=9354468; DOI=10.1016/S1074-7613(00)80369-6;
RA   Dessen A., Lawrence C.M., Cupo S., Zaller D.M., Wiley D.C.;
RT   "X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed
RT   with a peptide from human collagen II.";
RL   Immunity 7:473-481(1997).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route; where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules; and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments; exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides; autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs; other cells of the gastrointestinal tract; such
CC       as epithelial cells; express MHC class II molecules and CD74 and
CC       act as APCs; which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen; three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs; CD74 undergoes a sequential
CC       degradation by various proteases; including CTSS and CTSL; leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells; the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules; increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-4 are known:
CC       DRB1*04:01, DRB1*04:02, DRB1*04:03, DRB1*04:04, DRB1*04:05,
CC       DRB1*04:06, DRB1*04:07, DRB1*04:08, DRB1*04:09, DRB1*04:10,
CC       DRB1*04:11, DRB1*04:12, DRB1*04:13, DRB1*04:14, DRB1*04:15,
CC       DRB1*04:16, DRB1*04:17, DRB1*04:18, DRB1*04:19, DRB1*04:20,
CC       DRB1*04:21, DRB1*04:22, DRB1*04:23, DRB1*04:24, DRB1*04:25,
CC       DRB1*04:26, DRB1*04:27, DRB1*04:28, DRB1*04:29, DRB1*04:30,
CC       DRB1*04:31, DRB1*04:32, DRB1*04:33, DRB1*04:34, DRB1*04:35,
CC       DRB1*04:36, DRB1*04:37, DRB1*04:38, DRB1*04:39, DRB1*04:40,
CC       DRB1*04:41, DRB1*04:42, DRB1*04:43, DRB1*04:44, DRB1*04:45,
CC       DRB1*04:46, DRB1*04:47, DRB1*04:48, DRB1*04:49, DRB1*04:50,
CC       DRB1*04:51, DRB1*04:52, DRB1*04:53, DRB1*04:54, DRB1*04:55,
CC       DRB1*04:56, DRB1*04:57, DRB1*04:58, DRB1*04:59, DRB1*04:60,
CC       DRB1*04:61, DRB1*04:62, DRB1*04:63, DRB1*04:64, DRB1*04:65,
CC       DRB1*04:66, DRB1*04:67, DRB1*04:68, DRB1*04:69, DRB1*04:70,
CC       DRB1*04:71, DRB1*04:72, DRB1*04:73, DRB1*04:74, DRB1*04:75,
CC       DRB1*04:76, DRB1*04:77 and DRB1*04:78. The sequence shown is that
CC       of DRB1*04:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M20548; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M20549; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M20550; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137064; CAC19360.1; -; Genomic_DNA.
DR   EMBL; M17381; AAA59805.1; -; mRNA.
DR   EMBL; K02776; AAA59808.1; -; Genomic_DNA.
DR   EMBL; X96851; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ297586; CAC08826.2; -; mRNA.
DR   EMBL; AF029269; AAF65479.1; -; Genomic_DNA.
DR   EMBL; AF112876; AAD29581.1; -; Genomic_DNA.
DR   EMBL; AJ295845; CAC08181.1; -; Genomic_DNA.
DR   EMBL; X02902; CAA26660.1; -; mRNA.
DR   EMBL; M15069; AAA59809.1; -; mRNA.
DR   EMBL; L42143; AAA67104.1; -; mRNA.
DR   IPI; IPI00887633; -.
DR   PIR; A94681; A29310.
DR   PIR; I79419; I79419.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   UniGene; Hs.716081; -.
DR   UniGene; Hs.723344; -.
DR   PDB; 1D5M; X-ray; 2.00 A; B=30-221.
DR   PDB; 1D5X; X-ray; 2.45 A; B=30-221.
DR   PDB; 1D5Z; X-ray; 2.00 A; B=30-221.
DR   PDB; 1D6E; X-ray; 2.45 A; B=30-221.
DR   PDB; 1J8H; X-ray; 2.40 A; B=30-221.
DR   PDB; 2SEB; X-ray; 2.50 A; B=30-221.
DR   PDB; 3O6F; X-ray; 2.80 A; B/F=30-221.
DR   PDB; 3T0E; X-ray; 4.00 A; B=30-221.
DR   PDBsum; 1D5M; -.
DR   PDBsum; 1D5X; -.
DR   PDBsum; 1D5Z; -.
DR   PDBsum; 1D6E; -.
DR   PDBsum; 1J8H; -.
DR   PDBsum; 2SEB; -.
DR   PDBsum; 3O6F; -.
DR   PDBsum; 3T0E; -.
DR   ProteinModelPortal; P13760; -.
DR   IntAct; P13760; 6.
DR   STRING; P13760; -.
DR   DMDM; 122253; -.
DR   PRIDE; P13760; -.
DR   Ensembl; ENST00000419393; ENSP00000403458; ENSG00000228080.
DR   Ensembl; ENST00000450362; ENSP00000410118; ENSG00000228080.
DR   GeneCards; GC06M032546; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   neXtProt; NX_P13760; -.
DR   eggNOG; NOG68200; -.
DR   HOVERGEN; HBG012730; -.
DR   InParanoid; P13760; -.
DR   OrthoDB; EOG461454; -.
DR   PhylomeDB; P13760; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P13760; -.
DR   ArrayExpress; P13760; -.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; P13760; -.
DR   GermOnline; ENSG00000196126; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-4 beta chain.
FT                                /FTId=PRO_0000018950.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID     44    108       By similarity.
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT       5      5       K -> R (in dbSNP:rs9270305).
FT                                /FTId=VAR_056529.
FT   VARIANT      86     86       D -> S (in allele DRB1*04:11; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016673.
FT   VARIANT      96     96       L -> I (in allele DRB1*04:02).
FT                                /FTId=VAR_016674.
FT   VARIANT      99     99       Q -> D (in allele DRB1*04:02; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016675.
FT   VARIANT     100    100       K -> E (in allele DRB1*04:02).
FT                                /FTId=VAR_016676.
FT   VARIANT     100    100       K -> R (in allele DRB1*04:03, allele
FT                                DRB1*04:04 and allele DRB1*04:11).
FT                                /FTId=VAR_016677.
FT   VARIANT     103    103       A -> E (in allele DRB1*04:03 and allele
FT                                DRB1*04:11).
FT                                /FTId=VAR_016678.
FT   VARIANT     115    115       G -> V (in allele DRB1*04:02, allele
FT                                DRB1*04:03, allele DRB1*04:04 and allele
FT                                DRB1*04:11).
FT                                /FTId=VAR_016679.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_056530.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_056531.
FT   CONFLICT    154    154       G -> A (in Ref. 4; AAA59805).
FT   STRAND       36     47
FT   TURN         48     51
FT   STRAND       52     61
FT   STRAND       64     70
FT   TURN         71     73
FT   STRAND       75     80
FT   HELIX        81     83
FT   HELIX        84     91
FT   HELIX        94    101
FT   HELIX       103    106
FT   HELIX       108    115
FT   HELIX       116    118
FT   TURN        119    121
FT   STRAND      127    132
FT   STRAND      143    154
FT   STRAND      157    162
FT   STRAND      169    173
FT   STRAND      180    182
FT   STRAND      184    191
FT   STRAND      199    205
FT   STRAND      213    218
SQ   SEQUENCE   266 AA;  30112 MW;  8116E91DA38294E5 CRC64;
     MVCLKFPGGS CMAALTVTLM VLSSPLALAG DTRPRFLEQV KHECHFFNGT ERVRFLDRYF
     YHQEEYVRFD SDVGEYRAVT ELGRPDAEYW NSQKDLLEQK RAAVDTYCRH NYGVGESFTV
     QRRVYPEVTV YPAKTQPLQH HNLLVCSVNG FYPGSIEVRW FRNGQEEKTG VVSTGLIQNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSLT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
ID   2B17_HUMAN              Reviewed;         266 AA.
AC   P13761; B0UYW1; O46699; O46872;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   18-APR-2012, entry version 111.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-7 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*7;
DE            Short=DR-7;
DE            Short=DR7;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*07:01).
RX   MEDLINE=87260902; PubMed=3110774; DOI=10.1073/pnas.84.14.4929;
RA   Young J.A.T., Wilkinson D., Bodmer W.F., Trowsdale J.;
RT   "Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain
RT   genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4929-4933(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DRB1*07:01).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DRB1*07:03).
RC   TISSUE=Blood;
RA   Buyse I.M., Couture C., Ouellet S., Hashemi-tavoularis S.;
RT   "Identification of novel DR7, DRB5 and DQB1*03 alleles using the
RT   CANTYPE assay.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-117 (ALLELE DRB1*07:04).
RC   TISSUE=Blood;
RX   MEDLINE=21017543; PubMed=11144299;
RX   DOI=10.1034/j.1399-0039.2000.560514.x;
RA   Darke C., Guttridge M.G., Street J., Thompson J., Thomas M.;
RT   "Molecular, serological and genetic studies on two new HLA-DRB1
RT   alleles -- HLA-DRB1*0704 and HLA-DRB1*1507.";
RL   Tissue Antigens 56:467-469(2000).
RN   [6]
RP   ASSOCIATION WITH SUSCEPTIBILITY TO HEPATITIS C VIRUS.
RX   MEDLINE=20075909; PubMed=10609818; DOI=10.1016/S0140-6736(99)91443-5;
RG   Hepatitis C European Network for Cooperative Research;
RA   Thursz M., Yallop R., Goldin R., Trepo C., Thomas H.C.;
RT   "Influence of MHC class II genotype on outcome of infection with
RT   hepatitis C virus.";
RL   Lancet 354:2119-2124(1999).
RN   [7]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [8]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [9]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [10]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [11]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [12]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [13]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route; where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules; and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments; exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides; autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs; other cells of the gastrointestinal tract; such
CC       as epithelial cells; express MHC class II molecules and CD74 and
CC       act as APCs; which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen; three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs; CD74 undergoes a sequential
CC       degradation by various proteases; including CTSS and CTSL; leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells; the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules; increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-7 are known:
CC       DRB1*07:01, DRB1*07:03, DRB1*07:04, DRB1*07:05, DRB1*07:06,
CC       DRB1*07:07, DRB1*07:08, DRB1*07:09, DRB1*07:11, DRB1*07:12,
CC       DRB1*07:13, DRB1*07:14, DRB1*07:15, DRB1*07:16 and DRB1*07:17. The
CC       sequence shown is that of DRB1*07:01.
CC   -!- POLYMORPHISM: Allele DRB1*07:01 is associated with persistent
CC       hepatitis C virus (HCV) infections [MIM:609532].
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16941; AAA36282.1; -; mRNA.
DR   EMBL; CR753309; CAQ07518.1; -; Genomic_DNA.
DR   EMBL; CR753835; CAQ08239.1; -; Genomic_DNA.
DR   EMBL; BC001023; AAH01023.1; -; mRNA.
DR   EMBL; Y13785; CAA74112.1; -; Genomic_DNA.
DR   EMBL; Y16224; CAA76123.1; -; Genomic_DNA.
DR   IPI; IPI00465279; -.
DR   PIR; A28031; A28031.
DR   RefSeq; XP_003119307.1; XM_003119259.1.
DR   RefSeq; XP_003119308.1; XM_003119260.1.
DR   RefSeq; XP_003119339.1; XM_003119291.1.
DR   RefSeq; XP_003119340.1; XM_003119292.1.
DR   UniGene; Hs.696211; -.
DR   ProteinModelPortal; P13761; -.
DR   SMR; P13761; 30-219.
DR   STRING; P13761; -.
DR   DMDM; 122256; -.
DR   PeptideAtlas; P13761; -.
DR   PRIDE; P13761; -.
DR   Ensembl; ENST00000418312; ENSP00000406194; ENSG00000236884.
DR   Ensembl; ENST00000437784; ENSP00000405960; ENSG00000229074.
DR   Ensembl; ENST00000444645; ENSP00000409322; ENSG00000236884.
DR   GeneID; 100507709; -.
DR   GeneID; 100507714; -.
DR   KEGG; hsa:100507709; -.
DR   KEGG; hsa:100507714; -.
DR   UCSC; uc011gjy.2; human.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mk32516; -.
DR   GeneCards; GC06Ml32694; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   MIM; 609532; phenotype.
DR   neXtProt; NX_P13761; -.
DR   eggNOG; NOG68200; -.
DR   HOVERGEN; HBG012730; -.
DR   InParanoid; P13761; -.
DR   OrthoDB; EOG461454; -.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 20783901; -.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; P13761; -.
DR   GermOnline; ENSG00000196126; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; IDA:UniProtKB.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:2001179; P:regulation of interleukin-10 secretion; IDA:UniProtKB.
DR   GO; GO:0032673; P:regulation of interleukin-4 production; IDA:UniProtKB.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-7 beta chain.
FT                                /FTId=PRO_0000018951.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    216       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID     44    108       By similarity.
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT       5      5       K -> R (in dbSNP:rs9270305).
FT                                /FTId=VAR_056532.
FT   VARIANT      58     58       R -> S (in allele DRB1*07:03).
FT                                /FTId=VAR_016680.
FT   VARIANT     106    106       T -> N (in allele DRB1*07:04).
FT                                /FTId=VAR_016681.
FT   VARIANT     107    107       V -> Y (in allele DRB1*07:04; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016682.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_056533.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_056534.
SQ   SEQUENCE   266 AA;  29822 MW;  439B6AFA553F162C CRC64;
     MVCLKLPGGS CMAALTVTLM VLSSPLALAG DTQPRFLWQG KYKCHFFNGT ERVQFLERLF
     YNQEEFVRFD SDVGEYRAVT ELGRPVAESW NSQKDILEDR RGQVDTVCRH NYGVGESFTV
     QRRVHPEVTV YPAKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKAG VVSTGLIQNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVM SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
ID   2B18_HUMAN              Reviewed;         266 AA.
AC   Q30134; O19718; O19788; Q29968; Q30108; Q30115; Q9BCP0; Q9BCP1;
AC   Q9BCP2; Q9BD33; Q9TQ37; Q9UIM9;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   29-AUG-2003, sequence version 2.
DT   18-APR-2012, entry version 95.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-8 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*8;
DE            Short=DR-8;
DE            Short=DR8;
DE            Short=DRw8;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*08:02).
RX   MEDLINE=89233296; PubMed=2497068; DOI=10.1007/BF00352840;
RA   Jonsson A.K., Andersson L., Rask L.;
RT   "A cellular and functional split in the DRw8 haplotype is due to a
RT   single amino acid replacement (DR beta ser 57- asp 57).";
RL   Immunogenetics 29:308-316(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21.
RX   MEDLINE=94148705; PubMed=8106268; DOI=10.1016/0198-8859(93)90531-5;
RA   Emery P., Mach B., Reith W.;
RT   "The different level of expression of HLA-DRB1 and -DRB3 genes is
RT   controlled by conserved isotypic differences in promoter sequence.";
RL   Hum. Immunol. 38:137-147(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 32-115 (ALLELE DRB1*08:01).
RX   MEDLINE=87317627; PubMed=3476943; DOI=10.1073/pnas.84.17.6234;
RA   Bell J.I., Denney D. Jr., Foster L., Belt T.K., Todd J.A.,
RA   McDevitt H.O.;
RT   "Allelic variation in the DR subregion of the human major
RT   histocompatibility complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6234-6238(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123.
RX   MEDLINE=91065701; PubMed=1979063;
RA   Van Kerckhove C., Melin-Aldana H., Elma M.S., Luyrink L., Donnelly P.,
RA   Taylor J., Maksymowych W.P., Lovell D.J., Choi E., Glass D.N.;
RT   "A distinct HLA-DRw8 haplotype characterizes patients with juvenile
RT   rheumatoid arthritis.";
RL   Immunogenetics 32:304-308(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*08:01).
RA   Dormoy A., Froelich N., Weschler B., Tongio M.M.;
RT   "A new DRB1*08 allele.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*08:04).
RC   TISSUE=Blood;
RA   Hurley C.K., Tang T., Li L.;
RT   "Human leukocyte antigen class II DRB1*0804 variant.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-208 (ALLELE DRB1*08:01).
RA   Greville W.D.;
RT   "SBT of DRB1*0801, exons two and three.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-115 (ALLELE DRB1*08:03).
RX   MEDLINE=90077529; PubMed=2592019; DOI=10.1007/BF02421173;
RA   Abe A., Ito I., Ohkubo M., Kaneko T., Ito K., Kato H., Kashiwagi N.,
RA   Obata F.;
RT   "Two distinct subtypes of the HLA-DRw12 haplotypes in the Japanese
RT   population detected by nucleotide sequence analysis and
RT   oligonucleotide genotyping.";
RL   Immunogenetics 30:422-426(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 43-120 (ALLELE DRB1*08:01).
RA   Eberle M., Asu U., Taylor M., Hunter J.B., Fuller T.C., Maurer D.;
RT   "Identification of a putative DR8 founder haplotype containing a novel
RT   DRB1*08 allele.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 47-122 (ALLELE DRB1*08:04).
RC   TISSUE=Blood;
RX   MEDLINE=94295583; PubMed=8023844;
RA   Titus-Trachtenberg E.A., Rickards O., De Stefano G.F., Erlich H.A.;
RT   "Analysis of HLA class II haplotypes in the Cayapa Indians of Ecuador:
RT   a novel DRB1 allele reveals evidence for convergent evolution and
RT   balancing selection at position 86.";
RL   Am. J. Hum. Genet. 55:160-167(1994).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 124-217.
RX   MEDLINE=89278667; PubMed=2471740;
RA   Gorski J.;
RT   "HLA-DR beta-chain polymorphism. Second domain polymorphism reflects
RT   evolutionary relatedness of alleles and may explain public serologic
RT   epitopes.";
RL   J. Immunol. 143:329-333(1989).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 256-266.
RX   MEDLINE=86206008; PubMed=3458223; DOI=10.1073/pnas.83.8.2642;
RA   Gregersen P.K., Shen M., Song Q.-L., Merryman P., Degar S., Seki T.,
RA   Maccari J., Goldberg D., Murphy H., Schwenzer J., Wang C.Y.,
RA   Winchester R.J., Nepom G.T., Silver J.;
RT   "Molecular diversity of HLA-DR4 haplotypes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:2642-2646(1986).
RN   [13]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [14]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [15]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [16]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [17]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [18]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [19]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route; where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules; and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments; exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides; autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs; other cells of the gastrointestinal tract; such
CC       as epithelial cells; express MHC class II molecules and CD74 and
CC       act as APCs; which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen; three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs; CD74 undergoes a sequential
CC       degradation by various proteases; including CTSS and CTSL; leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells; the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules; increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-8 are known:
CC       DRB1*08:01 (Dw8.1), DRB1*08:02 (Dw8.2; DRB1L), DRB1*08:03 (Dw8.3);
CC       DRB1*08:04; DRB1*08:05, DRB1*08:06, DRB1*08:07, DRB1*08:08,
CC       DRB1*08:09, DRB1*08:10, DRB1*08:11, DRB1*08:12, DRB1*08:13,
CC       DRB1*08:14, DRB1*08:15, DRB1*08:16, DRB1*08:17, DRB1*08:18,
CC       DRB1*08:19, DRB1*08:20, DRB1*08:21, DRB1*08:22, DRB1*08:23,
CC       DRB1*08:24, DRB1*08:25, DRB1*08:26, DRB1*08:27, DRB1*08:28,
CC       DRB1*08:29, DRB1*08:30, DRB1*08:31, DRB1*08:32, DRB1*08:33,
CC       DRB1*08:34, DRB1*08:35 and DRB1*08:36. The sequence shown is that
CC       of DRB1*08:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26038; AAA59794.1; -; mRNA.
DR   EMBL; S69987; AAD14052.1; -; Genomic_DNA.
DR   EMBL; M17386; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M60216; AAA36298.1; -; Genomic_DNA.
DR   EMBL; AJ249626; CAB56284.1; -; Genomic_DNA.
DR   EMBL; AF330103; AAK08504.1; -; Genomic_DNA.
DR   EMBL; AY028515; AAK31608.1; -; Genomic_DNA.
DR   EMBL; AY028514; AAK31608.1; JOINED; Genomic_DNA.
DR   EMBL; AY028517; AAK31609.1; -; Genomic_DNA.
DR   EMBL; AY028516; AAK31609.1; JOINED; Genomic_DNA.
DR   EMBL; AY028519; AAK31610.1; -; Genomic_DNA.
DR   EMBL; AY028518; AAK31610.1; JOINED; Genomic_DNA.
DR   EMBL; M27511; AAA59817.1; -; Genomic_DNA.
DR   EMBL; AF144105; AAD38374.1; -; Genomic_DNA.
DR   EMBL; L10402; AAA51400.1; -; Genomic_DNA.
DR   EMBL; M15074; AAA59810.1; -; mRNA.
DR   IPI; IPI00005180; -.
DR   PIR; A45856; A45856.
DR   PIR; F60748; F60748.
DR   PIR; I51875; I51875.
DR   PIR; I54473; I54473.
DR   PIR; I68778; I68778.
DR   PIR; PH0160; PH0160.
DR   PIR; PT0161; PT0161.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   ProteinModelPortal; Q30134; -.
DR   STRING; Q30134; -.
DR   DMDM; 34395492; -.
DR   PRIDE; Q30134; -.
DR   Ensembl; ENST00000328980; ENSP00000331343; ENSG00000206306.
DR   Ensembl; ENST00000399450; ENSP00000382378; ENSG00000206240.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mn32480; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   neXtProt; NX_Q30134; -.
DR   eggNOG; NOG68200; -.
DR   HOVERGEN; HBG012730; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; Q30134; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-8 beta chain.
FT                                /FTId=PRO_0000018952.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID     44    108       By similarity.
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT      86     86       S -> D (in allele DRB1*08:02 and allele
FT                                DRB1*08:04; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016683.
FT   VARIANT      96     96       F -> I (in allele DRB1*08:03).
FT                                /FTId=VAR_016684.
FT   VARIANT     115    115       G -> V (in allele DRB1*08:04).
FT                                /FTId=VAR_016685.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_056535.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_056536.
SQ   SEQUENCE   266 AA;  30004 MW;  D452D1C3A75CEA31 CRC64;
     MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEYS TGECYFFNGT ERVRFLDRYF
     YNQEEYVRFD SDVGEYRAVT ELGRPSAEYW NSQKDFLEDR RALVDTYCRH NYGVGESFTV
     QRRVHPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKTG VVSTGLIHNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWSAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
ID   2B19_HUMAN              Reviewed;         266 AA.
AC   Q9TQE0; Q30149;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   18-APR-2012, entry version 94.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-9 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*9;
DE            Short=DR-9;
DE            Short=DR9;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*09:01).
RC   TISSUE=Blood;
RX   MEDLINE=98450507; PubMed=9777332;
RX   DOI=10.1046/j.1365-2370.1998.00105.x;
RA   Martinez-Quiles N., Martin-Villa J.M., Ferre-Lopez S.,
RA   Moreno-Pelayo M.A., Martinez-Laso J., Perez-Blas M., Alegre R.,
RA   Arnaiz-Villena A.;
RT   "Complete cDNA sequence of the HLA-DRB1*09012 allele.";
RL   Eur. J. Immunogenet. 25:307-309(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-115 (ALLELE DRB1*09:01).
RX   MEDLINE=87317627; PubMed=3476943; DOI=10.1073/pnas.84.17.6234;
RA   Bell J.I., Denney D. Jr., Foster L., Belt T.K., Todd J.A.,
RA   McDevitt H.O.;
RT   "Allelic variation in the DR subregion of the human major
RT   histocompatibility complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6234-6238(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-115.
RX   PubMed=2023919; DOI=10.1073/pnas.88.9.3686;
RA   Gyllensten U.B., Sundvall M., Erlich H.A.;
RT   "Allelic diversity is generated by intraexon sequence exchange at the
RT   DRB1 locus of primates.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3686-3690(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 45-266.
RX   PubMed=3466180; DOI=10.1073/pnas.83.23.9149;
RA   Gregersen P.K., Moriuchi T., Karr R.W., Obata F., Moriuchi J.,
RA   Maccari J., Goldberg D., Winchester R.J., Silver J.;
RT   "Polymorphism of HLA-DR beta chains in DR4, -7, and -9 haplotypes:
RT   implications for the mechanisms of allelic variation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:9149-9153(1986).
RN   [5]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [6]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [7]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [8]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [9]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [10]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [11]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route; where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules; and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments; exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides; autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs; other cells of the gastrointestinal tract; such
CC       as epithelial cells; express MHC class II molecules and CD74 and
CC       act as APCs; which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen; three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs; CD74 undergoes a sequential
CC       degradation by various proteases; including CTSS and CTSL; leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells; the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules; increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-9 are known:
CC       DRB1*09:01, DRB1*09:02, DRB1*09:03, DRB1*09:04, DRB1*09:05,
CC       DRB1*09:06, DRB1*09:07 and DRB1*09:08. The sequence shown is that
CC       of DRB1*09:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U66826; AAD43829.1; -; mRNA.
DR   EMBL; M17387; AAA36297.1; -; mRNA.
DR   IPI; IPI00983635; -.
DR   PIR; A25925; A25925.
DR   PIR; C28515; C28515.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   ProteinModelPortal; Q9TQE0; -.
DR   STRING; Q9TQE0; -.
DR   PhosphoSite; Q9TQE0; -.
DR   PRIDE; Q9TQE0; -.
DR   Ensembl; ENST00000418312; ENSP00000406194; ENSG00000236884.
DR   Ensembl; ENST00000437784; ENSP00000405960; ENSG00000229074.
DR   Ensembl; ENST00000444645; ENSP00000409322; ENSG00000236884.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mk32516; -.
DR   GeneCards; GC06Ml32694; -.
DR   H-InvDB; HIX0166371; -.
DR   H-InvDB; HIX0166636; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   neXtProt; NX_Q9TQE0; -.
DR   Orphanet; 243377; Diabetes mellitus type 1.
DR   Orphanet; 802; Multiple sclerosis.
DR   Orphanet; 2073; Narcolepsy-cataplexy.
DR   Orphanet; 284130; Rheumatoid arthritis.
DR   Orphanet; 797; Sarcoidosis.
DR   eggNOG; NOG68200; -.
DR   HOVERGEN; HBG012730; -.
DR   InParanoid; Q9TQE0; -.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 20784208; -.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; Q9TQE0; -.
DR   GermOnline; ENSG00000198502; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-9 beta chain.
FT                                /FTId=PRO_0000018953.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    216       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID     44    108       By similarity.
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT       5      5       K -> R (in dbSNP:rs9270305).
FT                                /FTId=VAR_056537.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_056538.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_056539.
SQ   SEQUENCE   266 AA;  29826 MW;  AD46B4AD27BAD8F2 CRC64;
     MVCLKLPGGS CMAALTVTLM VLSSPLALAG DTQPRFLKQD KFECHFFNGT ERVRYLHRGI
     YNQEENVRFD SDVGEYRAVT ELGRPVAESW NSQKDFLERR RAEVDTVCRH NYGVGESFTV
     QRRVHPEVTV YPAKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKAG VVSTGLIQNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVM SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
ID   2B1A_HUMAN              Reviewed;         266 AA.
AC   Q30167; P01914; Q9MYF5;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   18-APR-2012, entry version 88.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-10 beta chain;
DE   AltName: Full=DRw10;
DE   AltName: Full=MHC class II antigen DRB1*10;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*10:01).
RX   MEDLINE=84261468; PubMed=6589154;
RA   Peterson P.A., Gustafsson K., Wiman K.G., Emmoth E., Larhammar D.,
RA   Boehme J., Hyldig-Nielsen J.J., Ronne H., Rask L.;
RT   "Mutations and selection in the generation of class II
RT   histocompatibility antigen polymorphism.";
RL   EMBO J. 3:1655-1660(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*10:01).
RX   MEDLINE=88170832; PubMed=2450924;
RA   Merryman P., Gregersen P.K., Lee S., Silver J., Nunez-Roldan A.,
RA   Crapper R., Winchester R.;
RT   "Nucleotide sequence of a DRw10 beta chain cDNA clone. Identity of the
RT   third D region with that of the DRw53 allele of the beta 2 locus and
RT   as the probable site encoding a polymorphic MHC class II epitope.";
RL   J. Immunol. 140:2447-2452(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*10:01).
RX   MEDLINE=84031733; PubMed=6415003; DOI=10.1016/0198-8859(83)90087-3;
RA   Larhammar D., Andersson G., Andersson M., Bill P., Boehme J.,
RA   Claesson L., Denaro M., Emmoth E., Gustafsson K., Hammarling U.,
RA   Heldin E., Hyldig-Nielsen J.-J., Lind P., Schenning L., Servenius B.,
RA   Widmark E., Rask L., Peterson P.A.;
RT   "Molecular analysis of human class II transplantation antigens and
RT   their genes.";
RL   Hum. Immunol. 8:95-103(1983).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*10:01).
RA   Woelpl A.;
RT   "Sequence of an HLA-DRB gene.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [6]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [7]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [8]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [9]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [10]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [11]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route; where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules; and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments; exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides; autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs; other cells of the gastrointestinal tract; such
CC       as epithelial cells; express MHC class II molecules and CD74 and
CC       act as APCs; which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen; three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs; CD74 undergoes a sequential
CC       degradation by various proteases; including CTSS and CTSL; leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells; the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules; increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-10 are known:
CC       DRB1*10:01; DRB1*10:02 and DRB1*10:03. The sequence shown is that
CC       of DRB1*10:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00700; CAA25296.1; -; mRNA.
DR   EMBL; M20138; AAA59832.1; -; mRNA.
DR   EMBL; AF225565; AAF65542.1; -; Genomic_DNA.
DR   IPI; IPI00473139; -.
DR   PIR; A27614; HLHU4D.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   ProteinModelPortal; Q30167; -.
DR   SMR; Q30167; 30-219.
DR   STRING; Q30167; -.
DR   DMDM; 292494999; -.
DR   PRIDE; Q30167; -.
DR   Ensembl; ENST00000419393; ENSP00000403458; ENSG00000228080.
DR   Ensembl; ENST00000450362; ENSP00000410118; ENSG00000228080.
DR   GeneCards; GC06M032546; -.
DR   H-InvDB; HIX0175866; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   neXtProt; NX_Q30167; -.
DR   HOVERGEN; HBG012730; -.
DR   Reactome; REACT_6900; Immune System.
DR   ArrayExpress; P01914; -.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; Q30167; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-10 beta chain.
FT                                /FTId=PRO_0000018954.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    216       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID     44    108       By similarity.
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_056540.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_056541.
FT   CONFLICT    180    180       G -> E (in Ref. 2; AAA59832).
SQ   SEQUENCE   266 AA;  30002 MW;  45AB410F8AC21750 CRC64;
     MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEEV KFECHFFNGT ERVRLLERRV
     HNQEEYARYD SDVGEYRAVT ELGRPDAEYW NSQKDLLERR RAAVDTYCRH NYGVGESFTV
     QRRVQPKVTV YPSKTQPLQH HNLLVCSVNG FYPGSIEVRW FRNGQEEKTG VVSTGLIQNG
     DWTFQTLVML ETVPQSGEVY TCQVEHPSVM SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLP PTGFLS
//
ID   2B1B_HUMAN              Reviewed;         266 AA.
AC   P20039; Q30006; Q9GIX8;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-11 beta chain;
DE   AltName: Full=DR-5;
DE            Short=DR5;
DE   AltName: Full=DRw11;
DE   AltName: Full=MHC class II antigen DRB1*11;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*11:01).
RX   MEDLINE=86140021; PubMed=3456344;
RA   Tieber V.L., Abruzzini L.F., Didier D.K., Schwartz B.D., Rotwein P.;
RT   "Complete characterization and sequence of an HLA class II DR beta
RT   chain cDNA from the DR5 haplotype.";
RL   J. Biol. Chem. 261:2738-2742(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DRB1*11:03).
RX   MEDLINE=88314191; PubMed=3137159; DOI=10.1007/BF00375861;
RA   Steimle V., Hinkkanen A., Schlesier M., Epplen J.T.;
RT   "A novel HLA-DR beta I sequence from the DRw11 haplotype.";
RL   Immunogenetics 28:208-210(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*11:04).
RX   MEDLINE=22246460; PubMed=12358860;
RX   DOI=10.1046/j.1365-2370.2002.00354.x;
RA   Ramon D., Corell A., Cox S.T., Soteriou B., Madrigal J.A.,
RA   Marsh S.G.E.;
RT   "Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041
RT   alleles.";
RL   Eur. J. Immunogenet. 29:453-455(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 124-217.
RX   MEDLINE=89278667; PubMed=2471740;
RA   Gorski J.;
RT   "HLA-DR beta-chain polymorphism. Second domain polymorphism reflects
RT   evolutionary relatedness of alleles and may explain public serologic
RT   epitopes.";
RL   J. Immunol. 143:329-333(1989).
RN   [5]
RP   ASSOCIATION WITH SUSCEPTIBILITY TO HEPATITIS C VIRUS.
RX   MEDLINE=20075909; PubMed=10609818; DOI=10.1016/S0140-6736(99)91443-5;
RG   Hepatitis C European Network for Cooperative Research;
RA   Thursz M., Yallop R., Goldin R., Trepo C., Thomas H.C.;
RT   "Influence of MHC class II genotype on outcome of infection with
RT   hepatitis C virus.";
RL   Lancet 354:2119-2124(1999).
RN   [6]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [7]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [8]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [9]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [10]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [11]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [12]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route, where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules, and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments, exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides, autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs, other cells of the gastrointestinal tract, such
CC       as epithelial cells, express MHC class II molecules and CD74 and
CC       act as APCs, which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen, three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells, the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules, increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-11 are known:
CC       DRB1*11:01, DRB1*11:03, DRB1*11:04, DRB1*11:05, DRB1*11:06,
CC       DRB1*11:07, DRB1*11:08, DRB1*11:09, DRB1*11:10, DRB1*11:11,
CC       DRB1*11:12, DRB1*11:13, DRB1*11:14, DRB1*11:15, DRB1*11:16,
CC       DRB1*11:17, DRB1*11:18, DRB1*11:19, DRB1*11:20, DRB1*11:21,
CC       DRB1*11:22, DRB1*11:23, DRB1*11:24, DRB1*11:25, DRB1*11:26,
CC       DRB1*11:27, DRB1*11:28, DRB1*11:29, DRB1*11:30, DRB1*11:31,
CC       DRB1*11:32, DRB1*11:33, DRB1*11:34, DRB1*11:35, DRB1*11:36,
CC       DRB1*11:37, DRB1*11:38, DRB1*11:39, DRB1*11:40, DRB1*11:41,
CC       DRB1*11:42, DRB1*11:43, DRB1*11:44, DRB1*11:45, DRB1*11:46,
CC       DRB1*11:47, DRB1*11:48, DRB1*11:49, DRB1*11:50, DRB1*11:51,
CC       DRB1*11:52, DRB1*11:53, DRB1*11:54, DRB1*11:55, DRB1*11:56,
CC       DRB1*11:57, DRB1*11:58, DRB1*11:59, DRB1*11:60, DRB1*11:61,
CC       DRB1*11:62, DRB1*11:63, DRB1*11:64, DRB1*11:65, DRB1*11:66,
CC       DRB1*11:67, DRB1*11:68, DRB1*11:69, DRB1*11:70 and DRB1*11:72. The
CC       sequence shown is that of DRB1*11:01.
CC   -!- POLYMORPHISM: Allele DRB1*11:01 is associated with self-limiting
CC       hepatitis C virus (HCV) infections [MIM:609532].
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M11867; AAA36274.1; -; mRNA.
DR   EMBL; M22050; AAA59713.1; -; Genomic_DNA.
DR   EMBL; M21966; AAA59713.1; JOINED; Genomic_DNA.
DR   EMBL; M22047; AAA59713.1; JOINED; Genomic_DNA.
DR   EMBL; M22048; AAA59713.1; JOINED; Genomic_DNA.
DR   EMBL; M22049; AAA59713.1; JOINED; Genomic_DNA.
DR   EMBL; AJ297587; CAC08827.1; -; mRNA.
DR   IPI; IPI00746667; -.
DR   PIR; A25324; A25324.
DR   PIR; F60748; F60748.
DR   PIR; I54448; I54448.
DR   PIR; PH0153; PH0153.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   ProteinModelPortal; P20039; -.
DR   SMR; P20039; 34-220.
DR   STRING; P20039; -.
DR   DMDM; 122254; -.
DR   PRIDE; P20039; -.
DR   Ensembl; ENST00000328980; ENSP00000331343; ENSG00000206306.
DR   Ensembl; ENST00000399450; ENSP00000382378; ENSG00000206240.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mn32480; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   MIM; 609532; phenotype.
DR   neXtProt; NX_P20039; -.
DR   HOVERGEN; HBG012730; -.
DR   Reactome; REACT_6900; Immune System.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; P20039; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-11 beta chain.
FT                                /FTId=PRO_0000018955.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    250       Helical; (Potential).
FT   TOPO_DOM    251    266       Cytoplasmic (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID     44    108       By similarity.
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VARIANT      55     55       F -> Y (in dbSNP:rs16822516).
FT                                /FTId=VAR_056542.
FT   VARIANT     100    100       R -> E (in allele DRB1*11:03; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016717.
FT   VARIANT     115    115       G -> V (in allele DRB1*11:03 and allele
FT                                DRB1*11:04).
FT                                /FTId=VAR_016718.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_056543.
SQ   SEQUENCE   266 AA;  30160 MW;  6CFC0D44391B1059 CRC64;
     MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEYS TSECHFFNGT ERVRFLDRYF
     YNQEEYVRFD SDVGEFRAVT ELGRPDEEYW NSQKDFLEDR RAAVDTYCRH NYGVGESFTV
     QRRVHPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKTG VVSTGLIHNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PRGFLS
//
ID   2B1C_HUMAN              Reviewed;         266 AA.
AC   Q95IE3; A7LA26; B0LUZ6; B6VCX2; B7UDB2; O19585; Q19AF2; Q29771;
AC   Q2L9H4; Q2MZ92; Q5EER6; Q5NDB9; Q5UT58; Q5Y7G0; Q768U4; Q7YP04;
AC   Q861H8; Q95IT6; Q9BD40;
DT   02-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   18-APR-2012, entry version 79.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-12 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*12;
DE            Short=DR-12;
DE            Short=DR12;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*12:01).
RX   PubMed=12028552; DOI=10.1034/j.1399-0039.2002.590221.x;
RA   Zanone R., Bettens F., Tiercy J.M.;
RT   "Sequence of a new DR12 allele with two silent mutations that affect
RT   PCR-SSP typing.";
RL   Tissue Antigens 59:165-167(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*12:10).
RX   PubMed=15361134; DOI=10.1111/j.1399-0039.2004.00309.x;
RA   Kim E., Lee E.J., Lim Y.H., Lee J.Y., Koh I.S., Kimm K., Ji G.E.,
RA   Kwack K.;
RT   "Identification of a novel HLA-DRB1*12 allele (DRB1*1210) in the
RT   Korean population.";
RL   Tissue Antigens 64:518-519(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*12:17).
RX   PubMed=19493243; DOI=10.1111/j.1399-0039.2009.01224.x;
RA   Park M.H., Kim Y., Lee J.Y.;
RT   "Identification of a novel HLA-DRB1 allele, HLA-DRB1*1217, in a Korean
RT   individual.";
RL   Tissue Antigens 73:627-628(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-262 (ALLELE DRB1*12:01).
RX   PubMed=16140993; DOI=10.1101/gr.3554305;
RA   Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S.,
RA   Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V.;
RT   "Ancient haplotypes of the HLA Class II region.";
RL   Genome Res. 15:1250-1257(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-208 (ALLELE DRB1*12:07).
RX   PubMed=12028551; DOI=10.1034/j.1399-0039.2002.590220.x;
RA   Dunckley H., Le T., Dodd R., Hogbin J.P., Strickland J., Chapman G.,
RA   Greville W.D.;
RT   "Description of a novel HLA-DRB1 allele, DRB1*1207.";
RL   Tissue Antigens 59:162-164(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:11).
RC   TISSUE=Peripheral blood;
RX   PubMed=16690413; DOI=10.1016/j.humimm.2005.05.002;
RA   Horn P.A., DeLuca D.S., Jindra P., Blasczyk R.;
RT   "The replacement mutation in HLA-DRB1*1211 affects a likely keystone
RT   position.";
RL   Hum. Immunol. 66:1254-1257(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:08).
RX   PubMed=12144630; DOI=10.1034/j.1399-0039.2002.590513.x;
RA   Sheldon M.H., Bunce M., Dunn P.P., Day S., Lee G.D., Park Y.J.,
RA   Bang B.K., Kim B.K., Oh E.J.;
RT   "Identification of two new alleles in a single Korean individual, HLA-
RT   B*1568 and HLA-DRB1*1208.";
RL   Tissue Antigens 59:430-432(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:15).
RX   PubMed=19046299; DOI=10.1111/j.1744-313X.2008.00785.x;
RA   Lee H.L., Chu C.C., Trejaut J.A., Yang K.L., Lin M.;
RT   "Identification of two novel HLA-DRB1 alleles, HLA-DRB1*1214 and HLA-
RT   DRB1*1215, in two Taiwanese individuals.";
RL   Int. J. Immunogenet. 35:423-426(2008).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:19).
RX   PubMed=19624612; DOI=10.1111/j.1399-0039.2009.01316.x;
RA   Nie X.M., Fang Y.H., Zhang Y., He W.D., Zhu C.F.;
RT   "A novel HLA-DRB1 allele, DRB1*1219, was identified by sequence-based
RT   typing in a Chinese leukaemia family.";
RL   Tissue Antigens 74:352-354(2009).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:18).
RX   PubMed=19508407; DOI=10.1111/j.1399-0039.2009.01294.x;
RA   Gao S.Q., Deng Z.H., Xu Y.P.;
RT   "Identification of a novel HLA-DRB1*12 allele, DRB1*1218, in Chinese
RT   population.";
RL   Tissue Antigens 74:265-267(2009).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:05).
RA   Kashiwase K., Tokunaga K., Akaza T., Tadokoro K., Juji T.;
RT   "Sequence of new allele.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:09).
RA   Ono A.;
RT   "A new HLA-DR12V allele detected by PCR-RFLP.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:04).
RA   Gedil M.A., Steiner N.K., Hurley C.K.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:12).
RA   Zhu F., Lu Q., Zhang W.;
RT   "Identification a novel HLA-DRB1*12 in Chinese by sequence-based
RT   typed.";
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:13).
RA   Hur S.S., Lee M.N., Park S.Y., Kwon O.J.;
RT   "Novel HLA-DRB1*120201 variant allele.";
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:14).
RA   Chu C.-C.;
RT   "A novel HLA-DRB1 allele.";
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*12:16).
RA   Zhang C., Liu J.;
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-122 (ALLELE DRB1*12:03).
RX   PubMed=8851733; DOI=10.1111/j.1399-0039.1996.tb02532.x;
RA   Hashemi S., Couture C., Buyse I., Cole R., Aye M.T.;
RT   "Sequence analysis of three novel HLA-DRB1 alleles: DRB1*1113,
RT   DRB1*1114 and DRB1*12032.";
RL   Tissue Antigens 47:155-158(1996).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-123 (ALLELE DRB1*12:02).
RA   Lo B.;
RT   "HLA Class II DRB1*120201 coxnfirmatory sequence.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [20]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 88-197 (ALLELE DRB1*12:06).
RX   PubMed=10372549; DOI=10.1034/j.1399-0039.1999.530510.x;
RA   Maeng C.Y., Kim K.H., Kang J.H., Han H., Kim K.L.;
RT   "A novel HLA-DR12 allele (DRB1*1206) found in a Korean B-cell line.";
RL   Tissue Antigens 53:516-518(1999).
RN   [21]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [22]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [23]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [24]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [25]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [26]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [27]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route, where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules, and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments, exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides, autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs, other cells of the gastrointestinal tract, such
CC       as epithelial cells, express MHC class II molecules and CD74 and
CC       act as APCs, which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen, three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells, the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules, increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-12 are known:
CC       DRB1*12:01, DRB1*12:02, DRB1*12:03, DRB1*12:04, DRB1*12:05,
CC       DRB1*12:06, DRB1*12:07, DRB1*12:08, DRB1*12:09, DRB1*12:10,
CC       DRB1*12:11, DRB1*12:12, DRB1*12:13, DRB1*12:14, DRB1*12:15,
CC       DRB1*12:16, DRB1*12:17, DRB1*12:18 and DRB1*12:19. The sequence
CC       shown is that of DRB1*12:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ302075; CAC44379.1; -; mRNA.
DR   EMBL; AY626551; AAV34808.1; -; mRNA.
DR   EMBL; EU375850; ABY78039.1; -; mRNA.
DR   EMBL; AY663396; AAU87983.1; -; Genomic_DNA.
DR   EMBL; AF316619; AAK07563.1; -; Genomic_DNA.
DR   EMBL; AF315825; AAK07563.1; JOINED; Genomic_DNA.
DR   EMBL; AJ870921; CAI35044.1; -; Genomic_DNA.
DR   EMBL; AY033428; AAK55114.1; -; Genomic_DNA.
DR   EMBL; DQ533486; ABF74752.1; -; Genomic_DNA.
DR   EMBL; FJ374889; ACJ09136.1; -; Genomic_DNA.
DR   EMBL; FJ481086; ACK77491.1; -; Genomic_DNA.
DR   EMBL; D86503; BAA13098.1; -; Genomic_DNA.
DR   EMBL; AB112911; BAD02942.1; -; Genomic_DNA.
DR   EMBL; AY339246; AAQ18913.1; -; Genomic_DNA.
DR   EMBL; AY899825; AAW82078.1; -; Genomic_DNA.
DR   EMBL; DQ250650; ABC59072.1; -; Genomic_DNA.
DR   EMBL; DQ343834; ABC70992.1; -; Genomic_DNA.
DR   EMBL; EF688603; ABS11697.1; -; Genomic_DNA.
DR   EMBL; X83455; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY174091; AAO20088.1; -; Genomic_DNA.
DR   EMBL; AF017439; AAB70553.1; -; mRNA.
DR   IPI; IPI00955461; -.
DR   PIR; C60748; C60748.
DR   PIR; F60748; F60748.
DR   PIR; PH0154; PH0154.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   UniGene; Hs.716081; -.
DR   UniGene; Hs.723344; -.
DR   HSSP; P01903; 1JWU.
DR   ProteinModelPortal; Q95IE3; -.
DR   SMR; Q95IE3; 34-220.
DR   STRING; Q95IE3; -.
DR   DMDM; 74760669; -.
DR   Ensembl; ENST00000328980; ENSP00000331343; ENSG00000206306.
DR   Ensembl; ENST00000399437; ENSP00000382366; ENSG00000206240.
DR   Ensembl; ENST00000399450; ENSP00000382378; ENSG00000206240.
DR   Ensembl; ENST00000399692; ENSP00000382599; ENSG00000206306.
DR   Ensembl; ENST00000412634; ENSP00000408795; ENSG00000228080.
DR   Ensembl; ENST00000415796; ENSP00000412168; ENSG00000206306.
DR   Ensembl; ENST00000419393; ENSP00000403458; ENSG00000228080.
DR   Ensembl; ENST00000428566; ENSP00000392280; ENSG00000206240.
DR   Ensembl; ENST00000446898; ENSP00000397982; ENSG00000228080.
DR   Ensembl; ENST00000450362; ENSP00000410118; ENSG00000228080.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mn32480; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   neXtProt; NX_Q95IE3; -.
DR   HOVERGEN; HBG012730; -.
DR   Reactome; REACT_6900; Immune System.
DR   ArrayExpress; O19585; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29       Potential.
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-12 beta chain.
FT                                /FTId=PRO_0000391832.
FT   TRANSMEM    228    248       Helical; (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT       5      5       R -> K (in allele DRB1*12:17).
FT                                /FTId=VAR_062818.
FT   VARIANT      13     13       A -> T (in allele DRB1*12:17).
FT                                /FTId=VAR_062819.
FT   VARIANT      14     14       V -> A (in allele DRB1*12:17).
FT                                /FTId=VAR_062820.
FT   VARIANT      14     14       V -> I (in allele DRB1*12:10).
FT                                /FTId=VAR_062821.
FT   VARIANT      54     54       R -> L (in allele DRB1*12:13).
FT                                /FTId=VAR_062822.
FT   VARIANT      55     55       L -> F (in allele DRB1*12:08).
FT                                /FTId=VAR_062823.
FT   VARIANT      66     66       L -> F (in allele DRB1*12:05, allele
FT                                DRB1*12:14 and allele DRB1*12:15).
FT                                /FTId=VAR_062824.
FT   VARIANT      67     67       L -> V (in allele DRB1*12:14).
FT                                /FTId=VAR_062825.
FT   VARIANT      76     76       F -> L (in allele DRB1*12:11).
FT                                /FTId=VAR_062826.
FT   VARIANT      86     86       V -> D (in allele DRB1*12:04 and allele
FT                                DRB1*12:09).
FT                                /FTId=VAR_062827.
FT   VARIANT      87     87       A -> E (in allele DRB1*12:04).
FT                                /FTId=VAR_062828.
FT   VARIANT      88     88       E -> Q (in allele DRB1*12:18).
FT                                /FTId=VAR_062829.
FT   VARIANT      89     89       S -> Y (in allele DRB1*12:04 and allele
FT                                DRB1*12:09).
FT                                /FTId=VAR_062830.
FT   VARIANT      96     96       I -> F (in allele DRB1*12:02, allele
FT                                DRB1*12:13, allele DRB1*12:15, allele
FT                                DRB1*12:16, allele DRB1*12:18 and allele
FT                                DRB1*12:19).
FT                                /FTId=VAR_062831.
FT   VARIANT      96     96       I -> L (in allele DRB1*12:12).
FT                                /FTId=VAR_062832.
FT   VARIANT      98     98       E -> G (in allele DRB1*12:07).
FT                                /FTId=VAR_062833.
FT   VARIANT     114    114       A -> V (in allele DRB1*12:03, allele
FT                                DRB1*12:16 and allele DRB1*12:19).
FT                                /FTId=VAR_062834.
FT   VARIANT     115    115       V -> G (in allele DRB1*12:16).
FT                                /FTId=VAR_062835.
FT   VARIANT     125    125       H -> E (in allele DRB1*12:17; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_062836.
FT   VARIANT     169    169       T -> A (in allele DRB1*12:17).
FT                                /FTId=VAR_062837.
FT   VARIANT     178    178       H -> Q (in allele DRB1*12:06 and allele
FT                                DRB1*12:17).
FT                                /FTId=VAR_062838.
FT   VARIANT     262    262       R -> T (in allele DRB1*12:17;
FT                                dbSNP:rs9269744).
FT                                /FTId=VAR_062839.
SQ   SEQUENCE   266 AA;  29878 MW;  FFDD0001C2F0BAF9 CRC64;
     MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEYS TGECYFFNGT ERVRLLERHF
     HNQEELLRFD SDVGEFRAVT ELGRPVAESW NSQKDILEDR RAAVDTYCRH NYGAVESFTV
     QRRVHPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKTG VVSTGLIHNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PRGFLS
//
ID   2B1D_HUMAN              Reviewed;         266 AA.
AC   Q5Y7A7; A0MWF2; A2ICT1; A4ZXA5; A4ZXA6; A7UHG2; A7X5K7; A8YQE9;
AC   B0BK85; B3VTQ3; B5A8Y2; B5A8Y3; B5B9V6; B5QSK8; C0LAB5; O02930;
AC   O62889; O78047; P79545; Q14280; Q14QT2; Q19K86; Q1G0Z9; Q1KLJ6;
AC   Q29673; Q29720; Q29722; Q29806; Q29833; Q29874; Q29886; Q2MF40;
AC   Q2YHQ2; Q30112; Q3LA93; Q3LA94; Q3LA95; Q3LA96; Q3LA97; Q3LA98;
AC   Q3LA99; Q3LAA0; Q3LAA1; Q3LAA2; Q3MQ60; Q53IG1; Q56FP2; Q56FP3;
AC   Q58F52; Q5K3W2; Q5UBA2; Q5W3L4; Q6REE2; Q6U387; Q701T1; Q70Q85;
AC   Q768U2; Q7YP03; Q7YQ26; Q7YQA3; Q860E5; Q860H8; Q860Z3; Q861G6;
AC   Q861H0; Q861H4; Q8HWQ6; Q8WMA0; Q95389; Q95HL1; Q96HZ9; Q9BCP5;
AC   Q9BD21; Q9GIP3; Q9GJ25; Q9GJ60; Q9GJF8; Q9GJF9; Q9GJG0; Q9MY45;
AC   Q9MY56; Q9TPW3; Q9TPW9; Q9TPX4; Q9UBY1; Q9UIN0; Q9XRX1; Q9Y453;
DT   23-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   18-APR-2012, entry version 70.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-13 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*13;
DE            Short=DR-13;
DE            Short=DR13;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DRB1*13:01 AND DRB1*13:02).
RX   PubMed=16140993; DOI=10.1101/gr.3554305;
RA   Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S.,
RA   Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V.;
RT   "Ancient haplotypes of the HLA Class II region.";
RL   Genome Res. 15:1250-1257(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*13:05).
RX   PubMed=15896200; DOI=10.1111/j.1399-0039.2005.00407.x;
RA   Vilches C., Sepulveda S., Balas A., Solis R., Aviles M.J.,
RA   Estefania E., Gomez-Lozano N., Vicario J.L., DePablo R.;
RT   "Complete coding sequences and haplotypic associations of HLA-B*0707,
RT   -B*1524, -B*4405, -B*4802, -DRB1*0409, -DRB1*0411, -DRB1*1115, -
RT   DRB1*1305, and the novel allele -DRB1*0709. Group-specific
RT   amplification of cDNA from DRB1 alleles associated to DRB3 and DRB4.";
RL   Tissue Antigens 65:529-538(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DRB1*13:27 AND DRB1*13:56).
RX   PubMed=17174751; DOI=10.1016/j.humimm.2006.09.002;
RA   Balas A., Vilches C., Rodriguez M.A., Fernandez B., Martinez M.P.,
RA   de Pablo R., Garcia-Sanchez F., Vicario J.L.;
RT   "Group-specific amplification of cDNA from DRB1 genes. Complete coding
RT   sequences of partially defined alleles and identification of the new
RT   alleles DRB1*040602, DRB1*111102, DRB1*080103, and DRB1*0113.";
RL   Hum. Immunol. 67:1008-1016(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*13:02).
RC   TISSUE=Blood;
RA   Arnaiz-Villena A., Martinez-Quiles N., De Juan-Echavarri D.,
RA   Martin-Villa M., Martinez-Laso J.;
RT   "New complete sequences of MHC-DR in Spanish family wih Systemic Lupus
RT   erythematosus.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DRB1*13:01).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DRB1*13:02).
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 5-148 (ALLELE DRB1*13:21).
RC   TISSUE=Leukocyte;
RA   Maurer D.H.;
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-123 (ALLELE DRB1*13:19).
RC   TISSUE=Blood;
RX   MEDLINE=95381230; PubMed=7652736;
RX   DOI=10.1111/j.1399-0039.1995.tb02458.x;
RA   Robbins F., Tang T., Yao H., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Direct sequencing of SSP-PCR-amplified cDNA to identify new alleles
RT   in the DR52-associated DRB1 group: identification of DRB1*1115,
RT   DRB1*1117 and DRB1*1319.";
RL   Tissue Antigens 45:302-308(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-130 (ALLELE DRB1*13:04).
RX   MEDLINE=91010809; PubMed=2212675;
RA   Lee K.W., Johnson A.H., Hurley C.K.;
RT   "Two divergent routes of evolution gave rise to the DRw13
RT   haplotypes.";
RL   J. Immunol. 145:3119-3125(1990).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-217 (ALLELE DRB1*13:87).
RA   Ogrzewalla K., Tillmann G., Scheibelhut N., Lauber J., Enczmann J.;
RT   "A novel HLA-DRB1*13 allele identified by sequence-based typing.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-216 (ALLELES DRB1*13:03;
RP   DRB1*13:06; DRB1*13:08; DRB1*13:10; DRB1*13:11; DRB1*13:14;
RP   DRB1*13:17; DRB1*13:20; DRB1*13:29 AND DRB1*13:36).
RC   TISSUE=Peripheral blood;
RX   PubMed=17767557; DOI=10.1111/j.1399-0039.2007.00918.x;
RA   Horn P.A., Albis-Camps M., Verboom M., Bunce M., Yousaf K.,
RA   Williams S., Blasczyk R.;
RT   "The nature of diversity of HLA-DRB1 exon 3.";
RL   Tissue Antigens 70:335-337(2007).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-124 (ALLELE DRB1*13:12).
RA   Hu C.J.;
RT   "DR variant with a DR5-like-haplotype found in Taiwan.";
RL   Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:18).
RX   PubMed=8575826; DOI=10.1007/s002510050054;
RA   Dormoy A., Delbosc A., Galy-Floc'h M., Tongio M.M.;
RT   "A new HLA-DRB1(*)13 allele (DRB1(*)1318) with a short DRB1(*)08
RT   sequence.";
RL   Immunogenetics 43:240-241(1996).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:22).
RX   PubMed=9271638; DOI=10.1007/s002510050302;
RA   Duran K.J., Maeda H., Otten H.G., Vries R.D., Schreuder G.M.,
RA   Tilanus M.G.;
RT   "Two newly identified HLA-DRB1 alleles: DRB1*1322 and DRB1*1327.";
RL   Immunogenetics 46:442-443(1997).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*13:42 AND
RP   DRB1*13:43), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-122 (ALLELES
RP   DRB1*13:35; DRB1*13:37 AND DRB1*13:49), AND NUCLEOTIDE SEQUENCE
RP   [GENOMIC DNA] OF 35-115 (ALLELE DRB1*13:38).
RX   PubMed=11972885; DOI=10.1034/j.1399-0039.2002.590115.x;
RA   Tang T.F., Lin Y.-S., Robbins F.M., Li L., Sintasath D.,
RA   Coquillard G., Huang A., Heine U., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Description of fourteen new DRB alleles found in a stem cell donor
RT   registry.";
RL   Tissue Antigens 59:63-65(2002).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:46).
RX   MEDLINE=22025786; PubMed=12028548;
RX   DOI=10.1034/j.1399-0039.2002.590217.x;
RA   Greville W.D., Chapman G., Hogbin J.-P., Kennedy A., Dunckley H.;
RT   "Novel HLA-DRB1 alleles discovered during routine sequencing based
RT   typing, DRB1*03052, DRB1*04032, DRB1*1139 and DRB1*1346.";
RL   Tissue Antigens 59:154-156(2002).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:44).
RX   PubMed=12028549; DOI=10.1034/j.1399-0039.2002.590218.x;
RA   Kennedy A., Le T., Chapman G., Greville W.D., Dunckley H.;
RT   "Identification of two new HLA-DRB1 alleles, DRB1*1138 and
RT   DRB1*1344.";
RL   Tissue Antigens 59:157-158(2002).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:60).
RX   PubMed=15140048; DOI=10.1111/j.0001-2815.2004.00226.x;
RA   Testa G.V., Bunce M., Sheldon M.H., Dunn P.P., Day S., Marques S.B.;
RT   "Identification of a new allele, HLA-DRB1*1360, on a DRB5 haplotype in
RT   a Brazilian individual.";
RL   Tissue Antigens 63:617-618(2004).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:57).
RX   PubMed=15245379; DOI=10.1111/j.1399-0039.2004.00261.x;
RA   Danzer M., Leitner D., Gangl E., Fae I., Fischer G.F., Gabriel C.;
RT   "A novel HLA-DRB1*13 allele (DRB1*1357) identified by polymerase chain
RT   reaction with sequence-specific primers and direct sequencing.";
RL   Tissue Antigens 64:213-214(2004).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:50).
RX   PubMed=15304013; DOI=10.1111/j.0001-2815.2004.00282.x;
RA   Chen Z.X., Tsan S.G., Dang C.W., Chu C.C., Lin M., Lee Y.J.;
RT   "Identification of two new HLA-DRB1 alleles: HLA-DRB1*1350 and
RT   DRB1*140502.";
RL   Tissue Antigens 64:300-303(2004).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:51).
RX   PubMed=15304015; DOI=10.1111/j.0001-2815.2004.00275.x;
RA   Chu C.C., Lee H.L., Hsieh N.K., Trejaut J., Lin M.;
RT   "Two novel HLA-DRB1 alleles identified using a sequence-based typing:
RT   HLA-DRB1*1443 and HLA-DRB1*1351*.";
RL   Tissue Antigens 64:308-310(2004).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:66).
RX   PubMed=15982265; DOI=10.1111/j.1399-0039.2005.00427.x;
RA   Milia S., Lai S., Valentini T., Testi M., Cappai L., Moscetti A.,
RA   Mariani M., Alba F., Carcassi C.;
RT   "Identification of a new allele, HLA-DRB1*1366*.";
RL   Tissue Antigens 66:69-71(2005).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:64).
RC   TISSUE=Peripheral blood;
RX   PubMed=16029439; DOI=10.1111/j.1399-0039.2005.00440.x;
RA   Czachurski D., Scollo A., Skambraks A., Perichon A.M., Scherer S.,
RA   Tran T.H., Opelz G., Grappiolo I., Mytilineos J.;
RT   "Description and characterization of two new HLA alleles, B*4051 and
RT   DRB1*1364, identified by sequence-based typing.";
RL   Tissue Antigens 66:151-155(2005).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:68).
RX   PubMed=16101838; DOI=10.1111/j.1399-0039.2005.00451.x;
RA   Caggiari L., Simula M.P., Marzotto A., Caragnano A., Luchetti M.,
RA   Gabrielli A., De Re V.;
RT   "Identification of a novel human DRB1*13 allele by sequence-based DRB
RT   typing.";
RL   Tissue Antigens 66:246-247(2005).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:70).
RC   TISSUE=Peripheral blood;
RX   PubMed=16634878; DOI=10.1111/j.1399-0039.2006.00580.x;
RA   Horn P.A., Zingsem J., Eckstein R., Blasczyk R.;
RT   "Novel HLA-DRB1*1370 allele identified in a cord blood donor and her
RT   mother.";
RL   Tissue Antigens 67:345-347(2006).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:77).
RC   TISSUE=Blood;
RA   Tavoularis S., Conrod V., Ribeiro E.;
RT   "Identification of three novel DRB1 alleles.";
RL   Hum. Immunol. 68:S63-S63(2007).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:75).
RX   PubMed=17257328; DOI=10.1111/j.1399-0039.2006.00750.x;
RA   Sanchez-Gordo F., Balas A., Ortiz M., Prat I., Vicario J.L.;
RT   "A new human leukocyte antigen DRB1 allele, HLA-DRB1*1375.";
RL   Tissue Antigens 69:204-205(2007).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:71).
RX   PubMed=17493158; DOI=10.1111/j.1399-0039.2006.00753.x;
RA   McWhinnie A.J., Shah A., Peat J., Tavarozzi F., Little A.M.;
RT   "Description of HLA-DRB1*1371 allele, which has the 3' intron 1
RT   sequence and HLA-DQB1 association normally seen with a DRB1*0301
RT   allele.";
RL   Tissue Antigens 69:284-285(2007).
RN   [29]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:76).
RX   PubMed=17498272; DOI=10.1111/j.1399-0039.2007.00835.x;
RA   Abdeen H., McErlean C., Moraes M.E., Torres M., Campiotto S.,
RA   Galvao S., Gouvea C., Middleton D.;
RT   "Identification of three novel alleles of HLA-DRB1 and HLA-A in the
RT   Brazilian population.";
RL   Tissue Antigens 69:607-610(2007).
RN   [30]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:82).
RC   TISSUE=Blood;
RX   PubMed=19744147; DOI=10.1111/j.1399-0039.2009.01334.x;
RA   Anholts J.D., Aneq M., Dirks H.L., Tas A., Verduyn W., Oudshoorn M.;
RT   "Thirty-six novel HLA alleles: 7 HLA-A, 11 HLA-B, 15 HLA-C and 3 HLA-
RT   DRB1.";
RL   Tissue Antigens 74:424-428(2009).
RN   [31]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:32).
RC   TISSUE=Peripheral blood;
RA   Lester S., Laham N., Humphreys I., McCluskey J.;
RT   "A new DRB1*13 allele detected by PCR-SSOP and confirmed by
RT   sequencing.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [32]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:34).
RA   Erne G., Schmid C., Schwarz K., Woelpl A.;
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [33]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:39).
RA   Park M.H., Whang D.H., Kang S.J.;
RT   "A new HLA-DRB1*13 allele in a Korean individual.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [34]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:14).
RC   TISSUE=Peripheral blood;
RA   Guttridge M.G.;
RT   "Sequence confirmation of HLA-DRB1*1314.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [35]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:41).
RA   Bois M., Dormoy A., Alcalay D.;
RT   "Caracterization of a new HLA-DRB1*13 class II allele.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [36]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:48).
RC   TISSUE=Peripheral blood;
RA   Moine A.;
RT   "A new HLA DRB1* allele close to DRB1*1304.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [37]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:47).
RA   Kashiwase K., Shimizu M., Juji T., Tanaka H., Ishikawa Y.;
RT   "HLA-DRB1-1307V for exon2.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [38]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:07).
RA   Tamouza R., Keyhani M., Poirier J.C., Schaeffer V., Fortier C.,
RA   Labie D., Charron D.;
RT   "New HLA-DRB1*13.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [39]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:01).
RA   Voorter C.E., van den Berg-Loonen E.M.;
RT   "New HLA DRB1*13 allele identified by sequence-based typing.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [40]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*13:01 AND
RP   DRB1*13:16).
RA   Rizzo M., Gedil M.A., Steiner N.K., Hurley C.K.;
RT   "Complete exon 2 sequence for HLA-DRB1*1316.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [41]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:69).
RA   Rodriguez-Marino S., Coquillard G.J.;
RT   "Novel HLA-DRB1*1301 Variant.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [42]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:58).
RA   Chen D.-F., Dong L., Janzen M., Rabson A., Fraser P.;
RT   "Novel HLA-DRB1*13 alleles detected by PCR-SSOP and confirmed by
RT   single allele specific sequencing.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [43]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:54).
RA   Ono A.;
RT   "A new HLA-DR12V allele detected by PCR-RFLP.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [44]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:61).
RA   Lazaro A.M., Gedil M.A., Rizzo M., Hurley C.K.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [45]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*13:62 AND
RP   DRB1*13:63).
RA   Hirv K., Krauss A., Schwarz K.;
RT   "Characterization of a new HLA-DRB1 allele by direct sequencing.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [46]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:59).
RA   Bendukidze N.;
RT   "Rare DRB1*1359 alleles confirmatory testing.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [47]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:65).
RA   Czachurski D.;
RT   "Hochaufloesende Typisierung von HLA-Klasse I und Klasse II mittels
RT   Sequenzanalyse. Einfluss auf das Transplantatueberleben.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [48]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:67).
RC   TISSUE=Peripheral blood;
RA   Binder T.M.C., Mosebach M., Kuehnl P., Heim M.U., Blasczyk R.,
RA   Eiermann T.H.;
RT   "A new HLA-DRB1*13 variant similar to DRB1*130201 and DRB3*020101.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [49]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:74).
RC   TISSUE=Peripheral blood;
RA   Dunne C., Crowley J.;
RT   "Sequence of new HLA-DRB1*13 allele DRB1*13XX.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [50]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:79).
RC   TISSUE=Blood;
RA   Duignan P., Varney M., Holdsworth R.;
RT   "New DRB1*13 allele found in cord blood.";
RL   Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [51]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:78).
RA   Moore J., Bowman S., Varney M., Tait B.;
RT   "New HLA DR13 sequence found in bone marrow donor.";
RL   Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [52]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*13:83).
RA   Horn P.A., Blasczyk R.;
RT   "A novel HLA-DRB1*13 allele.";
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [53]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*13:31;
RP   DRB1*13:72; DRB1*13:73; DRB1*13:80; DRB1*13:81; DRB1*13:84;
RP   DRB1*13:85; DRB1*13:86 AND DRB1*13:88).
RA   Lazaro A.M., Xiao Y., Cao K., Shan X., Zhang B., Masaberg C.,
RA   Hurley C.K.;
RT   "Novel HLA-class II allele.";
RL   Submitted (MAY-2008) to the EMBL/GenBank/DDBJ databases.
RN   [54]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-122 (ALLELES DRB1*13:23 AND
RP   DRB1*13:24).
RX   MEDLINE=97387737; PubMed=9243754;
RX   DOI=10.1111/j.1399-0039.1997.tb02832.x;
RA   Ellis J.M., Robbins F., Wang J., Tang T., Heine U., Mason J.M.,
RA   Sese D., Milford E., Hurley C.K.;
RT   "Identification of four new DR52-associated DRB1 alleles: DRB1*1424,
RT   *1425, *1323 and *1324.";
RL   Tissue Antigens 50:42-46(1997).
RN   [55]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-120 (ALLELE DRB1*13:13).
RC   TISSUE=Blood;
RA   Hurley C.K., Noreen H., Lin Y.S.;
RT   "DRB1*1313.";
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [56]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-120 (ALLELE DRB1*13:52).
RA   Rodriguez-Marino S., Coquillard G.;
RT   "Characterization of a new DRB1*13011 variant allele.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [57]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-116 (ALLELE DRB1*13:25).
RX   PubMed=9008317; DOI=10.1111/j.1399-0039.1996.tb02698.x;
RA   Poli F., Bianchi P., Crespiatico L., Sirchia G.;
RT   "Identification of a new DRB1 allele (DRB1*1325) by PCR-SSP and DNA
RT   sequencing.";
RL   Tissue Antigens 48:714-716(1996).
RN   [58]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DRB1*13:33).
RC   TISSUE=Blood;
RX   PubMed=9694360; DOI=10.1111/j.1399-0039.1998.tb03010.x;
RA   Buyse I.M., Ouellet S., Hashemi-Tavoularis S.;
RT   "Identification of novel DRB1*13 (DRB1*1333), DRB1*04 (DRB1*0426) and
RT   DRB5* (DRB5*0109) alleles.";
RL   Tissue Antigens 51:658-662(1998).
RN   [59]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-123 (ALLELE DRB1*13:40).
RC   TISSUE=Cervix;
RX   MEDLINE=20470606; PubMed=11019927;
RX   DOI=10.1034/j.1399-0039.2000.560218.x;
RA   Maciag P.C., Junes K.S., Villa L.L., Petzl-Erler M.L.;
RT   "Identification of a novel allele, DRB1*1340, in two Brazilian
RT   individuals.";
RL   Tissue Antigens 56:194-196(2000).
RN   [60]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-123 (ALLELE DRB1*13:53).
RC   TISSUE=Peripheral blood;
RA   Poli F., Longhi E., Frison S.;
RT   "Identification of a new HLA DRB1*13 by SBT.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [61]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-123 (ALLELES DRB1*13:15 AND
RP   DRB1*13:55).
RA   Lo B.;
RT   "Confirmatory Sequence of HLA Class II DRB1*1315.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [62]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-120 (ALLELE DRB1*13:09).
RC   TISSUE=Blood;
RX   MEDLINE=94294985; PubMed=8023320;
RX   DOI=10.1111/j.1399-0039.1994.tb02298.x;
RA   Yunis J.J., Kineke E., Yunis E.J.;
RT   "Characterization of a new DRB1 allele, DRB1*1309, by PCR-SSOP and
RT   sequencing.";
RL   Tissue Antigens 43:54-57(1994).
RN   [63]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-119 (ALLELE DRB1*13:30).
RA   Greville W.D., Bowman S.;
RT   "New HLA class II (DRB1) allele from Melbourne BTS.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [64]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-119 (ALLELE DRB1*13:28).
RA   Varney M.D., Tait B.D.;
RT   "Identification of a novel DPB allele.";
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [65]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-116 (ALLELE DRB1*13:26).
RX   MEDLINE=97179738; PubMed=9027974;
RX   DOI=10.1111/j.1399-0039.1997.tb02718.x;
RA   Voorter C.E.M., de Bruyn-Geraets D., Verduyn W., Schreuder G.M.T.,
RA   van den Berg-Loonen E.M.;
RT   "Identification of a new HLA-DRB1*13 allele (DRB1*1326) with a short
RT   DRB1*16 sequence.";
RL   Tissue Antigens 49:88-91(1997).
RN   [66]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-116 (ALLELE DRB1*13:45).
RX   PubMed=12028550; DOI=10.1034/j.1399-0039.2002.590219.x;
RA   Bengtsson M., Jansson I.E., Danielsson F., Henrysson H., Kallsten K.;
RT   "Identification of a novel HLA DRB1 exon 2 sequence, DRB1*1345.";
RL   Tissue Antigens 59:159-161(2002).
RN   [67]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [68]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [69]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [70]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [71]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [72]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [73]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route, where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules, and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments, exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides, autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs, other cells of the gastrointestinal tract, such
CC       as epithelial cells, express MHC class II molecules and CD74 and
CC       act as APCs, which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen, three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells, the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules, increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-13 are known:
CC       DRB1*13:01, DRB1*13:02, DRB1*13:03, DRB1*13:04, DRB1*13:05,
CC       DRB1*13:06, DRB1*13:07, DRB1*13:08, DRB1*13:09, DRB1*13:10,
CC       DRB1*13:11, DRB1*13:12, DRB1*13:13, DRB1*13:14, DRB1*13:15,
CC       DRB1*13:16, DRB1*13:17, DRB1*13:18, DRB1*13:19, DRB1*13:20,
CC       DRB1*13:21, DRB1*13:22, DRB1*13:23, DRB1*13:24, DRB1*13:25,
CC       DRB1*13:26, DRB1*13:27, DRB1*13:28, DRB1*13:29, DRB1*13:30,
CC       DRB1*13:31, DRB1*13:32, DRB1*13:33, DRB1*13:34, DRB1*13:35,
CC       DRB1*13:36, DRB1*13:37, DRB1*13:38, DRB1*13:39, DRB1*13:40,
CC       DRB1*13:41, DRB1*13:42, DRB1*13:43, DRB1*13:44, DRB1*13:45,
CC       DRB1*13:46, DRB1*13:47, DRB1*13:48, DRB1*13:49, DRB1*13:50,
CC       DRB1*13:51, DRB1*13:52, DRB1*13:53, DRB1*13:54, DRB1*13:55,
CC       DRB1*13:56, DRB1*13:57, DRB1*13:58, DRB1*13:59, DRB1*13:60,
CC       DRB1*13:61, DRB1*13:62, DRB1*13:63, DRB1*13:64, DRB1*13:65,
CC       DRB1*13:66, DRB1*13:67, DRB1*13:68, DRB1*13:69, DRB1*13:70,
CC       DRB1*13:71, DRB1*13:72, DRB1*13:73, DRB1*13:74, DRB1*13:75,
CC       DRB1*13:76, DRB1*13:77, DRB1*13:78, DRB1*13:79, DRB1*13:80,
CC       DRB1*13:81, DRB1*13:82, DRB1*13:83, DRB1*13:84, DRB1*13:85,
CC       DRB1*13:86, DRB1*13:87 and DRB1*13:88. The sequence shown is that
CC       of DRB1*13:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB40418.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY663413; AAU88029.1; -; Genomic_DNA.
DR   EMBL; AY663415; AAU88035.1; -; Genomic_DNA.
DR   EMBL; AJ697893; CAG27026.1; -; mRNA.
DR   EMBL; AY961069; AAX63457.1; -; mRNA.
DR   EMBL; AY961070; AAX63458.2; -; mRNA.
DR   EMBL; L76133; AAL40069.1; -; mRNA.
DR   EMBL; AK293020; BAF85709.1; -; mRNA.
DR   EMBL; BC007920; AAH07920.1; -; mRNA.
DR   EMBL; L41992; AAA65914.1; -; Genomic_DNA.
DR   EMBL; U17381; AAC50167.1; -; mRNA.
DR   EMBL; M59803; AAA64237.1; -; mRNA.
DR   EMBL; FM196526; CAQ86517.1; -; Genomic_DNA.
DR   EMBL; AM109988; CAJ33595.1; -; Genomic_DNA.
DR   EMBL; AM109989; CAJ33596.1; -; Genomic_DNA.
DR   EMBL; AM109990; CAJ33597.1; -; Genomic_DNA.
DR   EMBL; AM109991; CAJ33598.1; -; Genomic_DNA.
DR   EMBL; AM109992; CAJ33599.1; -; Genomic_DNA.
DR   EMBL; AM109993; CAJ33600.1; -; Genomic_DNA.
DR   EMBL; AM109994; CAJ33601.1; -; Genomic_DNA.
DR   EMBL; AM109995; CAJ33602.1; -; Genomic_DNA.
DR   EMBL; AM109996; CAJ33603.1; -; Genomic_DNA.
DR   EMBL; AM109997; CAJ33604.1; -; Genomic_DNA.
DR   EMBL; D29836; BAA06216.1; -; Genomic_DNA.
DR   EMBL; Z48631; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X86326; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF136155; AAD27646.1; -; Genomic_DNA.
DR   EMBL; AF164346; AAD47814.1; -; Genomic_DNA.
DR   EMBL; AF169239; AAD51315.1; -; Genomic_DNA.
DR   EMBL; AF243537; AAG00414.1; -; Genomic_DNA.
DR   EMBL; AF243538; AAG00415.1; -; Genomic_DNA.
DR   EMBL; AF352295; AAK27712.1; -; Genomic_DNA.
DR   EMBL; AF306862; AAG42258.1; -; Genomic_DNA.
DR   EMBL; AF247533; AAF99607.1; -; Genomic_DNA.
DR   EMBL; AY178845; AAO18733.1; -; Genomic_DNA.
DR   EMBL; AJ555156; CAD87537.1; -; Genomic_DNA.
DR   EMBL; AY048687; AAL12226.1; -; Genomic_DNA.
DR   EMBL; AF441789; AAL35834.1; -; Genomic_DNA.
DR   EMBL; AY765349; AAV35213.1; -; Genomic_DNA.
DR   EMBL; AJ634529; CAG25408.1; -; Genomic_DNA.
DR   EMBL; AY963587; AAX51706.1; -; Genomic_DNA.
DR   EMBL; AM086025; CAJ30431.1; -; Genomic_DNA.
DR   EMBL; AM494414; CAM36736.1; -; Genomic_DNA.
DR   EMBL; EF053230; ABK33462.1; -; Genomic_DNA.
DR   EMBL; AM158254; CAJ43560.1; -; Genomic_DNA.
DR   EMBL; EF196873; ABM69041.1; -; Genomic_DNA.
DR   EMBL; AM904556; CAP17407.1; -; Genomic_DNA.
DR   EMBL; U97554; AAB58309.1; -; Genomic_DNA.
DR   EMBL; AF048688; AAC05271.1; -; Genomic_DNA.
DR   EMBL; AF170582; AAD50971.1; -; Genomic_DNA.
DR   EMBL; AJ245717; CAB53346.1; -; Genomic_DNA.
DR   EMBL; AJ249591; CAB56840.1; -; Genomic_DNA.
DR   EMBL; AJ401236; CAB96577.1; -; Genomic_DNA.
DR   EMBL; AB049459; BAB16298.1; -; Genomic_DNA.
DR   EMBL; AF305212; AAG22826.1; -; Genomic_DNA.
DR   EMBL; AJ271206; CAC27122.1; -; Genomic_DNA.
DR   EMBL; AY178184; AAO21939.1; -; Genomic_DNA.
DR   EMBL; AY277392; AAP34696.1; -; Genomic_DNA.
DR   EMBL; AY225520; AAO67727.1; -; Genomic_DNA.
DR   EMBL; AY259126; AAP21612.1; -; Genomic_DNA.
DR   EMBL; AB112913; BAD02944.1; -; Genomic_DNA.
DR   EMBL; AY339247; AAQ18914.1; -; Genomic_DNA.
DR   EMBL; AY379480; AAQ85128.1; -; Genomic_DNA.
DR   EMBL; AY502108; AAR89455.1; -; Genomic_DNA.
DR   EMBL; AJ627565; CAF28889.1; -; Genomic_DNA.
DR   EMBL; AJ783982; CAH04455.1; -; Genomic_DNA.
DR   EMBL; AJ853708; CAH68606.1; -; Genomic_DNA.
DR   EMBL; AM279417; CAK50561.1; -; Genomic_DNA.
DR   EMBL; EF493833; ABP68561.1; -; Genomic_DNA.
DR   EMBL; EF493832; ABP68560.1; -; Genomic_DNA.
DR   EMBL; AM931066; CAP62371.1; -; Genomic_DNA.
DR   EMBL; DQ473293; ABF18979.1; -; Genomic_DNA.
DR   EMBL; DQ514602; ABF60565.1; -; Genomic_DNA.
DR   EMBL; DQ525629; ABF74594.1; -; Genomic_DNA.
DR   EMBL; EU029803; ABU86862.1; -; Genomic_DNA.
DR   EMBL; EU071684; ABS87343.1; -; Genomic_DNA.
DR   EMBL; EU812541; ACE88700.1; -; Genomic_DNA.
DR   EMBL; EU826130; ACF36162.1; -; Genomic_DNA.
DR   EMBL; EU826129; ACF36161.1; -; Genomic_DNA.
DR   EMBL; FJ688163; ACN56340.1; -; Genomic_DNA.
DR   EMBL; U36827; AAC51629.1; -; Genomic_DNA.
DR   EMBL; U36825; AAC51628.1; -; Genomic_DNA.
DR   EMBL; U79025; AAB52235.1; -; Genomic_DNA.
DR   EMBL; AF499445; AAP68877.1; -; Genomic_DNA.
DR   EMBL; X93924; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ001254; CAA04628.1; -; Genomic_DNA.
DR   EMBL; AJ237964; CAB40418.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ488066; CAD32373.1; -; Genomic_DNA.
DR   EMBL; AY174182; AAO17054.1; -; Genomic_DNA.
DR   EMBL; AY179366; AAO23237.1; -; Genomic_DNA.
DR   EMBL; L23534; AAA62591.1; -; Genomic_DNA.
DR   EMBL; U72264; AAB17276.1; -; Genomic_DNA.
DR   EMBL; X97407; CAA66060.1; -; Genomic_DNA.
DR   EMBL; X96396; CAA65260.1; -; Genomic_DNA.
DR   EMBL; AJ276873; CAB82169.1; -; Genomic_DNA.
DR   IPI; IPI01018156; -.
DR   PIR; D25239; D25239.
DR   PIR; I38899; I38899.
DR   PIR; I59647; I59647.
DR   PIR; I72484; I72484.
DR   PIR; PH0155; PH0155.
DR   PIR; S03439; S03439.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   UniGene; Hs.716081; -.
DR   UniGene; Hs.723344; -.
DR   ProteinModelPortal; Q5Y7A7; -.
DR   SMR; Q5Y7A7; 34-220.
DR   STRING; Q5Y7A7; -.
DR   DMDM; 74757225; -.
DR   Ensembl; ENST00000328980; ENSP00000331343; ENSG00000206306.
DR   Ensembl; ENST00000383125; ENSP00000372606; ENSG00000206240.
DR   Ensembl; ENST00000399437; ENSP00000382366; ENSG00000206240.
DR   Ensembl; ENST00000399450; ENSP00000382378; ENSG00000206240.
DR   Ensembl; ENST00000399692; ENSP00000382599; ENSG00000206306.
DR   Ensembl; ENST00000415796; ENSP00000412168; ENSG00000206306.
DR   Ensembl; ENST00000428566; ENSP00000392280; ENSG00000206240.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mn32480; -.
DR   H-InvDB; HIX0176057; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   MIM; 142857; gene.
DR   neXtProt; NX_Q5Y7A7; -.
DR   HOVERGEN; HBG012730; -.
DR   Reactome; REACT_6900; Immune System.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29       Potential.
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-13 beta chain.
FT                                /FTId=PRO_0000392290.
FT   TRANSMEM    228    248       Helical; (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT      39     39       Y -> L (in allele DRB1*13:67; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_062866.
FT   VARIANT      40     40       S -> L (in allele DRB1*13:67).
FT                                /FTId=VAR_062867.
FT   VARIANT      41     41       T -> K (in allele DRB1*13:67).
FT                                /FTId=VAR_062868.
FT   VARIANT      42     42       S -> G (in allele DRB1*13:17).
FT                                /FTId=VAR_062869.
FT   VARIANT      45     45       H -> Q (in allele DRB1*13:72).
FT                                /FTId=VAR_062871.
FT   VARIANT      45     45       H -> Y (in allele DRB1*13:17).
FT                                /FTId=VAR_062870.
FT   VARIANT      54     54       R -> L (in allele DRB1*13:73).
FT                                /FTId=VAR_062872.
FT   VARIANT      55     55       F -> Y (in allele DRB1*13:27, allele
FT                                DRB1*13:41 and allele DRB1*13:71).
FT                                /FTId=VAR_062873.
FT   VARIANT      56     56       L -> Q (in allele DRB1*13:59).
FT                                /FTId=VAR_062874.
FT   VARIANT      57     57       D -> E (in allele DRB1*13:15, allele
FT                                DRB1*13:19, allele DRB1*13:26, allele
FT                                DRB1*13:53, allele DRB1*13:57, allele
FT                                DRB1*13:85 and allele DRB1*13:86).
FT                                /FTId=VAR_062875.
FT   VARIANT      61     61       H -> Y (in allele DRB1*13:03, allele
FT                                DRB1*13:07, allele DRB1*13:04, allele
FT                                DRB1*13:11, allele DRB1*13:12, allele
FT                                DRB1*13:13, allele DRB1*13:14, allele
FT                                DRB1*13:17, allele DRB1*13:21, allele
FT                                DRB1*13:22, allele DRB1*13:23, allele
FT                                DRB1*13:24, allele DRB1*13:25, allele
FT                                DRB1*13:30, allele DRB1*13:33, allele
FT                                DRB1*13:37, allele DRB1*13:38, allele
FT                                DRB1*13:44, allele DRB1*13:45, allele
FT                                DRB1*13:46, allele DRB1*13:47, allele
FT                                DRB1*13:48, allele DRB1*13:49, allele
FT                                DRB1*13:50, allele DRB1*13:54, allele
FT                                DRB1*13:55, allele DRB1*13:58, allele
FT                                DRB1*13:60, allele DRB1*13:62, allele
FT                                DRB1*13:66, allele DRB1*13:69, allele
FT                                DRB1*13:70, allele DRB1*13:75, allele
FT                                DRB1*13:81, allele DRB1*13:82, allele
FT                                DRB1*13:86 and allele DRB1*13:88).
FT                                /FTId=VAR_062876.
FT   VARIANT      66     66       N -> D (in allele DRB1*13:62 and allele
FT                                DRB1*13:68).
FT                                /FTId=VAR_062880.
FT   VARIANT      66     66       N -> F (in allele DRB1*13:08, allele
FT                                DRB1*13:19, allele DRB1*13:57, allele
FT                                DRB1*13:64, allele DRB1*13:72, allele
FT                                DRB1*13:76 and allele DRB1*13:83;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_062878.
FT   VARIANT      66     66       N -> I (in allele DRB1*13:87).
FT                                /FTId=VAR_062881.
FT   VARIANT      66     66       N -> S (in allele DRB1*13:60 and allele
FT                                DRB1*13:84).
FT                                /FTId=VAR_062879.
FT   VARIANT      66     66       N -> Y (in allele DRB1*13:03, allele
FT                                DRB1*13:07, allele DRB1*13:04, allele
FT                                DRB1*13:11, allele DRB1*13:12, allele
FT                                DRB1*13:13, allele DRB1*13:14, allele
FT                                DRB1*13:17, allele DRB1*13:21, allele
FT                                DRB1*13:22, allele DRB1*13:23, allele
FT                                DRB1*13:24, allele DRB1*13:25, allele
FT                                DRB1*13:30, allele DRB1*13:33, allele
FT                                DRB1*13:37, allele DRB1*13:38, allele
FT                                DRB1*13:44, allele DRB1*13:45, allele
FT                                DRB1*13:46, allele DRB1*13:47, allele
FT                                DRB1*13:48, allele DRB1*13:49, allele
FT                                DRB1*13:52, allele DRB1*13:54, allele
FT                                DRB1*13:55, allele DRB1*13:58, allele
FT                                DRB1*13:66, allele DRB1*13:70, allele
FT                                DRB1*13:75, allele DRB1*13:81, allele
FT                                DRB1*13:82, allele DRB1*13:86 and allele
FT                                DRB1*13:88).
FT                                /FTId=VAR_062877.
FT   VARIANT      67     67       V -> L (in allele DRB1*13:34, allele
FT                                DRB1*13:62 and allele DRB1*13:64).
FT                                /FTId=VAR_062882.
FT   VARIANT      76     76       F -> Y (in allele DRB1*13:03, allele
FT                                DRB1*13:07, allele DRB1*13:08, allele
FT                                DRB1*13:12, allele DRB1*13:13, allele
FT                                DRB1*13:19, allele DRB1*13:26, allele
FT                                DRB1*13:32, allele DRB1*13:33, allele
FT                                DRB1*13:36, allele DRB1*13:37, allele
FT                                DRB1*13:38, allele DRB1*13:40, allele
FT                                DRB1*13:47, allele DRB1*13:48, allele
FT                                DRB1*13:49, allele DRB1*13:53, allele
FT                                DRB1*13:55, allele DRB1*13:58, allele
FT                                DRB1*13:60, allele DRB1*13:65, allele
FT                                DRB1*13:70, allele DRB1*13:72, allele
FT                                DRB1*13:76, allele DRB1*13:81, allele
FT                                DRB1*13:84, allele DRB1*13:85 and allele
FT                                DRB1*13:88).
FT                                /FTId=VAR_062883.
FT   VARIANT      77     77       R -> L (in allele DRB1*13:35).
FT                                /FTId=VAR_062884.
FT   VARIANT      77     77       R -> W (in allele DRB1*13:80).
FT                                /FTId=VAR_062885.
FT   VARIANT      79     79       V -> L (in allele DRB1*13:51).
FT                                /FTId=VAR_062886.
FT   VARIANT      86     86       D -> A (in allele DRB1*13:43 and allele
FT                                DRB1*13:45).
FT                                /FTId=VAR_062889.
FT   VARIANT      86     86       D -> S (in allele DRB1*13:03, allele
FT                                DRB1*13:04, allele DRB1*13:12, allele
FT                                DRB1*13:13, allele DRB1*13:21, allele
FT                                DRB1*13:30, allele DRB1*13:32, allele
FT                                DRB1*13:33, allele DRB1*13:38, allele
FT                                DRB1*13:48, allele DRB1*13:49, allele
FT                                DRB1*13:55, allele DRB1*13:58, allele
FT                                DRB1*13:65, allele DRB1*13:66, allele
FT                                DRB1*13:75, allele DRB1*13:81 and allele
FT                                DRB1*13:88; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062887.
FT   VARIANT      86     86       D -> V (in allele DRB1*13:31, allele
FT                                DRB1*13:46, allele DRB1*13:54 and allele
FT                                DRB1*13:77).
FT                                /FTId=VAR_062888.
FT   VARIANT      89     89       Y -> H (in allele DRB1*13:43 and allele
FT                                DRB1*13:45).
FT                                /FTId=VAR_062891.
FT   VARIANT      89     89       Y -> S (in allele DRB1*13:39, allele
FT                                DRB1*13:54, allele DRB1*13:77, allele
FT                                DRB1*13:78 and allele DRB1*13:79).
FT                                /FTId=VAR_062890.
FT   VARIANT      96     96       I -> F (in allele DRB1*13:07, allele
FT                                DRB1*13:05, allele DRB1*13:11, allele
FT                                DRB1*13:14, allele DRB1*13:18, allele
FT                                DRB1*13:21, allele DRB1*13:24, allele
FT                                DRB1*13:26, allele DRB1*13:42, allele
FT                                DRB1*13:46, allele DRB1*13:47, allele
FT                                DRB1*13:49, allele DRB1*13:50, allele
FT                                DRB1*13:54, allele DRB1*13:55, allele
FT                                DRB1*13:62, allele DRB1*13:63 and allele
FT                                DRB1*13:75).
FT                                /FTId=VAR_062892.
FT   VARIANT      96     96       I -> L (in allele DRB1*13:20, allele
FT                                DRB1*13:25, allele DRB1*13:29, allele
FT                                DRB1*13:43, allele DRB1*13:44, allele
FT                                DRB1*13:56, allele DRB1*13:60, allele
FT                                DRB1*13:71, allele DRB1*13:78, allele
FT                                DRB1*13:86 and allele DRB1*13:88).
FT                                /FTId=VAR_062893.
FT   VARIANT      97     97       L -> R (in allele DRB1*13:74).
FT                                /FTId=VAR_062894.
FT   VARIANT      99     99       D -> Q (in allele DRB1*13:09, allele
FT                                DRB1*13:44 and allele DRB1*13:86;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_062895.
FT   VARIANT     100    100       E -> A (in allele DRB1*13:09).
FT                                /FTId=VAR_062898.
FT   VARIANT     100    100       E -> K (in allele DRB1*13:03, allele
FT                                DRB1*13:10, allele DRB1*13:33, allele
FT                                DRB1*13:37, allele DRB1*13:66, allele
FT                                DRB1*13:81, allele DRB1*13:85 and allele
FT                                DRB1*13:88).
FT                                /FTId=VAR_062897.
FT   VARIANT     100    100       E -> R (in allele DRB1*13:07, allele
FT                                DRB1*13:05, allele DRB1*13:06, allele
FT                                DRB1*13:11, allele DRB1*13:12, allele
FT                                DRB1*13:13, allele DRB1*13:14, allele
FT                                DRB1*13:18, allele DRB1*13:21, allele
FT                                DRB1*13:25, allele DRB1*13:26, allele
FT                                DRB1*13:30, allele DRB1*13:42, allele
FT                                DRB1*13:44, allele DRB1*13:46, allele
FT                                DRB1*13:47, allele DRB1*13:49, allele
FT                                DRB1*13:50, allele DRB1*13:55, allele
FT                                DRB1*13:56, allele DRB1*13:58, allele
FT                                DRB1*13:60, allele DRB1*13:62, allele
FT                                DRB1*13:77, allele DRB1*13:82 and allele
FT                                DRB1*13:86; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062896.
FT   VARIANT     103    103       A -> E (in allele DRB1*13:76).
FT                                /FTId=VAR_062900.
FT   VARIANT     103    103       A -> L (in allele DRB1*13:13, allele
FT                                DRB1*13:18, allele DRB1*13:47 and allele
FT                                DRB1*13:55; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062899.
FT   VARIANT     106    106       T -> N (in allele DRB1*13:33 and allele
FT                                DRB1*13:61).
FT                                /FTId=VAR_062901.
FT   VARIANT     113    113       G -> R (in allele DRB1*13:28).
FT                                /FTId=VAR_062902.
FT   VARIANT     114    114       V -> A (in allele DRB1*13:58 and allele
FT                                DRB1*13:81).
FT                                /FTId=VAR_062903.
FT   VARIANT     115    115       V -> D (in allele DRB1*13:16).
FT                                /FTId=VAR_062905.
FT   VARIANT     115    115       V -> G (in allele DRB1*13:02, allele
FT                                DRB1*13:03, allele DRB1*13:07, allele
FT                                DRB1*13:05, allele DRB1*13:12, allele
FT                                DRB1*13:13, allele DRB1*13:14, allele
FT                                DRB1*13:21, allele DRB1*13:23, allele
FT                                DRB1*13:25, allele DRB1*13:26, allele
FT                                DRB1*13:29, allele DRB1*13:30, allele
FT                                DRB1*13:31, allele DRB1*13:33, allele
FT                                DRB1*13:34, allele DRB1*13:36, allele
FT                                DRB1*13:37, allele DRB1*13:38, allele
FT                                DRB1*13:39, allele DRB1*13:41, allele
FT                                DRB1*13:45, allele DRB1*13:46, allele
FT                                DRB1*13:47, allele DRB1*13:49, allele
FT                                DRB1*13:50, allele DRB1*13:55, allele
FT                                DRB1*13:56, allele DRB1*13:60, allele
FT                                DRB1*13:62, allele DRB1*13:63, allele
FT                                DRB1*13:65, allele DRB1*13:66, allele
FT                                DRB1*13:67, allele DRB1*13:73, allele
FT                                DRB1*13:74, allele DRB1*13:82, allele
FT                                DRB1*13:85, allele DRB1*13:86 and allele
FT                                DRB1*13:88).
FT                                /FTId=VAR_062904.
FT   CONFLICT    104    104       V -> L (in Ref. 46; CAA04628).
FT   CONFLICT    121    121       Q -> H (in Ref. 25; AAC05271).
FT   CONFLICT    124    124       V -> G (in Ref. 11; BAA06216).
SQ   SEQUENCE   266 AA;  30008 MW;  17731F784445CC39 CRC64;
     MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEYS TSECHFFNGT ERVRFLDRYF
     HNQEENVRFD SDVGEFRAVT ELGRPDAEYW NSQKDILEDE RAAVDTYCRH NYGVVESFTV
     QRRVHPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKTG VVSTGLIHNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PRGFLS
//
ID   2B1E_HUMAN              Reviewed;         266 AA.
AC   Q9GIY3; A0N0W1; A2TGX3; A4ZY86; A5H000; A5HKN8; A7DZP9; A7X5B1;
AC   A7X5B7; A7X5E0; A7X5E6; A7X5H8; A9JPG0; B1GWE7; B2CR03; B2LVF9;
AC   B2NJ29; B2ZCY1; B3VTP8; B5B8U0; B5B9V5; B5LZ25; B6VEL9; B9VRA4;
AC   B9X248; O02876; O46793; O77969; O78210; Q0PQ39; Q155F7; Q1AP33;
AC   Q1JRP3; Q27PR6; Q27PR7; Q29734; Q29770; Q29772; Q29800; Q2A120;
AC   Q2HZE5; Q2LE76; Q2MJA6; Q2VQU1; Q307W5; Q31636; Q3LA87; Q3LA88;
AC   Q3LA89; Q3LA90; Q3LA91; Q3LA92; Q3T919; Q4PRC3; Q4PRC5; Q4VZY7;
AC   Q56FP1; Q5BM92; Q5U9W6; Q683P7; Q70GL2; Q7YNY9; Q7YQA5; Q860D8;
AC   Q860D9; Q860S0; Q861H5; Q861H7; Q8MH59; Q8MH60; Q8WLU3; Q95348;
AC   Q95HK1; Q95HL0; Q95IG2; Q9GIL5; Q9GIL6; Q9GIY0; Q9GIY1; Q9GIY2;
AC   Q9GJ56; Q9GJ57; Q9GJ58; Q9TPB6; Q9TPW1; Q9XRY4; Q9Y4H7;
DT   23-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   18-APR-2012, entry version 83.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-14 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*14;
DE            Short=DR-14;
DE            Short=DR14;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*14:05).
RX   MEDLINE=22540232; PubMed=12652907; DOI=10.1080/1042517021000041822;
RA   Kohsaka H., Nasu K., Matsushita S., Miyasaka N.;
RT   "Complete cDNA coding sequence of the HLA-DRB1*1405 allele.";
RL   DNA Seq. 13:359-361(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DRB1*14:01 AND DRB1*14:04),
RP   AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-264 (ALLELES DRB1*14:02 AND
RP   DRB1*14:03).
RX   MEDLINE=21970284; PubMed=11972886;
RX   DOI=10.1034/j.1399-0039.2002.590116.x;
RA   Corell A., Cox S.T., Soteriou B., Ramon D., Madrigal J.A.,
RA   Marsh S.G.E.;
RT   "Complete cDNA sequences of the HLA-DRB1*14011, *1402, *1403 and *1404
RT   alleles.";
RL   Tissue Antigens 59:66-69(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DRB1*14:05).
RX   PubMed=16140993; DOI=10.1101/gr.3554305;
RA   Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S.,
RA   Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V.;
RT   "Ancient haplotypes of the HLA Class II region.";
RL   Genome Res. 15:1250-1257(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*14:11), AND NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 1-265 (ALLELE DRB1*14:46).
RX   PubMed=17174751; DOI=10.1016/j.humimm.2006.09.002;
RA   Balas A., Vilches C., Rodriguez M.A., Fernandez B., Martinez M.P.,
RA   de Pablo R., Garcia-Sanchez F., Vicario J.L.;
RT   "Group-specific amplification of cDNA from DRB1 genes. Complete coding
RT   sequences of partially defined alleles and identification of the new
RT   alleles DRB1*040602, DRB1*111102, DRB1*080103, and DRB1*0113.";
RL   Hum. Immunol. 67:1008-1016(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-217 (ALLELE DRB1*14:57).
RX   PubMed=17026471; DOI=10.1111/j.1399-0039.2006.00669.x;
RA   Chen Q., Zou H., Xu X.H., Luo M., Wang J., Zuo Y.Q., Chen Y.H.,
RA   Chen X.H., Chen X.L., Yao Z.Q., Song N., Zeng J., Mi X.Y., Sun S.X.,
RA   Wang J.X., Zhao T.M.;
RT   "Characterization of HLA-B*5516, -B*1313, -B*9512, and -DRB1*1457
RT   alleles identified in a southwest Chinese population.";
RL   Tissue Antigens 68:339-343(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-208 (ALLELE DRB1*14:54).
RX   PubMed=19284446; DOI=10.1111/j.1744-313X.2008.00826.x;
RA   Yang K.L., Chen M.J., Lee S.K., Lin C.C., Tsai M.J., Chiu H.M.,
RA   Jiang S., Chao Y.C., Chen S.P., Lin S., Shyr M.H., Lin P.Y.;
RT   "New allele name of some HLA-DRB1*1401: HLA-DRB1*1454.";
RL   Int. J. Immunogenet. 36:119-120(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 30-123 (ALLELE DRB1*14:19).
RX   MEDLINE=96124449; PubMed=8560458;
RX   DOI=10.1111/j.1399-0039.1995.tb02506.x;
RA   Loeffler D., Woelpl A., Kern P., Eiermann T.H.;
RT   "A novel HLA-DR allele, DRB1*1419.";
RL   Tissue Antigens 46:343-344(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-217 (ALLELE DRB1*14:82).
RA   Ogrzewalla K., Tillmann G., Scheibelhut N., Lauber J., Enczmann J.;
RT   "A novel HLA-DRB1*14 allele identified by sequence-based typing.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-216 (ALLELES DRB1*14:06;
RP   DRB1*14:07; DRB1*14:10; DRB1*14:13; DRB1*14:14 AND DRB1*14:21).
RC   TISSUE=Peripheral blood;
RX   PubMed=17767557; DOI=10.1111/j.1399-0039.2007.00918.x;
RA   Horn P.A., Albis-Camps M., Verboom M., Bunce M., Yousaf K.,
RA   Williams S., Blasczyk R.;
RT   "The nature of diversity of HLA-DRB1 exon 3.";
RL   Tissue Antigens 70:335-337(2007).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-124 (ALLELE DRB1*14:85).
RA   Maruya E., Matsushita M., Saji H., Ounuma T., Futagami T., Kojima H.,
RA   Tujino T., Hayashi K., Kusunoki Y., Yoshida T., Maekawajiri S.;
RT   "HLA-DR new allele related with DRB1*1403.";
RL   Submitted (FEB-2009) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:22).
RX   PubMed=8575830; DOI=10.1007/s002510050058;
RA   Adami N., Aubert V., Jeannet M., Tiercy J.M.;
RT   "Sequencing of a new HLA-DR14 allele (DRB1(*)1422).";
RL   Immunogenetics 43:248-249(1996).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:36).
RX   MEDLINE=99253507; PubMed=10321590;
RX   DOI=10.1034/j.1399-0039.1999.530421.x;
RA   Bodmer J., Marsh S., Albert E., Bodmer W.;
RT   "Nomenclature for factors of the HLA system, 1998.";
RL   Tissue Antigens 53:407-446(1999).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:37).
RC   TISSUE=Blood;
RX   MEDLINE=21276064; PubMed=11380954;
RX   DOI=10.1034/j.1399-0039.2001.057004384.x;
RA   Wu S., Shiao Y.M., Lai C.Y., Lai S.M., Chen S.P., Sidebottom D.A.,
RA   Hildebrand W.H., Tilanus M.G.J., Chou F.C., Tsai M.F.;
RT   "Polymorphism of human HLA-DRB1 antigens generated by genetic exchange
RT   between DR2 (DRB1*15011) and DR6 (DRB1*1405) alleles: a novel DRB1
RT   allele (DRB1*1437) identified in a Paiwan tribe member of Taiwan.";
RL   Tissue Antigens 57:384-387(2001).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:41), AND
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-123 (ALLELE DRB1*14:42).
RX   PubMed=12144619; DOI=10.1034/j.1399-0039.2002.590502.x;
RA   Gans C.P., Tang T.F., Slack R., Ng J., Hartzman R.J., Hurley C.K.;
RT   "DRB1*14 diversity and DRB3 associations in four major population
RT   groups in the United States.";
RL   Tissue Antigens 59:364-369(2002).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:43).
RX   PubMed=15304015; DOI=10.1111/j.0001-2815.2004.00275.x;
RA   Chu C.C., Lee H.L., Hsieh N.K., Trejaut J., Lin M.;
RT   "Two novel HLA-DRB1 alleles identified using a sequence-based typing:
RT   HLA-DRB1*1443 and HLA-DRB1*1351*.";
RL   Tissue Antigens 64:308-310(2004).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*14:47 AND
RP   DRB1*14:48).
RX   PubMed=16185331; DOI=10.1111/j.1399-0039.2005.00459.x;
RA   Lazaro A.M., Steiner N.K., Moraes M.E., Moraes J.R., Ng J.,
RA   Hartzman R.J., Hurley C.K.;
RT   "Ten novel HLA-DRB1 alleles and one novel DRB3 allele.";
RL   Tissue Antigens 66:327-329(2005).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:50).
RC   TISSUE=Peripheral blood;
RX   PubMed=16185333; DOI=10.1111/j.1399-0039.2005.00472a.x;
RA   Tijssen H.J., Zeeuw van der S.C., Joosten I.;
RT   "Exon 2 sequence analysis of a novel HLA-DRB1 allele, DRB1*1450.";
RL   Tissue Antigens 66:332-333(2005).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:49).
RX   PubMed=16426240; DOI=10.1111/j.1744-313X.2005.00557.x;
RA   Miao K.R., Xue M., Zhou X.Y., Xu R., Fei X.M., Pan Q.Q., Zhang J.W.,
RA   Zhao X., Fan S., Kukuruga D., Xu A.L., Wang C.Y.;
RT   "Characterization of a novel DRB1*14 allele (DRB1*1449) in the Han-
RT   Chinese population.";
RL   Int. J. Immunogenet. 33:33-35(2006).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:56).
RX   PubMed=16774552; DOI=10.1111/j.1399-0039.2006.00612.x;
RA   Baek J.Y., Yun H.S., Hur S.S., Kwon O.J., Kwack K.;
RT   "Identification of a novel HLA-DRB1*14 allele, DRB1*1456, in the cord
RT   blood of a Korean baby.";
RL   Tissue Antigens 68:97-98(2006).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:60).
RC   TISSUE=Peripheral blood;
RX   PubMed=17026474; DOI=10.1111/j.1399-0039.2006.00675.x;
RA   Tijssen H.J., van den Dungen-Toet J.H.G., van Houwelingen K.P.,
RA   Allebes W.A., Joosten I.;
RT   "Exon 2 sequence analysis of a novel HLA-DRB1 allele, DRB1*1460.";
RL   Tissue Antigens 68:346-347(2006).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:65).
RX   PubMed=17498272; DOI=10.1111/j.1399-0039.2007.00835.x;
RA   Abdeen H., McErlean C., Moraes M.E., Torres M., Campiotto S.,
RA   Galvao S., Gouvea C., Middleton D.;
RT   "Identification of three novel alleles of HLA-DRB1 and HLA-A in the
RT   Brazilian population.";
RL   Tissue Antigens 69:607-610(2007).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:74).
RX   PubMed=18179646; DOI=10.1111/j.1399-0039.2007.00993.x;
RA   Rahal M., Kervaire B., Villard J., Tiercy J.M.;
RT   "DNA typing by microbead arrays and PCR-SSP: apparent false-negative
RT   or -positive hybridization or amplification signals disclose new HLA-B
RT   and -DRB1 alleles.";
RL   Tissue Antigens 71:238-241(2008).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:67).
RC   TISSUE=Blood;
RX   PubMed=18643964; DOI=10.1111/j.1399-0039.2008.01089.x;
RA   Yan L.N., Li S.Y., Dong Z., Dong L., Xie J.H., An S.P., Yuan Y.H.;
RT   "Sequence-based typing reveals the novel HLA-DRB1*1467 allele in a
RT   Chinese individual.";
RL   Tissue Antigens 72:409-410(2008).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:75).
RX   PubMed=18937796; DOI=10.1111/j.1399-0039.2008.01116.x;
RA   Schuett S., Geflitter A., von Baehr V.;
RT   "Sequence-based typing of a novel HLA-DRB1*14 allele, DRB1*1475, in a
RT   Caucasian woman.";
RL   Tissue Antigens 72:501-502(2008).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:61).
RX   PubMed=19000132; DOI=10.1111/j.1399-0039.2008.01135.x;
RA   Wang Z., Shan X., Zhang Z.;
RT   "Identification of a novel HLA-DRB allele, HLA-DRB1*1461.";
RL   Tissue Antigens 72:603-604(2008).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:78).
RX   PubMed=19140840; DOI=10.1111/j.1399-0039.2008.01175.x;
RA   Han S.H., Jung S.M., Park S.R., Chung S.Y., Han H.;
RT   "Identification of a new HLA-DRB1*14 variant, HLA-DRB1*1478, in a
RT   Korean individual.";
RL   Tissue Antigens 73:81-83(2009).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*14:26;
RP   DRB1*14:27 AND DRB1*14:29).
RA   Kashiwase K., Tokunaga K., Akaza T., Tadokoro K., Juji T.;
RT   "Sequence of new allele.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [28]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:32).
RA   Blasczyk R.;
RT   "A new HLA-DRB1*14 variant.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [29]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:34).
RA   Whidborne R.S., Sayer D.C., Christiansen F.T.;
RT   "Novel DRB1*14 and 15 alleles in the Western Australian population.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [30]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:17).
RA   Gervais T.G., Latinne D.;
RT   "Confirmatory sequence for HLA-DRB1*1417 gene obtained by sequence
RT   based typing.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [31]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:18).
RA   Rizzo M., Steiner N.K., Nichol L., Hurley C.K.;
RT   "Complete exon 2 sequence for HLA-DRB1*1418.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [32]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:15).
RA   Kervaire B., Villard J., Tiercy J.M.;
RT   "An unusual HLA-DR/DQ haplotype carrying a new DR8 variant and the
RT   DRB3*0202 allele.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [33]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:23).
RC   TISSUE=Blood;
RA   Velickovic Z.M.;
RT   "Novel HLA-DRB1*11 allele.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [34]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:12).
RA   Oh H.B., Byun E.K., Hong S.A., Lee M.N., Kwon O.J.;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [35]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:01).
RA   Lee T.D.;
RT   "Identification of a novel HLA-DRB1*14 allele.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [36]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:53).
RA   Dormoy A.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [37]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:55).
RC   TISSUE=Leukocyte;
RA   Hirv K., Krauss A., Mytilineos J.;
RT   "Characterization of a new HLA-DRB1*14 allele.";
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [38]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:58).
RA   Karvunidis T., Jindra P., Fischer G., Koza V.;
RT   "Identification of a new HLA-DRB1*14 allele by sequence-based
RT   typing.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [39]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:59).
RA   Dormoy A., Weschler B., Leinsenbach R.;
RT   "A new DRB1*14 allele close to the DRB1*1418 allele is different for 3
RT   substitutions at nucleaotide positions 84, 152 and 174 leading to the
RT   change of 2 amino acids at positions 28 and 51.";
RL   Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [40]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:63).
RA   Ye S., Liu M., Qi J.;
RT   "Identification a novel HLA-DRB1*14 new allele.";
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [41]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:30).
RA   Greville W.D., Dunckley H.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [42]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:76).
RC   TISSUE=Blood;
RA   Tavoularis S., Rebeiro E., Sayer D.;
RT   "Identification of a novel DRB1 allele.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [43]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:77).
RC   TISSUE=Blood;
RA   Yan L.N., An S.P., Li S.Y., Xie J.H., Dong L., Dong Z., Yuan Y.H.;
RT   "A new allele of HLA-DRB1*14 detected with SBT.";
RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [44]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*14:38;
RP   DRB1*14:39; DRB1*14:40; DRB1*14:44; DRB1*14:45 AND DRB1*14:80).
RA   Juji T., Shimizu M., Kashiwase K., Nakajima F., Tadokoro K.,
RA   Tanaka H.;
RT   "HLA-DRB1*1401V1M, HLA-DRB1*1401V2, HLA-DRB1*1403V2, HLA-DRB1*1405V1,
RT   HLA-DRB1*1405V2, HLA-DRB1*1406V1.";
RL   Submitted (MAY-2008) to the EMBL/GenBank/DDBJ databases.
RN   [45]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELES DRB1*14:51;
RP   DRB1*14:52; DRB1*14:62; DRB1*14:64; DRB1*14:68; DRB1*14:69;
RP   DRB1*14:70; DRB1*14:71; DRB1*14:72; DRB1*14:73; DRB1*14:79; DRB1*14:81
RP   AND DRB1*14:83).
RA   Lazaro A.M., Cao K., Xiao Y., Lebeck L., Hurley C.K.;
RT   "Novel class II allele.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
RN   [46]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:24).
RA   Dormoy A., Weschler B.;
RT   "The HLA-DRB1*14New allele has 3 nucleotide changes from the DRB1*1402
RT   allele at positions 286, 298 and 299 of exon 2 where: C286->A286
RT   (codon 72 (CTC->ATC)) resulting in a change of amino acid: Leu->Ile
RT   A298->G298 + G299->C299 (codon 76 (AGG->GCG)) resulting in a change of
RT   amino acid: Arg->Ala.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
RN   [47]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*14:84).
RC   TISSUE=Peripheral blood;
RA   Lee T.-D., Chien W.-C.;
RT   "A new DR14-related DRB1 allele, identified by sequence-based
RT   typing.";
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [48]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-122 (ALLELE DRB1*14:35).
RX   MEDLINE=21423502; PubMed=11532019;
RX   DOI=10.1046/j.1365-2370.2001.00243.x;
RA   Trejaut J., Kennedy A., Hobart D., Le T., Greville W.D., Ng G.,
RA   Taverniti A., Dunckley H.;
RT   "PCR-RFLP typing detects new HLA-DRB1 alleles: DRB1*13022, DRB1*1336
RT   and DRB1*1435.";
RL   Eur. J. Immunogenet. 28:441-447(2001).
RN   [49]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DRB1*14:28).
RC   TISSUE=Blood;
RX   MEDLINE=97387748; PubMed=9243765;
RX   DOI=10.1111/j.1399-0039.1997.tb02843.x;
RA   Hashemi-Tavoularis S., Couture C., Buyse I.M.;
RT   "Identification of new DRB1*01 (DRB1*01022), DRB1*14 (DRB1*1428) and
RT   DRB3* (DRB3*0206) alleles.";
RL   Tissue Antigens 50:89-93(1997).
RN   [50]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DRB1*14:01).
RC   TISSUE=Peripheral blood;
RX   PubMed=15104685; DOI=10.1111/j.0001-2815.2004.00186.x;
RA   Tavoularis S., Couture C., Ribeiro-Barros E.;
RT   "Identification of three novel alleles: DRB3*0110, DRB1*1140, and
RT   DRB1*140102.";
RL   Tissue Antigens 63:496-500(2004).
RN   [51]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-123 (ALLELES DRB1*14:09 AND
RP   DRB1*14:25).
RA   Vayntrub T., Lo B.;
RT   "Confirmatory Sequence of HLA Class II DRB1*1409 and DRB1*1425.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [52]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-122 (ALLELE DRB1*14:08).
RC   TISSUE=Blood;
RX   MEDLINE=92355118; PubMed=1644450; DOI=10.1007/BF00215663;
RA   Gao X., Veale A., Serjeantson S.W.;
RT   "HLA class II diversity in Australian aborigines: unusual HLA-DRB1
RT   alleles.";
RL   Immunogenetics 36:333-337(1992).
RN   [53]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-119 (ALLELE DRB1*14:31).
RX   PubMed=10599892; DOI=10.1034/j.1399-0039.1999.540510.x;
RA   Panigoro R., Greville W.D., Kennedy A., Trejaut J., Dunckley H.;
RT   "New HLA class II alleles in the Indonesian population.";
RL   Tissue Antigens 54:521-523(1999).
RN   [54]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-122 (ALLELE DRB1*14:33).
RA   Greville W.D., van Eijck A., Dunckley H.;
RT   "New HLA class II (DRB1) alleles detected by sequencing-based
RT   typing.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [55]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-116 (ALLELE DRB1*14:20).
RX   PubMed=8883296; DOI=10.1111/j.1399-0039.1996.tb02611.x;
RA   Verduyn W., Anholts J.D., Versluis L.F., Parlevliet J., Drabbels J.,
RA   De Meester J., Tilanus M.G., Doxiadis I.I., Giphart M.J.,
RA   Schreuder G.M.;
RT   "Six newly identified HLA-DRB alleles: DRB1*1121, *1419, *1420, *1421,
RT   DRB3*0203 and DRB5*0103.";
RL   Tissue Antigens 48:80-86(1996).
RN   [56]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 42-131 (ALLELE DRB1*14:24).
RC   TISSUE=B-cell;
RA   Hurley C.K.;
RL   Submitted (NOV-1995) to the EMBL/GenBank/DDBJ databases.
RN   [57]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 43-120 (ALLELE DRB1*14:16).
RA   Gervais T.G., Latinne D.;
RT   "Confirmatory typing for exon 2 of HLA-DRB1*1416 gene, obtained by
RT   sequence-based typing.";
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [58]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [59]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [60]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [61]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [62]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [63]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [64]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route, where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules, and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments, exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides, autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs, other cells of the gastrointestinal tract, such
CC       as epithelial cells, express MHC class II molecules and CD74 and
CC       act as APCs, which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen, three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells, the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules, increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-14 are known:
CC       DRB1*14:01, DRB1*14:02, DRB1*14:03, DRB1*14:04, DRB1*14:05,
CC       DRB1*14:06, DRB1*14:07, DRB1*14:08, DRB1*14:09, DRB1*14:10,
CC       DRB1*14:11, DRB1*14:12, DRB1*14:13, DRB1*14:14, DRB1*14:15,
CC       DRB1*14:16, DRB1*14:17, DRB1*14:18, DRB1*14:19, DRB1*14:20,
CC       DRB1*14:21, DRB1*14:22, DRB1*14:23, DRB1*14:24, DRB1*14:25,
CC       DRB1*14:26, DRB1*14:27, DRB1*14:28, DRB1*14:29, DRB1*14:30,
CC       DRB1*14:31, DRB1*14:32, DRB1*14:33, DRB1*14:34, DRB1*14:35,
CC       DRB1*14:36, DRB1*14:37, DRB1*14:38, DRB1*14:39, DRB1*14:40,
CC       DRB1*14:41, DRB1*14:42, DRB1*14:43, DRB1*14:44, DRB1*14:45,
CC       DRB1*14:46, DRB1*14:47, DRB1*14:48, DRB1*14:49, DRB1*14:50,
CC       DRB1*14:51, DRB1*14:52, DRB1*14:53, DRB1*14:54, DRB1*14:55,
CC       DRB1*14:56, DRB1*14:57, DRB1*14:58, DRB1*14:59, DRB1*14:60,
CC       DRB1*14:61, DRB1*14:62, DRB1*14:63, DRB1*14:64, DRB1*14:65,
CC       DRB1*14:67, DRB1*14:68, DRB1*14:69, DRB1*14:70, DRB1*14:71,
CC       DRB1*14:72, DRB1*14:73, DRB1*14:74, DRB1*14:75, DRB1*14:76,
CC       DRB1*14:77, DRB1*14:78, DRB1*14:79, DRB1*14:80, DRB1*14:81,
CC       DRB1*14:82, DRB1*14:83, DRB1*14:84 and DRB1*14:85. The sequence
CC       shown is that of DRB1*14:01.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB45249.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB062112; BAB84521.2; -; mRNA.
DR   EMBL; AJ297582; CAC08822.1; -; mRNA.
DR   EMBL; AJ297583; CAC08823.1; -; mRNA.
DR   EMBL; AJ297584; CAC08824.1; -; mRNA.
DR   EMBL; AJ297585; CAC08825.1; -; mRNA.
DR   EMBL; AY663408; AAU88014.1; -; Genomic_DNA.
DR   EMBL; AY935719; AAX33315.1; -; mRNA.
DR   EMBL; AY961071; AAX63459.2; -; mRNA.
DR   EMBL; DQ235685; ABB52004.1; -; Genomic_DNA.
DR   EMBL; DQ390459; ABD60300.1; -; Genomic_DNA.
DR   EMBL; DQ390460; ABD60301.1; -; Genomic_DNA.
DR   EMBL; FJ379259; ACJ06537.1; -; Genomic_DNA.
DR   EMBL; Z38072; CAA86217.1; -; Genomic_DNA.
DR   EMBL; FM196525; CAQ86516.1; -; Genomic_DNA.
DR   EMBL; AM109998; CAJ33605.1; -; Genomic_DNA.
DR   EMBL; AM109999; CAJ33606.1; -; Genomic_DNA.
DR   EMBL; AM110000; CAJ33607.1; -; Genomic_DNA.
DR   EMBL; AM110001; CAJ33608.1; -; Genomic_DNA.
DR   EMBL; AM110002; CAJ33609.1; -; Genomic_DNA.
DR   EMBL; AM110003; CAJ33610.1; -; Genomic_DNA.
DR   EMBL; AB485773; BAH23562.1; -; Genomic_DNA.
DR   EMBL; Z50730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ242985; CAB45249.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ251985; CAC19086.1; -; Genomic_DNA.
DR   EMBL; AY050186; AAL23547.1; -; Genomic_DNA.
DR   EMBL; AY054375; AAL15169.1; -; mRNA.
DR   EMBL; AF400066; AAK85431.1; -; Genomic_DNA.
DR   EMBL; AY267905; AAP32696.1; -; Genomic_DNA.
DR   EMBL; AY267906; AAP32697.1; -; Genomic_DNA.
DR   EMBL; AJ969417; CAI94542.1; -; Genomic_DNA.
DR   EMBL; AY912075; AAY17288.1; -; Genomic_DNA.
DR   EMBL; DQ333353; ABC59115.1; -; Genomic_DNA.
DR   EMBL; AM259285; CAJ90660.1; -; Genomic_DNA.
DR   EMBL; EF199810; ABM90423.1; -; Genomic_DNA.
DR   EMBL; AM774161; CAO81738.1; -; Genomic_DNA.
DR   EMBL; EF495154; ABP38039.1; -; Genomic_DNA.
DR   EMBL; AM922324; CAP58300.1; -; Genomic_DNA.
DR   EMBL; DQ494324; ABF50050.1; -; Genomic_DNA.
DR   EMBL; EU588391; ACB97664.1; -; Genomic_DNA.
DR   EMBL; D86502; BAA13097.1; -; Genomic_DNA.
DR   EMBL; D86504; BAA13099.1; -; Genomic_DNA.
DR   EMBL; D88310; BAA13587.1; -; Genomic_DNA.
DR   EMBL; AJ010982; CAA09450.1; -; Genomic_DNA.
DR   EMBL; AF172071; AAD51970.1; -; Genomic_DNA.
DR   EMBL; AJ543433; CAD65908.1; -; Genomic_DNA.
DR   EMBL; AY277390; AAP34694.1; -; Genomic_DNA.
DR   EMBL; AJ581744; CAE46451.1; -; Genomic_DNA.
DR   EMBL; AJ812566; CAH23708.1; -; Genomic_DNA.
DR   EMBL; AY770520; AAV37191.1; -; Genomic_DNA.
DR   EMBL; DQ021915; AAY85747.1; -; Genomic_DNA.
DR   EMBL; AM084908; CAJ29895.1; -; Genomic_DNA.
DR   EMBL; DQ327711; ABC59293.1; -; Genomic_DNA.
DR   EMBL; DQ358688; ABC84557.1; -; Genomic_DNA.
DR   EMBL; AM233907; CAJ80873.1; -; Genomic_DNA.
DR   EMBL; DQ643390; ABG25965.1; -; Genomic_DNA.
DR   EMBL; U95115; AAB58397.2; -; Genomic_DNA.
DR   EMBL; AM933133; CAP69806.1; -; Genomic_DNA.
DR   EMBL; EU545181; ACB30275.1; -; Genomic_DNA.
DR   EMBL; AB049830; BAB16682.1; -; Genomic_DNA.
DR   EMBL; AB049831; BAB16683.1; -; Genomic_DNA.
DR   EMBL; AB049832; BAB16684.1; -; Genomic_DNA.
DR   EMBL; AB087875; BAC02938.1; -; Genomic_DNA.
DR   EMBL; AB087876; BAC02939.1; -; Genomic_DNA.
DR   EMBL; AB436778; BAG32234.1; -; Genomic_DNA.
DR   EMBL; EF078986; ABK56696.1; -; Genomic_DNA.
DR   EMBL; EF536016; ABQ08747.1; -; Genomic_DNA.
DR   EMBL; EU029787; ABU86846.1; -; Genomic_DNA.
DR   EMBL; EU029788; ABU86847.1; -; Genomic_DNA.
DR   EMBL; EU029792; ABU86851.1; -; Genomic_DNA.
DR   EMBL; EU029793; ABU86852.1; -; Genomic_DNA.
DR   EMBL; EU029798; ABU86857.1; -; Genomic_DNA.
DR   EMBL; EU643616; ACD01094.1; -; Genomic_DNA.
DR   EMBL; EU812536; ACE88696.1; -; Genomic_DNA.
DR   EMBL; EU924810; ACH57405.1; -; Genomic_DNA.
DR   EMBL; DQ060439; AAY59541.1; -; Genomic_DNA.
DR   EMBL; DQ060441; AAY59543.1; -; Genomic_DNA.
DR   EMBL; DQ782331; ABG91054.1; -; Genomic_DNA.
DR   EMBL; FM179681; CAQ77159.1; -; Genomic_DNA.
DR   EMBL; FJ594768; ACM47962.1; -; Genomic_DNA.
DR   EMBL; AF177215; AAD53910.1; -; Genomic_DNA.
DR   EMBL; X99839; CAA68150.1; -; Genomic_DNA.
DR   EMBL; AJ289123; CAC19015.1; -; Genomic_DNA.
DR   EMBL; AY174092; AAO20089.1; -; Genomic_DNA.
DR   EMBL; AY174181; AAO17053.1; -; Genomic_DNA.
DR   EMBL; M77673; AAA73131.1; -; Genomic_DNA.
DR   EMBL; AF028010; AAB94612.1; -; Genomic_DNA.
DR   EMBL; AF112879; AAD29584.1; -; Genomic_DNA.
DR   EMBL; X86974; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U41489; AAA86242.1; -; Genomic_DNA.
DR   EMBL; AJ508388; CAD48196.1; -; Genomic_DNA.
DR   IPI; IPI00956007; -.
DR   PIR; B33287; B33287.
DR   PIR; C33287; C33287.
DR   PIR; C60748; C60748.
DR   PIR; F60748; F60748.
DR   PIR; PH0157; PH0157.
DR   PIR; PH0158; PH0158.
DR   PIR; S03440; S03440.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   UniGene; Hs.716081; -.
DR   UniGene; Hs.723344; -.
DR   HSSP; Q9MY13; 1D5M.
DR   ProteinModelPortal; Q9GIY3; -.
DR   SMR; Q9GIY3; 34-220.
DR   IntAct; Q9GIY3; 1.
DR   STRING; Q9GIY3; -.
DR   DMDM; 74761361; -.
DR   Ensembl; ENST00000328980; ENSP00000331343; ENSG00000206306.
DR   Ensembl; ENST00000360004; ENSP00000353099; ENSG00000196126.
DR   Ensembl; ENST00000383125; ENSP00000372606; ENSG00000206240.
DR   Ensembl; ENST00000399437; ENSP00000382366; ENSG00000206240.
DR   Ensembl; ENST00000399450; ENSP00000382378; ENSG00000206240.
DR   Ensembl; ENST00000399692; ENSP00000382599; ENSG00000206306.
DR   Ensembl; ENST00000412634; ENSP00000408795; ENSG00000228080.
DR   Ensembl; ENST00000415796; ENSP00000412168; ENSG00000206306.
DR   Ensembl; ENST00000419393; ENSP00000403458; ENSG00000228080.
DR   Ensembl; ENST00000428566; ENSP00000392280; ENSG00000206240.
DR   Ensembl; ENST00000446898; ENSP00000397982; ENSG00000228080.
DR   Ensembl; ENST00000450362; ENSP00000410118; ENSG00000228080.
DR   GeneCards; GC06M032546; -.
DR   GeneCards; GC06Mn32480; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   HPA; CAB015400; -.
DR   HPA; CAB034021; -.
DR   MIM; 142857; gene.
DR   neXtProt; NX_Q9GIY3; -.
DR   HOVERGEN; HBG012730; -.
DR   Reactome; REACT_6900; Immune System.
DR   ArrayExpress; Q3LA90; -.
DR   Bgee; Q9GIY3; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29       Potential.
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-14 beta chain.
FT                                /FTId=PRO_5000066676.
FT   TRANSMEM    228    248       Helical; (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT      39     39       Y -> L (in allele DRB1*14:46; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_062907.
FT   VARIANT      39     39       Y -> Q (in allele DRB1*14:10 and allele
FT                                DRB1*14:57; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062906.
FT   VARIANT      40     40       S -> P (in allele DRB1*14:39).
FT                                /FTId=VAR_062910.
FT   VARIANT      40     40       S -> R (in allele DRB1*14:46).
FT                                /FTId=VAR_062908.
FT   VARIANT      40     40       S -> V (in allele DRB1*14:10 and allele
FT                                DRB1*14:57; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062909.
FT   VARIANT      41     41       T -> K (in allele DRB1*14:10, allele
FT                                DRB1*14:46 and allele DRB1*14:57).
FT                                /FTId=VAR_062911.
FT   VARIANT      42     42       S -> G (in allele DRB1*14:04, allele
FT                                DRB1*14:11, allele DRB1*14:15, allele
FT                                DRB1*14:28, allele DRB1*14:31, allele
FT                                DRB1*14:50, allele DRB1*14:52, allele
FT                                DRB1*14:61, allele DRB1*14:68, allele
FT                                DRB1*14:71, allele DRB1*14:73, allele
FT                                DRB1*14:76 and allele DRB1*14:79).
FT                                /FTId=VAR_062913.
FT   VARIANT      42     42       S -> H (in allele DRB1*14:10 and allele
FT                                DRB1*14:57; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062912.
FT   VARIANT      45     45       H -> Q (in allele DRB1*14:05, allele
FT                                DRB1*14:37, allele DRB1*14:43, allele
FT                                DRB1*14:44, allele DRB1*14:45, allele
FT                                DRB1*14:56 and allele DRB1*14:84).
FT                                /FTId=VAR_062915.
FT   VARIANT      45     45       H -> Y (in allele DRB1*14:04, allele
FT                                DRB1*14:11, allele DRB1*14:15, allele
FT                                DRB1*14:28, allele DRB1*14:31, allele
FT                                DRB1*14:50, allele DRB1*14:52, allele
FT                                DRB1*14:68, allele DRB1*14:71, allele
FT                                DRB1*14:73, allele DRB1*14:76 and allele
FT                                DRB1*14:79).
FT                                /FTId=VAR_062914.
FT   VARIANT      54     54       R -> Q (in allele DRB1*14:26).
FT                                /FTId=VAR_062916.
FT   VARIANT      55     55       F -> Y (in allele DRB1*14:82).
FT                                /FTId=VAR_062917.
FT   VARIANT      56     56       L -> M (in allele DRB1*14:83).
FT                                /FTId=VAR_062918.
FT   VARIANT      57     57       D -> E (in allele DRB1*14:02, allele
FT                                DRB1*14:03, allele DRB1*14:06, allele
FT                                DRB1*14:12, allele DRB1*14:13, allele
FT                                DRB1*14:18, allele DRB1*14:19, allele
FT                                DRB1*14:20, allele DRB1*14:24, allele
FT                                DRB1*14:27, allele DRB1*14:29, allele
FT                                DRB1*14:40, allele DRB1*14:41, allele
FT                                DRB1*14:46, allele DRB1*14:47, allele
FT                                DRB1*14:48, allele DRB1*14:49, allele
FT                                DRB1*14:51, allele DRB1*14:52, allele
FT                                DRB1*14:63, allele DRB1*14:67, allele
FT                                DRB1*14:77, allele DRB1*14:78, allele
FT                                DRB1*14:81, allele DRB1*14:83 and allele
FT                                DRB1*14:85).
FT                                /FTId=VAR_062919.
FT   VARIANT      59     59       Y -> H (in allele DRB1*14:70).
FT                                /FTId=VAR_062920.
FT   VARIANT      61     61       H -> Y (in allele DRB1*14:25, allele
FT                                DRB1*14:42, allele DRB1*14:53, allele
FT                                DRB1*14:58 and allele DRB1*14:69).
FT                                /FTId=VAR_062921.
FT   VARIANT      66     66       F -> N (in allele DRB1*14:02, allele
FT                                DRB1*14:03, allele DRB1*14:06, allele
FT                                DRB1*14:09, allele DRB1*14:12, allele
FT                                DRB1*14:13, allele DRB1*14:17, allele
FT                                DRB1*14:18, allele DRB1*14:19, allele
FT                                DRB1*14:21, allele DRB1*14:24, allele
FT                                DRB1*14:27, allele DRB1*14:29, allele
FT                                DRB1*14:30, allele DRB1*14:33, allele
FT                                DRB1*14:46, allele DRB1*14:47, allele
FT                                DRB1*14:48, allele DRB1*14:51, allele
FT                                DRB1*14:52, allele DRB1*14:59, allele
FT                                DRB1*14:63, allele DRB1*14:64, allele
FT                                DRB1*14:67, allele DRB1*14:78, allele
FT                                DRB1*14:80, allele DRB1*14:81, allele
FT                                DRB1*14:83 and allele DRB1*14:85;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_062923.
FT   VARIANT      66     66       F -> Y (in allele DRB1*14:25, allele
FT                                DRB1*14:42, allele DRB1*14:53, allele
FT                                DRB1*14:58 and allele DRB1*14:69).
FT                                /FTId=VAR_062922.
FT   VARIANT      67     67       V -> L (in allele DRB1*14:41 and allele
FT                                DRB1*14:77).
FT                                /FTId=VAR_062924.
FT   VARIANT      74     74       G -> R (in allele DRB1*14:36 and allele
FT                                DRB1*14:60).
FT                                /FTId=VAR_062925.
FT   VARIANT      76     76       Y -> F (in allele DRB1*14:17, allele
FT                                DRB1*14:21, allele DRB1*14:30, allele
FT                                DRB1*14:33, allele DRB1*14:35, allele
FT                                DRB1*14:42, allele DRB1*14:53, allele
FT                                DRB1*14:64, allele DRB1*14:65 and allele
FT                                DRB1*14:72).
FT                                /FTId=VAR_062926.
FT   VARIANT      80     80       T -> R (in allele DRB1*14:59).
FT                                /FTId=VAR_062927.
FT   VARIANT      86     86       A -> D (in allele DRB1*14:02, allele
FT                                DRB1*14:03, allele DRB1*14:05, allele
FT                                DRB1*14:06, allele DRB1*14:08, allele
FT                                DRB1*14:09, allele DRB1*14:11, allele
FT                                DRB1*14:12, allele DRB1*14:14, allele
FT                                DRB1*14:15, allele DRB1*14:17, allele
FT                                DRB1*14:18, allele DRB1*14:19, allele
FT                                DRB1*14:20, allele DRB1*14:21, allele
FT                                DRB1*14:23, allele DRB1*14:24, allele
FT                                DRB1*14:27, allele DRB1*14:29, allele
FT                                DRB1*14:30, allele DRB1*14:33, allele
FT                                DRB1*14:34, allele DRB1*14:36, allele
FT                                DRB1*14:37, allele DRB1*14:40, allele
FT                                DRB1*14:41, allele DRB1*14:42, allele
FT                                DRB1*14:43, allele DRB1*14:44, allele
FT                                DRB1*14:45, allele DRB1*14:46, allele
FT                                DRB1*14:47, allele DRB1*14:51, allele
FT                                DRB1*14:52, allele DRB1*14:56, allele
FT                                DRB1*14:59, allele DRB1*14:64, allele
FT                                DRB1*14:67, allele DRB1*14:72, allele
FT                                DRB1*14:77, allele DRB1*14:80, allele
FT                                DRB1*14:81, allele DRB1*14:83 and allele
FT                                DRB1*14:84).
FT                                /FTId=VAR_062928.
FT   VARIANT      86     86       A -> S (in allele DRB1*14:13, allele
FT                                DRB1*14:63, allele DRB1*14:65, allele
FT                                DRB1*14:78 and allele DRB1*14:85).
FT                                /FTId=VAR_062929.
FT   VARIANT      86     86       A -> T (in allele DRB1*14:62).
FT                                /FTId=VAR_062930.
FT   VARIANT      86     86       A -> V (in allele DRB1*14:48).
FT                                /FTId=VAR_062931.
FT   VARIANT      87     87       A -> E (in allele DRB1*14:11).
FT                                /FTId=VAR_062932.
FT   VARIANT      89     89       H -> S (in allele DRB1*14:48 and allele
FT                                DRB1*14:64; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062934.
FT   VARIANT      89     89       H -> Y (in allele DRB1*14:02, allele
FT                                DRB1*14:03, allele DRB1*14:05, allele
FT                                DRB1*14:06, allele DRB1*14:09, allele
FT                                DRB1*14:11, allele DRB1*14:12, allele
FT                                DRB1*14:13, allele DRB1*14:14, allele
FT                                DRB1*14:15, allele DRB1*14:17, allele
FT                                DRB1*14:18, allele DRB1*14:19, allele
FT                                DRB1*14:20, allele DRB1*14:21, allele
FT                                DRB1*14:23, allele DRB1*14:24, allele
FT                                DRB1*14:27, allele DRB1*14:29, allele
FT                                DRB1*14:30, allele DRB1*14:33, allele
FT                                DRB1*14:36, allele DRB1*14:37, allele
FT                                DRB1*14:40, allele DRB1*14:41, allele
FT                                DRB1*14:42, allele DRB1*14:43, allele
FT                                DRB1*14:44, allele DRB1*14:45, allele
FT                                DRB1*14:46, allele DRB1*14:47, allele
FT                                DRB1*14:51, allele DRB1*14:52, allele
FT                                DRB1*14:56, allele DRB1*14:57, allele
FT                                DRB1*14:59, allele DRB1*14:63, allele
FT                                DRB1*14:65, allele DRB1*14:67, allele
FT                                DRB1*14:76, allele DRB1*14:77, allele
FT                                DRB1*14:78, allele DRB1*14:80, allele
FT                                DRB1*14:81, allele DRB1*14:83, allele
FT                                DRB1*14:84 and allele DRB1*14:85).
FT                                /FTId=VAR_062933.
FT   VARIANT      96     96       L -> F (in allele DRB1*14:15, allele
FT                                DRB1*14:22, allele DRB1*14:25, allele
FT                                DRB1*14:27, allele DRB1*14:53 and allele
FT                                DRB1*14:73).
FT                                /FTId=VAR_062935.
FT   VARIANT      96     96       L -> I (in allele DRB1*14:16, allele
FT                                DRB1*14:24, allele DRB1*14:37, allele
FT                                DRB1*14:45, allele DRB1*14:57, allele
FT                                DRB1*14:63, allele DRB1*14:67 and allele
FT                                DRB1*14:78).
FT                                /FTId=VAR_062936.
FT   VARIANT      99     99       R -> D (in allele DRB1*14:03, allele
FT                                DRB1*14:12, allele DRB1*14:15, allele
FT                                DRB1*14:16, allele DRB1*14:22, allele
FT                                DRB1*14:25, allele DRB1*14:27, allele
FT                                DRB1*14:40, allele DRB1*14:53, allele
FT                                DRB1*14:57, allele DRB1*14:63, allele
FT                                DRB1*14:67, allele DRB1*14:69, allele
FT                                DRB1*14:73, allele DRB1*14:74, allele
FT                                DRB1*14:77, allele DRB1*14:78, allele
FT                                DRB1*14:84 and allele DRB1*14:85;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_062938.
FT   VARIANT      99     99       R -> Q (in allele DRB1*14:02, allele
FT                                DRB1*14:06, allele DRB1*14:09, allele
FT                                DRB1*14:13, allele DRB1*14:17, allele
FT                                DRB1*14:19, allele DRB1*14:20, allele
FT                                DRB1*14:21, allele DRB1*14:24, allele
FT                                DRB1*14:29, allele DRB1*14:30, allele
FT                                DRB1*14:33, allele DRB1*14:37, allele
FT                                DRB1*14:41, allele DRB1*14:46, allele
FT                                DRB1*14:47, allele DRB1*14:48, allele
FT                                DRB1*14:49, allele DRB1*14:51, allele
FT                                DRB1*14:52, allele DRB1*14:76, allele
FT                                DRB1*14:79, allele DRB1*14:80 and allele
FT                                DRB1*14:83).
FT                                /FTId=VAR_062937.
FT   VARIANT     100    100       R -> A (in allele DRB1*14:24 and allele
FT                                DRB1*14:37; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062941.
FT   VARIANT     100    100       R -> E (in allele DRB1*14:16 and allele
FT                                DRB1*14:57; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062940.
FT   VARIANT     100    100       R -> K (in allele DRB1*14:19, allele
FT                                DRB1*14:21, allele DRB1*14:76 and allele
FT                                DRB1*14:79).
FT                                /FTId=VAR_062939.
FT   VARIANT     102    102       A -> G (in allele DRB1*14:76 and allele
FT                                DRB1*14:79).
FT                                /FTId=VAR_062943.
FT   VARIANT     102    102       A -> S (in allele DRB1*14:56).
FT                                /FTId=VAR_062942.
FT   VARIANT     103    103       E -> A (in allele DRB1*14:02, allele
FT                                DRB1*14:06, allele DRB1*14:09, allele
FT                                DRB1*14:13, allele DRB1*14:16, allele
FT                                DRB1*14:17, allele DRB1*14:19, allele
FT                                DRB1*14:20, allele DRB1*14:21, allele
FT                                DRB1*14:22, allele DRB1*14:24, allele
FT                                DRB1*14:25, allele DRB1*14:29, allele
FT                                DRB1*14:30, allele DRB1*14:31, allele
FT                                DRB1*14:32, allele DRB1*14:34, allele
FT                                DRB1*14:37, allele DRB1*14:41, allele
FT                                DRB1*14:46, allele DRB1*14:47, allele
FT                                DRB1*14:48, allele DRB1*14:49, allele
FT                                DRB1*14:52, allele DRB1*14:53, allele
FT                                DRB1*14:57, allele DRB1*14:65, allele
FT                                DRB1*14:69, allele DRB1*14:74, allele
FT                                DRB1*14:80, allele DRB1*14:81 and allele
FT                                DRB1*14:83).
FT                                /FTId=VAR_062944.
FT   VARIANT     103    103       E -> L (in allele DRB1*14:03, allele
FT                                DRB1*14:12, allele DRB1*14:15, allele
FT                                DRB1*14:27, allele DRB1*14:40, allele
FT                                DRB1*14:55, allele DRB1*14:63, allele
FT                                DRB1*14:67, allele DRB1*14:77, allele
FT                                DRB1*14:78, allele DRB1*14:84 and allele
FT                                DRB1*14:85; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062945.
FT   VARIANT     103    103       E -> R (in allele DRB1*14:76 and allele
FT                                DRB1*14:79; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_062946.
FT   VARIANT     106    106       T -> A (in allele DRB1*14:43).
FT                                /FTId=VAR_062948.
FT   VARIANT     106    106       T -> N (in allele DRB1*14:38, allele
FT                                DRB1*14:47, allele DRB1*14:50, allele
FT                                DRB1*14:76 and allele DRB1*14:79).
FT                                /FTId=VAR_062947.
FT   VARIANT     110    110       H -> Y (in allele DRB1*14:75).
FT                                /FTId=VAR_062949.
FT   VARIANT     114    114       V -> A (in allele DRB1*14:28 and allele
FT                                DRB1*14:29).
FT                                /FTId=VAR_062950.
FT   VARIANT     115    115       V -> G (in allele DRB1*14:02, allele
FT                                DRB1*14:03, allele DRB1*14:07, allele
FT                                DRB1*14:09, allele DRB1*14:13, allele
FT                                DRB1*14:14, allele DRB1*14:19, allele
FT                                DRB1*14:22, allele DRB1*14:24, allele
FT                                DRB1*14:25, allele DRB1*14:27, allele
FT                                DRB1*14:30, allele DRB1*14:36, allele
FT                                DRB1*14:40, allele DRB1*14:41, allele
FT                                DRB1*14:42, allele DRB1*14:44, allele
FT                                DRB1*14:46, allele DRB1*14:47, allele
FT                                DRB1*14:48, allele DRB1*14:49, allele
FT                                DRB1*14:51, allele DRB1*14:53, allele
FT                                DRB1*14:63, allele DRB1*14:67, allele
FT                                DRB1*14:68, allele DRB1*14:69, allele
FT                                DRB1*14:77 and allele DRB1*14:85).
FT                                /FTId=VAR_062951.
FT   VARIANT     115    115       V -> M (in allele DRB1*14:71).
FT                                /FTId=VAR_062952.
FT   VARIANT     141    141       Y -> H (in allele DRB1*14:02, allele
FT                                DRB1*14:03, allele DRB1*14:04, allele
FT                                DRB1*14:05, allele DRB1*14:06, allele
FT                                DRB1*14:07, allele DRB1*14:10, allele
FT                                DRB1*14:11, allele DRB1*14:13, allele
FT                                DRB1*14:14, allele DRB1*14:21, allele
FT                                DRB1*14:46, allele DRB1*14:54, allele
FT                                DRB1*14:57 and allele DRB1*14:82).
FT                                /FTId=VAR_062953.
FT   CONFLICT    124    124       V -> G (in Ref. 10; BAH23562).
SQ   SEQUENCE   266 AA;  30139 MW;  FA4BE90DFAB4FA55 CRC64;
     MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEYS TSECHFFNGT ERVRFLDRYF
     HNQEEFVRFD SDVGEYRAVT ELGRPAAEHW NSQKDLLERR RAEVDTYCRH NYGVVESFTV
     QRRVHPKVTV YPSKTQPLQH YNLLVCSVSG FYPGSIEVRW FRNGQEEKTG VVSTGLIHNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PRGFLS
//
ID   2B1F_HUMAN              Reviewed;         266 AA.
AC   P01911; Q29790; Q29975; Q30142; Q30166; Q32MY7; Q56FN9; Q5Y7B0;
AC   Q5Y7B9;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-15 beta chain;
DE   AltName: Full=DW2.2/DR2.2;
DE   AltName: Full=MHC class II antigen DRB1*15;
DE   Flags: Precursor;
GN   Name=HLA-DRB1; Synonyms=HLA-DRB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*15:01).
RC   TISSUE=B-cell;
RX   MEDLINE=88226788; PubMed=3259543; DOI=10.1007/BF00364432;
RA   Lock C.B., So A.K., Welsh K.I., Parkes J.D., Trowsdale J.;
RT   "MHC class II sequences of an HLA-DR2 narcoleptic.";
RL   Immunogenetics 27:449-455(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DRB1*15:01; DRB1*15:02 AND
RP   DRB1*15:03).
RX   PubMed=16140993; DOI=10.1101/gr.3554305;
RA   Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S.,
RA   Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V.;
RT   "Ancient haplotypes of the HLA Class II region.";
RL   Genome Res. 15:1250-1257(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DRB1*15:03 AND DRB1*15:04).
RC   TISSUE=Blood;
RX   PubMed=17174751; DOI=10.1016/j.humimm.2006.09.002;
RA   Balas A., Vilches C., Rodriguez M.A., Fernandez B., Martinez M.P.,
RA   de Pablo R., Garcia-Sanchez F., Vicario J.L.;
RT   "Group-specific amplification of cDNA from DRB1 genes. Complete coding
RT   sequences of partially defined alleles and identification of the new
RT   alleles DRB1*040602, DRB1*111102, DRB1*080103, and DRB1*0113.";
RL   Hum. Immunol. 67:1008-1016(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE DRB1*15:01).
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELES DRB1*15:01 AND
RP   DRB1*15:02).
RC   TISSUE=Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-266 (ALLELE DRB1*15:02).
RC   TISSUE=Lymphoblast;
RX   MEDLINE=87196420; PubMed=3571980;
RA   Wu S.K., Yabe T., Madden M., Saunders T.L., Bach F.H.;
RT   "cDNA cloning and sequencing reveals that the electrophoretically
RT   constant DR beta 2 molecules, as well as the variable DR beta 1
RT   molecules, from HLA-DR2 subtypes have different amino acid sequences
RT   including a hypervariable region for a functionally important
RT   epitope.";
RL   J. Immunol. 138:2953-2959(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*15:01).
RC   TISSUE=Lymphoblast;
RX   MEDLINE=87260854; PubMed=2885840; DOI=10.1073/pnas.84.13.4591;
RA   Lee B.S.M., Rust N.A., McMichael A.J., McDevitt H.O.;
RT   "HLA-DR2 subtypes form an additional supertypic family of DR beta
RT   alleles.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4591-4595(1987).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*15:01).
RC   TISSUE=Lymphoblast;
RX   MEDLINE=87317627; PubMed=3476943; DOI=10.1073/pnas.84.17.6234;
RA   Bell J.I., Denney D. Jr., Foster L., Belt T.K., Todd J.A.,
RA   McDevitt H.O.;
RT   "Allelic variation in the DR subregion of the human major
RT   histocompatibility complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6234-6238(1987).
RN   [9]
RP   PROTEIN SEQUENCE OF 30-228.
RC   TISSUE=Lymphoblast;
RX   MEDLINE=82096757; PubMed=6947956;
RA   Kratzin H., Yang C.-Y., Gotz H., Pauly E., Kolbel S., Egert G.,
RA   Thinnes F.P., Wernet P., Altevogt P., Hilschmann N.;
RT   "Primary structure of class II human histocompatibility antigens. 1st
RT   communication. Amino acid sequence of the N-terminal 198 residues of
RT   the beta chain of a HLA-Dw2,2;DR2,2-alloantigen.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 362:1665-1669(1981).
RN   [10]
RP   PROTEIN SEQUENCE OF 30-64.
RC   TISSUE=B-cell;
RX   MEDLINE=83153579; PubMed=6600932; DOI=10.1021/bi00270a027;
RA   Walker L.E., Hewick R., Hunkapiller M.W., Hood L.E., Dreyer W.J.,
RA   Reisfeld R.A.;
RT   "N-terminal amino acid sequences of the alpha and beta chains of HLA-
RT   DR1 and HLA-DR2 antigens.";
RL   Biochemistry 22:185-188(1983).
RN   [11]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [12]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [13]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [14]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [15]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [16]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [17]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 30-227.
RX   PubMed=15821740; DOI=10.1038/ni1187;
RA   Hahn M., Nicholson M.J., Pyrdol J., Wucherpfennig K.W.;
RT   "Unconventional topology of self peptide-major histocompatibility
RT   complex binding by a human autoimmune T cell receptor.";
RL   Nat. Immunol. 6:490-496(2005).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route, where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules, and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments, exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides, autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs, other cells of the gastrointestinal tract, such
CC       as epithelial cells, express MHC class II molecules and CD74 and
CC       act as APCs, which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen, three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells, the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules, increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-15 are known:
CC       DRB1*15:01, DRB1*15:02, DRB1*15:03, DRB1*15:04, DRB1*15:05,
CC       DRB1*15:06, DRB1*15:07, DRB1*15:08, DRB1*15:09, DRB1*15:10,
CC       DRB1*15:11, DRB1*15:12, DRB1*15:13, DRB1*15:14, DRB1*15:15,
CC       DRB1*15:16, DRB1*15:18, DRB1*15:19, DRB1*15:20, DRB1*15:21,
CC       DRB1*15:22, DRB1*15:23, DRB1*15:24, DRB1*15:25, DRB1*15:26,
CC       DRB1*15:27, DRB1*15:28, DRB1*15:29, DRB1*15:30, DRB1*15:31 and
CC       DRB1*15:32. The sequence shown is that of DRB1*15:01.
CC   -!- MISCELLANEOUS: The chain shown constituted about 70% of a pool of
CC       at least seven similar beta chains.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M20430; AAA59831.1; -; mRNA.
DR   EMBL; AY663395; AAU87979.1; -; Genomic_DNA.
DR   EMBL; AY663406; AAU88008.1; -; Genomic_DNA.
DR   EMBL; AY663411; AAU88023.1; -; Genomic_DNA.
DR   EMBL; AY663414; AAU88033.1; -; Genomic_DNA.
DR   EMBL; AY961072; AAX63460.1; -; mRNA.
DR   EMBL; AY961073; AAX63461.1; -; mRNA.
DR   EMBL; AL713966; CAI18081.1; -; Genomic_DNA.
DR   EMBL; BC033827; AAH33827.1; -; mRNA.
DR   EMBL; BC108922; AAI08923.1; -; mRNA.
DR   EMBL; M28584; AAA59681.1; -; mRNA.
DR   EMBL; M16957; AAA36279.1; -; mRNA.
DR   EMBL; M17378; AAA59801.1; -; mRNA.
DR   IPI; IPI00472169; -.
DR   PIR; I68734; HLHUWB.
DR   RefSeq; NP_002115.2; NM_002124.3.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   PDB; 1BX2; X-ray; 2.60 A; B/E=32-222.
DR   PDB; 1YMM; X-ray; 3.50 A; B=30-227.
DR   PDB; 2WBJ; X-ray; 3.00 A; B/F=30-227.
DR   PDBsum; 1BX2; -.
DR   PDBsum; 1YMM; -.
DR   PDBsum; 2WBJ; -.
DR   ProteinModelPortal; P01911; -.
DR   SMR; P01911; 32-222.
DR   IntAct; P01911; 1.
DR   STRING; P01911; -.
DR   PRIDE; P01911; -.
DR   DNASU; 3123; -.
DR   Ensembl; ENST00000360004; ENSP00000353099; ENSG00000196126.
DR   GeneID; 3123; -.
DR   KEGG; hsa:3123; -.
DR   UCSC; uc003obp.4; human.
DR   CTD; 3123; -.
DR   GeneCards; GC06M032546; -.
DR   H-InvDB; HIX0018378; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   HPA; CAB015400; -.
DR   HPA; CAB034021; -.
DR   MIM; 142857; gene.
DR   neXtProt; NX_P01911; -.
DR   PharmGKB; PA35072; -.
DR   GeneTree; ENSGT00560000076676; -.
DR   HOVERGEN; HBG012730; -.
DR   InParanoid; P01911; -.
DR   KO; K06752; -.
DR   OMA; DAENWNS; -.
DR   PhylomeDB; P01911; -.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P01911; -.
DR   NextBio; 12394; -.
DR   Bgee; P01911; -.
DR   CleanEx; HS_HLA-DRB1; -.
DR   Genevestigator; P01911; -.
DR   GermOnline; ENSG00000196126; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum;
KW   Endosome; Glycoprotein; Golgi apparatus; Immunity; Isopeptide bond;
KW   Lysosome; Membrane; MHC II; Polymorphism; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     29
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-15 beta chain.
FT                                /FTId=PRO_0000080744.
FT   TOPO_DOM     30    227       Extracellular (Potential).
FT   TRANSMEM    228    248       Helical; (Potential).
FT   TOPO_DOM    249    266       Cytoplasmic (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   REGION       30    124       Beta-1.
FT   REGION      125    227       Beta-2.
FT   CARBOHYD     48     48       N-linked (GlcNAc...).
FT   DISULFID     44    108
FT   DISULFID    146    202
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT       5      5       K -> R (in dbSNP:rs9270305).
FT                                /FTId=VAR_050364.
FT   VARIANT      55     55       F -> Y (in dbSNP:rs16822516).
FT                                /FTId=VAR_050365.
FT   VARIANT      59     59       Y -> H (in allele DRB1*15:03).
FT                                /FTId=VAR_038162.
FT   VARIANT      96     96       I -> F (in allele DRB1*15:04).
FT                                /FTId=VAR_038163.
FT   VARIANT     106    106       T -> N (in dbSNP:rs9269941).
FT                                /FTId=VAR_050366.
FT   VARIANT     115    115       V -> G (in allele DRB1*15:02).
FT                                /FTId=VAR_038164.
FT   VARIANT     164    164       G -> S (in dbSNP:rs1059633).
FT                                /FTId=VAR_050367.
FT   VARIANT     169    169       A -> T (in dbSNP:rs2308768).
FT                                /FTId=VAR_050368.
FT   VARIANT     236    236       V -> M (in dbSNP:rs2230816).
FT                                /FTId=VAR_050369.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_050370.
FT   CONFLICT    119    119       T -> A (in Ref. 5; AAI08923).
FT   CONFLICT    154    154       G -> A (in Ref. 8; AAA59801).
FT   CONFLICT    171    171       M -> G (in Ref. 9; AA sequence).
FT   CONFLICT    179    180       NG -> D (in Ref. 9; AA sequence).
FT   STRAND       36     38
FT   STRAND       41     47
FT   HELIX        49     51
FT   STRAND       52     54
FT   STRAND       56     61
FT   STRAND       64     70
FT   TURN         71     74
FT   STRAND       77     80
FT   HELIX        81     83
FT   HELIX        84     92
FT   HELIX        95    106
FT   HELIX       108    115
FT   HELIX       116    118
FT   TURN        119    121
FT   STRAND      127    132
FT   STRAND      144    154
FT   STRAND      157    162
FT   STRAND      165    167
FT   STRAND      169    172
FT   STRAND      180    182
FT   STRAND      184    190
FT   STRAND      200    205
FT   STRAND      209    211
FT   STRAND      213    217
SQ   SEQUENCE   266 AA;  29966 MW;  3B5912820A4654BE CRC64;
     MVCLKLPGGS CMTALTVTLM VLSSPLALSG DTRPRFLWQP KRECHFFNGT ERVRFLDRYF
     YNQEESVRFD SDVGEFRAVT ELGRPDAEYW NSQKDILEQA RAAVDTYCRH NYGVVESFTV
     QRRVQPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FLNGQEEKAG MVSTGLIQNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
ID   2B1G_HUMAN              Reviewed;         266 AA.
AC   Q29974; A7X5J4; O98212; Q0PGR5; Q29792; Q30120; Q30159; Q30200;
AC   Q3HUP9; Q3KTM1; Q3LA84; Q6T865; Q95383;
DT   02-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 94.
DE   RecName: Full=HLA class II histocompatibility antigen, DRB1-16 beta chain;
DE   AltName: Full=MHC class II antigen DRB1*16;
DE            Short=DR-16;
DE            Short=DR16;
DE   Flags: Precursor;
GN   Name=HLA-DRB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*16:01).
RX   MEDLINE=87196420; PubMed=3571980;
RA   Wu S.K., Yabe T., Madden M., Saunders T.L., Bach F.H.;
RT   "cDNA cloning and sequencing reveals that the electrophoretically
RT   constant DR beta 2 molecules, as well as the variable DR beta 1
RT   molecules, from HLA-DR2 subtypes have different amino acid sequences
RT   including a hypervariable region for a functionally important
RT   epitope.";
RL   J. Immunol. 138:2953-2959(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*16:02).
RX   MEDLINE=88199016; PubMed=3129499;
RA   Liu C.P., Bach F.H., Wu S.K.;
RT   "Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype.
RT   Multiple genetic mechanisms in the generation of polymorphic HLA class
RT   II genes.";
RL   J. Immunol. 140:3631-3639(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*16:03).
RC   TISSUE=Blood;
RX   MEDLINE=93170899; PubMed=8436426; DOI=10.1007/BF00222476;
RA   Rosenlicht J.W., Hartung K., Deicher H., Frey J.;
RT   "A novel HLA-DRB1-DR2 allele associated with HLA mistyping.";
RL   Immunogenetics 37:479-479(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DRB1*16:01).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*16:01).
RX   MEDLINE=87260854; PubMed=2885840; DOI=10.1073/pnas.84.13.4591;
RA   Lee B.S.M., Rust N.A., McMichael A.J., McDevitt H.O.;
RT   "HLA-DR2 subtypes form an additional supertypic family of DR beta
RT   alleles.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4591-4595(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-216 (ALLELE DRB1*16:04).
RC   TISSUE=Peripheral blood;
RX   PubMed=17767557; DOI=10.1111/j.1399-0039.2007.00918.x;
RA   Horn P.A., Albis-Camps M., Verboom M., Bunce M., Yousaf K.,
RA   Williams S., Blasczyk R.;
RT   "The nature of diversity of HLA-DRB1 exon 3.";
RL   Tissue Antigens 70:335-337(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*16:08).
RX   PubMed=9271639; DOI=10.1007/s002510050303;
RA   Reviron D., Dormoy A., Andre M., Froelich N., Roudier J., Tongio M.M.,
RA   Mercier P.;
RT   "HLA-DRB1*1608: a new HLA-DRB1*16 allele with a short DRB1*03
RT   sequence.";
RL   Immunogenetics 46:444-445(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*16:09).
RX   PubMed=16101839; DOI=10.1111/j.1399-0039.2005.00443.x;
RA   Miao K.R., Pan Q.Q., Xue M., Zhou X.Y., Fei X.M., Tang Y.H., Xu R.,
RA   Zhang J.W., Zhao X., Osowski L., Shi W.X., Xu A.L., Wang C.Y.,
RA   Kukuruga D.;
RT   "A novel HLA allele, DRB1*1609, identified in the Chinese Han
RT   population*.";
RL   Tissue Antigens 66:248-250(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*16:11).
RX   PubMed=19500310; DOI=10.1111/j.1399-0039.2009.01260.x;
RA   Chu C.-C., Lee H.-L., Lin M.;
RT   "A novel HLA-DRB1 allele, DRB*1611, is identified in two Taiwanese
RT   individuals.";
RL   Tissue Antigens 74:175-176(2009).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*16:05).
RA   Gedil M.A., Steiner N.K., Hurley C.K.;
RT   "Novel HLA-DRB1 allele.";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*16:10).
RA   Yan L., Zhu F., He J.;
RT   "Idenfication a novel HLA-DRB1*16 allele by sequence based typing in
RT   Chinese.";
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*16:12).
RA   Lazaro A.M., Xiao Y., Hurley C.K.;
RT   "Novel HLA class II allele.";
RL   Submitted (JUL-2007) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-119 (ALLELE DRB1*16:01).
RC   TISSUE=Blood;
RX   MEDLINE=20017587; PubMed=10551425;
RX   DOI=10.1034/j.1399-0039.1999.540411.x;
RA   Lin Y.S., Tang T.F., Ng J., Hartzman R., Hurley C.K.;
RT   "Two DR2-associated novel alleles arose from the silent mutation of
RT   codon 72: DRB1*16012, DRB5*01012.";
RL   Tissue Antigens 54:405-408(1999).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 39-120 (ALLELE DRB1*16:07).
RA   Brautbar C., Israel S., Safirman C., Smith A.G.;
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [16]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [17]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [18]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [19]
RP   UBIQUITINATION BY MARCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305173; DOI=10.1073/pnas.0708874105;
RA   De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N.,
RA   Pierre P., Gatti E.;
RT   "MHC class II stabilization at the surface of human dendritic cells is
RT   the result of maturation-dependent MARCH I down-regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008).
RN   [20]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [21]
RP   REVIEW.
RX   PubMed=19533806;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route, where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules, and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments, exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides, autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs, other cells of the gastrointestinal tract, such
CC       as epithelial cells, express MHC class II molecules and CD74 and
CC       act as APCs, which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen, three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form an heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells, the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal miroenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules, increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms an heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Late endosome membrane; Single-pass type I
CC       membrane protein. Note=The MHC class II complex transits through a
CC       number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- PTM: Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to
CC       sorting into the endosome system and down-regulation of MHC class
CC       II (Probable).
CC   -!- POLYMORPHISM: The following alleles of DRB1-16 are known:
CC       DRB1*16:01; DRB1*16:02; DRB1*16:03; DRB1*16:04; DRB1*16:05;
CC       DRB1*16:07; DRB1*16:08; DRB1*16:09; DRB1*16:10; DRB1*16:11 and
CC       DRB1*16:12. The sequence shown is that of DRB1*16:02.
CC   -!- SIMILARITY: Belongs to the MHC class II family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28583; AAA59680.1; -; mRNA.
DR   EMBL; M20504; AAA59827.1; -; mRNA.
DR   EMBL; L02545; AAA59777.1; -; mRNA.
DR   EMBL; AK291987; BAF84676.1; -; mRNA.
DR   EMBL; M16959; AAA36281.1; -; mRNA.
DR   EMBL; AM110006; CAJ33613.1; -; Genomic_DNA.
DR   EMBL; Z72424; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY912074; AAY17287.1; -; Genomic_DNA.
DR   EMBL; DQ837166; ABH05946.1; -; Genomic_DNA.
DR   EMBL; AY428805; AAR07616.1; -; Genomic_DNA.
DR   EMBL; DQ192647; ABA39176.1; -; Genomic_DNA.
DR   EMBL; EU029801; ABU86860.1; -; Genomic_DNA.
DR   EMBL; U59686; AAB52230.1; -; Genomic_DNA.
DR   EMBL; U26659; AAD09441.1; -; Genomic_DNA.
DR   IPI; IPI00955414; -.
DR   PIR; B27618; B27618.
DR   PIR; D25239; D25239.
DR   PIR; F27060; F27060.
DR   PIR; I54509; I54509.
DR   RefSeq; NP_002115.2; NM_002124.3.
DR   UniGene; Hs.534322; -.
DR   UniGene; Hs.696211; -.
DR   UniGene; Hs.716081; -.
DR   UniGene; Hs.723344; -.
DR   HSSP; P01903; 1JWU.
DR   ProteinModelPortal; Q29974; -.
DR   SMR; Q29974; 32-222.
DR   STRING; Q29974; -.
DR   DMDM; 74762149; -.
DR   PRIDE; Q29974; -.
DR   DNASU; 3123; -.
DR   Ensembl; ENST00000360004; ENSP00000353099; ENSG00000196126.
DR   GeneID; 3123; -.
DR   KEGG; hsa:3123; -.
DR   CTD; 3123; -.
DR   GeneCards; GC06M032546; -.
DR   HGNC; HGNC:4948; HLA-DRB1.
DR   HPA; CAB015400; -.
DR   HPA; CAB034021; -.
DR   MIM; 142857; gene.
DR   neXtProt; NX_Q29974; -.
DR   HOVERGEN; HBG012730; -.
DR   KO; K06752; -.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 12394; -.
DR   Bgee; Q29974; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:3.10.320.10; MHC_II_alpha_N; 1.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   ProDom; PD000328; MHC_II_b_N; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF54452; MHC_I/II-like_Ag-recog; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Immunity; Isopeptide bond; Lysosome; Membrane; MHC II; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     29       Potential.
FT   CHAIN        30    266       HLA class II histocompatibility antigen,
FT                                DRB1-16 beta chain.
FT                                /FTId=PRO_0000391833.
FT   TRANSMEM    228    248       Helical; (Potential).
FT   DOMAIN      126    214       Ig-like C1-type.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) (Potential).
FT   DISULFID    146    202       By similarity.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin) (By
FT                                similarity).
FT   VARIANT      42     42       R -> K (in allele DRB1*16:12).
FT                                /FTId=VAR_062840.
FT   VARIANT      43     43       E -> K (in allele DRB1*16:11).
FT                                /FTId=VAR_062841.
FT   VARIANT      56     56       L -> P (in allele DRB1*16:07).
FT                                /FTId=VAR_062842.
FT   VARIANT      66     66       S -> N (in allele DRB1*16:08).
FT                                /FTId=VAR_062843.
FT   VARIANT      76     76       Y -> F (in allele DRB1*16:09 and allele
FT                                DRB1*16:10).
FT                                /FTId=VAR_062844.
FT   VARIANT      96     96       F -> I (in allele DRB1*16:05 and allele
FT                                DRB1*16:07).
FT                                /FTId=VAR_062845.
FT   VARIANT      96     96       F -> L (in allele DRB1*16:02, allele
FT                                DRB1*16:10, allele DRB1*16:11 and allele
FT                                DRB1*16:12).
FT                                /FTId=VAR_062846.
FT   VARIANT     101    101       R -> A (in allele DRB1*16:03; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_062847.
FT   VARIANT     103    103       A -> L (in allele DRB1*16:04; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_062848.
FT   VARIANT     262    262       T -> R (in dbSNP:rs9269744).
FT                                /FTId=VAR_062849.
SQ   SEQUENCE   266 AA;  30030 MW;  871CC341692ECA4D CRC64;
     MVCLKLPGGS CMTALTVTLM VLSSPLALAG DTRPRFLWQP KRECHFFNGT ERVRFLDRYF
     YNQEESVRFD SDVGEYRAVT ELGRPDAEYW NSQKDFLEDR RAAVDTYCRH NYGVGESFTV
     QRRVQPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FLNGQEEKAG MVSTGLIQNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
ID   3BHS1_HUMAN             Reviewed;         373 AA.
AC   P14060; A8K691; Q14545; Q8IV65;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   18-APR-2012, entry version 132.
DE   RecName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1;
DE   AltName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I;
DE            Short=3-beta-HSD I;
DE   AltName: Full=Trophoblast antigen FDO161G;
DE   Includes:
DE     RecName: Full=3-beta-hydroxy-Delta(5)-steroid dehydrogenase;
DE              EC=1.1.1.145;
DE     AltName: Full=3-beta-hydroxy-5-ene steroid dehydrogenase;
DE     AltName: Full=Progesterone reductase;
DE   Includes:
DE     RecName: Full=Steroid Delta-isomerase;
DE              EC=5.3.3.1;
DE     AltName: Full=Delta-5-3-ketosteroid isomerase;
GN   Name=HSD3B1; Synonyms=3BH, HSDB3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 2-30.
RX   MEDLINE=89384668; PubMed=2779585;
RA   Luu-The V., Lachance Y., Labrie F., Leblanc G., Thomas J.L.,
RA   Strickler R.C., Labrie C.;
RT   "Full length cDNA structure and deduced amino acid sequence of human 3
RT   beta-hydroxy-5-ene steroid dehydrogenase.";
RL   Mol. Endocrinol. 3:1310-1312(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Placenta;
RX   MEDLINE=90228249; PubMed=2139411;
RA   Lorence M.C., Murry B.A., Trant J.M., Mason J.I.;
RT   "Human 3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase from
RT   placenta: expression in nonsteroidogenic cells of a protein that
RT   catalyzes the dehydrogenation/isomerization of C21 and C19 steroids.";
RL   Endocrinology 126:2493-2498(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=91186993; PubMed=2082186;
RA   Lorence M.C., Corbin C.J., Kamimura N., Mahendroo M.S., Mason J.I.;
RT   "Structural analysis of the gene encoding human 3 beta-hydroxysteroid
RT   dehydrogenase/delta 5-->4-isomerase.";
RL   Mol. Endocrinol. 4:1850-1855(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-367.
RX   MEDLINE=91056097; PubMed=2243100;
RA   Lachance Y., Luu-The V., Labrie C., Simard J., Dumont M.,
RA   Launoit Y.D., Guerin S., Leblanc G., Labrie F.;
RT   "Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta
RT   5-delta 4-isomerase gene and its expression in mammalian cells.";
RL   J. Biol. Chem. 265:20469-20475(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=92015040; PubMed=1920284;
RA   Nickson D.A., McBride M.W., Zeinali S., Hawes C.S., Petropoulos A.,
RA   Mueller U.W., Sutcliffe R.G.;
RT   "Molecular cloning and expression of human trophoblast antigen FDO161G
RT   and its identification as 3 beta-hydroxy-5-ene steroid
RT   dehydrogenase.";
RL   J. Reprod. Fertil. 93:149-156(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   MEDLINE=93018017; PubMed=1401999; DOI=10.1111/1523-1747.ep12616131;
RA   Dumont M., Van L.T., Dupont E., Pelletier G., Labrie F.;
RT   "Characterization, expression, and immunohistochemical localization of
RT   3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human
RT   skin.";
RL   J. Invest. Dermatol. 99:415-421(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-367.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   VARIANTS VAL-79 AND LEU-286.
RX   MEDLINE=99318093; PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [10]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: 3-beta-HSD is a bifunctional enzyme, that catalyzes the
CC       oxidative conversion of Delta(5)-ene-3-beta-hydroxy steroid, and
CC       the oxidative conversion of ketosteroids. The 3-beta-HSD enzymatic
CC       system plays a crucial role in the biosynthesis of all classes of
CC       hormonal steroids. Efficiently catalyzes the transformation of
CC       pregnenolone to progesterone, 17-alpha-hydroxypregnenolone to 17-
CC       alpha-hydroxyprogesterone, DHEA to 4-androstenedione,
CC       dihydrotestosterone to 5-alpha-androstane-3 beta,17 beta-diol,
CC       dehydroepiandrosterone to androstenedione and 5-alpha-androstan-3
CC       beta,17 beta-diol to 5-alpha-dihydrotestosterone.
CC   -!- CATALYTIC ACTIVITY: A 3-beta-hydroxy-Delta(5)-steroid + NAD(+) = a
CC       3-oxo-Delta(5)-steroid + NADH.
CC   -!- CATALYTIC ACTIVITY: A 3-oxo-Delta(5)-steroid = a 3-oxo-Delta(4)-
CC       steroid.
CC   -!- PATHWAY: Lipid metabolism; steroid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein. Mitochondrion membrane; Single-pass membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Placenta and skin. Predominantly expressed in
CC       mammary gland tissue.
CC   -!- SIMILARITY: Belongs to the 3-beta-HSD family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36001.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M27137; AAA36015.1; -; mRNA.
DR   EMBL; M28392; AAA36001.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M28162; AAA36001.1; JOINED; Genomic_DNA.
DR   EMBL; M28391; AAA36001.1; JOINED; Genomic_DNA.
DR   EMBL; X53321; CAA37408.1; -; mRNA.
DR   EMBL; M35493; AAA51538.1; -; mRNA.
DR   EMBL; M63397; AAA51662.1; -; Genomic_DNA.
DR   EMBL; M63395; AAA51662.1; JOINED; Genomic_DNA.
DR   EMBL; M63396; AAA51662.1; JOINED; Genomic_DNA.
DR   EMBL; M38180; AAA51831.1; -; Genomic_DNA.
DR   EMBL; X55997; CAA39469.1; -; mRNA.
DR   EMBL; S45679; AAB23543.1; -; mRNA.
DR   EMBL; AK291556; BAF84245.1; -; mRNA.
DR   EMBL; BC031999; AAH31999.1; -; mRNA.
DR   IPI; IPI00843838; -.
DR   PIR; A36551; DEHUHS.
DR   RefSeq; NP_000853.1; NM_000862.2.
DR   UniGene; Hs.364941; -.
DR   ProteinModelPortal; P14060; -.
DR   SMR; P14060; 3-360.
DR   STRING; P14060; -.
DR   DMDM; 112767; -.
DR   PRIDE; P14060; -.
DR   DNASU; 3283; -.
DR   Ensembl; ENST00000235547; ENSP00000235547; ENSG00000203857.
DR   Ensembl; ENST00000369413; ENSP00000358421; ENSG00000203857.
DR   GeneID; 3283; -.
DR   KEGG; hsa:3283; -.
DR   UCSC; uc001ehv.1; human.
DR   CTD; 3283; -.
DR   GeneCards; GC01P120049; -.
DR   H-InvDB; HIX0000948; -.
DR   HGNC; HGNC:5217; HSD3B1.
DR   MIM; 109715; gene.
DR   neXtProt; NX_P14060; -.
DR   PharmGKB; PA29486; -.
DR   eggNOG; COG0451; -.
DR   GeneTree; ENSGT00550000074557; -.
DR   HOVERGEN; HBG000014; -.
DR   InParanoid; P14060; -.
DR   KO; K00070; -.
DR   OrthoDB; EOG4K3KWG; -.
DR   PhylomeDB; P14060; -.
DR   BioCyc; MetaCyc:HS08829-MONOMER; -.
DR   BRENDA; 1.1.1.145; 2681.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_15493; Steroid hormones.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB01108; Trilostane.
DR   NextBio; 13031; -.
DR   ArrayExpress; P14060; -.
DR   Bgee; P14060; -.
DR   CleanEx; HS_HSD3B1; -.
DR   Genevestigator; P14060; -.
DR   GermOnline; ENSG00000203857; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005792; C:microsome; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IDA:UniProtKB.
DR   GO; GO:0030868; C:smooth endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0004769; F:steroid delta-isomerase activity; ISS:UniProtKB.
DR   GO; GO:0006702; P:androgen biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0006703; P:estrogen biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1.
DR   InterPro; IPR002225; 3Beta_OHSteriod_DH/Estase.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF01073; 3Beta_HSD; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Endoplasmic reticulum;
KW   Isomerase; Membrane; Mitochondrion; Multifunctional enzyme; NAD;
KW   Oxidoreductase; Polymorphism; Reference proteome; Steroidogenesis;
KW   Transmembrane; Transmembrane helix.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    373       3 beta-hydroxysteroid dehydrogenase/Delta
FT                                5-->4-isomerase type 1.
FT                                /FTId=PRO_0000087774.
FT   TRANSMEM    288    308       Helical; (Potential).
FT   ACT_SITE    155    155       Proton acceptor (By similarity).
FT   BINDING     159    159       NAD (By similarity).
FT   VARIANT      54     54       T -> I (in dbSNP:rs3088283).
FT                                /FTId=VAR_048096.
FT   VARIANT      71     71       R -> I (in dbSNP:rs4986952).
FT                                /FTId=VAR_048097.
FT   VARIANT      79     79       I -> V (in dbSNP:rs6201).
FT                                /FTId=VAR_014174.
FT   VARIANT      90     90       G -> S (in dbSNP:rs6684974).
FT                                /FTId=VAR_048098.
FT   VARIANT     286    286       F -> L (in dbSNP:rs6205).
FT                                /FTId=VAR_014175.
FT   VARIANT     367    367       T -> N (in dbSNP:rs1047303).
FT                                /FTId=VAR_000005.
SQ   SEQUENCE   373 AA;  42252 MW;  2C76616E7EA7433A CRC64;
     MTGWSCLVTG AGGFLGQRII RLLVKEKELK EIRVLDKAFG PELREEFSKL QNKTKLTVLE
     GDILDEPFLK RACQDVSVII HTACIIDVFG VTHRESIMNV NVKGTQLLLE ACVQASVPVF
     IYTSSIEVAG PNSYKEIIQN GHEEEPLENT WPAPYPHSKK LAEKAVLAAN GWNLKNGGTL
     YTCALRPMYI YGEGSRFLSA SINEALNNNG ILSSVGKFST VNPVYVGNVA WAHILALRAL
     QDPKKAPSIR GQFYYISDDT PHQSYDNLNY TLSKEFGLRL DSRWSFPLSL MYWIGFLLEI
     VSFLLRPIYT YRPPFNRHIV TLSNSVFTFS YKKAQRDLAY KPLYSWEEAK QKTVEWVGSL
     VDRHKETLKS KTQ
//
ID   3BHS2_HUMAN             Reviewed;         372 AA.
AC   P26439; A2RRA5; Q16010; Q53GD4; Q6AI10; Q6LDB9; Q99890; Q9UD08;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   18-APR-2012, entry version 133.
DE   RecName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2;
DE   AltName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II;
DE            Short=3-beta-HSD II;
DE   AltName: Full=3-beta-HSD adrenal and gonadal type;
DE   Includes:
DE     RecName: Full=3-beta-hydroxy-Delta(5)-steroid dehydrogenase;
DE              EC=1.1.1.145;
DE     AltName: Full=3-beta-hydroxy-5-ene steroid dehydrogenase;
DE     AltName: Full=Progesterone reductase;
DE   Includes:
DE     RecName: Full=Steroid Delta-isomerase;
DE              EC=5.3.3.1;
DE     AltName: Full=Delta-5-3-ketosteroid isomerase;
GN   Name=HSD3B2; Synonyms=HSDB3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92075161; PubMed=1741954; DOI=10.1089/dna.1991.10.701;
RA   Lachance Y., Luu-The V., Verreault H., Dumont M., Rheaume E.,
RA   Leblanc G., Labrie F.;
RT   "Structure of the human type II 3 beta-hydroxysteroid
RT   dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and
RT   gonadal specificity.";
RL   DNA Cell Biol. 10:701-711(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adrenal gland;
RX   MEDLINE=92049394; PubMed=1944309;
RA   Rheaume E., Lachance Y., Zhao H.-F., Breton N., Dumont M.,
RA   de Launoit Y., Trudel C., Luu-The V., Simard J., Labrie F.;
RT   "Structure and expression of a new complementary DNA encoding the
RT   almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-
RT   isomerase in human adrenals and gonads.";
RL   Mol. Endocrinol. 5:1147-1157(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLN-94.
RC   TISSUE=Adrenal gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 49-102.
RX   MEDLINE=96065327; PubMed=7588414;
RA   Russell A.J., McCartin S., Corcao G., Burridge S.M., McBride M.W.,
RA   McNicol A.M., Hawes C.S., Mason J.I., Sutcliffe R.G.;
RT   "Variation in the expression of human 3 beta-hydroxysteroid
RT   dehydrogenase.";
RL   Endocr. Res. 21:485-494(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 167-205.
RX   PubMed=1363812; DOI=10.1038/ng0792-239;
RA   Rheaume E., Simard J., Morel Y., Mebarki F., Zachmann M., Forest M.G.,
RA   New M.I., Labrie F.;
RT   "Congenital adrenal hyperplasia due to point mutations in the type II
RT   3 beta-hydroxysteroid dehydrogenase gene.";
RL   Nat. Genet. 1:239-245(1992).
RN   [10]
RP   POSSIBLE INVOLVEMENT IN INSULIN-RESISTANT POLYCYSTIC OVARY SYNDROME.
RX   PubMed=14764797; DOI=10.1210/jc.2003-030934;
RA   Carbunaru G., Prasad P., Scoccia B., Shea P., Hopwood N., Ziai F.,
RA   Chang Y.T., Myers S.E., Mason J.I., Pang S.;
RT   "The hormonal phenotype of nonclassic 3 beta-hydroxysteroid
RT   dehydrogenase (HSD3B) deficiency in hyperandrogenic females is
RT   associated with insulin-resistant polycystic ovary syndrome and is not
RT   a variant of inherited HSD3B2 deficiency.";
RL   J. Clin. Endocrinol. Metab. 89:783-794(2004).
RN   [11]
RP   VARIANTS AH2 LYS-142; PRO-245 AND ASN-253.
RX   MEDLINE=93302780; PubMed=8316254; DOI=10.1210/me.7.5.716;
RA   Simard J., Rheaume E., Sanchez R., Laflamme N., de Launoit Y.,
RA   Luu-The V., van Seters A.P., Gordon R.D., Bettendorf M., Heinrich U.,
RA   Moshang T., New M.I., Labrie F.;
RT   "Molecular basis of congenital adrenal hyperplasia due to 3 beta-
RT   hydroxysteroid dehydrogenase deficiency.";
RL   Mol. Endocrinol. 7:716-728(1993).
RN   [12]
RP   VARIANTS AH2 TRP-108 AND LEU-186.
RX   MEDLINE=95135422; PubMed=7833923; DOI=10.1093/hmg/3.9.1639;
RA   Sanchez R., Mebarki F., Rheaume E., Laflamme N., Forest M.G.,
RA   Bey-Omar F., David M., Morel Y., Labrie F., Simard J.;
RT   "Functional characterization of the novel L108W and P186L mutations
RT   detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a
RT   male pseudohermaphrodite with congenital adrenal hyperplasia.";
RL   Hum. Mol. Genet. 3:1639-1645(1994).
RN   [13]
RP   VARIANT AH2 ASP-254.
RX   MEDLINE=94171959; PubMed=8126127; DOI=10.1210/jc.78.3.561;
RA   Sanchez R., Rheaume E., Laflamme N., Rosenfield R.L., Labrie F.,
RA   Simard J.;
RT   "Detection and functional characterization of the novel missense
RT   mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta
RT   HSD) gene of a female patient with nonsalt-losing 3 beta HSD
RT   deficiency.";
RL   J. Clin. Endocrinol. Metab. 78:561-567(1994).
RN   [14]
RP   VARIANT AH2 ARG-129.
RX   MEDLINE=95051232; PubMed=7962268; DOI=10.1210/jc.79.4.1012;
RA   Rheaume E., Sanchez R., Simard J., Chang Y.T., Wang J., Pang S.,
RA   Labrie F.;
RT   "Molecular basis of congenital adrenal hyperplasia in two siblings
RT   with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase
RT   deficiency.";
RL   J. Clin. Endocrinol. Metab. 79:1012-1018(1994).
RN   [15]
RP   VARIANT AH2 THR-82.
RX   MEDLINE=94242228; PubMed=8185809;
RA   Mendonca B.B., Russell A.J., Vasconcelos-Leite M., Arnhold I.J.,
RA   Bloise W., Wajchenberg B.L., Nicolau W., Sutcliffe R.G., Wallace A.M.;
RT   "Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated
RT   with pseudohermaphroditism in males and premature pubarche or cryptic
RT   expression in females.";
RL   J. Mol. Endocrinol. 12:119-122(1994).
RN   [16]
RP   VARIANT AH2 ARG-173.
RX   MEDLINE=94338525; PubMed=8060486;
RA   Russell A.J., Wallace A.M., Forest M.G., Donaldson M.D., Edwards C.R.,
RA   Sutcliffe R.G.;
RT   "Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase
RT   type II leading to male pseudohermaphroditism without salt loss.";
RL   J. Mol. Endocrinol. 12:225-237(1994).
RN   [17]
RP   VARIANT AH2 ASP-15.
RX   MEDLINE=95200911; PubMed=7893703; DOI=10.1021/bi00009a020;
RA   Rheaume E., Sanchez R., Mebarki F., Gagnon E., Carel J.-C.,
RA   Chaussain J.-L., Morel Y., Labrie F., Simard J.;
RT   "Identification and characterization of the G15D mutation found in a
RT   male patient with 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD)
RT   deficiency: alteration of the putative NAD-binding domain of type II 3
RT   beta-HSD.";
RL   Biochemistry 34:2893-2900(1995).
RN   [18]
RP   VARIANT AH2 PRO-205.
RX   MEDLINE=95359984; PubMed=7633426; DOI=10.1093/hmg/4.4.745;
RA   Katsumata N., Tanae A., Yasunaga T., Horikawa R., Tanaka T., Hibi I.;
RT   "A novel missense mutation in the type II 3 beta-hydroxysteroid
RT   dehydrogenase gene in a family with classical salt-wasting congenital
RT   adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase
RT   deficiency.";
RL   Hum. Mol. Genet. 4:745-746(1995).
RN   [19]
RP   VARIANT AH2 ARG-259.
RX   MEDLINE=95360019; PubMed=7633460; DOI=10.1093/hmg/4.5.969;
RA   Tajima T., Fujieda K., Nakae J., Shinohara N., Yoshimoto M., Baba T.,
RA   Kinoshita E., Igarashi Y., Oomura T.;
RT   "Molecular analysis of type II 3 beta-hydroxysteroid dehydrogenase
RT   gene in Japanese patients with classical 3 beta-hydroxysteroid
RT   dehydrogenase deficiency.";
RL   Hum. Mol. Genet. 4:969-971(1995).
RN   [20]
RP   VARIANT AH2 SER-100.
RX   MEDLINE=95332416; PubMed=7608265; DOI=10.1210/jc.80.7.2127;
RA   Mebarki F., Sanchez R., Rheaume E., Laflamme N., Simard J.,
RA   Forest M.G., Bey-Omar F., David M., Labrie F., Morel Y.;
RT   "Nonsalt-losing male pseudohermaphroditism due to the novel homozygous
RT   N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase
RT   gene.";
RL   J. Clin. Endocrinol. Metab. 80:2127-2134(1995).
RN   [21]
RP   VARIANT AH2 SER-236.
RX   MEDLINE=98387937; PubMed=9719627; DOI=10.1006/mgme.1998.2715;
RA   Nayak S., Lee P.A., Witchel S.F.;
RT   "Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in
RT   children with premature pubic hair and hyperandrogenic adolescents.";
RL   Mol. Genet. Metab. 64:184-192(1998).
RN   [22]
RP   VARIANTS AH2.
RX   MEDLINE=20066679; PubMed=10599696; DOI=10.1210/jc.84.12.4410;
RA   Moisan A.M., Ricketts M.L., Tardy V., Desrochers M., Mebarki F.,
RA   Chaussain J.-L., Cabrol S., Raux-Demay M.C., Forest M.G.,
RA   Sippell W.G., Peter M., Morel Y., Simard J.;
RT   "New insight into the molecular basis of 3beta-hydroxysteroid
RT   dehydrogenase deficiency: identification of eight mutations in the
RT   HSD3B2 gene in eleven patients from seven new families and comparison
RT   of the functional properties of twenty-five mutant enzymes.";
RL   J. Clin. Endocrinol. Metab. 84:4410-4425(1999).
RN   [23]
RP   VARIANTS AH2 ARG-129; GLN-222 AND MET-259.
RX   MEDLINE=20191658; PubMed=10651755;
RX   DOI=10.1046/j.1365-2265.2000.00873.x;
RA   Marui S., Castro M., Latronico A.C., Elias L.L., Arnhold I.J.,
RA   Moreira A.C., Mendonca B.B.;
RT   "Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2)
RT   gene can cause premature pubarche in girls.";
RL   Clin. Endocrinol. (Oxf.) 52:67-75(2000).
RN   [24]
RP   VARIANT AH2 GLU-10.
RX   MEDLINE=20300169; PubMed=10843183; DOI=10.1210/jc.85.5.1968;
RA   Alos N., Moisan A.M., Ward L., Desrochers M., Legault L., Leboeuf G.,
RA   van Vliet G., Simard J.;
RT   "A novel A10E homozygous mutation in the HSD3B2 gene causing severe
RT   salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX
RT   and 46,XY French-Canadians: evaluation of gonadal function after
RT   puberty.";
RL   J. Clin. Endocrinol. Metab. 85:1968-1974(2000).
RN   [25]
RP   VARIANTS AH2 LYS-142 AND THR-222.
RX   MEDLINE=22045346; PubMed=12050213; DOI=10.1210/jc.87.6.2556;
RA   Pang S., Wang W., Rich B., David R., Chang Y.T., Carbunaru G.,
RA   Myers S.E., Howie A.F., Smillie K.J., Mason J.I.;
RT   "A novel nonstop mutation in the stop codon and a novel missense
RT   mutation in the type II 3-beta-hydroxysteroid dehydrogenase (3-beta-
RT   HSD) gene causing, respectively, nonclassic and classic 3-beta-HSD
RT   deficiency congenital adrenal hyperplasia.";
RL   J. Clin. Endocrinol. Metab. 87:2556-2563(2002).
RN   [26]
RP   VARIANT AH2 LEU-341, AND CHARACTERIZATION OF VARIANT AH2 LEU-341.
RX   PubMed=18252794; DOI=10.1210/jc.2007-1874;
RA   Welzel M., Wustemann N., Simic-Schleicher G., Dorr H.G., Schulze E.,
RA   Shaikh G., Clayton P., Grotzinger J., Holterhus P.M., Riepe F.G.;
RT   "Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase
RT   type II cause severe salt-wasting congenital adrenal hyperplasia.";
RL   J. Clin. Endocrinol. Metab. 93:1418-1425(2008).
CC   -!- FUNCTION: 3-beta-HSD is a bifunctional enzyme, that catalyzes the
CC       oxidative conversion of Delta(5)-ene-3-beta-hydroxy steroid, and
CC       the oxidative conversion of ketosteroids. The 3-beta-HSD enzymatic
CC       system plays a crucial role in the biosynthesis of all classes of
CC       hormonal steroids.
CC   -!- CATALYTIC ACTIVITY: A 3-beta-hydroxy-Delta(5)-steroid + NAD(+) = a
CC       3-oxo-Delta(5)-steroid + NADH.
CC   -!- CATALYTIC ACTIVITY: A 3-oxo-Delta(5)-steroid = a 3-oxo-Delta(4)-
CC       steroid.
CC   -!- PATHWAY: Lipid metabolism; steroid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein. Mitochondrion membrane; Single-pass membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P26439-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P26439-2; Sequence=VSP_037399, VSP_037400;
CC   -!- TISSUE SPECIFICITY: Expressed in adrenal gland, testis and ovary.
CC   -!- DISEASE: Defects in HSD3B2 are the cause of adrenal hyperplasia
CC       type 2 (AH2) [MIM:201810]. AH2 is a form of congenital adrenal
CC       hyperplasia, a common recessive disease due to defective synthesis
CC       of cortisol. Congenital adrenal hyperplasia is characterized by
CC       androgen excess leading to ambiguous genitalia in affected
CC       females, rapid somatic growth during childhood in both sexes with
CC       premature closure of the epiphyses and short adult stature. Four
CC       clinical types: 'salt wasting' (SW, the most severe type), 'simple
CC       virilizing' (SV, less severely affected patients), with normal
CC       aldosterone biosynthesis, 'non-classic form' or late onset (NC or
CC       LOAH), and 'cryptic' (asymptomatic). In AH2, virilization is much
CC       less marked or does not occur. AH2 is frequently lethal in early
CC       life.
CC   -!- DISEASE: Note=Mild HSD3B2 deficiency in hyperandrogenic females is
CC       associated with characteristic traits of polycystic ovary
CC       syndrome, such as insulin resistance and luteinizing hormon
CC       hypersecretion.
CC   -!- SIMILARITY: Belongs to the 3-beta-HSD family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC60600.1; Type=Frameshift; Positions=186; Note=The frameshift is caused by a single nucleotide insertion which is found in AH2;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/HSD3B2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M77144; AAA36014.1; -; Genomic_DNA.
DR   EMBL; M67466; AAA36016.1; -; mRNA.
DR   EMBL; CR627415; CAH10504.1; -; mRNA.
DR   EMBL; AK222997; BAD96717.1; -; mRNA.
DR   EMBL; AL359553; CAC19799.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56700.1; -; Genomic_DNA.
DR   EMBL; BC038419; AAH38419.1; -; mRNA.
DR   EMBL; BC131488; AAI31489.1; -; mRNA.
DR   EMBL; S80140; AAD14329.1; -; Genomic_DNA.
DR   EMBL; S60309; AAC60599.1; -; Genomic_DNA.
DR   EMBL; S60310; AAC60600.1; ALT_FRAME; Genomic_DNA.
DR   IPI; IPI00218494; -.
DR   IPI; IPI00465001; -.
DR   PIR; A39488; DEHUH2.
DR   RefSeq; NP_000189.1; NM_000198.3.
DR   RefSeq; NP_001159592.1; NM_001166120.1.
DR   UniGene; Hs.654399; -.
DR   ProteinModelPortal; P26439; -.
DR   SMR; P26439; 2-360.
DR   STRING; P26439; -.
DR   DMDM; 112770; -.
DR   PRIDE; P26439; -.
DR   DNASU; 3284; -.
DR   Ensembl; ENST00000369416; ENSP00000358424; ENSG00000203859.
DR   GeneID; 3284; -.
DR   KEGG; hsa:3284; -.
DR   UCSC; uc001ehs.3; human.
DR   UCSC; uc001ehu.3; human.
DR   CTD; 3284; -.
DR   GeneCards; GC01P119957; -.
DR   H-InvDB; HIX0023638; -.
DR   HGNC; HGNC:5218; HSD3B2.
DR   MIM; 201810; phenotype.
DR   MIM; 613890; gene.
DR   neXtProt; NX_P26439; -.
DR   Orphanet; 90791; Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency.
DR   Orphanet; 1331; Familial prostate cancer.
DR   Orphanet; 3185; Stein-Leventhal syndrome.
DR   PharmGKB; PA29487; -.
DR   eggNOG; COG0451; -.
DR   GeneTree; ENSGT00550000074557; -.
DR   HOVERGEN; HBG000014; -.
DR   InParanoid; P26439; -.
DR   KO; K00070; -.
DR   OMA; TFSAVIN; -.
DR   PhylomeDB; P26439; -.
DR   BioCyc; MetaCyc:HS10943-MONOMER; -.
DR   BRENDA; 1.1.1.145; 2681.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_15493; Steroid hormones.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB01108; Trilostane.
DR   NextBio; 13035; -.
DR   ArrayExpress; P26439; -.
DR   Bgee; P26439; -.
DR   CleanEx; HS_HSD3B2; -.
DR   Genevestigator; P26439; -.
DR   GermOnline; ENSG00000203859; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; NAS:UniProtKB.
DR   GO; GO:0005792; C:microsome; ISS:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; ISS:UniProtKB.
DR   GO; GO:0030868; C:smooth endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0004769; F:steroid delta-isomerase activity; IDA:UniProtKB.
DR   GO; GO:0006702; P:androgen biosynthetic process; TAS:Reactome.
DR   GO; GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1.
DR   InterPro; IPR002225; 3Beta_OHSteriod_DH/Estase.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF01073; 3Beta_HSD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital adrenal hyperplasia; Disease mutation;
KW   Endoplasmic reticulum; Isomerase; Membrane; Mitochondrion;
KW   Multifunctional enzyme; NAD; Oxidoreductase; Polymorphism;
KW   Reference proteome; Steroidogenesis; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    372       3 beta-hydroxysteroid dehydrogenase/Delta
FT                                5-->4-isomerase type 2.
FT                                /FTId=PRO_0000087775.
FT   TRANSMEM    287    307       Helical; (Potential).
FT   ACT_SITE    154    154       Proton acceptor (By similarity).
FT   BINDING     158    158       NAD (By similarity).
FT   VAR_SEQ     103    222       GTQLLLEACVQASVPVFIYTSSIEVAGPNSYKEIIQNGHEE
FT                                EPLENTWPTPYPYSKKLAEKAVLAANGWNLKNGDTLYTCAL
FT                                RPTYIYGEGGPFLSASINEALNNNGILSSVGKFSTVNP ->
FT                                ELQNKIKLTVLEGDILDEPFLKRACQDVSVVIHTACIIDVF
FT                                GVTHRQSIMNVNVKGRVAWGGDKARWGNEDQKEGQEGKRSL
FT                                SIEHLLCSGPSDFADHYQLGELKAAIFSFIDEKTRTEQ
FT                                (in isoform 2).
FT                                /FTId=VSP_037399.
FT   VAR_SEQ     223    372       Missing (in isoform 2).
FT                                /FTId=VSP_037400.
FT   VARIANT      10     10       A -> E (in AH2; activity abolished;
FT                                dbSNP:rs28934880).
FT                                /FTId=VAR_010517.
FT   VARIANT      10     10       A -> V (in AH2; nonsalt-wasting form).
FT                                /FTId=VAR_010518.
FT   VARIANT      15     15       G -> D (in AH2; activity abolished).
FT                                /FTId=VAR_010519.
FT   VARIANT      74     74       D -> N (in dbSNP:rs4986954).
FT                                /FTId=VAR_048099.
FT   VARIANT      82     82       A -> T (in AH2).
FT                                /FTId=VAR_010520.
FT   VARIANT      94     94       E -> Q (in dbSNP:rs6211).
FT                                /FTId=VAR_014818.
FT   VARIANT     100    100       N -> S (in AH2; nonsalt-wasting form).
FT                                /FTId=VAR_010521.
FT   VARIANT     108    108       L -> W (in AH2; activity abolished).
FT                                /FTId=VAR_010522.
FT   VARIANT     129    129       G -> R (in AH2; nonsalt-wasting form).
FT                                /FTId=VAR_010523.
FT   VARIANT     142    142       E -> K (in AH2; activity abolished).
FT                                /FTId=VAR_000006.
FT   VARIANT     155    155       P -> L (in AH2; nonsalt-wasting form).
FT                                /FTId=VAR_010524.
FT   VARIANT     167    167       A -> V (in AH2; late onset; almost normal
FT                                activity; dbSNP:rs35486059).
FT                                /FTId=VAR_010525.
FT   VARIANT     173    173       L -> R (in AH2; nonsalt-wasting form).
FT                                /FTId=VAR_010526.
FT   VARIANT     186    186       P -> L (in AH2; activity abolished).
FT                                /FTId=VAR_010527.
FT   VARIANT     205    205       L -> P (in AH2).
FT                                /FTId=VAR_000007.
FT   VARIANT     213    213       S -> G (in AH2; late onset; partial loss
FT                                of activity).
FT                                /FTId=VAR_010528.
FT   VARIANT     216    216       K -> E (in AH2; late onset; partial loss
FT                                of activity).
FT                                /FTId=VAR_010529.
FT   VARIANT     222    222       P -> H (in AH2; nonsalt-wasting form;
FT                                activity abolished).
FT                                /FTId=VAR_010530.
FT   VARIANT     222    222       P -> Q (in AH2; activity abolished).
FT                                /FTId=VAR_010531.
FT   VARIANT     222    222       P -> T (in AH2).
FT                                /FTId=VAR_015411.
FT   VARIANT     231    238       Missing (in AH2; activity abolished).
FT                                /FTId=VAR_010532.
FT   VARIANT     236    236       L -> S (in AH2; mild; 100% of activity;
FT                                dbSNP:rs35887327).
FT                                /FTId=VAR_010533.
FT   VARIANT     245    245       A -> P (in AH2; loss of 88% of activity).
FT                                /FTId=VAR_000008.
FT   VARIANT     253    253       Y -> N (in AH2; activity abolished).
FT                                /FTId=VAR_000009.
FT   VARIANT     254    254       Y -> D (in AH2; activity abolished).
FT                                /FTId=VAR_000010.
FT   VARIANT     259    259       T -> M (in AH2; activity abolished).
FT                                /FTId=VAR_010534.
FT   VARIANT     259    259       T -> R (in AH2; activity abolished).
FT                                /FTId=VAR_000011.
FT   VARIANT     294    294       G -> V (in AH2; nonsalt-wasting form;
FT                                activity abolished).
FT                                /FTId=VAR_010535.
FT   VARIANT     341    341       P -> L (in AH2; strongly reduced
FT                                activity).
FT                                /FTId=VAR_065665.
FT   CONFLICT     52     53       RT -> KI (in Ref. 8; AAD14329).
FT   CONFLICT     92     94       HRE -> RRQ (in Ref. 8; AAD14329).
FT   CONFLICT    232    232       H -> L (in Ref. 4; BAD96717).
SQ   SEQUENCE   372 AA;  42052 MW;  8E0D933488988451 CRC64;
     MGWSCLVTGA GGLLGQRIVR LLVEEKELKE IRALDKAFRP ELREEFSKLQ NRTKLTVLEG
     DILDEPFLKR ACQDVSVVIH TACIIDVFGV THRESIMNVN VKGTQLLLEA CVQASVPVFI
     YTSSIEVAGP NSYKEIIQNG HEEEPLENTW PTPYPYSKKL AEKAVLAANG WNLKNGDTLY
     TCALRPTYIY GEGGPFLSAS INEALNNNGI LSSVGKFSTV NPVYVGNVAW AHILALRALR
     DPKKAPSVRG QFYYISDDTP HQSYDNLNYI LSKEFGLRLD SRWSLPLTLM YWIGFLLEVV
     SFLLSPIYSY QPPFNRHTVT LSNSVFTFSY KKAQRDLAYK PLYSWEEAKQ KTVEWVGSLV
     DRHKETLKSK TQ
//
ID   3BHS7_HUMAN             Reviewed;         369 AA.
AC   Q9H2F3; Q96M28; Q9BSN9;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 2.
DT   18-APR-2012, entry version 91.
DE   RecName: Full=3 beta-hydroxysteroid dehydrogenase type 7;
DE   AltName: Full=3 beta-hydroxysteroid dehydrogenase type VII;
DE            Short=3-beta-HSD VII;
DE   AltName: Full=3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase;
DE            Short=C(27) 3-beta-HSD;
DE            EC=1.1.1.-;
DE   AltName: Full=Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase;
DE            EC=1.1.1.181;
GN   Name=HSD3B7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INVOLVEMENT IN CBAS1, AND
RP   VARIANT ALA-250.
RX   MEDLINE=20521690; PubMed=11067870; DOI=10.1172/JCI10902;
RA   Schwarz M., Wright A.C., Davis D.L., Nazer H., Bjorkhem I.,
RA   Russell D.W.;
RT   "The bile acid synthetic gene 3beta-hydroxy-delta(5)-C(27)-steroid
RT   oxidoreductase is mutated in progressive intrahepatic cholestasis.";
RL   J. Clin. Invest. 106:1175-1184(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Stomach, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS CBAS1 SER-19 AND LYS-147, AND CHARACTERIZATION OF VARIANT
RP   CBAS1 LYS-147.
RX   PubMed=12679481; DOI=10.1210/jc.2002-021580;
RA   Cheng J.B., Jacquemin E., Gerhardt M., Nazer H., Cresteil D.,
RA   Heubi J.E., Setchell K.D., Russell D.W.;
RT   "Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase
RT   deficiency in 16 patients with loss of bile acid synthesis and liver
RT   disease.";
RL   J. Clin. Endocrinol. Metab. 88:1833-1841(2003).
CC   -!- FUNCTION: The 3-beta-HSD enzymatic system plays a crucial role in
CC       the biosynthesis of all classes of hormonal steroids. HSD VII is
CC       active against four 7-alpha-hydroxylated sterols. Does not
CC       metabolize several different C(19/21) steroids as substrates.
CC       Involved in bile acid synthesis.
CC   -!- CATALYTIC ACTIVITY: 3-beta-hydroxy-Delta(5)-steroid + NAD(+) = 3-
CC       oxo-Delta(5)-steroid + NADH.
CC   -!- CATALYTIC ACTIVITY: Cholest-5-ene-3-beta,7-alpha-diol + NAD(+) =
CC       7-alpha-hydroxycholest-4-en-3-one + NADH.
CC   -!- PATHWAY: Lipid metabolism; steroid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2F3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2F3-2; Sequence=VSP_042658;
CC         Note=No experimental confirmation available;
CC   -!- DISEASE: Defects in HSD3B7 are the cause of congenital bile acid
CC       synthesis defect type 1 (CBAS1) [MIM:607765]; also known as
CC       neonatal progressive intrahepatic cholestasis. CBAS1 is due to a
CC       primary defect in bile synthesis leading to progressive liver
CC       disease. Clinical features include neonatal jaundice, severe
CC       intrahepatic cholestasis and cirrhosis.
CC   -!- SIMILARITY: Belongs to the 3-beta-HSD family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF277719; AAG37824.1; -; mRNA.
DR   EMBL; AK057436; BAB71486.1; -; mRNA.
DR   EMBL; AK290950; BAF83639.1; -; mRNA.
DR   EMBL; AK292068; BAF84757.1; -; mRNA.
DR   EMBL; AC135048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471192; EAW52183.1; -; Genomic_DNA.
DR   EMBL; BC004929; AAH04929.1; -; mRNA.
DR   IPI; IPI00065225; -.
DR   IPI; IPI00106783; -.
DR   RefSeq; NP_079469.2; NM_025193.3.
DR   UniGene; Hs.460618; -.
DR   ProteinModelPortal; Q9H2F3; -.
DR   SMR; Q9H2F3; 10-365.
DR   IntAct; Q9H2F3; 3.
DR   STRING; Q9H2F3; -.
DR   PhosphoSite; Q9H2F3; -.
DR   DMDM; 47605550; -.
DR   PRIDE; Q9H2F3; -.
DR   DNASU; 80270; -.
DR   Ensembl; ENST00000262520; ENSP00000262520; ENSG00000099377.
DR   Ensembl; ENST00000297679; ENSP00000297679; ENSG00000099377.
DR   Ensembl; ENST00000353250; ENSP00000370662; ENSG00000099377.
DR   GeneID; 80270; -.
DR   KEGG; hsa:80270; -.
DR   UCSC; uc002eaf.2; human.
DR   CTD; 80270; -.
DR   GeneCards; GC16P030997; -.
DR   H-InvDB; HIX0022193; -.
DR   HGNC; HGNC:18324; HSD3B7.
DR   MIM; 607764; gene.
DR   MIM; 607765; phenotype.
DR   neXtProt; NX_Q9H2F3; -.
DR   Orphanet; 79301; Congenital bile acid synthesis defect type 1.
DR   PharmGKB; PA134940289; -.
DR   eggNOG; COG0451; -.
DR   GeneTree; ENSGT00550000074557; -.
DR   HOGENOM; HBG755066; -.
DR   HOVERGEN; HBG000014; -.
DR   InParanoid; Q9H2F3; -.
DR   KO; K12408; -.
DR   OMA; EDFNMEF; -.
DR   OrthoDB; EOG4N5VX7; -.
DR   PhylomeDB; Q9H2F3; -.
DR   Reactome; REACT_111217; Metabolism.
DR   NextBio; 70733; -.
DR   ArrayExpress; Q9H2F3; -.
DR   Bgee; Q9H2F3; -.
DR   CleanEx; HS_HSD3B7; -.
DR   Genevestigator; Q9H2F3; -.
DR   GermOnline; ENSG00000099377; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; NAS:UniProtKB.
DR   GO; GO:0047016; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; IEA:EC.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:UniProtKB.
DR   Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1.
DR   InterPro; IPR002225; 3Beta_OHSteriod_DH/Estase.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF01073; 3Beta_HSD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Intrahepatic cholestasis; Membrane; NAD;
KW   Oxidoreductase; Polymorphism; Reference proteome; Steroidogenesis;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    369       3 beta-hydroxysteroid dehydrogenase type
FT                                7.
FT                                /FTId=PRO_0000087791.
FT   TRANSMEM    289    309       Helical; (Potential).
FT   TRANSMEM    311    331       Helical; (Potential).
FT   ACT_SITE    159    159       Proton acceptor (By similarity).
FT   BINDING     163    163       NAD (By similarity).
FT   VAR_SEQ     178    369       VRGGLPLVTCALRPTGIYGEGHQIMRDFYRQGLRLGGWLFR
FT                                AIPASVEHGRVYVGNVAWMHVLAARELEQRATLMGGQVYFC
FT                                YDGSPYRSYEDFNMEFLGPCGLRLVGARPLLPYWLLVFLAA
FT                                LNALLQWLLRPLVLYAPLLNPYTLAVANTTFTVSTDKAQRH
FT                                FGYEPLFSWEDSRTRTILWVQAATGSAQ -> AMLPGCTCW
FT                                QPGSWSSGQP (in isoform 2).
FT                                /FTId=VSP_042658.
FT   VARIANT      19     19       G -> S (in CBAS1).
FT                                /FTId=VAR_054775.
FT   VARIANT     147    147       E -> K (in CBAS1; loss of activity).
FT                                /FTId=VAR_054776.
FT   VARIANT     250    250       T -> A (in dbSNP:rs9938550).
FT                                /FTId=VAR_031040.
FT   VARIANT     347    347       L -> P (in dbSNP:rs34212827).
FT                                /FTId=VAR_048100.
FT   CONFLICT    265    265       Y -> H (in Ref. 1; AAG37824).
FT   CONFLICT    329    329       T -> A (in Ref. 1; AAG37824).
SQ   SEQUENCE   369 AA;  41016 MW;  7254A5DAAFAC23E7 CRC64;
     MADSAQAQKL VYLVTGGCGF LGEHVVRMLL QREPRLGELR VFDQHLGPWL EELKTGPVRV
     TAIQGDVTQA HEVAAAVAGA HVVIHTAGLV DVFGRASPKT IHEVNVQGTR NVIEACVQTG
     TRFLVYTSSM EVVGPNTKGH PFYRGNEDTP YEAVHRHPYP CSKALAEWLV LEANGRKVRG
     GLPLVTCALR PTGIYGEGHQ IMRDFYRQGL RLGGWLFRAI PASVEHGRVY VGNVAWMHVL
     AARELEQRAT LMGGQVYFCY DGSPYRSYED FNMEFLGPCG LRLVGARPLL PYWLLVFLAA
     LNALLQWLLR PLVLYAPLLN PYTLAVANTT FTVSTDKAQR HFGYEPLFSW EDSRTRTILW
     VQAATGSAQ
//
ID   3BP1_HUMAN              Reviewed;         701 AA.
AC   Q9Y3L3; Q5R3N0; Q6IBZ2; Q6ZVL9; Q96HQ5; Q9NSQ9;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 3.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=SH3 domain-binding protein 1;
DE            Short=3BP-1;
GN   Name=SH3BP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 33-701 (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 360-701 (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544 AND THR-626, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Binds differentially to the SH3 domains of certain
CC       proteins of signal transduction pathways. This protein binds
CC       preferentially to the ABL1 proto-oncogene, SRC and GRB2. Shows GAP
CC       activity for Rac-related proteins but not for Rho- or Ras-related
CC       proteins. It inhibits PDGF-induced membrane ruffling mediated by
CC       Rac (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y3L3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y3L3-2; Sequence=VSP_011373, VSP_011374;
CC   -!- SIMILARITY: Contains 1 BAR domain.
CC   -!- SIMILARITY: Contains 1 Rho-GAP domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH08282.1; Type=Erroneous initiation;
CC       Sequence=BAC85842.1; Type=Erroneous initiation;
CC       Sequence=BAC85842.1; Type=Erroneous termination; Positions=56; Note=Translated as Cys;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR456576; CAG30462.1; -; mRNA.
DR   EMBL; AK124370; BAC85842.1; ALT_INIT; mRNA.
DR   EMBL; Z83844; CAI20370.2; -; Genomic_DNA.
DR   EMBL; BC008282; AAH08282.1; ALT_INIT; mRNA.
DR   EMBL; AL157480; CAB75671.2; -; mRNA.
DR   IPI; IPI00456744; -.
DR   IPI; IPI01011491; -.
DR   PIR; T46916; T46916.
DR   RefSeq; NP_061830.3; NM_018957.3.
DR   UniGene; Hs.601143; -.
DR   ProteinModelPortal; Q9Y3L3; -.
DR   IntAct; Q9Y3L3; 1.
DR   STRING; Q9Y3L3; -.
DR   PhosphoSite; Q9Y3L3; -.
DR   DMDM; 51338841; -.
DR   PRIDE; Q9Y3L3; -.
DR   DNASU; 23616; -.
DR   Ensembl; ENST00000357436; ENSP00000350018; ENSG00000100092.
DR   GeneID; 23616; -.
DR   KEGG; hsa:23616; -.
DR   UCSC; uc003ati.3; human.
DR   CTD; 23616; -.
DR   GeneCards; GC22P038030; -.
DR   H-InvDB; HIX0016448; -.
DR   H-InvDB; HIX0016449; -.
DR   HGNC; HGNC:10824; SH3BP1.
DR   HPA; HPA000757; -.
DR   neXtProt; NX_Q9Y3L3; -.
DR   PharmGKB; PA35732; -.
DR   eggNOG; NOG318612; -.
DR   GeneTree; ENSGT00650000092854; -.
DR   HOGENOM; HBG446214; -.
DR   HOVERGEN; HBG000015; -.
DR   InParanoid; Q9Y3L3; -.
DR   OrthoDB; EOG495ZRN; -.
DR   NextBio; 46338; -.
DR   ArrayExpress; Q9Y3L3; -.
DR   Bgee; Q9Y3L3; -.
DR   CleanEx; HS_SH3BP1; -.
DR   Genevestigator; Q9Y3L3; -.
DR   GermOnline; ENSG00000100092; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; G3DSA:1.10.555.10; RhoGAP; 1.
DR   InterPro; IPR004148; BAR_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   Pfam; PF03114; BAR; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF48350; Rho_GAP; 1.
DR   PROSITE; PS51021; BAR; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; GTPase activation;
KW   Phosphoprotein; Polymorphism; Reference proteome; SH3-binding.
FT   CHAIN         1    701       SH3 domain-binding protein 1.
FT                                /FTId=PRO_0000056723.
FT   DOMAIN       17    262       BAR.
FT   DOMAIN      276    469       Rho-GAP.
FT   MOTIF       617    625       SH3-binding (By similarity).
FT   MOD_RES     544    544       Phosphoserine.
FT   MOD_RES     550    550       Phosphoserine.
FT   MOD_RES     626    626       Phosphothreonine.
FT   MOD_RES     653    653       Phosphoserine (By similarity).
FT   VAR_SEQ     440    452       DQAQLDAASVSSI -> TEPARELGSQTLC (in
FT                                isoform 2).
FT                                /FTId=VSP_011373.
FT   VAR_SEQ     453    701       Missing (in isoform 2).
FT                                /FTId=VSP_011374.
FT   VARIANT     511    511       P -> L (in dbSNP:rs929038).
FT                                /FTId=VAR_033450.
FT   VARIANT     656    656       S -> F (in dbSNP:rs2269548).
FT                                /FTId=VAR_033451.
SQ   SEQUENCE   701 AA;  75713 MW;  877D144E81F0F974 CRC64;
     MMKRQLHRMR QLAQTGSLGR TPETAEFLGE DLLQVEQRLE PAKRAAHNIH KRLQACLQGQ
     SGADMDKRVK KLPLMALSTT MAESFKELDP DSSMGKALEM SCAIQNQLAR ILAEFEMTLE
     RDVLQPLSRL SEEELPAILK HKKSLQKLVS DWNTLKSRLS QATKNSGSSQ GLGGSPGSHS
     HTTMANKVET LKEEEEELKR KVEQCRDEYL ADLYHFVTKE DSYANYFIRL LEIQADYHRR
     SLSSLDTALA ELRENHGQAD HSPSMTATHF PRVYGVSLAT HLQELGREIA LPIEACVMML
     LSEGMKEEGL FRLAAGASVL KRLKQTMASD PHSLEEFCSD PHAVAGALKS YLRELPEPLM
     TFDLYDDWMR AASLKEPGAR LQALQEVCSR LPPENLSNLR YLMKFLARLA EEQEVNKMTP
     SNIAIVLGPN LLWPPEKEGD QAQLDAASVS SIQVVGVVEA LIQSADTLFP GDINFNVSGL
     FSAVTLQDTV SDRLASEELP STAVPTPATT PAPAPAPAPA PAPALASAAT KERTESEVPP
     RPASPKVTRS PPETAAPVED MARRTKRPAP ARPTMPPPQV SGSRSSPPAP PLPPGSGSPG
     TPQALPRRLV GSSLRAPTVP PPLPPTPPQP ARRQSRRSPA SPSPASPGPA SPSPVSLSNP
     AQVDLGAATA EGGAPEAISG VPTPPAIPPQ PRPRSLASET N
//
ID   3BP2_HUMAN              Reviewed;         561 AA.
AC   P78314; A6NNC2; B2R5R6; D3DVR0; O00500; O15373; P78315;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=SH3 domain-binding protein 2;
DE            Short=3BP-2;
GN   Name=SH3BP2; Synonyms=3BP2; ORFNames=RES4-23;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RC   TISSUE=Tonsil;
RA   Gokemeijer J., Deligiannidis K.E., Ligris K., Ernst T.J.;
RT   "3BP2 binds to phosphatidylinositols; linking the hemopoietic tyrosine
RT   kinase c-FES to the cytoplasmic membrane in a phosphorylation
RT   dependent mechanism.";
RL   Blood 88:473A-473A(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RX   MEDLINE=97446134; PubMed=9299232; DOI=10.1006/geno.1997.4849;
RA   Bell S.M., Shaw M., Jou Y.-S., Myers R.M., Knowles M.A.;
RT   "Identification and characterization of the human homologue of SH3BP2,
RT   an SH3 binding domain protein within a common region of deletion at
RT   4p16.3 involved in bladder cancer.";
RL   Genomics 44:163-170(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   MEDLINE=98403881; PubMed=9734812; DOI=10.1093/dnares/5.3.177;
RA   Hadano S., Ishida Y., Ikeda J.-E.;
RT   "The primary structure and genomic organization of five novel
RT   transcripts located close to the Huntington's disease gene on human
RT   chromosome 4p16.3.";
RL   DNA Res. 5:177-186(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   STRUCTURE BY NMR OF 444-558.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH2 domain of human SH3BP2 protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [11]
RP   VARIANTS CRBM GLN-415; PRO-415; ARG-418; HIS-418; LEU-418; ARG-420 AND
RP   GLU-420.
RX   MEDLINE=21275962; PubMed=11381256; DOI=10.1038/88832;
RA   Ueki Y., Tiziani V., Santanna C., Fukai N., Maulik C., Garfinkle J.,
RA   Ninomiya C., doAmaral C., Peters H., Habal M., Rhee-Morris L.,
RA   Doss J.B., Kreiborg S., Olsen B.R., Reichenberger E.;
RT   "Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause
RT   cherubism.";
RL   Nat. Genet. 28:125-126(2001).
RN   [12]
RP   VARIANT CRBM ARG-420.
RX   MEDLINE=22781491; PubMed=12900899; DOI=10.1002/ajmg.a.20226;
RA   Lo B., Faiyaz-Ul-Haque M., Kennedy S., Aviv R., Tsui L.-C.,
RA   Teebi A.S.;
RT   "Novel mutation in the gene encoding c-Abl-binding protein SH3BP2
RT   causes cherubism.";
RL   Am. J. Med. Genet. A 121:37-40(2003).
RN   [13]
RP   VARIANT CRBM ARG-418.
RX   PubMed=14577811; DOI=10.1597/1545-1569(2003)040<0632:AMMITS>2.0.CO;2;
RA   Imai Y., Kanno K., Moriya T., Kayano S., Seino H., Matsubara Y.,
RA   Yamada A.;
RT   "A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in
RT   a case of nonfamilial cherubism.";
RL   Cleft Palate Craniofac. J. 40:632-638(2003).
CC   -!- FUNCTION: Binds differentially to the SH3 domains of certain
CC       proteins of signal transduction pathways. Binds to
CC       phosphatidylinositols; linking the hemopoietic tyrosine kinase fes
CC       to the cytoplasmic membrane in a phosphorylation dependent
CC       mechanism.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P78314-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P78314-2; Sequence=VSP_004085, VSP_004086;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay;
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of tissues including
CC       lung, liver, skeletal muscle, kidney and pancreas.
CC   -!- PTM: Phosphorylated. Phosphorylation at Tyr-448 may stimulate the
CC       activity of the LYN kinase (By similarity).
CC   -!- DISEASE: Defects in SH3BP2 are the cause of cherubism (CRBM)
CC       [MIM:118400]. CRBM is an autosomal dominant inherited syndrome
CC       characterized by excessive bone degradation of the upper and lower
CC       jaws, which often begins around three years of age. It is followed
CC       by development of fibrous tissue masses, which causes a
CC       characteristic facial swelling.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/SH3BP2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000936; AAB59973.1; -; mRNA.
DR   EMBL; U56386; AAB72034.1; -; mRNA.
DR   EMBL; AB000462; BAA19119.1; -; mRNA.
DR   EMBL; AB000463; BAA19120.1; -; mRNA.
DR   EMBL; AK312286; BAG35213.1; -; mRNA.
DR   EMBL; AL121750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471131; EAW82509.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82510.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82511.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82512.1; -; Genomic_DNA.
DR   EMBL; BC022996; AAH22996.1; -; mRNA.
DR   IPI; IPI00218997; -.
DR   IPI; IPI00219071; -.
DR   RefSeq; NP_001116153.1; NM_001122681.1.
DR   RefSeq; NP_001139327.1; NM_001145855.1.
DR   RefSeq; NP_001139328.1; NM_001145856.1.
DR   RefSeq; NP_003014.3; NM_003023.4.
DR   UniGene; Hs.167679; -.
DR   PDB; 2CR4; NMR; -; A=446-558.
DR   PDB; 3TWR; X-ray; 1.55 A; E/F/G/H=410-425.
DR   PDBsum; 2CR4; -.
DR   PDBsum; 3TWR; -.
DR   ProteinModelPortal; P78314; -.
DR   SMR; P78314; 26-130, 444-560.
DR   IntAct; P78314; 3.
DR   MINT; MINT-254189; -.
DR   STRING; P78314; -.
DR   PhosphoSite; P78314; -.
DR   DMDM; 3023207; -.
DR   PRIDE; P78314; -.
DR   Ensembl; ENST00000356331; ENSP00000348685; ENSG00000087266.
DR   Ensembl; ENST00000442312; ENSP00000388152; ENSG00000087266.
DR   Ensembl; ENST00000452765; ENSP00000409746; ENSG00000087266.
DR   GeneID; 6452; -.
DR   KEGG; hsa:6452; -.
DR   UCSC; uc003gfi.4; human.
DR   CTD; 6452; -.
DR   GeneCards; GC04P002831; -.
DR   H-InvDB; HIX0004037; -.
DR   HGNC; HGNC:10825; SH3BP2.
DR   HPA; HPA036790; -.
DR   MIM; 118400; phenotype.
DR   MIM; 602104; gene.
DR   neXtProt; NX_P78314; -.
DR   Orphanet; 184; Cherubism.
DR   PharmGKB; PA35733; -.
DR   eggNOG; NOG42035; -.
DR   GeneTree; ENSGT00390000002216; -.
DR   HOVERGEN; HBG000016; -.
DR   InParanoid; P78314; -.
DR   KO; K07984; -.
DR   OrthoDB; EOG4SN1P6; -.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   EvolutionaryTrace; P78314; -.
DR   NextBio; 25079; -.
DR   ArrayExpress; P78314; -.
DR   Bgee; P78314; -.
DR   CleanEx; HS_SH3BP2; -.
DR   Genevestigator; P78314; -.
DR   GermOnline; ENSG00000087266; Homo sapiens.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 1.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   InterPro; IPR011993; PH_like_dom.
DR   InterPro; IPR001849; Pleckstrin_homology.
DR   InterPro; IPR000980; SH2.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00017; SH2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Disease mutation; Phosphoprotein; Reference proteome; SH2 domain;
KW   SH3-binding.
FT   CHAIN         1    561       SH3 domain-binding protein 2.
FT                                /FTId=PRO_0000064365.
FT   DOMAIN       26    130       PH.
FT   DOMAIN      457    555       SH2.
FT   MOTIF       201    210       SH3-binding.
FT   COMPBIAS    205    212       Poly-Pro.
FT   COMPBIAS    236    240       Poly-Pro.
FT   MOD_RES     174    174       Phosphotyrosine; by SYK (By similarity).
FT   MOD_RES     183    183       Phosphotyrosine; by SYK (By similarity).
FT   MOD_RES     278    278       Phosphoserine.
FT   MOD_RES     444    444       Phosphoserine (By similarity).
FT   MOD_RES     448    448       Phosphotyrosine; by SYK (By similarity).
FT   VAR_SEQ      81     97       VMRAAEETTSNNVFPFK -> QPRPQPAQALSQTEAGP
FT                                (in isoform Short).
FT                                /FTId=VSP_004085.
FT   VAR_SEQ      98    561       Missing (in isoform Short).
FT                                /FTId=VSP_004086.
FT   VARIANT     415    415       R -> P (in CRBM).
FT                                /FTId=VAR_013257.
FT   VARIANT     415    415       R -> Q (in CRBM).
FT                                /FTId=VAR_013258.
FT   VARIANT     418    418       P -> H (in CRBM).
FT                                /FTId=VAR_013259.
FT   VARIANT     418    418       P -> L (in CRBM).
FT                                /FTId=VAR_013260.
FT   VARIANT     418    418       P -> R (in CRBM).
FT                                /FTId=VAR_013261.
FT   VARIANT     420    420       G -> E (in CRBM; dbSNP:rs28938171).
FT                                /FTId=VAR_013262.
FT   VARIANT     420    420       G -> R (in CRBM; dbSNP:rs28938170).
FT                                /FTId=VAR_013263.
FT   CONFLICT     27     27       V -> L (in Ref. 3; AAB59973).
FT   CONFLICT    224    224       H -> N (in Ref. 3; AAB59973).
FT   CONFLICT    249    249       L -> R (in Ref. 3; AAB59973).
FT   CONFLICT    251    251       A -> P (in Ref. 3; AAB59973).
FT   TURN        455    457
FT   HELIX       464    474
FT   STRAND      485    489
FT   STRAND      496    501
FT   TURN        503    505
FT   STRAND      506    508
FT   STRAND      514    516
FT   STRAND      519    525
FT   STRAND      527    530
FT   HELIX       531    538
FT   STRAND      544    548
FT   STRAND      553    556
SQ   SEQUENCE   561 AA;  62244 MW;  69E6846A4F6D8F15 CRC64;
     MAAEEMHWPV PMKAIGAQNL LTMPGGVAKA GYLHKKGGTQ LQLLKWPLRF VIIHKRCVYY
     FKSSTSASPQ GAFSLSGYNR VMRAAEETTS NNVFPFKIIH ISKKHRTWFF SASSEEERKS
     WMALLRREIG HFHEKKDLPL DTSDSSSDTD SFYGAVERPV DISLSPYPTD NEDYEHDDED
     DSYLEPDSPE PGRLEDALMH PPAYPPPPVP TPRKPAFSDM PRAHSFTSKG PGPLLPPPPP
     KHGLPDVGLA AEDSKRDPLC PRRAEPCPRV PATPRRMSDP PLSTMPTAPG LRKPPCFRES
     ASPSPEPWTP GHGACSTSSA AIMATATSRN CDKLKSFHLS PRGPPTSEPP PVPANKPKFL
     KIAEEDPPRE AAMPGLFVPP VAPRPPALKL PVPEAMARPA VLPRPEKPQL PHLQRSPPDG
     QSFRSFSFEK PRQPSQADTG GDDSDEDYEK VPLPNSVFVN TTESCEVERL FKATSPRGEP
     QDGLYCIRNS STKSGKVLVV WDETSNKVRN YRIFEKDSKF YLEGEVLFVS VGSMVEHYHT
     HVLPSHQSLL LRHPYGYTGP R
//
ID   3BP5L_HUMAN             Reviewed;         393 AA.
AC   Q7L8J4; Q96FI5; Q9BQH8; Q9C0E3;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   18-APR-2012, entry version 68.
DE   RecName: Full=SH3 domain-binding protein 5-like;
DE            Short=SH3BP-5-like;
GN   Name=SH3BP5L; Synonyms=KIAA1720; ORFNames=UNQ2766/PRO7133;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=21082932; PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   MEDLINE=21154917; PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   MEDLINE=22887296; PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; SER-350 AND
RP   SER-362, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- SIMILARITY: Belongs to the SH3BP5 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB21811.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB051507; BAB21811.1; ALT_INIT; mRNA.
DR   EMBL; AL136569; CAB66504.1; -; mRNA.
DR   EMBL; AY358453; AAQ88818.1; -; mRNA.
DR   EMBL; AK056382; BAB71171.1; -; mRNA.
DR   EMBL; AL732583; CAI18798.1; -; Genomic_DNA.
DR   EMBL; CH471257; EAW57534.1; -; Genomic_DNA.
DR   EMBL; BC010871; AAH10871.1; -; mRNA.
DR   EMBL; BC017254; AAH17254.1; -; mRNA.
DR   IPI; IPI00028359; -.
DR   RefSeq; NP_085148.1; NM_030645.1.
DR   UniGene; Hs.298573; -.
DR   ProteinModelPortal; Q7L8J4; -.
DR   IntAct; Q7L8J4; 2.
DR   MINT; MINT-1688351; -.
DR   PhosphoSite; Q7L8J4; -.
DR   DMDM; 74749902; -.
DR   PRIDE; Q7L8J4; -.
DR   Ensembl; ENST00000366472; ENSP00000355428; ENSG00000175137.
DR   GeneID; 80851; -.
DR   KEGG; hsa:80851; -.
DR   UCSC; uc001iev.1; human.
DR   CTD; 80851; -.
DR   GeneCards; GC01M249104; -.
DR   H-InvDB; HIX0021856; -.
DR   HGNC; HGNC:29360; SH3BP5L.
DR   HPA; HPA038068; -.
DR   neXtProt; NX_Q7L8J4; -.
DR   PharmGKB; PA142670923; -.
DR   eggNOG; NOG263345; -.
DR   GeneTree; ENSGT00390000018500; -.
DR   HOGENOM; HBG716595; -.
DR   HOVERGEN; HBG057307; -.
DR   InParanoid; Q7L8J4; -.
DR   OMA; GVRGGRH; -.
DR   OrthoDB; EOG4PZJ78; -.
DR   NextBio; 71284; -.
DR   ArrayExpress; Q7L8J4; -.
DR   Bgee; Q7L8J4; -.
DR   CleanEx; HS_SH3BP5L; -.
DR   Genevestigator; Q7L8J4; -.
DR   InterPro; IPR007940; SH3-bd_5.
DR   PANTHER; PTHR19423; SH3_bd_5; 1.
DR   Pfam; PF05276; SH3BP5; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Complete proteome; Phosphoprotein; Reference proteome.
FT   CHAIN         1    393       SH3 domain-binding protein 5-like.
FT                                /FTId=PRO_0000317508.
FT   COILED       59    140       Potential.
FT   COILED      169    272       Potential.
FT   COMPBIAS     37     40       Poly-Gly.
FT   COMPBIAS     41     44       Poly-Ser.
FT   COMPBIAS     52     55       Poly-Glu.
FT   MOD_RES     343    343       Phosphoserine.
FT   MOD_RES     350    350       Phosphoserine.
FT   MOD_RES     362    362       Phosphoserine.
FT   MOD_RES     378    378       Phosphoserine (By similarity).
SQ   SEQUENCE   393 AA;  43499 MW;  3693431765F90FDC CRC64;
     MAELRQVPGG RETPQGELRP EVVEDEVPRS PVAEEPGGGG SSSSEAKLSP REEEELDPRI
     QEELEHLNQA SEEINQVELQ LDEARTTYRR ILQESARKLN TQGSHLGSCI EKARPYYEAR
     RLAKEAQQET QKAALRYERA VSMHNAAREM VFVAEQGVMA DKNRLDPTWQ EMLNHATCKV
     NEAEEERLRG EREHQRVTRL CQQAEARVQA LQKTLRRAIG KSRPYFELKA QFSQILEEHK
     AKVTELEQQV AQAKTRYSVA LRNLEQISEQ IHARRRGGLP PHPLGPRRSS PVGAEAGPED
     MEDGDSGIEG AEGAGLEEGS SLGPGPAPDT DTLSLLSLRT VASDLQKCDS VEHLRGLSDH
     VSLDGQELGT RSGGRRGSDG GARGGRHQRS VSL
//
ID   3BP5_HUMAN              Reviewed;         455 AA.
AC   O60239; B3KQW6; Q5JWV9;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=SH3 domain-binding protein 5;
DE            Short=SH3BP-5;
DE   AltName: Full=SH3 domain-binding protein that preferentially associates with BTK;
GN   Name=SH3BP5; Synonyms=SAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Adrenal gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-455 (ISOFORM 1), FUNCTION,
RP   INTERACTION WITH BTK, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   MEDLINE=98238637; PubMed=9571151; DOI=10.1006/bbrc.1998.8420;
RA   Matsushita M., Yamadori T., Kato S., Takemoto Y., Inazawa J., Baba Y.,
RA   Hashimoto S., Sekine S., Arai S., Kunikata T., Kurimoto M.,
RA   Kishimoto T., Tsukada S.;
RT   "Identification and characterization of a novel SH3-domain binding
RT   protein, Sab, which preferentially associates with Bruton's tyrosine
RT   kinase (Btk).";
RL   Biochem. Biophys. Res. Commun. 245:337-343(1998).
RN   [7]
RP   INTERACTION WITH BTK, AND FUNCTION.
RX   MEDLINE=99272695; PubMed=10339589; DOI=10.1073/pnas.96.11.6341;
RA   Yamadori T., Baba Y., Mastushita M., Hashimoto S., Kurosaki M.,
RA   Kurosaki T., Kishimoto T., Tsukada S.;
RT   "Bruton's tyrosine kinase activity is negatively regulated by Sab, the
RT   Btk-SH3 domain-binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6341-6346(1999).
RN   [8]
RP   INTERACTION WITH MAPK8; MAPK9 AND MAPK10, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LEU-347; LEU-349; LEU-434 AND LEU-436.
RX   MEDLINE=22280328; PubMed=12167088; DOI=10.1042/BJ20020553;
RA   Wiltshire C., Matsushita M., Tsukada S., Gillespie D.A., May G.H.;
RT   "A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab
RT   (SH3BP5), associates with mitochondria.";
RL   Biochem. J. 367:577-585(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Inhibits the auto- and transphosphorylation activity of
CC       BTK. Plays a negative regulatory role in BTK-related cytoplasmic
CC       signaling in B-cells. May be involved in BCR-induced apoptotic
CC       cell death.
CC   -!- SUBUNIT: Interacts with BTK. Interacts with all isoforms of MAPK8,
CC       MAPK9, MAPK10 and MAPK12.
CC   -!- INTERACTION:
CC       Q06187:BTK; NbExp=4; IntAct=EBI-624860, EBI-624835;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60239-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60239-2; Sequence=VSP_042854;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis and ovaries. It is
CC       also expressed in a variety of tissues including spleen, lymph
CC       node, thymus, bone marrow, fetal liver, colon, small intestine and
CC       prostate.
CC   -!- SIMILARITY: Belongs to the SH3BP5 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25922.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK090524; BAG52178.1; -; mRNA.
DR   EMBL; AC087590; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117422; CAI46220.1; -; mRNA.
DR   EMBL; CH471055; EAW64225.1; -; Genomic_DNA.
DR   EMBL; BC010123; AAH10123.2; -; mRNA.
DR   EMBL; AB005047; BAA25922.1; ALT_INIT; mRNA.
DR   IPI; IPI00744182; -.
DR   IPI; IPI00914942; -.
DR   PIR; JE0086; JE0086.
DR   RefSeq; NP_004835.2; NM_004844.3.
DR   UniGene; Hs.257761; -.
DR   UniGene; Hs.726063; -.
DR   ProteinModelPortal; O60239; -.
DR   IntAct; O60239; 6.
DR   STRING; O60239; -.
DR   PhosphoSite; O60239; -.
DR   PRIDE; O60239; -.
DR   DNASU; 9467; -.
DR   Ensembl; ENST00000253688; ENSP00000253688; ENSG00000131370.
DR   Ensembl; ENST00000383791; ENSP00000373301; ENSG00000131370.
DR   GeneID; 9467; -.
DR   KEGG; hsa:9467; -.
DR   UCSC; uc003bzp.1; human.
DR   CTD; 9467; -.
DR   GeneCards; GC03M015296; -.
DR   H-InvDB; HIX0003100; -.
DR   HGNC; HGNC:10827; SH3BP5.
DR   HPA; HPA036445; -.
DR   MIM; 605612; gene.
DR   neXtProt; NX_O60239; -.
DR   PharmGKB; PA35735; -.
DR   eggNOG; NOG263345; -.
DR   GeneTree; ENSGT00390000018500; -.
DR   HOGENOM; HBG716674; -.
DR   HOVERGEN; HBG018168; -.
DR   InParanoid; O60239; -.
DR   OMA; KYNAAMG; -.
DR   OrthoDB; EOG4Q84XV; -.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   NextBio; 35476; -.
DR   ArrayExpress; O60239; -.
DR   Bgee; O60239; -.
DR   CleanEx; HS_SH3BP5; -.
DR   Genevestigator; O60239; -.
DR   GermOnline; ENSG00000131370; Homo sapiens.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; IDA:MGI.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:MGI.
DR   InterPro; IPR007940; SH3-bd_5.
DR   PANTHER; PTHR19423; SH3_bd_5; 1.
DR   Pfam; PF05276; SH3BP5; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Mitochondrion;
KW   Phosphoprotein; Reference proteome; SH3-binding.
FT   CHAIN         1    455       SH3 domain-binding protein 5.
FT                                /FTId=PRO_0000064368.
FT   COMPBIAS     11     67       Glu-rich.
FT   COMPBIAS     36     40       Poly-Glu.
FT   COMPBIAS    278    421       Ser-rich.
FT   COMPBIAS    405    410       Poly-Ser.
FT   MOD_RES     351    351       Phosphoserine; by MAPK12 and MAPK9 (By
FT                                similarity).
FT   MOD_RES     418    418       Phosphoserine (By similarity).
FT   MOD_RES     421    421       Phosphoserine.
FT   VAR_SEQ       1    157       Missing (in isoform 2).
FT                                /FTId=VSP_042854.
FT   MUTAGEN     347    347       L->A: Loss of phosphorylation and binding
FT                                by phospho-JNK; when associated with A-
FT                                349.
FT   MUTAGEN     349    349       L->A: Loss of phosphorylation and binding
FT                                by phospho-JNK; when associated with A-
FT                                347.
FT   MUTAGEN     434    434       L->A: No change of phosphorylation or
FT                                binding by phospho-JNK; when associated
FT                                with A-436.
FT   MUTAGEN     436    436       L->A: No change of phosphorylation or
FT                                binding by phospho-JNK; when associated
FT                                with A-434.
SQ   SEQUENCE   455 AA;  50425 MW;  5C8CA4861D66346B CRC64;
     MDAALKRSRS EEPAEILPPA RDEEEEEEEG MEQGLEEEEE VDPRIQGELE KLNQSTDDIN
     RRETELEDAR QKFRSVLVEA TVKLDELVKK IGKAVEDSKP YWEARRVARQ AQLEAQKATQ
     DFQRATEVLR AAKETISLAE QRLLEDDKRQ FDSAWQEMLN HATQRVMEAE QTKTRSELVH
     KETAARYNAA MGRMRQLEKK LKRAINKSKP YFELKAKYYV QLEQLKKTVD DLQAKLTLAK
     GEYKMALKNL EMISDEIHER RRSSAMGPRG CGVGAEGSST SVEDLPGSKP EPDAISVASE
     AFEDDSCSNF VSEDDSETQS VSSFSSGPTS PSEMPDQFPA VVRPGSLDLP SPVSLSEFGM
     MFPVLGPRSE CSGASSPECE VERGDRAEGA ENKTSDKANN NRGLSSSSGS GGSSKSQSST
     SPEGQALENR MKQLSLQCSK GRDGIIADIK MVQIG
//
ID   3HAO_HUMAN              Reviewed;         286 AA.
AC   P46952; A6NE56; B4DIN2; Q53QZ7; Q8N6N9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   18-APR-2012, entry version 109.
DE   RecName: Full=3-hydroxyanthranilate 3,4-dioxygenase;
DE            EC=1.13.11.6;
DE   AltName: Full=3-hydroxyanthranilate oxygenase;
DE            Short=3-HAO;
DE   AltName: Full=3-hydroxyanthranilic acid dioxygenase;
DE            Short=HAD;
GN   Name=HAAO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, AND VARIANT VAL-37.
RX   MEDLINE=94245687; PubMed=7514594;
RA   Malherbe P., Kohler C., da Prada M., Lang G., Kiefer V., Schwarcz R.,
RA   Lahm H., Cesura A.M.;
RT   "Molecular cloning and functional expression of human 3-
RT   hydroxyanthranilic-acid dioxygenase.";
RL   J. Biol. Chem. 269:13792-13797(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-37.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-37.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH NICKEL IONS.
RG   Center for eukaryotic structural genomics (CESG);
RT   "Crystal structure of human 3-hydroxyanthranilate 3,4-dioxygenase.";
RL   Submitted (AUG-2007) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the oxidative ring opening of 3-
CC       hydroxyanthranilate to 2-amino-3-carboxymuconate semialdehyde,
CC       which spontaneously cyclizes to quinolinate.
CC   -!- CATALYTIC ACTIVITY: 3-hydroxyanthranilate + O(2) = 2-amino-3-
CC       carboxymuconate semialdehyde.
CC   -!- COFACTOR: Fe(2+) ion.
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate
CC       from L-kynurenine: step 3/3.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P46952-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P46952-2; Sequence=VSP_036239;
CC   -!- SIMILARITY: Belongs to the 3-HAO family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z29481; CAA82618.1; -; mRNA.
DR   EMBL; CR457063; CAG33344.1; -; mRNA.
DR   EMBL; CR624693; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK295693; BAG58544.1; -; mRNA.
DR   EMBL; AC098824; AAY14701.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00309.1; -; Genomic_DNA.
DR   EMBL; BC029510; AAH29510.1; -; mRNA.
DR   IPI; IPI00009375; -.
DR   IPI; IPI00921062; -.
DR   PIR; A54070; A54070.
DR   RefSeq; NP_036337.2; NM_012205.2.
DR   UniGene; Hs.368805; -.
DR   PDB; 2QNK; X-ray; 1.60 A; A=2-286.
DR   PDBsum; 2QNK; -.
DR   ProteinModelPortal; P46952; -.
DR   SMR; P46952; 2-286.
DR   IntAct; P46952; 1.
DR   MINT; MINT-1468803; -.
DR   STRING; P46952; -.
DR   PhosphoSite; P46952; -.
DR   DMDM; 308153402; -.
DR   PRIDE; P46952; -.
DR   DNASU; 23498; -.
DR   Ensembl; ENST00000294973; ENSP00000294973; ENSG00000162882.
DR   GeneID; 23498; -.
DR   KEGG; hsa:23498; -.
DR   UCSC; uc002rst.4; human.
DR   CTD; 23498; -.
DR   GeneCards; GC02M042994; -.
DR   HGNC; HGNC:4796; HAAO.
DR   HPA; HPA036394; -.
DR   MIM; 604521; gene.
DR   neXtProt; NX_P46952; -.
DR   PharmGKB; PA29171; -.
DR   eggNOG; NOG77058; -.
DR   GeneTree; ENSGT00390000013008; -.
DR   HOGENOM; HBG717838; -.
DR   HOVERGEN; HBG000018; -.
DR   InParanoid; P46952; -.
DR   KO; K00452; -.
DR   OMA; FYCKDLG; -.
DR   OrthoDB; EOG4F4SBR; -.
DR   BioCyc; MetaCyc:MONOMER-15008; -.
DR   Reactome; REACT_111217; Metabolism.
DR   EvolutionaryTrace; P46952; -.
DR   NextBio; 45867; -.
DR   ArrayExpress; P46952; -.
DR   Bgee; P46952; -.
DR   CleanEx; HS_HAAO; -.
DR   Genevestigator; P46952; -.
DR   GermOnline; ENSG00000162882; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005625; C:soluble fraction; IDA:UniProtKB.
DR   GO; GO:0000334; F:3-hydroxyanthranilate 3,4-dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; NAS:UniProtKB.
DR   GO; GO:0008198; F:ferrous iron binding; IDA:UniProtKB.
DR   GO; GO:0070050; P:neuron homeostasis; IMP:UniProtKB.
DR   GO; GO:0019363; P:pyridine nucleotide biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0019805; P:quinolinate biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0046686; P:response to cadmium ion; IDA:UniProtKB.
DR   GO; GO:0010043; P:response to zinc ion; IDA:UniProtKB.
DR   GO; GO:0006569; P:tryptophan catabolic process; TAS:Reactome.
DR   InterPro; IPR010329; 3hydroanth_dOase.
DR   InterPro; IPR016700; 3hydroanth_dOase_met.
DR   InterPro; IPR011051; Cupin_RmlC_type.
DR   PANTHER; PTHR15497; PTHR15497; 1.
DR   Pfam; PF06052; 3-HAO; 1.
DR   PIRSF; PIRSF017681; 3hydroanth_dOase_animal; 1.
DR   SUPFAM; SSF51182; RmlC_like_cupin; 2.
DR   TIGRFAMs; TIGR03037; Anthran_nbaC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Dioxygenase; Iron; Metal-binding; Oxidoreductase; Polymorphism;
KW   Pyridine nucleotide biosynthesis; Reference proteome.
FT   CHAIN         1    286       3-hydroxyanthranilate 3,4-dioxygenase.
FT                                /FTId=PRO_0000064372.
FT   REGION        1    160       Domain A (catalytic) (By similarity).
FT   REGION      161    177       Linker (By similarity).
FT   REGION      178    286       Domain B (By similarity).
FT   METAL        47     47       Iron; catalytic (By similarity).
FT   METAL        53     53       Iron; catalytic (By similarity).
FT   METAL        91     91       Iron; catalytic (By similarity).
FT   BINDING      43     43       Dioxygen (By similarity).
FT   BINDING      53     53       Substrate (By similarity).
FT   BINDING      95     95       Substrate (By similarity).
FT   BINDING     105    105       Substrate (By similarity).
FT   VAR_SEQ     148    286       Missing (in isoform 2).
FT                                /FTId=VSP_036239.
FT   VARIANT      37     37       I -> V (in dbSNP:rs3816183).
FT                                /FTId=VAR_021507.
FT   VARIANT      42     42       T -> S (in dbSNP:rs3816182).
FT                                /FTId=VAR_030470.
FT   STRAND        4      6
FT   HELIX         7     13
FT   HELIX        15     17
FT   TURN         20     22
FT   STRAND       24     37
FT   STRAND       46     48
FT   STRAND       53     60
FT   STRAND       62     68
FT   STRAND       71     77
FT   STRAND       81     85
FT   STRAND       91     95
FT   STRAND      100    106
FT   STRAND      114    120
FT   STRAND      123    132
FT   HELIX       137    149
FT   HELIX       152    156
FT   HELIX       161    163
FT   HELIX       183    189
FT   HELIX       191    195
FT   STRAND      200    203
FT   STRAND      207    214
FT   STRAND      216    221
FT   STRAND      228    235
FT   STRAND      237    241
FT   STRAND      244    248
FT   STRAND      252    256
FT   STRAND      262    266
FT   STRAND      271    277
FT   HELIX       279    281
SQ   SEQUENCE   286 AA;  32556 MW;  4DA6AC20FC6EC885 CRC64;
     MERRLGVRAW VKENRGSFQP PVCNKLMHQE QLKVMFIGGP NTRKDYHIEE GEEVFYQLEG
     DMVLRVLEQG KHRDVVIRQG EIFLLPARVP HSPQRFANTV GLVVERRRLE TELDGLRYYV
     GDTMDVLFEK WFYCKDLGTQ LAPIIQEFFS SEQYRTGKPI PDQLLKEPPF PLSTRSIMEP
     MSLDAWLDSH HRELQAGTPL SLFGDTYETQ VIAYGQGSSE GLRQNVDVWL WQLEGSSVVT
     MGGRRLSLAP DDSLLVLAGT SYAWERTQGS VALSVTQDPA CKKPLG
//
ID   3HIDH_HUMAN             Reviewed;         336 AA.
AC   P31937; Q9UDN3;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   18-APR-2012, entry version 124.
DE   RecName: Full=3-hydroxyisobutyrate dehydrogenase, mitochondrial;
DE            Short=HIBADH;
DE            EC=1.1.1.31;
DE   Flags: Precursor;
GN   Name=HIBADH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 37-47.
RC   TISSUE=Liver;
RX   MEDLINE=94147969; PubMed=8313870; DOI=10.1002/elps.11501401181;
RA   Hughes G.J., Frutiger S., Paquet N., Pasquali C., Sanchez J.-C.,
RA   Tissot J.-D., Bairoch A., Appel R.D., Hochstrasser D.F.;
RT   "Human liver protein map: update 1993.";
RL   Electrophoresis 14:1216-1222(1993).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.38 ANGSTROMS) OF 41-335 OF APOPROTEIN AND IN
RP   COMPLEX WITH NADH.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human hydroxyisobutyrate dehydrogenase.";
RL   Submitted (APR-2006) to the PDB data bank.
CC   -!- CATALYTIC ACTIVITY: 3-hydroxy-2-methylpropanoate + NAD(+) = 2-
CC       methyl-3-oxopropanoate + NADH.
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- SIMILARITY: Belongs to the 3-hydroxyisobutyrate dehydrogenase
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005091; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032324; AAH32324.1; -; mRNA.
DR   IPI; IPI00013860; -.
DR   RefSeq; NP_689953.1; NM_152740.3.
DR   UniGene; Hs.406758; -.
DR   PDB; 2GF2; X-ray; 2.38 A; A/B/C/D=41-335.
DR   PDB; 2I9P; X-ray; 2.55 A; A/B/C/D=41-336.
DR   PDBsum; 2GF2; -.
DR   PDBsum; 2I9P; -.
DR   ProteinModelPortal; P31937; -.
DR   SMR; P31937; 41-335.
DR   STRING; P31937; -.
DR   PhosphoSite; P31937; -.
DR   DMDM; 12643395; -.
DR   Siena-2DPAGE; P31937; -.
DR   SWISS-2DPAGE; P31937; -.
DR   PRIDE; P31937; -.
DR   DNASU; 11112; -.
DR   Ensembl; ENST00000265395; ENSP00000265395; ENSG00000106049.
DR   GeneID; 11112; -.
DR   KEGG; hsa:11112; -.
DR   UCSC; uc003szf.3; human.
DR   CTD; 11112; -.
DR   GeneCards; GC07M027565; -.
DR   H-InvDB; HIX0006550; -.
DR   HGNC; HGNC:4907; HIBADH.
DR   HPA; HPA019522; -.
DR   HPA; HPA021002; -.
DR   MIM; 608475; gene.
DR   neXtProt; NX_P31937; -.
DR   PharmGKB; PA29280; -.
DR   eggNOG; COG2084; -.
DR   GeneTree; ENSGT00530000063270; -.
DR   HOGENOM; HBG729179; -.
DR   HOVERGEN; HBG050424; -.
DR   InParanoid; P31937; -.
DR   KO; K00020; -.
DR   OMA; PMARNLI; -.
DR   OrthoDB; EOG476K0N; -.
DR   PhylomeDB; P31937; -.
DR   Reactome; REACT_111217; Metabolism.
DR   DrugBank; DB00157; NADH.
DR   EvolutionaryTrace; P31937; -.
DR   NextBio; 42238; -.
DR   ArrayExpress; P31937; -.
DR   Bgee; P31937; -.
DR   CleanEx; HS_HIBADH; -.
DR   Genevestigator; P31937; -.
DR   GermOnline; ENSG00000106049; Homo sapiens.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0008442; F:3-hydroxyisobutyrate dehydrogenase activity; NAS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0004616; F:phosphogluconate dehydrogenase (decarboxylating) activity; IEA:InterPro.
DR   GO; GO:0009083; P:branched chain family amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006098; P:pentose-phosphate shunt; IEA:InterPro.
DR   GO; GO:0006573; P:valine metabolic process; NAS:UniProtKB.
DR   Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1.
DR   Gene3D; G3DSA:1.10.1040.10; Opine_DH; 1.
DR   InterPro; IPR002204; 3-OH-isobutyrate_DH-rel_CS.
DR   InterPro; IPR015815; 3hydroxyacid_DH/Rdtase.
DR   InterPro; IPR008927; 6-PGluconate_DH_C-like.
DR   InterPro; IPR006115; 6PGDH_NADP-bd.
DR   InterPro; IPR013328; DH_multihelical.
DR   InterPro; IPR011548; IsoBut3OH_DH.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   PANTHER; PTHR22981; 3hydroxy_acid_DH; 1.
DR   Pfam; PF03446; NAD_binding_2; 1.
DR   SUPFAM; SSF48179; 6DGDH_C_like; 1.
DR   TIGRFAMs; TIGR01692; HIBADH; 1.
DR   PROSITE; PS00895; 3_HYDROXYISOBUT_DH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Mitochondrion; NAD; Oxidoreductase; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     36       Mitochondrion.
FT   CHAIN        37    336       3-hydroxyisobutyrate dehydrogenase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000007158.
FT   NP_BIND      40     68       NAD.
FT   NP_BIND     103    104       NAD.
FT   ACT_SITE    209    209       By similarity.
FT   BINDING     108    108       NAD.
FT   BINDING     134    134       NAD.
FT   BINDING     284    284       NAD.
FT   STRAND       42     45
FT   HELIX        51     60
FT   STRAND       65     68
FT   HELIX        73     79
FT   TURN         80     82
FT   HELIX        89     95
FT   STRAND       97    101
FT   HELIX       106    114
FT   HELIX       119    121
FT   STRAND      128    131
FT   HELIX       137    149
FT   STRAND      153    156
FT   STRAND      159    161
FT   HELIX       162    168
FT   STRAND      171    177
FT   HELIX       179    181
FT   HELIX       182    189
FT   TURN        190    192
FT   STRAND      193    201
FT   HELIX       204    232
FT   HELIX       237    245
FT   HELIX       252    256
FT   TURN        261    263
FT   STRAND      265    267
FT   HELIX       268    271
FT   STRAND      275    278
FT   HELIX       279    295
FT   HELIX       301    314
FT   TURN        315    317
FT   HELIX       323    325
FT   HELIX       326    330
SQ   SEQUENCE   336 AA;  35329 MW;  DA3128774A91AF48 CRC64;
     MAASLRLLGA ASGLRYWSRR LRPAAGSFAA VCSRSVASKT PVGFIGLGNM GNPMAKNLMK
     HGYPLIIYDV FPDACKEFQD AGEQVVSSPA DVAEKADRII TMLPTSINAI EAYSGANGIL
     KKVKKGSLLI DSSTIDPAVS KELAKEVEKM GAVFMDAPVS GGVGAARSGN LTFMVGGVED
     EFAAAQELLG CMGSNVVYCG AVGTGQAAKI CNNMLLAISM IGTAEAMNLG IRLGLDPKLL
     AKILNMSSGR CWSSDTYNPV PGVMDGVPSA NNYQGGFGTT LMAKDLGLAQ DSATSTKSPI
     LLGSLAHQIY RMMCAKGYSK KDFSSVFQFL REEETF
//
ID   3MG_HUMAN               Reviewed;         298 AA.
AC   P29372; Q13770; Q15275; Q15961; Q96BZ6; Q96S33; Q9NNX5;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 3.
DT   18-APR-2012, entry version 138.
DE   RecName: Full=DNA-3-methyladenine glycosylase;
DE            EC=3.2.2.21;
DE   AltName: Full=3-alkyladenine DNA glycosylase;
DE   AltName: Full=3-methyladenine DNA glycosidase;
DE   AltName: Full=ADPG;
DE   AltName: Full=N-methylpurine-DNA glycosylase;
GN   Name=MPG; Synonyms=AAG, ANPG, MID1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   MEDLINE=92021003; PubMed=1924375; DOI=10.1073/pnas.88.20.9127;
RA   Samson L., Derfler B., Boosalis M., Call K.;
RT   "Cloning and characterization of a 3-methyladenine DNA glycosylase
RT   cDNA from human cells whose gene maps to chromosome 16.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9127-9131(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   MEDLINE=93234512; PubMed=8475094; DOI=10.1073/pnas.90.8.3437;
RA   Vickers M.A., Vyas P., Harris P.C., Simmons D.L., Higgs D.R.;
RT   "Structure of the human 3-methyladenine DNA glycosylase gene and
RT   localization close to the 16p telomere.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:3437-3441(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-22; HIS-71;
RP   VAL-258 AND SER-298.
RG   NIEHS SNPs program;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21096910; PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K.,
RA   Tufarelli C., Kearney L., Buckle V.J., Doggett N.A., Flint J.,
RA   Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2
RT   Mb of the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 28-298 (ISOFORMS 1/2).
RX   MEDLINE=91340707; PubMed=1874728;
RA   Chakravarti D., Ibeanu G.C., Tano K., Mitra S.;
RT   "Cloning and expression in Escherichia coli of a human cDNA encoding
RT   the DNA repair protein N-methylpurine-DNA glycosylase.";
RL   J. Biol. Chem. 266:15710-15715(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 69-298 (ISOFORMS 1/2).
RX   MEDLINE=91248199; PubMed=1645538; DOI=10.1016/0006-291X(91)90408-Y;
RA   O'Connor T.R., Laval J.;
RT   "Human cDNA expressing a functional DNA glycosylase excising 3-
RT   methyladenine and 7-methylguanine.";
RL   Biochem. Biophys. Res. Commun. 176:1170-1177(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 230-298 (ISOFORMS 1/2).
RX   MEDLINE=93305988; PubMed=8318735; DOI=10.1007/BF00357090;
RA   Kielman M.F., Smits R., Devi T.S., Fodde R., Bernini L.F.;
RT   "Homology of a 130-kb region enclosing the alpha-globin gene cluster,
RT   the alpha-locus controlling region, and two non-globin genes in human
RT   and mouse.";
RL   Mamm. Genome 4:314-323(1993).
RN   [10]
RP   INTERACTION WITH MBD1.
RX   PubMed=14555760; DOI=10.1073/pnas.2131819100;
RA   Watanabe S., Ichimura T., Fujita N., Tsuruzoe S., Ohki I.,
RA   Shirakawa M., Kawasuji M., Nakao M.;
RT   "Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link
RT   transcriptional repression and DNA repair in chromatin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12859-12864(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 80-199.
RX   MEDLINE=99005192; PubMed=9790531; DOI=10.1016/S0092-8674(00)81755-9;
RA   Lau A.Y., Scharer O.D., Samson L., Verdine G.L., Ellenberger T.;
RT   "Crystal structure of a human alkylbase-DNA repair enzyme complexed to
RT   DNA: mechanisms for nucleotide flipping and base excision.";
RL   Cell 95:249-258(1998).
CC   -!- FUNCTION: Hydrolysis of the deoxyribose N-glycosidic bond to
CC       excise 3-methyladenine, and 7-methylguanine from the damaged DNA
CC       polymer formed by alkylation lesions.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of alkylated DNA, releasing 3-
CC       methyladenine, 3-methylguanine, 7-methylguanine and 7-
CC       methyladenine.
CC   -!- SUBUNIT: Binds MBD1.
CC   -!- INTERACTION:
CC       P04156:PRNP; NbExp=4; IntAct=EBI-1043398, EBI-977302;
CC   -!- SUBCELLULAR LOCATION: Nucleus (Potential).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms;
CC       Name=1;
CC         IsoId=P29372-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29372-2; Sequence=VSP_003249, VSP_035485;
CC   -!- SIMILARITY: Belongs to the DNA glycosylase MPG family.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mpg/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M74905; AAA58627.1; -; mRNA.
DR   EMBL; L10752; AAF77073.1; -; mRNA.
DR   EMBL; AF499437; AAM14628.1; -; Genomic_DNA.
DR   EMBL; AE006462; AAK61213.1; -; Genomic_DNA.
DR   EMBL; Z69720; CAA93540.1; -; Genomic_DNA.
DR   EMBL; BC014991; AAH14991.1; -; mRNA.
DR   EMBL; S51033; AAB19537.1; -; mRNA.
DR   EMBL; X56528; CAA39875.1; -; mRNA.
DR   EMBL; M71215; AAA58369.1; -; mRNA.
DR   EMBL; M99626; AAB46421.1; -; mRNA.
DR   IPI; IPI00218495; -.
DR   IPI; IPI00295497; -.
DR   PIR; A40798; A40798.
DR   PIR; A41230; A41230.
DR   PIR; A47471; A47471.
DR   PIR; JN0062; JN0062.
DR   RefSeq; NP_001015052.1; NM_001015052.1.
DR   RefSeq; NP_001015054.1; NM_001015054.1.
DR   RefSeq; NP_002425.2; NM_002434.2.
DR   UniGene; Hs.459596; -.
DR   PDB; 1BNK; X-ray; 2.70 A; A=80-295.
DR   PDB; 1EWN; X-ray; 2.10 A; A=80-298.
DR   PDB; 1F4R; X-ray; 2.40 A; A=80-298.
DR   PDB; 1F6O; X-ray; 2.40 A; A=80-298.
DR   PDB; 3QI5; X-ray; 2.20 A; A/B=84-298.
DR   PDB; 3UBY; X-ray; 2.00 A; A/B=84-298.
DR   PDBsum; 1BNK; -.
DR   PDBsum; 1EWN; -.
DR   PDBsum; 1F4R; -.
DR   PDBsum; 1F6O; -.
DR   PDBsum; 3QI5; -.
DR   PDBsum; 3UBY; -.
DR   ProteinModelPortal; P29372; -.
DR   SMR; P29372; 80-295.
DR   IntAct; P29372; 1.
DR   STRING; P29372; -.
DR   PhosphoSite; P29372; -.
DR   DMDM; 206729922; -.
DR   PRIDE; P29372; -.
DR   DNASU; 4350; -.
DR   Ensembl; ENST00000219431; ENSP00000219431; ENSG00000103152.
DR   Ensembl; ENST00000397818; ENSP00000380919; ENSG00000103152.
DR   GeneID; 4350; -.
DR   KEGG; hsa:4350; -.
DR   UCSC; uc002cfm.3; human.
DR   CTD; 4350; -.
DR   GeneCards; GC16P000127; -.
DR   H-InvDB; HIX0012638; -.
DR   HGNC; HGNC:7211; MPG.
DR   HPA; HPA006531; -.
DR   MIM; 156565; gene.
DR   neXtProt; NX_P29372; -.
DR   PharmGKB; PA30917; -.
DR   eggNOG; COG2094; -.
DR   GeneTree; ENSGT00390000009825; -.
DR   HOVERGEN; HBG000019; -.
DR   InParanoid; P29372; -.
DR   KO; K03652; -.
DR   OMA; EHISSQY; -.
DR   PhylomeDB; P29372; -.
DR   Reactome; REACT_216; DNA Repair.
DR   EvolutionaryTrace; P29372; -.
DR   NextBio; 17110; -.
DR   ArrayExpress; P29372; -.
DR   Bgee; P29372; -.
DR   CleanEx; HS_MID1; -.
DR   CleanEx; HS_MPG; -.
DR   Genevestigator; P29372; -.
DR   GermOnline; ENSG00000103152; Homo sapiens.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003684; F:damaged DNA binding; TAS:ProtInc.
DR   GO; GO:0008725; F:DNA-3-methyladenine glycosylase activity; IEA:EC.
DR   GO; GO:0052822; F:DNA-3-methylguanine glycosylase activity; IEA:EC.
DR   GO; GO:0052821; F:DNA-7-methyladenine glycosylase activity; IEA:EC.
DR   GO; GO:0043916; F:DNA-7-methylguanine glycosylase activity; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0045007; P:depurination; TAS:Reactome.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; TAS:ProtInc.
DR   Gene3D; G3DSA:3.10.300.10; PurDNA_glycsylse; 1.
DR   InterPro; IPR011034; Formyl_transferase_C-like.
DR   InterPro; IPR003180; PurDNA_glycsylse.
DR   PANTHER; PTHR10429; PurDNA_glycsylse; 1.
DR   Pfam; PF02245; Pur_DNA_glyco; 1.
DR   SUPFAM; SSF50486; FMT_C_like; 1.
DR   TIGRFAMs; TIGR00567; 3mg; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA damage;
KW   DNA repair; Hydrolase; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    298       DNA-3-methyladenine glycosylase.
FT                                /FTId=PRO_0000100065.
FT   MOD_RES      78     78       Phosphoserine.
FT   MOD_RES     252    252       Phosphoserine.
FT   VAR_SEQ       1     12       MVTPALQMKKPK -> MPARSGA (in isoform 2).
FT                                /FTId=VSP_003249.
FT   VAR_SEQ     195    196       QL -> HV (in isoform 2).
FT                                /FTId=VSP_035485.
FT   VARIANT      22     22       K -> Q (in dbSNP:rs3176383).
FT                                /FTId=VAR_019138.
FT   VARIANT      64     64       P -> L (in dbSNP:rs2308315).
FT                                /FTId=VAR_014831.
FT   VARIANT      71     71       Y -> H (in dbSNP:rs2266607).
FT                                /FTId=VAR_014832.
FT   VARIANT      93     93       Q -> R (in dbSNP:rs25671).
FT                                /FTId=VAR_050096.
FT   VARIANT     120    120       R -> C (in dbSNP:rs2308313).
FT                                /FTId=VAR_014833.
FT   VARIANT     141    141       R -> Q (in dbSNP:rs2308312).
FT                                /FTId=VAR_014834.
FT   VARIANT     258    258       A -> V (in dbSNP:rs769193).
FT                                /FTId=VAR_014835.
FT   VARIANT     298    298       A -> S (in dbSNP:rs2234949).
FT                                /FTId=VAR_014836.
FT   CONFLICT     13     13       Q -> QV (in Ref. 4; AAK61213).
FT   CONFLICT     29     31       GQP -> ARA (in Ref. 7; AAB19537).
FT   CONFLICT     44     44       Q -> R (in Ref. 7; AAB19537).
FT   CONFLICT     69     71       GPY -> SKD (in Ref. 8; AAA58369/
FT                                CAA39875).
FT   CONFLICT     82     82       H -> L (in Ref. 8; AAA58369/CAA39875).
FT   CONFLICT    134    134       A -> P (in Ref. 1; AAA58627).
FT   CONFLICT    287    287       V -> E (in Ref. 8; AAA58369).
FT   HELIX        88     91
FT   HELIX        95    102
FT   STRAND      106    110
FT   STRAND      116    127
FT   HELIX       138    140
FT   STRAND      144    146
FT   HELIX       147    150
FT   STRAND      155    161
FT   TURN        162    164
FT   STRAND      165    171
FT   STRAND      178    188
FT   HELIX       190    196
FT   HELIX       211    213
FT   STRAND      214    217
FT   HELIX       218    224
FT   HELIX       229    231
FT   STRAND      240    245
FT   STRAND      256    259
FT   HELIX       269    272
FT   STRAND      276    279
FT   HELIX       290    293
SQ   SEQUENCE   298 AA;  32869 MW;  BEA8C4CB250D572B CRC64;
     MVTPALQMKK PKQFCRRMGQ KKQRPARAGQ PHSSSDAAQA PAEQPHSSSD AAQAPCPRER
     CLGPPTTPGP YRSIYFSSPK GHLTRLGLEF FDQPAVPLAR AFLGQVLVRR LPNGTELRGR
     IVETEAYLGP EDEAAHSRGG RQTPRNRGMF MKPGTLYVYI IYGMYFCMNI SSQGDGACVL
     LRALEPLEGL ETMRQLRSTL RKGTASRVLK DRELCSGPSK LCQALAINKS FDQRDLAQDE
     AVWLERGPLE PSEPAVVAAA RVGVGHAGEW ARKPLRFYVR GSPWVSVVDR VAEQDTQA
//
ID   41_HUMAN                Reviewed;         864 AA.
AC   P11171; B1ALH8; B1ALH9; D3DPM9; D3DPN0; P11176; Q14245; Q5TB35;
AC   Q5VXN8; Q8IXV9; Q9Y578; Q9Y579;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 4.
DT   18-APR-2012, entry version 149.
DE   RecName: Full=Protein 4.1;
DE            Short=P4.1;
DE   AltName: Full=4.1R;
DE   AltName: Full=Band 4.1;
DE   AltName: Full=EPB4.1;
GN   Name=EPB41; Synonyms=E41P;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND PROTEIN SEQUENCE OF
RP   378-393.
RC   TISSUE=Reticulocyte;
RX   MEDLINE=87092279; PubMed=3467321; DOI=10.1073/pnas.83.24.9512;
RA   Conboy J.G., Kan Y.W., Shohet S.B., Mohandas N.;
RT   "Molecular cloning of protein 4.1, a major structural element of the
RT   human erythrocyte membrane skeleton.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:9512-9516(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 6).
RX   MEDLINE=89132003; PubMed=3223413;
RA   Tang T.K., Leto T.L., Marchesi V.T., Benz E.J. Jr.;
RT   "Expression of specific isoforms of protein 4.1 in erythroid and non-
RT   erythroid tissues.";
RL   Adv. Exp. Med. Biol. 241:81-95(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 6).
RX   MEDLINE=88234496; PubMed=3375238; DOI=10.1073/pnas.85.11.3713;
RA   Tang T.K., Leto T.L., Correas I., Alonso M.A., Marchesi V.T.,
RA   Benz E.J. Jr.;
RT   "Selective expression of an erythroid-specific isoform of protein
RT   4.1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:3713-3717(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   MEDLINE=91217063; PubMed=2022644;
RA   Conboy J.G., Chan J.Y.C., Chasis J.A., Kan Y.W., Mohandas N.;
RT   "Tissue- and development-specific alternative RNA splicing regulates
RT   expression of multiple isoforms of erythroid membrane protein 4.1.";
RL   J. Biol. Chem. 266:8273-8280(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Huang S.C., Wang C., Lichtenauer U., Vortmeyer A., Zhuang Z.;
RT   "Sequence of protein 4.1 from a human neuroblastoma cell line: LAN5.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 157-227, AND VARIANT ILE-214.
RA   Lichtenauer U., Huang S.C., Vortmeyer A., Zhuang Z.;
RT   "Valine to isoleucine polymorphism in exon 4 of human protein 4.1.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 669-864 (ISOFORM 4), AND ALTERNATIVE SPLICING.
RX   MEDLINE=89057876; PubMed=3194408; DOI=10.1073/pnas.85.23.9062;
RA   Conboy J.G., Chan J., Mohandas N., Kan Y.W.;
RT   "Multiple protein 4.1 isoforms produced by alternative splicing in
RT   human erythroid cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:9062-9065(1988).
RN   [11]
RP   PROTEIN SEQUENCE OF 534-541; 693-701 AND 793-794, AND PHOSPHORYLATION
RP   AT SERINE RESIDUES.
RX   MEDLINE=91027920; PubMed=2171679; DOI=10.1016/0167-4889(90)90095-U;
RA   Horne W.C., Prinz W.C., Tang E.K.;
RT   "Identification of two cAMP-dependent phosphorylation sites on
RT   erythrocyte protein 4.1.";
RL   Biochim. Biophys. Acta 1055:87-92(1990).
RN   [12]
RP   PROTEIN SEQUENCE OF 648-714.
RX   MEDLINE=87008553; PubMed=3531202;
RA   Correas I., Speicher D.W., Marchesi V.T.;
RT   "Structure of the spectrin-actin binding site of erythrocyte protein
RT   4.1.";
RL   J. Biol. Chem. 261:13362-13366(1986).
RN   [13]
RP   STRUCTURE OF CARBOHYDRATES.
RX   MEDLINE=90036892; PubMed=2808371;
RA   Inaba M., Maede Y.;
RT   "O-N-acetyl-D-glucosamine moiety on discrete peptide of multiple
RT   protein 4.1 isoforms regulated by alternative pathways.";
RL   J. Biol. Chem. 264:18149-18155(1989).
RN   [14]
RP   PHOSPHORYLATION AT TYR-660 BY EGFR.
RX   MEDLINE=91271361; PubMed=1647028; DOI=10.1073/pnas.88.12.5222;
RA   Subrahmanyan G., Bertics P.J., Anderson R.A.;
RT   "Phosphorylation of protein 4.1 on tyrosine-418 modulates its function
RT   in vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:5222-5226(1991).
RN   [15]
RP   INTERACTION WITH DLG1.
RX   MEDLINE=95024052; PubMed=7937897; DOI=10.1073/pnas.91.21.9818;
RA   Lue R.A., Marfatia S.M., Branton D., Chishti A.H.;
RT   "Cloning and characterization of hdlg: the human homologue of the
RT   Drosophila discs large tumor suppressor binds to protein 4.1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:9818-9822(1994).
RN   [16]
RP   INTERACTION WITH CALMODULIN.
RX   MEDLINE=20158947; PubMed=10692436; DOI=10.1074/jbc.275.9.6360;
RA   Nunomura W., Takakuwa Y., Parra M., Conboy J.G., Mohandas N.;
RT   "Ca(2+)-dependent and Ca(2+)-independent calmodulin binding sites in
RT   erythrocyte protein 4.1. Implications for regulation of protein 4.1
RT   interactions with transmembrane proteins.";
RL   J. Biol. Chem. 275:6360-6367(2000).
RN   [17]
RP   INTERACTION WITH CENPJ.
RX   MEDLINE=20459281; PubMed=11003675;
RX   DOI=10.1128/MCB.20.20.7813-7825.2000;
RA   Hung L.-Y., Tang C.J., Tang T.K.;
RT   "Protein 4.1 R-135 interacts with a novel centrosomal protein (CPAP)
RT   which is associated with the gamma-tubulin complex.";
RL   Mol. Cell. Biol. 20:7813-7825(2000).
RN   [18]
RP   CHARACTERIZATION OF C-TERMINAL DOMAIN.
RX   MEDLINE=21325946; PubMed=11432737;
RX   DOI=10.1046/j.1432-1327.2001.02276.x;
RA   Scott C., Phillips G.W., Baines A.J.;
RT   "Properties of the C-terminal domain of 4.1 proteins.";
RL   Eur. J. Biochem. 268:3709-3717(2001).
RN   [19]
RP   SUBCELLULAR LOCATION, AND ALTERNATIVE SPLICING.
RX   MEDLINE=22421379; PubMed=12427749; DOI=10.1074/jbc.M201521200;
RA   Luque C.M., Perez-Ferreiro C.M., Perez-Gonzalez A., Englmeier L.,
RA   Koffa M.D., Correas I.;
RT   "An alternative domain containing a leucine-rich sequence regulates
RT   nuclear cytoplasmic localization of protein 4.1R.";
RL   J. Biol. Chem. 278:2686-2691(2003).
RN   [20]
RP   MUTAGENESIS OF THR-60 AND SER-712, AND PHOSPHORYLATION AT THR-60 AND
RP   SER-712.
RX   PubMed=15525677; DOI=10.1091/mbc.E04-05-0426;
RA   Huang S.-C., Liu E.S., Chan S.-H., Munagala I.D., Cho H.T.,
RA   Jagadeeswaran R., Benz E.J. Jr.;
RT   "Mitotic regulation of protein 4.1R involves phosphorylation by cdc2
RT   kinase.";
RL   Mol. Biol. Cell 16:117-127(2005).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-712, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188; SER-191; SER-555
RP   AND SER-712, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-542, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 210-488.
RX   MEDLINE=20473226; PubMed=11017195; DOI=10.1038/82819;
RA   Han B.-G., Nunomura W., Takakuwa Y., Mohandas N., Jap B.K.;
RT   "Protein 4.1R core domain structure and insights into regulation of
RT   cytoskeletal organization.";
RL   Nat. Struct. Biol. 7:871-875(2000).
CC   -!- FUNCTION: Protein 4.1 is a major structural element of the
CC       erythrocyte membrane skeleton. It plays a key role in regulating
CC       membrane physical properties of mechanical stability and
CC       deformability by stabilizing spectrin-actin interaction. Recruits
CC       DLG1 to membranes.
CC   -!- SUBUNIT: Binds with a high affinity to glycophorin and with lower
CC       affinity to band III protein. Associates with the nuclear mitotic
CC       apparatus. Binds calmodulin, CENPJ and DLG1. Also found to
CC       associate with contractile apparatus and tight junctions.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cell
CC       cortex. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=P11171-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11171-2; Sequence=VSP_000470;
CC       Name=3;
CC         IsoId=P11171-3; Sequence=VSP_000468, VSP_000471;
CC       Name=4; Synonyms=Erythroid;
CC         IsoId=P11171-4; Sequence=VSP_000468, VSP_000470, VSP_000473;
CC       Name=5; Synonyms=Non-erythroid A;
CC         IsoId=P11171-5; Sequence=VSP_000469, VSP_000470, VSP_000472;
CC       Name=6; Synonyms=Non-erythroid B;
CC         IsoId=P11171-6; Sequence=VSP_000468, VSP_000469, VSP_000470,
CC                                  VSP_000472;
CC       Name=7;
CC         IsoId=P11171-7; Sequence=VSP_000471, VSP_012872, VSP_012873;
CC   -!- PTM: Phosphorylated at multiple sites by different protein kinases
CC       and each phosphorylation event selectively modulates the protein's
CC       functions.
CC   -!- PTM: Phosphorylation on Tyr-660 reduces the ability of 4.1 to
CC       promote the assembly of the spectrin/actin/4.1 ternary complex.
CC   -!- PTM: O-glycosylated; contains N-acetylglucosamine side chains in
CC       the C-terminal domain.
CC   -!- DISEASE: Defects in EPB41 are the cause of elliptocytosis type 1
CC       (EL1) [MIM:611804]. EL1 is a Rhesus-linked form of hereditary
CC       elliptocytosis, a genetically heterogeneous, autosomal dominant,
CC       hematologic disorder. It is characterized by variable hemolytic
CC       anemia and elliptical or oval red cell shape.
CC   -!- DISEASE: Defects in EPB41 are a cause of hereditary
CC       pyropoikilocytosis (HPP) [MIM:266140]. HPP is an autosomal
CC       recessive hematologic disorder characterized by hemolytic anemia,
CC       microspherocytosis, poikilocytosis, and an unusual thermal
CC       sensitivity of red cells.
CC   -!- SIMILARITY: Contains 1 FERM domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14993; AAA35795.1; -; mRNA.
DR   EMBL; J03796; AAA35793.1; -; mRNA.
DR   EMBL; J03796; AAA35794.1; -; mRNA.
DR   EMBL; M61733; AAA35797.1; -; mRNA.
DR   EMBL; AF156225; AAD42222.1; -; mRNA.
DR   EMBL; AL138785; CAI21967.1; -; Genomic_DNA.
DR   EMBL; AL357500; CAI21967.1; JOINED; Genomic_DNA.
DR   EMBL; AL138785; CAI21966.1; -; Genomic_DNA.
DR   EMBL; AL357500; CAI21966.1; JOINED; Genomic_DNA.
DR   EMBL; AL138785; CAI21968.1; -; Genomic_DNA.
DR   EMBL; AL138785; CAI21969.1; -; Genomic_DNA.
DR   EMBL; AL357500; CAI21969.1; JOINED; Genomic_DNA.
DR   EMBL; AL138785; CAI21970.1; -; Genomic_DNA.
DR   EMBL; AL357500; CAI21970.1; JOINED; Genomic_DNA.
DR   EMBL; AL357500; CAH71636.1; -; Genomic_DNA.
DR   EMBL; AL138785; CAH71636.1; JOINED; Genomic_DNA.
DR   EMBL; AL357500; CAH71637.1; -; Genomic_DNA.
DR   EMBL; AL138785; CAH71637.1; JOINED; Genomic_DNA.
DR   EMBL; AL357500; CAH71638.1; -; Genomic_DNA.
DR   EMBL; AL138785; CAH71638.1; JOINED; Genomic_DNA.
DR   EMBL; AL357500; CAH71639.1; -; Genomic_DNA.
DR   EMBL; AL138785; CAH71639.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX07663.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07665.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07667.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07668.1; -; Genomic_DNA.
DR   EMBL; BC039079; AAH39079.1; -; mRNA.
DR   EMBL; AF156226; AAD42223.1; -; Genomic_DNA.
DR   IPI; IPI00003921; -.
DR   IPI; IPI00218697; -.
DR   IPI; IPI00218698; -.
DR   IPI; IPI00218699; -.
DR   IPI; IPI00218700; -.
DR   IPI; IPI00218701; -.
DR   IPI; IPI00553103; -.
DR   PIR; A39810; MMHUE4.
DR   RefSeq; NP_001159477.1; NM_001166005.1.
DR   RefSeq; NP_001159478.1; NM_001166006.1.
DR   RefSeq; NP_004428.1; NM_004437.3.
DR   RefSeq; NP_976217.1; NM_203342.2.
DR   RefSeq; NP_976218.1; NM_203343.2.
DR   UniGene; Hs.175437; -.
DR   UniGene; Hs.708933; -.
DR   UniGene; Hs.712722; -.
DR   PDB; 1GG3; X-ray; 2.80 A; A/B/C=210-488.
DR   PDB; 2RQ1; NMR; -; A=292-396.
DR   PDB; 3QIJ; X-ray; 1.80 A; A/B=211-488.
DR   PDBsum; 1GG3; -.
DR   PDBsum; 2RQ1; -.
DR   PDBsum; 3QIJ; -.
DR   ProteinModelPortal; P11171; -.
DR   SMR; P11171; 206-517.
DR   DIP; DIP-17032N; -.
DR   IntAct; P11171; 2.
DR   MINT; MINT-1208648; -.
DR   STRING; P11171; -.
DR   GlycoSuiteDB; P11171; -.
DR   PhosphoSite; P11171; -.
DR   DMDM; 90101808; -.
DR   PRIDE; P11171; -.
DR   DNASU; 2035; -.
DR   Ensembl; ENST00000343067; ENSP00000345259; ENSG00000159023.
DR   Ensembl; ENST00000373798; ENSP00000362904; ENSG00000159023.
DR   GeneID; 2035; -.
DR   KEGG; hsa:2035; -.
DR   UCSC; uc001brg.2; human.
DR   UCSC; uc001brh.2; human.
DR   UCSC; uc001bri.2; human.
DR   UCSC; uc001brk.3; human.
DR   UCSC; uc001brl.2; human.
DR   UCSC; uc001brm.2; human.
DR   UCSC; uc009vtm.2; human.
DR   CTD; 2035; -.
DR   GeneCards; GC01P029213; -.
DR   HGNC; HGNC:3377; EPB41.
DR   HPA; HPA028414; -.
DR   MIM; 130500; gene.
DR   MIM; 266140; phenotype.
DR   MIM; 611804; phenotype.
DR   neXtProt; NX_P11171; -.
DR   Orphanet; 288; Hereditary elliptocytosis.
DR   PharmGKB; PA27810; -.
DR   eggNOG; NOG242913; -.
DR   GeneTree; ENSGT00650000092876; -.
DR   HOVERGEN; HBG007777; -.
DR   InParanoid; P11171; -.
DR   KO; K06107; -.
DR   OMA; HREDPDF; -.
DR   OrthoDB; EOG4K3KVZ; -.
DR   PhylomeDB; P11171; -.
DR   Pathway_Interaction_DB; syndecan_2_pathway; Syndecan-2-mediated signaling events.
DR   EvolutionaryTrace; P11171; -.
DR   NextBio; 8259; -.
DR   PMAP-CutDB; B1ALH9; -.
DR   ArrayExpress; P11171; -.
DR   Bgee; P11171; -.
DR   CleanEx; HS_EPB41; -.
DR   Genevestigator; P11171; -.
DR   GermOnline; ENSG00000159023; Homo sapiens.
DR   GO; GO:0019898; C:extrinsic to membrane; IEA:InterPro.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0008091; C:spectrin; TAS:ProtInc.
DR   GO; GO:0014731; C:spectrin-associated cytoskeleton; TAS:BHF-UCL.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030507; F:spectrin binding; TAS:BHF-UCL.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0030866; P:cortical actin cytoskeleton organization; IEA:InterPro.
DR   GO; GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL.
DR   Gene3D; G3DSA:1.20.80.10; ACBP; 1.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 1.
DR   InterPro; IPR008379; Band_4.1_C.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR019750; Band_41_fam.
DR   InterPro; IPR021187; Band_41_protein.
DR   InterPro; IPR000798; Ez/rad/moesin.
DR   InterPro; IPR014847; FERM-adjacent.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR011993; PH_like_dom.
DR   InterPro; IPR007477; SAB.
DR   Pfam; PF05902; 4_1_CTD; 1.
DR   Pfam; PF08736; FA; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   Pfam; PF04382; SAB; 1.
DR   PIRSF; PIRSF002304; Membrane_skeletal_4_1; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SUPFAM; SSF47031; FERM_3-hlx; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; Calmodulin-binding;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Elliptocytosis; Glycoprotein; Hereditary hemolytic anemia; Nucleus;
KW   Phosphoprotein; Polymorphism; Pyropoikilocytosis; Reference proteome.
FT   CHAIN         1    864       Protein 4.1.
FT                                /FTId=PRO_0000219390.
FT   DOMAIN      210    491       FERM.
FT   REGION      494    614       Hydrophilic.
FT   REGION      615    713       Spectrin--actin-binding.
FT   REGION      714    864       C-terminal (CTD).
FT   MOD_RES      60     60       Phosphothreonine; by CDK1.
FT   MOD_RES      92     92       Phosphoserine.
FT   MOD_RES     188    188       Phosphoserine.
FT   MOD_RES     191    191       Phosphoserine.
FT   MOD_RES     222    222       Phosphotyrosine (By similarity).
FT   MOD_RES     540    540       Phosphoserine (By similarity).
FT   MOD_RES     542    542       Phosphoserine.
FT   MOD_RES     555    555       Phosphoserine.
FT   MOD_RES     660    660       Phosphotyrosine; by EGFR.
FT   MOD_RES     674    674       Phosphoserine (By similarity).
FT   MOD_RES     712    712       Phosphoserine; by CDK1.
FT   VAR_SEQ       1    209       Missing (in isoform 3, isoform 4 and
FT                                isoform 6).
FT                                /FTId=VSP_000468.
FT   VAR_SEQ     228    262       Missing (in isoform 5 and isoform 6).
FT                                /FTId=VSP_000469.
FT   VAR_SEQ     616    648       Missing (in isoform 2, isoform 4, isoform
FT                                5 and isoform 6).
FT                                /FTId=VSP_000470.
FT   VAR_SEQ     635    648       Missing (in isoform 3 and isoform 7).
FT                                /FTId=VSP_000471.
FT   VAR_SEQ     649    669       Missing (in isoform 5 and isoform 6).
FT                                /FTId=VSP_000472.
FT   VAR_SEQ     729    733       PPLVK -> VSTLS (in isoform 7).
FT                                /FTId=VSP_012872.
FT   VAR_SEQ     734    864       Missing (in isoform 7).
FT                                /FTId=VSP_012873.
FT   VAR_SEQ     772    805       Missing (in isoform 4).
FT                                /FTId=VSP_000473.
FT   VARIANT     214    214       V -> I.
FT                                /FTId=VAR_009122.
FT   MUTAGEN      60     60       T->A: Loss of CDK1-mediated
FT                                phosphorylation. Abolishes targeting onto
FT                                the mitotic spindle; when associated with
FT                                A-712.
FT   MUTAGEN     712    712       S->A: Loss of CDK1-mediated
FT                                phosphorylation. Abolishes targeting onto
FT                                the mitotic spindle; when associated with
FT                                A-60.
FT   CONFLICT     51     51       Q -> H (in Ref. 5; AAD42222).
FT   CONFLICT     76     76       S -> N (in Ref. 5; AAD42222).
FT   CONFLICT    168    168       F -> S (in Ref. 9; AAD42223).
FT   CONFLICT    259    259       A -> T (in Ref. 5; AAD42222).
FT   CONFLICT    665    665       N -> S (in Ref. 5; AAD42222).
FT   CONFLICT    669    669       E -> K (in Ref. 10; no nucleotide entry).
FT   CONFLICT    679    679       K -> E (in Ref. 5; AAD42222).
FT   CONFLICT    802    802       Q -> K (in Ref. 2; no nucleotide entry
FT                                and 3; AAA35793/AAA35794).
FT   CONFLICT    852    852       K -> L (in Ref. 10; no nucleotide entry).
FT   CONFLICT    863    863       D -> E (in Ref. 10; no nucleotide entry).
FT   STRAND      211    215
FT   STRAND      221    225
FT   HELIX       232    243
FT   STRAND      250    252
FT   STRAND      254    256
FT   STRAND      259    261
FT   HELIX       271    274
FT   TURN        275    277
FT   STRAND      280    285
FT   HELIX       293    295
FT   HELIX       299    314
FT   HELIX       322    337
FT   HELIX       350    352
FT   HELIX       361    373
FT   HELIX       379    392
FT   TURN        394    397
FT   STRAND      399    402
FT   STRAND      412    426
FT   STRAND      430    433
FT   HELIX       434    436
FT   STRAND      439    443
FT   STRAND      446    450
FT   STRAND      454    458
FT   STRAND      462    466
FT   HELIX       470    486
SQ   SEQUENCE   864 AA;  97017 MW;  B466E7A9D7FBF12B CRC64;
     MTTEKSLVTE AENSQHQQKE EGEEAINSGQ QEPQQEESCQ TAAEGDNWCE QKLKASNGDT
     PTHEDLTKNK ERTSESRGLS RLFSSFLKRP KSQVSEEEGK EVESDKEKGE GGQKEIEFGT
     SLDEEIILKA PIAAPEPELK TDPSLDLHSL SSAETQPAQE ELREDPDFEI KEGEGLEECS
     KIEVKEESPQ SKAETELKAS QKPIRKHRNM HCKVSLLDDT VYECVVEKHA KGQDLLKRVC
     EHLNLLEEDY FGLAIWDNAT SKTWLDSAKE IKKQVRGVPW NFTFNVKFYP PDPAQLTEDI
     TRYYLCLQLR QDIVAGRLPC SFATLALLGS YTIQSELGDY DPELHGVDYV SDFKLAPNQT
     KELEEKVMEL HKSYRSMTPA QADLEFLENA KKLSMYGVDL HKAKDLEGVD IILGVCSSGL
     LVYKDKLRIN RFPWPKVLKI SYKRSSFFIK IRPGEQEQYE STIGFKLPSY RAAKKLWKVC
     VEHHTFFRLT STDTIPKSKF LALGSKFRYS GRTQAQTRQA SALIDRPAPH FERTASKRAS
     RSLDGAAAVD SADRSPRPTS APAITQGQVA EGGVLDASAK KTVVPKAQKE TVKAEVKKED
     EPPEQAEPEP TEAWKVEKTH IEVTVPTSNG DQTQKLAEKT EDLIRMRKKK RERLDGENIY
     IRHSNLMLED LDKSQEEIKK HHASISELKK NFMESVPEPR PSEWDKRLST HSPFRTLNIN
     GQIPTGEGPP LVKTQTVTIS DNANAVKSEI PTKDVPIVHT ETKTITYEAA QTDDNSGDLD
     PGVLLTAQTI TSETPSSTTT TQITKTVKGG ISETRIEKRI VITGDADIDH DQVLVQAIKE
     AKEQHPDMSV TKVVVHQETE IADE
//
ID   4EBP1_HUMAN             Reviewed;         118 AA.
AC   Q13541; B2R502; D3DSW8; Q6IBN3;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   18-APR-2012, entry version 111.
DE   RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 1;
DE            Short=4E-BP1;
DE            Short=eIF4E-binding protein 1;
DE   AltName: Full=Phosphorylated heat- and acid-stable protein regulated by insulin 1;
DE            Short=PHAS-I;
GN   Name=EIF4EBP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH EIF4E, AND
RP   PHOSPHORYLATION.
RC   TISSUE=Placenta;
RX   MEDLINE=95021760; PubMed=7935836; DOI=10.1038/371762a0;
RA   Pause A., Belsham G.J., Gingras A.-C., Donze O., Lin T.-A.,
RA   Lawrence J.C. Jr., Sonenberg N.;
RT   "Insulin-dependent stimulation of protein synthesis by phosphorylation
RT   of a regulator of 5'-cap function.";
RL   Nature 371:762-767(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Ito M., Shichijo S., Tsuda N., Ochi M., Harashima N., Saito N.,
RA   Itoh K.;
RT   "Identification of multiple genes and immunogenic epitopes of
RT   pancreatic cancer cells.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-13, AND ACETYLATION AT SER-2.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   INTERACTION WITH EIF4E AND EIF4G.
RX   MEDLINE=96091142; PubMed=8521827;
RA   Haghighat A., Mader S., Pause A., Sonenberg N.;
RT   "Repression of cap-dependent translation by 4E-binding protein 1:
RT   competition with p220 for binding to eukaryotic initiation factor-
RT   4E.";
RL   EMBO J. 14:5701-5709(1995).
RN   [10]
RP   PHOSPHORYLATION BY MTOR.
RX   PubMed=9465032; DOI=10.1073/pnas.95.4.1432;
RA   Burnett P.E., Barrow R.K., Cohen N.A., Snyder S.H., Sabatini D.M.;
RT   "RAFT1 phosphorylation of the translational regulators p70 S6 kinase
RT   and 4E-BP1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:1432-1437(1998).
RN   [11]
RP   INTERACTION WITH RPTOR.
RX   MEDLINE=22145924; PubMed=12150926; DOI=10.1016/S0092-8674(02)00833-4;
RA   Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S.,
RA   Tokunaga C., Avruch J., Yonezawa K.;
RT   "Raptor, a binding partner of target of rapamycin (TOR), mediates TOR
RT   action.";
RL   Cell 110:177-189(2002).
RN   [12]
RP   INTERACTION WITH RPTOR, AND PHOSPHORYLATION AT THR-37; THR-46; SER-65
RP   AND THR-70 BY MTOR.
RX   PubMed=12747827; DOI=10.1016/S0960-9822(03)00329-4;
RA   Schalm S.S., Fingar D.C., Sabatini D.M., Blenis J.;
RT   "TOS motif-mediated raptor binding regulates 4E-BP1 multisite
RT   phosphorylation and function.";
RL   Curr. Biol. 13:797-806(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-46, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; THR-70; SER-94 AND
RP   SER-101, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65 AND THR-68, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35; THR-36; THR-37;
RP   THR-41; THR-46; THR-50; THR-70; THR-82; SER-83; SER-94 AND SER-101,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37; THR-41; THR-46;
RP   THR-50; TYR-54; SER-65; THR-70; THR-77; SER-83 AND SER-94, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-10; TYR-34; THR-37;
RP   THR-41; SER-44; THR-45 AND THR-46, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND THR-46, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   STRUCTURE BY NMR OF 4-118.
RX   PubMed=9684899;
RA   Fletcher C.M., Wagner G.;
RT   "The interaction of eIF4E with 4E-BP1 is an induced fit to a
RT   completely disordered protein.";
RL   Protein Sci. 7:1639-1642(1998).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 36-70 IN COMPLEX WITH EIF4E
RP   AND MRNA CAP ANALOG.
RX   PubMed=16271312; DOI=10.1016/j.bbapap.2005.07.023;
RA   Tomoo K., Matsushita Y., Fujisaki H., Abiko F., Shen X., Taniguchi T.,
RA   Miyagawa H., Kitamura K., Miura K., Ishida T.;
RT   "Structural basis for mRNA cap-binding regulation of eukaryotic
RT   initiation factor 4E by 4E-binding protein, studied by spectroscopic,
RT   X-ray crystal structural, and molecular dynamics simulation methods.";
RL   Biochim. Biophys. Acta 1753:191-208(2005).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 51-67 IN COMPLEX WITH EIF4E2
RP   AND MRNA CAP ANALOG.
RX   PubMed=17368478; DOI=10.1016/j.jmb.2007.02.019;
RA   Rosettani P., Knapp S., Vismara M.-G., Rusconi L., Cameron A.D.;
RT   "Structures of the human eIF4E homologous protein, h4EHP, in its
RT   m7GTP-bound and unliganded forms.";
RL   J. Mol. Biol. 368:691-705(2007).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 51-64 IN COMPLEX WITH EIF4E
RP   AND MRNA CAP ANALOG.
RX   PubMed=17631896; DOI=10.1016/j.jmb.2007.06.033;
RA   Brown C.J., McNae I., Fischer P.M., Walkinshaw M.D.;
RT   "Crystallographic and mass spectrometric characterisation of eIF4E
RT   with N7-alkylated cap derivatives.";
RL   J. Mol. Biol. 372:7-15(2007).
CC   -!- FUNCTION: Regulates eIF4E activity by preventing its assembly into
CC       the eIF4F complex. Mediates the regulation of protein translation
CC       by hormones, growth factors and other stimuli that signal through
CC       the MAP kinase and mTORC1 pathways.
CC   -!- SUBUNIT: Nonphosphorylated EIF4EBP1 competes with EIF4G1/EIF4G3 to
CC       interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and
CC       MAPK3) or mTORC1 phosphorylation of EIF4EBP1 causes dissociation
CC       of the complex allowing EIF4G1/EIF4G3 to bind and consequent
CC       initiation of translation. Interacts with RPTOR.
CC   -!- INTERACTION:
CC       P06730:EIF4E; NbExp=4; IntAct=EBI-74090, EBI-73440;
CC       P42345:MTOR; NbExp=2; IntAct=EBI-74090, EBI-359260;
CC       Q9JLN9:Mtor (xeno); NbExp=2; IntAct=EBI-74090, EBI-1571628;
CC       Q8N122:RPTOR; NbExp=4; IntAct=EBI-74090, EBI-1567928;
CC   -!- PTM: Phosphorylated on serine and threonine residues in response
CC       to insulin, EGF and PDGF. Phosphorylation at Thr-37, Thr-46, Ser-
CC       65 and Thr-70 is regulated by mTORC1. Phosphorylated upon DNA
CC       damage, probably by ATM or ATR.
CC   -!- SIMILARITY: Belongs to the eIF4E-binding protein family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36055; AAA62269.1; -; mRNA.
DR   EMBL; AB044548; BAB18650.1; -; mRNA.
DR   EMBL; BT007162; AAP35826.1; -; mRNA.
DR   EMBL; CR456769; CAG33050.1; -; mRNA.
DR   EMBL; AK312011; BAG34949.1; -; mRNA.
DR   EMBL; CH471080; EAW63341.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63342.1; -; Genomic_DNA.
DR   EMBL; BC004459; AAH04459.1; -; mRNA.
DR   EMBL; BC058073; AAH58073.1; -; mRNA.
DR   IPI; IPI00002569; -.
DR   PIR; S50866; S50866.
DR   RefSeq; NP_004086.1; NM_004095.3.
DR   UniGene; Hs.411641; -.
DR   PDB; 1WKW; X-ray; 2.10 A; B=47-66.
DR   PDB; 2JGB; X-ray; 1.70 A; B=51-67.
DR   PDB; 2JGC; X-ray; 2.40 A; B=51-67.
DR   PDB; 2V8W; X-ray; 2.30 A; B/F=51-64.
DR   PDB; 2V8X; X-ray; 2.30 A; B/F=51-64.
DR   PDB; 2V8Y; X-ray; 2.10 A; B/F=51-64.
DR   PDB; 3HXG; X-ray; 2.10 A; C=51-67.
DR   PDB; 3HXI; X-ray; 1.80 A; C=51-67.
DR   PDB; 3M93; X-ray; 2.90 A; C=51-67.
DR   PDB; 3M94; X-ray; 2.05 A; C=51-67.
DR   PDB; 3U7X; X-ray; 2.10 A; C/D=47-66.
DR   PDBsum; 1WKW; -.
DR   PDBsum; 2JGB; -.
DR   PDBsum; 2JGC; -.
DR   PDBsum; 2V8W; -.
DR   PDBsum; 2V8X; -.
DR   PDBsum; 2V8Y; -.
DR   PDBsum; 3HXG; -.
DR   PDBsum; 3HXI; -.
DR   PDBsum; 3M93; -.
DR   PDBsum; 3M94; -.
DR   PDBsum; 3U7X; -.
DR   DisProt; DP00028; -.
DR   ProteinModelPortal; Q13541; -.
DR   DIP; DIP-30944N; -.
DR   IntAct; Q13541; 10.
DR   MINT; MINT-210160; -.
DR   STRING; Q13541; -.
DR   PhosphoSite; Q13541; -.
DR   DMDM; 34921508; -.
DR   PeptideAtlas; Q13541; -.
DR   PRIDE; Q13541; -.
DR   DNASU; 1978; -.
DR   Ensembl; ENST00000338825; ENSP00000340691; ENSG00000187840.
DR   GeneID; 1978; -.
DR   KEGG; hsa:1978; -.
DR   UCSC; uc003xks.3; human.
DR   CTD; 1978; -.
DR   GeneCards; GC08P037888; -.
DR   H-InvDB; HIX0004694; -.
DR   HGNC; HGNC:3288; EIF4EBP1.
DR   HPA; CAB005032; -.
DR   HPA; CAB005039; -.
DR   HPA; HPA023501; -.
DR   MIM; 602223; gene.
DR   neXtProt; NX_Q13541; -.
DR   PharmGKB; PA27715; -.
DR   eggNOG; NOG78084; -.
DR   GeneTree; ENSGT00390000013843; -.
DR   HOGENOM; HBG714775; -.
DR   HOVERGEN; HBG050425; -.
DR   InParanoid; Q13541; -.
DR   KO; K07205; -.
DR   OMA; DKPAGGE; -.
DR   OrthoDB; EOG40P486; -.
DR   PhylomeDB; Q13541; -.
DR   Pathway_Interaction_DB; insulin_pathway; Insulin Pathway.
DR   Pathway_Interaction_DB; mtor_4pathway; mTOR signaling pathway.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_17015; Metabolism of proteins.
DR   Reactome; REACT_71; Gene Expression.
DR   EvolutionaryTrace; Q13541; -.
DR   NextBio; 8003; -.
DR   PMAP-CutDB; Q13541; -.
DR   ArrayExpress; Q13541; -.
DR   Bgee; Q13541; -.
DR   CleanEx; HS_EIF4EBP1; -.
DR   Genevestigator; Q13541; -.
DR   GermOnline; ENSG00000187840; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0031929; P:TOR signaling cascade; IDA:UniProtKB.
DR   GO; GO:0006413; P:translational initiation; TAS:Reactome.
DR   InterPro; IPR008606; EIF4EBP.
DR   PANTHER; PTHR12669; EIF4EBP; 1.
DR   Pfam; PF05456; eIF_4EBP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Phosphoprotein;
KW   Protein synthesis inhibitor; Reference proteome;
KW   Translation regulation.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    118       Eukaryotic translation initiation factor
FT                                4E-binding protein 1.
FT                                /FTId=PRO_0000190513.
FT   MOD_RES       2      2       N-acetylserine.
FT   MOD_RES      10     10       Phosphothreonine.
FT   MOD_RES      34     34       Phosphotyrosine.
FT   MOD_RES      35     35       Phosphoserine.
FT   MOD_RES      36     36       Phosphothreonine.
FT   MOD_RES      37     37       Phosphothreonine; by MTOR.
FT   MOD_RES      41     41       Phosphothreonine.
FT   MOD_RES      44     44       Phosphoserine.
FT   MOD_RES      45     45       Phosphothreonine.
FT   MOD_RES      46     46       Phosphothreonine; by MTOR.
FT   MOD_RES      50     50       Phosphothreonine.
FT   MOD_RES      54     54       Phosphotyrosine.
FT   MOD_RES      65     65       Phosphoserine; by MAPK1, MAPK3 and MTOR.
FT   MOD_RES      68     68       Phosphothreonine.
FT   MOD_RES      70     70       Phosphothreonine; by MTOR.
FT   MOD_RES      77     77       Phosphothreonine.
FT   MOD_RES      82     82       Phosphothreonine.
FT   MOD_RES      83     83       Phosphoserine.
FT   MOD_RES      94     94       Phosphoserine.
FT   MOD_RES     101    101       Phosphoserine.
FT   MOD_RES     112    112       Phosphoserine.
FT   HELIX        56     61
SQ   SEQUENCE   118 AA;  12580 MW;  1682A6BA74132966 CRC64;
     MSGGSSCSQT PSRAIPATRR VVLGDGVQLP PGDYSTTPGG TLFSTTPGGT RIIYDRKFLM
     ECRNSPVTKT PPRDLPTIPG VTSPSSDEPP MEASQSHLRN SPEDKRAGGE ESQFEMDI
//
ID   4EBP2_HUMAN             Reviewed;         120 AA.
AC   Q13542;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-APR-2012, entry version 93.
DE   RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 2;
DE            Short=4E-BP2;
DE            Short=eIF4E-binding protein 2;
GN   Name=EIF4EBP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH EIF4E.
RC   TISSUE=Placenta;
RX   MEDLINE=95021760; PubMed=7935836; DOI=10.1038/371762a0;
RA   Pause A., Belsham G.J., Gingras A.-C., Donze O., Lin T.-A.,
RA   Lawrence J.C. Jr., Sonenberg N.;
RT   "Insulin-dependent stimulation of protein synthesis by phosphorylation
RT   of a regulator of 5'-cap function.";
RL   Nature 371:762-767(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND THR-46, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37; THR-41; SER-44 AND
RP   THR-45, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Regulates eIF4E activity by preventing its assembly into
CC       the eIF4F complex. Mediates the regulation of protein translation
CC       by hormones, growth factors and other stimuli that signal through
CC       the MAP kinase pathway.
CC   -!- SUBUNIT: Nonphosphorylated EIF4EBP2 interacts with EIF4E.
CC   -!- PTM: Phosphorylated on serine and threonine residues in response
CC       to insulin, EGF and PDGF.
CC   -!- SIMILARITY: Belongs to the eIF4E-binding protein family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36056; AAA62270.1; -; mRNA.
DR   EMBL; BT007317; AAP35981.1; -; mRNA.
DR   EMBL; BC005057; AAH05057.1; -; mRNA.
DR   EMBL; BC050633; AAH50633.1; -; mRNA.
DR   IPI; IPI00002570; -.
DR   PIR; S50867; S50867.
DR   RefSeq; NP_004087.1; NM_004096.4.
DR   UniGene; Hs.621200; -.
DR   UniGene; Hs.730236; -.
DR   PDB; 3AM7; X-ray; 2.20 A; B=47-65.
DR   PDBsum; 3AM7; -.
DR   ProteinModelPortal; Q13542; -.
DR   IntAct; Q13542; 3.
DR   STRING; Q13542; -.
DR   PhosphoSite; Q13542; -.
DR   DMDM; 34921510; -.
DR   PeptideAtlas; Q13542; -.
DR   PRIDE; Q13542; -.
DR   DNASU; 1979; -.
DR   Ensembl; ENST00000373218; ENSP00000362314; ENSG00000148730.
DR   GeneID; 1979; -.
DR   KEGG; hsa:1979; -.
DR   UCSC; uc001jrb.3; human.
DR   CTD; 1979; -.
DR   GeneCards; GC10P072163; -.
DR   H-InvDB; HIX0008896; -.
DR   HGNC; HGNC:3289; EIF4EBP2.
DR   HPA; CAB019415; -.
DR   MIM; 602224; gene.
DR   neXtProt; NX_Q13542; -.
DR   PharmGKB; PA27716; -.
DR   eggNOG; NOG78084; -.
DR   GeneTree; ENSGT00390000013843; -.
DR   HOGENOM; HBG714775; -.
DR   HOVERGEN; HBG050425; -.
DR   InParanoid; Q13542; -.
DR   OMA; NKKNEAN; -.
DR   OrthoDB; EOG47SSG8; -.
DR   PhylomeDB; Q13542; -.
DR   NextBio; 8007; -.
DR   ArrayExpress; Q13542; -.
DR   Bgee; Q13542; -.
DR   CleanEx; HS_EIF4EBP2; -.
DR   Genevestigator; Q13542; -.
DR   GermOnline; ENSG00000148730; Homo sapiens.
DR   GO; GO:0008190; F:eukaryotic initiation factor 4E binding; IEA:InterPro.
DR   GO; GO:0045947; P:negative regulation of translational initiation; IEA:InterPro.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   InterPro; IPR008606; EIF4EBP.
DR   PANTHER; PTHR12669; EIF4EBP; 1.
DR   Pfam; PF05456; eIF_4EBP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Phosphoprotein;
KW   Protein synthesis inhibitor; Reference proteome;
KW   Translation regulation.
FT   CHAIN         1    120       Eukaryotic translation initiation factor
FT                                4E-binding protein 2.
FT                                /FTId=PRO_0000190516.
FT   MOD_RES      37     37       Phosphothreonine.
FT   MOD_RES      41     41       Phosphothreonine.
FT   MOD_RES      44     44       Phosphoserine.
FT   MOD_RES      45     45       Phosphothreonine.
FT   MOD_RES      46     46       Phosphothreonine.
FT   MOD_RES      65     65       Phosphoserine; by MAPK1 and MAPK3 (By
FT                                similarity).
FT   HELIX        56     60
SQ   SEQUENCE   120 AA;  12939 MW;  B8F109261A504193 CRC64;
     MSSSAGSGHQ PSQSRAIPTR TVAISDAAQL PHDYCTTPGG TLFSTTPGGT RIIYDRKFLL
     DRRNSPMAQT PPCHLPNIPG VTSPGTLIED SKVEVNNLNN LNNHDRKHAV GDDAQFEMDI
//
ID   4EBP3_HUMAN             Reviewed;         100 AA.
AC   O60516;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   18-APR-2012, entry version 85.
DE   RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 3;
DE            Short=4E-BP3;
DE            Short=eIF4E-binding protein 3;
GN   Name=EIF4EBP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH EIF4E, MUTAGENESIS OF
RP   TYR-40 AND LEU-45, AND TISSUE SPECIFICITY.
RX   MEDLINE=98256334; PubMed=9593750; DOI=10.1074/jbc.273.22.14002;
RA   Poulin F., Gingras A.-C., Olsen H., Chevalier S., Sonenberg N.;
RT   "4E-BP3, a new member of the eukaryotic initiation factor 4E-binding
RT   protein family.";
RL   J. Biol. Chem. 273:14002-14007(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Regulates eIF4E activity by preventing its assembly into
CC       the eIF4F complex.
CC   -!- SUBUNIT: EIF4EBP3 interacts with EIF4E.
CC   -!- INTERACTION:
CC       P06730:EIF4E; NbExp=2; IntAct=EBI-746950, EBI-73440;
CC       Q80ZJ3:Eif4e2 (xeno); NbExp=2; IntAct=EBI-746950, EBI-934970;
CC   -!- TISSUE SPECIFICITY: Expression is highest in skeletal muscle,
CC       heart, kidney, and pancreas, whereas there is very little
CC       expression in brain and thymus.
CC   -!- PTM: Phosphorylated.
CC   -!- SIMILARITY: Belongs to the eIF4E-binding protein family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF038869; AAC39761.1; -; mRNA.
DR   EMBL; BC010881; AAH10881.1; -; mRNA.
DR   EMBL; BC069293; AAH69293.1; -; mRNA.
DR   EMBL; BC073751; AAH73751.1; -; mRNA.
DR   IPI; IPI00021476; -.
DR   RefSeq; NP_003723.1; NM_003732.2.
DR   UniGene; Hs.594084; -.
DR   ProteinModelPortal; O60516; -.
DR   IntAct; O60516; 3.
DR   STRING; O60516; -.
DR   PhosphoSite; O60516; -.
DR   PRIDE; O60516; -.
DR   Ensembl; ENST00000310331; ENSP00000308472; ENSG00000243056.
DR   GeneID; 8637; -.
DR   KEGG; hsa:8637; -.
DR   UCSC; uc003lfy.1; human.
DR   CTD; 8637; -.
DR   GeneCards; GC05P139928; -.
DR   HGNC; HGNC:3290; EIF4EBP3.
DR   HPA; HPA045537; -.
DR   MIM; 603483; gene.
DR   neXtProt; NX_O60516; -.
DR   PharmGKB; PA27718; -.
DR   eggNOG; NOG78084; -.
DR   GeneTree; ENSGT00390000013843; -.
DR   HOVERGEN; HBG050425; -.
DR   OrthoDB; EOG47SSG8; -.
DR   NextBio; 32379; -.
DR   ArrayExpress; O60516; -.
DR   Genevestigator; O60516; -.
DR   GermOnline; ENSG00000131503; Homo sapiens.
DR   GO; GO:0016281; C:eukaryotic translation initiation factor 4F complex; NAS:UniProtKB.
DR   GO; GO:0008190; F:eukaryotic initiation factor 4E binding; IEA:InterPro.
DR   GO; GO:0030371; F:translation repressor activity; NAS:UniProtKB.
DR   GO; GO:0045947; P:negative regulation of translational initiation; NAS:UniProtKB.
DR   InterPro; IPR008606; EIF4EBP.
DR   PANTHER; PTHR12669; EIF4EBP; 1.
DR   Pfam; PF05456; eIF_4EBP; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Phosphoprotein; Protein synthesis inhibitor;
KW   Reference proteome; Translation regulation.
FT   CHAIN         1    100       Eukaryotic translation initiation factor
FT                                4E-binding protein 3.
FT                                /FTId=PRO_0000190518.
FT   MUTAGEN      40     40       Y->A: Loss of interaction with EIF4E.
FT   MUTAGEN      45     45       L->A: Loss of interaction with EIF4E.
SQ   SEQUENCE   100 AA;  10873 MW;  FD29A7F3829E546E CRC64;
     MSTSTSCPIP GGRDQLPDCY STTPGGTLYA TTPGGTRIIY DRKFLLECKN SPIARTPPCC
     LPQIPGVTTP PTAPLSKLEE LKEQETEEEI PDDAQFEMDI
//
ID   4ET_HUMAN               Reviewed;         985 AA.
AC   Q9NRA8; B1AKL2; B2RBF1; Q8NCF2; Q9H708;
DT   02-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2002, sequence version 2.
DT   18-APR-2012, entry version 98.
DE   RecName: Full=Eukaryotic translation initiation factor 4E transporter;
DE            Short=4E-T;
DE            Short=eIF4E transporter;
DE   AltName: Full=Eukaryotic translation initiation factor 4E nuclear import factor 1;
GN   Name=EIF4ENIF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHARACTERIZATION,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF TYR-30 AND 195-ARG-ARG-196.
RC   TISSUE=Fetal brain;
RX   MEDLINE=20315895; PubMed=10856257; DOI=10.1093/emboj/19.12.3142;
RA   Dostie J., Ferraiuolo M., Pause A., Adam S.A., Sonenberg N.;
RT   "A novel shuttling protein, 4E-T, mediates the nuclear import of the
RT   mRNA 5' cap-binding protein, eIF4E.";
RL   EMBO J. 19:3142-3156(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-914 AND SER-920, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120; SER-136; SER-138;
RP   SER-345; SER-564 AND SER-951, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-564, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-564; SER-587;
RP   SER-693 AND SER-951, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-486, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Nucleoplasmic shuttling protein. Mediates the nuclear
CC       import of EIF4E by a piggy-back mechanism.
CC   -!- SUBUNIT: Interacts with EIF4E. Interacts with importin beta only
CC       in the presence of importin alpha, suggesting a direct interaction
CC       with importin alpha.
CC   -!- INTERACTION:
CC       P06730:EIF4E; NbExp=5; IntAct=EBI-301024, EBI-73440;
CC       O60573:EIF4E2; NbExp=3; IntAct=EBI-301024, EBI-398610;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Predominantly
CC       cytoplasmic. Shuttles between the nucleus and the cytoplasm in a
CC       CRM1-dependent manner.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NRA8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRA8-2; Sequence=VSP_003783, VSP_003784;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15092.1; Type=Erroneous initiation;
CC       Sequence=BAC11194.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF240775; AAF81693.1; -; mRNA.
DR   EMBL; CR456386; CAG30272.1; -; mRNA.
DR   EMBL; AK025254; BAB15092.1; ALT_INIT; mRNA.
DR   EMBL; AK074768; BAC11194.1; ALT_INIT; mRNA.
DR   EMBL; AK314636; BAG37198.1; -; mRNA.
DR   EMBL; AL096701; CAI12878.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59977.1; -; Genomic_DNA.
DR   EMBL; BC032941; AAH32941.1; -; mRNA.
DR   EMBL; BC033028; AAH33028.1; -; mRNA.
DR   IPI; IPI00291800; -.
DR   IPI; IPI00550518; -.
DR   RefSeq; NP_001157973.1; NM_001164501.1.
DR   RefSeq; NP_001157974.1; NM_001164502.1.
DR   RefSeq; NP_062817.2; NM_019843.3.
DR   UniGene; Hs.517559; -.
DR   ProteinModelPortal; Q9NRA8; -.
DR   IntAct; Q9NRA8; 10.
DR   MINT; MINT-1956064; -.
DR   STRING; Q9NRA8; -.
DR   PhosphoSite; Q9NRA8; -.
DR   DMDM; 22095430; -.
DR   PRIDE; Q9NRA8; -.
DR   DNASU; 56478; -.
DR   Ensembl; ENST00000330125; ENSP00000328103; ENSG00000184708.
DR   Ensembl; ENST00000397525; ENSP00000380659; ENSG00000184708.
DR   Ensembl; ENST00000420671; ENSP00000409372; ENSG00000184708.
DR   GeneID; 56478; -.
DR   KEGG; hsa:56478; -.
DR   UCSC; uc003aky.2; human.
DR   CTD; 56478; -.
DR   GeneCards; GC22M031835; -.
DR   HGNC; HGNC:16687; EIF4ENIF1.
DR   HPA; HPA001619; -.
DR   HPA; HPA002078; -.
DR   MIM; 607445; gene.
DR   neXtProt; NX_Q9NRA8; -.
DR   PharmGKB; PA38410; -.
DR   eggNOG; NOG43453; -.
DR   GeneTree; ENSGT00390000012071; -.
DR   HOGENOM; HBG267574; -.
DR   HOVERGEN; HBG023298; -.
DR   InParanoid; Q9NRA8; -.
DR   OMA; GRKTPTL; -.
DR   PhylomeDB; Q9NRA8; -.
DR   NextBio; 62017; -.
DR   ArrayExpress; Q9NRA8; -.
DR   Bgee; Q9NRA8; -.
DR   CleanEx; HS_EIF4ENIF1; -.
DR   Genevestigator; Q9NRA8; -.
DR   GermOnline; ENSG00000184708; Homo sapiens.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0008565; F:protein transporter activity; TAS:ProtInc.
DR   InterPro; IPR018862; eIF4E_transporter.
DR   Pfam; PF10477; EIF4E-T; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   Nucleus; Phosphoprotein; Protein transport; Reference proteome;
KW   Transport.
FT   CHAIN         1    985       Eukaryotic translation initiation factor
FT                                4E transporter.
FT                                /FTId=PRO_0000064381.
FT   REGION       30     36       EIF4E-binding.
FT   MOTIF       195    211       Nuclear localization signal.
FT   MOTIF       438    447       Nuclear export signal.
FT   MOTIF       613    638       Nuclear export signal.
FT   COMPBIAS    148    210       Arg-rich.
FT   MOD_RES       5      5       Phosphoserine.
FT   MOD_RES      74     74       Phosphoserine.
FT   MOD_RES      78     78       Phosphoserine (By similarity).
FT   MOD_RES     120    120       Phosphoserine.
FT   MOD_RES     136    136       Phosphoserine.
FT   MOD_RES     138    138       Phosphoserine.
FT   MOD_RES     345    345       Phosphoserine.
FT   MOD_RES     486    486       N6-acetyllysine.
FT   MOD_RES     564    564       Phosphoserine.
FT   MOD_RES     587    587       Phosphoserine.
FT   MOD_RES     693    693       Phosphoserine.
FT   MOD_RES     914    914       Phosphoserine.
FT   MOD_RES     920    920       Phosphoserine.
FT   MOD_RES     951    951       Phosphoserine.
FT   VAR_SEQ     100    262       Missing (in isoform 2).
FT                                /FTId=VSP_003783.
FT   VAR_SEQ     493    504       Missing (in isoform 2).
FT                                /FTId=VSP_003784.
FT   MUTAGEN      30     30       Y->A: Abolishes interaction with EIF4E.
FT   MUTAGEN     195    196       RR->NS: Abolishes the nuclear
FT                                localization.
FT   CONFLICT    114    114       L -> F (in Ref. 1; AAF81693).
FT   CONFLICT    616    616       Q -> QQ (in Ref. 3; BAB15092 and 6;
FT                                AAH32941).
FT   CONFLICT    825    825       Q -> R (in Ref. 6; AAH33028).
SQ   SEQUENCE   985 AA;  108201 MW;  4C898E0488903C04 CRC64;
     MDRRSMGETE SGDAFLDLKK PPASKCPHRY TKEELLDIKE LPHSKQRPSC LSEKYDSDGV
     WDPEKWHASL YPASGRSSPV ESLKKELDTD RPSLVRRIVD PRERVKEDDL DVVLSPQRRS
     FGGGCHVTAA VSSRRSGSPL EKDSDGLRLL GGRRIGSGRI ISARTFEKDH RLSDKDLRDL
     RDRDRERDFK DKRFRREFGD SKRVFGERRR NDSYTEEEPE WFSAGPTSQS ETIELTGFDD
     KILEEDHKGR KRTRRRTASV KEGIVECNGG VAEEDEVEVI LAQEPAADQE VPRDAVLPEQ
     SPGDFDFNEF FNLDKVPCLA SMIEDVLGEG SVSASRFSRW FSNPSRSGSR SSSLGSTPHE
     ELERLAGLEQ AILSPGQNSG NYFAPIPLED HAENKVDILE MLQKAKVDLK PLLSSLSANK
     EKLKESSHSG VVLSVEEVEA GLKGLKVDQQ VKNSTPFMAE HLEETLSAVT NNRQLKKDGD
     MTAFNKLVST MKASGTLPSQ PKVSRNLESH LMSPAEIPGQ PVPKNILQEL LGQPVQRPAS
     SNLLSGLMGS LEPTTSLLGQ RAPSPPLSQV FQTRAASADY LRPRIPSPIG FTPGPQQLLG
     DPFQGMRKPM SPITAQMSQL ELQQAALEGL ALPHDLAVQA ANFYQPGFGK PQVDRTRDGF
     RNRQQRVTKS PAPVHRGNSS SPAPAASITS MLSPSFTPTS VIRKMYESKE KSKEEPASGK
     AALGDSKEDT QKASEENLLS SSSVPSADRD SSPTTNSKLS ALQRSSCSTP LSQANRYTKE
     QDYRPKATGR KTPTLASPVP TTPFLRPVHQ VPLVPHVPMV RPAHQLHPGL VQRMLAQGVH
     PQHLPSLLQT GVLPPGMDLS HLQGISGPIL GQPFYPLPAA SHPLLNPRPG TPLHLAMVQQ
     QLQRSVLHPP GSGSHAAAVS VQTTPQNVPS RSGLPHMHSQ LEHRPSQRSS SPVGLAKWFG
     SDVLQQPLPS MPAKVISVDE LEYRQ
//
ID   4F2_HUMAN               Reviewed;         630 AA.
AC   P08195; Q13543;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 3.
DT   18-APR-2012, entry version 144.
DE   RecName: Full=4F2 cell-surface antigen heavy chain;
DE            Short=4F2hc;
DE   AltName: Full=4F2 heavy chain antigen;
DE   AltName: Full=Lymphocyte activation antigen 4F2 large subunit;
DE   AltName: CD_antigen=CD98;
GN   Name=SLC3A2; Synonyms=MDU1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   MEDLINE=87317685; PubMed=3476959; DOI=10.1073/pnas.84.18.6526;
RA   Quackenbush E., Clabby M., Gottesdiener K.M., Barbosa J., Jones N.H.,
RA   Strominger J.L., Speck S., Leiden J.M.;
RT   "Molecular cloning of complementary DNAs encoding the heavy chain of
RT   the human 4F2 cell-surface antigen: a type II membrane glycoprotein
RT   involved in normal and neoplastic cell growth.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6526-6530(1987).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION.
RA   Quackenbush E., Clabby M., Gottesdiener K.M., Barbosa J., Jones N.H.,
RA   Strominger J.L., Speck S., Leiden J.M.;
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8618-8618(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   MEDLINE=87250620; PubMed=3036867;
RA   Teixeira S., di Grandi S., Kuehn L.C.;
RT   "Primary structure of the human 4F2 antigen heavy chain predicts a
RT   transmembrane protein with a cytoplasmic NH2 terminus.";
RL   J. Biol. Chem. 262:9574-9580(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   INDUCTION.
RC   TISSUE=Fibroblast;
RX   MEDLINE=88097456; PubMed=3480538; DOI=10.1073/pnas.84.24.9204;
RA   Lumadue J.A., Glick A.B., Ruddle F.H.;
RT   "Cloning, sequence analysis, and expression of the large subunit of
RT   the human lymphocyte activation antigen 4F2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:9204-9208(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 2),
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   MEDLINE=89127222; PubMed=3265470;
RA   Gottesdiener K.M., Karpinski B.A., Lindsten T., Strominger J.L.,
RA   Jones N.H., Thompson C.B., Leiden J.M.;
RT   "Isolation and structural characterization of the human 4F2 heavy-
RT   chain gene, an inducible gene involved in T-lymphocyte activation.";
RL   Mol. Cell. Biol. 8:3809-3819(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBUNIT, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=11557028; DOI=10.1016/S0005-2736(01)00384-4;
RA   Yanagida O., Kanai Y., Chairoungdua A., Kim D.K., Segawa H., Nii T.,
RA   Cha S.H., Matsuo H., Fukushima J., Fukasawa Y., Tani Y., Taketani Y.,
RA   Uchino H., Kim J.Y., Inatomi J., Okayasu I., Miyamoto K., Takeda E.,
RA   Goya T., Endou H.;
RT   "Human L-type amino acid transporter 1 (LAT1): characterization of
RT   function and expression in tumor cell lines.";
RL   Biochim. Biophys. Acta 1514:291-302(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING (ISOFORM 4).
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-17; 146-171; 227-245; 304-313; 440-451; 511-525
RP   AND 593-630, ACETYLATION AT MET-1, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Lao L., Ryan K.L.;
RL   Submitted (OCT-2009) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 83-209 (ISOFORM 4).
RC   TISSUE=Lung carcinoma;
RA   Strausberg R.L.;
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 112-122; 148-160; 227-245; 248-255; 288-298;
RP   304-313; 440-451; 511-524 AND 593-625, AND MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [12]
RP   FUNCTION, SUBUNIT, INHIBITION, AND MUTAGENESIS OF CYS-210 AND CYS-431.
RX   MEDLINE=99047611; PubMed=9829974; DOI=10.1074/jbc.273.49.32437;
RA   Torrents D., Estevez R., Pineda M., Fernandez E., Lloberas J.,
RA   Shi Y.-B., Zorzano A., Palacin M.;
RT   "Identification and characterization of a membrane protein (y+L amino
RT   acid transporter-1) that associates with 4F2hc to encode the amino
RT   acid transport activity y+L. A candidate gene for lysinuric protein
RT   intolerance.";
RL   J. Biol. Chem. 273:32437-32445(1998).
RN   [13]
RP   FUNCTION, AND SUBUNIT.
RX   MEDLINE=98421678; PubMed=9751058; DOI=10.1038/26246;
RA   Mastroberardino L., Spindler B., Pfeiffer R., Skelly P.J., Loffing J.,
RA   Shoemaker C.B., Verrey F.;
RT   "Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a
RT   permease family.";
RL   Nature 395:288-291(1998).
RN   [14]
RP   FUNCTION, AND SUBUNIT.
RX   MEDLINE=99094891; PubMed=9878049; DOI=10.1093/emboj/18.1.49;
RA   Pfeiffer R., Rossier G., Spindler B., Meier C., Kuehn L.C., Verrey F.;
RT   "Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and
RT   members of the glycoprotein-associated amino acid transporter
RT   family.";
RL   EMBO J. 18:49-57(1999).
RN   [15]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10903140;
RA   Broeer A., Wagner C.A., Lang F., Broeer S.;
RT   "The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates
RT   arginine efflux in exchange with glutamine.";
RL   Biochem. J. 349:787-795(2000).
RN   [16]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=11311135;
RA   Broeer A., Friedrich B., Wagner C.A., Fillon S., Ganapathy V.,
RA   Lang F., Broeer S.;
RT   "Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires
RT   different domains.";
RL   Biochem. J. 355:725-731(2001).
RN   [17]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11389679; DOI=10.1042/0264-6021:3560719;
RA   Ritchie J.W.A., Taylor P.M.;
RT   "Role of the System L permease LAT1 in amino acid and iodothyronine
RT   transport in placenta.";
RL   Biochem. J. 356:719-725(2001).
RN   [18]
RP   SUBUNIT, INTERACTION WITH BETA-1 INTEGRINS, AND MUTAGENESIS OF CYS-210
RP   AND CYS-431.
RX   PubMed=11696247; DOI=10.1186/1472-2091-2-10;
RA   Kolesnikova T.V., Mannion B.A., Berditchevski F., Hemler M.E.;
RT   "Beta1 integrins show specific association with CD98 protein in low
RT   density membranes.";
RL   BMC Biochem. 2:10-10(2001).
RN   [19]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=11564694; DOI=10.1210/en.142.10.4339;
RA   Friesema E.C.H., Docter R., Moerings E.P.C.M., Verrey F.,
RA   Krenning E.P., Hennemann G., Visser T.J.;
RT   "Thyroid hormone transport by the heterodimeric human system L amino
RT   acid transporter.";
RL   Endocrinology 142:4339-4348(2001).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11742812;
RA   Okamoto Y., Sakata M., Ogura K., Yamamoto T., Yamaguchi M., Tasaka K.,
RA   Kurachi H., Tsurudome M., Murata Y.;
RT   "Expression and regulation of 4F2hc and hLAT1 in human trophoblasts.";
RL   Am. J. Physiol. 282:C196-C204(2002).
RN   [21]
RP   INTERACTION WITH FAM57A/CT120.
RX   MEDLINE=22230983; PubMed=12270127; DOI=10.1016/S0006-291X(02)02227-1;
RA   He X.H., Di Y., Li J., Xie Y., Tang Y., Zhang F., Wei L., Zhang Y.,
RA   Qin W.X., Huo K., Li Y., Wan D.F., Gu J.R.;
RT   "Molecular cloning and characterization of CT120, a novel membrane-
RT   associated gene involved in amino acid transport and glutathione
RT   metabolism.";
RL   Biochem. Biophys. Res. Commun. 297:528-536(2002).
RN   [22]
RP   FUNCTION.
RX   PubMed=12117417; DOI=10.1042/BJ20020841;
RA   Simmons-Willis T.A., Koh A.S., Clarkson T.W., Ballatori N.;
RT   "Transport of a neurotoxicant by molecular mimicry: the methylmercury-
RT   L-cysteine complex is a substrate for human L-type large neutral amino
RT   acid transporter (LAT) 1 and LAT2.";
RL   Biochem. J. 367:239-246(2002).
RN   [23]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=12225859; DOI=10.1016/S0005-2736(02)00516-3;
RA   Kim D.K., Kanai Y., Choi H.W., Tangtrongsup S., Chairoungdua A.,
RA   Babu E., Tachampa K., Anzai N., Iribe Y., Endou H.;
RT   "Characterization of the system L amino acid transporter in T24 human
RT   bladder carcinoma cells.";
RL   Biochim. Biophys. Acta 1565:112-121(2002).
RN   [24]
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   MEDLINE=21829512; PubMed=11840567;
RX   DOI=10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H;
RA   Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A.,
RA   Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J.,
RA   Zvelebil M.J.;
RT   "Cluster analysis of an extensive human breast cancer cell line
RT   protein expression map database.";
RL   Proteomics 2:212-223(2002).
RN   [25]
RP   FUNCTION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=14603368; DOI=10.1113/eph8802647;
RA   Arancibia-Garavilla Y., Toledo F., Casanello P., Sobrevia L.;
RT   "Nitric oxide synthesis requires activity of the cationic and neutral
RT   amino acid transport system y+L in human umbilical vein endothelium.";
RL   Exp. Physiol. 88:699-710(2003).
RN   [26]
RP   FUNCTION, SUBUNIT, INTERACTION WITH ICAM1, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=12716892; DOI=10.1074/jbc.M302777200;
RA   Liu X., Charrier L., Gewirtz A., Sitaraman S., Merlin D.;
RT   "CD98 and intracellular adhesion molecule I regulate the activity of
RT   amino acid transporter LAT-2 in polarized intestinal epithelia.";
RL   J. Biol. Chem. 278:23672-23677(2003).
RN   [27]
RP   GLYCOSYLATION AT ASN-365; ASN-381 AND ASN-424.
RX   MEDLINE=22660472; PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [28]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15980244; DOI=10.1167/iovs.04-1175;
RA   Tomi M., Mori M., Tachikawa M., Katayama K., Terasaki T., Hosoya K.;
RT   "L-type amino acid transporter 1-mediated L-leucine transport at the
RT   inner blood-retinal barrier.";
RL   Invest. Ophthalmol. Vis. Sci. 46:2522-2530(2005).
RN   [29]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=15769744; DOI=10.1074/jbc.M413164200;
RA   Li S., Whorton A.R.;
RT   "Identification of stereoselective transporters for S-nitroso-L-
RT   cysteine: role of LAT1 and LAT2 in biological activity of S-
RT   nitrosothiols.";
RL   J. Biol. Chem. 280:20102-20110(2005).
RN   [30]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-381 AND ASN-424, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103 AND THR-106, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [32]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16496379; DOI=10.1002/ijc.21866;
RA   Nawashiro H., Otani N., Shinomiya N., Fukui S., Ooigawa H., Shima K.,
RA   Matsuo H., Kanai Y., Endou H.;
RT   "L-type amino acid transporter 1 as a potential molecular target in
RT   human astrocytic tumors.";
RL   Int. J. Cancer 119:484-492(2006).
RN   [33]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [34]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-147, AND MASS
RP   SPECTROMETRY.
RX   PubMed=18781797; DOI=10.1021/pr800468j;
RA   Meierhofer D., Wang X., Huang L., Kaiser P.;
RT   "Quantitative analysis of global ubiquitination in HeLa cells by mass
RT   spectrometry.";
RL   J. Proteome Res. 7:4566-4576(2008).
RN   [35]
RP   PHOSPHORYLATION AT SER-406; SER-408; SER-410; SER-527 AND SER-531.
RX   PubMed=19065266; DOI=10.1371/journal.pone.0003895;
RA   Nguyen H.T.T., Dalmasso G., Yan Y., Obertone T.S., Sitaraman S.V.,
RA   Merlin D.;
RT   "Ecto-phosphorylation of CD98 regulates cell-cell interactions.";
RL   PLoS ONE 3:E3895-E3895(2008).
RN   [36]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-365; ASN-381 AND ASN-506,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [37]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-365; ASN-381; ASN-424 AND
RP   ASN-506, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 212-630, SUBUNIT, MUTAGENESIS
RP   OF CYS-210, SUBCELLULAR LOCATION, AND DISULFIDE BOND.
RX   PubMed=17724034; DOI=10.1074/jbc.M704524200;
RA   Fort J., de la Ballina L.R., Burghardt H.E., Ferrer-Costa C.,
RA   Turnay J., Ferrer-Orta C., Uson I., Zorzano A., Fernandez-Recio J.,
RA   Orozco M., Lizarbe M.A., Fita I., Palacin M.;
RT   "The structure of human 4F2hc ectodomain provides a model for
RT   homodimerization and electrostatic interaction with plasma membrane.";
RL   J. Biol. Chem. 282:31444-31452(2007).
CC   -!- FUNCTION: Required for the function of light chain amino-acid
CC       transporters. Involved in sodium-independent, high-affinity
CC       transport of large neutral amino acids such as phenylalanine,
CC       tyrosine, leucine, arginine and tryptophan. Involved in guiding
CC       and targeting of LAT1 and LAT2 to the plasma membrane. When
CC       associated with SLC7A6 or SLC7A7 acts as an arginine/glutamine
CC       exchanger, following an antiport mechanism for amino acid
CC       transport, influencing arginine release in exchange for
CC       extracellular amino acids. Plays a role in nitric oxide synthesis
CC       in human umbilical vein endothelial cells (HUVECs) via transport
CC       of L-arginine. Required for normal and neoplastic cell growth.
CC       When associated with SLC7A5/LAT1, is also involved in the
CC       transport of L-DOPA across the blood-brain barrier, and that of
CC       thyroid hormones triiodothyronine (T3) and thyroxine (T4) across
CC       the cell membrane in tissues such as placenta. Involved in the
CC       uptake of methylmercury (MeHg) when administered as the L-cysteine
CC       or D,L-homocysteine complexes, and hence plays a role in metal ion
CC       homeostasis and toxicity. When associated with SLC7A5 or SLC7A8,
CC       involved in the cellular activity of small molecular weight
CC       nitrosothiols, via the stereoselective transport of L-
CC       nitrosocysteine (L-CNSO) across the transmembrane. Together with
CC       ICAM1, regulates the transport activity LAT2 in polarized
CC       intestinal cells, by generating and delivering intracellular
CC       signals. When associated with SLC7A5, plays an important role in
CC       transporting L-leucine from the circulating blood to the retina
CC       across the inner blood-retinal barrier.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=295 uM for glutamine (in the presence of NaCl);
CC         KM=236 uM for leucine (in the presence of NaCl);
CC         KM=120 uM for arginine (in the presence of NaCl);
CC         KM=138 uM for arginine (in the absence of NaCl);
CC   -!- SUBUNIT: Disulfide-linked heterodimer of a glycosylated heavy
CC       chain and a non-glycosylated light chain (SLC7A5, SLC7A6, SLCA7A7,
CC       SLC7A8, SLC7A10 or SLCA7A11). Colocalizes with cadherins (By
CC       similarity). Interacts with FAM57A/CT120 and ICAM1. Constitutively
CC       and specifically associates with beta-1 integrins (alpha-2/beta-1,
CC       alpha-3/beta-1, alpha-5/beta-1 and alpha-6/beta-1), but minimally
CC       with alpha-4/beta-1.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane; Single-pass type II
CC       membrane protein. Melanosome. Note=Identified by mass spectrometry
CC       in melanosome fractions from stage I to stage IV. Localized to the
CC       plasma membrane when associated with SLC7A5 or SLC7A8. Localized
CC       to the placental apical membrane. Located selectively at cell-cell
CC       adhesion sites (By similarity). Colocalized with SLC7A8/LAT2 at
CC       the basolateral membrane of kidney proximal tubules and small
CC       intestine epithelia. Expressed in both luminal and abluminal
CC       membranes of brain capillary endothelial cells (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P08195-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P08195-2; Sequence=VSP_037907;
CC       Name=3;
CC         IsoId=P08195-3; Sequence=VSP_037908;
CC       Name=4;
CC         IsoId=P08195-4; Sequence=VSP_037909;
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously in all tissues tested
CC       with highest levels detected in kidney, placenta and testis and
CC       weakest level in thymus. During gestation, expression in the
CC       placenta was significantly stronger at full-term than at the mid-
CC       trimester stage. Expressed in HUVECS and at low levels in resting
CC       peripheral blood T-lymphocytes and quiescent fibroblasts. Also
CC       expressed in fetal liver and in the astrocytic process of primary
CC       astrocytic gliomas. Expressed in retinal endothelial cells and in
CC       the intestinal epithelial cell line Caco2-BBE.
CC   -!- INDUCTION: Expression is induced in resting peripheral blood T-
CC       lymphocytes following PHA stimulation. Expression increases at the
CC       time of maximal DNA synthesis, in fibroblasts stimulated to
CC       divide. Expression and the uptake of leucine is stimulated in
CC       mononuclear, cytotrophoblast-like choriocarcinoma cells by
CC       combined treatment with PMA and calcium ionophore.
CC   -!- PTM: Phosphorylation on Ser-406; Ser-408 or Ser-410 and on Ser-527
CC       or Ser-531 by ecto-protein kinases favors heterotypic cell-cell
CC       interactions.
CC   -!- MASS SPECTROMETRY: Mass=57944.93; Method=MALDI; Range=1-529;
CC       Source=PubMed:11840567;
CC   -!- MISCELLANEOUS: Arginine uptake is inhibited by increasing
CC       concentrations of leucine in the presence of Na(+).
CC   -!- SIMILARITY: Belongs to the SLC3A transporter family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02939; AAA52497.1; -; mRNA.
DR   EMBL; J02769; AAA51540.1; -; mRNA.
DR   EMBL; J03569; AAA35536.1; -; mRNA.
DR   EMBL; M21904; AAA35489.1; -; Genomic_DNA.
DR   EMBL; M21898; AAA35489.1; JOINED; Genomic_DNA.
DR   EMBL; M21899; AAA35489.1; JOINED; Genomic_DNA.
DR   EMBL; M21900; AAA35489.1; JOINED; Genomic_DNA.
DR   EMBL; M21901; AAA35489.1; JOINED; Genomic_DNA.
DR   EMBL; M21902; AAA35489.1; JOINED; Genomic_DNA.
DR   EMBL; M21903; AAA35489.1; JOINED; Genomic_DNA.
DR   EMBL; AB018010; BAA84649.1; -; mRNA.
DR   EMBL; AP001160; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001061; AAH01061.2; -; mRNA.
DR   EMBL; BC003000; AAH03000.2; -; mRNA.
DR   EMBL; BE794697; -; NOT_ANNOTATED_CDS; mRNA.
DR   IPI; IPI00027493; -.
DR   IPI; IPI00554481; -.
DR   IPI; IPI00554722; -.
DR   IPI; IPI00604710; -.
DR   PIR; A28455; SAHU4F.
DR   RefSeq; NP_001012680.1; NM_001012662.2.
DR   RefSeq; NP_001012682.1; NM_001012664.2.
DR   RefSeq; NP_001013269.1; NM_001013251.2.
DR   RefSeq; NP_002385.3; NM_002394.5.
DR   UniGene; Hs.502769; -.
DR   PDB; 2DH2; X-ray; 2.10 A; A=212-630.
DR   PDB; 2DH3; X-ray; 2.80 A; A/B=212-630.
DR   PDBsum; 2DH2; -.
DR   PDBsum; 2DH3; -.
DR   ProteinModelPortal; P08195; -.
DR   SMR; P08195; 212-630.
DR   IntAct; P08195; 4.
DR   STRING; P08195; -.
DR   CAZy; GH13; Glycoside Hydrolase Family 13.
DR   TCDB; 8.A.9.2.2; rBAT transport accessory protein (rBAT) family.
DR   PhosphoSite; P08195; -.
DR   DMDM; 257051063; -.
DR   PRIDE; P08195; -.
DR   DNASU; 6520; -.
DR   Ensembl; ENST00000338663; ENSP00000340815; ENSG00000168003.
DR   Ensembl; ENST00000377889; ENSP00000367121; ENSG00000168003.
DR   Ensembl; ENST00000377890; ENSP00000367122; ENSG00000168003.
DR   Ensembl; ENST00000377891; ENSP00000367123; ENSG00000168003.
DR   Ensembl; ENST00000377892; ENSP00000367124; ENSG00000168003.
DR   GeneID; 6520; -.
DR   KEGG; hsa:6520; -.
DR   UCSC; uc001nwc.3; human.
DR   UCSC; uc001nwd.3; human.
DR   UCSC; uc001nwf.3; human.
DR   CTD; 6520; -.
DR   GeneCards; GC11P062623; -.
DR   H-InvDB; HIX0018301; -.
DR   HGNC; HGNC:11026; SLC3A2.
DR   MIM; 158070; gene.
DR   neXtProt; NX_P08195; -.
DR   PharmGKB; PA35894; -.
DR   eggNOG; COG0366; -.
DR   GeneTree; ENSGT00530000063127; -.
DR   HOGENOM; HBG714831; -.
DR   HOVERGEN; HBG000023; -.
DR   InParanoid; P08195; -.
DR   KO; K06519; -.
DR   OMA; NMTVKGQ; -.
DR   OrthoDB; EOG4S7JPP; -.
DR   BioCyc; MetaCyc:MONOMER-15188; -.
DR   Pathway_Interaction_DB; nfat_tfpathway; Calcineurin-regulated NFAT-dependent transcription in lymphocytes.
DR   Reactome; REACT_15518; Transmembrane transport of small molecules.
DR   Reactome; REACT_19419; Amino acid and oligopeptide SLC transporters.
DR   Reactome; REACT_604; Hemostasis.
DR   EvolutionaryTrace; P08195; -.
DR   NextBio; 25353; -.
DR   ArrayExpress; P08195; -.
DR   Bgee; P08195; -.
DR   CleanEx; HS_SLC3A2; -.
DR   Genevestigator; P08195; -.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral to membrane; NAS:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005432; F:calcium:sodium antiporter activity; TAS:UniProtKB.
DR   GO; GO:0003824; F:catalytic activity; IEA:InterPro.
DR   GO; GO:0043169; F:cation binding; IEA:InterPro.
DR   GO; GO:0015175; F:neutral amino acid transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0016049; P:cell growth; NAS:UniProtKB.
DR   GO; GO:0060356; P:leucine import; ISS:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0015827; P:tryptophan transport; ISS:UniProtKB.
DR   Gene3D; G3DSA:2.60.40.1180; Glyco_hydro_13_b; 1.
DR   Gene3D; G3DSA:3.20.20.80; Glyco_hydro_cat; 1.
DR   InterPro; IPR015902; Alpha_amylase.
DR   InterPro; IPR013780; Glyco_hydro_13_b.
DR   InterPro; IPR006047; Glyco_hydro_13_cat_dom.
DR   InterPro; IPR013781; Glyco_hydro_subgr_catalytic.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR10357; Alpha_amylase; 1.
DR   Pfam; PF00128; Alpha-amylase; 1.
DR   SUPFAM; SSF51445; Glyco_hydro_cat; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Amino-acid transport;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Isopeptide bond; Membrane;
KW   Phosphoprotein; Reference proteome; Signal-anchor; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN         1    630       4F2 cell-surface antigen heavy chain.
FT                                /FTId=PRO_0000064383.
FT   TOPO_DOM    102    184       Cytoplasmic (Potential).
FT   TRANSMEM    185    205       Helical; Signal-anchor for type II
FT                                membrane protein; (Potential).
FT   TOPO_DOM    206    630       Extracellular (Potential).
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES     103    103       Phosphoserine.
FT   MOD_RES     106    106       Phosphothreonine.
FT   MOD_RES     165    165       Phosphoserine.
FT   MOD_RES     406    406       Phosphoserine (Probable).
FT   MOD_RES     408    408       Phosphoserine (Probable).
FT   MOD_RES     410    410       Phosphoserine (Probable).
FT   MOD_RES     527    527       Phosphoserine (Probable).
FT   MOD_RES     531    531       Phosphoserine (Probable).
FT   CARBOHYD    365    365       N-linked (GlcNAc...).
FT   CARBOHYD    381    381       N-linked (GlcNAc...).
FT   CARBOHYD    424    424       N-linked (GlcNAc...).
FT   CARBOHYD    506    506       N-linked (GlcNAc...).
FT   DISULFID    210    210       Interchain (with light chain).
FT   CROSSLNK    147    147       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VAR_SEQ       1    101       Missing (in isoform 2).
FT                                /FTId=VSP_037907.
FT   VAR_SEQ      38     99       Missing (in isoform 3).
FT                                /FTId=VSP_037908.
FT   VAR_SEQ      98     98       V -> VTETGFHHVSQADIEFLTSIDPTASASGSAGI (in
FT                                isoform 4).
FT                                /FTId=VSP_037909.
FT   MUTAGEN     210    210       C->S: Abolishes dimerization, leucine
FT                                uptake and interaction with beta-1
FT                                integrins.
FT   MUTAGEN     431    431       C->S: No effect on dimerization, leucine
FT                                uptake or interaction with beta-1
FT                                integrins.
FT   CONFLICT    137    137       G -> E (in Ref. 4; AAA35536).
FT   CONFLICT    158    158       A -> P (in Ref. 3; AAA51540).
FT   CONFLICT    223    223       A -> P (in Ref. 4; AAA35536).
FT   CONFLICT    315    315       E -> D (in Ref. 4; AAA35536).
FT   CONFLICT    320    320       S -> F (in Ref. 5; AAA35489).
FT   CONFLICT    372    372       E -> G (in Ref. 4; AAA35536).
FT   CONFLICT    412    413       GE -> PQ (in Ref. 4; AAA35536).
FT   CONFLICT    465    465       V -> L (in Ref. 4; AAA35536).
FT   CONFLICT    481    481       G -> P (in Ref. 4; AAA35536).
FT   CONFLICT    549    549       G -> E (in Ref. 5; AAA35489).
FT   CONFLICT    609    609       L -> P (in Ref. 4; AAA35536).
FT   CONFLICT    612    612       E -> G (in Ref. 4; AAA35536).
FT   HELIX       218    220
FT   STRAND      224    227
FT   HELIX       230    234
FT   HELIX       241    245
FT   HELIX       248    253
FT   STRAND      257    261
FT   STRAND      265    267
FT   STRAND      275    280
FT   HELIX       282    284
FT   HELIX       287    299
FT   STRAND      303    307
FT   TURN        310    313
FT   STRAND      314    316
FT   HELIX       323    340
FT   STRAND      344    347
FT   HELIX       350    352
FT   HELIX       356    370
FT   STRAND      375    379
FT   HELIX       385    391
FT   TURN        392    394
FT   STRAND      399    401
FT   TURN        404    407
FT   HELIX       412    426
FT   HELIX       441    443
FT   HELIX       447    449
FT   HELIX       450    457
FT   STRAND      460    467
FT   HELIX       470    472
FT   HELIX       476    478
FT   STRAND      479    481
FT   STRAND      484    486
FT   HELIX       505    507
FT   HELIX       509    513
FT   HELIX       519    532
FT   HELIX       534    538
FT   STRAND      540    545
FT   STRAND      550    556
FT   STRAND      562    568
FT   STRAND      570    572
FT   STRAND      581    583
FT   HELIX       585    587
FT   STRAND      591    603
FT   STRAND      607    610
FT   HELIX       611    613
FT   STRAND      621    626
SQ   SEQUENCE   630 AA;  67994 MW;  AE427F8204CC10B0 CRC64;
     MELQPPEASI AVVSIPRQLP GSHSEAGVQG LSAGDDSELG SHCVAQTGLE LLASGDPLPS
     ASQNAEMIET GSDCVTQAGL QLLASSDPPA LASKNAEVTG TMSQDTEVDM KEVELNELEP
     EKQPMNAASG AAMSLAGAEK NGLVKIKVAE DEAEAAAAAK FTGLSKEELL KVAGSPGWVR
     TRWALLLLFW LGWLGMLAGA VVIIVRAPRC RELPAQKWWH TGALYRIGDL QAFQGHGAGN
     LAGLKGRLDY LSSLKVKGLV LGPIHKNQKD DVAQTDLLQI DPNFGSKEDF DSLLQSAKKK
     SIRVILDLTP NYRGENSWFS TQVDTVATKV KDALEFWLQA GVDGFQVRDI ENLKDASSFL
     AEWQNITKGF SEDRLLIAGT NSSDLQQILS LLESNKDLLL TSSYLSDSGS TGEHTKSLVT
     QYLNATGNRW CSWSLSQARL LTSFLPAQLL RLYQLMLFTL PGTPVFSYGD EIGLDAAALP
     GQPMEAPVML WDESSFPDIP GAVSANMTVK GQSEDPGSLL SLFRRLSDQR SKERSLLHGD
     FHAFSAGPGL FSYIRHWDQN ERFLVVLNFG DVGLSAGLQA SDLPASASLP AKADLLLSTQ
     PGREEGSPLE LERLKLEPHE GLLLRFPYAA
//
ID   5HT1A_HUMAN             Reviewed;         422 AA.
AC   P08908; Q6LAE7;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 3.
DT   18-APR-2012, entry version 123.
DE   RecName: Full=5-hydroxytryptamine receptor 1A;
DE            Short=5-HT-1A;
DE            Short=5-HT1A;
DE   AltName: Full=G-21;
DE   AltName: Full=Serotonin receptor 1A;
GN   Name=HTR1A; Synonyms=ADRB2RL1, ADRBRL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=87315369; PubMed=3041227; DOI=10.1038/329075a0;
RA   Kobilka B.K., Frielle T., Collins S., Yang-Feng T.L., Kobilka T.S.,
RA   Francke U., Lefkowitz R.J., Caron M.G.;
RT   "An intronless gene encoding a potential member of the family of
RT   receptors coupled to guanine nucleotide regulatory proteins.";
RL   Nature 329:75-79(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Saltzman A.G., Morse B., Felder S.;
RT   "Nucleotide and deduced amino acid sequence of the human serotonin 5-
RT   HT1a receptor gene.";
RL   Submitted (FEB-1991) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Levy F.O., Gudermann T., Birnbaumer M., Kaumann A.J., Birnbaumer L.;
RL   Submitted (MAY-1992) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15014171; DOI=10.1093/molbev/msh100;
RA   Kitano T., Liu Y.-H., Ueda S., Saitou N.;
RT   "Human-specific amino acid changes found in 103 protein-coding
RT   genes.";
RL   Mol. Biol. Evol. 21:936-944(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RX   MEDLINE=92115564; PubMed=1766875; DOI=10.1093/nar/19.25.7155;
RA   Parks C.L., Chang L.S., Shenk T.;
RT   "A polymerase chain reaction mediated by a single primer: cloning of
RT   genomic sequences adjacent to a serotonin receptor protein coding
RT   region.";
RL   Nucleic Acids Res. 19:7155-7160(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 200-365.
RX   MEDLINE=93329096; PubMed=8393041;
RA   Aune T.M., McGrath K.M., Sarr T., Bombara M.P., Kelley K.A.;
RT   "Expression of 5HT1a receptors on activated human T cells. Regulation
RT   of cyclic AMP levels and T cell proliferation by 5-
RT   hydroxytryptamine.";
RL   J. Immunol. 151:1175-1183(1993).
RN   [9]
RP   FUNCTION.
RX   MEDLINE=88334700; PubMed=3138543; DOI=10.1038/335358a0;
RA   Fargin A., Raymond J.R., Lohse M.L., Kobilka B.K., Caron M.G.,
RA   Lefkowitz R.J.;
RT   "The genomic clone G-21 which resembles a beta-adrenergic receptor
RT   sequence encodes the 5-HT1A receptor.";
RL   Nature 335:358-360(1988).
RN   [10]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-334, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung adenocarcinoma;
RX   PubMed=17203973; DOI=10.1021/pr060438j;
RA   Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M.,
RA   Haines D.S., Figeys D.;
RT   "The proteomic reactor facilitates the analysis of affinity-purified
RT   proteins by mass spectrometry: application for identifying
RT   ubiquitinated proteins in human cells.";
RL   J. Proteome Res. 6:298-305(2007).
RN   [11]
RP   VARIANTS SER-22 AND VAL-28.
RX   MEDLINE=95275307; PubMed=7755630; DOI=10.1006/bbrc.1995.1692;
RA   Nakhai B., Nielsen D.A., Linnoila M., Goldman D.;
RT   "Two naturally occurring amino acid substitutions in the human 5-HT1A
RT   receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28.";
RL   Biochem. Biophys. Res. Commun. 210:530-536(1995).
RN   [12]
RP   VARIANTS LEU-16 AND ASP-273.
RX   MEDLINE=98425601; PubMed=9754630;
RX   DOI=10.1002/(SICI)1096-8628(19980907)81:5<434::AID-AJMG13>3.0.CO;2-D;
RA   Kawanishi Y., Harada S., Tachikawa H., Okubo T., Shiraishi H.;
RT   "Novel mutations in the promoter and coding region of the human 5-HT1A
RT   receptor gene and association analysis in schizophrenia.";
RL   Am. J. Med. Genet. 81:434-439(1998).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that inhibit adenylate
CC       cyclase activity.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. 5-
CC       hydroxytryptamine receptor subfamily. HTR1A sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28269; AAA36440.1; -; Genomic_DNA.
DR   EMBL; X13556; CAA31908.1; -; Genomic_DNA.
DR   EMBL; X57829; CAA40962.1; -; Genomic_DNA.
DR   EMBL; M83181; AAA66493.1; -; Genomic_DNA.
DR   EMBL; AB041403; BAA94488.1; -; Genomic_DNA.
DR   EMBL; AF498978; AAM21125.1; -; mRNA.
DR   EMBL; BC069159; AAH69159.1; -; mRNA.
DR   EMBL; Z11168; CAA77560.1; -; Genomic_DNA.
DR   IPI; IPI00031686; -.
DR   PIR; I38209; I38209.
DR   RefSeq; NP_000515.2; NM_000524.2.
DR   UniGene; Hs.247940; -.
DR   ProteinModelPortal; P08908; -.
DR   SMR; P08908; 32-417.
DR   STRING; P08908; -.
DR   PhosphoSite; P08908; -.
DR   DMDM; 231454; -.
DR   PRIDE; P08908; -.
DR   DNASU; 3350; -.
DR   Ensembl; ENST00000323865; ENSP00000316244; ENSG00000178394.
DR   GeneID; 3350; -.
DR   KEGG; hsa:3350; -.
DR   UCSC; uc011cqt.2; human.
DR   CTD; 3350; -.
DR   GeneCards; GC05M063292; -.
DR   H-InvDB; HIX0032004; -.
DR   HGNC; HGNC:5286; HTR1A.
DR   HPA; HPA018073; -.
DR   MIM; 109760; gene.
DR   neXtProt; NX_P08908; -.
DR   PharmGKB; PA192; -.
DR   eggNOG; NOG249628; -.
DR   GeneTree; ENSGT00650000092921; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P08908; -.
DR   KO; K04153; -.
DR   OMA; ETECDST; -.
DR   OrthoDB; EOG4CC41F; -.
DR   PhylomeDB; P08908; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00866; Alprenolol.
DR   DrugBank; DB01238; Aripiprazole.
DR   DrugBank; DB00490; Buspirone.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00589; Lisuride.
DR   DrugBank; DB00247; Methysergide.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB00960; Pindolol.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00656; Trazodone.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00246; Ziprasidone.
DR   NextBio; 13248; -.
DR   ArrayExpress; P08908; -.
DR   Bgee; P08908; -.
DR   CleanEx; HS_HTR1A; -.
DR   Genevestigator; P08908; -.
DR   GermOnline; ENSG00000178394; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0004993; F:serotonin receptor activity; TAS:ProtInc.
DR   GO; GO:0007610; P:behavior; TAS:ProtInc.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   InterPro; IPR000610; 5HT1A_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00512; 5HT1ARECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Isopeptide bond; Membrane;
KW   Polymorphism; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN         1    422       5-hydroxytryptamine receptor 1A.
FT                                /FTId=PRO_0000068903.
FT   TOPO_DOM      1     36       Extracellular (By similarity).
FT   TRANSMEM     37     62       Helical; Name=1; (By similarity).
FT   TOPO_DOM     63     73       Cytoplasmic (By similarity).
FT   TRANSMEM     74     98       Helical; Name=2; (By similarity).
FT   TOPO_DOM     99    109       Extracellular (By similarity).
FT   TRANSMEM    110    132       Helical; Name=3; (By similarity).
FT   TOPO_DOM    133    152       Cytoplasmic (By similarity).
FT   TRANSMEM    153    178       Helical; Name=4; (By similarity).
FT   TOPO_DOM    179    191       Extracellular (By similarity).
FT   TRANSMEM    192    217       Helical; Name=5; (By similarity).
FT   TOPO_DOM    218    345       Cytoplasmic (By similarity).
FT   TRANSMEM    346    367       Helical; Name=6; (By similarity).
FT   TOPO_DOM    368    378       Extracellular (By similarity).
FT   TRANSMEM    379    403       Helical; Name=7; (By similarity).
FT   TOPO_DOM    404    422       Cytoplasmic (By similarity).
FT   CARBOHYD     10     10       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     11     11       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     24     24       N-linked (GlcNAc...) (Potential).
FT   DISULFID    109    187       By similarity.
FT   CROSSLNK    334    334       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VARIANT      16     16       P -> L (in dbSNP:rs1800041).
FT                                /FTId=VAR_003446.
FT   VARIANT      22     22       G -> S (in dbSNP:rs1799920).
FT                                /FTId=VAR_011826.
FT   VARIANT      28     28       I -> V (in dbSNP:rs1799921).
FT                                /FTId=VAR_011827.
FT   VARIANT     184    184       P -> L (in dbSNP:rs1800043).
FT                                /FTId=VAR_011828.
FT   VARIANT     220    220       R -> L (in dbSNP:rs1800044).
FT                                /FTId=VAR_011829.
FT   VARIANT     273    273       G -> D (in dbSNP:rs1800042).
FT                                /FTId=VAR_011830.
FT   CONFLICT    152    154       RAA -> PR (in Ref. 1; AAA36440/CAA31908).
FT   CONFLICT    172    172       M -> I (in Ref. 1; AAA36440/CAA31908).
FT   CONFLICT    200    202       TFG -> RPR (in Ref. 8).
FT   CONFLICT    228    228       K -> R (in Ref. 8).
FT   CONFLICT    244    244       A -> AA (in Ref. 8).
FT   CONFLICT    355    355       I -> T (in Ref. 8).
FT   CONFLICT    363    365       IVA -> MRP (in Ref. 8).
FT   CONFLICT    418    418       K -> N (in Ref. 1; AAA36440/CAA31908).
SQ   SEQUENCE   422 AA;  46107 MW;  762664FCF62CFD8F CRC64;
     MDVLSPGQGN NTTSPPAPFE TGGNTTGISD VTVSYQVITS LLLGTLIFCA VLGNACVVAA
     IALERSLQNV ANYLIGSLAV TDLMVSVLVL PMAALYQVLN KWTLGQVTCD LFIALDVLCC
     TSSILHLCAI ALDRYWAITD PIDYVNKRTP RRAAALISLT WLIGFLISIP PMLGWRTPED
     RSDPDACTIS KDHGYTIYST FGAFYIPLLL MLVLYGRIFR AARFRIRKTV KKVEKTGADT
     RHGASPAPQP KKSVNGESGS RNWRLGVESK AGGALCANGA VRQGDDGAAL EVIEVHRVGN
     SKEHLPLPSE AGPTPCAPAS FERKNERNAE AKRKMALARE RKTVKTLGII MGTFILCWLP
     FFIVALVLPF CESSCHMPTL LGAIINWLGY SNSLLNPVIY AYFNKDFQNA FKKIIKCKFC
     RQ
//
ID   5HT1B_HUMAN             Reviewed;         390 AA.
AC   P28222; Q4VAY7;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   22-FEB-2012, entry version 114.
DE   RecName: Full=5-hydroxytryptamine receptor 1B;
DE            Short=5-HT-1B;
DE            Short=5-HT1B;
DE   AltName: Full=S12;
DE   AltName: Full=Serotonin 1D beta receptor;
DE            Short=5-HT-1D-beta;
DE   AltName: Full=Serotonin receptor 1B;
GN   Name=HTR1B; Synonyms=HTR1DB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92246962; PubMed=1315531; DOI=10.1016/0006-291X(92)90654-4;
RA   Hamblin M.W., Metcalf M.A., McGuffin R.W., Karpells S.;
RT   "Molecular cloning and functional characterization of a human 5-HT1B
RT   serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-
RT   HT1D-like pharmacological specificity.";
RL   Biochem. Biophys. Res. Commun. 184:752-759(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92304270; PubMed=1610347; DOI=10.1016/0006-291X(92)91655-A;
RA   Mochizuki D., Yuyama Y., Tsujita R., Komaki H., Sagai H.;
RT   "Cloning and expression of the human 5-HT1B-type receptor gene.";
RL   Biochem. Biophys. Res. Commun. 185:517-523(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92210526; PubMed=1348246;
RA   Jin H., Oksenberg D., Ashkenazi A., Peroutka S.J., Duncan A.M.V.,
RA   Rozmahel R., Yang Y., Mengod G., Palacios J.M., O'Dowd B.F.;
RT   "Characterization of the human 5-hydroxytryptamine1B receptor.";
RL   J. Biol. Chem. 267:5735-5738(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92218412; PubMed=1559993;
RA   Levy F.O., Gudermann T., Perez-Reyes E., Birnbaumer M., Kaumann A.J.,
RA   Birnbaumer L.;
RT   "Molecular cloning of a human serotonin receptor (S12) with a
RT   pharmacological profile resembling that of the 5-HT1D subtype.";
RL   J. Biol. Chem. 267:7553-7562(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=92228840; PubMed=1565658; DOI=10.1073/pnas.89.8.3630;
RA   Weinshank R.L., Zgombick J.M., Macchi M.J., Branchek T.A.,
RA   Hartig P.R.;
RT   "Human serotonin 1D receptor is encoded by a subfamily of two distinct
RT   genes: 5-HT1D alpha and 5-HT1D beta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:3630-3634(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92302275; PubMed=1351684; DOI=10.1073/pnas.89.12.5522;
RA   Demchyshyn L., Sunahara R.K., Miller K., Teitler M., Hoffman B.J.,
RA   Kennedy J.L., Seeman P., van Tol H.H.M., Niznik H.B.;
RT   "A human serotonin 1D receptor variant (5HT1D beta) encoded by an
RT   intronless gene on chromosome 6.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:5522-5526(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=93024334; PubMed=1328844;
RA   Veldman S.A., Bienkowski M.J.;
RT   "Cloning and pharmacological characterization of a novel human 5-
RT   hydroxytryptamine1D receptor subtype.";
RL   Mol. Pharmacol. 42:439-444(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15014171; DOI=10.1093/molbev/msh100;
RA   Kitano T., Liu Y.-H., Ueda S., Saitou N.;
RT   "Human-specific amino acid changes found in 103 protein-coding
RT   genes.";
RL   Mol. Biol. Evol. 21:936-944(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "Isolation of complete coding sequence for 5-hydroxytryptamine
RT   (serotonin) receptor 1B (HTR1B).";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PALMITOYLATION, AND PHOSPHORYLATION.
RX   MEDLINE=94032297; PubMed=8218242; DOI=10.1021/bi00094a032;
RA   Ng G.Y.K., George S.R., Zastawny R.L., Caron M., Bouvier M.,
RA   Dennis M., O'Dowd B.F.;
RT   "Human serotonin1B receptor expression in Sf9 cells: phosphorylation,
RT   palmitoylation, and adenylyl cyclase inhibition.";
RL   Biochemistry 32:11727-11733(1993).
RN   [13]
RP   VARIANT CYS-124.
RX   MEDLINE=95100945; PubMed=7802650; DOI=10.1006/bbrc.1994.2792;
RA   Nothen M.M., Erdmann J., Shimron-Abarbanell D., Propping P.;
RT   "Identification of genetic variation in the human serotonin 1D beta
RT   receptor gene.";
RL   Biochem. Biophys. Res. Commun. 205:1194-1200(1994).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that inhibit adenylate
CC       cyclase activity.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- PTM: Phosphorylated. Desensitization of the receptor may be
CC       mediated by its phosphorylation.
CC   -!- PTM: Palmitoylated.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M89478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; D10995; BAA01763.1; -; Genomic_DNA.
DR   EMBL; M83180; AAA36029.1; -; Genomic_DNA.
DR   EMBL; L09732; AAA36030.1; -; Genomic_DNA.
DR   EMBL; M81590; AAA60316.1; -; mRNA.
DR   EMBL; M75128; AAA58675.1; -; Genomic_DNA.
DR   EMBL; AB041370; BAA94455.1; -; Genomic_DNA.
DR   EMBL; AY225227; AAO67712.1; -; Genomic_DNA.
DR   EMBL; AL049595; CAB51537.1; -; Genomic_DNA.
DR   EMBL; BC069065; AAH69065.1; -; mRNA.
DR   EMBL; BC096206; AAH96206.1; -; mRNA.
DR   EMBL; BC096207; AAH96207.1; -; mRNA.
DR   EMBL; BC096208; AAH96208.1; -; mRNA.
DR   IPI; IPI00002184; -.
DR   PIR; JN0268; JN0268.
DR   RefSeq; NP_000854.1; NM_000863.1.
DR   UniGene; Hs.123016; -.
DR   PDB; 2G1X; Model; -; A=1-390.
DR   PDBsum; 2G1X; -.
DR   ProteinModelPortal; P28222; -.
DR   SMR; P28222; 43-387.
DR   STRING; P28222; -.
DR   PhosphoSite; P28222; -.
DR   DMDM; 112821; -.
DR   PRIDE; P28222; -.
DR   Ensembl; ENST00000369947; ENSP00000358963; ENSG00000135312.
DR   GeneID; 3351; -.
DR   KEGG; hsa:3351; -.
DR   UCSC; uc003pil.1; human.
DR   CTD; 3351; -.
DR   GeneCards; GC06M078228; -.
DR   H-InvDB; HIX0032923; -.
DR   HGNC; HGNC:5287; HTR1B.
DR   MIM; 182131; gene.
DR   neXtProt; NX_P28222; -.
DR   PharmGKB; PA29549; -.
DR   eggNOG; NOG249628; -.
DR   GeneTree; ENSGT00650000092921; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P28222; -.
DR   KO; K04153; -.
DR   OMA; ALPWKVL; -.
DR   OrthoDB; EOG4R7VB6; -.
DR   PhylomeDB; P28222; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB00320; Dihydroergotamine.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB00696; Ergotamine.
DR   DrugBank; DB00998; Frovatriptan.
DR   DrugBank; DB00952; Naratriptan.
DR   DrugBank; DB00960; Pindolol.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB00953; Rizatriptan.
DR   DrugBank; DB00669; Sumatriptan.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00315; Zolmitriptan.
DR   NextBio; 13252; -.
DR   ArrayExpress; P28222; -.
DR   Bgee; P28222; -.
DR   CleanEx; HS_HTR1B; -.
DR   Genevestigator; P28222; -.
DR   GermOnline; ENSG00000135312; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0004993; F:serotonin receptor activity; TAS:ProtInc.
DR   GO; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   InterPro; IPR002147; 5HT1B_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00513; 5HT1BRECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane;
KW   Palmitate; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN         1    390       5-hydroxytryptamine receptor 1B.
FT                                /FTId=PRO_0000068916.
FT   TOPO_DOM      1     49       Extracellular (By similarity).
FT   TRANSMEM     50     73       Helical; Name=1; (By similarity).
FT   TOPO_DOM     74     86       Cytoplasmic (By similarity).
FT   TRANSMEM     87    109       Helical; Name=2; (By similarity).
FT   TOPO_DOM    110    119       Extracellular (By similarity).
FT   TRANSMEM    120    145       Helical; Name=3; (By similarity).
FT   TOPO_DOM    146    165       Cytoplasmic (By similarity).
FT   TRANSMEM    166    187       Helical; Name=4; (By similarity).
FT   TOPO_DOM    188    205       Extracellular (By similarity).
FT   TRANSMEM    206    229       Helical; Name=5; (By similarity).
FT   TOPO_DOM    230    315       Cytoplasmic (By similarity).
FT   TRANSMEM    316    340       Helical; Name=6; (By similarity).
FT   TOPO_DOM    341    347       Extracellular (By similarity).
FT   TRANSMEM    348    373       Helical; Name=7; (By similarity).
FT   TOPO_DOM    374    390       Cytoplasmic (By similarity).
FT   LIPID       388    388       S-palmitoyl cysteine (Potential).
FT   CARBOHYD     24     24       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     32     32       N-linked (GlcNAc...) (Potential).
FT   DISULFID    122    199       By similarity.
FT   VARIANT     124    124       F -> C (in dbSNP:rs130060).
FT                                /FTId=VAR_011715.
FT   VARIANT     219    219       F -> L (in dbSNP:rs130061).
FT                                /FTId=VAR_011831.
FT   VARIANT     367    367       I -> V (in dbSNP:rs130063).
FT                                /FTId=VAR_011832.
FT   VARIANT     374    374       E -> K (in dbSNP:rs130064).
FT                                /FTId=VAR_011833.
SQ   SEQUENCE   390 AA;  43568 MW;  CD874DC7EB44CF12 CRC64;
     MEEPGAQCAP PPPAGSETWV PQANLSSAPS QNCSAKDYIY QDSISLPWKV LLVMLLALIT
     LATTLSNAFV IATVYRTRKL HTPANYLIAS LAVTDLLVSI LVMPISTMYT VTGRWTLGQV
     VCDFWLSSDI TCCTASILHL CVIALDRYWA ITDAVEYSAK RTPKRAAVMI ALVWVFSISI
     SLPPFFWRQA KAEEEVSECV VNTDHILYTV YSTVGAFYFP TLLLIALYGR IYVEARSRIL
     KQTPNRTGKR LTRAQLITDS PGSTSSVTSI NSRVPDVPSE SGSPVYVNQV KVRVSDALLE
     KKKLMAARER KATKTLGIIL GAFIVCWLPF FIISLVMPIC KDACWFHLAI FDFFTWLGYL
     NSLINPIIYT MSNEDFKQAF HKLIRFKCTS
//
ID   5HT1D_HUMAN             Reviewed;         377 AA.
AC   P28221;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   18-APR-2012, entry version 116.
DE   RecName: Full=5-hydroxytryptamine receptor 1D;
DE            Short=5-HT-1D;
DE            Short=5-HT1D;
DE   AltName: Full=5-HT-1D-alpha;
DE   AltName: Full=Serotonin receptor 1D;
GN   Name=HTR1D; Synonyms=HTR1DA, HTRL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=91342595; PubMed=1652050;
RA   Hamblin M.W., Metcalf M.A.;
RT   "Primary structure and functional characterization of a human 5-HT1D-
RT   type serotonin receptor.";
RL   Mol. Pharmacol. 40:143-148(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=92228840; PubMed=1565658; DOI=10.1073/pnas.89.8.3630;
RA   Weinshank R.L., Zgombick J.M., Macchi M.J., Branchek T.A.,
RA   Hartig P.R.;
RT   "Human serotonin 1D receptor is encoded by a subfamily of two distinct
RT   genes: 5-HT1D alpha and 5-HT1D beta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:3630-3634(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   VARIANT LEU-265.
RX   MEDLINE=99318093; PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [8]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that inhibit adenylate
CC       cyclase activity.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M89955; AAA35491.1; -; Genomic_DNA.
DR   EMBL; M81589; AAA60315.1; -; mRNA.
DR   EMBL; AF498979; AAM21126.1; -; mRNA.
DR   EMBL; BT007027; AAP35673.1; -; mRNA.
DR   EMBL; AL049576; CAB81617.1; -; Genomic_DNA.
DR   EMBL; BC007720; AAH07720.1; -; mRNA.
DR   IPI; IPI00002183; -.
DR   PIR; A53279; A53279.
DR   RefSeq; NP_000855.1; NM_000864.4.
DR   UniGene; Hs.121482; -.
DR   ProteinModelPortal; P28221; -.
DR   SMR; P28221; 35-375.
DR   STRING; P28221; -.
DR   DMDM; 112819; -.
DR   PRIDE; P28221; -.
DR   DNASU; 3352; -.
DR   Ensembl; ENST00000314113; ENSP00000313661; ENSG00000179546.
DR   Ensembl; ENST00000374619; ENSP00000363748; ENSG00000179546.
DR   GeneID; 3352; -.
DR   KEGG; hsa:3352; -.
DR   UCSC; uc001bgn.3; human.
DR   CTD; 3352; -.
DR   GeneCards; GC01M023517; -.
DR   H-InvDB; HIX0199958; -.
DR   HGNC; HGNC:5289; HTR1D.
DR   MIM; 182133; gene.
DR   neXtProt; NX_P28221; -.
DR   PharmGKB; PA29550; -.
DR   eggNOG; NOG249628; -.
DR   GeneTree; ENSGT00650000092921; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P28221; -.
DR   KO; K04153; -.
DR   OMA; LHEGHSH; -.
DR   OrthoDB; EOG4R7VB6; -.
DR   PhylomeDB; P28221; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB00320; Dihydroergotamine.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB00696; Ergotamine.
DR   DrugBank; DB00998; Frovatriptan.
DR   DrugBank; DB00952; Naratriptan.
DR   DrugBank; DB00953; Rizatriptan.
DR   DrugBank; DB00669; Sumatriptan.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00246; Ziprasidone.
DR   DrugBank; DB00315; Zolmitriptan.
DR   NextBio; 13256; -.
DR   ArrayExpress; P28221; -.
DR   Bgee; P28221; -.
DR   CleanEx; HS_HTR1D; -.
DR   Genevestigator; P28221; -.
DR   GermOnline; ENSG00000179546; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0004993; F:serotonin receptor activity; TAS:ProtInc.
DR   GO; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0014827; P:intestine smooth muscle contraction; IMP:UniProtKB.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   InterPro; IPR000505; 5HT1D_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00514; 5HT1DRECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    377       5-hydroxytryptamine receptor 1D.
FT                                /FTId=PRO_0000068927.
FT   TOPO_DOM      1     38       Extracellular (By similarity).
FT   TRANSMEM     39     62       Helical; Name=1; (By similarity).
FT   TOPO_DOM     63     75       Cytoplasmic (By similarity).
FT   TRANSMEM     76     98       Helical; Name=2; (By similarity).
FT   TOPO_DOM     99    108       Extracellular (By similarity).
FT   TRANSMEM    109    134       Helical; Name=3; (By similarity).
FT   TOPO_DOM    135    154       Cytoplasmic (By similarity).
FT   TRANSMEM    155    176       Helical; Name=4; (By similarity).
FT   TOPO_DOM    177    194       Extracellular (By similarity).
FT   TRANSMEM    195    218       Helical; Name=5; (By similarity).
FT   TOPO_DOM    219    302       Cytoplasmic (By similarity).
FT   TRANSMEM    303    326       Helical; Name=6; (By similarity).
FT   TOPO_DOM    327    335       Extracellular (By similarity).
FT   TRANSMEM    336    360       Helical; Name=7; (By similarity).
FT   TOPO_DOM    361    377       Cytoplasmic (By similarity).
FT   CARBOHYD      5      5       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     17     17       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     21     21       N-linked (GlcNAc...) (Potential).
FT   DISULFID    111    188       By similarity.
FT   VARIANT     265    265       S -> L (in dbSNP:rs6299).
FT                                /FTId=VAR_011834.
SQ   SEQUENCE   377 AA;  41907 MW;  0A4FCF81FFE2322A CRC64;
     MSPLNQSAEG LPQEASNRSL NATETSEAWD PRTLQALKIS LAVVLSVITL ATVLSNAFVL
     TTILLTRKLH TPANYLIGSL ATTDLLVSIL VMPISIAYTI THTWNFGQIL CDIWLSSDIT
     CCTASILHLC VIALDRYWAI TDALEYSKRR TAGHAATMIA IVWAISICIS IPPLFWRQAK
     AQEEMSDCLV NTSQISYTIY STCGAFYIPS VLLIILYGRI YRAARNRILN PPSLYGKRFT
     TAHLITGSAG SSLCSLNSSL HEGHSHSAGS PLFFNHVKIK LADSALERKR ISAARERKAT
     KILGIILGAF IICWLPFFVV SLVLPICRDS CWIHPALFDF FTWLGYLNSL INPIIYTVFN
     EEFRQAFQKI VPFRKAS
//
ID   5HT1E_HUMAN             Reviewed;         365 AA.
AC   P28566; E1P503; Q9P1Y1;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   18-APR-2012, entry version 117.
DE   RecName: Full=5-hydroxytryptamine receptor 1E;
DE            Short=5-HT-1E;
DE            Short=5-HT1E;
DE   AltName: Full=S31;
DE   AltName: Full=Serotonin receptor 1E;
GN   Name=HTR1E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=92302274; PubMed=1608964; DOI=10.1073/pnas.89.12.5517;
RA   McAllister G., Charlesworth A., Snodin C., Beer M.S., Noble A.J.,
RA   Middlemiss D.N., Iversen L.L., Whiting P.;
RT   "Molecular cloning of a serotonin receptor from human brain (5HT1E): a
RT   fifth 5HT1-like subtype.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:5517-5521(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92128546; PubMed=1733778; DOI=10.1016/0014-5793(92)80379-U;
RA   Levy F.O., Gudermann T., Birnbaumer M., Kaumann A.J., Birnbaumer L.;
RT   "Molecular cloning of a human gene (S31) encoding a novel serotonin
RT   receptor mediating inhibition of adenylyl cyclase.";
RL   FEBS Lett. 296:201-206(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92382553; PubMed=1513320;
RA   Zgombick J.M., Schechter L.E., Macchi M., Hartig P.R., Branchek T.A.,
RA   Weinshank R.L.;
RT   "Human gene S31 encodes the pharmacologically defined serotonin 5-
RT   hydroxytryptamine1E receptor.";
RL   Mol. Pharmacol. 42:180-185(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-363.
RX   PubMed=15014171; DOI=10.1093/molbev/msh100;
RA   Kitano T., Liu Y.-H., Ueda S., Saitou N.;
RT   "Human-specific amino acid changes found in 103 protein-coding
RT   genes.";
RL   Mol. Biol. Evol. 21:936-944(2004).
RN   [9]
RP   VARIANT PHE-262.
RX   MEDLINE=99318093; PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [10]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that inhibit adenylate
CC       cyclase activity.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M91467; AAA58353.1; -; mRNA.
DR   EMBL; Z11166; CAA77558.1; -; Genomic_DNA.
DR   EMBL; M92826; AAA58355.1; -; Genomic_DNA.
DR   EMBL; AF498980; AAM21127.1; -; mRNA.
DR   EMBL; AL157777; CAC10582.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48616.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48617.1; -; Genomic_DNA.
DR   EMBL; BC069751; AAH69751.1; -; mRNA.
DR   EMBL; AB041373; BAA94458.1; -; Genomic_DNA.
DR   IPI; IPI00003932; -.
DR   PIR; S20579; A45260.
DR   RefSeq; NP_000856.1; NM_000865.2.
DR   UniGene; Hs.1611; -.
DR   ProteinModelPortal; P28566; -.
DR   SMR; P28566; 18-359.
DR   STRING; P28566; -.
DR   DMDM; 112822; -.
DR   PRIDE; P28566; -.
DR   Ensembl; ENST00000305344; ENSP00000307766; ENSG00000168830.
DR   Ensembl; ENST00000369584; ENSP00000358597; ENSG00000168830.
DR   GeneID; 3354; -.
DR   KEGG; hsa:3354; -.
DR   UCSC; uc003pli.3; human.
DR   CTD; 3354; -.
DR   GeneCards; GC06P087647; -.
DR   H-InvDB; HIX0032800; -.
DR   HGNC; HGNC:5291; HTR1E.
DR   HPA; HPA004931; -.
DR   MIM; 182132; gene.
DR   neXtProt; NX_P28566; -.
DR   PharmGKB; PA29552; -.
DR   eggNOG; NOG249628; -.
DR   GeneTree; ENSGT00650000092921; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P28566; -.
DR   KO; K04153; -.
DR   OMA; PLFWRSH; -.
DR   OrthoDB; EOG43XV41; -.
DR   PhylomeDB; P28566; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00216; Eletriptan.
DR   NextBio; 13262; -.
DR   ArrayExpress; P28566; -.
DR   Bgee; P28566; -.
DR   CleanEx; HS_HTR1E; -.
DR   Genevestigator; P28566; -.
DR   GermOnline; ENSG00000168830; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0051378; F:serotonin binding; IDA:MGI.
DR   GO; GO:0004993; F:serotonin receptor activity; IDA:MGI.
DR   GO; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    365       5-hydroxytryptamine receptor 1E.
FT                                /FTId=PRO_0000068933.
FT   TOPO_DOM      1     22       Extracellular (By similarity).
FT   TRANSMEM     23     47       Helical; Name=1; (By similarity).
FT   TOPO_DOM     48     59       Cytoplasmic (By similarity).
FT   TRANSMEM     60     81       Helical; Name=2; (By similarity).
FT   TOPO_DOM     82     96       Extracellular (By similarity).
FT   TRANSMEM     97    118       Helical; Name=3; (By similarity).
FT   TOPO_DOM    119    138       Cytoplasmic (By similarity).
FT   TRANSMEM    139    159       Helical; Name=4; (By similarity).
FT   TOPO_DOM    160    179       Extracellular (By similarity).
FT   TRANSMEM    180    201       Helical; Name=5; (By similarity).
FT   TOPO_DOM    202    291       Cytoplasmic (By similarity).
FT   TRANSMEM    292    314       Helical; Name=6; (By similarity).
FT   TOPO_DOM    315    324       Extracellular (By similarity).
FT   TRANSMEM    325    347       Helical; Name=7; (By similarity).
FT   TOPO_DOM    348    365       Cytoplasmic (By similarity).
FT   CARBOHYD      2      2       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD      5      5       N-linked (GlcNAc...) (Potential).
FT   DISULFID     95    173       By similarity.
FT   VARIANT     208    208       A -> T (in dbSNP:rs3828741).
FT                                /FTId=VAR_022061.
FT   VARIANT     262    262       S -> F (in dbSNP:rs6303).
FT                                /FTId=VAR_014165.
SQ   SEQUENCE   365 AA;  41682 MW;  4C31DD783A3F7483 CRC64;
     MNITNCTTEA SMAIRPKTIT EKMLICMTLV VITTLTTLLN LAVIMAIGTT KKLHQPANYL
     ICSLAVTDLL VAVLVMPLSI IYIVMDRWKL GYFLCEVWLS VDMTCCTCSI LHLCVIALDR
     YWAITNAIEY ARKRTAKRAA LMILTVWTIS IFISMPPLFW RSHRRLSPPP SQCTIQHDHV
     IYTIYSTLGA FYIPLTLILI LYYRIYHAAK SLYQKRGSSR HLSNRSTDSQ NSFASCKLTQ
     TFCVSDFSTS DPTTEFEKFH ASIRIPPFDN DLDHPGERQQ ISSTRERKAA RILGLILGAF
     ILSWLPFFIK ELIVGLSIYT VSSEVADFLT WLGYVNSLIN PLLYTSFNED FKLAFKKLIR
     CREHT
//
ID   5HT1F_HUMAN             Reviewed;         366 AA.
AC   P30939;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   22-FEB-2012, entry version 99.
DE   RecName: Full=5-hydroxytryptamine receptor 1F;
DE            Short=5-HT-1F;
DE            Short=5-HT1F;
DE   AltName: Full=Serotonin receptor 1F;
GN   Name=HTR1F; Synonyms=HTR1EL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=93211926; PubMed=8384716; DOI=10.1073/pnas.90.6.2184;
RA   Lovenberg T.W., Erlander M.G., Baron B.M., Racke M., Slone A.L.,
RA   Siegel B.W., Craft C.M., Burns J.E., Danielson P.E., Sutcliffe G.J.;
RT   "Molecular cloning and functional expression of 5-HT1E-like rat and
RT   human 5-hydroxytryptamine receptor genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:2184-2188(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=93133800; PubMed=8380639; DOI=10.1073/pnas.90.2.408;
RA   Adham N., Kao H.-T., Schechter L.E., Bard J., Olsen M., Urquhart D.,
RA   Durkin M., Hartig P.R., Winshank R.L., Branchek T.A.;
RT   "Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1
RT   receptor subtype coupled to the inhibition of adenylate cyclase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:408-412(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that inhibit adenylate
CC       cyclase activity.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L05597; AAA36605.1; -; Genomic_DNA.
DR   EMBL; L04962; AAA36646.1; -; Genomic_DNA.
DR   EMBL; AF498981; AAM21128.1; -; mRNA.
DR   EMBL; BC069125; AAH69125.1; -; mRNA.
DR   IPI; IPI00028093; -.
DR   PIR; A47321; A47321.
DR   RefSeq; NP_000857.1; NM_000866.3.
DR   UniGene; Hs.248136; -.
DR   ProteinModelPortal; P30939; -.
DR   SMR; P30939; 21-364.
DR   STRING; P30939; -.
DR   DMDM; 398967; -.
DR   PRIDE; P30939; -.
DR   Ensembl; ENST00000319595; ENSP00000322924; ENSG00000179097.
DR   GeneID; 3355; -.
DR   KEGG; hsa:3355; -.
DR   UCSC; uc003dqr.2; human.
DR   CTD; 3355; -.
DR   GeneCards; GC03P088031; -.
DR   H-InvDB; HIX0030749; -.
DR   HGNC; HGNC:5292; HTR1F.
DR   HPA; HPA005555; -.
DR   MIM; 182134; gene.
DR   neXtProt; NX_P30939; -.
DR   PharmGKB; PA29553; -.
DR   eggNOG; NOG249628; -.
DR   GeneTree; ENSGT00650000092921; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P30939; -.
DR   KO; K04153; -.
DR   OMA; VNVCEKC; -.
DR   OrthoDB; EOG43XV41; -.
DR   PhylomeDB; P30939; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB00952; Naratriptan.
DR   DrugBank; DB00953; Rizatriptan.
DR   DrugBank; DB00669; Sumatriptan.
DR   DrugBank; DB00315; Zolmitriptan.
DR   NextBio; 13266; -.
DR   ArrayExpress; P30939; -.
DR   Bgee; P30939; -.
DR   CleanEx; HS_HTR1F; -.
DR   Genevestigator; P30939; -.
DR   GermOnline; ENSG00000179097; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0051378; F:serotonin binding; IDA:MGI.
DR   GO; GO:0004993; F:serotonin receptor activity; IDA:MGI.
DR   GO; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   InterPro; IPR000450; 5HT1F_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00515; 5HT1FRECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN         1    366       5-hydroxytryptamine receptor 1F.
FT                                /FTId=PRO_0000068937.
FT   TOPO_DOM      1     29       Extracellular (By similarity).
FT   TRANSMEM     30     50       Helical; Name=1; (By similarity).
FT   TOPO_DOM     51     64       Cytoplasmic (By similarity).
FT   TRANSMEM     65     85       Helical; Name=2; (By similarity).
FT   TOPO_DOM     86     97       Extracellular (By similarity).
FT   TRANSMEM     98    118       Helical; Name=3; (By similarity).
FT   TOPO_DOM    119    140       Cytoplasmic (By similarity).
FT   TRANSMEM    141    161       Helical; Name=4; (By similarity).
FT   TOPO_DOM    162    178       Extracellular (By similarity).
FT   TRANSMEM    179    199       Helical; Name=5; (By similarity).
FT   TOPO_DOM    200    290       Cytoplasmic (By similarity).
FT   TRANSMEM    291    311       Helical; Name=6; (By similarity).
FT   TOPO_DOM    312    329       Extracellular (By similarity).
FT   TRANSMEM    330    350       Helical; Name=7; (By similarity).
FT   TOPO_DOM    351    366       Cytoplasmic (By similarity).
FT   CARBOHYD      5      5       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     10     10       N-linked (GlcNAc...) (Potential).
FT   DISULFID     96    172       By similarity.
SQ   SEQUENCE   366 AA;  41709 MW;  16EA80344793B54F CRC64;
     MDFLNSSDQN LTSEELLNRM PSKILVSLTL SGLALMTTTI NSLVIAAIIV TRKLHHPANY
     LICSLAVTDF LVAVLVMPFS IVYIVRESWI MGQVVCDIWL SVDITCCTCS ILHLSAIALD
     RYRAITDAVE YARKRTPKHA GIMITIVWII SVFISMPPLF WRHQGTSRDD ECIIKHDHIV
     STIYSTFGAF YIPLALILIL YYKIYRAAKT LYHKRQASRI AKEEVNGQVL LESGEKSTKS
     VSTSYVLEKS LSDPSTDFDK IHSTVRSLRS EFKHEKSWRR QKISGTRERK AATTLGLILG
     AFVICWLPFF VKELVVNVCD KCKISEEMSN FLAWLGYLNS LINPLIYTIF NEDFKKAFQK
     LVRCRC
//
ID   5HT2A_HUMAN             Reviewed;         471 AA.
AC   P28223; B2RAC5; Q5T8C0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   18-APR-2012, entry version 122.
DE   RecName: Full=5-hydroxytryptamine receptor 2A;
DE            Short=5-HT-2;
DE            Short=5-HT-2A;
DE   AltName: Full=Serotonin receptor 2A;
GN   Name=HTR2A; Synonyms=HTR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain stem;
RX   MEDLINE=92109767; PubMed=1722404; DOI=10.1016/0006-291X(91)92105-S;
RA   Saltzman A.G., Morse B., Whitman M.M., Ivanshchenko Y., Jaye M.,
RA   Felder S.;
RT   "Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes.";
RL   Biochem. Biophys. Res. Commun. 181:1469-1478(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92356792; PubMed=1323014; DOI=10.1016/0169-328X(92)90005-V;
RA   Chen K., Yang W., Grimsby J., Shih J.C.;
RT   "The human 5-HT2 receptor is encoded by a multiple intron-exon gene.";
RL   Brain Res. Mol. Brain Res. 14:20-26(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94308772; PubMed=8035173;
RA   Cook E.H. Jr., Fletcher K.E., Wainwright M., Marks N., Yan S.Y.,
RA   Leventhal B.L.;
RT   "Primary structure of the human platelet serotonin 5-HT2A receptor:
RT   identify with frontal cortex serotonin 5-HT2A receptor.";
RL   J. Neurochem. 63:465-469(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-464.
RC   TISSUE=Brain;
RA   Tritch R.J., Robinson D.L., Sahagan B.G., Horlick R.A.;
RT   "Cloning and nucleotide sequence of the human(5HT) type 2 receptor.";
RL   Submitted (MAY-1992) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 105-218.
RX   MEDLINE=93049882; PubMed=1330647; DOI=10.1016/0922-4106(92)90123-D;
RA   Stam N.J., van Huizen F., van Alebeek C., Brands J., Dijkema R.,
RA   Tonnaer J.A., Olijve W.;
RT   "Genomic organization, coding sequence and functional expression of
RT   human 5-HT2 and 5-HT1A receptor genes.";
RL   Eur. J. Pharmacol. 227:153-162(1992).
RN   [11]
RP   INTERACTION WITH MPDZ.
RX   MEDLINE=21201137; PubMed=11150294; DOI=10.1074/jbc.M008089200;
RA   Becamel C., Figge A., Poliak S., Dumuis A., Peles E., Bockaert J.,
RA   Luebbert H., Ullmer C.;
RT   "Interaction of serotonin 5-hydroxytryptamine type 2C receptors with
RT   PDZ10 of the multi-PDZ domain protein MUPP1.";
RL   J. Biol. Chem. 276:12974-12982(2001).
RN   [12]
RP   INTERACTION WITH INADL; MPP3; PRDX6; DLG4; DLG1; CASK; APBA1 AND
RP   MAGI2, AND MUTAGENESIS OF GLY-463; ASN-465; CYS-470 AND VAL-471.
RX   PubMed=14988405; DOI=10.1074/jbc.M312106200;
RA   Becamel C., Gavarini S., Chanrion B., Alonso G., Galeotti N.,
RA   Dumuis A., Bockaert J., Marin P.;
RT   "The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets
RT   of PDZ proteins.";
RL   J. Biol. Chem. 279:20257-20266(2004).
RN   [13]
RP   VARIANTS ASN-25 AND TYR-452.
RX   MEDLINE=96209907; PubMed=8655141; DOI=10.1007/s004390050104;
RA   Erdmann J., Shimron-Abarbanell D., Rietschel M., Albus M., Maier W.,
RA   Koerner J., Bondy B., Chen K., Shih J.C., Knapp M., Propping P.,
RA   Noethen M.M.;
RT   "Systematic screening for mutations in the human serotonin-2A (5-HT2A)
RT   receptor gene: identification of two naturally occurring receptor
RT   variants and association analysis in schizophrenia.";
RL   Hum. Genet. 97:614-619(1996).
RN   [14]
RP   VARIANTS ASN-25 AND TYR-452.
RX   MEDLINE=20049881; PubMed=10581480;
RX   DOI=10.1002/(SICI)1096-8628(19991215)88:6<621::AID-AJMG9>3.0.CO;2-H;
RA   Marshall S.E., Bird T.G., Hart K., Welsh K.I.;
RT   "Unified approach to the analysis of genetic variation in serotonergic
RT   pathways.";
RL   Am. J. Med. Genet. 88:621-627(1999).
RN   [15]
RP   VARIANTS VAL-197; VAL-447 AND TYR-452.
RX   MEDLINE=99318093; PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [16]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor
CC       mediates its action by association with G proteins that activate a
CC       phosphatidylinositol-calcium second messenger system. This
CC       receptor is involved in tracheal smooth muscle contraction,
CC       bronchoconstriction, and control of aldosterone production.
CC   -!- SUBUNIT: Interacts with MPDZ and INADL. May interact with MPP3,
CC       PRDX6, DLG4, DLG1, CASK, APBA1 and MAGI2.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein
CC       (By similarity). Note=Localizes to the post-synaptic thickening of
CC       axo-dendritic synapses (By similarity).
CC   -!- DOMAIN: The PDZ domain-binding motif is involved in the
CC       interaction with INADL, CASK, APBA1, DLG1 and DLG4.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=HTR2A";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X57830; CAA40963.1; -; mRNA.
DR   EMBL; S42168; AAB22791.2; -; Genomic_DNA.
DR   EMBL; S42165; AAB22791.2; JOINED; Genomic_DNA.
DR   EMBL; S42167; AAB22791.2; JOINED; Genomic_DNA.
DR   EMBL; S71229; AAB31320.1; -; mRNA.
DR   EMBL; AF498982; AAM21129.1; -; mRNA.
DR   EMBL; AK314132; BAG36822.1; -; mRNA.
DR   EMBL; AL160397; CAI16877.1; -; Genomic_DNA.
DR   EMBL; AL136958; CAI16877.1; JOINED; Genomic_DNA.
DR   EMBL; AL136958; CAI12227.1; -; Genomic_DNA.
DR   EMBL; AL160397; CAI12227.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08770.1; -; Genomic_DNA.
DR   EMBL; BC069356; AAH69356.1; -; mRNA.
DR   EMBL; BC069576; AAH69576.1; -; mRNA.
DR   EMBL; BC074848; AAH74848.1; -; mRNA.
DR   EMBL; BC074849; AAH74849.1; -; mRNA.
DR   EMBL; BC096839; AAH96839.1; -; mRNA.
DR   EMBL; M86841; AAA58354.1; -; mRNA.
DR   EMBL; S50130; AAB24166.2; -; Genomic_DNA.
DR   EMBL; S49737; AAB24166.2; JOINED; Genomic_DNA.
DR   EMBL; S50113; AAB24166.2; JOINED; Genomic_DNA.
DR   IPI; IPI00002185; -.
DR   PIR; A43956; A43956.
DR   RefSeq; NP_000612.1; NM_000621.4.
DR   UniGene; Hs.654586; -.
DR   ProteinModelPortal; P28223; -.
DR   SMR; P28223; 74-395.
DR   MINT; MINT-443877; -.
DR   STRING; P28223; -.
DR   PhosphoSite; P28223; -.
DR   DMDM; 543727; -.
DR   PRIDE; P28223; -.
DR   Ensembl; ENST00000378688; ENSP00000367959; ENSG00000102468.
DR   GeneID; 3356; -.
DR   KEGG; hsa:3356; -.
DR   UCSC; uc010acr.3; human.
DR   CTD; 3356; -.
DR   GeneCards; GC13M047407; -.
DR   H-InvDB; HIX0026550; -.
DR   HGNC; HGNC:5293; HTR2A.
DR   HPA; HPA014011; -.
DR   MIM; 182135; gene.
DR   neXtProt; NX_P28223; -.
DR   PharmGKB; PA193; -.
DR   eggNOG; NOG247243; -.
DR   GeneTree; ENSGT00650000093057; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG107487; -.
DR   InParanoid; P28223; -.
DR   KO; K04157; -.
DR   OMA; NSGEANT; -.
DR   OrthoDB; EOG4TMR24; -.
DR   PhylomeDB; P28223; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB01238; Aripiprazole.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB01239; Chlorprothixene.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00924; Cyclobenzaprine.
DR   DrugBank; DB00434; Cyproheptadine.
DR   DrugBank; DB00320; Dihydroergotamine.
DR   DrugBank; DB00843; Donepezil.
DR   DrugBank; DB00751; Epinastine.
DR   DrugBank; DB00696; Ergotamine.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00933; Mesoridazine.
DR   DrugBank; DB00247; Methysergide.
DR   DrugBank; DB06148; Mianserin.
DR   DrugBank; DB00805; Minaprine.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01149; Nefazodone.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB01267; Paliperidone.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB00433; Prochlorperazine.
DR   DrugBank; DB00420; Promazine.
DR   DrugBank; DB01069; Promethazine.
DR   DrugBank; DB00777; Propiomazine.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB00734; Risperidone.
DR   DrugBank; DB06144; Sertindole.
DR   DrugBank; DB00372; Thiethylperazine.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB00752; Tranylcypromine.
DR   DrugBank; DB00656; Trazodone.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00246; Ziprasidone.
DR   NextBio; 13270; -.
DR   ArrayExpress; P28223; -.
DR   Bgee; P28223; -.
DR   CleanEx; HS_HTR2A; -.
DR   Genevestigator; P28223; -.
DR   GermOnline; ENSG00000102468; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IMP:UniProtKB.
DR   GO; GO:0051378; F:serotonin binding; IDA:UniProtKB.
DR   GO; GO:0004993; F:serotonin receptor activity; IDA:UniProtKB.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase cascade; IMP:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   InterPro; IPR000455; 5HT2A_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00516; 5HT2ARECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    471       5-hydroxytryptamine receptor 2A.
FT                                /FTId=PRO_0000068946.
FT   TOPO_DOM      1     75       Extracellular (By similarity).
FT   TRANSMEM     76     99       Helical; Name=1; (By similarity).
FT   TOPO_DOM    100    110       Cytoplasmic (By similarity).
FT   TRANSMEM    111    132       Helical; Name=2; (By similarity).
FT   TOPO_DOM    133    147       Extracellular (By similarity).
FT   TRANSMEM    148    171       Helical; Name=3; (By similarity).
FT   TOPO_DOM    172    191       Cytoplasmic (By similarity).
FT   TRANSMEM    192    215       Helical; Name=4; (By similarity).
FT   TOPO_DOM    216    233       Extracellular (By similarity).
FT   TRANSMEM    234    254       Helical; Name=5; (By similarity).
FT   TOPO_DOM    255    324       Cytoplasmic (By similarity).
FT   TRANSMEM    325    346       Helical; Name=6; (By similarity).
FT   TOPO_DOM    347    362       Extracellular (By similarity).
FT   TRANSMEM    363    384       Helical; Name=7; (By similarity).
FT   TOPO_DOM    385    471       Cytoplasmic (By similarity).
FT   MOTIF       469    471       PDZ-binding.
FT   CARBOHYD      8      8       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     38     38       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     44     44       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     51     51       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     54     54       N-linked (GlcNAc...) (Potential).
FT   DISULFID    148    227       By similarity.
FT   VARIANT      25     25       T -> N (in dbSNP:rs1805055).
FT                                /FTId=VAR_003448.
FT   VARIANT     197    197       I -> V (in dbSNP:rs6304).
FT                                /FTId=VAR_013901.
FT   VARIANT     447    447       A -> V (in dbSNP:rs6308).
FT                                /FTId=VAR_013902.
FT   VARIANT     452    452       H -> Y (in dbSNP:rs6314).
FT                                /FTId=VAR_003449.
FT   MUTAGEN     463    463       G->V: Loss of interaction with INADL.
FT   MUTAGEN     465    465       N->S: No effect on interaction with
FT                                INADL. Acquires the binding properties of
FT                                HTR2C; when associated with S-470.
FT   MUTAGEN     470    470       C->S: No effect on interaction with
FT                                INADL. Acquires the binding properties of
FT                                HTR2C; when associated with S-465.
FT   MUTAGEN     471    471       V->A: Loss of interaction with INADL,
FT                                CASK, APBA1, DLG1 and DLG4.
SQ   SEQUENCE   471 AA;  52603 MW;  EF8AAC0BC5379DA2 CRC64;
     MDILCEENTS LSSTTNSLMQ LNDDTRLYSN DFNSGEANTS DAFNWTVDSE NRTNLSCEGC
     LSPSCLSLLH LQEKNWSALL TAVVIILTIA GNILVIMAVS LEKKLQNATN YFLMSLAIAD
     MLLGFLVMPV SMLTILYGYR WPLPSKLCAV WIYLDVLFST ASIMHLCAIS LDRYVAIQNP
     IHHSRFNSRT KAFLKIIAVW TISVGISMPI PVFGLQDDSK VFKEGSCLLA DDNFVLIGSF
     VSFFIPLTIM VITYFLTIKS LQKEATLCVS DLGTRAKLAS FSFLPQSSLS SEKLFQRSIH
     REPGSYTGRR TMQSISNEQK ACKVLGIVFF LFVVMWCPFF ITNIMAVICK ESCNEDVIGA
     LLNVFVWIGY LSSAVNPLVY TLFNKTYRSA FSRYIQCQYK ENKKPLQLIL VNTIPALAYK
     SSQLQMGQKK NSKQDAKTTD NDCSMVALGK QHSEEASKDN SDGVNEKVSC V
//
ID   5HT2B_HUMAN             Reviewed;         481 AA.
AC   P41595; B2R9D5; Q53TI1; Q62221; Q6P523;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   18-APR-2012, entry version 116.
DE   RecName: Full=5-hydroxytryptamine receptor 2B;
DE            Short=5-HT-2B;
DE            Short=5-HT2B;
DE   AltName: Full=Serotonin receptor 2B;
GN   Name=HTR2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94192809; PubMed=8143856; DOI=10.1016/0014-5793(94)80590-3;
RA   Schmuck K., Ullmer C., Engels P., Luebbert H.;
RT   "Cloning and functional characterization of the human 5-HT2B serotonin
RT   receptor.";
RL   FEBS Lett. 342:85-90(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=95010749; PubMed=7926008; DOI=10.1016/0014-5793(94)00968-6;
RA   Choi D.S., Birraux G., Launay J.-M., Maroteaux L.;
RT   "The human serotonin 5-HT2B receptor: pharmacological link between 5-
RT   HT2 and 5-HT1D receptors.";
RL   FEBS Lett. 352:393-399(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Uterus;
RX   MEDLINE=94359485; PubMed=8078486;
RA   Kursar J.D., Nelson D.L., Wainscott D.B., Baez M.;
RT   "Molecular cloning, functional expression, and mRNA tissue
RT   distribution of the human 5-hydroxytryptamine2B receptor.";
RL   Mol. Pharmacol. 46:227-234(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=20189989; PubMed=10722792; DOI=10.1006/mcpr.1999.0281;
RA   Kim S.J., Veenstra-VanderWeele J., Hanna G.L., Gonen D.,
RA   Leventhal B.L., Cook E.H. Jr.;
RT   "Mutation screening of human 5-HT(2B) receptor gene in early-onset
RT   obsessive-compulsive disorder.";
RL   Mol. Cell. Probes 14:47-52(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH MPDZ.
RX   MEDLINE=21201137; PubMed=11150294; DOI=10.1074/jbc.M008089200;
RA   Becamel C., Figge A., Poliak S., Dumuis A., Peles E., Bockaert J.,
RA   Luebbert H., Ullmer C.;
RT   "Interaction of serotonin 5-hydroxytryptamine type 2C receptors with
RT   PDZ10 of the multi-PDZ domain protein MUPP1.";
RL   J. Biol. Chem. 276:12974-12982(2001).
RN   [11]
RP   INVOLVEMENT IN IMPULSIVE BEHAVIOR, TISSUE SPECIFICITY, POLYMORPHISM,
RP   AND VARIANTS GLU-45; LEU-173 AND TRP-388.
RX   PubMed=21179162; DOI=10.1038/nature09629;
RA   Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T.,
RA   Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A.,
RA   Hodgkinson C.A., Dell'osso L., Suvisaari J., Coccaro E., Rose R.J.,
RA   Peltonen L., Virkkunen M., Goldman D.;
RT   "A population-specific HTR2B stop codon predisposes to severe
RT   impulsivity.";
RL   Nature 468:1061-1066(2010).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor
CC       mediates its action by association with G proteins that activate a
CC       phosphatidylinositol-calcium second messenger system. Plays a role
CC       in the regulation of impulsive behavior.
CC   -!- SUBUNIT: Interacts with MPDZ.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in brain. Higher levels of
CC       expression are observed in the cerebellum, occipital cortex and
CC       frontal cortex.
CC   -!- POLYMORPHISM: A variation at a single nucleotide base, which
CC       results in an erroneous stop codon and affects Gln-20, triggers
CC       non-sense mediated RNA decay, such that no HTR2B-receptor protein
CC       is expressed. It is associated with impulsive behavior and co-
CC       segregates with disorders characterized by impulsivity. However,
CC       the presence of this variant is not in itself sufficient to cause
CC       impulsive behavior: male sex, testosterone level, alcohol and
CC       stress exposure are other factors playing important roles.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=On the spur of a whim -
CC       Issue 127 of March 2011;
CC       URL="http://web.expasy.org/spotlight/back_issues/sptlt127.shtml";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X77307; CAA54513.1; -; mRNA.
DR   EMBL; Z36748; CAA85319.1; -; mRNA.
DR   EMBL; AF156160; AAD39259.1; -; Genomic_DNA.
DR   EMBL; AF156158; AAD39259.1; JOINED; Genomic_DNA.
DR   EMBL; AF156159; AAD39259.1; JOINED; Genomic_DNA.
DR   EMBL; AY136751; AAN01277.1; -; mRNA.
DR   EMBL; AC009407; AAX93128.1; -; Genomic_DNA.
DR   EMBL; AK313741; BAG36482.1; -; mRNA.
DR   EMBL; CH471063; EAW70949.1; -; Genomic_DNA.
DR   EMBL; BC063123; AAH63123.1; -; mRNA.
DR   IPI; IPI00015134; -.
DR   PIR; S43687; S43687.
DR   PIR; S49442; S49442.
DR   RefSeq; NP_000858.3; NM_000867.4.
DR   UniGene; Hs.421649; -.
DR   ProteinModelPortal; P41595; -.
DR   SMR; P41595; 57-395.
DR   MINT; MINT-444010; -.
DR   STRING; P41595; -.
DR   DMDM; 1168220; -.
DR   PRIDE; P41595; -.
DR   Ensembl; ENST00000258400; ENSP00000258400; ENSG00000135914.
DR   GeneID; 3357; -.
DR   KEGG; hsa:3357; -.
DR   UCSC; uc002vro.3; human.
DR   CTD; 3357; -.
DR   GeneCards; GC02M231936; -.
DR   H-InvDB; HIX0029887; -.
DR   HGNC; HGNC:5294; HTR2B.
DR   HPA; CAB011448; -.
DR   HPA; HPA012867; -.
DR   MIM; 601122; gene.
DR   neXtProt; NX_P41595; -.
DR   PharmGKB; PA29554; -.
DR   eggNOG; NOG247243; -.
DR   GeneTree; ENSGT00650000093057; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG107487; -.
DR   InParanoid; P41595; -.
DR   KO; K04157; -.
DR   OMA; FTPLAIM; -.
DR   OrthoDB; EOG41ZF9R; -.
DR   PhylomeDB; P41595; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB01239; Chlorprothixene.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB00574; Fenfluramine.
DR   DrugBank; DB01403; Methotrimeprazine.
DR   DrugBank; DB00805; Minaprine.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB00669; Sumatriptan.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00508; Triflupromazine.
DR   NextBio; 13274; -.
DR   ArrayExpress; P41595; -.
DR   Bgee; P41595; -.
DR   CleanEx; HS_HTR2B; -.
DR   Genevestigator; P41595; -.
DR   GermOnline; ENSG00000135914; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IMP:UniProtKB.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB.
DR   GO; GO:0005099; F:Ras GTPase activator activity; ISS:UniProtKB.
DR   GO; GO:0051378; F:serotonin binding; IDA:UniProtKB.
DR   GO; GO:0004993; F:serotonin receptor activity; IDA:UniProtKB.
DR   GO; GO:0007205; P:activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB.
DR   GO; GO:0071502; P:cellular response to temperature stimulus; ISS:UniProtKB.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0048598; P:embryonic morphogenesis; ISS:UniProtKB.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0002031; P:G-protein coupled receptor internalization; IMP:UniProtKB.
DR   GO; GO:0003007; P:heart morphogenesis; ISS:UniProtKB.
DR   GO; GO:0014827; P:intestine smooth muscle contraction; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0010507; P:negative regulation of autophagy; IMP:UniProtKB.
DR   GO; GO:0001755; P:neural crest cell migration; ISS:UniProtKB.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase cascade; IMP:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0016310; P:phosphorylation; IMP:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; ISS:UniProtKB.
DR   GO; GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB.
DR   GO; GO:0050715; P:positive regulation of cytokine secretion; ISS:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; IEP:UniProtKB.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:UniProtKB.
DR   GO; GO:0070528; P:protein kinase C signaling cascade; IMP:UniProtKB.
DR   GO; GO:0050795; P:regulation of behavior; IMP:UniProtKB.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0042310; P:vasoconstriction; IMP:UniProtKB.
DR   InterPro; IPR000482; 5HT2B_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00651; 5HT2BRECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane;
KW   Palmitate; Polymorphism; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    481       5-hydroxytryptamine receptor 2B.
FT                                /FTId=PRO_0000068953.
FT   TOPO_DOM      1     56       Extracellular (By similarity).
FT   TRANSMEM     57     79       Helical; Name=1; (By similarity).
FT   TOPO_DOM     80     91       Cytoplasmic (By similarity).
FT   TRANSMEM     92    113       Helical; Name=2; (By similarity).
FT   TOPO_DOM    114    129       Extracellular (By similarity).
FT   TRANSMEM    130    151       Helical; Name=3; (By similarity).
FT   TOPO_DOM    152    171       Cytoplasmic (By similarity).
FT   TRANSMEM    172    192       Helical; Name=4; (By similarity).
FT   TOPO_DOM    193    216       Extracellular (By similarity).
FT   TRANSMEM    217    239       Helical; Name=5; (By similarity).
FT   TOPO_DOM    240    324       Cytoplasmic (By similarity).
FT   TRANSMEM    325    345       Helical; Name=6; (By similarity).
FT   TOPO_DOM    346    360       Extracellular (By similarity).
FT   TRANSMEM    361    383       Helical; Name=7; (By similarity).
FT   TOPO_DOM    384    481       Cytoplasmic (By similarity).
FT   MOTIF       479    481       PDZ-binding.
FT   LIPID       397    397       S-palmitoyl cysteine (Potential).
FT   CARBOHYD     30     30       N-linked (GlcNAc...) (Potential).
FT   DISULFID    128    207       By similarity.
FT   VARIANT      45     45       Q -> E (in dbSNP:rs78484969).
FT                                /FTId=VAR_064574.
FT   VARIANT     173    173       F -> L (in dbSNP:rs77570025).
FT                                /FTId=VAR_064575.
FT   VARIANT     388    388       R -> W (in dbSNP:rs77982984).
FT                                /FTId=VAR_064576.
FT   VARIANT     421    421       M -> V (in dbSNP:rs6736017).
FT                                /FTId=VAR_055907.
FT   CONFLICT    452    452       T -> P (in Ref. 2; CAA85319).
FT   CONFLICT    477    477       Q -> R (in Ref. 9; AAH63123).
SQ   SEQUENCE   481 AA;  54298 MW;  CDA4447ECDBA3B46 CRC64;
     MALSYRVSEL QSTIPEHILQ STFVHVISSN WSGLQTESIP EEMKQIVEEQ GNKLHWAALL
     ILMVIIPTIG GNTLVILAVS LEKKLQYATN YFLMSLAVAD LLVGLFVMPI ALLTIMFEAM
     WPLPLVLCPA WLFLDVLFST ASIMHLCAIS VDRYIAIKKP IQANQYNSRA TAFIKITVVW
     LISIGIAIPV PIKGIETDVD NPNNITCVLT KERFGDFMLF GSLAAFFTPL AIMIVTYFLT
     IHALQKKAYL VKNKPPQRLT WLTVSTVFQR DETPCSSPEK VAMLDGSRKD KALPNSGDET
     LMRRTSTIGK KSVQTISNEQ RASKVLGIVF FLFLLMWCPF FITNITLVLC DSCNQTTLQM
     LLEIFVWIGY VSSGVNPLVY TLFNKTFRDA FGRYITCNYR ATKSVKTLRK RSSKIYFRNP
     MAENSKFFKK HGIRNGINPA MYQSPMRLRS STIQSSSIIL LDTLLLTENE GDKTEEQVSY
     V
//
ID   5HT2C_HUMAN             Reviewed;         458 AA.
AC   P28335; Q5VUF8; Q9NP28;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   18-APR-2012, entry version 128.
DE   RecName: Full=5-hydroxytryptamine receptor 2C;
DE            Short=5-HT-2C;
DE            Short=5-HT2C;
DE            Short=5-HTR2C;
DE   AltName: Full=5-hydroxytryptamine receptor 1C;
DE            Short=5-HT-1C;
DE            Short=5-HT1C;
DE   AltName: Full=Serotonin receptor 2C;
GN   Name=HTR2C; Synonyms=HTR1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=92109767; PubMed=1722404; DOI=10.1016/0006-291X(91)92105-S;
RA   Saltzman A.G., Morse B., Whitman M.M., Ivanshchenko Y., Jaye M.,
RA   Felder S.;
RT   "Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes.";
RL   Biochem. Biophys. Res. Commun. 181:1469-1478(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   TISSUE=Hippocampus, and Placenta;
RX   MEDLINE=95203331; PubMed=7895773; DOI=10.1016/0922-4106(94)90042-6;
RA   Stam N.J., Vanderheyden P., Van Alebeek C., Klomp J., De Boer T.,
RA   Van Delft A.M.L., Olijve W.;
RT   "Genomic organisation and functional expression of the gene encoding
RT   the human serotonin 5-HT2C receptor.";
RL   Eur. J. Pharmacol. 269:339-348(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=97001158; PubMed=8812491; DOI=10.1006/geno.1996.0397;
RA   Xie E., Zhao L., Levine A.J., Shenk T., Chang L.-S.;
RT   "The human serotonin 5-HT2C receptor: complete cDNA, genomic
RT   structure, and alternatively spliced variant.";
RL   Genomics 35:551-561(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND RNA EDITING OF POSITIONS 156; 158 AND
RP   160.
RC   TISSUE=Brain;
RX   MEDLINE=99127198; PubMed=9928237;
RX   DOI=10.1111/j.1749-6632.1998.tb10171.x;
RA   Niswender C.M., Sanders-Bush E., Emeson R.B.;
RT   "Identification and characterization of RNA editing events within the
RT   5-HT2C receptor.";
RL   Ann. N. Y. Acad. Sci. 861:38-48(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH MPDZ, DOMAIN, MUTAGENESIS OF SER-456; SER-457 AND
RP   VAL-458, AND GLYCOSYLATION.
RX   MEDLINE=21201137; PubMed=11150294; DOI=10.1074/jbc.M008089200;
RA   Becamel C., Figge A., Poliak S., Dumuis A., Peles E., Bockaert J.,
RA   Luebbert H., Ullmer C.;
RT   "Interaction of serotonin 5-hydroxytryptamine type 2C receptors with
RT   PDZ10 of the multi-PDZ domain protein MUPP1.";
RL   J. Biol. Chem. 276:12974-12982(2001).
RN   [9]
RP   INTERACTION WITH ARRB2, AND MUTAGENESIS OF PRO-159.
RX   PubMed=16319069; DOI=10.1074/jbc.M508074200;
RA   Marion S., Oakley R.H., Kim K.-M., Caron M.G., Barak L.S.;
RT   "A beta-arrestin binding determinant common to the second
RT   intracellular loops of rhodopsin family G protein-coupled receptors.";
RL   J. Biol. Chem. 281:2932-2938(2006).
RN   [10]
RP   VARIANT SER-23.
RX   MEDLINE=96044432; PubMed=7557992; DOI=10.1006/geno.1995.1042;
RA   Lappalainen J., Zhang L., Dean M., Oz M., Ozaki N., Yu D.,
RA   Virkkunen M., Weight F., Linnoila M., Goldman D.;
RT   "Identification, expression, and pharmacology of a Cys23-Ser23
RT   substitution in the human 5-HT2c receptor gene (HTR2C).";
RL   Genomics 27:274-279(1995).
RN   [11]
RP   VARIANT SER-23.
RX   MEDLINE=99221071; PubMed=10206230;
RX   DOI=10.1002/(SICI)1096-8628(19990416)88:2<126::AID-AJMG6>3.3.CO;2-D;
RA   Samochowiec J., Smolka M., Winterer G., Rommelspacher H.,
RA   Schmidt L.G., Sander T.;
RT   "Association analysis between a Cys23Ser substitution polymorphism of
RT   the human 5-HT2c receptor gene and neuronal hyperexcitability.";
RL   Am. J. Med. Genet. 88:126-130(1999).
RN   [12]
RP   VARIANT SER-23.
RX   MEDLINE=20049881; PubMed=10581480;
RX   DOI=10.1002/(SICI)1096-8628(19991215)88:6<621::AID-AJMG9>3.0.CO;2-H;
RA   Marshall S.E., Bird T.G., Hart K., Welsh K.I.;
RT   "Unified approach to the analysis of genetic variation in serotonergic
RT   pathways.";
RL   Am. J. Med. Genet. 88:621-627(1999).
RN   [13]
RP   VARIANT SER-23.
RX   MEDLINE=99318093; PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [14]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor
CC       mediates its action by association with G proteins that activate a
CC       phosphatidylinositol-calcium second messenger system.
CC   -!- SUBUNIT: Interacts with MPDZ. Interacts with ARRB2.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- DOMAIN: The PDZ domain-binding motif is involved in the
CC       interaction with MPDZ.
CC   -!- PTM: N-glycosylated.
CC   -!- RNA EDITING: Modified_positions=156, 158, 160; Note=Partially
CC       edited. RNA editing generates receptor isoforms that differ in
CC       their ability to interact with the phospholipase C signaling
CC       cascade in a transfected cell line, suggesting that this RNA
CC       processing event may contribute to the modulation of serotonergic
CC       neurotransmission in the central nervous system.
CC   -!- POLYMORPHISM: Position 23 is polymorphic; the frequencies in
CC       unrelated Caucasians are 0.87 for Cys and 0.13 for Ser.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M81778; AAA60317.1; -; mRNA.
DR   EMBL; X80763; CAB59978.1; -; Genomic_DNA.
DR   EMBL; U49516; AAB40898.1; -; mRNA.
DR   EMBL; AF208053; AAF35842.1; -; mRNA.
DR   EMBL; AF498983; AAM21130.1; -; mRNA.
DR   EMBL; AC004822; AAC71658.1; -; Genomic_DNA.
DR   EMBL; AL355812; CAI41335.1; -; Genomic_DNA.
DR   EMBL; AL590097; CAI41335.1; JOINED; Genomic_DNA.
DR   EMBL; AC004822; CAI41335.1; JOINED; Genomic_DNA.
DR   EMBL; AL590097; CAH70193.1; -; Genomic_DNA.
DR   EMBL; AC004822; CAH70193.1; JOINED; Genomic_DNA.
DR   EMBL; AL355812; CAH70193.1; JOINED; Genomic_DNA.
DR   EMBL; BC095543; AAH95543.1; -; mRNA.
DR   IPI; IPI00002876; -.
DR   PIR; JS0616; JS0616.
DR   RefSeq; NP_000859.1; NM_000868.2.
DR   RefSeq; NP_001243689.1; NM_001256760.1.
DR   UniGene; Hs.149037; -.
DR   ProteinModelPortal; P28335; -.
DR   SMR; P28335; 56-384.
DR   IntAct; P28335; 1.
DR   MINT; MINT-443944; -.
DR   STRING; P28335; -.
DR   PhosphoSite; P28335; -.
DR   DMDM; 112816; -.
DR   PRIDE; P28335; -.
DR   Ensembl; ENST00000276198; ENSP00000276198; ENSG00000147246.
DR   Ensembl; ENST00000371951; ENSP00000361019; ENSG00000147246.
DR   GeneID; 3358; -.
DR   KEGG; hsa:3358; -.
DR   UCSC; uc004epu.1; human.
DR   CTD; 3358; -.
DR   GeneCards; GC0XP113818; -.
DR   H-InvDB; HIX0028341; -.
DR   HGNC; HGNC:5295; HTR2C.
DR   HPA; CAB006857; -.
DR   HPA; HPA003133; -.
DR   MIM; 312861; gene.
DR   neXtProt; NX_P28335; -.
DR   PharmGKB; PA194; -.
DR   eggNOG; NOG247243; -.
DR   GeneTree; ENSGT00650000093057; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG107487; -.
DR   InParanoid; P28335; -.
DR   KO; K04157; -.
DR   OMA; ACNQKLM; -.
DR   OrthoDB; EOG4M0F2D; -.
DR   PhylomeDB; P28335; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB01239; Chlorprothixene.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB00574; Fenfluramine.
DR   DrugBank; DB00247; Methysergide.
DR   DrugBank; DB06148; Mianserin.
DR   DrugBank; DB00805; Minaprine.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00420; Promazine.
DR   DrugBank; DB00777; Propiomazine.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB06144; Sertindole.
DR   DrugBank; DB00372; Thiethylperazine.
DR   DrugBank; DB00193; Tramadol.
DR   DrugBank; DB00246; Ziprasidone.
DR   NextBio; 13278; -.
DR   ArrayExpress; P28335; -.
DR   Bgee; P28335; -.
DR   CleanEx; HS_HTR2C; -.
DR   Genevestigator; P28335; -.
DR   GermOnline; ENSG00000147246; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB.
DR   GO; GO:0051378; F:serotonin binding; IDA:UniProtKB.
DR   GO; GO:0004993; F:serotonin receptor activity; IDA:MGI.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0007631; P:feeding behavior; TAS:ProtInc.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   InterPro; IPR000377; 5HT2C_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00517; 5HT2CRECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; RNA editing; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    458       5-hydroxytryptamine receptor 2C.
FT                                /FTId=PRO_0000068958.
FT   TOPO_DOM      1     52       Extracellular (By similarity).
FT   TRANSMEM     53     78       Helical; Name=1; (By similarity).
FT   TOPO_DOM     79     89       Cytoplasmic (By similarity).
FT   TRANSMEM     90    110       Helical; Name=2; (By similarity).
FT   TOPO_DOM    111    127       Extracellular (By similarity).
FT   TRANSMEM    128    150       Helical; Name=3; (By similarity).
FT   TOPO_DOM    151    170       Cytoplasmic (By similarity).
FT   TRANSMEM    171    193       Helical; Name=4; (By similarity).
FT   TOPO_DOM    194    213       Extracellular (By similarity).
FT   TRANSMEM    214    235       Helical; Name=5; (By similarity).
FT   TOPO_DOM    236    311       Cytoplasmic (By similarity).
FT   TRANSMEM    312    333       Helical; Name=6; (By similarity).
FT   TOPO_DOM    334    348       Extracellular (By similarity).
FT   TRANSMEM    349    371       Helical; Name=7; (By similarity).
FT   TOPO_DOM    372    458       Cytoplasmic (By similarity).
FT   MOTIF       456    458       PDZ-binding.
FT   CARBOHYD     39     39       N-linked (GlcNAc...) (Probable).
FT   DISULFID    127    207       By similarity.
FT   VARIANT      23     23       C -> S (in dbSNP:rs6318).
FT                                /FTId=VAR_003450.
FT   VARIANT     156    156       I -> V (in RNA edited version).
FT                                /FTId=VAR_010166.
FT   VARIANT     158    158       N -> S (in RNA edited version).
FT                                /FTId=VAR_010167.
FT   VARIANT     160    160       I -> V (in RNA edited version).
FT                                /FTId=VAR_010168.
FT   MUTAGEN     159    159       P->A: Decreases interaction with ARRB2.
FT   MUTAGEN     456    456       S->A: Loss of interaction with MPDZ.
FT   MUTAGEN     456    456       S->T: No effect on interaction with MPDZ.
FT   MUTAGEN     457    457       S->A: No effect on interaction with MPDZ.
FT   MUTAGEN     458    458       V->A: Loss of interaction with MPDZ.
SQ   SEQUENCE   458 AA;  51821 MW;  9E76B3FFD3E09C93 CRC64;
     MVNLRNAVHS FLVHLIGLLV WQCDISVSPV AAIVTDIFNT SDGGRFKFPD GVQNWPALSI
     VIIIIMTIGG NILVIMAVSM EKKLHNATNY FLMSLAIADM LVGLLVMPLS LLAILYDYVW
     PLPRYLCPVW ISLDVLFSTA SIMHLCAISL DRYVAIRNPI EHSRFNSRTK AIMKIAIVWA
     ISIGVSVPIP VIGLRDEEKV FVNNTTCVLN DPNFVLIGSF VAFFIPLTIM VITYCLTIYV
     LRRQALMLLH GHTEEPPGLS LDFLKCCKRN TAEEENSANP NQDQNARRRK KKERRPRGTM
     QAINNERKAS KVLGIVFFVF LIMWCPFFIT NILSVLCEKS CNQKLMEKLL NVFVWIGYVC
     SGINPLVYTL FNKIYRRAFS NYLRCNYKVE KKPPVRQIPR VAATALSGRE LNVNIYRHTN
     EPVIEKASDN EPGIEMQVEN LELPVNPSSV VSERISSV
//
ID   5HT3A_HUMAN             Reviewed;         478 AA.
AC   P46098; B4DSY6; O60854; Q99918; Q9BSZ9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   18-APR-2012, entry version 123.
DE   RecName: Full=5-hydroxytryptamine receptor 3A;
DE            Short=5-HT3-A;
DE            Short=5-HT3A;
DE   AltName: Full=5-hydroxytryptamine receptor 3;
DE            Short=5-HT-3;
DE            Short=5-HT3R;
DE   AltName: Full=Serotonin receptor 3A;
DE   AltName: Full=Serotonin-gated ion channel receptor;
DE   Flags: Precursor;
GN   Name=HTR3A; Synonyms=5HT3R, HTR3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   MEDLINE=96018832; PubMed=7565620;
RA   Miyake A., Mochizuki S., Takemoto Y., Akuzawa S.;
RT   "Molecular cloning of human 5-hydroxytryptamine3 receptor:
RT   heterogeneity in distribution and function among species.";
RL   Mol. Pharmacol. 48:407-416(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   MEDLINE=96110993; PubMed=8848005;
RA   Belelli D., Balcarek J.M., Hope A.G., Peters J.A., Lambert J.J.,
RA   Blackburn T.P.;
RT   "Cloning and functional expression of a human 5-hydroxytryptamine type
RT   3AS receptor subunit.";
RL   Mol. Pharmacol. 48:1054-1062(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Hippocampus;
RX   MEDLINE=99127223; PubMed=9928262;
RX   DOI=10.1111/j.1749-6632.1998.tb10196.x;
RA   Bruess M., Goethert M., Hayer M., Bonisch H.;
RT   "Molecular cloning of alternatively spliced human 5HT3 receptor
RT   cDNAs.";
RL   Ann. N. Y. Acad. Sci. 861:234-235(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   MEDLINE=20133886; PubMed=10670426; DOI=10.1016/S0028-3908(99)00116-1;
RA   Bruess M., Eucker T., Goethert M., Bonisch H.;
RT   "Exon-intron organization of the human 5-HT3A receptor gene.";
RL   Neuropharmacology 39:308-315(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND SUBUNIT.
RX   MEDLINE=99133928; PubMed=9950429; DOI=10.1038/16941;
RA   Davies P.A., Pistis M., Hanna M.C., Peters J.A., Lambert J.J.,
RA   Hales T.G., Kirkness E.F.;
RT   "The 5-HT3B subunit is a major determinant of serotonin-receptor
RT   function.";
RL   Nature 397:359-363(1999).
RN   [10]
RP   SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Small intestine;
RX   MEDLINE=99452976; PubMed=10521471; DOI=10.1074/jbc.274.43.30799;
RA   Dubin A.E., Huvar R., D'Andrea M.R., Pyati J., Zhu J.Y., Joy K.C.,
RA   Wilson S.J., Galindo J.E., Glass C.A., Luo L., Jackson M.R.,
RA   Lovenberg T.W., Erlander M.G.;
RT   "The pharmacological and functional characteristics of the serotonin
RT   5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor
RT   subunit.";
RL   J. Biol. Chem. 274:30799-30810(1999).
RN   [11]
RP   FUNCTION, REGION, AND MUTAGENESIS OF ARG-432; ARG-436 AND ARG-440.
RX   PubMed=12867984; DOI=10.1038/nature01788;
RA   Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A.;
RT   "A cytoplasmic region determines single-channel conductance in 5-HT3
RT   receptors.";
RL   Nature 424:321-324(2003).
RN   [12]
RP   INTERACTION WITH RIC3.
RX   PubMed=15809299; DOI=10.1074/jbc.M414341200;
RA   Cheng A., McDonald N.A., Connolly C.N.;
RT   "Cell surface expression of 5-hydroxytryptamine type 3 receptors is
RT   promoted by RIC-3.";
RL   J. Biol. Chem. 280:22502-22507(2005).
RN   [13]
RP   SUBUNIT, AND MUTAGENESIS OF TRP-178.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [14]
RP   VARIANT THR-33.
RX   PubMed=15293096; DOI=10.1007/s10067-004-0927-2;
RA   Frank B., Niesler B., Bondy B., Spaeth M., Pongratz D.E.,
RA   Ackenheil M., Fischer C., Rappold G.;
RT   "Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in
RT   fibromyalgia patients.";
RL   Clin. Rheumatol. 23:338-344(2004).
RN   [15]
RP   VARIANTS HIS-344; ARG-391 AND GLN-409.
RX   PubMed=16487942; DOI=10.1016/j.biopsych.2005.11.008;
RA   Yamada K., Hattori E., Iwayama Y., Ohnishi T., Ohba H., Toyota T.,
RA   Takao H., Minabe Y., Nakatani N., Higuchi T., Detera-Wadleigh S.D.,
RA   Yoshikawa T.;
RT   "Distinguishable haplotype blocks in the HTR3A and HTR3B region in the
RT   Japanese reveal evidence of association of HTR3B with female major
RT   depression.";
RL   Biol. Psychiatry 60:192-201(2006).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses in neurons. It is a cation-specific, but
CC       otherwise relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms pentahomomeric complex as well as pentaheteromeric
CC       complex with HTR3B or HTR3C or HTR3D or HTR3E; homomeric complex
CC       is functional but exhibits low conductance with modified voltage
CC       dependence, and decreased agonist and antagonist affinity.
CC       Interacts with RIC3.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=5-HT3R-AS;
CC         IsoId=P46098-1; Sequence=Displayed;
CC       Name=2; Synonyms=5-HT3R-AL;
CC         IsoId=P46098-2; Sequence=VSP_000078;
CC       Name=3;
CC         IsoId=P46098-3; Sequence=VSP_042214;
CC   -!- TISSUE SPECIFICITY: Expressed in cerebral cortex, amygdala,
CC       hippocampus, and testis. Detected in monocytes of the spleen and
CC       tonsil, in small and large intestine, uterus, prostate, ovary and
CC       placenta.
CC   -!- MISCELLANEOUS: The HA-stretch region of HTR3A seems to be
CC       responsible for the low conductance of HTR3A homomers compared to
CC       that of HTR3A/HTR3B heteromers.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3A
CC       sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49394; BAA08387.1; -; mRNA.
DR   EMBL; S82612; AAB37533.2; -; mRNA.
DR   EMBL; AJ003078; CAA05851.1; -; mRNA.
DR   EMBL; AJ003079; CAA05852.1; -; mRNA.
DR   EMBL; AJ005205; CAA06442.3; -; Genomic_DNA.
DR   EMBL; AF498984; AAM21131.1; -; mRNA.
DR   EMBL; AK299973; BAG61798.1; -; mRNA.
DR   EMBL; AP000908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002354; AAH02354.1; -; mRNA.
DR   EMBL; BC004453; AAH04453.2; -; mRNA.
DR   IPI; IPI00179555; -.
DR   IPI; IPI00748737; -.
DR   RefSeq; NP_000860.2; NM_000869.5.
DR   RefSeq; NP_001155244.1; NM_001161772.2.
DR   RefSeq; NP_998786.2; NM_213621.3.
DR   UniGene; Hs.413899; -.
DR   ProteinModelPortal; P46098; -.
DR   SMR; P46098; 31-471.
DR   STRING; P46098; -.
DR   TCDB; 1.A.9.2.1; neurotransmitter receptor, cys loop, ligand-gated ion channel (LIC) family.
DR   PhosphoSite; P46098; -.
DR   DMDM; 1168222; -.
DR   PRIDE; P46098; -.
DR   DNASU; 3359; -.
DR   Ensembl; ENST00000299961; ENSP00000299961; ENSG00000166736.
DR   Ensembl; ENST00000375498; ENSP00000364648; ENSG00000166736.
DR   GeneID; 3359; -.
DR   KEGG; hsa:3359; -.
DR   UCSC; uc010rxb.2; human.
DR   CTD; 3359; -.
DR   GeneCards; GC11P113879; -.
DR   H-InvDB; HIX0010139; -.
DR   HGNC; HGNC:5297; HTR3A.
DR   MIM; 182139; gene.
DR   neXtProt; NX_P46098; -.
DR   PharmGKB; PA29555; -.
DR   eggNOG; NOG302526; -.
DR   GeneTree; ENSGT00570000078866; -.
DR   HOVERGEN; HBG106638; -.
DR   KO; K04819; -.
DR   OMA; GEVQNYK; -.
DR   Reactome; REACT_15518; Transmembrane transport of small molecules.
DR   DrugBank; DB00969; Alosetron.
DR   DrugBank; DB01161; Chloroprocaine.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00757; Dolasetron.
DR   DrugBank; DB00889; Granisetron.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB00904; Ondansetron.
DR   DrugBank; DB00377; Palonosetron.
DR   DrugBank; DB00721; Procaine.
DR   DrugBank; DB01199; Tubocurarine.
DR   NextBio; 13282; -.
DR   ArrayExpress; P46098; -.
DR   Bgee; B4DSY6; -.
DR   CleanEx; HS_HTR3A; -.
DR   Genevestigator; P46098; -.
DR   GermOnline; ENSG00000166736; Homo sapiens.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0051378; F:serotonin binding; IDA:MGI.
DR   GO; GO:0004993; F:serotonin receptor activity; NAS:UniProtKB.
DR   GO; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome.
DR   GO; GO:0007586; P:digestion; TAS:ProtInc.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   Gene3D; G3DSA:2.70.170.10; Neur_chan_lig_bd; 1.
DR   InterPro; IPR008132; 5HT3_rcpt.
DR   InterPro; IPR008133; 5HT3_rcpt_A.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; Neur_channel; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01709; 5HT3ARECEPTR.
DR   PRINTS; PR01708; 5HT3RECEPTOR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neu_channel_TM; 1.
DR   SUPFAM; SSF63712; Neur_chan_LBD; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion transport; Ionic channel;
KW   Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       Potential.
FT   CHAIN        24    478       5-hydroxytryptamine receptor 3A.
FT                                /FTId=PRO_0000000408.
FT   TOPO_DOM     24    241       Extracellular (Potential).
FT   TRANSMEM    242    268       Helical; Name=1; (Potential).
FT   TOPO_DOM    269    273       Cytoplasmic (Potential).
FT   TRANSMEM    274    292       Helical; Name=2; (Potential).
FT   TOPO_DOM    293    302       Extracellular (Potential).
FT   TRANSMEM    303    321       Helical; Name=3; (Potential).
FT   TOPO_DOM    322    455       Cytoplasmic (Potential).
FT   TRANSMEM    456    475       Helical; Name=4; (Potential).
FT   TOPO_DOM    476    478       Extracellular (Potential).
FT   REGION      414    450       HA-stretch.
FT   CARBOHYD     28     28       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    104    104       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    170    170       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    186    186       N-linked (GlcNAc...) (Potential).
FT   DISULFID    157    171       By similarity.
FT   VAR_SEQ       1     22       MLLWVQQALLALLLPTLLAQGE -> MHRSFLQ (in
FT                                isoform 3).
FT                                /FTId=VSP_042214.
FT   VAR_SEQ     306    306       G -> GKAPPGSRAQSGEKPAPSHLLHVSLASALGCTG
FT                                (in isoform 2).
FT                                /FTId=VSP_000078.
FT   VARIANT      33     33       A -> T.
FT                                /FTId=VAR_037398.
FT   VARIANT     253    253       S -> N (in dbSNP:rs4938063).
FT                                /FTId=VAR_037399.
FT   VARIANT     344    344       R -> H (in dbSNP:rs35815285).
FT                                /FTId=VAR_037400.
FT   VARIANT     391    391       P -> R.
FT                                /FTId=VAR_037401.
FT   VARIANT     409    409       R -> Q.
FT                                /FTId=VAR_037402.
FT   MUTAGEN     178    178       W->S: Abolished ligand binding to the
FT                                heteromeric receptor.
FT   MUTAGEN     432    432       R->Q: Little effect on conductance.
FT                                Massive increase of conductance; when
FT                                associated with D-436 and A-440.
FT   MUTAGEN     436    436       R->D: Increased conductance. Massive
FT                                increase of conductance; when associated
FT                                with Q-432 and A-440.
FT   MUTAGEN     440    440       R->A: Increased conductance. Massive
FT                                increase of conductance; when associated
FT                                with Q-432 and D-436.
FT   CONFLICT     46     46       R -> T (in Ref. 2; AAB37533).
FT   CONFLICT    125    125       F -> L (in Ref. 2; AAB37533).
FT   CONFLICT    321    321       A -> T (in Ref. 2; AAB37533).
FT   CONFLICT    386    386       S -> T (in Ref. 2; AAB37533).
SQ   SEQUENCE   478 AA;  55280 MW;  24CA9A232286FBC9 CRC64;
     MLLWVQQALL ALLLPTLLAQ GEARRSRNTT RPALLRLSDY LLTNYRKGVR PVRDWRKPTT
     VSIDVIVYAI LNVDEKNQVL TTYIWYRQYW TDEFLQWNPE DFDNITKLSI PTDSIWVPDI
     LINEFVDVGK SPNIPYVYIR HQGEVQNYKP LQVVTACSLD IYNFPFDVQN CSLTFTSWLH
     TIQDINISLW RLPEKVKSDR SVFMNQGEWE LLGVLPYFRE FSMESSNYYA EMKFYVVIRR
     RPLFYVVSLL LPSIFLMVMD IVGFYLPPNS GERVSFKITL LLGYSVFLII VSDTLPATAI
     GTPLIGVYFV VCMALLVISL AETIFIVRLV HKQDLQQPVP AWLRHLVLER IAWLLCLREQ
     STSQRPPATS QATKTDDCSA MGNHCSHMGG PQDFEKSPRD RCSPPPPPRE ASLAVCGLLQ
     ELSSIRQFLE KRDEIREVAR DWLRVGSVLD KLLFHIYLLA VLAYSITLVM LWSIWQYA
//
ID   5HT3B_HUMAN             Reviewed;         441 AA.
AC   O95264; B0YJ23; Q0VJC3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   18-APR-2012, entry version 85.
DE   RecName: Full=5-hydroxytryptamine receptor 3B;
DE            Short=5-HT3-B;
DE            Short=5-HT3B;
DE   AltName: Full=Serotonin receptor 3B;
DE   Flags: Precursor;
GN   Name=HTR3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Small intestine;
RX   MEDLINE=99452976; PubMed=10521471; DOI=10.1074/jbc.274.43.30799;
RA   Dubin A.E., Huvar R., D'Andrea M.R., Pyati J., Zhu J.Y., Joy K.C.,
RA   Wilson S.J., Galindo J.E., Glass C.A., Luo L., Jackson M.R.,
RA   Lovenberg T.W., Erlander M.G.;
RT   "The pharmacological and functional characteristics of the serotonin
RT   5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor
RT   subunit.";
RL   J. Biol. Chem. 274:30799-30810(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   SUBUNIT.
RX   MEDLINE=99133928; PubMed=9950429; DOI=10.1038/16941;
RA   Davies P.A., Pistis M., Hanna M.C., Peters J.A., Lambert J.J.,
RA   Hales T.G., Kirkness E.F.;
RT   "The 5-HT3B subunit is a major determinant of serotonin-receptor
RT   function.";
RL   Nature 397:359-363(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT SER-129.
RC   TISSUE=Brain;
RX   PubMed=17010535; DOI=10.1016/j.gene.2006.08.002;
RA   Tzvetkov M.V., Meineke C., Oetjen E., Hirsch-Ernst K., Brockmoller J.;
RT   "Tissue-specific alternative promoters of the serotonin receptor gene
RT   HTR3B in human brain and intestine.";
RL   Gene 386:52-62(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   FUNCTION, AND REGION.
RX   PubMed=12867984; DOI=10.1038/nature01788;
RA   Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A.;
RT   "A cytoplasmic region determines single-channel conductance in 5-HT3
RT   receptors.";
RL   Nature 424:321-324(2003).
RN   [7]
RP   SUBUNIT.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [8]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-52; ASN-96; ASN-138;
RP   ASN-168 AND ASN-203, AND MUTAGENESIS OF ASN-52; ASN-96; ASN-138;
RP   ASN-168 AND ASN-203.
RX   PubMed=21138434; DOI=10.1111/j.1471-4159.2010.07129.x;
RA   Massoura A.N., Dover T.J., Newman A.S., Barnes N.M.;
RT   "The identification of N-glycosylated residues of the human 5-HT3B
RT   receptor subunit: importance for cell membrane expression.";
RL   J. Neurochem. 116:975-983(2011).
RN   [9]
RP   VARIANTS SER-129; ARG-156 AND ILE-183.
RX   PubMed=15389765; DOI=10.1002/ajmg.b.30070;
RA   Frank B., Niesler B., Noethen M.M., Neidt H., Propping P., Bondy B.,
RA   Rietschel M., Maier W., Albus M., Rappold G.;
RT   "Investigation of the human serotonin receptor gene HTR3B in bipolar
RT   affective and schizophrenic patients.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 131:1-5(2004).
RN   [10]
RP   VARIANTS SER-129; ARG-156 AND ILE-183.
RX   PubMed=15293096; DOI=10.1007/s10067-004-0927-2;
RA   Frank B., Niesler B., Bondy B., Spaeth M., Pongratz D.E.,
RA   Ackenheil M., Fischer C., Rappold G.;
RT   "Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in
RT   fibromyalgia patients.";
RL   Clin. Rheumatol. 23:338-344(2004).
RN   [11]
RP   VARIANTS SER-129; THR-143 AND ILE-183.
RX   PubMed=16487942; DOI=10.1016/j.biopsych.2005.11.008;
RA   Yamada K., Hattori E., Iwayama Y., Ohnishi T., Ohba H., Toyota T.,
RA   Takao H., Minabe Y., Nakatani N., Higuchi T., Detera-Wadleigh S.D.,
RA   Yoshikawa T.;
RT   "Distinguishable haplotype blocks in the HTR3A and HTR3B region in the
RT   Japanese reveal evidence of association of HTR3B with female major
RT   depression.";
RL   Biol. Psychiatry 60:192-201(2006).
RN   [12]
RP   VARIANT ARG-156.
RX   PubMed=21179162; DOI=10.1038/nature09629;
RA   Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T.,
RA   Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A.,
RA   Hodgkinson C.A., Dell'osso L., Suvisaari J., Coccaro E., Rose R.J.,
RA   Peltonen L., Virkkunen M., Goldman D.;
RT   "A population-specific HTR2B stop codon predisposes to severe
RT   impulsivity.";
RL   Nature 468:1061-1066(2010).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95264-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95264-2; Sequence=VSP_029796;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain cortex, in the caudate
CC       nucleus, the hyppocampus, the thalamus and the amygdala. Detected
CC       in the kidney and testis as well as in monocytes of the spleen,
CC       small and large intestine, uterus, prostate, ovary and placenta.
CC   -!- PTM: N-glycosylation required for membrane localization.
CC   -!- MISCELLANEOUS: The HA-stretch region of HTR3B seems to confer
CC       increased conductance to HTR3A/HTR3B heteromers compared to that
CC       of HTR3A homomers.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3B
CC       sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169255; AAF03691.1; -; mRNA.
DR   EMBL; AF080582; AAD12242.1; -; mRNA.
DR   EMBL; AM293589; CAL25321.1; -; mRNA.
DR   EMBL; EF444985; ACA06001.1; -; Genomic_DNA.
DR   EMBL; AK314268; BAG36930.1; -; mRNA.
DR   IPI; IPI00005673; -.
DR   IPI; IPI00876974; -.
DR   RefSeq; NP_006019.1; NM_006028.4.
DR   UniGene; Hs.241377; -.
DR   HSSP; P02711; 2BG9.
DR   ProteinModelPortal; O95264; -.
DR   SMR; O95264; 30-434.
DR   STRING; O95264; -.
DR   PRIDE; O95264; -.
DR   DNASU; 9177; -.
DR   Ensembl; ENST00000260191; ENSP00000260191; ENSG00000149305.
DR   GeneID; 9177; -.
DR   KEGG; hsa:9177; -.
DR   UCSC; uc001pok.3; human.
DR   UCSC; uc001pol.3; human.
DR   CTD; 9177; -.
DR   GeneCards; GC11P113809; -.
DR   H-InvDB; HIX0035859; -.
DR   HGNC; HGNC:5298; HTR3B.
DR   HPA; HPA039559; -.
DR   MIM; 604654; gene.
DR   neXtProt; NX_O95264; -.
DR   PharmGKB; PA29556; -.
DR   eggNOG; NOG260507; -.
DR   GeneTree; ENSGT00570000078866; -.
DR   HOGENOM; HBG714660; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; O95264; -.
DR   KO; K04819; -.
DR   OMA; RSREDIK; -.
DR   OrthoDB; EOG4N8R4Z; -.
DR   PhylomeDB; O95264; -.
DR   Reactome; REACT_15518; Transmembrane transport of small molecules.
DR   NextBio; 34409; -.
DR   ArrayExpress; O95264; -.
DR   Bgee; O95264; -.
DR   CleanEx; HS_HTR3B; -.
DR   Genevestigator; O95264; -.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:InterPro.
DR   GO; GO:0004993; F:serotonin receptor activity; TAS:ProtInc.
DR   GO; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   Gene3D; G3DSA:2.70.170.10; Neur_chan_lig_bd; 1.
DR   InterPro; IPR008132; 5HT3_rcpt.
DR   InterPro; IPR008134; 5HT3_rcpt_B.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; Neur_channel; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01710; 5HT3BRECEPTR.
DR   PRINTS; PR01708; 5HT3RECEPTOR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neu_channel_TM; 1.
DR   SUPFAM; SSF63712; Neur_chan_LBD; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion transport; Ionic channel;
KW   Ligand-gated ion channel; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     21       Potential.
FT   CHAIN        22    441       5-hydroxytryptamine receptor 3B.
FT                                /FTId=PRO_0000312289.
FT   TOPO_DOM     22    238       Extracellular (Potential).
FT   TRANSMEM    239    259       Helical; Name=1; (Potential).
FT   TOPO_DOM    260    268       Cytoplasmic (Potential).
FT   TRANSMEM    269    286       Helical; Name=2; (Potential).
FT   TOPO_DOM    287    303       Extracellular (Potential).
FT   TRANSMEM    304    324       Helical; Name=3; (Potential).
FT   TOPO_DOM    325    414       Cytoplasmic (Potential).
FT   TRANSMEM    415    435       Helical; Name=4; (Potential).
FT   TOPO_DOM    436    441       Extracellular (Potential).
FT   REGION      381    413       HA-stretch.
FT   CARBOHYD     52     52       N-linked (GlcNAc...).
FT   CARBOHYD     96     96       N-linked (GlcNAc...).
FT   CARBOHYD    138    138       N-linked (GlcNAc...).
FT   CARBOHYD    168    168       N-linked (GlcNAc...).
FT   CARBOHYD    203    203       N-linked (GlcNAc...).
FT   CARBOHYD    287    287       N-linked (GlcNAc...) (Potential).
FT   DISULFID    155    169       By similarity.
FT   VAR_SEQ       1     17       MLSSVMAPLWACILVAA -> MIVYFP (in isoform
FT                                2).
FT                                /FTId=VSP_029796.
FT   VARIANT     129    129       Y -> S (in dbSNP:rs1176744).
FT                                /FTId=VAR_037472.
FT   VARIANT     143    143       I -> T (in dbSNP:rs34550504).
FT                                /FTId=VAR_037473.
FT   VARIANT     156    156       S -> R (in dbSNP:rs72466469).
FT                                /FTId=VAR_037474.
FT   VARIANT     183    183       V -> I (in dbSNP:rs17116138).
FT                                /FTId=VAR_037475.
FT   MUTAGEN      52     52       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
FT   MUTAGEN      96     96       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
FT   MUTAGEN     138    138       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
FT   MUTAGEN     168    168       N->S: Reduced molecular weight and cell
FT                                membrane expression.
FT   MUTAGEN     203    203       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
SQ   SEQUENCE   441 AA;  50292 MW;  2ED59E4E11400648 CRC64;
     MLSSVMAPLW ACILVAAGIL ATDTHHPQDS ALYHLSKQLL QKYHKEVRPV YNWTKATTVY
     LDLFVHAILD VDAENQILKT SVWYQEVWND EFLSWNSSMF DEIREISLPL SAIWAPDIII
     NEFVDIERYP DLPYVYVNSS GTIENYKPIQ VVSACSLETY AFPFDVQNCS LTFKSILHTV
     EDVDLAFLRS PEDIQHDKKA FLNDSEWELL SVSSTYSILQ SSAGGFAQIQ FNVVMRRHPL
     VYVVSLLIPS IFLMLVDLGS FYLPPNCRAR IVFKTSVLVG YTVFRVNMSN QVPRSVGSTP
     LIGHFFTICM AFLVLSLAKS IVLVKFLHDE QRGGQEQPFL CLRGDTDADR PRVEPRAQRA
     VVTESSLYGE HLAQPGTLKE VWSQLQSISN YLQTQDQTDQ QEAEWLVLLS RFDRLLFQSY
     LFMLGIYTIT LCSLWALWGG V
//
ID   5HT3C_HUMAN             Reviewed;         447 AA.
AC   Q8WXA8; A2RRR5;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   18-APR-2012, entry version 84.
DE   RecName: Full=5-hydroxytryptamine receptor 3C;
DE            Short=5-HT3-C;
DE            Short=5-HT3C;
DE   AltName: Full=Serotonin receptor 3C;
DE   Flags: Precursor;
GN   Name=HTR3C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANTS LYS-163
RP   AND ALA-405.
RC   TISSUE=Lung;
RX   MEDLINE=22686529; PubMed=12801637; DOI=10.1016/S0378-1119(03)00503-1;
RA   Niesler B., Frank B., Kapeller J., Rappold G.A.;
RT   "Cloning, physical mapping and expression analysis of the human 5-HT3
RT   serotonin receptor-like genes HTR3C, HTR3D and HTR3E.";
RL   Gene 310:101-111(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-128.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues including adult
CC       brain, colon, intestine, lung, muscle and stomach as well as fetal
CC       colon and kidney.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3C
CC       sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF459285; AAL66182.1; -; mRNA.
DR   EMBL; CH471052; EAW78305.1; -; Genomic_DNA.
DR   EMBL; BC131799; AAI31800.1; -; mRNA.
DR   IPI; IPI00103496; -.
DR   RefSeq; NP_570126.2; NM_130770.2.
DR   UniGene; Hs.632579; -.
DR   HSSP; P02711; 2BG9.
DR   ProteinModelPortal; Q8WXA8; -.
DR   SMR; Q8WXA8; 43-445.
DR   STRING; Q8WXA8; -.
DR   DMDM; 166198366; -.
DR   PRIDE; Q8WXA8; -.
DR   Ensembl; ENST00000318351; ENSP00000322617; ENSG00000178084.
DR   GeneID; 170572; -.
DR   KEGG; hsa:170572; -.
DR   UCSC; uc003fmk.3; human.
DR   CTD; 170572; -.
DR   GeneCards; GC03P183770; -.
DR   H-InvDB; HIX0030746; -.
DR   HGNC; HGNC:24003; HTR3C.
DR   MIM; 610121; gene.
DR   neXtProt; NX_Q8WXA8; -.
DR   PharmGKB; PA134925741; -.
DR   eggNOG; NOG316889; -.
DR   GeneTree; ENSGT00570000078866; -.
DR   HOGENOM; HBG714660; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; Q8WXA8; -.
DR   KO; K04819; -.
DR   OMA; AFTINCS; -.
DR   OrthoDB; EOG4R5034; -.
DR   PhylomeDB; Q8WXA8; -.
DR   Reactome; REACT_15518; Transmembrane transport of small molecules.
DR   NextBio; 89041; -.
DR   ArrayExpress; Q8WXA8; -.
DR   Bgee; Q8WXA8; -.
DR   CleanEx; HS_HTR3C; -.
DR   Genevestigator; Q8WXA8; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:InterPro.
DR   GO; GO:0004872; F:receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome.
DR   Gene3D; G3DSA:2.70.170.10; Neur_chan_lig_bd; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; Neur_channel; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neu_channel_TM; 1.
DR   SUPFAM; SSF63712; Neur_chan_LBD; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond; Ion transport;
KW   Ionic channel; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     27       Potential.
FT   CHAIN        28    447       5-hydroxytryptamine receptor 3C.
FT                                /FTId=PRO_0000312292.
FT   TOPO_DOM     28    248       Extracellular (Potential).
FT   TRANSMEM    249    269       Helical; Name=1; (Potential).
FT   TOPO_DOM    270    282       Cytoplasmic (Potential).
FT   TRANSMEM    283    303       Helical; Name=2; (Potential).
FT   TOPO_DOM    304    306       Extracellular (Potential).
FT   TRANSMEM    307    329       Helical; Name=3; (Potential).
FT   TOPO_DOM    330    424       Cytoplasmic (Potential).
FT   TRANSMEM    425    445       Helical; Name=4; (Potential).
FT   TOPO_DOM    446    447       Extracellular (Potential).
FT   DISULFID    162    176       By similarity.
FT   VARIANT     128    128       V -> M (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_037552.
FT   VARIANT     163    163       N -> K (in dbSNP:rs6766410).
FT                                /FTId=VAR_037476.
FT   VARIANT     405    405       G -> A (in dbSNP:rs6807362).
FT                                /FTId=VAR_037477.
SQ   SEQUENCE   447 AA;  50220 MW;  E99260743598E596 CRC64;
     MEGGWPARQS ALLCLTVSLL LQGRGDAFTI NCSGFDQHGV DPAVFQAVFD RKAFRPFTNY
     SIPTRVNISF TLSAILGVDA QLQLLTSFLW MDLVWDNPFI NWNPKECVGI NKLTVLAENL
     WLPDIFIVES MDVDQTPSGL TAYISSEGRI KYDKPMRVTS ICNLDIFYFP FDQQNCTFTF
     SSFLYTVDSM LLGMDKEVWE ITDTSRKVIQ TQGEWELLGI NKATPKMSMG NNLYDQIMFY
     VAIRRRPSLY IINLLVPSSF LVAIDALSFY LPAESENRAP FKITLLLGYN VFLLMMNDLL
     PASGTPLISV YFALCLSLMV VSLLETVFIT YLLHVATTQP PPMPRWLHSL LLHCTSPGRC
     CPTAPQKGNK GLGLTLTHLP GPKEPGELAG KKLGPRETEP DGGSGWTKTQ LMELWVQFSH
     AMDTLLFRLY LLFMASSILT VIVLWNT
//
ID   5HT3D_HUMAN             Reviewed;         454 AA.
AC   Q70Z44; C9J2I6; Q495N5; Q495N6; Q7Z6B3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 3.
DT   18-APR-2012, entry version 74.
DE   RecName: Full=5-hydroxytryptamine receptor 3D;
DE            Short=5-HT3-D;
DE            Short=5-HT3D;
DE   AltName: Full=Serotonin receptor 3D;
DE   Flags: Precursor;
GN   Name=HTR3D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   MEDLINE=22686529; PubMed=12801637; DOI=10.1016/S0378-1119(03)00503-1;
RA   Niesler B., Frank B., Kapeller J., Rappold G.A.;
RT   "Cloning, physical mapping and expression analysis of the human 5-HT3
RT   serotonin receptor-like genes HTR3C, HTR3D and HTR3E.";
RL   Gene 310:101-111(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBUNIT, SUBCELLULAR LOCATION,
RP   AND VARIANT GLY-171.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANTS HIS-225 AND HIS-435.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q70Z44-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q70Z44-2; Sequence=VSP_029798, VSP_029799, VSP_029801;
CC       Name=3;
CC         IsoId=Q70Z44-3; Sequence=VSP_029797, VSP_029800, VSP_029801;
CC   -!- TISSUE SPECIFICITY: Expressed in liver, as well as fetal and adult
CC       colon and kidney.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3D
CC       sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ437318; CAD24817.1; -; mRNA.
DR   EMBL; AY159812; AAO38166.2; -; mRNA.
DR   EMBL; AC068644; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131235; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101090; AAI01091.1; -; mRNA.
DR   EMBL; BC101091; AAI01092.1; -; mRNA.
DR   IPI; IPI00376256; -.
DR   IPI; IPI00429176; -.
DR   IPI; IPI00877166; -.
DR   RefSeq; NP_001157118.1; NM_001163646.1.
DR   RefSeq; NP_872343.2; NM_182537.2.
DR   UniGene; Hs.448004; -.
DR   HSSP; P02711; 1OED.
DR   ProteinModelPortal; Q70Z44; -.
DR   STRING; Q70Z44; -.
DR   DMDM; 300669602; -.
DR   PRIDE; Q70Z44; -.
DR   Ensembl; ENST00000382489; ENSP00000371929; ENSG00000186090.
DR   Ensembl; ENST00000428798; ENSP00000405409; ENSG00000186090.
DR   GeneID; 200909; -.
DR   KEGG; hsa:200909; -.
DR   UCSC; uc010hxp.3; human.
DR   UCSC; uc011bqv.2; human.
DR   CTD; 200909; -.
DR   GeneCards; GC03P183749; -.
DR   H-InvDB; HIX0030755; -.
DR   HGNC; HGNC:24004; HTR3D.
DR   MIM; 610122; gene.
DR   neXtProt; NX_Q70Z44; -.
DR   PharmGKB; PA134866755; -.
DR   eggNOG; NOG302603; -.
DR   GeneTree; ENSGT00570000078866; -.
DR   HOGENOM; HBG714660; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; Q70Z44; -.
DR   KO; K04819; -.
DR   Reactome; REACT_15518; Transmembrane transport of small molecules.
DR   NextBio; 90004; -.
DR   ArrayExpress; Q495N5; -.
DR   CleanEx; HS_HTR3D; -.
DR   Genevestigator; Q70Z44; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004872; F:receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome.
DR   Gene3D; G3DSA:2.70.170.10; Neur_chan_lig_bd; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; Neur_channel; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   SUPFAM; SSF90112; Neu_channel_TM; 1.
DR   SUPFAM; SSF63712; Neur_chan_LBD; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion transport; Ionic channel; Ligand-gated ion channel; Membrane;
KW   Polymorphism; Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       Potential.
FT   CHAIN        25    454       5-hydroxytryptamine receptor 3D.
FT                                /FTId=PRO_0000312293.
FT   TOPO_DOM     25    232       Extracellular (Potential).
FT   TRANSMEM    233    253       Helical; Name=1; (Potential).
FT   TOPO_DOM    254    264       Cytoplasmic (Potential).
FT   TRANSMEM    265    285       Helical; Name=2; (Potential).
FT   TOPO_DOM    286    306       Extracellular (Potential).
FT   TRANSMEM    307    327       Helical; Name=3; (Potential).
FT   TOPO_DOM    328    431       Cytoplasmic (Potential).
FT   TRANSMEM    432    452       Helical; Name=4; (Potential).
FT   TOPO_DOM    453    454       Extracellular (Potential).
FT   CARBOHYD     66     66       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ       1    219       Missing (in isoform 3).
FT                                /FTId=VSP_029797.
FT   VAR_SEQ       1    135       Missing (in isoform 2).
FT                                /FTId=VSP_029798.
FT   VAR_SEQ     172    220       RAWRRMSRSFQIHHRTSFRTRREWVLLGIQKRTIKVTVATN
FT                                QYEQAIFH -> ERSPSALSPTQ (in isoform 2).
FT                                /FTId=VSP_029799.
FT   VAR_SEQ     220    220       H -> M (in isoform 3).
FT                                /FTId=VSP_029800.
FT   VAR_SEQ     295    306       APLALMQTPLPA -> RPHPSRDQKR (in isoform 2
FT                                and isoform 3).
FT                                /FTId=VSP_029801.
FT   VARIANT     171    171       A -> G (in dbSNP:rs6443930).
FT                                /FTId=VAR_037478.
FT   VARIANT     225    225       R -> H (in dbSNP:rs1000952).
FT                                /FTId=VAR_037479.
FT   VARIANT     435    435       R -> H (in dbSNP:rs6789754).
FT                                /FTId=VAR_037480.
FT   CONFLICT    155    155       S -> P (in Ref. 4; AAI01092).
FT   CONFLICT    368    368       K -> R (in Ref. 2; AAO38166).
SQ   SEQUENCE   454 AA;  50191 MW;  8B12F6CC31C4446C CRC64;
     MQKHSPGPPA LALLSQSLLT TGNGDTLIIN CPGFGQHRVD PAAFQAVFDR KAIGPVTNYS
     VATHVNISFT LSAIWNCYSR IHTFNCHHAR PWHNQFVQWN PDECGGIKKS GMATENLWLS
     DVFIEESVDQ TPAGLMASMS IVKATSNTIS QCGWSASANW TPSISPSMDR ARAWRRMSRS
     FQIHHRTSFR TRREWVLLGI QKRTIKVTVA TNQYEQAIFH VAIRRRCRPS PYVVNFLVPS
     GILIAIDALS FYLPLESGNC APFKMTVLLG YSVFLLMMND LLPATSTSSH ASLVAPLALM
     QTPLPAGVYF ALCLSLMVGS LLETIFITHL LHVATTQPLP LPRWLHSLLL HCTGQGRCCP
     TAPQKGNKGP GLTPTHLPGV KEPEVSAGQM PGPGEAELTG GSEWTRAQRE HEAQKQHSVE
     LWVQFSHAMD ALLFRLYLLF MASSIITVIC LWNT
//
ID   5HT3E_HUMAN             Reviewed;         456 AA.
AC   A5X5Y0; Q495G1; Q495G3; Q6V706; Q6V707; Q7Z6B2;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 1.
DT   18-APR-2012, entry version 53.
DE   RecName: Full=5-hydroxytryptamine receptor 3E;
DE            Short=5-HT3-E;
DE            Short=5-HT3E;
DE   AltName: Full=Serotonin receptor 3E;
DE   Flags: Precursor;
GN   Name=HTR3E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY.
RX   MEDLINE=22686529; PubMed=12801637; DOI=10.1016/S0378-1119(03)00503-1;
RA   Niesler B., Frank B., Kapeller J., Rappold G.A.;
RT   "Cloning, physical mapping and expression analysis of the human 5-HT3
RT   serotonin receptor-like genes HTR3C, HTR3D and HTR3E.";
RL   Gene 310:101-111(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 4), AND TISSUE SPECIFICITY.
RX   MEDLINE=22959642; PubMed=14597179; DOI=10.1016/S0378-1119(03)00803-5;
RA   Karnovsky A.M., Gotow L.F., McKinley D.D., Piechan J.L., Ruble C.L.,
RA   Mills C.J., Schellin K.A.B., Slightom J.L., Fitzgerald L.R.,
RA   Benjamin C.W., Roberds S.L.;
RT   "A cluster of novel serotonin receptor 3-like genes on human
RT   chromosome 3.";
RL   Gene 319:137-148(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=A5X5Y0-1; Sequence=Displayed;
CC       Name=2; Synonyms=5-HT3c1;
CC         IsoId=A5X5Y0-2; Sequence=VSP_029804;
CC       Name=3;
CC         IsoId=A5X5Y0-3; Sequence=VSP_029803;
CC       Name=4; Synonyms=5-HT3c1 long;
CC         IsoId=A5X5Y0-4; Sequence=VSP_029803, VSP_029804;
CC   -!- TISSUE SPECIFICITY: Expressed in adult colon and intestine.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3E
CC       sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY349352; AAQ93476.1; -; mRNA.
DR   EMBL; AY349353; AAQ93477.1; -; mRNA.
DR   EMBL; AY159813; AAO38167.2; -; mRNA.
DR   EMBL; DQ644022; ABG35128.1; -; mRNA.
DR   EMBL; BC101182; AAI01183.1; -; mRNA.
DR   EMBL; BC101183; AAI01184.1; -; mRNA.
DR   EMBL; BC101185; AAI01186.1; -; mRNA.
DR   IPI; IPI00376255; -.
DR   IPI; IPI00876853; -.
DR   IPI; IPI00877063; -.
DR   IPI; IPI00877086; -.
DR   RefSeq; NP_001243542.1; NM_001256613.1.
DR   RefSeq; NP_872395.2; NM_182589.2.
DR   RefSeq; NP_938055.1; NM_198313.2.
DR   RefSeq; NP_938056.1; NM_198314.2.
DR   UniGene; Hs.449179; -.
DR   ProteinModelPortal; A5X5Y0; -.
DR   STRING; A5X5Y0; -.
DR   PRIDE; A5X5Y0; -.
DR   Ensembl; ENST00000415389; ENSP00000401444; ENSG00000186038.
DR   GeneID; 285242; -.
DR   KEGG; hsa:285242; -.
DR   UCSC; uc003fml.4; human.
DR   UCSC; uc003fmm.3; human.
DR   UCSC; uc003fmn.3; human.
DR   UCSC; uc010hxq.3; human.
DR   CTD; 285242; -.
DR   GeneCards; GC03P183814; -.
DR   HGNC; HGNC:24005; HTR3E.
DR   MIM; 610123; gene.
DR   neXtProt; NX_A5X5Y0; -.
DR   PharmGKB; PA134900226; -.
DR   eggNOG; NOG316889; -.
DR   GeneTree; ENSGT00570000078866; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; A5X5Y0; -.
DR   KO; K04819; -.
DR   OrthoDB; EOG4R5034; -.
DR   Reactome; REACT_15518; Transmembrane transport of small molecules.
DR   NextBio; 95380; -.
DR   CleanEx; HS_HTR3E; -.
DR   Genevestigator; A5X5Y0; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:InterPro.
DR   GO; GO:0004872; F:receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome.
DR   Gene3D; G3DSA:2.70.170.10; Neur_chan_lig_bd; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; Neur_channel; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neu_channel_TM; 1.
DR   SUPFAM; SSF63712; Neur_chan_LBD; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion transport; Ionic channel;
KW   Ligand-gated ion channel; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     25       Potential.
FT   CHAIN        26    456       5-hydroxytryptamine receptor 3E.
FT                                /FTId=PRO_0000312294.
FT   TOPO_DOM     26    248       Extracellular (Potential).
FT   TRANSMEM    249    269       Helical; Name=1; (Potential).
FT   TOPO_DOM    270    282       Cytoplasmic (Potential).
FT   TRANSMEM    283    303       Helical; Name=2; (Potential).
FT   TOPO_DOM    304    307       Extracellular (Potential).
FT   TRANSMEM    308    328       Helical; Name=3; (Potential).
FT   TOPO_DOM    329    433       Cytoplasmic (Potential).
FT   TRANSMEM    434    454       Helical; Name=4; (Potential).
FT   TOPO_DOM    455    456       Extracellular (Potential).
FT   CARBOHYD    175    175       N-linked (GlcNAc...) (Potential).
FT   DISULFID    162    176       By similarity.
FT   VAR_SEQ       1     22       MEGSWFHRKRFSFYLLLGFLLQ -> MLAFILSRATPRPAL
FT                                GPLSYREHRVALLHLTHSMSTT (in isoform 3 and
FT                                isoform 4).
FT                                /FTId=VSP_029803.
FT   VAR_SEQ      79     93       Missing (in isoform 2 and isoform 4).
FT                                /FTId=VSP_029804.
FT   VARIANT      71     71       A -> T (in dbSNP:rs7627615).
FT                                /FTId=VAR_037481.
FT   VARIANT     430    430       A -> T (in dbSNP:rs13324468).
FT                                /FTId=VAR_037482.
FT   CONFLICT     44     44       A -> T (in Ref. 4; AAI01183/AAI01184).
SQ   SEQUENCE   456 AA;  51438 MW;  4BFA6561BA309E83 CRC64;
     MEGSWFHRKR FSFYLLLGFL LQGRGVTFTI NCSGFGQHGA DPTALNSVFN RKPFRPVTNI
     SVPTQVNISF AMSAILDVNE QLHLLSSFLW LEMVWDNPFI SWNPEECEGI TKMSMAAKNL
     WLPDIFIIEL MDVDKTPKGL TAYVSNEGRI RYKKPMKVDS ICNLDIFYFP FDQQNCTLTF
     SSFLYTVDSM LLDMEKEVWE ITDASRNILQ THGEWELLGL SKATAKLSRG GNLYDQIVFY
     VAIRRRPSLY VINLLVPSGF LVAIDALSFY LPVKSGNRVP FKITLLLGYN VFLLMMSDLL
     PTSGTPLIGV YFALCLSLMV GSLLETIFIT HLLHVATTQP PPLPRWLHSL LLHCNSPGRC
     CPTAPQKENK GPGLTPTHLP GVKEPEVSAG QMPGPAEAEL TGGSEWTRAQ REHEAQKQHS
     VELWLQFSHA MDAMLFRLYL LFMASSIITV ICLWNT
//
ID   5HT4R_HUMAN             Reviewed;         388 AA.
AC   Q13639; Q96KH9; Q96KI0; Q9H199; Q9NY73; Q9UBM6; Q9UBT4; Q9UE22;
AC   Q9UE23; Q9UQR6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   18-APR-2012, entry version 115.
DE   RecName: Full=5-hydroxytryptamine receptor 4;
DE            Short=5-HT-4;
DE            Short=5-HT4;
DE   AltName: Full=Serotonin receptor 4;
GN   Name=HTR4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5-HT4(A); 5-HT4(B); 5-HT4(C) AND
RP   5-HT4(D)).
RC   TISSUE=Intestine;
RX   MEDLINE=98264328; PubMed=9603189;
RA   Blondel O., Gastineau M., Dahmoune Y., Langlois M., Fischmeister R.;
RT   "Cloning, expression, and pharmacology of four human 5-
RT   hydroxytryptamine 4 receptor isoforms produced by alternative splicing
RT   in the carboxyl terminus.";
RL   J. Neurochem. 70:2252-2261(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5-HT4(A) AND 5-HT4(B)).
RC   TISSUE=Brain;
RA   Van den Wyngaert I., Gommeren W., Jurzak M., Verhasselt P., Gordon R.,
RA   Leysen J., Luyten W., Bender E.;
RT   "Cloning and expression of 5-HT4 receptor species and splice
RT   variants.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5-HT4(A)).
RC   TISSUE=Heart;
RX   MEDLINE=98012006; PubMed=9351641;
RA   Claeysen S., Faye P., Sebben M., Lemaire S., Bockaert J., Dumuis A.;
RT   "Cloning and expression of human 5-HT4S receptors. Effect of receptor
RT   density on their coupling to adenylyl cyclase.";
RL   NeuroReport 8:3189-3195(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5-HT4(E)).
RC   TISSUE=Brain;
RX   MEDLINE=99238795; PubMed=10220570;
RA   Claeysen S., Sebben M., Becamel C., Bockaert J., Dumuis A.;
RT   "Novel brain-specific 5-HT4 receptor splice variants show marked
RT   constitutive activity: role of the C-terminal intracellular domain.";
RL   Mol. Pharmacol. 55:910-920(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5-HT4(A); 5-HT4(E) AND 5-HT4(G)).
RC   TISSUE=Hippocampus;
RA   Vilaro M.T., Domenech T., Palacios J.M., Mengod G.;
RT   "Cloning and characterization of multiple human 5-HT4 receptor
RT   variants including a novel variant that lacks the alternatively
RT   spliced C-terminal exon.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5-HT4(B)).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 10-388 (ISOFORM 5-HT4(F)).
RX   MEDLINE=20110418; PubMed=10646498;
RX   DOI=10.1046/j.1471-4159.2000.740478.x;
RA   Bender E., Pindon A., van Oers I., Zhang Y.B., Gommeren W.,
RA   Verhasselt P., Jurzak M., Leysen J., Luyten W.;
RT   "Structure of the human serotonin 5-HT4 receptor gene and cloning of a
RT   novel 5-HT4 splice variant.";
RL   J. Neurochem. 74:478-489(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 112-255.
RC   TISSUE=Brain;
RX   MEDLINE=95385798; PubMed=7656980; DOI=10.1016/0014-5793(95)00828-W;
RA   Ullmer C., Schmuck K., Kalkman H.O., Luebbert H.;
RT   "Expression of serotonin receptor mRNAs in blood vessels.";
RL   FEBS Lett. 370:215-221(1995).
RN   [9]
RP   MASS SPECTROMETRY, AND INTERACTION WITH GRK5.
RX   PubMed=19661922; DOI=10.1038/emboj.2009.215;
RA   Barthet G., Carrat G., Cassier E., Barker B., Gaven F., Pillot M.,
RA   Framery B., Pellissier L.P., Augier J., Kang D.S., Claeysen S.,
RA   Reiter E., Baneres J.L., Benovic J.L., Marin P., Bockaert J.,
RA   Dumuis A.;
RT   "Beta-arrestin1 phosphorylation by GRK5 regulates G protein-
RT   independent 5-HT4 receptor signalling.";
RL   EMBO J. 28:2706-2718(2009).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that stimulate adenylate
CC       cyclase.
CC   -!- SUBUNIT: Isoform 5-HT4(A) interacts with MAGI2, MPP3, SLC9A3R1 and
CC       SNX27 isoforms 1 and 2. Isoform 5-HT4(E) interacts with INADL,
CC       NOS1 and SEC23A. Isoform 5-HT4(A) forms a complex including
CC       SLC9A3R1 and EZR (By similarity). Interacts (via C-terminus 330-
CC       346 AA) with GRK5; this interaction is promoted by 5-HT
CC       (serotonin).
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Endosome. Note=Interaction with SNX27 mediates recruitment to
CC       early endosomes, while interaction with SLC9A3R1 and EZR might
CC       target the protein to specialized subcellular regions, such as
CC       microvilli (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist;
CC       Name=5-HT4(B);
CC         IsoId=Q13639-1; Sequence=Displayed;
CC       Name=5-HT4(A); Synonyms=5-HT4S;
CC         IsoId=Q13639-2; Sequence=VSP_001849;
CC       Name=5-HT4(C);
CC         IsoId=Q13639-3; Sequence=VSP_001848;
CC       Name=5-HT4(D);
CC         IsoId=Q13639-4; Sequence=VSP_001847;
CC       Name=5-HT4(E); Synonyms=H5-HT4(g);
CC         IsoId=Q13639-5; Sequence=VSP_001846;
CC       Name=5-HT4(F);
CC         IsoId=Q13639-6; Sequence=VSP_001845;
CC       Name=5-HT4(G);
CC         IsoId=Q13639-7; Sequence=VSP_001850;
CC   -!- TISSUE SPECIFICITY: Isoform 5-HT4(A) is expressed in ileum, brain,
CC       and atrium, but not in the ventricle.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y08756; CAA70002.1; -; mRNA.
DR   EMBL; Y12505; CAA73107.1; -; mRNA.
DR   EMBL; Y12506; CAA73108.1; -; mRNA.
DR   EMBL; Y12507; CAA73109.1; -; mRNA.
DR   EMBL; Y10437; CAA71462.1; -; mRNA.
DR   EMBL; Y13584; CAA73911.1; -; mRNA.
DR   EMBL; Y09586; CAA70774.1; -; mRNA.
DR   EMBL; AJ011371; CAA09600.1; -; mRNA.
DR   EMBL; AJ278979; CAC22248.1; -; mRNA.
DR   EMBL; AJ278981; CAC22250.1; -; mRNA.
DR   EMBL; AJ278982; CAC22251.1; -; mRNA.
DR   EMBL; BC074755; AAH74755.1; -; mRNA.
DR   EMBL; AJ243213; CAB71316.1; -; Genomic_DNA.
DR   EMBL; Z48150; CAA88167.1; -; mRNA.
DR   IPI; IPI00014378; -.
DR   IPI; IPI00064638; -.
DR   IPI; IPI00186777; -.
DR   IPI; IPI00216427; -.
DR   IPI; IPI00216428; -.
DR   IPI; IPI00216429; -.
DR   IPI; IPI00291659; -.
DR   PIR; S66493; S66493.
DR   RefSeq; NP_000861.1; NM_000870.5.
DR   RefSeq; NP_001035259.1; NM_001040169.2.
DR   RefSeq; NP_001035262.2; NM_001040172.2.
DR   RefSeq; NP_955525.1; NM_199453.3.
DR   UniGene; Hs.483773; -.
DR   ProteinModelPortal; Q13639; -.
DR   SMR; Q13639; 12-327.
DR   MINT; MINT-1347413; -.
DR   STRING; Q13639; -.
DR   DMDM; 12644029; -.
DR   PRIDE; Q13639; -.
DR   Ensembl; ENST00000377888; ENSP00000367120; ENSG00000164270.
DR   GeneID; 3360; -.
DR   KEGG; hsa:3360; -.
DR   UCSC; uc003lpn.3; human.
DR   UCSC; uc021yfh.1; human.
DR   UCSC; uc021yfi.1; human.
DR   CTD; 3360; -.
DR   GeneCards; GC05M147810; -.
DR   HGNC; HGNC:5299; HTR4.
DR   MIM; 602164; gene.
DR   neXtProt; NX_Q13639; -.
DR   PharmGKB; PA29557; -.
DR   eggNOG; NOG262978; -.
DR   GeneTree; ENSGT00650000092903; -.
DR   HOVERGEN; HBG106962; -.
DR   KO; K04160; -.
DR   OrthoDB; EOG4933HZ; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00953; Rizatriptan.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00315; Zolmitriptan.
DR   NextBio; 13288; -.
DR   ArrayExpress; Q13639; -.
DR   Bgee; Q13639; -.
DR   Genevestigator; Q13639; -.
DR   GermOnline; ENSG00000164270; Homo sapiens.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005624; C:membrane fraction; IDA:MGI.
DR   GO; GO:0004993; F:serotonin receptor activity; IDA:MGI.
DR   GO; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   InterPro; IPR001520; 5HT4_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01059; 5HT4RECEPTR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Endosome; G-protein coupled receptor; Glycoprotein;
KW   Lipoprotein; Membrane; Palmitate; Polymorphism; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN         1    388       5-hydroxytryptamine receptor 4.
FT                                /FTId=PRO_0000068965.
FT   TOPO_DOM      1     19       Extracellular (By similarity).
FT   TRANSMEM     20     40       Helical; Name=1; (By similarity).
FT   TOPO_DOM     41     58       Cytoplasmic (By similarity).
FT   TRANSMEM     59     79       Helical; Name=2; (By similarity).
FT   TOPO_DOM     80     93       Extracellular (By similarity).
FT   TRANSMEM     94    116       Helical; Name=3; (By similarity).
FT   TOPO_DOM    117    137       Cytoplasmic (By similarity).
FT   TRANSMEM    138    158       Helical; Name=4; (By similarity).
FT   TOPO_DOM    159    192       Extracellular (By similarity).
FT   TRANSMEM    193    213       Helical; Name=5; (By similarity).
FT   TOPO_DOM    214    260       Cytoplasmic (By similarity).
FT   TRANSMEM    261    281       Helical; Name=6; (By similarity).
FT   TOPO_DOM    282    294       Extracellular (By similarity).
FT   TRANSMEM    295    315       Helical; Name=7; (By similarity).
FT   TOPO_DOM    316    388       Cytoplasmic (By similarity).
FT   LIPID       329    329       S-palmitoyl cysteine (By similarity).
FT   CARBOHYD      7      7       N-linked (GlcNAc...) (Potential).
FT   DISULFID     93    184       By similarity.
FT   VAR_SEQ     169    169       L -> LERSLNQGLGQDFHA (in isoform 5-
FT                                HT4(F)).
FT                                /FTId=VSP_001845.
FT   VAR_SEQ     359    388       RDAVECGGQWESQCHPPATSPLVAAQPSDT -> SSGTETD
FT                                RRNFGIRKRRLTKPS (in isoform 5-HT4(D)).
FT                                /FTId=VSP_001847.
FT   VAR_SEQ     359    388       RDAVECGGQWESQCHPPATSPLVAAQPSDT -> SGCSPVS
FT                                SFLLLFCNRPVPV (in isoform 5-HT4(E)).
FT                                /FTId=VSP_001846.
FT   VAR_SEQ     360    388       DAVECGGQWESQCHPPATSPLVAAQPSDT -> YTVLHRGH
FT                                HQELEKLPIHNDPESLESCF (in isoform 5-
FT                                HT4(A)).
FT                                /FTId=VSP_001849.
FT   VAR_SEQ     360    388       DAVECGGQWESQCHPPATSPLVAAQPSDT -> F (in
FT                                isoform 5-HT4(C)).
FT                                /FTId=VSP_001848.
FT   VAR_SEQ     360    388       Missing (in isoform 5-HT4(G)).
FT                                /FTId=VSP_001850.
FT   VARIANT     372    372       C -> Y (in dbSNP:rs34826744).
FT                                /FTId=VAR_049364.
SQ   SEQUENCE   388 AA;  43761 MW;  7FCFEC60E7BDF560 CRC64;
     MDKLDANVSS EEGFGSVEKV VLLTFLSTVI LMAILGNLLV MVAVCWDRQL RKIKTNYFIV
     SLAFADLLVS VLVMPFGAIE LVQDIWIYGE VFCLVRTSLD VLLTTASIFH LCCISLDRYY
     AICCQPLVYR NKMTPLRIAL MLGGCWVIPT FISFLPIMQG WNNIGIIDLI EKRKFNQNSN
     STYCVFMVNK PYAITCSVVA FYIPFLLMVL AYYRIYVTAK EHAHQIQMLQ RAGASSESRP
     QSADQHSTHR MRTETKAAKT LCIIMGCFCL CWAPFFVTNI VDPFIDYTVP GQVWTAFLWL
     GYINSGLNPF LYAFLNKSFR RAFLIILCCD DERYRRPSIL GQTVPCSTTT INGSTHVLRD
     AVECGGQWES QCHPPATSPL VAAQPSDT
//
ID   5HT5A_HUMAN             Reviewed;         357 AA.
AC   P47898; Q2M2D2;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   18-APR-2012, entry version 102.
DE   RecName: Full=5-hydroxytryptamine receptor 5A;
DE            Short=5-HT-5;
DE            Short=5-HT-5A;
DE            Short=5-HT5A;
DE   AltName: Full=Serotonin receptor 5A;
GN   Name=HTR5A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=95080386; PubMed=7988681; DOI=10.1016/0014-5793(94)01209-1;
RA   Rees S., den Daas I., Foord S., Goodson S., Bull D., Kilpatrick G.,
RA   Lee M.;
RT   "Cloning and characterisation of the human 5-HT5A serotonin
RT   receptor.";
RL   FEBS Lett. 355:242-246(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-262.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X81411; CAA57168.1; -; Genomic_DNA.
DR   EMBL; X81412; CAA57168.1; JOINED; Genomic_DNA.
DR   EMBL; AF498985; AAM21132.1; -; mRNA.
DR   EMBL; BC112021; AAI12022.1; -; mRNA.
DR   IPI; IPI00026666; -.
DR   PIR; I37107; I37107.
DR   RefSeq; NP_076917.1; NM_024012.3.
DR   UniGene; Hs.65791; -.
DR   ProteinModelPortal; P47898; -.
DR   SMR; P47898; 38-356.
DR   STRING; P47898; -.
DR   DMDM; 1345607; -.
DR   PRIDE; P47898; -.
DR   DNASU; 3361; -.
DR   Ensembl; ENST00000287907; ENSP00000287907; ENSG00000157219.
DR   GeneID; 3361; -.
DR   KEGG; hsa:3361; -.
DR   UCSC; uc003wlu.1; human.
DR   CTD; 3361; -.
DR   GeneCards; GC07P154862; -.
DR   H-InvDB; HIX0033634; -.
DR   HGNC; HGNC:5300; HTR5A.
DR   HPA; CAB017467; -.
DR   MIM; 601305; gene.
DR   neXtProt; NX_P47898; -.
DR   PharmGKB; PA29558; -.
DR   eggNOG; NOG260742; -.
DR   GeneTree; ENSGT00650000092921; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P47898; -.
DR   KO; K04161; -.
DR   OMA; NSAFKNF; -.
DR   OrthoDB; EOG4K6G4Q; -.
DR   PhylomeDB; P47898; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   NextBio; 13304; -.
DR   ArrayExpress; P47898; -.
DR   Bgee; P47898; -.
DR   CleanEx; HS_HTR5A; -.
DR   Genevestigator; P47898; -.
DR   GermOnline; ENSG00000157219; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0004993; F:serotonin receptor activity; IDA:MGI.
DR   InterPro; IPR001397; 5HT5A_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00518; 5HT5ARECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    357       5-hydroxytryptamine receptor 5A.
FT                                /FTId=PRO_0000068969.
FT   TOPO_DOM      1     40       Extracellular (By similarity).
FT   TRANSMEM     41     63       Helical; Name=1; (By similarity).
FT   TOPO_DOM     64     78       Cytoplasmic (By similarity).
FT   TRANSMEM     79     99       Helical; Name=2; (By similarity).
FT   TOPO_DOM    100    115       Extracellular (By similarity).
FT   TRANSMEM    116    137       Helical; Name=3; (By similarity).
FT   TOPO_DOM    138    158       Cytoplasmic (By similarity).
FT   TRANSMEM    159    181       Helical; Name=4; (By similarity).
FT   TOPO_DOM    182    198       Extracellular (By similarity).
FT   TRANSMEM    199    219       Helical; Name=5; (By similarity).
FT   TOPO_DOM    220    282       Cytoplasmic (By similarity).
FT   TRANSMEM    283    303       Helical; Name=6; (By similarity).
FT   TOPO_DOM    304    320       Extracellular (By similarity).
FT   TRANSMEM    321    341       Helical; Name=7; (By similarity).
FT   TOPO_DOM    342    357       Cytoplasmic (By similarity).
FT   CARBOHYD      6      6       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     21     21       N-linked (GlcNAc...) (Potential).
FT   DISULFID    120    192       By similarity.
FT   VARIANT     262    262       R -> C (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035753.
SQ   SEQUENCE   357 AA;  40255 MW;  92F8A78C69169790 CRC64;
     MDLPVNLTSF SLSTPSPLET NHSLGKDDLR PSSPLLSVFG VLILTLLGFL VAATFAWNLL
     VLATILRVRT FHRVPHNLVA SMAVSDVLVA ALVMPLSLVH ELSGRRWQLG RRLCQLWIAC
     DVLCCTASIW NVTAIALDRY WSITRHMEYT LRTRKCVSNV MIALTWALSA VISLAPLLFG
     WGETYSEGSE ECQVSREPSY AVFSTVGAFY LPLCVVLFVY WKIYKAAKFR VGSRKTNSVS
     PISEAVEVKD SAKQPQMVFT VRHATVTFQP EGDTWREQKE QRAALMVGIL IGVFVLCWIP
     FFLTELISPL CSCDIPAIWK SIFLWLGYSN SFFNPLIYTA FNKNYNSAFK NFFSRQH
//
ID   5HT6R_HUMAN             Reviewed;         440 AA.
AC   P50406; Q13640; Q5TGZ1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=5-hydroxytryptamine receptor 6;
DE            Short=5-HT-6;
DE            Short=5-HT6;
DE   AltName: Full=Serotonin receptor 6;
GN   Name=HTR6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Corpus striatum;
RX   MEDLINE=96102917; PubMed=8522988;
RA   Kohen R., Metcalf M.A., Khan N., Druck T., Huebner K., Lachowicz J.E.,
RA   Sibley D.R., Roth B., Hamblin M.W.;
RT   "Cloning, characterization, and chromosomal localization of a human 5-
RT   HT6 serotonin receptor.";
RL   J. Neurochem. 66:47-56(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 215-280.
RC   TISSUE=Corpus striatum;
RX   MEDLINE=95385798; PubMed=7656980; DOI=10.1016/0014-5793(95)00828-W;
RA   Ullmer C., Schmuck K., Kalkman H.O., Luebbert H.;
RT   "Expression of serotonin receptor mRNAs in blood vessels.";
RL   FEBS Lett. 370:215-221(1995).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-125, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=16094384; DOI=10.1038/nmeth776;
RA   Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,
RA   Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
RT   "Quantitative phosphoproteome analysis using a dendrimer conjugation
RT   chemistry and tandem mass spectrometry.";
RL   Nat. Methods 2:591-598(2005).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that stimulate adenylate
CC       cyclase. It has a high affinity for tricyclic psychotropic drugs.
CC   -!- INTERACTION:
CC       P06241:FYN; NbExp=7; IntAct=EBI-1182222, EBI-515315;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in several human brain regions, most
CC       prominently in the caudate nucleus.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L41147; AAA92622.1; -; mRNA.
DR   EMBL; AY429105; AAR07900.1; -; mRNA.
DR   EMBL; AL031727; CAI19020.1; -; Genomic_DNA.
DR   EMBL; CH471134; EAW94896.1; -; Genomic_DNA.
DR   EMBL; BC074995; AAH74995.1; -; mRNA.
DR   EMBL; BC074996; AAH74996.1; -; mRNA.
DR   EMBL; Z49119; CAA88929.1; -; mRNA.
DR   IPI; IPI00032009; -.
DR   PIR; JC5520; JC5520.
DR   RefSeq; NP_000862.1; NM_000871.1.
DR   UniGene; Hs.22180; -.
DR   ProteinModelPortal; P50406; -.
DR   SMR; P50406; 25-338.
DR   IntAct; P50406; 1.
DR   STRING; P50406; -.
DR   PhosphoSite; P50406; -.
DR   DMDM; 1703010; -.
DR   PRIDE; P50406; -.
DR   Ensembl; ENST00000289753; ENSP00000289753; ENSG00000158748.
DR   GeneID; 3362; -.
DR   KEGG; hsa:3362; -.
DR   UCSC; uc001bcl.3; human.
DR   CTD; 3362; -.
DR   GeneCards; GC01P019991; -.
DR   H-InvDB; HIX0200015; -.
DR   HGNC; HGNC:5301; HTR6.
DR   MIM; 601109; gene.
DR   neXtProt; NX_P50406; -.
DR   PharmGKB; PA29560; -.
DR   eggNOG; NOG299437; -.
DR   GeneTree; ENSGT00650000092903; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P50406; -.
DR   KO; K04162; -.
DR   OMA; RMTPPRA; -.
DR   OrthoDB; EOG47WNPD; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00889; Granisetron.
DR   DrugBank; DB00904; Ondansetron.
DR   DrugBank; DB06144; Sertindole.
DR   NextBio; 13308; -.
DR   ArrayExpress; P50406; -.
DR   Bgee; P50406; -.
DR   CleanEx; HS_HTR6; -.
DR   Genevestigator; P50406; -.
DR   GermOnline; ENSG00000158748; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0004969; F:histamine receptor activity; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN         1    440       5-hydroxytryptamine receptor 6.
FT                                /FTId=PRO_0000068974.
FT   TOPO_DOM      1     34       Extracellular (By similarity).
FT   TRANSMEM     35     57       Helical; Name=1; (By similarity).
FT   TOPO_DOM     58     64       Cytoplasmic (By similarity).
FT   TRANSMEM     65     85       Helical; Name=2; (By similarity).
FT   TOPO_DOM     86    100       Extracellular (By similarity).
FT   TRANSMEM    101    122       Helical; Name=3; (By similarity).
FT   TOPO_DOM    123    144       Cytoplasmic (By similarity).
FT   TRANSMEM    145    166       Helical; Name=4; (By similarity).
FT   TOPO_DOM    167    184       Extracellular (By similarity).
FT   TRANSMEM    185    208       Helical; Name=5; (By similarity).
FT   TOPO_DOM    209    265       Cytoplasmic (By similarity).
FT   TRANSMEM    266    290       Helical; Name=6; (By similarity).
FT   TOPO_DOM    291    295       Extracellular (By similarity).
FT   TRANSMEM    296    320       Helical; Name=7; (By similarity).
FT   TOPO_DOM    321    440       Cytoplasmic (By similarity).
FT   MOD_RES     125    125       Phosphotyrosine.
FT   DISULFID     99    180       By similarity.
FT   CONFLICT    247    247       V -> M (in Ref. 6; CAA88929).
SQ   SEQUENCE   440 AA;  46954 MW;  C888F47650C1D2EF CRC64;
     MVPEPGPTAN STPAWGAGPP SAPGGSGWVA AALCVVIALT AAANSLLIAL ICTQPALRNT
     SNFFLVSLFT SDLMVGLVVM PPAMLNALYG RWVLARGLCL LWTAFDVMCC SASILNLCLI
     SLDRYLLILS PLRYKLRMTP LRALALVLGA WSLAALASFL PLLLGWHELG HARPPVPGQC
     RLLASLPFVL VASGLTFFLP SGAICFTYCR ILLAARKQAV QVASLTTGMA SQASETLQVP
     RTPRPGVESA DSRRLATKHS RKALKASLTL GILLGMFFVT WLPFFVANIV QAVCDCISPG
     LFDVLTWLGY CNSTMNPIIY PLFMRDFKRA LGRFLPCPRC PRERQASLAS PSLRTSHSGP
     RPGLSLQQVL PLPLPPDSDS DSDAGSGGSS GLRLTAQLLL PGEATQDPPL PTRAAAAVNF
     FNIDPAEPEL RPHPLGIPTN
//
ID   5HT7R_HUMAN             Reviewed;         479 AA.
AC   P34969; B5BUP6; P78336; P78372; P78516; Q5VX01; Q5VX02;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   18-APR-2012, entry version 117.
DE   RecName: Full=5-hydroxytryptamine receptor 7;
DE            Short=5-HT-7;
DE            Short=5-HT7;
DE   AltName: Full=5-HT-X;
DE   AltName: Full=Serotonin receptor 7;
GN   Name=HTR7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], ALTERNATIVE SPLICING, AND
RP   TISSUE SPECIFICITY.
RX   MEDLINE=97238071; PubMed=9084407;
RA   Heidmann D.E.A., Metcalf M.A., Kohen R., Hamblin M.W.;
RT   "Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat
RT   produced by alternative splicing: species differences due to altered
RT   intron-exon organization.";
RL   J. Neurochem. 68:1372-1381(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Fetal brain, and Placenta;
RX   MEDLINE=94043137; PubMed=8226867;
RA   Bard J.A., Zgombick J.M., Adham N., Vaysse P., Branchek T.A.,
RA   Weinshank R.L.;
RT   "Cloning of a novel human serotonin receptor (5-HT7) positively linked
RT   to adenylate cyclase.";
RL   J. Biol. Chem. 268:23422-23426(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Brain;
RA   King M.M., Aronstam R.S., Sharma S.V.;
RT   "Isolation of cDNA coding for 5-hydroxytryptamine receptor 7,
RT   transcript variant b (HTR7B).";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   VARIANTS LYS-92 AND LEU-279.
RX   MEDLINE=97298817; PubMed=9154233;
RA   Erdmann J., Nothen M.M., Shimron-Abarbanell D., Rietschel M.,
RA   Albus M., Borrmann M., Maier W., Franzek E., Korner J., Weigelt B.,
RA   Fimmers R., Propping P.;
RT   "The human serotonin 7 (5-HT7) receptor gene: genomic organization and
RT   systematic mutation screening in schizophrenia and bipolar affective
RT   disorder.";
RL   Mol. Psychiatry 1:392-397(1996).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. The activity of
CC       this receptor is mediated by G proteins that stimulate adenylate
CC       cyclase.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Isoform A and isoform B appear to be expressed at higher
CC         levels;
CC       Name=D;
CC         IsoId=P34969-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=P34969-2; Sequence=VSP_001857;
CC       Name=B;
CC         IsoId=P34969-3; Sequence=VSP_001856;
CC   -!- TISSUE SPECIFICITY: Isoform A is the predominant isoform in
CC       spleen, caudate and hippocampus. Isoform B is expressed at lower
CC       levels. Isoform D is a minor isoform in term of expression.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U68487; AAB48393.1; -; mRNA.
DR   EMBL; U68488; AAB48394.1; -; mRNA.
DR   EMBL; U68492; AAF07218.1; -; Genomic_DNA.
DR   EMBL; U68493; AAF07217.1; -; Genomic_DNA.
DR   EMBL; U68492; AAF07217.1; JOINED; Genomic_DNA.
DR   EMBL; U68493; AAB48397.2; -; Genomic_DNA.
DR   EMBL; U68492; AAB48397.2; JOINED; Genomic_DNA.
DR   EMBL; L21195; AAC37538.1; -; mRNA.
DR   EMBL; AY493988; AAR87480.1; -; mRNA.
DR   EMBL; AB451482; BAG70296.1; -; mRNA.
DR   EMBL; AL360011; CAH69967.1; -; Genomic_DNA.
DR   EMBL; AL360011; CAH69968.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50118.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50119.1; -; Genomic_DNA.
DR   EMBL; BC047526; AAH47526.1; -; mRNA.
DR   IPI; IPI00003048; -.
DR   IPI; IPI00015395; -.
DR   IPI; IPI00553192; -.
DR   PIR; A48881; A48881.
DR   RefSeq; NP_000863.1; NM_000872.4.
DR   RefSeq; NP_062873.1; NM_019859.3.
DR   RefSeq; NP_062874.1; NM_019860.3.
DR   UniGene; Hs.73739; -.
DR   ProteinModelPortal; P34969; -.
DR   SMR; P34969; 78-401.
DR   IntAct; P34969; 2.
DR   STRING; P34969; -.
DR   DMDM; 8488960; -.
DR   PRIDE; P34969; -.
DR   Ensembl; ENST00000336152; ENSP00000337949; ENSG00000148680.
DR   GeneID; 3363; -.
DR   KEGG; hsa:3363; -.
DR   UCSC; uc001kgz.3; human.
DR   UCSC; uc001kha.3; human.
DR   CTD; 3363; -.
DR   GeneCards; GC10M092490; -.
DR   H-InvDB; HIX0025953; -.
DR   HGNC; HGNC:5302; HTR7.
DR   HPA; CAB022708; -.
DR   MIM; 182137; gene.
DR   neXtProt; NX_P34969; -.
DR   PharmGKB; PA29561; -.
DR   eggNOG; NOG249628; -.
DR   GeneTree; ENSGT00650000092921; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P34969; -.
DR   KO; K04163; -.
DR   OMA; NSSGRPD; -.
DR   OrthoDB; EOG4F1X37; -.
DR   PhylomeDB; P34969; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB00247; Methysergide.
DR   DrugBank; DB00246; Ziprasidone.
DR   NextBio; 13312; -.
DR   ArrayExpress; P34969; -.
DR   Bgee; P34969; -.
DR   CleanEx; HS_HTR7; -.
DR   Genevestigator; P34969; -.
DR   GermOnline; ENSG00000148680; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0004993; F:serotonin receptor activity; TAS:ProtInc.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0007623; P:circadian rhythm; TAS:ProtInc.
DR   InterPro; IPR001069; 5HT_7_rcpt.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00652; 5HT7RECEPTR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; G-protein coupled receptor; Glycoprotein; Lipoprotein;
KW   Membrane; Palmitate; Polymorphism; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN         1    479       5-hydroxytryptamine receptor 7.
FT                                /FTId=PRO_0000068979.
FT   TOPO_DOM      1     83       Extracellular (By similarity).
FT   TRANSMEM     84    104       Helical; Name=1; (By similarity).
FT   TOPO_DOM    105    117       Cytoplasmic (By similarity).
FT   TRANSMEM    118    138       Helical; Name=2; (By similarity).
FT   TOPO_DOM    139    157       Extracellular (By similarity).
FT   TRANSMEM    158    178       Helical; Name=3; (By similarity).
FT   TOPO_DOM    179    201       Cytoplasmic (By similarity).
FT   TRANSMEM    202    222       Helical; Name=4; (By similarity).
FT   TOPO_DOM    223    236       Extracellular (By similarity).
FT   TRANSMEM    237    257       Helical; Name=5; (By similarity).
FT   TOPO_DOM    258    325       Cytoplasmic (By similarity).
FT   TRANSMEM    326    346       Helical; Name=6; (By similarity).
FT   TOPO_DOM    347    367       Extracellular (By similarity).
FT   TRANSMEM    368    388       Helical; Name=7; (By similarity).
FT   TOPO_DOM    389    479       Cytoplasmic (By similarity).
FT   LIPID       401    401       S-palmitoyl cysteine (Potential).
FT   CARBOHYD      5      5       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     66     66       N-linked (GlcNAc...) (Potential).
FT   DISULFID    155    231       By similarity.
FT   VAR_SEQ     433    479       RACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEK
FT                                KVMIHD -> QNADYCRKKGHDS (in isoform A).
FT                                /FTId=VSP_001857.
FT   VAR_SEQ     433    479       Missing (in isoform B).
FT                                /FTId=VSP_001856.
FT   VARIANT      92     92       T -> K.
FT                                /FTId=VAR_012995.
FT   VARIANT     279    279       P -> L.
FT                                /FTId=VAR_012996.
FT   VARIANT     448    448       P -> Q (in dbSNP:rs33954285).
FT                                /FTId=VAR_049365.
SQ   SEQUENCE   479 AA;  53555 MW;  1F62E985EADE1F23 CRC64;
     MMDVNSSGRP DLYGHLRSFL LPEVGRGLPD LSPDGGADPV AGSWAPHLLS EVTASPAPTW
     DAPPDNASGC GEQINYGRVE KVVIGSILTL ITLLTIAGNC LVVISVCFVK KLRQPSNYLI
     VSLALADLSV AVAVMPFVSV TDLIGGKWIF GHFFCNVFIA MDVMCCTASI MTLCVISIDR
     YLGITRPLTY PVRQNGKCMA KMILSVWLLS ASITLPPLFG WAQNVNDDKV CLISQDFGYT
     IYSTAVAFYI PMSVMLFMYY QIYKAARKSA AKHKFPGFPR VEPDSVIALN GIVKLQKEVE
     ECANLSRLLK HERKNISIFK REQKAATTLG IIVGAFTVCW LPFFLLSTAR PFICGTSCSC
     IPLWVERTFL WLGYANSLIN PFIYAFFNRD LRTTYRSLLQ CQYRNINRKL SAAGMHEALK
     LAERPERPEF VLRACTRRVL LRPEKRPPVS VWVLQSPDHH NWLADKMLTT VEKKVMIHD
//
ID   5NT1A_HUMAN             Reviewed;         368 AA.
AC   Q9BXI3; Q3SYB9; Q5TG98; Q9BWT8;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   22-FEB-2012, entry version 75.
DE   RecName: Full=Cytosolic 5'-nucleotidase 1A;
DE            Short=cN1A;
DE            EC=3.1.3.5;
DE   AltName: Full=Cytosolic 5'-nucleotidase IA;
DE            Short=cN-I;
DE            Short=cN-IA;
GN   Name=NT5C1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   MEDLINE=21167865; PubMed=11133996; DOI=10.1074/jbc.M011218200;
RA   Hunsucker S.A., Spychala J., Mitchell B.S.;
RT   "Human cytosolic 5'-nucleotidase I: characterization and role in
RT   nucleoside analog resistance.";
RL   J. Biol. Chem. 276:10498-10504(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RA   Lowenstein J.M., Huang J., Steiner A.;
RT   "5'-nucleotidase I from human heart.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Dephosphorylates the 5' and 2'(3')-phosphates of
CC       deoxyribonucleotides and has a broad substrate specificity. Helps
CC       to regulate adenosine levels in heart during ischemia and hypoxia.
CC   -!- CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside
CC       + phosphate.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by ADP.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle. Detected
CC       at intermediate levels in heart, brain, kidney and pancreas.
CC   -!- SIMILARITY: Belongs to the 5'-nucleotidase type 3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF331801; AAK01294.1; -; mRNA.
DR   EMBL; AY028778; AAK30000.1; -; mRNA.
DR   EMBL; AL035404; CAI19573.1; -; Genomic_DNA.
DR   EMBL; BC103879; AAI03880.1; -; mRNA.
DR   EMBL; BC103880; AAI03881.1; -; mRNA.
DR   IPI; IPI00000146; -.
DR   RefSeq; NP_115915.1; NM_032526.1.
DR   UniGene; Hs.307006; -.
DR   ProteinModelPortal; Q9BXI3; -.
DR   STRING; Q9BXI3; -.
DR   PhosphoSite; Q9BXI3; -.
DR   DMDM; 47116736; -.
DR   PRIDE; Q9BXI3; -.
DR   Ensembl; ENST00000235628; ENSP00000235628; ENSG00000116981.
DR   GeneID; 84618; -.
DR   KEGG; hsa:84618; -.
DR   UCSC; uc001cdq.1; human.
DR   CTD; 84618; -.
DR   GeneCards; GC01M040154; -.
DR   H-InvDB; HIX0200031; -.
DR   HGNC; HGNC:17819; NT5C1A.
DR   MIM; 610525; gene.
DR   neXtProt; NX_Q9BXI3; -.
DR   PharmGKB; PA31799; -.
DR   eggNOG; NOG46880; -.
DR   GeneTree; ENSGT00390000017767; -.
DR   HOGENOM; HBG350968; -.
DR   HOVERGEN; HBG101325; -.
DR   InParanoid; Q9BXI3; -.
DR   KO; K01081; -.
DR   OMA; LEHENEP; -.
DR   OrthoDB; EOG4PNXHC; -.
DR   PhylomeDB; Q9BXI3; -.
DR   BioCyc; MetaCyc:MONOMER-15168; -.
DR   BRENDA; 3.1.3.5; 2681.
DR   Reactome; REACT_111217; Metabolism.
DR   NextBio; 74492; -.
DR   ArrayExpress; Q9BXI3; -.
DR   Bgee; Q9BXI3; -.
DR   CleanEx; HS_NT5C1A; -.
DR   Genevestigator; Q9BXI3; -.
DR   GermOnline; ENSG00000116981; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; NAS:UniProtKB.
DR   GO; GO:0008253; F:5'-nucleotidase activity; NAS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0006144; P:purine base metabolic process; TAS:Reactome.
DR   GO; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome.
DR   GO; GO:0006206; P:pyrimidine base metabolic process; TAS:Reactome.
DR   GO; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome.
DR   InterPro; IPR010394; 5-nucleotidase.
DR   Pfam; PF06189; 5-nucleotidase; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Cytoplasm; Hydrolase; Magnesium;
KW   Nucleotide metabolism; Nucleotide-binding; Reference proteome.
FT   CHAIN         1    368       Cytosolic 5'-nucleotidase 1A.
FT                                /FTId=PRO_0000144795.
FT   ACT_SITE    211    211       Nucleophile (By similarity).
FT   CONFLICT      9     11       Missing (in Ref. 2; AAK30000).
SQ   SEQUENCE   368 AA;  41021 MW;  7FB3CCEED50BA50D CRC64;
     MEPGQPREPQ EPREPGPGAE TAAAPVWEEA KIFYDNLAPK KKPKSPKPQN AVTIAVSSRA
     LFRMDEEQQI YTEQGVEEYV RYQLEHENEP FSPGPAFPFV KALEAVNRRL RELYPDSEDV
     FDIVLMTNNH AQVGVRLINS INHYDLFIER FCMTGGNSPI CYLKAYHTNL YLSADAEKVR
     EAIDEGIAAA TIFSPSRDVV VSQSQLRVAF DGDAVLFSDE SERIVKAHGL DRFFEHEKAH
     ENKPLAQGPL KGFLEALGRL QKKFYSKGLR LECPIRTYLV TARSAASSGA RALKTLRSWG
     LETDEALFLA GAPKGPLLEK IRPHIFFDDQ MFHVAGAQEM GTVAAHVPYG VAQTPRRTAP
     AKQAPSAQ
//
ID   5NT1B_HUMAN             Reviewed;         610 AA.
AC   Q96P26; B5MCR0; B7ZVX7; Q53RX2; Q8N9W3; Q8NA26; Q96DU5; Q96KE6;
AC   Q96M25; Q96SA3;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   18-APR-2012, entry version 84.
DE   RecName: Full=Cytosolic 5'-nucleotidase 1B;
DE            Short=cN1B;
DE            EC=3.1.3.5;
DE   AltName: Full=Autoimmune infertility-related protein;
DE   AltName: Full=Cytosolic 5'-nucleotidase IB;
DE            Short=cN-IB;
GN   Name=NT5C1B; Synonyms=AIRP; ORFNames=FKSG85;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RA   Setiady Y.Y., Pujianto D.A., Ekowati A.L., Harahap A., Marzuki S.;
RT   "Isolation of a novel human testis cDNA encoding a polypeptide related
RT   to autoimmune infertility.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Ji Y., Mitchell B.S., Spychala J.;
RT   "Homo sapiens cytosolic nucleotidase Ib alpha mRNA.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 312-610.
RA   Wang Y.-G., Gong L.;
RT   "Identification and characterization of FKSG85 which encodes a
RT   nucleotidase protein.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 325-601, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   MEDLINE=21548829; PubMed=11690631; DOI=10.1016/S0167-4781(01)00278-0;
RA   Sala-Newby G.B., Newby A.C.;
RT   "Cloning of a mouse cytosolic 5'-nucleotidase-I identifies a new gene
RT   related to human autoimmune infertility-related protein.";
RL   Biochim. Biophys. Acta 1521:12-18(2001).
CC   -!- FUNCTION: Dephosphorylates the 5' and 2'(3')-phosphates of
CC       deoxyribonucleotides. Helps to regulate adenosine levels (By
CC       similarity).
CC   -!- CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside
CC       + phosphate.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- ENZYME REGULATION: Activated by ADP (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=CN-Ib alpha;
CC         IsoId=Q96P26-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96P26-2; Sequence=VSP_010201;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q96P26-3; Sequence=VSP_010202;
CC         Note=No experimental confirmation available;
CC       Name=4;
CC         IsoId=Q96P26-4; Sequence=VSP_010203;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, placenta and
CC       pancreas. Detected at lower levels in heart, kidney, liver and
CC       lung.
CC   -!- SIMILARITY: Belongs to the 5'-nucleotidase type 3 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK39108.1; Type=Erroneous initiation;
CC       Sequence=AAK83285.1; Type=Frameshift; Positions=320;
CC       Sequence=BAC04103.1; Type=Erroneous initiation;
CC       Sequence=CAC44363.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF356185; AAK39108.1; ALT_INIT; mRNA.
DR   EMBL; AF417165; AAL11910.1; -; mRNA.
DR   EMBL; AK093234; BAC04103.1; ALT_INIT; mRNA.
DR   EMBL; AK093464; BAC04174.1; -; mRNA.
DR   EMBL; AK057444; BAB71489.1; -; mRNA.
DR   EMBL; AC079148; AAX93260.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00853.1; -; Genomic_DNA.
DR   EMBL; BC136387; AAI36388.1; -; mRNA.
DR   EMBL; BC171761; AAI71761.1; -; mRNA.
DR   EMBL; AF352326; AAK83285.1; ALT_FRAME; mRNA.
DR   EMBL; AJ295254; CAC44363.1; ALT_INIT; mRNA.
DR   IPI; IPI00169426; -.
DR   IPI; IPI00410373; -.
DR   IPI; IPI00410375; -.
DR   IPI; IPI00892609; -.
DR   RefSeq; NP_001002006.1; NM_001002006.2.
DR   RefSeq; NP_001186015.1; NM_001199086.1.
DR   RefSeq; NP_001186016.1; NM_001199087.1.
DR   RefSeq; NP_001186017.1; NM_001199088.1.
DR   RefSeq; NP_001186033.1; NM_001199104.1.
DR   RefSeq; NP_150278.2; NM_033253.3.
DR   UniGene; Hs.120319; -.
DR   ProteinModelPortal; Q96P26; -.
DR   STRING; Q96P26; -.
DR   PhosphoSite; Q96P26; -.
DR   DMDM; 47116569; -.
DR   PRIDE; Q96P26; -.
DR   Ensembl; ENST00000359846; ENSP00000352904; ENSG00000185013.
DR   Ensembl; ENST00000403770; ENSP00000384831; ENSG00000185013.
DR   GeneID; 100526794; -.
DR   GeneID; 93034; -.
DR   KEGG; hsa:100526794; -.
DR   KEGG; hsa:93034; -.
DR   UCSC; uc002rcy.3; human.
DR   UCSC; uc002rcz.3; human.
DR   UCSC; uc002rda.3; human.
DR   CTD; 100526794; -.
DR   CTD; 93034; -.
DR   GeneCards; GC02M018744; -.
DR   H-InvDB; HIX0001850; -.
DR   HGNC; HGNC:17818; NT5C1B.
DR   MIM; 610526; gene.
DR   neXtProt; NX_Q96P26; -.
DR   PharmGKB; PA31800; -.
DR   eggNOG; NOG46880; -.
DR   GeneTree; ENSGT00390000017767; -.
DR   HOVERGEN; HBG050426; -.
DR   InParanoid; Q96P26; -.
DR   KO; K01081; -.
DR   OrthoDB; EOG44XJGN; -.
DR   PhylomeDB; Q96P26; -.
DR   Reactome; REACT_111217; Metabolism.
DR   NextBio; 77947; -.
DR   ArrayExpress; Q96P26; -.
DR   Bgee; Q96P26; -.
DR   CleanEx; HS_NT5C1B; -.
DR   Genevestigator; Q96P26; -.
DR   GermOnline; ENSG00000185013; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0008253; F:5'-nucleotidase activity; IEA:EC.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0006144; P:purine base metabolic process; TAS:Reactome.
DR   GO; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome.
DR   InterPro; IPR010394; 5-nucleotidase.
DR   Pfam; PF06189; 5-nucleotidase; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Cytoplasm; Hydrolase;
KW   Magnesium; Nucleotide metabolism; Reference proteome.
FT   CHAIN         1    610       Cytosolic 5'-nucleotidase 1B.
FT                                /FTId=PRO_0000144796.
FT   COMPBIAS    102    176       Ser-rich.
FT   COMPBIAS    157    201       Pro-rich.
FT   COMPBIAS    267    271       Poly-Gln.
FT   ACT_SITE    467    467       Nucleophile (By similarity).
FT   VAR_SEQ       1    208       Missing (in isoform 3).
FT                                /FTId=VSP_010202.
FT   VAR_SEQ      41    100       Missing (in isoform 2).
FT                                /FTId=VSP_010201.
FT   VAR_SEQ     596    610       LGSIAAYGFNKKFSS -> KSLGWMS (in isoform
FT                                4).
FT                                /FTId=VSP_010203.
FT   CONFLICT    173    173       G -> R (in Ref. 2; AAL11910).
FT   CONFLICT    287    287       R -> K (in Ref. 1; AAK39108).
FT   CONFLICT    297    297       S -> W (in Ref. 1; AAK39108).
FT   CONFLICT    351    351       P -> Q (in Ref. 2; AAL11910).
FT   CONFLICT    362    362       V -> I (in Ref. 3; BAC04174).
FT   CONFLICT    528    528       L -> P (in Ref. 8; CAC44363).
FT   CONFLICT    552    552       L -> F (in Ref. 1; AAK39108).
SQ   SEQUENCE   610 AA;  68804 MW;  EEC0BE9E5498B3E9 CRC64;
     MSQTSLKQKK NEPGMRSSKE SLEAEKRKES DKTGVRLSNQ MRRAVNPNHS LRCCPFQGHS
     SCRRCLCAAE GTALGPCHTI RIYIHMCLLW EQGQQITMMR GSQESSLRKT DSRGYLVRSQ
     WSRISRSPST KAPSIDEPRS RNTSAKLPSS STSSRTPSTS PSLHDSSPPP LSGQPSLQPP
     ASPQLPRSLD SRPPTPPEPD PGSRRSTKMQ ENPEAWAQGI VREIRQTRDS QPLEYSRTSP
     TEWKSSSQRR GIYPASTQLD RNSLSEQQQQ QREDEDDYEA AYWASMRSFY EKNPSCSRPW
     PPKPKNAITI ALSSCALFNM VDGRKIYEQE GLEKYMEYQL TNENVILTPG PAFRFVKALQ
     YVNARLRDLY PDEQDLFDIV LMTNNHAQVG VRLINSVNHY GLLIDRFCLT GGKDPIGYLK
     AYLTNLYIAA DSEKVQEAIQ EGIASATMFD GAKDMAYCDT QLRVAFDGDA VLFSDESEHF
     TKEHGLDKFF QYDTLCESKP LAQGPLKGFL EDLGRLQKKF YAKNERLLCP IRTYLVTARS
     AASSGARVLK TLRRWGLEID EALFLAGAPK SPILVKIRPH IFFDDHMFHI EGAQRLGSIA
     AYGFNKKFSS
//
ID   5NT3L_HUMAN             Reviewed;         292 AA.
AC   Q969T7; A8MWB9; Q7L3B7;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   18-APR-2012, entry version 86.
DE   RecName: Full=Cytosolic 5'-nucleotidase III-like protein;
DE            Short=cN-III-like protein;
DE            EC=3.1.3.5;
GN   Name=NT5C3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS VAL-201
RP   AND CYS-205.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-201 AND
RP   CYS-205.
RC   TISSUE=Liver, Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-248, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Can act both as nucleotidase and as phosphotransferase
CC       (By similarity).
CC   -!- CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside
CC       + phosphate.
CC   -!- INTERACTION:
CC       P40692:MLH1; NbExp=3; IntAct=EBI-2932564, EBI-744248;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Potential).
CC   -!- SIMILARITY: Belongs to the pyrimidine 5'-nucleotidase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC091172; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471152; EAW60771.1; -; Genomic_DNA.
DR   EMBL; BC013742; AAH13742.2; -; mRNA.
DR   EMBL; BC014132; AAH14132.2; -; mRNA.
DR   EMBL; BC016971; AAH16971.2; -; mRNA.
DR   EMBL; BC067788; AAH67788.1; -; mRNA.
DR   IPI; IPI00056505; -.
DR   UniGene; Hs.237536; -.
DR   HSSP; Q9UC45; 2CN1.
DR   ProteinModelPortal; Q969T7; -.
DR   SMR; Q969T7; 1-281.
DR   IntAct; Q969T7; 1.
DR   STRING; Q969T7; -.
DR   PhosphoSite; Q969T7; -.
DR   DMDM; 296439454; -.
DR   PRIDE; Q969T7; -.
DR   Ensembl; ENST00000269534; ENSP00000269534; ENSG00000141698.
DR   Ensembl; ENST00000393911; ENSP00000377488; ENSG00000141698.
DR   UCSC; uc002hxy.4; human.
DR   GeneCards; GC17M039981; -.
DR   HGNC; HGNC:28300; NT5C3L.
DR   HPA; HPA030786; -.
DR   neXtProt; NX_Q969T7; -.
DR   eggNOG; NOG266578; -.
DR   GeneTree; ENSGT00390000012959; -.
DR   HOGENOM; HBG382723; -.
DR   HOVERGEN; HBG059750; -.
DR   InParanoid; Q969T7; -.
DR   OMA; QLQGKTN; -.
DR   OrthoDB; EOG4JWVDW; -.
DR   PhylomeDB; Q969T7; -.
DR   NextBio; 79498; -.
DR   ArrayExpress; Q969T7; -.
DR   Bgee; Q969T7; -.
DR   CleanEx; HS_NT5C3L; -.
DR   Genevestigator; Q969T7; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0008253; F:5'-nucleotidase activity; IEA:EC.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:3.40.50.1000; HAD-like_dom; 1.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006434; Pyrimidine_nucleotidase_eu.
DR   PANTHER; PTHR13045; HAD-SF_hydro_IE; 1.
DR   Pfam; PF05822; UMPH-1; 1.
DR   SUPFAM; SSF56784; HAD-like_dom; 1.
DR   TIGRFAMs; TIGR01544; HAD-SF-IE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Cytoplasm; Hydrolase; Magnesium;
KW   Metal-binding; Nucleotide metabolism; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    292       Cytosolic 5'-nucleotidase III-like
FT                                protein.
FT                                /FTId=PRO_0000328948.
FT   REGION      148    149       Substrate binding (By similarity).
FT   ACT_SITE     33     33       Nucleophile (By similarity).
FT   ACT_SITE     35     35       Proton donor (By similarity).
FT   METAL        33     33       Magnesium (By similarity).
FT   METAL        35     35       Magnesium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       222    222       Magnesium (By similarity).
FT   BINDING     197    197       Substrate (By similarity).
FT   MOD_RES     248    248       N6-acetyllysine.
FT   VARIANT     201    201       A -> V (in dbSNP:rs1046403).
FT                                /FTId=VAR_042582.
FT   VARIANT     205    205       S -> C (in dbSNP:rs1046404).
FT                                /FTId=VAR_042583.
SQ   SEQUENCE   292 AA;  33528 MW;  8ACC59D5F25E629A CRC64;
     MKATVLMRQP GRVQEIVGAL RKGGGDRLQV ISDFDMTLSR FAYNGKRCPS SYNILDNSKI
     ISEECRKELT ALLHHYYPIE IDPHRTVKEK LPHMVEWWTK AHNLLCQQKI QKFQIAQVVR
     ESNAMLREGY KTFFNTLYHN NIPLFIFSAG IGDILEEIIR QMKVFHPNIH IVSNYMDFNE
     DGFLQGFKGQ LIHTYNKNSS ACENSGYFQQ LEGKTNVILL GDSIGDLTMA DGVPGVQNIL
     KIGFLNDKVE ERRERYMDSY DIVLEKDETL DVVNGLLQHI LCQGVQLEMQ GP
//
ID   5NT3_HUMAN              Reviewed;         336 AA.
AC   Q9H0P0; A8K253; B2RAA5; B8ZZC4; Q6IPZ1; Q6NXS6; Q7L3G6; Q9P0P5;
AC   Q9UC42; Q9UC43; Q9UC44; Q9UC45;
DT   13-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 3.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=Cytosolic 5'-nucleotidase 3;
DE            EC=3.1.3.5;
DE   AltName: Full=Cytosolic 5'-nucleotidase III;
DE            Short=cN-III;
DE   AltName: Full=Pyrimidine 5'-nucleotidase 1;
DE            Short=P5'N-1;
DE            Short=P5N-1;
DE            Short=PN-I;
DE   AltName: Full=Uridine 5'-monophosphate hydrolase 1;
DE   AltName: Full=p36;
GN   Name=NT5C3; Synonyms=P5N1, UMPH1; ORFNames=HSPC233;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Placenta;
RX   MEDLINE=20400029; PubMed=10942414;
RA   Amici A., Emanuelli M., Raffaelli N., Ruggieri S., Saccucci F.,
RA   Magni G.;
RT   "Human erythrocyte pyrimidine 5'-nucleotidase, PN-I, is identical to
RT   p36, a protein associated to lupus inclusion formation in response to
RT   alpha-interferon.";
RL   Blood 96:1596-1598(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), TISSUE SPECIFICITY, AND
RP   VARIANT P5N DEFICIENCY VAL-137.
RX   PubMed=11369620; DOI=10.1182/blood.V97.11.3327;
RA   Marinaki A.M., Escuredo E., Duley J.A., Simmonds H.A., Amici A.,
RA   Naponelli V., Magni G., Seip M., Ben-Bassat I., Harley E.H.,
RA   Thein S.L., Rees D.C.;
RT   "Genetic basis of hemolytic anemia caused by pyrimidine 5'
RT   nucleotidase deficiency.";
RL   Blood 97:3327-3332(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), TISSUE SPECIFICITY, VARIANTS
RP   P5N DEFICIENCY PRO-181 AND ARG-280, AND CHARACTERIZATION OF VARIANTS
RP   P5N DEFICIENCY PRO-181 AND ARG-280.
RX   PubMed=15238149; DOI=10.1111/j.1365-2141.2004.05029.x;
RA   Kanno H., Takizawa T., Miwa S., Fujii H.;
RT   "Molecular basis of Japanese variants of pyrimidine 5'-nucleotidase
RT   deficiency.";
RL   Br. J. Haematol. 126:265-271(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   MEDLINE=21154917; PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain cortex, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Lung, Muscle, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 29-336 (ISOFORM 2).
RC   TISSUE=Umbilical cord blood;
RX   MEDLINE=20499367; PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [11]
RP   PROTEIN SEQUENCE OF 83-95; 131-147; 226-240; 268-296 AND 311-329,
RP   INDUCTION, AND SUBCELLULAR LOCATION.
RX   MEDLINE=96132854; PubMed=8557639; DOI=10.1074/jbc.271.20.11595;
RA   Rich S.A., Bose M., Tempst P., Rudofsky U.H.;
RT   "Purification, microsequencing, and immunolocalization of p36, a new
RT   interferon-alpha-induced protein that is associated with human lupus
RT   inclusions.";
RL   J. Biol. Chem. 271:1118-1126(1996).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-11, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES,
RP   CHARACTERIZATION OF VARIANTS P5N DEFICIENCY VAL-137; PRO-181; SER-229
RP   AND ARG-280, AND MUTAGENESIS OF ASP-88; PHE-89; ASP-90; GLU-135 AND
RP   PHE-233.
RX   PubMed=15968458; DOI=10.1007/s00018-005-5135-y;
RA   Amici A., Ciccioli K., Naponelli V., Raffaelli N., Magni G.;
RT   "Evidence for essential catalytic determinants for human erythrocyte
RT   pyrimidine 5'-nucleotidase.";
RL   Cell. Mol. Life Sci. 62:1613-1620(2005).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.67 ANGSTROMS) OF 64-336 IN COMPLEX WITH
RP   PHOSPHATE AND MAGNESIUM IONS.
RX   PubMed=17405878; DOI=10.1074/jbc.M700917200;
RA   Wallden K., Stenmark P., Nyman T., Flodin S., Graeslund S.,
RA   Loppnau P., Bianchi V., Nordlund P.;
RT   "Crystal structure of human cytosolic 5'-nucleotidase II: insights
RT   into allosteric regulation and substrate recognition.";
RL   J. Biol. Chem. 282:17828-17836(2007).
RN   [15]
RP   VARIANT P5N DEFICIENCY SER-229.
RX   PubMed=12930399; DOI=10.1046/j.1365-2141.2003.04532.x;
RA   Bianchi P., Fermo E., Alfinito F., Vercellati C., Baserga M.,
RA   Ferraro F., Guzzo I., Rotoli B., Zanella A.;
RT   "Molecular characterization of six unrelated Italian patients affected
RT   by pyrimidine 5'-nucleotidase deficiency.";
RL   Br. J. Haematol. 122:847-851(2003).
CC   -!- FUNCTION: Can act both as nucleotidase and as phosphotransferase.
CC   -!- CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside
CC       + phosphate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=66 uM for CMP;
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Potential).
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=2;
CC         IsoId=Q9H0P0-4; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q9H0P0-1; Sequence=VSP_021565;
CC       Name=3;
CC         IsoId=Q9H0P0-2; Sequence=VSP_015623;
CC       Name=4; Synonyms=P5N-R;
CC         IsoId=Q9H0P0-3; Sequence=VSP_015624;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 3 are expressed in
CC       reticulocytes and lymphocytes. Isoform 4 is expressed only in
CC       reticulocytes.
CC   -!- INDUCTION: Isoform 2 is induced by interferon alpha in Raji cells
CC       in association with lupus inclusions.
CC   -!- DISEASE: Defects in NT5C3 are the cause of P5N deficiency (P5ND)
CC       [MIM:266120]; also called hemolytic anemia due to P5N deficiency
CC       or hemolytic anemia due to UMPH1 deficiency. P5ND is an autosomal
CC       recessive condition causing hemolytic anemia characterized by
CC       marked basophilic stipplig and the accumulation of high
CC       concentrations of pyrimidine nucleotides within the erythrocyte.
CC       It is implicated in the anemia of lead poisoning and is possibly
CC       associated with learning difficulties.
CC   -!- SIMILARITY: Belongs to the pyrimidine 5'-nucleotidase family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF36153.1; Type=Erroneous initiation;
CC       Sequence=AAG33630.1; Type=Frameshift; Positions=Several;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF312735; AAG33630.1; ALT_SEQ; mRNA.
DR   EMBL; AL136716; CAB66650.1; -; mRNA.
DR   EMBL; AK290118; BAF82807.1; -; mRNA.
DR   EMBL; AK314109; BAG36802.1; -; mRNA.
DR   EMBL; CR533518; CAG38549.1; -; mRNA.
DR   EMBL; AC074338; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW94007.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW94008.1; -; Genomic_DNA.
DR   EMBL; BC013292; AAH13292.2; -; mRNA.
DR   EMBL; BC015856; AAH15856.2; -; mRNA.
DR   EMBL; BC066914; AAH66914.1; -; mRNA.
DR   EMBL; BC071652; AAH71652.2; -; mRNA.
DR   EMBL; AF151067; AAF36153.1; ALT_INIT; mRNA.
DR   IPI; IPI00100192; -.
DR   IPI; IPI00619911; -.
DR   IPI; IPI00647805; -.
DR   IPI; IPI00807412; -.
DR   RefSeq; NP_001002010.1; NM_001002010.1.
DR   RefSeq; NP_001159590.1; NM_001166118.1.
DR   RefSeq; NP_057573.2; NM_016489.11.
DR   UniGene; Hs.487933; -.
DR   PDB; 2CN1; X-ray; 2.67 A; A=64-336.
DR   PDB; 2JGA; X-ray; 3.01 A; A=64-336.
DR   PDB; 2VKQ; X-ray; 2.50 A; A=64-336.
DR   PDBsum; 2CN1; -.
DR   PDBsum; 2JGA; -.
DR   PDBsum; 2VKQ; -.
DR   ProteinModelPortal; Q9H0P0; -.
DR   SMR; Q9H0P0; 64-336.
DR   IntAct; Q9H0P0; 3.
DR   STRING; Q9H0P0; -.
DR   PhosphoSite; Q9H0P0; -.
DR   DMDM; 117949804; -.
DR   PRIDE; Q9H0P0; -.
DR   DNASU; 51251; -.
DR   Ensembl; ENST00000242210; ENSP00000242210; ENSG00000122643.
DR   GeneID; 51251; -.
DR   KEGG; hsa:51251; -.
DR   UCSC; uc003tdi.3; human.
DR   UCSC; uc003tdk.3; human.
DR   CTD; 51251; -.
DR   GeneCards; GC07M033053; -.
DR   HGNC; HGNC:17820; NT5C3.
DR   HPA; HPA029058; -.
DR   MIM; 266120; phenotype.
DR   MIM; 606224; gene.
DR   neXtProt; NX_Q9H0P0; -.
DR   Orphanet; 35120; Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency.
DR   PharmGKB; PA31802; -.
DR   eggNOG; NOG266578; -.
DR   GeneTree; ENSGT00390000012959; -.
DR   HOVERGEN; HBG059750; -.
DR   InParanoid; Q9H0P0; -.
DR   KO; K01081; -.
DR   OMA; NTEYFKQ; -.
DR   PhylomeDB; Q9H0P0; -.
DR   Reactome; REACT_111217; Metabolism.
DR   EvolutionaryTrace; Q9H0P0; -.
DR   NextBio; 54391; -.
DR   ArrayExpress; Q9H0P0; -.
DR   Bgee; Q9H0P0; -.
DR   Genevestigator; Q9H0P0; -.
DR   GermOnline; ENSG00000122643; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0008665; F:2'-phosphotransferase activity; NAS:UniProtKB.
DR   GO; GO:0008253; F:5'-nucleotidase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; NAS:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006206; P:pyrimidine base metabolic process; TAS:Reactome.
DR   GO; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome.
DR   Gene3D; G3DSA:3.40.50.1000; HAD-like_dom; 1.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006434; Pyrimidine_nucleotidase_eu.
DR   PANTHER; PTHR13045; HAD-SF_hydro_IE; 1.
DR   Pfam; PF05822; UMPH-1; 1.
DR   SUPFAM; SSF56784; HAD-like_dom; 1.
DR   TIGRFAMs; TIGR01544; HAD-SF-IE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Endoplasmic reticulum;
KW   Hydrolase; Magnesium; Metal-binding; Nucleotide metabolism;
KW   Nucleotide-binding; Reference proteome; Transferase.
FT   CHAIN         1    336       Cytosolic 5'-nucleotidase 3.
FT                                /FTId=PRO_0000064387.
FT   REGION      203    204       Substrate binding.
FT   ACT_SITE     88     88       Nucleophile.
FT   ACT_SITE     90     90       Proton donor.
FT   METAL        88     88       Magnesium.
FT   METAL        90     90       Magnesium; via carbonyl oxygen.
FT   METAL       277    277       Magnesium.
FT   BINDING     252    252       Substrate.
FT   VAR_SEQ       1     51       Missing (in isoform 4).
FT                                /FTId=VSP_015624.
FT   VAR_SEQ       1     50       MRAPSMDRAAVARVGAVASASVCALVAGVVLAQYIFTLKRK
FT                                TGRKTKIIE -> MTNQESAVHVK (in isoform 1).
FT                                /FTId=VSP_021565.
FT   VAR_SEQ       1     50       Missing (in isoform 3).
FT                                /FTId=VSP_015623.
FT   VARIANT     137    137       D -> V (in P5N deficiency; may alter
FT                                protein structure).
FT                                /FTId=VAR_023511.
FT   VARIANT     181    181       L -> P (in P5N deficiency; may alter
FT                                protein structure and markedly decreases
FT                                activity).
FT                                /FTId=VAR_023512.
FT   VARIANT     229    229       N -> S (in P5N deficiency; markedly
FT                                decreases activity).
FT                                /FTId=VAR_023513.
FT   VARIANT     280    280       G -> R (in P5N deficiency; markedly
FT                                decreases activity).
FT                                /FTId=VAR_023514.
FT   MUTAGEN      88     88       D->N: Loss of nucleotidase and
FT                                phosphotransferase activity.
FT   MUTAGEN      89     89       F->A: Increases Km for CMP 45-fold.
FT                                Reduces nucleotidase and
FT                                phosphotransferase activity by 99%.
FT   MUTAGEN      90     90       D->N: Loss of nucleotidase and
FT                                phosphotransferase activity.
FT   MUTAGEN     135    135       E->D: No effect on nucleotidase activity.
FT                                Reduces phosphotransferase activity by
FT                                99%.
FT   MUTAGEN     233    233       F->A: Reduces nucleotidase and
FT                                phosphotransferase activity by 97%.
FT   CONFLICT     95     95       R -> K (in Ref. 11; AA sequence).
FT   CONFLICT    144    144       E -> Q (in Ref. 11; AA sequence).
FT   CONFLICT    329    329       N -> R (in Ref. 11; AA sequence).
FT   HELIX        65     78
FT   HELIX        80     82
FT   STRAND       83     87
FT   TURN         90     93
FT   STRAND       96     98
FT   HELIX       106    111
FT   HELIX       118    135
FT   STRAND      138    140
FT   HELIX       142    162
FT   HELIX       167    169
FT   HELIX       170    175
FT   HELIX       185    193
FT   TURN        194    196
FT   STRAND      199    206
FT   HELIX       207    216
FT   STRAND      224    229
FT   STRAND      231    233
FT   STRAND      237    242
FT   HELIX       252    257
FT   HELIX       260    264
FT   TURN        265    268
FT   STRAND      271    279
FT   HELIX       280    283
FT   TURN        284    287
FT   STRAND      292    300
FT   HELIX       304    312
FT   STRAND      315    320
FT   HELIX       326    335
SQ   SEQUENCE   336 AA;  37948 MW;  C5D75CCF1BB61021 CRC64;
     MRAPSMDRAA VARVGAVASA SVCALVAGVV LAQYIFTLKR KTGRKTKIIE MMPEFQKSSV
     RIKNPTRVEE IICGLIKGGA AKLQIITDFD MTLSRFSYKG KRCPTCHNII DNCKLVTDEC
     RKKLLQLKEK YYAIEVDPVL TVEEKYPYMV EWYTKSHGLL VQQALPKAKL KEIVAESDVM
     LKEGYENFFD KLQQHSIPVF IFSAGIGDVL EEVIRQAGVY HPNVKVVSNF MDFDETGVLK
     GFKGELIHVF NKHDGALRNT EYFNQLKDNS NIILLGDSQG DLRMADGVAN VEHILKIGYL
     NDRVDELLEK YMDSYDIVLV QDESLEVANS ILQKIL
//
ID   5NTC_HUMAN              Reviewed;         561 AA.
AC   P49902; D3DR91; Q5JUV5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   18-APR-2012, entry version 115.
DE   RecName: Full=Cytosolic purine 5'-nucleotidase;
DE            EC=3.1.3.5;
DE   AltName: Full=Cytosolic 5'-nucleotidase II;
GN   Name=NT5C2; Synonyms=NT5B, NT5CP, PNT5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=95091838; PubMed=7999131; DOI=10.1006/bbrc.1994.2752;
RA   Oka J., Matsumoto A., Hosokawa Y., Inoue S.;
RT   "Molecular cloning of human cytosolic purine 5'-nucleotidase.";
RL   Biochem. Biophys. Res. Commun. 205:917-922(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-3.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 1-536 IN COMPLEX WITH
RP   ALLOSTERIC EFFECTOR AND MAGNESIUM IONS, AND SUBUNIT.
RX   PubMed=17405878; DOI=10.1074/jbc.M700917200;
RA   Wallden K., Stenmark P., Nyman T., Flodin S., Graeslund S.,
RA   Loppnau P., Bianchi V., Nordlund P.;
RT   "Crystal structure of human cytosolic 5'-nucleotidase II: insights
RT   into allosteric regulation and substrate recognition.";
RL   J. Biol. Chem. 282:17828-17836(2007).
CC   -!- FUNCTION: May have a critical role in the maintenance of a
CC       constant composition of intracellular purine/pyrimidine
CC       nucleotides in cooperation with other nucleotidases.
CC       Preferentially hydrolyzes inosine 5'-monophosphate (IMP) and other
CC       purine nucleotides.
CC   -!- CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside
CC       + phosphate.
CC   -!- COFACTOR: Binds 1 magnesium ion per subunit.
CC   -!- ENZYME REGULATION: Allosterically activated by various compounds,
CC       including ATP.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- INTERACTION:
CC       P51116:FXR2; NbExp=3; IntAct=EBI-742084, EBI-740459;
CC       Q86TA1:MOB3B; NbExp=3; IntAct=EBI-742084, EBI-751703;
CC       Q6ZVK8:NUDT18; NbExp=3; IntAct=EBI-742084, EBI-740486;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the 5'(3')-deoxyribonucleotidase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D38524; BAA07529.1; -; mRNA.
DR   EMBL; AL139817; CAI40080.1; -; Genomic_DNA.
DR   EMBL; AL360001; CAI40080.1; JOINED; Genomic_DNA.
DR   EMBL; AL360001; CAI13473.1; -; Genomic_DNA.
DR   EMBL; AL139817; CAI13473.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW49656.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49657.1; -; Genomic_DNA.
DR   EMBL; BC001595; AAH01595.1; -; mRNA.
DR   IPI; IPI00029054; -.
DR   PIR; JC2436; JC2436.
DR   RefSeq; NP_001127845.1; NM_001134373.2.
DR   RefSeq; NP_036361.1; NM_012229.4.
DR   UniGene; Hs.97439; -.
DR   PDB; 2J2C; X-ray; 2.20 A; A=1-536.
DR   PDB; 2JC9; X-ray; 1.50 A; A=1-536.
DR   PDB; 2JCM; X-ray; 2.15 A; A=1-536.
DR   PDB; 2XCV; X-ray; 2.30 A; A=1-536.
DR   PDB; 2XCW; X-ray; 1.90 A; A=1-536.
DR   PDB; 2XCX; X-ray; 2.30 A; A=1-536.
DR   PDB; 2XJB; X-ray; 2.30 A; A=1-536.
DR   PDB; 2XJC; X-ray; 2.00 A; A=1-536.
DR   PDB; 2XJD; X-ray; 2.00 A; A=1-536.
DR   PDB; 2XJE; X-ray; 2.30 A; A=1-536.
DR   PDB; 2XJF; X-ray; 2.10 A; A=1-536.
DR   PDBsum; 2J2C; -.
DR   PDBsum; 2JC9; -.
DR   PDBsum; 2JCM; -.
DR   PDBsum; 2XCV; -.
DR   PDBsum; 2XCW; -.
DR   PDBsum; 2XCX; -.
DR   PDBsum; 2XJB; -.
DR   PDBsum; 2XJC; -.
DR   PDBsum; 2XJD; -.
DR   PDBsum; 2XJE; -.
DR   PDBsum; 2XJF; -.
DR   ProteinModelPortal; P49902; -.
DR   SMR; P49902; 3-488.
DR   IntAct; P49902; 6.
DR   MINT; MINT-1436872; -.
DR   STRING; P49902; -.
DR   PhosphoSite; P49902; -.
DR   DMDM; 1703012; -.
DR   PeptideAtlas; P49902; -.
DR   PRIDE; P49902; -.
DR   DNASU; 22978; -.
DR   Ensembl; ENST00000343289; ENSP00000339479; ENSG00000076685.
DR   Ensembl; ENST00000404739; ENSP00000383960; ENSG00000076685.
DR   GeneID; 22978; -.
DR   KEGG; hsa:22978; -.
DR   UCSC; uc001kwo.3; human.
DR   CTD; 22978; -.
DR   GeneCards; GC10M104837; -.
DR   H-InvDB; HIX0009172; -.
DR   HGNC; HGNC:8022; NT5C2.
DR   HPA; HPA003751; -.
DR   MIM; 600417; gene.
DR   neXtProt; NX_P49902; -.
DR   PharmGKB; PA31801; -.
DR   eggNOG; NOG75103; -.
DR   GeneTree; ENSGT00550000074539; -.
DR   HOGENOM; HBG506335; -.
DR   HOVERGEN; HBG000025; -.
DR   InParanoid; P49902; -.
DR   KO; K01081; -.
DR   OMA; WERVFRA; -.
DR   OrthoDB; EOG4MGS72; -.
DR   PhylomeDB; P49902; -.
DR   BioCyc; MetaCyc:MONOMER-15169; -.
DR   BRENDA; 3.1.3.5; 2681.
DR   Reactome; REACT_111217; Metabolism.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB00811; Ribavirin.
DR   EvolutionaryTrace; P49902; -.
DR   NextBio; 43793; -.
DR   ArrayExpress; P49902; -.
DR   Bgee; P49902; -.
DR   CleanEx; HS_NT5C2; -.
DR   Genevestigator; P49902; -.
DR   GermOnline; ENSG00000076685; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0008253; F:5'-nucleotidase activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0006144; P:purine base metabolic process; TAS:Reactome.
DR   GO; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR008380; HAD-SF_hydro_IG_5-nucl.
DR   InterPro; IPR016695; Pur_nucleotidase.
DR   PANTHER; PTHR12103; HAD-SF_hydro_IG_5-nucl; 1.
DR   Pfam; PF05761; 5_nucleotid; 1.
DR   PIRSF; PIRSF017434; Purine_5'-nucleotidase; 1.
DR   SUPFAM; SSF56784; HAD-like_dom; 1.
DR   TIGRFAMs; TIGR02244; HAD-IG-Ncltidse; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Complete proteome; Cytoplasm;
KW   Hydrolase; Magnesium; Metal-binding; Nucleotide metabolism;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    561       Cytosolic purine 5'-nucleotidase.
FT                                /FTId=PRO_0000064389.
FT   REGION      202    210       Substrate binding (Potential).
FT   COMPBIAS    549    561       Asp/Glu-rich (acidic).
FT   ACT_SITE     52     52       Nucleophile.
FT   ACT_SITE     54     54       Proton donor.
FT   METAL        52     52       Magnesium.
FT   METAL        54     54       Magnesium; via carbonyl oxygen.
FT   METAL       351    351       Magnesium.
FT   BINDING     127    127       Allosteric activator 1.
FT   BINDING     154    154       Allosteric activator 2.
FT   BINDING     354    354       Allosteric activator 2.
FT   BINDING     436    436       Allosteric activator 1; via carbonyl
FT                                oxygen.
FT   BINDING     453    453       Allosteric activator 2.
FT   MOD_RES     502    502       Phosphoserine.
FT   MOD_RES     527    527       Phosphoserine (By similarity).
FT   VARIANT       3      3       T -> A (in dbSNP:rs10883841).
FT                                /FTId=VAR_024244.
FT   VARIANT     136    136       Q -> R (in dbSNP:rs12262171).
FT                                /FTId=VAR_030242.
FT   HELIX         5     13
FT   HELIX        21     29
FT   HELIX        31     33
FT   STRAND       36     39
FT   HELIX        43     45
FT   STRAND       48     51
FT   TURN         55     57
FT   HELIX        64     79
FT   HELIX        84     88
FT   STRAND      101    103
FT   TURN        104    107
FT   STRAND      108    112
FT   STRAND      117    123
FT   HELIX       130    133
FT   TURN        134    136
FT   TURN        147    149
FT   STRAND      150    152
FT   HELIX       156    158
FT   HELIX       159    174
FT   STRAND      178    180
FT   STRAND      182    187
FT   STRAND      190    193
FT   HELIX       194    210
FT   HELIX       214    219
FT   HELIX       222    225
FT   HELIX       231    242
FT   STRAND      243    248
FT   HELIX       253    263
FT   STRAND      266    271
FT   HELIX       279    282
FT   STRAND      284    289
FT   HELIX       294    296
FT   STRAND      302    305
FT   TURN        307    309
FT   STRAND      314    317
FT   STRAND      327    329
FT   HELIX       332    339
FT   HELIX       343    345
FT   STRAND      346    351
FT   HELIX       353    357
FT   HELIX       358    364
FT   STRAND      367    371
FT   HELIX       375    384
FT   HELIX       386    399
FT   HELIX       418    432
FT   STRAND      440    443
FT   HELIX       449    457
FT   STRAND      459    463
FT   HELIX       465    470
FT   HELIX       485    487
SQ   SEQUENCE   561 AA;  64970 MW;  4C27D762575E0EA2 CRC64;
     MSTSWSDRLQ NAADMPANMD KHALKKYRRE AYHRVFVNRS LAMEKIKCFG FDMDYTLAVY
     KSPEYESLGF ELTVERLVSI GYPQELLSFA YDSTFPTRGL VFDTLYGNLL KVDAYGNLLV
     CAHGFNFIRG PETREQYPNK FIQRDDTERF YILNTLFNLP ETYLLACLVD FFTNCPRYTS
     CETGFKDGDL FMSYRSMFQD VRDAVDWVHY KGSLKEKTVE NLEKYVVKDG KLPLLLSRMK
     EVGKVFLATN SDYKYTDKIM TYLFDFPHGP KPGSSHRPWQ SYFDLILVDA RKPLFFGEGT
     VLRQVDTKTG KLKIGTYTGP LQHGIVYSGG SSDTICDLLG AKGKDILYIG DHIFGDILKS
     KKRQGWRTFL VIPELAQELH VWTDKSSLFE ELQSLDIFLA ELYKHLDSSS NERPDISSIQ
     RRIKKVTHDM DMCYGMMGSL FRSGSRQTLF ASQVMRYADL YAASFINLLY YPFSYLFRAA
     HVLMPHESTV EHTHVDINEM ESPLATRNRT SVDFKDTDYK RHQLTRSISE IKPPNLFPLA
     PQEITHCHDE DDDEEEEEEE E
//
ID   5NTD_HUMAN              Reviewed;         574 AA.
AC   P21589; B3KQI8; O75520; Q5W116;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 1.
DT   18-APR-2012, entry version 132.
DE   RecName: Full=5'-nucleotidase;
DE            Short=5'-NT;
DE            EC=3.1.3.5;
DE   AltName: Full=Ecto-5'-nucleotidase;
DE   AltName: CD_antigen=CD73;
DE   Flags: Precursor;
GN   Name=NT5E; Synonyms=NT5, NTE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   GPI-ANCHOR AT SER-549.
RC   TISSUE=Placenta;
RX   MEDLINE=90361037; PubMed=2129526;
RX   DOI=10.1111/j.1432-1033.1990.tb19158.x;
RA   Misumi Y., Ogata S., Ohkubo K., Hirose S., Ikehara Y.;
RT   "Primary structure of human placental 5'-nucleotidase and
RT   identification of the glycolipid anchor in the mature form.";
RL   Eur. J. Biochem. 191:563-569(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-113.
RC   TISSUE=Placenta;
RX   MEDLINE=96144293; PubMed=8566797; DOI=10.1016/0378-1119(95)00574-9;
RA   Hansen K.R., Resta R., Webb C.F., Thompson L.F.;
RT   "Isolation and characterization of the promoter of the human 5'-
RT   nucleotidase (CD73)-encoding gene.";
RL   Gene 167:307-312(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 359-489, AND VARIANT ALA-376.
RC   TISSUE=Leukocyte;
RA   Zanoni L., Rosi F., Pagani R., Marinello E.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 27-40.
RC   TISSUE=Placenta;
RX   MEDLINE=91058583; PubMed=2173922; DOI=10.1016/0006-291X(90)91601-N;
RA   Klemens M.R., Sherman W.R., Holmberg N.J., Ruedi J.M., Low M.G.,
RA   Thompson L.F.;
RT   "Characterization of soluble vs membrane-bound human placental 5'-
RT   nucleotidase.";
RL   Biochem. Biophys. Res. Commun. 172:1371-1377(1990).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-311; ASN-333 AND ASN-403,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-333, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [9]
RP   VARIANT CALJA TYR-358.
RX   PubMed=21288095; DOI=10.1056/NEJMoa0912923;
RA   St Hilaire C., Ziegler S.G., Markello T.C., Brusco A., Groden C.,
RA   Gill F., Carlson-Donohoe H., Lederman R.J., Chen M.Y., Yang D.,
RA   Siegenthaler M.P., Arduino C., Mancini C., Freudenthal B.,
RA   Stanescu H.C., Zdebik A.A., Chaganti R.K., Nussbaum R.L., Kleta R.,
RA   Gahl W.A., Boehm M.;
RT   "NT5E mutations and arterial calcifications.";
RL   N. Engl. J. Med. 364:432-442(2011).
CC   -!- FUNCTION: Hydrolyzes extracellular nucleotides into membrane
CC       permeable nucleosides.
CC   -!- CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside
CC       + phosphate.
CC   -!- COFACTOR: Zinc.
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P21589-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21589-2; Sequence=VSP_043076;
CC         Note=No experimental confirmation available;
CC   -!- DISEASE: Defects in NT5E are the cause of calcification of joints
CC       and arteries (CALJA) [MIM:211800]. A condition characterized by
CC       adult-onset calcification of the lower extremity arteries,
CC       including the iliac, femoral and tibial arteries, and hand and
CC       foot capsule joints. Age of onset has been reported as early as
CC       the second decade of life, usually involving intense joint pain or
CC       calcification in the hands.
CC   -!- SIMILARITY: Belongs to the 5'-nucleotidase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X55740; CAA39271.1; -; mRNA.
DR   EMBL; AK075008; BAG52050.1; -; mRNA.
DR   EMBL; AL135903; CAH72337.1; -; Genomic_DNA.
DR   EMBL; AL589666; CAH72337.1; JOINED; Genomic_DNA.
DR   EMBL; AL589666; CAI40168.1; -; Genomic_DNA.
DR   EMBL; AL135903; CAI40168.1; JOINED; Genomic_DNA.
DR   EMBL; U21730; AAA96950.1; -; Genomic_DNA.
DR   EMBL; AF069067; AAC98672.1; -; Genomic_DNA.
DR   IPI; IPI00009456; -.
DR   IPI; IPI00552302; -.
DR   PIR; S11032; S11032.
DR   RefSeq; NP_001191742.1; NM_001204813.1.
DR   RefSeq; NP_002517.1; NM_002526.3.
DR   UniGene; Hs.153952; -.
DR   ProteinModelPortal; P21589; -.
DR   SMR; P21589; 27-550.
DR   STRING; P21589; -.
DR   DMDM; 112825; -.
DR   PRIDE; P21589; -.
DR   DNASU; 4907; -.
DR   Ensembl; ENST00000257770; ENSP00000257770; ENSG00000135318.
DR   Ensembl; ENST00000369651; ENSP00000358665; ENSG00000135318.
DR   GeneID; 4907; -.
DR   KEGG; hsa:4907; -.
DR   UCSC; uc003pko.4; human.
DR   CTD; 4907; -.
DR   GeneCards; GC06P086216; -.
DR   H-InvDB; HIX0032840; -.
DR   HGNC; HGNC:8021; NT5E.
DR   HPA; HPA017357; -.
DR   MIM; 129190; gene.
DR   MIM; 211800; phenotype.
DR   neXtProt; NX_P21589; -.
DR   PharmGKB; PA31804; -.
DR   eggNOG; COG0737; -.
DR   GeneTree; ENSGT00530000063775; -.
DR   HOGENOM; HBG534106; -.
DR   HOVERGEN; HBG000026; -.
DR   InParanoid; P21589; -.
DR   KO; K01081; -.
DR   OMA; TGSHCHG; -.
DR   OrthoDB; EOG4TMR1Q; -.
DR   PhylomeDB; P21589; -.
DR   Pathway_Interaction_DB; hif1_tfpathway; HIF-1-alpha transcription factor network.
DR   Reactome; REACT_111217; Metabolism.
DR   DrugBank; DB00806; Pentoxifylline.
DR   NextBio; 18883; -.
DR   ArrayExpress; P21589; -.
DR   Bgee; P21589; -.
DR   CleanEx; HS_NT5E; -.
DR   Genevestigator; P21589; -.
DR   GermOnline; ENSG00000135318; Homo sapiens.
DR   GO; GO:0031225; C:anchored to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005624; C:membrane fraction; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008253; F:5'-nucleotidase activity; EXP:Reactome.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0006259; P:DNA metabolic process; TAS:ProtInc.
DR   GO; GO:0006144; P:purine base metabolic process; TAS:Reactome.
DR   GO; GO:0006206; P:pyrimidine base metabolic process; TAS:Reactome.
DR   GO; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome.
DR   Gene3D; G3DSA:3.90.780.10; 5'-Nucleotdase_C; 1.
DR   InterPro; IPR008334; 5'-Nucleotdase_C.
DR   InterPro; IPR006146; 5'-Nucleotdase_CS.
DR   InterPro; IPR006179; 5_nucleotidase/apyrase.
DR   InterPro; IPR004843; Metallo_PEstase_dom.
DR   PANTHER; PTHR11575; 5_nucleotidase; 1.
DR   Pfam; PF02872; 5_nucleotid_C; 1.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR01607; APYRASEFAMLY.
DR   SUPFAM; SSF55816; 5'-Nucleotdase_C; 1.
DR   PROSITE; PS00785; 5_NUCLEOTIDASE_1; 1.
DR   PROSITE; PS00786; 5_NUCLEOTIDASE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; GPI-anchor; Hydrolase; Lipoprotein; Membrane;
KW   Metal-binding; Nucleotide-binding; Polymorphism; Reference proteome;
KW   Signal; Zinc.
FT   SIGNAL        1     26
FT   CHAIN        27    549       5'-nucleotidase.
FT                                /FTId=PRO_0000000015.
FT   PROPEP      550    574       Removed in mature form.
FT                                /FTId=PRO_0000000016.
FT   REGION      500    506       Substrate binding (By similarity).
FT   METAL        36     36       Zinc 1 (By similarity).
FT   METAL        38     38       Zinc 1 (By similarity).
FT   METAL        85     85       Zinc 1 (By similarity).
FT   METAL        85     85       Zinc 2 (By similarity).
FT   METAL       117    117       Zinc 2 (By similarity).
FT   METAL       220    220       Zinc 2 (By similarity).
FT   METAL       243    243       Zinc 2 (By similarity).
FT   BINDING     417    417       Substrate (By similarity).
FT   SITE        118    118       Transition state stabilizer (By
FT                                similarity).
FT   SITE        121    121       Transition state stabilizer (By
FT                                similarity).
FT   LIPID       549    549       GPI-anchor amidated serine.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    311    311       N-linked (GlcNAc...).
FT   CARBOHYD    333    333       N-linked (GlcNAc...).
FT   CARBOHYD    403    403       N-linked (GlcNAc...).
FT   VAR_SEQ     404    453       Missing (in isoform 2).
FT                                /FTId=VSP_043076.
FT   VARIANT     358    358       C -> Y (in CALJA).
FT                                /FTId=VAR_065185.
FT   VARIANT     376    376       T -> A (in dbSNP:rs2229523).
FT                                /FTId=VAR_022091.
FT   VARIANT     379    379       M -> T (in dbSNP:rs2229524).
FT                                /FTId=VAR_048103.
SQ   SEQUENCE   574 AA;  63368 MW;  A99AF170AB7EAECE CRC64;
     MCPRAARAPA TLLLALGAVL WPAAGAWELT ILHTNDVHSR LEQTSEDSSK CVNASRCMGG
     VARLFTKVQQ IRRAEPNVLL LDAGDQYQGT IWFTVYKGAE VAHFMNALRY DAMALGNHEF
     DNGVEGLIEP LLKEAKFPIL SANIKAKGPL ASQISGLYLP YKVLPVGDEV VGIVGYTSKE
     TPFLSNPGTN LVFEDEITAL QPEVDKLKTL NVNKIIALGH SGFEMDKLIA QKVRGVDVVV
     GGHSNTFLYT GNPPSKEVPA GKYPFIVTSD DGRKVPVVQA YAFGKYLGYL KIEFDERGNV
     ISSHGNPILL NSSIPEDPSI KADINKWRIK LDNYSTQELG KTIVYLDGSS QSCRFRECNM
     GNLICDAMIN NNLRHTDEMF WNHVSMCILN GGGIRSPIDE RNNGTITWEN LAAVLPFGGT
     FDLVQLKGST LKKAFEHSVH RYGQSTGEFL QVGGIHVVYD LSRKPGDRVV KLDVLCTKCR
     VPSYDPLKMD EVYKVILPNF LANGGDGFQM IKDELLRHDS GDQDINVVST YISKMKVIYP
     AVEGRIKFST GSHCHGSFSL IFLSLWAVIF VLYQ
//
ID   68MP_HUMAN              Reviewed;          58 AA.
AC   P56378; B2R588; Q86TT7;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 1.
DT   18-APR-2012, entry version 89.
DE   RecName: Full=6.8 kDa mitochondrial proteolipid;
GN   Name=MP68; Synonyms=C14orf2; ORFNames=PRO1574;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   MEDLINE=98318631; PubMed=9653160; DOI=10.1073/pnas.95.14.8175;
RA   Mao M., Fu G., Wu J.-S., Zhang Q.-H., Zhou J., Kan L.-X., Huang Q.-H.,
RA   He K.-L., Gu B.-W., Han Z.-G., Shen Y., Gu J., Yu Y.-P., Xu S.-H.,
RA   Wang Y.-X., Chen S.-J., Chen Z.;
RT   "Identification of genes expressed in human CD34(+) hematopoietic
RT   stem/progenitor cells by expressed sequence tags and efficient full-
RT   length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8175-8180(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhou G., Ouyang S., Luo L., Bi J.,
RA   Liu M., He F.;
RT   "Functional prediction of the coding sequences of 121 new genes
RT   deduced by analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-14, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- SUBUNIT: Component of an ATP synthase complex composed of ATP5F1,
CC       ATP5G1, ATP5E, ATP5H, ATP5I, ATP5J, ATP5J2, MT-ATP6, MT-ATP8,
CC       ATP5A1, ATP5B, ATP5D, ATP5C1, ATP5O, ATP5L, USMG5 and MP68 (By
CC       similarity).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion (By similarity). Mitochondrion
CC       membrane; Single-pass membrane protein (Potential).
CC   -!- SIMILARITY: Belongs to the small mitochondrial proteolipid family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD61878.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF054175; AAC39909.1; -; mRNA.
DR   EMBL; AF116639; AAF71062.1; -; mRNA.
DR   EMBL; BX161388; CAD61878.1; ALT_INIT; mRNA.
DR   EMBL; AK312099; BAG35035.1; -; mRNA.
DR   EMBL; CH471061; EAW81850.1; -; Genomic_DNA.
DR   EMBL; BC000429; AAH00429.1; -; mRNA.
DR   EMBL; BC001944; AAH01944.1; -; mRNA.
DR   IPI; IPI00749237; -.
DR   RefSeq; NP_001120865.1; NM_001127393.1.
DR   RefSeq; NP_004885.1; NM_004894.2.
DR   UniGene; Hs.109052; -.
DR   ProteinModelPortal; P56378; -.
DR   STRING; P56378; -.
DR   PhosphoSite; P56378; -.
DR   DMDM; 3023202; -.
DR   PRIDE; P56378; -.
DR   Ensembl; ENST00000286953; ENSP00000286953; ENSG00000156411.
DR   Ensembl; ENST00000414262; ENSP00000401770; ENSG00000156411.
DR   GeneID; 9556; -.
DR   KEGG; hsa:9556; -.
DR   UCSC; uc001yoi.4; human.
DR   CTD; 9556; -.
DR   GeneCards; GC14M104378; -.
DR   H-InvDB; HIX0012010; -.
DR   HGNC; HGNC:1188; C14orf2.
DR   MIM; 604573; gene.
DR   neXtProt; NX_P56378; -.
DR   PharmGKB; PA25514; -.
DR   eggNOG; NOG47225; -.
DR   GeneTree; ENSGT00390000016760; -.
DR   HOGENOM; HBG127351; -.
DR   HOVERGEN; HBG000027; -.
DR   InParanoid; P56378; -.
DR   OrthoDB; EOG4KD6NR; -.
DR   PhylomeDB; P56378; -.
DR   NextBio; 35845; -.
DR   ArrayExpress; P56378; -.
DR   Bgee; P56378; -.
DR   CleanEx; HS_C14orf2; -.
DR   Genevestigator; P56378; -.
DR   GermOnline; ENSG00000156411; Homo sapiens.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   InterPro; IPR012574; Mit_proteolip.
DR   PANTHER; PTHR15233; Mit_preoteolip; 1.
DR   Pfam; PF08039; Mit_proteolip; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Membrane; Mitochondrion; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1     58       6.8 kDa mitochondrial proteolipid.
FT                                /FTId=PRO_0000064393.
FT   TRANSMEM     20     38       Helical; (Potential).
FT   MOD_RES      14     14       N6-acetyllysine.
FT   VARIANT       9      9       I -> V (in dbSNP:rs1053419).
FT                                /FTId=VAR_014526.
SQ   SEQUENCE   58 AA;  6662 MW;  1B8A63046C0383F6 CRC64;
     MLQSIIKNIW IPMKPYYTKV YQEIWIGMGL MGFIVYKIRA ADKRSKALKA SAPAPGHH
//
ID   6PGD_HUMAN              Reviewed;         483 AA.
AC   P52209; Q9BWD8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   18-APR-2012, entry version 122.
DE   RecName: Full=6-phosphogluconate dehydrogenase, decarboxylating;
DE            EC=1.1.1.44;
GN   Name=PGD; Synonyms=PGDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   MEDLINE=97133513; PubMed=8978909; DOI=10.1007/BF00554412;
RA   Tsui S.K.W., Chan J.Y., Waye M.M.Y., Fung K.-P., Lee C.-Y.;
RT   "Identification of a cDNA encoding 6-phosphogluconate dehydrogenase
RT   from a human heart cDNA library.";
RL   Biochem. Genet. 34:367-373(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-38; LYS-59; LYS-76; LYS-154
RP   AND LYS-309, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.53 ANGSTROMS) IN COMPLEX WITH NADP, AND
RP   SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "Structure of human phosphogluconate dehydrogenase in complex with
RT   NADPH at 2.53 A.";
RL   Submitted (SEP-2009) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the oxidative decarboxylation of 6-
CC       phosphogluconate to ribulose 5-phosphate and CO(2), with
CC       concomitant reduction of NADP to NADPH (By similarity).
CC   -!- CATALYTIC ACTIVITY: 6-phospho-D-gluconate + NADP(+) = D-ribulose
CC       5-phosphate + CO(2) + NADPH.
CC   -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-
CC       ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage):
CC       step 3/3.
CC   -!- SUBUNIT: Homodimer.
CC   -!- INTERACTION:
CC       O95777:NAA38; NbExp=1; IntAct=EBI-372761, EBI-347779;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the 6-phosphogluconate dehydrogenase
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U30255; AAA75302.1; -; mRNA.
DR   EMBL; BC000368; AAH00368.1; -; mRNA.
DR   IPI; IPI00219525; -.
DR   PIR; G01922; G01922.
DR   RefSeq; NP_002622.2; NM_002631.2.
DR   UniGene; Hs.464071; -.
DR   PDB; 2JKV; X-ray; 2.53 A; A/B/C/D/E/F=1-483.
DR   PDBsum; 2JKV; -.
DR   ProteinModelPortal; P52209; -.
DR   SMR; P52209; 2-483.
DR   IntAct; P52209; 6.
DR   MINT; MINT-1415782; -.
DR   STRING; P52209; -.
DR   PhosphoSite; P52209; -.
DR   DMDM; 20981679; -.
DR   PeptideAtlas; P52209; -.
DR   PRIDE; P52209; -.
DR   DNASU; 5226; -.
DR   Ensembl; ENST00000270776; ENSP00000270776; ENSG00000142657.
DR   GeneID; 5226; -.
DR   KEGG; hsa:5226; -.
DR   UCSC; uc001arc.3; human.
DR   CTD; 5226; -.
DR   GeneCards; GC01P010393; -.
DR   H-InvDB; HIX0000112; -.
DR   HGNC; HGNC:8891; PGD.
DR   HPA; HPA031314; -.
DR   MIM; 172200; gene.
DR   neXtProt; NX_P52209; -.
DR   PharmGKB; PA33229; -.
DR   eggNOG; COG0362; -.
DR   GeneTree; ENSGT00390000009023; -.
DR   HOGENOM; HBG286913; -.
DR   HOVERGEN; HBG000029; -.
DR   InParanoid; P52209; -.
DR   KO; K00033; -.
DR   OMA; MEHNEMA; -.
DR   OrthoDB; EOG4C2H9D; -.
DR   PhylomeDB; P52209; -.
DR   Reactome; REACT_111217; Metabolism.
DR   EvolutionaryTrace; P52209; -.
DR   NextBio; 20204; -.
DR   ArrayExpress; P52209; -.
DR   Bgee; P52209; -.
DR   CleanEx; HS_PGD; -.
DR   Genevestigator; P52209; -.
DR   GermOnline; ENSG00000142657; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0004616; F:phosphogluconate dehydrogenase (decarboxylating) activity; ISS:UniProtKB.
DR   GO; GO:0009051; P:pentose-phosphate shunt, oxidative branch; IDA:UniProtKB.
DR   Gene3D; G3DSA:1.20.5.320; Fibritin/6PGD_C-extension; 1.
DR   Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1.
DR   Gene3D; G3DSA:1.10.1040.10; Opine_DH; 1.
DR   InterPro; IPR008927; 6-PGluconate_DH_C-like.
DR   InterPro; IPR006114; 6PGDH_C.
DR   InterPro; IPR006113; 6PGDH_decarbox.
DR   InterPro; IPR006115; 6PGDH_NADP-bd.
DR   InterPro; IPR006184; 6PGdom_BS.
DR   InterPro; IPR013328; DH_multihelical.
DR   InterPro; IPR012284; Fibritin/6PGD_C-extension.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF00393; 6PGD; 1.
DR   Pfam; PF03446; NAD_binding_2; 1.
DR   PIRSF; PIRSF000109; 6PGD; 1.
DR   SUPFAM; SSF48179; 6DGDH_C_like; 1.
DR   TIGRFAMs; TIGR00873; Gnd; 1.
DR   PROSITE; PS00461; 6PGD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; NADP;
KW   Oxidoreductase; Pentose shunt; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    483       6-phosphogluconate dehydrogenase,
FT                                decarboxylating.
FT                                /FTId=PRO_0000090063.
FT   NP_BIND      10     15       NADP.
FT   NP_BIND      33     35       NADP.
FT   NP_BIND      75     77       NADP.
FT   NP_BIND     478    481       NADP; shared with dimeric partner.
FT   REGION      129    131       Substrate binding (By similarity).
FT   REGION      187    188       Substrate binding (By similarity).
FT   ACT_SITE    184    184       Proton acceptor (By similarity).
FT   ACT_SITE    191    191       Proton donor (By similarity).
FT   BINDING     103    103       NADP.
FT   BINDING     103    103       Substrate (By similarity).
FT   BINDING     192    192       Substrate (By similarity).
FT   BINDING     261    261       Substrate; via amide nitrogen (By
FT                                similarity).
FT   BINDING     288    288       Substrate (By similarity).
FT   BINDING     447    447       Substrate; shared with dimeric partner
FT                                (By similarity).
FT   BINDING     453    453       Substrate; shared with dimeric partner
FT                                (By similarity).
FT   MOD_RES      38     38       N6-acetyllysine.
FT   MOD_RES      59     59       N6-acetyllysine.
FT   MOD_RES      76     76       N6-acetyllysine.
FT   MOD_RES     154    154       N6-acetyllysine.
FT   MOD_RES     309    309       N6-acetyllysine.
FT   VARIANT     268    268       A -> S (in dbSNP:rs11547610).
FT                                /FTId=VAR_048104.
FT   CONFLICT    118    118       A -> G (in Ref. 1; AAA75302).
FT   CONFLICT    135    135       A -> P (in Ref. 1; AAA75302).
FT   STRAND        4      9
FT   HELIX        17     24
FT   STRAND       29     31
FT   HELIX        37     44
FT   TURN         45     47
FT   HELIX        58     63
FT   STRAND       70     73
FT   HELIX        80     88
FT   HELIX        89     91
FT   STRAND       97     99
FT   HELIX       106    118
FT   STRAND      122    124
FT   HELIX       147    150
FT   HELIX       151    157
FT   STRAND      169    171
FT   HELIX       182    187
FT   HELIX       195    207
FT   HELIX       213    223
FT   TURN        224    228
FT   HELIX       231    241
FT   HELIX       251    253
FT   HELIX       266    273
FT   HELIX       284    292
FT   HELIX       294    303
FT   HELIX       316    336
FT   HELIX       340    348
FT   HELIX       360    362
FT   HELIX       376    382
FT   HELIX       389    391
FT   HELIX       393    411
FT   HELIX       421    430
FT   HELIX       440    449
FT   STRAND      455    457
FT   STRAND      463    465
SQ   SEQUENCE   483 AA;  53140 MW;  6CEFC0077D1283E3 CRC64;
     MAQADIALIG LAVMGQNLIL NMNDHGFVVC AFNRTVSKVD DFLANEAKGT KVVGAQSLKE
     MVSKLKKPRR IILLVKAGQA VDDFIEKLVP LLDTGDIIID GGNSEYRDTT RRCRDLKAKG
     ILFVGSGVSG GEEGARYGPS LMPGGNKEAW PHIKTIFQGI AAKVGTGEPC CDWVGDEGAG
     HFVKMVHNGI EYGDMQLICE AYHLMKDVLG MAQDEMAQAF EDWNKTELDS FLIEITANIL
     KFQDTDGKHL LPKIRDSAGQ KGTGKWTAIS ALEYGVPVTL IGEAVFARCL SSLKDERIQA
     SKKLKGPQKF QFDGDKKSFL EDIRKALYAS KIISYAQGFM LLRQAATEFG WTLNYGGIAL
     MWRGGCIIRS VFLGKIKDAF DRNPELQNLL LDDFFKSAVE NCQDSWRRAV STGVQAGIPM
     PCFTTALSFY DGYRHEMLPA SLIQAQRDYF GAHTYELLAK PGQFIHTNWT GHGGTVSSSS
     YNA
//
ID   6PGL_HUMAN              Reviewed;         258 AA.
AC   O95336;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=6-phosphogluconolactonase;
DE            Short=6PGL;
DE            EC=3.1.1.31;
GN   Name=PGLS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=99447648; PubMed=10518023; DOI=10.1016/S0014-5793(99)01247-8;
RA   Collard F., Collet J.-F., Gerin I., Veiga-da-Cunha M.,
RA   van Schaftingen E.;
RT   "Identification of the cDNA encoding human 6-phosphogluconolactonase,
RT   the enzyme catalyzing the second step of the pentose phosphate
RT   pathway.";
RL   FEBS Lett. 459:223-226(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 41-72 AND 82-96, AND MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 97-242.
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-180, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Hydrolysis of 6-phosphogluconolactone to 6-
CC       phosphogluconate.
CC   -!- CATALYTIC ACTIVITY: 6-phospho-D-glucono-1,5-lactone + H(2)O = 6-
CC       phospho-D-gluconate.
CC   -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-
CC       ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage):
CC       step 2/3.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the glucosamine/galactosamine-6-phosphate
CC       isomerase family. 6-phosphogluconolactonase subfamily.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72960.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ243972; CAB57866.1; -; mRNA.
DR   EMBL; BC014006; AAH14006.1; -; mRNA.
DR   EMBL; AF091091; AAC72960.1; ALT_INIT; mRNA.
DR   IPI; IPI00029997; -.
DR   RefSeq; NP_036220.1; NM_012088.2.
DR   UniGene; Hs.466165; -.
DR   ProteinModelPortal; O95336; -.
DR   SMR; O95336; 7-250.
DR   MINT; MINT-5000838; -.
DR   STRING; O95336; -.
DR   PhosphoSite; O95336; -.
DR   OGP; O95336; -.
DR   REPRODUCTION-2DPAGE; IPI00029997; -.
DR   PeptideAtlas; O95336; -.
DR   PRIDE; O95336; -.
DR   DNASU; 25796; -.
DR   Ensembl; ENST00000252603; ENSP00000252603; ENSG00000130313.
DR   GeneID; 25796; -.
DR   KEGG; hsa:25796; -.
DR   UCSC; uc002ngw.3; human.
DR   CTD; 25796; -.
DR   GeneCards; GC19P017622; -.
DR   H-InvDB; HIX0202829; -.
DR   HGNC; HGNC:8903; PGLS.
DR   MIM; 604951; gene.
DR   neXtProt; NX_O95336; -.
DR   PharmGKB; PA33240; -.
DR   eggNOG; COG0363; -.
DR   GeneTree; ENSGT00550000075110; -.
DR   HOGENOM; HBG725991; -.
DR   HOVERGEN; HBG000030; -.
DR   InParanoid; O95336; -.
DR   KO; K01057; -.
DR   OMA; TYGLYRT; -.
DR   OrthoDB; EOG4ZS945; -.
DR   PhylomeDB; O95336; -.
DR   BRENDA; 3.1.1.31; 2681.
DR   Reactome; REACT_111217; Metabolism.
DR   NextBio; 46981; -.
DR   ArrayExpress; O95336; -.
DR   Bgee; O95336; -.
DR   CleanEx; HS_PGLS; -.
DR   Genevestigator; O95336; -.
DR   GermOnline; ENSG00000130313; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0017057; F:6-phosphogluconolactonase activity; IDA:UniProtKB.
DR   InterPro; IPR005900; 6-phosphogluconolactonase_DevB.
DR   InterPro; IPR006148; Glc/Gal-6P_isomerase.
DR   Pfam; PF01182; Glucosamine_iso; 1.
DR   TIGRFAMs; TIGR01198; Pgl; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Hydrolase; Reference proteome.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    258       6-phosphogluconolactonase.
FT                                /FTId=PRO_0000090078.
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     180    180       N6-acetyllysine.
SQ   SEQUENCE   258 AA;  27547 MW;  A753FB7E662116DD CRC64;
     MAAPAPGLIS VFSSSQELGA ALAQLVAQRA ACCLAGARAR FALGLSGGSL VSMLARELPA
     AVAPAGPASL ARWTLGFCDE RLVPFDHAES TYGLYRTHLL SRLPIPESQV ITINPELPVE
     EAAEDYAKKL RQAFQGDSIP VFDLLILGVG PDGHTCSLFP DHPLLQEREK IVAPISDSPK
     PPPQRVTLTL PVLNAARTVI FVATGEGKAA VLKRILEDQE ENPLPAALVQ PHTGKLCWFL
     DEAAARLLTV PFEKHSTL
//
ID   7B2_HUMAN               Reviewed;         212 AA.
AC   P05408; P01164; Q9BS38;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 2.
DT   18-APR-2012, entry version 115.
DE   RecName: Full=Neuroendocrine protein 7B2;
DE   AltName: Full=Pituitary polypeptide;
DE   AltName: Full=Secretogranin V;
DE   AltName: Full=Secretogranin-5;
DE   AltName: Full=Secretory granule endocrine protein I;
DE   Contains:
DE     RecName: Full=N-terminal peptide;
DE   Contains:
DE     RecName: Full=C-terminal peptide;
DE   Flags: Precursor;
GN   Name=SCG5; Synonyms=SGNE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Pituitary;
RX   MEDLINE=88271601; PubMed=3134253; DOI=10.1016/0014-5793(88)81324-3;
RA   Martens G.J.M.;
RT   "Cloning and sequence analysis of human pituitary cDNA encoding the
RT   novel polypeptide 7B2.";
RL   FEBS Lett. 234:160-164(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF
RP   125-140 (ISOFORM 1), AND PROTEIN SEQUENCE OF 126-132 (ISOFORM 2).
RC   TISSUE=Pituitary;
RX   MEDLINE=91113188; PubMed=1989596; DOI=10.1016/0006-291X(91)90499-W;
RA   Paquet L., Lazure C., Seidah N.G., Chretien M., Mbikay M.;
RT   "The production by alternate splicing of two mRNAs differing by one
RT   codon could be an intrinsic property of neuroendocrine protein 7B2
RT   gene expression in man.";
RL   Biochem. Biophys. Res. Commun. 174:156-162(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Jackson R.S.;
RT   "Human neuroendocrine protein 7B2 genomic organization.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 61-92.
RX   MEDLINE=96184880; PubMed=8617287;
RX   DOI=10.1111/j.1432-1033.1996.00060.x;
RA   Braks J.A., Broers C.A., Danger J.M., Martens G.J.M.;
RT   "Structural organization of the gene encoding the neuroendocrine
RT   chaperone 7B2.";
RL   Eur. J. Biochem. 236:60-67(1996).
RN   [6]
RP   PROTEIN SEQUENCE OF 27-103.
RX   MEDLINE=84022554; PubMed=6625600; DOI=10.1016/0003-9861(83)90063-2;
RA   Seidah N.G., Hsi K.L., de Serres G., Rochemont J., Hamelin J.,
RA   Antakly T., Cantin M., Chretien M.;
RT   "Isolation and NH2-terminal sequence of a highly conserved human and
RT   porcine pituitary protein belonging to a new superfamily.
RT   Immunocytochemical localization in pars distalis and pars nervosa of
RT   the pituitary and in the supraoptic nucleus of the hypothalamus.";
RL   Arch. Biochem. Biophys. 225:525-534(1983).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH PCSK2.
RX   MEDLINE=94320138; PubMed=7913882; DOI=10.1016/0092-8674(94)90296-8;
RA   Braks J.A., Martens G.J.M.;
RT   "7B2 is a neuroendocrine chaperone that transiently interacts with
RT   prohormone convertase PC2 in the secretory pathway.";
RL   Cell 78:263-273(1994).
RN   [8]
RP   REVIEW.
RX   MEDLINE=21332545; PubMed=11439082; DOI=10.1042/0264-6021:3570329;
RA   Mbikay M., Seidah N.G., Chretien M.;
RT   "Neuroendocrine secretory protein 7B2: structure, expression and
RT   functions.";
RL   Biochem. J. 357:329-342(2001).
CC   -!- FUNCTION: Acts as a molecular chaperone for PCSK2/PC2, preventing
CC       its premature activation in the regulated secretory pathway. Binds
CC       to inactive PCSK2 in the endoplasmic reticulum and facilitates its
CC       transport from there to later compartments of the secretory
CC       pathway where it is proteolytically matured and activated. Also
CC       required for cleavage of PCSK2 but does not appear to be involved
CC       in its folding. Plays a role in regulating pituitary hormone
CC       secretion. The C-terminal peptide inhibits PCSK2 in vitro.
CC   -!- SUBUNIT: Interacts with PCSK2/PC2 early in the secretory pathway.
CC       Dissociation occurs at later stages.
CC   -!- SUBCELLULAR LOCATION: Secreted. Note=Neuroendocrine and endocrine
CC       secretory granules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05408-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05408-2; Sequence=VSP_011754;
CC   -!- PTM: Proteolytically cleaved in the Golgi by a furin-like
CC       convertase to generate bioactive peptides (By similarity).
CC   -!- PTM: Sulfated on tyrosine residues (By similarity).
CC   -!- SIMILARITY: Belongs to the 7B2 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00757; CAA68726.1; -; mRNA.
DR   EMBL; AJ290438; CAB90397.1; -; Genomic_DNA.
DR   EMBL; AJ290439; CAB90397.1; JOINED; Genomic_DNA.
DR   EMBL; AJ290440; CAB90397.1; JOINED; Genomic_DNA.
DR   EMBL; AJ290441; CAB90397.1; JOINED; Genomic_DNA.
DR   EMBL; AJ290442; CAB90397.1; JOINED; Genomic_DNA.
DR   EMBL; BC005349; AAH05349.1; -; mRNA.
DR   IPI; IPI00008944; -.
DR   IPI; IPI00470716; -.
DR   PIR; S01008; PUHU.
DR   RefSeq; NP_001138229.1; NM_001144757.1.
DR   RefSeq; NP_003011.1; NM_003020.3.
DR   UniGene; Hs.156540; -.
DR   ProteinModelPortal; P05408; -.
DR   IntAct; P05408; 2.
DR   MINT; MINT-1402757; -.
DR   STRING; P05408; -.
DR   MEROPS; I21.001; -.
DR   PhosphoSite; P05408; -.
DR   DMDM; 23830842; -.
DR   PRIDE; P05408; -.
DR   DNASU; 6447; -.
DR   Ensembl; ENST00000300175; ENSP00000300175; ENSG00000166922.
DR   GeneID; 6447; -.
DR   KEGG; hsa:6447; -.
DR   UCSC; uc001zha.2; human.
DR   CTD; 6447; -.
DR   GeneCards; GC15P032933; -.
DR   HGNC; HGNC:10816; SCG5.
DR   HPA; HPA013136; -.
DR   MIM; 173120; gene.
DR   neXtProt; NX_P05408; -.
DR   PharmGKB; PA35724; -.
DR   eggNOG; NOG271457; -.
DR   GeneTree; ENSGT00390000009816; -.
DR   HOGENOM; HBG713767; -.
DR   HOVERGEN; HBG000031; -.
DR   InParanoid; P05408; -.
DR   OMA; GPYGNIP; -.
DR   OrthoDB; EOG44MXSZ; -.
DR   PhylomeDB; P05408; -.
DR   NextBio; 25057; -.
DR   ArrayExpress; P05408; -.
DR   Bgee; P05408; -.
DR   CleanEx; HS_SCG5; -.
DR   Genevestigator; P05408; -.
DR   GermOnline; ENSG00000166922; Homo sapiens.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030141; C:secretory granule; ISS:UniProtKB.
DR   GO; GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; TAS:ProtInc.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; ISS:UniProtKB.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016486; P:peptide hormone processing; ISS:UniProtKB.
DR   GO; GO:0046883; P:regulation of hormone secretion; ISS:UniProtKB.
DR   InterPro; IPR007945; Secretogranin_V.
DR   PANTHER; PTHR12738; Secretogranin_V; 1.
DR   Pfam; PF05281; Secretogranin_V; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chaperone; Cleavage on pair of basic residues;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Neuropeptide; Phosphoprotein; Reference proteome; Secreted; Signal;
KW   Sulfation; Transport.
FT   SIGNAL        1     26
FT   CHAIN        27    212       Neuroendocrine protein 7B2.
FT                                /FTId=PRO_0000000041.
FT   CHAIN        27    176       N-terminal peptide (By similarity).
FT                                /FTId=PRO_0000000042.
FT   PEPTIDE     200    212       C-terminal peptide (By similarity).
FT                                /FTId=PRO_0000000043.
FT   MOD_RES     205    205       Phosphoserine (By similarity).
FT   DISULFID    120    130       By similarity.
FT   VAR_SEQ     126    126       Missing (in isoform 2).
FT                                /FTId=VSP_011754.
FT   CONFLICT    151    151       F -> S (in Ref. 4; AAH05349).
SQ   SEQUENCE   212 AA;  23730 MW;  A459702055C0FE84 CRC64;
     MVSRMVSTML SGLLFWLASG WTPAFAYSPR TPDRVSEADI QRLLHGVMEQ LGIARPRVEY
     PAHQAMNLVG PQSIEGGAHE GLQHLGPFGN IPNIVAELTG DNIPKDFSED QGYPDPPNPC
     PVGKTADDGC LENTPDTAEF SREFQLHQHL FDPEHDYPGL GKWNKKLLYE KMKGGERRKR
     RSVNPYLQGQ RLDNVVAKKS VPHFSDEDKD PE
//
ID   8ODP_HUMAN              Reviewed;         197 AA.
AC   P36639; A4D205; Q6P0Y6; Q8IV95; Q9UBM0; Q9UBM9;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 3.
DT   18-APR-2012, entry version 114.
DE   RecName: Full=7,8-dihydro-8-oxoguanine triphosphatase;
DE            EC=3.6.1.55;
DE   AltName: Full=2-hydroxy-dATP diphosphatase;
DE            EC=3.6.1.56;
DE   AltName: Full=8-oxo-dGTPase;
DE   AltName: Full=Nucleoside diphosphate-linked moiety X motif 1;
DE            Short=Nudix motif 1;
GN   Name=NUDT1; Synonyms=MTH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM P18), PARTIAL PROTEIN SEQUENCE,
RP   AND CATALYTIC ACTIVITY.
RX   MEDLINE=94043152; PubMed=8226881;
RA   Sakumi K., Furuichi M., Tsuzuki T., Kakuma T., Kawabata S., Maki H.,
RA   Sekiguchi M.;
RT   "Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-
RT   oxo-dGTP, a mutagenic substrate for DNA synthesis.";
RL   J. Biol. Chem. 268:23524-23530(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=95229148; PubMed=7713500; DOI=10.1006/geno.1994.1657;
RA   Furuichi M., Yoshida M.C., Oda H., Tajiri T., Nakabeppu Y.,
RA   Tsuzuki T., Sekiguchi M.;
RT   "Genomic structure and chromosome location of the human mutT homologue
RT   gene MTH1 encoding 8-oxo-dGTPase for prevention of A:T to C:G
RT   transversion.";
RL   Genomics 24:485-490(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM P18), TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND VARIANT MET-124.
RX   MEDLINE=97362283; PubMed=9211940; DOI=10.1074/jbc.272.28.17843;
RA   Oda H., Nakabeppu Y., Furuichi M., Sekiguchi M.;
RT   "Regulation of expression of the human MTH1 gene encoding 8-oxo-
RT   dGTPase. Alternative splicing of transcription products.";
RL   J. Biol. Chem. 272:17843-17850(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE INITIATION.
RX   MEDLINE=20007875; PubMed=10536140; DOI=10.1093/nar/27.22.4335;
RA   Oda H., Taketomi A., Maruyama R., Itoh R., Nishioka K., Yakushiji H.,
RA   Suzuki T., Sekiguchi M., Nakabeppu Y.;
RT   "Multi-forms of human MTH1 polypeptides produced by alternative
RT   translation initiation and single nucleotide polymorphism.";
RL   Nucleic Acids Res. 27:4335-4343(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22616434; PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS P18 AND P22), AND
RP   VARIANT MET-124.
RC   TISSUE=Bone, Lymph, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   MUTAGENESIS OF GLY-77; GLY-78; VAL-80; GLN-81; GLY-83; ILE-86; ASP-88;
RP   GLY-89; ALA-90; LEU-94; GLN-95; GLU-96; GLU-97 AND SER-98, FUNCTION,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=10608900; DOI=10.1074/jbc.274.53.38251;
RA   Fujii Y., Shimokawa H., Sekiguchi M., Nakabeppu Y.;
RT   "Functional significance of the conserved residues for the 23-residue
RT   module among MTH1 and MutT family proteins.";
RL   J. Biol. Chem. 274:38251-38259(1999).
RN   [11]
RP   STRUCTURE BY NMR OF 42-197, SUBUNIT, COFACTOR, AND SUBSTRATE BINDING
RP   SITE.
RX   PubMed=15133035; DOI=10.1074/jbc.M402393200;
RA   Mishima M., Sakai Y., Itoh N., Kamiya H., Furuichi M., Takahashi M.,
RA   Yamagata Y., Iwai S., Nakabeppu Y., Shirakawa M.;
RT   "Structure of human MTH1, a Nudix family hydrolase that selectively
RT   degrades oxidized purine nucleoside triphosphates.";
RL   J. Biol. Chem. 279:33806-33815(2004).
CC   -!- FUNCTION: Antimutagenic. Responsible for preventing
CC       misincorporation of 8-oxo-dGTP into DNA thus preventing A:T to C:G
CC       transversions.
CC   -!- CATALYTIC ACTIVITY: 8-oxo-dGTP + H(2)O = 8-oxo-dGMP + diphosphate.
CC   -!- CATALYTIC ACTIVITY: 2-hydroxy-dATP + H(2)O = 2-hydroxy-dAMP +
CC       diphosphate.
CC   -!- COFACTOR: Binds 1 magnesium ion per subunit (Probable).
CC   -!- SUBUNIT: Monomer.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=4;
CC       Name=p26;
CC         IsoId=P36639-1; Sequence=Displayed;
CC         Note=Derived from a B-type mRNA with a polymorphic alteration
CC         (GU-->GC) at the beginning of exon 2c that converts an in-frame
CC         UGA to CGA yielding another in-frame AUG further upstream;
CC       Name=p22;
CC         IsoId=P36639-2; Sequence=VSP_018812;
CC       Name=p21;
CC         IsoId=P36639-3; Sequence=VSP_018813;
CC       Name=p18;
CC         IsoId=P36639-4; Sequence=VSP_018814;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest expression in
CC       thymus, testis, embryo and proliferating blood lymphocytes.
CC   -!- DEVELOPMENTAL STAGE: In peripheral blood lymphocytes, expressed at
CC       much higher levels in proliferating cells than in resting cells.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- POLYMORPHISM: A polymorphism between Met-1 and Met-19 removes a
CC       stop codon before the initiation codon for isoform p22 and gives
CC       rise to the production of isoform p26. The allele frequency of
CC       isoform p26 is about 20%.
CC   -!- SIMILARITY: Belongs to the Nudix hydrolase family.
CC   -!- SIMILARITY: Contains 1 nudix hydrolase domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nudt1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D16581; BAA04013.1; -; mRNA.
DR   EMBL; D38594; BAA07601.1; -; Genomic_DNA.
DR   EMBL; AB025233; BAA83791.1; -; mRNA.
DR   EMBL; AB025234; BAA83792.1; -; mRNA.
DR   EMBL; AB025235; BAA83793.1; -; mRNA.
DR   EMBL; AB025236; BAA83794.1; -; mRNA.
DR   EMBL; AB025237; BAA83795.1; -; mRNA.
DR   EMBL; AB025238; BAA83796.1; -; mRNA.
DR   EMBL; AB025239; BAA83797.1; -; mRNA.
DR   EMBL; AB025240; BAA83798.1; -; mRNA.
DR   EMBL; AB025241; BAA83799.1; -; mRNA.
DR   EMBL; AB025242; BAA83800.1; -; mRNA.
DR   EMBL; DQ230907; ABB02181.1; -; Genomic_DNA.
DR   EMBL; AC004971; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236953; EAL23948.1; -; Genomic_DNA.
DR   EMBL; CH471144; EAW87227.1; -; Genomic_DNA.
DR   EMBL; BC014618; AAH14618.1; -; mRNA.
DR   EMBL; BC040144; AAH40144.2; -; mRNA.
DR   EMBL; BC065367; AAH65367.1; -; mRNA.
DR   IPI; IPI00004392; -.
DR   IPI; IPI00396056; -.
DR   IPI; IPI00759462; -.
DR   IPI; IPI00759578; -.
DR   RefSeq; NP_002443.3; NM_002452.3.
DR   RefSeq; NP_945186.1; NM_198948.1.
DR   RefSeq; NP_945187.1; NM_198949.1.
DR   RefSeq; NP_945188.1; NM_198950.1.
DR   RefSeq; NP_945190.1; NM_198952.1.
DR   RefSeq; NP_945191.1; NM_198953.1.
DR   RefSeq; NP_945192.1; NM_198954.1.
DR   UniGene; Hs.534331; -.
DR   PDB; 1IRY; NMR; -; A=42-197.
DR   PDB; 3Q93; X-ray; 1.80 A; A/B=42-197.
DR   PDB; 3ZR0; X-ray; 1.80 A; A/B=42-197.
DR   PDB; 3ZR1; X-ray; 1.90 A; A/B=42-197.
DR   PDBsum; 1IRY; -.
DR   PDBsum; 3Q93; -.
DR   PDBsum; 3ZR0; -.
DR   PDBsum; 3ZR1; -.
DR   ProteinModelPortal; P36639; -.
DR   SMR; P36639; 44-197.
DR   IntAct; P36639; 4.
DR   STRING; P36639; -.
DR   DMDM; 254763430; -.
DR   PRIDE; P36639; -.
DR   DNASU; 4521; -.
DR   Ensembl; ENST00000343985; ENSP00000339503; ENSG00000106268.
DR   Ensembl; ENST00000397048; ENSP00000380241; ENSG00000106268.
DR   Ensembl; ENST00000397049; ENSP00000380242; ENSG00000106268.
DR   GeneID; 4521; -.
DR   KEGG; hsa:4521; -.
DR   UCSC; uc003slp.1; human.
DR   CTD; 4521; -.
DR   GeneCards; GC07P002248; -.
DR   HGNC; HGNC:8048; NUDT1.
DR   HPA; HPA012636; -.
DR   MIM; 600312; gene.
DR   neXtProt; NX_P36639; -.
DR   PharmGKB; PA31830; -.
DR   eggNOG; COG0494; -.
DR   GeneTree; ENSGT00390000000341; -.
DR   HOGENOM; HBG322338; -.
DR   HOVERGEN; HBG000032; -.
DR   InParanoid; P36639; -.
DR   KO; K03574; -.
DR   OMA; QWFQLDQ; -.
DR   EvolutionaryTrace; P36639; -.
DR   NextBio; 17452; -.
DR   ArrayExpress; P36639; -.
DR   Bgee; P36639; -.
DR   CleanEx; HS_NUDT1; -.
DR   Genevestigator; P36639; -.
DR   GermOnline; ENSG00000106268; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0035539; F:8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042262; P:DNA protection; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:InterPro.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   Gene3D; G3DSA:3.90.79.10; NUDIX_hydrolase; 1.
DR   InterPro; IPR020476; Nudix_hydrolase.
DR   InterPro; IPR020084; NUDIX_hydrolase_CS.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   InterPro; IPR015797; NUDIX_hydrolase_dom-like.
DR   InterPro; IPR003563; OxG-triPHTase.
DR   Pfam; PF00293; NUDIX; 1.
DR   PRINTS; PR01403; 8OXTPHPHTASE.
DR   PRINTS; PR00502; NUDIXFAMILY.
DR   SUPFAM; SSF55811; NUDIX_hydrolase; 1.
DR   PROSITE; PS51462; NUDIX; 1.
DR   PROSITE; PS00893; NUDIX_BOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Complete proteome;
KW   Direct protein sequencing; Hydrolase; Magnesium; Metal-binding;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    197       7,8-dihydro-8-oxoguanine triphosphatase.
FT                                /FTId=PRO_0000019944.
FT   DOMAIN       44    173       Nudix hydrolase.
FT   REGION       76     79       Substrate binding (Probable).
FT   MOTIF        78     99       Nudix box.
FT   METAL        78     78       Magnesium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        93     93       Magnesium (By similarity).
FT   METAL        96     96       Magnesium (By similarity).
FT   METAL        97     97       Magnesium (By similarity).
FT   VAR_SEQ       1     41       Missing (in isoform p18).
FT                                /FTId=VSP_018814.
FT   VAR_SEQ       1     26       Missing (in isoform p21).
FT                                /FTId=VSP_018813.
FT   VAR_SEQ       1     18       Missing (in isoform p22).
FT                                /FTId=VSP_018812.
FT   VARIANT     124    124       V -> M (in dbSNP:rs4866).
FT                                /FTId=VAR_013757.
FT   MUTAGEN      77     77       G->R: Reduces activity by 97%.
FT   MUTAGEN      78     78       G->F: Loss of activity.
FT   MUTAGEN      80     80       V->E: Loss of activity.
FT   MUTAGEN      81     81       Q->P: Reduces activity by 97%.
FT   MUTAGEN      83     83       G->I: Reduces activity by 60%.
FT   MUTAGEN      86     86       I->K: Loss of activity.
FT   MUTAGEN      88     88       D->P: Loss of activity.
FT   MUTAGEN      89     89       G->M: Loss of activity.
FT   MUTAGEN      90     90       A->P: Loss of activity.
FT   MUTAGEN      94     94       L->P: Loss of activity.
FT   MUTAGEN      95     95       Q->P: Loss of activity.
FT   MUTAGEN      96     96       E->G: Loss of activity.
FT   MUTAGEN      97     97       E->Y: Loss of activity.
FT   MUTAGEN      98     98       S->R: Loss of activity.
FT   STRAND       46     51
FT   STRAND       56     70
FT   HELIX        86     98
FT   STRAND      107    115
FT   STRAND      121    127
FT   STRAND      140    148
FT   TURN        155    157
FT   HELIX       161    170
FT   STRAND      173    184
FT   STRAND      186    194
SQ   SEQUENCE   197 AA;  22520 MW;  82AFF5E1CE287957 CRC64;
     MYWSNQITRR LGERVQGFMS GISPQQMGEP EGSWSGKNPG TMGASRLYTL VLVLQPQRVL
     LGMKKRGFGA GRWNGFGGKV QEGETIEDGA RRELQEESGL TVDALHKVGQ IVFEFVGEPE
     LMDVHVFCTD SIQGTPVESD EMRPCWFQLD QIPFKDMWPD DSYWFPLLLQ KKKFHGYFKF
     QGQDTILDYT LREVDTV
//
ID   A16A1_HUMAN             Reviewed;         802 AA.
AC   Q8IZ83; C9JBH6; Q86YF0; Q8IYL4; Q8TEI8;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 2.
DT   18-APR-2012, entry version 76.
DE   RecName: Full=Aldehyde dehydrogenase family 16 member A1;
GN   Name=ALDH16A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-227.
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human
RT   spleen.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-227.
RC   TISSUE=Lymph, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5]
RP   INTERACTION WITH SPG21.
RX   PubMed=19184135; DOI=10.1007/s10048-009-0172-6;
RA   Hanna M.C., Blackstone C.;
RT   "Interaction of the SPG21 protein ACP33/maspardin with the aldehyde
RT   dehydrogenase ALDH16A1.";
RL   Neurogenetics 10:217-228(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- SUBUNIT: Interacts with SPG21.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IZ83-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IZ83-2; Sequence=VSP_029982, VSP_029983;
CC         Note=No experimental confirmation available;
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC   -!- CAUTION: The active site cysteine and glutamate residues are not
CC       conserved in this protein. Its activity is therefore unsure.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH35641.1; Type=Erroneous initiation;
CC       Sequence=BAB84962.1; Type=Erroneous translation; Note=Wrong choice of frame;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK074136; BAB84962.1; ALT_SEQ; mRNA.
DR   EMBL; AC010619; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014895; AAH14895.2; -; mRNA.
DR   EMBL; BC035641; AAH35641.1; ALT_INIT; mRNA.
DR   EMBL; BC042142; AAH42142.1; -; mRNA.
DR   IPI; IPI00217920; -.
DR   IPI; IPI00646424; -.
DR   RefSeq; NP_699160.2; NM_153329.3.
DR   UniGene; Hs.719998; -.
DR   ProteinModelPortal; Q8IZ83; -.
DR   SMR; Q8IZ83; 36-495, 519-794.
DR   IntAct; Q8IZ83; 7.
DR   STRING; Q8IZ83; -.
DR   PhosphoSite; Q8IZ83; -.
DR   DMDM; 269849532; -.
DR   PRIDE; Q8IZ83; -.
DR   Ensembl; ENST00000293350; ENSP00000293350; ENSG00000161618.
DR   GeneID; 126133; -.
DR   KEGG; hsa:126133; -.
DR   UCSC; uc002pnt.3; human.
DR   CTD; 126133; -.
DR   GeneCards; GC19P049958; -.
DR   HGNC; HGNC:28114; ALDH16A1.
DR   MIM; 613358; gene.
DR   neXtProt; NX_Q8IZ83; -.
DR   PharmGKB; PA134903503; -.
DR   eggNOG; COG1012; -.
DR   GeneTree; ENSGT00560000077032; -.
DR   HOGENOM; HBG752218; -.
DR   HOVERGEN; HBG069396; -.
DR   InParanoid; Q8IZ83; -.
DR   OMA; CPIPALE; -.
DR   OrthoDB; EOG4CNQQG; -.
DR   PhylomeDB; Q8IZ83; -.
DR   NextBio; 81700; -.
DR   ArrayExpress; Q8IZ83; -.
DR   Bgee; Q8IZ83; -.
DR   CleanEx; HS_ALDH16A1; -.
DR   Genevestigator; Q8IZ83; -.
DR   GO; GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IEA:InterPro.
DR   Gene3D; G3DSA:3.40.309.10; Aldehyde_dehydrogenase_C; 1.
DR   Gene3D; G3DSA:3.40.605.10; Aldehyde_dehydrogenase_N; 2.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR011408; Aldehyde_DH.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 2.
DR   PIRSF; PIRSF036490; Aldedh_dupl; 1.
DR   SUPFAM; SSF53720; Aldehyde_DH/Histidinol_DH; 2.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; FALSE_NEG.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    802       Aldehyde dehydrogenase family 16 member
FT                                A1.
FT                                /FTId=PRO_0000312986.
FT   MOD_RES      50     50       N6-acetyllysine.
FT   VAR_SEQ     254    308       EGRALRRSLAGECAELGLALGTESLLLLTDTADVDSAVEGV
FT                                VDAAWSDRGPGGLR -> VPSGQGSWRNAAGGRKAPPAAEL
FT                                GGVPRKGVPFDGAWRESVRSWAWRWGRSRCCC (in
FT                                isoform 2).
FT                                /FTId=VSP_029982.
FT   VAR_SEQ     309    802       Missing (in isoform 2).
FT                                /FTId=VSP_029983.
FT   VARIANT     110    110       E -> K (in dbSNP:rs3745312).
FT                                /FTId=VAR_037638.
FT   VARIANT     227    227       L -> V (in dbSNP:rs1320303).
FT                                /FTId=VAR_037639.
SQ   SEQUENCE   802 AA;  85127 MW;  2820628CD0EF5823 CRC64;
     MAATRAGPRA REIFTSLEYG PVPESHACAL AWLDTQDRCL GHYVNGKWLK PEHRNSVPCQ
     DPITGENLAS CLQAQAEDVA AAVEAARMAF KGWSAHPGVV RAQHLTRLAE VIQKHQRLLW
     TLESLVTGRA VREVRDGDVQ LAQQLLHYHA IQASTQEEAL AGWEPMGVIG LILPPTFSFL
     EMMWRICPAL AVGCTVVALV PPASPAPLLL AQLAGELGPF PGILNVLSGP ASLVPILASQ
     PGIRKVAFCG APEEGRALRR SLAGECAELG LALGTESLLL LTDTADVDSA VEGVVDAAWS
     DRGPGGLRLL IQESVWDEAM RRLQERMGRL RSGRGLDGAV DMGARGAAAC DLVQRFVREA
     QSQGAQVFQA GDVPSERPFY PPTLVSNLPP ASPCAQVEVP WPVVVASPFR TAKEALLVAN
     GTPRGGSASV WSERLGQALE LGYGLQVGTV WINAHGLRDP SVPTGGCKES GCSWHGGPDG
     LYEYLRPSGT PARLSCLSKN LNYDTFGLAV PSTLPAGPEI GPSPAPPYGL FVGGRFQAPG
     ARSSRPIRDS SGNLHGYVAE GGAKDIRGAV EAAHQAFPGW AGQSPGARAA LLWALAAALE
     RRKSTLASRL ERQGAELKAA EAEVELSARR LRAWGARVQA QGHTLQVAGL RGPVLRLREP
     LGVLAVVCPD EWPLLAFVSL LAPALAYGNT VVMVPSAACP LLALEVCQDM ATVFPAGLAN
     VVTGDRDHLT RCLALHQDVQ AMWYFGSAQG SQFVEWASAG NLKPVWASRG CPRAWDQEAE
     GAGPELGLRV ARTKALWLPM GD
//
ID   A16L1_HUMAN             Reviewed;         607 AA.
AC   Q676U5; A3EXK9; Q6IPN1; Q6UXW4; Q6ZVZ5; Q8NCY2; Q96JV5; Q9H619;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 2.
DT   18-APR-2012, entry version 88.
DE   RecName: Full=Autophagy-related protein 16-1;
DE   AltName: Full=APG16-like 1;
GN   Name=ATG16L1; Synonyms=APG16L; ORFNames=UNQ9393/PRO34307;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-300.
RC   TISSUE=Fetal brain;
RX   PubMed=15620219; DOI=10.1080/10425170400004104;
RA   Zheng H., Ji C., Li J., Jiang H., Ren M., Lu Q., Gu S., Mao Y.,
RA   Xie Y.;
RT   "Cloning and analysis of human Apg16L.";
RL   DNA Seq. 15:303-305(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ASSOCIATION OF VARIANT
RP   ALA-300 WITH SUSCEPTIBILITY TO IBD10.
RX   PubMed=17200669; DOI=10.1038/ng1954;
RA   Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K.,
RA   Albrecht M., Mayr G., De La Vega F.M., Briggs J., Guenther S.,
RA   Prescott N.J., Onnie C.M., Haesler R., Sipos B., Foelsch U.R.,
RA   Lengauer T., Platzer M., Mathew C.G., Krawczak M., Schreiber S.;
RT   "A genome-wide association scan of nonsynonymous SNPs identifies a
RT   susceptibility variant for Crohn disease in ATG16L1.";
RL   Nat. Genet. 39:207-211(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   MEDLINE=22887296; PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 55-607 (ISOFORM 2).
RC   TISSUE=Brain, Placenta, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 114-607 (ISOFORM 2).
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 513-607.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287; SER-290 AND
RP   SER-304, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ASSOCIATION OF VARIANT ALA-300 WITH SUSCEPTIBILITY TO IBD10.
RX   PubMed=17435756; DOI=10.1038/ng2032;
RA   Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P.,
RA   Huett A., Green T., Kuballa P., Barmada M.M., Datta L.W.,
RA   Shugart Y.Y., Griffiths A.M., Targan S.R., Ippoliti A.F.,
RA   Bernard E.-J., Mei L., Nicolae D.L., Regueiro M., Schumm L.P.,
RA   Steinhart A.H., Rotter J.I., Duerr R.H., Cho J.H., Daly M.J.,
RA   Brant S.R.;
RT   "Genome-wide association study identifies new susceptibility loci for
RT   Crohn disease and implicates autophagy in disease pathogenesis.";
RL   Nat. Genet. 39:596-604(2007).
CC   -!- FUNCTION: Plays an essential role in autophagy (By similarity).
CC   -!- SUBUNIT: Homooligomer. Interacts with ATG5. Part of either the
CC       minor and major complexes respectively composed of 4 sets of
CC       ATG12-ATG5 and ATG16L1 (400 kDa) or 8 sets of ATG12-ATG5 and
CC       ATG16L1 (800 kDa) (By similarity).
CC   -!- INTERACTION:
CC       Q9GZQ8:MAP1LC3B; NbExp=2; IntAct=EBI-535909, EBI-373144;
CC       Q9BXW4:MAP1LC3C; NbExp=4; IntAct=EBI-535909, EBI-2603996;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Preautophagosomal
CC       structure membrane; Peripheral membrane protein (By similarity).
CC       Note=Localized to preautophagosomal structure (PAS) where it is
CC       involved in the membrane targeting of ATG5 (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=APG16L beta;
CC         IsoId=Q676U5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q676U5-2; Sequence=VSP_013386;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay;
CC       Name=3;
CC         IsoId=Q676U5-3; Sequence=VSP_013387, VSP_013388;
CC         Note=No experimental confirmation available;
CC       Name=4;
CC         IsoId=Q676U5-4; Sequence=VSP_013389, VSP_013390;
CC         Note=No experimental confirmation available;
CC   -!- DISEASE: Genetic variations in ATG16L1 are associated with
CC       susceptibility to inflammatory bowel disease type 10 (IBD10)
CC       [MIM:611081]. IBD is characterized by a chronic relapsing
CC       intestinal inflammation. IBD is subdivided into Crohn disease (CD)
CC       and ulcerative colitis phenotypes. IBD10 individuals show the
CC       phenotype characteristic to CD. It may involve any part of the
CC       gastrointestinal tract, but most frequently the terminal ileum and
CC       colon. CD is commonly classified as autoimmune disease.
CC   -!- SIMILARITY: Belongs to the WD repeat ATG16 family.
CC   -!- SIMILARITY: Contains 7 WD repeats.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15448.1; Type=Erroneous translation; Note=Wrong choice of CDS;
CC       Sequence=BAB55412.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY398617; AAR32130.1; -; mRNA.
DR   EMBL; EF079889; ABN48554.1; -; mRNA.
DR   EMBL; AY358182; AAQ88549.1; -; mRNA.
DR   EMBL; AK026330; BAB15448.1; ALT_SEQ; mRNA.
DR   EMBL; AK027854; BAB55412.1; ALT_INIT; mRNA.
DR   EMBL; AK123876; BAC85713.1; -; mRNA.
DR   EMBL; CH471063; EAW71034.1; -; Genomic_DNA.
DR   EMBL; BC071846; AAH71846.1; -; mRNA.
DR   EMBL; AL834526; CAD39182.1; -; mRNA.
DR   IPI; IPI00432751; -.
DR   IPI; IPI00446614; -.
DR   IPI; IPI00470446; -.
DR   IPI; IPI00555905; -.
DR   RefSeq; NP_001177195.1; NM_001190266.1.
DR   RefSeq; NP_001177196.1; NM_001190267.1.
DR   RefSeq; NP_060444.3; NM_017974.3.
DR   RefSeq; NP_110430.5; NM_030803.6.
DR   RefSeq; NP_942593.2; NM_198890.2.
DR   UniGene; Hs.529322; -.
DR   ProteinModelPortal; Q676U5; -.
DR   SMR; Q676U5; 310-606.
DR   DIP; DIP-27552N; -.
DR   IntAct; Q676U5; 20.
DR   MINT; MINT-1141152; -.
DR   STRING; Q676U5; -.
DR   PhosphoSite; Q676U5; -.
DR   DMDM; 62510482; -.
DR   PRIDE; Q676U5; -.
DR   DNASU; 55054; -.
DR   Ensembl; ENST00000392017; ENSP00000375872; ENSG00000085978.
DR   GeneID; 55054; -.
DR   KEGG; hsa:55054; -.
DR   UCSC; uc002vty.3; human.
DR   UCSC; uc002vtz.3; human.
DR   UCSC; uc002vua.3; human.
DR   CTD; 55054; -.
DR   GeneCards; GC02P234118; -.
DR   HGNC; HGNC:21498; ATG16L1.
DR   HPA; HPA012577; -.
DR   MIM; 610767; gene.
DR   MIM; 611081; phenotype.
DR   neXtProt; NX_Q676U5; -.
DR   Orphanet; 206; Crohn disease.
DR   PharmGKB; PA134902949; -.
DR   eggNOG; COG2319; -.
DR   GeneTree; ENSGT00650000093357; -.
DR   HOVERGEN; HBG050534; -.
DR   OrthoDB; EOG4SXNC8; -.
DR   NextBio; 58531; -.
DR   ArrayExpress; Q676U5; -.
DR   Bgee; Q676U5; -.
DR   CleanEx; HS_ATG16L1; -.
DR   Genevestigator; Q676U5; -.
DR   GermOnline; ENSG00000085978; Homo sapiens.
DR   GO; GO:0005776; C:autophagic vacuole; ISS:UniProtKB.
DR   GO; GO:0034045; C:pre-autophagosomal structure membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0000045; P:autophagic vacuole assembly; NAS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; NAS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 2.
DR   InterPro; IPR013923; Autophagy-rel_prot_16.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF08614; ATG16; 1.
DR   Pfam; PF00400; WD40; 5.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; WD40_like; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 3.
DR   PROSITE; PS50082; WD_REPEATS_2; 6.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autophagy; Coiled coil; Complete proteome;
KW   Cytoplasm; Membrane; Phosphoprotein; Polymorphism; Protein transport;
KW   Reference proteome; Repeat; Transport; WD repeat.
FT   CHAIN         1    607       Autophagy-related protein 16-1.
FT                                /FTId=PRO_0000050848.
FT   REPEAT      320    359       WD 1.
FT   REPEAT      364    403       WD 2.
FT   REPEAT      406    445       WD 3.
FT   REPEAT      447    484       WD 4.
FT   REPEAT      486    525       WD 5.
FT   REPEAT      532    573       WD 6.
FT   REPEAT      575    607       WD 7.
FT   COILED       78    230       Potential.
FT   MOD_RES     287    287       Phosphoserine.
FT   MOD_RES     289    289       Phosphoserine (By similarity).
FT   MOD_RES     290    290       Phosphoserine.
FT   MOD_RES     304    304       Phosphoserine.
FT   VAR_SEQ      70    213       Missing (in isoform 4).
FT                                /FTId=VSP_013389.
FT   VAR_SEQ     266    284       Missing (in isoform 2).
FT                                /FTId=VSP_013386.
FT   VAR_SEQ     334    368       Missing (in isoform 4).
FT                                /FTId=VSP_013390.
FT   VAR_SEQ     443    470       IKTVFAGSSCNDIVCTEQCVMSGHFDKK -> EEIQSLCLC
FT                                ICLDVSVEVCVCTSEPAFM (in isoform 3).
FT                                /FTId=VSP_013387.
FT   VAR_SEQ     471    607       Missing (in isoform 3).
FT                                /FTId=VSP_013388.
FT   VARIANT     300    300       T -> A (associated with susceptibility to
FT                                IBD10; dbSNP:rs2241880).
FT                                /FTId=VAR_021834.
FT   VARIANT     307    307       E -> K (in dbSNP:rs1866878).
FT                                /FTId=VAR_053386.
FT   CONFLICT    151    151       K -> R (in Ref. 5; BAB55412).
FT   CONFLICT    328    328       V -> A (in Ref. 5; BAB55412).
FT   CONFLICT    529    529       P -> T (in Ref. 5; BAB55412).
SQ   SEQUENCE   607 AA;  68265 MW;  5A5816AE2CF03CA0 CRC64;
     MSSGLRAADF PRWKRHISEQ LRRRDRLQRQ AFEEIILQYN KLLEKSDLHS VLAQKLQAEK
     HDVPNRHEIS PGHDGTWNDN QLQEMAQLRI KHQEELTELH KKRGELAQLV IDLNNQMQRK
     DREMQMNEAK IAECLQTISD LETECLDLRT KLCDLERANQ TLKDEYDALQ ITFTALEGKL
     RKTTEENQEL VTRWMAEKAQ EANRLNAENE KDSRRRQARL QKELAEAAKE PLPVEQDDDI
     EVIVDETSDH TEETSPVRAI SRAATKRLSQ PAGGLLDSIT NIFGRRSVSS FPVPQDNVDT
     HPGSGKEVRV PATALCVFDA HDGEVNAVQF SPGSRLLATG GMDRRVKLWE VFGEKCEFKG
     SLSGSNAGIT SIEFDSAGSY LLAASNDFAS RIWTVDDYRL RHTLTGHSGK VLSAKFLLDN
     ARIVSGSHDR TLKLWDLRSK VCIKTVFAGS SCNDIVCTEQ CVMSGHFDKK IRFWDIRSES
     IVREMELLGK ITALDLNPER TELLSCSRDD LLKVIDLRTN AIKQTFSAPG FKCGSDWTRV
     VFSPDGSYVA AGSAEGSLYI WSVLTGKVEK VLSKQHSSSI NAVAWSPSGS HVVSVDKGCK
     AVLWAQY
//
ID   A16L2_HUMAN             Reviewed;         619 AA.
AC   Q8NAA4; A5PL30; B2RPK5; Q658V4; Q6PID3; Q8NBG0;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   18-APR-2012, entry version 74.
DE   RecName: Full=Autophagy-related protein 16-2;
DE   AltName: Full=APG16-like 2;
DE   AltName: Full=WD repeat-containing protein 80;
GN   Name=ATG16L2; Synonyms=WDR80;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Astrocyte, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 297-619.
RC   TISSUE=Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
CC   -!- FUNCTION: May play a role in autophagy (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NAA4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NAA4-2; Sequence=VSP_033904;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q8NAA4-3; Sequence=VSP_033905;
CC         Note=No experimental confirmation available;
CC   -!- SIMILARITY: Belongs to the WD repeat ATG16 family.
CC   -!- SIMILARITY: Contains 7 WD repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK093017; BAC04021.1; -; mRNA.
DR   EMBL; AK090597; BAC03485.1; -; mRNA.
DR   EMBL; CH471076; EAW74876.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74874.1; -; Genomic_DNA.
DR   EMBL; BC036713; AAH36713.1; -; mRNA.
DR   EMBL; BC137489; AAI37490.1; -; mRNA.
DR   EMBL; BC137490; AAI37491.1; -; mRNA.
DR   EMBL; BC142718; AAI42719.1; -; mRNA.
DR   EMBL; BC146660; AAI46661.1; -; mRNA.
DR   EMBL; AL832974; CAH56355.1; -; mRNA.
DR   IPI; IPI00300536; -.
DR   IPI; IPI00892538; -.
DR   IPI; IPI00892678; -.
DR   RefSeq; NP_203746.1; NM_033388.1.
DR   UniGene; Hs.653186; -.
DR   ProteinModelPortal; Q8NAA4; -.
DR   SMR; Q8NAA4; 327-619.
DR   IntAct; Q8NAA4; 3.
DR   PhosphoSite; Q8NAA4; -.
DR   DMDM; 189027648; -.
DR   PRIDE; Q8NAA4; -.
DR   Ensembl; ENST00000321297; ENSP00000326340; ENSG00000168010.
DR   GeneID; 89849; -.
DR   KEGG; hsa:89849; -.
DR   UCSC; uc001otd.3; human.
DR   CTD; 89849; -.
DR   GeneCards; GC11P072525; -.
DR   H-InvDB; HIX0009913; -.
DR   HGNC; HGNC:25464; ATG16L2.
DR   neXtProt; NX_Q8NAA4; -.
DR   PharmGKB; PA142672575; -.
DR   eggNOG; COG2319; -.
DR   GeneTree; ENSGT00650000093357; -.
DR   HOGENOM; HBG564640; -.
DR   HOVERGEN; HBG050534; -.
DR   InParanoid; Q8NAA4; -.
DR   OMA; LRVKWQE; -.
DR   OrthoDB; EOG44F68R; -.
DR   PhylomeDB; Q8NAA4; -.
DR   NextBio; 76342; -.
DR   ArrayExpress; Q8NAA4; -.
DR   Bgee; Q8NAA4; -.
DR   CleanEx; HS_ATG16L2; -.
DR   Genevestigator; Q8NAA4; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 1.
DR   InterPro; IPR013923; Autophagy-rel_prot_16.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF08614; ATG16; 1.
DR   Pfam; PF00400; WD40; 4.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; WD40_like; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 3.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Autophagy; Coiled coil; Complete proteome;
KW   Cytoplasm; Polymorphism; Protein transport; Reference proteome;
KW   Repeat; Transport; WD repeat.
FT   CHAIN         1    619       Autophagy-related protein 16-2.
FT                                /FTId=PRO_0000337110.
FT   REPEAT      334    373       WD 1.
FT   REPEAT      378    417       WD 2.
FT   REPEAT      420    454       WD 3.
FT   REPEAT      455    498       WD 4.
FT   REPEAT      500    539       WD 5.
FT   REPEAT      546    585       WD 6.
FT   REPEAT      589    619       WD 7.
FT   COILED      116    227       Potential.
FT   VAR_SEQ       1    106       Missing (in isoform 2).
FT                                /FTId=VSP_033904.
FT   VAR_SEQ     276    619       Missing (in isoform 3).
FT                                /FTId=VSP_033905.
FT   VARIANT     220    220       R -> W (in dbSNP:rs11235604).
FT                                /FTId=VAR_043605.
FT   CONFLICT    124    124       E -> G (in Ref. 1; BAC03485).
FT   CONFLICT    256    256       A -> V (in Ref. 3; AAH36713).
FT   CONFLICT    343    343       R -> G (in Ref. 1; BAC03485).
FT   CONFLICT    492    492       G -> E (in Ref. 1; BAC04021).
FT   CONFLICT    508    508       L -> R (in Ref. 4; CAH56355).
SQ   SEQUENCE   619 AA;  68998 MW;  7F2962AA3C6BB850 CRC64;
     MAGPGVPGAP AARWKRHIVR QLRLRDRTQK ALFLELVPAY NHLLEKAELL DKFSKKLQPE
     PNSVTPTTHQ GPWEESELDS DQVPSLVALR VKWQEEEEGL RLVCGEMAYQ VVEKGAALGT
     LESELQQRQS RLAALEARVA QLREARAQQA QQVEEWRAQN AVQRAAYEAL RAHVGLREAA
     LRRLQEEARD LLERLVQRKA RAAAERNLRN ERRERAKQAR VSQELKKAAK RTVSISEGPD
     TLGDGMRERR ETLALAPEPE PLEKEACEKW KRPFRSASAT SLTLSHCVDV VKGLLDFKKR
     RGHSIGGAPE QRYQIIPVCV AARLPTRAQD VLDAHLSEVN AVRFGPNSSL LATGGADRLI
     HLWNVVGSRL EANQTLEGAG GSITSVDFDP SGYQVLAATY NQAAQLWKVG EAQSKETLSG
     HKDKVTAAKF KLTRHQAVTG SRDRTVKEWD LGRAYCSRTI NVLSYCNDVV CGDHIIISGH
     NDQKIRFWDS RGPHCTQVIP VQGRVTSLSL SHDQLHLLSC SRDNTLKVID LRVSNIRQVF
     RADGFKCGSD WTKAVFSPDR SYALAGSCDG ALYIWDVDTG KLESRLQGPH CAAVNAVAWC
     YSGSHMVSVD QGRKVVLWQ
//
ID   A1AG1_HUMAN             Reviewed;         201 AA.
AC   P02763; B7ZKQ5; Q5T539; Q5U067; Q8TC16;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   18-APR-2012, entry version 140.
DE   RecName: Full=Alpha-1-acid glycoprotein 1;
DE            Short=AGP 1;
DE   AltName: Full=Orosomucoid-1;
DE            Short=OMD 1;
DE   Flags: Precursor;
GN   Name=ORM1; Synonyms=AGP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=88029318; PubMed=2822385;
RA   Dente L., Pizza M.G., Metspalu A., Cortese R.;
RT   "Structure and expression of the genes coding for human alpha 1-acid
RT   glycoprotein.";
RL   EMBO J. 6:2289-2296(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=87031577; PubMed=3770479; DOI=10.1016/0378-1119(86)90051-X;
RA   Board P.G., Jones I.M., Bentley A.K.;
RT   "Molecular cloning and nucleotide sequence of human alpha 1 acid
RT   glycoprotein cDNA.";
RL   Gene 44:127-131(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=85242080; PubMed=2409529; DOI=10.1093/nar/13.11.3941;
RA   Dente L., Ciliberto G., Cortese R.;
RT   "Structure of the human alpha 1-acid glycoprotein gene: sequence
RT   homology with other human acute phase protein genes.";
RL   Nucleic Acids Res. 13:3941-3952(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-38.
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-38.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-38; CYS-167
RP   AND MET-174.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 19-129.
RX   MEDLINE=73197484; PubMed=4711474; DOI=10.1021/bi00738a026;
RA   Schmid K., Kaufmann H., Isemura S., Bauer F., Emura J., Motoyama T.,
RA   Ishiguro M., Nanno S.;
RT   "Structure of alpha 1-acid glycoprotein. The complete amino acid
RT   sequence, multiple amino acid substitutions, and homology with the
RT   immunoglobulins.";
RL   Biochemistry 12:2711-2724(1973).
RN   [10]
RP   PROTEIN SEQUENCE OF 129-201.
RX   MEDLINE=73006944; PubMed=4561179; DOI=10.1021/bi00770a022;
RA   Ikenaka T., Ishiguro M., Emura J., Kaufmann H., Isemura S., Bauer W.,
RA   Schmid K.;
RT   "Isolation and partial characterization of the cyanogen bromide
RT   fragments of alpha 1-acid glycoprotein and the elucidation of the
RT   amino acid sequence of the carboxyl-terminal cyanogen bromide
RT   fragment.";
RL   Biochemistry 11:3817-3829(1972).
RN   [11]
RP   DISULFIDE BONDS.
RX   MEDLINE=74290014; PubMed=4603214; DOI=10.1021/bi00710a006;
RA   Schmid K., Buergi W., Collins J.H., Nanno S.;
RT   "The disulfide bonds of alpha1-acid glycoprotein.";
RL   Biochemistry 13:2694-2697(1974).
RN   [12]
RP   GLYCOSYLATION AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103.
RX   MEDLINE=92231810; PubMed=1567356;
RA   Treuheit M.J., Costello C.E., Halsall H.B.;
RT   "Analysis of the five glycosylation sites of human alpha 1-acid
RT   glycoprotein.";
RL   Biochem. J. 283:105-112(1992).
RN   [13]
RP   GLYCOSYLATION AT ASN-33.
RX   MEDLINE=22660472; PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [14]
RP   GLYCOSYLATION AT ASN-33; ASN-72 AND ASN-93, AND MASS SPECTROMETRY.
RX   PubMed=15253437; DOI=10.1021/pr034112b;
RA   Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P.;
RT   "A new strategy for identification of N-glycosylated proteins and
RT   unambiguous assignment of their glycosylation sites using HILIC
RT   enrichment and partial deglycosylation.";
RL   J. Proteome Res. 3:556-566(2004).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33 AND ASN-93, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Bile;
RX   PubMed=15084671; DOI=10.1074/mcp.M400015-MCP200;
RA   Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,
RA   Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
RT   "A proteomic analysis of human bile.";
RL   Mol. Cell. Proteomics 3:715-728(2004).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93
RP   AND ASN-103, AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93
RP   AND ASN-103, AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [18]
RP   FUNCTION.
RX   PubMed=17008009; DOI=10.1016/j.bbagen.2006.08.015;
RA   Fitos I., Visy J., Zsila F., Mady G., Simonyi M.;
RT   "Selective binding of imatinib to the genetic variants of human
RT   alpha1-acid glycoprotein.";
RL   Biochim. Biophys. Acta 1760:1704-1712(2006).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93, AND MASS SPECTROMETRY.
RC   TISSUE=Saliva;
RX   PubMed=16740002; DOI=10.1021/pr050492k;
RA   Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,
RA   Loo J.A.;
RT   "Identification of N-linked glycoproteins in human saliva by
RT   glycoprotein capture and mass spectrometry.";
RL   J. Proteome Res. 5:1493-1503(2006).
RN   [20]
RP   FUNCTION.
RX   PubMed=17321687; DOI=10.1016/j.bbagen.2007.01.009;
RA   Zsila F., Iwao Y.;
RT   "The drug binding site of human alpha1-acid glycoprotein: insight from
RT   induced circular dichroism and electronic absorption spectra.";
RL   Biochim. Biophys. Acta 1770:797-809(2007).
RN   [21]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93 AND ASN-103, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [22]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33 AND ASN-72, STRUCTURE
RP   OF CARBOHYDRATES, AND MASS SPECTROMETRY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [23]
RP   GLYCOSYLATION AT ASN-33, STRUCTURE OF CARBOHYDRATES, AND MASS
RP   SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 20-201, DOMAIN, AND DISULFIDE
RP   BONDS.
RX   PubMed=18823996; DOI=10.1016/j.jmb.2008.09.020;
RA   Schonfeld D.L., Ravelli R.B., Mueller U., Skerra A.;
RT   "The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid)
RT   solved by UV RIP reveals the broad drug-binding activity of this human
RT   plasma lipocalin.";
RL   J. Mol. Biol. 384:393-405(2008).
RN   [25]
RP   VARIANTS ARG-38 AND MET-174.
RX   MEDLINE=97203211; PubMed=9050929; DOI=10.1007/s004390050378;
RA   Yuasa I., Umetsu K., Vogt U., Nakamura H., Nanba E., Tamaki N.,
RA   Irizawa Y.;
RT   "Human orosomucoid polymorphism: molecular basis of the three common
RT   ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S.";
RL   Hum. Genet. 99:393-398(1997).
CC   -!- FUNCTION: Functions as transport protein in the blood stream.
CC       Binds various ligands in the interior of its beta-barrel domain.
CC       Also binds synthetic drugs and influences their distribution and
CC       availability in the body. Appears to function in modulating the
CC       activity of the immune system during the acute-phase reaction.
CC   -!- INTERACTION:
CC       P05121:SERPINE1; NbExp=4; IntAct=EBI-976767, EBI-953978;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
CC   -!- INDUCTION: Synthesis is controlled by glucocorticoids,
CC       interleukin-1 and interleukin-6, It increases 5- to 50-fold upon
CC       inflammation.
CC   -!- DOMAIN: Contains a beta-barrel that binds various ligands in its
CC       interior.
CC   -!- PTM: N-glycosylated. N-glycan heterogeneity at Asn-33: Hex5HexNAc4
CC       (minor), Hex6HexNAc5 (major) and dHex1Hex6HexNAc5 (minor).
CC   -!- POLYMORPHISM: Three common alleles of ORM1 are known. ORM1*F1 has
CC       Gln-38/Val-174; ORM1*F2 has Gln-38/Met-174 and ORM1*S has Arg-
CC       38/Val-174. The sequence shown is that of allele ORM1*F1.
CC   -!- SIMILARITY: Belongs to the calycin superfamily. Lipocalin family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA29229.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X02544; CAA26397.1; -; mRNA.
DR   EMBL; M13692; AAA35515.1; -; mRNA.
DR   EMBL; X05779; CAA29229.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X05780; CAA29229.1; JOINED; Genomic_DNA.
DR   EMBL; X05781; CAA29229.1; JOINED; Genomic_DNA.
DR   EMBL; X05782; CAA29229.1; JOINED; Genomic_DNA.
DR   EMBL; X05783; CAA29229.1; JOINED; Genomic_DNA.
DR   EMBL; X05784; CAA29229.1; JOINED; Genomic_DNA.
DR   EMBL; X06676; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X06680; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BT019790; AAV38593.1; -; mRNA.
DR   EMBL; AK312035; BAG34972.1; -; mRNA.
DR   EMBL; AL356796; CAI16859.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87416.1; -; Genomic_DNA.
DR   EMBL; BC104818; AAI04819.1; -; mRNA.
DR   EMBL; BC104820; AAI04821.1; -; mRNA.
DR   EMBL; BC143313; AAI43314.1; -; mRNA.
DR   EMBL; BC143314; AAI43315.1; -; mRNA.
DR   EMBL; BC026238; AAH26238.1; -; mRNA.
DR   IPI; IPI00022429; -.
DR   PIR; A28346; OMHU1.
DR   RefSeq; NP_000598.2; NM_000607.2.
DR   UniGene; Hs.522356; -.
DR   PDB; 3KQ0; X-ray; 1.80 A; A=20-201.
DR   PDBsum; 3KQ0; -.
DR   ProteinModelPortal; P02763; -.
DR   IntAct; P02763; 7.
DR   STRING; P02763; -.
DR   GlycoSuiteDB; P02763; -.
DR   DMDM; 112877; -.
DR   Siena-2DPAGE; P02763; -.
DR   SWISS-2DPAGE; P02763; -.
DR   PeptideAtlas; P02763; -.
DR   PRIDE; P02763; -.
DR   DNASU; 5004; -.
DR   Ensembl; ENST00000259396; ENSP00000259396; ENSG00000229314.
DR   GeneID; 5004; -.
DR   KEGG; hsa:5004; -.
DR   UCSC; uc004bik.4; human.
DR   CTD; 5004; -.
DR   GeneCards; GC09P117085; -.
DR   HGNC; HGNC:8498; ORM1.
DR   HPA; CAB006265; -.
DR   MIM; 138600; gene.
DR   neXtProt; NX_P02763; -.
DR   PharmGKB; PA260; -.
DR   eggNOG; NOG41523; -.
DR   GeneTree; ENSGT00390000012130; -.
DR   HOGENOM; HBG126438; -.
DR   HOVERGEN; HBG000035; -.
DR   InParanoid; P02763; -.
DR   OrthoDB; EOG4V9TS3; -.
DR   DrugBank; DB01418; Acenocoumarol.
DR   DrugBank; DB00802; Alfentanil.
DR   DrugBank; DB01429; Aprindine.
DR   DrugBank; DB00280; Disopyramide.
DR   DrugBank; DB01359; Penbutolol.
DR   DrugBank; DB00946; Phenprocoumon.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00706; Tamsulosin.
DR   EvolutionaryTrace; P02763; -.
DR   NextBio; 19272; -.
DR   ArrayExpress; P02763; -.
DR   Bgee; P02763; -.
DR   CleanEx; HS_ORM1; -.
DR   Genevestigator; P02763; -.
DR   GermOnline; ENSG00000187681; Homo sapiens.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0006953; P:acute-phase response; TAS:ProtInc.
DR   GO; GO:0002682; P:regulation of immune system process; IEA:InterPro.
DR   GO; GO:0006810; P:transport; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.40.128.20; Calycin; 1.
DR   InterPro; IPR001500; A1A_glycop.
DR   InterPro; IPR012674; Calycin.
DR   InterPro; IPR011038; Calycin-like.
DR   InterPro; IPR000566; Lipocln_cytosolic_FA-bd_dom.
DR   PANTHER; PTHR11967; A1A_glycop; 1.
DR   Pfam; PF00061; Lipocalin; 1.
DR   PIRSF; PIRSF036899; AGP; 1.
DR   PRINTS; PR00708; A1AGLPROTEIN.
DR   SUPFAM; SSF50814; Calycin; 1.
DR   PROSITE; PS00213; LIPOCALIN; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Acute phase; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Polymorphism;
KW   Pyrrolidone carboxylic acid; Reference proteome; Secreted; Signal;
KW   Transport.
FT   SIGNAL        1     18
FT   CHAIN        19    201       Alpha-1-acid glycoprotein 1.
FT                                /FTId=PRO_0000017860.
FT   MOD_RES      19     19       Pyrrolidone carboxylic acid.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) (complex).
FT   CARBOHYD     56     56       N-linked (GlcNAc...).
FT   CARBOHYD     72     72       N-linked (GlcNAc...) (complex).
FT   CARBOHYD     93     93       N-linked (GlcNAc...).
FT   CARBOHYD    103    103       N-linked (GlcNAc...).
FT                                /FTId=CAR_000170.
FT   DISULFID     23    165
FT   DISULFID     90    183
FT   VARIANT      38     38       Q -> R (in allele ORM1*S).
FT                                /FTId=VAR_013840.
FT   VARIANT     167    167       R -> C (in dbSNP:rs3182034).
FT                                /FTId=VAR_056166.
FT   VARIANT     174    174       V -> M (in allele ORM1*F2;
FT                                dbSNP:rs1126801).
FT                                /FTId=VAR_013841.
FT   CONFLICT    170    170       K -> R (in Ref. 8; AAI43315).
FT   CONFLICT    182    182       Missing (in Ref. 10; AA sequence).
FT   CONFLICT    193    193       Missing (in Ref. 10; AA sequence).
FT   HELIX        24     26
FT   HELIX        33     39
FT   STRAND       43     48
FT   HELIX        53     59
FT   STRAND       62     72
FT   TURN         73     76
FT   STRAND       77     86
FT   STRAND       89     99
FT   STRAND      106    109
FT   STRAND      114    121
FT   STRAND      127    131
FT   HELIX       137    139
FT   STRAND      143    149
FT   TURN        153    155
FT   HELIX       159    166
FT   HELIX       170    172
FT   HELIX       178    180
FT   HELIX       184    189
SQ   SEQUENCE   201 AA;  23512 MW;  63292233AD6EAD8B CRC64;
     MALSWVLTVL SLLPLLEAQI PLCANLVPVP ITNATLDQIT GKWFYIASAF RNEEYNKSVQ
     EIQATFFYFT PNKTEDTIFL REYQTRQDQC IYNTTYLNVQ RENGTISRYV GGQEHFAHLL
     ILRDTKTYML AFDVNDEKNW GLSVYADKPE TTKEQLGEFY EALDCLRIPK SDVVYTDWKK
     DKCEPLEKQH EKERKQEEGE S
//
ID   A1AG2_HUMAN             Reviewed;         201 AA.
AC   P19652; B2R5L2; Q16571; Q5T538; Q6IB74;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 2.
DT   18-APR-2012, entry version 131.
DE   RecName: Full=Alpha-1-acid glycoprotein 2;
DE            Short=AGP 2;
DE   AltName: Full=Orosomucoid-2;
DE            Short=OMD 2;
DE   Flags: Precursor;
GN   Name=ORM2; Synonyms=AGP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=88029318; PubMed=2822385;
RA   Dente L., Pizza M.G., Metspalu A., Cortese R.;
RT   "Structure and expression of the genes coding for human alpha 1-acid
RT   glycoprotein.";
RL   EMBO J. 6:2289-2296(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=88329732; PubMed=2970990; DOI=10.1016/0378-1119(88)90228-4;
RA   Merritt C.M., Board P.G.;
RT   "Structure and characterisation of a duplicated human alpha 1 acid
RT   glycoprotein gene.";
RL   Gene 66:97-106(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   DISULFIDE BONDS.
RX   MEDLINE=74290014; PubMed=4603214; DOI=10.1021/bi00710a006;
RA   Schmid K., Buergi W., Collins J.H., Nanno S.;
RT   "The disulfide bonds of alpha1-acid glycoprotein.";
RL   Biochemistry 13:2694-2697(1974).
RN   [9]
RP   GLYCOSYLATION AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103.
RX   MEDLINE=92231810; PubMed=1567356;
RA   Treuheit M.J., Costello C.E., Halsall H.B.;
RT   "Analysis of the five glycosylation sites of human alpha 1-acid
RT   glycoprotein.";
RL   Biochem. J. 283:105-112(1992).
RN   [10]
RP   PYROGLUTAMATE FORMATION AT GLN-19, GLYCOSYLATION AT ASN-33 AND ASN-93,
RP   AND MASS SPECTROMETRY.
RX   PubMed=15253437; DOI=10.1021/pr034112b;
RA   Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P.;
RT   "A new strategy for identification of N-glycosylated proteins and
RT   unambiguous assignment of their glycosylation sites using HILIC
RT   enrichment and partial deglycosylation.";
RL   J. Proteome Res. 3:556-566(2004).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33, AND MASS SPECTROMETRY.
RC   TISSUE=Bile;
RX   PubMed=15084671; DOI=10.1074/mcp.M400015-MCP200;
RA   Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,
RA   Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
RT   "A proteomic analysis of human bile.";
RL   Mol. Cell. Proteomics 3:715-728(2004).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72 AND
RP   ASN-93, AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93
RP   AND ASN-103, AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-93 AND
RP   ASN-103, AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33, STRUCTURE OF
RP   CARBOHYDRATES, AND MASS SPECTROMETRY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [16]
RP   GLYCOSYLATION AT ASN-33, STRUCTURE OF CARBOHYDRATES, AND MASS
RP   SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 19-201 OF VARIANT ARG-167 IN
RP   COMPLEXES WITH DISOPYRAMIDE; AMITRIPTYLINE AND CHLORPROMAZINE,
RP   FUNCTION, DISULFIDE BONDS, AND DOMAIN.
RX   PubMed=21349832; DOI=10.1074/jbc.M110.208926;
RA   Nishi K., Ono T., Nakamura T., Fukunaga N., Izumi M., Watanabe H.,
RA   Suenaga A., Maruyama T., Yamagata Y., Curry S., Otagiri M.;
RT   "Structural insights into differences in drug-binding selectivity
RT   between two forms of human {alpha}1-acid glycoprotein genetic
RT   variants, the A and F1*S forms.";
RL   J. Biol. Chem. 286:14427-14434(2011).
CC   -!- FUNCTION: Functions as transport protein in the blood stream.
CC       Binds various hydrophobic ligands in the interior of its beta-
CC       barrel domain. Also binds synthetic drugs and influences their
CC       distribution and availability. Appears to function in modulating
CC       the activity of the immune system during the acute-phase reaction.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
CC   -!- INDUCTION: Synthesis is controlled by glucocorticoids,
CC       interleukin-1 and interleukin-6, It increases 5- to 50-fold upon
CC       inflammation.
CC   -!- DOMAIN: Contains a beta-barrel that binds various ligands in its
CC       interior.
CC   -!- PTM: N-glycosylated. N-glycan heterogeneity at Asn-33: Hex5HexNAc4
CC       (minor), Hex6HexNAc5 (major) and dHex1Hex6HexNAc5 (minor).
CC   -!- POLYMORPHISM: Many different variants of ORM2 are known.
CC   -!- SIMILARITY: Belongs to the calycin superfamily. Lipocalin family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA29873.2; Type=Erroneous gene model prediction;
CC       Sequence=CAA29874.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06675; CAA29874.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X05780; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X06674; CAA29873.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; X06676; CAA29873.2; JOINED; Genomic_DNA.
DR   EMBL; X06677; CAA29873.2; JOINED; Genomic_DNA.
DR   EMBL; X06678; CAA29873.2; JOINED; Genomic_DNA.
DR   EMBL; X06679; CAA29873.2; JOINED; Genomic_DNA.
DR   EMBL; X06680; CAA29873.2; JOINED; Genomic_DNA.
DR   EMBL; X05784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M21540; AAA51549.1; -; Genomic_DNA.
DR   EMBL; AK312226; BAG35159.1; -; mRNA.
DR   EMBL; CR456930; CAG33211.1; -; mRNA.
DR   EMBL; AL356796; CAI16860.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87417.1; -; Genomic_DNA.
DR   EMBL; BC015964; AAH15964.1; -; mRNA.
DR   EMBL; BC056239; AAH56239.1; -; mRNA.
DR   IPI; IPI00020091; -.
DR   PIR; JT0326; OMHU2.
DR   RefSeq; NP_000599.1; NM_000608.2.
DR   UniGene; Hs.719954; -.
DR   PDB; 3APU; X-ray; 2.10 A; A/B=19-201.
DR   PDB; 3APV; X-ray; 2.15 A; A/B=19-201.
DR   PDB; 3APW; X-ray; 2.20 A; A/B=19-201.
DR   PDB; 3APX; X-ray; 2.20 A; A=19-201.
DR   PDBsum; 3APU; -.
DR   PDBsum; 3APV; -.
DR   PDBsum; 3APW; -.
DR   PDBsum; 3APX; -.
DR   ProteinModelPortal; P19652; -.
DR   SMR; P19652; 19-193.
DR   IntAct; P19652; 3.
DR   STRING; P19652; -.
DR   GlycoSuiteDB; P19652; -.
DR   DMDM; 231458; -.
DR   DOSAC-COBS-2DPAGE; P19652; -.
DR   SWISS-2DPAGE; P19652; -.
DR   PeptideAtlas; P19652; -.
DR   PRIDE; P19652; -.
DR   DNASU; 5005; -.
DR   Ensembl; ENST00000431067; ENSP00000394936; ENSG00000228278.
DR   GeneID; 5005; -.
DR   KEGG; hsa:5005; -.
DR   UCSC; uc004bil.3; human.
DR   CTD; 5005; -.
DR   GeneCards; GC09P117092; -.
DR   HGNC; HGNC:8499; ORM2.
DR   MIM; 138610; gene.
DR   neXtProt; NX_P19652; -.
DR   PharmGKB; PA32818; -.
DR   GeneTree; ENSGT00390000012130; -.
DR   HOGENOM; HBG126438; -.
DR   HOVERGEN; HBG000035; -.
DR   InParanoid; P19652; -.
DR   OMA; FYIASAS; -.
DR   OrthoDB; EOG4V9TS3; -.
DR   EvolutionaryTrace; P19652; -.
DR   NextBio; 19276; -.
DR   ArrayExpress; P19652; -.
DR   Bgee; P19652; -.
DR   Genevestigator; P19652; -.
DR   GermOnline; ENSG00000204154; Homo sapiens.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0005488; F:binding; IEA:InterPro.
DR   GO; GO:0006953; P:acute-phase response; TAS:ProtInc.
DR   GO; GO:0002682; P:regulation of immune system process; IEA:InterPro.
DR   GO; GO:0006810; P:transport; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.40.128.20; Calycin; 1.
DR   InterPro; IPR001500; A1A_glycop.
DR   InterPro; IPR012674; Calycin.
DR   InterPro; IPR011038; Calycin-like.
DR   InterPro; IPR000566; Lipocln_cytosolic_FA-bd_dom.
DR   PANTHER; PTHR11967; A1A_glycop; 1.
DR   Pfam; PF00061; Lipocalin; 1.
DR   PIRSF; PIRSF036899; AGP; 1.
DR   PRINTS; PR00708; A1AGLPROTEIN.
DR   SUPFAM; SSF50814; Calycin; 1.
DR   PROSITE; PS00213; LIPOCALIN; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Acute phase; Complete proteome; Disulfide bond;
KW   Glycoprotein; Polymorphism; Pyrrolidone carboxylic acid;
KW   Reference proteome; Secreted; Signal; Transport.
FT   SIGNAL        1     18
FT   CHAIN        19    201       Alpha-1-acid glycoprotein 2.
FT                                /FTId=PRO_0000017861.
FT   MOD_RES      19     19       Pyrrolidone carboxylic acid.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) (complex).
FT   CARBOHYD     56     56       N-linked (GlcNAc...).
FT   CARBOHYD     72     72       N-linked (GlcNAc...).
FT   CARBOHYD     93     93       N-linked (GlcNAc...).
FT   CARBOHYD    103    103       N-linked (GlcNAc...).
FT                                /FTId=CAR_000171.
FT   DISULFID     23    165
FT   DISULFID     90    183
FT   VARIANT      38     38       R -> Q (in dbSNP:rs17650).
FT                                /FTId=VAR_014667.
FT   VARIANT      99     99       V -> A (in dbSNP:rs2636889).
FT                                /FTId=VAR_050172.
FT   VARIANT     141    141       G -> R (in dbSNP:rs12685968).
FT                                /FTId=VAR_050173.
FT   VARIANT     167    167       C -> R (in dbSNP:rs1126777).
FT                                /FTId=VAR_050174.
FT   VARIANT     174    174       M -> V (in dbSNP:rs2636890).
FT                                /FTId=VAR_050175.
FT   CONFLICT     32     32       T -> I (in Ref. 4; CAG33211).
FT   CONFLICT    102    102       E -> D (in Ref. 3; BAG35159).
FT   CONFLICT    125    125       T -> I (in Ref. 3; BAG35159).
FT   CONFLICT    162    162       A -> V (in Ref. 3; BAG35159).
FT   CONFLICT    189    189       Q -> H (in Ref. 3; BAG35159).
FT   HELIX        24     26
FT   HELIX        33     39
FT   STRAND       43     48
FT   HELIX        53     60
FT   STRAND       62     72
FT   TURN         73     76
FT   STRAND       77     86
FT   STRAND       89     99
FT   STRAND      106    109
FT   STRAND      114    117
FT   STRAND      127    130
FT   TURN        137    139
FT   STRAND      143    150
FT   TURN        153    155
FT   HELIX       159    165
FT   HELIX       170    172
FT   HELIX       178    180
FT   HELIX       184    191
SQ   SEQUENCE   201 AA;  23603 MW;  49167ABCC22933B9 CRC64;
     MALSWVLTVL SLLPLLEAQI PLCANLVPVP ITNATLDRIT GKWFYIASAF RNEEYNKSVQ
     EIQATFFYFT PNKTEDTIFL REYQTRQNQC FYNSSYLNVQ RENGTVSRYE GGREHVAHLL
     FLRDTKTLMF GSYLDDEKNW GLSFYADKPE TTKEQLGEFY EALDCLCIPR SDVMYTDWKK
     DKCEPLEKQH EKERKQEEGE S
//
ID   A1ATR_HUMAN             Reviewed;         420 AA.
AC   P20848;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   22-FEB-2012, entry version 100.
DE   RecName: Full=Putative alpha-1-antitrypsin-related protein;
DE   AltName: Full=Serpin A2;
DE   Flags: Precursor;
GN   Name=SERPINA2; Synonyms=ARGS, ATR, PIL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=88314108; PubMed=2842251; DOI=10.1016/0888-7543(88)90099-7;
RA   Bao J.J., Reed-Fourquet L., Sifers R.N., Kidd V.J., Woo S.L.C.;
RT   "Molecular structure and sequence homology of a gene related to alpha
RT   1-antitrypsin in the human genome.";
RL   Genomics 2:165-173(1988).
CC   -!- FUNCTION: Could be a serine protease inhibitor.
CC   -!- DOMAIN: The reactive center loop (RCL) extends out from the body
CC       of the protein and directs binding to the target protease. The
CC       protease cleaves the serpin at the reactive site within the RCL,
CC       establishing a covalent linkage between the carboxyl group of the
CC       serpin reactive site and the serine hydroxyl of the protease. The
CC       resulting inactive serpin-protease complex is highly stable (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the serpin family.
CC   -!- CAUTION: Could be the product of a pseudogene.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M19684; AAA51544.1; -; Genomic_DNA.
DR   EMBL; M19685; AAA51544.1; JOINED; Genomic_DNA.
DR   IPI; IPI00736763; -.
DR   PIR; A28882; A28882.
DR   UniGene; Hs.666160; -.
DR   ProteinModelPortal; P20848; -.
DR   SMR; P20848; 47-420.
DR   STRING; P20848; -.
DR   MEROPS; I04.952; -.
DR   DMDM; 112891; -.
DR   PRIDE; P20848; -.
DR   Ensembl; ENST00000238576; ENSP00000238576; ENSG00000165951.
DR   GeneCards; GC14M094830; -.
DR   HGNC; HGNC:8985; SERPINA2.
DR   MIM; 107410; gene.
DR   neXtProt; NX_P20848; -.
DR   eggNOG; COG4826; -.
DR   HOGENOM; HBG714743; -.
DR   HOVERGEN; HBG005957; -.
DR   InParanoid; P20848; -.
DR   OrthoDB; EOG47WNP9; -.
DR   ArrayExpress; P20848; -.
DR   CleanEx; HS_ATR; -.
DR   Genevestigator; P20848; -.
DR   GermOnline; ENSG00000165951; Homo sapiens.
DR   GO; GO:0005576; C:extracellular region; IBA:RefGenome.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome.
DR   GO; GO:0030162; P:regulation of proteolysis; IBA:RefGenome.
DR   InterPro; IPR000215; Protease_inhib_I4_serpin.
DR   InterPro; IPR023795; Protease_inhib_I4_serpin_CS.
DR   InterPro; IPR023796; Sepin_dom.
DR   PANTHER; PTHR11461; Prot_inh_serpin; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; Prot_inh_serpin; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   5: Uncertain;
KW   Complete proteome; Glycoprotein; Protease inhibitor;
KW   Reference proteome; Serine protease inhibitor; Signal.
FT   SIGNAL        1     21       Potential.
FT   CHAIN        22    420       Putative alpha-1-antitrypsin-related
FT                                protein.
FT                                /FTId=PRO_0000032410.
FT   SITE        384    385       Reactive bond (Potential).
FT   CARBOHYD     56     56       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    109    109       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    147    147       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    273    273       N-linked (GlcNAc...) (Potential).
SQ   SEQUENCE   420 AA;  47891 MW;  4A5A7B9BE05BCEAA CRC64;
     MPFSVSWGVL LLAGLCCLVP SSLVEDPQGD AAQKTDTSHH DQGDWEDLAC QKISYNVTDL
     AFDLYKSWLI YHNQHVLVTP TSVAMAFRML SLGTKADTRT EILEGLNVNL TETPEAKIHE
     CFQQVLQALS RPDTRLQLTT GSSLFVNKSM KLVDTFLEDT KKLYHSEASS INFRDTEEAK
     EQINNYVEKR TGRKVVDLVK HLKKDTSLAL VDYISFHGKW KDKFKAERIM VEGFHVDDKT
     IIRVPMINHL GRFDIHRDRE LSSWVLAQHY VGNATAFFIL PDPKKMWQLE EKLTYSHLEN
     IQRAFDIRSI NLHFPKLSIS GTYKLKRVPR NLGITKIFSN EADLSGVSQE APLKLSKAVH
     VAVLTIDEKG TEATGAPHLE EKAWSKYQTV MFNRPFLVII KEYITNFPLF IGKVVNPTQK
//
ID   A1AT_HUMAN              Reviewed;         418 AA.
AC   P01009; A6PX14; B2RDQ8; Q0PVP5; Q13672; Q53XB8; Q5U0M1; Q7M4R2;
AC   Q86U18; Q86U19; Q96BF9; Q96ES1; Q9P1P0; Q9UCE6; Q9UCM3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 3.
DT   18-APR-2012, entry version 183.
DE   RecName: Full=Alpha-1-antitrypsin;
DE   AltName: Full=Alpha-1 protease inhibitor;
DE   AltName: Full=Alpha-1-antiproteinase;
DE   AltName: Full=Serpin A1;
DE   Contains:
DE     RecName: Full=Short peptide from AAT;
DE              Short=SPAAT;
DE   Flags: Precursor;
GN   Name=SERPINA1; Synonyms=AAT, PI; ORFNames=PRO0684, PRO2209;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=84107980; PubMed=6319097;
RA   Bollen A., Herzog A., Cravador A., Herion P., Chuchana P.,
RA   van der Straten A., Loriau R., Jacobs P., van Elsen A.;
RT   "Cloning and expression in Escherichia coli of full-length
RT   complementary DNA coding for human alpha 1-antitrypsin.";
RL   DNA 2:255-264(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=85047190; PubMed=6093867; DOI=10.1021/bi00316a003;
RA   Long G.L., Chandra T., Woo S.L.C., Davie E.W., Kurachi K.;
RT   "Complete sequence of the cDNA for human alpha 1-antitrypsin and the
RT   gene for the S variant.";
RL   Biochemistry 23:4828-4837(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF MET-382.
RX   MEDLINE=85036645; PubMed=6387509; DOI=10.1038/312077a0;
RA   Rosenberg S., Barr P.J., Najarian R.C., Hallewell R.A.;
RT   "Synthesis in yeast of a functional oxidation-resistant mutant of
RT   human alpha-antitrypsin.";
RL   Nature 312:77-80(1984).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=85176977; PubMed=2985281; DOI=10.1016/S0092-8674(85)80026-X;
RA   Ciliberto G., Dente L., Cortese R.;
RT   "Cell-specific expression of a transfected human alpha 1-antitrypsin
RT   gene.";
RL   Cell 41:531-540(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION OF VARIANT Z.
RX   MEDLINE=87057257; PubMed=3491072;
RA   Nukiwa T., Satoh K., Brantly M.L., Ogushi F., Fells G.A., Courtney M.,
RA   Crystal R.G.;
RT   "Identification of a second mutation in the protein-coding sequence of
RT   the Z type alpha 1-antitrypsin gene.";
RL   J. Biol. Chem. 261:15989-15994(1986).
RN   [6]
RP   ERRATUM.
RA   Nukiwa T., Satoh K., Brantly M.L., Ogushi F., Fells G.A., Courtney M.,
RA   Crystal R.G.;
RL   J. Biol. Chem. 262:10412-10412(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ALA-237 AND
RP   ASP-400.
RC   TISSUE=Liver;
RX   PubMed=17650587;
RA   Shasany A.K., Shukla A.K., Darokar M.P., Saraiya M., Chaturvedi N.,
RA   Tewari L., Khanuja S.P.;
RT   "An alpha-1 antitrypsin genetic variant from India.";
RL   Indian J. Biochem. Biophys. 44:176-178(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS TRP-172; ALA-237 AND
RP   LYS-366.
RC   TISSUE=Lymphocyte;
RA   Balduyck M., Porchet N., Aubert J.-P., Zerimech F., Douchain F.,
RA   Verchain S.;
RT   "Characterization of a new variant of alpha1 antitrypsin M Lille
RT   (p.Gly148Trp).";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Ouyang S., Luo L., Wei H., Zhou G.,
RA   Zhou W., Bi J., Zhang Y., Liu M., He F.;
RT   "Functional prediction of the coding sequences of 32 new genes deduced
RT   by analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Fetal liver, and Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ALA-237.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67; 196-255 AND 387-418.
RX   MEDLINE=82220035; PubMed=6979715; DOI=10.1038/297655a0;
RA   Leicht M., Long G.L., Chandra T., Kurachi K., Kidd V.J., Mace M. Jr.,
RA   Davie E.W., Woo S.L.C.;
RT   "Sequence homology and structural comparison between the chromosomal
RT   human alpha 1-antitrypsin and chicken ovalbumin genes.";
RL   Nature 297:655-659(1982).
RN   [15]
RP   PRELIMINARY PROTEIN SEQUENCE OF 25-418 (ISOFORM 1).
RA   Chan S.K.;
RT   "The covalent structure of human alpha1-protease inhibitor.";
RL   Fed. Proc. 41:1016-1016(1982).
RN   [16]
RP   PROTEIN SEQUENCE OF 25-418 (ISOFORM 1).
RX   MEDLINE=82220135; PubMed=7045697; DOI=10.1038/298329a0;
RA   Carrell R.W., Jeppsson J.-O., Laurell C.-B., Brennan S.O., Owen M.C.,
RA   Vaughan L., Boswell D.R.;
RT   "Structure and variation of human alpha 1-antitrypsin.";
RL   Nature 298:329-334(1982).
RN   [17]
RP   PROTEIN SEQUENCE OF 25-418 (ISOFORM 1), VARIANTS ABERRANT FORM
RP   190-GLY--ARG-198 AND VAL-288, AND FUNCTION.
RC   TISSUE=Blood;
RA   Sinha A.K., Girish G.V.;
RT   "Appearance of an aberrant form of alpha-antitrypsin in the
RT   circulation of chronic cigarette smokers and its effect on the insulin
RT   induced NO synthesis in blood platelets.";
RL   Submitted (AUG-2007) to UniProtKB.
RN   [18]
RP   PROTEIN SEQUENCE OF 25-39, AND FUNCTION.
RC   TISSUE=Ascites;
RX   MEDLINE=91310496; PubMed=1906855;
RA   Tanaka N., Sekiya S., Takamizawa H., Kato N., Moriyama Y.,
RA   Fujimura S.;
RT   "Characterization of a 54 kDa, alpha 1-antitrypsin-like protein
RT   isolated from ascitic fluid of an endometrial cancer patient.";
RL   Jpn. J. Cancer Res. 82:693-700(1991).
RN   [19]
RP   PROTEIN SEQUENCE OF 30-48 AND 248-257 (ISOFORMS 1/2/3), GLYCOSYLATION
RP   AT ASN-70; ASN-107 AND ASN-271, STRUCTURE OF CARBOHYDRATES,
RP   CYSTEINE-BINDING, AND MASS SPECTROMETRY.
RX   PubMed=16622833; DOI=10.1002/pmic.200500751;
RA   Kolarich D., Weber A., Turecek P.L., Schwarz H.P., Altmann F.;
RT   "Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin
RT   and its charge isoforms.";
RL   Proteomics 6:3369-3380(2006).
RN   [20]
RP   PROTEIN SEQUENCE OF 47-66.
RC   TISSUE=Urine;
RX   MEDLINE=93312288; PubMed=8323530; DOI=10.1006/bbrc.1993.1731;
RA   Umekawa T., Kohri K., Amasaki N., Yamate T., Yoshida K., Yamamoto K.,
RA   Suzuki Y., Sinohara H., Kurita T.;
RT   "Sequencing of a urinary stone protein, identical to alpha-one
RT   antitrypsin, which lacks 22 amino acids.";
RL   Biochem. Biophys. Res. Commun. 193:1049-1053(1993).
RN   [21]
RP   PROTEIN SEQUENCE OF 50-63 AND 161-178 (ISOFORMS 1/2/3), AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [22]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 292-418 (ISOFORM 1).
RX   MEDLINE=86005469; PubMed=3876243; DOI=10.1016/0014-5793(85)81056-5;
RA   Riley J.H., Bathurst I.C., Edbrooke M.R., Carrell R.W., Craig R.K.;
RT   "Alpha 1-antitrypsin and serum albumin mRNA accumulation in normal,
RT   acute phase and ZZ human liver.";
RL   FEBS Lett. 189:361-366(1985).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 350-418 (ISOFORM 1).
RX   MEDLINE=82082539; PubMed=7031661; DOI=10.1073/pnas.78.11.6826;
RA   Kurachi K., Chandra T., Friezner Degen S.J., White T.T.,
RA   Marchioro T.L., Woo S.L.C., Davie E.W.;
RT   "Cloning and sequence of cDNA coding for alpha 1-antitrypsin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:6826-6830(1981).
RN   [24]
RP   PROTEIN SEQUENCE OF 375-414, IDENTIFICATION OF SPAAT, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Placenta;
RX   MEDLINE=93024095; PubMed=1406456;
RA   Niemann M.A., Narkates A.J., Miller E.J.;
RT   "Isolation and serine protease inhibitory activity of the 44-residue,
RT   C-terminal fragment of alpha 1-antitrypsin from human placenta.";
RL   Matrix 12:233-241(1992).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 387-418 (ISOFORM 1).
RX   MEDLINE=85225507; PubMed=3873938;
RA   Coutelle C., Speer A., Rogers J., Kalsheker N., Humphries S.,
RA   Williamson R.;
RT   "Construction and partial characterization of a human liver cDNA
RT   library.";
RL   Biomed. Biochim. Acta 44:421-431(1985).
RN   [26]
RP   GLYCOSYLATION AT ASN-70 AND ASN-271.
RX   MEDLINE=22660472; PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [27]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70 AND ASN-271, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Bile;
RX   PubMed=15084671; DOI=10.1074/mcp.M400015-MCP200;
RA   Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,
RA   Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
RT   "A proteomic analysis of human bile.";
RL   Mol. Cell. Proteomics 3:715-728(2004).
RN   [28]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70 AND ASN-271, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [29]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70; ASN-107 AND ASN-271,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [30]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70, AND MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [31]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70; ASN-107 AND ASN-271,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [32]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70; ASN-107 AND ASN-271,
RP   STRUCTURE OF CARBOHYDRATES, AND MASS SPECTROMETRY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [34]
RP   GLYCOSYLATION AT ASN-70 AND ASN-271, STRUCTURE OF CARBOHYDRATES, AND
RP   MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   MEDLINE=84292309; PubMed=6332197; DOI=10.1016/0022-2836(84)90298-5;
RA   Loebermann H., Tokuoka R., Deisenhofer J., Huber R.;
RT   "Human alpha 1-proteinase inhibitor. Crystal structure analysis of two
RT   crystal modifications, molecular model and preliminary analysis of the
RT   implications for function.";
RL   J. Mol. Biol. 177:531-556(1984).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   MEDLINE=89221004; PubMed=2785270; DOI=10.1093/protein/2.6.407;
RA   Engh R., Loebermann H., Schneider M., Wiegand G., Huber R.,
RA   Laurell C.-B.;
RT   "The S variant of human alpha 1-antitrypsin, structure and
RT   implications for function and metabolism.";
RL   Protein Eng. 2:407-415(1989).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (3.46 ANGSTROMS) OF 25-418.
RX   MEDLINE=96128217; PubMed=8543039; DOI=10.1016/0014-5793(95)01331-8;
RA   Song H.K., Lee K.N., Kwon K.-S., Yu M.-H., Suh S.W.;
RT   "Crystal structure of an uncleaved alpha 1-antitrypsin reveals the
RT   conformation of its inhibitory reactive loop.";
RL   FEBS Lett. 377:150-154(1995).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 26-418.
RX   MEDLINE=96313123; PubMed=8756325; DOI=10.1038/nsb0896-676;
RA   Elliott P.R., Lomas D.A., Carrell R.W., Abrahams J.P.;
RT   "Inhibitory conformation of the reactive loop of alpha 1-
RT   antitrypsin.";
RL   Nat. Struct. Biol. 3:676-681(1996).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 45-418.
RX   MEDLINE=97094975; PubMed=8939743; DOI=10.1016/S0969-2126(96)00126-8;
RA   Ryu S.-E., Choi H.-J., Kwon K.-S., Lee K.N., Yu M.-H.;
RT   "The native strains in the hydrophobic core and flexible reactive loop
RT   of a serine protease inhibitor: crystal structure of an uncleaved
RT   alpha1-antitrypsin at 2.7 A.";
RL   Structure 4:1181-1192(1996).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 26-418.
RX   MEDLINE=98139957; PubMed=9466920; DOI=10.1006/jmbi.1997.1458;
RA   Elliott P.R., Abrahams J.P., Lomas D.A.;
RT   "Wild-type alpha 1-antitrypsin is in the canonical inhibitory
RT   conformation.";
RL   J. Mol. Biol. 275:419-425(1998).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 48-418 IN COMPLEX WITH BOVINE
RP   TRYPSIN.
RX   MEDLINE=20509356; PubMed=11057674; DOI=10.1038/35038119;
RA   Huntington J.A., Read R.J., Carrell R.W.;
RT   "Structure of a serpin-protease complex shows inhibition by
RT   deformation.";
RL   Nature 407:923-926(2000).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 44-418.
RX   MEDLINE=20178938; PubMed=10716194;
RA   Dunstone M.A., Dai W., Whisstock J.C., Rossjohn J., Pike R.N.,
RA   Feil S.C., Le Bonniec B.F., Parker M.W., Bottomley S.P.;
RT   "Cleaved antitrypsin polymers at atomic resolution.";
RL   Protein Sci. 9:417-420(2000).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE=20386623; PubMed=10933492;
RA   Elliott P.R., Pei X.Y., Dafforn T.R., Lomas D.A.;
RT   "Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets
RT   for rational drug design to prevent conformational disease.";
RL   Protein Sci. 9:1274-1281(2000).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-418.
RX   MEDLINE=21103710; PubMed=11178897; DOI=10.1006/jmbi.2000.4357;
RA   Kim S.-J., Woo J.-R., Seo E.J., Yu M.-H., Ryu S.-E.;
RT   "A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin
RT   shows variability of the reactive center and other loops.";
RL   J. Mol. Biol. 306:109-119(2001).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 25-418.
RX   MEDLINE=22336385; PubMed=12244055; DOI=10.1074/jbc.M207682200;
RA   Im H., Woo M.-S., Hwang K.Y., Yu M.-H.;
RT   "Interactions causing the kinetic trap in serpin protein folding.";
RL   J. Biol. Chem. 277:46347-46354(2002).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 26-418 OF VARIANT PITTSBURGH
RP   ARG-382.
RX   MEDLINE=22863108; PubMed=12860985; DOI=10.1074/jbc.M305195200;
RA   Dementiev A., Simonovic M., Volz K., Gettins P.G.;
RT   "Canonical inhibitor-like interactions explain reactivity of alpha1-
RT   proteinase inhibitor Pittsburgh and antithrombin with proteinases.";
RL   J. Biol. Chem. 278:37881-37887(2003).
RN   [47]
RP   REVIEW.
RX   MEDLINE=89352843; PubMed=2669992; DOI=10.1007/BF01115992;
RA   Kalsheker N.;
RT   "Alpha 1-antitrypsin: structure, function and molecular biology of the
RT   gene.";
RL   Biosci. Rep. 9:129-138(1989).
RN   [48]
RP   REVIEW.
RX   MEDLINE=91315455; PubMed=1859394; DOI=10.1002/bies.950130404;
RA   Wu Y., Foreman R.C.;
RT   "The molecular genetics of alpha 1 antitrypsin deficiency.";
RL   Bioessays 13:163-169(1991).
RN   [49]
RP   CHARACTERIZATION OF VARIANT M2.
RX   MEDLINE=88324438; PubMed=2901226;
RA   Nukiwa T., Brantly M.L., Ogushi F., Fells G.A., Crystal R.G.;
RT   "Characterization of the gene and protein of the common alpha 1-
RT   antitrypsin normal M2 allele.";
RL   Am. J. Hum. Genet. 43:322-330(1988).
RN   [50]
RP   VARIANT M3 ASP-400.
RX   MEDLINE=90368097; PubMed=2394452; DOI=10.1007/BF00206766;
RA   Graham A., Hayes K., Weidinger S., Newton C.R., Markham A.F.,
RA   Kalsheker N.A.;
RT   "Characterisation of the alpha-1-antitrypsin M3 gene, a normal
RT   variant.";
RL   Hum. Genet. 85:381-382(1990).
RN   [51]
RP   VARIANT F CYS-247.
RX   MEDLINE=91241132; PubMed=2035534;
RA   Okayama H., Brantly M., Holmes M., Crystal R.G.;
RT   "Characterization of the molecular basis of the alpha 1-antitrypsin F
RT   allele.";
RL   Am. J. Hum. Genet. 48:1154-1158(1991).
RN   [52]
RP   VARIANT M-HEERLEN LEU-393.
RX   MEDLINE=89154435; PubMed=2784123; DOI=10.1007/BF00279001;
RA   Hofker M.H., Nukiwa T., van Paassen H.M.B., Nelen M., Kramps J.A.,
RA   Klasen E.C., Frants R.R., Crystal R.G.;
RT   "A Pro-->Leu substitution in codon 369 of the alpha-1-antitrypsin
RT   deficiency variant PI M-Heerlen.";
RL   Hum. Genet. 81:264-268(1989).
RN   [53]
RP   VARIANT M-MALTON PHE-75 DEL.
RX   MEDLINE=89270478; PubMed=2786335;
RA   Fraizer G.C., Harrold T.R., Hofker M.H., Cox D.W.;
RT   "In-frame single codon deletion in the M-Malton deficiency allele of
RT   alpha 1-antitrypsin.";
RL   Am. J. Hum. Genet. 44:894-902(1989).
RN   [54]
RP   VARIANT M-MINERAL SPRINGS GLU-91.
RX   MEDLINE=90097863; PubMed=1967187;
RA   Curiel D.T., Vogelmeier C., Hubbard R.C., Stier L.E., Crystal R.G.;
RT   "Molecular basis of alpha 1-antitrypsin deficiency and emphysema
RT   associated with the alpha 1-antitrypsin M-Mineral springs allele.";
RL   Mol. Cell. Biol. 10:47-56(1990).
RN   [55]
RP   VARIANT M-NICHINAN PHE-75 DEL.
RX   MEDLINE=90178096; PubMed=2309708;
RA   Matsunaga E., Shiokawa S., Nakamura H., Maruyama T., Tsuda K.,
RA   Fukumaki Y.;
RT   "Molecular analysis of the gene of the alpha 1-antitrypsin deficiency
RT   variant, M-Nichinan.";
RL   Am. J. Hum. Genet. 46:602-612(1990).
RN   [56]
RP   VARIANT M-PROCIDA PRO-65.
RX   MEDLINE=89008457; PubMed=3262617;
RA   Takahashi H., Nukiwa T., Satoh K., Ogushi F., Brantly M., Fells G.,
RA   Stier L., Courtney M., Crystal R.G.;
RT   "Characterization of the gene and protein of the alpha 1-antitrypsin
RT   'deficiency' allele M-Procida.";
RL   J. Biol. Chem. 263:15528-15534(1988).
RN   [57]
RP   VARIANT P-DUARTE VAL-280.
RX   MEDLINE=93372875; PubMed=8364590; DOI=10.1002/humu.1380020311;
RA   Hildesheim J., Kinsley G., Bissell M., Pierce J., Brantly M.;
RT   "Genetic diversity from a limited repertoire of mutations on different
RT   common allelic backgrounds: alpha 1-antitrypsin deficiency variant P-
RT   Duarte.";
RL   Hum. Mutat. 2:221-228(1993).
RN   [58]
RP   INVOLVEMENT OF VARIANT PITTSBURGH ARG-382 IN BLEEDING DIATHESIS.
RX   MEDLINE=83297520; PubMed=6604220;
RA   Owen M.C., Brennan S.O., Lewis J.H., Carrell R.W.;
RT   "Mutation of antitrypsin to antithrombin. Alpha 1-antitrypsin
RT   Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.";
RL   N. Engl. J. Med. 309:694-698(1983).
RN   [59]
RP   INVOLVEMENT IN A1ATD, AND VARIANT S-IIYAMA PHE-77.
RX   MEDLINE=91286296; PubMed=1905728;
RA   Seyama K., Nukiwa T., Takabe K., Takahashi H., Miyake K., Kira S.;
RT   "Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-
RT   antitrypsin-deficient variant with mutation on a predicted conserved
RT   residue of the serpin backbone.";
RL   J. Biol. Chem. 266:12627-12632(1991).
RN   [60]
RP   VARIANT V-MUNICH ALA-26.
RX   MEDLINE=90196014; PubMed=2316526;
RA   Holmes M.D., Brantly M.L., Curiel D.T., Weidinger S., Crystal R.G.;
RT   "Characterization of the normal alpha 1-antitrypsin allele V-Munich: a
RT   variant associated with a unique protein isoelectric focusing
RT   pattern.";
RL   Am. J. Hum. Genet. 46:810-816(1990).
RN   [61]
RP   INVOLVEMENT IN A1ATD, AND VARIANT W-BETHESDA THR-360.
RX   MEDLINE=90358792; PubMed=2390072; DOI=10.1016/0006-291X(90)90493-7;
RA   Holmes M.D., Brantly M.L., Fells G.A., Crystal R.G.;
RT   "Alpha 1-antitrypsin W-Bethesda: molecular basis of an unusual alpha
RT   1-antitrypsin deficiency variant.";
RL   Biochem. Biophys. Res. Commun. 170:1013-1020(1990).
RN   [62]
RP   VARIANT Z-AUGSBURG LYS-366.
RX   MEDLINE=90252805; PubMed=2339709;
RA   Faber J.-P., Weidinger S., Olek K.;
RT   "Sequence data of the rare deficient alpha 1-antitrypsin variant PI
RT   Zaugsburg.";
RL   Am. J. Hum. Genet. 46:1158-1162(1990).
RN   [63]
RP   INVOLVEMENT IN A1ATD, AND VARIANTS Z-WREXHAM LEU-4 AND Q0-NEWPORT
RP   SER-139.
RX   MEDLINE=91033789; PubMed=2227940; DOI=10.1007/BF00194233;
RA   Graham A., Kalsheker N.A., Bamforth F.J., Newton C.R., Markham A.F.;
RT   "Molecular characterisation of two alpha-1-antitrypsin deficiency
RT   variants: proteinase inhibitor (Pi) Null(Newport) (Gly115-->Ser) and
RT   (Pi) Z Wrexham (Ser-19-->Leu).";
RL   Hum. Genet. 85:537-540(1990).
RN   [64]
RP   VARIANTS P-CARDIFF VAL-280; I CYS-63 AND M-MALTON PHE-75 DEL.
RX   MEDLINE=90109164; PubMed=2606478; DOI=10.1007/BF00210671;
RA   Graham A., Kalsheker N.A., Newton C.R., Bamforth F.J., Powell S.J.,
RA   Markham A.F.;
RT   "Molecular characterisation of three alpha-1-antitrypsin deficiency
RT   variants: proteinase inhibitor (Pi) nullcardiff (Asp256-->Val); PiM-
RT   Malton (Phe51-->deletion) and PiI (Arg39-->Cys).";
RL   Hum. Genet. 84:55-58(1989).
RN   [65]
RP   VARIANT QO-LUDWIGSHAFEN ASN-116.
RX   MEDLINE=91072661; PubMed=2254451; DOI=10.1172/JCI114919;
RA   Fraizer G.C., Siewertsen M.A., Hofker M.H., Brubacher M.G., Cox D.W.;
RT   "A null deficiency allele of alpha 1-antitrypsin, QO-Ludwigshafen,
RT   with altered tertiary structure.";
RL   J. Clin. Invest. 86:1878-1884(1990).
RN   [66]
RP   VARIANTS.
RX   MEDLINE=95067973; PubMed=7977369;
RA   Faber J.-P., Poller W., Weidinger S., Kirchgesser M., Schwaab R.,
RA   Bidlingmaier F., Olek K.;
RT   "Identification and DNA sequence analysis of 15 new alpha 1-
RT   antitrypsin variants, including two PI*Q0 alleles and one deficient
RT   PI*M allele.";
RL   Am. J. Hum. Genet. 55:1113-1121(1994).
RN   [67]
RP   VARIANT Z-BRISTOL MET-109.
RX   MEDLINE=98120621; PubMed=9459000; DOI=10.1017/S0003480097006404;
RA   Lovegrove J.U., Jeremiah S., Gillett G.T., Temple I.K., Povey S.,
RA   Whitehouse D.B.;
RT   "A new alpha 1-antitrypsin mutation, Thr-Met 85, (PI ZBristol)
RT   associated with novel electrophoretic properties.";
RL   Ann. Hum. Genet. 61:385-391(1997).
RN   [68]
RP   VARIANTS Y-BARCELONA VAL-280 AND HIS-415.
RX   PubMed=10651487;
RA   Jardi R., Rodriguez F., Miravitlles M., Vidal R., Cotrina M., Quer J.,
RA   Pascual C., Weidinger S.;
RT   "Identification and molecular charaterization of the new alpha-1-
RT   antitrypsin deficient allele PI YBarcelona (Asp256Val and
RT   Pro391His).";
RL   Hum. Mutat. 12:213-213(1998).
RN   [69]
RP   VARIANT SAO TOME HIS-386.
RA   Seixas S., Trovoada M.J., Santos M.T., Rocha J.;
RT   "A novel alpha-1-antitrypsin P362H variant found in a population
RT   sample from Sao Tome e Principe (Gulf of Guinea, West Africa).";
RL   Hum. Mutat. 13:414-414(1999).
RN   [70]
RP   VARIANT BASQUE ARG-305 DEL.
RX   MEDLINE=20081076; PubMed=10612848;
RX   DOI=10.1002/(SICI)1098-1004(200001)15:1<121::AID-HUMU37>3.0.CO;2-U;
RA   Seixas S., Garcia O., Amorim A., Rocha J.;
RT   "A novel alpha-1-antitrypsin r281del variant found in a population
RT   sample from the Basque country.";
RL   Hum. Mutat. 15:121-122(2000).
CC   -!- FUNCTION: Inhibitor of serine proteases. Its primary target is
CC       elastase, but it also has a moderate affinity for plasmin and
CC       thrombin. Irreversibly inhibits trypsin, chymotrypsin and
CC       plasminogen activator. The aberrant form inhibits insulin-induced
CC       NO synthesis in platelets, decreases coagulation time and has
CC       proteolytic activity against insulin and plasmin.
CC   -!- FUNCTION: Short peptide from AAT (SPAAT) is a reversible
CC       chymotrypsin inhibitor. It also inhibits elastase, but not
CC       trypsin. Its major physiological function is the protection of the
CC       lower respiratory tract against proteolytic destruction by human
CC       leukocyte elastase (HLE).
CC   -!- INTERACTION:
CC       P00760:- (xeno); NbExp=3; IntAct=EBI-986224, EBI-986385;
CC       P00772:CELA1 (xeno); NbExp=2; IntAct=EBI-986224, EBI-986248;
CC       P71213:espB (xeno); NbExp=3; IntAct=EBI-986224, EBI-2615322;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- SUBCELLULAR LOCATION: Short peptide from AAT: Secreted,
CC       extracellular space, extracellular matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P01009-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P01009-2; Sequence=VSP_028889;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=P01009-3; Sequence=VSP_028890;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay;
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- DOMAIN: The reactive center loop (RCL) extends out from the body
CC       of the protein and directs binding to the target protease. The
CC       protease cleaves the serpin at the reactive site within the RCL,
CC       establishing a covalent linkage between the carboxyl group of the
CC       serpin reactive site and the serine hydroxyl of the protease. The
CC       resulting inactive serpin-protease complex is highly stable.
CC   -!- PTM: N-glycosylated. Differential glycosylation produces a number
CC       of isoforms. N-linked glycan at Asn-107 is alternatively di-
CC       antennary, tri-antennary or tetra-antennary. The glycan at Asn-70
CC       is di-antennary with trace amounts of tri-antennary. Glycan at
CC       Asn-271 is exclusively di-antennary. Structure of glycans at Asn-
CC       70 and Asn-271 is Hex5HexNAc4. The structure of the antennae is
CC       Neu5Ac(alpha1-6)Gal(beta1-4)GlcNAc attached to the core structure
CC       Man(alpha1-6)[Man(alpha1-3)]Man(beta1-4)GlcNAc(beta1-4)GlcNAc.
CC       Some antennae are fucosylated, which forms a Lewis-X determinant.
CC   -!- PTM: Proteolytic processing may yield the truncated form that
CC       ranges from Asp-30 to Lys-418.
CC   -!- POLYMORPHISM: The sequence shown is that of the M1V allele which
CC       is the most common form of PI (44 to 49%). Other frequent alleles
CC       are: M1A 20 to 23%; M2 10 to 11%; M3 14 to 19%.
CC   -!- DISEASE: Defects in SERPINA1 are the cause of alpha-1-antitrypsin
CC       deficiency (A1ATD) [MIM:613490]. A disorder whose most common
CC       manifestation is emphysema, which becomes evident by the third to
CC       fourth decade. A less common manifestation of the deficiency is
CC       liver disease, which occurs in children and adults, and may result
CC       in cirrhosis and liver failure. Environmental factors,
CC       particularly cigarette smoking, greatly increase the risk of
CC       emphysema at an earlier age.
CC   -!- MISCELLANEOUS: The aberrant form is found in the plasma of chronic
CC       smokers, and persists after smoking is ceased. It can still be
CC       found ten years after smoking has ceased.
CC   -!- SIMILARITY: Belongs to the serpin family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD62334.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC       Sequence=CAD62585.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/SERPINA1";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Alpha-1 antitrypsin entry;
CC       URL="http://en.wikipedia.org/wiki/Alpha_1-antitrypsin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K01396; AAB59375.1; -; mRNA.
DR   EMBL; K02212; AAB59495.1; -; Genomic_DNA.
DR   EMBL; X01683; CAA25838.1; -; mRNA.
DR   EMBL; M11465; AAA51546.1; -; mRNA.
DR   EMBL; J02619; AAA51547.1; -; Genomic_DNA.
DR   EMBL; DQ682455; ABG73380.1; -; mRNA.
DR   EMBL; AM048838; CAJ15161.1; -; Genomic_DNA.
DR   EMBL; AF113676; AAF29581.1; -; mRNA.
DR   EMBL; AF130068; AAG35496.1; -; mRNA.
DR   EMBL; BX161449; CAD61914.1; -; mRNA.
DR   EMBL; BX247968; CAD62306.1; -; mRNA.
DR   EMBL; BX248002; CAD62334.1; ALT_INIT; mRNA.
DR   EMBL; BX248257; CAD62585.1; ALT_INIT; mRNA.
DR   EMBL; AK315637; BAG38005.1; -; mRNA.
DR   EMBL; BT019455; AAV38262.1; -; mRNA.
DR   EMBL; BC011991; AAH11991.1; -; mRNA.
DR   EMBL; BC015642; AAH15642.1; -; mRNA.
DR   EMBL; J00064; AAB59369.1; -; Genomic_DNA.
DR   EMBL; J00066; AAB59370.1; -; Genomic_DNA.
DR   EMBL; J00065; AAB59370.1; JOINED; Genomic_DNA.
DR   EMBL; J00067; AAB59371.1; -; Genomic_DNA.
DR   EMBL; X02920; CAA26677.1; -; mRNA.
DR   EMBL; V00496; CAA23755.1; -; mRNA.
DR   EMBL; M26123; AAA51545.1; -; mRNA.
DR   IPI; IPI00553177; -.
DR   IPI; IPI00790784; -.
DR   IPI; IPI00869004; -.
DR   PIR; A21853; ITHU.
DR   PIR; A61391; A61391.
DR   RefSeq; NP_000286.3; NM_000295.4.
DR   RefSeq; NP_001002235.1; NM_001002235.2.
DR   RefSeq; NP_001002236.1; NM_001002236.2.
DR   RefSeq; NP_001121172.1; NM_001127700.1.
DR   RefSeq; NP_001121173.1; NM_001127701.1.
DR   RefSeq; NP_001121174.1; NM_001127702.1.
DR   RefSeq; NP_001121175.1; NM_001127703.1.
DR   RefSeq; NP_001121176.1; NM_001127704.1.
DR   RefSeq; NP_001121177.1; NM_001127705.1.
DR   RefSeq; NP_001121178.1; NM_001127706.1.
DR   RefSeq; NP_001121179.1; NM_001127707.1.
DR   UniGene; Hs.525557; -.
DR   PDB; 1ATU; X-ray; 2.70 A; A=45-418.
DR   PDB; 1D5S; X-ray; 3.00 A; A=44-377, B=378-418.
DR   PDB; 1EZX; X-ray; 2.60 A; A=48-382, B=383-418.
DR   PDB; 1HP7; X-ray; 2.10 A; A=25-418.
DR   PDB; 1IZ2; X-ray; 2.20 A; A=25-418.
DR   PDB; 1KCT; X-ray; 3.46 A; A=25-418.
DR   PDB; 1OO8; X-ray; 2.65 A; A=26-418.
DR   PDB; 1OPH; X-ray; 2.30 A; A=26-418.
DR   PDB; 1PSI; X-ray; 2.92 A; A=26-418.
DR   PDB; 1QLP; X-ray; 2.00 A; A=26-418.
DR   PDB; 1QMB; X-ray; 2.60 A; A=49-376, B=377-418.
DR   PDB; 2D26; X-ray; 3.30 A; A=26-382, B=383-418.
DR   PDB; 2QUG; X-ray; 2.00 A; A=25-418.
DR   PDB; 3CWL; X-ray; 2.44 A; A=25-418.
DR   PDB; 3CWM; X-ray; 2.51 A; A=25-418.
DR   PDB; 3DRM; X-ray; 2.20 A; A=26-418.
DR   PDB; 3DRU; X-ray; 3.20 A; A/B/C=26-418.
DR   PDB; 3NDD; X-ray; 1.50 A; A=46-372, B=383-418.
DR   PDB; 3NDF; X-ray; 2.70 A; A=46-381, B=383-418.
DR   PDB; 3NE4; X-ray; 1.81 A; A=1-418.
DR   PDB; 3T1P; X-ray; 3.90 A; A=48-418.
DR   PDB; 7API; X-ray; 3.00 A; A=36-382, B=383-418.
DR   PDB; 8API; X-ray; 3.10 A; A=36-382, B=383-418.
DR   PDB; 9API; X-ray; 3.00 A; A=36-382, B=383-418.
DR   PDBsum; 1ATU; -.
DR   PDBsum; 1D5S; -.
DR   PDBsum; 1EZX; -.
DR   PDBsum; 1HP7; -.
DR   PDBsum; 1IZ2; -.
DR   PDBsum; 1KCT; -.
DR   PDBsum; 1OO8; -.
DR   PDBsum; 1OPH; -.
DR   PDBsum; 1PSI; -.
DR   PDBsum; 1QLP; -.
DR   PDBsum; 1QMB; -.
DR   PDBsum; 2D26; -.
DR   PDBsum; 2QUG; -.
DR   PDBsum; 3CWL; -.
DR   PDBsum; 3CWM; -.
DR   PDBsum; 3DRM; -.
DR   PDBsum; 3DRU; -.
DR   PDBsum; 3NDD; -.
DR   PDBsum; 3NDF; -.
DR   PDBsum; 3NE4; -.
DR   PDBsum; 3T1P; -.
DR   PDBsum; 7API; -.
DR   PDBsum; 8API; -.
DR   PDBsum; 9API; -.
DR   ProteinModelPortal; P01009; -.
DR   SMR; P01009; 48-417.
DR   IntAct; P01009; 15.
DR   MINT; MINT-365327; -.
DR   STRING; P01009; -.
DR   MEROPS; I04.001; -.
DR   GlycoSuiteDB; P01009; -.
DR   PhosphoSite; P01009; -.
DR   DMDM; 1703025; -.
DR   Cornea-2DPAGE; P01009; -.
DR   DOSAC-COBS-2DPAGE; P01009; -.
DR   OGP; P01009; -.
DR   REPRODUCTION-2DPAGE; IPI00553177; -.
DR   REPRODUCTION-2DPAGE; P01009; -.
DR   Siena-2DPAGE; P01009; -.
DR   SWISS-2DPAGE; P01009; -.
DR   UCD-2DPAGE; P01009; -.
DR   PRIDE; P01009; -.
DR   DNASU; 5265; -.
DR   Ensembl; ENST00000355814; ENSP00000348068; ENSG00000197249.
DR   Ensembl; ENST00000393087; ENSP00000376802; ENSG00000197249.
DR   Ensembl; ENST00000393088; ENSP00000376803; ENSG00000197249.
DR   Ensembl; ENST00000404814; ENSP00000385960; ENSG00000197249.
DR   Ensembl; ENST00000426226; ENSP00000415603; ENSG00000197249.
DR   Ensembl; ENST00000437074; ENSP00000408878; ENSG00000197249.
DR   Ensembl; ENST00000437397; ENSP00000408474; ENSG00000197249.
DR   Ensembl; ENST00000440909; ENSP00000390299; ENSG00000197249.
DR   Ensembl; ENST00000448140; ENSP00000416462; ENSG00000197249.
DR   Ensembl; ENST00000448921; ENSP00000416066; ENSG00000197249.
DR   Ensembl; ENST00000449399; ENSP00000416354; ENSG00000197249.
DR   GeneID; 5265; -.
DR   KEGG; hsa:5265; -.
DR   UCSC; uc001ycx.4; human.
DR   UCSC; uc001yda.1; human.
DR   CTD; 5265; -.
DR   GeneCards; GC14M094843; -.
DR   H-InvDB; HIX0011929; -.
DR   HGNC; HGNC:8941; SERPINA1.
DR   HPA; CAB013211; -.
DR   HPA; CAB016648; -.
DR   HPA; HPA000927; -.
DR   HPA; HPA001292; -.
DR   MIM; 107400; gene.
DR   MIM; 613490; phenotype.
DR   neXtProt; NX_P01009; -.
DR   Orphanet; 60; Alpha-1 antitrypsin deficiency.
DR   Orphanet; 178396; Hemorrhagic disease due to alpha-1 antitrypsin Pittsburgh mutation.
DR   PharmGKB; PA35509; -.
DR   eggNOG; COG4826; -.
DR   GeneTree; ENSGT00560000076583; -.
DR   HOVERGEN; HBG005957; -.
DR   InParanoid; P01009; -.
DR   KO; K03984; -.
DR   OMA; PMMNRLG; -.
DR   OrthoDB; EOG4FR0S4; -.
DR   PhylomeDB; P01009; -.
DR   Pathway_Interaction_DB; hnf3apathway; FOXA1 transcription factor network.
DR   Reactome; REACT_604; Hemostasis.
DR   DrugBank; DB00058; Alpha-1-proteinase inhibitor.
DR   EvolutionaryTrace; P01009; -.
DR   NextBio; 20336; -.
DR   PMAP-CutDB; P01009; -.
DR   ArrayExpress; P01009; -.
DR   Bgee; P01009; -.
DR   Genevestigator; P01009; -.
DR   GermOnline; ENSG00000197249; Homo sapiens.
DR   GO; GO:0005615; C:extracellular space; IMP:UniProtKB.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB.
DR   GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0030162; P:regulation of proteolysis; IBA:RefGenome.
DR   InterPro; IPR000215; Protease_inhib_I4_serpin.
DR   InterPro; IPR023795; Protease_inhib_I4_serpin_CS.
DR   InterPro; IPR023796; Sepin_dom.
DR   PANTHER; PTHR11461; Prot_inh_serpin; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; Prot_inh_serpin; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acute phase; Alternative splicing; Blood coagulation;
KW   Complete proteome; Direct protein sequencing; Extracellular matrix;
KW   Glycoprotein; Hemostasis; Polymorphism; Protease inhibitor;
KW   Reference proteome; Secreted; Serine protease inhibitor; Signal.
FT   SIGNAL        1     24
FT   CHAIN        25    418       Alpha-1-antitrypsin.
FT                                /FTId=PRO_0000032377.
FT   PEPTIDE     375    418       Short peptide from AAT.
FT                                /FTId=PRO_0000364030.
FT   REGION      368    392       RCL.
FT   SITE        382    383       Reactive bond.
FT   MOD_RES     256    256       S-cysteinyl cysteine.
FT   CARBOHYD     70     70       N-linked (GlcNAc...) (complex).
FT   CARBOHYD    107    107       N-linked (GlcNAc...) (complex).
FT   CARBOHYD    271    271       N-linked (GlcNAc...) (complex).
FT   VAR_SEQ     307    418       Missing (in isoform 3).
FT                                /FTId=VSP_028890.
FT   VAR_SEQ     356    418       AVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVF
FT                                LMIEQNTKSPLFMGKVVNPTQK -> VRSP (in
FT                                isoform 2).
FT                                /FTId=VSP_028889.
FT   VARIANT       4      4       S -> L (in Z-Wrexham).
FT                                /FTId=VAR_006978.
FT   VARIANT      26     26       D -> A (in V-Munich).
FT                                /FTId=VAR_006979.
FT   VARIANT      37     37       T -> A (in dbSNP:rs11558262).
FT                                /FTId=VAR_051938.
FT   VARIANT      58     58       A -> T (in M5-Karlsruhe).
FT                                /FTId=VAR_006980.
FT   VARIANT      63     63       R -> C (in I; dbSNP:rs28931570).
FT                                /FTId=VAR_006981.
FT   VARIANT      65     65       L -> P (in M-Procida; dbSNP:rs28931569).
FT                                /FTId=VAR_006982.
FT   VARIANT      69     69       S -> F (in M6-Bonn).
FT                                /FTId=VAR_006983.
FT   VARIANT      75     75       Missing (in M-Malton, M-Nichinan and M-
FT                                Palermo; associated with very low serum
FT                                levels of AAT; homozygosity for allele M-
FT                                Malton may be associated with a risk for
FT                                chronic emphysema or infantile liver
FT                                cirrhosis).
FT                                /FTId=VAR_006984.
FT   VARIANT      77     77       S -> F (in S-Iiyama; dbSNP:rs55819880).
FT                                /FTId=VAR_006985.
FT   VARIANT      84     84       A -> T (in M6-Passau).
FT                                /FTId=VAR_006986.
FT   VARIANT      91     91       G -> E (in M-Mineral springs; causes
FT                                reduced AAT secretion; dbSNP:rs28931568).
FT                                /FTId=VAR_006987.
FT   VARIANT      92     92       T -> I (in QO-Lisbon; deficient AAT with
FT                                very low serum levels).
FT                                /FTId=VAR_006988.
FT   VARIANT     109    109       T -> M (in Z-Bristol; deficient AA;
FT                                disrupts the N-glycosylation site N-107).
FT                                /FTId=VAR_011620.
FT   VARIANT     112    112       P -> T (in M5-Berlin).
FT                                /FTId=VAR_006989.
FT   VARIANT     116    116       I -> N (in QO-Ludwigshafen;
FT                                dbSNP:rs28931572).
FT                                /FTId=VAR_006990.
FT   VARIANT     125    125       R -> H (in M2; associated with D-400;
FT                                dbSNP:rs709932).
FT                                /FTId=VAR_006991.
FT   VARIANT     139    139       G -> S (in QO-Newport; dbSNP:rs11558261).
FT                                /FTId=VAR_006992.
FT   VARIANT     172    172       G -> R (in V and M-Nichinan).
FT                                /FTId=VAR_006993.
FT   VARIANT     172    172       G -> W (in M2-Obernburg).
FT                                /FTId=VAR_006994.
FT   VARIANT     180    180       Q -> E (in L-Frankfurt).
FT                                /FTId=VAR_006995.
FT   VARIANT     190    198       QGKIVDLVK -> GFQNAILVR (in Aberrant
FT                                form).
FT                                /FTId=VAR_036746.
FT   VARIANT     228    228       E -> K (in X).
FT                                /FTId=VAR_006996.
FT   VARIANT     237    237       V -> A (in M1A and Z; associated with K-
FT                                366 in Z; dbSNP:rs6647).
FT                                /FTId=VAR_006997.
FT   VARIANT     247    247       R -> C (in F; dbSNP:rs28929470).
FT                                /FTId=VAR_006998.
FT   VARIANT     280    280       D -> V (in P-Duarte/P-Cardiff/P-Lowell;
FT                                associated with H-415 in Y-Barcelona;
FT                                dbSNP:rs28929472).
FT                                /FTId=VAR_006999.
FT   VARIANT     288    288       E -> V (in S and T; dbSNP:rs17580).
FT                                /FTId=VAR_007000.
FT   VARIANT     305    305       Missing (in Basque).
FT                                /FTId=VAR_009216.
FT   VARIANT     354    354       S -> F (in S-Munich).
FT                                /FTId=VAR_007001.
FT   VARIANT     360    360       A -> T (in W-Bethesda; dbSNP:rs1802959).
FT                                /FTId=VAR_007002.
FT   VARIANT     365    365       D -> N (in P-St.Albans/P-Donauwoerth).
FT                                /FTId=VAR_007003.
FT   VARIANT     366    366       E -> K (in Z/Z-Augsburg/Z-Tun; associated
FT                                with A-237 in Z; dbSNP:rs28929474).
FT                                /FTId=VAR_007004.
FT   VARIANT     382    382       M -> R (in Pittsburgh; has antithrombin
FT                                activity; causes fatal bleeding
FT                                diathesis).
FT                                /FTId=VAR_007005.
FT   VARIANT     386    386       P -> H (in Sao Tome).
FT                                /FTId=VAR_007006.
FT   VARIANT     386    386       P -> T (in L-Offenbach).
FT                                /FTId=VAR_007007.
FT   VARIANT     387    387       E -> K (in Christchurch).
FT                                /FTId=VAR_007008.
FT   VARIANT     393    393       P -> L (in M-Heerlen).
FT                                /FTId=VAR_007009.
FT   VARIANT     400    400       E -> D (in M2 and M3; associated with H-
FT                                125 in M2; dbSNP:rs1303).
FT                                /FTId=VAR_007010.
FT   VARIANT     415    415       P -> H (in Y-Barcelona; associated with
FT                                V-280).
FT                                /FTId=VAR_007011.
FT   MUTAGEN     382    382       M->V: Oxidation-resistant inhibitor of
FT                                therapeutic importance.
FT   CONFLICT     12     12       Missing (in Ref. 4; AAA51546).
FT   CONFLICT     23     23       L -> P (in Ref. 11; BAG38005).
FT   CONFLICT     26     26       D -> H (in Ref. 18; AA sequence).
FT   CONFLICT     39     39       H -> L (in Ref. 18; AA sequence).
FT   CONFLICT     61     61       L -> P (in Ref. 9; AAF29581).
FT   CONFLICT     96     96       T -> A (in Ref. 7; ABG73380).
FT   CONFLICT    139    140       GN -> DG (in Ref. 1; AAB59375).
FT   CONFLICT    174    174       T -> H (in Ref. 4; AAA51546).
FT   CONFLICT    229    229       E -> D (in Ref. 4; AAA51546).
FT   CONFLICT    273    273       T -> N (in Ref. 1; AAB59375).
FT   CONFLICT    280    280       D -> G (in Ref. 7; ABG73380).
FT   CONFLICT    326    326       V -> I (in Ref. 3; CAA25838).
FT   CONFLICT    410    410       G -> L (in Ref. 24; AA sequence).
FT   CONFLICT    414    414       N -> S (in Ref. 24; AA sequence).
FT   TURN         48     50
FT   HELIX        51     68
FT   STRAND       70     72
FT   STRAND       74     76
FT   HELIX        78     89
FT   HELIX        94    103
FT   TURN        108    110
FT   HELIX       113    127
FT   STRAND      135    145
FT   HELIX       152    160
FT   STRAND      165    169
FT   HELIX       174    188
FT   TURN        189    191
FT   STRAND      206    215
FT   STRAND      218    220
FT   HELIX       224    226
FT   STRAND      228    237
FT   STRAND      239    256
FT   TURN        257    260
FT   STRAND      261    268
FT   TURN        269    271
FT   STRAND      272    279
FT   HELIX       284    290
FT   HELIX       293    299
FT   STRAND      306    313
FT   STRAND      315    322
FT   HELIX       323    329
FT   HELIX       334    336
FT   TURN        343    345
FT   STRAND      346    349
FT   STRAND      355    364
FT   STRAND      387    389
FT   STRAND      394    400
FT   TURN        401    403
FT   STRAND      406    413
SQ   SEQUENCE   418 AA;  46737 MW;  7016555F273B7F16 CRC64;
     MPSSVSWGIL LLAGLCCLVP VSLAEDPQGD AAQKTDTSHH DQDHPTFNKI TPNLAEFAFS
     LYRQLAHQSN STNIFFSPVS IATAFAMLSL GTKADTHDEI LEGLNFNLTE IPEAQIHEGF
     QELLRTLNQP DSQLQLTTGN GLFLSEGLKL VDKFLEDVKK LYHSEAFTVN FGDTEEAKKQ
     INDYVEKGTQ GKIVDLVKEL DRDTVFALVN YIFFKGKWER PFEVKDTEEE DFHVDQVTTV
     KVPMMKRLGM FNIQHCKKLS SWVLLMKYLG NATAIFFLPD EGKLQHLENE LTHDIITKFL
     ENEDRRSASL HLPKLSITGT YDLKSVLGQL GITKVFSNGA DLSGVTEEAP LKLSKAVHKA
     VLTIDEKGTE AAGAMFLEAI PMSIPPEVKF NKPFVFLMIE QNTKSPLFMG KVVNPTQK
//
ID   A1BG_HUMAN              Reviewed;         495 AA.
AC   P04217; A8K052; Q68CK0; Q8IYJ6; Q96P39;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   18-APR-2012, entry version 118.
DE   RecName: Full=Alpha-1B-glycoprotein;
DE   AltName: Full=Alpha-1-B glycoprotein;
DE   Flags: Precursor;
GN   Name=A1BG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=15221005; DOI=10.1038/sj.onc.1207782;
RA   Yamada S., Ohira M., Horie H., Ando K., Takayasu H., Suzuki Y.,
RA   Sugano S., Hirata T., Goto T., Matsunaga T., Hiyama E., Hayashi Y.,
RA   Ando H., Suita S., Kaneko M., Sasaki F., Hashizume K., Ohnuma N.,
RA   Nakagawara A.;
RT   "Expression profiling and differential screening between
RT   hepatoblastomas and the corresponding normal livers: identification of
RT   high expression of the PLK1 oncogene as a poor-prognostic indicator of
RT   hepatoblastomas.";
RL   Oncogene 23:5901-5911(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-52.
RA   Zhao Y., Sun D.;
RT   "Molecular cloning and characterization of the human A1BG gene.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-52.
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 22-495, DISULFIDE BONDS, GLYCOSYLATION AT ASN-44;
RP   ASN-179; ASN-363 AND ASN-371, AND VARIANT ARG-52.
RX   MEDLINE=86205955; PubMed=3458201; DOI=10.1073/pnas.83.8.2363;
RA   Ishioka N., Takahashi N., Putnam F.W.;
RT   "Amino acid sequence of human plasma alpha 1B-glycoprotein: homology
RT   to the immunoglobulin supergene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:2363-2367(1986).
RN   [7]
RP   INTERACTION WITH CRISP3.
RX   PubMed=15461460; DOI=10.1021/bi048823e;
RA   Udby L., Sorensen O.E., Pass J., Johnsen A.H., Behrendt N.,
RA   Borregaard N., Kjeldsen L.;
RT   "Cysteine-rich secretory protein 3 is a ligand of alpha1B-glycoprotein
RT   in human plasma.";
RL   Biochemistry 43:12877-12886(2004).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-44 AND ASN-179, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-44; ASN-179; ASN-363 AND
RP   ASN-371, AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-44, STRUCTURE OF
RP   CARBOHYDRATES, AND MASS SPECTROMETRY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
CC   -!- SUBUNIT: Interacts with CRISP3.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P04217-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P04217-2; Sequence=VSP_040323;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- SIMILARITY: Contains 5 Ig-like V-type (immunoglobulin-like)
CC       domains.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=alpha1B";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB073611; BAD38648.1; -; mRNA.
DR   EMBL; AF414429; AAL07469.1; -; mRNA.
DR   EMBL; AK289417; BAF82106.1; -; mRNA.
DR   EMBL; AC010642; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012313; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC035719; AAH35719.1; -; mRNA.
DR   IPI; IPI00022895; -.
DR   IPI; IPI00644018; -.
DR   RefSeq; NP_570602.2; NM_130786.3.
DR   UniGene; Hs.529161; -.
DR   ProteinModelPortal; P04217; -.
DR   SMR; P04217; 25-495.
DR   IntAct; P04217; 3.
DR   STRING; P04217; -.
DR   MEROPS; I43.950; -.
DR   DMDM; 46577680; -.
DR   Cornea-2DPAGE; P04217; -.
DR   DOSAC-COBS-2DPAGE; P04217; -.
DR   REPRODUCTION-2DPAGE; IPI00022895; -.
DR   Siena-2DPAGE; P04217; -.
DR   SWISS-2DPAGE; P04217; -.
DR   PeptideAtlas; P04217; -.
DR   PRIDE; P04217; -.
DR   Ensembl; ENST00000263100; ENSP00000263100; ENSG00000121410.
DR   GeneID; 1; -.
DR   KEGG; hsa:1; -.
DR   UCSC; uc002qsd.4; human.
DR   CTD; 1; -.
DR   GeneCards; GC19M058858; -.
DR   HGNC; HGNC:5; A1BG.
DR   HPA; CAB016673; -.
DR   MIM; 138670; gene.
DR   neXtProt; NX_P04217; -.
DR   PharmGKB; PA24356; -.
DR   eggNOG; NOG26440; -.
DR   GeneTree; ENSGT00570000078800; -.
DR   HOGENOM; HBG125406; -.
DR   HOVERGEN; HBG000037; -.
DR   InParanoid; P04217; -.
DR   OMA; EATFPVH; -.
DR   OrthoDB; EOG45MN53; -.
DR   PhylomeDB; P04217; -.
DR   NextBio; 1; -.
DR   ArrayExpress; P04217; -.
DR   Bgee; P04217; -.
DR   CleanEx; HS_A1BG; -.
DR   Genevestigator; P04217; -.
DR   GermOnline; ENSG00000121410; Homo sapiens.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 5.
DR   InterPro; IPR016332; A1B_glyco/leuk_Ig-like_rcpt.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003598; Ig_sub2.
DR   PIRSF; PIRSF001979; Alpha_1B_glycoprot_prd; 1.
DR   SMART; SM00408; IGc2; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     21
FT   CHAIN        22    495       Alpha-1B-glycoprotein.
FT                                /FTId=PRO_0000014502.
FT   DOMAIN       22    113       Ig-like V-type 1.
FT   DOMAIN      114    206       Ig-like V-type 2.
FT   DOMAIN      207    299       Ig-like V-type 3.
FT   DOMAIN      300    397       Ig-like V-type 4.
FT   DOMAIN      398    495       Ig-like V-type 5.
FT   CARBOHYD     44     44       N-linked (GlcNAc...) (complex).
FT   CARBOHYD    179    179       N-linked (GlcNAc...).
FT   CARBOHYD    363    363       N-linked (GlcNAc...).
FT   CARBOHYD    371    371       N-linked (GlcNAc...).
FT   DISULFID     49     93       Probable.
FT   DISULFID    139    182
FT   DISULFID    232    279
FT   DISULFID    325    374
FT   DISULFID    423    470       Probable.
FT   VAR_SEQ       1    122       Missing (in isoform 2).
FT                                /FTId=VSP_040323.
FT   VARIANT      52     52       H -> R (in dbSNP:rs893184).
FT                                /FTId=VAR_018369.
FT   VARIANT     395    395       H -> R (in dbSNP:rs2241788).
FT                                /FTId=VAR_018370.
FT   CONFLICT    105    105       S -> G (in Ref. 2; AAL07469).
FT   CONFLICT    127    127       S -> P (in Ref. 2; AAL07469).
FT   CONFLICT    146    146       V -> E (in Ref. 2; AAL07469).
FT   CONFLICT    304    304       E -> G (in Ref. 3; BAF82106).
FT   CONFLICT    413    413       V -> A (in Ref. 2; AAL07469).
FT   CONFLICT    446    447       VR -> IP (in Ref. 2; AAL07469).
SQ   SEQUENCE   495 AA;  54254 MW;  8E611BDC3BC824C8 CRC64;
     MSMLVVFLLL WGVTWGPVTE AAIFYETQPS LWAESESLLK PLANVTLTCQ AHLETPDFQL
     FKNGVAQEPV HLDSPAIKHQ FLLTGDTQGR YRCRSGLSTG WTQLSKLLEL TGPKSLPAPW
     LSMAPVSWIT PGLKTTAVCR GVLRGVTFLL RREGDHEFLE VPEAQEDVEA TFPVHQPGNY
     SCSYRTDGEG ALSEPSATVT IEELAAPPPP VLMHHGESSQ VLHPGNKVTL TCVAPLSGVD
     FQLRRGEKEL LVPRSSTSPD RIFFHLNAVA LGDGGHYTCR YRLHDNQNGW SGDSAPVELI
     LSDETLPAPE FSPEPESGRA LRLRCLAPLE GARFALVRED RGGRRVHRFQ SPAGTEALFE
     LHNISVADSA NYSCVYVDLK PPFGGSAPSE RLELHVDGPP PRPQLRATWS GAVLAGRDAV
     LRCEGPIPDV TFELLREGET KAVKTVRTPG AAANLELIFV GPQHAGNYRC RYRSWVPHTF
     ESELSDPVEL LVAES
//
ID   A1CF_HUMAN              Reviewed;         594 AA.
AC   Q9NQ94; A1L4F2; A8K7G7; B7ZM14; Q5SZQ0; Q9NQ93; Q9NQX8; Q9NQX9;
AC   Q9NXC9; Q9NZD3;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   18-APR-2012, entry version 101.
DE   RecName: Full=APOBEC1 complementation factor;
DE   AltName: Full=APOBEC1-stimulating protein;
GN   Name=A1CF; Synonyms=ACF, ASP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   INTERACTION WITH APOBEC1.
RC   TISSUE=Liver, and Small intestine;
RX   MEDLINE=20347895; PubMed=10781591; DOI=10.1074/jbc.M001786200;
RA   Lellek H., Kirsten R., Diehl I., Apostel F., Buck F., Greeve J.;
RT   "Purification and molecular cloning of a novel essential component of
RT   the apolipoprotein B mRNA editing enzyme-complex.";
RL   J. Biol. Chem. 275:19848-19856(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH
RP   APOBEC1, AND TISSUE SPECIFICITY.
RX   MEDLINE=20136062; PubMed=10669759;
RX   DOI=10.1128/MCB.20.5.1846-1854.2000;
RA   Mehta A., Kinter M.T., Sherman N.E., Driscoll D.M.;
RT   "Molecular cloning of APOBEC-1 complementation factor, a novel RNA-
RT   binding protein involved in the editing of apolipoprotein B mRNA.";
RL   Mol. Cell. Biol. 20:1846-1854(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Liver;
RA   Sowden M.P., Smith H.C.;
RT   "Human APOBEC-1 complementation factor related protein.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SYNCRIP.
RX   PubMed=11134005; DOI=10.1074/jbc.M006435200;
RA   Blanc V., Navaratnam N., Henderson J.O., Anant S., Kennedy S.,
RA   Jarmuz A., Scott J., Davidson N.O.;
RT   "Identification of GRY-RBP as an apolipoprotein B RNA-binding protein
RT   that interacts with both apobec-1 and apobec-1 complementation factor
RT   to modulate C to U editing.";
RL   J. Biol. Chem. 276:10272-10283(2001).
RN   [9]
RP   GENE STRUCTURE, AND ALTERNATIVE SPLICING.
RX   MEDLINE=21575688; PubMed=11718896; DOI=10.1016/S0167-4781(01)00295-0;
RA   Henderson J.O., Blanc V., Davidson N.O.;
RT   "Isolation, characterization and developmental regulation of the human
RT   apobec-1 complementation factor (ACF) gene.";
RL   Biochim. Biophys. Acta 1522:22-30(2001).
RN   [10]
RP   RNA-BINDING DOMAIN, AND MUTAGENESIS OF PHE-59; PHE-100; PHE-139;
RP   PHE-183; TYR-234 AND PHE-270.
RX   MEDLINE=21860382; PubMed=11871661; DOI=10.1017/S1355838202015649;
RA   Mehta A., Driscoll D.M.;
RT   "Identification of domains in apobec-1 complementation factor required
RT   for RNA binding and apolipoprotein-B mRNA editing.";
RL   RNA 8:69-82(2002).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12881431; DOI=10.1093/emboj/cdg369;
RA   Chester A., Somasekaram A., Tzimina M., Jarmuz A., Gisbourne J.,
RA   O'Keefe R., Scott J., Navaratnam N.;
RT   "The apolipoprotein B mRNA editing complex performs a multifunctional
RT   cycle and suppresses nonsense-mediated decay.";
RL   EMBO J. 22:3971-3982(2003).
RN   [12]
RP   NUCLEAR LOCALIZATION SIGNAL, AND INTERACTION WITH TNPO2.
RX   PubMed=12896982; DOI=10.1074/jbc.M302951200;
RA   Blanc V., Kennedy S., Davidson N.O.;
RT   "A novel nuclear localization signal in the auxiliary domain of
RT   apobec-1 complementation factor regulates nucleocytoplasmic import and
RT   shuttling.";
RL   J. Biol. Chem. 278:41198-41204(2003).
RN   [13]
RP   STRUCTURE BY NMR OF 223-308.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RNA recognition motif of human APOBEC-1
RT   complementation factor, ACF.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Essential component of the apolipoprotein B mRNA editing
CC       enzyme complex which is responsible for the postranscriptional
CC       editing of a CAA codon for Gln to a UAA codon for stop in APOB
CC       mRNA. Binds to APOB mRNA and is probably responsible for docking
CC       the catalytic subunit, APOBEC1, to the mRNA to allow it to
CC       deaminate its target cytosine. The complex also protects the
CC       edited APOB mRNA from nonsense-mediated decay.
CC   -!- SUBUNIT: Part of the apolipoprotein B mRNA editing complex with
CC       APOBEC1. Interacts with TNPO2; TNPO2 may be responsible for
CC       transport of A1CF into the nucleus. Interacts with SYNCRIP.
CC       Interacts with CELF2/CUGBP2 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Nucleus. Endoplasmic reticulum (By
CC       similarity). Cytoplasm. Note=Predominantly nuclear where it
CC       localizes to heterochromatin. Also cytoplasmic where it is found
CC       at the outer surface of the endoplasmic reticulum (By similarity).
CC       Shuttles between the nucleus and cytoplasm. May be transported
CC       into the nucleus by the nuclear import protein TNPO2/TRN2 or by
CC       APOBEC1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q9NQ94-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQ94-2; Sequence=VSP_051929;
CC         Note=Major isoform found in 66-78% of cDNA clones;
CC       Name=3;
CC         IsoId=Q9NQ94-3; Sequence=VSP_051926, VSP_051929;
CC       Name=4;
CC         IsoId=Q9NQ94-4; Sequence=VSP_051927, VSP_051929;
CC         Note=Does not exhibit APOBEC1 complementation activity;
CC       Name=5;
CC         IsoId=Q9NQ94-5; Sequence=VSP_051925;
CC         Note=Does not exhibit APOBEC1 complementation activity;
CC       Name=6;
CC         IsoId=Q9NQ94-6; Sequence=VSP_051928;
CC         Note=Minor isoform found in 2-3% of cDNA clones;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in brain,
CC       liver, pancreas, colon and spleen.
CC   -!- DOMAIN: The RRM domains are necessary but not sufficient for
CC       binding to APOB mRNA. Additional residues in the pre-RRM and C-
CC       terminal regions are required for RNA-binding and for
CC       complementing APOBEC1 activity.
CC   -!- SIMILARITY: Contains 3 RRM (RNA recognition motif) domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91086.1; Type=Frameshift; Positions=148;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272078; CAB94754.1; -; mRNA.
DR   EMBL; AJ272079; CAB94755.1; -; mRNA.
DR   EMBL; AF209192; AAF34824.1; -; mRNA.
DR   EMBL; AF271789; AAF76221.1; -; mRNA.
DR   EMBL; AF271790; AAF76222.1; -; mRNA.
DR   EMBL; AK000324; BAA91086.1; ALT_FRAME; mRNA.
DR   EMBL; AK291982; BAF84671.1; -; mRNA.
DR   EMBL; AL512366; CAI14233.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14233.1; JOINED; Genomic_DNA.
DR   EMBL; AL512366; CAI14235.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14235.1; JOINED; Genomic_DNA.
DR   EMBL; AL512366; CAI14236.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14236.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15762.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15762.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15763.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15763.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15764.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15764.1; JOINED; Genomic_DNA.
DR   EMBL; CH471083; EAW54133.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54134.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54135.1; -; Genomic_DNA.
DR   EMBL; BC130519; AAI30520.1; -; mRNA.
DR   EMBL; BC144196; AAI44197.1; -; mRNA.
DR   IPI; IPI00071360; -.
DR   IPI; IPI00148257; -.
DR   IPI; IPI00299499; -.
DR   IPI; IPI00657723; -.
DR   IPI; IPI00657770; -.
DR   IPI; IPI00981528; -.
DR   RefSeq; NP_001185747.1; NM_001198818.1.
DR   RefSeq; NP_001185748.1; NM_001198819.1.
DR   RefSeq; NP_001185749.1; NM_001198820.1.
DR   RefSeq; NP_055391.2; NM_014576.3.
DR   RefSeq; NP_620310.1; NM_138932.2.
DR   RefSeq; NP_620311.1; NM_138933.2.
DR   UniGene; Hs.282795; -.
DR   PDB; 2CPD; NMR; -; A=223-308.
DR   PDBsum; 2CPD; -.
DR   ProteinModelPortal; Q9NQ94; -.
DR   SMR; Q9NQ94; 13-308.
DR   IntAct; Q9NQ94; 1.
DR   STRING; Q9NQ94; -.
DR   PhosphoSite; Q9NQ94; -.
DR   DMDM; 74761651; -.
DR   PRIDE; Q9NQ94; -.
DR   Ensembl; ENST00000282641; ENSP00000282641; ENSG00000148584.
DR   Ensembl; ENST00000373993; ENSP00000363105; ENSG00000148584.
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   UCSC; uc001jjh.3; human.
DR   UCSC; uc001jji.3; human.
DR   UCSC; uc001jjj.3; human.
DR   CTD; 29974; -.
DR   GeneCards; GC10M052566; -.
DR   H-InvDB; HIX0008828; -.
DR   HGNC; HGNC:24086; A1CF.
DR   HPA; HPA037779; -.
DR   neXtProt; NX_Q9NQ94; -.
DR   PharmGKB; PA162375098; -.
DR   eggNOG; NOG258596; -.
DR   GeneTree; ENSGT00550000074366; -.
DR   HOVERGEN; HBG051917; -.
DR   InParanoid; Q9NQ94; -.
DR   OMA; TMLQGEY; -.
DR   PhylomeDB; Q9NQ94; -.
DR   Reactome; REACT_1675; mRNA Processing.
DR   Reactome; REACT_71; Gene Expression.
DR   EvolutionaryTrace; Q9NQ94; -.
DR   NextBio; 52719; -.
DR   ArrayExpress; Q9NQ94; -.
DR   Bgee; Q9NQ94; -.
DR   CleanEx; HS_A1CF; -.
DR   Genevestigator; Q9NQ94; -.
DR   GermOnline; ENSG00000148584; Homo sapiens.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0016554; P:cytidine to uridine editing; TAS:Reactome.
DR   GO; GO:0016556; P:mRNA modification; TAS:Reactome.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   Gene3D; G3DSA:3.30.70.330; a_b_plait_nuc_bd; 3.
DR   Gene3D; G3DSA:3.30.160.20; dsRNA-bd-like; 1.
DR   InterPro; IPR014720; dsRNA-bd-like.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 3.
DR   TIGRFAMs; TIGR01648; HnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; mRNA processing; Nucleus; Polymorphism;
KW   Reference proteome; Repeat; RNA-binding.
FT   CHAIN         1    594       APOBEC1 complementation factor.
FT                                /FTId=PRO_0000081482.
FT   DOMAIN       56    134       RRM 1.
FT   DOMAIN      136    218       RRM 2.
FT   DOMAIN      231    303       RRM 3.
FT   REGION      360    409       Required for nuclear localization.
FT   VAR_SEQ       1     84       Missing (in isoform 5).
FT                                /FTId=VSP_051925.
FT   VAR_SEQ       1     33       MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MLCS
FT                                PSFCKLCWKRKK (in isoform 3).
FT                                /FTId=VSP_051926.
FT   VAR_SEQ       1     33       MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MEAV
FT                                CLGTCPEPEASMSTAIPGLKKGNNALQSIILQTLLEK (in
FT                                isoform 4).
FT                                /FTId=VSP_051927.
FT   VAR_SEQ     202    256       Missing (in isoform 6).
FT                                /FTId=VSP_051928.
FT   VAR_SEQ     381    388       Missing (in isoform 2, isoform 3 and
FT                                isoform 4).
FT                                /FTId=VSP_051929.
FT   VARIANT     555    555       V -> M (in dbSNP:rs9073).
FT                                /FTId=VAR_052201.
FT   VARIANT     558    558       A -> S (in dbSNP:rs11817448).
FT                                /FTId=VAR_059821.
FT   MUTAGEN      59     59       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     100    100       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     139    139       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     183    183       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     234    234       Y->A: Slightly reduced RNA binding.
FT   MUTAGEN     270    270       F->A: Slightly reduced RNA binding.
FT   CONFLICT    191    191       A -> T (in Ref. 2; AAF34824).
FT   CONFLICT    277    277       E -> K (in Ref. 2 and 3).
FT   STRAND      232    237
FT   HELIX       244    252
FT   STRAND      259    264
FT   STRAND      266    275
FT   HELIX       276    286
FT   STRAND      297    299
SQ   SEQUENCE   594 AA;  65202 MW;  AA5EF76BD8815807 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR EIYMNVPVGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//
ID   A20A1_HUMAN             Reviewed;         823 AA.
AC   Q5TYW2; Q9H0H6;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   18-APR-2012, entry version 59.
DE   RecName: Full=Ankyrin repeat domain-containing protein 20A1;
GN   Name=ANKRD20A1; Synonyms=ANKRD20A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   MEDLINE=21154917; PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-297, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- SIMILARITY: Contains 5 ANK repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136793; CAB66727.1; -; mRNA.
DR   EMBL; BX649567; CAH71137.1; -; Genomic_DNA.
DR   IPI; IPI00020265; -.
DR   RefSeq; NP_115626.2; NM_032250.3.
DR   UniGene; Hs.632671; -.
DR   ProteinModelPortal; Q5TYW2; -.
DR   SMR; Q5TYW2; 6-255.
DR   PhosphoSite; Q5TYW2; -.
DR   DMDM; 74746676; -.
DR   PRIDE; Q5TYW2; -.
DR   DNASU; 84210; -.
DR   Ensembl; ENST00000377477; ENSP00000366697; ENSG00000196774.
DR   GeneID; 84210; -.
DR   KEGG; hsa:84210; -.
DR   UCSC; uc010mnn.3; human.
DR   CTD; 84210; -.
DR   GeneCards; GC09P067926; -.
DR   HGNC; HGNC:23665; ANKRD20A1.
DR   neXtProt; NX_Q5TYW2; -.
DR   PharmGKB; PA134953648; -.
DR   eggNOG; COG0666; -.
DR   GeneTree; ENSGT00560000076605; -.
DR   HOGENOM; HBG100718; -.
DR   HOVERGEN; HBG079958; -.
DR   InParanoid; Q5TYW2; -.
DR   OrthoDB; EOG4CNQQH; -.
DR   PhylomeDB; Q5TYW2; -.
DR   NextBio; 73621; -.
DR   Bgee; Q5TYW2; -.
DR   CleanEx; HS_ANKRD20A1; -.
DR   Genevestigator; Q5TYW2; -.
DR   GermOnline; ENSG00000196774; Homo sapiens.
DR   GO; GO:0005886; C:plasma membrane; IDA:LIFEdb.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 6.
DR   SUPFAM; SSF48403; ANK; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
PE   1: Evidence at protein level;
KW   ANK repeat; Coiled coil; Complete proteome; Phosphoprotein;
KW   Reference proteome; Repeat.
FT   CHAIN         1    823       Ankyrin repeat domain-containing protein
FT                                20A1.
FT                                /FTId=PRO_0000240834.
FT   REPEAT       66     95       ANK 1.
FT   REPEAT       99    128       ANK 2.
FT   REPEAT      132    161       ANK 3.
FT   REPEAT      165    194       ANK 4.
FT   REPEAT      198    227       ANK 5.
FT   COILED      431    480       Potential.
FT   COILED      565    724       Potential.
FT   COILED      776    805       Potential.
FT   MOD_RES     297    297       Phosphothreonine.
FT   CONFLICT     76     76       T -> A (in Ref. 1; CAB66727).
FT   CONFLICT    128    128       L -> F (in Ref. 1; CAB66727).
FT   CONFLICT    499    499       W -> R (in Ref. 1; CAB66727).
FT   CONFLICT    679    679       R -> C (in Ref. 1; CAB66727).
FT   CONFLICT    772    772       G -> E (in Ref. 1; CAB66727).
FT   CONFLICT    805    805       E -> G (in Ref. 1; CAB66727).
SQ   SEQUENCE   823 AA;  94048 MW;  0AE8585829E6E91B CRC64;
     MKLFGFGSRR GQTAQGSIDH VYTGSGYRIR DSELQKIHRA AVKGDAAEVE RCLARRSGDL
     DALDKQHRTA LHLACTSGHV QVVTLLVNRK CQIDVCDKEN RTPLIQAVHC QEEACAVILL
     EHGANPNLKD IYGNTALHYA VYSESTSLAE KLLSHGAHIE ALDKDNNTPL LFAIICKKEK
     MVEFLLKKKA SSHAVDRLRR SALMLAVYYD SPGIVNILLK QNIDVFAQDM CGRDAEDYAI
     SHHLTKIQQQ ILEHKKKILK KEKSDVGSSD ESAVSIFHEL RVDSLPASDD KDLNVATKQC
     VPEKVSEPLP GSSHEKGNRI VNGQGEGPPA KHPSLKPSTE VEDPAVKGAV QRKNVQTLRA
     EQALPVASEE EQERHERSEK KQPQVKEGNN TNKSEKIQLS ENICDSTSSA AAGRLTQQRK
     IGKTYPQQFP KKLKEEHDRC TLKQENEEKT NVNMLYKKNR EELERKEKQY KKEVEAKQLE
     PTVQSLEMKS KTARNTPNWD FHNHEEMKGL MDENCILKAD IAILRQEICT MKNDNLEKEN
     KYLKDIKIVK ETNAALEKYI KLNEEMITET AFRYQQELND LKAENTRLNA ELLKEKESKK
     RLEADIESYQ SRLAAAISKH SESVKTERNL KLALERTRDV SVQVEMSSAI SKVKAENEFL
     TEQLSETQIK FNALKDKFRK TRDSLRKKSL ALETVQNDLS QTQQQTQEMK EMYQNAEAKV
     NNSTGKWNCV EERICHLQRE NAWLVQQLDD VHQKEDHKEI VTNIQRGFIE SGKKDLVLEE
     KSKKLMNECD HLKESLFQYE REKTEGVVSI KEDKYFQTSR KTI
//
ID   A20A2_HUMAN             Reviewed;         823 AA.
AC   Q5SQ80;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   18-APR-2012, entry version 58.
DE   RecName: Full=Ankyrin repeat domain-containing protein 20A2;
GN   Name=ANKRD20A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
CC   -!- SIMILARITY: Contains 5 ANK repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL773545; CAI12706.1; -; Genomic_DNA.
DR   EMBL; BX664727; CAI12706.1; JOINED; Genomic_DNA.
DR   EMBL; BX664727; CAI39536.1; -; Genomic_DNA.
DR   EMBL; AL773545; CAI39536.1; JOINED; Genomic_DNA.
DR   IPI; IPI00644106; -.
DR   RefSeq; NP_001012421.1; NM_001012421.1.
DR   UniGene; Hs.632663; -.
DR   ProteinModelPortal; Q5SQ80; -.
DR   SMR; Q5SQ80; 7-254.
DR   PhosphoSite; Q5SQ80; -.
DR   PRIDE; Q5SQ80; -.
DR   Ensembl; ENST00000377601; ENSP00000366826; ENSG00000183148.
DR   GeneID; 441430; -.
DR   KEGG; hsa:441430; -.
DR   UCSC; uc004acw.1; human.
DR   CTD; 441430; -.
DR   GeneCards; GC09P042358; -.
DR   HGNC; HGNC:31979; ANKRD20A2.
DR   neXtProt; NX_Q5SQ80; -.
DR   PharmGKB; PA142672619; -.
DR   eggNOG; COG0666; -.
DR   GeneTree; ENSGT00560000076605; -.
DR   HOGENOM; HBG100718; -.
DR   HOVERGEN; HBG079958; -.
DR   InParanoid; Q5SQ80; -.
DR   OMA; HEEIVIN; -.
DR   OrthoDB; EOG4CNQQH; -.
DR   PhylomeDB; Q5SQ80; -.
DR   NextBio; 110164; -.
DR   CleanEx; HS_ANKRD20A2; -.
DR   Genevestigator; Q5SQ80; -.
DR   GermOnline; ENSG00000183148; Homo sapiens.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 6.
DR   SUPFAM; SSF48403; ANK; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
PE   2: Evidence at transcript level;
KW   ANK repeat; Coiled coil; Complete proteome; Reference proteome;
KW   Repeat.
FT   CHAIN         1    823       Ankyrin repeat domain-containing protein
FT                                20A2.
FT                                /FTId=PRO_0000240837.
FT   REPEAT       66     95       ANK 1.
FT   REPEAT       99    128       ANK 2.
FT   REPEAT      132    161       ANK 3.
FT   REPEAT      165    194       ANK 4.
FT   REPEAT      198    227       ANK 5.
FT   COILED      431    480       Potential.
FT   COILED      565    724       Potential.
FT   COILED      776    805       Potential.
SQ   SEQUENCE   823 AA;  94087 MW;  6C1C478C3EE9B67F CRC64;
     MKLFGFGSRR GQTAQGSIDH VYTGSGYRIR DSELQKIHRA AVKGDAAEVE RCLARRSGDL
     DALDKQHRTA LHLACASGHV QVVTLLVNRK CQIDVCDKEN RTPLIQAVHC QEEACAVILL
     EHGANPNLKD IYGNTALHYA VYSESTSLAE KLLSHGAHIE ALDKDNNTPL LFAIICKKEK
     MVEFLLKRKA SSHAVDRLRR SALMLAVYYD SPGIVNILLK QNIDVFAQDM CGRDAEDYAI
     SHHLTKIQQQ ILEHKKKILK KEKSDVGSSD ESAVSIFHEL RVDSLPASDD KDLNVATKQC
     VPEKVSEPLP GSSHEKGNRI VNGQGEGPPA KHPSLKPSTE VEDPAVKGAV QRKNVQTLRA
     EQALPVASEE EQERHERSEK KQPQVKEGNN TNKSEKIQLS ENICDSTSSA AAGRLTQQRK
     IGKTYPQQFP KKLKEEHDRC TLKQENEEKT NVNMLYKKNR EELERKEKQY KKEVEAKQLE
     PTVQSLEMKS KTARNTPNRD FHNHEEMKGL MDENCILKAD IAILRQEICT MKNDNLEKEN
     KYLKDIKIVK ETNAALEKYI KLNEEMITET AFRYQQELND LKAENTRLNA ELLKEKESKK
     RLEADIESYQ SRLAAAISKH SESVKTERNL KLALERTRDV SVQVEMSSAI SKVKDENEFL
     TEQLSETQIK FNALKDKFRK TRDSLRKKSL ALETVQNDLS QTQQQTQEMK EMYQNAEAKV
     NNSTGKWNCV EERICHLQRE NAWLVQQLDD VHQKEDHKEI VTNIQRGFIE SGKKDLVLEE
     KSKKLMNECD HLKESLFQYE REKTEGVVSI KEDKYFQTSR KKI
//
ID   A20A3_HUMAN             Reviewed;         823 AA.
AC   Q5VUR7;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   18-APR-2012, entry version 60.
DE   RecName: Full=Ankyrin repeat domain-containing protein 20A3;
GN   Name=ANKRD20A3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
CC   -!- SIMILARITY: Contains 5 ANK repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL513478; CAH72532.1; -; Genomic_DNA.
DR   IPI; IPI00478457; -.
DR   RefSeq; NP_001012419.1; NM_001012419.1.
DR   UniGene; Hs.632663; -.
DR   ProteinModelPortal; Q5VUR7; -.
DR   SMR; Q5VUR7; 11-255.
DR   PhosphoSite; Q5VUR7; -.
DR   DMDM; 74747147; -.
DR   PRIDE; Q5VUR7; -.
DR   DNASU; 441425; -.
DR   Ensembl; ENST00000254835; ENSP00000254835; ENSG00000132498.
DR   GeneID; 441425; -.
DR   KEGG; hsa:441425; -.
DR   UCSC; uc004acd.3; human.
DR   CTD; 441425; -.
DR   GeneCards; GC09M043079; -.
DR   HGNC; HGNC:31981; ANKRD20A3.
DR   neXtProt; NX_Q5VUR7; -.
DR   PharmGKB; PA143485301; -.
DR   eggNOG; COG0666; -.
DR   GeneTree; ENSGT00560000076605; -.
DR   HOGENOM; HBG100718; -.
DR   HOVERGEN; HBG079958; -.
DR   InParanoid; Q5VUR7; -.
DR   OrthoDB; EOG4CNQQH; -.
DR   PhylomeDB; Q5VUR7; -.
DR   NextBio; 110155; -.
DR   Bgee; Q5VUR7; -.
DR   Genevestigator; Q5VUR7; -.
DR   GermOnline; ENSG00000132498; Homo sapiens.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 6.
DR   SUPFAM; SSF48403; ANK; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
PE   4: Predicted;
KW   ANK repeat; Coiled coil; Complete proteome; Reference proteome;
KW   Repeat.
FT   CHAIN         1    823       Ankyrin repeat domain-containing protein
FT                                20A3.
FT                                /FTId=PRO_0000240836.
FT   REPEAT       66     95       ANK 1.
FT   REPEAT       99    128       ANK 2.
FT   REPEAT      132    161       ANK 3.
FT   REPEAT      165    194       ANK 4.
FT   REPEAT      198    227       ANK 5.
FT   COILED      431    480       Potential.
FT   COILED      571    724       Potential.
FT   COILED      776    805       Potential.
SQ   SEQUENCE   823 AA;  94108 MW;  CC0ED7895CA092E4 CRC64;
     MKLFGFGSRR GQTAQGSIDH VYTGSGYRIR DSELQKIHRA AVKGDAAEVE RCLARRSGDL
     DALDKQHRTA LHLACASGHV QVVTLLVNRK CQIDVCDKEN RTPLIQAVHC QEEACAVILL
     EHGANPNLKD IYGNTALHYA VYSESTSLAE KLLSHGAHIE ALDKDNNTPL LFAIICKKEK
     MVEFLLKRKA SSHAVDRLRR SALMLAVYYD SPGIVNILLK QNIDVFAQDM CGRDAEDYAI
     SHHLTKIQQQ ILEHKKKILK KEKSDVGSSD ESAVSIFHEL RVDSLPASDD KDLNVATKQC
     VPEKVSEPLP GSSHEKGNRI VNGQGEGPPA KHPSLKPSTE VEDPAVKGAV QRKNVQTLRA
     EQALPVASEE EQERHERSEK KQPQVKEGNN TNKSEKIQLS ENICDSTSSA AAGRLTQQRK
     IGKTYPQQFP KKLKEEHDRC TLKQENEEKT NVNMLYKKNR EELERKEKQY KKEVEAKQLE
     PTVQSLEMKS KTARNTPNRD FHNHEEMKGL MDENCILKAD IAILRQEICT MKNDNLEKEN
     KYLKDIKIVK ETNAALEKYI KLNEEMITET AFRYQQELNY LKAENTRLNA ELLKEKESKK
     RLEADIESYQ SRLAAAISKH SESVKTERNL KLALERTRDV SVQVEMSSAI SKVKDENEFL
     TEQLSETQIK FNALKDKFRK TRDSLRKKSL ALETVQNDLS QTQQQTQEMK EMYQNAEAKV
     NNSTGKWNCV EERICHLQRE NAWLVQQLDD VHQKEDHKEI VTNIQRGFIE SGKKDLVLEE
     KSKKLMNECD HLKESLFQYE REKTEGVVSI KEDKYFQTSR KTI
//
ID   A20A4_HUMAN             Reviewed;         823 AA.
AC   Q4UJ75;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   18-APR-2012, entry version 52.
DE   RecName: Full=Ankyrin repeat domain-containing protein 20A4;
GN   Name=ANKRD20A4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
CC   -!- SIMILARITY: Contains 5 ANK repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR769776; CAI95383.1; -; Genomic_DNA.
DR   IPI; IPI00552956; -.
DR   RefSeq; NP_001092275.1; NM_001098805.1.
DR   UniGene; Hs.645502; -.
DR   ProteinModelPortal; Q4UJ75; -.
DR   SMR; Q4UJ75; 7-257.
DR   DMDM; 74753541; -.
DR   PRIDE; Q4UJ75; -.
DR   Ensembl; ENST00000357336; ENSP00000349891; ENSG00000172014.
DR   GeneID; 728747; -.
DR   KEGG; hsa:728747; -.
DR   UCSC; uc004afn.3; human.
DR   CTD; 728747; -.
DR   GeneCards; GC09P069381; -.
DR   HGNC; HGNC:31982; ANKRD20A4.
DR   neXtProt; NX_Q4UJ75; -.
DR   PharmGKB; PA145149866; -.
DR   GeneTree; ENSGT00560000076605; -.
DR   HOGENOM; HBG100718; -.
DR   HOVERGEN; HBG079958; -.
DR   InParanoid; Q4UJ75; -.
DR   OrthoDB; EOG4CNQQH; -.
DR   NextBio; 128184; -.
DR   Bgee; Q4UJ75; -.
DR   CleanEx; HS_ANKRD20A4; -.
DR   Genevestigator; Q4UJ75; -.
DR   GermOnline; ENSG00000172014; Homo sapiens.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 6.
DR   SUPFAM; SSF48403; ANK; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
PE   2: Evidence at transcript level;
KW   ANK repeat; Coiled coil; Complete proteome; Reference proteome;
KW   Repeat.
FT   CHAIN         1    823       Ankyrin repeat domain-containing protein
FT                                20A4.
FT                                /FTId=PRO_0000240835.
FT   REPEAT       66     95       ANK 1.
FT   REPEAT       99    128       ANK 2.
FT   REPEAT      132    161       ANK 3.
FT   REPEAT      165    194       ANK 4.
FT   REPEAT      198    227       ANK 5.
FT   COILED      431    480       Potential.
FT   COILED      565    724       Potential.
FT   COILED      776    806       Potential.
SQ   SEQUENCE   823 AA;  94149 MW;  597B760D5733208A CRC64;
     MKLFGFGSRR GQTAQGSIDH VYTGSGYRIR DSELQKIHRA AVKGDAAEVE RCLARRSGEL
     DALDKQHRTA LHLACASGHV QVVTLLVNRK CQIDVCDKEN RTPLIQAVHC QEEACAVILL
     EHGANPNLKD IYGNTALHYA VYSESTSLAE KLLSHGAHIE ALDKDNNTPL LFAIICKKEK
     MVEFLLKKKA SSHAVDRLRR SALMLAVYYD SPGIVNILLK QNIDVFAQDM CGRDAEDYAI
     SHHLTKIQQQ ILEHKKKILK KEKSDVGSSD ESAVSIFHEL RVDSLPASDD KDLNVATKQC
     VPEKVSEPLP GSSHEKGNRI VNGQGEGPPA KHPSLKPSTE VEDPAVKGAV QRKNVQTLRA
     EQALPVASEE EQQRHERSEK KQPQVKEGNN TNKSEKIQLS ENICDSTSSA AAGRLTQQRK
     IGKTYPQQFP KKLKEEHDRC TLKQENEEKT NVNMLYKKNR EELERKEKQY KKEVEAKQLE
     PTVQSLEMKS KTARNTPNWD FHNHEEMKGL MDENCILKAD IAILRQEICT MKNDNLEKEN
     KYLKDIKIVK ETNAALEKYI KLNEEMITET AFRYQQELND LKAENTRLNA ELLKEKESKK
     RLEADIESYQ SRLAAAISKH SESVKTERNL KLALERTQDV SVQVEMSSAI SKVKDENEFL
     TEQLSETQIK FNALKDKFRK TRDSLRKKSL ALETVQNNLS QTQQQTQEMK EMYQNAEAKV
     NNSTGKWNCV EERICHLQRE NAWLVQQLDD VHQKEDHKEI VTNIQRGFIE SGKKDFVLEE
     KSKKLMNECD HLKESLFQYE REKTEVVVSI KEDKYFQTSR KKI
//
ID   A20A5_HUMAN             Reviewed;         165 AA.
AC   A0PJZ0; Q4G1B6;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 1.
DT   18-APR-2012, entry version 44.
DE   RecName: Full=Putative ankyrin repeat domain-containing protein 20A5;
DE   AltName: Full=Ankyrin repeat domain-containing protein 20A5 pseudogene;
GN   Name=ANKRD20A5P; Synonyms=ANKRD20A5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SIMILARITY: Contains 3 ANK repeats.
CC   -!- CAUTION: Could be the product of a pseudogene.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22023.1; Type=Frameshift; Positions=44;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022023; AAH22023.1; ALT_FRAME; mRNA.
DR   EMBL; BC127726; AAI27727.1; -; mRNA.
DR   IPI; IPI00455358; -.
DR   UniGene; Hs.632352; -.
DR   ProteinModelPortal; A0PJZ0; -.
DR   SMR; A0PJZ0; 7-164.
DR   PRIDE; A0PJZ0; -.
DR   UCSC; uc010xag.2; human.
DR   GeneCards; GC18U900665; -.
DR   HGNC; HGNC:33833; ANKRD20A5P.
DR   neXtProt; NX_A0PJZ0; -.
DR   eggNOG; COG0666; -.
DR   InParanoid; A0PJZ0; -.
DR   Genevestigator; A0PJZ0; -.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   Pfam; PF12796; Ank_2; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; ANK; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
PE   5: Uncertain;
KW   ANK repeat; Complete proteome; Reference proteome; Repeat.
FT   CHAIN         1    165       Putative ankyrin repeat domain-containing
FT                                protein 20A5.
FT                                /FTId=PRO_0000348534.
FT   REPEAT       66     95       ANK 1.
FT   REPEAT       99    128       ANK 2.
FT   REPEAT      132    161       ANK 3.
SQ   SEQUENCE   165 AA;  18446 MW;  383D167903D39BB2 CRC64;
     MKLFGFRSRR GQTVLGSIDH LYTGSGYRIR YSELQKIHKA AVKGDAAEME RCLARRSGDL
     DALDKQHRTA LHLACASGHV KVVTLLVNRK CQIDIYDKEN RTPLIQAVHC QEEACAVILL
     EHGANPNLKD IYGNTALHYA VYSESTSLAE KLLFHGENIE ALDKV
//
ID   A26L1_HUMAN             Reviewed;         119 AA.
AC   Q96IX9;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-FEB-2012, entry version 52.
DE   RecName: Full=Putative ankyrin repeat domain-containing protein 26-like 1;
DE   AltName: Full=Ankyrin repeat domain-containing protein 36B pseudogene 1;
GN   Name=ANKRD36BP1; Synonyms=ANKRD26L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CAUTION: Could be the product of a pseudogene.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL009051; CAI22641.1; -; Genomic_DNA.
DR   EMBL; BC007072; -; NOT_ANNOTATED_CDS; mRNA.
DR   IPI; IPI00063907; -.
DR   UniGene; Hs.537067; -.
DR   ProteinModelPortal; Q96IX9; -.
DR   IntAct; Q96IX9; 3.
DR   STRING; Q96IX9; -.
DR   DMDM; 74751951; -.
DR   PRIDE; Q96IX9; -.
DR   Ensembl; ENST00000358576; ENSP00000351384; ENSG00000214262.
DR   GeneCards; GC01M168214; -.
DR   HGNC; HGNC:28169; ANKRD36BP1.
DR   neXtProt; NX_Q96IX9; -.
DR   eggNOG; NOG326299; -.
DR   GeneTree; ENSGT00560000077879; -.
DR   OMA; TIAHYSG; -.
DR   OrthoDB; EOG45X7Z6; -.
DR   PhylomeDB; Q96IX9; -.
DR   ArrayExpress; Q96IX9; -.
DR   Bgee; Q96IX9; -.
DR   Genevestigator; Q96IX9; -.
PE   5: Uncertain;
KW   Coiled coil; Complete proteome; Reference proteome.
FT   CHAIN         1    119       Putative ankyrin repeat domain-containing
FT                                protein 26-like 1.
FT                                /FTId=PRO_0000318851.
FT   COILED       15    112       Potential.
SQ   SEQUENCE   119 AA;  14172 MW;  E06449B08455E397 CRC64;
     MGTRTLQFEI SDSHEKEEDL LHKNHLMQDE IARLRLEIHT IKNQILEKKY LKDIEIIKRK
     HEDLQKALKQ NGEKSTKTIA HYSGQLTALT DENTMLRSKL EKEKQSRQRL TKWNHTIVD
//
ID   A2AP_HUMAN              Reviewed;         491 AA.
AC   P08697; Q8N5U7; Q9UCG2; Q9UCG3;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 3.
DT   18-APR-2012, entry version 137.
DE   RecName: Full=Alpha-2-antiplasmin;
DE            Short=Alpha-2-AP;
DE   AltName: Full=Alpha-2-plasmin inhibitor;
DE            Short=Alpha-2-PI;
DE   AltName: Full=Serpin F2;
DE   Flags: Precursor;
GN   Name=SERPINF2; Synonyms=AAP, PLI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   MEDLINE=88139254; PubMed=2830248;
RA   Tone M., Kikuno R., Kume-Iwaki A., Hashimoto-Gotoh T.;
RT   "Structure of human alpha 2-plasmin inhibitor deduced from the cDNA
RT   sequence.";
RL   J. Biochem. 102:1033-1041(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=88320531; PubMed=3166140; DOI=10.1073/pnas.85.18.6836;
RA   Hirosawa S., Nakamura Y., Miura O., Sumi Y., Aoki N.;
RT   "Organization of the human alpha 2-plasmin inhibitor gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:6836-6840(1988).
RN   [3]
RP   ERRATUM.
RA   Hirosawa S., Nakamura Y., Miura O., Sumi Y., Aoki N.;
RL   Proc. Natl. Acad. Sci. U.S.A. 86:1612-1613(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-2.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-491.
RX   MEDLINE=87109313; PubMed=2433286;
RA   Holmes W.E., Nelles L., Lijnen H.R., Collen D.;
RT   "Primary structure of human alpha 2-antiplasmin, a serine protease
RT   inhibitor (serpin).";
RL   J. Biol. Chem. 262:1659-1664(1987).
RN   [6]
RP   PROTEIN SEQUENCE OF 28-58.
RC   TISSUE=Plasma;
RX   MEDLINE=93249387; PubMed=8484741;
RA   Bangert K., Johnsen A.H., Christensen U., Thorsen S.;
RT   "Different N-terminal forms of alpha 2-plasmin inhibitor in human
RT   plasma.";
RL   Biochem. J. 291:623-625(1993).
RN   [7]
RP   PROTEIN SEQUENCE OF 28-52.
RC   TISSUE=Plasma;
RX   MEDLINE=93050153; PubMed=1385210; DOI=10.1016/0014-5793(92)81419-M;
RA   Christensen S., Sottrup-Jensen L.;
RT   "Bovine alpha 2-antiplasmin. N-terminal and reactive site sequence.";
RL   FEBS Lett. 312:100-104(1992).
RN   [8]
RP   PROTEIN SEQUENCE OF 40-491.
RX   MEDLINE=87275946; PubMed=2440681;
RX   DOI=10.1111/j.1432-1033.1987.tb13551.x;
RA   Lijnen H.R., Holmes W.E., van Hoef B., Wiman B., Rodriguez H.,
RA   Collen D.;
RT   "Amino-acid sequence of human alpha 2-antiplasmin.";
RL   Eur. J. Biochem. 166:565-574(1987).
RN   [9]
RP   PROTEIN SEQUENCE OF 40-43.
RX   MEDLINE=78023887; PubMed=21075;
RX   DOI=10.1111/j.1432-1033.1977.tb11709.x;
RA   Wiman B., Collen D.;
RT   "Purification and characterization of human antiplasmin, the fast-
RT   acting plasmin inhibitor in plasma.";
RL   Eur. J. Biochem. 78:19-26(1977).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 218-491.
RX   MEDLINE=87137400; PubMed=3818581;
RA   Sumi Y., Nakamura Y., Aoki N., Sakai M., Muramatsu M.;
RT   "Structure of the carboxyl-terminal half of human alpha 2-plasmin
RT   inhibitor deduced from that of cDNA.";
RL   J. Biochem. 100:1399-1402(1986).
RN   [11]
RP   PROTEIN SEQUENCE OF 481-491, AND SULFATION.
RX   MEDLINE=87137577; PubMed=2434496;
RA   Hortin G., Fok K.F., Toren P.C., Strauss A.W.;
RT   "Sulfation of a tyrosine residue in the plasmin-binding domain of
RT   alpha 2-antiplasmin.";
RL   J. Biol. Chem. 262:3082-3085(1987).
RN   [12]
RP   ACTIVE SITES.
RX   MEDLINE=88290696; PubMed=2456616; DOI=10.1126/science.2456616;
RA   Potempa J., Shieh B.-H., Travis J.;
RT   "Alpha-2-antiplasmin: a serpin with two separate but overlapping
RT   reactive sites.";
RL   Science 241:699-700(1988).
RN   [13]
RP   DISULFIDE BOND.
RX   MEDLINE=97270633; PubMed=9169621;
RA   Christensen S., Valnickova Z., Thogersen I.B., Olsen E.H.,
RA   Enghild J.J.;
RT   "Assignment of a single disulphide bridge in human alpha2-antiplasmin:
RT   implications for the structural and functional properties.";
RL   Biochem. J. 323:847-852(1997).
RN   [14]
RP   FUNCTION IN MEMBRANE-ANCHORED SERINE PROTEASE TMPRSS7 INHIBITION, AND
RP   HETERODIMER WITH TMPRSS7.
RX   PubMed=15853774; DOI=10.1042/BJ20050299;
RA   Szabo R., Netzel-Arnett S., Hobson J.P., Antalis T.M., Bugge T.H.;
RT   "Matriptase-3 is a novel phylogenetically preserved membrane-anchored
RT   serine protease with broad serpin reactivity.";
RL   Biochem. J. 390:231-242(2005).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-126; ASN-295 AND ASN-309,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [16]
RP   VARIANT APLID GLU-176 DEL.
RX   MEDLINE=90036902; PubMed=2572590;
RA   Miura O., Sugahara Y., Aoki N.;
RT   "Hereditary alpha 2-plasmin inhibitor deficiency caused by a
RT   transport-deficient mutation (alpha 2-PI-Okinawa). Deletion of Glu137
RT   by a trinucleotide deletion blocks intracellular transport.";
RL   J. Biol. Chem. 264:18213-18219(1989).
RN   [17]
RP   VARIANT APLID MET-411, AND VARIANTS VAL-27; TRP-33 AND LYS-434.
RX   MEDLINE=20051147; PubMed=10583218;
RX   DOI=10.1046/j.1365-2141.1999.01708.x;
RA   Lind B., Thorsen S.;
RT   "A novel missense mutation in the human plasmin inhibitor (alpha2-
RT   antiplasmin) gene associated with a bleeding tendency.";
RL   Br. J. Haematol. 107:317-322(1999).
CC   -!- FUNCTION: Serine protease inhibitor. The major targets of this
CC       inhibitor are plasmin and trypsin, but it also inactivates
CC       matriptase-3/TMPRSS7 and chymotrypsin.
CC   -!- SUBUNIT: Forms protease inhibiting heterodimer with TMPRSS7.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
CC   -!- DISEASE: Defects in SERPINF2 are the cause of alpha-2-plasmin
CC       inhibitor deficiency (APLID) [MIM:262850]. APLID is an autosomal
CC       recessive disorder resulting in severe hemorrhagic diathesis.
CC   -!- SIMILARITY: Belongs to the serpin family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00174; BAA00124.1; -; mRNA.
DR   EMBL; M20786; AAA51554.1; -; Genomic_DNA.
DR   EMBL; M20782; AAA51554.1; JOINED; Genomic_DNA.
DR   EMBL; M20783; AAA51554.1; JOINED; Genomic_DNA.
DR   EMBL; M20784; AAA51554.1; JOINED; Genomic_DNA.
DR   EMBL; M20785; AAA51554.1; JOINED; Genomic_DNA.
DR   EMBL; BC031592; AAH31592.1; -; mRNA.
DR   EMBL; J02654; AAA35543.1; -; mRNA.
DR   EMBL; D00116; BAA00070.1; -; mRNA.
DR   IPI; IPI00879231; -.
DR   PIR; A31402; ITHUA2.
DR   RefSeq; NP_000925.2; NM_000934.3.
DR   RefSeq; NP_001159392.1; NM_001165920.1.
DR   RefSeq; NP_001159393.1; NM_001165921.1.
DR   UniGene; Hs.159509; -.
DR   ProteinModelPortal; P08697; -.
DR   SMR; P08697; 74-446.
DR   IntAct; P08697; 2.
DR   STRING; P08697; -.
DR   MEROPS; I04.023; -.
DR   DMDM; 112907; -.
DR   SWISS-2DPAGE; P08697; -.
DR   PRIDE; P08697; -.
DR   DNASU; 5345; -.
DR   Ensembl; ENST00000324015; ENSP00000321853; ENSG00000167711.
DR   Ensembl; ENST00000382061; ENSP00000371493; ENSG00000167711.
DR   GeneID; 5345; -.
DR   KEGG; hsa:5345; -.
DR   UCSC; uc002ftk.1; human.
DR   CTD; 5345; -.
DR   GeneCards; GC17P001593; -.
DR   H-InvDB; HIX0202497; -.
DR   HGNC; HGNC:9075; SERPINF2.
DR   HPA; CAB024863; -.
DR   HPA; HPA001885; -.
DR   MIM; 262850; phenotype.
DR   MIM; 613168; gene.
DR   neXtProt; NX_P08697; -.
DR   Orphanet; 79; Congenital alpha2 antiplasmin deficiency.
DR   PharmGKB; PA35522; -.
DR   eggNOG; COG4826; -.
DR   GeneTree; ENSGT00560000076649; -.
DR   HOGENOM; HBG445330; -.
DR   HOVERGEN; HBG000043; -.
DR   InParanoid; P08697; -.
DR   KO; K03983; -.
DR   OMA; LFGAKPM; -.
DR   PhylomeDB; P08697; -.
DR   Reactome; REACT_604; Hemostasis.
DR   DrugBank; DB00086; Streptokinase.
DR   NextBio; 20714; -.
DR   PMAP-CutDB; P08697; -.
DR   ArrayExpress; P08697; -.
DR   Bgee; P08697; -.
DR   CleanEx; HS_SERPINF2; -.
DR   Genevestigator; P08697; -.
DR   GO; GO:0005577; C:fibrinogen complex; IDA:BHF-UCL.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0043499; F:eukaryotic cell surface binding; IDA:BHF-UCL.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB.
DR   GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR   GO; GO:0048514; P:blood vessel morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0030199; P:collagen fibril organization; ISS:BHF-UCL.
DR   GO; GO:0042730; P:fibrinolysis; TAS:Reactome.
DR   GO; GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL.
DR   GO; GO:0010757; P:negative regulation of plasminogen activation; IDA:BHF-UCL.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IDA:BHF-UCL.
DR   GO; GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; TAS:BHF-UCL.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:BHF-UCL.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0071636; P:positive regulation of transforming growth factor beta production; IDA:BHF-UCL.
DR   GO; GO:0002034; P:regulation of blood vessel size by renin-angiotensin; ISS:BHF-UCL.
DR   GO; GO:0030162; P:regulation of proteolysis; IBA:RefGenome.
DR   InterPro; IPR000215; Protease_inhib_I4_serpin.
DR   InterPro; IPR023795; Protease_inhib_I4_serpin_CS.
DR   InterPro; IPR023796; Sepin_dom.
DR   PANTHER; PTHR11461; Prot_inh_serpin; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; Prot_inh_serpin; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   1: Evidence at protein level;
KW   Acute phase; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Glycoprotein; Isopeptide bond;
KW   Polymorphism; Protease inhibitor; Reference proteome; Secreted;
KW   Serine protease inhibitor; Signal; Sulfation.
FT   SIGNAL        1     27
FT   PROPEP       28     39
FT                                /FTId=PRO_0000032511.
FT   CHAIN        40    491       Alpha-2-antiplasmin.
FT                                /FTId=PRO_0000032512.
FT   SITE        403    404       Reactive bond for plasmin.
FT   SITE        404    405       Reactive bond for chymotrypsin.
FT   MOD_RES     484    484       Sulfotyrosine.
FT   CARBOHYD    126    126       N-linked (GlcNAc...).
FT   CARBOHYD    295    295       N-linked (GlcNAc...).
FT   CARBOHYD    309    309       N-linked (GlcNAc...).
FT   CARBOHYD    316    316       N-linked (GlcNAc...) (Potential).
FT   DISULFID     70    143
FT   CROSSLNK     41     41       Isoglutamyl lysine isopeptide (Gln-Lys)
FT                                (interchain with K-322 in alpha-
FT                                fibrinogen).
FT   VARIANT       2      2       A -> V (in dbSNP:rs2070862).
FT                                /FTId=VAR_047951.
FT   VARIANT      27     27       A -> V.
FT                                /FTId=VAR_013252.
FT   VARIANT      33     33       R -> W (in dbSNP:rs2070863).
FT                                /FTId=VAR_013253.
FT   VARIANT      98     98       A -> G (in dbSNP:rs36021516).
FT                                /FTId=VAR_051956.
FT   VARIANT     176    176       Missing (in APLID; variant Okinawa;
FT                                probably blocks intracellular transport
FT                                of alpha-2-plasmin inhibitor).
FT                                /FTId=VAR_013254.
FT   VARIANT     411    411       V -> M (in APLID).
FT                                /FTId=VAR_013255.
FT   VARIANT     434    434       R -> K (in dbSNP:rs1057335).
FT                                /FTId=VAR_013256.
FT   VARIANT     451    451       P -> S (in dbSNP:rs57360598).
FT                                /FTId=VAR_061792.
FT   CONFLICT     49     49       L -> G (in Ref. 8; AA sequence).
FT   CONFLICT    105    105       N -> D (in Ref. 8; AA sequence).
FT   CONFLICT    289    289       H -> D (in Ref. 5; AAA35543).
FT   CONFLICT    408    408       S -> G (in Ref. 8; AA sequence).
FT   CONFLICT    455    455       D -> N (in Ref. 8; AA sequence).
SQ   SEQUENCE   491 AA;  54566 MW;  385A1C90E91A63CB CRC64;
     MALLWGLLVL SWSCLQGPCS VFSPVSAMEP LGRQLTSGPN QEQVSPLTLL KLGNQEPGGQ
     TALKSPPGVC SRDPTPEQTH RLARAMMAFT ADLFSLVAQT STCPNLILSP LSVALALSHL
     ALGAQNHTLQ RLQQVLHAGS GPCLPHLLSR LCQDLGPGAF RLAARMYLQK GFPIKEDFLE
     QSEQLFGAKP VSLTGKQEDD LANINQWVKE ATEGKIQEFL SGLPEDTVLL LLNAIHFQGF
     WRNKFDPSLT QRDSFHLDEQ FTVPVEMMQA RTYPLRWFLL EQPEIQVAHF PFKNNMSFVV
     LVPTHFEWNV SQVLANLSWD TLHPPLVWER PTKVRLPKLY LKHQMDLVAT LSQLGLQELF
     QAPDLRGISE QSLVVSGVQH QSTLELSEVG VEAAAATSIA MSRMSLSSFS VNRPFLFFIF
     EDTTGLPLFV GSVRNPNPSA PRELKEQQDS PGNKDFLQSL KGFPRGDKLF GPDLKLVPPM
     EEDYPQFGSP K
//
ID   A2GL_HUMAN              Reviewed;         347 AA.
AC   P02750; Q8N4F5; Q96QZ4;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 2.
DT   18-APR-2012, entry version 116.
DE   RecName: Full=Leucine-rich alpha-2-glycoprotein;
DE            Short=LRG;
DE   Flags: Precursor;
GN   Name=LRG1; Synonyms=LRG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12223515;
RA   O'Donnell L.C., Druhan L.J., Avalos B.R.;
RT   "Molecular characterization and expression analysis of leucine-rich
RT   alpha2-glycoprotein, a novel marker of granulocytic differentiation.";
RL   J. Leukoc. Biol. 72:478-485(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-133.
RC   TISSUE=Colon, Kidney, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 36-347.
RX   MEDLINE=85166241; PubMed=3856868; DOI=10.1073/pnas.82.7.1906;
RA   Takahashi N., Takahashi Y., Putnam F.W.;
RT   "Periodicity of leucine and tandem repetition of a 24-amino acid
RT   segment in the primary structure of leucine-rich alpha 2-glycoprotein
RT   of human serum.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:1906-1910(1985).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-186, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-186; ASN-269 AND ASN-325,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-186, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Saliva;
RX   PubMed=16740002; DOI=10.1021/pr050492k;
RA   Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,
RA   Loo J.A.;
RT   "Identification of N-linked glycoproteins in human saliva by
RT   glycoprotein capture and mass spectrometry.";
RL   J. Proteome Res. 5:1493-1503(2006).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-186, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-79 AND ASN-186, STRUCTURE
RP   OF CARBOHYDRATES, AND MASS SPECTROMETRY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- SIMILARITY: Contains 8 LRR (leucine-rich) repeats.
CC   -!- SIMILARITY: Contains 1 LRRCT domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF403428; AAK95527.1; -; mRNA.
DR   EMBL; BC034389; AAH34389.1; -; mRNA.
DR   EMBL; BC070198; AAH70198.1; -; mRNA.
DR   IPI; IPI00022417; -.
DR   PIR; A03211; NBHUA2.
DR   RefSeq; NP_443204.1; NM_052972.2.
DR   UniGene; Hs.655559; -.
DR   ProteinModelPortal; P02750; -.
DR   SMR; P02750; 41-343.
DR   STRING; P02750; -.
DR   PhosphoSite; P02750; -.
DR   DMDM; 23503037; -.
DR   DOSAC-COBS-2DPAGE; P02750; -.
DR   Siena-2DPAGE; P02750; -.
DR   SWISS-2DPAGE; P02750; -.
DR   PeptideAtlas; P02750; -.
DR   PRIDE; P02750; -.
DR   DNASU; 116844; -.
DR   Ensembl; ENST00000306390; ENSP00000302621; ENSG00000171236.
DR   GeneID; 116844; -.
DR   KEGG; hsa:116844; -.
DR   UCSC; uc002mau.3; human.
DR   CTD; 116844; -.
DR   GeneCards; GC19M004489; -.
DR   H-InvDB; HIX0014668; -.
DR   HGNC; HGNC:29480; LRG1.
DR   HPA; HPA001888; -.
DR   HPA; HPA001889; -.
DR   MIM; 611289; gene.
DR   neXtProt; NX_P02750; -.
DR   PharmGKB; PA134919634; -.
DR   eggNOG; COG4886; -.
DR   GeneTree; ENSGT00630000089822; -.
DR   HOGENOM; HBG125661; -.
DR   HOVERGEN; HBG000045; -.
DR   InParanoid; P02750; -.
DR   OMA; RCAGPEA; -.
DR   OrthoDB; EOG4TMR2P; -.
DR   PhylomeDB; P02750; -.
DR   NextBio; 80020; -.
DR   ArrayExpress; P02750; -.
DR   Bgee; P02750; -.
DR   CleanEx; HS_LRG1; -.
DR   Genevestigator; P02750; -.
DR   GermOnline; ENSG00000171236; Homo sapiens.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   Pfam; PF00560; LRR_1; 2.
DR   SMART; SM00369; LRR_TYP; 4.
DR   SMART; SM00082; LRRCT; 1.
DR   PROSITE; PS51450; LRR; 8.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Leucine-rich repeat; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL        1     35
FT   CHAIN        36    347       Leucine-rich alpha-2-glycoprotein.
FT                                /FTId=PRO_0000020579.
FT   REPEAT       93    114       LRR 1.
FT   REPEAT      117    138       LRR 2.
FT   REPEAT      141    162       LRR 3.
FT   REPEAT      165    186       LRR 4.
FT   REPEAT      189    210       LRR 5.
FT   REPEAT      213    234       LRR 6.
FT   REPEAT      237    258       LRR 7.
FT   REPEAT      261    282       LRR 8.
FT   DOMAIN      299    347       LRRCT.
FT   SITE        306    306       Not glycosylated.
FT   CARBOHYD     37     37       O-linked (GalNAc...).
FT   CARBOHYD     79     79       N-linked (GlcNAc...) (complex).
FT   CARBOHYD    186    186       N-linked (GlcNAc...) (complex).
FT   CARBOHYD    269    269       N-linked (GlcNAc...).
FT   CARBOHYD    325    325       N-linked (GlcNAc...).
FT   DISULFID     43     56
FT   DISULFID    303    329
FT   VARIANT      64     64       G -> S (in dbSNP:rs7251081).
FT                                /FTId=VAR_050629.
FT   VARIANT     133    133       P -> S (in dbSNP:rs966384).
FT                                /FTId=VAR_024245.
SQ   SEQUENCE   347 AA;  38178 MW;  20C99ED50152FA9C CRC64;
     MSSWSRQRPK SPGGIQPHVS RTLFLLLLLA ASAWGVTLSP KDCQVFRSDH GSSISCQPPA
     EIPGYLPADT VHLAVEFFNL THLPANLLQG ASKLQELHLS SNGLESLSPE FLRPVPQLRV
     LDLTRNALTG LPPGLFQASA TLDTLVLKEN QLEVLEVSWL HGLKALGHLD LSGNRLRKLP
     PGLLANFTLL RTLDLGENQL ETLPPDLLRG PLQLERLHLE GNKLQVLGKD LLLPQPDLRY
     LFLNGNKLAR VAAGAFQGLR QLDMLDLSNN SLASVPEGLW ASLGQPNWDM RDGFDISGNP
     WICDQNLSDL YRWLQAQKDK MFSQNDTRCA GPEAVKGQTL LAVAKSQ
//
ID   A2LD1_HUMAN             Reviewed;         153 AA.
AC   Q9BVM4; B3KTN1; Q9BT41;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   18-APR-2012, entry version 74.
DE   RecName: Full=Gamma-glutamylaminecyclotransferase;
DE            Short=GGACT;
DE            EC=2.3.2.4;
DE   AltName: Full=AIG2-like domain-containing protein 1;
GN   Name=A2LD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (0.98 ANGSTROMS) IN COMPLEX WITH 5-OXOPROLINE
RP   AND NITRATE, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, ACTIVE SITE, AND
RP   MUTAGENESIS OF GLU-82.
RX   PubMed=20110353; DOI=10.1074/jbc.M109.082099;
RA   Oakley A.J., Coggan M., Board P.G.;
RT   "Identification and characterization of gamma-glutamylamine
RT   cyclotransferase, an enzyme responsible for gamma-glutamyl-epsilon-
RT   lysine catabolism.";
RL   J. Biol. Chem. 285:9642-9648(2010).
CC   -!- FUNCTION: Contributes to degradation of proteins cross-linked by
CC       transglutaminases. Degrades the cross-link between a lysine and a
CC       glutamic acid residue from two proteins that have been cross-
CC       linked by transglutaminases. Catalyzes the formation of 5-
CC       oxoproline from L-gamma-glutamyl-L-epsilon-lysine. Inactive with
CC       L-gamma-glutamyl-alpha-amino acid substrates such as L-gamma-
CC       glutamyl-L-alpha-cysteine and L-gamma-glutamyl-L-alpha-alanine.
CC   -!- CATALYTIC ACTIVITY: (Gamma-L-glutamyl)-L-amino acid = 5-oxoproline
CC       + L-amino acid.
CC   -!- SUBUNIT: Monomer.
CC   -!- SIMILARITY: Belongs to the gamma-glutamylcyclotransferase family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04360.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK095850; BAG53143.1; -; mRNA.
DR   EMBL; AL136526; CAI39558.1; -; Genomic_DNA.
DR   EMBL; CH471085; EAX09037.1; -; Genomic_DNA.
DR   EMBL; BC001077; AAH01077.2; -; mRNA.
DR   EMBL; BC004360; AAH04360.1; ALT_INIT; mRNA.
DR   IPI; IPI00900332; -.
DR   RefSeq; NP_001182016.1; NM_001195087.1.
DR   RefSeq; NP_149101.1; NM_033110.2.
DR   UniGene; Hs.350868; -.
DR   PDB; 3JUB; X-ray; 1.20 A; A=1-153.
DR   PDB; 3JUC; X-ray; 1.20 A; A=1-153.
DR   PDB; 3JUD; X-ray; 0.98 A; A=1-153.
DR   PDBsum; 3JUB; -.
DR   PDBsum; 3JUC; -.
DR   PDBsum; 3JUD; -.
DR   ProteinModelPortal; Q9BVM4; -.
DR   SMR; Q9BVM4; 1-151.
DR   STRING; Q9BVM4; -.
DR   DMDM; 74752384; -.
DR   PRIDE; Q9BVM4; -.
DR   DNASU; 87769; -.
DR   Ensembl; ENST00000376250; ENSP00000365426; ENSG00000134864.
DR   Ensembl; ENST00000455100; ENSP00000410449; ENSG00000134864.
DR   GeneID; 87769; -.
DR   KEGG; hsa:87769; -.
DR   UCSC; uc001voq.2; human.
DR   CTD; 87769; -.
DR   GeneCards; GC13M101183; -.
DR   HGNC; HGNC:25100; A2LD1.
DR   MIM; 613378; gene.
DR   neXtProt; NX_Q9BVM4; -.
DR   PharmGKB; PA164714645; -.
DR   eggNOG; NOG242813; -.
DR   GeneTree; ENSGT00390000010543; -.
DR   HOGENOM; HBG445045; -.
DR   HOVERGEN; HBG105481; -.
DR   InParanoid; Q9BVM4; -.
DR   OMA; RYNPREN; -.
DR   OrthoDB; EOG47WNQ1; -.
DR   PhylomeDB; Q9BVM4; -.
DR   EvolutionaryTrace; Q9BVM4; -.
DR   NextBio; 76214; -.
DR   ArrayExpress; Q9BVM4; -.
DR   Bgee; Q9BVM4; -.
DR   CleanEx; HS_A2LD1; -.
DR   Genevestigator; Q9BVM4; -.
DR   GO; GO:0003839; F:gamma-glutamylcyclotransferase activity; IDA:UniProtKB.
DR   GO; GO:0042219; P:cellular modified amino acid catabolic process; IDA:UniProtKB.
DR   Gene3D; G3DSA:3.10.490.10; Butirosin_synth_BtrG-like; 1.
DR   InterPro; IPR009288; AIG2-like.
DR   InterPro; IPR013024; Butirosin_synth_BtrG-like.
DR   Pfam; PF06094; AIG2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Complete proteome; Reference proteome;
KW   Transferase.
FT   CHAIN         1    153       Gamma-glutamylaminecyclotransferase.
FT                                /FTId=PRO_0000320203.
FT   REGION        7     10       Substrate binding.
FT   ACT_SITE     82     82       Proton acceptor.
FT   MUTAGEN      82     82       E->A,Q: Loss of activity.
FT   STRAND        2      5
FT   HELIX        17     20
FT   STRAND       28     33
FT   STRAND       35     38
FT   STRAND       42     45
FT   STRAND       50     55
FT   STRAND       67     70
FT   HELIX        72     81
FT   TURN         82     86
FT   STRAND       89     98
FT   STRAND      113    121
FT   HELIX       126    130
FT   STRAND      135    137
SQ   SEQUENCE   153 AA;  17329 MW;  1A01F350F761D208 CRC64;
     MALVFVYGTL KRGQPNHRVL RDGAHGSAAF RARGRTLEPY PLVIAGEHNI PWLLHLPGSG
     RLVEGEVYAV DERMLRFLDD FESCPALYQR TVLRVQLLED RAPGAEEPPA PTAVQCFVYS
     RATFPPEWAQ LPHHDSYDSE GPHGLRYNPR ENR
//
ID   A2MG_HUMAN              Reviewed;        1474 AA.
AC   P01023; Q13677; Q59F47; Q5QTS0; Q68DN2; Q6PIY3; Q6PN97;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   18-APR-2012, entry version 150.
DE   RecName: Full=Alpha-2-macroglobulin;
DE            Short=Alpha-2-M;
DE   AltName: Full=C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5;
DE   Flags: Precursor;
GN   Name=A2M; Synonyms=CPAMD5; ORFNames=FWP007;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ASP-639 AND VAL-1000.
RX   MEDLINE=85190481; PubMed=2581245; DOI=10.1073/pnas.82.8.2282;
RA   Kan C.-C., Solomon E., Belt K.T., Chain A.C., Hiorns L.R., Fey G.H.;
RT   "Nucleotide sequence of cDNA encoding human alpha 2-macroglobulin and
RT   assignment of the chromosomal locus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:2282-2286(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ASP-639 AND VAL-1000.
RC   TISSUE=Prostate;
RX   PubMed=15611997; DOI=10.1002/pros.20183;
RA   Lin V.K., Wang S.-Y., Boetticher N.C., Vazquez D.V., Saboorian H.,
RA   McConnell J.D., Roehrborn C.G.;
RT   "Alpha(2) macroglobulin, a PSA-binding protein, is expressed in human
RT   prostate stroma.";
RL   Prostate 63:299-308(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-639.
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASP-639 AND
RP   VAL-1000.
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASP-639 AND
RP   VAL-1000.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RC   TISSUE=Placenta;
RX   MEDLINE=92246939; PubMed=1374237; DOI=10.1016/0006-291X(92)90631-T;
RA   Matthijs G., Devriendt K., Cassiman J.-J., van den Berghe H.,
RA   Marynen P.;
RT   "Structure of the human alpha-2 macroglobulin gene and its promotor.";
RL   Biochem. Biophys. Res. Commun. 184:596-603(1992).
RN   [8]
RP   PROTEIN SEQUENCE OF 24-1474, SUBUNIT, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DISULFIDE BONDS.
RX   MEDLINE=84239807; PubMed=6203908;
RA   Sottrup-Jensen L., Stepanik T.M., Kristensen T., Wierzbicki D.M.,
RA   Jones C.M., Loenblad P.B., Magnusson S., Petersen T.E.;
RT   "Primary structure of human alpha 2-macroglobulin. V. The complete
RT   structure.";
RL   J. Biol. Chem. 259:8318-8327(1984).
RN   [9]
RP   ERRATUM.
RA   Sottrup-Jensen L., Stepanik T.M., Kristensen T., Wierzbicki D.M.,
RA   Jones C.M., Loenblad P.B., Magnusson S., Petersen T.E.;
RL   J. Biol. Chem. 260:6500-6500(1985).
RN   [10]
RP   PROTEIN SEQUENCE OF 273-286 AND 426-436, AND DISULFIDE BONDS.
RX   PubMed=2430963;
RA   Jensen P.E.H., Sottrup-Jensen L.;
RT   "Primary structure of human alpha 2-macroglobulin. Complete disulfide
RT   bridge assignment and localization of two interchain bridges in the
RT   dimeric proteinase binding unit.";
RL   J. Biol. Chem. 261:15863-15869(1986).
RN   [11]
RP   PROTEIN SEQUENCE OF 672-747.
RX   MEDLINE=90242963; PubMed=1692292; DOI=10.1016/0014-5793(90)80226-9;
RA   Marynen P., Devriendt K., van den Berghe H., Cassiman J.-J.;
RT   "A genetic polymorphism in a functional domain of human pregnancy zone
RT   protein: the bait region. Genomic structure of the bait domains of
RT   human pregnancy zone protein and alpha 2 macroglobulin.";
RL   FEBS Lett. 262:349-352(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 672-746, AND VARIANT TYR-972.
RX   MEDLINE=92128897; PubMed=1370808; DOI=10.1007/BF00197266;
RA   Poller W., Faber J.-P., Klobeck G., Olek K.;
RT   "Cloning of the human alpha 2-macroglobulin gene and detection of
RT   mutations in two functional domains: the bait region and the
RT   thiolester site.";
RL   Hum. Genet. 88:313-319(1992).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 832-1474.
RC   TISSUE=Liver;
RX   MEDLINE=85219061; PubMed=2408344; DOI=10.1007/BF01534685;
RA   Bell G.I., Rall L.B., Sanchez-Pescador R., Merryweather J.P.,
RA   Scott J., Eddy R.L., Shows T.B.;
RT   "Human alpha 2-macroglobulin gene is located on chromosome 12.";
RL   Somat. Cell Mol. Genet. 11:285-289(1985).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1208-1474.
RC   TISSUE=Aorta;
RA   Liu B., Zhao B., Wang X.Y., Xu Y.Y., Liu Y.Q., Song L., Ye J.,
RA   Sheng H., Gao Y., Zhang C.L., Wei Y.J., Zhang J., Song L., Jiang Y.X.,
RA   Zhao Z.W., Ding J.F., Liu L.S., Gao R.L., Wu Q.Y., Qiang B.Q.,
RA   Yuan J.G., Liew C.C., Zhao M.S., Hui R.T.;
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   INHIBITORY SITE.
RX   MEDLINE=81255805; PubMed=6167263; DOI=10.1016/S0006-291X(81)80055-1;
RA   Hall P.K., Nelles L.P., Travis J., Roberts R.C.;
RT   "Proteolytic cleavage sites on alpha 2-macroglobulin resulting in
RT   proteinase binding are different for trypsin and Staphylococcus aureus
RT   V-8 proteinase.";
RL   Biochem. Biophys. Res. Commun. 100:8-16(1981).
RN   [16]
RP   INHIBITORY SITE.
RX   MEDLINE=81212827; PubMed=6165619; DOI=10.1016/0014-5793(81)80197-4;
RA   Sottrup-Jensen L., Loenblad P.B., Stepanik T.M., Petersen T.E.,
RA   Magnusson S., Joernvall H.;
RT   "Primary structure of the 'bait' region for proteinases in alpha 2-
RT   macroglobulin. Nature of the complex.";
RL   FEBS Lett. 127:167-173(1981).
RN   [17]
RP   INHIBITORY SITE.
RX   MEDLINE=82095610; PubMed=6172288; DOI=10.1016/0014-5793(81)80804-6;
RA   Mortensen S.B., Sottrup-Jensen L., Hansen H.F., Petersen T.E.,
RA   Magnusson S.;
RT   "Primary and secondary cleavage sites in the bait region of alpha 2-
RT   macroglobulin.";
RL   FEBS Lett. 135:295-300(1981).
RN   [18]
RP   INHIBITORY SITE.
RX   MEDLINE=84030513; PubMed=6195065;
RA   Virca G.D., Salvesen G.S., Travis J.;
RT   "Human neutrophil elastase and cathepsin G cleavage sites in the bait
RT   region of alpha 2-macroglobulin. Proposed structural limits of the
RT   bait region.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 364:1297-1302(1983).
RN   [19]
RP   GLYCOSYLATION AT ASN-991.
RX   MEDLINE=22660472; PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [20]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-869 AND ASN-1424, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [21]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-55; ASN-247; ASN-396;
RP   ASN-410; ASN-869; ASN-991 AND ASN-1424, AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [22]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-396; ASN-991 AND ASN-1424,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   STRUCTURE BY NMR OF 1337-1474.
RX   MEDLINE=99081553; PubMed=9865955;
RA   Huang W., Dolmer K., Liao X., Gettins P.G.W.;
RT   "Localization of basic residues required for receptor binding to the
RT   single alpha-helix of the receptor binding domain of human alpha2-
RT   macroglobulin.";
RL   Protein Sci. 7:2602-2612(1998).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 126-227, AND DOMAIN
RP   STRUCTURE.
RX   PubMed=17608619; DOI=10.1042/BJ20070764;
RA   Doan N., Gettins P.G.W.;
RT   "Human alpha2-macroglobulin is composed of multiple domains, as
RT   predicted by homology with complement component C3.";
RL   Biochem. J. 407:23-30(2007).
RN   [26]
RP   VARIANT VAL-1000.
RX   MEDLINE=91187639; PubMed=1707161; DOI=10.1093/nar/19.1.198-a;
RA   Poller W., Faber J.-P., Olek K.;
RT   "Sequence polymorphism in the human alpha2-macroglobulin (A2M) gene.";
RL   Nucleic Acids Res. 19:198-198(1991).
CC   -!- FUNCTION: Is able to inhibit all four classes of proteinases by a
CC       unique 'trapping' mechanism. This protein has a peptide stretch,
CC       called the 'bait region' which contains specific cleavage sites
CC       for different proteinases. When a proteinase cleaves the bait
CC       region, a conformational change is induced in the protein which
CC       traps the proteinase. The entrapped enzyme remains active against
CC       low molecular weight substrates (activity against high molecular
CC       weight substrates is greatly reduced). Following cleavage in the
CC       bait region a thioester bond is hydrolyzed and mediates the
CC       covalent binding of the protein to the proteinase.
CC   -!- SUBUNIT: Homotetramer; disulfide-linked.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Secreted in plasma.
CC   -!- DEVELOPMENTAL STAGE: Contrary to the rat protein, which is an
CC       acute phase protein, this protein is always present at high levels
CC       in circulation.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I39 (alpha-2-
CC       macroglobulin) family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAT02228.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC       Sequence=BAD92851.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Alpha-2 macroglobulin entry;
CC       URL="http://en.wikipedia.org/wiki/Alpha_2-macroglobulin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M11313; AAA51551.1; -; mRNA.
DR   EMBL; AY591530; AAT02228.1; ALT_INIT; mRNA.
DR   EMBL; AB209614; BAD92851.1; ALT_INIT; mRNA.
DR   EMBL; CR749334; CAH18188.1; -; mRNA.
DR   EMBL; AC007436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC026246; AAH26246.1; -; mRNA.
DR   EMBL; BC040071; AAH40071.1; -; mRNA.
DR   EMBL; Z11711; CAA77774.1; -; Genomic_DNA.
DR   EMBL; X68728; CAA48670.1; -; Genomic_DNA.
DR   EMBL; X68729; CAA48670.1; JOINED; Genomic_DNA.
DR   EMBL; M36501; AAA51552.1; -; mRNA.
DR   EMBL; AF109189; AAQ13498.1; -; mRNA.
DR   IPI; IPI00478003; -.
DR   PIR; A94033; MAHU.
DR   RefSeq; NP_000005.2; NM_000014.4.
DR   UniGene; Hs.212838; -.
DR   PDB; 1BV8; NMR; -; A=1337-1474.
DR   PDB; 2P9R; X-ray; 2.30 A; A/B=126-227.
DR   PDB; 4ACQ; X-ray; 4.30 A; A/B/C/D=24-1474.
DR   PDBsum; 1BV8; -.
DR   PDBsum; 2P9R; -.
DR   PDBsum; 4ACQ; -.
DR   ProteinModelPortal; P01023; -.
DR   SMR; P01023; 126-227, 1338-1474.
DR   DIP; DIP-1118N; -.
DR   IntAct; P01023; 40.
DR   MINT; MINT-122288; -.
DR   STRING; P01023; -.
DR   MEROPS; I39.001; -.
DR   PhosphoSite; P01023; -.
DR   DMDM; 308153640; -.
DR   DOSAC-COBS-2DPAGE; P01023; -.
DR   SWISS-2DPAGE; P01023; -.
DR   PeptideAtlas; P01023; -.
DR   PRIDE; P01023; -.
DR   Ensembl; ENST00000318602; ENSP00000323929; ENSG00000175899.
DR   GeneID; 2; -.
DR   KEGG; hsa:2; -.
DR   UCSC; uc001qvk.1; human.
DR   CTD; 2; -.
DR   GeneCards; GC12M009220; -.
DR   H-InvDB; HIX0026392; -.
DR   HGNC; HGNC:7; A2M.
DR   HPA; CAB017621; -.
DR   HPA; HPA002265; -.
DR   MIM; 103950; gene+phenotype.
DR   neXtProt; NX_P01023; -.
DR   PharmGKB; PA24357; -.
DR   eggNOG; COG2373; -.
DR   GeneTree; ENSGT00560000076685; -.
DR   HOVERGEN; HBG000039; -.
DR   KO; K03910; -.
DR   OMA; ICGNGRQ; -.
DR   OrthoDB; EOG4H9XJN; -.
DR   Pathway_Interaction_DB; il6_7pathway; IL6-mediated signaling events.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_604; Hemostasis.
DR   DrugBank; DB00626; Bacitracin.
DR   DrugBank; DB00102; Becaplermin.
DR   EvolutionaryTrace; P01023; -.
DR   NextBio; 5; -.
DR   ArrayExpress; P01023; -.
DR   Bgee; P01023; -.
DR   CleanEx; HS_A2M; -.
DR   Genevestigator; P01023; -.
DR   GermOnline; ENSG00000175899; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0019966; F:interleukin-1 binding; IDA:UniProtKB.
DR   GO; GO:0019959; F:interleukin-8 binding; IPI:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0043120; F:tumor necrosis factor binding; IDA:UniProtKB.
DR   GO; GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome.
DR   GO; GO:0001869; P:negative regulation of complement activation, lectin pathway; IDA:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome.
DR   Gene3D; G3DSA:2.60.40.690; A-macroglobulin_rcpt-bd; 1.
DR   InterPro; IPR009048; A-macroglobulin_rcpt-bd.
DR   InterPro; IPR011626; A2M_comp.
DR   InterPro; IPR002890; A2M_N.
DR   InterPro; IPR011625; A2M_N_2.
DR   InterPro; IPR001599; Macroglobln_a2.
DR   InterPro; IPR019742; MacrogloblnA2_CS.
DR   InterPro; IPR019565; MacrogloblnA2_thiol-ester-bond.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   InterPro; IPR010916; TonB_box_CS.
DR   Pfam; PF00207; A2M; 1.
DR   Pfam; PF07678; A2M_comp; 1.
DR   Pfam; PF01835; A2M_N; 1.
DR   Pfam; PF07703; A2M_N_2; 1.
DR   Pfam; PF07677; A2M_recep; 1.
DR   Pfam; PF10569; Thiol-ester_cl; 1.
DR   SUPFAM; SSF49410; AM_receptor_bind; 1.
DR   SUPFAM; SSF48239; Terp_cyc_toroid; 1.
DR   PROSITE; PS00477; ALPHA_2_MACROGLOBULIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Bait region; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Isopeptide bond; Polymorphism; Protease inhibitor; Reference proteome;
KW   Secreted; Serine protease inhibitor; Signal; Thioester bond.
FT   SIGNAL        1     23
FT   CHAIN        24   1474       Alpha-2-macroglobulin.
FT                                /FTId=PRO_0000000055.
FT   REGION      690    728       Bait region.
FT   REGION      704    709       Inhibitory.
FT   REGION      719    723       Inhibitory.
FT   REGION      730    735       Inhibitory.
FT   CARBOHYD     55     55       N-linked (GlcNAc...).
FT   CARBOHYD     70     70       N-linked (GlcNAc...).
FT   CARBOHYD    247    247       N-linked (GlcNAc...).
FT   CARBOHYD    396    396       N-linked (GlcNAc...).
FT   CARBOHYD    410    410       N-linked (GlcNAc...).
FT   CARBOHYD    869    869       N-linked (GlcNAc...).
FT   CARBOHYD    991    991       N-linked (GlcNAc...).
FT   CARBOHYD   1424   1424       N-linked (GlcNAc...).
FT   DISULFID     48     86
FT   DISULFID    251    299
FT   DISULFID    269    287
FT   DISULFID    278    278       Interchain (with C-431).
FT   DISULFID    431    431       Interchain (with C-278).
FT   DISULFID    470    563
FT   DISULFID    595    771
FT   DISULFID    642    689
FT   DISULFID    821    849
FT   DISULFID    847    883
FT   DISULFID    921   1321
FT   DISULFID   1079   1127
FT   DISULFID   1352   1467
FT   CROSSLNK    693    693       Isoglutamyl lysine isopeptide (Gln-Lys)
FT                                (interchain with K-? in other proteins)
FT                                (Potential).
FT   CROSSLNK    694    694       Isoglutamyl lysine isopeptide (Gln-Lys)
FT                                (interchain with K-? in other proteins)
FT                                (Potential).
FT   CROSSLNK    972    975       Isoglutamyl cysteine thioester (Cys-Gln).
FT   VARIANT     639    639       N -> D (in dbSNP:rs226405).
FT                                /FTId=VAR_026820.
FT   VARIANT     704    704       R -> H (in dbSNP:rs1800434).
FT                                /FTId=VAR_000012.
FT   VARIANT     815    815       L -> Q (in dbSNP:rs3180392).
FT                                /FTId=VAR_026821.
FT   VARIANT     972    972       C -> Y (probably interferes with the
FT                                activity; dbSNP:rs1800433).
FT                                /FTId=VAR_000013.
FT   VARIANT    1000   1000       I -> V (in dbSNP:rs669).
FT                                /FTId=VAR_000014.
FT   CONFLICT     63     63       Missing (in Ref. 8; AA sequence).
FT   CONFLICT     82     82       D -> V (in Ref. 3; AAT02228).
FT   CONFLICT    350    353       LSFV -> ACCS (in Ref. 6; AAH26246).
FT   CONFLICT    563    563       C -> E (in Ref. 8; AA sequence).
FT   CONFLICT    844    844       A -> V (in Ref. 4; BAD92851).
FT   CONFLICT    872    872       V -> M (in Ref. 5; CAH18188).
FT   CONFLICT   1148   1148       A -> D (in Ref. 13; AAA51552).
FT   CONFLICT   1195   1195       H -> D (in Ref. 13; AAA51552).
FT   STRAND     1341   1347
FT   HELIX      1355   1359
FT   STRAND     1360   1369
FT   STRAND     1379   1384
FT   STRAND     1389   1391
FT   HELIX      1393   1400
FT   TURN       1401   1403
FT   STRAND     1407   1410
FT   STRAND     1412   1419
FT   STRAND     1427   1434
FT   STRAND     1445   1450
FT   STRAND     1454   1456
FT   STRAND     1459   1463
SQ   SEQUENCE   1474 AA;  163291 MW;  0A46DF09EFD3CF40 CRC64;
     MGKNKLLHPS LVLLLLVLLP TDASVSGKPQ YMVLVPSLLH TETTEKGCVL LSYLNETVTV
     SASLESVRGN RSLFTDLEAE NDVLHCVAFA VPKSSSNEEV MFLTVQVKGP TQEFKKRTTV
     MVKNEDSLVF VQTDKSIYKP GQTVKFRVVS MDENFHPLNE LIPLVYIQDP KGNRIAQWQS
     FQLEGGLKQF SFPLSSEPFQ GSYKVVVQKK SGGRTEHPFT VEEFVLPKFE VQVTVPKIIT
     ILEEEMNVSV CGLYTYGKPV PGHVTVSICR KYSDASDCHG EDSQAFCEKF SGQLNSHGCF
     YQQVKTKVFQ LKRKEYEMKL HTEAQIQEEG TVVELTGRQS SEITRTITKL SFVKVDSHFR
     QGIPFFGQVR LVDGKGVPIP NKVIFIRGNE ANYYSNATTD EHGLVQFSIN TTNVMGTSLT
     VRVNYKDRSP CYGYQWVSEE HEEAHHTAYL VFSPSKSFVH LEPMSHELPC GHTQTVQAHY
     ILNGGTLLGL KKLSFYYLIM AKGGIVRTGT HGLLVKQEDM KGHFSISIPV KSDIAPVARL
     LIYAVLPTGD VIGDSAKYDV ENCLANKVDL SFSPSQSLPA SHAHLRVTAA PQSVCALRAV
     DQSVLLMKPD AELSASSVYN LLPEKDLTGF PGPLNDQDNE DCINRHNVYI NGITYTPVSS
     TNEKDMYSFL EDMGLKAFTN SKIRKPKMCP QLQQYEMHGP EGLRVGFYES DVMGRGHARL
     VHVEEPHTET VRKYFPETWI WDLVVVNSAG VAEVGVTVPD TITEWKAGAF CLSEDAGLGI
     SSTASLRAFQ PFFVELTMPY SVIRGEAFTL KATVLNYLPK CIRVSVQLEA SPAFLAVPVE
     KEQAPHCICA NGRQTVSWAV TPKSLGNVNF TVSAEALESQ ELCGTEVPSV PEHGRKDTVI
     KPLLVEPEGL EKETTFNSLL CPSGGEVSEE LSLKLPPNVV EESARASVSV LGDILGSAMQ
     NTQNLLQMPY GCGEQNMVLF APNIYVLDYL NETQQLTPEI KSKAIGYLNT GYQRQLNYKH
     YDGSYSTFGE RYGRNQGNTW LTAFVLKTFA QARAYIFIDE AHITQALIWL SQRQKDNGCF
     RSSGSLLNNA IKGGVEDEVT LSAYITIALL EIPLTVTHPV VRNALFCLES AWKTAQEGDH
     GSHVYTKALL AYAFALAGNQ DKRKEVLKSL NEEAVKKDNS VHWERPQKPK APVGHFYEPQ
     APSAEVEMTS YVLLAYLTAQ PAPTSEDLTS ATNIVKWITK QQNAQGGFSS TQDTVVALHA
     LSKYGAATFT RTGKAAQVTI QSSGTFSSKF QVDNNNRLLL QQVSLPELPG EYSMKVTGEG
     CVYLQTSLKY NILPEKEEFP FALGVQTLPQ TCDEPKAHTS FQISLSVSYT GSRSASNMAI
     VDVKMVSGFI PLKPTVKMLE RSNHVSRTEV SSNHVLIYLD KVSNQTLSLF FTVLQDVPVR
     DLKPAIVKVY DYYETDEFAI AEYNAPCSKD LGNA
//
ID   A2ML1_HUMAN             Reviewed;        1454 AA.
AC   A8K2U0; B5MDD1; Q2M224; Q6ZW52; Q6ZW53; Q8N1M4; Q96LQ8;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   18-APR-2012, entry version 38.
DE   RecName: Full=Alpha-2-macroglobulin-like protein 1;
DE   AltName: Full=C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9;
DE   Flags: Precursor;
GN   Name=A2ML1; Synonyms=CPAMD9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-850 AND
RP   ARG-1229.
RC   TISSUE=Brain, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-850 AND
RP   ARG-1229.
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1290-1454.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=16298998; DOI=10.1074/jbc.M508017200;
RA   Galliano M.-F., Toulza E., Gallinaro H., Jonca N., Ishida-Yamamoto A.,
RA   Serre G., Guerrin M.;
RT   "A novel protease inhibitor of the alpha2-macroglobulin family
RT   expressed in the human epidermis.";
RL   J. Biol. Chem. 281:5780-5789(2006).
CC   -!- FUNCTION: Is able to inhibit all four classes of proteinases by a
CC       unique 'trapping' mechanism. This protein has a peptide stretch,
CC       called the 'bait region' which contains specific cleavage sites
CC       for different proteinases. When a proteinase cleaves the bait
CC       region, a conformational change is induced in the protein which
CC       traps the proteinase. The entrapped enzyme remains active against
CC       low molecular weight substrates (activity against high molecular
CC       weight substrates is greatly reduced). Following cleavage in the
CC       bait region a thioester bond is hydrolyzed and mediates the
CC       covalent binding of the protein to the proteinase (By similarity).
CC       Displays inhibitory activity against chymotrypsin, papain,
CC       thermolysin, subtilisin A and, to a lesser extent, elastase but
CC       not trypsin. May play an important role during desquamation by
CC       inhibiting extracellular proteases.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: In the epidermis, expressed predominantly in
CC       the granular layer at the apical edge of keratinocytes (at protein
CC       level). Also detected in placenta, testis and thymus but not in
CC       epithelia of kidney, lung, small intestine or colon.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated during keratinocyte
CC       differentiation.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I39 (alpha-2-
CC       macroglobulin) family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB71612.1; Type=Erroneous initiation;
CC       Sequence=BAC04793.1; Type=Erroneous initiation;
CC       Sequence=BAC85653.1; Type=Erroneous initiation;
CC       Sequence=BAC85654.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK057908; BAB71612.1; ALT_INIT; mRNA.
DR   EMBL; AK096448; BAC04793.1; ALT_INIT; mRNA.
DR   EMBL; AK123591; BAC85653.1; ALT_INIT; mRNA.
DR   EMBL; AK123592; BAC85654.1; ALT_INIT; mRNA.
DR   EMBL; AK290355; BAF83044.1; -; mRNA.
DR   EMBL; AL832139; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC006513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006581; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC093840; AAH93840.2; -; mRNA.
DR   EMBL; BC112131; AAI12132.1; -; mRNA.
DR   IPI; IPI00419215; -.
DR   UniGene; Hs.620532; -.
DR   ProteinModelPortal; A8K2U0; -.
DR   SMR; A8K2U0; 119-217, 721-952, 957-1257, 1260-1454.
DR   STRING; A8K2U0; -.
DR   MEROPS; I39.007; -.
DR   PRIDE; A8K2U0; -.
DR   Ensembl; ENST00000299698; ENSP00000299698; ENSG00000166535.
DR   UCSC; uc001quz.4; human.
DR   GeneCards; GC12P008975; -.
DR   HGNC; HGNC:23336; A2ML1.
DR   HPA; HPA038848; -.
DR   MIM; 610627; gene.
DR   neXtProt; NX_A8K2U0; -.
DR   eggNOG; COG2373; -.
DR   GeneTree; ENSGT00560000076685; -.
DR   HOGENOM; HBG444284; -.
DR   HOVERGEN; HBG000039; -.
DR   OMA; QVSVCQK; -.
DR   OrthoDB; EOG4FTVZQ; -.
DR   Bgee; A8K2U0; -.
DR   CleanEx; HS_A2ML1; -.
DR   Genevestigator; A8K2U0; -.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.690; A-macroglobulin_rcpt-bd; 1.
DR   InterPro; IPR009048; A-macroglobulin_rcpt-bd.
DR   InterPro; IPR011626; A2M_comp.
DR   InterPro; IPR002890; A2M_N.
DR   InterPro; IPR011625; A2M_N_2.
DR   InterPro; IPR001599; Macroglobln_a2.
DR   InterPro; IPR019742; MacrogloblnA2_CS.
DR   InterPro; IPR019565; MacrogloblnA2_thiol-ester-bond.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   Pfam; PF00207; A2M; 1.
DR   Pfam; PF07678; A2M_comp; 1.
DR   Pfam; PF01835; A2M_N; 1.
DR   Pfam; PF07703; A2M_N_2; 1.
DR   Pfam; PF07677; A2M_recep; 1.
DR   Pfam; PF10569; Thiol-ester_cl; 1.
DR   SUPFAM; SSF49410; AM_receptor_bind; 1.
DR   SUPFAM; SSF48239; Terp_cyc_toroid; 1.
DR   PROSITE; PS00477; ALPHA_2_MACROGLOBULIN; 1.
PE   1: Evidence at protein level;
KW   Bait region; Complete proteome; Disulfide bond; Glycoprotein;
KW   Polymorphism; Protease inhibitor; Reference proteome; Secreted;
KW   Serine protease inhibitor; Signal; Thioester bond.
FT   SIGNAL        1     17       Potential.
FT   CHAIN        18   1454       Alpha-2-macroglobulin-like protein 1.
FT                                /FTId=PRO_0000318074.
FT   REGION      695    726       Bait region.
FT   CARBOHYD    120    120       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    281    281       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    409    409       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    857    857       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1020   1020       N-linked (GlcNAc...) (Potential).
FT   DISULFID     40     78       By similarity.
FT   DISULFID    241    291       By similarity.
FT   DISULFID    259    279       By similarity.
FT   DISULFID    464    557       By similarity.
FT   DISULFID    589    769       By similarity.
FT   DISULFID    819    847       By similarity.
FT   DISULFID    845    881       By similarity.
FT   DISULFID    919   1307       By similarity.
FT   DISULFID   1075   1123       By similarity.
FT   DISULFID   1338   1453       By similarity.
FT   CROSSLNK    970    973       Isoglutamyl cysteine thioester (Cys-Gln)
FT                                (By similarity).
FT   VARIANT     207    207       G -> R (in dbSNP:rs11047499).
FT                                /FTId=VAR_055463.
FT   VARIANT     850    850       D -> E (in dbSNP:rs1860926).
FT                                /FTId=VAR_059083.
FT   VARIANT     970    970       C -> Y (in dbSNP:rs1558526).
FT                                /FTId=VAR_055464.
FT   VARIANT    1131   1131       T -> M (in dbSNP:rs7959680).
FT                                /FTId=VAR_055465.
FT   VARIANT    1229   1229       H -> R (in dbSNP:rs10219561).
FT                                /FTId=VAR_059084.
FT   VARIANT    1412   1412       T -> A (in dbSNP:rs7315591).
FT                                /FTId=VAR_055466.
FT   CONFLICT    733    733       F -> L (in Ref. 1; BAC85654/BAF83044).
FT   CONFLICT    748    748       G -> E (in Ref. 2; AL832139).
FT   CONFLICT   1122   1122       R -> W (in Ref. 1; BAC04793/BAC85653/
FT                                BAC85654/BAF83044 and 2; AL832139).
FT   CONFLICT   1150   1150       M -> I (in Ref. 1; BAF83044).
FT   CONFLICT   1248   1248       L -> P (in Ref. 1; BAC85654).
FT   CONFLICT   1257   1257       M -> V (in Ref. 1; BAC04793/BAC85653/
FT                                BAC85654/BAF83044 and 2; AL832139).
FT   CONFLICT   1452   1452       P -> L (in Ref. 2; AL832139).
SQ   SEQUENCE   1454 AA;  161107 MW;  15ED65D000834E33 CRC64;
     MWAQLLLGML ALSPAIAEEL PNYLVTLPAR LNFPSVQKVC LDLSPGYSDV KFTVTLETKD
     KTQKLLEYSG LKKRHLHCIS FLVPPPAGGT EEVATIRVSG VGNNISFEEK KKVLIQRQGN
     GTFVQTDKPL YTPGQQVYFR IVTMDSNFVP VNDKYSMVEL QDPNSNRIAQ WLEVVPEQGI
     VDLSFQLAPE AMLGTYTVAV AEGKTFGTFS VEEYVLPKFK VEVVEPKELS TVQESFLVKI
     CCRYTYGKPM LGAVQVSVCQ KANTYWYREV EREQLPDKCR NLSGQTDKTG CFSAPVDMAT
     FDLIGYAYSH QINIVATVVE EGTGVEANAT QNIYISPQMG SMTFEDTSNF YHPNFPFSGK
     IRVRGHDDSF LKNHLVFLVI YGTNGTFNQT LVTDNNGLAP FTLETSGWNG TDVSLEGKFQ
     MEDLVYNPEQ VPRYYQNAYL HLRPFYSTTR SFLGIHRLNG PLKCGQPQEV LVDYYIDPAD
     ASPDQEISFS YYLIGKGSLV MEGQKHLNSK KKGLKASFSL SLTFTSRLAP DPSLVIYAIF
     PSGGVVADKI QFSVEMCFDN QVSLGFSPSQ QLPGAEVELQ LQAAPGSLCA LRAVDESVLL
     LRPDRELSNR SVYGMFPFWY GHYPYQVAEY DQCPVSGPWD FPQPLIDPMP QGHSSQRSII
     WRPSFSEGTD LFSFFRDVGL KILSNAKIKK PVDCSHRSPE YSTAMGAGGG HPEAFESSTP
     LHQAEDSQVR QYFPETWLWD LFPIGNSGKE AVHVTVPDAI TEWKAMSFCT SQSRGFGLSP
     TVGLTAFKPF FVDLTLPYSV VRGESFRLTA TIFNYLKDCI RVQTDLAKSH EYQLESWADS
     QTSSCLCADD AKTHHWNITA VKLGHINFTI STKILDSNEP CGGQKGFVPQ KGRSDTLIKP
     VLVKPEGVLV EKTHSSLLCP KGKVASESVS LELPVDIVPD STKAYVTVLG DIMGTALQNL
     DGLVQMPSGC GEQNMVLFAP IIYVLQYLEK AGLLTEEIRS RAVGFLEIGY QKELMYKHSN
     GSYSAFGERD GNGNTWLTAF VTKCFGQAQK FIFIDPKNIQ DALKWMAGNQ LPSGCYANVG
     NLLHTAMKGG VDDEVSLTAY VTAALLEMGK DVDDPMVSQG LRCLKNSATS TTNLYTQALL
     AYIFSLAGEM DIRNILLKQL DQQAIISGES IYWSQKPTPS SNASPWSEPA AVDVELTAYA
     LLAQLTKPSL TQKEIAKATS IVAWLAKQHN AYGGFSSTQD TVVALQALAK YATTAYMPSE
     EINLVVKSTE NFQRTFNIQS VNRLVFQQDT LPNVPGMYTL EASGQGCVYV QTVLRYNILP
     PTNMKTFSLS VEIGKARCEQ PTSPRSLTLT IHTSYVGSRS SSNMAIVEVK MLSGFSPMEG
     TNQLLLQQPL VKKVEFGTDT LNIYLDELIK NTQTYTFTIS QSVLVTNLKP ATIKVYDYYL
     PDEQATIQYS DPCE
//
ID   A30BL_HUMAN             Reviewed;         258 AA.
AC   A7E2S9; B8ZZL7;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   18-APR-2012, entry version 39.
DE   RecName: Full=Putative ankyrin repeat domain-containing protein 30B-like;
GN   Name=ANKRD30BL; Synonyms=NCRNA00164;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 42-258 (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A7E2S9-1; Sequence=Displayed;
CC         Note=Gene prediction based on EST data;
CC       Name=2;
CC         IsoId=A7E2S9-2; Sequence=VSP_039808;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay;
CC   -!- SIMILARITY: Contains 4 ANK repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC097532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098826; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11682.1; -; Genomic_DNA.
DR   EMBL; BC150521; -; NOT_ANNOTATED_CDS; mRNA.
DR   IPI; IPI00887420; -.
DR   IPI; IPI00915765; -.
DR   UniGene; Hs.380689; -.
DR   ProteinModelPortal; A7E2S9; -.
DR   SMR; A7E2S9; 12-257.
DR   PRIDE; A7E2S9; -.
DR   Ensembl; ENST00000295181; ENSP00000295181; ENSG00000163046.
DR   Ensembl; ENST00000409867; ENSP00000386398; ENSG00000163046.
DR   GeneCards; GC02M132906; -.
DR   HGNC; HGNC:35167; ANKRD30BL.
DR   neXtProt; NX_A7E2S9; -.
DR   eggNOG; COG0666; -.
DR   GeneTree; ENSGT00560000076605; -.
DR   HOGENOM; HBG506323; -.
DR   HOVERGEN; HBG108744; -.
DR   InParanoid; A7E2S9; -.
DR   OMA; KEAVECQ; -.
DR   OrthoDB; EOG4PNXHX; -.
DR   Bgee; A7E2S9; -.
DR   Genevestigator; A7E2S9; -.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 4.
DR   SUPFAM; SSF48403; ANK; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ANK repeat; Complete proteome;
KW   Reference proteome; Repeat.
FT   CHAIN         1    258       Putative ankyrin repeat domain-containing
FT                                protein 30B-like.
FT                                /FTId=PRO_0000341256.
FT   REPEAT       71    100       ANK 1.
FT   REPEAT      104    133       ANK 2.
FT   REPEAT      137    166       ANK 3.
FT   REPEAT      170    199       ANK 4.
FT   VAR_SEQ     206    258       VHQQLLEYKQKISKNSQNSNPEGTSEGTPDEAAPLAERTPD
FT                                TAESLVERTPDE -> TALMLAICHGSSEIVGKLLQQNVDI
FT                                CAEATCGMIAERYAVACGFNL (in isoform 2).
FT                                /FTId=VSP_039808.
SQ   SEQUENCE   258 AA;  28549 MW;  529F3DEEC99F27E1 CRC64;
     MERLSAAPVK GQTGPERPSP FSQLVYTNND SYVIHHGDLR KIHKAASRGQ AWKLERMMKK
     TTMDLNIRDA KKRTALYWAC ANGHAEVVTL LVDRKCQLDV LDGENRTILM KALQCQREAC
     ANILIDSGAD PNIVDVYGNT AVHYAVNSEN LSVVAKLLSC GADIEVKNKA GHTPLLLAIR
     KRSEEIVEFL LTKNANANAV DKFKCVHQQL LEYKQKISKN SQNSNPEGTS EGTPDEAAPL
     AERTPDTAES LVERTPDE
//
ID   A4GAT_HUMAN             Reviewed;         353 AA.
AC   Q9NPC4; B2R7C4; Q9P1X5;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   18-APR-2012, entry version 104.
DE   RecName: Full=Lactosylceramide 4-alpha-galactosyltransferase;
DE            EC=2.4.1.228;
DE   AltName: Full=Alpha-1,4-N-acetylglucosaminyltransferase;
DE   AltName: Full=Alpha-1,4-galactosyltransferase;
DE   AltName: Full=Alpha4Gal-T1;
DE   AltName: Full=CD77 synthase;
DE   AltName: Full=Globotriaosylceramide synthase;
DE            Short=Gb3 synthase;
DE   AltName: Full=P1/Pk synthase;
DE   AltName: Full=UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase;
GN   Name=A4GALT; Synonyms=A14GALT, A4GALT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Melanoma;
RX   MEDLINE=20270223; PubMed=10748143; DOI=10.1074/jbc.M909620199;
RA   Kojima Y., Fukumoto S., Furukawa K., Okajima T., Wiels J.,
RA   Yokoyama K., Suzuki Y., Urano T., Ohta M., Furukawa K.;
RT   "Molecular cloning of globotriaosylceramide/CD77 synthase, a
RT   glycosyltransferase that initiates the synthesis of globo series
RT   glycosphingolipids.";
RL   J. Biol. Chem. 275:15152-15156(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS VAL-37 AND LYS-183.
RX   MEDLINE=20287540; PubMed=10747952; DOI=10.1074/jbc.M000728200;
RA   Steffensen R., Carlier K., Wiels J., Levery S.B., Stroud M.,
RA   Cedergren B., Nilsson Sojka B., Bennett E.P., Jersild C., Clausen H.;
RT   "Cloning and expression of the histo-blood group Pk UDP-
RT   galactose:Galbeta1-4Glcbeta1-Cer alpha1,4-galactosyltransferase.
RT   Molecular genetic basis of the p phenotype.";
RL   J. Biol. Chem. 275:16723-16729(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15014171; DOI=10.1093/molbev/msh100;
RA   Kitano T., Liu Y.-H., Ueda S., Saitou N.;
RT   "Human-specific amino acid changes found in 103 protein-coding
RT   genes.";
RL   Mol. Biol. Evol. 21:936-944(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-37 AND ARG-163.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   VARIANTS VAL-37; LYS-183; ASP-187 AND LEU-251.
RX   PubMed=10993874; DOI=10.1074/jbc.C000625200;
RA   Furukawa K., Iwamura K., Uchikawa M., Sojka B.N., Wiels J.,
RA   Okajima T., Urano T., Furukawa K.;
RT   "Molecular basis for the p phenotype. Identification of distinct and
RT   multiple mutations in the alpha 1,4-galactosyltransferase gene in
RT   Swedish and Japanese individuals.";
RL   J. Biol. Chem. 275:37752-37756(2000).
RN   [10]
RP   VARIANT PHE-80 DEL.
RX   PubMed=11896312; DOI=10.1046/j.1537-2995.2002.00014.x;
RA   Koda Y., Soejima M., Sato H., Maeda Y., Kimura H.;
RT   "Three-base deletion and one-base insertion of the
RT   alpha(1,4)galactosyltransferase gene responsible for the P
RT   phenotype.";
RL   Transfusion 42:48-51(2002).
CC   -!- FUNCTION: Necessary for the biosynthesis of the Pk antigen of
CC       blood histogroup P. Catalyzes the transfer of galactose to
CC       lactosylceramide and galactosylceramide. Necessary for the
CC       synthesis of the receptor for bacterial verotoxins.
CC   -!- CATALYTIC ACTIVITY: UDP-galactose + beta-D-galactosyl-(1->4)-D-
CC       glucosyl-(1<->1)-ceramide = UDP + alpha-D-galactosyl-(1->4)-beta-
CC       D-galactosyl-(1->4)-D-glucosyl-(1<->1)-ceramide.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type
CC       II membrane protein (Probable).
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in kidney, heart,
CC       spleen, liver, testis and placenta.
CC   -!- DOMAIN: The conserved DXD motif is involved in enzyme activity (By
CC       similarity).
CC   -!- POLYMORPHISM: Genetic variation in A4GALT is responsible for the P
CC       system blood group phenotypes [MIM:111400]. Different combinations
CC       or absence of the P blood group system antigens define 5 different
CC       phenotypes: P1, P2, P1(k), P2(k), and p. Genetic variation in
CC       A4GALT determines the p phenotype, which is rare and does not
CC       express any antigens. It is also known as null phenotype; p
CC       individuals have antibodies against P, P1 and Pk antigens in their
CC       sera. These antibodies are clinically important because they can
CC       cause severe transfusion reactions and miscarriage.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 32 family.
CC   -!- WEB RESOURCE: Name=GGDB; Note=GlycoGene database;
CC       URL="http://riodb.ibase.aist.go.jp/rcmg/ggdb/";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/a4galt/";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Lactosylceramide 4-alpha-galactosyltransferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_428";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB037883; BAA95915.1; -; mRNA.
DR   EMBL; AJ245581; CAB93532.1; -; mRNA.
DR   EMBL; AB041418; BAA94503.1; -; Genomic_DNA.
DR   EMBL; AY941797; AAX20109.1; -; Genomic_DNA.
DR   EMBL; AK312927; BAG35771.1; -; mRNA.
DR   EMBL; Z82176; CAI18757.1; -; Genomic_DNA.
DR   EMBL; CH471138; EAW73274.1; -; Genomic_DNA.
DR   EMBL; BC017068; AAH17068.1; -; mRNA.
DR   IPI; IPI00033541; -.
DR   RefSeq; NP_059132.1; NM_017436.4.
DR   UniGene; Hs.105956; -.
DR   ProteinModelPortal; Q9NPC4; -.
DR   SMR; Q9NPC4; 171-197.
DR   MINT; MINT-5210812; -.
DR   STRING; Q9NPC4; -.
DR   CAZy; GT32; Glycosyltransferase Family 32.
DR   DMDM; 25452796; -.
DR   PRIDE; Q9NPC4; -.
DR   DNASU; 53947; -.
DR   Ensembl; ENST00000249005; ENSP00000249005; ENSG00000128274.
DR   Ensembl; ENST00000381278; ENSP00000370678; ENSG00000128274.
DR   Ensembl; ENST00000401850; ENSP00000384794; ENSG00000128274.
DR   GeneID; 53947; -.
DR   KEGG; hsa:53947; -.
DR   UCSC; uc003bdb.3; human.
DR   CTD; 53947; -.
DR   GeneCards; GC22M043088; -.
DR   H-InvDB; HIX0016546; -.
DR   HGNC; HGNC:18149; A4GALT.
DR   HPA; HPA001141; -.
DR   MIM; 111400; phenotype.
DR   MIM; 607922; gene.
DR   neXtProt; NX_Q9NPC4; -.
DR   PharmGKB; PA24359; -.
DR   eggNOG; NOG251623; -.
DR   GeneTree; ENSGT00510000047981; -.
DR   HOVERGEN; HBG050427; -.
DR   InParanoid; Q9NPC4; -.
DR   KO; K01988; -.
DR   OMA; RVCTLFI; -.
DR   OrthoDB; EOG4NVZKK; -.
DR   PhylomeDB; Q9NPC4; -.
DR   BRENDA; 2.4.1.228; 2681.
DR   NextBio; 56264; -.
DR   ArrayExpress; Q9NPC4; -.
DR   Bgee; Q9NPC4; -.
DR   CleanEx; HS_A4GALT; -.
DR   Genevestigator; Q9NPC4; -.
DR   GermOnline; ENSG00000128274; Homo sapiens.
DR   GO; GO:0005795; C:Golgi stack; IEA:InterPro.
DR   GO; GO:0030173; C:integral to Golgi membrane; NAS:UniProtKB.
DR   GO; GO:0005624; C:membrane fraction; IDA:MGI.
DR   GO; GO:0050512; F:lactosylceramide 4-alpha-galactosyltransferase activity; IEA:EC.
DR   GO; GO:0006688; P:glycosphingolipid biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0007009; P:plasma membrane organization; IDA:MGI.
DR   InterPro; IPR007652; A1-4-GlycosylTfrase_dom.
DR   InterPro; IPR007577; GlycoTrfase_DXD_sugar-bd_CS.
DR   Pfam; PF04572; Gb3_synth; 1.
DR   Pfam; PF04488; Gly_transf_sug; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Lipid synthesis; Membrane; Polymorphism; Reference proteome;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    353       Lactosylceramide 4-alpha-
FT                                galactosyltransferase.
FT                                /FTId=PRO_0000080578.
FT   TOPO_DOM      1     22       Cytoplasmic (Potential).
FT   TRANSMEM     23     43       Helical; Signal-anchor for type II
FT                                membrane protein; (Potential).
FT   TOPO_DOM     44    353       Lumenal (Potential).
FT   MOTIF       192    194       DXD motif (By similarity).
FT   CARBOHYD    121    121       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    203    203       N-linked (GlcNAc...) (Potential).
FT   VARIANT      37     37       M -> V (in dbSNP:rs11541159).
FT                                /FTId=VAR_014296.
FT   VARIANT      80     80       Missing (in p individuals).
FT                                /FTId=VAR_017507.
FT   VARIANT     163    163       Q -> R (in dbSNP:rs28915383).
FT                                /FTId=VAR_022320.
FT   VARIANT     183    183       M -> K (in p individuals; complete loss
FT                                of activity).
FT                                /FTId=VAR_014297.
FT   VARIANT     187    187       G -> D (in p individuals; partial loss of
FT                                activity; dbSNP:rs28940572).
FT                                /FTId=VAR_017508.
FT   VARIANT     251    251       P -> L (in p individuals; complete loss
FT                                of activity; dbSNP:rs28940571).
FT                                /FTId=VAR_017509.
SQ   SEQUENCE   353 AA;  40499 MW;  8755865BDA5DA205 CRC64;
     MSKPPDLLLR LLRGAPRQRV CTLFIIGFKF TFFVSIMIYW HVVGEPKEKG QLYNLPAEIP
     CPTLTPPTPP SHGPTPGNIF FLETSDRTNP NFLFMCSVES AARTHPESHV LVLMKGLPGG
     NASLPRHLGI SLLSCFPNVQ MLPLDLRELF RDTPLADWYA AVQGRWEPYL LPVLSDASRI
     ALMWKFGGIY LDTDFIVLKN LRNLTNVLGT QSRYVLNGAF LAFERRHEFM ALCMRDFVDH
     YNGWIWGHQG PQLLTRVFKK WCSIRSLAES RACRGVTTLP PEAFYPIPWQ DWKKYFEDIN
     PEELPRLLSA TYAVHVWNKK SQGTRFEATS RALLAQLHAR YCPTTHEAMK MYL
//
ID   A4GCT_HUMAN             Reviewed;         340 AA.
AC   Q9UNA3; Q0VDK1; Q0VDK2;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   18-APR-2012, entry version 93.
DE   RecName: Full=Alpha-1,4-N-acetylglucosaminyltransferase;
DE            Short=Alpha4GnT;
DE            EC=2.4.1.-;
GN   Name=A4GNT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Stomach;
RX   MEDLINE=99362698; PubMed=10430883; DOI=10.1073/pnas.96.16.8991;
RA   Nakayama J., Yeh J.-C., Misra A.K., Ito S., Katsuyama T., Fukuda M.;
RT   "Expression cloning of a human alpha1, 4-N-
RT   acetylglucosaminyltransferase that forms GlcNAcalpha1-->4Galbeta-->R,
RT   a glycan specifically expressed in the gastric gland mucous cell-type
RT   mucin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:8991-8996(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-218.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Necessary for the synthesis of type III mucin. Catalyzes
CC       the transfer of N-acetylglucosamine (GlcNAc) to core 2 branched O-
CC       glycans.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type
CC       II membrane protein (Probable).
CC   -!- TISSUE SPECIFICITY: Detected in stomach and pancreas.
CC   -!- DOMAIN: The conserved DXD motif is involved in enzyme activity (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 32 family.
CC   -!- WEB RESOURCE: Name=GGDB; Note=GlycoGene database;
CC       URL="http://riodb.ibase.aist.go.jp/rcmg/ggdb/";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Alpha-1,4-N-acetylglucosaminyltransferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_532";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF141315; AAD48406.1; -; mRNA.
DR   EMBL; BC119639; AAI19640.1; -; mRNA.
DR   EMBL; BC119640; AAI19641.1; -; mRNA.
DR   IPI; IPI00007712; -.
DR   RefSeq; NP_057245.1; NM_016161.2.
DR   UniGene; Hs.278960; -.
DR   ProteinModelPortal; Q9UNA3; -.
DR   SMR; Q9UNA3; 127-173.
DR   STRING; Q9UNA3; -.
DR   CAZy; GT32; Glycosyltransferase Family 32.
DR   DMDM; 25452797; -.
DR   PRIDE; Q9UNA3; -.
DR   DNASU; 51146; -.
DR   Ensembl; ENST00000236709; ENSP00000236709; ENSG00000118017.
DR   GeneID; 51146; -.
DR   KEGG; hsa:51146; -.
DR   UCSC; uc003ers.2; human.
DR   CTD; 51146; -.
DR   GeneCards; GC03M137842; -.
DR   H-InvDB; HIX0030726; -.
DR   HGNC; HGNC:17968; A4GNT.
DR   HPA; HPA008017; -.
DR   neXtProt; NX_Q9UNA3; -.
DR   PharmGKB; PA134960042; -.
DR   eggNOG; NOG251623; -.
DR   GeneTree; ENSGT00510000047981; -.
DR   HOGENOM; HBG755248; -.
DR   HOVERGEN; HBG106704; -.
DR   InParanoid; Q9UNA3; -.
DR   KO; K08251; -.
DR   OMA; PSFNDSY; -.
DR   OrthoDB; EOG4TTGJ8; -.
DR   NextBio; 54017; -.
DR   ArrayExpress; Q9UNA3; -.
DR   Bgee; Q9UNA3; -.
DR   CleanEx; HS_A4GNT; -.
DR   Genevestigator; Q9UNA3; -.
DR   GermOnline; ENSG00000118017; Homo sapiens.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005795; C:Golgi stack; IEA:InterPro.
DR   GO; GO:0016021; C:integral to membrane; TAS:ProtInc.
DR   GO; GO:0005624; C:membrane fraction; TAS:ProtInc.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:MGI.
DR   GO; GO:0008378; F:galactosyltransferase activity; IEA:InterPro.
DR   GO; GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc.
DR   InterPro; IPR007652; A1-4-GlycosylTfrase_dom.
DR   InterPro; IPR007577; GlycoTrfase_DXD_sugar-bd_CS.
DR   Pfam; PF04572; Gb3_synth; 1.
DR   Pfam; PF04488; Gly_transf_sug; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Membrane; Polymorphism; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    340       Alpha-1,4-N-
FT                                acetylglucosaminyltransferase.
FT                                /FTId=PRO_0000080583.
FT   TOPO_DOM      1      4       Cytoplasmic (Potential).
FT   TRANSMEM      5     25       Helical; Signal-anchor for type II
FT                                membrane protein; (Potential).
FT   TOPO_DOM     26    340       Lumenal (Potential).
FT   MOTIF       167    169       DXD motif (By similarity).
FT   CARBOHYD     99     99       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    138    138       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    251    251       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    282    282       N-linked (GlcNAc...) (Potential).
FT   VARIANT     218    218       A -> D (in dbSNP:rs2246945).
FT                                /FTId=VAR_022096.
SQ   SEQUENCE   340 AA;  39497 MW;  00D667A8394300AB CRC64;
     MRKELQLSLS VTLLLVCGFL YQFTLKSSCL FCLPSFKSHQ GLEALLSHRR GIVFLETSER
     MEPPHLVSCS VESAAKIYPE WPVVFFMKGL TDSTPMPSNS TYPAFSFLSA IDNVFLFPLD
     MKRLLEDTPL FSWYNQINAS AERNWLHISS DASRLAIIWK YGGIYMDTDV ISIRPIPEEN
     FLAAQASRYS SNGIFGFLPH HPFLWECMEN FVEHYNSAIW GNQGPELMTR MLRVWCKLED
     FQEVSDLRCL NISFLHPQRF YPISYREWRR YYEVWDTEPS FNVSYALHLW NHMNQEGRAV
     IRGSNTLVEN LYRKHCPRTY RDLIKGPEGS VTGELGPGNK
//
ID   A4_HUMAN                Reviewed;         770 AA.
AC   P05067; B2R5V1; D3DSD1; D3DSD2; D3DSD3; P09000; P78438; Q13764;
AC   Q13778; Q13793; Q16011; Q16014; Q16019; Q16020; Q6GSC0; Q8WZ99;
AC   Q9BT38; Q9UC33; Q9UCA9; Q9UCB6; Q9UCC8; Q9UCD1; Q9UQ58;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 3.
DT   18-APR-2012, entry version 203.
DE   RecName: Full=Amyloid beta A4 protein;
DE   AltName: Full=ABPP;
DE   AltName: Full=APPI;
DE            Short=APP;
DE   AltName: Full=Alzheimer disease amyloid protein;
DE   AltName: Full=Cerebral vascular amyloid peptide;
DE            Short=CVAP;
DE   AltName: Full=PreA4;
DE   AltName: Full=Protease nexin-II;
DE            Short=PN-II;
DE   Contains:
DE     RecName: Full=N-APP;
DE   Contains:
DE     RecName: Full=Soluble APP-alpha;
DE              Short=S-APP-alpha;
DE   Contains:
DE     RecName: Full=Soluble APP-beta;
DE              Short=S-APP-beta;
DE   Contains:
DE     RecName: Full=C99;
DE   Contains:
DE     RecName: Full=Beta-amyloid protein 42;
DE     AltName: Full=Beta-APP42;
DE   Contains:
DE     RecName: Full=Beta-amyloid protein 40;
DE     AltName: Full=Beta-APP40;
DE   Contains:
DE     RecName: Full=C83;
DE   Contains:
DE     RecName: Full=P3(42);
DE   Contains:
DE     RecName: Full=P3(40);
DE   Contains:
DE     RecName: Full=C80;
DE   Contains:
DE     RecName: Full=Gamma-secretase C-terminal fragment 59;
DE     AltName: Full=Amyloid intracellular domain 59;
DE              Short=AICD-59;
DE              Short=AID(59);
DE     AltName: Full=Gamma-CTF(59);
DE   Contains:
DE     RecName: Full=Gamma-secretase C-terminal fragment 57;
DE     AltName: Full=Amyloid intracellular domain 57;
DE              Short=AICD-57;
DE              Short=AID(57);
DE     AltName: Full=Gamma-CTF(57);
DE   Contains:
DE     RecName: Full=Gamma-secretase C-terminal fragment 50;
DE     AltName: Full=Amyloid intracellular domain 50;
DE              Short=AICD-50;
DE              Short=AID(50);
DE     AltName: Full=Gamma-CTF(50);
DE   Contains:
DE     RecName: Full=C31;
DE   Flags: Precursor;
GN   Name=APP; Synonyms=A4, AD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695).
RC   TISSUE=Brain;
RX   MEDLINE=87144572; PubMed=2881207; DOI=10.1038/325733a0;
RA   Kang J., Lemaire H.-G., Unterbeck A., Salbaum J.M., Masters C.L.,
RA   Grzeschik K.-H., Multhaup G., Beyreuther K., Mueller-Hill B.;
RT   "The precursor of Alzheimer's disease amyloid A4 protein resembles a
RT   cell-surface receptor.";
RL   Nature 325:733-736(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751).
RC   TISSUE=Brain;
RX   MEDLINE=88122639; PubMed=2893289; DOI=10.1038/331525a0;
RA   Ponte P., Gonzalez-Dewhitt P., Schilling J., Miller J., Hsu D.,
RA   Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F.,
RA   Cordell B.;
RT   "A new A4 amyloid mRNA contains a domain homologous to serine
RT   proteinase inhibitors.";
RL   Nature 331:525-527(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP695).
RX   MEDLINE=89128427; PubMed=2783775; DOI=10.1093/nar/17.2.517;
RA   Lemaire H.-G., Salbaum J.M., Multhaup G., Kang J., Bayney R.M.,
RA   Unterbeck A., Beyreuther K., Mueller-Hill B.;
RT   "The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is
RT   encoded by 16 exons.";
RL   Nucleic Acids Res. 17:517-522(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770).
RX   MEDLINE=90236318; PubMed=2110105; DOI=10.1016/0378-1119(90)90310-N;
RA   Yoshikai S., Sasaki H., Doh-ura K., Furuya H., Sakaki Y.;
RT   "Genomic organization of the human amyloid beta-protein precursor
RT   gene.";
RL   Gene 87:257-263(1990).
RN   [5]
RP   ERRATUM.
RX   PubMed=1908403; DOI=10.1016/0378-1119(91)90093-Q;
RA   Yoshikai S., Sasaki H., Doh-ura K., Furuya H., Sakaki Y.;
RL   Gene 102:291-292(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM L-APP733).
RC   TISSUE=Leukocyte;
RX   MEDLINE=92268136; PubMed=1587857;
RA   Koenig G., Moenning U., Czech C., Prior R., Banati R.,
RA   Schreiter-Gasser U., Bauer J., Masters C.L., Beyreuther K.;
RT   "Identification and differential expression of a novel alternative
RT   splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in
RT   leukocytes and brain microglial cells.";
RL   J. Biol. Chem. 267:10804-10809(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770).
RX   MEDLINE=97263807; PubMed=9108164; DOI=10.1093/nar/25.9.1802;
RA   Hattori M., Tsukahara F., Furuhata Y., Tanahashi H., Hirose M.,
RA   Saito M., Tsukuni S., Sakaki Y.;
RT   "A novel method for making nested deletions and its application for
RT   sequencing of a 300 kb region of human APP locus.";
RL   Nucleic Acids Res. 25:1802-1808(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP639), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   MEDLINE=22744650; PubMed=12859342;
RX   DOI=10.1046/j.1460-9568.2003.02731.x;
RA   Tang K., Wang C., Shen C., Sheng S., Ravid R., Jing N.;
RT   "Identification of a novel alternative splicing isoform of human
RT   amyloid precursor protein gene, APP639.";
RL   Eur. J. Neurosci. 18:102-108(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-501.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM APP770).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS APP305 AND APP751).
RC   TISSUE=Eye, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-10.
RC   TISSUE=Liver;
RX   MEDLINE=89016647; PubMed=3140222; DOI=10.1093/nar/16.19.9351;
RA   Schon E.A., Mita S., Sadlock J., Herbert J.;
RT   "A cDNA specifying the human amyloid beta precursor protein (ABPP)
RT   encodes a 95-kDa polypeptide.";
RL   Nucleic Acids Res. 16:9351-9351(1988).
RN   [14]
RP   ERRATUM, AND SEQUENCE REVISION.
RA   Schon E.A., Mita S., Sadlock J., Herbert J.;
RL   Nucleic Acids Res. 16:11402-11402(1988).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-75.
RX   MEDLINE=89165870; PubMed=2538123; DOI=10.1016/0006-291X(89)92437-6;
RA   La Fauci G., Lahiri D.K., Salton S.R., Robakis N.K.;
RT   "Characterization of the 5'-end region and the first two exons of the
RT   beta-protein precursor gene.";
RL   Biochem. Biophys. Res. Commun. 159:297-304(1989).
RN   [16]
RP   PROTEIN SEQUENCE OF 18-50.
RC   TISSUE=Fibroblast;
RX   MEDLINE=87250462; PubMed=3597385;
RA   van Nostrand W.E., Cunningham D.D.;
RT   "Purification of protease nexin II from human fibroblasts.";
RL   J. Biol. Chem. 262:8508-8514(1987).
RN   [17]
RP   PROTEIN SEQUENCE OF 18-40.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 286-366.
RX   MEDLINE=88122640; PubMed=2893290; DOI=10.1038/331528a0;
RA   Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L.,
RA   Gusella J.F., Neve R.L.;
RT   "Protease inhibitor domain encoded by an amyloid protein precursor
RT   mRNA associated with Alzheimer's disease.";
RL   Nature 331:528-530(1988).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 287-367.
RX   MEDLINE=88122641; PubMed=2893291; DOI=10.1038/331530a0;
RA   Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H.;
RT   "Novel precursor of Alzheimer's disease amyloid protein shows protease
RT   inhibitory activity.";
RL   Nature 331:530-532(1988).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 507-770.
RC   TISSUE=Brain cortex;
RX   MEDLINE=88124954; PubMed=2893379; DOI=10.1073/pnas.85.3.929;
RA   Zain S.B., Salim M., Chou W.G., Sajdel-Sulkowska E.M., Majocha R.E.,
RA   Marotta C.A.;
RT   "Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer
RT   disease brain: coding and noncoding regions of the fetal precursor
RT   mRNA are expressed in the cortex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:929-933(1988).
RN   [21]
RP   PROTEIN SEQUENCE OF 523-555, AND DOMAIN COLLAGEN-BINDING.
RX   MEDLINE=96139497; PubMed=8576160; DOI=10.1074/jbc.271.3.1613;
RA   Beher D., Hesse L., Masters C.L., Multhaup G.;
RT   "Regulation of amyloid protein precursor (APP) binding to collagen and
RT   mapping of the binding sites on APP and collagen type I.";
RL   J. Biol. Chem. 271:1613-1620(1996).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 655-737, AND VARIANTS AD1 GLY-717;
RP   ILE-717 AND PHE-717.
RX   MEDLINE=93236601; PubMed=8476439; DOI=10.1006/bbrc.1993.1386;
RA   Denman R.B., Rosenzcwaig R., Miller D.L.;
RT   "A system for studying the effect(s) of familial Alzheimer disease
RT   mutations on the processing of the beta-amyloid peptide precursor.";
RL   Biochem. Biophys. Res. Commun. 192:96-103(1993).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 656-737.
RX   MEDLINE=89392030; PubMed=2675837; DOI=10.1016/0006-291X(89)91112-1;
RA   Johnstone E.M., Chaney M.O., Moore R.E., Ward K.E., Norris F.H.,
RA   Little S.P.;
RT   "Alzheimer's disease amyloid peptide is encoded by two exons and shows
RT   similarity to soybean trypsin inhibitor.";
RL   Biochem. Biophys. Res. Commun. 163:1248-1255(1989).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 672-723, AND VARIANT AD1 ASN-678.
RX   PubMed=15201367; DOI=10.1136/jnnp.2003.010611;
RA   Wakutani Y., Watanabe K., Adachi Y., Wada-Isoe K., Urakami K.,
RA   Ninomiya H., Saido T.C., Hashimoto T., Iwatsubo T., Nakashima K.;
RT   "Novel amyloid precursor protein gene missense mutation (D678N) in
RT   probable familial Alzheimer's disease.";
RL   J. Neurol. Neurosurg. Psych. 75:1039-1042(2004).
RN   [25]
RP   PROTEIN SEQUENCE OF 672-713.
RC   TISSUE=Blood vessel;
RX   MEDLINE=94068497; PubMed=8248178; DOI=10.1073/pnas.90.22.10836;
RA   Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J.,
RA   Gowing E., Ball M.J.;
RT   "Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid
RT   deposits: implications for the pathology of Alzheimer disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10836-10840(1993).
RN   [26]
RP   PROTEIN SEQUENCE OF 672-704, AND TISSUE SPECIFICITY.
RX   MEDLINE=93024877; PubMed=1406936; DOI=10.1038/359325a0;
RA   Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D.,
RA   Sinha S., Schlossmacher M., Whaley J., Swindlehurst C.;
RT   "Isolation and quantification of soluble Alzheimer's beta-peptide from
RT   biological fluids.";
RL   Nature 359:325-327(1992).
RN   [27]
RP   PROTEIN SEQUENCE OF 672-701 AND 707-713.
RX   MEDLINE=94153015; PubMed=8109908; DOI=10.1002/ana.410350223;
RA   Wisniewski T., Lalowski M., Levy E., Marques M.R.F., Frangione B.;
RT   "The amino acid sequence of neuritic plaque amyloid from a familial
RT   Alzheimer's disease patient.";
RL   Ann. Neurol. 35:245-246(1994).
RN   [28]
RP   PROTEIN SEQUENCE OF 672-701.
RC   TISSUE=Cerebrospinal fluid;
RX   MEDLINE=94045685; PubMed=8229004;
RX   DOI=10.1111/j.1471-4159.1993.tb09841.x;
RA   Vigo-Pelfrey C., Lee D., Keim P., Lieberburg I., Schenk D.B.;
RT   "Characterization of beta-amyloid peptide from human cerebrospinal
RT   fluid.";
RL   J. Neurochem. 61:1965-1968(1993).
RN   [29]
RP   PROTEIN SEQUENCE OF 672-681.
RC   TISSUE=Brain cortex;
RX   MEDLINE=88035004; PubMed=3312495;
RX   DOI=10.1111/j.1471-4159.1987.tb01005.x;
RA   Pardridge W.M., Vinters H.V., Yang J., Eisenberg J., Choi T.B.,
RA   Tourtellotte W.W., Huebner V., Shively J.E.;
RT   "Amyloid angiopathy of Alzheimer's disease: amino acid composition and
RT   partial sequence of a 4,200-dalton peptide isolated from cortical
RT   microvessels.";
RL   J. Neurochem. 49:1394-1401(1987).
RN   [30]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 674-770.
RC   TISSUE=Brain;
RX   MEDLINE=87120328; PubMed=3810169; DOI=10.1126/science.3810169;
RA   Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C.;
RT   "Characterization and chromosomal localization of a cDNA encoding
RT   brain amyloid of Alzheimer's disease.";
RL   Science 235:877-880(1987).
RN   [31]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 674-703.
RC   TISSUE=Fetal brain;
RX   MEDLINE=87120329; PubMed=2949367; DOI=10.1126/science.2949367;
RA   Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A.,
RA   St George-Hyslop P.H., Van Keuren M.L., Patterson D., Pagan S.,
RA   Kurnit D.M., Neve R.L.;
RT   "Amyloid beta protein gene: cDNA, mRNA distribution, and genetic
RT   linkage near the Alzheimer locus.";
RL   Science 235:880-884(1987).
RN   [32]
RP   PROTEIN SEQUENCE OF 691-698, AND CLEAVAGE BY THETA-SECRETASE.
RX   PubMed=16816112; DOI=10.1096/fj.05-5632com;
RA   Sun X., He G., Song W.;
RT   "BACE2, as a novel APP theta-secretase, is not responsible for the
RT   pathogenesis of Alzheimer's disease in Down syndrome.";
RL   FASEB J. 20:1369-1376(2006).
RN   [33]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751).
RC   TISSUE=Brain;
RX   MEDLINE=89346754; PubMed=2569763; DOI=10.1126/science.2569763;
RA   de Sauvage F., Octave J.-N.;
RT   "A novel mRNA of the A4 amyloid precursor gene coding for a possibly
RT   secreted protein.";
RL   Science 245:651-653(1989).
RN   [34]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695).
RC   TISSUE=Brain;
RX   MEDLINE=87231971; PubMed=3035574; DOI=10.1073/pnas.84.12.4190;
RA   Robakis N.K., Ramakrishna N., Wolfe G., Wisniewski H.M.;
RT   "Molecular cloning and characterization of a cDNA encoding the
RT   cerebrovascular and the neuritic plaque amyloid peptides.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4190-4194(1987).
RN   [35]
RP   CHARACTERIZATION OF L-APP733, AND MUTAGENESIS OF SER-656.
RX   MEDLINE=95256193; PubMed=7737970; DOI=10.1074/jbc.270.18.10388;
RA   Pangalos M.N., Efthimiopoulos S., Shioi J., Robakis N.K.;
RT   "The chondroitin sulfate attachment site of appican is formed by
RT   splicing out exon 15 of the amyloid precursor gene.";
RL   J. Biol. Chem. 270:10388-10391(1995).
RN   [36]
RP   FUNCTION OF BETA-AMYLOID PEPTIDE AS LIPID PEROXIDATION INHIBITOR, AND
RP   MUTAGENESIS OF MET-706.
RX   MEDLINE=97312488; PubMed=9168929; DOI=10.1006/bbrc.1997.6547;
RA   Walter M.F., Mason P.E., Mason R.P.;
RT   "Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid
RT   peroxidation as a result of its membrane interactions.";
RL   Biochem. Biophys. Res. Commun. 233:760-764(1997).
RN   [37]
RP   REVIEW ON FUNCTION OF BETA-AMYLOID AS ANTIOXIDANT.
RX   MEDLINE=21630800; PubMed=11775062; DOI=10.1023/A:1012629603390;
RA   Kontush A.;
RT   "Alzheimer's amyloid-beta as a preventive antioxidant for brain
RT   lipoproteins.";
RL   Cell. Mol. Neurobiol. 21:299-315(2001).
RN   [38]
RP   IDENTITY OF APP WITH NEXIN-II.
RX   MEDLINE=89384866; PubMed=2506449; DOI=10.1038/341144a0;
RA   Oltersdorf T., Fritz L.C., Schenk D.B., Lieberburg I.,
RA   Johnson-Wood K.L., Beattie E.C., Ward P.J., Blacher R.W., Dovey H.F.,
RA   Sinha S.;
RT   "The secreted form of the Alzheimer's amyloid precursor protein with
RT   the Kunitz domain is protease nexin-II.";
RL   Nature 341:144-147(1989).
RN   [39]
RP   PROTEASE-SPECIFICITY OF INHIBITOR DOMAIN.
RX   MEDLINE=90211252; PubMed=1969731; DOI=10.1016/0006-291X(90)92084-D;
RA   Kido H., Fukutomi A., Schilling J., Wang Y., Cordell B., Katunuma N.;
RT   "Protease-specificity of Kunitz inhibitor domain of Alzheimer's
RT   disease amyloid protein precursor.";
RL   Biochem. Biophys. Res. Commun. 167:716-721(1990).
RN   [40]
RP   EXTRACELLULAR ZINC-BINDING DOMAIN.
RX   MEDLINE=93346344; PubMed=8344894;
RA   Bush A.I., Multhaup G., Moir R.D., Williamson T.G., Small D.H.,
RA   Rumble B., Pollwein P., Beyreuther K., Masters C.L.;
RT   "A novel zinc(II) binding site modulates the function of the beta A4
RT   amyloid protein precursor of Alzheimer's disease.";
RL   J. Biol. Chem. 268:16109-16112(1993).
RN   [41]
RP   INTERACTION WITH G(O).
RX   MEDLINE=93188965; PubMed=8446172; DOI=10.1038/362075a0;
RA   Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T.,
RA   Murayama Y., Ogata E.;
RT   "Alzheimer amyloid protein precursor complexes with brain GTP-binding
RT   protein G(o).";
RL   Nature 362:75-79(1993).
RN   [42]
RP   EXTRACELLULAR COPPER-BINDING DOMAIN, AND MUTAGENESIS OF HIS-137;
RP   MET-141; CYS-144; HIS-147 AND HIS-151.
RX   MEDLINE=94320627; PubMed=7913895; DOI=10.1016/0014-5793(94)00658-X;
RA   Hesse L., Beher D., Masters C.L., Multhaup G.;
RT   "The beta A4 amyloid precursor protein binding to copper.";
RL   FEBS Lett. 349:109-116(1994).
RN   [43]
RP   N-TERMINAL HEPARIN-BINDING DOMAIN, AND MUTAGENESIS OF 99-LYS--ARG-102.
RX   MEDLINE=94210049; PubMed=8158260;
RA   Small D.H., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K.,
RA   Masters C.L.;
RT   "A heparin-binding domain in the amyloid protein precursor of
RT   Alzheimer's disease is involved in the regulation of neurite
RT   outgrowth.";
RL   J. Neurosci. 14:2117-2127(1994).
RN   [44]
RP   MUTAGENESIS OF VAL-717.
RX   MEDLINE=97040689; PubMed=8886002; DOI=10.1006/bbrc.1996.1577;
RA   Maruyama K., Tomita T., Shinozaki K., Kume H., Asada H., Saido T.C.,
RA   Ishiura S., Iwatsubo T., Obata K.;
RT   "Familial Alzheimer's disease-linked mutations at Val717 of amyloid
RT   precursor protein are specific for the increased secretion of A beta
RT   42(43).";
RL   Biochem. Biophys. Res. Commun. 227:730-735(1996).
RN   [45]
RP   INTERACTION WITH APP-BP1.
RX   MEDLINE=96212203; PubMed=8626687; DOI=10.1074/jbc.271.19.11339;
RA   Chow N., Korenberg J.R., Chen X.-N., Neve R.L.;
RT   "APP-BP1, a novel protein that binds to the carboxyl-terminal region
RT   of the amyloid precursor protein.";
RL   J. Biol. Chem. 271:11339-11346(1996).
RN   [46]
RP   INTERACTION WITH APBA1 AND APBB1, AND MUTAGENESIS OF TYR-728; TYR-757;
RP   ASN-759 AND TYR-762.
RX   MEDLINE=97042453; PubMed=8887653;
RA   Borg J.-P., Ooi J., Levy E., Margolis B.;
RT   "The phosphotyrosine interaction domains of X11 and FE65 bind to
RT   distinct sites on the YENPTY motif of amyloid precursor protein.";
RL   Mol. Cell. Biol. 16:6229-6241(1996).
RN   [47]
RP   INTERACTION WITH APBB2.
RX   MEDLINE=97008090; PubMed=8855266; DOI=10.1073/pnas.93.20.10832;
RA   Guenette S.Y., Chen J., Jondro P.D., Tanzi R.E.;
RT   "Association of a novel human FE65-like protein with the cytoplasmic
RT   domain of the beta-amyloid precursor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10832-10837(1996).
RN   [48]
RP   HEPARIN-BINDING DOMAINS.
RX   MEDLINE=98019020; PubMed=9357988; DOI=10.1016/S0014-5793(97)01146-0;
RA   Mok S.S., Sberna G., Heffernan D., Cappai R., Galatis D.,
RA   Clarris H.J., Sawyer W.H., Beyreuther K., Masters C.L., Small D.H.;
RT   "Expression and analysis of heparin-binding regions of the amyloid
RT   precursor protein of Alzheimer's disease.";
RL   FEBS Lett. 415:303-307(1997).
RN   [49]
RP   INTERACTION OF BETA-AMYLOID PEPTIDE WITH HADH2.
RC   TISSUE=Brain;
RX   MEDLINE=97478528; PubMed=9338779; DOI=10.1038/39522;
RA   Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F.,
RA   Collinson K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S.,
RA   Roher A., Stern D.;
RT   "An intracellular protein that binds amyloid-beta peptide and mediates
RT   neurotoxicity in Alzheimer's disease.";
RL   Nature 389:689-695(1997).
RN   [50]
RP   INTERACTION WITH APPBP2, AND MUTAGENESIS OF TYR-728.
RX   MEDLINE=99061938; PubMed=9843960; DOI=10.1073/pnas.95.25.14745;
RA   Zheng P., Eastman J., Vande Pol S., Pimplikar S.W.;
RT   "PAT1, a microtubule-interacting protein, recognizes the basolateral
RT   sorting signal of amyloid precursor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:14745-14750(1998).
RN   [51]
RP   BETA-AMYLOID ZINC-BINDING, AND MUTAGENESIS OF ARG-676; TYR-681 AND
RP   HIS-684.
RX   MEDLINE=99343552; PubMed=10413512; DOI=10.1021/bi990205o;
RA   Liu S.T., Howlett G., Barrow C.J.;
RT   "Histidine-13 is a crucial residue in the zinc ion-induced aggregation
RT   of the A beta peptide of Alzheimer's disease.";
RL   Biochemistry 38:9373-9378(1999).
RN   [52]
RP   IMPORTANCE OF MET-706 IN FREE RADICAL OXIDATIVE STRESS, AND
RP   MUTAGENESIS OF MET-706.
RX   MEDLINE=20003990; PubMed=10535332; DOI=10.1016/S0361-9230(99)00093-3;
RA   Varadarajan S., Yatin S., Kanski J., Jahanshahi F., Butterfield D.A.;
RT   "Methionine residue 35 is important in amyloid beta-peptide-associated
RT   free radical oxidative stress.";
RL   Brain Res. Bull. 50:133-141(1999).
RN   [53]
RP   INTERACTION WITH APBA2.
RX   MEDLINE=99107877; PubMed=9890987; DOI=10.1074/jbc.274.4.2243;
RA   Tomita S., Ozaki T., Taru H., Oguchi S., Takeda S., Yagi Y.,
RA   Sakiyama S., Kirino Y., Suzuki T.;
RT   "Interaction of a neuron-specific protein containing PDZ domains with
RT   Alzheimer's amyloid precursor protein.";
RL   J. Biol. Chem. 274:2243-2254(1999).
RN   [54]
RP   ENDOCYTOSIS SIGNAL, AND MUTAGENESIS OF TYR-728; GLY-756; TYR-757;
RP   ASN-759; PRO-760 AND TYR-762.
RX   MEDLINE=99315817; PubMed=10383380; DOI=10.1074/jbc.274.27.18851;
RA   Perez R.G., Soriano S., Hayes J.D., Ostaszewski B., Xia W.,
RA   Selkoe D.J., Chen X., Stokin G.B., Koo E.H.;
RT   "Mutagenesis identifies new signals for beta-amyloid precursor protein
RT   endocytosis, turnover, and the generation of secreted fragments,
RT   including Abeta42.";
RL   J. Biol. Chem. 274:18851-18856(1999).
RN   [55]
RP   IMPORTANCE OF CYS-144 IN COPPER REDUCTION, AND MUTAGENESIS OF CYS-144
RP   AND 147-HIS--HIS-149.
RX   MEDLINE=99389019; PubMed=10461923;
RX   DOI=10.1046/j.1471-4159.1999.0731288.x;
RA   Ruiz F.H., Gonzalez M., Bodini M., Opazo C., Inestrosa N.C.;
RT   "Cysteine 144 is a key residue in the copper reduction by the beta-
RT   amyloid precursor protein.";
RL   J. Neurochem. 73:1288-1292(1999).
RN   [56]
RP   INTERACTION OF BETA-AMYLOID WITH APOE.
RX   MEDLINE=20277938; PubMed=10816430; DOI=10.1042/0264-6021:3480359;
RA   Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B.,
RA   Zlokovic B., Smith J.D., Ladu M.J., Rostagno A., Frangione B.,
RA   Ghiso J.;
RT   "Lipidation of apolipoprotein E influences its isoform-specific
RT   interaction with Alzheimer's amyloid beta peptides.";
RL   Biochem. J. 348:359-365(2000).
RN   [57]
RP   INTERACTION OF BETA-APP42 WITH CHRNA7.
RX   MEDLINE=20148766; PubMed=10681545; DOI=10.1074/jbc.275.8.5626;
RA   Wang H.-Y., Lee D.H.S., D'Andrea M.R., Peterson P.A., Shank R.P.,
RA   Reitz A.B.;
RT   "Beta-amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor
RT   with high affinity. Implications for Alzheimer's disease pathology.";
RL   J. Biol. Chem. 275:5626-5632(2000).
RN   [58]
RP   IDENTIFICATION OF GAMMA-CTFS BY MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   ASP-739.
RX   PubMed=12214090;
RA   Passer B., Pellegrini L., Russo C., Siegel R.M., Lenardo M.J.,
RA   Schettini G., Bachmann M., Tabaton M., D'Adamio L.;
RT   "Generation of an apoptotic intracellular peptide by gamma-secretase
RT   cleavage of Alzheimer's amyloid beta protein precursor.";
RL   J. Alzheimers Dis. 2:289-301(2000).
RN   [59]
RP   INTERACTION WITH FPRL1.
RX   MEDLINE=21548005; PubMed=11689470; DOI=10.1096/fj.01-0251com;
RA   Yazawa H., Yu Z.-X., Takeda K., Le Y., Gong W., Ferrans V.J.,
RA   Oppenheim J.J., Li C.C.H., Wang J.M.;
RT   "Beta amyloid peptide (Abeta42) is internalized via the G-protein-
RT   coupled receptor FPRL1 and forms fibrillar aggregates in
RT   macrophages.";
RL   FASEB J. 15:2454-2462(2001).
RN   [60]
RP   INTERACTION WITH BBP.
RX   MEDLINE=21276355; PubMed=11278849; DOI=10.1074/jbc.M011161200;
RA   Kajkowski E.M., Lo C.F., Ning X., Walker S., Sofia H.J., Wang W.,
RA   Edris W., Chanda P., Wagner E., Vile S., Ryan K., McHendry-Rinde B.,
RA   Smith S.C., Wood A., Rhodes K.J., Kennedy J.D., Bard J.,
RA   Jacobsen J.S., Ozenberger B.A.;
RT   "Beta-amyloid peptide-induced apoptosis regulated by a novel protein
RT   containing a G protein activation module.";
RL   J. Biol. Chem. 276:18748-18756(2001).
RN   [61]
RP   BETA-AMYLOID COPPER AND ZINC-BINDING.
RX   MEDLINE=21282933; PubMed=11274207; DOI=10.1074/jbc.M100175200;
RA   Curtain C.C., Ali F., Volitakis I., Cherny R.A., Norton R.S.,
RA   Beyreuther K., Barrow C.J., Masters C.L., Bush A.I., Barnham K.J.;
RT   "Alzheimer's disease amyloid-beta binds copper and zinc to generate an
RT   allosterically ordered structure containing superoxide dismutase-like
RT   subunits.";
RL   J. Biol. Chem. 276:20466-20473(2001).
RN   [62]
RP   SUBUNIT.
RX   MEDLINE=21423984; PubMed=11438549; DOI=10.1074/jbc.M105410200;
RA   Scheuermann S., Hambsch B., Hesse L., Stumm J., Schmidt C., Beher D.,
RA   Bayer T.A., Beyreuther K., Multhaup G.;
RT   "Homodimerization of amyloid precursor protein and its implication in
RT   the amyloidogenic pathway of Alzheimer's disease.";
RL   J. Biol. Chem. 276:33923-33929(2001).
RN   [63]
RP   INTERACTION WITH APBB1, FUNCTION, AND SUBCELLULAR LOCATION.
RX   MEDLINE=21523969; PubMed=11544248; DOI=10.1074/jbc.C100447200;
RA   Kimberly W.T., Zheng J.B., Guenette S.Y., Selkoe D.J.;
RT   "The intracellular domain of the beta-amyloid precursor protein is
RT   stabilized by Fe65 and translocates to the nucleus in a notch-like
RT   manner.";
RL   J. Biol. Chem. 276:40288-40292(2001).
RN   [64]
RP   INTERACTION WITH FBLN1.
RX   MEDLINE=21136579; PubMed=11238726;
RX   DOI=10.1046/j.1471-4159.2001.00144.x;
RA   Ohsawa I., Takamura C., Kohsaka S.;
RT   "Fibulin-1 binds the amino-terminal head of beta-amyloid precursor
RT   protein and modulates its physiological function.";
RL   J. Neurochem. 76:1411-1420(2001).
RN   [65]
RP   INTERACTION WITH MAPT, AND FUNCTION.
RX   MEDLINE=21940546; PubMed=11943163; DOI=10.1016/S0014-5793(02)02376-1;
RA   Rank K.B., Pauley A.M., Bhattacharya K., Wang Z., Evans D.B.,
RA   Fleck T.J., Johnston J.A., Sharma S.K.;
RT   "Direct interaction of soluble human recombinant tau protein with
RT   Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau
RT   protein kinase II.";
RL   FEBS Lett. 514:263-268(2002).
RN   [66]
RP   INTERACTION WITH MAPK8IP1, AND MUTAGENESIS OF TYR-757.
RX   MEDLINE=21671381; PubMed=11724784; DOI=10.1074/jbc.M108357200;
RA   Scheinfeld M.H., Roncarati R., Vito P., Lopez P.A., Abdallah M.,
RA   D'Adamio L.;
RT   "Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the
RT   cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein
RT   (APP).";
RL   J. Biol. Chem. 277:3767-3775(2002).
RN   [67]
RP   COPPER-MEDIATED LIPID PEROXIDATION, AND MUTAGENESIS OF HIS-147 AND
RP   HIS-151.
RX   MEDLINE=21644241; PubMed=11784781;
RA   White A.R., Multhaup G., Galatis D., McKinstry W.J., Parker M.W.,
RA   Pipkorn R., Beyreuther K., Masters C.L., Cappai R.;
RT   "Contrasting species-dependent modulation of copper-mediated
RT   neurotoxicity by the Alzheimer's disease amyloid precursor protein.";
RL   J. Neurosci. 22:365-376(2002).
RN   [68]
RP   REVIEW ON ZINC-BINDING.
RX   MEDLINE=22028940; PubMed=12032279; DOI=10.1073/pnas.122249699;
RA   Bush A.I., Tanzi R.E.;
RT   "The galvanization of beta-amyloid in Alzheimer's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7317-7319(2002).
RN   [69]
RP   INTERACTION WITH ANKS1B.
RX   PubMed=15347684; DOI=10.1074/jbc.M405329200;
RA   Ghersi E., Noviello C., D'Adamio L.;
RT   "Amyloid-beta protein precursor (AbetaPP) intracellular domain-
RT   associated protein-1 proteins bind to AbetaPP and modulate its
RT   processing in an isoform-specific manner.";
RL   J. Biol. Chem. 279:49105-49112(2004).
RN   [70]
RP   PHOSPHORYLATION AT THR-743.
RX   MEDLINE=94178254; PubMed=8131745;
RA   Suzuki T., Oishi M., Marshak D.R., Czernik A.J., Nairn A.C.,
RA   Greengard P.;
RT   "Cell cycle-dependent regulation of the phosphorylation and metabolism
RT   of the Alzheimer amyloid precursor protein.";
RL   EMBO J. 13:1114-1122(1994).
RN   [71]
RP   PHOSPHORYLATION BY CASEIN KINASES, AND MUTAGENESIS OF SER-198 AND
RP   SER-206.
RX   MEDLINE=97153157; PubMed=8999878; DOI=10.1074/jbc.272.3.1896;
RA   Walter J., Capell A., Hung A.Y., Langen H., Schnoelzer M.,
RA   Thinakaran G., Sisodia S.S., Selkoe D.J., Haass C.;
RT   "Ectodomain phosphorylation of beta-amyloid precursor protein at two
RT   distinct cellular locations.";
RL   J. Biol. Chem. 272:1896-1903(1997).
RN   [72]
RP   COPPER-BINDING, AND DISULFIDE BOND FORMATION.
RX   MEDLINE=98254507; PubMed=9585534; DOI=10.1021/bi980022m;
RA   Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Bill E.,
RA   Pipkorn R., Masters C.L., Beyreuther K.;
RT   "Copper-binding amyloid precursor protein undergoes a site-specific
RT   fragmentation in the reduction of hydrogen peroxide.";
RL   Biochemistry 37:7224-7230(1998).
RN   [73]
RP   CLEAVAGE BY CASPASES, AND MUTAGENESIS OF ASP-739.
RX   MEDLINE=99251537; PubMed=10319819; DOI=10.1016/S0092-8674(00)80748-5;
RA   Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y.,
RA   Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E.,
RA   Zheng H., van der Ploeg L.H.T., Ruffolo S.C., Thornberry N.A.,
RA   Xanthoudakis S., Zamboni R.J., Roy S., Nicholson D.W.;
RT   "Involvement of caspases in proteolytic cleavage of Alzheimer's
RT   amyloid-beta precursor protein and amyloidogenic A beta peptide
RT   formation.";
RL   Cell 97:395-406(1999).
RN   [74]
RP   PHOSPHORYLATION, AND MUTAGENESIS OF THR-743.
RX   MEDLINE=99274744; PubMed=10341243;
RA   Ando K., Oishi M., Takeda S., Iijima K., Isohara T., Nairn A.C.,
RA   Kirino Y., Greengard P., Suzuki T.;
RT   "Role of phosphorylation of Alzheimer's amyloid precursor protein
RT   during neuronal differentiation.";
RL   J. Neurosci. 19:4421-4427(1999).
RN   [75]
RP   CHARACTERIZATION OF CASEIN KINASE PHOSPHORYLATION, AND MUTAGENESIS OF
RP   SER-198 AND SER-206.
RX   MEDLINE=20378979; PubMed=10806211; DOI=10.1074/jbc.M002850200;
RA   Walter J., Schindzielorz A., Hartung B., Haass C.;
RT   "Phosphorylation of the beta-amyloid precursor protein at the cell
RT   surface by ectocasein kinases 1 and 2.";
RL   J. Biol. Chem. 275:23523-23529(2000).
RN   [76]
RP   CLEAVAGE BY CASPASES, AND MUTAGENESIS OF ASP-739.
RX   MEDLINE=20207084; PubMed=10742146; DOI=10.1038/74656;
RA   Lu D.C., Rabizadeh S., Chandra S., Shayya R.F., Ellerby L.M., Ye X.,
RA   Salvesen G.S., Koo E.H., Bredesen D.E.;
RT   "A second cytotoxic proteolytic peptide derived from amyloid beta-
RT   protein precursor.";
RL   Nat. Med. 6:397-404(2000).
RN   [77]
RP   PHOSPHORYLATION, INTERACTION WITH APBB1, AND MUTAGENESIS OF THR-743.
RX   MEDLINE=21523939; PubMed=11517218; DOI=10.1074/jbc.M104059200;
RA   Ando K., Iijima K., Elliott J.I., Kirino Y., Suzuki T.;
RT   "Phosphorylation-dependent regulation of the interaction of amyloid
RT   precursor protein with Fe65 affects the production of beta-amyloid.";
RL   J. Biol. Chem. 276:40353-40361(2001).
RN   [78]
RP   PHOSPHORYLATION BY MAPK10, AND MUTAGENESIS OF THR-743.
RX   MEDLINE=20582004; PubMed=11146006;
RX   DOI=10.1046/j.1471-4159.2001.00102.x;
RA   Standen C.L., Brownlees J., Grierson A.J., Kesavapany S., Lau K.-F.,
RA   McLoughlin D.M., Miller C.C.J.;
RT   "Phosphorylation of thr(668) in the cytoplasmic domain of the
RT   Alzheimer's disease amyloid precursor protein by stress-activated
RT   protein kinase 1b (Jun N-terminal kinase-3).";
RL   J. Neurochem. 76:316-320(2001).
RN   [79]
RP   CLEAVAGE AT LEU-720.
RX   MEDLINE=21840707; PubMed=11851430; DOI=10.1021/bi015794o;
RA   Weidemann A., Eggert S., Reinhard F.B.M., Vogel M., Paliga K.,
RA   Baier G., Masters C.L., Beyreuther K., Evin G.;
RT   "A novel epsilon-cleavage within the transmembrane domain of the
RT   Alzheimer amyloid precursor protein demonstrates homology with Notch
RT   processing.";
RL   Biochemistry 41:2825-2835(2002).
RN   [80]
RP   PHOSPHORYLATION AT TYROSINE RESIDUES, INTERACTION WITH SHC1, AND
RP   MUTAGENESIS OF THR-743 AND TYR-757.
RX   MEDLINE=21988180; PubMed=11877420; DOI=10.1074/jbc.M110286200;
RA   Tarr P.E., Roncarati R., Pelicci G., Pelicci P.G., D'Adamio L.;
RT   "Tyrosine phosphorylation of the beta-amyloid precursor protein
RT   cytoplasmic tail promotes interaction with Shc.";
RL   J. Biol. Chem. 277:16798-16804(2002).
RN   [81]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-542, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [82]
RP   SIGNAL SEQUENCE CLEAVAGE SITE, AND TOPOLOGY.
RX   MEDLINE=88296437; PubMed=2900137;
RA   Dyrks T., Weidemann A., Multhaup G., Salbaum J.M., Lemaire H.-G.,
RA   Kang J., Mueller-Hill B., Masters C.L., Beyreuther K.;
RT   "Identification, transmembrane orientation and biogenesis of the
RT   amyloid A4 precursor of Alzheimer's disease.";
RL   EMBO J. 7:949-957(1988).
RN   [83]
RP   REVIEW.
RX   MEDLINE=22252442; PubMed=12142279;
RX   DOI=10.1146/annurev.cellbio.18.020402.142302;
RA   Annaert W., De Strooper B.;
RT   "A cell biological perspective on Alzheimer's disease.";
RL   Annu. Rev. Cell Dev. Biol. 18:25-51(2002).
RN   [84]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-757 AND TYR-762, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [85]
RP   INTERACTION WITH APBB1.
RX   PubMed=18468999; DOI=10.1074/jbc.M801827200;
RA   Nakaya T., Kawai T., Suzuki T.;
RT   "Regulation of FE65 nuclear translocation and function by amyloid
RT   beta-protein precursor in osmotically stressed cells.";
RL   J. Biol. Chem. 283:19119-19131(2008).
RN   [86]
RP   INTERACTION WITH ITM2C.
RX   PubMed=19366692; DOI=10.1074/jbc.M109.006403;
RA   Matsuda S., Matsuda Y., D'Adamio L.;
RT   "BRI3 inhibits amyloid precursor protein processing in a
RT   mechanistically distinct manner from its homologue dementia gene
RT   BRI2.";
RL   J. Biol. Chem. 284:15815-15825(2009).
RN   [87]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-757, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [88]
RP   FUNCTION, CLEAVAGE, AND INTERACTION WITH TNFRSF21.
RX   PubMed=19225519; DOI=10.1038/nature07767;
RA   Nikolaev A., McLaughlin T., O'Leary D.D.M., Tessier-Lavigne M.;
RT   "APP binds DR6 to trigger axon pruning and neuron death via distinct
RT   caspases.";
RL   Nature 457:981-989(2009).
RN   [89]
RP   FUNCTION, AND INTERACTION WITH AGER.
RX   PubMed=19901339; DOI=10.1073/pnas.0905686106;
RA   Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., Sosunov A.,
RA   McKhann G., Funatsu Y., Nakamichi N., Nagai T., Mizoguchi H., Ibi D.,
RA   Hori O., Ogawa S., Stern D.M., Yamada K., Yan S.S.;
RT   "RAGE-mediated signaling contributes to intraneuronal transport of
RT   amyloid-{beta} and neuronal dysfunction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:20021-20026(2009).
RN   [90]
RP   GLYCOSYLATION AT THR-633; THR-651; THR-652; SER-656; THR-663 AND
RP   SER-667 PROTEOLYTIC PROCESSING, STRUCTURE OF CARBOHYDRATES, AND MASS
RP   SPECTROMETRY.
RX   PubMed=21712440; DOI=10.1073/pnas.1102664108;
RA   Halim A., Brinkmalm G., Ruetschi U., Westman-Brinkmalm A.,
RA   Portelius E., Zetterberg H., Blennow K., Larson G., Nilsson J.;
RT   "Site-specific characterization of threonine, serine, and tyrosine
RT   glycosylations of amyloid precursor protein/amyloid beta-peptides in
RT   human cerebrospinal fluid.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:11848-11853(2011).
RN   [91]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 287-344.
RX   MEDLINE=91104913; PubMed=2125487; DOI=10.1021/bi00495a002;
RA   Hynes T.R., Randal M., Kennedy L.A., Eigenbrot C., Kossiakof A.A.;
RT   "X-ray crystal structure of the protease inhibitor domain of
RT   Alzheimer's amyloid beta-protein precursor.";
RL   Biochemistry 29:10018-10022(1990).
RN   [92]
RP   STRUCTURE BY NMR OF 289-344.
RX   MEDLINE=92031488; PubMed=1718421; DOI=10.1021/bi00107a015;
RA   Heald S.L., Tilton R.F. Jr., Hammond L.S., Lee A., Bayney R.M.,
RA   Kamarck M.E., Ramabhadran T.V., Dreyer R.N., Davis G., Unterbeck A.,
RA   Tamburini P.P.;
RT   "Sequential NMR resonance assignment and structure determination of
RT   the Kunitz-type inhibitor domain of the Alzheimer's beta-amyloid
RT   precursor protein.";
RL   Biochemistry 30:10467-10478(1991).
RN   [93]
RP   STRUCTURE BY NMR OF 672-699.
RX   MEDLINE=94281210; PubMed=7516706; DOI=10.1021/bi00191a006;
RA   Talafous J., Marcinowski K.J., Klopman G., Zagorski M.G.;
RT   "Solution structure of residues 1-28 of the amyloid beta-peptide.";
RL   Biochemistry 33:7788-7796(1994).
RN   [94]
RP   STRUCTURE BY NMR OF 672-711.
RX   MEDLINE=96061961; PubMed=7588758;
RX   DOI=10.1111/j.1432-1033.1995.293_1.x;
RA   Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K.,
RA   Frank R.W., Rosch P.;
RT   "Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.";
RL   Eur. J. Biochem. 233:293-298(1995).
RN   [95]
RP   STRUCTURE BY NMR OF 696-706.
RX   MEDLINE=97128622; PubMed=8973180; DOI=10.1021/bi961598j;
RA   Kohno T., Kobayashi K., Maeda T., Sato K., Takashima A.;
RT   "Three-dimensional structures of the amyloid beta peptide (25-35) in
RT   membrane-mimicking environment.";
RL   Biochemistry 35:16094-16104(1996).
RN   [96]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF KUNITZ DOMAIN IN COMPLEX WITH
RP   CHYMOTRYPSIN; TRYPSIN AND BASIC PANCREATIC TRYPSIN INHIBITOR.
RX   MEDLINE=97445596; PubMed=9300481;
RA   Scheidig A.J., Hynes T.R., Pelletier L.A., Wells J.A.,
RA   Kossiakoff A.A.;
RT   "Crystal structures of bovine chymotrypsin and trypsin complexed to
RT   the inhibitor domain of Alzheimer's amyloid beta-protein precursor
RT   (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of
RT   inhibitors with altered specificities.";
RL   Protein Sci. 6:1806-1824(1997).
RN   [97]
RP   STRUCTURE BY NMR OF 672-711.
RX   MEDLINE=98359783; PubMed=9693002; DOI=10.1021/bi972979f;
RA   Coles M., Bicknell W., Watson A.A., Fairlie D.P., Craik D.J.;
RT   "Solution structure of amyloid beta-peptide(1-40) in a water-micelle
RT   environment. Is the membrane-spanning domain where we think it is?";
RL   Biochemistry 37:11064-11077(1998).
RN   [98]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 28-123.
RX   MEDLINE=99215582; PubMed=10201399; DOI=10.1038/7562;
RA   Rossjohn J., Cappai R., Feil S.C., Henry A., McKinstry W.J.,
RA   Galatis D., Hesse L., Multhaup G., Beyreuther K., Masters C.L.,
RA   Parker M.W.;
RT   "Crystal structure of the N-terminal, growth factor-like domain of
RT   Alzheimer amyloid precursor protein.";
RL   Nat. Struct. Biol. 6:327-331(1999).
RN   [99]
RP   STRUCTURE OF CAA-APP VARIANTS.
RX   MEDLINE=20418085; PubMed=10821838; DOI=10.1074/jbc.M003154200;
RA   Miravalle L., Tokuda T., Chiarle R., Giaccone G., Bugiani O.,
RA   Tagliavini F., Frangione B., Ghiso J.;
RT   "Substitutions at codon 22 of Alzheimer's Abeta peptide induce diverse
RT   conformational changes and apoptotic effects in human cerebral
RT   endothelial cells.";
RL   J. Biol. Chem. 275:27110-27116(2000).
RN   [100]
RP   STRUCTURE BY NMR OF 681-706.
RX   MEDLINE=20400065; PubMed=10940221; DOI=10.1006/jsbi.2000.4288;
RA   Zhang S., Iwata K., Lachenmann M.J., Peng J.W., Li S., Stimson E.R.,
RA   Lu Y., Felix A.M., Maggio J.E., Lee J.P.;
RT   "The Alzheimer's peptide a beta adopts a collapsed coil structure in
RT   water.";
RL   J. Struct. Biol. 130:130-141(2000).
RN   [101]
RP   STRUCTURE BY NMR OF 672-699.
RX   MEDLINE=20400066; PubMed=10940222; DOI=10.1006/jsbi.2000.4267;
RA   Poulsen S.-A., Watson A.A., Craik D.J.;
RT   "Solution structures in aqueous SDS micelles of two amyloid beta
RT   peptides of Abeta(1-28) mutated at the alpha-secretase cleavage
RT   site.";
RL   J. Struct. Biol. 130:142-152(2000).
RN   [102]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 346-551, PARTIAL PROTEIN
RP   SEQUENCE, MASS SPECTROMETRY, AND MUTAGENESIS OF ARG-499 AND LYS-503.
RX   PubMed=15304215; DOI=10.1016/j.molcel.2004.06.037;
RA   Wang Y., Ha Y.;
RT   "The X-ray structure of an antiparallel dimer of the human amyloid
RT   precursor protein E2 domain.";
RL   Mol. Cell 15:343-353(2004).
RN   [103]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 672-711 IN COMPLEX WITH IDE.
RX   PubMed=17051221; DOI=10.1038/nature05143;
RA   Shen Y., Joachimiak A., Rosner M.R., Tang W.-J.;
RT   "Structures of human insulin-degrading enzyme reveal a new substrate
RT   recognition mechanism.";
RL   Nature 443:870-874(2006).
RN   [104]
RP   X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 133-189, AND DISULFIDE
RP   BONDS.
RX   PubMed=17909280; DOI=10.1107/S1744309107041139;
RA   Kong G.K., Adams J.J., Cappai R., Parker M.W.;
RT   "Structure of Alzheimer's disease amyloid precursor protein copper-
RT   binding domain at atomic resolution.";
RL   Acta Crystallogr. F 63:819-824(2007).
RN   [105]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 133-189 IN COMPLEXES WITH
RP   COPPER IONS, AND DISULFIDE BONDS.
RX   PubMed=17239395; DOI=10.1016/j.jmb.2006.12.041;
RA   Kong G.K., Adams J.J., Harris H.H., Boas J.F., Curtain C.C.,
RA   Galatis D., Masters C.L., Barnham K.J., McKinstry W.J., Cappai R.,
RA   Parker M.W.;
RT   "Structural studies of the Alzheimer's amyloid precursor protein
RT   copper-binding domain reveal how it binds copper ions.";
RL   J. Mol. Biol. 367:148-161(2007).
RN   [106]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 672-679 IN COMPLEX WITH IGG.
RX   PubMed=17895381; DOI=10.1073/pnas.0705888104;
RA   Gardberg A.S., Dice L.T., Ou S., Rich R.L., Helmbrecht E., Ko J.,
RA   Wetzel R., Myszka D.G., Patterson P.H., Dealwis C.;
RT   "Molecular basis for passive immunotherapy of Alzheimer's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:15659-15664(2007).
RN   [107]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 672-678 IN COMPLEXES WITH
RP   ANTIBODY FAB FRAGMENTS.
RX   PubMed=19923222; DOI=10.1074/jbc.M109.045187;
RA   Basi G.S., Feinberg H., Oshidari F., Anderson J., Barbour R.,
RA   Baker J., Comery T.A., Diep L., Gill D., Johnson-Wood K., Goel A.,
RA   Grantcharova K., Lee M., Li J., Partridge A., Griswold-Prenner I.,
RA   Piot N., Walker D., Widom A., Pangalos M.N., Seubert P.,
RA   Jacobsen J.S., Schenk D., Weis W.I.;
RT   "Structural correlates of antibodies associated with acute reversal of
RT   amyloid beta-related behavioral deficits in a mouse model of Alzheimer
RT   disease.";
RL   J. Biol. Chem. 285:3417-3427(2010).
RN   [108]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 18-190, PARTIAL PROTEIN
RP   SEQUENCE, MASS SPECTROMETRY, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=20212142; DOI=10.1073/pnas.0911326107;
RA   Dahms S.O., Hoefgen S., Roeser D., Schlott B., Guhrs K.H., Than M.E.;
RT   "Structure and biochemical analysis of the heparin-induced E1 dimer of
RT   the amyloid precursor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:5381-5386(2010).
RN   [109]
RP   REVIEW ON VARIANTS.
RX   MEDLINE=93250996; PubMed=1363811; DOI=10.1038/ng0792-233;
RA   Hardy J.;
RT   "Framing beta-amyloid.";
RL   Nat. Genet. 1:233-234(1992).
RN   [110]
RP   VARIANT CAA-APP GLN-693.
RX   MEDLINE=90260663; PubMed=2111584; DOI=10.1126/science.2111584;
RA   Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D.,
RA   Lieberburg I., van Duinen S.G., Bots G.T.A.M., Luyendijk W.,
RA   Frangione B.;
RT   "Mutation of the Alzheimer's disease amyloid gene in hereditary
RT   cerebral hemorrhage, Dutch type.";
RL   Science 248:1124-1126(1990).
RN   [111]
RP   VARIANT AD1 ILE-717.
RX   MEDLINE=91141581; PubMed=1671712; DOI=10.1038/349704a0;
RA   Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F.,
RA   Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R.,
RA   Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M.,
RA   Roses A.D., Williamson R., Rossor M., Owen M., Hardy J.;
RT   "Segregation of a missense mutation in the amyloid precursor protein
RT   gene with familial Alzheimer's disease.";
RL   Nature 349:704-706(1991).
RN   [112]
RP   VARIANT AD1 ILE-717.
RX   MEDLINE=91337051; PubMed=1908231; DOI=10.1016/0006-291X(91)91011-Z;
RA   Yoshioka K., Miki T., Katsuya T., Ogihara T., Sakaki Y.;
RT   "The 717Val-->Ile substitution in amyloid precursor protein is
RT   associated with familial Alzheimer's disease regardless of ethnic
RT   groups.";
RL   Biochem. Biophys. Res. Commun. 178:1141-1146(1991).
RN   [113]
RP   VARIANT AD1 ILE-717.
RX   MEDLINE=91325715; PubMed=1678058; DOI=10.1016/0140-6736(91)91612-X;
RA   Naruse S., Igarashi S., Kobayashi H., Aoki K., Inuzuka T., Kaneko K.,
RA   Shimizu T., Iihara K., Kojima T., Miyatake T., Tsuji S.;
RT   "Mis-sense mutation Val->Ile in exon 17 of amyloid precursor protein
RT   gene in Japanese familial Alzheimer's disease.";
RL   Lancet 337:978-979(1991).
RN   [114]
RP   VARIANT AD1 GLY-717.
RX   MEDLINE=92049731; PubMed=1944558; DOI=10.1038/353844a0;
RA   Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D.,
RA   Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M.;
RT   "Early-onset Alzheimer's disease caused by mutations at codon 717 of
RT   the beta-amyloid precursor protein gene.";
RL   Nature 353:844-846(1991).
RN   [115]
RP   VARIANT AD1 PHE-717.
RX   MEDLINE=92022553; PubMed=1925564; DOI=10.1126/science.1925564;
RA   Murrell J.R., Farlow M., Ghetti B., Benson M.D.;
RT   "A mutation in the amyloid precursor protein associated with
RT   hereditary Alzheimer's disease.";
RL   Science 254:97-99(1991).
RN   [116]
RP   VARIANT AD1 GLY-693.
RX   MEDLINE=93035397; PubMed=1415269;
RA   Kamino K., Orr H.T., Payami H., Wijsman E.M., Alonso M.E., Pulst S.M.,
RA   Anderson L., O'Dahl S., Nemens E., White J.A., Sadovnick A.D.,
RA   Ball M.J., Kaye J., Warren A., McInnis M.G., Antonarakis S.E.,
RA   Korenberg J.R., Sharma V., Kukull W., Larson E., Heston L.L.,
RA   Martin G.M., Bird T.D., Schellenberg G.D.;
RT   "Linkage and mutational analysis of familial Alzheimer disease
RT   kindreds for the APP gene region.";
RL   Am. J. Hum. Genet. 51:998-1014(1992).
RN   [117]
RP   VARIANT AD1 GLY-692.
RX   MEDLINE=93265107; PubMed=1303239; DOI=10.1038/ng0692-218;
RA   Hendriks L., van Duijn C.M., Cras P., Cruts M., Van Hul W.,
RA   van Harskamp F., Warren A., McInnis M.G., Antonarakis S.E.,
RA   Martin J.J., Hofman A., Van Broeckhoven C.;
RT   "Presenile dementia and cerebral haemorrhage linked to a mutation at
RT   codon 692 of the beta-amyloid precursor protein gene.";
RL   Nat. Genet. 1:218-221(1992).
RN   [118]
RP   VARIANT AD1 670-ASN-LEU-671.
RX   MEDLINE=93251023; PubMed=1302033; DOI=10.1038/ng0892-345;
RA   Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B.,
RA   Lannfelt L.;
RT   "A pathogenic mutation for probable Alzheimer's disease in the APP
RT   gene at the N-terminus of beta-amyloid.";
RL   Nat. Genet. 1:345-347(1992).
RN   [119]
RP   VARIANT VAL-713.
RX   MEDLINE=93251011; PubMed=1307241; DOI=10.1038/ng0792-306;
RA   Jones C.T., Morris S., Yates C.M., Moffoot A., Sharpe C.,
RA   Brock D.J.H., St Clair D.;
RT   "Mutation in codon 713 of the beta amyloid precursor protein gene
RT   presenting with schizophrenia.";
RL   Nat. Genet. 1:306-309(1992).
RN   [120]
RP   VARIANT AD1 THR-713.
RX   MEDLINE=93265154; PubMed=1303275; DOI=10.1038/ng1292-255;
RA   Carter D.A., Desmarais E., Bellis M., Campion D., Clerget-Darpoux F.,
RA   Brice A., Agid Y., Jaillard-Serradt A., Mallet J.;
RT   "More missense in amyloid gene.";
RL   Nat. Genet. 2:255-256(1992).
RN   [121]
RP   VARIANTS AD1 ILE-717 AND PHE-717.
RX   MEDLINE=94092106; PubMed=8267572; DOI=10.1006/bbrc.1993.2491;
RA   Liepnieks J.J., Ghetti B., Farlow M., Roses A.D., Benson M.D.;
RT   "Characterization of amyloid fibril beta-peptide in familial
RT   Alzheimer's disease with APP717 mutations.";
RL   Biochem. Biophys. Res. Commun. 197:386-392(1993).
RN   [122]
RP   VARIANT ASP-665.
RX   MEDLINE=94206013; PubMed=8154870; DOI=10.1002/ana.410350410;
RA   Peacock M.L., Murman D.L., Sima A.A.F., Warren J.T. Jr., Roses A.D.,
RA   Fink J.K.;
RT   "Novel amyloid precursor protein gene mutation (codon 665Asp) in a
RT   patient with late-onset Alzheimer's disease.";
RL   Ann. Neurol. 35:432-438(1994).
RN   [123]
RP   VARIANT AD1 PHE-717.
RX   MEDLINE=94119354; PubMed=8290042;
RA   Farlow M., Murrell J., Ghetti B., Unverzagt F., Zeldenrust S.,
RA   Benson M.D.;
RT   "Clinical characteristics in a kindred with early-onset Alzheimer's
RT   disease and their linkage to a G-->T change at position 2149 of the
RT   amyloid precursor protein gene.";
RL   Neurology 44:105-111(1994).
RN   [124]
RP   VARIANT AD1 ILE-717.
RX   MEDLINE=96154988; PubMed=8577393; DOI=10.1016/0304-3940(95)12046-7;
RA   Brooks W.S., Martins R.N., De Voecht J., Nicholson G.A.,
RA   Schofield P.R., Kwok J.B.J., Fisher C., Yeung L.U.,
RA   Van Broeckhoven C.;
RT   "A mutation in codon 717 of the amyloid precursor protein gene in an
RT   Australian family with Alzheimer's disease.";
RL   Neurosci. Lett. 199:183-186(1995).
RN   [125]
RP   VARIANT AD1 VAL-716.
RX   MEDLINE=97472460; PubMed=9328472; DOI=10.1093/hmg/6.12.2087;
RA   Eckman C.B., Mehta N.D., Crook R., Perez-Tur J., Prihar G.,
RA   Pfeiffer E., Graff-Radford N., Hinder P., Yager D., Zenk B.,
RA   Refolo L.M., Prada C.M., Younkin S.G., Hutton M., Hardy J.;
RT   "A new pathogenic mutation in the APP gene (I716V) increases the
RT   relative proportion of A beta 42(43).";
RL   Hum. Mol. Genet. 6:2087-2089(1997).
RN   [126]
RP   VARIANT AD1 GLY-692, AND CHARACTERIZATION OF PHENOTYPE.
RX   MEDLINE=98425953; PubMed=9754958; DOI=10.1007/s004010050892;
RA   Cras P., van Harskamp F., Hendriks L., Ceuterick C., van Duijn C.M.,
RA   Stefanko S.Z., Hofman A., Kros J.M., Van Broeckhoven C., Martin J.J.;
RT   "Presenile Alzheimer dementia characterized by amyloid angiopathy and
RT   large amyloid core type senile plaques in the APP 692Ala-->Gly
RT   mutation.";
RL   Acta Neuropathol. 96:253-260(1998).
RN   [127]
RP   VARIANT AD1 MET-715, AND CHARACTERIZATION OF VARIANT AD1 MET-715.
RX   MEDLINE=99199320; PubMed=10097173; DOI=10.1073/pnas.96.7.4119;
RA   Ancolio K., Dumanchin C., Barelli H., Warter J.-M., Brice A.,
RA   Campion D., Frebourg T., Checler F.;
RT   "Unusual phenotypic alteration of beta amyloid precursor protein
RT   (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation
RT   responsible for probable early-onset Alzheimer's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:4119-4124(1999).
RN   [128]
RP   VARIANT AD1 ILE-717.
RX   MEDLINE=20100613; PubMed=10631141; DOI=10.1086/302702;
RA   Finckh U., Mueller-Thomsen T., Mann U., Eggers C., Marksteiner J.,
RA   Meins W., Binetti G., Alberici A., Hock C., Nitsch R.M., Gal A.;
RT   "High prevalence of pathogenic mutations in patients with early-onset
RT   dementia detected by sequence analyses of four different genes.";
RL   Am. J. Hum. Genet. 66:110-117(2000).
RN   [129]
RP   VARIANT AD1 PRO-723.
RX   MEDLINE=20127265; PubMed=10665499;
RX   DOI=10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.0.CO;2-8;
RA   Kwok J.B.J., Li Q.X., Hallupp M., Whyte S., Ames D., Beyreuther K.,
RA   Masters C.L., Schofield P.R.;
RT   "Novel Leu723Pro amyloid precursor protein mutation increases amyloid
RT   beta42(43) peptide levels and induces apoptosis.";
RL   Ann. Neurol. 47:249-253(2000).
RN   [130]
RP   VARIANT AD1 LEU-717.
RX   MEDLINE=20328146; PubMed=10867787; DOI=10.1001/archneur.57.6.885;
RA   Murrell J.R., Hake A.M., Quaid K.A., Farlow M.R., Ghetti B.;
RT   "Early-onset Alzheimer disease caused by a new mutation (V717L) in the
RT   amyloid precursor protein gene.";
RL   Arch. Neurol. 57:885-887(2000).
RN   [131]
RP   VARIANT AD1 ILE-714, CHARACTERIZATION OF VARIANT AD1 ILE-714, AND
RP   MUTAGENESIS OF VAL-717.
RX   MEDLINE=20519219; PubMed=11063718; DOI=10.1093/hmg/9.18.2589;
RA   Kumar-Singh S., De Jonghe C., Cruts M., Kleinert R., Wang R.,
RA   Mercken M., De Strooper B., Vanderstichele H., Loefgren A.,
RA   Vanderhoeven I., Backhovens H., Vanmechelen E., Kroisel P.M.,
RA   Van Broeckhoven C.;
RT   "Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase
RT   site mutation points to an essential role for N-truncated A beta(42)
RT   in Alzheimer's disease.";
RL   Hum. Mol. Genet. 9:2589-2598(2000).
RN   [132]
RP   VARIANT CAA-APP ASN-694.
RX   MEDLINE=21302085; PubMed=11409420; DOI=10.1002/ana.1009;
RA   Grabowski T.J., Cho H.S., Vonsattel J.P.G., Rebeck G.W.,
RA   Greenberg S.M.;
RT   "Novel amyloid precursor protein mutation in an Iowa family with
RT   dementia and severe cerebral amyloid angiopathy.";
RL   Ann. Neurol. 49:697-705(2001).
RN   [133]
RP   CHARACTERIZATION OF VARIANT AD1 GLY-692.
RX   PubMed=11311152;
RA   Walsh D.M., Hartley D.M., Condron M.M., Selkoe D.J., Teplow D.B.;
RT   "In vitro studies of amyloid beta-protein fibril assembly and toxicity
RT   provide clues to the aetiology of Flemish variant (Ala692-->Gly)
RT   Alzheimer's disease.";
RL   Biochem. J. 355:869-877(2001).
RN   [134]
RP   VARIANT AD1 GLY-693.
RX   MEDLINE=21419679; PubMed=11528419; DOI=10.1038/nn0901-887;
RA   Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M.,
RA   Axelman K., Forsell C., Stenh C., Luthman J., Teplow D.B.,
RA   Younkin S.G., Naeslund J., Lannfelt L.;
RT   "The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by
RT   enhanced Abeta protofibril formation.";
RL   Nat. Neurosci. 4:887-893(2001).
RN   [135]
RP   VARIANT AD1 ALA-714.
RX   PubMed=12034808;
RA   Pasalar P., Najmabadi H., Noorian A.R., Moghimi B., Jannati A.,
RA   Soltanzadeh A., Krefft T., Crook R., Hardy J.;
RT   "An Iranian family with Alzheimer's disease caused by a novel APP
RT   mutation (Thr714Ala).";
RL   Neurology 58:1574-1575(2002).
RN   [136]
RP   VARIANT CAA-APP ASN-694.
RX   PubMed=12654973;
RA   Greenberg S.M., Shin Y., Grabowski T.J., Cooper G.E., Rebeck G.W.,
RA   Iglesias S., Chapon F., Tournier-Lasserve E., Baron J.-C.;
RT   "Hemorrhagic stroke associated with the Iowa amyloid precursor protein
RT   mutation.";
RL   Neurology 60:1020-1022(2003).
RN   [137]
RP   VARIANT AD1 THR-713.
RX   PubMed=15365148;
RA   Rossi G., Giaccone G., Maletta R., Morbin M., Capobianco R.,
RA   Mangieri M., Giovagnoli A.R., Bizzi A., Tomaino C., Perri M.,
RA   Di Natale M., Tagliavini F., Bugiani O., Bruni A.C.;
RT   "A family with Alzheimer disease and strokes associated with A713T
RT   mutation of the APP gene.";
RL   Neurology 63:910-912(2004).
RN   [138]
RP   VARIANT CAA-APP VAL-705.
RX   PubMed=16178030; DOI=10.1002/ana.20571;
RA   Obici L., Demarchi A., de Rosa G., Bellotti V., Marciano S.,
RA   Donadei S., Arbustini E., Palladini G., Diegoli M., Genovese E.,
RA   Ferrari G., Coverlizza S., Merlini G.;
RT   "A novel AbetaPP mutation exclusively associated with cerebral amyloid
RT   angiopathy.";
RL   Ann. Neurol. 58:639-644(2005).
RN   [139]
RP   VARIANT AD1 ILE-714.
RX   PubMed=15668448; DOI=10.1212/01.WNL.0000149761.70566.3E;
RA   Edwards-Lee T., Ringman J.M., Chung J., Werner J., Morgan A.,
RA   St George-Hyslop P.H., Thompson P., Dutton R., Mlikotic A.,
RA   Rogaeva E., Hardy J.;
RT   "An African American family with early-onset Alzheimer disease and an
RT   APP (T714I) mutation.";
RL   Neurology 64:377-379(2005).
CC   -!- FUNCTION: Functions as a cell surface receptor and performs
CC       physiological functions on the surface of neurons relevant to
CC       neurite growth, neuronal adhesion and axonogenesis. Involved in
CC       cell mobility and transcription regulation through protein-protein
CC       interactions. Can promote transcription activation through binding
CC       to APBB1-KAT5 and inhibits Notch signaling through interaction
CC       with Numb. Couples to apoptosis-inducing pathways such as those
CC       mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By
CC       similarity). Acts as a kinesin I membrane receptor, mediating the
CC       axonal transport of beta-secretase and presenilin 1. Involved in
CC       copper homeostasis/oxidative stress through copper ion reduction.
CC       In vitro, copper-metallated APP induces neuronal death directly or
CC       is potentiated through Cu(2+)-mediated low-density lipoprotein
CC       oxidation. Can regulate neurite outgrowth through binding to
CC       components of the extracellular matrix such as heparin and
CC       collagen I and IV. The splice isoforms that contain the BPTI
CC       domain possess protease inhibitor activity. Induces a AGER-
CC       dependent pathway that involves activation of p38 MAPK, resulting
CC       in internalization of amyloid-beta peptide and leading to
CC       mitochondrial dysfunction in cultured cortical neurons.
CC   -!- FUNCTION: Beta-amyloid peptides are lipophilic metal chelators
CC       with metal-reducing activity. Bind transient metals such as
CC       copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to
CC       Cu(+) and Fe(2+), respectively. Beta-amyloid 42 is a more
CC       effective reductant than beta-amyloid 40. Beta-amyloid peptides
CC       bind to lipoproteins and apolipoproteins E and J in the CSF and to
CC       HDL particles in plasma, inhibiting metal-catalyzed oxidation of
CC       lipoproteins. Beta-APP42 may activate mononuclear phagocytes in
CC       the brain and elicit inflammatory responses. Promotes both tau
CC       aggregation and TPK II-mediated phosphorylation. Interaction with
CC       overexpressed HADH2 leads to oxidative stress and neurotoxicity.
CC   -!- FUNCTION: Appicans elicit adhesion of neural cells to the
CC       extracellular matrix and may regulate neurite outgrowth in the
CC       brain (By similarity).
CC   -!- FUNCTION: The gamma-CTF peptides as well as the caspase-cleaved
CC       peptides, including C31, are potent enhancers of neuronal
CC       apoptosis.
CC   -!- FUNCTION: N-APP binds TNFRSF21 triggering caspase activation and
CC       degeneration of both neuronal cell bodies (via caspase-3) and
CC       axons (via caspase-6).
CC   -!- SUBUNIT: Binds, via its C-terminus, to the PID domain of several
CC       cytoplasmic proteins, including APBB family members, the APBA
CC       family, MAPK8IP1, SHC1 and, NUMB and DAB1 (By similarity). Binding
CC       to DAB1 inhibits its serine phosphorylation (By similarity). Also
CC       interacts with GPCR-like protein BPP, FPRL1, APPBP1, IB1, KNS2
CC       (via its TPR domains) (By similarity), APPBP2 (via BaSS) and DDB1.
CC       In vitro, it binds MAPT via the MT-binding domains (By
CC       similarity). Associates with microtubules in the presence of ATP
CC       and in a kinesin-dependent manner (By similarity). Interacts,
CC       through a C-terminal domain, with GNAO1. Amyloid beta-42 binds
CC       CHRNA7 in hippocampal neurons. Beta-amyloid associates with HADH2.
CC       Soluble APP binds, via its N-terminal head, to FBLN1. Interacts
CC       with CPEB1 and AGER (By similarity). Interacts with ANKS1B and
CC       TNFRSF21. Interacts with ITM2B. Interacts with ITM2C. Interacts
CC       with IDE. Can form homodimers; this is promoted by heparin
CC       binding.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-821758, EBI-821758;
CC       P31696:AGRN (xeno); NbExp=3; IntAct=EBI-2431589, EBI-457650;
CC       Q02410:APBA1; NbExp=3; IntAct=EBI-77613, EBI-368690;
CC       O00213:APBB1; NbExp=5; IntAct=EBI-77613, EBI-81694;
CC       Q92870:APBB2; NbExp=2; IntAct=EBI-77613, EBI-79277;
CC       P51693:APLP1; NbExp=2; IntAct=EBI-302641, EBI-74648;
CC       Q06481:APLP2; NbExp=2; IntAct=EBI-302641, EBI-79306;
CC       P02647:APOA1; NbExp=5; IntAct=EBI-77613, EBI-701692;
CC       Q13867:BLMH; NbExp=2; IntAct=EBI-302641, EBI-718504;
CC       P39060:COL18A1; NbExp=2; IntAct=EBI-821758, EBI-2566375;
CC       O75955:FLOT1; NbExp=5; IntAct=EBI-77613, EBI-603643;
CC       P01100:FOS; NbExp=3; IntAct=EBI-77613, EBI-852851;
CC       Q9NSC5:HOMER3; NbExp=3; IntAct=EBI-302661, EBI-748420;
CC       Q99714:HSD17B10; NbExp=4; IntAct=EBI-77613, EBI-79964;
CC       O43736:ITM2A; NbExp=3; IntAct=EBI-302641, EBI-2431769;
CC       P05412:JUN; NbExp=2; IntAct=EBI-77613, EBI-852823;
CC       Q9UQF2:MAPK8IP1; NbExp=4; IntAct=EBI-77613, EBI-78404;
CC       Q9WVI9-1:Mapk8ip1 (xeno); NbExp=2; IntAct=EBI-77613, EBI-288461;
CC       P10636:MAPT; NbExp=9; IntAct=EBI-77613, EBI-366182;
CC       P03897:MT-ND3; NbExp=2; IntAct=EBI-821758, EBI-1246249;
CC       P21359:NF1; NbExp=3; IntAct=EBI-77613, EBI-1172917;
CC       P08138:NGFR; NbExp=4; IntAct=EBI-77613, EBI-1387782;
CC       P07174:Ngfr (xeno); NbExp=2; IntAct=EBI-2431589, EBI-1038810;
CC       P61457:PCBD1; NbExp=2; IntAct=EBI-77613, EBI-740475;
CC       P30101:PDIA3; NbExp=3; IntAct=EBI-77613, EBI-979862;
CC       Q13526:PIN1; NbExp=2; IntAct=EBI-302641, EBI-714158;
CC       P49768:PSEN1; NbExp=6; IntAct=EBI-77613, EBI-297277;
CC       P29353:SHC1; NbExp=5; IntAct=EBI-77613, EBI-78835;
CC       Q92529:SHC3; NbExp=2; IntAct=EBI-77613, EBI-79084;
CC       Q9NP59:SLC40A1; NbExp=4; IntAct=EBI-77613, EBI-725153;
CC       Q8BGY9:Slc5a7 (xeno); NbExp=2; IntAct=EBI-77613, EBI-2010752;
CC       Q9HCB6:SPON1; NbExp=3; IntAct=EBI-302641, EBI-2431846;
CC       P01137:TGFB1; NbExp=2; IntAct=EBI-77613, EBI-779636;
CC       P61812:TGFB2; NbExp=6; IntAct=EBI-77613, EBI-779581;
CC       O75509:TNFRSF21; NbExp=3; IntAct=EBI-77613, EBI-2313231;
CC       Q13625:TP53BP2; NbExp=3; IntAct=EBI-77613, EBI-77642;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Membrane, clathrin-coated pit. Note=Cell surface protein
CC       that rapidly becomes internalized via clathrin-coated pits. During
CC       maturation, the immature APP (N-glycosylated in the endoplasmic
CC       reticulum) moves to the Golgi complex where complete maturation
CC       occurs (O-glycosylated and sulfated). After alpha-secretase
CC       cleavage, soluble APP is released into the extracellular space and
CC       the C-terminal is internalized to endosomes and lysosomes. Some
CC       APP accumulates in secretory transport vesicles leaving the late
CC       Golgi compartment and returns to the cell surface. Gamma-CTF(59)
CC       peptide is located to both the cytoplasm and nuclei of neurons. It
CC       can be translocated to the nucleus through association with APBB1
CC       (Fe65). Beta-APP42 associates with FRPL1 at the cell surface and
CC       the complex is then rapidly internalized. APP sorts to the
CC       basolateral surface in epithelial cells. During neuronal
CC       differentiation, the Thr-743 phosphorylated form is located mainly
CC       in growth cones, moderately in neurites and sparingly in the cell
CC       body. Casein kinase phosphorylation can occur either at the cell
CC       surface or within a post-Golgi compartment.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC         Comment=Additional isoforms seem to exist. Experimental
CC         confirmation may be lacking for some isoforms;
CC       Name=APP770; Synonyms=PreA4 770;
CC         IsoId=P05067-1; Sequence=Displayed;
CC         Note=A major isoform;
CC       Name=APP305;
CC         IsoId=P05067-2; Sequence=VSP_000005, VSP_000006;
CC       Name=L-APP677;
CC         IsoId=P05067-3; Sequence=VSP_000002, VSP_000004, VSP_000009;
CC         Note=The L-isoforms are referred to as appicans;
CC       Name=APP695; Synonyms=PreA4 695;
CC         IsoId=P05067-4; Sequence=VSP_000002, VSP_000004;
CC         Note=A major isoform;
CC       Name=L-APP696;
CC         IsoId=P05067-5; Sequence=VSP_000002, VSP_000003, VSP_000009;
CC         Note=The L-isoforms are referred to as appicans;
CC       Name=APP714;
CC         IsoId=P05067-6; Sequence=VSP_000002, VSP_000003;
CC       Name=L-APP733;
CC         IsoId=P05067-7; Sequence=VSP_000007, VSP_000008, VSP_000009;
CC         Note=The L-isoforms are referred to as appicans;
CC       Name=APP751; Synonyms=PreA4 751;
CC         IsoId=P05067-8; Sequence=VSP_000007, VSP_000008;
CC         Note=A major isoform;
CC       Name=L-APP752;
CC         IsoId=P05067-9; Sequence=VSP_000009;
CC       Name=APP639;
CC         IsoId=P05067-10; Sequence=VSP_009116, VSP_009117, VSP_009118;
CC   -!- TISSUE SPECIFICITY: Expressed in all fetal tissues examined with
CC       highest levels in brain, kidney, heart and spleen. Weak expression
CC       in liver. In adult brain, highest expression found in the frontal
CC       lobe of the cortex and in the anterior perisylvian cortex-
CC       opercular gyri. Moderate expression in the cerebellar cortex, the
CC       posterior perisylvian cortex-opercular gyri and the temporal
CC       associated cortex. Weak expression found in the striate, extra-
CC       striate and motor cortices. Expressed in cerebrospinal fluid, and
CC       plasma. Isoform APP695 is the predominant form in neuronal tissue,
CC       isoform APP751 and isoform APP770 are widely expressed in non-
CC       neuronal cells. Isoform APP751 is the most abundant form in T-
CC       lymphocytes. Appican is expressed in astrocytes.
CC   -!- INDUCTION: Increased levels during neuronal differentiation.
CC   -!- DOMAIN: The basolateral sorting signal (BaSS) is required for
CC       sorting of membrane proteins to the basolateral surface of
CC       epithelial cells.
CC   -!- DOMAIN: The NPXY sequence motif found in many tyrosine-
CC       phosphorylated proteins is required for the specific binding of
CC       the PID domain. However, additional amino acids either N- or C-
CC       terminal to the NPXY motif are often required for complete
CC       interaction. The PID domain-containing proteins which bind APP
CC       require the YENPTY motif for full interaction. These interactions
CC       are independent of phosphorylation on the terminal tyrosine
CC       residue. The NPXY site is also involved in clathrin-mediated
CC       endocytosis.
CC   -!- PTM: Proteolytically processed under normal cellular conditions.
CC       Cleavage either by alpha-secretase, beta-secretase or theta-
CC       secretase leads to generation and extracellular release of soluble
CC       APP peptides, S-APP-alpha and S-APP-beta, and the retention of
CC       corresponding membrane-anchored C-terminal fragments, C80, C83 and
CC       C99. Subsequent processing of C80 and C83 by gamma-secretase
CC       yields P3 peptides. This is the major secretory pathway and is
CC       non-amyloidogenic. Alternatively, presenilin/nicastrin-mediated
CC       gamma-secretase processing of C99 releases the amyloid beta
CC       proteins, amyloid-beta 40 (Abeta40) and amyloid-beta 42 (Abeta42),
CC       major components of amyloid plaques, and the cytotoxic C-terminal
CC       fragments, gamma-CTF(50), gamma-CTF(57) and gamma-CTF(59). Many
CC       other minor beta-amyloid peptides, beta-amyloid 1-X peptides, are
CC       found in cerebral spinal fluid (CSF) including the beta-amyloid X-
CC       15 peptides, produced from the cleavage by alpha-secretase and all
CC       terminatiing at Gln-686.
CC   -!- PTM: Proteolytically cleaved by caspases during neuronal
CC       apoptosis. Cleavage at Asp-739 by either caspase-6, -8 or -9
CC       results in the production of the neurotoxic C31 peptide and the
CC       increased production of beta-amyloid peptides.
CC   -!- PTM: N- and O-glycosylated. O-glycosylation on Ser and Thr
CC       residues with core 1 or possibly core 8 glycans. Partial tyrosine
CC       glycosylation (Tyr-681) is found on some minor, short beta-amyloid
CC       peptides (beta-amyloid 1-15, 1-16, 1-17, 1-18, 1-19 and 1-20) but
CC       not found on beta-amyloid 38, beta-amyloid 40 nor on beta-amyloid
CC       42. Modification on a tyrosine is unusual and is more prevelant in
CC       AD patients. Glycans had Neu5AcHex(Neu5Ac)HexNAc-O-Tyr,
CC       Neu5AcNeu5AcHex(Neu5Ac)HexNAc-O-Tyr and O-
CC       AcNeu5AcNeu5AcHex(Neu5Ac)HexNAc-O-Tyr structures, where O-Ac is O-
CC       acetylation of Neu5Ac. Neu5AcNeu5Ac is most likely Neu5Ac
CC       2,8Neu5Ac linked. O-glycosylations in the vicinity of the cleavage
CC       sites may influence the proteolytic processing. Appicans are L-APP
CC       isoforms with O-linked chondroitin sulfate.
CC   -!- PTM: Phosphorylation in the C-terminal on tyrosine, threonine and
CC       serine residues is neuron-specific. Phosphorylation can affect APP
CC       processing, neuronal differentiation and interaction with other
CC       proteins. Phosphorylated on Thr-743 in neuronal cells by Cdc5
CC       kinase and Mapk10, in dividing cells by Cdc2 kinase in a cell-
CC       cycle dependent manner with maximal levels at the G2/M phase and,
CC       in vitro, by GSK-3-beta. The Thr-743 phosphorylated form causes a
CC       conformational change which reduces binding of Fe65 family
CC       members. Phosphorylation on Tyr-757 is required for SHC binding.
CC       Phosphorylated in the extracellular domain by casein kinases on
CC       both soluble and membrane-bound APP. This phosphorylation is
CC       inhibited by heparin.
CC   -!- PTM: Extracellular binding and reduction of copper, results in a
CC       corresponding oxidation of Cys-144 and Cys-158, and the formation
CC       of a disulfide bond. In vitro, the APP-Cu(+) complex in the
CC       presence of hydrogen peroxide results in an increased production
CC       of beta-amyloid-containing peptides.
CC   -!- PTM: Trophic-factor deprivation triggers the cleavage of surface
CC       APP by beta-secretase to release sAPP-beta which is further
CC       cleaved to release an N-terminal fragment of APP (N-APP).
CC   -!- PTM: Beta-amyloid peptides are degraded by IDE.
CC   -!- MASS SPECTROMETRY: Mass=6461.6; Method=MALDI; Range=712-767;
CC       Source=PubMed:12214090;
CC   -!- MASS SPECTROMETRY: Mass=6451.6; Method=MALDI; Range=714-770;
CC       Source=PubMed:12214090;
CC   -!- MASS SPECTROMETRY: Mass=6436.8; Method=MALDI; Range=715-769;
CC       Source=PubMed:12214090;
CC   -!- MASS SPECTROMETRY: Mass=5752.5; Method=MALDI; Range=719-767;
CC       Source=PubMed:12214090;
CC   -!- DISEASE: Defects in APP are the cause of Alzheimer disease type 1
CC       (AD1) [MIM:104300]. AD1 is a familial early-onset form of
CC       Alzheimer disease. It can be associated with cerebral amyloid
CC       angiopathy. Alzheimer disease is a neurodegenerative disorder
CC       characterized by progressive dementia, loss of cognitive
CC       abilities, and deposition of fibrillar amyloid proteins as
CC       intraneuronal neurofibrillary tangles, extracellular amyloid
CC       plaques and vascular amyloid deposits. The major constituent of
CC       these plaques is the neurotoxic amyloid-beta-APP 40-42 peptide
CC       (s), derived proteolytically from the transmembrane precursor
CC       protein APP by sequential secretase processing. The cytotoxic C-
CC       terminal fragments (CTFs) and the caspase-cleaved products such as
CC       C31 derived from APP, are also implicated in neuronal death.
CC   -!- DISEASE: Defects in APP are the cause of cerebral amyloid
CC       angiopathy APP-related (CAA-APP) [MIM:605714]. A hereditary
CC       localized amyloidosis due to amyloid-beta A4 peptide(s) deposition
CC       in the cerebral vessels. The principal clinical characteristics
CC       are recurrent cerebral and cerebellar hemorrhages, recurrent
CC       strokes, cerebral ischemia, cerebral infarction, and progressive
CC       mental deterioration. Patients develop cerebral hemorrhage because
CC       of the severe cerebral amyloid angiopathy. Parenchymal amyloid
CC       deposits are rare and largely in the form of pre-amyloid lesions
CC       or diffuse plaque-like structures. They are Congo red negative and
CC       lack the dense amyloid cores commonly present in Alzheimer
CC       disease. Some affected individuals manifest progressive aphasic
CC       dementia, leukoencephalopathy, and occipital calcifications.
CC   -!- MISCELLANEOUS: Chelation of metal ions, notably copper, iron and
CC       zinc, can induce histidine-bridging between beta-amyloid molecules
CC       resulting in beta-amyloid-metal aggregates. The affinity for
CC       copper is much higher than for other transient metals and is
CC       increased under acidic conditions. Extracellular zinc-binding
CC       increases binding of heparin to APP and inhibits collagen-binding.
CC   -!- SIMILARITY: Belongs to the APP family.
CC   -!- SIMILARITY: Contains 1 BPTI/Kunitz inhibitor domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA58727.1; Type=Miscellaneous discrepancy; Note=Contamination by an Alu repeat;
CC   -!- WEB RESOURCE: Name=Alzheimer Research Forum; Note=APP mutations;
CC       URL="http://www.alzforum.org/res/com/mut/app/default.asp";
CC   -!- WEB RESOURCE: Name=AD mutations;
CC       URL="http://www.molgen.ua.ac.be/ADmutations/";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/APP";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/app/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Amyloid beta entry;
CC       URL="http://en.wikipedia.org/wiki/Amyloid_beta";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00264; CAA68374.1; -; mRNA.
DR   EMBL; X13466; CAA31830.1; -; Genomic_DNA.
DR   EMBL; X13467; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13468; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13469; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13470; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13471; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13472; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13473; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13474; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13475; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13476; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13477; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13478; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13479; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13487; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13488; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X06989; CAA30050.1; -; mRNA.
DR   EMBL; M33112; AAB59502.1; -; Genomic_DNA.
DR   EMBL; M34862; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34863; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34864; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34865; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34866; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34867; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34868; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34869; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34870; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34871; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34872; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34873; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34874; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34876; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34877; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34878; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34879; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34875; AAB59501.1; ALT_TERM; Genomic_DNA.
DR   EMBL; M34862; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34863; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34864; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34865; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34866; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34867; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34868; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34869; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34870; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34871; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34872; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34873; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; D87675; BAA22264.1; -; Genomic_DNA.
DR   EMBL; AY919674; AAW82435.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09958.1; -; Genomic_DNA.
DR   EMBL; AK312326; BAG35248.1; -; mRNA.
DR   EMBL; CH471079; EAX09959.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09960.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09961.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09963.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09965.1; -; Genomic_DNA.
DR   EMBL; BC004369; AAH04369.1; -; mRNA.
DR   EMBL; BC065529; AAH65529.1; -; mRNA.
DR   EMBL; M35675; AAA60163.1; ALT_SEQ; mRNA.
DR   EMBL; M24547; AAC13654.1; -; Genomic_DNA.
DR   EMBL; M24546; AAC13654.1; JOINED; Genomic_DNA.
DR   EMBL; M28373; AAA58727.1; ALT_SEQ; mRNA.
DR   EMBL; X06982; CAA30042.1; -; mRNA.
DR   EMBL; X06981; CAA30041.1; -; mRNA.
DR   EMBL; M18734; AAA51726.1; -; mRNA.
DR   EMBL; M29270; AAA51768.1; -; Genomic_DNA.
DR   EMBL; M29269; AAA51768.1; JOINED; Genomic_DNA.
DR   EMBL; AB066441; BAB71958.2; -; mRNA.
DR   EMBL; M15533; AAA35540.1; -; mRNA.
DR   EMBL; M15532; AAA51564.1; -; mRNA.
DR   EMBL; M37896; AAA51727.1; -; Genomic_DNA.
DR   EMBL; M37895; AAA51727.1; JOINED; Genomic_DNA.
DR   EMBL; S45136; AAB23646.1; -; Genomic_DNA.
DR   EMBL; S60317; AAC60601.2; -; Genomic_DNA.
DR   EMBL; AF282245; AAQ14327.1; -; mRNA.
DR   EMBL; S60721; AAB26263.2; -; mRNA.
DR   EMBL; S61380; AAB26264.2; -; mRNA.
DR   EMBL; S61383; AAB26265.2; -; mRNA.
DR   EMBL; M16765; AAA51722.1; -; mRNA.
DR   IPI; IPI00006608; -.
DR   IPI; IPI00219182; -.
DR   IPI; IPI00219183; -.
DR   IPI; IPI00219185; -.
DR   IPI; IPI00219186; -.
DR   IPI; IPI00219187; -.
DR   IPI; IPI00394658; -.
DR   IPI; IPI00412568; -.
DR   IPI; IPI00412681; -.
DR   IPI; IPI00412924; -.
DR   PIR; S01442; S01442.
DR   PIR; S02260; QRHUA4.
DR   RefSeq; NP_000475.1; NM_000484.3.
DR   RefSeq; NP_001129601.1; NM_001136129.2.
DR   RefSeq; NP_001129602.1; NM_001136130.2.
DR   RefSeq; NP_001191230.1; NM_001204301.1.
DR   RefSeq; NP_001191231.1; NM_001204302.1.
DR   RefSeq; NP_001191232.1; NM_001204303.1.
DR   RefSeq; NP_958816.1; NM_201413.2.
DR   RefSeq; NP_958817.1; NM_201414.2.
DR   UniGene; Hs.434980; -.
DR   PDB; 1AAP; X-ray; 1.50 A; A/B=287-344.
DR   PDB; 1AMB; NMR; -; A=672-699.
DR   PDB; 1AMC; NMR; -; A=672-699.
DR   PDB; 1AML; NMR; -; A=672-711.
DR   PDB; 1BA4; NMR; -; A=672-711.
DR   PDB; 1BA6; NMR; -; A=672-711.
DR   PDB; 1BJB; NMR; -; A=672-699.
DR   PDB; 1BJC; NMR; -; A=672-699.
DR   PDB; 1BRC; X-ray; 2.50 A; I=287-342.
DR   PDB; 1CA0; X-ray; 2.10 A; D/I=289-342.
DR   PDB; 1HZ3; NMR; -; A=681-706.
DR   PDB; 1IYT; NMR; -; A=672-713.
DR   PDB; 1MWP; X-ray; 1.80 A; A=28-123.
DR   PDB; 1OWT; NMR; -; A=124-189.
DR   PDB; 1QCM; NMR; -; A=696-706.
DR   PDB; 1QWP; NMR; -; A=696-706.
DR   PDB; 1QXC; NMR; -; A=696-706.
DR   PDB; 1QYT; NMR; -; A=696-706.
DR   PDB; 1TAW; X-ray; 1.80 A; B=287-344.
DR   PDB; 1TKN; NMR; -; A=460-569.
DR   PDB; 1UO7; Model; -; A=672-713.
DR   PDB; 1UO8; Model; -; A=672-713.
DR   PDB; 1UOA; Model; -; A=672-713.
DR   PDB; 1UOI; Model; -; A=672-713.
DR   PDB; 1X11; X-ray; 2.50 A; C/D=754-766.
DR   PDB; 1Z0Q; NMR; -; A=672-713.
DR   PDB; 1ZE7; NMR; -; A=672-687.
DR   PDB; 1ZE9; NMR; -; A=672-687.
DR   PDB; 1ZJD; X-ray; 2.60 A; B=289-344.
DR   PDB; 2BEG; NMR; -; A/B/C/D/E=672-713.
DR   PDB; 2BOM; Model; -; A/B=681-713.
DR   PDB; 2BP4; NMR; -; A=672-687.
DR   PDB; 2FJZ; X-ray; 1.61 A; A=133-189.
DR   PDB; 2FK1; X-ray; 1.60 A; A=133-189.
DR   PDB; 2FK2; X-ray; 1.65 A; A=133-189.
DR   PDB; 2FK3; X-ray; 2.40 A; A/B/C/D/E/F/G/H=133-189.
DR   PDB; 2FKL; X-ray; 2.50 A; A/B=124-189.
DR   PDB; 2FMA; X-ray; 0.85 A; A=133-189.
DR   PDB; 2G47; X-ray; 2.10 A; C/D=672-711.
DR   PDB; 2IPU; X-ray; 1.65 A; P/Q=672-679.
DR   PDB; 2LFM; NMR; -; A=672-711.
DR   PDB; 2LMN; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L=672-711.
DR   PDB; 2LMO; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L=672-711.
DR   PDB; 2LMP; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=672-711.
DR   PDB; 2LMQ; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=672-711.
DR   PDB; 2LNQ; NMR; -; A/B/C/D/E/F/G/H=672-711.
DR   PDB; 2OTK; NMR; -; C=672-711.
DR   PDB; 2R0W; X-ray; 2.50 A; Q=672-679.
DR   PDB; 2WK3; X-ray; 2.59 A; C/D=672-713.
DR   PDB; 2Y29; X-ray; 2.30 A; A=687-692.
DR   PDB; 2Y2A; X-ray; 1.91 A; A=687-692.
DR   PDB; 2Y3J; X-ray; 1.99 A; A/B/C/D/E/F/G/H=701-706.
DR   PDB; 2Y3K; X-ray; 1.90 A; A/B/C/D/E/F/G/H=706-713.
DR   PDB; 2Y3L; X-ray; 2.10 A; A/B/C/G=706-713.
DR   PDB; 3AYU; X-ray; 2.00 A; B=586-595.
DR   PDB; 3DXC; X-ray; 2.10 A; B/D=739-770.
DR   PDB; 3DXD; X-ray; 2.20 A; B/D=739-770.
DR   PDB; 3DXE; X-ray; 2.00 A; B/D=739-770.
DR   PDB; 3GCI; X-ray; 2.04 A; P=707-713.
DR   PDB; 3IFL; X-ray; 1.50 A; P=672-678.
DR   PDB; 3IFN; X-ray; 1.50 A; P=672-711.
DR   PDB; 3IFO; X-ray; 2.15 A; P/Q=672-678.
DR   PDB; 3IFP; X-ray; 2.95 A; P/Q/R/S=672-678.
DR   PDB; 3JTI; X-ray; 1.80 A; B=699-706.
DR   PDB; 3KTM; X-ray; 2.70 A; A/B/C/D/E/F/G/H=18-190.
DR   PDB; 3L33; X-ray; 2.48 A; E/F/G/H=290-341.
DR   PDB; 3L81; X-ray; 1.60 A; B=761-767.
DR   PDB; 3MOQ; X-ray; 2.05 A; A/B/C/D=689-712.
DR   PDB; 3MXC; X-ray; 2.00 A; L=754-762.
DR   PDB; 3MXY; X-ray; 2.30 A; L=754-762.
DR   PDB; 3NYJ; X-ray; 3.20 A; A=365-567.
DR   PDB; 3NYL; X-ray; 2.80 A; A=365-570.
DR   PDB; 3OVJ; X-ray; 1.80 A; A/B/C/D=687-692.
DR   PDB; 3OW9; X-ray; 1.80 A; A/B=687-692.
DR   PDB; 3U0T; X-ray; 2.50 A; E/F=701-711.
DR   PDB; 3UMH; X-ray; 2.00 A; A=370-575.
DR   PDB; 3UMI; X-ray; 2.40 A; A=370-575.
DR   PDB; 3UMK; X-ray; 2.60 A; A=370-575.
DR   PDBsum; 1AAP; -.
DR   PDBsum; 1AMB; -.
DR   PDBsum; 1AMC; -.
DR   PDBsum; 1AML; -.
DR   PDBsum; 1BA4; -.
DR   PDBsum; 1BA6; -.
DR   PDBsum; 1BJB; -.
DR   PDBsum; 1BJC; -.
DR   PDBsum; 1BRC; -.
DR   PDBsum; 1CA0; -.
DR   PDBsum; 1HZ3; -.
DR   PDBsum; 1IYT; -.
DR   PDBsum; 1MWP; -.
DR   PDBsum; 1OWT; -.
DR   PDBsum; 1QCM; -.
DR   PDBsum; 1QWP; -.
DR   PDBsum; 1QXC; -.
DR   PDBsum; 1QYT; -.
DR   PDBsum; 1TAW; -.
DR   PDBsum; 1TKN; -.
DR   PDBsum; 1UO7; -.
DR   PDBsum; 1UO8; -.
DR   PDBsum; 1UOA; -.
DR   PDBsum; 1UOI; -.
DR   PDBsum; 1X11; -.
DR   PDBsum; 1Z0Q; -.
DR   PDBsum; 1ZE7; -.
DR   PDBsum; 1ZE9; -.
DR   PDBsum; 1ZJD; -.
DR   PDBsum; 2BEG; -.
DR   PDBsum; 2BOM; -.
DR   PDBsum; 2BP4; -.
DR   PDBsum; 2FJZ; -.
DR   PDBsum; 2FK1; -.
DR   PDBsum; 2FK2; -.
DR   PDBsum; 2FK3; -.
DR   PDBsum; 2FKL; -.
DR   PDBsum; 2FMA; -.
DR   PDBsum; 2G47; -.
DR   PDBsum; 2IPU; -.
DR   PDBsum; 2LFM; -.
DR   PDBsum; 2LMN; -.
DR   PDBsum; 2LMO; -.
DR   PDBsum; 2LMP; -.
DR   PDBsum; 2LMQ; -.
DR   PDBsum; 2LNQ; -.
DR   PDBsum; 2OTK; -.
DR   PDBsum; 2R0W; -.
DR   PDBsum; 2WK3; -.
DR   PDBsum; 2Y29; -.
DR   PDBsum; 2Y2A; -.
DR   PDBsum; 2Y3J; -.
DR   PDBsum; 2Y3K; -.
DR   PDBsum; 2Y3L; -.
DR   PDBsum; 3AYU; -.
DR   PDBsum; 3DXC; -.
DR   PDBsum; 3DXD; -.
DR   PDBsum; 3DXE; -.
DR   PDBsum; 3GCI; -.
DR   PDBsum; 3IFL; -.
DR   PDBsum; 3IFN; -.
DR   PDBsum; 3IFO; -.
DR   PDBsum; 3IFP; -.
DR   PDBsum; 3JTI; -.
DR   PDBsum; 3KTM; -.
DR   PDBsum; 3L33; -.
DR   PDBsum; 3L81; -.
DR   PDBsum; 3MOQ; -.
DR   PDBsum; 3MXC; -.
DR   PDBsum; 3MXY; -.
DR   PDBsum; 3NYJ; -.
DR   PDBsum; 3NYL; -.
DR   PDBsum; 3OVJ; -.
DR   PDBsum; 3OW9; -.
DR   PDBsum; 3U0T; -.
DR   PDBsum; 3UMH; -.
DR   PDBsum; 3UMI; -.
DR   PDBsum; 3UMK; -.
DR   ProteinModelPortal; P05067; -.
DR   SMR; P05067; 26-192, 287-342, 371-566, 672-770.
DR   DIP; DIP-574N; -.
DR   IntAct; P05067; 95.
DR   MINT; MINT-150767; -.
DR   STRING; P05067; -.
DR   MEROPS; I02.015; -.
DR   TCDB; 1.C.50.1.2; amyloid beta,-protein peptide (Abeta,PP) family.
DR   GlycoSuiteDB; P05067; -.
DR   PhosphoSite; P05067; -.
DR   DMDM; 112927; -.
DR   SWISS-2DPAGE; P05067; -.
DR   PRIDE; P05067; -.
DR   DNASU; 351; -.
DR   Ensembl; ENST00000346798; ENSP00000284981; ENSG00000142192.
DR   GeneID; 351; -.
DR   KEGG; hsa:351; -.
DR   UCSC; uc002ylz.3; human.
DR   UCSC; uc002yma.3; human.
DR   UCSC; uc002ymb.3; human.
DR   UCSC; uc010glj.3; human.
DR   UCSC; uc011acj.2; human.
DR   UCSC; uc021whz.1; human.
DR   UCSC; uc021wia.1; human.
DR   UCSC; uc021wib.1; human.
DR   CTD; 351; -.
DR   GeneCards; GC21M027252; -.
DR   HGNC; HGNC:620; APP.
DR   HPA; CAB000157; -.
DR   HPA; HPA001462; -.
DR   MIM; 104300; phenotype.
DR   MIM; 104760; gene+phenotype.
DR   MIM; 605714; phenotype.
DR   neXtProt; NX_P05067; -.
DR   Orphanet; 1020; Early-onset autosomal dominant Alzheimer disease.
DR   Orphanet; 85458; Hereditary cerebral hemorrhage with amyloidosis.
DR   PharmGKB; PA24910; -.
DR   eggNOG; NOG289770; -.
DR   GeneTree; ENSGT00530000063252; -.
DR   HOVERGEN; HBG000051; -.
DR   InParanoid; P05067; -.
DR   KO; K04520; -.
DR   OMA; RKQCKTH; -.
DR   PhylomeDB; P05067; -.
DR   BioCyc; MetaCyc:ENSG00000142192-MONOMER; -.
DR   Pathway_Interaction_DB; caspase_pathway; Caspase cascade in apoptosis.
DR   Pathway_Interaction_DB; glypican_1pathway; Glypican 1 network.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_116125; Disease.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   EvolutionaryTrace; P05067; -.
DR   NextBio; 1445; -.
DR   PMAP-CutDB; P05067; -.
DR   ArrayExpress; P05067; -.
DR   Bgee; P05067; -.
DR   Genevestigator; P05067; -.
DR   GermOnline; ENSG00000142192; Homo sapiens.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005905; C:coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043198; C:dendritic shaft; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; IDA:MGI.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0033130; F:acetylcholine receptor binding; IPI:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0051425; F:PTB domain binding; IPI:BHF-UCL.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0046914; F:transition metal ion binding; IEA:InterPro.
DR   GO; GO:0008344; P:adult locomotory behavior; ISS:UniProtKB.
DR   GO; GO:0008088; P:axon cargo transport; ISS:UniProtKB.
DR   GO; GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0006878; P:cellular copper ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0048669; P:collateral sprouting in absence of injury; ISS:UniProtKB.
DR   GO; GO:0016358; P:dendrite development; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; ISS:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; ISS:UniProtKB.
DR   GO; GO:0000085; P:G2 phase of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007617; P:mating behavior; ISS:UniProtKB.
DR   GO; GO:0006378; P:mRNA polyadenylation; ISS:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptosis; IMP:UniProtKB.
DR   GO; GO:0016322; P:neuron remodeling; ISS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; ISS:UniProtKB.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISS:UniProtKB.
DR   GO; GO:0050803; P:regulation of synapse structure and activity; ISS:UniProtKB.
DR   GO; GO:0006417; P:regulation of translation; ISS:UniProtKB.
DR   GO; GO:0008542; P:visual learning; ISS:UniProtKB.
DR   Gene3D; G3DSA:4.10.230.10; Amyloid_glyco_Abeta; 1.
DR   Gene3D; G3DSA:3.30.1490.140; Amyloid_glyco_Cu-bd; 1.
DR   Gene3D; G3DSA:3.90.570.10; Amyloid_glyco_heparin-bd; 1.
DR   Gene3D; G3DSA:4.10.410.10; Prot_inh_Kunz-m; 1.
DR   InterPro; IPR008155; Amyloid_glyco.
DR   InterPro; IPR013803; Amyloid_glyco_Abeta.
DR   InterPro; IPR011178; Amyloid_glyco_Cu-bd.
DR   InterPro; IPR024329; Amyloid_glyco_E2_domain.
DR   InterPro; IPR008154; Amyloid_glyco_extra.
DR   InterPro; IPR019744; Amyloid_glyco_extracell_CS.
DR   InterPro; IPR015849; Amyloid_glyco_heparin-bd.
DR   InterPro; IPR019745; Amyloid_glyco_intracell_CS.
DR   InterPro; IPR019543; APP_amyloid_C.
DR   InterPro; IPR002223; Prot_inh_Kunz-m.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   Pfam; PF10515; APP_amyloid; 1.
DR   Pfam; PF12924; APP_Cu_bd; 1.
DR   Pfam; PF12925; APP_E2; 1.
DR   Pfam; PF02177; APP_N; 1.
DR   Pfam; PF03494; Beta-APP; 1.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   PRINTS; PR00203; AMYLOIDA4.
DR   PRINTS; PR00759; BASICPTASE.
DR   PRINTS; PR00204; BETAAMYLOID.
DR   SMART; SM00006; A4_EXTRA; 1.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF56491; A4_extra; 1.
DR   SUPFAM; SSF89811; Amyloid_glyco_Cu-bd; 1.
DR   SUPFAM; SSF57362; Prot_inh_Kunz-m; 1.
DR   SUPFAM; SSF109843; SSF109843; 1.
DR   PROSITE; PS00319; A4_EXTRA; 1.
DR   PROSITE; PS00320; A4_INTRA; 1.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Alzheimer disease; Amyloid;
KW   Amyloidosis; Apoptosis; Cell adhesion; Coated pit; Complete proteome;
KW   Copper; Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Endocytosis; Glycoprotein; Heparin-binding; Iron; Membrane;
KW   Metal-binding; Neurodegeneration; Notch signaling pathway;
KW   Phosphoprotein; Polymorphism; Protease inhibitor; Proteoglycan;
KW   Reference proteome; Serine protease inhibitor; Signal; Transmembrane;
KW   Transmembrane helix; Zinc.
FT   SIGNAL        1     17
FT   CHAIN        18    770       Amyloid beta A4 protein.
FT                                /FTId=PRO_0000000088.
FT   CHAIN        18    687       Soluble APP-alpha.
FT                                /FTId=PRO_0000000089.
FT   CHAIN        18    671       Soluble APP-beta.
FT                                /FTId=PRO_0000000090.
FT   CHAIN        18    286       N-APP.
FT                                /FTId=PRO_0000381966.
FT   CHAIN       672    770       C99.
FT                                /FTId=PRO_0000000091.
FT   CHAIN       672    713       Beta-amyloid protein 42.
FT                                /FTId=PRO_0000000092.
FT   CHAIN       672    711       Beta-amyloid protein 40.
FT                                /FTId=PRO_0000000093.
FT   CHAIN       688    770       C83.
FT                                /FTId=PRO_0000000094.
FT   PEPTIDE     688    713       P3(42).
FT                                /FTId=PRO_0000000095.
FT   PEPTIDE     688    711       P3(40).
FT                                /FTId=PRO_0000000096.
FT   CHAIN       691    770       C80.
FT                                /FTId=PRO_0000384574.
FT   CHAIN       712    770       Gamma-secretase C-terminal fragment 59.
FT                                /FTId=PRO_0000000097.
FT   CHAIN       714    770       Gamma-secretase C-terminal fragment 57.
FT                                /FTId=PRO_0000000098.
FT   CHAIN       721    770       Gamma-secretase C-terminal fragment 50
FT                                (By similarity).
FT                                /FTId=PRO_0000000099.
FT   CHAIN       740    770       C31.
FT                                /FTId=PRO_0000000100.
FT   TOPO_DOM     18    699       Extracellular (Potential).
FT   TRANSMEM    700    723       Helical; (Potential).
FT   TOPO_DOM    724    770       Cytoplasmic (Potential).
FT   DOMAIN      291    341       BPTI/Kunitz inhibitor.
FT   REGION       96    110       Heparin-binding.
FT   REGION      181    188       Zinc-binding.
FT   REGION      391    423       Heparin-binding.
FT   REGION      491    522       Heparin-binding.
FT   REGION      523    540       Collagen-binding.
FT   REGION      732    751       Interaction with G(o)-alpha.
FT   MOTIF       724    734       Basolateral sorting signal.
FT   MOTIF       759    762       NPXY motif; contains endocytosis signal.
FT   COMPBIAS    230    260       Asp/Glu-rich (acidic).
FT   COMPBIAS    274    280       Poly-Thr.
FT   METAL       147    147       Copper 1.
FT   METAL       151    151       Copper 1.
FT   METAL       168    168       Copper 1.
FT   METAL       677    677       Copper or zinc 2.
FT   METAL       681    681       Copper or zinc 2 (Probable).
FT   METAL       684    684       Copper or zinc 2.
FT   METAL       685    685       Copper or zinc 2.
FT   SITE        144    144       Required for Cu(2+) reduction.
FT   SITE        301    302       Reactive bond.
FT   SITE        671    672       Cleavage; by beta-secretase.
FT   SITE        672    673       Cleavage; by caspase-6; when associated
FT                                with variant 670-N-L-671.
FT   SITE        687    688       Cleavage; by alpha-secretase.
FT   SITE        690    691       Cleavage; by theta-secretase.
FT   SITE        704    704       Implicated in free radical propagation
FT                                (By similarity).
FT   SITE        706    706       Susceptible to oxidation.
FT   SITE        711    712       Cleavage; by gamma-secretase; site 1.
FT   SITE        713    714       Cleavage; by gamma-secretase; site 2.
FT   SITE        720    721       Cleavage; by gamma-secretase; site 3.
FT   SITE        739    740       Cleavage; by caspase-6, caspase-8 or
FT                                caspase-9.
FT   MOD_RES     198    198       Phosphoserine; by CK2.
FT   MOD_RES     206    206       Phosphoserine; by CK1.
FT   MOD_RES     729    729       Phosphothreonine (By similarity).
FT   MOD_RES     730    730       Phosphoserine; by APP-kinase I (By
FT                                similarity).
FT   MOD_RES     743    743       Phosphothreonine; by CDK5 and MAPK10.
FT   MOD_RES     757    757       Phosphotyrosine.
FT   MOD_RES     757    757       Phosphotyrosine; by ABL1 (By similarity).
FT   MOD_RES     762    762       Phosphotyrosine.
FT   CARBOHYD    542    542       N-linked (GlcNAc...).
FT   CARBOHYD    571    571       N-linked (GlcNAc...) (Probable).
FT   CARBOHYD    633    633       O-linked (GalNAc...).
FT   CARBOHYD    651    651       O-linked (GalNAc...).
FT   CARBOHYD    652    652       O-linked (GalNAc...).
FT   CARBOHYD    656    656       O-linked (Xyl...) (chondroitin sulfate);
FT                                in L-APP isoforms.
FT   CARBOHYD    659    659       O-linked (GalNAc...).
FT   CARBOHYD    663    663       O-linked (GalNAc...) (Probable).
FT   CARBOHYD    667    667       O-linked (GalNAc...) (Probable).
FT   DISULFID     38     62
FT   DISULFID     73    117
FT   DISULFID     98    105
FT   DISULFID    133    187
FT   DISULFID    144    174
FT   DISULFID    158    186
FT   DISULFID    291    341
FT   DISULFID    300    324
FT   DISULFID    316    337
FT   VAR_SEQ      19     74       Missing (in isoform APP639).
FT                                /FTId=VSP_009116.
FT   VAR_SEQ     289    363       Missing (in isoform APP639).
FT                                /FTId=VSP_009117.
FT   VAR_SEQ     289    289       E -> V (in isoform APP695, isoform L-
FT                                APP696, isoform L-APP677 and isoform
FT                                APP714).
FT                                /FTId=VSP_000002.
FT   VAR_SEQ     290    364       Missing (in isoform APP695 and isoform L-
FT                                APP677).
FT                                /FTId=VSP_000004.
FT   VAR_SEQ     290    345       Missing (in isoform L-APP696 and isoform
FT                                APP714).
FT                                /FTId=VSP_000003.
FT   VAR_SEQ     290    305       VCSEQAETGPCRAMIS -> KWYKEVHSGQARWLML (in
FT                                isoform APP305).
FT                                /FTId=VSP_000005.
FT   VAR_SEQ     306    770       Missing (in isoform APP305).
FT                                /FTId=VSP_000006.
FT   VAR_SEQ     345    345       M -> I (in isoform L-APP733 and isoform
FT                                APP751).
FT                                /FTId=VSP_000007.
FT   VAR_SEQ     346    364       Missing (in isoform L-APP733 and isoform
FT                                APP751).
FT                                /FTId=VSP_000008.
FT   VAR_SEQ     364    364       L -> V (in isoform APP639).
FT                                /FTId=VSP_009118.
FT   VAR_SEQ     637    654       Missing (in isoform L-APP677, isoform L-
FT                                APP696, isoform L-APP733 and isoform L-
FT                                APP752).
FT                                /FTId=VSP_000009.
FT   VARIANT     501    501       E -> K (in dbSNP:rs45588932).
FT                                /FTId=VAR_022315.
FT   VARIANT     665    665       E -> D (in a patient with late onset
FT                                Alzheimer disease).
FT                                /FTId=VAR_010107.
FT   VARIANT     670    671       KM -> NL (in AD1).
FT                                /FTId=VAR_000015.
FT   VARIANT     678    678       D -> N (in AD1).
FT                                /FTId=VAR_044424.
FT   VARIANT     692    692       A -> G (in AD1; Flemish mutation;
FT                                increases the solubility of processed
FT                                beta-amyloid peptides and increases the
FT                                stability of peptide oligomers).
FT                                /FTId=VAR_000016.
FT   VARIANT     693    693       E -> G (in AD1).
FT                                /FTId=VAR_014215.
FT   VARIANT     693    693       E -> K (in CAA-APP; Italian type).
FT                                /FTId=VAR_014216.
FT   VARIANT     693    693       E -> Q (in CAA-APP; Dutch type).
FT                                /FTId=VAR_000017.
FT   VARIANT     694    694       D -> N (in CAA-APP; Iowa type).
FT                                /FTId=VAR_014217.
FT   VARIANT     705    705       L -> V (in CAA-APP; Italian type).
FT                                /FTId=VAR_032276.
FT   VARIANT     713    713       A -> T (in AD1).
FT                                /FTId=VAR_000019.
FT   VARIANT     713    713       A -> V (in one chronic schizophrenia
FT                                patient; unknown pathological
FT                                significance; dbSNP:rs1800557).
FT                                /FTId=VAR_000018.
FT   VARIANT     714    714       T -> A (in AD1).
FT                                /FTId=VAR_032277.
FT   VARIANT     714    714       T -> I (in AD1; increased beta-APP42/
FT                                beta-APP40 ratio).
FT                                /FTId=VAR_014218.
FT   VARIANT     715    715       V -> M (in AD1; decreased beta-APP40/
FT                                total APP-beta).
FT                                /FTId=VAR_010108.
FT   VARIANT     716    716       I -> V (in AD1).
FT                                /FTId=VAR_000020.
FT   VARIANT     717    717       V -> F (in AD1).
FT                                /FTId=VAR_000023.
FT   VARIANT     717    717       V -> G (in AD1).
FT                                /FTId=VAR_000022.
FT   VARIANT     717    717       V -> I (in AD1).
FT                                /FTId=VAR_000021.
FT   VARIANT     717    717       V -> L (in AD1).
FT                                /FTId=VAR_014219.
FT   VARIANT     723    723       L -> P (in AD1).
FT                                /FTId=VAR_010109.
FT   MUTAGEN      99    102       KRGR->NQGG: Reduced heparin-binding.
FT   MUTAGEN     137    137       H->N: Binds copper. Forms dimer.
FT   MUTAGEN     141    141       M->T: Binds copper. Forms dimer.
FT   MUTAGEN     144    144       C->S: Binds copper. No dimer formation.
FT                                No copper reducing activity.
FT   MUTAGEN     147    149       HLH->ALA: 50% decrease in copper reducing
FT                                activity.
FT   MUTAGEN     147    147       H->A: Some decrease in copper reducing
FT                                activity.
FT   MUTAGEN     147    147       H->N: Binds copper. Forms dimer.
FT   MUTAGEN     147    147       H->Y: Greatly reduced copper-mediated
FT                                low-density lipoprotein oxidation.
FT   MUTAGEN     151    151       H->K: Greatly reduced copper-mediated
FT                                low-density lipoprotein oxidation.
FT   MUTAGEN     151    151       H->N: Binds copper. Forms dimer.
FT   MUTAGEN     198    198       S->A: Greatly reduced casein kinase
FT                                phosphorylation.
FT   MUTAGEN     206    206       S->A: Reduced casein kinase
FT                                phosphorylation.
FT   MUTAGEN     499    499       R->A: Reduced affinity for heparin; when
FT                                associated with A-503.
FT   MUTAGEN     503    503       K->A: Reduced affinity for heparin; when
FT                                associated with A-499.
FT   MUTAGEN     656    656       S->A: Abolishes chondroitin sulfate
FT                                binding in L-APP733 isoform.
FT   MUTAGEN     676    676       R->G: 60-70% zinc-induced beta-APP (28)
FT                                peptide aggregation.
FT   MUTAGEN     681    681       Y->F: 60-70% zinc-induced beta-APP (28)
FT                                peptide aggregation.
FT   MUTAGEN     684    684       H->R: Only 23% zinc-induced beta-APP (28)
FT                                peptide aggregation.
FT   MUTAGEN     704    704       G->V: Reduced protein oxidation. No
FT                                hippocampal neuron toxicity.
FT   MUTAGEN     706    706       M->L: Reduced lipid peroxidation
FT                                inhibition.
FT   MUTAGEN     706    706       M->V: No free radical production. No
FT                                hippocampal neuron toxicity.
FT   MUTAGEN     717    717       V->C,S: Unchanged beta-APP42/total APP-
FT                                beta ratio.
FT   MUTAGEN     717    717       V->F,G,I: Increased beta-APP42/beta-APP40
FT                                ratio.
FT   MUTAGEN     717    717       V->K: Decreased beta-APP42/total APP-beta
FT                                ratio.
FT   MUTAGEN     717    717       V->M: Increased beta-APP42/beta-APP40
FT                                ratio. No change in apoptosis after
FT                                caspase cleavage.
FT   MUTAGEN     728    728       Y->A: No effect on APBA1 nor APBB1
FT                                binding. Greatly reduces the binding to
FT                                APPBP2. APP internalization unchanged. No
FT                                change in beta-APP42 secretion.
FT   MUTAGEN     739    739       D->A: No cleavage by caspases during
FT                                apoptosis.
FT   MUTAGEN     739    739       D->N: No effect on FADD-induced
FT                                apoptosis.
FT   MUTAGEN     743    743       T->A: Greatly reduces the binding to SHC1
FT                                and APBB family members; no effect on
FT                                NGF-stimulated neurite extension.
FT   MUTAGEN     743    743       T->E: Reduced NGF-stimulated neurite
FT                                extension. No effect on APP maturation.
FT   MUTAGEN     756    756       G->A: APP internalization unchanged. No
FT                                change in beta-APP42 secretion.
FT   MUTAGEN     757    757       Y->A: Little APP internalization. Reduced
FT                                beta-APP42 secretion.
FT   MUTAGEN     757    757       Y->G: Loss of binding to MAPK8IP1, APBA1,
FT                                APBB1, APPBP2 and SHC1.
FT   MUTAGEN     759    759       N->A: No binding to APBA1, no effect on
FT                                APBB1 binding. Little APP
FT                                internalization. Reduced beta-APP42
FT                                secretion.
FT   MUTAGEN     760    760       P->A: Little APP internalization. Reduced
FT                                beta-APP42 secretion.
FT   MUTAGEN     762    762       Y->A: Loss of binding to APBA1 and APBB1.
FT                                APP internalization unchanged. No change
FT                                in beta-APP42 secretion.
FT   CONFLICT     15     16       AR -> VW (in Ref. 3; CAA31830).
FT   CONFLICT    647    647       D -> E (in Ref. 34; AAA51722).
FT   CONFLICT    724    724       Missing (in Ref. 22; AAB26263/AAB26264).
FT   CONFLICT    731    731       I -> N (in Ref. 22; AAB26263/AAB26264/
FT                                AAB26265).
FT   CONFLICT    757    757       Y -> S (in Ref. 30; AAA35540).
FT   STRAND       33     35
FT   STRAND       43     45
FT   TURN         47     49
FT   STRAND       52     54
FT   HELIX        66     76
FT   STRAND       82     87
FT   STRAND       92     94
FT   STRAND       97     99
FT   HELIX       100    102
FT   STRAND      103    106
FT   STRAND      110    112
FT   STRAND      115    119
FT   STRAND      134    139
FT   HELIX       147    160
FT   STRAND      163    174
FT   TURN        175    177
FT   STRAND      178    188
FT   HELIX       288    292
FT   STRAND      299    301
FT   STRAND      304    310
FT   TURN        311    314
FT   STRAND      315    321
FT   STRAND      323    325
FT   STRAND      331    333
FT   HELIX       334    341
FT   HELIX       461    482
FT   HELIX       487    518
FT   HELIX       520    549
FT   HELIX       552    566
FT   HELIX       680    697
FT   HELIX       703    706
FT   TURN        707    710
SQ   SEQUENCE   770 AA;  86943 MW;  A12EE761403740F5 CRC64;
     MLPGLALLLL AAWTARALEV PTDGNAGLLA EPQIAMFCGR LNMHMNVQNG KWDSDPSGTK
     TCIDTKEGIL QYCQEVYPEL QITNVVEANQ PVTIQNWCKR GRKQCKTHPH FVIPYRCLVG
     EFVSDALLVP DKCKFLHQER MDVCETHLHW HTVAKETCSE KSTNLHDYGM LLPCGIDKFR
     GVEFVCCPLA EESDNVDSAD AEEDDSDVWW GGADTDYADG SEDKVVEVAE EEEVAEVEEE
     EADDDEDDED GDEVEEEAEE PYEEATERTT SIATTTTTTT ESVEEVVREV CSEQAETGPC
     RAMISRWYFD VTEGKCAPFF YGGCGGNRNN FDTEEYCMAV CGSAMSQSLL KTTQEPLARD
     PVKLPTTAAS TPDAVDKYLE TPGDENEHAH FQKAKERLEA KHRERMSQVM REWEEAERQA
     KNLPKADKKA VIQHFQEKVE SLEQEAANER QQLVETHMAR VEAMLNDRRR LALENYITAL
     QAVPPRPRHV FNMLKKYVRA EQKDRQHTLK HFEHVRMVDP KKAAQIRSQV MTHLRVIYER
     MNQSLSLLYN VPAVAEEIQD EVDELLQKEQ NYSDDVLANM ISEPRISYGN DALMPSLTET
     KTTVELLPVN GEFSLDDLQP WHSFGADSVP ANTENEVEPV DARPAADRGL TTRPGSGLTN
     IKTEEISEVK MDAEFRHDSG YEVHHQKLVF FAEDVGSNKG AIIGLMVGGV VIATVIVITL
     VMLKKKQYTS IHHGVVEVDA AVTPEERHLS KMQQNGYENP TYKFFEQMQN
//
ID   A7L3B_HUMAN             Reviewed;          97 AA.
AC   Q96GX2;
DT   23-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   18-APR-2012, entry version 45.
DE   RecName: Full=Putative ataxin-7-like protein 3B;
GN   Name=ATXN7L3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION.
RX   PubMed=16680195; DOI=10.1371/journal.pcbi.0020046;
RA   Svensson O., Arvestad L., Lagergren J.;
RT   "Genome-wide survey for biologically functional pseudogenes.";
RL   PLoS Comput. Biol. 2:E46-E46(2006).
CC   -!- MISCELLANEOUS: Encoded by an expressed retrotransposed copy of the
CC       ATXN7L3 locus that emerged prior to the speciation event
CC       separating primates and rodents.
CC   -!- SIMILARITY: Belongs to the SGF11 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH09111.1; Type=Erroneous translation; Note=Wrong choice of CDS;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC025257; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009111; AAH09111.1; ALT_SEQ; mRNA.
DR   IPI; IPI00062860; -.
DR   RefSeq; NP_001129734.1; NM_001136262.1.
DR   UniGene; Hs.727494; -.
DR   IntAct; Q96GX2; 1.
DR   PhosphoSite; Q96GX2; -.
DR   PRIDE; Q96GX2; -.
DR   GeneID; 552889; -.
DR   KEGG; hsa:552889; -.
DR   UCSC; uc001sxd.4; human.
DR   CTD; 552889; -.
DR   GeneCards; GC12P074931; -.
DR   HGNC; HGNC:37931; ATXN7L3B.
DR   neXtProt; NX_Q96GX2; -.
DR   PharmGKB; PA165512339; -.
DR   GeneTree; ENSGT00390000012202; -.
DR   OrthoDB; EOG4XSKRD; -.
DR   NextBio; 112362; -.
DR   Bgee; Q96GX2; -.
PE   3: Inferred from homology;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1     97       Putative ataxin-7-like protein 3B.
FT                                /FTId=PRO_0000392529.
SQ   SEQUENCE   97 AA;  10771 MW;  722ADB410FCEFC9A CRC64;
     MEEISLANLD TNKLEAIAQE IYVDLIEDSC LGFCFEVHRA VKCGYFYLEF AETGSVKDFG
     IQPVEDKGAC RLPLCSLPGE PGNGPDQQLQ RSPPEFQ
//
ID   AA1R_HUMAN              Reviewed;         326 AA.
AC   P30542; A6NFY5; A6NGP4; A8K1L3; B3KXQ4; Q6FHK3; Q8TAM8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   21-MAR-2012, entry version 115.
DE   RecName: Full=Adenosine receptor A1;
GN   Name=ADORA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   MEDLINE=92412143; PubMed=1530647; DOI=10.1016/0006-291X(92)91285-X;
RA   Libert F., van Sande J., Lefort A., Czernilofsky A., Dumont J.E.,
RA   Vassart G., Ensinger H.A., Mendla K.D.;
RT   "Cloning and functional characterization of a human A1 adenosine
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 187:919-926(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=93180653; PubMed=1339301; DOI=10.1016/0169-328X(92)90248-A;
RA   Townsend-Nicholson A., Shine J.;
RT   "Molecular cloning and characterisation of a human brain A1 adenosine
RT   receptor cDNA.";
RL   Brain Res. Mol. Brain Res. 16:365-370(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   MEDLINE=94132091; PubMed=8300646;
RA   Ren H., Stiles G.L.;
RT   "Characterization of the human A1 adenosine receptor gene. Evidence
RT   for alternative splicing.";
RL   J. Biol. Chem. 269:3104-3110(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Salvatore C.A., Luneau C.J., Johnson R.G., Jacobson M.;
RL   Submitted (SEP-1992) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Hirabatake Y., Takao K., Hagiwara S., Kasanuki H., Hosoda S.,
RA   Kokubun S.;
RT   "Complete nucleotide sequence of an adenosine A1-receptor from
RT   heart.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   SER-43; PRO-50; HIS-105 AND GLN-261.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-170.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Receptor for adenosine. The activity of this receptor is
CC       mediated by G proteins which inhibit adenylyl cyclase.
CC   -!- INTERACTION:
CC       P29274:ADORA2A; NbExp=4; IntAct=EBI-2903663, EBI-2902702;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30542-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P30542-2; Sequence=VSP_034401, VSP_034402;
CC         Note=Gene prediction based on EST data;
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S45235; AAB23388.1; -; mRNA.
DR   EMBL; S56143; AAB25533.2; -; mRNA.
DR   EMBL; L22214; AAA17544.1; -; mRNA.
DR   EMBL; X68485; CAA48503.1; -; mRNA.
DR   EMBL; AB004662; BAA20433.1; -; mRNA.
DR   EMBL; AK127752; BAG54566.1; -; mRNA.
DR   EMBL; AK289928; BAF82617.1; -; mRNA.
DR   EMBL; AY136746; AAN01272.1; -; mRNA.
DR   EMBL; BT019854; AAV38657.1; -; mRNA.
DR   EMBL; CR541749; CAG46549.1; -; mRNA.
DR   EMBL; AC105940; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91465.1; -; Genomic_DNA.
DR   EMBL; BC026340; AAH26340.1; -; mRNA.
DR   IPI; IPI00026872; -.
DR   IPI; IPI00645335; -.
DR   PIR; A53005; A53005.
DR   RefSeq; NP_000665.1; NM_000674.2.
DR   RefSeq; NP_001041695.1; NM_001048230.1.
DR   UniGene; Hs.77867; -.
DR   ProteinModelPortal; P30542; -.
DR   SMR; P30542; 10-319.
DR   IntAct; P30542; 2.
DR   MINT; MINT-138736; -.
DR   STRING; P30542; -.
DR   DMDM; 231473; -.
DR   PRIDE; P30542; -.
DR   DNASU; 134; -.
DR   Ensembl; ENST00000309502; ENSP00000308549; ENSG00000163485.
DR   Ensembl; ENST00000337894; ENSP00000338435; ENSG00000163485.
DR   Ensembl; ENST00000367236; ENSP00000356205; ENSG00000163485.
DR   GeneID; 134; -.
DR   KEGG; hsa:134; -.
DR   UCSC; uc001gze.1; human.
DR   CTD; 134; -.
DR   GeneCards; GC01P203059; -.
DR   H-InvDB; HIX0001486; -.
DR   HGNC; HGNC:262; ADORA1.
DR   MIM; 102775; gene.
DR   neXtProt; NX_P30542; -.
DR   PharmGKB; PA24583; -.
DR   eggNOG; NOG284456; -.
DR   GeneTree; ENSGT00550000074524; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P30542; -.
DR   KO; K04265; -.
DR   OMA; IAGCWIL; -.
DR   OrthoDB; EOG4BVRV7; -.
DR   PhylomeDB; P30542; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB01223; Aminophylline.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB04932; Defibrotide.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB00061; Pegademase bovine.
DR   DrugBank; DB00277; Theophylline.
DR   NextBio; 537; -.
DR   ArrayExpress; P30542; -.
DR   Bgee; P30542; -.
DR   CleanEx; HS_ADORA1; -.
DR   Genevestigator; P30542; -.
DR   GermOnline; ENSG00000163485; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0008624; P:induction of apoptosis by extracellular signals; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0006909; P:phagocytosis; TAS:ProtInc.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR001068; Adeno_A1_rcpt.
DR   InterPro; IPR001634; Adenosn_rcpt.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00552; ADENOSINEA1R.
DR   PRINTS; PR00424; ADENOSINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; G-protein coupled receptor; Glycoprotein; Lipoprotein;
KW   Membrane; Palmitate; Polymorphism; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN         1    326       Adenosine receptor A1.
FT                                /FTId=PRO_0000068991.
FT   TOPO_DOM      1     10       Extracellular (Potential).
FT   TRANSMEM     11     33       Helical; Name=1; (Potential).
FT   TOPO_DOM     34     46       Cytoplasmic (Potential).
FT   TRANSMEM     47     69       Helical; Name=2; (Potential).
FT   TOPO_DOM     70     80       Extracellular (Potential).
FT   TRANSMEM     81    102       Helical; Name=3; (Potential).
FT   TOPO_DOM    103    123       Cytoplasmic (Potential).
FT   TRANSMEM    124    146       Helical; Name=4; (Potential).
FT   TOPO_DOM    147    176       Extracellular (Potential).
FT   TRANSMEM    177    201       Helical; Name=5; (Potential).
FT   TOPO_DOM    202    235       Cytoplasmic (Potential).
FT   TRANSMEM    236    259       Helical; Name=6; (Potential).
FT   TOPO_DOM    260    267       Extracellular (Potential).
FT   TRANSMEM    268    292       Helical; Name=7; (Potential).
FT   TOPO_DOM    293    326       Cytoplasmic (Potential).
FT   LIPID       309    309       S-palmitoyl cysteine (Potential).
FT   CARBOHYD    159    159       N-linked (GlcNAc...) (Potential).
FT   DISULFID     80    169       By similarity.
FT   VAR_SEQ     115    125       YKMVVTPRRAA -> RISQCMASTKS (in isoform
FT                                2).
FT                                /FTId=VSP_034401.
FT   VAR_SEQ     126    326       Missing (in isoform 2).
FT                                /FTId=VSP_034402.
FT   VARIANT      43     43       A -> S (in dbSNP:rs11547175).
FT                                /FTId=VAR_044138.
FT   VARIANT      50     50       S -> P (in dbSNP:rs11547174).
FT                                /FTId=VAR_044139.
FT   VARIANT     105    105       R -> H (in dbSNP:rs11547176).
FT                                /FTId=VAR_044140.
FT   VARIANT     170    170       E -> K (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035754.
FT   VARIANT     261    261       P -> Q (in dbSNP:rs17852405).
FT                                /FTId=VAR_044141.
FT   CONFLICT    312    312       A -> T (in Ref. 6; BAF82617).
SQ   SEQUENCE   326 AA;  36512 MW;  1B555893BCDEC9A6 CRC64;
     MPPSISAFQA AYIGIEVLIA LVSVPGNVLV IWAVKVNQAL RDATFCFIVS LAVADVAVGA
     LVIPLAILIN IGPQTYFHTC LMVACPVLIL TQSSILALLA IAVDRYLRVK IPLRYKMVVT
     PRRAAVAIAG CWILSFVVGL TPMFGWNNLS AVERAWAANG SMGEPVIKCE FEKVISMEYM
     VYFNFFVWVL PPLLLMVLIY LEVFYLIRKQ LNKKVSASSG DPQKYYGKEL KIAKSLALIL
     FLFALSWLPL HILNCITLFC PSCHKPSILT YIAIFLTHGN SAMNPIVYAF RIQKFRVTFL
     KIWNDHFRCQ PAPPIDEDLP EERPDD
//
ID   AA2AR_HUMAN             Reviewed;         412 AA.
AC   P29274; B2R7E0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   18-APR-2012, entry version 131.
DE   RecName: Full=Adenosine receptor A2a;
GN   Name=ADORA2A; Synonyms=ADORA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tiffany H.L., Murphy P.M.;
RL   Submitted (JUL-1992) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Salvatore C.A., Luneau C.J., Johnson R.G., Jacobson M.;
RL   Submitted (SEP-1992) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hippocampus;
RX   MEDLINE=93061821; PubMed=1331670; DOI=10.1016/0169-328X(92)90152-2;
RA   Furlong T.J., Pierce K.D., Selbie L.A., Shine J.;
RT   "Molecular characterization of a human brain adenosine A2 receptor.";
RL   Brain Res. Mol. Brain Res. 15:62-66(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=96264663; PubMed=8670304; DOI=10.1006/bbrc.1996.0916;
RA   Le F., Townsend-Nicholson A., Baker E., Sutherland G.R.,
RA   Schofield P.R.;
RT   "Characterization and chromosomal localization of the human A2a
RT   adenosine receptor gene: ADORA2A.";
RL   Biochem. Biophys. Res. Commun. 223:461-467(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   POSSIBLE INTERACTION WITH DRD4.
RX   PubMed=20836733; DOI=10.3109/10799893.2010.513842;
RA   Woods A.S.;
RT   "The dopamine D(4) receptor, the ultimate disordered protein.";
RL   J. Recept. Signal Transduct. 30:331-336(2010).
RN   [12]
RP   3D-STRUCTURE MODELING OF TRANSMEMBRANE DOMAINS.
RX   MEDLINE=95294002; PubMed=7775460; DOI=10.1074/jbc.270.23.13879;
RA   Kim J., Wess J., van Rhee A.M., Schoneberg T., Jacobson K.A.;
RT   "Site-directed mutagenesis identifies residues involved in ligand
RT   recognition in the human A2a adenosine receptor.";
RL   J. Biol. Chem. 270:13987-13997(1995).
RN   [13]
RP   INTERACTION WITH USP4, UBIQUITINATION, AND DEUBIQUITINATION BY USP4.
RX   PubMed=16339847; DOI=10.1124/mol.105.015818;
RA   Milojevic T., Reiterer V., Stefan E., Korkhov V.M., Dorostkar M.M.,
RA   Ducza E., Ogris E., Boehm S., Freissmuth M., Nanoff C.;
RT   "The ubiquitin-specific protease Usp4 regulates the cell surface level
RT   of the A2A receptor.";
RL   Mol. Pharmacol. 69:1083-1094(2006).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 2-316 IN COMPLEX WITH
RP   ANTAGONIST, TOPOLOGY, AND DISULFIDE BONDS.
RX   PubMed=18832607; DOI=10.1126/science.1164772;
RA   Jaakola V.-P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y.T.,
RA   Lane J.R., Ijzerman A.P., Stevens R.C.;
RT   "The 2.6 angstrom crystal structure of a human A2A adenosine receptor
RT   bound to an antagonist.";
RL   Science 322:1211-1217(2008).
RN   [15]
RP   VARIANT VAL-50.
RX   MEDLINE=99318093; PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [16]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Receptor for adenosine. The activity of this receptor is
CC       mediated by G proteins which activate adenylyl cyclase.
CC   -!- SUBUNIT: Interacts (via cytoplasmic C-terminal domain) with USP4;
CC       the interaction is direct. May interact with DRD4.
CC   -!- INTERACTION:
CC       P30542:ADORA1; NbExp=4; IntAct=EBI-2902702, EBI-2903663;
CC       P62158:CALM1; NbExp=3; IntAct=EBI-2902702, EBI-397435;
CC       Q99418:CYTH2; NbExp=6; IntAct=EBI-2902702, EBI-448974;
CC       P14416:DRD2; NbExp=2; IntAct=EBI-2902702, EBI-2928178;
CC       P31424-1:Grm5 (xeno); NbExp=3; IntAct=EBI-2902702, EBI-2902778;
CC       Q7Z6G3:NECAB2; NbExp=5; IntAct=EBI-2902702, EBI-950070;
CC       Q13107:USP4; NbExp=4; IntAct=EBI-2902702, EBI-723290;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- DOMAIN: The cytoplasmic C-terminal domain is necessary for
CC       targeting the non-ubiquitinated form of this protein to the cell
CC       surface.
CC   -!- PTM: Ubiquitinated. Deubiquitinated by USP4; leading to
CC       stabilization and expression at the cell surface.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA58356.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97370; AAA58356.1; ALT_INIT; mRNA.
DR   EMBL; X68486; CAA48504.1; -; mRNA.
DR   EMBL; S46950; AAB23956.1; -; mRNA.
DR   EMBL; U40771; AAA83270.1; -; Genomic_DNA.
DR   EMBL; U40770; AAA83270.1; JOINED; Genomic_DNA.
DR   EMBL; AY136747; AAN01273.1; -; mRNA.
DR   EMBL; CR456367; CAG30253.1; -; mRNA.
DR   EMBL; BT006999; AAP35645.1; -; mRNA.
DR   EMBL; AK312946; BAG35787.1; -; mRNA.
DR   EMBL; CH471095; EAW59658.1; -; Genomic_DNA.
DR   EMBL; BC013780; AAH13780.1; -; mRNA.
DR   IPI; IPI00020974; -.
DR   PIR; A48978; A48978.
DR   RefSeq; NP_000666.2; NM_000675.4.
DR   UniGene; Hs.197029; -.
DR   PDB; 1MMH; Model; -; 1=6-36, 2=42-69, 3=78-102, 4=117-143, 5=175-203, 6=233-260, 7=264-296.
DR   PDB; 1UPE; Model; -; A=1-304.
DR   PDB; 2YDO; X-ray; 3.00 A; A=1-317.
DR   PDB; 2YDV; X-ray; 2.60 A; A=1-317.
DR   PDB; 3EML; X-ray; 2.60 A; A=2-316.
DR   PDB; 3PWH; X-ray; 3.30 A; A=1-317.
DR   PDB; 3QAK; X-ray; 2.71 A; A=2-316.
DR   PDB; 3REY; X-ray; 3.31 A; A=1-317.
DR   PDB; 3RFM; X-ray; 3.60 A; A=1-317.
DR   PDB; 3VG9; X-ray; 2.70 A; A=1-316.
DR   PDB; 3VGA; X-ray; 3.10 A; A=1-316.
DR   PDBsum; 1MMH; -.
DR   PDBsum; 1UPE; -.
DR   PDBsum; 2YDO; -.
DR   PDBsum; 2YDV; -.
DR   PDBsum; 3EML; -.
DR   PDBsum; 3PWH; -.
DR   PDBsum; 3QAK; -.
DR   PDBsum; 3REY; -.
DR   PDBsum; 3RFM; -.
DR   PDBsum; 3VG9; -.
DR   PDBsum; 3VGA; -.
DR   ProteinModelPortal; P29274; -.
DR   SMR; P29274; 6-310.
DR   IntAct; P29274; 8.
DR   MINT; MINT-4823612; -.
DR   STRING; P29274; -.
DR   PhosphoSite; P29274; -.
DR   DMDM; 543740; -.
DR   PRIDE; P29274; -.
DR   DNASU; 135; -.
DR   Ensembl; ENST00000337539; ENSP00000336630; ENSG00000128271.
DR   GeneID; 135; -.
DR   KEGG; hsa:135; -.
DR   UCSC; uc002zzx.3; human.
DR   CTD; 135; -.
DR   GeneCards; GC22P024813; -.
DR   HGNC; HGNC:263; ADORA2A.
DR   MIM; 102776; gene.
DR   neXtProt; NX_P29274; -.
DR   PharmGKB; PA24584; -.
DR   eggNOG; NOG287824; -.
DR   GeneTree; ENSGT00550000074524; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P29274; -.
DR   KO; K04266; -.
DR   OMA; PGVWANG; -.
DR   PhylomeDB; P29274; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB04932; Defibrotide.
DR   DrugBank; DB00061; Pegademase bovine.
DR   DrugBank; DB00277; Theophylline.
DR   EvolutionaryTrace; P29274; -.
DR   NextBio; 543; -.
DR   Bgee; P29274; -.
DR   CleanEx; HS_ADORA2A; -.
DR   Genevestigator; P29274; -.
DR   GermOnline; ENSG00000128271; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0044446; C:intracellular organelle part; IDA:UniProtKB.
DR   GO; GO:0005624; C:membrane fraction; TAS:ProtInc.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0001609; F:G-protein coupled adenosine receptor activity; IEA:InterPro.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; GO:0006171; P:cAMP biosynthetic process; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0007188; P:G-protein signaling, coupled to cAMP nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006909; P:phagocytosis; TAS:ProtInc.
DR   GO; GO:0007600; P:sensory perception; TAS:ProtInc.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR001513; Adeno_A2A_rcpt.
DR   InterPro; IPR001634; Adenosn_rcpt.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00553; ADENOSINA2AR.
DR   PRINTS; PR00424; ADENOSINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN         1    412       Adenosine receptor A2a.
FT                                /FTId=PRO_0000068999.
FT   TOPO_DOM      1      7       Extracellular.
FT   TRANSMEM      8     32       Helical; Name=1.
FT   TOPO_DOM     33     42       Cytoplasmic.
FT   TRANSMEM     43     66       Helical; Name=2.
FT   TOPO_DOM     67     77       Extracellular.
FT   TRANSMEM     78    100       Helical; Name=3.
FT   TOPO_DOM    101    120       Cytoplasmic.
FT   TRANSMEM    121    143       Helical; Name=4.
FT   TOPO_DOM    144    173       Extracellular.
FT   TRANSMEM    174    198       Helical; Name=5.
FT   TOPO_DOM    199    234       Cytoplasmic.
FT   TRANSMEM    235    258       Helical; Name=6.
FT   TOPO_DOM    259    266       Extracellular.
FT   TRANSMEM    267    290       Helical; Name=7.
FT   TOPO_DOM    291    412       Cytoplasmic.
FT   REGION      168    177       Agonist binding.
FT   REGION      246    253       Agonist binding.
FT   REGION      264    274       Agonist binding.
FT   CARBOHYD    154    154       N-linked (GlcNAc...) (Potential).
FT   DISULFID     71    159
FT   DISULFID     74    146
FT   DISULFID     77    166
FT   DISULFID    259    262
FT   VARIANT      50     50       A -> V (in dbSNP:rs4530).
FT                                /FTId=VAR_011835.
FT   VARIANT     300    300       R -> H (in dbSNP:rs4990).
FT                                /FTId=VAR_011836.
FT   VARIANT     392    392       G -> R.
FT                                /FTId=VAR_003451.
FT   HELIX         7     21
FT   HELIX        25     33
FT   HELIX        35     37
FT   HELIX        41     54
FT   HELIX        59     66
FT   HELIX        78    106
FT   HELIX       109    111
FT   HELIX       125    134
FT   TURN        138    140
FT   HELIX       168    171
FT   HELIX       174    178
FT   TURN        179    181
FT   HELIX       182    185
FT   HELIX       187    193
FT   HELIX       197    204
FT   HELIX       210    214
FT   HELIX       219    238
FT   HELIX       242    258
FT   HELIX       267    291
FT   HELIX       293    305
SQ   SEQUENCE   412 AA;  44707 MW;  9438E9D64A6BE61B CRC64;
     MPIMGSSVYI TVELAIAVLA ILGNVLVCWA VWLNSNLQNV TNYFVVSLAA ADIAVGVLAI
     PFAITISTGF CAACHGCLFI ACFVLVLTQS SIFSLLAIAI DRYIAIRIPL RYNGLVTGTR
     AKGIIAICWV LSFAIGLTPM LGWNNCGQPK EGKNHSQGCG EGQVACLFED VVPMNYMVYF
     NFFACVLVPL LLMLGVYLRI FLAARRQLKQ MESQPLPGER ARSTLQKEVH AAKSLAIIVG
     LFALCWLPLH IINCFTFFCP DCSHAPLWLM YLAIVLSHTN SVVNPFIYAY RIREFRQTFR
     KIIRSHVLRQ QEPFKAAGTS ARVLAAHGSD GEQVSLRLNG HPPGVWANGS APHPERRPNG
     YALGLVSGGS AQESQGNTGL PDVELLSHEL KGVCPEPPGL DDPLAQDGAG VS
//
ID   AA2BR_HUMAN             Reviewed;         332 AA.
AC   P29275;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   18-APR-2012, entry version 119.
DE   RecName: Full=Adenosine receptor A2b;
GN   Name=ADORA2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=92392387; PubMed=1325798; DOI=10.1016/S0006-291X(05)81462-7;
RA   Pierce K.D., Furlong T.J., Selbie L.A., Shine J.;
RT   "Molecular cloning and expression of an adenosine A2b receptor from
RT   human brain.";
RL   Biochem. Biophys. Res. Commun. 187:86-93(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=96044451; PubMed=7558011; DOI=10.1006/geno.1995.1061;
RA   Jacobson M.A., Johnson R.G., Luneau C.J., Salvatore C.A.;
RT   "Cloning and chromosomal localization of the human A2b adenosine
RT   receptor gene (ADORA2B) and its pseudogene.";
RL   Genomics 27:374-376(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for adenosine. The activity of this receptor is
CC       mediated by G proteins which activate adenylyl cyclase.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97759; AAA51598.1; -; mRNA.
DR   EMBL; X68487; CAA48505.1; -; mRNA.
DR   EMBL; AY136748; AAN01274.1; -; mRNA.
DR   EMBL; BC025722; AAH25722.1; -; mRNA.
DR   IPI; IPI00020976; -.
DR   PIR; JC1229; JC1229.
DR   RefSeq; NP_000667.1; NM_000676.2.
DR   UniGene; Hs.167046; -.
DR   ProteinModelPortal; P29275; -.
DR   SMR; P29275; 8-310.
DR   IntAct; P29275; 2.
DR   STRING; P29275; -.
DR   DMDM; 112938; -.
DR   PRIDE; P29275; -.
DR   DNASU; 136; -.
DR   Ensembl; ENST00000304222; ENSP00000304501; ENSG00000170425.
DR   GeneID; 136; -.
DR   KEGG; hsa:136; -.
DR   UCSC; uc002gpd.1; human.
DR   CTD; 136; -.
DR   GeneCards; GC17P015788; -.
DR   H-InvDB; HIX0013564; -.
DR   HGNC; HGNC:264; ADORA2B.
DR   MIM; 600446; gene.
DR   neXtProt; NX_P29275; -.
DR   PharmGKB; PA24585; -.
DR   eggNOG; NOG287824; -.
DR   GeneTree; ENSGT00550000074524; -.
DR   HOGENOM; HBG445348; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P29275; -.
DR   KO; K04267; -.
DR   OMA; CTDFHSC; -.
DR   OrthoDB; EOG4FBHTB; -.
DR   PhylomeDB; P29275; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   DrugBank; DB04932; Defibrotide.
DR   DrugBank; DB00824; Enprofylline.
DR   DrugBank; DB00061; Pegademase bovine.
DR   DrugBank; DB00277; Theophylline.
DR   NextBio; 547; -.
DR   ArrayExpress; P29275; -.
DR   Bgee; P29275; -.
DR   CleanEx; HS_ADORA2B; -.
DR   Genevestigator; P29275; -.
DR   GermOnline; ENSG00000170425; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:ProtInc.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0007588; P:excretion; TAS:ProtInc.
DR   GO; GO:0007254; P:JNK cascade; TAS:ProtInc.
DR   InterPro; IPR000276; 7TM_GPCR_Rhodpsn.
DR   InterPro; IPR001435; Adeno_A2B_rcpt.
DR   InterPro; IPR001634; Adenosn_rcpt.
DR   InterPro; IPR017452; GPCR_Rhodpsn_supfam.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00554; ADENOSINA2BR.
DR   PRINTS; PR00424; ADENOSINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane;
KW   Palmitate; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    332       Adenosine receptor A2b.
FT                                /FTId=PRO_0000069003.
FT   TOPO_DOM      1      8       Extracellular (By similarity).
FT   TRANSMEM      9     33       Helical; Name=1; (By similarity).
FT   TOPO_DOM     34     43       Cytoplasmic (By similarity).
FT   TRANSMEM     44     67       Helical; Name=2; (By similarity).
FT   TOPO_DOM     68     78       Extracellular (By similarity).
FT   TRANSMEM     79    101       Helical; Name=3; (By similarity).
FT   TOPO_DOM    102    121       Cytoplasmic (By similarity).
FT   TRANSMEM    122    144       Helical; Name=4; (By similarity).
FT   TOPO_DOM    145    178       Extracellular (By similarity).
FT   TRANSMEM    179    203       Helical; Name=5; (By similarity).
FT   TOPO_DOM    204    235       Cytoplasmic (By similarity).
FT   TRANSMEM    236    259       Helical; Name=6; (By similarity).
FT   TOPO_DOM    260    267       Extracellular (By similarity).
FT   TRANSMEM    268    291       Helical; Name=7; (By similarity).
FT   TOPO_DOM    292    332       Cytoplasmic (By similarity).
FT   REGION      173    182       Agonist binding (By similarity).
FT   REGION      247    254       Agonist binding (By similarity).
FT   REGION      266    276       Agonist binding (By similarity).
FT   LIPID       311    311       S-palmitoyl cysteine (Potential).
FT   CARBOHYD    153    153       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    163    163       N-linked (GlcNAc...) (Potential).
FT   DISULFID     78    171       By similarity.
SQ   SEQUENCE   332 AA;  36333 MW;  38AD088E2439C7FA CRC64;
     MLLETQDALY VALELVIAAL SVAGNVLVCA AVGTANTLQT PTNYFLVSLA AADVAVGLFA
     IPFAITISLG FCTDFYGCLF LACFVLVLTQ SSIFSLLAVA VDRYLAICVP LRYKSLVTGT
     RARGVIAVLW VLAFGIGLTP FLGWNSKDSA TNNCTEPWDG TTNESCCLVK CLFENVVPMS
     YMVYFNFFGC VLPPLLIMLV IYIKIFLVAC RQLQRTELMD HSRTTLQREI HAAKSLAMIV
     GIFALCWLPV HAVNCVTLFQ PAQGKNKPKW AMNMAILLSH ANSVVNPIVY AYRNRDFRYT
     FHKIISRYLL CQADVKSGNG QAGVQPALGV GL
//
ID   AA3RB_HUMAN             Reviewed;         266 AA.
AC   Q6P2N6; Q5QNY7;
DT   21-MAR-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2012, sequence version 2.
DT   18-APR-2012, entry version 54.
DE   RecName: Full=Protein ADORA3, isoform 3;
GN   Name=ADORA3; ORFNames=UNQ1931/PRO4406;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-266 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for adenosine. The activity of this receptor is
CC       mediated by G proteins which inhibits adenylyl cyclase. Possible
CC       role in reproduction (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=Q6P2N6-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P33765-1; Sequence=External;
CC       Name=2;
CC         IsoId=P33765-2; Sequence=External;
CC   -!- SIMILARITY: Contains 1 Ig-like V-type (immunoglobulin-like)
CC       domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH41707.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC       Sequence=AAH64411.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC       Sequence=EAW56500.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL390195; CAI15626.1; -; Genomic_DNA.
DR   EMBL; AL391063; CAI15626.1; JOINED; Genomic_DNA.
DR   EMBL; AL391063; CAI22964.1; -; Genomic_DNA.
DR   EMBL; AL390195; CAI22964.1; JOINED; Genomic_DNA.
DR   EMBL; CH471122; EAW56500.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC041707; AAH41707.1; ALT_INIT; mRNA.
DR   EMBL; BC064411; AAH64411.1; ALT_INIT; mRNA.
DR   IPI; IPI00645655; -.
DR   RefSeq; NP_001075445.1; NM_001081976.1.
DR   UniGene; Hs.281342; -.
DR   ProteinModelPortal; Q6P2N6; -.
DR   STRING; Q6P2N6; -.
DR   PRIDE; Q6P2N6; -.
DR   DNASU; 140; -.
DR   Ensembl; ENST00000369717; ENSP00000358731; ENSG00000121933.
DR   GeneID; 140; -.
DR   KEGG; hsa:140; -.
DR   CTD; 140; -.
DR   HGNC; HGNC:268; ADORA3.
DR   MIM; 600445; gene.
DR   PharmGKB; PA24589; -.
DR   HOVERGEN; HBG058258; -.
DR   KO; K04268; -.
DR   NextBio; 553; -.
DR   ArrayExpress; Q6P2N6; -.
DR   Bgee; Q6P2N6; -.
DR   GO; GO:0004872; F:receptor activity; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   InterPro; IPR013783; Ig-like_fold.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    266       Protein ADORA3, isoform 3.
FT                                /FTId=PRO_0000416044.
FT   TRANSMEM     55     75       Helical; (Potential).
FT   TRANSMEM    213    233       Helical; (Potential).
FT   DOMAIN       88    174       Ig-like V-type.
FT   CARBOHYD    192    192       N-linked (GlcNAc...) (Potential).
SQ   SEQUENCE   266 AA;  30327 MW;  8D6506430DD5C208 CRC64;
     MEGSPAGPIE QKEARWESSW EEQPDWTLGC LSPESQFRIP GLPGCILSFQ LKVCFLPVMW
     LFILLSLALI SDAMVMDEKV KRSFVLDTAS AICNYNAHYK NHPKYWCRGY FRDYCNIIAF
     SPNSTNHVAL RDTGNQLIVT MSCLTKEDTG WYWCGIQRDF ARDDMDFTEL IVTDDKGTLA
     NDFWSGKDLS GNKTRSCKAP KVVRKADRSR TSILIICILI TGLGIISVIS HLTKRRRSQR
     NRRVGNTLKP FSRVLTPKEM APTEQM
